Citrus Sinensis ID: 004088
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 774 | 2.2.26 [Sep-21-2011] | |||||||
| Q86IX1 | 737 | Serine/threonine-protein | yes | no | 0.339 | 0.356 | 0.611 | 2e-99 | |
| O61125 | 461 | Serine/threonine-protein | no | no | 0.382 | 0.642 | 0.482 | 9e-84 | |
| Q9Y4K4 | 846 | Mitogen-activated protein | yes | no | 0.337 | 0.308 | 0.533 | 3e-82 | |
| Q8BPM2 | 847 | Mitogen-activated protein | yes | no | 0.337 | 0.308 | 0.533 | 4e-82 | |
| Q55FS2 | 1105 | Serine/threonine-protein | no | no | 0.373 | 0.261 | 0.489 | 3e-81 | |
| Q8IVH8 | 894 | Mitogen-activated protein | no | no | 0.337 | 0.291 | 0.533 | 1e-80 | |
| Q99JP0 | 894 | Mitogen-activated protein | no | no | 0.337 | 0.291 | 0.529 | 3e-80 | |
| Q924I2 | 873 | Mitogen-activated protein | no | no | 0.337 | 0.298 | 0.529 | 1e-79 | |
| Q55GC2 | 1142 | Serine/threonine-protein | no | no | 0.365 | 0.247 | 0.482 | 1e-79 | |
| A4K2M3 | 487 | Serine/threonine-protein | N/A | no | 0.374 | 0.595 | 0.488 | 4e-79 |
| >sp|Q86IX1|DST1_DICDI Serine/threonine-protein kinase dst1 OS=Dictyostelium discoideum GN=dst1 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 363 bits (933), Expect = 2e-99, Method: Compositional matrix adjust.
Identities = 162/265 (61%), Positives = 205/265 (77%), Gaps = 2/265 (0%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC 243
+DP T Y + LGKGS+G V+KA ++VAIK+ISL + +E +++R EI +L +C
Sbjct: 23 DDPQTIYHIQERLGKGSFGQVFKAVHFANGKVVAIKIISLDD-QEAIKDVRKEISILAEC 81
Query: 244 SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYL 303
++PN+V+Y GSY + LWIVMEYCGGGSV+DL+ V + + E +IA ICREALKGL YL
Sbjct: 82 NYPNIVQYFGSYFKDHQLWIVMEYCGGGSVSDLLQVIDT-ISEDEIALICREALKGLNYL 140
Query: 304 HSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESR 363
H K+HRDIKGGNILL D+GEVKL DFGV+AQL T SKRNTF+GTP+WMAPEVIQE++
Sbjct: 141 HEFKKIHRDIKGGNILLNDRGEVKLADFGVSAQLFNTFSKRNTFVGTPYWMAPEVIQENK 200
Query: 364 YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAK 423
YDGK DVW+LG++A+EMAEGLPP S VHPMRV+FMI E +P L DK WS F DF++K
Sbjct: 201 YDGKADVWSLGITAIEMAEGLPPNSNVHPMRVIFMIPREESPALTDKSIWSDKFQDFISK 260
Query: 424 CLTKEPRARPTAAEMLKHKFIERCK 448
CLTK+P RPTA E+L H+FI+ K
Sbjct: 261 CLTKDPAERPTAKELLNHEFIQTKK 285
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O61125|STK4_DICDI Serine/threonine-protein kinase 4 homolog A OS=Dictyostelium discoideum GN=krsA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 311 bits (798), Expect = 9e-84, Method: Compositional matrix adjust.
Identities = 150/311 (48%), Positives = 213/311 (68%), Gaps = 15/311 (4%)
Query: 172 VSSSSIP-ESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY 230
+S+ ++P E+++R+DP + ++ +LG+GSYG+VYKA ++ T +VAIK +S+ +
Sbjct: 1 MSTLNVPKETMSRKDPEKFFTIVEKLGEGSYGSVYKAINISTGIVVAIKKVSV---DNDL 57
Query: 231 EEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIA 290
E++ EI ++QC P +V Y S++ E +WIVME+CG GSV D M +T++ L E QIA
Sbjct: 58 EDMEKEISFMKQCKSPYIVTYYASFRKENEVWIVMEHCGAGSVCDAMKITDKTLSEDQIA 117
Query: 291 YICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350
+ R+ L+GLAYLHS+ K+HRDIK GNIL+ +GE KL DFGV+ QL+ TM+KR T IGT
Sbjct: 118 VVSRDVLQGLAYLHSVRKIHRDIKAGNILMNHKGESKLADFGVSGQLSDTMAKRQTVIGT 177
Query: 351 PHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI--SIEPAPMLE 408
P WMAPEVIQE YD K D+W+ G++ +EMAE PP VHPMRV+FMI P P L
Sbjct: 178 PFWMAPEVIQEIGYDYKADIWSYGITCIEMAESKPPLFNVHPMRVIFMIPNPSRPPPKLT 237
Query: 409 DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKI--------EK 460
+ EKWS F+DF+AKCLT++P RP+A E+LKH FI + K + ++P I EK
Sbjct: 238 EPEKWSPEFNDFLAKCLTRKPELRPSAEELLKHPFITKAK-SHSLLVPLIDEQDIIINEK 296
Query: 461 ARQIRASMAQQ 471
R++ + Q+
Sbjct: 297 GREVALGIEQR 307
|
Regulates both cAMP signaling during early development and the stress response. Functions as an activator of adenylylcyclase. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Y4K4|M4K5_HUMAN Mitogen-activated protein kinase kinase kinase kinase 5 OS=Homo sapiens GN=MAP4K5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 306 bits (785), Expect = 3e-82, Method: Compositional matrix adjust.
Identities = 144/270 (53%), Positives = 192/270 (71%), Gaps = 9/270 (3%)
Query: 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEML 240
+ R +P YEL+ +G G+YG VYKAR++ T EL A+K+I L G++ + I+ EI M+
Sbjct: 11 ILRRNPQQDYELVQRVGSGTYGDVYKARNVHTGELAAVKIIKLEPGDD-FSLIQQEIFMV 69
Query: 241 QQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGL 300
++C H N+V Y GSY E LWI MEYCGGGS+ D+ +VT PL E QIAY+CRE L+GL
Sbjct: 70 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGL 128
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ 360
AYLH+ K+HRDIKG NILLTD G+VKL DFGVAA++T T++KR +FIGTP+WMAPEV
Sbjct: 129 AYLHTKGKMHRDIKGANILLTDHGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAA 188
Query: 361 ESR---YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMIS---IEPAPMLEDKEKWS 414
+ Y+ D+WA+G++A+E+ E PP +HPMR LF++S +P P L+DK KWS
Sbjct: 189 VEKNGGYNQLCDIWAVGITAIELGELQPPMFDLHPMRALFLMSKSNFQP-PKLKDKTKWS 247
Query: 415 LVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
FH+FV LTK P+ RPTA +L H F+
Sbjct: 248 STFHNFVKIALTKNPKKRPTAERLLTHTFV 277
|
May play a role in the response to environmental stress. Appears to act upstream of the JUN N-terminal pathway. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8BPM2|M4K5_MOUSE Mitogen-activated protein kinase kinase kinase kinase 5 OS=Mus musculus GN=Map4k5 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 306 bits (784), Expect = 4e-82, Method: Compositional matrix adjust.
Identities = 144/270 (53%), Positives = 192/270 (71%), Gaps = 9/270 (3%)
Query: 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEML 240
+ R +P YEL+ +G G+YG VYKAR++ T EL A+K+I L G++ + I+ EI M+
Sbjct: 11 ILRRNPQHDYELVQRVGSGTYGDVYKARNVHTGELAAVKIIKLEPGDD-FSLIQQEIFMV 69
Query: 241 QQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGL 300
++C H N+V Y GSY E LWI MEYCGGGS+ D+ +VT PL E QIAY+CRE L+GL
Sbjct: 70 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG-PLSEMQIAYVCRETLQGL 128
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ 360
AYLH+ K+HRDIKG NILLTD G+VKL DFGVAA++T T++KR +FIGTP+WMAPEV
Sbjct: 129 AYLHTKGKMHRDIKGANILLTDHGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAA 188
Query: 361 ESR---YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMIS---IEPAPMLEDKEKWS 414
+ Y+ D+WA+G++A+E+ E PP +HPMR LF++S +P P L+DK KWS
Sbjct: 189 VEKNGGYNQLCDIWAVGITAIELGELQPPMFDLHPMRALFLMSKSNFQP-PKLKDKTKWS 247
Query: 415 LVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
FH+FV LTK P+ RPTA +L H F+
Sbjct: 248 STFHNFVKIALTKNPKKRPTAERLLTHTFV 277
|
May play a role in the response to environmental stress. Appears to act upstream of the JUN N-terminal pathway. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55FS2|STK4L_DICDI Serine/threonine-protein kinase 4 homolog B OS=Dictyostelium discoideum GN=krsB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 303 bits (777), Expect = 3e-81, Method: Compositional matrix adjust.
Identities = 144/294 (48%), Positives = 200/294 (68%), Gaps = 5/294 (1%)
Query: 171 KVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY 230
++S +PE + +DP+ +++L+ LG+GS+G+VYKA KT +VA+K++ ++E +
Sbjct: 6 QLSDFKLPEGI--KDPSLEFDLIECLGRGSFGSVYKATYKKTGNIVAVKLVPINED---F 60
Query: 231 EEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIA 290
+EI EI +++QC VV+Y G+Y +E WI+MEYC GSV+D+MN+T L E QIA
Sbjct: 61 QEILKEINIMKQCKSKYVVQYYGNYFKDETCWIIMEYCAFGSVSDMMNITNRVLNEEQIA 120
Query: 291 YICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350
+C LKGL YLH K+HRDIK GNIL++++GE KL DFGV+ QL+ KRNT IGT
Sbjct: 121 LVCYSTLKGLYYLHRNSKIHRDIKPGNILVSEEGECKLADFGVSGQLSERTRKRNTVIGT 180
Query: 351 PHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDK 410
P ++APEVIQE YD K D+WALG+SA+EMAE PP +HPMRVLFMI +P L++
Sbjct: 181 PFFLAPEVIQEVGYDNKADIWALGISAIEMAEFHPPYHDLHPMRVLFMIPTSTSPTLKEP 240
Query: 411 EKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQI 464
KWS F DF+A CL KE RP+A ++LKH F E+ G+ M E A+ +
Sbjct: 241 HKWSPEFSDFIALCLAKEQSQRPSAKDLLKHSFFEKKLKGSYVMKSLSETAQMV 294
|
Probable serine/threonine-protein kinase. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8IVH8|M4K3_HUMAN Mitogen-activated protein kinase kinase kinase kinase 3 OS=Homo sapiens GN=MAP4K3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 301 bits (772), Expect = 1e-80, Method: Compositional matrix adjust.
Identities = 144/270 (53%), Positives = 192/270 (71%), Gaps = 9/270 (3%)
Query: 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEML 240
++R +P +EL+ +G G+YG VYKAR++ T EL AIKVI L GE+ + ++ EI M+
Sbjct: 7 LSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED-FAVVQQEIIMM 65
Query: 241 QQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGL 300
+ C HPN+V Y GSY + LWI ME+CGGGS+ D+ +VT PL E QIAY+ RE L+GL
Sbjct: 66 KDCKHPNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSELQIAYVSRETLQGL 124
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ 360
YLHS K+HRDIKG NILLTD G VKL DFGV+AQ+T T++KR +FIGTP+WMAPEV
Sbjct: 125 YYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAA 184
Query: 361 ESR---YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMIS---IEPAPMLEDKEKWS 414
R Y+ D+WA+G++A+E+AE PP +HPMR LF+++ +P P L+DK KWS
Sbjct: 185 VERKGGYNQLCDLWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP-PKLKDKMKWS 243
Query: 415 LVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
FH FV LTK P+ RPTA ++L+H F+
Sbjct: 244 NSFHHFVKMALTKNPKKRPTAEKLLQHPFV 273
|
May play a role in the response to environmental stress. Appears to act upstream of the JUN N-terminal pathway. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q99JP0|M4K3_MOUSE Mitogen-activated protein kinase kinase kinase kinase 3 OS=Mus musculus GN=Map4k3 PE=1 SV=4 | Back alignment and function description |
|---|
Score = 300 bits (768), Expect = 3e-80, Method: Compositional matrix adjust.
Identities = 143/270 (52%), Positives = 191/270 (70%), Gaps = 9/270 (3%)
Query: 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEML 240
++R +P +EL+ +G G+YG VYKAR++ T EL AIKVI L GE+ + ++ EI M+
Sbjct: 7 LSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED-FAVVQQEIIMM 65
Query: 241 QQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGL 300
+ C HPN+V Y GSY + LWI ME+CGGGS+ D+ +VT PL E QIAY+ RE L+GL
Sbjct: 66 KDCKHPNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSELQIAYVSRETLQGL 124
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ 360
YLHS K+HRDIKG NILLTD G VKL DFGV+AQ+T T++KR +FIGTP+WMAPEV
Sbjct: 125 YYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAA 184
Query: 361 ESR---YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMIS---IEPAPMLEDKEKWS 414
R Y+ D+WA+G++A+E+AE PP +HPMR LF+++ +P P L+DK KWS
Sbjct: 185 VERKGGYNQLCDLWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP-PKLKDKLKWS 243
Query: 415 LVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
FH FV LTK P+ RP A ++L+H F+
Sbjct: 244 NSFHHFVKMALTKNPKKRPNAEKLLQHPFV 273
|
May play a role in the response to environmental stress. Appears to act upstream of the JUN N-terminal pathway. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q924I2|M4K3_RAT Mitogen-activated protein kinase kinase kinase kinase 3 OS=Rattus norvegicus GN=Map4k3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 298 bits (763), Expect = 1e-79, Method: Compositional matrix adjust.
Identities = 143/270 (52%), Positives = 191/270 (70%), Gaps = 9/270 (3%)
Query: 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEML 240
++R +P +EL+ +G G+YG VYKAR++ T EL AIKVI L GE+ + ++ EI M+
Sbjct: 7 LSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED-FAVVQQEIIMM 65
Query: 241 QQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGL 300
+ C H N+V Y GSY + LWI ME+CGGGS+ D+ +VT PL E QIAY+ RE L+GL
Sbjct: 66 KDCKHANIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSELQIAYVSRETLQGL 124
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ 360
YLHS K+HRDIKG NILLTD G VKL DFGV+AQ+T T++KR +FIGTP+WMAPEV
Sbjct: 125 YYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAA 184
Query: 361 ESR---YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMIS---IEPAPMLEDKEKWS 414
R Y+ D+WA+G++A+E+AE PP +HPMR LF+++ +P P L+DK KWS
Sbjct: 185 VERKGGYNQLCDLWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP-PKLKDKLKWS 243
Query: 415 LVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
FH FV LTK P+ RPTA ++L+H F+
Sbjct: 244 NSFHHFVKMALTKNPKKRPTAEKLLQHPFV 273
|
May play a role in the response to environmental stress. Appears to act upstream of the JUN N-terminal pathway. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GC2|DST2_DICDI Serine/threonine-protein kinase dst2 OS=Dictyostelium discoideum GN=dst2 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 298 bits (762), Expect = 1e-79, Method: Compositional matrix adjust.
Identities = 141/292 (48%), Positives = 199/292 (68%), Gaps = 9/292 (3%)
Query: 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEML 240
V +EDP +EL+ E+ +GS+G VYK + L T ++A+K+I+L E +E +E++ EI++L
Sbjct: 11 VGKEDPVELFELIEEIAEGSFGTVYKGKHLPTGNIMAVKIIALDE-DETFEDLVVEIDIL 69
Query: 241 QQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGL 300
+C+H N+V+Y GS+ + L+I ME CGGGS+ ++ PL E QIAY+CRE LKGL
Sbjct: 70 NRCNHNNIVKYYGSWVKGDELFIAMECCGGGSITEIYQELNIPLNESQIAYVCRETLKGL 129
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ 360
YLH +HRD+KG NILLT+ G+VKL DFGV+ L ++ SKRNTFIGTP+WMAPEVI
Sbjct: 130 EYLHHTNVIHRDLKGANILLTESGDVKLADFGVSGLLDKS-SKRNTFIGTPYWMAPEVI- 187
Query: 361 ESR-----YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSL 415
E+R YD K D+W+LG++ +E+AE PP S +HPM+VLF I P L+++E +S
Sbjct: 188 ENRSNPVPYDTKADIWSLGITLIELAEAEPPLSEIHPMKVLFQIPYRDPPKLKNQENYSK 247
Query: 416 VFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRAS 467
F +F+ CL K+P R TA E+LKH F+ K A + I K R+ RA+
Sbjct: 248 DFINFIQSCLQKDPNQRKTATELLKHPFVTNTKEKA-VLTDLITKYRKFRAA 298
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A4K2M3|STK4_PAPAN Serine/threonine-protein kinase 4 OS=Papio anubis GN=STK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 296 bits (759), Expect = 4e-79, Method: Compositional matrix adjust.
Identities = 144/295 (48%), Positives = 197/295 (66%), Gaps = 5/295 (1%)
Query: 179 ESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIE 238
+S+T++ P +++L +LG+GSYG+VYKA +T ++VAIK + + E +EI EI
Sbjct: 20 DSLTKQ-PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV---ESDLQEIIKEIS 75
Query: 239 MLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALK 298
++QQC P+VV+Y GSY LWIVMEYCG GSV+D++ + + L E +IA I + LK
Sbjct: 76 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK 135
Query: 299 GLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEV 358
GL YLH + K+HRDIK GNILL +G+ KL DFGVA QLT TM+KRNT IGTP WMAPEV
Sbjct: 136 GLEYLHFMRKIHRDIKAGNILLNTEGQAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEV 195
Query: 359 IQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418
IQE Y+ D+W+LG++A+EMAEG PP + +HPMR +FMI P P E WS F
Sbjct: 196 IQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFT 255
Query: 419 DFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRASMAQQAQ 473
DFV +CL K P R TA ++L+H F++ K G + + I +A ++ + Q
Sbjct: 256 DFVKQCLVKSPEQRATATQLLQHPFVKSAK-GVSILRDLINEAMDVKLKRQESQQ 309
|
Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation. Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. STK3/MST2 and STK4/MST1 are required to repress proliferation of mature hepatocytes, to prevent activation of facultative adult liver stem cells (oval cells), and to inhibit tumor formation. Phosphorylates 'Ser-14' of histone H2B (H2BS14ph) during apoptosis. Phosphorylates FOXO3 upon oxidative stress, which results in its nuclear translocation and cell death initiation. Phosphorylates MOBKL1A, MOBKL1B and RASSF2. Phosphorylates TNNI3 (cardiac Tn-I) and alters its binding affinity to TNNC1 (cardiac Tn-C) and TNNT2 (cardiac Tn-T). Phosphorylates FOXO1 on 'Ser-212' and regulates its activation and stimulates transcription of PMAIP1 in a FOXO1-dependent manner. Phosphorylates SIRT1 and inhibits SIRT1-mediated p53/TP53 deacetylation, thereby promoting p53/TP53 dependent transcription and apoptosis upon DNA damage. Acts as an inhibitor of PKB/AKT1. Phosphorylates AR on 'Ser-650' and suppresses its activity by intersecting with PKB/AKT1 signaling and antagonizing formation of AR-chromatin complexes. Papio anubis (taxid: 9555) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 774 | ||||||
| 225423442 | 831 | PREDICTED: uncharacterized protein LOC10 | 0.975 | 0.908 | 0.662 | 0.0 | |
| 297738102 | 809 | unnamed protein product [Vitis vinifera] | 0.961 | 0.919 | 0.666 | 0.0 | |
| 255541998 | 810 | serine/threonine protein kinase, putativ | 0.970 | 0.927 | 0.659 | 0.0 | |
| 18409220 | 836 | protein kinase domain-containing protein | 0.983 | 0.910 | 0.627 | 0.0 | |
| 224112100 | 804 | predicted protein [Populus trichocarpa] | 0.954 | 0.919 | 0.654 | 0.0 | |
| 449449072 | 829 | PREDICTED: uncharacterized protein LOC10 | 0.949 | 0.886 | 0.626 | 0.0 | |
| 357487685 | 825 | Serine/threonine protein kinase [Medicag | 0.970 | 0.910 | 0.614 | 0.0 | |
| 356498008 | 795 | PREDICTED: uncharacterized protein LOC10 | 0.944 | 0.919 | 0.624 | 0.0 | |
| 225423444 | 804 | PREDICTED: uncharacterized protein LOC10 | 0.953 | 0.917 | 0.643 | 0.0 | |
| 6730645 | 1120 | F4N2.17 [Arabidopsis thaliana] | 0.970 | 0.670 | 0.615 | 0.0 |
| >gi|225423442|ref|XP_002264872.1| PREDICTED: uncharacterized protein LOC100267868 isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 991 bits (2563), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 558/842 (66%), Positives = 627/842 (74%), Gaps = 87/842 (10%)
Query: 4 TPTSRRTPKPPSRSEIYSTVVIHDDDDDDDDDEETRYDSDSRTNYSQNDAVM-------- 55
TP+ R P P +S+IYST V+HDD+DDD+ + +Y S RT + + +
Sbjct: 6 TPSRRTRPAVP-KSDIYSTFVVHDDEDDDETAFQEKY-SRRRTKSQEKEDIYATMVYKDD 63
Query: 56 -----EDDDSLPPLLKRLPKDFGAAPP--EDDDEEDGDFGTMIIKTRTKTKAKNSRTIVN 108
+DD SLPPLLKRLPKDF AA ++D GDFGTMI+KT ++ + S +I++
Sbjct: 64 PNDDDDDDSSLPPLLKRLPKDFDAAHDYYDEDSTGTGDFGTMIVKT---SRDRLSPSILS 120
Query: 109 -----------KPY---SEFKKTDGDDEFGTFVVRSKDGERRSG---------GYDDSTM 145
PY S K+TD +D + TFVVRS G R SG STM
Sbjct: 121 PSILSPAKPRGSPYLERSTGKRTDDEDNYSTFVVRSTLGTRESGTVVRRGSGGASASSTM 180
Query: 146 GRAVASMR----------RFGSSSSLHGEDVRQQTKVSSSSIPESVTREDPTTKYELLNE 195
RAVASM+ R GS SS E Q +K+S+SSIPES+TREDP+TKYELLNE
Sbjct: 181 SRAVASMQASGELGFRKHRKGSGSSQGDEARFQASKISTSSIPESMTREDPSTKYELLNE 240
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSY 255
LGKGSYGAVYKARD++TSELVAIKVISL EGEEGYEEIRGEIEMLQQCSHPNVVRYLGSY
Sbjct: 241 LGKGSYGAVYKARDIRTSELVAIKVISLCEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSY 300
Query: 256 QGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKG 315
QGEEYLWIVMEYCGGGSVADLMN TEEPL+EYQIAYICREALKGL+YLHSIFKVHRDIKG
Sbjct: 301 QGEEYLWIVMEYCGGGSVADLMNTTEEPLDEYQIAYICREALKGLSYLHSIFKVHRDIKG 360
Query: 316 GNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGV 375
GNILLT+QGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGV
Sbjct: 361 GNILLTEQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGV 420
Query: 376 SAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTA 435
SA+EMAEGLPPRS VHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPR RPTA
Sbjct: 421 SAIEMAEGLPPRSAVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRLRPTA 480
Query: 436 AEMLKHKFIERCKCGATAMLPKIEKARQIRASMAQQAQ------NILSDEPEVNATMGLK 489
+EMLKHKFIE+CKCGA+AMLPKIEKARQIRASMA QAQ +I D P G K
Sbjct: 481 SEMLKHKFIEKCKCGASAMLPKIEKARQIRASMALQAQSLARITSISGDAP----PEGPK 536
Query: 490 LNEDYGDTVPSKP---QVQVTNEVLATSTLKKQHTLEDME---EGDFGTVVVH---ETDK 540
LNEDYGDTVPS+P +QVTNEV STL KQ + +E EG+FGTV+VH E DK
Sbjct: 537 LNEDYGDTVPSRPFNNGLQVTNEVPTASTLVKQKISDGVELEGEGEFGTVIVHGGFEMDK 596
Query: 541 TISKTQCSNIKESSTLPGHTE---ISGTGGKLADVRVDGAAGVALNNKLVGESH----HL 593
T ++T S+ KE S + E + G G K + V+ VA NN VGESH
Sbjct: 597 TANQTPVSSTKEPSAAHENVESHPVGGPGIKSTNNWVEDTVDVAANNDQVGESHPGEQTT 656
Query: 594 THTIQPSSAENLKT-TISQGQIGSGRDTGSGTLKSETVSKKAFALQDKCFWFLQLWSIYA 652
+ ++ S +NL+T +ISQ Q G G S LK+ETVS+ AFA QDK LWSIYA
Sbjct: 657 SKSVFGSPEQNLRTSSISQVQAGGG-GVSSSQLKNETVSRTAFASQDK------LWSIYA 709
Query: 653 AGNTVPIPILRATDISPIALLSDNVLGAMQHDNKGTVAVEALQELFTGDGQSKKGRRGQN 712
AGNTVPIP LRATDISPIALLS NVLG Q ++ G VAVEA+QELFTGD Q KKGRRGQN
Sbjct: 710 AGNTVPIPFLRATDISPIALLSGNVLGGRQRESSGAVAVEAVQELFTGDSQLKKGRRGQN 769
Query: 713 EIPLPPSVYQRLTSSSTLLNLAQALAYHRMCYDEMPLQELQVTQEEQTIQNLCDTLRTIL 772
EIPLPPS+YQRLTSSSTLLNLAQALAYH+ Y+EMPLQ+LQ QE+QTIQNLCDTLRTIL
Sbjct: 770 EIPLPPSMYQRLTSSSTLLNLAQALAYHKTSYEEMPLQDLQAVQEQQTIQNLCDTLRTIL 829
Query: 773 RL 774
RL
Sbjct: 830 RL 831
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297738102|emb|CBI27303.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 986 bits (2549), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 554/831 (66%), Positives = 617/831 (74%), Gaps = 87/831 (10%)
Query: 4 TPTSRRTPKPPSRSEIYSTVVIHDDDDDDDDDEETRYDSDSRTNYSQNDAVM-------- 55
TP+ R P P +S+IYST V+HDD+DDD+ + +Y S RT + + +
Sbjct: 6 TPSRRTRPAVP-KSDIYSTFVVHDDEDDDETAFQEKY-SRRRTKSQEKEDIYATMVYKDD 63
Query: 56 -----EDDDSLPPLLKRLPKDFGAAPP--EDDDEEDGDFGTMIIKTRTKTKAKNSRTIVN 108
+DD SLPPLLKRLPKDF AA ++D GDFGTMI +
Sbjct: 64 PNDDDDDDSSLPPLLKRLPKDFDAAHDYYDEDSTGTGDFGTMIPR--------------G 109
Query: 109 KPY---SEFKKTDGDDEFGTFVVRSKDGERRSG---------GYDDSTMGRAVASMR--- 153
PY S K+TD +D + TFVVRS G R SG STM RAVASM+
Sbjct: 110 SPYLERSTGKRTDDEDNYSTFVVRSTLGTRESGTVVRRGSGGASASSTMSRAVASMQASG 169
Query: 154 -------RFGSSSSLHGEDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYK 206
R GS SS E Q +K+S+SSIPES+TREDP+TKYELLNELGKGSYGAVYK
Sbjct: 170 ELGFRKHRKGSGSSQGDEARFQASKISTSSIPESMTREDPSTKYELLNELGKGSYGAVYK 229
Query: 207 ARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266
ARD++TSELVAIKVISL EGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME
Sbjct: 230 ARDIRTSELVAIKVISLCEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 289
Query: 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEV 326
YCGGGSVADLMN TEEPL+EYQIAYICREALKGL+YLHSIFKVHRDIKGGNILLT+QGEV
Sbjct: 290 YCGGGSVADLMNTTEEPLDEYQIAYICREALKGLSYLHSIFKVHRDIKGGNILLTEQGEV 349
Query: 327 KLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPP 386
KLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSA+EMAEGLPP
Sbjct: 350 KLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAIEMAEGLPP 409
Query: 387 RSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446
RS VHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPR RPTA+EMLKHKFIE+
Sbjct: 410 RSAVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRLRPTASEMLKHKFIEK 469
Query: 447 CKCGATAMLPKIEKARQIRASMAQQAQ------NILSDEPEVNATMGLKLNEDYGDTVPS 500
CKCGA+AMLPKIEKARQIRASMA QAQ +I D P G KLNEDYGDTVPS
Sbjct: 470 CKCGASAMLPKIEKARQIRASMALQAQSLARITSISGDAP----PEGPKLNEDYGDTVPS 525
Query: 501 KP---QVQVTNEVLATSTLKKQHTLEDME---EGDFGTVVVH---ETDKTISKTQCSNIK 551
+P +QVTNEV STL KQ + +E EG+FGTV+VH E DKT ++T S+ K
Sbjct: 526 RPFNNGLQVTNEVPTASTLVKQKISDGVELEGEGEFGTVIVHGGFEMDKTANQTPVSSTK 585
Query: 552 ESSTLPGHTE---ISGTGGKLADVRVDGAAGVALNNKLVGESH----HLTHTIQPSSAEN 604
E S + E + G G K + V+ VA NN VGESH + ++ S +N
Sbjct: 586 EPSAAHENVESHPVGGPGIKSTNNWVEDTVDVAANNDQVGESHPGEQTTSKSVFGSPEQN 645
Query: 605 LKT-TISQGQIGSGRDTGSGTLKSETVSKKAFALQDKCFWFLQLWSIYAAGNTVPIPILR 663
L+T +ISQ Q G G S LK+ETVS+ AFA QDK LWSIYAAGNTVPIP LR
Sbjct: 646 LRTSSISQVQAGGG-GVSSSQLKNETVSRTAFASQDK------LWSIYAAGNTVPIPFLR 698
Query: 664 ATDISPIALLSDNVLGAMQHDNKGTVAVEALQELFTGDGQSKKGRRGQNEIPLPPSVYQR 723
ATDISPIALLS NVLG Q ++ G VAVEA+QELFTGD Q KKGRRGQNEIPLPPS+YQR
Sbjct: 699 ATDISPIALLSGNVLGGRQRESSGAVAVEAVQELFTGDSQLKKGRRGQNEIPLPPSMYQR 758
Query: 724 LTSSSTLLNLAQALAYHRMCYDEMPLQELQVTQEEQTIQNLCDTLRTILRL 774
LTSSSTLLNLAQALAYH+ Y+EMPLQ+LQ QE+QTIQNLCDTLRTILRL
Sbjct: 759 LTSSSTLLNLAQALAYHKTSYEEMPLQDLQAVQEQQTIQNLCDTLRTILRL 809
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255541998|ref|XP_002512063.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223549243|gb|EEF50732.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 970 bits (2508), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 549/833 (65%), Positives = 614/833 (73%), Gaps = 82/833 (9%)
Query: 1 MDHTPTSRRT---PKPPSRSEIYSTVVIHDDDDD----------DDDDEETRYDSDSRTN 47
MD+ P+ RRT K P +S+IYST VIHD + DDD Y +
Sbjct: 1 MDYPPSGRRTIRARKTPKKSDIYSTFVIHDSSPEPESDTKPQQLDDDSNSDMYATMLYKG 60
Query: 48 YSQNDAVMEDDD------SLPPLLKRLPKDFGAAPPEDDDEEDGDFGTMIIKT---RTKT 98
S ND + +D SLPPLLKRLPKDFG DDD +DGDFGTMI+K+ R T
Sbjct: 61 GSGNDNKKDQNDDEDDEDSLPPLLKRLPKDFGGGDSLDDDVDDGDFGTMIVKSGWGRPPT 120
Query: 99 KAKNSRTIVNKPYSEFKKTDGDDE------------FGTFVVRSKDGERRSGGYDDSTMG 146
+ +S V KP + G + FGTFVV++ R G STMG
Sbjct: 121 QTASS--FVRKPNYNYNYNSGASDNGEDSEGEEGEGFGTFVVKTS---VRGRGDSGSTMG 175
Query: 147 RAVASMRRFG------------SSSSLHGEDVRQQTKVSSSSIPESVTREDPTTKYELLN 194
RAVASM+ G S S G ++ +K+SSSSIPES+TREDPTTKYELLN
Sbjct: 176 RAVASMQAVGELGFGKQRNSGSSPPSFQGGEL--HSKMSSSSIPESLTREDPTTKYELLN 233
Query: 195 ELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGS 254
ELGKGSYGAVYKARDL+TSELVAIKVISL+EGEEGYEEIRGEIEMLQQCSHPNVVRYLGS
Sbjct: 234 ELGKGSYGAVYKARDLRTSELVAIKVISLTEGEEGYEEIRGEIEMLQQCSHPNVVRYLGS 293
Query: 255 YQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIK 314
YQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIK
Sbjct: 294 YQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIK 353
Query: 315 GGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALG 374
GGNILLT+QGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALG
Sbjct: 354 GGNILLTEQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALG 413
Query: 375 VSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPT 434
VSA+EMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPR+RPT
Sbjct: 414 VSAIEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRSRPT 473
Query: 435 AAEMLKHKFIERCKCGATAMLPKIEKARQIRASMAQQAQNILSDEPEVNATMGLKLNEDY 494
A+EMLKHKFIE+CK GA+AML KI+KARQIRASMA +AQN++ E E KLNE Y
Sbjct: 474 ASEMLKHKFIEKCKYGASAMLQKIDKARQIRASMALEAQNVVPVESETPEAP--KLNEYY 531
Query: 495 GDTVPSKPQVQVTNEVLATSTLKKQHTLEDMEEGDFGTVVVH---ETDKTISKTQCSNIK 551
GDTVPSK + Q +E+ K + ++ E DFGTVV+H ETDK + + +
Sbjct: 532 GDTVPSK-RPQTADEI-----PKSEVVMDLAGEVDFGTVVIHGGEETDKEAVQNALDSAR 585
Query: 552 ESSTLPGHTE---ISGTGGKLADVRVDGAAGVALNNKLVGESHHLTHTIQP------SSA 602
+ S + H E ++ TGGK D RVD A+ VA N L+GESH L I+ S
Sbjct: 586 DPSQVLRHFESPSVTATGGKSIDSRVDNASVVAANKILIGESHPLLQNIRTLPPVPGSPL 645
Query: 603 ENLKT-TISQGQIGSGRDTGSGTLKSETVSKKAFALQDKCFWFLQLWSIYAAGNTVPIPI 661
+NLK + Q +G G+ TLK+ETVSKKAFALQDK LWSIYAAGNTVPIP
Sbjct: 646 QNLKKGSTLQSPVGRSGVMGTSTLKNETVSKKAFALQDK------LWSIYAAGNTVPIPF 699
Query: 662 LRATDISPIALLSDNVLGAMQHDNKGTVAVEALQELFTGDGQSKKGRRGQNEIPLPPSVY 721
L+ATDISPIALLSDNVLG MQ DN + A E LQELF+GDG S+KGRR QNE+PLP SVY
Sbjct: 700 LKATDISPIALLSDNVLGGMQRDN--SEAGEVLQELFSGDGPSRKGRRLQNEMPLPASVY 757
Query: 722 QRLTSSSTLLNLAQALAYHRMCYDEMPLQELQVTQEEQTIQNLCDTLRTILRL 774
+RLTSSSTLLNLAQALAYHR CY+EMPLQELQ TQE+QTIQNL DTLRTILRL
Sbjct: 758 KRLTSSSTLLNLAQALAYHRTCYEEMPLQELQATQEQQTIQNLSDTLRTILRL 810
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18409220|ref|NP_564955.1| protein kinase domain-containing protein [Arabidopsis thaliana] gi|12325090|gb|AAG52499.1|AC018364_17 putative serine/threonine kinase; 70789-76610 [Arabidopsis thaliana] gi|2352084|gb|AAB68776.1| serine/threonine kinase [Arabidopsis thaliana] gi|332196775|gb|AEE34896.1| protein kinase domain-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 957 bits (2474), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 533/849 (62%), Positives = 625/849 (73%), Gaps = 88/849 (10%)
Query: 1 MDH-TPTSRRTPKPPSRSEIYSTVVIHDDDDDDD----DDEETRYDSDSRTNY------- 48
MDH +P SRR+ KP + +IYST V+H D D D D + + + D +
Sbjct: 1 MDHNSPKSRRSRKPEPKPDIYSTFVVHSDSDSDQGRDRDKRKAKPEEDENVDLYATMVYK 60
Query: 49 ----SQNDAVMEDDDSLPPLLKRLPKDFGAAPP----EDDDEEDGDFGTMIIKTRTKTKA 100
+ + +DD LPPLLKRLPKDFG +DD +E GDFGTMI+KT + +
Sbjct: 61 GDSDGEGEEDDDDDSMLPPLLKRLPKDFGGGASLDYDDDDGDESGDFGTMIVKTDRSSHS 120
Query: 101 KNSRTIVNKP---------------------YSEFKKTDGDDEFGTFVVRSKDGERRSGG 139
K + +KP E D D ++GTFVV+SKD + +
Sbjct: 121 KKNSPYSSKPRMGVSPRRRARGGDEESSDEEDEEEDDDDDDGDYGTFVVKSKDKKGKKKD 180
Query: 140 --YDDSTMGRAVASMRR--FG----------SSSSLHGEDVR----QQTKVSSSSIPESV 181
D +TMGRAVASM++ FG SSS LHGED R Q +K+S++S+P+S+
Sbjct: 181 KEIDMTTMGRAVASMQKSNFGGKTRKLDPSSSSSKLHGEDNRKMQQQNSKMSTTSLPDSI 240
Query: 182 TREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQ 241
TREDPTTKYE LNELGKGSYG+VYKARDLKTSE+VA+KVISL+EGEEGYEEIRGEIEMLQ
Sbjct: 241 TREDPTTKYEFLNELGKGSYGSVYKARDLKTSEIVAVKVISLTEGEEGYEEIRGEIEMLQ 300
Query: 242 QCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLA 301
QC+HPNVVRYLGSYQGE+YLWIVMEYCGGGSVADLMNVTEE LEEYQIAYICREALKGLA
Sbjct: 301 QCNHPNVVRYLGSYQGEDYLWIVMEYCGGGSVADLMNVTEEALEEYQIAYICREALKGLA 360
Query: 302 YLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQE 361
YLHSI+KVHRDIKGGNILLT+QGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQE
Sbjct: 361 YLHSIYKVHRDIKGGNILLTEQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQE 420
Query: 362 SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421
+RYDGKVDVWALGVSA+EMAEGLPPRS+VHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV
Sbjct: 421 NRYDGKVDVWALGVSAIEMAEGLPPRSSVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 480
Query: 422 AKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRASMAQQAQNILSDEPE 481
AKCLTKEPR RPTAAEMLKHKF+ERCK GA+AM PKIEK+RQIRA+MA QAQ++++ E
Sbjct: 481 AKCLTKEPRLRPTAAEMLKHKFVERCKTGASAMSPKIEKSRQIRATMALQAQSVVAPSLE 540
Query: 482 VNATMGLKLNEDYGDTVPSKPQVQVTNEVLATSTLKKQH----TLEDMEEGDFGTVVVH- 536
+T+G K +E+ G TVPSKP Q + E TSTL +QH T+ E GDFGT++VH
Sbjct: 541 DTSTLGPKSSEELGITVPSKPP-QNSTEAPLTSTLNRQHITGNTVLAGEGGDFGTMIVHG 599
Query: 537 --ETDKTISKTQCSNIKESSTLPGHTEISGT-----GGKLADVRVDGAAGVALNNKLVGE 589
ET+++ S++Q KESS+ ++ G G +L D + + V
Sbjct: 600 EDETEESDSRSQLVREKESSS----SQFEGVPREFPGEELPDSWIHDKKKPPAIDLPVEA 655
Query: 590 SHHLTHTIQPSSAENLKT---TISQGQIGSGRDTGSGTLKSETVSKKAFALQDKCFWFLQ 646
S ++ ++Q SS+ +T I+ Q+ G D TLK+ETV +KAFALQDK
Sbjct: 656 S--ISQSMQASSSHEHRTKLHNIAGTQMEGGSDASGSTLKNETVGRKAFALQDK------ 707
Query: 647 LWSIYAAGNTVPIPILRATDISPIALLSDNVLGAMQHDNKGTVAVEALQELFT-GDGQSK 705
LWSIYAAGNTVPIP LRATDISPIALLS+N++G MQ D GTVAVEALQELFT D QSK
Sbjct: 708 LWSIYAAGNTVPIPFLRATDISPIALLSENMIGGMQQDGNGTVAVEALQELFTSSDPQSK 767
Query: 706 KGRRGQNEIPLPPSVYQRLTSSSTLLNLAQALAYHRMCYDEMPLQELQVTQEEQTIQNLC 765
KGRRGQNE+PLPPSVYQRLT+SS+L+NLAQ LAYHR CY+EMPLQELQ TQE+QTIQNLC
Sbjct: 768 KGRRGQNEMPLPPSVYQRLTTSSSLMNLAQVLAYHRACYEEMPLQELQATQEQQTIQNLC 827
Query: 766 DTLRTILRL 774
DTLRTILRL
Sbjct: 828 DTLRTILRL 836
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224112100|ref|XP_002316082.1| predicted protein [Populus trichocarpa] gi|222865122|gb|EEF02253.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 955 bits (2469), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 549/839 (65%), Positives = 619/839 (73%), Gaps = 100/839 (11%)
Query: 1 MDHTPTSRRT--PKPPSRSEIYSTVVIHDDDDDDDDDEETRYD-------------SDSR 45
MDH SRRT K P++SE+YSTVVIH+ D D + + +++ D ++
Sbjct: 1 MDHPSPSRRTRTSKTPNKSELYSTVVIHNSDSDSEPESKSKTDDNNIYATMLYKGGGENN 60
Query: 46 TNYSQNDAVMEDDDSLPPLLKRLPKDFGAAPPEDDDEEDGDFGTMIIKTRTKTKAKNS-- 103
+ D ED++SLPPLLKRLPKDFG DD++D DFGTMI+K ++ + +N
Sbjct: 61 SKDDDVDVEEEDEESLPPLLKRLPKDFGGG----DDDDDADFGTMIVKA-SRGRHQNQSW 115
Query: 104 ---------RTIVNKPYSEFKK------------TDGDDEFGTFVVRSKDGERRSGGYDD 142
R + P++EF+ DG EFGTF+V+S R G
Sbjct: 116 SSSSSVAPPRKPYSAPFTEFESRINDIGDNSDGDDDGRGEFGTFLVKSTVVRRSGSGGGG 175
Query: 143 STMGRAVASMRRFG--------SSSSLHGEDVRQQTKVSSSS----IPESVTREDPTTKY 190
STMG+AVASM+ G S L GE+ +Q + S IPESVTREDPTTKY
Sbjct: 176 STMGKAVASMQASGELGFGKERKGSGLLGEEGKQHQQKQSKMSSSSIPESVTREDPTTKY 235
Query: 191 ELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVR 250
ELLNELGKGSYGAVYKARDL++SELVAIKVISL+EGEEGYEEIRGEIEMLQQCSHPNVVR
Sbjct: 236 ELLNELGKGSYGAVYKARDLRSSELVAIKVISLTEGEEGYEEIRGEIEMLQQCSHPNVVR 295
Query: 251 YLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVH 310
YLGSYQGEEYLWIVMEYCGGGSV+DLMNV EEPLEEYQIAYICREALKGLAYLHSIFKVH
Sbjct: 296 YLGSYQGEEYLWIVMEYCGGGSVSDLMNVAEEPLEEYQIAYICREALKGLAYLHSIFKVH 355
Query: 311 RDIKGGNILLTDQGEVKL-GDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVD 369
RDIKGGNILLT+QGEVKL GDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVD
Sbjct: 356 RDIKGGNILLTEQGEVKLAGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVD 415
Query: 370 VWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEP 429
VWALGVSA+EMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEP
Sbjct: 416 VWALGVSAIEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEP 475
Query: 430 RARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRASMAQQAQNILSDEPEVNATMGLK 489
R+RP A+EMLKHKFI+RCK GA+AMLPKIEKARQIR +M+ QAQN+ E E T G +
Sbjct: 476 RSRPMASEMLKHKFIDRCKVGASAMLPKIEKARQIRTAMSLQAQNLAPAESE--PTEGPQ 533
Query: 490 LNEDYGDTVPSKPQVQVTNEVLATSTLKKQHTLEDMEEGDFGTVVVH---ETDKTISKTQ 546
LNE YGDTVPS ++ + NEV ++S DM GD+GT VVH ETDKT +T
Sbjct: 534 LNEVYGDTVPSN-RLPMVNEVHSSSDGV------DMAGGDYGTFVVHGGEETDKTGLQTA 586
Query: 547 CSNIKESSTLPGHTEISGTGGKLAD--VRVDG-AAGVALNNKLVGESHHLTHTIQPSSAE 603
++ GG L D ++G + VA NN LVGES TIQ S+ E
Sbjct: 587 LYDV---------------GGILQDHPGNIEGLSVRVAANNPLVGESLPALQTIQTSTPE 631
Query: 604 -------NL-KTTISQGQIGSGRDTGSGTLKSETVSKKAFALQDKCFWFLQLWSIYAAGN 655
NL K T+S+ + G GS TLK+ETVS+KAFALQDK LWSIYAAGN
Sbjct: 632 VSGYSEQNLKKNTVSKVHVEGGGGLGSSTLKNETVSRKAFALQDK------LWSIYAAGN 685
Query: 656 TVPIPILRATDISPIALLSDNVLGAMQHDNKGTVAVEALQELFTGDGQSKKGRRGQNEIP 715
TVPIP LRATDISPIALLSDNVLG +Q DN GTVA EALQELF+GDG SKKGRR QNE+P
Sbjct: 686 TVPIPFLRATDISPIALLSDNVLGGIQCDNSGTVAAEALQELFSGDGPSKKGRRIQNEMP 745
Query: 716 LPPSVYQRLTSSSTLLNLAQALAYHRMCYDEMPLQELQVTQEEQTIQNLCDTLRTILRL 774
LPP VYQRLTSSSTLLNLAQALAYH+MCY+EMPLQELQ TQE+QTIQNLCDTLRTILRL
Sbjct: 746 LPPGVYQRLTSSSTLLNLAQALAYHKMCYEEMPLQELQATQEKQTIQNLCDTLRTILRL 804
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449449072|ref|XP_004142289.1| PREDICTED: uncharacterized protein LOC101209775 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 951 bits (2458), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 539/861 (62%), Positives = 606/861 (70%), Gaps = 126/861 (14%)
Query: 5 PTSRRTPKPPSRSEIYSTVVIHDDDDDDD----DDEETRYDSDSRTNYSQNDAVMEDDD- 59
PTS R+ + ++S++YSTVVIH + D D D T A M D
Sbjct: 4 PTSYRSRRTTNKSDLYSTVVIHSNSDSDSDNNPDHRNPHRRPRPPTEGQDLYATMLYKDV 63
Query: 60 ------------SLPPLLKRLPKDFGAAPP--------EDDDEEDGDFGTMIIKT---RT 96
SLPPLLKRLPKDFG P D D++ DFGTMI+KT R
Sbjct: 64 DKPRDEDDDDDSSLPPLLKRLPKDFGGGAPIGYEDDDAFDFDQDTEDFGTMIVKTDRNRP 123
Query: 97 KTKAKNSRTIVNK-----PYSEFK-----KTDGDDE------------FGTFVVRS---- 130
+ ++ +S N P+ F+ K DG DE + TFVVRS
Sbjct: 124 RNRSVSSSVSTNPRTSPLPFVNFQQGSPGKRDGSDEVEDSEEEDDGDGYSTFVVRSTARS 183
Query: 131 KDGERRSG------------------GYDDSTMGRAVASMR----------RFGSSSSLH 162
++ E SG G D STMGRAVASM+ R G+ S +
Sbjct: 184 RNRESVSGTVVRRTGGSRSGSRDGGGGLDGSTMGRAVASMQGMGELGFGKQRKGNGSPMS 243
Query: 163 GEDV-RQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVI 221
ED R ++KVSSSSIPES+TREDP +KYELLNELGKGSYGAVYKARD+KTSELVAIKVI
Sbjct: 244 EEDGGRIRSKVSSSSIPESITREDPHSKYELLNELGKGSYGAVYKARDIKTSELVAIKVI 303
Query: 222 SLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE 281
SL EGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE
Sbjct: 304 SLCEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE 363
Query: 282 EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341
E LEEYQIAYICREALKGL YLHSIFKVHRDIKGGNILLT+QG+VKLGDFGVAAQLTRTM
Sbjct: 364 EALEEYQIAYICREALKGLTYLHSIFKVHRDIKGGNILLTEQGDVKLGDFGVAAQLTRTM 423
Query: 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI 401
SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSA+EMAEGLPPRS VHPMRVLFMISI
Sbjct: 424 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAIEMAEGLPPRSAVHPMRVLFMISI 483
Query: 402 EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKA 461
EPAPMLEDKEKWSL+FHDFVAKCLTK+PR+RP A+EMLKHKFIE+C+CGA+AMLPKIEKA
Sbjct: 484 EPAPMLEDKEKWSLLFHDFVAKCLTKDPRSRPAASEMLKHKFIEKCRCGASAMLPKIEKA 543
Query: 462 RQIRASMAQQAQNILSDEPEVNATMGLKLNEDYGDTVPSKPQ---VQVTNEVLATSTLKK 518
R+IR MAQQAQ+I D + LN+DYGDTVPSKPQ +QV +E+ +
Sbjct: 544 RKIRTLMAQQAQSIAPDASGDGTIVAANLNQDYGDTVPSKPQNIGLQVASEIAGS----- 598
Query: 519 QHTLEDMEEGDFGTVVVH---ETDKTISKTQCSNIKESSTLPGHTEISGTGGKLADVRVD 575
E + EG FGTV+VH E DK S+ I E P + + RVD
Sbjct: 599 ----ELVAEGTFGTVIVHDGDENDKVASQLDI-GIAE----PPTGSLRNESLSINVTRVD 649
Query: 576 GAA--GVALNNKLVGESHHLTHTIQPSSAENLKTTISQGQIGSGRDTGSGTLKSETVSKK 633
+ G +NN L G+S P+ +L + + ++ TLKSETVS+K
Sbjct: 650 SSVRTGGIVNNILDGKS-------DPTMPASLPSFLGIHEL--------STLKSETVSRK 694
Query: 634 AFALQDKCFWFLQLWSIYAAGNTVPIPILRATDISPIALLSDNVLGAMQHDNKGTVAVEA 693
+FALQDK LWSIYAAGNTVPIP LRATDISPIALLSDNVLG +QHDN+GTVAVE
Sbjct: 695 SFALQDK------LWSIYAAGNTVPIPFLRATDISPIALLSDNVLGGVQHDNRGTVAVET 748
Query: 694 LQELFTGDGQSKKGRRGQNEIPLPPSVYQRLTSSSTLLNLAQALAYHRMCYDEMPLQELQ 753
LQELFTGDGQSKKGRRGQNE+PLPPSVYQRLTSS TLLNLAQALAYHRMCY++MPLQELQ
Sbjct: 749 LQELFTGDGQSKKGRRGQNEMPLPPSVYQRLTSSPTLLNLAQALAYHRMCYEDMPLQELQ 808
Query: 754 VTQEEQTIQNLCDTLRTILRL 774
TQE+QTIQNLCDTLRTILRL
Sbjct: 809 ATQEQQTIQNLCDTLRTILRL 829
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357487685|ref|XP_003614130.1| Serine/threonine protein kinase [Medicago truncatula] gi|355515465|gb|AES97088.1| Serine/threonine protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 938 bits (2424), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 521/848 (61%), Positives = 595/848 (70%), Gaps = 97/848 (11%)
Query: 1 MDHTPTSRRTPKPPSRSEIYSTVVIHDDDDDDDDDEETRYDSDSRTNYSQND--AVME-- 56
MD S RT +S+IYST VIH+DDDDD + R + + +Q D A M+
Sbjct: 1 MDRGSFSPRTRNTRPKSDIYSTFVIHNDDDDDGETNRRRKTASAE---AQEDPYATMKFK 57
Query: 57 ------------DDDSLPPLLKRLPKDFGAAPP---EDDDEEDGDFGTMIIKTRTKTKAK 101
+D LPPLLKRLPKDFG +DD++E GDFGTMI+K +
Sbjct: 58 DNGHDDNDDDEDEDSFLPPLLKRLPKDFGGGASMDYDDDEDESGDFGTMIVKNDRSRQRD 117
Query: 102 NSRTIVNKPYSEFKKTDGDDE--------------FGTFVVRS--KDGER---------R 136
S + V P KT + F TFV+RS ++ ER R
Sbjct: 118 RSSSGVASPAGLTWKTGNSSQVTALNDEDDDDGGGFSTFVMRSTVRNSERESVSGTMVRR 177
Query: 137 SGGYDD---STMGRAVASMRRFG-------SSSSLHGEDVRQQTKVSSSSIPESVTREDP 186
+ G D STM RA+ASM+ G S S E + TKVS+SSIP+SV REDP
Sbjct: 178 TSGNDGGGGSTMERAIASMQGVGEFGKQRKGSGSSQNEAI--TTKVSTSSIPDSVIREDP 235
Query: 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHP 246
TTKYELLNELGKGSYGAVYKARD +TSE+VAIKVISLSEGEEGYEEIRGEIEMLQQC+HP
Sbjct: 236 TTKYELLNELGKGSYGAVYKARDYRTSEMVAIKVISLSEGEEGYEEIRGEIEMLQQCNHP 295
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI 306
NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVT+E L+E QIAYICREALKGL YLHSI
Sbjct: 296 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTDEALDEGQIAYICREALKGLDYLHSI 355
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDG 366
FKVHRDIKGGNILLT+QG+VKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDG
Sbjct: 356 FKVHRDIKGGNILLTEQGDVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDG 415
Query: 367 KVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLT 426
KVDVWALGVSA+EMAEG+PPRS+VHPMRVLFMISIEPAPMLEDKEKWSL FHDFVAKCLT
Sbjct: 416 KVDVWALGVSAIEMAEGVPPRSSVHPMRVLFMISIEPAPMLEDKEKWSLYFHDFVAKCLT 475
Query: 427 KEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRASMAQQAQNIL-----SDEPE 481
KEPR RP A+EMLKHKF E+ K G+ AM PK+EKARQ+RASMA Q Q + EP
Sbjct: 476 KEPRLRPAASEMLKHKFFEKWKVGSAAMFPKLEKARQVRASMALQVQTLAPAAAGDQEPM 535
Query: 482 VNATMGLKLNEDYGDTVPSKPQVQVTNEVLATSTLKKQHTLE-----DMEEGDFGTVVVH 536
+ + LN++YGDTVPS+PQ E S+ L+ D EG+FGT++VH
Sbjct: 536 IASI----LNDEYGDTVPSRPQNMGVEEAAYISSHGTTRKLQRVDEVDNSEGNFGTMIVH 591
Query: 537 ETD-KTISKTQCSNIKESSTLPGHTEISGTGGKLADVRVDGAAGVALNNKLVGESHHLTH 595
+ KT T ++ K + T S TGG+L+D V +N S
Sbjct: 592 GDEFKTTQDTYSASYKTAFT-------SSTGGRLSDPGVGSLKVGDMNTASFRGSGPTAD 644
Query: 596 TIQP-------SSAENLKTTIS-QGQIGSGRDTGSGTLKSETVSKKAFALQDKCFWFLQL 647
TIQP S+ +NLKT + + Q G G D G+ TLK+ETV++K FALQDK L
Sbjct: 645 TIQPALPSVSNSTEQNLKTKGTYRAQAGIGSDIGNSTLKNETVNRK-FALQDK------L 697
Query: 648 WSIYAAGNTVPIPILRATDISPIALLSDNVLGAMQHDNKGTVAVEALQELFTGDGQSKKG 707
WSIYAAGNTVPIP LRATDISPIALLSDNVLG MQ D GT VEALQELF GDGQSKKG
Sbjct: 698 WSIYAAGNTVPIPFLRATDISPIALLSDNVLGGMQQDTGGTGTVEALQELFGGDGQSKKG 757
Query: 708 RRGQNE-IPLPPSVYQRLTSSSTLLNLAQALAYHRMCYDEMPLQELQVTQEEQTIQNLCD 766
RRG NE +PLPPS+ QRLTSSSTL+NLAQALAYH+MCY++MPLQELQ TQE++TIQNL D
Sbjct: 758 RRGINEQMPLPPSICQRLTSSSTLMNLAQALAYHKMCYEDMPLQELQATQEQRTIQNLSD 817
Query: 767 TLRTILRL 774
TLRTILRL
Sbjct: 818 TLRTILRL 825
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356498008|ref|XP_003517847.1| PREDICTED: uncharacterized protein LOC100784666 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 935 bits (2417), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 523/838 (62%), Positives = 598/838 (71%), Gaps = 107/838 (12%)
Query: 1 MDHTPTSRRTPKPPSRSEIYSTVVIHDDDDDDDDDEETRYDSDSRTNYSQNDAVMEDDDS 60
MD + S T K ++ +IYST V+HDDDD+D S
Sbjct: 1 MDRSSFSPGTGKTRTKPDIYSTFVVHDDDDEDS--------------------------S 34
Query: 61 LPPLLKRLPKDFGAAPPED----DDEEDGDFGTMIIKTRTKTKAKNSRTIVNKPYSEFKK 116
LPPLL+RLPKDFG P D +DE GDFGTMI+K+ + S + V P +K
Sbjct: 35 LPPLLRRLPKDFGGGAPLDYDDDEDEGAGDFGTMIVKSDRSRQRDRSSSGVASP--AWKA 92
Query: 117 TDGDDEFG-----------------TFVVRS--KDGERRS--------------GGYDDS 143
+ + FG TFVVRS K GER S G S
Sbjct: 93 RNPLNRFGAEDDGDEEDDDDGGGFSTFVVRSTVKSGERESVSGTVVRRTSGGSGGLGVGS 152
Query: 144 TMGRAVASMR----------RFGSSSSLHGEDVRQQ--TKVSSSSIPESVTREDPTTKYE 191
TM RAVASM+ R GS SS + E Q TKVS+SSIP+SVTREDPTTKYE
Sbjct: 153 TMERAVASMQGMGEFGFGKQRKGSGSSQNDEGRHQSITTKVSTSSIPDSVTREDPTTKYE 212
Query: 192 LLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRY 251
LLNELGKGSYGAVYKARDL+TSE+VAIKVISLSEGEEGYEEIRGEIEMLQQC+HPNVVRY
Sbjct: 213 LLNELGKGSYGAVYKARDLRTSEMVAIKVISLSEGEEGYEEIRGEIEMLQQCNHPNVVRY 272
Query: 252 LGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHR 311
L SYQGEEYLWIVMEYCGGGSVADLM+VT+EPL+E QIAYICREALKGL YLHSIFKVHR
Sbjct: 273 LASYQGEEYLWIVMEYCGGGSVADLMSVTDEPLDEGQIAYICREALKGLDYLHSIFKVHR 332
Query: 312 DIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVW 371
DIKGGNILLT+QG+VKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVW
Sbjct: 333 DIKGGNILLTEQGDVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVW 392
Query: 372 ALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRA 431
ALGVSA+EMAEG+PPRS+VHPMRVLFMISIEPAPMLEDKEKWSL FHDFVAKCLTKE R
Sbjct: 393 ALGVSAIEMAEGVPPRSSVHPMRVLFMISIEPAPMLEDKEKWSLYFHDFVAKCLTKELRL 452
Query: 432 RPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRASMAQQAQN--ILSDEPEVNATMGLK 489
RPTA+EMLKHKF E+ K G+ AMLPK+EKARQIRASMA Q Q + S++ E+++ K
Sbjct: 453 RPTASEMLKHKFFEKWKSGSAAMLPKLEKARQIRASMASQVQALPVTSEDQELDS----K 508
Query: 490 LNEDYGDTVPSKPQ---VQVTNEVLATSTLKKQHTLE--DMEEGDFGTVVVHETDKTISK 544
LN++YGDTVPS+P V+ ++ + T +K H +E DM EG+FGTV++H D+
Sbjct: 509 LNDEYGDTVPSRPHNIGVEGAADLSSHGTTRKLHKVEDVDMSEGNFGTVIIH-GDELHKT 567
Query: 545 TQCSNIKESSTLPGHTEISGTGGKLADVRVDGAAGVALNNKLVGESHHLTHTIQPS---- 600
TQ ++ S + SGT G+L D ++ +N T+TIQ S
Sbjct: 568 TQDAD----SAVSVSALTSGTRGRLTDSGIESQKVGIMNTASFRGYSATTNTIQSSLPYV 623
Query: 601 --SAE-NLKTT-ISQGQIGSGRDTGSGTLKSETVSKKAFALQDKCFWFLQLWSIYAAGNT 656
SAE +LKT + Q G G D + K+ETVS KAFALQDK LWSIYAAGNT
Sbjct: 624 SNSAEQSLKTKGTHRAQAGIGGDISNSIFKNETVSHKAFALQDK------LWSIYAAGNT 677
Query: 657 VPIPILRATDISPIALLSDNVLGAMQHDNKGTVAVEALQELFTGDGQSKKGRRGQNEIPL 716
VPIP LRATDISPIALLSDNVLG +Q D GT VEALQELF+GDGQSKKGRRG NE+P
Sbjct: 678 VPIPFLRATDISPIALLSDNVLGGIQQDTGGTGTVEALQELFSGDGQSKKGRRGLNEMPF 737
Query: 717 PPSVYQRLTSSSTLLNLAQALAYHRMCYDEMPLQELQVTQEEQTIQNLCDTLRTILRL 774
PPS+YQRLTSSSTL+NLAQALAYH+MCY++MPLQELQ TQE++TIQNL DTLRTILRL
Sbjct: 738 PPSIYQRLTSSSTLMNLAQALAYHKMCYEDMPLQELQATQEQRTIQNLSDTLRTILRL 795
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225423444|ref|XP_002264991.1| PREDICTED: uncharacterized protein LOC100267868 isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 932 bits (2408), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 535/832 (64%), Positives = 602/832 (72%), Gaps = 94/832 (11%)
Query: 4 TPTSRRTPKPPSRSEIYSTVVIHDDDDDDDDDEETRYDSDSRTNYSQNDAVM-------- 55
TP+ R P P +S+IYST V+HDD+DDD+ + +Y S RT + + +
Sbjct: 6 TPSRRTRPAVP-KSDIYSTFVVHDDEDDDETAFQEKY-SRRRTKSQEKEDIYATMVYKDD 63
Query: 56 -----EDDDSLPPLLKRLPKDFGAAPP--EDDDEEDGDFGTMIIKTRTKTKAKNSRTIVN 108
+DD SLPPLLKRLPKDF AA ++D GDFGTMI+KT ++ + S +I++
Sbjct: 64 PNDDDDDDSSLPPLLKRLPKDFDAAHDYYDEDSTGTGDFGTMIVKT---SRDRLSPSILS 120
Query: 109 -----------KPY---SEFKKTDGDDEFGTFVVRSKDGERRSG---------GYDDSTM 145
PY S K+TD +D + TFVVRS G R SG STM
Sbjct: 121 PSILSPAKPRGSPYLERSTGKRTDDEDNYSTFVVRSTLGTRESGTVVRRGSGGASASSTM 180
Query: 146 GRAVASMRRFGSSSSLHGEDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVY 205
RAVASM+ G R+ K S SS + E + KGSYGAVY
Sbjct: 181 SRAVASMQASGELG------FRKHRKGSGSSQGD-----------EARFQARKGSYGAVY 223
Query: 206 KARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265
KARD++TSELVAIKVISL EGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM
Sbjct: 224 KARDIRTSELVAIKVISLCEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 283
Query: 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE 325
EYCGGGSVADLMN TEEPL+EYQIAYICREALKGL+YLHSIFKVHRDIKGGNILLT+QGE
Sbjct: 284 EYCGGGSVADLMNTTEEPLDEYQIAYICREALKGLSYLHSIFKVHRDIKGGNILLTEQGE 343
Query: 326 VKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLP 385
VKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSA+EMAEGLP
Sbjct: 344 VKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAIEMAEGLP 403
Query: 386 PRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445
PRS VHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPR RPTA+EMLKHKFIE
Sbjct: 404 PRSAVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRLRPTASEMLKHKFIE 463
Query: 446 RCKCGATAMLPKIEKARQIRASMAQQAQ------NILSDEPEVNATMGLKLNEDYGDTVP 499
+CKCGA+AMLPKIEKARQIRASMA QAQ +I D P G KLNEDYGDTVP
Sbjct: 464 KCKCGASAMLPKIEKARQIRASMALQAQSLARITSISGDAP----PEGPKLNEDYGDTVP 519
Query: 500 SKP---QVQVTNEVLATSTLKKQHTLEDME---EGDFGTVVVH---ETDKTISKTQCSNI 550
S+P +QVTNEV STL KQ + +E EG+FGTV+VH E DKT ++T S+
Sbjct: 520 SRPFNNGLQVTNEVPTASTLVKQKISDGVELEGEGEFGTVIVHGGFEMDKTANQTPVSST 579
Query: 551 KESSTLPGHTE---ISGTGGKLADVRVDGAAGVALNNKLVGESH----HLTHTIQPSSAE 603
KE S + E + G G K + V+ VA NN VGESH + ++ S +
Sbjct: 580 KEPSAAHENVESHPVGGPGIKSTNNWVEDTVDVAANNDQVGESHPGEQTTSKSVFGSPEQ 639
Query: 604 NLKT-TISQGQIGSGRDTGSGTLKSETVSKKAFALQDKCFWFLQLWSIYAAGNTVPIPIL 662
NL+T +ISQ Q G G S LK+ETVS+ AFA QDK LWSIYAAGNTVPIP L
Sbjct: 640 NLRTSSISQVQAGGG-GVSSSQLKNETVSRTAFASQDK------LWSIYAAGNTVPIPFL 692
Query: 663 RATDISPIALLSDNVLGAMQHDNKGTVAVEALQELFTGDGQSKKGRRGQNEIPLPPSVYQ 722
RATDISPIALLS NVLG Q ++ G VAVEA+QELFTGD Q KKGRRGQNEIPLPPS+YQ
Sbjct: 693 RATDISPIALLSGNVLGGRQRESSGAVAVEAVQELFTGDSQLKKGRRGQNEIPLPPSMYQ 752
Query: 723 RLTSSSTLLNLAQALAYHRMCYDEMPLQELQVTQEEQTIQNLCDTLRTILRL 774
RLTSSSTLLNLAQALAYH+ Y+EMPLQ+LQ QE+QTIQNLCDTLRTILRL
Sbjct: 753 RLTSSSTLLNLAQALAYHKTSYEEMPLQDLQAVQEQQTIQNLCDTLRTILRL 804
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|6730645|gb|AAF27066.1|AC008262_15 F4N2.17 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 931 bits (2407), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 522/848 (61%), Positives = 614/848 (72%), Gaps = 97/848 (11%)
Query: 1 MDH-TPTSRRTPKPPSRSEIYSTVVIHDDDDDDD----DDEETRYDSDSRTNY------- 48
MDH +P SRR+ KP + +IYST V+H D D D D + + + D +
Sbjct: 1 MDHNSPKSRRSRKPEPKPDIYSTFVVHSDSDSDQGRDRDKRKAKPEEDENVDLYATMVYK 60
Query: 49 ----SQNDAVMEDDDSLPPLLKRLPKDFGAAPP----EDDDEEDGDFGTMIIKTRTKTKA 100
+ + +DD LPPLLKRLPKDFG +DD +E GDFGTMI+KT + +
Sbjct: 61 GDSDGEGEEDDDDDSMLPPLLKRLPKDFGGGASLDYDDDDGDESGDFGTMIVKTDRSSHS 120
Query: 101 KNSRTIVNKP---------------------YSEFKKTDGDDEFGTFVVRSKDGERRSGG 139
K + +KP E D D ++GTFVV+SKD + +
Sbjct: 121 KKNSPYSSKPRMGVSPRRRARGGDEESSDEEDEEEDDDDDDGDYGTFVVKSKDKKGKKKD 180
Query: 140 --YDDSTMGRAVASMRR--FG----------SSSSLHGEDVR----QQTKVSSSSIPESV 181
D +TMGRAVASM++ FG SSS LHGED R Q +K+S++S+P+S+
Sbjct: 181 KEIDMTTMGRAVASMQKSNFGGKTRKLDPSSSSSKLHGEDNRKMQQQNSKMSTTSLPDSI 240
Query: 182 TREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQ 241
TREDPTTKYE LNELGKGSYG+VYKARDLKTSE+VA+KVISL+EGEEGYEEIRGEIEMLQ
Sbjct: 241 TREDPTTKYEFLNELGKGSYGSVYKARDLKTSEIVAVKVISLTEGEEGYEEIRGEIEMLQ 300
Query: 242 QCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLA 301
QC+HPNVVRYLGSYQGE+YLWIVMEYCGGGSVADLMNVTEE LEEYQIAYICREALKGLA
Sbjct: 301 QCNHPNVVRYLGSYQGEDYLWIVMEYCGGGSVADLMNVTEEALEEYQIAYICREALKGLA 360
Query: 302 YLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQE 361
YLHSI+KVHRDIKGGNILLT+QGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQE
Sbjct: 361 YLHSIYKVHRDIKGGNILLTEQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQE 420
Query: 362 SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421
+RYDGKVDVWALGVSA+EMAEGLPPRS+VHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV
Sbjct: 421 NRYDGKVDVWALGVSAIEMAEGLPPRSSVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 480
Query: 422 AKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRASMAQQAQNILSDEPE 481
AKCLTKEPR RPTAAEMLKHKF+ERCK GA+AM PKIEK+RQIRA+MA QAQ++++ E
Sbjct: 481 AKCLTKEPRLRPTAAEMLKHKFVERCKTGASAMSPKIEKSRQIRATMALQAQSVVAPSLE 540
Query: 482 VNATMGLKLNEDYGDTVPSKPQVQVTNEVLATSTLKKQHT-------------LEDMEEG 528
+T+G K +E+ G TVPSKP Q + E TSTL +QH + D G
Sbjct: 541 DTSTLGPKSSEELGITVPSKPP-QNSTEAPLTSTLNRQHITGNTVLAGEGKYYMHDYLCG 599
Query: 529 DFGTVVVH---ETDKTISKTQCSNIKESSTLPGHTEISGT-----GGKLADVRVDGAAGV 580
DFGT++VH ET+++ S++Q KESS+ ++ G G +L D +
Sbjct: 600 DFGTMIVHGEDETEESDSRSQLVREKESSS----SQFEGVPREFPGEELPDSWIHDKKKP 655
Query: 581 ALNNKLVGESHHLTHTIQPSSAENLKT---TISQGQIGSGRDTGSGTLKSETVSKKAFAL 637
+ V S ++ ++Q SS+ +T I+ Q+ G D TLK+ETV +KAFAL
Sbjct: 656 PAIDLPVEAS--ISQSMQASSSHEHRTKLHNIAGTQMEGGSDASGSTLKNETVGRKAFAL 713
Query: 638 QDKCFWFLQLWSIYAAGNTVPIPILRATDISPIALLSDNVLGAMQHDNKGTVAVEALQEL 697
QDK LWSIYAAGNTVPIP LRATDISPIALLS+N++G MQ D GTVAVEALQEL
Sbjct: 714 QDK------LWSIYAAGNTVPIPFLRATDISPIALLSENMIGGMQQDGNGTVAVEALQEL 767
Query: 698 FT-GDGQSKKGRRGQNEIPLPPSVYQRLTSSSTLLNLAQALAYHRMCYDEMPLQELQVTQ 756
FT D QSKKGRRGQNE+PLPPSVYQRLT+SS+L+NLAQ LAYHR CY+EMPLQELQ TQ
Sbjct: 768 FTSSDPQSKKGRRGQNEMPLPPSVYQRLTTSSSLMNLAQVLAYHRACYEEMPLQELQATQ 827
Query: 757 EEQTIQNL 764
E+QTIQNL
Sbjct: 828 EQQTIQNL 835
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 774 | ||||||
| TAIR|locus:2026459 | 836 | SIK1 [Arabidopsis thaliana (ta | 0.837 | 0.775 | 0.655 | 3.3e-230 | |
| DICTYBASE|DDB_G0274593 | 737 | dst1 "STE20 family protein kin | 0.356 | 0.374 | 0.575 | 1.5e-97 | |
| UNIPROTKB|B3KYA7 | 519 | STK3 "Serine/threonine-protein | 0.493 | 0.736 | 0.420 | 6.3e-76 | |
| UNIPROTKB|F1P4Y3 | 486 | STK4 "Serine/threonine-protein | 0.457 | 0.728 | 0.428 | 9.6e-76 | |
| RGD|1312035 | 487 | Stk4 "serine/threonine kinase | 0.457 | 0.726 | 0.420 | 5.2e-75 | |
| UNIPROTKB|Q5ZJK4 | 486 | STK4 "Serine/threonine-protein | 0.457 | 0.728 | 0.425 | 6.7e-75 | |
| MGI|MGI:1929004 | 487 | Stk4 "serine/threonine kinase | 0.457 | 0.726 | 0.420 | 6.7e-75 | |
| DICTYBASE|DDB_G0284181 | 461 | krsA "STE20 family protein kin | 0.468 | 0.787 | 0.413 | 1.5e-74 | |
| ZFIN|ZDB-GENE-030131-6497 | 878 | map4k5 "mitogen-activated prot | 0.337 | 0.297 | 0.522 | 2.9e-74 | |
| UNIPROTKB|Q13188 | 491 | STK3 "Serine/threonine-protein | 0.470 | 0.741 | 0.425 | 6.5e-74 |
| TAIR|locus:2026459 SIK1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2122 (752.0 bits), Expect = 3.3e-230, Sum P(2) = 3.3e-230
Identities = 449/685 (65%), Positives = 517/685 (75%)
Query: 118 DGDDEFGTFVVRSKDGERRSGGYDDSTMGRAVASMRR--FG----------SSSSLHGED 165
DGD + K G+++ D +TMGRAVASM++ FG SSS LHGED
Sbjct: 161 DGDYGTFVVKSKDKKGKKKDKEIDMTTMGRAVASMQKSNFGGKTRKLDPSSSSSKLHGED 220
Query: 166 VR----QQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVI 221
R Q +K+S++S+P+S+TREDPTTKYE LNELGKGSYG+VYKARDLKTSE+VA+KVI
Sbjct: 221 NRKMQQQNSKMSTTSLPDSITREDPTTKYEFLNELGKGSYGSVYKARDLKTSEIVAVKVI 280
Query: 222 SLSXXXXXXXXXXXXXXMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE 281
SL+ MLQQC+HPNVVRYLGSYQGE+YLWIVMEYCGGGSVADLMNVTE
Sbjct: 281 SLTEGEEGYEEIRGEIEMLQQCNHPNVVRYLGSYQGEDYLWIVMEYCGGGSVADLMNVTE 340
Query: 282 EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341
E LEEYQIAYICREALKGLAYLHSI+KVHRDIKGGNILLT+QGEVKLGDFGVAAQLTRTM
Sbjct: 341 EALEEYQIAYICREALKGLAYLHSIYKVHRDIKGGNILLTEQGEVKLGDFGVAAQLTRTM 400
Query: 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI 401
SKRNTFIGTPHWMAPEVIQE+RYDGKVDVWALGVSA+EMAEGLPPRS+VHPMRVLFMISI
Sbjct: 401 SKRNTFIGTPHWMAPEVIQENRYDGKVDVWALGVSAIEMAEGLPPRSSVHPMRVLFMISI 460
Query: 402 EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKA 461
EPAPMLEDKEKWSLVFHDFVAKCLTKEPR RPTAAEMLKHKF+ERCK GA+AM PKIEK+
Sbjct: 461 EPAPMLEDKEKWSLVFHDFVAKCLTKEPRLRPTAAEMLKHKFVERCKTGASAMSPKIEKS 520
Query: 462 RQIRASMAQQAQNILSDEPEVNATMGLKLNEDYGDTVPSKPQVQVTNEVLATSTLKKQH- 520
RQIRA+MA QAQ++++ E +T+G K +E+ G TVPSKP Q + E TSTL +QH
Sbjct: 521 RQIRATMALQAQSVVAPSLEDTSTLGPKSSEELGITVPSKPP-QNSTEAPLTSTLNRQHI 579
Query: 521 ---TLEDMEEGDFGTVVVH---ETDKTISKTQCSNIKESSTLPGH-TEISGTGGKLXXXX 573
T+ E GDFGT++VH ET+++ S++Q KESS+ G +L
Sbjct: 580 TGNTVLAGEGGDFGTMIVHGEDETEESDSRSQLVREKESSSSQFEGVPREFPGEELPDSW 639
Query: 574 XXXXXXXXLNNKLVGESHHLTHTIQPSSAENLKT---TISQGQIGSGRDTGSGTLKSETV 630
+ V S ++ ++Q SS+ +T I+ Q+ G D TLK+ETV
Sbjct: 640 IHDKKKPPAIDLPVEAS--ISQSMQASSSHEHRTKLHNIAGTQMEGGSDASGSTLKNETV 697
Query: 631 SKKAFALQDKCFWFLQLWSIYAAGNTVPIPILRATDISPIALLSDNVLGAMQHDNKGTVA 690
+KAFALQDK LWSIYAAGNTVPIP LRATDISPIALLS+N++G MQ D GTVA
Sbjct: 698 GRKAFALQDK------LWSIYAAGNTVPIPFLRATDISPIALLSENMIGGMQQDGNGTVA 751
Query: 691 VEALQELFTG-DGQSKKGRRGQNEIPLPPSVYQRLTSSSTLLNLAQALAYHRMCYDEMPX 749
VEALQELFT D QSKKGRRGQNE+PLPPSVYQRLT+SS+L+NLAQ LAYHR CY+EMP
Sbjct: 752 VEALQELFTSSDPQSKKGRRGQNEMPLPPSVYQRLTTSSSLMNLAQVLAYHRACYEEMPL 811
Query: 750 XXXXXXXXXXXXXNLCDTLRTILRL 774
NLCDTLRTILRL
Sbjct: 812 QELQATQEQQTIQNLCDTLRTILRL 836
|
|
| DICTYBASE|DDB_G0274593 dst1 "STE20 family protein kinase Dst1" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 842 (301.5 bits), Expect = 1.5e-97, Sum P(4) = 1.5e-97
Identities = 160/278 (57%), Positives = 200/278 (71%)
Query: 171 KVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSXXXXXX 230
K S + + +DP T Y + LGKGS+G V+KA ++VAIK+ISL
Sbjct: 10 KQLSDKLGVPILPDDPQTIYHIQERLGKGSFGQVFKAVHFANGKVVAIKIISLDDQEAIK 69
Query: 231 XXXXXXXXMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIA 290
+L +C++PN+V+Y GSY + LWIVMEYCGGGSV+DL+ V + + E +IA
Sbjct: 70 DVRKEIS-ILAECNYPNIVQYFGSYFKDHQLWIVMEYCGGGSVSDLLQVIDT-ISEDEIA 127
Query: 291 YICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350
ICREALKGL YLH K+HRDIKGGNILL D+GEVKL DFGV+AQL T SKRNTF+GT
Sbjct: 128 LICREALKGLNYLHEFKKIHRDIKGGNILLNDRGEVKLADFGVSAQLFNTFSKRNTFVGT 187
Query: 351 PHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDK 410
P+WMAPEVIQE++YDGK DVW+LG++A+EMAEGLPP S VHPMRV+FMI E +P L DK
Sbjct: 188 PYWMAPEVIQENKYDGKADVWSLGITAIEMAEGLPPNSNVHPMRVIFMIPREESPALTDK 247
Query: 411 EKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448
WS F DF++KCLTK+P RPTA E+L H+FI+ K
Sbjct: 248 SIWSDKFQDFISKCLTKDPAERPTAKELLNHEFIQTKK 285
|
|
| UNIPROTKB|B3KYA7 STK3 "Serine/threonine-protein kinase 3 36kDa subunit" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 765 (274.4 bits), Expect = 6.3e-76, P = 6.3e-76
Identities = 170/404 (42%), Positives = 244/404 (60%)
Query: 160 SLHGEDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIK 219
S GE+ +Q +K+ S +S+T++ P +++L +LG+GSYG+V+KA ++ ++VAIK
Sbjct: 27 STQGEENKQDSKLKKLS-EDSLTKQ-PEEVFDVLEKLGEGSYGSVFKAIHKESGQVVAIK 84
Query: 220 VISLSXXXXXXXXXXXXXXMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNV 279
+ + ++QQC P VV+Y GSY LWIVMEYCG GSV+D++ +
Sbjct: 85 QVPVESDLQEIIKEIS---IMQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL 141
Query: 280 TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339
+ L E +IA I + LKGL YLH + K+HRDIK GNILL +G KL DFGVA QLT
Sbjct: 142 RNKTLIEDEIATILKSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 201
Query: 340 TMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI 399
TM+KRNT IGTP WMAPEVIQE Y+ D+W+LG++++EMAEG PP + +HPMR +FMI
Sbjct: 202 TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITSIEMAEGKPPYADIHPMRAIFMI 261
Query: 400 SIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIE 459
P P E WS F DFV KCL K P R TA ++L+H FI+ K + + I
Sbjct: 262 PTNPPPTFRKPELWSDDFTDFVKKCLVKNPEQRATATQLLQHPFIKNAK-PVSILRDLIT 320
Query: 460 KARQIRASMAQQAQNILSDEPEVNATMGLKLNEDYGDT-VPSKPQVQVTNEVLATSTLKK 518
+A +I+A ++ Q L +E E N+ +ED D+ K V+ + ATST+ +
Sbjct: 321 EAMEIKAKRHEEQQRELEEEEE-NS------DEDELDSHTMVKTSVESVGTMRATSTMSE 373
Query: 519 --QHTLED---MEEGDFGTVVVHETDKTISKTQCSNIKESSTLP 557
Q +E M E D GT+V++ D+ + + +K ++T P
Sbjct: 374 GAQTMIEHNSTMLESDLGTMVINSEDE---EEEDGTMKRNATSP 414
|
|
| UNIPROTKB|F1P4Y3 STK4 "Serine/threonine-protein kinase 4" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 735 (263.8 bits), Expect = 9.6e-76, Sum P(2) = 9.6e-76
Identities = 156/364 (42%), Positives = 216/364 (59%)
Query: 179 ESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSXXXXXXXXXXXXXX 238
+S+T++ P +++L +LG+GSYG+V+KA +T ++VAIK + +
Sbjct: 19 DSLTKQ-PEEVFDVLEKLGEGSYGSVFKAIHKETGQVVAIKQVPVESDLQEIIKEIS--- 74
Query: 239 MLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALK 298
++QQC P+VV+Y GSY LWIVMEYCG GSV+D++ + + L E +IA I + LK
Sbjct: 75 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEEEIATIVQSTLK 134
Query: 299 GLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEV 358
GL YLH + K+HRDIK GNILL +G KL DFGVA QLT TM+KRNT IGTP WMAPEV
Sbjct: 135 GLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEV 194
Query: 359 IQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418
IQE Y+ D+W+LG++A+EMAEG PP + +HPMR +FMI P P E WS F
Sbjct: 195 IQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDAFT 254
Query: 419 DFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRASMAQQAQNILSD 478
DFV +CL K P R TA ++L+H F++ K GA+ + I +A I+ + Q L
Sbjct: 255 DFVKQCLVKSPEQRATATQLLQHPFVKSAK-GASILRDLINEAMDIKLKRQEAQQRELDQ 313
Query: 479 EPEVNATMGLKLNEDYGDTVPSKPQVQVTNEVLATSTLKKQHTLED--MEEGDFGTVVVH 536
E E N+ D G V + T V+ T + +E E GT+V++
Sbjct: 314 EDEENSEED---ETDSGTMVRASGDETGTIRVVNTMSDGANTMIEHDGTLESQLGTMVIN 370
Query: 537 ETDK 540
D+
Sbjct: 371 TEDE 374
|
|
| RGD|1312035 Stk4 "serine/threonine kinase 4" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 727 (261.0 bits), Expect = 5.2e-75, Sum P(2) = 5.2e-75
Identities = 153/364 (42%), Positives = 215/364 (59%)
Query: 179 ESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSXXXXXXXXXXXXXX 238
+S+T++ P +++L +LG+GSYG+VYKA +T ++VAIK + +
Sbjct: 20 DSLTKQ-PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEIS--- 75
Query: 239 MLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALK 298
++QQC P+VV+Y GSY LWIVMEYCG GSV+D++ + + L E +IA I + LK
Sbjct: 76 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK 135
Query: 299 GLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEV 358
GL YLH + K+HRDIK GNILL +G KL DFGVA QLT TM+KRNT IGTP WMAPEV
Sbjct: 136 GLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEV 195
Query: 359 IQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418
IQE Y+ D+W+LG++A+EMAEG PP + +HPMR +FMI P P E WS F
Sbjct: 196 IQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPEVWSDNFM 255
Query: 419 DFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRASMAQQAQNILSD 478
DFV +CL K P R TA ++L+H F++ K GA + I +A ++ + Q +
Sbjct: 256 DFVKQCLVKSPEQRATATQLLQHPFVKSAK-GAAILRDLINEAMDVKLKRQEAQQRAVDQ 314
Query: 479 EPEVNATMGLKLNEDYGDTVPSKPQVQVTNEVLATSTLKKQHTLE--DMEEGDFGTVVVH 536
+ + N+ D G V + T V +T + +E D GT+V++
Sbjct: 315 DDDENSEED---EMDSGTMVRAAGDDMGTVRVASTMSGGANTMIEHGDTLPSQLGTMVIN 371
Query: 537 ETDK 540
D+
Sbjct: 372 TEDE 375
|
|
| UNIPROTKB|Q5ZJK4 STK4 "Serine/threonine-protein kinase 4" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 727 (261.0 bits), Expect = 6.7e-75, Sum P(2) = 6.7e-75
Identities = 155/364 (42%), Positives = 215/364 (59%)
Query: 179 ESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSXXXXXXXXXXXXXX 238
+S+T++ P +++L +LG+GSYG+V+KA +T ++VAIK + +
Sbjct: 19 DSLTKQ-PEEVFDVLEKLGEGSYGSVFKAIHKETGQVVAIKQVPVESDLQEIIKEIS--- 74
Query: 239 MLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALK 298
++QQC P+VV+Y GSY LWIVMEYCG GSV+D++ + + L E +IA I + LK
Sbjct: 75 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEEEIATIVQSTLK 134
Query: 299 GLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEV 358
GL YLH + K+HRDIK GNILL +G KL DFGVA QLT TM+KRNT IGTP WMAP V
Sbjct: 135 GLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPGV 194
Query: 359 IQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418
IQE Y+ D+W+LG++A+EMAEG PP + +HPMR +FMI P P E WS F
Sbjct: 195 IQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDAFT 254
Query: 419 DFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRASMAQQAQNILSD 478
DFV +CL K P R TA ++L+H F++ K GA+ + I +A I+ + Q L
Sbjct: 255 DFVKQCLVKSPEQRATAIQLLQHPFVKSAK-GASILRDLINEAMDIKLKRQEAQQRELDQ 313
Query: 479 EPEVNATMGLKLNEDYGDTVPSKPQVQVTNEVLATSTLKKQHTLED--MEEGDFGTVVVH 536
E E N+ D G V + T V+ T + +E E GT+V++
Sbjct: 314 EDEENSEED---ETDSGTMVRASGDETGTIRVVNTMSDGANTMIEHDGTLESQLGTMVIN 370
Query: 537 ETDK 540
D+
Sbjct: 371 TEDE 374
|
|
| MGI|MGI:1929004 Stk4 "serine/threonine kinase 4" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 726 (260.6 bits), Expect = 6.7e-75, Sum P(2) = 6.7e-75
Identities = 153/364 (42%), Positives = 215/364 (59%)
Query: 179 ESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSXXXXXXXXXXXXXX 238
+S+T++ P +++L +LG+GSYG+VYKA +T ++VAIK + +
Sbjct: 20 DSLTKQ-PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEIS--- 75
Query: 239 MLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALK 298
++QQC P+VV+Y GSY LWIVMEYCG GSV+D++ + + L E +IA I + LK
Sbjct: 76 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK 135
Query: 299 GLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEV 358
GL YLH + K+HRDIK GNILL +G KL DFGVA QLT TM+KRNT IGTP WMAPEV
Sbjct: 136 GLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEV 195
Query: 359 IQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418
IQE Y+ D+W+LG++A+EMAEG PP + +HPMR +FMI P P E WS F
Sbjct: 196 IQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFM 255
Query: 419 DFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRASMAQQAQNILSD 478
DFV +CL K P R TA ++L+H F++ K G + + I +A ++ + Q +
Sbjct: 256 DFVKQCLVKSPEQRATATQLLQHPFVKSAK-GVSILRDLINEAMDVKLKRQEAQQREVDQ 314
Query: 479 EPEVNATMGLKLNEDYGDTVPSKPQVQVTNEVLATSTLKKQHTLE--DMEEGDFGTVVVH 536
+ E N+ D G V + T V +T + +E D GT+V++
Sbjct: 315 DDEENSEED---EMDSGTMVRAAGDEMGTVRVASTMSGGANTMIEHGDTLPSQLGTMVIN 371
Query: 537 ETDK 540
D+
Sbjct: 372 TEDE 375
|
|
| DICTYBASE|DDB_G0284181 krsA "STE20 family protein kinase KrsA" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 752 (269.8 bits), Expect = 1.5e-74, P = 1.5e-74
Identities = 163/394 (41%), Positives = 240/394 (60%)
Query: 172 VSSSSIP-ESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSXXXXXX 230
+S+ ++P E+++R+DP + ++ +LG+GSYG+VYKA ++ T +VAIK +S+
Sbjct: 1 MSTLNVPKETMSRKDPEKFFTIVEKLGEGSYGSVYKAINISTGIVVAIKKVSVDNDLEDM 60
Query: 231 XXXXXXXXMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIA 290
++QC P +V Y S++ E +WIVME+CG GSV D M +T++ L E QIA
Sbjct: 61 EKEIS---FMKQCKSPYIVTYYASFRKENEVWIVMEHCGAGSVCDAMKITDKTLSEDQIA 117
Query: 291 YICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350
+ R+ L+GLAYLHS+ K+HRDIK GNIL+ +GE KL DFGV+ QL+ TM+KR T IGT
Sbjct: 118 VVSRDVLQGLAYLHSVRKIHRDIKAGNILMNHKGESKLADFGVSGQLSDTMAKRQTVIGT 177
Query: 351 PHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMIS--IEPAPMLE 408
P WMAPEVIQE YD K D+W+ G++ +EMAE PP VHPMRV+FMI P P L
Sbjct: 178 PFWMAPEVIQEIGYDYKADIWSYGITCIEMAESKPPLFNVHPMRVIFMIPNPSRPPPKLT 237
Query: 409 DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKI--------EK 460
+ EKWS F+DF+AKCLT++P RP+A E+LKH FI + K + ++P I EK
Sbjct: 238 EPEKWSPEFNDFLAKCLTRKPELRPSAEELLKHPFITKAK-SHSLLVPLIDEQDIIINEK 296
Query: 461 ARQIRASMAQQAQNILSDEPEVNATMGLKLNEDYGDTVPSKPQVQVTNEVLATSTLKKQH 520
R++ + Q+ + DE E + +++ G V +KP+ +++
Sbjct: 297 GREVALGIEQRDEEE-EDEDEDSEDS----DDNRGTMVRAKPR-----------SMQNSG 340
Query: 521 TLEDMEEGDFGTVVVHETDKTISKTQCSNIKESS 554
++ EE D GT+V+ + + +N E S
Sbjct: 341 GEDNDEEYDTGTMVITDNKNSYDTVVFNNDDEDS 374
|
|
| ZFIN|ZDB-GENE-030131-6497 map4k5 "mitogen-activated protein kinase kinase kinase kinase 5" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 731 (262.4 bits), Expect = 2.9e-74, Sum P(2) = 2.9e-74
Identities = 141/270 (52%), Positives = 185/270 (68%)
Query: 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSXXXXXXXXXXXXXXML 240
+ R +P +EL+ +G G+YG VYKAR + T EL A+K+I L M+
Sbjct: 11 IQRRNPQHDFELIQRVGSGTYGDVYKARKISTGELAAVKIIKLEPGDDFSIIQQEIF-MV 69
Query: 241 QQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGL 300
++C+H N+V Y GSY E LWI MEYCGGGS+ D+ +VT PL E QIAY+CRE L+GL
Sbjct: 70 KECTHHNIVAYFGSYLCREKLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGL 128
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ 360
YLHS K+HRDIKG NILLTD G+VKL DFGVAA++T TM+KR +FIGTP+WMAPEV
Sbjct: 129 GYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATMAKRKSFIGTPYWMAPEVAA 188
Query: 361 ESR---YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMIS---IEPAPMLEDKEKWS 414
+ Y+ D+WA+G++++E+AE PP +HPMR LF++S +P P L+DK KWS
Sbjct: 189 VEKNGGYNHLCDIWAVGITSIELAELQPPMFDLHPMRALFLMSKSNFQP-PKLKDKTKWS 247
Query: 415 LVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
FH+FV LTK P+ RPTA +ML H F+
Sbjct: 248 TAFHNFVKLSLTKNPKRRPTAEKMLSHLFV 277
|
|
| UNIPROTKB|Q13188 STK3 "Serine/threonine-protein kinase 3" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 746 (267.7 bits), Expect = 6.5e-74, P = 6.5e-74
Identities = 164/385 (42%), Positives = 234/385 (60%)
Query: 179 ESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSXXXXXXXXXXXXXX 238
+S+T++ P +++L +LG+GSYG+V+KA ++ ++VAIK + +
Sbjct: 17 DSLTKQ-PEEVFDVLEKLGEGSYGSVFKAIHKESGQVVAIKQVPVESDLQEIIKEIS--- 72
Query: 239 MLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALK 298
++QQC P VV+Y GSY LWIVMEYCG GSV+D++ + + L E +IA I + LK
Sbjct: 73 IMQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLIEDEIATILKSTLK 132
Query: 299 GLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEV 358
GL YLH + K+HRDIK GNILL +G KL DFGVA QLT TM+KRNT IGTP WMAPEV
Sbjct: 133 GLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEV 192
Query: 359 IQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418
IQE Y+ D+W+LG++++EMAEG PP + +HPMR +FMI P P E WS F
Sbjct: 193 IQEIGYNCVADIWSLGITSIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDDFT 252
Query: 419 DFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRASMAQQAQNILSD 478
DFV KCL K P R TA ++L+H FI+ K + + I +A +I+A ++ Q L +
Sbjct: 253 DFVKKCLVKNPEQRATATQLLQHPFIKNAK-PVSILRDLITEAMEIKAKRHEEQQRELEE 311
Query: 479 EPEVNATMGLKLNEDYGDT-VPSKPQVQVTNEVLATSTLKK--QHTLED---MEEGDFGT 532
E E N+ +ED D+ K V+ + ATST+ + Q +E M E D GT
Sbjct: 312 EEE-NS------DEDELDSHTMVKTSVESVGTMRATSTMSEGAQTMIEHNSTMLESDLGT 364
Query: 533 VVVHETDKTISKTQCSNIKESSTLP 557
+V++ D+ + + +K ++T P
Sbjct: 365 MVINSEDE---EEEDGTMKRNATSP 386
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 774 | |||
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-173 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-131 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-129 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-128 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-116 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-112 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-104 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-103 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-102 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-98 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-97 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-94 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-94 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-94 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-91 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-90 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-87 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-86 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-83 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-83 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-83 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-83 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-80 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-80 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-79 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-78 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-78 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-78 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-76 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-75 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-75 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-72 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-71 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-71 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-70 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-69 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-69 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-68 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-62 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-62 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-61 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-56 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-54 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-54 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-53 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-53 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-51 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-51 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-51 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-51 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-50 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-49 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-48 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-47 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-47 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-47 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-47 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-46 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-44 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-44 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-44 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-44 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-43 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-43 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-43 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-43 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-42 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-42 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-42 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-42 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-42 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-42 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-42 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-41 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-41 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-40 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-40 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-40 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-40 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-40 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-40 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-39 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-39 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-38 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-38 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-37 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-36 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-36 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-36 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-35 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-35 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-34 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-34 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-34 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-34 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-33 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-33 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-33 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-32 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-32 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-31 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-31 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-31 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-30 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-30 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-30 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-30 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-30 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-29 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-29 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-29 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-29 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 6e-29 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-29 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-28 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-28 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-28 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-28 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-28 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-27 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-27 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-27 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-27 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-27 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-27 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-26 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-26 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-26 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 7e-26 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-26 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-26 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-25 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-25 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-25 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-25 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-25 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-25 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-25 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-25 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-25 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-25 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-25 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-25 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-25 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-25 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-25 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-24 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-24 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-24 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-24 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-23 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-23 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-23 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-23 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-23 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-23 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-23 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-23 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-23 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-23 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-23 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-23 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-22 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-22 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-22 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-22 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-22 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-22 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-22 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-22 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-22 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-21 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-21 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-21 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-21 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-21 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-21 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-21 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-21 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-20 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-20 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-20 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-20 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-20 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-20 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-20 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-20 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-20 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-19 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-19 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-19 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-18 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-18 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-18 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-18 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-18 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-17 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-17 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-17 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-17 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-17 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-16 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-16 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-16 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-16 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-15 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-14 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-12 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-10 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-09 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 5e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 4e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.002 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.004 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 496 bits (1280), Expect = e-173
Identities = 162/263 (61%), Positives = 199/263 (75%), Gaps = 6/263 (2%)
Query: 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSH 245
P YEL+ +G G+YG VYKARD+ T ELVAIKVI L G++ +E I+ EI ML++C H
Sbjct: 1 PQEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDD-FEIIQQEISMLKECRH 59
Query: 246 PNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS 305
PN+V Y GSY + LWIVMEYCGGGS+ D+ VT PL E QIAY+CRE LKGLAYLH
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE 119
Query: 306 IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESR-- 363
K+HRDIKG NILLT+ G+VKL DFGV+AQLT T++KR +FIGTP+WMAPEV R
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKG 179
Query: 364 -YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE--PAPMLEDKEKWSLVFHDF 420
YDGK D+WALG++A+E+AE PP +HPMR LF+IS P P L+DKEKWS VFHDF
Sbjct: 180 GYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDF 239
Query: 421 VAKCLTKEPRARPTAAEMLKHKF 443
+ KCLTK+P+ RPTA ++L+H F
Sbjct: 240 IKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 390 bits (1005), Expect = e-131
Identities = 147/259 (56%), Positives = 190/259 (73%), Gaps = 3/259 (1%)
Query: 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSH 245
P +++L +LG+GSYG+VYKA +T ++VAIKV+ + EE +EI EI +L+QC
Sbjct: 1 PEEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV---EEDLQEIIKEISILKQCDS 57
Query: 246 PNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS 305
P +V+Y GSY LWIVMEYCG GSV+D+M +T + L E +IA I + LKGL YLHS
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS 117
Query: 306 IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYD 365
K+HRDIK GNILL ++G+ KL DFGV+ QLT TM+KRNT IGTP WMAPEVIQE Y+
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177
Query: 366 GKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCL 425
K D+W+LG++A+EMAEG PP S +HPMR +FMI +P P L D EKWS F+DFV KCL
Sbjct: 178 NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCL 237
Query: 426 TKEPRARPTAAEMLKHKFI 444
K+P RP+A ++L+H FI
Sbjct: 238 VKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 383 bits (987), Expect = e-129
Identities = 140/255 (54%), Positives = 182/255 (71%), Gaps = 2/255 (0%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV 248
+E+L ++GKG +G VYKAR +T + VAIKVI L E+ E+I EI++L++C HPN+
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEK-KEKIINEIQILKKCKHPNI 59
Query: 249 VRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFK 308
V+Y GSY ++ LWIVME+C GGS+ DL+ T + L E QIAY+C+E LKGL YLHS
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGI 119
Query: 309 VHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKV 368
+HRDIK NILLT GEVKL DFG++AQL+ T RNT +GTP+WMAPEVI YD K
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK-ARNTMVGTPYWMAPEVINGKPYDYKA 178
Query: 369 DVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKE 428
D+W+LG++A+E+AEG PP S + PM+ LF I+ P L + EKWS F DF+ KCL K
Sbjct: 179 DIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKN 238
Query: 429 PRARPTAAEMLKHKF 443
P RPTA ++LKH F
Sbjct: 239 PEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 383 bits (986), Expect = e-128
Identities = 145/260 (55%), Positives = 189/260 (72%), Gaps = 3/260 (1%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV 248
+ LL +GKGS+G VYKA D +T+++VAIKVI L E E+ E+I+ EI+ L QC P +
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYI 61
Query: 249 VRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFK 308
+Y GS+ LWI+MEYCGGGS DL+ L+E IA+I RE L GL YLH K
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGSCLDLLK--PGKLDETYIAFILREVLLGLEYLHEEGK 119
Query: 309 VHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKV 368
+HRDIK NILL+++G+VKL DFGV+ QLT TMSKRNTF+GTP WMAPEVI++S YD K
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKA 179
Query: 369 DVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKE 428
D+W+LG++A+E+A+G PP S +HPMRVLF+I P LE K+S F DFV+ CL K+
Sbjct: 180 DIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEG-NKFSKPFKDFVSLCLNKD 238
Query: 429 PRARPTAAEMLKHKFIERCK 448
P+ RP+A E+LKHKFI++ K
Sbjct: 239 PKERPSAKELLKHKFIKKAK 258
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 351 bits (904), Expect = e-116
Identities = 138/275 (50%), Positives = 185/275 (67%), Gaps = 17/275 (6%)
Query: 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQ-C 243
DPT +EL+ +G+G+YG VYKAR KT +LVAIK++ + E EE EEI+ E +L++
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE--EEIKEEYNILRKYS 60
Query: 244 SHPNVVRYLGSY------QGEEYLWIVMEYCGGGSVADLMNVT---EEPLEEYQIAYICR 294
+HPN+ + G++ ++ LW+VME CGGGSV DL+ + L+E IAYI R
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 295 EALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWM 354
E L+GLAYLH +HRDIKG NILLT EVKL DFGV+AQL T+ +RNTFIGTP+WM
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWM 180
Query: 355 APEVIQ-----ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLED 409
APEVI ++ YD + DVW+LG++A+E+A+G PP +HPMR LF I P P L+
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS 240
Query: 410 KEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
E WS F+DF+++CL K RP E+L+H FI
Sbjct: 241 PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 340 bits (875), Expect = e-112
Identities = 134/280 (47%), Positives = 182/280 (65%), Gaps = 3/280 (1%)
Query: 179 ESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIE 238
+ V+ DP Y+ L ++G+G+ G VYKA D T + VAIK + L + + E I EI
Sbjct: 10 DIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNK--ELIINEIL 67
Query: 239 MLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALK 298
+++ C HPN+V Y SY + LW+VMEY GGS+ D++ + E QIAY+CRE L+
Sbjct: 68 IMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQ 127
Query: 299 GLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEV 358
GL YLHS +HRDIK NILL+ G VKL DFG AAQLT+ SKRN+ +GTP+WMAPEV
Sbjct: 128 GLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEV 187
Query: 359 IQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418
I+ Y KVD+W+LG+ +EMAEG PP P+R LF+I+ + P L++ EKWS F
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFK 247
Query: 419 DFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKI 458
DF+ KCL K+P RP+A E+L+H F+++ C P I
Sbjct: 248 DFLNKCLVKDPEKRPSAEELLQHPFLKKA-CPKEEFAPLI 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 320 bits (822), Expect = e-104
Identities = 122/268 (45%), Positives = 175/268 (65%), Gaps = 6/268 (2%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC 243
+P +E++ ELG G++G VYKA+ +T A K+I + EE E+ EI++L +C
Sbjct: 1 VNPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEE-LEDFMVEIDILSEC 59
Query: 244 SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYL 303
HPN+V +Y E LWI++E+C GG++ +M E L E QI Y+CR+ L+ L +L
Sbjct: 60 KHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL 119
Query: 304 HSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVI---- 359
HS +HRD+K GNILLT G+VKL DFGV+A+ T+ KR+TFIGTP+WMAPEV+
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179
Query: 360 -QESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418
+++ YD K D+W+LG++ +E+A+ PP ++PMRVL I P L+ KWS F+
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239
Query: 419 DFVAKCLTKEPRARPTAAEMLKHKFIER 446
DF+ CL K+P RPTAAE+LKH F+
Sbjct: 240 DFLKSCLVKDPDDRPTAAELLKHPFVSD 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 316 bits (811), Expect = e-103
Identities = 110/256 (42%), Positives = 148/256 (57%), Gaps = 3/256 (1%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVV 249
YE+L +LG+GS+G VY ARD KT +LVAIKVI + ++ E I EI++L++ HPN+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 250 RYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKV 309
R ++ E+ L++VMEYC GG + DL+ L E + + R+ L L YLHS V
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLHSKGIV 119
Query: 310 HRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVD 369
HRD+K NILL + G VKL DFG+A QL K TF+GTP +MAPEV+ Y VD
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFVGTPEYMAPEVLLGKGYGKAVD 178
Query: 370 VWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAP-MLEDKEKWSLVFHDFVAKCLTKE 428
+W+LGV E+ G PP + LF +P P + S D + K L K+
Sbjct: 179 IWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKD 238
Query: 429 PRARPTAAEMLKHKFI 444
P R TA E L+H F
Sbjct: 239 PEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 316 bits (810), Expect = e-102
Identities = 147/269 (54%), Positives = 192/269 (71%), Gaps = 9/269 (3%)
Query: 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEML 240
+ R +P YEL+ +G G+YG VYKAR+L T EL A+K+I L G++ + I+ EI M+
Sbjct: 2 ILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD-FSLIQQEIFMV 60
Query: 241 QQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGL 300
++C H N+V Y GSY E LWI MEYCGGGS+ D+ +VT PL E QIAY+CRE L+GL
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGL 119
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ 360
AYLHS K+HRDIKG NILLTD G+VKL DFGVAA++T T++KR +FIGTP+WMAPEV
Sbjct: 120 AYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAA 179
Query: 361 ESR---YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMIS---IEPAPMLEDKEKWS 414
+ Y+ D+WA+G++A+E+AE PP +HPMR LF++S +P P L+DK KWS
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQP-PKLKDKTKWS 238
Query: 415 LVFHDFVAKCLTKEPRARPTAAEMLKHKF 443
FH+FV LTK P+ RPTA +L H F
Sbjct: 239 STFHNFVKISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 305 bits (781), Expect = 3e-98
Identities = 143/269 (53%), Positives = 190/269 (70%), Gaps = 9/269 (3%)
Query: 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEML 240
++R +P +EL+ +G G+YG VYKAR++ T EL AIKVI L GE+ + ++ EI M+
Sbjct: 2 LSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED-FAVVQQEIIMM 60
Query: 241 QQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGL 300
+ C H N+V Y GSY + LWI ME+CGGGS+ D+ +VT PL E QIAY+ RE L+GL
Sbjct: 61 KDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGL 119
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ 360
YLHS K+HRDIKG NILLTD G VKL DFGV+AQ+T T++KR +FIGTP+WMAPEV
Sbjct: 120 YYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAA 179
Query: 361 ESR---YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI---SIEPAPMLEDKEKWS 414
R Y+ D+WA+G++A+E+AE PP +HPMR LF++ + +P P L+DK KWS
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP-PKLKDKMKWS 238
Query: 415 LVFHDFVAKCLTKEPRARPTAAEMLKHKF 443
FH FV LTK P+ RPTA ++L+H F
Sbjct: 239 NSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 301 bits (773), Expect = 7e-97
Identities = 149/262 (56%), Positives = 184/262 (70%), Gaps = 4/262 (1%)
Query: 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS 244
DP + L +GKGS+G VYK D +T E+VAIK+I L E E+ E+I+ EI +L QC
Sbjct: 1 DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 245 HPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLH 304
P + RY GSY LWI+MEY GGGS DL+ PLEE IA I RE LKGL YLH
Sbjct: 61 SPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLH 118
Query: 305 SIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRY 364
S K+HRDIK N+LL++QG+VKL DFGVA QLT T KRNTF+GTP WMAPEVI++S Y
Sbjct: 119 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 365 DGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424
D K D+W+LG++A+E+A+G PP S +HPMRVLF+I P LE ++S F +FV C
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEG--QYSKPFKEFVEAC 236
Query: 425 LTKEPRARPTAAEMLKHKFIER 446
L K+PR RPTA E+LKHKFI R
Sbjct: 237 LNKDPRFRPTAKELLKHKFITR 258
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 295 bits (756), Expect = 2e-94
Identities = 121/265 (45%), Positives = 165/265 (62%), Gaps = 10/265 (3%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVV 249
YEL+ +G G+ VY A L +E VAIK I L + + +E+R E++ + QC+HPNVV
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV 62
Query: 250 RYLGSYQGEEYLWIVMEYCGGGSVADLMN--VTEEPLEEYQIAYICREALKGLAYLHSIF 307
+Y S+ + LW+VM Y GGS+ D+M L+E IA + +E LKGL YLHS
Sbjct: 63 KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQL----TRTMSKRNTFIGTPHWMAPEVIQESR 363
++HRDIK GNILL + G VK+ DFGV+A L RT R TF+GTP WMAPEV+++
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 364 -YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLE---DKEKWSLVFHD 419
YD K D+W+ G++A+E+A G P S PM+VL + P LE D +K+S F
Sbjct: 183 GYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRK 242
Query: 420 FVAKCLTKEPRARPTAAEMLKHKFI 444
++ CL K+P RPTA E+LKHKF
Sbjct: 243 MISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 295 bits (757), Expect = 5e-94
Identities = 133/276 (48%), Positives = 186/276 (67%), Gaps = 11/276 (3%)
Query: 176 SIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS--EGEEGYEEI 233
I E +++DP + L E+G GS+GAVY ARD++T+E+VAIK +S S + E +++I
Sbjct: 3 EIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI 62
Query: 234 RGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYIC 293
E+ LQQ HPN + Y G Y E W+VMEYC G S +D++ V ++PL+E +IA IC
Sbjct: 63 IKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAIC 121
Query: 294 REALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHW 353
AL+GLAYLHS ++HRDIK GNILLT+ G VKL DFG A+ +S N+F+GTP+W
Sbjct: 122 HGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSAS----LVSPANSFVGTPYW 177
Query: 354 MAPEVI---QESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDK 410
MAPEVI E +YDGKVDVW+LG++ +E+AE PP ++ M L+ I+ +P L
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSN 237
Query: 411 EKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446
+ WS F +FV CL K P+ RP++ E+LKH+F+ R
Sbjct: 238 D-WSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 294 bits (753), Expect = 6e-94
Identities = 143/274 (52%), Positives = 188/274 (68%), Gaps = 5/274 (1%)
Query: 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS 244
DP + L +GKGS+G V+K D +T ++VAIK+I L E E+ E+I+ EI +L QC
Sbjct: 1 DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 245 HPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLH 304
P V +Y GSY LWI+MEY GGGS DL+ P +E+QIA + +E LKGL YLH
Sbjct: 61 SPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH 118
Query: 305 SIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRY 364
S K+HRDIK N+LL++QG+VKL DFGVA QLT T KRNTF+GTP WMAPEVIQ+S Y
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAY 178
Query: 365 DGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424
D K D+W+LG++A+E+A+G PP S +HPMRVLF+I P L ++S F +F+ C
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTG--EFSKPFKEFIDAC 236
Query: 425 LTKEPRARPTAAEMLKHKFIERCKCGATAMLPKI 458
L K+P RPTA E+LKHKFI + T+ L ++
Sbjct: 237 LNKDPSFRPTAKELLKHKFIVK-NAKKTSYLTEL 269
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 288 bits (737), Expect = 1e-91
Identities = 145/262 (55%), Positives = 183/262 (69%), Gaps = 4/262 (1%)
Query: 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS 244
DP + L ++GKGS+G V+K D +T ++VAIK+I L E E+ E+I+ EI +L QC
Sbjct: 1 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 245 HPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLH 304
P V +Y GSY + LWI+MEY GGGS DL+ PL+E QIA I RE LKGL YLH
Sbjct: 61 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLH 118
Query: 305 SIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRY 364
S K+HRDIK N+LL++ GEVKL DFGVA QLT T KRNTF+GTP WMAPEVI++S Y
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 365 DGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424
D K D+W+LG++A+E+A+G PP S +HPM+VLF+I P LE +S +FV C
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEG--NYSKPLKEFVEAC 236
Query: 425 LTKEPRARPTAAEMLKHKFIER 446
L KEP RPTA E+LKHKFI R
Sbjct: 237 LNKEPSFRPTAKELLKHKFIVR 258
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 284 bits (729), Expect = 2e-90
Identities = 141/273 (51%), Positives = 189/273 (69%), Gaps = 16/273 (5%)
Query: 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS 244
DP +EL+ +G G+YG VYK R +KT +L AIKV+ ++E EE EEI+ EI ML++ S
Sbjct: 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE--EEIKLEINMLKKYS 70
Query: 245 H-PNVVRYLGSY------QGEEYLWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREA 296
H N+ Y G++ ++ LW+VME+CG GSV DL+ T+ L+E IAYICRE
Sbjct: 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREI 130
Query: 297 LKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAP 356
L+GLA+LH+ +HRDIKG N+LLT+ EVKL DFGV+AQL RT+ +RNTFIGTP+WMAP
Sbjct: 131 LRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 190
Query: 357 EVIQ-----ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKE 411
EVI ++ YD + D+W+LG++A+EMAEG PP +HPMR LF+I P P L+ K
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSK- 249
Query: 412 KWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
KWS F DF+ CL K +RP+ ++LKH FI
Sbjct: 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 276 bits (707), Expect = 4e-87
Identities = 119/263 (45%), Positives = 165/263 (62%), Gaps = 10/263 (3%)
Query: 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSH 245
+ EL+ G+G+YGAVY+ + + T +VA+K+I+L ++ +I+ E+ +L Q
Sbjct: 2 LYQRLELI---GRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ 58
Query: 246 ---PNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAY 302
PN+ +Y GSY LWI+MEY GGSV LM P+ E I+ I RE L L Y
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKY 116
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQES 362
+H + +HRDIK NIL+T+ G VKL DFGVAA L + SKR+TF+GTP+WMAPEVI E
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176
Query: 363 R-YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421
+ YD K D+W+LG++ EMA G PP S V R + +I P LED +S + +FV
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNG-YSKLLREFV 235
Query: 422 AKCLTKEPRARPTAAEMLKHKFI 444
A CL +EP+ R +A E+LK K+I
Sbjct: 236 AACLDEEPKERLSAEELLKSKWI 258
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 273 bits (698), Expect = 5e-86
Identities = 140/273 (51%), Positives = 185/273 (67%), Gaps = 16/273 (5%)
Query: 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS 244
DP +EL+ +G G+YG VYK R +KT +L AIKV+ ++ EE EEI+ EI ML++ S
Sbjct: 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE--EEIKQEINMLKKYS 60
Query: 245 H-PNVVRYLGSYQG------EEYLWIVMEYCGGGSVADLM-NVTEEPLEEYQIAYICREA 296
H N+ Y G++ ++ LW+VME+CG GSV DL+ N L+E IAYICRE
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 120
Query: 297 LKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAP 356
L+GL++LH +HRDIKG N+LLT+ EVKL DFGV+AQL RT+ +RNTFIGTP+WMAP
Sbjct: 121 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 180
Query: 357 EVIQ-----ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKE 411
EVI ++ YD K D+W+LG++A+EMAEG PP +HPMR LF+I PAP L+ K
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK- 239
Query: 412 KWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
KWS F F+ CL K RPT +++KH FI
Sbjct: 240 KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 266 bits (681), Expect = 2e-83
Identities = 111/261 (42%), Positives = 162/261 (62%), Gaps = 7/261 (2%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISL-SEGEEGYEEIRGEIEMLQQCSHPNV 248
YELL +LG GS+G VYKA+ T ++VA+K++ SE + + R EI +L++ SHPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 249 VRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFK 308
VR + +++ +++L++VMEYC GG + D + PL E + I + L+GL YLHS
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYL-SRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 309 VHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDG-K 367
+HRD+K NILL + G VK+ DFG+A +L ++ S TF+GTP +MAPEV+ G K
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 368 VDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI-SIEPAPMLEDKEKWSLV---FHDFVAK 423
VDVW+LGV E+ G PP S + + L +I I P+ D+ KWS D + K
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239
Query: 424 CLTKEPRARPTAAEMLKHKFI 444
CL K+P RPTA E+L+H +
Sbjct: 240 CLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 264 bits (678), Expect = 4e-83
Identities = 106/257 (41%), Positives = 154/257 (59%), Gaps = 4/257 (1%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPN 247
Y+L + +G+G++G VYK +L+T + VAIK ISL + EE + I EI++L+ HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307
+V+Y+GS + + L+I++EY GS+ ++ P E +A + L+GLAYLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIK-KFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGK 367
+HRDIK NIL T G VKL DFGVA +L + +GTP+WMAPEVI+ S
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTA 179
Query: 368 VDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTK 427
D+W+LG + +E+ G PP ++PM LF I + P L E S DF+ +C K
Sbjct: 180 SDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPL--PEGISPELKDFLMQCFQK 237
Query: 428 EPRARPTAAEMLKHKFI 444
+P RPTA ++LKH +I
Sbjct: 238 DPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 264 bits (678), Expect = 4e-83
Identities = 115/265 (43%), Positives = 153/265 (57%), Gaps = 14/265 (5%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPN 247
++ LG+GS+G+VY A D T EL+A+K + LS EE E + EI +L HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 248 VVRYLGSYQGEE--YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS 305
+VRY GS + EE L I +EY GGS++ L+ L E I R+ L+GLAYLHS
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 306 --IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL--TRTMSKRNTFIGTPHWMAPEVIQE 361
I VHRDIKG NIL+ G VKL DFG A +L T + GTP+WMAPEVI+
Sbjct: 120 NGI--VHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 362 SRYDGKVDVWALGVSAVEMAEGLPPRSTVH-PMRVLFMISI-EPAPMLEDKEKWSLVFHD 419
Y D+W+LG + +EMA G PP S + PM L+ I P + + S D
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHL--SEEAKD 235
Query: 420 FVAKCLTKEPRARPTAAEMLKHKFI 444
F+ KCL ++P+ RPTA E+L+H F+
Sbjct: 236 FLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 266 bits (680), Expect = 5e-83
Identities = 122/274 (44%), Positives = 183/274 (66%), Gaps = 7/274 (2%)
Query: 179 ESVTRE-DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEI 237
E V R+ DP +E++ ELG G++G VYKA++ +T L A KVI ++ EE E+ EI
Sbjct: 2 EHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIE-TKSEEELEDYMVEI 60
Query: 238 EMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREAL 297
E+L C+HP +V+ LG++ + LWI++E+C GG+V +M + L E QI ICR+ L
Sbjct: 61 EILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML 120
Query: 298 KGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPE 357
+ L YLHS+ +HRD+K GN+LLT G++KL DFGV+A+ +T+ +R++FIGTP+WMAPE
Sbjct: 121 EALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPE 180
Query: 358 VI-----QESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEK 412
V+ +++ YD K D+W+LG++ +EMA+ PP ++PMRVL I+ P L K
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK 240
Query: 413 WSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446
WS+ F DF+ L K P RP+AA++L+H F+
Sbjct: 241 WSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 260 bits (665), Expect = 2e-80
Identities = 135/275 (49%), Positives = 184/275 (66%), Gaps = 11/275 (4%)
Query: 177 IPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS--EGEEGYEEIR 234
I E +EDP + L E+G GS+GAVY ARD++T+E+VAIK +S S + E +++I
Sbjct: 14 IAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDII 73
Query: 235 GEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICR 294
E++ LQ+ HPN + Y G Y E W+VMEYC G S +DL+ V ++PL+E +IA I
Sbjct: 74 KEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITH 132
Query: 295 EALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWM 354
AL+GLAYLHS +HRDIK GNILLT+ G+VKL DFG A+ S N+F+GTP+WM
Sbjct: 133 GALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSAS----IASPANSFVGTPYWM 188
Query: 355 APEVI---QESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKE 411
APEVI E +YDGKVDVW+LG++ +E+AE PP ++ M L+ I+ +P L+ E
Sbjct: 189 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNE 248
Query: 412 KWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446
WS F +FV CL K P+ RPT+ E+LKH F+ R
Sbjct: 249 -WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 258 bits (660), Expect = 6e-80
Identities = 129/275 (46%), Positives = 182/275 (66%), Gaps = 11/275 (4%)
Query: 177 IPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS--EGEEGYEEIR 234
+ E ++DP + L E+G GS+GAVY ARD++ SE+VAIK +S S + E +++I
Sbjct: 4 VAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 63
Query: 235 GEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICR 294
E+ LQ+ HPN ++Y G Y E W+VMEYC G S +DL+ V ++PL+E +IA +
Sbjct: 64 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTH 122
Query: 295 EALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWM 354
AL+GLAYLHS +HRD+K GNILL++ G VKLGDFG A+ M+ N F+GTP+WM
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS----IMAPANXFVGTPYWM 178
Query: 355 APEVI---QESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKE 411
APEVI E +YDGKVDVW+LG++ +E+AE PP ++ M L+ I+ +P L+
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238
Query: 412 KWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446
WS F +FV CL K P+ RPT+ +LKH+F+ R
Sbjct: 239 -WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 256 bits (654), Expect = 6e-79
Identities = 128/269 (47%), Positives = 179/269 (66%), Gaps = 11/269 (4%)
Query: 183 REDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS--EGEEGYEEIRGEIEML 240
++DP + L+E+G GS+GAVY A + T+E+VA+K +S S + E +++I E++ L
Sbjct: 16 KDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFL 75
Query: 241 QQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGL 300
QQ HPN + Y G Y E W+VMEYC G S +DL+ V ++PL+E +IA I AL+GL
Sbjct: 76 QQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGL 134
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVI- 359
AYLHS +HRDIK GNILLT+ G+VKL DFG A+ S N+F+GTP+WMAPEVI
Sbjct: 135 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSAS----KSSPANSFVGTPYWMAPEVIL 190
Query: 360 --QESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVF 417
E +YDGKVDVW+LG++ +E+AE PP ++ M L+ I+ +P L+ E W+ F
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNE-WTDSF 249
Query: 418 HDFVAKCLTKEPRARPTAAEMLKHKFIER 446
FV CL K P+ RP +AE+L+H F+ R
Sbjct: 250 RGFVDYCLQKIPQERPASAELLRHDFVRR 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 254 bits (649), Expect = 2e-78
Identities = 124/284 (43%), Positives = 180/284 (63%), Gaps = 4/284 (1%)
Query: 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEML 240
V+ DP KY ++G+G+ G VY A D+ T + VAIK ++L + + E I EI ++
Sbjct: 12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVM 70
Query: 241 QQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGL 300
++ HPN+V YL SY + LW+VMEY GGS+ D+ VTE ++E QIA +CRE L+ L
Sbjct: 71 RENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQAL 128
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ 360
+LHS +HRDIK NILL G VKL DFG AQ+T SKR+T +GTP+WMAPEV+
Sbjct: 129 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 361 ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420
Y KVD+W+LG+ A+EM EG PP +P+R L++I+ P L++ EK S +F DF
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 248
Query: 421 VAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQI 464
+ +CL + R +A E+L+H F+ + +++ P I A++
Sbjct: 249 LNRCLEMDVEKRGSAKELLQHPFL-KIAKPLSSLTPLIAAAKEA 291
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 253 bits (648), Expect = 2e-78
Identities = 129/274 (47%), Positives = 173/274 (63%), Gaps = 16/274 (5%)
Query: 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS 244
DP+ +E++ +GKG+YG V+K + K A+K+ L + EEI E +L+ S
Sbjct: 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKI--LDPIHDIDEEIEAEYNILKALS 72
Query: 245 -HPNVVRYLGSY-----QGEEYLWIVMEYCGGGSVADL---MNVTEEPLEEYQIAYICRE 295
HPNVV++ G Y + + LW+V+E C GGSV DL E +EE IAYI E
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 296 ALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMA 355
AL GL +LH +HRD+KG NILLT +G VKL DFGV+AQLT T +RNT +GTP WMA
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192
Query: 356 PEVIQ-----ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDK 410
PEVI +S YD + DVW+LG++A+E+ +G PP + +HPMR LF I P P L
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQP 252
Query: 411 EKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
E WS F+DF+ KCLTK+ RPT +++L+H FI
Sbjct: 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 253 bits (647), Expect = 2e-78
Identities = 119/265 (44%), Positives = 174/265 (65%), Gaps = 6/265 (2%)
Query: 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS 244
+P +E++ ELG G++G VYKA++ +T L A KVI ++ EE E+ EI++L C
Sbjct: 2 NPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVID-TKSEEELEDYMVEIDILASCD 60
Query: 245 HPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLH 304
HPN+V+ L ++ E LWI++E+C GG+V +M E PL E QI +C++ L+ L YLH
Sbjct: 61 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120
Query: 305 SIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVI----- 359
+HRD+K GNIL T G++KL DFGV+A+ TRT+ +R++FIGTP+WMAPEV+
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 360 QESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHD 419
++ YD K DVW+LG++ +EMA+ PP ++PMRVL I+ P L +WS F D
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD 240
Query: 420 FVAKCLTKEPRARPTAAEMLKHKFI 444
F+ KCL K AR T ++L+H F+
Sbjct: 241 FLKKCLEKNVDARWTTTQLLQHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 247 bits (632), Expect = 3e-76
Identities = 103/258 (39%), Positives = 154/258 (59%), Gaps = 6/258 (2%)
Query: 191 ELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVR 250
E + LG+GS G VYK R T ++ A+K I + EE +++ E++ L+ C P VV+
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK 63
Query: 251 YLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFK-V 309
G++ E + IV+EY GGS+ADL+ + E +AYI R+ LKGL YLH+ +
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLADLLKKVG-KIPEPVLAYIARQILKGLDYLHTKRHII 122
Query: 310 HRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVD 369
HRDIK N+L+ +GEVK+ DFG++ L T+ + NTF+GT +M+PE IQ Y D
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAAD 182
Query: 370 VWALGVSAVEMAEG---LPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLT 426
+W+LG++ +E A G P ++ I P P L +E +S F DF++ CL
Sbjct: 183 IWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEE-FSPEFRDFISACLQ 241
Query: 427 KEPRARPTAAEMLKHKFI 444
K+P+ RP+AAE+L+H FI
Sbjct: 242 KDPKKRPSAAELLQHPFI 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 245 bits (626), Expect = 4e-75
Identities = 122/275 (44%), Positives = 173/275 (62%), Gaps = 16/275 (5%)
Query: 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS 244
DPT +E++ +GKG+YG VYK + K L A+K+ L + EEI E +LQ
Sbjct: 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKI--LDPISDVDEEIEAEYNILQSLP 76
Query: 245 -HPNVVRYLGS-YQGEEY----LWIVMEYCGGGSVADLMN---VTEEPLEEYQIAYICRE 295
HPNVV++ G Y+ ++ LW+V+E C GGSV +L+ + + L+E I+YI
Sbjct: 77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136
Query: 296 ALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMA 355
AL GL +LH+ +HRD+KG NILLT +G VKL DFGV+AQLT T +RNT +GTP WMA
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 196
Query: 356 PEVIQ-----ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDK 410
PEVI + YD + DVW+LG++A+E+ +G PP +HP++ LF I P P L
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHP 256
Query: 411 EKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445
EKW F+ F+++CL K+ ARP+ +L+H FI+
Sbjct: 257 EKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 242 bits (619), Expect = 4e-75
Identities = 99/248 (39%), Positives = 137/248 (55%), Gaps = 36/248 (14%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSY 255
LG+G +G VY ARD KT + VAIK+I + EE+ EIE+L++ +HPN+V+ G +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 256 QGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKG 315
+ E +L++VMEYC GGS+ DL+ E L E +I I + L+GL YLHS +HRD+K
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 316 GNILLT-DQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDG-KVDVWAL 373
NILL D G+VKL DFG++ LT S T +GTP +MAPEV+ Y K D+W+L
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSL 180
Query: 374 GVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARP 433
GV E+ E D + K L K+P RP
Sbjct: 181 GVILYELPE----------------------------------LKDLIRKMLQKDPEKRP 206
Query: 434 TAAEMLKH 441
+A E+L+H
Sbjct: 207 SAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 236 bits (605), Expect = 2e-72
Identities = 89/260 (34%), Positives = 143/260 (55%), Gaps = 6/260 (2%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPN 247
KYE++ ++GKGS+G VY R +L +K I LS E+ E+ E+++L++ +HPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLM---NVTEEPLEEYQIAYICREALKGLAYLH 304
+++Y S++ + L IVMEY GG ++ + +P E QI + L YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 305 SIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRY 364
S +HRDIK NI LT G VKLGDFG++ L+ T+ T +GTP++++PE+ Q Y
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPY 180
Query: 365 DGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424
+ K D+W+LG E+ P + + + I P + ++S + V+
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIP--SQYSSELRNLVSSL 238
Query: 425 LTKEPRARPTAAEMLKHKFI 444
L K+P RP+ A++L+ FI
Sbjct: 239 LQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 235 bits (601), Expect = 1e-71
Identities = 124/283 (43%), Positives = 181/283 (63%), Gaps = 4/283 (1%)
Query: 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEML 240
V+ DP KY ++G+G+ G VY A D+ T + VAIK ++L + + E I EI ++
Sbjct: 12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVM 70
Query: 241 QQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGL 300
++ +PN+V YL SY + LW+VMEY GGS+ D+ VTE ++E QIA +CRE L+ L
Sbjct: 71 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQAL 128
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ 360
+LHS +HRDIK NILL G VKL DFG AQ+T SKR+T +GTP+WMAPEV+
Sbjct: 129 DFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 361 ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420
Y KVD+W+LG+ A+EM EG PP +P+R L++I+ P L++ E+ S VF DF
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDF 248
Query: 421 VAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQ 463
+ +CL + R +A E+L+H F++ K +++ P I A++
Sbjct: 249 LNRCLEMDVDRRGSAKELLQHPFLKLAK-PLSSLTPLIIAAKE 290
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 235 bits (599), Expect = 3e-71
Identities = 123/283 (43%), Positives = 182/283 (64%), Gaps = 4/283 (1%)
Query: 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEML 240
V+ DP KY ++G+G+ G VY A D+ T + VAI+ ++L + + E I EI ++
Sbjct: 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVM 71
Query: 241 QQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGL 300
++ +PN+V YL SY + LW+VMEY GGS+ D+ VTE ++E QIA +CRE L+ L
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQAL 129
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ 360
+LHS +HRDIK NILL G VKL DFG AQ+T SKR+T +GTP+WMAPEV+
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 361 ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420
Y KVD+W+LG+ A+EM EG PP +P+R L++I+ P L++ EK S +F DF
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249
Query: 421 VAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQ 463
+ +CL + R +A E+L+H+F++ K +++ P I A++
Sbjct: 250 LNRCLDMDVEKRGSAKELLQHQFLKIAK-PLSSLTPLIAAAKE 291
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 231 bits (590), Expect = 5e-70
Identities = 101/276 (36%), Positives = 160/276 (57%), Gaps = 4/276 (1%)
Query: 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEML 240
V DP + + ++G+GS G V A D T VA+K + L + ++ E + E+ ++
Sbjct: 12 VDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIM 70
Query: 241 QQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGL 300
+ HPN+V SY + LW+VME+ GG++ D+ VT + E QIA +C LK L
Sbjct: 71 RDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDI--VTHTRMNEEQIATVCLAVLKAL 128
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ 360
++LH+ +HRDIK +ILLT G VKL DFG AQ+++ + +R + +GTP+WMAPEVI
Sbjct: 129 SFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVIS 188
Query: 361 ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420
Y +VD+W+LG+ +EM +G PP P++ + I P L++ K S F
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSF 248
Query: 421 VAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLP 456
+ + L ++P R TAAE+L H F+ + ++++P
Sbjct: 249 LDRMLVRDPAQRATAAELLNHPFLAKA-GPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 229 bits (585), Expect = 1e-69
Identities = 107/259 (41%), Positives = 152/259 (58%), Gaps = 18/259 (6%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISL----SEGEEGYEEIRGEIEMLQQCSHPNVVRY 251
LG GS+G+VY+ +L + A+K +SL G+E +++ EI +L + HPN+V+Y
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 252 LGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHR 311
LG+ + E+ L+I +E GGS+A L+ E I R+ L GL YLH VHR
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLK-KYGSFPEPVIRLYTRQILLGLEYLHDRNTVHR 126
Query: 312 DIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVI-QESRYDGKVDV 370
DIKG NIL+ G VKL DFG+A Q+ S +F G+P+WMAPEVI Q+ Y D+
Sbjct: 127 DIKGANILVDTNGVVKLADFGMAKQVV-EFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185
Query: 371 WALGVSAVEMAEGLPPRSTVHPMRVLFMI----SIEPAP-MLEDKEKWSLVFHDFVAKCL 425
W+LG + +EMA G PP S + + +F I + P P L D+ K DF+ KCL
Sbjct: 186 WSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAK------DFILKCL 239
Query: 426 TKEPRARPTAAEMLKHKFI 444
++P RPTAAE+L+H F+
Sbjct: 240 QRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 228 bits (582), Expect = 7e-69
Identities = 120/287 (41%), Positives = 182/287 (63%), Gaps = 4/287 (1%)
Query: 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEML 240
V+ DP KY ++G+G+ G V+ A D+ T + VAIK I+L + + E I EI ++
Sbjct: 12 VSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVM 70
Query: 241 QQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGL 300
++ +PN+V +L S+ + L++VMEY GGS+ D+ VTE ++E QIA +CRE L+ L
Sbjct: 71 KELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDV--VTETCMDEAQIAAVCRECLQAL 128
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ 360
+LH+ +HRDIK N+LL G VKL DFG AQ+T SKR+T +GTP+WMAPEV+
Sbjct: 129 EFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 361 ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420
Y KVD+W+LG+ A+EM EG PP +P+R L++I+ P L++ EK S +F DF
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDF 248
Query: 421 VAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRAS 467
+ +CL + R +A E+L+H F++ K +++ P I A++ S
Sbjct: 249 LNRCLEMDVEKRGSAKELLQHPFLKLAK-PLSSLTPLILAAKEAMKS 294
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 226 bits (577), Expect = 2e-68
Identities = 102/262 (38%), Positives = 152/262 (58%), Gaps = 9/262 (3%)
Query: 191 ELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVR 250
E L ELG G+ G V K T +++A+K I L E ++I E+++L +C+ P +V
Sbjct: 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVG 63
Query: 251 YLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKV- 309
+ G++ + I MEY GGS+ ++ + + E + I LKGL YLH K+
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKII 123
Query: 310 HRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVD 369
HRD+K NIL+ +G++KL DFGV+ QL +++K TF+GT +MAPE IQ + Y K D
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQGNDYSVKSD 181
Query: 370 VWALGVSAVEMAEG---LPPRSTVHPM--RVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424
+W+LG+S +E+A G PP + +L I EP P L K+S F DFV C
Sbjct: 182 IWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP-SGKFSPDFQDFVNLC 240
Query: 425 LTKEPRARPTAAEMLKHKFIER 446
L K+PR RP+ E+L+H FI++
Sbjct: 241 LIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 208 bits (531), Expect = 7e-62
Identities = 102/265 (38%), Positives = 157/265 (59%), Gaps = 10/265 (3%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEG-YEEIRGEIEMLQQCSHPN 247
+++ N++G G++G VY A +L T EL+A+K I + + + +EI E+++L+ HPN
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307
+V+Y G E ++I MEYC GG++ +L+ L+E+ I + L+GLAYLHS
Sbjct: 61 LVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLHSHG 119
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQL---TRTMSKR-NTFIGTPHWMAPEVIQESR 363
VHRDIK NI L G +KLGDFG A +L T TM + + GTP +MAPEVI +
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 364 YDGK---VDVWALGVSAVEMAEGLPPRSTV-HPMRVLFMISIEPAPMLEDKEKWSLVFHD 419
G D+W+LG +EMA G P S + + +++F + P + D + S D
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239
Query: 420 FVAKCLTKEPRARPTAAEMLKHKFI 444
F+ +CL +P+ RPTA+E+L+H F+
Sbjct: 240 FLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 209 bits (533), Expect = 9e-62
Identities = 108/283 (38%), Positives = 171/283 (60%), Gaps = 4/283 (1%)
Query: 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEML 240
V + DP + E ++G+GS G V AR+ + VA+K++ L + ++ E + E+ ++
Sbjct: 14 VDQGDPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIM 72
Query: 241 QQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGL 300
+ H NVV SY E LW++ME+ GG++ D+ V++ L E QIA +C L+ L
Sbjct: 73 RDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDI--VSQTRLNEEQIATVCESVLQAL 130
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ 360
YLHS +HRDIK +ILLT G VKL DFG AQ+++ + KR + +GTP+WMAPEVI
Sbjct: 131 CYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 190
Query: 361 ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420
+ Y +VD+W+LG+ +EM +G PP + P++ + + P P L++ K S V DF
Sbjct: 191 RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDF 250
Query: 421 VAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQ 463
+ + LT+EP+ R TA E+L H F+ + ++P I++ R+
Sbjct: 251 LERMLTREPQERATAQELLDHPFLLQTGL-PECLVPLIQQYRK 292
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 207 bits (529), Expect = 3e-61
Identities = 104/270 (38%), Positives = 154/270 (57%), Gaps = 16/270 (5%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV 248
K L+ LG+G+ G+V K R T + A+K I+ + ++I E+E+ + C P +
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 249 VRYLGSYQGEE--YLWIVMEYCGGGSV-ADLMNVTEEP--LEEYQIAYICREALKGLAYL 303
V+Y G++ E + I MEYC GGS+ + V + + E + I LKGL+YL
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 304 HSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESR 363
HS +HRDIK NILLT +G+VKL DFGV+ +L +++ TF GT +MAPE IQ
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG--TFTGTSFYMAPERIQGKP 179
Query: 364 YDGKVDVWALGVSAVEMAEG---LPPRST--VHPMRVLFMISIEPAPMLEDKE----KWS 414
Y DVW+LG++ +E+A+ PP + P+ +L I P P L+D+ KWS
Sbjct: 180 YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWS 239
Query: 415 LVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
F DF+ +CL K+P RPT +ML+H +I
Sbjct: 240 EEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 7e-56
Identities = 96/262 (36%), Positives = 148/262 (56%), Gaps = 13/262 (4%)
Query: 194 NELGKGSYGAVYKARDLKTSELVAIKVISLS-----EGEEGYEEIRGEIEMLQQCSHPNV 248
LGKG+YG VY +L+A+K + L E+ YE+++ E+++L+ H N+
Sbjct: 6 EVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 249 VRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFK 308
V+YLG+ + + I ME+ GGS++ ++N PL E ++ L G+AYLH+
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 309 VHRDIKGGNILLTDQGEVKLGDFGVAAQL---TRTMSKRN---TFIGTPHWMAPEVIQES 362
VHRDIKG N++L G +KL DFG A +L + N + GTP+WMAPEVI ES
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183
Query: 363 RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVA 422
Y K D+W++G + EMA G PP +++ + +F I M + +S DFV
Sbjct: 184 GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVT 243
Query: 423 KCLTKEPRARPTAAEMLKHKFI 444
CLT++ RP+A ++L+H F+
Sbjct: 244 SCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 1e-54
Identities = 100/262 (38%), Positives = 155/262 (59%), Gaps = 3/262 (1%)
Query: 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS 244
DP T + ++G+GS G V A + +LVA+K + L + ++ E + E+ +++
Sbjct: 17 DPRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQ 75
Query: 245 HPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLH 304
H NVV SY + LW+VME+ GG++ D+ VT + E QIA +C LK L+ LH
Sbjct: 76 HENVVEMYNSYLVGDELWVVMEFLEGGALTDI--VTHTRMNEEQIAAVCLAVLKALSVLH 133
Query: 305 SIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRY 364
+ +HRDIK +ILLT G VKL DFG AQ+++ + +R + +GTP+WMAPE+I Y
Sbjct: 134 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY 193
Query: 365 DGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424
+VD+W+LG+ +EM +G PP P++ + MI P L++ K S F+ +
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRL 253
Query: 425 LTKEPRARPTAAEMLKHKFIER 446
L ++P R TAAE+LKH F+ +
Sbjct: 254 LVRDPAQRATAAELLKHPFLAK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 188 bits (478), Expect = 3e-54
Identities = 95/265 (35%), Positives = 143/265 (53%), Gaps = 21/265 (7%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE--------IRGEIEMLQQCSHPN 247
+G GS+G+VY + + EL+A+K + L ++ + EI +L++ H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307
+V+YLGS ++L I +EY GGSVA L+N EE + R+ LKGL YLH+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETLVRNFVRQILKGLNYLHNRG 126
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQL------TRTMSKRNTFIGTPHWMAPEVIQE 361
+HRDIKG NIL+ ++G +K+ DFG++ +L T+T R + G+ WMAPEV+++
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ 186
Query: 362 SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMIS--IEPAPMLEDKEKWSLVFHD 419
+ Y K D+W+LG VEM G P ++ +F I P S D
Sbjct: 187 TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEI----PSNISSEAID 242
Query: 420 FVAKCLTKEPRARPTAAEMLKHKFI 444
F+ K + RPTAAE+LKH F+
Sbjct: 243 FLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 2e-53
Identities = 96/265 (36%), Positives = 139/265 (52%), Gaps = 17/265 (6%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISLSEGEEG---------YEEIRGEIEMLQQCSHP 246
+GKG+YG VY A ++ T E++A+K + L G + +R EIE L+ H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI 306
N+V+YLG EEYL I +EY GGS+ + T EE + + + L+GLAYLHS
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR-TYGRFEEQLVRFFTEQVLEGLAYLHSK 127
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESR- 363
+HRD+K N+L+ G K+ DFG++ + + + G+ WMAPEVI
Sbjct: 128 GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQ 187
Query: 364 -YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA--PMLED-KEKWSLVFHD 419
Y KVD+W+LG +EM G P S + +F + + + P+ D S V D
Sbjct: 188 GYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALD 247
Query: 420 FVAKCLTKEPRARPTAAEMLKHKFI 444
F+ C T P RPTA E+L+H FI
Sbjct: 248 FLNACFTINPDNRPTARELLQHPFI 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 186 bits (472), Expect = 3e-53
Identities = 100/265 (37%), Positives = 155/265 (58%), Gaps = 3/265 (1%)
Query: 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEML 240
V+ DP + ++G+GS G V A + T + VA+K + L + ++ E + E+ ++
Sbjct: 15 VSPGDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIM 73
Query: 241 QQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGL 300
+ H NVV SY + LW+VME+ GG++ D+ VT + E QIA +C L+ L
Sbjct: 74 RDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDI--VTHTRMNEEQIATVCLSVLRAL 131
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ 360
+YLH+ +HRDIK +ILLT G +KL DFG AQ+++ + KR + +GTP+WMAPEVI
Sbjct: 132 SYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVIS 191
Query: 361 ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420
Y +VD+W+LG+ +EM +G PP P++ + I P ++D K S V F
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGF 251
Query: 421 VAKCLTKEPRARPTAAEMLKHKFIE 445
+ L +EP R TA E+L+H F++
Sbjct: 252 LDLMLVREPSQRATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 2e-51
Identities = 92/257 (35%), Positives = 134/257 (52%), Gaps = 11/257 (4%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISL----SEGEEGYEEIRGEIEMLQQCSHPNVVRY 251
LG+G++G VY D+ T +A+K + E ++ + EI++L+ H +V+Y
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 252 LGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHR 311
G + +E L I MEY GGSV D + L E R+ L+G+ YLHS VHR
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLK-AYGALTETVTRKYTRQILEGVEYLHSNMIVHR 128
Query: 312 DIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK---RNTFIGTPHWMAPEVIQESRYDGKV 368
DIKG NIL G VKLGDFG + +L S + GTP+WM+PEVI Y K
Sbjct: 129 DIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKA 188
Query: 369 DVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA-PMLEDKEKWSLVFHDFVAKCLTK 427
DVW++G + VEM PP + M +F I+ +P P L +F+ + +
Sbjct: 189 DVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDAR--NFLRRTFVE 246
Query: 428 EPRARPTAAEMLKHKFI 444
+ RP+A E+L+H F+
Sbjct: 247 NAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 3e-51
Identities = 85/273 (31%), Positives = 134/273 (49%), Gaps = 25/273 (9%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVIS---LSEGEEGYEEIRGEIEMLQQCSH 245
YE+L +GKGS+G V K R +++ K I ++E E+ +++ E+ +L++ H
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK--QQLVSEVNILRELKH 58
Query: 246 PNVVRYLGSYQGE-----EYLWIVMEYCGGGSVADLMN---VTEEPLEEYQIAYICREAL 297
PN+VRY Y + L+IVMEYC GG +A L+ + +EE I I + L
Sbjct: 59 PNIVRY---YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLL 115
Query: 298 KGLAYLHSIFK-----VHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH 352
L H+ +HRD+K NI L VKLGDFG+A L S T++GTP+
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPY 175
Query: 353 WMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPP-RSTVHPMRVLFMISIEPAPMLEDKE 411
+M+PE + YD K D+W+LG E+ PP + + I+
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLASKIKEGKFRRIPY 232
Query: 412 KWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
++S ++ + L +P RP+ E+L+ I
Sbjct: 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 182 bits (462), Expect = 6e-51
Identities = 100/285 (35%), Positives = 146/285 (51%), Gaps = 28/285 (9%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY--EEIRGEIEMLQQCSHP 246
Y +L +LG+GS+G VY ARD K VA+KV++ + E EI++L +HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 247 -NVVRYLGSYQGEEYLWIVMEYCGGGSVADLM--NVTEEPLEEYQIAYICREALKGLAYL 303
N+V+ +Q E L++VMEY GGS+ DL+ + PL E + +I + L L YL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 304 HSIFKVHRDIKGGNILLTDQG-EVKLGDFGVAAQLTRTMSKR------NTFIGTPHWMAP 356
HS +HRDIK NILL G VKL DFG+A L S +T +GTP +MAP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 357 EVIQ---ESRYDGKVDVWALGVSAVEMAEGLPPR----STVHPMRVLFMISIEPAPML-- 407
EV+ + D+W+LG++ E+ GLPP ++ + L +I P P L
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 408 ----EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448
+ E S D + K L K+P+ R +++ L H + K
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 9e-51
Identities = 89/255 (34%), Positives = 131/255 (51%), Gaps = 13/255 (5%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVIS----LSEGEEGYEEIRGEIEMLQQCSHPNVVRY 251
LGKGS+G V R T +L A+KV+ + E + E +L + +HP +V+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEH--TLTERNILSRINHPFIVKL 58
Query: 252 LGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHR 311
++Q EE L++V+EY GG + ++ E E + + E + L YLHS+ ++R
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLS-KEGRFSEERARFYAAEIVLALEYLHSLGIIYR 117
Query: 312 DIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVW 371
D+K NILL G +KL DFG+A +L+ S+ NTF GTP ++APEV+ Y VD W
Sbjct: 118 DLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWW 177
Query: 372 ALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRA 431
+LGV EM G PP + I +P L E S D ++ L K+P
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP---LRFPEFLSPEARDLISGLLQKDPTK 234
Query: 432 RPTA--AEMLK-HKF 443
R + AE +K H F
Sbjct: 235 RLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 9e-50
Identities = 87/261 (33%), Positives = 144/261 (55%), Gaps = 19/261 (7%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISL-----SEGEEGYEEIRGEIEMLQQCSHPNVVR 250
LG G++ + Y+ARD+KT L+A+K ++ SE EE E +R EI ++ + +HP+++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 251 YLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVH 310
LG+ + + + +E+ GGSV+ L++ E I Y + L+GL+YLH +H
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINY-TEQLLRGLSYLHENQIIH 126
Query: 311 RDIKGGNILLTDQGE-VKLGDFGVAAQLTRTMSKRNTF----IGTPHWMAPEVIQESRYD 365
RD+KG N+L+ G+ +++ DFG AA+L + F +GT +MAPEV++ +Y
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYG 186
Query: 366 GKVDVWALGVSAVEMAEGLPP-RSTVHP--MRVLFMI--SIEPAPMLEDKEKWSLVFHDF 420
DVW++G +EMA PP + H + ++F I + + E S D
Sbjct: 187 RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI---PEHLSPGLRDV 243
Query: 421 VAKCLTKEPRARPTAAEMLKH 441
+CL +P RP + E+LKH
Sbjct: 244 TLRCLELQPEDRPPSRELLKH 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 4e-49
Identities = 82/265 (30%), Positives = 127/265 (47%), Gaps = 27/265 (10%)
Query: 191 ELLNELGKGSYGAVYKAR----DLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHP 246
EL +LG+G++G VYK T VA+K + EE EE E ++++ SHP
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI 306
N+VR LG E L+IV EY GG + D + E L + + + KG+ YL S
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK 121
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH------WMAPEVIQ 360
VHRD+ N L+T+ VK+ DFG L+R + + + + WMAPE ++
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFG----LSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 361 ESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIE-----PAPMLEDKEKWS 414
+ ++ K DVW+ GV E+ G P + VL + +E P P E
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEL--LEDGYRLPRPENCPDE--- 232
Query: 415 LVFHDFVAKCLTKEPRARPTAAEML 439
++ + +C +P RPT +E++
Sbjct: 233 --LYELMLQCWAYDPEDRPTFSELV 255
|
Length = 258 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 2e-48
Identities = 92/270 (34%), Positives = 150/270 (55%), Gaps = 15/270 (5%)
Query: 193 LNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYL 252
LG G+ G VYKA L T ++A+KVI L E ++I E+E+L +C P ++ +
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 253 GSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRD 312
G++ E + I E+ GGS+ + E L +A +KGL YL S+ +HRD
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVA-----VVKGLTYLWSLKILHRD 120
Query: 313 IKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWA 372
+K N+L+ +G+VKL DFGV+ QL +++K T++GT +MAPE I +Y DVW+
Sbjct: 121 VKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK--TYVGTNAYMAPERISGEQYGIHSDVWS 178
Query: 373 LGVSAVEMAEGLPP-------RSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCL 425
LG+S +E+A G P + ++ P+++L I E P+L + +S F F+ +C+
Sbjct: 179 LGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQ-FSEKFVHFITQCM 237
Query: 426 TKEPRARPTAAEMLKHKFIERCKCGATAML 455
K+P+ RP ++ H FI + G ++
Sbjct: 238 RKQPKERPAPENLMDHPFIVQYNDGNAEVV 267
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 2e-47
Identities = 95/300 (31%), Positives = 146/300 (48%), Gaps = 58/300 (19%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY--EEIRGEIEMLQQCSHPN 247
YE + ++G+G+YG VYKAR+ KT ELVA+K I + +EG+ IR EI++LQ+ HPN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLRHPN 59
Query: 248 VVR----YLGSYQGEEYLWIVMEYC-----GGGSVADLMNVTEEPLEEYQIAYICREALK 298
+VR +G Y+ V EY G L++ E E QI ++ L+
Sbjct: 60 IVRLKEIVTSKGKGSIYM--VFEYMDHDLTG------LLDSPEVKFTESQIKCYMKQLLE 111
Query: 299 GLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH----WM 354
GL YLHS +HRDIKG NIL+ + G +KL DFG L R +KRN+ T W
Sbjct: 112 GLQYLHSNGILHRDIKGSNILINNDGVLKLADFG----LARPYTKRNSADYTNRVITLWY 167
Query: 355 -APEVI-QESRYDGKVDVWALGVSAVEMAEGLPP---RSTVHPMRVLF------------ 397
PE++ +RY +VD+W++G E+ G P + + + +F
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227
Query: 398 -------MISIEPAPMLED------KEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
+++P + K D + K LT +P+ R +A + L+H++
Sbjct: 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 4e-47
Identities = 99/268 (36%), Positives = 146/268 (54%), Gaps = 20/268 (7%)
Query: 191 ELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVR 250
E+L+ELGKG+YG+VYK T +A+K I L E + +I E+++L + P +V
Sbjct: 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVD 63
Query: 251 YLGSYQGEEYLWIVMEYCGGGSVADLM--NVTEEPLEEYQIAYICREALKGLAYL---HS 305
+ G++ E +++ MEY GS+ L V E + E + I +KGL +L H+
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 306 IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVI------ 359
I +HRD+K N+L+ G+VKL DFGV+ L +++K N IG +MAPE I
Sbjct: 124 I--IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN--IGCQSYMAPERIKSGGPN 179
Query: 360 QESRYDGKVDVWALGVSAVEMAEG---LPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLV 416
Q Y + DVW+LG+S +EMA G PP + + L I P L +S
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPS--GYSDD 237
Query: 417 FHDFVAKCLTKEPRARPTAAEMLKHKFI 444
DFVAKCL K P RPT A++L+H ++
Sbjct: 238 AQDFVAKCLNKIPNRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 4e-47
Identities = 97/258 (37%), Positives = 135/258 (52%), Gaps = 14/258 (5%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSY 255
LGKG+YG VY ARDL T +AIK I + + + EI + H N+V+YLGS
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRY-VQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 256 QGEEYLWIVMEYCGGGSVADLMNVTEEPLE--EYQIAYICREALKGLAYLHSIFKVHRDI 313
+ I ME GGS++ L+ PL+ E I + ++ L+GL YLH VHRDI
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDI 134
Query: 314 KGGNILL-TDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESR--YDGKVDV 370
KG N+L+ T G VK+ DFG + +L TF GT +MAPEVI + Y D+
Sbjct: 135 KGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADI 194
Query: 371 WALGVSAVEMAEGLPPRSTV-HPMRVLF---MISIEPAPMLEDKEKWSLVFHDFVAKCLT 426
W+LG + VEMA G PP + P +F M I P E E S +F+ +C
Sbjct: 195 WSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP----EIPESLSAEAKNFILRCFE 250
Query: 427 KEPRARPTAAEMLKHKFI 444
+P R +A ++L+ F+
Sbjct: 251 PDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 8e-47
Identities = 87/260 (33%), Positives = 133/260 (51%), Gaps = 18/260 (6%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLS-----EGEEGYEEIRGEIEMLQQCS 244
+E+LN++GKGS+G V+K + A+K I LS E EE +E R +L +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEAR----VLAKLD 57
Query: 245 HPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYL 303
++RY S+ + L IVMEY G + L+ + PL E Q+ + L GLA+L
Sbjct: 58 SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL 117
Query: 304 HSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESR 363
HS +HRDIK N+ L VK+GD GVA L+ + NT +GTP++++PE+ ++
Sbjct: 118 HSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP 177
Query: 364 YDGKVDVWALGVSAVEMAEGLPP---RSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420
Y+ K DVWALGV E G P + + + P + +S
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS-----QMYSQQLAQL 232
Query: 421 VAKCLTKEPRARPTAAEMLK 440
+ +CLTK+ R RP ++L+
Sbjct: 233 IDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 1e-46
Identities = 105/324 (32%), Positives = 161/324 (49%), Gaps = 59/324 (18%)
Query: 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPN 247
+E L ELG G+ G V K + ++A K+I L +I E+++L +C+ P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMN----VTEEPLEEYQIAYICREALKGLAYL 303
+V + G++ + + I ME+ GGS+ ++ + E L + IA L+GL YL
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA-----VLRGLTYL 115
Query: 304 ---HSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ 360
H I +HRD+K NIL+ +GE+KL DFGV+ QL +M+ N+F+GT +M+PE +Q
Sbjct: 116 REKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQ 171
Query: 361 ESRYDGKVDVWALGVSAVEMAEG---LPP------------------------RSTVHPM 393
+ Y + D+W+LG+S VEMA G +PP + HP
Sbjct: 172 GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231
Query: 394 ---------RVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
+L I EP P L +S F DFV KCL K P+ R E+ KH FI
Sbjct: 232 DSPRPMAIFELLDYIVNEPPPKLPSG-AFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290
Query: 445 ERCKCGATAMLPKIEKARQIRASM 468
+R A L +++ A + ++M
Sbjct: 291 KR------AELEEVDFAGWVCSTM 308
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 4e-46
Identities = 97/290 (33%), Positives = 137/290 (47%), Gaps = 43/290 (14%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY--EEIRGEIEMLQQCSHPN 247
YE L +LG+G+YG VYKARD KT E+VA+K I L EEG +R EI +L++ HPN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-EISLLKELKHPN 59
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADL---MNVTEEPLEEYQIAYICREALKGLAYLH 304
+V+ L E L++V EYC DL ++ PL I I + L+GLAY H
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 305 SIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT---RTMSKRNTFIGTPHWMAPEVI-Q 360
S +HRD+K NIL+ G +KL DFG+A RT + + T + APE++
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE---VVTLWYRAPEILLG 172
Query: 361 ESRYDGKVDVWALGVSAVEMAEG---LPPRSTVHP----MRVLFMISIEPAPMLEDKEKW 413
Y VD+W++G EM G P S + ++L + E P + +
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232
Query: 414 SLVFH-------------------DFVAKCLTKEPRARPTAAEMLKHKFI 444
F D ++K L P R +A E LKH +
Sbjct: 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 2e-44
Identities = 79/261 (30%), Positives = 124/261 (47%), Gaps = 18/261 (6%)
Query: 191 ELLNELGKGSYGAVYKAR----DLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHP 246
L +LG+G++G VYK + K VA+K + E+ EE E ++++ HP
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI 306
NVV+ LG EE L+IVMEY GG + + L + + +G+ YL S
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT--MSKRNTFIGTP-HWMAPEVIQESR 363
+HRD+ N L+ + VK+ DFG++ L KR + P WMAPE ++E +
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKEGK 179
Query: 364 YDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMI---SIEPAPMLEDKEKWSLVFHD 419
+ K DVW+ GV E+ G P + VL + P P E +D
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPE-----LYD 234
Query: 420 FVAKCLTKEPRARPTAAEMLK 440
+ +C ++P RPT +E+++
Sbjct: 235 LMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 3e-44
Identities = 84/263 (31%), Positives = 145/263 (55%), Gaps = 16/263 (6%)
Query: 191 ELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVR 250
E +++LG G+ G+V K + + T ++A KV+ + ++I E++++ +C P +V
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVS 67
Query: 251 YLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFK-V 309
+ G++ E + + ME+ GS+ D + P+ + I ++GL YL+++ + +
Sbjct: 68 FYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIM 126
Query: 310 HRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVD 369
HRDIK NIL+ +G++KL DFGV+ +L +++ +TF+GT +M+PE IQ +Y K D
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINSIA--DTFVGTSTYMSPERIQGGKYTVKSD 184
Query: 370 VWALGVSAVEMAEGLPPRS--------TVHPMRVLFM---ISIEPAPMLEDKEKWSLVFH 418
VW+LG+S +E+A G P + PM +L + I EP P L +
Sbjct: 185 VWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP-SSDFPEDLR 243
Query: 419 DFVAKCLTKEPRARPTAAEMLKH 441
DFV CL K+P RPT ++
Sbjct: 244 DFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 7e-44
Identities = 89/263 (33%), Positives = 134/263 (50%), Gaps = 22/263 (8%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVI---SLSEGEEGYEEIRGEIEMLQQCSHP 246
+++L +LGKGSYG+VYK + L ++ A+K + S+S+ E E+ EI +L +HP
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKER--EDAVNEIRILASVNHP 59
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNV------TEEPLEEYQIAYICREALKGL 300
N++ Y ++ L IVMEY G DL + + E +I I + L+GL
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFG---DLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ 360
LH +HRD+K NILL VK+GD G++ L + M+K T IGTPH+MAPEV +
Sbjct: 117 QALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK--TQIGTPHYMAPEVWK 174
Query: 361 ESRYDGKVDVWALGVSAVEMAEGLPP--RSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418
Y K D+W+LG EMA PP ++ +R P +S
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI----PPIYSQDLQ 230
Query: 419 DFVAKCLTKEPRARPTAAEMLKH 441
+F+ L +P+ RP ++L
Sbjct: 231 NFIRSMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 7e-44
Identities = 90/265 (33%), Positives = 139/265 (52%), Gaps = 13/265 (4%)
Query: 191 ELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSH-PNVV 249
E L E+G G+ G VYK R KT ++A+K + + +E + I +++++ + P +V
Sbjct: 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIV 77
Query: 250 RYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYL---HSI 306
+ G + + ++I ME + L+ + P+ E + + +K L YL H +
Sbjct: 78 KCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGV 136
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVI----QES 362
+HRD+K NILL G VKL DFG++ +L + +K + G +MAPE I
Sbjct: 137 --IHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-AGCAAYMAPERIDPPDPNP 193
Query: 363 RYDGKVDVWALGVSAVEMAEGLPP-RSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421
+YD + DVW+LG+S VE+A G P ++ VL I E P L E +S F FV
Sbjct: 194 KYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFV 253
Query: 422 AKCLTKEPRARPTAAEMLKHKFIER 446
CLTK+ R RP E+L+H FI R
Sbjct: 254 DLCLTKDHRKRPKYRELLQHPFIRR 278
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 1e-43
Identities = 81/259 (31%), Positives = 127/259 (49%), Gaps = 8/259 (3%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNV 248
Y + LGKG++G R + LV K ++L+ E+ + EI +L HPN+
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 249 VRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPL--EEYQIAYICREALKGLAYLHSI 306
+ Y + + L I MEY GG++ D + + L EE + Y+ + + ++Y+H
Sbjct: 62 IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYL-FQIVSAVSYIHKA 120
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDG 366
+HRDIK NI LT G +KLGDFG++ L S T +GTP++M+PE+ Q +Y+
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNF 180
Query: 367 KVDVWALGVSAVEMAEGLPPRSTVHPMRVL-FMISIEPAPMLEDKEKWSLVFHDFVAKCL 425
K D+WALG E+ L + T L ++ I +S V L
Sbjct: 181 KSDIWALGCVLYEL---LTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLL 237
Query: 426 TKEPRARPTAAEMLKHKFI 444
++P RPTA E+L +
Sbjct: 238 QQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 5e-43
Identities = 94/285 (32%), Positives = 146/285 (51%), Gaps = 21/285 (7%)
Query: 173 SSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE 232
SSS+ + + ++ E +N +G G+ G VYK T L A+KVI + + +
Sbjct: 59 SSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQ 118
Query: 233 IRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYI 292
I EIE+L+ +HPNVV+ + + +++E+ GGS+ + ++ +E +A +
Sbjct: 119 ICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL-EGTHIADEQ----FLADV 173
Query: 293 CREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH 352
R+ L G+AYLH VHRDIK N+L+ VK+ DFGV+ L +TM N+ +GT
Sbjct: 174 ARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIA 233
Query: 353 WMAPEVI----QESRYDGKV-DVWALGVSAVEMAEGLPPRST------VHPMRVLFMISI 401
+M+PE I YDG D+W+LGVS +E G P M + M
Sbjct: 234 YMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP 293
Query: 402 EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446
AP +E F F++ CL +EP R +A ++L+H FI R
Sbjct: 294 PEAPATASRE-----FRHFISCCLQREPAKRWSAMQLLQHPFILR 333
|
Length = 353 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 7e-43
Identities = 76/264 (28%), Positives = 121/264 (45%), Gaps = 23/264 (8%)
Query: 191 ELLNELGKGSYGAVYKAR----DLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHP 246
L +LG+G++G VYK VA+K + E+ EE E ++++ HP
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVAD-LMNVTEEPLEEYQIAYICREALKGLAYLHS 305
N+V+ LG EE L IVMEY GG + D L + L + + +G+ YL S
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 306 IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH-----WMAPEVIQ 360
+HRD+ N L+ + VK+ DFG L+R + + + WMAPE ++
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFG----LSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 361 ESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMI---SIEPAPMLEDKEKWSLV 416
E ++ K DVW+ GV E+ G P + VL + P P E
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPE----- 232
Query: 417 FHDFVAKCLTKEPRARPTAAEMLK 440
+ + +C ++P RPT +E+++
Sbjct: 233 LYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 7e-43
Identities = 85/266 (31%), Positives = 129/266 (48%), Gaps = 21/266 (7%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLG 253
+ KG+YG V+ A+ T ++ AIKVI ++ + +++ E ++L Q P VV+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 254 SYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDI 313
S+QG++ L++VMEY GG +A L+ L+E E + L YLHS +HRD+
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLE-NVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119
Query: 314 KGGNILLTDQGEVKLGDFGVAAQ-LTRTMSKRN-------TFIGTPHWMAPEVIQESRYD 365
K NIL+ G +KL DFG++ L R N +GTP ++APEVI +
Sbjct: 120 KPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHS 179
Query: 366 GKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI---SIEPAPMLEDKEKWSLVFHDFVA 422
VD W+LG E G+PP P + I IE + + S D ++
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEW----PEDVEVSDEAIDLIS 235
Query: 423 KCLTKEPRARPTAA---EMLKHKFIE 445
K L +P R A E+ H F +
Sbjct: 236 KLLVPDPEKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 8e-43
Identities = 73/284 (25%), Positives = 124/284 (43%), Gaps = 37/284 (13%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVIS----LSEGEEGYEEIRGEIEMLQQCS- 244
++ +G+GS+ V A++ +T++ AIK++ + E + Y ++ E E+L + +
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKY--VKIEKEVLTRLNG 60
Query: 245 HPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLH 304
HP +++ ++Q EE L+ V+EY G + + L+E + E L L YLH
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDEKCTRFYAAEILLALEYLH 119
Query: 305 SIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS--------------------KR 344
S +HRD+K NILL +K+ DFG A L S +
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI-SIEP 403
+F+GT +++PE++ E D+WALG +M G PP + I +E
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE- 238
Query: 404 APMLEDKEKWSLVFHDFVAKCLTKEPRARPTA----AEMLKHKF 443
+ D + K L +P+ R E+ H F
Sbjct: 239 ---YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-42
Identities = 87/310 (28%), Positives = 151/310 (48%), Gaps = 44/310 (14%)
Query: 191 ELLNELGKGSYGA--VYKARDLKTSELVAIKVISL-SEGEEGYEEIRGEIEMLQQCSHPN 247
ELL +GK V+ A+ T+ LVA+K I+L S +E + ++ EI +Q HPN
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLM-NVTEEPLEEYQIAYICREALKGLAYLHSI 306
++ Y+ S+ + L++V GS DL+ E L E IA+I ++ L L Y+HS
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK 120
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP-------HWMAPEVI 359
+HR +K +ILL+ G+V L + + + ++ P W++PEV+
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 360 QESR--YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLF---------MISIEPAPMLE 408
Q++ Y+ K D++++G++A E+A G P + ++L ++ P+ E
Sbjct: 181 QQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240
Query: 409 DKEK----------------------WSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446
D +S FH FV CL ++P +RP+A+++L H F ++
Sbjct: 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300
Query: 447 CKCGATAMLP 456
CK T++L
Sbjct: 301 CKRRNTSLLD 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 155 bits (392), Expect = 1e-42
Identities = 102/260 (39%), Positives = 139/260 (53%), Gaps = 14/260 (5%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISLS-EGEEGYEEIRG---EIEMLQQCSHPNVVRY 251
LG+G++G VY D+ T +A K + E E +E+ EI++L+ H +V+Y
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 252 LGSYQ--GEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKV 309
G + E+ L I MEY GGSV D + E Y R+ L+G++YLHS V
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYT-RQILEGMSYLHSNMIV 128
Query: 310 HRDIKGGNILLTDQGEVKLGDFGVAAQL-TRTMSKRN--TFIGTPHWMAPEVIQESRYDG 366
HRDIKG NIL G VKLGDFG + +L T MS + GTP+WM+PEVI Y
Sbjct: 129 HRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGR 188
Query: 367 KVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA-PMLEDKEKWSLVFHDFVAKCL 425
K DVW+LG + VEM PP + M +F I+ +P P L S DF+ C+
Sbjct: 189 KADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHI--SEHARDFL-GCI 245
Query: 426 TKEPRARPTAAEMLKHKFIE 445
E R RP+A E+L+H F +
Sbjct: 246 FVEARHRPSAEELLRHPFAQ 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 90/295 (30%), Positives = 139/295 (47%), Gaps = 49/295 (16%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEI--RGEIEMLQQCSHP 246
KYE+L +G+G+YG V K R+ T E+VAIK SE +E ++ R E+++L+Q H
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR-EVKVLRQLRHE 60
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQ----IAYICR---EALKG 299
N+V +++ + L++V EY + E LE + + L+
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVE-------RTLLEL-LEASPGGLPPDAVRSYIWQLLQA 112
Query: 300 LAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT-RTMSKRNTFIGTPHWMAPEV 358
+AY HS +HRDIK NIL+++ G +KL DFG A L R S ++ T + APE+
Sbjct: 113 IAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPEL 172
Query: 359 -IQESRYDGKVDVWALGVSAVEMAEG----------------------LPPRSTV---HP 392
+ ++ Y VDVWA+G E+ +G LPP
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232
Query: 393 MRVLFMISIEPAPM--LEDK--EKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKF 443
R + EP+ LE + K S DF+ CL +P+ R T E+L+H +
Sbjct: 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 92/296 (31%), Positives = 134/296 (45%), Gaps = 52/296 (17%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY--EEIRGEIEML---QQCS 244
YE L E+G+G+YG VYKARDL T VA+K + + EEG +R EI +L +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFE 59
Query: 245 HPNVVRYLGSYQGEEY-----LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKG 299
HPN+VR L G L +V E+ L + L I + R+ L+G
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 300 LAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVI 359
+ +LHS VHRD+K NIL+T G+VK+ DFG+A + M+ + + T + APEV+
Sbjct: 120 VDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAPEVL 178
Query: 360 QESRYDGKVDVWALGVSAVEMAE---------------------GLP-----------PR 387
+S Y VD+W++G E+ GLP PR
Sbjct: 179 LQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR 238
Query: 388 STVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKF 443
S+ S P + ++ D + K LT P R +A E L+H +
Sbjct: 239 SSFPSYTPRSFKSFVPE--ICEEG------LDLLKKMLTFNPHKRISAFEALQHPY 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 2e-42
Identities = 91/273 (33%), Positives = 140/273 (51%), Gaps = 29/273 (10%)
Query: 191 ELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSH-PNVV 249
E++ ELG+G+YG V K R + T ++A+K I + + + + ++++ + P V
Sbjct: 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTV 63
Query: 250 RYLGSYQGEEYLWIVMEYCGGGSVADLM---------NVTEEPL--EEYQIAYICREALK 298
+ G+ E +WI ME +M V ++ L E + I +K
Sbjct: 64 TFYGALFREGDVWICME---------VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVK 114
Query: 299 GLAYLHSIFKV-HRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPE 357
L YLHS V HRD+K N+L+ G+VKL DFG++ L +++K G +MAPE
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK-TIDAGCKPYMAPE 173
Query: 358 VI----QESRYDGKVDVWALGVSAVEMAEGLPPRSTVH-PMRVLFMISIEPAPMLEDKEK 412
I + YD K DVW+LG++ +E+A G P + P + L + EP+P L EK
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP-AEK 232
Query: 413 WSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445
+S F DFV KCL K + RP E+L+H F E
Sbjct: 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 7e-42
Identities = 78/269 (28%), Positives = 127/269 (47%), Gaps = 32/269 (11%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVIS----LSEGEEGYEEIRGEIEMLQQCSHPNVVRY 251
LG G +G V + + A+K + + G++ E I E E+L++C+HP +V+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ--EHIFSEKEILEECNHPFIVKL 58
Query: 252 LGSYQGEEYLWIVMEYCGGGSVADLMNVTEEP--LEEYQIAYICREALKGLAYLHSIFKV 309
+++ ++Y++++MEYC GG +L + + +EY + + YLH+ +
Sbjct: 59 YRTFKDKKYIYMLMEYCLGG---ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGII 115
Query: 310 HRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVD 369
+RD+K N+LL G VKL DFG A +L K TF GTP ++APE+I YD VD
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSG-QKTWTFCGTPEYVAPEIILNKGYDFSVD 174
Query: 370 VWALGVSAVEMAEGLPPRST--VHPMRVLFMISIEPAPMLEDKEKW------SLVFHDFV 421
W+LG+ E+ G PP PM + I L+ K D +
Sbjct: 175 YWSLGILLYELLTGRPPFGEDDEDPMEIYNDI-------LKGNGKLEFPNYIDKAAKDLI 227
Query: 422 AKCLTKEPRAR-----PTAAEMLKHKFIE 445
+ L + P R ++ KHK+
Sbjct: 228 KQLLRRNPEERLGNLKGGIKDIKKHKWFN 256
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 9e-42
Identities = 73/204 (35%), Positives = 118/204 (57%), Gaps = 12/204 (5%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE--IRGEIEMLQQCSHP 246
+Y++L +G+G++G V+KA+D +T E VA+K ++L E G +R EI+ LQ C HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHP 59
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI 306
VV+ L + +VMEY +++++ E PL E Q+ R LKG+AY+H+
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVA----AQLTRTMSKRNTFIGTPHWMAPEVIQES 362
+HRD+K N+L++ G +K+ DFG+A + R S + + T + APE++ +
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ---VATRWYRAPELLYGA 175
Query: 363 R-YDGKVDVWALGVSAVEMAEGLP 385
R YD VD+WA+G E+ G P
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 4e-41
Identities = 73/273 (26%), Positives = 119/273 (43%), Gaps = 38/273 (13%)
Query: 194 NELGKGSYGAVYKAR---DLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVR 250
+LG+G++G VYK + + VA+K + EE ++ E ++++ HPNVVR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 251 YLGSYQGEEYLWIVMEYCGGGS--------VADLMNVTEEPLEEYQIAYICREALKGLAY 302
LG EE L++V+EY GG + + L + + KG+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH------WMAP 356
L S VHRD+ N L+ + VK+ DFG L+R + + + WMAP
Sbjct: 121 LASKKFVHRDLAARNCLVGEDLVVKISDFG----LSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 357 EVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVL-------FMISIEPAPMLE 408
E +++ + K DVW+ GV E+ G P + VL + P P
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL----PKPEYC 232
Query: 409 DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441
E ++ + C +P RPT +E+++
Sbjct: 233 PDE-----LYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 82/289 (28%), Positives = 138/289 (47%), Gaps = 40/289 (13%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE--IRGEIEMLQQCSHPN 247
Y+ L ++G+G+YG VYKARD T E+VAIK I L EG + +R EI++L++ +HPN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPN 59
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307
+++ L ++ + L++V E+ + L+ + L E I + L+GLA+ HS
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF----IGTPHWMAPEVIQESR 363
+HRD+K N+L+ +G +KL DFG+A R+ + T + APE++ +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLA----RSFGSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 364 -YDGKVDVWALGVSAVEMAEG---LPPRSTVHPMRVLFMISIEPAP---------MLEDK 410
Y VD+W++G E+ P +S + + +F P P K
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234
Query: 411 EK--------WSLVFH-------DFVAKCLTKEPRARPTAAEMLKHKFI 444
+F D +++ L +P R TA + L H +
Sbjct: 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 98/260 (37%), Positives = 140/260 (53%), Gaps = 16/260 (6%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRG---EIEMLQQCSHPNVVRY 251
LG+G++G VY D T +A+K + +E +E+ EI++L+ H +V+Y
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 252 LGSYQG--EEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKV 309
G + E+ L I +EY GGS+ D + E Y R+ L+G++YLHS V
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYT-RQILQGVSYLHSNMIV 128
Query: 310 HRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFI----GTPHWMAPEVIQESRYD 365
HRDIKG NIL G VKLGDFG A++ +T+ T I GTP+WM+PEVI Y
Sbjct: 129 HRDIKGANILRDSAGNVKLGDFG-ASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYG 187
Query: 366 GKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA-PMLEDKEKWSLVFHDFVAKC 424
K DVW++ + VEM PP + M +F I+ +P PML D S DF+ +
Sbjct: 188 RKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGV--SDACRDFLKQI 245
Query: 425 LTKEPRARPTAAEMLKHKFI 444
+E R RPTA +L+H F+
Sbjct: 246 FVEEKR-RPTAEFLLRHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 91/286 (31%), Positives = 142/286 (49%), Gaps = 33/286 (11%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEI--RGEIEMLQQCSHP 246
KYE L+++G+GSYG V+K R+ +T ++VAIK SE + ++I R EI ML+Q HP
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR-EIRMLKQLKHP 60
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI 306
N+V + ++ + L +V EYC +V + + + E+ I I + L+ + + H
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVI-QESRYD 365
+HRD+K NIL+T QG++KL DFG A LT ++ T + APE++ +++Y
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYG 179
Query: 366 GKVDVWALGVSAVEMAEGLP----------------------PR-----STVHPMRVLFM 398
VDVWA+G E+ G P PR ST + L +
Sbjct: 180 PPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI 239
Query: 399 ISIEPAPMLEDK-EKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKF 443
E LE K S F+ CL +P R + E+L+H +
Sbjct: 240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 3e-40
Identities = 97/276 (35%), Positives = 145/276 (52%), Gaps = 32/276 (11%)
Query: 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS-EGEEGYEEIRG---EIEMLQQC 243
T + L LG+G++G VY D T +A+K + E E +E+ EI++L+
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 244 SHPNVVRYLGSYQG--EEYLWIVMEYCGGGSVADLMN----VTEEPLEEYQIAYICREAL 297
H +V+Y G + E L I ME+ GGS+ D + +TE +Y R+ L
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYT-----RQIL 116
Query: 298 KGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFI----GTPHW 353
+G++YLHS VHRDIKG NIL G VKLGDFG + +L +T+ T + GTP+W
Sbjct: 117 EGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL-QTICLSGTGMKSVTGTPYW 175
Query: 354 MAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA-----PMLE 408
M+PEVI Y K D+W++G + VEM PP + M +F I+ +P P +
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVS 235
Query: 409 DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
D + DF+ + E + RP+A E+L+H F+
Sbjct: 236 DHCR------DFLKRIFV-EAKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 4e-40
Identities = 86/262 (32%), Positives = 133/262 (50%), Gaps = 12/262 (4%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPN 247
KY + ++G+GS+G + + + IK I++S+ + EE R E+ +L HPN
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEE-PLEEYQIAYICREALKGLAYLHSI 306
+V+Y S++ L+IVM+YC GG + +N E QI + L ++H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDG 366
+HRDIK NI LT G +KLGDFG+A L T+ T IGTP++++PE+ + Y+
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNN 180
Query: 367 KVDVWALGVSAVEMAEGLPPRSTVHPMR--VLFMI--SIEPAPMLEDKEKWSLVFHDFVA 422
K D+WALG EM L M+ VL +I S P +S + V+
Sbjct: 181 KSDIWALGCVLYEMCT-LKHAFEAGNMKNLVLKIIRGSYPPVSS-----HYSYDLRNLVS 234
Query: 423 KCLTKEPRARPTAAEMLKHKFI 444
+ + PR RP+ +L+ FI
Sbjct: 235 QLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 4e-40
Identities = 89/262 (33%), Positives = 143/262 (54%), Gaps = 11/262 (4%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEI-RGEIEMLQQCSHPN 247
+YE++ ++G+GS+G +Y A+ SE IK I L++ +E + E+ +L + HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPL-EEYQI-AYICREALKGLAYLHS 305
+V + S+Q L+IVMEYC GG + +N L E QI ++ + +L GL ++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL-GLKHIHD 119
Query: 306 IFKVHRDIKGGNILLTDQGEV-KLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRY 364
+HRDIK NI L+ G V KLGDFG+A QL +M T +GTP++++PE+ Q Y
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPY 179
Query: 365 DGKVDVWALGVSAVEMAEGLPP--RSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVA 422
+ K D+W+LG E+ P + +H + VL + AP+ +S ++
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFEGNNLHQL-VLKICQGYFAPI---SPNFSRDLRSLIS 235
Query: 423 KCLTKEPRARPTAAEMLKHKFI 444
+ PR RP+ +LK F+
Sbjct: 236 QLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 9e-40
Identities = 87/294 (29%), Positives = 141/294 (47%), Gaps = 40/294 (13%)
Query: 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY--EEIRGEIEMLQQ 242
T++E LN +G+G+YG VY+ARD + E+VA+K + + +G +R EI +L
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLN 62
Query: 243 CSHPNVVRYLGSYQGE--EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGL 300
HPN+V G+ + +++VMEYC +A L++ P E Q+ + + L+GL
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGL 121
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ 360
YLH F +HRD+K N+LLTD+G +K+ DFG+A + T + APE++
Sbjct: 122 QYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL 181
Query: 361 ESR-YDGKVDVWALGVSAVEMAEG---LPPRSTVH-----------------------PM 393
Y +D+WA+G E+ LP +S + P+
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241
Query: 394 RVLFMISIEPAPMLEDKEKWS----LVFHDFVAKCLTKEPRARPTAAEMLKHKF 443
F + +P L+ K W L +F+ L +P+ R TA E L+ +
Sbjct: 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFL---LMYDPKKRATAEEALESSY 292
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 82/253 (32%), Positives = 125/253 (49%), Gaps = 20/253 (7%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYE--EIRGEIEMLQQCSHPN 247
+ELL +GKG++G V + T ++ A+K ++ + E + E +LQ+ +HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE--EPLEEYQIA-YICREALKGLAYLH 304
+V S+Q EE +++V++ GG DL E Q+ +IC L L YLH
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGG---DLRYHLSQKVKFSEEQVKFWICEIVL-ALEYLH 117
Query: 305 SIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRY 364
S +HRDIK NILL +QG V + DF +A ++T + + GTP +MAPEV+ Y
Sbjct: 118 SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD-TLTTSTSGTPGYMAPEVLCRQGY 176
Query: 365 DGKVDVWALGVSAVEMAEGLPP-----RSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHD 419
VD W+LGV+A E G P R+ +R + P WS D
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP-----ATWSTEAID 231
Query: 420 FVAKCLTKEPRAR 432
+ K L ++P+ R
Sbjct: 232 AINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 78/243 (32%), Positives = 121/243 (49%), Gaps = 20/243 (8%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE----GEEGYEEIRGEIEMLQQCSH 245
+E + LG GS+G V R + + A+K++S ++ + E + E +LQ H
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQV--EHVLNEKRILQSIRH 60
Query: 246 PNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS 305
P +V GS+Q + L++VMEY GG + + + E + + + L YLHS
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGR-FPEPVARFYAAQVVLALEYLHS 119
Query: 306 IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL-TRTMSKRNTFIGTPHWMAPEVIQESRY 364
+ V+RD+K N+LL G +K+ DFG A ++ RT T GTP ++APE+I Y
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY----TLCGTPEYLAPEIILSKGY 175
Query: 365 DGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424
VD WALG+ EM G PP +P+++ I LE K ++ F AK
Sbjct: 176 GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI-------LEGKVRFP-SFFSPDAKD 227
Query: 425 LTK 427
L +
Sbjct: 228 LIR 230
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 76/260 (29%), Positives = 133/260 (51%), Gaps = 14/260 (5%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPN 247
+++ ++GKG + VYKA L +VA+K + + E + ++ EI++L+Q HPN
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEE---PLEEYQIAYICREALKGLAYLH 304
V++YL S+ L IV+E G ++ ++ ++ + E I + L ++H
Sbjct: 64 VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123
Query: 305 SIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRY 364
S +HRDIK N+ +T G VKLGD G+ + + ++ +GTP++M+PE I E+ Y
Sbjct: 124 SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 365 DGKVDVWALGVSAVEMAEGLPP--RSTVHPMRVLFMIS---IEPAPMLEDKEKWSLVFHD 419
+ K D+W+LG EMA P ++ + I P P + +S D
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLP----ADHYSEELRD 239
Query: 420 FVAKCLTKEPRARPTAAEML 439
V++C+ +P RP + +L
Sbjct: 240 LVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 4e-38
Identities = 77/256 (30%), Positives = 133/256 (51%), Gaps = 11/256 (4%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV 248
+Y +L +G+GS+G + + + + A+K I L + E+ R E +L + HPN+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 249 VRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPL--EEYQIAYICREALKGLAYLHSI 306
V + S++ + +L+IVMEYC GG + + + L E+ + + + L G+ ++H
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL-GVQHIHEK 119
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDG 366
+HRDIK NI LT G+VKLGDFG A LT + T++GTP+++ PE+ + Y+
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNN 179
Query: 367 KVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI---SIEPAPMLEDKEKWSLVFHDFVAK 423
K D+W+LG E+ P ++ + S +P P +S + +
Sbjct: 180 KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPS-----HYSYELRSLIKQ 234
Query: 424 CLTKEPRARPTAAEML 439
+ PR+RP+A +L
Sbjct: 235 MFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 84/302 (27%), Positives = 139/302 (46%), Gaps = 68/302 (22%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVI-----SLSEGEEGYEEIRGEIEMLQQC- 243
Y+++ +LG G++G+VY AR+ +T ELVAIK + S E +R E++ L++
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEE----CMNLR-EVKSLRKLN 55
Query: 244 SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLM-NVTEEPLEEYQIAYICREALKGLAY 302
HPN+V+ ++ + L+ V EY G++ LM + +P E I I + L+GLA+
Sbjct: 56 EHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQES 362
+H HRD+K N+L++ VK+ DFG+A + R+ ++ T + APE++ S
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLARE-IRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 363 R-YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLF-----------MISIEPAPMLEDK 410
Y VD+WALG E+ +R LF + S+ P K
Sbjct: 174 TSYSSPVDIWALGCIMAELYT----------LRPLFPGSSEIDQLYKICSVLGTP---TK 220
Query: 411 EKW-----------------------------SLVFHDFVAKCLTKEPRARPTAAEMLKH 441
+ W S D + L +P+ RPTA++ L+H
Sbjct: 221 QDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280
Query: 442 KF 443
+
Sbjct: 281 PY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 81/274 (29%), Positives = 135/274 (49%), Gaps = 30/274 (10%)
Query: 193 LNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSH-PNVVRY 251
L E+G+G++G V K + ++A+K I + E+ + + +++++ + S P +V++
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68
Query: 252 LGSYQGEEYLWIVMEYCGGGSVADLM------------NVTEEPLEEYQIAYICREALKG 299
G+ E WI ME LM V + + E + I +K
Sbjct: 69 YGALFREGDCWICME---------LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKA 119
Query: 300 LAYLHSIFKV-HRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEV 358
L YL K+ HRD+K NILL G +KL DFG++ QL +++K G +MAPE
Sbjct: 120 LNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPER 178
Query: 359 IQESR---YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRV-LFMISIEPAPML--EDKEK 412
I S YD + DVW+LG++ E+A G P + + L + P+L ++ +
Sbjct: 179 IDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238
Query: 413 WSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446
+S F +F+ CL K+ RP E+L+H FI+
Sbjct: 239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 2e-36
Identities = 96/306 (31%), Positives = 150/306 (49%), Gaps = 57/306 (18%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVV 249
+E ++ELG G+ G V+K + ++A K+I L +I E+++L +C+ P +V
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 250 RYLGSYQGEEYLWIVMEYCGGGSVADLMN----VTEEPLEEYQIAYICREALKGLAYLHS 305
+ G++ + + I ME+ GGS+ ++ + E+ L + IA I KGL YL
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI-----KGLTYLRE 121
Query: 306 IFKV-HRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRY 364
K+ HRD+K NIL+ +GE+KL DFGV+ QL +M+ N+F+GT +M+PE +Q + Y
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHY 179
Query: 365 DGKVDVWALGVSAVEMAEG----------------------------LPPR--------- 387
+ D+W++G+S VEMA G PR
Sbjct: 180 SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS 239
Query: 388 ----STVHPMRV---LFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440
+ PM + L I EP P L + F DFV KCL K P R +++
Sbjct: 240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSG-VFGAEFQDFVNKCLIKNPAERADLKQLMV 298
Query: 441 HKFIER 446
H FI+R
Sbjct: 299 HAFIKR 304
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 83/289 (28%), Positives = 128/289 (44%), Gaps = 39/289 (13%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEI-----RGEIEMLQQC 243
+YE +LG+G+Y VYKARD +T +VAIK I L E +E + I R EI++LQ+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQEL 59
Query: 244 SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNV---TEEPLEEYQIAYICREALKGL 300
HPN++ L + + + +V E+ DL V L I L+GL
Sbjct: 60 KHPNIIGLLDVFGHKSNINLVFEFMET----DLEKVIKDKSIVLTPADIKSYMLMTLRGL 115
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ 360
YLHS + +HRD+K N+L+ G +KL DFG+A K + T + APE++
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLF 175
Query: 361 ESR-YDGKVDVWALGVSAVEMAEG---LPPRSTVHPMRVLFMI-----SIEPAPMLEDKE 411
+R Y VD+W++G E+ LP S + + +F + +
Sbjct: 176 GARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235
Query: 412 KWSLVFH-----------------DFVAKCLTKEPRARPTAAEMLKHKF 443
D + + LT P R TA + L+H +
Sbjct: 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 84/303 (27%), Positives = 133/303 (43%), Gaps = 56/303 (18%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVIS-----LSEGEEGYEEIRGEIEMLQQC 243
+YELL +G G+YG V A D +T VAIK IS L + + EI+ +L+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIK----LLRHL 56
Query: 244 SHPNVVRYL-----GSYQGEEYLWIVMEYCGGGSVADLMNV--TEEPLEEYQIAYICREA 296
H N++ L S + ++IV E DL V + +PL + I Y +
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTELME----TDLHKVIKSPQPLTDDHIQYFLYQI 112
Query: 297 LKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIG---TPHW 353
L+GL YLHS +HRD+K NIL+ ++K+ DFG+A + ++ T +
Sbjct: 113 LRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWY 172
Query: 354 MAPEVI-QESRYDGKVDVWALGVSAVEMAEG---LPPRSTVHPMRVLFMISIEPAPMLED 409
APE++ SRY +D+W++G E+ P R + + ++ + P ED
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIV--EVLGTPSEED 230
Query: 410 --------------------KEKWSLVFH-------DFVAKCLTKEPRARPTAAEMLKHK 442
K+ S +F D + K L +P+ R TA E L H
Sbjct: 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290
Query: 443 FIE 445
++
Sbjct: 291 YLA 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 79/295 (26%), Positives = 138/295 (46%), Gaps = 51/295 (17%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVIS----LSEGEEGYEEIRGEIEMLQQCSH 245
+E++ +G+G++G V+ RD T ++ A+KV+ + + + +R E ++L
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH--VRAERDILADADS 60
Query: 246 PNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN--VTEEPLEEYQIAYICREALKGLAYL 303
P +V+ S+Q EE+L++VMEY GG DLMN + ++ E + E + L +
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGG---DLMNLLIRKDVFPEETARFYIAELVLALDSV 117
Query: 304 HSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL-------------------------- 337
H + +HRDIK NIL+ G +KL DFG+ ++
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 338 ---TRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPP--RSTVHP 392
+ + N+ +GTP ++APEV++ + Y + D W+LGV EM G PP T+
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237
Query: 393 --MRVL-FMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK-HKF 443
+++ + S+ S D + + L +P R + E +K H F
Sbjct: 238 TYNKIINWKESLR----FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 134 bits (337), Expect = 2e-34
Identities = 93/310 (30%), Positives = 153/310 (49%), Gaps = 59/310 (19%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVV 249
+E ++ELG G+ G V K + + ++A K+I L +I E+++L +C+ P +V
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 250 RYLGSYQGEEYLWIVMEYCGGGSVADLMN----VTEEPLEEYQIAYICREALKGLAYLHS 305
+ G++ + + I ME+ GGS+ ++ + EE L + IA L+GLAYL
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA-----VLRGLAYLRE 121
Query: 306 IFKV-HRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRY 364
++ HRD+K NIL+ +GE+KL DFGV+ QL +M+ N+F+GT +M+PE +Q + Y
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHY 179
Query: 365 DGKVDVWALGVSAVEMAEG---LPP----------------------------------- 386
+ D+W++G+S VE+A G +PP
Sbjct: 180 SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP 239
Query: 387 --------RSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEM 438
R + +L I EP P L + ++ F +FV KCL K P R +
Sbjct: 240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNG-VFTPDFQEFVNKCLIKNPAERADLKML 298
Query: 439 LKHKFIERCK 448
+ H FI+R +
Sbjct: 299 MNHTFIKRSE 308
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 85/285 (29%), Positives = 141/285 (49%), Gaps = 31/285 (10%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIR-GEIEMLQQCSHPN 247
KYE L +G+GSYG V K + +T ++VAIK SE ++ ++I EI ML+Q H N
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307
+V + ++ ++ L++V E+ + DL L+E ++ + L+G+ + HS
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHN 120
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPE-VIQESRYDG 366
+HRDIK NIL++ G VKL DFG A L ++ T + APE ++ +++Y
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGR 180
Query: 367 KVDVWALGVSAVEMAEG---LPPRSTV----HPMRVLFMISI------------------ 401
VD+WA+G EM G P S + H ++ L +
Sbjct: 181 AVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLP 240
Query: 402 ---EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKF 443
E P+ + K S + D +CL +P RP+++++L H+F
Sbjct: 241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 7e-34
Identities = 90/262 (34%), Positives = 128/262 (48%), Gaps = 13/262 (4%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISL---SEGEEGYEEIRGEIEMLQQCSHP 246
Y + +GKGSYG V R + IK ++L S E E E ++L Q HP
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAE--QEAQLLSQLKHP 59
Query: 247 NVVRYLGSYQGEE-YLWIVMEYCGGGSV-ADLMNVTEEPLEEYQIAYICREALKGLAYLH 304
N+V Y S++GE+ L+IVM +C GG + L + L E Q+ + L YLH
Sbjct: 60 NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119
Query: 305 SIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRY 364
+HRD+K N+ LT +K+GD G+A L +T IGTP++M+PE+ Y
Sbjct: 120 EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPY 179
Query: 365 DGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA--PMLEDKEKWSLVFHDFVA 422
+ K DVWALG EMA L M L IE PM +D +S + +A
Sbjct: 180 NYKSDVWALGCCVYEMAT-LKHAFNAKDMNSLVYRIIEGKLPPMPKD---YSPELGELIA 235
Query: 423 KCLTKEPRARPTAAEMLKHKFI 444
L+K P RP+ +L+ +I
Sbjct: 236 TMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 7e-34
Identities = 85/263 (32%), Positives = 132/263 (50%), Gaps = 10/263 (3%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVI-SLSEGEEGYEEI---RGEIEMLQQCS 244
+Y L LGKGS+G VY +D K +KV+ + GE E E ++L +
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 245 HPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNV---TEEPLEEYQIAYICREALKGLA 301
HP +V++ S+ + I+ EYC G + + T + L E Q+ + L G+
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 302 YLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQE 361
Y+H +HRD+K NI L + +K+GDFGV+ L + TF GTP++M+PE ++
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179
Query: 362 SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421
YD K D+W+LG EM + + V+ I P P L E +S + +
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL--PETYSRQLNSIM 237
Query: 422 AKCLTKEPRARPTAAEMLKHKFI 444
L K+P RP+AAE+L++ FI
Sbjct: 238 QSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 82/258 (31%), Positives = 122/258 (47%), Gaps = 12/258 (4%)
Query: 193 LNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIE---MLQQCSHPNVV 249
L + KG++G+VY A+ T + AIKV+ S+ + + E M+ Q P V
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 250 RYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKV 309
+ S+Q ++YL++VMEY GG A L+ E++ YI E + G+ LH +
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIA-EVVLGVEDLHQRGII 119
Query: 310 HRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVD 369
HRDIK N+L+ G +KL DFG L+R + F+GTP ++APE I D D
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFG----LSRNGLENKKFVGTPDYLAPETILGVGDDKMSD 175
Query: 370 VWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKW-SLVFHDFVAKCLTKE 428
W+LG E G PP P V I E+ +++ S D + + L +
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235
Query: 429 PRARPTA---AEMLKHKF 443
P R A E+ H F
Sbjct: 236 PAKRLGANGYQEIKSHPF 253
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 79/264 (29%), Positives = 139/264 (52%), Gaps = 22/264 (8%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPN 247
KYE + +G+G++G V+ R +LV IK I + + ++ + E ++L+ SHPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSI 306
++ Y ++ ++ L IVMEY GG++A+ + L+E I + + L L ++H+
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 307 FKVHRDIKGGNILLTD-QGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYD 365
+HRD+K NILL + VK+GDFG++ L+ + SK T +GTP +++PE+ + Y+
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 366 GKVDVWALGVSAVEM--------AEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVF 417
K D+WALG E+ A LP VL ++S AP+ +++S
Sbjct: 180 QKSDIWALGCVLYELASLKRAFEAANLPA-------LVLKIMSGTFAPI---SDRYSPDL 229
Query: 418 HDFVAKCLTKEPRARPTAAEMLKH 441
+ L +P RP ++++
Sbjct: 230 RQLILSMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 75/266 (28%), Positives = 130/266 (48%), Gaps = 15/266 (5%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYE--EIRGEIEMLQQCSHPN 247
+++L ++G+G YG V+ A+ T E+VA+K + S + E + E ++L
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307
+V+ L ++Q +EYL++ MEY GG L+N E++ Y+ E + + LH +
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMA-EMFEAVDALHELG 121
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGK 367
+HRD+K N L+ G +KL DFG++ ++ N+ +G+P +MAPEV++ YD
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKG---IVTYANSVVGSPDYMAPEVLRGKGYDFT 178
Query: 368 VDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE------PAPMLEDKEK-WSLVFHDF 420
VD W+LG E G PP S P +++ P+ +D S D
Sbjct: 179 VDYWSLGCMLYEFLCGFPPFSGSTPNET--WENLKYWKETLQRPVYDDPRFNLSDEAWDL 236
Query: 421 VAKCLTKEPRARPTAAEMLKHKFIER 446
+ K + R + ++ H F +
Sbjct: 237 ITKLINDPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 81/292 (27%), Positives = 145/292 (49%), Gaps = 42/292 (14%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY--EEIRGEIEMLQQCSHPN 247
YE LN + +G+YG VY+ARD KT E+VA+K + + + +EG+ +R EI +L + HPN
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQHPN 65
Query: 248 VVRY----LGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYL 303
+V +GS + Y +VMEY + LM ++P + ++ + + L G+A+L
Sbjct: 66 IVTVKEVVVGSNLDKIY--MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122
Query: 304 HSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWM-APEVI-QE 361
H + +HRD+K N+LL ++G +K+ DFG+A + + K T + W APE++
Sbjct: 123 HDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-KPYTQLVVTLWYRAPELLLGA 181
Query: 362 SRYDGKVDVWALGVSAVEMAEG---LPPRSTVHPMRVLFMI------------------- 399
Y +D+W++G E+ P +S + + +F +
Sbjct: 182 KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241
Query: 400 --SIEPAPMLEDKEKWSLVF-----HDFVAKCLTKEPRARPTAAEMLKHKFI 444
+ P + ++K+ + D + + LT +P R +A + LKH +
Sbjct: 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 74/204 (36%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKV------ISLSEGEEGYEEIRGEIEMLQQC 243
+ L LG+G +G V A KT EL AIK I+ E E E R E
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKR-IFETANSE 59
Query: 244 SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLM-NVTEEPLEEYQIAYICREALKGLAY 302
HP +V +Q E+++ VMEY GG DLM ++ + E + + + GL Y
Sbjct: 60 RHPFLVNLFACFQTEDHVCFVMEYAAGG---DLMMHIHTDVFSEPRAVFYAACVVLGLQY 116
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQES 362
LH V+RD+K N+LL +G VK+ DFG+ + + +TF GTP ++APEV+ E+
Sbjct: 117 LHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTET 176
Query: 363 RYDGKVDVWALGVSAVEMAEGLPP 386
Y VD W LGV EM G P
Sbjct: 177 SYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 80/261 (30%), Positives = 127/261 (48%), Gaps = 21/261 (8%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSE-LVAIKVISLS---------EGEEGYEEIRGEIEM 239
Y +L LG G++G VYK R + L+A+K I++ E ++ +I E+ +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 240 L-QQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEP---LEEYQIAYICRE 295
+ +Q HPN+VRY ++ + L+IVM+ G + + N +E E +I I +
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 296 ALKGLAYLH-SIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWM 354
+ L YLH VHRD+ NI+L + +V + DFG+A Q SK + +GT +
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE-SKLTSVVGTILYS 180
Query: 355 APEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA--PMLEDKEK 412
PE+++ Y K DVWA G +M PP + + M L +E P+ E
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-MLSLATKIVEAVYEPLPEG--M 237
Query: 413 WSLVFHDFVAKCLTKEPRARP 433
+S D + CLT + ARP
Sbjct: 238 YSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 67/196 (34%), Positives = 100/196 (51%), Gaps = 8/196 (4%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVI--SLSEGEEGYEEIRGEIEMLQQCS-HPNVVRYL 252
LGKGS+G V A T EL A+KV+ + ++ E E +L HP + +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 253 GSYQGEEYLWIVMEYCGGGSVADLMNVTEE--PLEEYQIAYICREALKGLAYLHSIFKVH 310
+Q ++ L+ VMEY GG DLM + +E + + E + GL +LH ++
Sbjct: 63 SCFQTKDRLFFVMEYVNGG---DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIY 119
Query: 311 RDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDV 370
RD+K N+LL +G +K+ DFG+ + +TF GTP ++APE++ Y VD
Sbjct: 120 RDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDW 179
Query: 371 WALGVSAVEMAEGLPP 386
WALGV EM G P
Sbjct: 180 WALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 78/242 (32%), Positives = 122/242 (50%), Gaps = 16/242 (6%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPN 247
E + +G G++G V+ RD + A+KV+++ E + + + E +L++ SHP
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307
++R + + +L+++MEY GG + + + + Y E + L YLHS
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFY-ASEIVCALEYLHSKE 121
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQLT-RTMSKRNTFIGTPHWMAPEVIQESRYDG 366
V+RD+K NILL +G +KL DFG A +L RT T GTP ++APEVIQ ++
Sbjct: 122 IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW----TLCGTPEYLAPEVIQSKGHNK 177
Query: 367 KVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLT 426
VD WALG+ EM G PP +P + I L K ++ D AK L
Sbjct: 178 AVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI-------LAGKLEFPRHL-DLYAKDLI 229
Query: 427 KE 428
K+
Sbjct: 230 KK 231
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 2e-31
Identities = 73/255 (28%), Positives = 132/255 (51%), Gaps = 16/255 (6%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPN 247
+++ ++G+G + VY+A L + VA+K + + E + ++ EI++L+Q +HPN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEP---LEEYQIAYICREALKGLAYLH 304
V++YL S+ + L IV+E G ++ ++ ++ + E + + + ++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 305 SIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRY 364
S +HRDIK N+ +T G VKLGD G+ + + ++ +GTP++M+PE I E+ Y
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 365 DGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI-SIE-----PAPMLEDKEKWSLVFH 418
+ K D+W+LG EMA P M + + IE P P E +S
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYG-DKMNLFSLCQKIEQCDYPPLP----TEHYSEKLR 238
Query: 419 DFVAKCLTKEPRARP 433
+ V+ C+ +P RP
Sbjct: 239 ELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 76/275 (27%), Positives = 123/275 (44%), Gaps = 34/275 (12%)
Query: 192 LLNELGKGSYGAVYKAR----DLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPN 247
+ +LG+G +G V R T E VA+K ++ S E+ + EIE+L+ H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 248 VVRYLG-SY-QGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS 305
+V+Y G G L ++MEY GS+ D + + + ++ + KG+ YL S
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 306 IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT------RTMSKRNTFIGTPHWMAPEVI 359
+HRD+ NIL+ + VK+ DFG+A L + I W APE +
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI---FWYAPECL 184
Query: 360 QESRYDGKVDVWALGVSAVEM-AEGLPPRSTVHPM-RVLFMISIEPAPM--------LED 409
+ S++ DVW+ GV+ E+ G + P L MI I M L++
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYG---DPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241
Query: 410 KEKWSL------VFHDFVAKCLTKEPRARPTAAEM 438
E+ +D + C EP+ RP+ A++
Sbjct: 242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 3e-30
Identities = 92/303 (30%), Positives = 146/303 (48%), Gaps = 53/303 (17%)
Query: 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY--EEIRGEIEMLQQCSH 245
K++++ ++G+G+YG VYKARD T ELVA+K + L +EG+ IR EI++L+Q +H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNH 65
Query: 246 PNVVRY----------LGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPL---EEYQIAYI 292
N+V L + + ++V EY DLM + E L E I
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD----HDLMGLLESGLVHFSEDHIKSF 121
Query: 293 CREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR---NTFIG 349
++ L+GL Y H +HRDIK NILL ++G++KL DFG+ A+L + R N I
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL-ARLYNSEESRPYTNKVI- 179
Query: 350 TPHWMAPE-VIQESRYDGKVDVWALGVSAVEMAEGLP--------------------PRS 388
T + PE ++ E RY +DVW+ G E+ P P
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239
Query: 389 TVHP--MRVLFMISIEPAPMLEDK--EKWSLVFH---DFVAKCLTKEPRARPTAAEMLKH 441
V P +++ + +++P + E++S + D + LT +P R TA E L
Sbjct: 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299
Query: 442 KFI 444
++
Sbjct: 300 PWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 84/290 (28%), Positives = 122/290 (42%), Gaps = 37/290 (12%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEG--YEEIRGEIEMLQQCSHPN 247
++ + LGKG G V+ R T +L A+KV+ E + + + E E+L HP
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEP-LEEYQIAYICREALKGLAYLHSI 306
+ S+Q E YL +VM+YC GG + L+ L E + E L L YLH +
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL 122
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQL---TRTMSKR------------------- 344
V+RD+K NILL + G + L DF ++ Q +SK
Sbjct: 123 GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182
Query: 345 -------NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLF 397
N+F+GT ++APEVI + VD W LG+ EM G P +
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFS 242
Query: 398 MISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRAR----PTAAEMLKHKF 443
I + S D + K L K+P R AAE+ +H F
Sbjct: 243 NILKKE-VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-30
Identities = 101/311 (32%), Positives = 140/311 (45%), Gaps = 71/311 (22%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRG---------EIEM 239
KYE+L +LGKG+YG V+KA D +T E+VA+K I ++ R EI
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKI--------FDAFRNATDAQRTFREIMF 59
Query: 240 LQQCS-HPNVVRYLGSYQGEE----YLWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYIC 293
LQ+ HPN+V+ L + E YL V EY DL V LE+ YI
Sbjct: 60 LQELGDHPNIVKLLNVIKAENDKDIYL--VFEYME----TDLHAVIRANILEDVHKRYIM 113
Query: 294 REALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP-- 351
+ LK L Y+HS +HRD+K NILL VKL DFG L R++S+ P
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFG----LARSLSELEENPENPVL 169
Query: 352 ------HWM-APEVIQES-RYDGKVDVWALGVSAVEMAEG---LPPRSTVHP----MRVL 396
W APE++ S RY VD+W++G EM G P ST++ + V+
Sbjct: 170 TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI 229
Query: 397 FMISIE---------PAPMLED---KEKWSL--VFH-------DFVAKCLTKEPRARPTA 435
S E A ML+ + + L + D + K L P R TA
Sbjct: 230 GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTA 289
Query: 436 AEMLKHKFIER 446
E L+H ++ +
Sbjct: 290 EEALEHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 5e-30
Identities = 79/264 (29%), Positives = 122/264 (46%), Gaps = 25/264 (9%)
Query: 181 VTREDPT----TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIR 234
T+ D + + +E+ LG GS+G V A+ T E AIK + E + + +
Sbjct: 7 FTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVA 66
Query: 235 GEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSV-ADLMNVTEEPLEEYQIAYIC 293
E +L + SHP +V + S+Q E ++ ++E+ GG + L P + + +
Sbjct: 67 QEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAK--FYH 124
Query: 294 REALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT-RTMSKRNTFIGTPH 352
E + YLHS ++RD+K N+LL ++G VK+ DFG A ++ RT T GTP
Sbjct: 125 AELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF----TLCGTPE 180
Query: 353 WMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEK 412
++APEVIQ + VD W +GV E G PP P R+ I L + K
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI-------LAGRLK 233
Query: 413 WSLVF----HDFVAKCLTKEPRAR 432
+ F D V L + R
Sbjct: 234 FPNWFDGRARDLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 91/312 (29%), Positives = 137/312 (43%), Gaps = 64/312 (20%)
Query: 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYE--EIRGEIEMLQQ 242
D +KYE L ++G+G++G V+KAR KT ++VA+K + + +EG+ +R EI++LQ
Sbjct: 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQL 67
Query: 243 CSHPNVVRYL----------GSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYI 292
H NVV + Y+G YL V E+C +A L++ +I +
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYL--VFEFCEH-DLAGLLSNKNVKFTLSEIKKV 124
Query: 293 CREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA-AQLTRTMSKRNTFIG-- 349
+ L GL Y+H +HRD+K NIL+T G +KL DFG+A A SK N +
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184
Query: 350 -TPHWMAPEVIQESR-YDGKVDVWALGVSAVEMAEGLPPRSTVHP-MR------VLFMI- 399
T + PE++ R Y +D+W G EM T P M+ L +I
Sbjct: 185 VTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW-------TRSPIMQGNTEQHQLTLIS 237
Query: 400 ----SIEPA--PMLEDKEKWSLV-------FH---------------DFVAKCLTKEPRA 431
SI P P ++ E + + D + K L +P
Sbjct: 238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAK 297
Query: 432 RPTAAEMLKHKF 443
R A L H F
Sbjct: 298 RIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 69/196 (35%), Positives = 102/196 (52%), Gaps = 8/196 (4%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVIS----LSEGEEGYEEIRGEIE-MLQQCSHPNVVR 250
+GKGS+G V A+ + A+KV+ L + E+ + I E +L+ HP +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQ--KHIMAERNVLLKNVKHPFLVG 60
Query: 251 YLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVH 310
S+Q + L+ V++Y GG + + E E + + E L YLHS+ ++
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQ-RERSFPEPRARFYAAEIASALGYLHSLNIIY 119
Query: 311 RDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDV 370
RD+K NILL QG V L DFG+ + +TF GTP ++APEV+++ YD VD
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDW 179
Query: 371 WALGVSAVEMAEGLPP 386
W LG EM GLPP
Sbjct: 180 WCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 69/204 (33%), Positives = 108/204 (52%), Gaps = 14/204 (6%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE--IRGEIEMLQQCSHPN 247
++ L +LG+G+Y VYK R+ T E+VA+K I L + EEG IR EI ++++ H N
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHL-DAEEGTPSTAIR-EISLMKELKHEN 59
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADL---MNVTEE--PLEEYQIAYICREALKGLAY 302
+VR E L +V EY DL M+ L+ + + LKG+A+
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDK----DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQES 362
H +HRD+K N+L+ +GE+KL DFG+A ++ + + T + AP+V+ S
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGS 175
Query: 363 R-YDGKVDVWALGVSAVEMAEGLP 385
R Y +D+W++G EM G P
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRP 199
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 89/311 (28%), Positives = 141/311 (45%), Gaps = 61/311 (19%)
Query: 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY--EEIRGEIEMLQQCS 244
YE+L +LG+G++G VYKAR +KT +VA+K I + ++G+ +R EI++L++
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLK 65
Query: 245 HPNVVRYL----------GSYQGEEYLWIVMEYCGGGSVADLMNVTEEP---LEEYQIAY 291
HPNVV + +G Y+ V Y DL + E P L E QI
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYM--VTPY----MDHDLSGLLENPSVKLTESQIKC 119
Query: 292 ICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT---------RTMS 342
+ L+G+ YLH +HRDIK NIL+ +QG +K+ DFG+A
Sbjct: 120 YMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 343 KRN--TFIGTPHWMAPE-VIQESRYDGKVDVWALGVSAVEMAEG---LPPRSTVHPMRVL 396
R + T + PE ++ E RY VD+W +G EM L +S + + ++
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239
Query: 397 FMISIEPA-----------------------PMLEDK-EKWSLVFHDFVAKCLTKEPRAR 432
F + P LE++ K D ++K L+ +P R
Sbjct: 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKR 299
Query: 433 PTAAEMLKHKF 443
TA++ L+H +
Sbjct: 300 LTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-29
Identities = 55/185 (29%), Positives = 81/185 (43%), Gaps = 20/185 (10%)
Query: 271 GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGD 330
S+AD++ V PL E +I +C + L L LH R K GNILLT G +KL
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALRELH------RQAKSGNILLTWDGLLKL-- 52
Query: 331 FGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTV 390
G A T S P++MAPEVIQ Y K D+++LG++ E + P +
Sbjct: 53 DGSVAFKTPEQS-----RPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107
Query: 391 HPMRVLFMISI-----EPAPMLEDKEKWS--LVFHDFVAKCLTKEPRARPTAAEMLKHKF 443
+ + I + + + E S F DF+ C ++ P+ R A L H
Sbjct: 108 RELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCR 167
Query: 444 IERCK 448
+
Sbjct: 168 ALFAE 172
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 67/196 (34%), Positives = 106/196 (54%), Gaps = 8/196 (4%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE--IRGEIEMLQQCSHPN 247
++ + ++G+G+YG VYKAR+ T E+VA+K I L EG IR EI +L++ +HPN
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 60
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGG--SVADLMNVTEEPLEEYQIAYICREALKGLAYLHS 305
+V+ L E L++V E+ D ++ PL I + L+GLA+ HS
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLP--LIKSYLFQLLQGLAFCHS 118
Query: 306 IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESR-Y 364
+HRD+K N+L+ +G +KL DFG+A + + T + APE++ + Y
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 178
Query: 365 DGKVDVWALGVSAVEM 380
VD+W+LG EM
Sbjct: 179 STAVDIWSLGCIFAEM 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 66/199 (33%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQ------CSHPNVV 249
LGKGS+G V A T+E AIK + + + E+ E M+++ HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKAL---KKDVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 250 RYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPL--EEYQIAYICREALKGLAYLHSIF 307
++Q +E+L+ VMEY GG DLM + +E + + E + GL +LH
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGK 367
++RD+K N+LL G +K+ DFG+ + K +TF GTP ++APE+++ +Y+
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNES 176
Query: 368 VDVWALGVSAVEMAEGLPP 386
VD W+ GV EM G P
Sbjct: 177 VDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 65/206 (31%), Positives = 109/206 (52%), Gaps = 9/206 (4%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPN 247
+++ + +G+G +G V R+ T ++ A+KV+ S +E E ++L + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307
+ + ++Q ++ L++VMEY GG + L+N E+ +E + E + + +H +
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT-MSKRNTFIGTPHWMAPEVIQ------ 360
VHRDIK N+L+ G +KL DFG AA+LT M +GTP ++APEV+
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 361 ESRYDGKVDVWALGVSAVEMAEGLPP 386
+ Y + D W+LGV A EM G P
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 80/296 (27%), Positives = 135/296 (45%), Gaps = 54/296 (18%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE--IRGEIEMLQQCSHP 246
KYE L ++G+G+YG V+KA++ +T E+VA+K + L + +EG +R EI +L++ H
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHK 59
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEY------QI-AYICR----E 295
N+VR ++ L +V EYC ++ L++Y I I + +
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEYC------------DQDLKKYFDSCNGDIDPEIVKSFMFQ 107
Query: 296 ALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMA 355
LKGLA+ HS +HRD+K N+L+ GE+KL DFG+A + + + T +
Sbjct: 108 LLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRP 167
Query: 356 PEVIQESR-YDGKVDVWALGVSAVEMAEG----LPPRSTVHPMRVLFMI----------- 399
P+V+ ++ Y +D+W+ G E+A P ++ +F +
Sbjct: 168 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPG 227
Query: 400 -----SIEPAPMLEDKEKWSLVF-------HDFVAKCLTKEPRARPTAAEMLKHKF 443
+P PM V D + L P R +A E L+H +
Sbjct: 228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 73/203 (35%), Positives = 110/203 (54%), Gaps = 12/203 (5%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE--IRGEIEMLQQCSHPN 247
Y+ + ++G+G+YG VYKARD T E+VA+K I L +EG IR EI +L++ +HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELNHPN 59
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADL---MN-VTEEPLEEYQIAYICREALKGLAYL 303
+VR L E L++V E+ DL M+ L+ I + L+G+AY
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLD----LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 304 HSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESR 363
HS +HRD+K N+L+ +G +KL DFG+A + + T + APE++ SR
Sbjct: 116 HSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSR 175
Query: 364 -YDGKVDVWALGVSAVEMAEGLP 385
Y VD+W++G EM P
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 9e-28
Identities = 69/196 (35%), Positives = 101/196 (51%), Gaps = 8/196 (4%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVIS----LSEGEEGYEEIRGEIE-MLQQCSHPNVVR 250
+GKGS+G V A+ A+KV+ L + E+ + I E +L+ HP +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNH--IMAERNVLLKNLKHPFLVG 60
Query: 251 YLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVH 310
S+Q E L+ V++Y GG + + E E + + E + YLHS+ ++
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQ-RERCFLEPRARFYAAEVASAIGYLHSLNIIY 119
Query: 311 RDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDV 370
RD+K NILL QG V L DFG+ + +TF GTP ++APEV+++ YD VD
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179
Query: 371 WALGVSAVEMAEGLPP 386
W LG EM GLPP
Sbjct: 180 WCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 70/259 (27%), Positives = 130/259 (50%), Gaps = 24/259 (9%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPN 247
+ + ++G+G + VY+A L VA+K + + + + + EI++L+Q +HPN
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMN--------VTEEPLEEYQIAYICREALKG 299
V++Y S+ + L IV+E G ++ ++ + E+ + +Y + +C
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQ-LC----SA 118
Query: 300 LAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVI 359
L ++HS +HRDIK N+ +T G VKLGD G+ + + ++ +GTP++M+PE I
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 360 QESRYDGKVDVWALGVSAVEMAEGLPP----RSTVHPM-RVLFMISIEPAPMLEDKEKWS 414
E+ Y+ K D+W+LG EMA P + ++ + + + P P + +S
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP----SDHYS 234
Query: 415 LVFHDFVAKCLTKEPRARP 433
V C+ +P RP
Sbjct: 235 EELRQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 73/196 (37%), Positives = 101/196 (51%), Gaps = 8/196 (4%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKV----ISLSEGEEGYEEIRGEIE-MLQQCSHPNVVR 250
+GKGS+G V A+ + A+KV I L+ E+ + I E +L+ HP +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQ--KHIMAERNVLLKNVKHPFLVG 60
Query: 251 YLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVH 310
S+Q E L+ V+++ GG + + E E + + E L YLHSI V+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQ-RERSFPEPRARFYAAEIASALGYLHSINIVY 119
Query: 311 RDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDV 370
RD+K NILL QG V L DFG+ + TF GTP ++APEVI++ YD VD
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDW 179
Query: 371 WALGVSAVEMAEGLPP 386
W LG EM GLPP
Sbjct: 180 WCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 71/197 (36%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVIS----LSEGEEGYEEIRGEIEMLQQCSHPNVVRY 251
LGKGS+G V A T E+ AIKV+ L + + I L HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTAL 61
Query: 252 LGSYQGEEYLWIVMEYCGGGSVADLMNVTEEP--LEEYQIAYICREALKGLAYLHSIFKV 309
+Q ++ L+ VMEY GG DLM + +E + + E L +LH +
Sbjct: 62 HCCFQTKDRLFFVMEYVNGG---DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVI 118
Query: 310 HRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVD 369
+RD+K NILL +G KL DFG+ + TF GTP ++APE++QE Y VD
Sbjct: 119 YRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVD 178
Query: 370 VWALGVSAVEMAEGLPP 386
WALGV EM G PP
Sbjct: 179 WWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 3e-27
Identities = 71/196 (36%), Positives = 101/196 (51%), Gaps = 8/196 (4%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVIS----LSEGEEGYEEIRGEIE-MLQQCSHPNVVR 250
+GKGS+G V AR + A+KV+ L + EE + I E +L+ HP +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEE--KHIMSERNVLLKNVKHPFLVG 60
Query: 251 YLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVH 310
S+Q + L+ V++Y GG + + E E + + E L YLHS+ V+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARFYAAEIASALGYLHSLNIVY 119
Query: 311 RDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDV 370
RD+K NILL QG + L DFG+ + +TF GTP ++APEV+ + YD VD
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179
Query: 371 WALGVSAVEMAEGLPP 386
W LG EM GLPP
Sbjct: 180 WCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 7e-27
Identities = 62/235 (26%), Positives = 107/235 (45%), Gaps = 35/235 (14%)
Query: 182 TREDPTTKYELLNE-LGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRG----- 235
+ +Y LG+G+YG V KA D T ++VAIK + + E + R
Sbjct: 2 MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMC 61
Query: 236 --------EIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEP--LE 285
E++++ + H N++ + Y +++ +VM+ DL V + L
Sbjct: 62 GIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS----DLKKVVDRKIRLT 117
Query: 286 EYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQ-----LTRT 340
E Q+ I + L GL LH + +HRD+ NI + +G K+ DFG+A + + T
Sbjct: 118 ESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177
Query: 341 MSKRNTF---------IGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLP 385
+SK T + T + APE++ + +Y VD+W++G E+ G P
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 77/268 (28%), Positives = 117/268 (43%), Gaps = 22/268 (8%)
Query: 181 VTREDPTTKYELLNE-LGKGSYGAVYKA--RDLKTSEL-VAIKVISLSEGEEGYEEIRGE 236
+ RED T L +G+G +G VY+ + ++ VA+K E+ E
Sbjct: 3 IQREDIT-----LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQE 57
Query: 237 IEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREA 296
+++Q HP++V+ +G E +WIVME G + + V + L+ + +
Sbjct: 58 AYIMRQFDHPHIVKLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQL 116
Query: 297 LKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT----P- 351
LAYL S VHRDI N+L++ VKLGDFG L+R + + + + P
Sbjct: 117 STALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFG----LSRYLEDESYYKASKGKLPI 172
Query: 352 HWMAPEVIQESRYDGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMISIEPAPMLEDK 410
WMAPE I R+ DVW GV E + G+ P V V+ IE L
Sbjct: 173 KWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI--GRIENGERLPMP 230
Query: 411 EKWSLVFHDFVAKCLTKEPRARPTAAEM 438
+ + KC +P RP E+
Sbjct: 231 PNCPPTLYSLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 72/304 (23%), Positives = 141/304 (46%), Gaps = 54/304 (17%)
Query: 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVIS-----LSEGEEGYEEIRGEIEMLQQ 242
++Y+ + +G G+YG V A D ++ + VAIK I + + E++ +L+
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----ILRH 60
Query: 243 CSHPNVVRYLGSYQGEEYL----WIVMEYCGGGSVADLMNV--TEEPLEEYQIAYICREA 296
H N++ + ++VM+ DL ++ +++PL E I Y +
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMDLMES----DLHHIIHSDQPLTEEHIRYFLYQL 116
Query: 297 LKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF----IGTPH 352
L+GL Y+HS +HRD+K N+L+ + E+++GDFG+A L+ + ++ F + T
Sbjct: 117 LRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 353 WMAPEVIQES-RYDGKVDVWALGVSAVEM---AEGLPPRSTVHPMRVLFMI--------- 399
+ APE++ Y +D+W++G EM + P ++ VH ++++ +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236
Query: 400 ----------SIEPAPMLEDKEKWSLVFH-------DFVAKCLTKEPRARPTAAEMLKHK 442
I+ P + WS +F D +++ L +P R T + L+H
Sbjct: 237 NRIGSDRVRKYIQNLPRKQPVP-WSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295
Query: 443 FIER 446
F+ +
Sbjct: 296 FLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 97/301 (32%), Positives = 145/301 (48%), Gaps = 64/301 (21%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEG--YEEIRGEIEMLQQCSHPN 247
Y+ L++LG+GSY VYK R T +LVA+K I L E EEG + IR E +L+ H N
Sbjct: 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRL-EHEEGAPFTAIR-EASLLKDLKHAN 64
Query: 248 VVRYLGSYQGEEYLWIVMEY-----------CGGGSVADLMNVTEEPLEEYQIAYICREA 296
+V ++ L +V EY CGGG + NV L +Q+
Sbjct: 65 IVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGG--LSMHNVR---LFLFQL------- 112
Query: 297 LKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA---AQLTRTMSKRNTFIGTPHW 353
L+GLAY H +HRD+K N+L++++GE+KL DFG+A + ++T S + T +
Sbjct: 113 LRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNE---VVTLWY 169
Query: 354 MAPEVIQESR-YDGKVDVWALGVSAVEMAEGLP--PRST-----VHPM-RVLFMISIE-- 402
P+V+ S Y +D+W +G EMA G P P ST +H + RVL + E
Sbjct: 170 RPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETW 229
Query: 403 ------------------PAPMLEDKEKWSLVFH--DFVAKCLTKEPRARPTAAEMLKHK 442
P P++ + + H + K L EP+ R +AAE +KH
Sbjct: 230 PGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP 289
Query: 443 F 443
+
Sbjct: 290 Y 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 69/201 (34%), Positives = 105/201 (52%), Gaps = 10/201 (4%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY--EEIR--GEIEMLQQCS 244
+YE + E+G G+YG VYKARD + VA+K + + E+G +R ++ L+
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 245 HPNVVRYL-----GSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKG 299
HPN+VR + E + +V E+ L V L I + R+ L+G
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 300 LAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVI 359
L +LH+ VHRD+K NIL+T G+VKL DFG+A + M+ + T + APEV+
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV-TLWYRAPEVL 179
Query: 360 QESRYDGKVDVWALGVSAVEM 380
+S Y VD+W++G EM
Sbjct: 180 LQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 86/324 (26%), Positives = 142/324 (43%), Gaps = 56/324 (17%)
Query: 191 ELLNELGKG--SYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPN 247
ELL +G+G V AR T E V ++ I+L E ++GE+ + + +HPN
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSI 306
+V Y ++ + LW+V + GS DL+ + + E IAYI + LK L Y+H +
Sbjct: 61 IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM 120
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH-------WMAPEVI 359
VHR +K +IL++ G+V L + + P W++PEV+
Sbjct: 121 GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVL 180
Query: 360 QESR--YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDK------- 410
Q++ YD K D++++G++A E+A G P + ++L P L D
Sbjct: 181 QQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240
Query: 411 ------------------------------------EKWSLVFHDFVAKCLTKEPRARPT 434
+S FH FV +CL + P ARP+
Sbjct: 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPS 300
Query: 435 AAEMLKHKFIERCKCGATAMLPKI 458
A+ +L H F ++ K A+ LP++
Sbjct: 301 ASTLLNHSFFKQIKRRASEALPEL 324
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 71/214 (33%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY--EEIRGEIEMLQQCSH- 245
YE L ++G+G+YG VYKARD T +LVA+K L EEG +R EI +LQ S
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSES 60
Query: 246 PNVVRYLG-----SYQGEEYLWIVMEYCGGGSVADLMNVTE-------EPLEEYQIAYIC 293
+VR L G+ L++V EY +DL + PL I
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLD----SDLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 294 REALKGLAYLHSIFKVHRDIKGGNILLTDQGEV-KLGDFGVAAQLTRTMSKRNTFIGTPH 352
+ LKG+A+ H +HRD+K N+L+ Q + K+ D G+ + + I T
Sbjct: 117 YQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLW 176
Query: 353 WMAPEVIQESR-YDGKVDVWALGVSAVEMAEGLP 385
+ APEV+ S Y VD+W++G EM+ P
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 66/196 (33%), Positives = 101/196 (51%), Gaps = 8/196 (4%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVIS--LSEGEEGYEEIRGEIEMLQ-QCSHPNVVRYL 252
LGKGS+G V AR ++ L A+KV+ + ++ E E +L +HP + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 253 GSYQGEEYLWIVMEYCGGGSVADLMNVTEEP--LEEYQIAYICREALKGLAYLHSIFKVH 310
+Q + L+ VME+ GG DLM ++ +E + + E L +LH ++
Sbjct: 63 CCFQTPDRLFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 311 RDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDV 370
RD+K N+LL +G KL DFG+ + +TF GTP ++APE++QE Y VD
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDW 179
Query: 371 WALGVSAVEMAEGLPP 386
WA+GV EM G P
Sbjct: 180 WAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 75/272 (27%), Positives = 119/272 (43%), Gaps = 35/272 (12%)
Query: 194 NELGKGSYGAV----YKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVV 249
ELG G++G+V Y + K E VA+K + G +E E ++ Q HP +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVE-VAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 250 RYLGSYQGEEYLWIVMEYCGGGSVADLM----NVTEEPLEEY--QIAYICREALKGLAYL 303
R +G +GE + +VME G + + + L+E Q+A G+AYL
Sbjct: 60 RLIGVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAM-------GMAYL 111
Query: 304 HSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFI-GTPH------WMAP 356
S VHRD+ N+LL ++ + K+ DFG ++R + + + T W AP
Sbjct: 112 ESKHFVHRDLAARNVLLVNRHQAKISDFG----MSRALGAGSDYYRATTAGRWPLKWYAP 167
Query: 357 EVIQESRYDGKVDVWALGVSAVEM-AEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSL 415
E I ++ K DVW+ GV+ E + G P + V+ M +E L E+
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM--LESGERLPRPEECPQ 225
Query: 416 VFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447
+ + C P RPT +E+ R
Sbjct: 226 EIYSIMLSCWKYRPEDRPTFSEL--ESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 82/266 (30%), Positives = 129/266 (48%), Gaps = 33/266 (12%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKV------ISLSEGEEGYEEIRGEIEMLQQCSHPNVV 249
LGKG++G V R+ T + A+K+ I+ E E R +LQ HP +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESR----VLQNTRHPFLT 58
Query: 250 RYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPL-EEYQIAYICREALKGLAYLHSIFK 308
S+Q + L VMEY GG + +++ E + E + + E + L YLHS
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALGYLHSCDV 116
Query: 309 VHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKV 368
V+RD+K N++L G +K+ DFG+ + + TF GTP ++APEV++++ Y V
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 369 DVWALGVSAVEMAEG-LPPRSTVHPMRVLF-MISIE----PAPMLEDKEKWSLVFHDFVA 422
D W LGV EM G LP + H LF +I +E P + + + +A
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILMEEIRFPRTLSPEAK-------SLLA 227
Query: 423 KCLTKEPRAR-----PTAAEMLKHKF 443
L K+P+ R A E+++H+F
Sbjct: 228 GLLKKDPKQRLGGGPEDAKEIMEHRF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 69/251 (27%), Positives = 120/251 (47%), Gaps = 12/251 (4%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSY 255
+GKG++G VYK LK + VA+K + + + E E+L+Q HPN+V+ +G
Sbjct: 3 IGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 256 QGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKG 315
++ ++IVME GGS+ + + L ++ + +A G+ YL S +HRD+
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAA 121
Query: 316 GNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIG-TP-HWMAPEVIQESRYDGKVDVWAL 373
N L+ + +K+ DFG++ + + + + P W APE + RY + DVW+
Sbjct: 122 RNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSY 181
Query: 374 GVSAVEM-AEGLPPRSTVHPMRVLFMISIE---PAPMLEDKEKWSLVFHDFVAKCLTKEP 429
G+ E + G P + + I PAP L +E + L+ C +P
Sbjct: 182 GILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQ-----CWAYDP 236
Query: 430 RARPTAAEMLK 440
RP+ +E+
Sbjct: 237 ENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 83/315 (26%), Positives = 135/315 (42%), Gaps = 72/315 (22%)
Query: 182 TREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVI-----SLSEGEEGYEEIRGE 236
T + +Y+ L+ +G G+YG V A D KT VAIK + S + Y E+R
Sbjct: 9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELR-- 66
Query: 237 IEMLQQCSHPNVVRYLGSYQGEEYL------WIVMEYCGGGSVADLMNVTE-EPLEEYQI 289
+L+ H NV+ L + L ++V G ADL N+ + + L + I
Sbjct: 67 --LLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMG----ADLNNIVKCQKLSDDHI 120
Query: 290 AYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIG 349
++ + L+GL Y+HS +HRD+K NI + + E+K+ DFG+A M+ ++
Sbjct: 121 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT---GYVA 177
Query: 350 TPHWMAPEVI-QESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLF----------- 397
T + APE++ Y+ VD+W++G E+ G + LF
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG----------KTLFPGSDHIDQLKR 227
Query: 398 MISIEPAPMLEDKEKWSL--------------------VFH-------DFVAKCLTKEPR 430
++++ P E +K S VF D + K L +P
Sbjct: 228 IMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPD 287
Query: 431 ARPTAAEMLKHKFIE 445
R TAAE L H ++
Sbjct: 288 KRITAAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 62/194 (31%), Positives = 100/194 (51%), Gaps = 4/194 (2%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISLS--EGEEGYEEIRGEIEMLQQCSHPNVVRYLG 253
LGKG +G V + T ++ A K + + +G + E ++L++ S +V
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 254 SYQGEEYLWIVMEYCGGGSVA-DLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRD 312
+++ ++ L +VM GG + + NV E E + + + + GL +LH V+RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 313 IKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWA 372
+K N+LL D G V++ D G+A +L + K GTP +MAPEV+Q YD VD +A
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFA 179
Query: 373 LGVSAVEMAEGLPP 386
LG + EM G P
Sbjct: 180 LGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 61/210 (29%), Positives = 115/210 (54%), Gaps = 21/210 (10%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIR--------GEIEMLQ 241
++++ +G+G++G V R + ++ A+K++S +E I+ E +++
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS------KFEMIKRSDSAFFWEERDIMA 98
Query: 242 QCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLA 301
+ +V+ ++Q ++YL++VMEY GG + +LM+ + P E++ Y E + L
Sbjct: 99 HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIP-EKWARFYTA-EVVLALD 156
Query: 302 YLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT-MSKRNTFIGTPHWMAPEVIQ 360
+HS+ +HRD+K N+LL G +KL DFG ++ M + +T +GTP +++PEV++
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLK 216
Query: 361 ESRYDG----KVDVWALGVSAVEMAEGLPP 386
DG + D W++GV EM G P
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 89/304 (29%), Positives = 139/304 (45%), Gaps = 25/304 (8%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVI--SLSEGEEGYEEIRGEIEMLQQCS-HPNVVRYL 252
+G+GSY V R KT + A+KV+ L +E + ++ E + +Q S HP +V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 253 GSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRD 312
+Q E L+ V+EY GG + M + EE+ Y +L L YLH ++RD
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL-ALNYLHERGIIYRD 121
Query: 313 IKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWA 372
+K N+LL +G +KL D+G+ + R +TF GTP+++APE+++ Y VD WA
Sbjct: 122 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWA 181
Query: 373 LGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRAR 432
LGV EM G P V S P ED +F + K + + PR+
Sbjct: 182 LGVLMFEMMAGRSPFDIVGS-------SDNPDQNTED-----YLFQVILEKQI-RIPRSL 228
Query: 433 PTAAEMLKHKFI-----ERCKCGATAMLPKIEKA---RQIRASMAQQAQNILSDEPEVNA 484
A + F+ ER C I+ R + + +Q Q + +P ++
Sbjct: 229 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISG 288
Query: 485 TMGL 488
GL
Sbjct: 289 EFGL 292
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 74/268 (27%), Positives = 120/268 (44%), Gaps = 36/268 (13%)
Query: 195 ELGKGSYGAV----YKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVR 250
LG+G +G V Y + T E+VA+K + G++ + EI +L+ H N+V+
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 251 YLG--SYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFK 308
Y G S QG + L ++MEY GS+ D + + L Q+ ++ +G+AYLHS
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLAQLLLFAQQICEGMAYLHSQHY 128
Query: 309 VHRDIKGGNILLTDQGEVKLGDFGVAAQL--------TRTMSKRNTFIGTPHWMAPEVIQ 360
+HRD+ N+LL + VK+GDFG+A + R F W A E ++
Sbjct: 129 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-----WYAVECLK 183
Query: 361 ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPM--------LEDKE- 411
E+++ DVW+ GV+ E+ + + P + MI + M LE
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSKQS-PPKKFEEMIGPKQGQMTVVRLIELLERGMR 242
Query: 412 -----KWSLVFHDFVAKCLTKEPRARPT 434
+ + C E + RPT
Sbjct: 243 LPCPKNCPQEVYILMKNCWETEAKFRPT 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 67/197 (34%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIK------VISLSEGEEGYEEIRGEIEMLQQCSHPNVV 249
+GKGS+G V + R T + A+K ++S SE E +L Q + P +V
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSE----VTHTLAERTVLAQVNCPFIV 56
Query: 250 RYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKV 309
S+Q E L++V+ + GG + + E + + + E L L LH +
Sbjct: 57 PLKFSFQSPEKLYLVLAFINGGELFHHLQ-REGRFDLSRARFYTAELLCALENLHKFNVI 115
Query: 310 HRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVD 369
+RD+K NILL QG + L DFG+ + K NTF GTP ++APE++ Y VD
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVD 175
Query: 370 VWALGVSAVEMAEGLPP 386
W LGV EM GLPP
Sbjct: 176 WWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 66/196 (33%), Positives = 100/196 (51%), Gaps = 8/196 (4%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVI--SLSEGEEGYEEIRGEIEMLQQCS-HPNVVRYL 252
+G+GSY V KT + A+KVI L +E + ++ E + + S HP +V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 253 GSYQGEEYLWIVMEYCGGGSVADLM--NVTEEPLEEYQIAYICREALKGLAYLHSIFKVH 310
+Q E L+ V+E+ GG DLM + L E + E L +LH ++
Sbjct: 63 SCFQTESRLFFVIEFVSGG---DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIY 119
Query: 311 RDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDV 370
RD+K N+LL +G +KL D+G+ + R +TF GTP+++APE+++ Y VD
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 371 WALGVSAVEMAEGLPP 386
WALGV EM G P
Sbjct: 180 WALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 89/294 (30%), Positives = 139/294 (47%), Gaps = 43/294 (14%)
Query: 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVI--SLSEGEEGYEEIRGEIEMLQQ 242
+ T +Y L +G G++G V ARD T + VAIK I S R E+++L+
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKH 65
Query: 243 CSHPNVVRYLGSY-QGEEYLWIVMEYCGGGSVADLMNV-TEEPLEEYQIAYICREALKGL 300
H N++ + E ++ V E G DL + T PLE+ I Y + L+GL
Sbjct: 66 LRHENIISLSDIFISPLEDIYFVTELLG----TDLHRLLTSRPLEKQFIQYFLYQILRGL 121
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT-FIGTPHWMAPEVI 359
Y+HS VHRD+K NIL+ + ++K+ DFG+A R + T ++ T ++ APE++
Sbjct: 122 KYVHSAGVVHRDLKPSNILINENCDLKICDFGLA----RIQDPQMTGYVSTRYYRAPEIM 177
Query: 360 QE-SRYDGKVDVWALGVSAVEMAEG---LPPRSTVH------------PMRVL------- 396
+YD +VD+W+ G EM EG P + V+ P V+
Sbjct: 178 LTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237
Query: 397 ---FMISI---EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
F+ S+ EP P E + D + K L +P+ R +AAE L H ++
Sbjct: 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 81/275 (29%), Positives = 133/275 (48%), Gaps = 29/275 (10%)
Query: 190 YELLNELGKGSYGAVYKARDL---KTSELVAIKV---ISLSEGEEGYEEIRGE---IEML 240
+ELL LG G+YG V+ R + +L A+KV ++ + + E R E +E +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 241 QQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGL 300
++C P +V ++Q + L ++++Y GG + + E E ++ E + L
Sbjct: 62 RRC--PFLVTLHYAFQTDTKLHLILDYVNGGELFTHL-YQREHFTESEVRVYIAEIVLAL 118
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQ-LTRTMSKRNTFIGTPHWMAPEVI 359
+LH + ++RDIK NILL +G V L DFG++ + L + +F GT +MAPEVI
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178
Query: 360 Q--ESRYDGKVDVWALGVSAVEMAEGLPP------RSTVHPMRVLFMISIEPAPMLEDKE 411
+ +D VD W+LGV E+ G P +++ + + S P P +
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFP-----K 233
Query: 412 KWSLVFHDFVAKCLTKEPRAR---PTAAEMLKHKF 443
S DF+ K L K+P+ R A E+ H F
Sbjct: 234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 70/202 (34%), Positives = 100/202 (49%), Gaps = 8/202 (3%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVIS--LSEGEEGYEEIRGEIEMLQQCSHPN 247
+ L LGKGS+G V A T EL AIK++ + ++ E E +L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 248 VVRYLGS-YQGEEYLWIVMEYCGGGSVADLMNVTEE--PLEEYQIAYICREALKGLAYLH 304
+ L S +Q + L+ VMEY GG DLM ++ +E + E GL +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGG---DLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118
Query: 305 SIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRY 364
S ++RD+K N++L +G +K+ DFG+ + TF GTP ++APE+I Y
Sbjct: 119 SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY 178
Query: 365 DGKVDVWALGVSAVEMAEGLPP 386
VD WA GV EM G PP
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 7e-25
Identities = 76/264 (28%), Positives = 130/264 (49%), Gaps = 25/264 (9%)
Query: 196 LGKGSYGAVYKARDLKTSE---LVAIKVI---SLSEGEEGYEEIRGEIEMLQQCSHPNVV 249
LGKG YG V++ R + ++ + A+KV+ ++ ++ + E +L+ HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 250 RYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEP--LEEYQIAYICREALKGLAYLHSIF 307
+ ++Q L++++EY GG + M++ E +E+ Y+ E L +LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLS-EISLALEHLHQQG 120
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGK 367
++RD+K NILL QG VKL DFG+ + + +TF GT +MAPE++ S +
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKA 180
Query: 368 VDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI---SIEPAPMLEDKEKWSLVFHDFVAKC 424
VD W+LG +M G PP + + + + I + P L + + D + K
Sbjct: 181 VDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEAR------DLLKKL 234
Query: 425 LTKEPRAR-----PTAAEMLKHKF 443
L + P +R AAE+ H F
Sbjct: 235 LKRNPSSRLGAGPGDAAEVQSHPF 258
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 78/276 (28%), Positives = 128/276 (46%), Gaps = 25/276 (9%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPN 247
+E + + G+YGAVY R +T + A+K I+ +++ E ++L +P
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLM-NVTEEPLEEYQIAYICREALKGLAYLHSI 306
VV S++ + +L +VMEY GG A L+ N+ P++ ++ + E + L YLH+
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFA--ETVLALEYLHNY 120
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVA----------------AQLTRTMSKRNTFIGT 350
VHRD+K N+L+T G +KL DFG++ + TR + GT
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC-GT 179
Query: 351 PHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDK 410
P ++APEVI Y VD WA+G+ E G P P + + + E
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239
Query: 411 EKWSLVFHDFVAKCLTKEPRAR---PTAAEMLKHKF 443
E D +++ L + P R A E+ +H+F
Sbjct: 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 70/211 (33%), Positives = 105/211 (49%), Gaps = 25/211 (11%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE--IRGEIEMLQQCSHP 246
Y + ++G+G+YG VYK R+ KT ++VA+K I L EEG IR EI +L++ HP
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHP 59
Query: 247 NVVRYLGSYQGEEYLWIVMEY-----------CGGGSVADLMNVTEEPLEEYQIAYICRE 295
N+V E L+++ E+ G D V YQI
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKS---YLYQI------ 110
Query: 296 ALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMA 355
L+G+ + HS +HRD+K N+L+ ++G +KL DFG+A + + T + A
Sbjct: 111 -LQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRA 169
Query: 356 PEVIQES-RYDGKVDVWALGVSAVEMAEGLP 385
PEV+ S RY VD+W++G EMA P
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMATKKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 8e-25
Identities = 76/208 (36%), Positives = 111/208 (53%), Gaps = 13/208 (6%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTS-ELVAIKVISLSEGEEGY--EEIRGEIEMLQQCS- 244
+YE + E+G+G+YG V+KARDLK VA+K + + GEEG IR E+ +L+
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLET 60
Query: 245 --HPNVVRY-----LGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREAL 297
HPNVVR + E L +V E+ L V E + I + + L
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 298 KGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPE 357
+GL +LHS VHRD+K NIL+T G++KL DFG+A + M+ + + T + APE
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRAPE 179
Query: 358 VIQESRYDGKVDVWALGVSAVEMAEGLP 385
V+ +S Y VD+W++G EM P
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 8e-25
Identities = 79/280 (28%), Positives = 132/280 (47%), Gaps = 22/280 (7%)
Query: 179 ESVTREDPTTKYELLNEL-GKGSYGAVYKA-RDLKTSELVAIKVISLSEGEEGYEEIRGE 236
E +P +L L G+ A + A R E V K + L++ E R E
Sbjct: 57 EVPESNNPREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSE 115
Query: 237 IEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEE------PLEEYQIA 290
+ L C H +V++ ++ ++ L ++MEY GG DL ++ P +EY++
Sbjct: 116 LHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGG---DLNKQIKQRLKEHLPFQEYEVG 172
Query: 291 YICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS--KRNTFI 348
+ + + L +HS +HRD+K NI L G +KLGDFG + Q + ++S ++F
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232
Query: 349 GTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPP---RSTVHPMRVLFMISIEPAP 405
GTP+++APE+ + RY K D+W+LGV E+ P S M+ + +P P
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFP 292
Query: 406 MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445
S + L+K P RPT ++L +F++
Sbjct: 293 C-----PVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 67/196 (34%), Positives = 101/196 (51%), Gaps = 8/196 (4%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVIS--LSEGEEGYEEIRGEIEMLQQC-SHPNVVRYL 252
LGKGS+G V+ A T++ AIK + + ++ E E +L HP +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 253 GSYQGEEYLWIVMEYCGGGSVADLMNVTE--EPLEEYQIAYICREALKGLAYLHSIFKVH 310
++Q +E L+ VMEY GG DLM + + + + E + GL +LHS V+
Sbjct: 63 CTFQTKENLFFVMEYLNGG---DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVY 119
Query: 311 RDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDV 370
RD+K NILL G +K+ DFG+ + +K TF GTP ++APE++ +Y+ VD
Sbjct: 120 RDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDW 179
Query: 371 WALGVSAVEMAEGLPP 386
W+ GV EM G P
Sbjct: 180 WSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 85/297 (28%), Positives = 135/297 (45%), Gaps = 51/297 (17%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVIS---LSE--GEEGYEEIRGEIEMLQQC 243
+Y L ++G G+YG+V A D +T E VAIK +S SE + Y E+ +L+
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELT----LLKHM 71
Query: 244 SHPNVVRYLG------SYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREAL 297
H NV+ L S + ++VM Y DL + PL E ++ Y+ + L
Sbjct: 72 QHENVIGLLDVFTSAVSGDEFQDFYLVMPYM----QTDLQKIMGHPLSEDKVQYLVYQML 127
Query: 298 KGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPE 357
GL Y+HS +HRD+K GN+ + + E+K+ DFG+A M+ ++ T + APE
Sbjct: 128 CGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG---YVVTRWYRAPE 184
Query: 358 VIQE-SRYDGKVDVWALGVSAVEMAEG---LPPRSTVHPMRVLFMISIEPAP----MLED 409
VI Y+ VD+W++G EM G + + + + ++ P P LED
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244
Query: 410 KE--------------KWSLVFH-------DFVAKCLTKEPRARPTAAEMLKHKFIE 445
K +S +F D + K L + R TA E L+H + +
Sbjct: 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFD 301
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 79/257 (30%), Positives = 123/257 (47%), Gaps = 15/257 (5%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVI--SLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLG 253
LGKG++G V R+ T A+K++ + ++ E +LQ HP +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 254 SYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDI 313
++Q + L VMEY GG + ++ E E + + E + L YLHS V+RDI
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121
Query: 314 KGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWAL 373
K N++L G +K+ DFG+ + + TF GTP ++APEV++++ Y VD W L
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181
Query: 374 GVSAVEMAEGLPPRSTVHPMRVLFMISIEPA--PMLEDKEKWSLVFHDFVAKCLTKEPRA 431
GV EM G P R+ +I +E P E SL +A L K+P+
Sbjct: 182 GVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL-----LAGLLKKDPKQ 236
Query: 432 R-----PTAAEMLKHKF 443
R A E+++H+F
Sbjct: 237 RLGGGPSDAKEVMEHRF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 82/274 (29%), Positives = 125/274 (45%), Gaps = 34/274 (12%)
Query: 193 LNELGKGSYGAVYKAR-----DLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPN 247
+ +LGKG++G+V R D T E+VA+K + S E + EIE+L+ H N
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQD-NTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDN 66
Query: 248 VVRYLG-SYQ-GEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS 305
+V+Y G Y G L +VMEY GS+ D + E L+ ++ + KG+ YL S
Sbjct: 67 IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 306 IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP-----HWMAPEVIQ 360
VHRD+ NIL+ + VK+GDFG+ L + K + P W APE +
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ--DKEYYKVREPGESPIFWYAPESLT 184
Query: 361 ESRYDGKVDVWALGVSAVEM-----AEGLPPRSTVHPM---RVLFMISIEPAPMLEDKEK 412
ES++ DVW+ GV E+ PP + M + MI +L K
Sbjct: 185 ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL--KNN 242
Query: 413 WSLV--------FHDFVAKCLTKEPRARPTAAEM 438
L + + +C +P RP+ +E+
Sbjct: 243 GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 7/204 (3%)
Query: 183 REDPTTKYELLNELGKGSYGAVYKAR---DLKTSEL-VAIKVISLSEGEEGYEEIRGEIE 238
R T+ E + LG G++G VYK + + ++ VAIKV+ + +EI E
Sbjct: 2 RILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAY 61
Query: 239 MLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALK 298
++ HP+VVR LG + + ++ + G + D + ++ + + C + K
Sbjct: 62 VMASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK 120
Query: 299 GLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIG-TP-HWMAP 356
G++YL VHRD+ N+L+ VK+ DFG+A L + + G P WMA
Sbjct: 121 GMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180
Query: 357 EVIQESRYDGKVDVWALGVSAVEM 380
E I Y K DVW+ GV+ E+
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-24
Identities = 69/239 (28%), Positives = 117/239 (48%), Gaps = 45/239 (18%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPN 247
+E + +G+G++G V + T + A+K + SE +E +R E ++L + +P
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMN--VTEEPLEEYQIAYICREALKGLAYLHS 305
VV+ S+Q E YL+++MEY GG D+M + ++ E + + E + + +H
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGG---DMMTLLMKKDTFTEEETRFYIAETILAIDSIHK 119
Query: 306 IFKVHRDIKGGNILLTDQGEVKLGDFGV------------------------AAQLTRTM 341
+ +HRDIK N+LL +G +KL DFG+ +++ M
Sbjct: 120 LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPM 179
Query: 342 S--------KRN------TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPP 386
S KRN + +GTP ++APEV ++ Y+ + D W+LGV EM G PP
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 64/210 (30%), Positives = 115/210 (54%), Gaps = 21/210 (10%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIR--------GEIEMLQ 241
Y+++ +G+G++G V R + ++ A+K++S +E I+ E +++
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLS------KFEMIKRSDSAFFWEERDIMA 98
Query: 242 QCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLA 301
+ P VV+ ++Q ++YL++VMEY GG + +LM+ + P E + E + L
Sbjct: 99 FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVP--EKWAKFYTAEVVLALD 156
Query: 302 YLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT-MSKRNTFIGTPHWMAPEVIQ 360
+HS+ +HRD+K N+LL G +KL DFG ++ T M + +T +GTP +++PEV++
Sbjct: 157 AIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLK 216
Query: 361 ESRYDG----KVDVWALGVSAVEMAEGLPP 386
DG + D W++GV EM G P
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 40/272 (14%)
Query: 196 LGKGSYGAVYKARDLKTSE-----LVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVR 250
LG+G +G V+ A+ E LV +K + ++ E E R E++M ++ SH NVVR
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 251 YLGSYQGEEYLWIVMEYCGGGSVADLMNVTE--------EPLEEYQIAYICREALKGLAY 302
LG + E ++++EY G + + T+ PL Q +C + G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK------RNTFIGTP-HWMA 355
L + VHRD+ N L++ Q EVK+ L++ + RN I P W+A
Sbjct: 133 LSNARFVHRDLAARNCLVSSQREVKVS----LLSLSKDVYNSEYYKLRNALI--PLRWLA 186
Query: 356 PEVIQESRYDGKVDVWALGVSAVEM-AEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWS 414
PE +QE + K DVW+ GV E+ +G P + VL + K +
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL-------NRLQAGKLELP 239
Query: 415 L------VFHDFVAKCLTKEPRARPTAAEMLK 440
+ + + +C P+ RP+ +E++
Sbjct: 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 21/210 (10%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIR--------GEIEMLQ 241
YE++ +G+G++G V R T ++ A+K++S +E I+ E +++
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS------KFEMIKRSDSAFFWEERDIMA 98
Query: 242 QCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLA 301
+ P VV+ ++Q + YL++VMEY GG + +LM+ + P E + E + L
Sbjct: 99 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP--EKWARFYTAEVVLALD 156
Query: 302 YLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT-MSKRNTFIGTPHWMAPEVIQ 360
+HS+ +HRD+K N+LL G +KL DFG ++ + M + +T +GTP +++PEV++
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 216
Query: 361 ESRYDG----KVDVWALGVSAVEMAEGLPP 386
DG + D W++GV EM G P
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-23
Identities = 62/194 (31%), Positives = 99/194 (51%), Gaps = 4/194 (2%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVI--SLSEGEEGYEEIRGEIEMLQQCS-HPNVVRYL 252
+G+GSY V R K ++ A+KV+ L +E + ++ E + +Q S +P +V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 253 GSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRD 312
+Q L++V+EY GG + M + L E + E L +LH ++RD
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQ-RQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121
Query: 313 IKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWA 372
+K N+LL G +KL D+G+ + +TF GTP+++APE+++ Y VD WA
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWA 181
Query: 373 LGVSAVEMAEGLPP 386
LGV EM G P
Sbjct: 182 LGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 82/273 (30%), Positives = 127/273 (46%), Gaps = 24/273 (8%)
Query: 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEG--YEEIRGEIEMLQQCSH 245
T Y L +LG+GSY VYK +LVA+KVIS+ + EEG + IR E +L+ H
Sbjct: 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISM-KTEEGVPFTAIR-EASLLKGLKH 62
Query: 246 PNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS 305
N+V +E L V EY +A M L Y + + L+GLAY+H
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG 121
Query: 306 IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ-ESRY 364
+HRD+K N+L++ GE+KL DFG+A + ++ + T + P+V+ + Y
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDY 181
Query: 365 DGKVDVWALGVSAVEMAEGLP--------PRSTVHPMRVLFMISIEPAPMLED----KEK 412
+D+W G +EM +G P VL + + + P + K +
Sbjct: 182 SSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241
Query: 413 WSL-----VFHDFVAKCLTKEPRARPTAAEMLK 440
W L V K L++ P+A A++ML
Sbjct: 242 WFLPCKPQQLRV-VWKRLSRPPKAEDLASQMLM 273
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 62/201 (30%), Positives = 105/201 (52%), Gaps = 18/201 (8%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIE--MLQQ------CSHPN 247
LGKGS+G V A E A+K + ++ I ++E M+++ +P
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKAL-----KKDVVLIDDDVECTMVEKRVLALAWENPF 57
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEP--LEEYQIAYICREALKGLAYLHS 305
+ ++Q +E+L+ VME+ GG DLM ++ + Y+ + E + GL +LHS
Sbjct: 58 LTHLYCTFQTKEHLFFVMEFLNGG---DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS 114
Query: 306 IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYD 365
++RD+K N++L G +K+ DFG+ + ++ +TF GTP ++APE++Q +Y
Sbjct: 115 KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYT 174
Query: 366 GKVDVWALGVSAVEMAEGLPP 386
VD W+ GV EM G P
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 72/208 (34%), Positives = 113/208 (54%), Gaps = 19/208 (9%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE--IRGEIEMLQQCSHP 246
+YE + ++G+G+YG VYKARD T+E +A+K I L + +EG IR EI +L++ H
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQHG 61
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADL---MNVTEEPLEEYQ-IAYICREALKGLAY 302
N+VR E+ L++V EY DL M+ + + + + I + L+G+AY
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 303 LHSIFKVHRDIKGGNILLTDQ-GEVKLGDFGVAAQL---TRTMSKRNTFIGTPHWMAPEV 358
HS +HRD+K N+L+ + +KL DFG+A RT + + T + APE+
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE---VVTLWYRAPEI 174
Query: 359 IQESR-YDGKVDVWALGVSAVEMAEGLP 385
+ SR Y VD+W++G EM P
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVNQKP 202
|
Length = 294 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 4e-23
Identities = 73/261 (27%), Positives = 119/261 (45%), Gaps = 27/261 (10%)
Query: 192 LLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRY 251
L ELG G +G V+ + + VAIK+I EG ++ E +++ + SHPN+V+
Sbjct: 8 FLKELGSGQFGVVHLGK-WRGKIDVAIKMIR--EGAMSEDDFIEEAKVMMKLSHPNLVQL 64
Query: 252 LGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHR 311
G + ++IV EY G + + + + L + +C + + + YL S +HR
Sbjct: 65 YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHR 124
Query: 312 DIKGGNILLTDQGEVKLGDFGVAAQLTR-------TMSKRNTFIGTP-HWMAPEVIQESR 363
D+ N L+ + VK+ DFG L R T S+ F P W PEV SR
Sbjct: 125 DLAARNCLVGEDNVVKVSDFG----LARYVLDDQYTSSQGTKF---PVKWAPPEVFDYSR 177
Query: 364 YDGKVDVWALGVSAVEM-AEGLPPRSTVHPMRVLFMIS---IEPAPMLEDKEKWSLVFHD 419
+ K DVW+ GV E+ +EG P V+ +S P L E +++++
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS- 236
Query: 420 FVAKCLTKEPRARPTAAEMLK 440
C ++P RP ++L
Sbjct: 237 ----CWHEKPEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 6e-23
Identities = 90/274 (32%), Positives = 135/274 (49%), Gaps = 39/274 (14%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY--EEIRGEIEMLQQCSHPN 247
Y L++LG+G+Y VYK R T LVA+K I L E EEG IR E+ +L+ H N
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRL-EHEEGAPCTAIR-EVSLLKDLKHAN 65
Query: 248 VVRYLGSYQGEEYLWIVMEY-----------CGGGSVADLMNVTEEPLEEYQIAYICREA 296
+V E+ L +V EY CG + +N+ L +Q+
Sbjct: 66 IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCG-----NSINMHNVKLFLFQL------- 113
Query: 297 LKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA-AQLTRTMSKRNTFIGTPHWMA 355
L+GL Y H +HRD+K N+L+ ++GE+KL DFG+A A+ T + N + T +
Sbjct: 114 LRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRP 172
Query: 356 PEVIQES-RYDGKVDVWALGVSAVEMAEGLP--PRSTVHP-----MRVLFMISIEPAP-M 406
P+++ S Y ++D+W +G EM+ G P P STV R+L + E P +
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 232
Query: 407 LEDKEKWSLVFHDFVAKCLTKE-PRARPTAAEML 439
L ++E S + + A CL PR AE+L
Sbjct: 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELL 266
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 7e-23
Identities = 68/198 (34%), Positives = 105/198 (53%), Gaps = 6/198 (3%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEG--YEEIRGEIEMLQQCSHPN 247
YE L +LG+GSY VYK + +LVA+KVI L E EEG + IR E +L+ H N
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE-EEGTPFTAIR-EASLLKGLKHAN 64
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307
+V +E L +V EY + M+ L + + L+GL+Y+H +
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQES-RYDG 366
+HRD+K N+L++D GE+KL DFG+A + + + T + P+V+ S Y
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 367 KVDVWALGVSAVEMAEGL 384
+D+W +G VEM +G+
Sbjct: 184 CLDMWGVGCIFVEMIQGV 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 7e-23
Identities = 67/280 (23%), Positives = 125/280 (44%), Gaps = 41/280 (14%)
Query: 196 LGKGSYGAVYKARDLKTSEL-----VAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVR 250
LG+G +G V KA + VA+K++ + ++ E +L+Q +HP+V++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 251 YLGSYQGEEYLWIVMEYCGGGSV-----------------------ADLMNVTEEPLEEY 287
G+ + L +++EY GS+ + L N E L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 288 QIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF 347
+ + +G+ YL + VHRD+ N+L+ + ++K+ DFG L+R + + +++
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFG----LSRDVYEEDSY 183
Query: 348 IGTPH------WMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMIS 400
+ WMA E + + Y + DVW+ GV E+ G P + P R+ +
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNL-- 241
Query: 401 IEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440
++ +E E S ++ + C +EP RPT A++ K
Sbjct: 242 LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 8e-23
Identities = 69/202 (34%), Positives = 99/202 (49%), Gaps = 8/202 (3%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVIS--LSEGEEGYEEIRGEIEMLQQCSHPN 247
+ L LGKGS+G V A T EL AIK++ + ++ E E +L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 248 VVRYLGS-YQGEEYLWIVMEYCGGGSVADLMNVTEE--PLEEYQIAYICREALKGLAYLH 304
+ L S +Q + L+ VMEY GG DLM ++ +E + E GL +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGG---DLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH 118
Query: 305 SIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRY 364
S ++RD+K N++L +G +K+ DFG+ + TF GTP ++APE+I Y
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY 178
Query: 365 DGKVDVWALGVSAVEMAEGLPP 386
VD WA GV EM G P
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 8e-23
Identities = 73/246 (29%), Positives = 114/246 (46%), Gaps = 12/246 (4%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISLS--EGEEGYEEIRGEIEMLQQCSHPNVVRYLG 253
LGKG +G V + T +L A K ++ + +GYE E +L + +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 254 SYQGEEYLWIVMEYCGGGSVA-DLMNVTEEP--LEEYQIAYICREALKGLAYLHSIFKVH 310
++Q + L +VM GG + + NV EE E + + + + GL +LH ++
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 311 RDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDV 370
RD+K N+LL + G V++ D G+A +L SK + GTP +MAPE++Q YD VD
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDY 180
Query: 371 WALGVSAVEMAEGLPPRST----VHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLT 426
+ALGV+ EM P V + I + +K+S F L
Sbjct: 181 FALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTY---PDKFSPASKSFCEALLA 237
Query: 427 KEPRAR 432
K+P R
Sbjct: 238 KDPEKR 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 9e-23
Identities = 91/296 (30%), Positives = 140/296 (47%), Gaps = 57/296 (19%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY--EEIRGEIEMLQQCSHPN 247
Y L +LG+G+Y V+K R T LVA+K I L E EEG IR E+ +L+ H N
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRL-EHEEGAPCTAIR-EVSLLKDLKHAN 65
Query: 248 VVRYLGSYQGEEYLWIVMEY-----------CGGGSVADLMNVTEEPLEEYQIAYICREA 296
+V ++ L +V EY CG ++M++ + YQI
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCG-----NIMSMHNVKIFLYQI------- 113
Query: 297 LKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA-AQLTRTMSKRNTFIGTPHWMA 355
L+GLAY H +HRD+K N+L+ ++GE+KL DFG+A A+ T + N + T +
Sbjct: 114 LRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRP 172
Query: 356 PEV-IQESRYDGKVDVWALGVSAVEMAEGLP--PRSTVHP-----MRVLFMISIEPAPML 407
P+V + S Y ++D+W +G EMA G P P STV R+L + E P +
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI 232
Query: 408 EDKEKWS-----------LVFH---------DFVAKCLTKEPRARPTAAEMLKHKF 443
+++ L+ H + + K L E + R +A E +KH +
Sbjct: 233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-22
Identities = 74/276 (26%), Positives = 115/276 (41%), Gaps = 35/276 (12%)
Query: 191 ELLNELGKGSYGAVYKA----RDLKTSEL-VAIKVISLSEGEEGYEEIRGEIEMLQQCSH 245
LL LG G++G VY+ RD EL VA+K + S E+ + E ++ + +H
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68
Query: 246 PNVVRYLG-SYQGEEYLWIVMEYCGGGSVADLMNVTEE---------PLEEYQIAYICRE 295
N+VR +G S++ I++E GG DL + E L + + R+
Sbjct: 69 QNIVRLIGVSFERLPRF-ILLELMAGG---DLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 296 ALKGLAYLHSIFKVHRDIKGGNILLTDQGE---VKLGDFGVAAQLTRT-MSKRNTFIGTP 351
KG YL +HRDI N LLT +G K+ DFG+A + R ++ P
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184
Query: 352 -HWMAPEVIQESRYDGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMIS----IEPAP 405
WM PE + + K DVW+ GV E + G P V+ ++ ++P
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPK 244
Query: 406 MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441
+ + C P RP A +L+
Sbjct: 245 GCPGP------VYRIMTDCWQHTPEDRPNFATILER 274
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-22
Identities = 69/196 (35%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVIS--LSEGEEGYEEIRGEIEMLQQCSHPNVVRYLG 253
LGKGS+G V A T EL AIK++ + ++ E E +L P + L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 254 S-YQGEEYLWIVMEYCGGGSVADLMNVTEE--PLEEYQIAYICREALKGLAYLHSIFKVH 310
S +Q + L+ VMEY GG DLM ++ +E Q + E GL +LH ++
Sbjct: 68 SCFQTVDRLYFVMEYVNGG---DLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIY 124
Query: 311 RDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDV 370
RD+K N++L +G +K+ DFG+ + TF GTP ++APE+I Y VD
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184
Query: 371 WALGVSAVEMAEGLPP 386
WA GV EM G PP
Sbjct: 185 WAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 61/189 (32%), Positives = 98/189 (51%), Gaps = 12/189 (6%)
Query: 192 LLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRY 251
L ELG G +G V K + VAIK+I EG +E E +++ + SH +V+
Sbjct: 8 FLKELGTGQFGVV-KYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMKLSHEKLVQL 64
Query: 252 LGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHR 311
G + ++IV EY G + + + + + Q+ +C++ +G+AYL S +HR
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHR 124
Query: 312 DIKGGNILLTDQGEVKLGDFGVAAQLTRTM--SKRNTFIGTP---HWMAPEVIQESRYDG 366
D+ N L+ DQG VK+ DFG L+R + + + +G+ W PEV+ S++
Sbjct: 125 DLAARNCLVDDQGCVKVSDFG----LSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSS 180
Query: 367 KVDVWALGV 375
K DVWA GV
Sbjct: 181 KSDVWAFGV 189
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 2e-22
Identities = 73/259 (28%), Positives = 123/259 (47%), Gaps = 19/259 (7%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVI--SLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLG 253
LGKG++G V R+ + + A+K++ + ++ E +L+ HP +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 254 SYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDI 313
S+Q ++ L VMEY GG + ++ E E + + E + L YLHS V+RD+
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLS-RERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 314 KGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWAL 373
K N++L G +K+ DFG+ + + TF GTP ++APEV++++ Y VD W L
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181
Query: 374 GVSAVEMAEGLPPRSTVHPMRVLFMISIE----PAPMLEDKEKWSLVFHDFVAKCLTKEP 429
GV EM G P ++ +I +E P + D + ++ L K+P
Sbjct: 182 GVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKS-------LLSGLLIKDP 234
Query: 430 RAR-----PTAAEMLKHKF 443
R A E+++H F
Sbjct: 235 NKRLGGGPDDAKEIMRHSF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 13/203 (6%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC 243
E P ++ L +LG G +G V++ K VAIK++ S+ ++ + E++ L++
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGL-WKNRVRVAIKILK-SDDLLKQQDFQKEVQALKRL 59
Query: 244 SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEP-LEEYQIAYICREALKGLAY 302
H +++ E ++I+ E GS+ + E L + + + +G+AY
Sbjct: 60 RHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAY 119
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH-----WMAPE 357
L +HRD+ NIL+ + K+ DFG+A + K + ++ + W APE
Sbjct: 120 LEEQNSIHRDLAARNILVGEDLVCKVADFGLARLI-----KEDVYLSSDKKIPYKWTAPE 174
Query: 358 VIQESRYDGKVDVWALGVSAVEM 380
+ K DVW+ G+ EM
Sbjct: 175 AASHGTFSTKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-22
Identities = 76/278 (27%), Positives = 140/278 (50%), Gaps = 27/278 (9%)
Query: 190 YELLNELGKGSYGAVYKARDLK---TSELVAIKVI---SLSEGEEGYEEIRGEIEMLQQC 243
+ELL LG G+YG V+ R + + +L A+KV+ ++ + + E R E ++L+
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 244 SH-PNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAY 302
P +V ++Q + L ++++Y GG + + E +E ++ E + L +
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL-SQRERFKEQEVQIYSGEIVLALEH 120
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN-TFIGTPHWMAPEVIQ- 360
LH + ++RDIK NILL G V L DFG++ + +R +F GT +MAP++++
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180
Query: 361 -ESRYDGKVDVWALGVSAVEMAEGLPP------RSTVHPMRVLFMISIEPAPMLEDKEKW 413
+ +D VD W++GV E+ G P +++ + + S P P ++
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP-----QEM 235
Query: 414 SLVFHDFVAKCLTKEPRAR----PTAA-EMLKHKFIER 446
S + D + + L K+P+ R P+ A E+ KH F ++
Sbjct: 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 3e-22
Identities = 77/315 (24%), Positives = 134/315 (42%), Gaps = 57/315 (18%)
Query: 191 ELLNELGKG--SYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPN 247
EL E+G+G + +VY AR T LV +++ L EE + ++ E+ + HPN
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPN 60
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLM-NVTEEPLEEYQIAYICREALKGLAYLHSI 306
++ + +LW++ + GS L+ E + E I I AL+GL YLH
Sbjct: 61 IMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN 120
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH-------WMAPEVI 359
+HR+IK +IL++ G V L L R K P W++PE++
Sbjct: 121 GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELL 180
Query: 360 QE--SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFM-----------ISIEP--- 403
++ Y+ K D++++G++A E+A G P + ++L I+ P
Sbjct: 181 RQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240
Query: 404 APMLEDK------------------------------EKWSLVFHDFVAKCLTKEPRARP 433
+ M + + +S F + V CL ++P RP
Sbjct: 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRP 300
Query: 434 TAAEMLKHKFIERCK 448
+A+ +L H F ++ K
Sbjct: 301 SASSLLSHAFFKQVK 315
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 77/282 (27%), Positives = 118/282 (41%), Gaps = 41/282 (14%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKAR-----DLKTSELVAIKVISLSEGEEG--YEEIRGE 236
E P + L ELG+G++G VYK + ++ VAIK +L E E +E R E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIK--TLKENAEPKVQQEFRQE 58
Query: 237 IEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSV---------------ADLMNVTE 281
E++ HPN+V LG E+ ++ EY G + +
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 282 EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA-----AQ 336
L+ +I + G+ YL S VHRD+ N L+ + VK+ DFG++ A
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD 178
Query: 337 LTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEM-AEGLPPRSTVHPMRV 395
R SK + WM PE I ++ + D+W+ GV E+ + GL P V
Sbjct: 179 YYRVQSKSLLPV---RWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235
Query: 396 LFMI---SIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPT 434
+ MI + P P ED + + +C + P RP
Sbjct: 236 IEMIRSRQLLPCP--EDCPAR---VYALMIECWNEIPARRPR 272
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-22
Identities = 76/218 (34%), Positives = 112/218 (51%), Gaps = 32/218 (14%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY--EEIRGEIEMLQQCSHPN 247
Y L++LG+G+Y V+K R T LVA+K I L E EEG IR E+ +L+ H N
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRL-EHEEGAPCTAIR-EVSLLKNLKHAN 64
Query: 248 VVRYLGSYQGEEYLWIVMEY-----------CGGGSVADLMNVTEEPLEEYQIAYICREA 296
+V E L +V EY CG +LM++ + +Q+
Sbjct: 65 IVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCG-----NLMSMHNVKIFMFQL------- 112
Query: 297 LKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA-AQLTRTMSKRNTFIGTPHWMA 355
L+GL+Y H +HRD+K N+L+ ++GE+KL DFG+A A+ T + N + T +
Sbjct: 113 LRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRP 171
Query: 356 PEVIQES-RYDGKVDVWALGVSAVEMAEGLP--PRSTV 390
P+V+ S Y +D+W +G EMA G P P STV
Sbjct: 172 PDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV 209
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 3e-22
Identities = 77/258 (29%), Positives = 124/258 (48%), Gaps = 16/258 (6%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVI--SLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLG 253
LGKG++G V ++ T A+K++ + ++ E +LQ HP +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 254 SYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKV-HRD 312
S+Q + L VMEY GG + ++ E E + + E + L YLHS V +RD
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121
Query: 313 IKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWA 372
+K N++L G +K+ DFG+ + + + TF GTP ++APEV++++ Y VD W
Sbjct: 122 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 181
Query: 373 LGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA--PMLEDKEKWSLVFHDFVAKCLTKEPR 430
LGV EM G P ++ +I +E P E SL ++ L K+P+
Sbjct: 182 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSL-----LSGLLKKDPK 236
Query: 431 AR-----PTAAEMLKHKF 443
R A E+++HKF
Sbjct: 237 QRLGGGPDDAKEIMQHKF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 6e-22
Identities = 69/253 (27%), Positives = 115/253 (45%), Gaps = 25/253 (9%)
Query: 195 ELGKGSYGAVYKA--RDLKTSELVAIKVISLSEGEEGY-EEIRGEIEMLQQCSHPNVVRY 251
ELG G++G V K + K+ + VA+K++ + +E+ E ++QQ +P +VR
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 252 LGSYQGEEYLWIVMEYCGGGSVADLM----NVTEEPLEEYQIAYICREALKGLAYLHSIF 307
+G + E ++ +VME G + + +VTE+ + E + + G+ YL
Sbjct: 62 IGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITE-----LVHQVSMGMKYLEETN 115
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH------WMAPEVIQE 361
VHRD+ N+LL Q K+ DFG++ L + N + H W APE +
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALG---ADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 362 SRYDGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420
++ K DVW+ GV E + G P + V M IE +E ++ +D
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM--IESGERMECPQRCPPEMYDL 230
Query: 421 VAKCLTKEPRARP 433
+ C T RP
Sbjct: 231 MKLCWTYGVDERP 243
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 6e-22
Identities = 84/297 (28%), Positives = 136/297 (45%), Gaps = 50/297 (16%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVI-----SLSEGEEGYEEIRGEIEMLQQC 243
+Y L ++G G+YG V A D +T VAIK + S + Y E+R +L+
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLKHM 71
Query: 244 SHPNVVRYLGSYQGEEYL------WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREAL 297
H NV+ L + + L ++VM + G + LM E L E +I ++ + L
Sbjct: 72 KHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGT-DLGKLMK--HEKLSEDRIQFLVYQML 128
Query: 298 KGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPE 357
KGL Y+H+ +HRD+K GN+ + + E+K+ DFG+A Q T S+ ++ T + APE
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ---TDSEMTGYVVTRWYRAPE 185
Query: 358 VIQE-SRYDGKVDVWALGVSAVEM---------------------AEGLPPRSTVHPMRV 395
VI Y VD+W++G EM G P + V ++
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245
Query: 396 LFMIS-IEPAPMLEDKEKWSLVFH------DFVAKCLTKEPRARPTAAEMLKHKFIE 445
+ ++ P K+ SL+ + + + K L + +R TAAE L H + E
Sbjct: 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 9e-22
Identities = 56/181 (30%), Positives = 91/181 (50%), Gaps = 2/181 (1%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSY 255
LGKG++G V+K LK VA+K +E + E +L+Q HPN+V+ +G
Sbjct: 3 LGKGNFGEVFKG-TLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 256 QGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKG 315
+ ++IVME GG + ++ L+ Q+ +A G+AYL S +HRD+
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAA 121
Query: 316 GNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP-HWMAPEVIQESRYDGKVDVWALG 374
N L+ + +K+ DFG++ Q + + P W APE + RY + DVW+ G
Sbjct: 122 RNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYG 181
Query: 375 V 375
+
Sbjct: 182 I 182
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 63/196 (32%), Positives = 107/196 (54%), Gaps = 8/196 (4%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISLS--EGEEGYEEIRGEIEMLQQCSHPNVVRYLG 253
LGKG +G V + T ++ A K + + + G + E E+L++ + P +V
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 254 SYQGEEYLWIVMEYCGGGSVA-DLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRD 312
+++ + +L +VM GG + + NV E LE ++ + + G+ +LHS+ V+RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 313 IKGGNILLTDQGEVKLGDFGVAAQLT--RTMSKRNTFIGTPHWMAPEVIQESRYDGKVDV 370
+K N+LL DQG +L D G+A +L +T+++R GT +MAPE+++E Y VD
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR---AGTNGYMAPEILKEEPYSYPVDW 177
Query: 371 WALGVSAVEMAEGLPP 386
+A+G S EM G P
Sbjct: 178 FAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-21
Identities = 67/240 (27%), Positives = 113/240 (47%), Gaps = 38/240 (15%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPN 247
+E L +G+G++G V + T + A+K++ ++ +E IR E ++L +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307
VV+ S+Q + L+++ME+ GG + L+ + ++ L E + E + + +H +
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLL-MKKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQLT---RTMSKRN------------------- 345
+HRDIK N+LL +G VKL DFG+ L RT RN
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181
Query: 346 -------------TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHP 392
+ +GTP ++APEV ++ Y+ D W+LGV EM G PP + P
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 68/226 (30%), Positives = 114/226 (50%), Gaps = 3/226 (1%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPN 247
K+E+L +G+G+YG V K R +T E+VAIK SE EE E E++ML+ N
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307
+V +++ L++V EY + L + E +YI + +K + + H
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKND 120
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT-FIGTPHWMAPEVIQESRYDG 366
VHRDIK N+L++ +KL DFG A L+ + T ++ T + +PE++ + Y
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 367 KVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEK 412
VD+W++G E+++G P + LF I P+ ++ K
Sbjct: 181 AVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMK 226
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 63/201 (31%), Positives = 111/201 (55%), Gaps = 11/201 (5%)
Query: 193 LNELGKGSYGAVYKARDLK---TSELVAIKVISLSEGEEGYEEIRGEIE--MLQQCSHPN 247
L LG+GS+G V+ R + +L A+KV+ + + + +R ++E +L + +HP
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT-LKVRDRVRTKMERDILAEVNHPF 59
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPL--EEYQIAYICREALKGLAYLHS 305
+V+ ++Q E L++++++ GG + +++E + EE Y+ AL L +LHS
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELAL-ALDHLHS 116
Query: 306 IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYD 365
+ ++RD+K NILL ++G +KL DFG++ + K +F GT +MAPEV+ +
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 176
Query: 366 GKVDVWALGVSAVEMAEGLPP 386
D W+ GV EM G P
Sbjct: 177 QSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 2e-21
Identities = 72/250 (28%), Positives = 122/250 (48%), Gaps = 7/250 (2%)
Query: 193 LNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYL 252
+ ELG G +G V+ + + VAIK I+ EG E+ E +++ + SHP +V+
Sbjct: 9 MKELGSGQFGVVHLGK-WRAQIKVAIKAIN--EGAMSEEDFIEEAKVMMKLSHPKLVQLY 65
Query: 253 GSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRD 312
G ++ L+IV E+ G + + + + L + + +C++ +G+ YL +HRD
Sbjct: 66 GVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRD 125
Query: 313 IKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP-HWMAPEVIQESRYDGKVDVW 371
+ N L++ G VK+ DFG+ + ++ P W PEV S+Y K DVW
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVW 185
Query: 372 ALGVSAVEM-AEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPR 430
+ GV E+ EG P V+ MIS L + S+ ++ + C ++P
Sbjct: 186 SFGVLMWEVFTEGKMPFEKKSNYEVVEMIS--RGFRLYRPKLASMTVYEVMYSCWHEKPE 243
Query: 431 ARPTAAEMLK 440
RPT AE+L+
Sbjct: 244 GRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 75/277 (27%), Positives = 121/277 (43%), Gaps = 27/277 (9%)
Query: 184 EDPTTKYELLNELGKGSYGAVYK--ARDLKTSEL---VAIKVISLSEGEEGYEEIRGEIE 238
E P K L+ ELG+GS+G VY+ A+ + E VAIK ++ + E E
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEAS 61
Query: 239 MLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEE---------PLEEYQI 289
++++ + +VVR LG + +VME G + + P +
Sbjct: 62 VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 290 AYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIG 349
+ E G+AYL + VHRD+ N ++ + VK+GDFG+ + T R G
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKG 181
Query: 350 T-P-HWMAPEVIQESRYDGKVDVWALGVSAVEMAE--GLPPRSTVHPMRVLFMIS---IE 402
P WMAPE +++ + K DVW+ GV EMA P + + + F+I ++
Sbjct: 182 LLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD 241
Query: 403 PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEML 439
DK + + C P+ RPT E++
Sbjct: 242 LPENCPDK------LLELMRMCWQYNPKMRPTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 70/254 (27%), Positives = 117/254 (46%), Gaps = 13/254 (5%)
Query: 192 LLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRY 251
L+ E+G G +G V+ L+ + VAIK I EG E+ E +++ + SHP +V+
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRK-VAIKTIR--EGAMSEEDFIEEAQVMMKLSHPKLVQL 64
Query: 252 LGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHR 311
G + +V E+ G ++D + + + +C + +G+AYL S +HR
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124
Query: 312 DIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP-HWMAPEVIQESRYDGKVDV 370
D+ N L+ + VK+ DFG+ + +T P W +PEV S+Y K DV
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 371 WALGVSAVEM-AEGLPPRSTVHPMRVLFMISIE---PAPMLEDKEKWSLVFHDFVAKCLT 426
W+ GV E+ +EG P V+ I+ P L + + L+ H C
Sbjct: 185 WSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQH-----CWK 239
Query: 427 KEPRARPTAAEMLK 440
+ P RP+ + +L
Sbjct: 240 ERPEDRPSFSLLLH 253
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 3e-21
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 12/207 (5%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVIS----LSEGEEGYEEIRGEIEMLQQCSH 245
+E+L +G+G++G V + T ++ A+K+++ L E R E ++L
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETAC--FREERDVLVNGDR 60
Query: 246 PNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS 305
+ ++Q E L++VM+Y GG + L++ E+ L E + E + + +H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 306 IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL-TRTMSKRNTFIGTPHWMAPEVIQ---- 360
+ VHRDIK N+LL G ++L DFG +L + N +GTP +++PE++Q
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180
Query: 361 -ESRYDGKVDVWALGVSAVEMAEGLPP 386
+ RY + D W+LGV EM G P
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 58/192 (30%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 195 ELGKGSYG----AVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVR 250
ELG G++G VYK R + VAIKV+ + +E+ E E++ Q +P +VR
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQID--VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 251 YLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVH 310
+G + E L +VME GG + ++ ++ + + + + G+ YL VH
Sbjct: 60 MIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 311 RDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS--KRNTFIGTP-HWMAPEVIQESRYDGK 367
RD+ N+LL +Q K+ DFG++ L S K + P W APE I ++ +
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178
Query: 368 VDVWALGVSAVE 379
DVW+ G++ E
Sbjct: 179 SDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 4e-21
Identities = 77/266 (28%), Positives = 123/266 (46%), Gaps = 25/266 (9%)
Query: 183 REDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQ 242
R D T K ++LG G YG VY+ K S VA+K +L E EE E ++++
Sbjct: 5 RTDITMK----HKLGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEEFLKEAAVMKE 58
Query: 243 CSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVAD-LMNVTEEPLEEYQIAYICREALKGLA 301
HPN+V+ LG E +I+ E+ G++ D L + + + Y+ + +
Sbjct: 59 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 118
Query: 302 YLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH--------W 353
YL +HRD+ N L+ + VK+ DFG L+R M +T+ T H W
Sbjct: 119 YLEKKNFIHRDLAARNCLVGENHLVKVADFG----LSRLM-TGDTY--TAHAGAKFPIKW 171
Query: 354 MAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEK 412
APE + +++ K DVWA GV E+A G+ P + +V + +E +E E
Sbjct: 172 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL--LEKGYRMERPEG 229
Query: 413 WSLVFHDFVAKCLTKEPRARPTAAEM 438
++ + C P RP+ AE+
Sbjct: 230 CPPKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 6e-21
Identities = 69/240 (28%), Positives = 115/240 (47%), Gaps = 38/240 (15%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPN 247
+E L +G+G++G V + T + A+K++ ++ +E IR E ++L +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307
VV+ S+Q + L+++ME+ GG + L+ + ++ L E + + E + + +H +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLL-MKKDTLTEEETQFYIAETVLAIDSIHQLG 121
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQLT---RTMSKRN---------TF-------- 347
+HRDIK N+LL +G VKL DFG+ L RT RN TF
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181
Query: 348 ---------------IGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHP 392
+GTP ++APEV ++ Y+ D W+LGV EM G PP + P
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 8e-21
Identities = 83/278 (29%), Positives = 135/278 (48%), Gaps = 30/278 (10%)
Query: 190 YELLNELGKGSYGAVYKARDL---KTSELVAIKVI---SLSEGEEGYEEIRGEIEMLQQC 243
+ELL LG G+YG V+ R + T +L A+KV+ +L + + E R E +L+
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 244 SH-PNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAY 302
P +V ++Q E L ++++Y GG + + + E ++ + E + L +
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHL-YQRDNFSEDEVRFYSGEIILALEH 120
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQ-LTRTMSKRNTFIGTPHWMAPEVIQE 361
LH + V+RDIK NILL +G V L DFG++ + L+ + +F GT +MAPE+I+
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG 180
Query: 362 SRYDGK-VDVWALGVSAVEMAEGLPP------RSTVHPM--RVLFMISIEPAPMLEDKEK 412
GK VD W+LG+ E+ G P R+T + R+L P+ +
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFI------ 234
Query: 413 WSLVFHDFVAKCLTKEPRAR----PTAAEMLK-HKFIE 445
D + K L K+P+ R P A +K H F +
Sbjct: 235 -GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 9e-21
Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 193 LNELGKGSYGAV----YKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV 248
+ +LG+G +G V Y T E VA+K + G +++ EIE+L+ H N+
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 249 VRYLG--SYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI 306
V+Y G + G + ++ME+ GS+ + + + + Q + KG+ YL S
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF------IGTP-HWMAPEVI 359
VHRD+ N+L+ + +VK+GDFG LT+ + + + +P W APE +
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFG----LTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 360 QESRYDGKVDVWALGVSAVEM 380
+S++ DVW+ GV+ E+
Sbjct: 185 IQSKFYIASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-20
Identities = 60/207 (28%), Positives = 109/207 (52%), Gaps = 12/207 (5%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE--IRGEIEML--QQCSH 245
+E++ +G+G++G V + T + A+K+++ E + E R E +L C
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 246 PNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS 305
+ Y ++Q E YL++VM+Y GG + L++ E+ L E + E + + +H
Sbjct: 63 ITTLHY--AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 306 IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF-IGTPHWMAPEVIQE--- 361
+ VHRDIK N+LL G ++L DFG ++ + + +++ +GTP +++PE++Q
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 362 --SRYDGKVDVWALGVSAVEMAEGLPP 386
+Y + D W+LGV EM G P
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 45/217 (20%)
Query: 189 KYELLNELGKGSYGAVYKAR--DLKTSELVAIKVI-SLSEGEEGYEE--IRGEIEMLQQC 243
KYE+ +G+G+YG VYKA+ + K + AIK E G + R EI +L++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR-EIALLREL 59
Query: 244 SHPNVVRYLGSY--QGEEYLWIVMEYC--------------GGGSVADLM--NVTEEPLE 285
H NVV + + ++ ++++ +Y S+ M ++
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLL----- 114
Query: 286 EYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLT----DQGEVKLGDFGVA---AQLT 338
+QI L G+ YLHS + +HRD+K NIL+ ++G VK+GD G+A
Sbjct: 115 -WQI-------LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166
Query: 339 RTMSKRNTFIGTPHWMAPEVIQESR-YDGKVDVWALG 374
+ ++ + + T + APE++ +R Y +D+WA+G
Sbjct: 167 KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-20
Identities = 70/199 (35%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYE--EIRGEIEMLQQCSH---PNVVR 250
+GKG++G VY+ R T + A+KV+S E E GE +L + P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 251 YLGSYQGEEYLWIVMEY-CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKV 309
S+Q + L++V +Y GG L E E + + E + L +LH V
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 310 HRDIKGGNILLTDQGEVKLGDFGVA-AQLTRTMSKRNTFIGTPHWMAPEV-IQESRYDGK 367
+RD+K NILL G + L DFG++ A LT + NTF GT ++APEV + E Y
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLSKANLTDNKTT-NTFCGTTEYLAPEVLLDEKGYTKH 177
Query: 368 VDVWALGVSAVEMAEGLPP 386
VD W+LGV EM G P
Sbjct: 178 VDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-20
Identities = 61/245 (24%), Positives = 107/245 (43%), Gaps = 52/245 (21%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPN 247
+ + +G G++G V R + T+ L A+K + ++ ++ E ++L + +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADL---MNVTEEPLEEYQIAYICREALKGLAYLH 304
VV+ S+Q ++ L+ VM+Y GG + L + + EE L + IA E + +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA----ELTCAIESVH 118
Query: 305 SIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL--------------------------- 337
+ +HRDIK NIL+ G +KL DFG+
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 338 ------TRTMSKRN----------TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMA 381
+ + +R + +GTP+++APEV+ + Y D W++GV EM
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
Query: 382 EGLPP 386
G PP
Sbjct: 239 VGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 69/258 (26%), Positives = 116/258 (44%), Gaps = 22/258 (8%)
Query: 195 ELGKGSYGAVYKAR-DLKTSEL--VAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRY 251
+LG GS+G V + ++ VA+K + + + ++ E ++ H N++R
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 252 LGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREAL---KGLAYLHSIFK 308
G L +V E GS+ D + ++ L + I+ +C A+ G+ YL S
Sbjct: 62 YGVVLTHP-LMMVTELAPLGSLLD--RLRKDALGHFLISTLCDYAVQIANGMRYLESKRF 118
Query: 309 VHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK-RNTFIGTPH------WMAPEVIQE 361
+HRD+ NILL +VK+GDFG L R + + + ++ H W APE ++
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFG----LMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 362 SRYDGKVDVWALGVSAVEM-AEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420
+ DVW GV+ EM G P + + ++L I E LE E ++
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE-GERLERPEACPQDIYNV 233
Query: 421 VAKCLTKEPRARPTAAEM 438
+ +C P RPT A +
Sbjct: 234 MLQCWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 78/265 (29%), Positives = 122/265 (46%), Gaps = 24/265 (9%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISLS--EGEEGYEEIRGEIEMLQQCSHPNVVRYLG 253
LGKG +G V + T ++ A K + + +G E ++L++ + VV
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 254 SYQGEEYLWIVMEYCGGGSVA-DLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRD 312
+Y+ ++ L +V+ GG + + N+ EE + + E L GL LH V+RD
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRD 127
Query: 313 IKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWA 372
+K NILL D G +++ D G+A ++ S R +GT +MAPEV+ RY D W
Sbjct: 128 LKPENILLDDYGHIRISDLGLAVKIPEGESIRGR-VGTVGYMAPEVLNNQRYTLSPDYWG 186
Query: 373 LGVSAVEMAEGLPP----RSTVHPMRVLFMISIEPAPMLEDKEKWSLVF-HDFVAKC--- 424
LG EM EG P + V V +LE +E +S F + + C
Sbjct: 187 LGCLIYEMIEGQSPFRGRKEKVKREEV-------DRRVLETEEVYSAKFSEEAKSICKML 239
Query: 425 LTKEPRAR-----PTAAEMLKHKFI 444
LTK+P+ R A E+ +H F
Sbjct: 240 LTKDPKQRLGCQEEGAGEVKRHPFF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 11/246 (4%)
Query: 195 ELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGS 254
+G+G++G V+ R + VA+K + + + E +L+Q SHPN+VR +G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 255 YQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIK 314
++ ++IVME GG + L+ ++ + A G+ YL S +HRD+
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121
Query: 315 GGNILLTDQGEVKLGDFGVAAQ-----LTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVD 369
N L+T++ +K+ DFG++ + T + + W APE + RY + D
Sbjct: 122 ARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV---KWTAPEALNYGRYSSESD 178
Query: 370 VWALGVSAVE-MAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKE 428
VW+ G+ E + G P + + + +IE L E + + +C +
Sbjct: 179 VWSFGILLWEAFSLGAVPYANLSNQQT--REAIEQGVRLPCPELCPDAVYRLMERCWEYD 236
Query: 429 PRARPT 434
P RP+
Sbjct: 237 PGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 2e-20
Identities = 72/236 (30%), Positives = 111/236 (47%), Gaps = 15/236 (6%)
Query: 168 QQTKVSSSSIPESVTREDPTTKYELLN---ELGKGSYGAVYKARDLKTSEL--VAIKVIS 222
Q K S + R++ KYE N LG GS+G V A K + VAIK
Sbjct: 8 QLHKKKDSDSTKEPKRKN-KMKYEDFNFIRTLGTGSFGRVILAT-YKNEDFPPVAIKRFE 65
Query: 223 LSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVT 280
S+ ++ + + E ++L +HP V GS++ E YL++V+E+ GG +
Sbjct: 66 KSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN 125
Query: 281 EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL-TR 339
+ + Y + L YL S+ V+RD+K N+LL G +K+ DFG A + TR
Sbjct: 126 KRFPNDVGCFYAAQIVLI-FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184
Query: 340 TMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRV 395
T T GTP ++APE++ + D W LG+ E+ G PP P+ +
Sbjct: 185 TY----TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI 236
|
Length = 340 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 3e-20
Identities = 76/279 (27%), Positives = 124/279 (44%), Gaps = 30/279 (10%)
Query: 182 TREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE-----IRGE 236
T ++ KY + LG G+ G V A+ + E A+KV+ + EG E + E
Sbjct: 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDM----EGMSEADKNRAQAE 81
Query: 237 IEMLQQCSHPNVVR------YLGSYQGEEYLWI--VMEYCGGGSVADLMNV---TEEPLE 285
+ L C ++V+ E L I V++Y G + + T
Sbjct: 82 VCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFR 141
Query: 286 EYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR- 344
E++ + + L + ++HS +HRDIK NILL G VKLGDFG + T+S
Sbjct: 142 EHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201
Query: 345 -NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPP---RSTVHPMRVLFMIS 400
TF GTP+++APE+ + Y K D+++LGV E+ P + M
Sbjct: 202 GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR 261
Query: 401 IEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEML 439
+P P E + V L+ +P+ RP+++++L
Sbjct: 262 YDPLPPSISPE-----MQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 4e-20
Identities = 65/274 (23%), Positives = 118/274 (43%), Gaps = 27/274 (9%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKAR----DLKTSELVAIKVISLSEGEEGYEEIRGEIEM 239
E P + + ELG+ ++G +YK + ++LVAIK + + + E + E +
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 240 LQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLM----------------NVTEEP 283
+ + HPN+V LG E+ + ++ EY G + + + +
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 284 LEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343
L+ +I + G+ YL S F VH+D+ NIL+ +Q VK+ D G++ ++
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYY 180
Query: 344 R---NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEM-AEGLPPRSTVHPMRVLFMI 399
R + + WM PE I ++ D+W+ GV E+ + GL P V+ M
Sbjct: 181 RVQPKSLLPI-RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM- 238
Query: 400 SIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARP 433
+ +L E + + +C + P RP
Sbjct: 239 -VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 74/273 (27%), Positives = 121/273 (44%), Gaps = 29/273 (10%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC 243
E P +L +LG G +G V+ T++ VA+K +L G E E +++++
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTK-VAVK--TLKPGTMSPEAFLQEAQIMKKL 58
Query: 244 SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVAD-LMNVTEEPLEEYQIAYICREALKGLAY 302
H +V+ EE ++IV EY GS+ D L + + L Q+ + + +G+AY
Sbjct: 59 RHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH--------WM 354
L S +HRD+ NIL+ + K+ DFG+A + + + + T W
Sbjct: 119 LESRNYIHRDLAARNILVGENLVCKIADFGLA-----RLIEDDEY--TAREGAKFPIKWT 171
Query: 355 APEVIQESRYDGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMISIE---PAPMLEDK 410
APE R+ K DVW+ G+ E + G P + VL + P P +
Sbjct: 172 APEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPE 231
Query: 411 EKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKF 443
E +D + +C K+P RPT E L+
Sbjct: 232 E-----LYDLMLQCWDKDPEERPT-FEYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 5e-20
Identities = 52/189 (27%), Positives = 84/189 (44%), Gaps = 14/189 (7%)
Query: 191 ELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVR 250
+L +GKG +G V + VA+K + + E ++ HPN+V+
Sbjct: 9 KLGATIGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAA--QAFLAEASVMTTLRHPNLVQ 64
Query: 251 YLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEP-LEEYQIAYICREALKGLAYLHSIFKV 309
LG L+IV EY GS+ D + + Q + +G+ YL V
Sbjct: 65 LLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFV 124
Query: 310 HRDIKGGNILLTDQGEVKLGDFGVA--AQLTRTMSKRNTFIGTP-HWMAPEVIQESRYDG 366
HRD+ N+L+++ K+ DFG+A A + K P W APE ++E ++
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK------LPVKWTAPEALREKKFST 178
Query: 367 KVDVWALGV 375
K DVW+ G+
Sbjct: 179 KSDVWSFGI 187
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 7e-20
Identities = 81/296 (27%), Positives = 142/296 (47%), Gaps = 39/296 (13%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVIS---LSEGEEGYEEIRGEIEML 240
E +YE++ ++G G +G V+ + +T E K IS L E E+ I E+ ++
Sbjct: 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI--EVNVM 66
Query: 241 QQCSHPNVVRYLGSY--QGEEYLWIVMEYCGGGSVADLMNVTEE---PLEEYQIAYICRE 295
++ H N+VRY+ + + + L+I+ME+C G ++ + + +EE+ I I R+
Sbjct: 67 RELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQ 126
Query: 296 ALKGLAYLHSIFK-------VHRDIKGGNILL----------TDQGE-------VKLGDF 331
L LAY H++ +HRD+K NI L T Q K+GDF
Sbjct: 127 LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF 186
Query: 332 GVAAQLTRTMSKRNTFIGTPHWMAPEVI--QESRYDGKVDVWALGVSAVEMAEGLPPRST 389
G++ + S ++ +GTP++ +PE++ + YD K D+WALG E+ G P
Sbjct: 187 GLSKNIG-IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
Query: 390 VHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445
+ L + ++ P L K K S + + L + RP+A + L ++ I+
Sbjct: 246 ANNFSQL-ISELKRGPDLPIKGK-SKELNILIKNLLNLSAKERPSALQCLGYQIIK 299
|
Length = 1021 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 8e-20
Identities = 76/292 (26%), Positives = 128/292 (43%), Gaps = 34/292 (11%)
Query: 177 IPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSE------LVAIKVISLSEGEEGY 230
+P E P + L LG+G++G V KA + + VA+K++ E+
Sbjct: 1 LPLDPEWELPRDRLTLGKPLGEGAFGQVVKA-EAVGLDNPNETSTVAVKMLKDDATEKDL 59
Query: 231 EEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN----------- 278
++ E+EM++ H N++ LG E L++V+EY G++ D +
Sbjct: 60 SDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASP 119
Query: 279 ----VTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA 334
EE L + + + +G+ +L S +HRD+ N+L+T+ +K+ DFG+A
Sbjct: 120 DDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA 179
Query: 335 AQLTRTMSKRNTFIG-TP-HWMAPEVIQESRYDGKVDVWALGVSAVE-MAEGLPPRSTVH 391
+ R T G P WMAPE + + Y + DVW+ GV E G P +
Sbjct: 180 RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI- 238
Query: 392 PMRVLFMISIEPAPMLEDKEKWSLVFHDFVA---KCLTKEPRARPTAAEMLK 440
P+ LF + E M EK + C + P RPT ++++
Sbjct: 239 PVEELFKLLKEGYRM----EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 8e-20
Identities = 64/261 (24%), Positives = 110/261 (42%), Gaps = 18/261 (6%)
Query: 192 LLNELGKGSYGAVYKARDLKTSE---LVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV 248
+ +G G +G V + R + VAIK + ++ + E ++ Q HPN+
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 249 VRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFK 308
+R G + I+ EY GS+ + + Q+ + R G+ YL +
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY 127
Query: 309 VHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIG-TP-HWMAPEVIQESRYDG 366
VHRD+ NIL+ K+ DFG++ +L + + T G P W APE I ++
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTS 187
Query: 367 KVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMISIE-----PAPMLEDKEKWSLVFHDF 420
DVW+ G+ E M+ G P + V + ++E P PM +
Sbjct: 188 ASDVWSFGIVMWEVMSYGERPYWDMSNQDV--IKAVEDGYRLPPPM-----DCPSALYQL 240
Query: 421 VAKCLTKEPRARPTAAEMLKH 441
+ C K+ RPT ++++
Sbjct: 241 MLDCWQKDRNERPTFSQIVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 8e-20
Identities = 59/208 (28%), Positives = 108/208 (51%), Gaps = 24/208 (11%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVIS-----LSEGEEGYEEIRGEIEMLQQC 243
+Y+ L +G G+YG+V A D + + VA+K +S L Y E+R +L+
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELR----LLKHM 71
Query: 244 SHPNVVRYLGSY----QGEEY--LWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREA 296
H NV+ L + E + +++V G ADL N+ + + L + + ++ +
Sbjct: 72 KHENVIGLLDVFTPATSIENFNEVYLVTNLMG----ADLNNIVKCQKLSDEHVQFLIYQL 127
Query: 297 LKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAP 356
L+GL Y+HS +HRD+K N+ + + E+++ DFG+A Q M+ ++ T + AP
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTG---YVATRWYRAP 184
Query: 357 EVIQE-SRYDGKVDVWALGVSAVEMAEG 383
E++ Y+ VD+W++G E+ +G
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 9e-20
Identities = 58/205 (28%), Positives = 108/205 (52%), Gaps = 8/205 (3%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE--IRGEIEMLQQCSHPN 247
+E+L +G+G++G V + ++ A+K+++ E + E R E ++L +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307
+ ++Q E L++VM+Y GG + L++ E+ L E + E + + +H +
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF-IGTPHWMAPEVIQ-----E 361
VHRDIK NIL+ G ++L DFG +L + +++ +GTP +++PE++Q +
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 362 SRYDGKVDVWALGVSAVEMAEGLPP 386
+Y + D W+LGV EM G P
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 71/269 (26%), Positives = 117/269 (43%), Gaps = 27/269 (10%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSE-----LVAIKVISLSEGEEGYEEIRGEIE 238
E P LG G++G V +A S+ VA+K++ + E + E++
Sbjct: 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK 90
Query: 239 MLQQC-SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEE--------YQI 289
++ +H N+V LG+ + ++ EYC G + + + E YQ+
Sbjct: 91 IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV 150
Query: 290 AYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL---TRTMSKRNT 346
A KG+A+L S +HRD+ N+LLT VK+ DFG+A + + + K N
Sbjct: 151 A-------KGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNA 203
Query: 347 FIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEM-AEGLPPRSTVHPMRVLFMISIEPAP 405
+ WMAPE I Y + DVW+ G+ E+ + G P + P+ F I+
Sbjct: 204 RLPV-KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM-PVDSKFYKLIKEGY 261
Query: 406 MLEDKEKWSLVFHDFVAKCLTKEPRARPT 434
+ E +D + C +P RPT
Sbjct: 262 RMAQPEHAPAEIYDIMKTCWDADPLKRPT 290
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 90/364 (24%), Positives = 150/364 (41%), Gaps = 78/364 (21%)
Query: 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS 244
D ++Y L LG GS G V+ A D + VA+K I L++ + +R EI+++++
Sbjct: 2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALR-EIKIIRRLD 60
Query: 245 HPNVVR--------------YLGSYQGEEYLWIVMEYCGGGSVADLMNVTEE-PLEEYQI 289
H N+V+ +GS ++IV EY DL NV E+ PL E
Sbjct: 61 HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME----TDLANVLEQGPLSEEHA 116
Query: 290 AYICREALKGLAYLHSIFKVHRDIKGGNILL-TDQGEVKLGDFGVA----------AQLT 338
+ L+GL Y+HS +HRD+K N+ + T+ +K+GDFG+A L+
Sbjct: 117 RLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176
Query: 339 RTMSKRNTFIGTPHWMAPE-VIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLF 397
+ T + +P ++ + Y +D+WA G EM G P + H + +
Sbjct: 177 EGLV-------TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229
Query: 398 MISIEPAPMLEDKEKWSL-------------------------VFH---DFVAKCLTKEP 429
+I +E P++ ++++ L V DF+ + LT P
Sbjct: 230 LI-LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNP 288
Query: 430 RARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRASMAQQAQNILSDEPEVNATMGLK 489
R TA E L H ++ C P E + ++ L D + +
Sbjct: 289 MDRLTAEEALMHPYMSCYSC------PFDEPV----SLHPFHIEDELDDILLMTEIHSII 338
Query: 490 LNED 493
N D
Sbjct: 339 YNWD 342
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 76/260 (29%), Positives = 118/260 (45%), Gaps = 12/260 (4%)
Query: 187 TTKYELLNELGKGSYGAVYKARDLKTSEL----VAIKVISLSEGEEGYEEIRGEIEMLQQ 242
T+ L LG G +G V+K + + VAIK I G + ++EI + +
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65
Query: 243 CSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAY 302
H +VR LG G L +V + GS+ D + + L+ ++ C + KG+ Y
Sbjct: 66 LDHAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF--IGTP-HWMAPEVI 359
L VHR++ NILL V++ DFGV A L K+ + TP WMA E I
Sbjct: 125 LEEHRMVHRNLAARNILLKSDSIVQIADFGV-ADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 360 QESRYDGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418
RY + DVW+ GV+ E M+ G P + + P V + +E L + ++ +
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL--LEKGERLAQPQICTIDVY 241
Query: 419 DFVAKCLTKEPRARPTAAEM 438
+ KC + RPT E+
Sbjct: 242 MVMVKCWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 1e-19
Identities = 58/191 (30%), Positives = 89/191 (46%), Gaps = 9/191 (4%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVV 249
Y ++ L GS G V+ A + V +K+ G++G I E +LQ +HP+V+
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKI-----GQKGTTLI--EAMLLQNVNHPSVI 120
Query: 250 RYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKV 309
R + +V+ + L PL Q I ++ L+GL YLH+ +
Sbjct: 121 RMKDTLVSGAITCMVLPHYSSDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQRII 179
Query: 310 HRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVD 369
HRD+K NI + D +V +GD G AAQ GT APEV+ +Y+ K D
Sbjct: 180 HRDVKTENIFINDVDQVCIGDLG-AAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKAD 238
Query: 370 VWALGVSAVEM 380
+W+ G+ EM
Sbjct: 239 IWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 79/309 (25%), Positives = 129/309 (41%), Gaps = 83/309 (26%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVI-----SLSEGEEGYEEIRGEIEMLQQCS 244
Y++L ++G+G++ V KA+ KT + AIK + SL + EI+ + L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQA-LRRLS--P 56
Query: 245 HPNVVRYL--------GSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREA 296
HPN++R + G L +V E ++ +L+ + PL E ++ +
Sbjct: 57 HPNILRLIEVLFDRKTGR------LALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQL 109
Query: 297 LKGLAYLHS--IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF---IGTP 351
LK L ++H IF HRDIK NIL+ +KL DFG R + + + I T
Sbjct: 110 LKSLDHMHRNGIF--HRDIKPENILI-KDDILKLADFGSC----RGIYSKPPYTEYISTR 162
Query: 352 HWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLF-------MIS-IE 402
+ APE + Y K+D+WA+G E+ ++ P LF I+ I
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEIL-------SLFP---LFPGTNELDQIAKIH 212
Query: 403 -----PAP-MLEDKEKWS----------------LVFH------DFVAKCLTKEPRARPT 434
P +L+ K L+ + D + K L +P R T
Sbjct: 213 DVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT 272
Query: 435 AAEMLKHKF 443
A + L+H +
Sbjct: 273 AKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 6e-19
Identities = 74/264 (28%), Positives = 120/264 (45%), Gaps = 24/264 (9%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISLS--EGEEGYEEIRGEIEMLQQCSHPNVVRYLG 253
LGKG +G V + T ++ A K + + +G E ++L++ + VV
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 254 SYQGEEYLWIVMEYCGGGSVA-DLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRD 312
+Y+ ++ L +V+ GG + + N+ +E + + E GL LH V+RD
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRD 127
Query: 313 IKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWA 372
+K NILL D G +++ D G+A ++ + R +GT +MAPEV++ RY D W
Sbjct: 128 LKPENILLDDYGHIRISDLGLAVEIPEGETIRGR-VGTVGYMAPEVVKNERYTFSPDWWG 186
Query: 373 LGVSAVEMAEGLPP----RSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV----AKC 424
LG EM EG P + V V + ED+E++S F + +
Sbjct: 187 LGCLIYEMIEGKSPFRQRKEKVKREEVERRV-------KEDQEEYSEKFSEAARSICRQL 239
Query: 425 LTKEPRAR-----PTAAEMLKHKF 443
LTK+P R A E+ H F
Sbjct: 240 LTKDPGFRLGCRGEGAEEVKAHPF 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 68/257 (26%), Positives = 117/257 (45%), Gaps = 14/257 (5%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC 243
E T +LL +LG G +G V++ T+ VA+K +L G ++ E +++++
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTP-VAVK--TLKPGTMDPKDFLAEAQIMKKL 58
Query: 244 SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVAD-LMNVTEEPLEEYQIAYICREALKGLAY 302
HP +++ EE ++IV E GS+ + L L+ Q+ + + G+AY
Sbjct: 59 RHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAY 118
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP-HWMAPEVIQE 361
L + +HRD+ N+L+ + K+ DFG+A + + + P W APE
Sbjct: 119 LEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY 178
Query: 362 SRYDGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMISIE---PAPMLEDKEKWSLVF 417
+R+ K DVW+ G+ E + G P + VL + P P KE
Sbjct: 179 NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKE-----L 233
Query: 418 HDFVAKCLTKEPRARPT 434
+D + C ++P RPT
Sbjct: 234 YDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 1e-18
Identities = 72/254 (28%), Positives = 115/254 (45%), Gaps = 9/254 (3%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC 243
E P L +LG+G +G V+ T+ VAIK +L G E E +++++
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIK--TLKPGTMSPEAFLQEAQVMKKL 58
Query: 244 SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN-VTEEPLEEYQIAYICREALKGLAY 302
H +V+ L + EE ++IV EY GS+ D + + L Q+ + + G+AY
Sbjct: 59 RHEKLVQ-LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 117
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP-HWMAPEVIQE 361
+ + VHRD++ NIL+ + K+ DFG+A + P W APE
Sbjct: 118 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 362 SRYDGKVDVWALGVSAVEMA-EGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420
R+ K DVW+ G+ E+ +G P + VL +E + + HD
Sbjct: 178 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL--DQVERGYRMPCPPECPESLHDL 235
Query: 421 VAKCLTKEPRARPT 434
+ +C KEP RPT
Sbjct: 236 MCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 69/263 (26%), Positives = 122/263 (46%), Gaps = 30/263 (11%)
Query: 196 LGKGSYGAVYK--ARDL---KTSEL-VAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVV 249
LG G++G VY+ A D+ + + VA+K + ++ +E E ++ +HPN+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 250 RYLGSYQGEEYLWIVMEYCGGGSV-----ADLMNVTEEP-LEEYQIAYICREALKGLAYL 303
+ LG E +I+ME GG + + P L ++ IC + KG YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 304 HSIFKVHRDIKGGNILLTDQGE-----VKLGDFGVAAQLTRT--MSKRNTFIGTPHWMAP 356
+ +HRD+ N L++++G VK+GDFG+A + ++ K + WMAP
Sbjct: 123 EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAP 182
Query: 357 EVIQESRYDGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMIS----IEPAPMLEDKE 411
E + + ++ + DVW+ GV E + G P ++ VL ++ ++ DK
Sbjct: 183 ESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDK- 241
Query: 412 KWSLVFHDFVAKCLTKEPRARPT 434
+ + C ++P RPT
Sbjct: 242 -----IYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 78/295 (26%), Positives = 131/295 (44%), Gaps = 44/295 (14%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVV 249
Y+ L+ +G+G+YG V A T VAIK IS E + + EI++L++ H N++
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66
Query: 250 RYL-----GSYQGEEYLWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYL 303
L S++ ++IV E DL + + + L I Y + L+GL Y+
Sbjct: 67 GILDIIRPPSFESFNDVYIVQELME----TDLYKLIKTQHLSNDHIQYFLYQILRGLKYI 122
Query: 304 HSIFKVHRDIKGGNILLTDQGEVKLGDFG---VAAQLTRTMSKRNTFIGTPHWMAPEVIQ 360
HS +HRD+K N+LL ++K+ DFG +A ++ T + APE++
Sbjct: 123 HSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIML 182
Query: 361 ESR-YDGKVDVWALGVSAVEMAEG---LPPRSTVHPMRVLFMI----------------- 399
S+ Y +D+W++G EM P + +H + ++ +
Sbjct: 183 NSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRA 242
Query: 400 --SIEPAPMLEDKEKWSLVFH-------DFVAKCLTKEPRARPTAAEMLKHKFIE 445
I+ P + K W+ +F D + K LT P R T E L H ++E
Sbjct: 243 RNYIKSLPF-KPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 26/207 (12%)
Query: 192 LLNELGKGSYGAVYKA--RDLKTS---ELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHP 246
L ELG+G++G V+ L+ ELVA+K + + + ++ E E+L H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADL-------------MNVTEEPLEEYQIAYIC 293
N+V++ G + +V EY G + + L Q+ I
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 294 REALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIG---- 349
+ G+ YL S VHRD+ N L+ VK+GDFG++ + T R +G
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR---VGGHTM 185
Query: 350 TP-HWMAPEVIQESRYDGKVDVWALGV 375
P WM PE I ++ + DVW+ GV
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGV 212
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 76/313 (24%), Positives = 133/313 (42%), Gaps = 70/313 (22%)
Query: 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVIS-----LSEGEEGYEEIRGEIEMLQQ 242
+Y+ L +G G+ G V A D T + VAIK +S ++ + Y E+ +++
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELV----LMKL 71
Query: 243 CSHPNVVRYLGSYQG----EEY--LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREA 296
+H N++ L + EE+ +++VME A+L V + L+ +++Y+ +
Sbjct: 72 VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQM 127
Query: 297 LKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP----- 351
L G+ +LHS +HRD+K NI++ +K+ DFG+A RT +F+ TP
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAG--TSFMMTPYVVTR 181
Query: 352 HWMAPEVIQESRYDGKVDVWALGVSAVEMAEG---LP----------------------- 385
++ APEVI Y VD+W++G EM G P
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241
Query: 386 --------------PRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRA 431
P+ + LF + P + + D ++K L +P
Sbjct: 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301
Query: 432 RPTAAEMLKHKFI 444
R + + L+H +I
Sbjct: 302 RISVDDALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 177 IPESVTREDPTTKYELLNELGKGSYGAVYKARDL-------KTSELVAIKVISLSEGEEG 229
+PE E K L LG+G +G V A L K + VA+K++ E+
Sbjct: 4 LPEDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD 63
Query: 230 YEEIRGEIEMLQQCS-HPNVVRYLGSYQGEEYLWIVMEYCGGGSVA-------------- 274
++ E+EM++ H N++ LG+ + L++++EY G++
Sbjct: 64 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 123
Query: 275 -DLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGV 333
D+ V +E + + + +G+ YL S +HRD+ N+L+T+ +K+ DFG+
Sbjct: 124 YDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 183
Query: 334 AAQLTRTMSKRNTFIG--TPHWMAPEVIQESRYDGKVDVWALGV 375
A + + T G WMAPE + + Y + DVW+ GV
Sbjct: 184 ARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-18
Identities = 76/296 (25%), Positives = 136/296 (45%), Gaps = 52/296 (17%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVIS-----LSEGEEGYEEIRGEIEMLQQC 243
+Y+ L+ +G G+YG+V A D KT VA+K +S + + Y E+R +L+
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR----LLKHM 73
Query: 244 SHPNVVRYLGSYQG----EEY--LWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREA 296
H NV+ L + EE+ +++V G ADL N+ + + L + + ++ +
Sbjct: 74 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQI 129
Query: 297 LKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAP 356
L+GL Y+HS +HRD+K N+ + + E+K+ DFG+A M+ ++ T + AP
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG---YVATRWYRAP 186
Query: 357 EVIQE-SRYDGKVDVWALGVSAVEMAEG---LPPRSTVHPMRVLFMISIEPAPMLED--- 409
E++ Y+ VD+W++G E+ G P + ++++ + P L
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246
Query: 410 ---------------KEKWSLVFH-------DFVAKCLTKEPRARPTAAEMLKHKF 443
K ++ VF D + K L + R TAA+ L H +
Sbjct: 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-18
Identities = 67/293 (22%), Positives = 128/293 (43%), Gaps = 35/293 (11%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDL-----KTSELVAIKVISLSEGEEGYEEIRGEIE 238
E P E + ++G+G++G V++AR + +VA+K++ + + + E
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 239 MLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGG----------------SVADLMNVTEE 282
++ + HPN+V+ LG + + ++ EY G + +
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 283 PLEEYQIA-----YICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL 337
L ++ I ++ G+AYL VHRD+ N L+ + VK+ DFG++ +
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 180
Query: 338 TRT---MSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEM-AEGLPPRSTVHPM 393
+ N I WM PE I +RY + DVWA GV E+ + G+ P +
Sbjct: 181 YSADYYKASENDAIPI-RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239
Query: 394 RVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446
V++ + +L + L ++ + C +K P RP+ A + ++ ++R
Sbjct: 240 EVIYY--VRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI--NRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 4e-18
Identities = 66/219 (30%), Positives = 105/219 (47%), Gaps = 35/219 (15%)
Query: 190 YELLNELGKGSYGAVYKARDLKTS--ELVAIKVISLSEGEE--GYEEIRGEIEMLQQC-S 244
YEL+ ELG+G+YG V AR+ +TS E VAIK I+ ++ +R E+++L+
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR-ELKLLRHFRG 60
Query: 245 HPNVV-----------RYLGSYQGEEYLWIVMEYCGGGSVADLMNV--TEEPLEEYQIAY 291
H N+ + Y EE +ME ADL + + +PL +
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEE----LME-------ADLHQIIRSGQPLTDAHFQS 109
Query: 292 ICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFI--- 348
+ L GL Y+HS +HRD+K GN+L+ E+K+ DFG+A + + F+
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEY 169
Query: 349 -GTPHWMAPEV-IQESRYDGKVDVWALGVSAVEMAEGLP 385
T + APE+ + Y +DVW++G E+ P
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 68/254 (26%), Positives = 118/254 (46%), Gaps = 9/254 (3%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC 243
E P +L+ +LG G +G V+ ++ VA+K +L G E E +++++
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTK-VAVK--TLKPGTMSPESFLEEAQIMKKL 58
Query: 244 SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAY 302
H +V+ L + EE ++IV EY GS+ D + E L+ + + + G+AY
Sbjct: 59 RHDKLVQ-LYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAY 117
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP-HWMAPEVIQE 361
+ + +HRD++ NIL+ D K+ DFG+A + P W APE
Sbjct: 118 IERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 362 SRYDGKVDVWALGVSAVEM-AEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420
R+ K DVW+ G+ E+ +G P ++ VL +E + + + H+
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL--EQVERGYRMPCPQDCPISLHEL 235
Query: 421 VAKCLTKEPRARPT 434
+ +C K+P RPT
Sbjct: 236 MLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 5e-18
Identities = 74/274 (27%), Positives = 117/274 (42%), Gaps = 19/274 (6%)
Query: 184 EDPTTKYELLNELGKGSYGAVYK--ARDLKTSEL---VAIKVISLSEGEEGYEEIRGEIE 238
E K LL ELG+GS+G VY+ ARD+ E VA+K ++ S E E
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 239 MLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSV--------ADLMNVTEEPLEEYQ-I 289
+++ + +VVR LG + +VME G + + N P Q +
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 290 AYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIG 349
+ E G+AYL++ VHRD+ N ++ VK+GDFG+ + T R G
Sbjct: 122 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKG 181
Query: 350 --TPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPM 406
WMAPE +++ + D+W+ GV E+ P + +VL +
Sbjct: 182 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM--DGGY 239
Query: 407 LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440
L+ + D + C P+ RPT E++
Sbjct: 240 LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 6e-18
Identities = 70/271 (25%), Positives = 113/271 (41%), Gaps = 24/271 (8%)
Query: 117 TDGDDEFGTFVVRSKDGERRSGGYDDSTMGRAVASMRRFGSSSSLHGEDVRQQTKVSSSS 176
TD D T + D + D + A + ++ + +SSS
Sbjct: 29 TDTSDSKDTTGDKFDDCDELGDSDDVTHATDYDADEESLSPQ----TDVCQEPCETTSSS 84
Query: 177 IPESVTREDPTTKYELLNELGKGSYGAVY--KARDLKTSELVAIKVISLSEGEEGYEEIR 234
P SV R +Y +L+ L GS G V+ + + V +K ++ G +
Sbjct: 85 DPASVVR----MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVT------GGKTPG 134
Query: 235 GEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE--EPLEEYQIAYI 292
EI++L+ SH ++ + +Y+ + + +VM DL + PL Q I
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPK----YKCDLFTYVDRSGPLPLEQAITI 190
Query: 293 CREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF--IGT 350
R L+ LAYLH +HRD+K NI L + LGDFG A +L + GT
Sbjct: 191 QRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGT 250
Query: 351 PHWMAPEVIQESRYDGKVDVWALGVSAVEMA 381
+PE++ Y K D+W+ G+ EM+
Sbjct: 251 LETNSPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 60/196 (30%), Positives = 97/196 (49%), Gaps = 8/196 (4%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISLS--EGEEGYEEIRGEIEMLQQCSHPNVVRYLG 253
LGKG +G V + T ++ A K + + +G E ++L++ + VV
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 254 SYQGEEYLWIVMEYCGGGSVA-DLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRD 312
+Y+ ++ L +V+ GG + + ++ E EE + + E GL LH V+RD
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRD 127
Query: 313 IKGGNILLTDQGEVKLGDFGVAAQLT--RTMSKRNTFIGTPHWMAPEVIQESRYDGKVDV 370
+K NILL D G +++ D G+A + +T+ R +GT +MAPEV++ RY D
Sbjct: 128 LKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEVVKNERYTFSPDW 184
Query: 371 WALGVSAVEMAEGLPP 386
WALG EM G P
Sbjct: 185 WALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 68/257 (26%), Positives = 114/257 (44%), Gaps = 15/257 (5%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC 243
E P +L+ +LG G +G V+ VAIK SL +G E E +++Q
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGY-YNGHTKVAIK--SLKQGSMSPEAFLAEANLMKQL 58
Query: 244 SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAY 302
HP +VR L + +E ++I+ EY GS+ D + E L ++ + + +G+A+
Sbjct: 59 QHPRLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP-HWMAPEVIQE 361
+ +HRD++ NIL+++ K+ DFG+A + P W APE I
Sbjct: 118 IERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 177
Query: 362 SRYDGKVDVWALGVSAVEMAE----GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVF 417
+ K DVW+ G+ E+ P + ++ L P P +E + L+
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMR 237
Query: 418 HDFVAKCLTKEPRARPT 434
C ++P RPT
Sbjct: 238 L-----CWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-17
Identities = 65/256 (25%), Positives = 106/256 (41%), Gaps = 56/256 (21%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG--EEGYEEIRGEIEMLQQCSHPN 247
+ + LG G++G V AR + T L A+K + + ++ E ++L + +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADL---MNVTEEPLEEYQIAYICREALKGLAYLH 304
VVR S+Q ++ L+ VM+Y GG + L M + E L + IA E + +H
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA----ELTCAVESVH 118
Query: 305 SIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR-------------------- 344
+ +HRDIK NIL+ G +KL DFG+ T +
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 345 ---------------------------NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSA 377
++ +GTP+++APEV+ + Y D W++GV
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 378 VEMAEGLPPRSTVHPM 393
EM G PP P+
Sbjct: 239 YEMLVGQPPFLAQTPL 254
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 78/301 (25%), Positives = 132/301 (43%), Gaps = 51/301 (16%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVI-SLSEGEEGYEEIRGEIEMLQQCSHPN 247
+Y++ +GKGSYG V A D T E VAIK I + E I EI++L+ HP+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 248 VVR----YLGSYQGE-EYLWIVMEYCGGGSVADLMNVTEE----PLEEYQIAYICREALK 298
+V L + E + +++V E +DL V + E +Q + + L+
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHHQ--FFLYQLLR 114
Query: 299 GLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFG---VAAQLTRTMSKRNTFIGTPHWMA 355
L Y+H+ HRD+K NIL ++K+ DFG VA T T ++ T + A
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 356 PEVIQE--SRYDGKVDVWALGVSAVEMAEG---LPPRSTVHPMRVL-------------- 396
PE+ S+Y +D+W++G E+ G P ++ VH + ++
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234
Query: 397 --------FMISIEPAPMLEDKEKW----SLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
++ S+ + +K+ L + + L +P+ RPTA E L +
Sbjct: 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLAL-RLLERLLAFDPKDRPTAEEALADPYF 293
Query: 445 E 445
+
Sbjct: 294 K 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-17
Identities = 79/306 (25%), Positives = 127/306 (41%), Gaps = 59/306 (19%)
Query: 193 LNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVR 250
+ LG G++G V A + T L A+K + + ++ E ++L + + VV+
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65
Query: 251 YLGSYQGEEYLWIVMEYCGGGSVADL---MNVTEEPLEEYQIAYICREALKGLAYLHSIF 307
S+Q ++ L+ VM+Y GG + L M V E L + IA E + +H +
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA----ELTLAIESVHKMG 121
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQLT----------------------------- 338
+HRDIK NIL+ G +KL DFG+
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 339 --------RTMSKR----------NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEM 380
+T+ +R ++ +GTP+++APEV+ Y D W++GV EM
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241
Query: 381 AEGLPPRSTVHPMRV-LFMISIEPAPMLEDKEKWSLVFHDFVAK-CLTKEPR-ARPTAAE 437
G PP P L +I+ E + + K S D + K C + E R R A +
Sbjct: 242 LVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD 301
Query: 438 MLKHKF 443
+ H F
Sbjct: 302 IKAHPF 307
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 75/298 (25%), Positives = 131/298 (43%), Gaps = 34/298 (11%)
Query: 172 VSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSE-------LVAIKVISLS 224
VS +PE E P + L LG+G +G V A + + VA+K++
Sbjct: 2 VSEYELPEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD 61
Query: 225 EGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEP 283
E+ ++ E+EM++ H N++ LG+ + L++++EY G++ + + P
Sbjct: 62 ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 121
Query: 284 LEEY---------------QIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKL 328
EY + + +G+ YL S +HRD+ N+L+T+ +K+
Sbjct: 122 GMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKI 181
Query: 329 GDFGVAAQLTRTMSKRNTFIG--TPHWMAPEVIQESRYDGKVDVWALGVSAVEM-AEGLP 385
DFG+A + + T G WMAPE + + Y + DVW+ GV E+ G
Sbjct: 182 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 241
Query: 386 PRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF---VAKCLTKEPRARPTAAEMLK 440
P V P+ LF + E M +K S ++ + C P RPT ++++
Sbjct: 242 PYPGV-PVEELFKLLKEGHRM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 66/236 (27%), Positives = 114/236 (48%), Gaps = 44/236 (18%)
Query: 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRG------EIEML 240
TKY + +G+G+YG V A++ +T+E VAIK I+ ++ EI++L
Sbjct: 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIA-----NAFDNRIDAKRTLREIKLL 58
Query: 241 QQCSHPNVVRY---LGSYQGEEY--LWIVMEYCGGGSVADLMNV-------TEEPLEEYQ 288
+ H NV+ + E + ++IV E LM+ + + L +
Sbjct: 59 RHLDHENVIAIKDIMPPPHREAFNDVYIVYE---------LMDTDLHQIIRSSQTLSDDH 109
Query: 289 IAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF- 347
Y + L+GL Y+HS +HRD+K N+LL ++K+ DFG+A RT S++ F
Sbjct: 110 CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA----RTTSEKGDFM 165
Query: 348 ---IGTPHWMAPEVI-QESRYDGKVDVWALGVSAVEMAEG---LPPRSTVHPMRVL 396
+ T + APE++ S Y +DVW++G E+ P + VH ++++
Sbjct: 166 TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLI 221
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 64/240 (26%), Positives = 102/240 (42%), Gaps = 21/240 (8%)
Query: 178 PESVTREDPTTKYELLNELGKGSYGAVYKARDLKTS----ELVAIKVISLSEGEEGYEEI 233
P +T++ +G G +G V++ LK VAIK + E+ ++
Sbjct: 4 PSHITKQ---------KVIGAGEFGEVFRGI-LKMPGRKEVAVAIKTLKPGYTEKQRQDF 53
Query: 234 RGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYIC 293
E ++ Q SH N++R G + I+ EY G++ + + YQ+ +
Sbjct: 54 LSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGML 113
Query: 294 REALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP-- 351
R G+ YL + VHRD+ NIL+ E K+ DFG++ L T G
Sbjct: 114 RGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIP 173
Query: 352 -HWMAPEVIQESRYDGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMISIE---PAPM 406
W APE I ++ DVW+ G+ E M+ G P + V+ I+ PAPM
Sbjct: 174 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPM 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 6e-17
Identities = 62/246 (25%), Positives = 106/246 (43%), Gaps = 62/246 (25%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLG 253
+GKG++G V + T ++ A+K + SE ++ ++ E ++L + P VV
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYY 68
Query: 254 SYQGEEYLWIVMEYCGGGSVADLM------NVTEEPLEEYQIAYICREALKGLAYLHSIF 307
S+Q +YL+++ME+ GG DLM + E + + +A E + + +H +
Sbjct: 69 SFQDAQYLYLIMEFLPGG---DLMTMLIKYDTFSEDVTRFYMA----ECVLAIEAVHKLG 121
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAA-------------------------------- 335
+HRDIK NIL+ G +KL DFG++
Sbjct: 122 FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAV 181
Query: 336 -QLTRTMSKRNTF--------------IGTPHWMAPEVIQESRYDGKVDVWALGVSAVEM 380
+ TMS ++ +GTP ++APE+ + Y + D W+LG E
Sbjct: 182 DSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFEC 241
Query: 381 AEGLPP 386
G PP
Sbjct: 242 LIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 69/274 (25%), Positives = 123/274 (44%), Gaps = 44/274 (16%)
Query: 196 LGKGSYGAVYKARDLKTSEL---VAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPNVVRY 251
+G+G++G V KAR +K L AIK + ++ + + GE+E+L + HPN++
Sbjct: 15 IGEGNFGQVLKAR-IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 252 LGSYQGEEYLWIVMEYCGGGSVADLM---------------NVTEEPLEEYQIAYICREA 296
LG+ + YL++ +EY G++ D + N T L Q+ + +
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 297 LKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA----AQLTRTMSKRNTFIGTPH 352
+G+ YL +HRD+ NIL+ + K+ DFG++ + +TM +
Sbjct: 134 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV-----R 188
Query: 353 WMAPEVIQESRYDGKVDVWALGVSAVEMAE-------GLPPRSTVHPMRVLFMISIEPAP 405
WMA E + S Y DVW+ GV E+ G+ + + + P
Sbjct: 189 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE---KP 245
Query: 406 MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEML 439
+ D E +D + +C ++P RP+ A++L
Sbjct: 246 LNCDDE-----VYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 53/197 (26%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKV-----ISLSEGEEGYEEIRGEIEMLQQCSHPNVVR 250
+G+G +G VY R T ++ A+K I + +GE R + ++ P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 251 YLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVH 310
++ + L +++ GG + ++ E ++ + E + GL ++H+ F V+
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLS-QHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 311 RDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQE-SRYDGKVD 369
RD+K NILL + G V++ D G+A ++ K + +GT +MAPEV+Q+ + YD D
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGTAYDSSAD 178
Query: 370 VWALGVSAVEMAEGLPP 386
++LG ++ G P
Sbjct: 179 WFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 72/257 (28%), Positives = 119/257 (46%), Gaps = 26/257 (10%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGS- 254
+G+G +GAV + T + VA+K I + + E E ++ + H N+VR LG
Sbjct: 14 IGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKNLVRLLGVI 68
Query: 255 -YQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEY-QIAYICREALKGLAYLHSIFKVHRD 312
+ G L+IVME G++ + + L Q+ + +G+ YL S VHRD
Sbjct: 69 LHNG---LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRD 125
Query: 313 IKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWA 372
+ NIL+++ G K+ DFG+A +M N+ + W APE ++ ++ K DVW+
Sbjct: 126 LAARNILVSEDGVAKVSDFGLAR--VGSMGVDNSKLPV-KWTAPEALKHKKFSSKSDVWS 182
Query: 373 LGVSAVEM-AEGLPPRSTVHPMRVLFMIS--IEPAPMLEDKEKWSLVFHDFVAKCLTKEP 429
GV E+ + G P +P L + +E +E E + + C EP
Sbjct: 183 YGVLLWEVFSYGRAP----YPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEP 238
Query: 430 RARPTAAEMLKHKFIER 446
+ RP+ HK E+
Sbjct: 239 KKRPSF-----HKLREK 250
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 29/203 (14%)
Query: 196 LGKGSYGAVYKARDLKTSEL---VAIKVISLSEGEEGYEEIRGEIEMLQQCSH-PNVVRY 251
+G+G++G V KAR +K L AIK + ++ + + GE+E+L + H PN++
Sbjct: 3 IGEGNFGQVLKAR-IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 252 LGSYQGEEYLWIVMEYCGGGSVADLM---------------NVTEEPLEEYQIAYICREA 296
LG+ + YL++ +EY G++ D + N T L Q+ + +
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 297 LKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA----AQLTRTMSKRNTFIGTPH 352
+G+ YL +HRD+ NIL+ + K+ DFG++ + +TM +
Sbjct: 122 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV-----R 176
Query: 353 WMAPEVIQESRYDGKVDVWALGV 375
WMA E + S Y DVW+ GV
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGV 199
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 70/254 (27%), Positives = 117/254 (46%), Gaps = 9/254 (3%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC 243
E P L +LG+G +G V+ T++ VAIK +L G E E +++++
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTK-VAIK--TLKPGTMMPEAFLQEAQIMKKL 58
Query: 244 SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAY 302
H +V L + EE ++IV E+ G GS+ D + + + L+ Q+ + + G+AY
Sbjct: 59 RHDKLVP-LYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAY 117
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP-HWMAPEVIQE 361
+ + +HRD++ NIL+ D K+ DFG+A + P W APE
Sbjct: 118 IERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 362 SRYDGKVDVWALGVSAVEM-AEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420
R+ K DVW+ G+ E+ +G P + VL +E + + H+
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL--EQVERGYRMPCPQGCPESLHEL 235
Query: 421 VAKCLTKEPRARPT 434
+ C K+P RPT
Sbjct: 236 MKLCWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-16
Identities = 85/360 (23%), Positives = 161/360 (44%), Gaps = 51/360 (14%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVIS-----LSEGEEGYEEIRGEIEMLQQC 243
+Y+ L +G G+ G V A D VAIK +S + + Y E+ +L +C
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL-----VLMKC 72
Query: 244 -SHPNVVRYLGSYQGEEYL------WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREA 296
+H N++ L + ++ L ++VME A+L V + L+ +++Y+ +
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQM 128
Query: 297 LKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAP 356
L G+ +LHS +HRD+K NI++ +K+ DFG+ A+ T ++ T ++ AP
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAP 187
Query: 357 EVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLV 416
EVI Y VD+W++G EM ++LF P + ++W+ V
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVR----------HKILF-------PGRDYIDQWNKV 230
Query: 417 FHDFVAKCLTKEPRARPTAAEML----KHKFIERCKCGATAMLPKIEKARQIRASMAQQA 472
C + +PT + K+ + K ++ P + +++AS QA
Sbjct: 231 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKAS---QA 287
Query: 473 QNILSD----EPEVNATMGLKLNEDYGDTVPSKPQVQVTNEVLATSTL-KKQHTLEDMEE 527
+++LS +P ++ L Y + +V+ + L +++HT+E+ +E
Sbjct: 288 RDLLSKMLVIDPAKRISVDEALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKE 347
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 27/202 (13%)
Query: 196 LGKGSYGAVYKARDLKTSELV--AIKVISLSEGEEGYEEIRGEIEMLQQCS-HPNVVRYL 252
+G+G++G V +A K + AIK++ E + + GE+E+L + HPN++ L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 253 GSYQGEEYLWIVMEYCGGGSVADLM---------------NVTEEPLEEYQIAYICREAL 297
G+ + YL+I +EY G++ D + + T L Q+ +
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 298 KGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA----AQLTRTMSKRNTFIGTPHW 353
G+ YL +HRD+ N+L+ + K+ DFG++ + +TM + W
Sbjct: 130 TGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPV-----RW 184
Query: 354 MAPEVIQESRYDGKVDVWALGV 375
MA E + S Y K DVW+ GV
Sbjct: 185 MAIESLNYSVYTTKSDVWSFGV 206
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 64/257 (24%), Positives = 105/257 (40%), Gaps = 19/257 (7%)
Query: 196 LGKGSYGAVYKAR---DLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYL 252
+G G +G V + R K VAIK + E+ + E ++ Q HPN++
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 253 GSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRD 312
G + I+ E+ G++ + + Q+ + R G+ YL + VHRD
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRD 131
Query: 313 IKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT-----P-HWMAPEVIQESRYDG 366
+ NIL+ K+ DFG++ L S T+ + P W APE I ++
Sbjct: 132 LAARNILVNSNLVCKVSDFGLSRFLEDDTSD-PTYTSSLGGKIPIRWTAPEAIAYRKFTS 190
Query: 367 KVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMISIE---PAPMLEDKEKWSLVFHDFVA 422
DVW+ G+ E M+ G P + V+ I + P PM H +
Sbjct: 191 ASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPM-----DCPTALHQLML 245
Query: 423 KCLTKEPRARPTAAEML 439
C K+ ARP +++
Sbjct: 246 DCWQKDRNARPKFGQIV 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 59/241 (24%), Positives = 95/241 (39%), Gaps = 60/241 (24%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSE----------------LVAIKVISLSEGE 227
E P + +LG+G +G V+ + LVA+KV+ +
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60
Query: 228 EGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEY 287
E+ E+++L + S PN+ R LG + L ++MEY G DL + L+++
Sbjct: 61 NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENG---DL----NQFLQKH 113
Query: 288 QIA-----------------YICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGD 330
Y+ + G+ YL S+ VHRD+ N L+ +K+ D
Sbjct: 114 VAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIAD 173
Query: 331 FGVAAQLTRTMSKRNTFIG--------TP---HWMAPEVIQESRYDGKVDVWALGVSAVE 379
FG RN + P WMA E + ++ K DVWA GV+ E
Sbjct: 174 FG---------MSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWE 224
Query: 380 M 380
+
Sbjct: 225 I 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 72/271 (26%), Positives = 118/271 (43%), Gaps = 37/271 (13%)
Query: 192 LLNELGKGSYGAVYKARDLKT-----SELVAIKVISLSEGEEG--YEEIRGEIEMLQQCS 244
+ ELG+ +G VYK T ++ VAIK +L + EG EE + E M +
Sbjct: 9 FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIK--TLKDKAEGPLREEFKHEAMMRSRLQ 66
Query: 245 HPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLM---------------NVTEEPLEEYQI 289
HPN+V LG E+ L ++ YC + + + + LE
Sbjct: 67 HPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF 126
Query: 290 AYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGV-----AAQLTRTMSKR 344
+I + G+ +L S VH+D+ N+L+ D+ VK+ D G+ AA + M
Sbjct: 127 VHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG-- 184
Query: 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEM-AEGLPPRSTVHPMRVLFMI-SIE 402
N+ + WM+PE I ++ D+W+ GV E+ + GL P V+ MI + +
Sbjct: 185 NSLLPI-RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ 243
Query: 403 PAPMLEDKEKWSLVFHDFVAKCLTKEPRARP 433
P +D W + + +C + P RP
Sbjct: 244 VLPCPDDCPAW---VYTLMLECWNEFPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-16
Identities = 89/364 (24%), Positives = 165/364 (45%), Gaps = 59/364 (16%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVIS-----LSEGEEGYEEIRGEIEMLQQC 243
+Y+ L +G G+ G V A D VAIK +S + + Y E+ +L +C
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYREL-----VLMKC 79
Query: 244 -SHPNVVRYLGSYQG----EEY--LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREA 296
+H N++ L + EE+ ++IVME A+L V + L+ +++Y+ +
Sbjct: 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQM 135
Query: 297 LKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAP 356
L G+ +LHS +HRD+K NI++ +K+ DFG+ A+ T ++ T ++ AP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAP 194
Query: 357 EVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLV 416
EVI Y VD+W++G EM +G VLF P + ++W+ V
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKG----------GVLF-------PGTDHIDQWNKV 237
Query: 417 FHDFVAKCLTKEPRARPTAAEML----KHKFIERCKCGATAMLPKIEKARQIRASMAQQA 472
C + +PT + K+ K + P + +++AS QA
Sbjct: 238 IEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKAS---QA 294
Query: 473 QNILSDEPEVNATMGLKLNED---------YGDTVPSKPQVQVTNEVLATSTLKKQHTLE 523
+++LS ++A+ + ++E Y + P ++ ++ L +++HT+E
Sbjct: 295 RDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLD----EREHTIE 350
Query: 524 DMEE 527
+ +E
Sbjct: 351 EWKE 354
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 57/194 (29%), Positives = 93/194 (47%), Gaps = 4/194 (2%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISLS--EGEEGYEEIRGEIEMLQQCSHPNVVRYLG 253
LGKG +G V + T ++ A K + + +G E +L++ + VV
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 254 SYQGEEYLWIVMEYCGGGSVA-DLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRD 312
+Y+ ++ L +V+ GG + + N+ +E + + E GL L V+RD
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRD 127
Query: 313 IKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWA 372
+K NILL D+G +++ D G+A Q+ + R +GT +MAPEVI +Y D W
Sbjct: 128 LKPENILLDDRGHIRISDLGLAVQIPEGETVRGR-VGTVGYMAPEVINNEKYTFSPDWWG 186
Query: 373 LGVSAVEMAEGLPP 386
LG EM +G P
Sbjct: 187 LGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 7e-16
Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 22/207 (10%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS-EGEEGYEEIRGEIEMLQQCSHPN 247
+Y+ L +G G+ G V A D VA+K +S + + + E+ +L+ +H N
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 81
Query: 248 VVRYLGSYQG----EEY--LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLA 301
++ L + EE+ +++VME A+L V L+ +++Y+ + L G+
Sbjct: 82 IISLLNVFTPQKSLEEFQDVYLVMELMD----ANLCQVIHMELDHERMSYLLYQMLCGIK 137
Query: 302 YLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP-----HWMAP 356
+LHS +HRD+K NI++ +K+ DFG+A RT F+ TP ++ AP
Sbjct: 138 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAC--TNFMMTPYVVTRYYRAP 191
Query: 357 EVIQESRYDGKVDVWALGVSAVEMAEG 383
EVI Y VD+W++G E+ +G
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-15
Identities = 72/257 (28%), Positives = 122/257 (47%), Gaps = 36/257 (14%)
Query: 146 GRAVASMRRFGSSSSLHGEDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVY 205
+ + R S ++ GED ++ + ++ P Y+L N +G GS+G VY
Sbjct: 32 DKKLDEEER--SHNNNAGEDEDEEKMI------DNDINRSPNKSYKLGNIIGNGSFGVVY 83
Query: 206 KARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE------ 259
+A + TSE VAIK + L + + Y+ E+ +++ +H N++ +L Y E
Sbjct: 84 EAICIDTSEKVAIKKV-LQDPQ--YKN--RELLIMKNLNHINII-FLKDYYYTECFKKNE 137
Query: 260 ---YLWIVMEYCGGGSVADLMNV---TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDI 313
+L +VME+ +V M L + + + + LAY+HS F HRD+
Sbjct: 138 KNIFLNVVMEFI-PQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDL 196
Query: 314 KGGNILLTDQGE-VKLGDFGVAAQL---TRTMSKRNTFIGTPHWMAPEV-IQESRYDGKV 368
K N+L+ +KL DFG A L R++S +I + + APE+ + + Y +
Sbjct: 197 KPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS----YICSRFYRAPELMLGATNYTTHI 252
Query: 369 DVWALGVSAVEMAEGLP 385
D+W+LG EM G P
Sbjct: 253 DLWSLGCIIAEMILGYP 269
|
Length = 440 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 62/254 (24%), Positives = 109/254 (42%), Gaps = 8/254 (3%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC 243
E P +L+ +LG G +G V+ S VA+K +L G + E +++
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGY-YNNSTKVAVK--TLKPGTMSVQAFLEEANLMKTL 58
Query: 244 SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAY 302
H +VR EE ++I+ EY GS+ D + E + ++ + +G+AY
Sbjct: 59 QHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAY 118
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP-HWMAPEVIQE 361
+ +HRD++ N+L+++ K+ DFG+A + P W APE I
Sbjct: 119 IERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 178
Query: 362 SRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420
+ K DVW+ G+ E+ G P + V M +++ + E +D
Sbjct: 179 GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV--MSALQRGYRMPRMENCPDELYDI 236
Query: 421 VAKCLTKEPRARPT 434
+ C ++ RPT
Sbjct: 237 MKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 68/251 (27%), Positives = 101/251 (40%), Gaps = 21/251 (8%)
Query: 196 LGKGSYGAVYKARDLKTSE----LVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRY 251
+G G +G V R LK VAIK + E+ + E ++ Q HPN++
Sbjct: 12 IGAGEFGEVCSGR-LKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 252 LGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHR 311
G + + IV EY GS+ + + Q+ + R G+ YL + VHR
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHR 130
Query: 312 DIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP---HWMAPEVIQESRYDGKV 368
D+ NIL+ K+ DFG++ L T G W APE I ++
Sbjct: 131 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSAS 190
Query: 369 DVWALGVSAVE-MAEGLPPRSTVHPMRVLFMISIE-----PAPMLEDKEKWSLVFHDFVA 422
DVW+ G+ E M+ G P + V+ +IE PAPM H +
Sbjct: 191 DVWSYGIVMWEVMSYGERPYWEMSNQDVI--KAIEEGYRLPAPM-----DCPAALHQLML 243
Query: 423 KCLTKEPRARP 433
C K+ RP
Sbjct: 244 DCWQKDRNERP 254
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-15
Identities = 47/152 (30%), Positives = 84/152 (55%), Gaps = 4/152 (2%)
Query: 186 PTTK-YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQ 242
P+ + + ++ + +G++G VY R S+L A+KV+ ++ + +++ E + L
Sbjct: 1 PSIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALAL 60
Query: 243 CSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAY 302
P +V S Q +++VMEY GG V L+++ EE + YI AL L Y
Sbjct: 61 SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVAL-ALDY 119
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA 334
LH +HRD+K N+L++++G +KL DFG++
Sbjct: 120 LHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 53/197 (26%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKV-----ISLSEGEEGYEEIRGEIEMLQQCSHPNVVR 250
+G+G +G VY R T ++ A+K I + +GE R + ++ P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 251 YLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVH 310
++ + L +++ GG + ++ E ++ + E + GL ++H+ F V+
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 311 RDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQES-RYDGKVD 369
RD+K NILL + G V++ D G+A ++ K + +GT +MAPEV+Q+ YD D
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSSAD 178
Query: 370 VWALGVSAVEMAEGLPP 386
++LG ++ G P
Sbjct: 179 WFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 70/267 (26%), Positives = 117/267 (43%), Gaps = 26/267 (9%)
Query: 188 TKYELLNELGKGSYGAVYKARDLKTSE----LVAIKVISLSEGEEGYEEIRGEIEMLQQC 243
T+++ + LG G++G VYK + E VAIK + + + +EI E ++
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66
Query: 244 SHPNVVRYLGSYQGEEYLWI--VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLA 301
+P+V R LG I +M + G + D + ++ + + C + KG+
Sbjct: 67 DNPHVCRLLGICLTSTVQLITQLMPF---GCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 123
Query: 302 YLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIG-TP-HWMAPEVI 359
YL VHRD+ N+L+ VK+ DFG+A L + + G P WMA E I
Sbjct: 124 YLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183
Query: 360 QESRYDGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKW----- 413
Y + DVW+ GV+ E M G P + P E + +LE E+
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PAS-------EISSILEKGERLPQPPI 235
Query: 414 -SLVFHDFVAKCLTKEPRARPTAAEML 439
++ + + KC + +RP E++
Sbjct: 236 CTIDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 67/273 (24%), Positives = 121/273 (44%), Gaps = 19/273 (6%)
Query: 184 EDPTTKYELLNELGKGSYGAVYK--ARDLKTSE---LVAIKVISLSEGEEGYEEIRGEIE 238
E K + ELG+GS+G VY+ A+ + E VAIK ++ + E E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 239 MLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLM---------NVTEEPLEEYQI 289
++++ + +VVR LG + ++ME G + + N + P ++
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 290 AYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIG 349
+ E G+AYL++ VHRD+ N ++ + VK+GDFG+ + T R G
Sbjct: 122 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 181
Query: 350 --TPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPM 406
WM+PE +++ + DVW+ GV E+A P + +VL + +
Sbjct: 182 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM--EGGL 239
Query: 407 LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEML 439
L+ + + + + C P+ RP+ E++
Sbjct: 240 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 67/262 (25%), Positives = 120/262 (45%), Gaps = 26/262 (9%)
Query: 191 ELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVR 250
+LL +GKG +G V D + ++ VA+K I + + + E ++ Q H N+V+
Sbjct: 9 KLLQTIGKGEFGDVMLG-DYRGNK-VAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQ 63
Query: 251 YLGSYQGEE-YLWIVMEYCGGGSVAD-LMNVTEEPLEEYQIAYICREALKGLAYLHSIFK 308
LG E+ L+IV EY GS+ D L + L + + + + YL +
Sbjct: 64 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNF 123
Query: 309 VHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKV 368
VHRD+ N+L+++ K+ DFG+ + + T ++T W APE ++E ++ K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKS 180
Query: 369 DVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSL------VFHDFV 421
DVW+ G+ E+ G P + P++ + P +E K V +D +
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRI-PLK-------DVVPRVEKGYKMDAPDGCPPVVYDVM 232
Query: 422 AKCLTKEPRARPTAAEMLKHKF 443
+C + RP+ L+ +
Sbjct: 233 KQCWHLDAATRPS-FLQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 34/276 (12%)
Query: 192 LLNELGKGSYGAVYKAR-----DLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHP 246
L ELG+G++G V+ A K LVA+K + ++ + E E+L H
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQREAELLTNLQHE 67
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN---------VTEEPLEE------YQIAY 291
++V++ G + L +V EY G + + V +P + Q+ +
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 292 ICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR---NTFI 348
I + G+ YL S VHRD+ N L+ VK+GDFG++ + T R +T +
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 349 GTPHWMAPEVIQESRYDGKVDVWALGVSAVEM-AEGLPPRSTVHPMRVLFMIS---IEPA 404
WM PE I ++ + DVW+ GV E+ G P + V+ I+ +
Sbjct: 188 PI-RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLER 246
Query: 405 PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440
P + KE +D + C +EP+ R E+ K
Sbjct: 247 PRVCPKE-----VYDIMLGCWQREPQQRLNIKEIYK 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 9e-15
Identities = 68/293 (23%), Positives = 127/293 (43%), Gaps = 34/293 (11%)
Query: 177 IPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSE-------LVAIKVISLSEGEEG 229
+P E T+ L LG+G +G V A + + VA+K++ ++
Sbjct: 1 LPADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD 60
Query: 230 YEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQ 288
++ E+EM++ H N++ LG+ + L++++EY G++ + + P +Y
Sbjct: 61 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYS 120
Query: 289 IAYICR----------------EALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFG 332
C+ + +G+ YL S +HRD+ N+L+T+ +K+ DFG
Sbjct: 121 FD-TCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFG 179
Query: 333 VAAQLTRTMSKRNTFIG--TPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTV 390
+A + + T G WMAPE + + Y + DVW+ GV E+
Sbjct: 180 LARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239
Query: 391 HPMRVLFMISIEPAPMLEDKEKWSLVFHDF---VAKCLTKEPRARPTAAEMLK 440
P+ LF + E M +K + H+ + +C P RPT ++++
Sbjct: 240 IPVEELFKLLKEGHRM----DKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 9e-15
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 192 LLNELGKGSYGAVYKAR--DLKTSE---LVAIKVISLSEGEEGYEEIRGEIEMLQQCSHP 246
L ELG+G++G V+ A +L + LVA+K + + ++ E E+L H
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLK-DASDNARKDFHREAELLTNLQHE 67
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSV----------ADLMNVTEEPLE--EYQIAYICR 294
++V++ G + L +V EY G + A LM P E + Q+ +I +
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 295 EALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR---NTFIGTP 351
+ G+ YL S VHRD+ N L+ + VK+GDFG++ + T R +T +
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI- 186
Query: 352 HWMAPEVIQESRYDGKVDVWALGVSAVEM 380
WM PE I ++ + DVW+LGV E+
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 14/213 (6%)
Query: 188 TKYELLNELGKGSYGAVYKARDLKTSELV----AIKVISLSEGEEGYEEIRGEIEMLQQC 243
T+ + + LG G++G VYK + E V AIK+++ + G + E E ++
Sbjct: 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 66
Query: 244 SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYL 303
HP++VR LG + +V + G + D ++ ++ + + C + KG+ YL
Sbjct: 67 DHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL 125
Query: 304 HSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP--HWMAPEVIQE 361
VHRD+ N+L+ VK+ DFG+A L + N G WMA E I
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185
Query: 362 SRYDGKVDVWALGVSAVEMA-------EGLPPR 387
++ + DVW+ GV+ E+ +G+P R
Sbjct: 186 RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR 218
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 28/217 (12%)
Query: 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKTSE-----LVAIKVISLSEGEEGYEEIRG 235
+ R D K+EL G+G++G V+ A LVA+K + E ++ +
Sbjct: 2 IKRRDIVLKWEL----GEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQR 56
Query: 236 EIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSV----------ADLMNVTEE--- 282
E E+L H ++VR+ G L +V EY G + A ++ E+
Sbjct: 57 EAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAP 116
Query: 283 -PLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341
L Q+ I + G+ YL S+ VHRD+ N L+ VK+GDFG++ + T
Sbjct: 117 GQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176
Query: 342 SKR---NTFIGTPHWMAPEVIQESRYDGKVDVWALGV 375
R T + WM PE I ++ + D+W+ GV
Sbjct: 177 YYRVGGRTMLPI-RWMPPESILYRKFTTESDIWSFGV 212
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-14
Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 22/201 (10%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVV 249
+ +L G+ G + D KT E V IK G+ G E +L+ +HP+++
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKA-----GQRGGTAT--EAHILRAINHPSII 146
Query: 250 RYLGSYQGEEYLWIVME------YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYL 303
+ G++ ++ +++ YC +A N+ + + I I R L+ + YL
Sbjct: 147 QLKGTFTYNKFTCLILPRYKTDLYC---YLAAKRNI---AICD--ILAIERSVLRAIQYL 198
Query: 304 HSIFKVHRDIKGGNILLTDQGEVKLGDFGVAA-QLTRTMSKRNTFIGTPHWMAPEVIQES 362
H +HRDIK NI + G+V LGDFG A + +K + GT APE++
Sbjct: 199 HENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARD 258
Query: 363 RYDGKVDVWALGVSAVEMAEG 383
Y VD+W+ G+ EMA
Sbjct: 259 PYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 63/256 (24%), Positives = 115/256 (44%), Gaps = 13/256 (5%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC 243
E P +L +LG G +G V+ A K ++ VA+K ++ G E E +++
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTK-VAVK--TMKPGSMSVEAFLAEANVMKTL 58
Query: 244 SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE---EPLEEYQIAYICREALKGL 300
H +V+ L + +E ++I+ E+ GS+ D + E +PL ++ + +G+
Sbjct: 59 QHDKLVK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGM 115
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP-HWMAPEVI 359
A++ +HRD++ NIL++ K+ DFG+A + P W APE I
Sbjct: 116 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 360 QESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418
+ K DVW+ G+ +E+ G P + V+ ++E + E +
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR--ALERGYRMPRPENCPEELY 233
Query: 419 DFVAKCLTKEPRARPT 434
+ + +C P RPT
Sbjct: 234 NIMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 22/204 (10%)
Query: 191 ELLNELGKGSYGAVYKARDLKTSELVAIKVI-----SLSEGEEGYEEIRGEIEMLQQCSH 245
E +G G++G V+ D + + VA+K + +L + + E++ ML H
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELK----MLCFFKH 58
Query: 246 PNVVRYLGSYQGE-----EYLWIVMEYCGGGSVADLMN--VTEEPLEEYQIAYICREALK 298
NV+ L Q E +++V E +DL V+ +PL + + L+
Sbjct: 59 DNVLSALDILQPPHIDPFEEIYVVTELMQ----SDLHKIIVSPQPLSSDHVKVFLYQILR 114
Query: 299 GLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF-IGTPHWMAPE 357
GL YLHS +HRDIK GN+L+ +K+ DFG+A SK T + T ++ APE
Sbjct: 115 GLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174
Query: 358 VIQESR-YDGKVDVWALGVSAVEM 380
++ SR Y VD+W++G E+
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAEL 198
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-14
Identities = 64/249 (25%), Positives = 102/249 (40%), Gaps = 23/249 (9%)
Query: 212 TSELVAIKV--ISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ-GEEYLWIVMEYC 268
T VAIK+ E E R E + + HPN+V L S + L+ V EY
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 269 GGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG---E 325
G ++ +++ + L + + + L LA H+ VHRD+K NI+++ G
Sbjct: 62 PGRTLREVL-AADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 326 VKLGDFGV-----------AAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALG 374
K+ DFG+ A LTRT +GTP + APE ++ D++A G
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRT----TEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 375 VSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPT 434
+ +E G +L+ + P + + K L K+PR R
Sbjct: 177 LIFLECLTGQRVVQGASVAEILYQ-QLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAA 235
Query: 435 AAEMLKHKF 443
+A L +F
Sbjct: 236 SAPALAERF 244
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 69/259 (26%), Positives = 117/259 (45%), Gaps = 10/259 (3%)
Query: 188 TKYELLNELGKGSYGAVYKARDLKTSE----LVAIKVISLSEGEEGYEEIRGEIEMLQQC 243
T+ + + LG G++G VYK + E VAIKV+ + + +EI E ++
Sbjct: 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV 66
Query: 244 SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYL 303
P V R LG + +V + G + D + ++ + + C + KG++YL
Sbjct: 67 GSPYVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL 125
Query: 304 HSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIG-TP-HWMAPEVIQE 361
+ VHRD+ N+L+ VK+ DFG+A L ++ + G P WMA E I
Sbjct: 126 EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH 185
Query: 362 SRYDGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420
R+ + DVW+ GV+ E M G P + P R + + +E L ++ +
Sbjct: 186 RRFTHQSDVWSYGVTVWELMTFGAKPYDGI-PAREIPDL-LEKGERLPQPPICTIDVYMI 243
Query: 421 VAKCLTKEPRARPTAAEML 439
+ KC + RP E++
Sbjct: 244 MVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 25/217 (11%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSE-------LVAIKVISLSEGEEGYEEIRGE 236
E P + L LG+G +G V +A + VA+K++ + ++ ++ E
Sbjct: 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISE 67
Query: 237 IEMLQQCS-HPNVVRYLGSYQGEEYLWIVMEYCGGGSVA---------------DLMNVT 280
+E+++ H N++ LG E L++++EY G++ D+ V
Sbjct: 68 MELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVP 127
Query: 281 EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340
EE L + + +G+ YL S +HRD+ N+L+T+ +K+ DFG+A +
Sbjct: 128 EEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI 187
Query: 341 MSKRNTFIG--TPHWMAPEVIQESRYDGKVDVWALGV 375
+ T G WMAPE + + Y + DVW+ G+
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGI 224
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 8e-14
Identities = 60/226 (26%), Positives = 91/226 (40%), Gaps = 38/226 (16%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVI--SLSEGEEGYEEIRGEIEMLQQCSHP 246
+Y+++ +GKG G VY A D S VA+K I LSE + E ++ HP
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEE------PLEEYQ--------IAYI 292
+V + ++ M Y G ++ L+ + L E I
Sbjct: 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 293 CREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA------------------ 334
C + Y+HS +HRD+K NILL GEV + D+G A
Sbjct: 123 C----ATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 335 AQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEM 380
+M+ +GTP +MAPE + D++ALGV +M
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQM 224
|
Length = 932 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 73/268 (27%), Positives = 113/268 (42%), Gaps = 43/268 (16%)
Query: 196 LGKGSYGAVYKARDLKTSEL---VAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYL 252
+GKG +G VY + + A+K ++ E E+ E +++ SHPNV+ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 253 G-SYQGEEYLWIVMEYCGGGSVADLM-NVTEEPLEEYQIAYICREALKGLAYLHSIFKVH 310
G E +V+ Y G + + + + T P + I + + A KG+ YL S VH
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVA-KGMEYLASKKFVH 121
Query: 311 RDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH----------WMAPEVIQ 360
RD+ N +L + VK+ DFG+A R + + + + H WMA E +Q
Sbjct: 122 RDLAARNCMLDESFTVKVADFGLA----RDIYDKEYY--SVHNHTGAKLPVKWMALESLQ 175
Query: 361 ESRYDGKVDVWALGVSAVE-MAEGLPPRSTVHPM---------RVLFMISIEPAPMLEDK 410
++ K DVW+ GV E M G PP V R L P P+ E
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYE-- 233
Query: 411 EKWSLVFHDFVAKCLTKEPRARPTAAEM 438
+ C +P RPT +E+
Sbjct: 234 ---------VMLSCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 57/214 (26%), Positives = 106/214 (49%), Gaps = 30/214 (14%)
Query: 195 ELGKGSYGAVYKAR--DLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYL 252
++G+G+YG VYKA+ D K + A+K I EG EI +L++ HPNV+
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI---EGTGISMSACREIALLRELKHPNVIALQ 64
Query: 253 GSY--QGEEYLWIVMEYCGGGSVADLMNV---------TEEPLE--EYQIAYICREALKG 299
+ + +W++ +Y + DL ++ ++P++ + + + L G
Sbjct: 65 KVFLSHSDRKVWLLFDY----AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120
Query: 300 LAYLHSIFKVHRDIKGGNILLT----DQGEVKLGDFGVAAQLT---RTMSKRNTFIGTPH 352
+ YLH+ + +HRD+K NIL+ ++G VK+ D G A + ++ + + T
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 353 WMAPEVIQESR-YDGKVDVWALGVSAVEMAEGLP 385
+ APE++ +R Y +D+WA+G E+ P
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 30/214 (14%)
Query: 195 ELGKGSYGAVYKAR--DLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYL 252
++G+G+YG VYKA+ D K A+K I EG EI +L++ HPNV+
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI---EGTGISMSACREIALLRELKHPNVISLQ 64
Query: 253 GSY--QGEEYLWIVMEYCGGGSVADLMNV---------TEEP--LEEYQIAYICREALKG 299
+ + +W++ +Y + DL ++ ++P L + + + L G
Sbjct: 65 KVFLSHADRKVWLLFDY----AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 300 LAYLHSIFKVHRDIKGGNILLT----DQGEVKLGDFGVAAQLT---RTMSKRNTFIGTPH 352
+ YLH+ + +HRD+K NIL+ ++G VK+ D G A + ++ + + T
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 353 WMAPEVIQESR-YDGKVDVWALGVSAVEMAEGLP 385
+ APE++ +R Y +D+WA+G E+ P
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 61/278 (21%), Positives = 112/278 (40%), Gaps = 48/278 (17%)
Query: 196 LGKGSYGAVYKAR---DLKTSELVAIKVISLS-EGEEGYEEIRGEIEMLQQCSHPNVVRY 251
LG+G +G+V + + D + VA+K + L EE E ++ HPNV++
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 252 LG-SYQGEEYLWI-----VMEYCGGGSVAD--LMNVTEEPLEEYQIAYICREAL---KGL 300
+G ++ I ++ + G + L + E+ + + + + G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT-P-HWMAPEV 358
YL + +HRD+ N +L + V + DFG++ ++ R I P W+A E
Sbjct: 127 EYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES 186
Query: 359 IQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418
+ + Y K DVWA GV+ E+A P P +E+ E + + H
Sbjct: 187 LADRVYTSKSDVWAFGVTMWEIA----------------TRGQTPYPGVENHEIYDYLRH 230
Query: 419 ---------------DFVAKCLTKEPRARPTAAEMLKH 441
D + C +P+ RPT ++ +
Sbjct: 231 GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 27/224 (12%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSE--------------LVAIKVISLSEGEEG 229
E P + L +LG+G +G V+ +E LVA+K++ +
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA 60
Query: 230 YEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEE------- 282
+ EI+++ + +PN++R LG ++ L ++ EY G + ++ E
Sbjct: 61 RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHA 120
Query: 283 ---PLEEYQ-IAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338
P + Y+ + G+ YL S+ VHRD+ N L+ + +K+ DFG++ L
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY 180
Query: 339 RTMSKR--NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEM 380
R + WMA E I ++ DVWA GV+ EM
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 68/277 (24%), Positives = 117/277 (42%), Gaps = 46/277 (16%)
Query: 194 NELGKGSYGAVY--KARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRY 251
+E+G G +G V +A + V +K + S + E++ ++ +HPNV++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 252 LGSYQGEEYLWIVMEYCGGGSVADLMN--------VTEEPLEEYQIAYICREALKGLAYL 303
LG +V+E+C G DL N V + ++ C E GL +L
Sbjct: 61 LGQCIESIPYLLVLEFCPLG---DLKNYLRSNRGMVAQMAQKDVLQRMAC-EVASGLLWL 116
Query: 304 HSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP-------HWMAP 356
H +H D+ N LT VK+GD+G+A + + T W+AP
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLALE-----QYPEDYYITKDCHAVPLRWLAP 171
Query: 357 EVIQESRYDGKV-------DVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIE-----P 403
E+++ D ++W+LGV+ E+ P + +VL + E P
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP 231
Query: 404 APMLEDK--EKWSLVFHDFVAKCLTKEPRARPTAAEM 438
P L+ K ++W ++ + C +P RPTA E+
Sbjct: 232 KPQLDLKYSDRW----YEVMQFCWL-DPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 54/231 (23%)
Query: 195 ELGKGSYGAVY-----KARDLKTSE-----------LVAIKVISLSEGEEGYEEIRGEIE 238
+LG+G +G V+ +DL T + LVA+K++ + + E++
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 239 MLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGG------SVADLMNVTEE---------- 282
+L + PN++R LG E+ L ++ EY G S L + E
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 283 -PLEEYQ-IAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340
P Y + ++ + G+ YL S+ VHRD+ N L+ + +K+ DFG++
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMS------ 185
Query: 341 MSKRNTFIGTPH-----------WMAPEVIQESRYDGKVDVWALGVSAVEM 380
RN + G + WMA E I ++ DVWA GV+ E+
Sbjct: 186 ---RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 9e-11
Identities = 66/258 (25%), Positives = 113/258 (43%), Gaps = 38/258 (14%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVA-IKVISLSEGEEGYEEIRGEIEMLQQ 242
++ T Y +L+ KG Y D+K ++ + ++ + E + Y +I+
Sbjct: 160 DESTRSYVILSFENKGDY------MDMKQADTTQYVPMLEIKEASK-YSDIQRSNY---- 208
Query: 243 CSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAY 302
P Y GS E + + G + DL++ T YQ+A +G+ +
Sbjct: 209 -DRP--ASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFT------YQVA-------RGMEF 252
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL---TRTMSKRNTFIGTPHWMAPEVI 359
L S VHRD+ N+LL VK+ DFG+A + + +SK +TF+ WMAPE I
Sbjct: 253 LASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV-KWMAPESI 311
Query: 360 QESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVL---FMISIEPAPMLEDKEKWSLV 416
++ Y DVW+ G+ E+ T +P ++ F I+ + + +
Sbjct: 312 FDNLYTTLSDVWSYGILLWEI---FSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQE 368
Query: 417 FHDFVAKCLTKEPRARPT 434
+D + KC EP RP+
Sbjct: 369 VYDIMVKCWNSEPEKRPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 63/259 (24%), Positives = 114/259 (44%), Gaps = 33/259 (12%)
Query: 199 GSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVR-YLGSYQG 257
G +G V + T +L K+I + + I + L + +PN ++ Y
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIK----AKNFNAIEPMVHQLMKD-NPNFIKLYYSVTTL 81
Query: 258 EEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGN 317
+ ++ I M+Y G + DL+ E L E ++ I R+ ++ L LH +H DIK N
Sbjct: 82 KGHVLI-MDYIKDGDLFDLLK-KEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLEN 139
Query: 318 ILLTD-QGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVS 376
+L + + L D+G L + + + + GT + +PE I+ YD D WA+GV
Sbjct: 140 VLYDRAKDRIYLCDYG----LCKIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVL 195
Query: 377 AVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVF--------HDFVAKCLTK- 427
E+ + HP + ++ +L+ +++ L F +DFV + + K
Sbjct: 196 TYELL------TGKHPFKEDEDEELDLESLLK-RQQKKLPFIKNVSKNANDFV-QSMLKY 247
Query: 428 --EPRARPTAAEMLKHKFI 444
R E++KH F+
Sbjct: 248 NINYRLT-NYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 72/278 (25%), Positives = 122/278 (43%), Gaps = 50/278 (17%)
Query: 195 ELGKGSYGAVYKAR---DLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRY 251
E+G G +G V +++V +K + +S + + E + + H N+++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVV-VKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 252 LGSYQGEEYLWIVMEYCGGGSV---------ADLMNVTEEPLEEYQIAYICREALKGLAY 302
LG +VME+C G + A+LM T +P ++A E GL +
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELM--TPDPTTLQRMAC---EIALGLLH 115
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP-------HWMA 355
LH +H D+ N LLT VK+GD+G L+ K + ++ TP W+A
Sbjct: 116 LHKNNFIHSDLALRNCLLTADLTVKIGDYG----LSHNKYKEDYYV-TPDQLWVPLRWIA 170
Query: 356 PEVIQESRYDGKV-------DVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIE----- 402
PE++ E + V +VW+LGV+ E+ E G P + +VL E
Sbjct: 171 PELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKL 230
Query: 403 PAPMLE--DKEKWSLVFHDFVAKCLTKEPRARPTAAEM 438
P P L+ ++W ++ + C +P RP+A E+
Sbjct: 231 PKPRLKLPLSDRW----YEVMQFCWL-QPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 53/225 (23%), Positives = 85/225 (37%), Gaps = 12/225 (5%)
Query: 215 LVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVA 274
VAI + ++ E L Q H N+VR G + IV EY G++
Sbjct: 35 PVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALD 94
Query: 275 DLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA 334
+ E L Q+ + G+ YL + VH+ + +L+ K+ F
Sbjct: 95 SFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRL 154
Query: 335 AQ-----LTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVE-MAEGLPPRS 388
+ + TMS ++ + W APE IQ + DVW+ G+ E M+ G P
Sbjct: 155 QEDKSEAIYTTMSGKSPVL----WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYW 210
Query: 389 TVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARP 433
+ V + ++E L + H + C KE RP
Sbjct: 211 DMSGQDV--IKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERP 253
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 44/151 (29%), Positives = 72/151 (47%), Gaps = 12/151 (7%)
Query: 298 KGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP------ 351
KG+ +L S +HRD+ NILL++ VK+ DFG+A R + K ++
Sbjct: 190 KGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA----RDIYKDPDYVRKGDARLPL 245
Query: 352 HWMAPEVIQESRYDGKVDVWALGVSAVEM-AEGLPPRSTVHPMRVLFMISIEPAPMLEDK 410
WMAPE I + Y + DVW+ GV E+ + G P V + F ++ +
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-IDEEFCRRLKEGTRMRAP 304
Query: 411 EKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441
+ + + + C EP RPT +E+++H
Sbjct: 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 48/176 (27%), Positives = 80/176 (45%), Gaps = 9/176 (5%)
Query: 269 GGGSVADLMNVTEEPLEEY-QIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVK 327
L+N E P Y + + G+ +L S VHRD+ N+L+ + VK
Sbjct: 222 ERTRRDTLIN--ESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVK 279
Query: 328 LGDFGVAAQLTRT---MSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEM-AEG 383
+ DFG+A + R +SK +TF+ WMAPE I + Y DVW+ G+ E+ G
Sbjct: 280 ICDFGLARDIMRDSNYISKGSTFLPL-KWMAPESIFNNLYTTLSDVWSFGILLWEIFTLG 338
Query: 384 LPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEML 439
P + PM F +I+ + S ++ + KC ++ RP ++++
Sbjct: 339 GTPYPEL-PMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 34/101 (33%), Positives = 51/101 (50%), Gaps = 2/101 (1%)
Query: 283 PLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA--AQLTRT 340
PL Q+ + R+ L + Y+H +HRDIK N+L+ ++ LGDFG A A+ + +
Sbjct: 256 PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315
Query: 341 MSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMA 381
GT APEV+ Y VD+W+ G+ E A
Sbjct: 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 66/262 (25%), Positives = 110/262 (41%), Gaps = 71/262 (27%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKAR--DLKTS---ELVAIKVISLSEGEEGYEEIRGEIE 238
E P + +L LG+G++G V +A ++ S VA+K++ Y+ + E++
Sbjct: 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELK 62
Query: 239 MLQQCS-HPNVVRYLGS-YQGEEYLWIVMEYCGGGSVAD--------------------- 275
+L H NVV LG+ + L +++EYC G++++
Sbjct: 63 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKRE 122
Query: 276 ----------LMNVT----------------------EEPLEEYQ--------IAYICRE 295
L +V+ EE E Y+ I+Y +
Sbjct: 123 MKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQV 182
Query: 296 ALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK-RNTFIGTP-HW 353
A +G+ +L S +HRD+ NILL++ VK+ DFG+A + + R P W
Sbjct: 183 A-RGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241
Query: 354 MAPEVIQESRYDGKVDVWALGV 375
MAPE I + Y + DVW+ GV
Sbjct: 242 MAPESIFDKVYTTQSDVWSFGV 263
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 64/271 (23%), Positives = 116/271 (42%), Gaps = 48/271 (17%)
Query: 196 LGKGSYGAVYKAR---DLKTSELVAIKVISLS-EGEEGYEEIRGEIEMLQQCSHPNVVRY 251
LGKG +G+V +A+ + + + VA+K++ EE E +++ HPNV++
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 252 LG--------------------SYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAY 291
+G G+ + +++M G + + + L + I
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIG----EEPFTLPLQTLVRFMID- 121
Query: 292 ICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT- 350
I G+ YL S +HRD+ N +L + V + DFG++ ++ R
Sbjct: 122 IAS----GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 351 P-HWMAPEVIQESRYDGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVL-FMIS----IEP 403
P W+A E + ++ Y DVWA GV+ E M G P + V + ++I +P
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP 237
Query: 404 APMLEDKEKWSLVFHDFVAKCLTKEPRARPT 434
LED ++ + +C + EP+ RP+
Sbjct: 238 PDCLED-------VYELMCQCWSPEPKCRPS 261
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 12/150 (8%)
Query: 298 KGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL------TRTMSKRNTFIGTP 351
+G+ +L S +HRD+ NILL++ VK+ DFG+A + R S R
Sbjct: 185 RGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL---- 240
Query: 352 HWMAPEVIQESRYDGKVDVWALGVSAVEM-AEGLPPRSTVHPMRVLFMISIEPAPMLEDK 410
WMAPE I + Y + DVW+ GV E+ + G P V + F ++ +
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ-INEEFCQRLKDGTRMRAP 299
Query: 411 EKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440
E + + + C +P+ RPT + +++
Sbjct: 300 ENATPEIYRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-09
Identities = 55/191 (28%), Positives = 83/191 (43%), Gaps = 28/191 (14%)
Query: 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLG 253
+LG+G++G VYKA + K + E G EI E +++ + ++
Sbjct: 138 KKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMN-ERVRRACPNSCADFVY 196
Query: 254 ------SYQGEEYLWIVMEYCGGGSVADLMNVTEEP--LEEYQ----------------- 288
S + E+ W+V Y G ++ADLM E P +E Y
Sbjct: 197 GFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKI 256
Query: 289 IAYICREALKGLAYLHSIFKVHRDIKGGNILLTD-QGEVKLGDFGVAAQLTRTMS-KRNT 346
I I R+ L L LHS VHRD+K NI+ ++ G K+ D G AA L ++
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKE 316
Query: 347 FIGTPHWMAPE 357
F+ P + APE
Sbjct: 317 FLLDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 69/274 (25%), Positives = 117/274 (42%), Gaps = 50/274 (18%)
Query: 192 LLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRY 251
LL+E+ + A ++LK + + L +G+ +LQ HPN+++
Sbjct: 12 LLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYR--------ILQ---HPNILQC 60
Query: 252 LGS-YQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICR---EALKGLAYLHSIF 307
LG + YL +V EYC G + ++ + Q+ + R E G+ ++H
Sbjct: 61 LGQCVEAIPYL-LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN 119
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP-------HWMAPEVIQ 360
+H D+ N LT VK+GD+G+ +R + +I T W+APE++
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIG--PSRY---KEDYIETEDDKCVPLRWLAPELVG 174
Query: 361 ESRYDGKV--------DVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIE-----PAPM 406
E + G + +VWALGV+ E+ E P S + VL + + P
Sbjct: 175 E-FHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQ 233
Query: 407 LED--KEKWSLVFHDFVAKCLTKEPRARPTAAEM 438
LE E+W ++ + C P R TA E+
Sbjct: 234 LELPYSERW----YEVLQFCWLS-PEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 28/225 (12%)
Query: 184 EDPTTKYELLNELGKGSYGAVY------------KARDLKTSE----LVAIKVISLSEGE 227
E P + +LG+G +G V+ K L S LVA+K++ +
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60
Query: 228 EGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE--EPLE 285
+ EI+++ + PN++R L + L ++ EY G + ++ E E E
Sbjct: 61 NARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAE 120
Query: 286 EYQIAYICREALK--------GLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL 337
+ + I L G+ YL S+ VHRD+ N L+ +K+ DFG++ L
Sbjct: 121 KADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
Query: 338 TRTMSKR--NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEM 380
R + WM+ E I ++ DVWA GV+ E+
Sbjct: 181 YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 8/103 (7%)
Query: 283 PLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342
PL+ + + +G+ +L S +HRD+ N+LLTD K+ DFG+A + M+
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI---MN 264
Query: 343 KRNTFI-GTPH----WMAPEVIQESRYDGKVDVWALGVSAVEM 380
N + G WMAPE I + Y + DVW+ G+ E+
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 50/161 (31%), Positives = 72/161 (44%), Gaps = 31/161 (19%)
Query: 287 YQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEV-KLGDFGVAAQLTRTMS--- 342
YQ+A KG+++L S +HRD+ NILLT G + K+ DFG+A + +
Sbjct: 221 YQVA-------KGMSFLASKNCIHRDLAARNILLT-HGRITKICDFGLARDIRNDSNYVV 272
Query: 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-------GLPPRSTVHPM-- 393
K N + WMAPE I Y + DVW+ G+ E+ G+P S + M
Sbjct: 273 KGNARLPV-KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK 331
Query: 394 RVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPT 434
M+S E AP +D + C +P RPT
Sbjct: 332 EGYRMLSPECAP---------SEMYDIMKSCWDADPLKRPT 363
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 18/203 (8%)
Query: 196 LGKGSYGAVYKARDLKTSELVAIKV----ISLSEGEEGYEEIRGEIEMLQQCSHPNVVRY 251
LG+G +G+V + + + ++ + V I++ E E+ E +++ HPNV+R
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE-MEDFLSEAVCMKEFDHPNVMRL 65
Query: 252 LG-SYQGEEYLW-----IVMEYCGGGSVADLM---NVTEEP--LEEYQIAYICREALKGL 300
+G Q E +++ + G + + + + P L + + G+
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT--PHWMAPEV 358
YL S +HRD+ N +L + V + DFG++ ++ R I W+A E
Sbjct: 126 EYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIES 185
Query: 359 IQESRYDGKVDVWALGVSAVEMA 381
+ + Y K DVW+ GV+ E+A
Sbjct: 186 LADRVYTTKSDVWSFGVTMWEIA 208
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 48/222 (21%), Positives = 82/222 (36%), Gaps = 45/222 (20%)
Query: 188 TKYELLNELGKGSYGAVYKA----RDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC 243
T +LL E G++G ++ E V +K + E + E +L
Sbjct: 9 TLSDLLQE---GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 244 SHPNVVRYLG-------------SYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIA 290
SH N++ L Y L + ++ C G + ++ + L I
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 291 YICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350
C G++YLH +H+DI N ++ ++ +VK+ D ++ R+ F
Sbjct: 126 IAC-----GMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS---------RDLFPMD 171
Query: 351 PH-----------WMAPEVIQESRYDGKVDVWALGVSAVEMA 381
H WMA E + Y DVW+ GV E+
Sbjct: 172 YHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 4e-08
Identities = 29/136 (21%), Positives = 54/136 (39%), Gaps = 14/136 (10%)
Query: 203 AVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262
VY +K+ E E +++L + P V + L S + + + +
Sbjct: 13 RVYLLGTKDED--YVLKINPSREKGADREREVAILQLLARKGLP-VPKVLASGESDGWSY 69
Query: 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFK---VHRDIKGGNIL 319
++ME+ G T + + E + I + + LA LH + H D+ GNIL
Sbjct: 70 LLMEWIEG--------ETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNIL 121
Query: 320 LTDQGEVKLGDFGVAA 335
+ D + + D+ A
Sbjct: 122 VDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 5e-08
Identities = 47/240 (19%), Positives = 100/240 (41%), Gaps = 41/240 (17%)
Query: 174 SSSIPESVTR----EDPTTKYELLNELGKGSYGAVY------------KARDL------- 210
+ +P + + ++ + ++++L G++G ++ R +
Sbjct: 130 AGPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGK 189
Query: 211 -KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME--- 266
K L+A +V G ++ EI L + +H N+++ + E +++ +
Sbjct: 190 PKCERLIAKRV---KAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYD 246
Query: 267 -----YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLT 321
+ + + + PL Q I ++ L + Y+H +HRDIK NI L
Sbjct: 247 FDLYSFMYDEA----FDWKDRPLL-KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301
Query: 322 DQGEVKLGDFGVAAQLTRTMSKRN-TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEM 380
G++ LGDFG A + + ++GT +PE++ Y D+W+ G+ ++M
Sbjct: 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361
|
Length = 501 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 9e-07
Identities = 31/96 (32%), Positives = 47/96 (48%)
Query: 348 IGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPML 407
+GTP ++APE++ + VD WALGV E G+PP + P +V I P
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 408 EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKF 443
E +EK S+ + + LT +P R E+ +H
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 53/247 (21%), Positives = 95/247 (38%), Gaps = 27/247 (10%)
Query: 198 KGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG 257
+ V +++ V +KV L ++ Q SH ++V+ G
Sbjct: 19 QSDLDIVGPGQEVS----VVLKV--LGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR 72
Query: 258 EEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGN 317
+E + +V EY G + ++ + + + + ++ L YL VH ++ G N
Sbjct: 73 DENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKN 131
Query: 318 ILLTDQGE-------VKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ--ESRYDGKV 368
IL+ G +KL D G+ T+ R + W+APE I+ ++
Sbjct: 132 ILVARYGLNEGYVPFIKLSDPGIP----ITVLSREERVERIPWIAPECIRNGQASLTIAA 187
Query: 369 DVWALGVSAVEMAEGLP-PRSTVHPMRVL-FMISIEPAPMLEDKEKWSLVFHDFVAKCLT 426
D W+ G + +E+ P ST+ F PM + E +L+ C T
Sbjct: 188 DKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAELANLINQ-----CWT 242
Query: 427 KEPRARP 433
+P RP
Sbjct: 243 YDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 24/49 (48%), Positives = 31/49 (63%)
Query: 289 IAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL 337
I + R+ L GL LH I VHRDIK N+L+T G+VK+ DFG A +
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDM 359
|
Length = 507 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 37/146 (25%), Positives = 59/146 (40%), Gaps = 20/146 (13%)
Query: 246 PNVVRYLGSYQGEEYLWIVMEYCGGGS----VADLMNVTEEPLEEYQIAYICREALKGLA 301
PN+V E+ +++V+++ GG ++ +N+ EE + E + L
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEE-----CVKRWAAEMVVALD 99
Query: 302 YLHSIFKVHRDIKGGNILLTDQGEVKLGDFG----VAAQLTRTMSKRNTFIGTPHWMAPE 357
LH V RD+ NILL D+G ++L F V + + APE
Sbjct: 100 ALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVEN-------MYCAPE 152
Query: 358 VIQESRYDGKVDVWALGVSAVEMAEG 383
V S D W+LG E+ G
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 4e-05
Identities = 25/72 (34%), Positives = 37/72 (51%), Gaps = 6/72 (8%)
Query: 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD 322
IVMEY G + DL+N E RE + + LHS +H D+ N++L+
Sbjct: 76 IVMEYIEGEPLKDLINSNGMEELEL-----SREIGRLVGKLHSAGIIHGDLTTSNMILSG 130
Query: 323 QGEVKLGDFGVA 334
G++ L DFG+A
Sbjct: 131 -GKIYLIDFGLA 141
|
Length = 211 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 82/391 (20%), Positives = 146/391 (37%), Gaps = 84/391 (21%)
Query: 129 RSKDGERRSGGYDDSTMGRAVASMRRFGSSSSLHGEDVRQQTKVSSSSIPES-------- 180
RS + RRSG S R A+ G + S G +Q + ++ E
Sbjct: 46 RSTNSARRSG----SKRDRETATSTDSGRTKSHEGAATTKQATTTPTTNVEVAPPPKKKK 101
Query: 181 -----------------VTRED---PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKV 220
V ED T ++++L+ LG+G++G V +A D K E A+K+
Sbjct: 102 VTYALPNQSREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKI 161
Query: 221 ISLSEGEEGYEEIRGEIEMLQQCSHPNVV---------RYLGSYQGEEYLWIVMEYCGGG 271
+ + + + EI+ +++ + RY + G ++ IVM G
Sbjct: 162 V--RNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG--HMCIVMPKYGPC 217
Query: 272 SVADLMNVTEEPLEEYQIAYICREALKGLAYLHS-IFKVHRDIKGGNILLT--------- 321
+ +M P +A I + L Y H+ + +H D+K NIL+
Sbjct: 218 LLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPV 275
Query: 322 -------DQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALG 374
D V++ D G + R + T H+ +PEV+ + D+W++G
Sbjct: 276 TNRALPPDPCRVRICDLGGCCDERHS---RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMG 332
Query: 375 VSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPT 434
E+ G T + L ++ + + W+ +C T+E R
Sbjct: 333 CIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSE---WA-------GRCGTEEARLLYN 382
Query: 435 AAEMLKHKFIERCKCGATAMLPKIEKARQIR 465
+A L+ C L +I +AR +R
Sbjct: 383 SAGQLR-------PCTDPKHLARIARARPVR 406
|
Length = 467 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 63/299 (21%), Positives = 123/299 (41%), Gaps = 40/299 (13%)
Query: 164 EDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVI-- 221
ED + + S + +S+T D + + N + +G GA YK + +K +K I
Sbjct: 666 EDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIND 725
Query: 222 --SLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVAD-LMN 278
S+ E I + + HPN+V+ +G + E+ +++ EY G ++++ L N
Sbjct: 726 VNSIPSSE---------IADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN 776
Query: 279 VTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL--TDQGEVKLGDFGVAAQ 336
++ E +IA +AL+ L S V ++ I++ D+ ++L
Sbjct: 777 LSWE--RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLS------- 827
Query: 337 LTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPP---RSTVHPM 393
L + + ++APE + K D++ G+ +E+ G P VH
Sbjct: 828 LPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS 887
Query: 394 RVLFM----------ISIEPAPMLEDKEKWSLVFH--DFVAKCLTKEPRARPTAAEMLK 440
V + + I+P+ + + + + C +P ARP A ++LK
Sbjct: 888 IVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946
|
Length = 968 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.004
Identities = 22/72 (30%), Positives = 34/72 (47%), Gaps = 10/72 (13%)
Query: 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD 322
IVMEY GG + D++ E + R+ + +A LH VH D+ N ++ D
Sbjct: 413 IVMEYIGGKDLKDVLEGNPE---------LVRKVGEIVAKLHKAGIVHGDLTTSNFIVRD 463
Query: 323 QGEVKLGDFGVA 334
+ L DFG+
Sbjct: 464 -DRLYLIDFGLG 474
|
Length = 535 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 774 | |||
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.57 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.54 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.44 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.44 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.39 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.37 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.32 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.22 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.01 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.0 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.93 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.92 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.91 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.72 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.71 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.68 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.63 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.51 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.44 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.38 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.28 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.27 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.21 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.15 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.14 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.07 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.03 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.97 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.77 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.73 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.6 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.58 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.58 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.57 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.36 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.34 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.3 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.3 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.24 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.22 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.2 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.08 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.98 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.85 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.31 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.24 | |
| PLN02236 | 344 | choline kinase | 96.2 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.04 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.8 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.44 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.36 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.85 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.84 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.79 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.78 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.34 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.33 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.3 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 93.1 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.64 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 92.47 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 92.25 |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-65 Score=573.37 Aligned_cols=574 Identities=37% Similarity=0.568 Sum_probs=454.2
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
+..+..+|+++.++|.|.||.||+++++.+++..|+|+++.... ..+.-+.+|+-+++.++|||||.|++.|...+.+|
T Consensus 10 rrnP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~-dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 10 RRNPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG-DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred hcCCccchhheeeecCCcccchhhhcccccCchhhheeeeccCC-ccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 34678899999999999999999999999999999999987653 44567889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
|+||||.+|+|.++.+ -.+++++.++..+++..+.||+|||++|-+|||||-.|||+++.|.+|++|||.+..+.....
T Consensus 89 icMEycgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred EEEEecCCCcccceee-ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhh
Confidence 9999999999999875 557899999999999999999999999999999999999999999999999999999988888
Q ss_pred ccccccccccccchhhhh---hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC--CCCccccchhchHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQ---ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE--PAPMLEDKEKWSLVF 417 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~--~~~~~~~~~~~s~~l 417 (774)
++..++||+.|||||+.. ...|...+|||++|++..|+-.-++|-...++++.++..... ..+.+.++.+|++.|
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~f 247 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFF 247 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence 888999999999999863 456999999999999999999999999999999998876543 456678899999999
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhhhhhh-------------hhccCc---------------------------------
Q 004088 418 HDFVAKCLTKEPRARPTAAEMLKHKFIE-------------RCKCGA--------------------------------- 451 (774)
Q Consensus 418 ~dLI~kcL~~DP~kRPTa~ElL~HPwf~-------------~~~~~~--------------------------------- 451 (774)
.+|++.+|.++|++||+++.+|.|||+. +++.+.
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~ 327 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMT 327 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCC
Confidence 9999999999999999999999999951 000000
Q ss_pred -------------------------------------------------------------------cccchhHHHH---
Q 004088 452 -------------------------------------------------------------------TAMLPKIEKA--- 461 (774)
Q Consensus 452 -------------------------------------------------------------------~~~lp~~~~~--- 461 (774)
..+.|.+...
T Consensus 328 ~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d~~l~s~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~ 407 (829)
T KOG0576|consen 328 VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRDNILGSEEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTI 407 (829)
T ss_pred hhhHhhhhhhhhhhhhhhcccccccccccccCcccccccccccccccccCCcccCcccccccCCCCCCCCCchhhccccc
Confidence 0000000000
Q ss_pred --------------------------------------------------------------------------------
Q 004088 462 -------------------------------------------------------------------------------- 461 (774)
Q Consensus 462 -------------------------------------------------------------------------------- 461 (774)
T Consensus 408 ~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvf 487 (829)
T KOG0576|consen 408 DGCPDSGSLAVSAIQMAPGLPPRSSPPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVF 487 (829)
T ss_pred ccCCCccCCCcchhhcCCCCCCCCCCccccCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHh
Confidence
Q ss_pred -----------------HHHHHHHHHHHHHHhcCCcchhhhcccccccccCCCCCCCCcccccccccccccccccccc--
Q 004088 462 -----------------RQIRASMAQQAQNILSDEPEVNATMGLKLNEDYGDTVPSKPQVQVTNEVLATSTLKKQHTL-- 522 (774)
Q Consensus 462 -----------------r~~~~~~~~~~~~iLs~e~e~~at~~lk~n~~~~~~~ps~~~~~v~~~~~~~~t~~~q~t~-- 522 (774)
.+.+..+.-+.+.+..-..++-.+.+++.-...+.+++..+.+.++ ....+.+...+|.+
T Consensus 488 ngCpl~i~~aaswIhp~t~dq~ll~gaeegIy~lnlnel~e~~le~l~~~r~Twly~~~n~l~-slsgks~~ly~H~l~~ 566 (829)
T KOG0576|consen 488 NGCPLRIHCAASWIHPSTRDQALLFGAEEGIYTLNLNELHEATLEKLFPRRCTWLYVINNVLT-SLSGKSTQLYSHDLGG 566 (829)
T ss_pred ccCcccceecccccCcchhhhHhhhhhccceeeccccccccccHhhccccCceEEEecCceee-eccCCccceeecchHH
Confidence 0000000000000000000000011111111122233322222221 11222233333332
Q ss_pred --ccccCCCceeEEEecchhhhhccccccccccCCCCCCccccCCCCCcccccccCccc-----eecccccccccccccC
Q 004088 523 --EDMEEGDFGTVVVHETDKTISKTQCSNIKESSTLPGHTEISGTGGKLADVRVDGAAG-----VALNNKLVGESHHLTH 595 (774)
Q Consensus 523 --e~~de~~~Gtivi~~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 595 (774)
+..+...+|+|++|.+.+.+....-..... .....+.++..|++.-.+| .+|+.||+.... .+|
T Consensus 567 l~~~~~~~~~~s~~~h~~per~~prk~a~stk--------ipeTkgc~~c~V~R~~~~g~~~lc~alp~sivl~qw-y~P 637 (829)
T KOG0576|consen 567 LFEAGEGTLFGSIIVHKEPERILPRKFALSTK--------IPETKGCQQCCVVRNPYTGGKFLCGALPTSIVLLQW-YEP 637 (829)
T ss_pred HHhhhcccccccccccCCCccccchhhceeee--------cCccccceeeeeecCCCCCCceeecccCceeEEeee-cCh
Confidence 334666899999999887776522222111 1223456778898885444 589999999988 888
Q ss_pred ccc-cc-ccccc----------cccccc---cCCCCCccccCcccccccccccceeccccchhhhhhHHhhcCCCccccc
Q 004088 596 TIQ-PS-SAENL----------KTTISQ---GQIGSGRDTGSGTLKSETVSKKAFALQDKCFWFLQLWSIYAAGNTVPIP 660 (774)
Q Consensus 596 ~~~-~~-~~~~~----------~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (774)
.++ |. .++++ -...+- .++.+|.+.+++|++++++.+++|.++|+ +|+||++|+++++|
T Consensus 638 m~kf~l~k~i~~pl~~p~~~f~~l~~~~~e~p~vc~Gv~~~~~~~~~~v~f~~~~~~~~~------~w~~~~~~~~~~v~ 711 (829)
T KOG0576|consen 638 MNKFMLVKSISFPLPSPLSVFEMLVLPESEYPQVCVGVSAGGGTLNNEVLFHTAFLNSDS------SWDIEAAGETLPVP 711 (829)
T ss_pred HHhhhHHHhcccCCCCccchhhhccccCcccceeeeeccCCCCCCCceeEEEeccccccc------ccceeccCcccCCc
Confidence 877 32 33333 111111 48999999999999999999999999999 99999999999999
Q ss_pred cccccCCCchhhcccccccccccCCchhHHHHHHHHHh-cCCCCCCCCCCCCCCCCCCchhhhccccchhHHHHHHHHHh
Q 004088 661 ILRATDISPIALLSDNVLGAMQHDNKGTVAVEALQELF-TGDGQSKKGRRGQNEIPLPPSVYQRLTSSSTLLNLAQALAY 739 (774)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (774)
|++++|++||+++.+++++.|++++||++++++++||+ +-+-+++++++|+++|+.|++||+|...|+.|+|+++.++|
T Consensus 712 ~v~qvdrd~I~v~~~n~V~~v~lqG~~~~~~~~~sel~f~f~iesv~~~~gsvlaf~~hgvqgr~l~S~~vtqei~d~tr 791 (829)
T KOG0576|consen 712 QVTQVDRDTILVLFENMVKIVNLQGNGKVAVKLLSELTFDFDIESVVCLQGSVLAFWKHGVQGRSLTSNEVTQEIQDLTR 791 (829)
T ss_pred eeEEecccceEeeecCeeEEEeccCCccccccccccccccCCcceEEeeCCceecccCCcceeeeccchHHHHHHHHHHH
Confidence 99999999999999999999999999999999999998 88889999999999999999999999999999999999999
Q ss_pred hhhhcccCC--CchhhhhHHHHHHHHHHHHHHHHhcC
Q 004088 740 HRMCYDEMP--LQELQVTQEEQTIQNLCDTLRTILRL 774 (774)
Q Consensus 740 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 774 (774)
|.+||+.|+ +++.|++||++.++|+|++|++|+++
T Consensus 792 ~~rllgs~rvi~lesq~t~~~~~~s~~~~~L~gh~~~ 828 (829)
T KOG0576|consen 792 HFRLLGSDRVIILESQPTQNPQAISNNLYILAGHERL 828 (829)
T ss_pred HHHHhcCCchhhhhcccCCCccCCCchhhHHhccccC
Confidence 999999999 99999999999999999999999875
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-54 Score=465.84 Aligned_cols=265 Identities=31% Similarity=0.457 Sum_probs=229.1
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChh------hHHHHHHHHHHHHhCCCCCcccccccccC
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEE------GYEEIRGEIEMLQQCSHPNVVRYLGSYQG 257 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~------~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~ 257 (774)
+...+.|.+.+.||+|+||.|-+|..+.+|+.||||++++..... ....+.+|+++|++|+|||||+++++|+.
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 445678999999999999999999999999999999998654211 22346799999999999999999999999
Q ss_pred CceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC---CcEEEeecccc
Q 004088 258 EEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ---GEVKLGDFGVA 334 (774)
Q Consensus 258 ~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~---g~vKL~DFGlA 334 (774)
.+..||||||++||.|.+.+- .++.+.+...+.+++||+.||.|||++||+||||||+|||+..+ ..+||+|||+|
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv-~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVV-ANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred CCceEEEEEEecCccHHHHHH-hccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 999999999999999999985 55779999999999999999999999999999999999999876 57999999999
Q ss_pred ccccccccccccccccccccchhhhhhcC---CCCccchhhhHHHHHHHHhCCCCCCCCCchh-hhhhhhcCCCCcc-cc
Q 004088 335 AQLTRTMSKRNTFIGTPHWMAPEVIQESR---YDGKVDVWALGVSAVEMAEGLPPRSTVHPMR-VLFMISIEPAPML-ED 409 (774)
Q Consensus 335 ~~i~~~~~~~~~~~GT~~Y~APEvl~~~~---~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~-~i~~i~~~~~~~~-~~ 409 (774)
+... ......++||||.|.|||++.... +..++||||+||+||-+|+|.+||+...... ....|........ ..
T Consensus 327 K~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 327 KVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred hccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 8776 557788999999999999998654 3458899999999999999999999766555 5555554433332 34
Q ss_pred chhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhccC
Q 004088 410 KEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCG 450 (774)
Q Consensus 410 ~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~~ 450 (774)
...++++..+||.+||..||++|||+.|+|+||||+...+.
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~ 446 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCL 446 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccccc
Confidence 56678999999999999999999999999999999876543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-53 Score=477.16 Aligned_cols=256 Identities=35% Similarity=0.609 Sum_probs=237.9
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
.+|...+.||+|||+.||.+++..+|+.||+|++.+.. .....+.+.+||+|.++|+|||||++|++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 78999999999999999999999999999999998643 4456678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
|+|..++|..+++ ..+.++|.+++.+++||+.||.|||+++|||||||..||||+++.+|||+|||+|..+........
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~ 176 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKK 176 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccc
Confidence 9999999999987 778999999999999999999999999999999999999999999999999999999987777888
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhc
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCL 425 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL 425 (774)
+.||||.|+|||++....++..+||||+||+||-||.|+|||....-.+.+..|......+ +..++.++++||.+||
T Consensus 177 TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~---P~~ls~~A~dLI~~lL 253 (592)
T KOG0575|consen 177 TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSM---PSHLSAEAKDLIRKLL 253 (592)
T ss_pred eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccc---ccccCHHHHHHHHHHh
Confidence 9999999999999999999999999999999999999999999988888877776554433 4478999999999999
Q ss_pred ccCCCCCCCHHHHHhhhhhhhh
Q 004088 426 TKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 426 ~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
.+||.+|||+.+||.|+||++-
T Consensus 254 ~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 254 RPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred cCCcccCCCHHHHhcCHhhhCC
Confidence 9999999999999999999543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-53 Score=451.97 Aligned_cols=259 Identities=38% Similarity=0.650 Sum_probs=236.9
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCc-eEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE-YLWIV 264 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~-~l~LV 264 (774)
...+.+.++.||+|..|+||+|+++.+++.+|+|++.........+++.+|+++|+.++|||||.+|+.|..+. .++|+
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~ 156 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC 156 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence 44578889999999999999999999999999999987777888899999999999999999999999999888 59999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHh-cCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS-IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs-~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
||||++|+|..++.. -++++|..+..|+.+|++||.|||+ ++||||||||+||||+..|.|||||||.++.+.+. .
T Consensus 157 mEYMDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~ 233 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--I 233 (364)
T ss_pred hhhcCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--h
Confidence 999999999999863 4789999999999999999999995 99999999999999999999999999999988776 5
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCC-----CchhhhhhhhcCCCCccccchhchHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTV-----HPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~-----~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
.++++||..|||||.+.+..|+.++||||||++++|++.|+.||... ...+++..|...+.|.++.. .|+++|+
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~-~fS~ef~ 312 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG-EFSPEFR 312 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc-cCCHHHH
Confidence 57889999999999999999999999999999999999999999874 55666667777676666544 6999999
Q ss_pred HHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 419 DFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
+||..||++||.+||++.|+++|||+++..
T Consensus 313 ~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 313 SFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 999999999999999999999999998754
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-53 Score=440.79 Aligned_cols=262 Identities=50% Similarity=0.923 Sum_probs=251.1
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
..+..-|.++.+||+|+||.||+|.++.+|+.||||.+... ..+.++..|+.||+++..|++|++|+.|.....+||
T Consensus 29 K~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI 105 (502)
T KOG0574|consen 29 KPPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI 105 (502)
T ss_pred CChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence 34456799999999999999999999999999999998643 456789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|||||..|++.++++.++++|++.++..+++..+.||+|||...-||||||..|||++.+|+.||+|||.|.++......
T Consensus 106 VMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred ehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHh
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAK 423 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~k 423 (774)
+++.+|||.|||||++..-.|+.++||||||++..||..|+|||...++++.+++|...+.|.+..++.|+.++.|||++
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~ 265 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRS 265 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 424 CLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 424 cL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
||.++|++|.||.++++|||+++.+
T Consensus 266 CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 266 CLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred HhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 9999999999999999999999765
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-51 Score=438.80 Aligned_cols=263 Identities=32% Similarity=0.514 Sum_probs=238.5
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
......|++++.||+|+||+||+++.+.+++.||+|++++.. .....+....|..||.+++||+||+++..|++.+.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 345678999999999999999999999999999999998765 234467889999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|||+||+.||.|..+|+ +.+.++|..++.++..|+.||.|||++|||||||||+||||+.+|+++|+|||+|+......
T Consensus 101 ylVld~~~GGeLf~hL~-~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQ-REGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEEEeccCCccHHHHHH-hcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 99999999999999996 56789999999999999999999999999999999999999999999999999999776666
Q ss_pred cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI 421 (774)
....++|||+.|||||++.+..|+..+|+|||||++|||++|.+||...+....+..+.....+ ..+..++.++++||
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~--~~p~~ls~~ardll 257 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLP--LPPGYLSEEARDLL 257 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCC--CCCccCCHHHHHHH
Confidence 6777899999999999999999999999999999999999999999999888888777665522 23445899999999
Q ss_pred HhhcccCCCCCC----CHHHHHhhhhhhhhcc
Q 004088 422 AKCLTKEPRARP----TAAEMLKHKFIERCKC 449 (774)
Q Consensus 422 ~kcL~~DP~kRP----Ta~ElL~HPwf~~~~~ 449 (774)
+++|.+||++|. .+.++-+||||+...+
T Consensus 258 ~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 258 KKLLKRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred HHHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 999999999995 7999999999987643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-51 Score=422.40 Aligned_cols=259 Identities=31% Similarity=0.498 Sum_probs=225.6
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChh-hHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEE-GYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~-~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
++|+.+.++|+|+||+||+|+++.+|+.||||++.-+.+.. ..+-..|||++|++|+|||+|.|+++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 47899999999999999999999999999999997555433 34456899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
||+..-|. .++.....++...++.++.|++.|+.|||++++|||||||+||||+.+|.+||||||+|+.+..+....+.
T Consensus 82 ~~dhTvL~-eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD 160 (396)
T KOG0593|consen 82 YCDHTVLH-ELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD 160 (396)
T ss_pred ecchHHHH-HHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence 99765444 45557778999999999999999999999999999999999999999999999999999998877778888
Q ss_pred ccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCcc------------------
Q 004088 347 FIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPML------------------ 407 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~------------------ 407 (774)
++-|.||+|||.+.+ .+|+..+||||+||++.||++|.+.|.+....+.++.|........
T Consensus 161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l 240 (396)
T KOG0593|consen 161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL 240 (396)
T ss_pred hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence 999999999999987 6899999999999999999999999999888777765532211111
Q ss_pred ----------ccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 408 ----------EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 408 ----------~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
...++.+..+.||+++||..||.+|++.+|+|.||||...
T Consensus 241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 1123446678899999999999999999999999999654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-50 Score=432.56 Aligned_cols=260 Identities=32% Similarity=0.555 Sum_probs=234.1
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
...+|.+.++||+|+||+||+|+++.++..||||.+.+.. .....+.+..|+.+|+.++|||||.|+++++.++.+|||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 4578999999999999999999999999999999998765 566778889999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC------CcEEEeecccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ------GEVKLGDFGVAAQLT 338 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~------g~vKL~DFGlA~~i~ 338 (774)
||||.||+|.++++ ..+.++|..++.++.||+.||++||+++||||||||.||||+.. -.+||+|||+|+.+.
T Consensus 88 MEyC~gGDLs~yi~-~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIR-RRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEeCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999999999997 45689999999999999999999999999999999999999875 358999999999876
Q ss_pred ccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 339 RTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 339 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
.. ....+.||+|.|||||++...+|+.|+|+||+|+|+|+|++|++||......++...+..........+...+..+.
T Consensus 167 ~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~ 245 (429)
T KOG0595|consen 167 PG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLR 245 (429)
T ss_pred ch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchh
Confidence 43 45567899999999999999999999999999999999999999999998888887766655544444556667778
Q ss_pred HHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 419 DFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
+++...|+.+|..|.+..+-+.|+++..-
T Consensus 246 ~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 246 ELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred hhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 99999999999999999999999998654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=441.17 Aligned_cols=262 Identities=44% Similarity=0.774 Sum_probs=246.8
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
...+...|...++||+|+-|.||.|+...+++.||||++.+.. ....+-+.+|+.+|+..+|+|||++++.|.-.+.+|
T Consensus 268 ~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 268 QGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELW 346 (550)
T ss_pred CCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc-CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence 4566788999999999999999999999999999999998654 334567899999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
+||||++||+|.+++.. ..++|.++..|++.++.||+|||.+||||||||.+|||++.+|.+||+|||+|..+.....
T Consensus 347 VVMEym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred EEEeecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999999999999863 4599999999999999999999999999999999999999999999999999999988888
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
.+.+.+|||.|||||++....|+.++||||||++++||+.|.|||...++.+.++.|.....+.+..+..++..|++|+.
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~ 504 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLD 504 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHH
Confidence 88999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 423 KCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
+||+.|+.+|++|.|||+||||+.+
T Consensus 505 ~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 505 RCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred HHhhcchhcCCCHHHHhcChhhhhc
Confidence 9999999999999999999999644
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-50 Score=434.47 Aligned_cols=260 Identities=56% Similarity=0.992 Sum_probs=246.0
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
.+...|+.+++||+|+||.||+|.+..+++.||||++.........+.+++|+.+|.+++++||.++|+.|..+..+||+
T Consensus 10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred CcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 34567888999999999999999999999999999999888888889999999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
||||.||++.++++ ....+.|..+..++++++.||.|||.++.||||||+.|||+..+|.+||+|||.+.++......+
T Consensus 90 Mey~~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLK-SGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HHHhcCcchhhhhc-cCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 99999999999996 45566999999999999999999999999999999999999999999999999999998887778
Q ss_pred ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
.+++|||.|||||++....|+.|+||||||+++|||++|.||+...+++..++.|....+|.+.. .|++.+++||..|
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~--~~S~~~kEFV~~C 246 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDG--DFSPPFKEFVEAC 246 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcccc--ccCHHHHHHHHHH
Confidence 99999999999999998899999999999999999999999999999999999998888887765 8999999999999
Q ss_pred cccCCCCCCCHHHHHhhhhhhhh
Q 004088 425 LTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 425 L~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
|.+||+.||+|.++|+|+|+++.
T Consensus 247 L~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 247 LDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred hhcCcccCcCHHHHhhhHHHHhc
Confidence 99999999999999999999973
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=438.50 Aligned_cols=262 Identities=31% Similarity=0.501 Sum_probs=232.8
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhC-CCCCcccccccccCCce
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEY 260 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~ 260 (774)
.....+|.+++.||.|+|++|++|+++.+++.|||||+.+.. .+...+-+.+|-.+|.+| .||.|++||..|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 345678999999999999999999999999999999997543 233345578899999999 89999999999999999
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
+|+|+||+++|+|.++|+ +-+.|++..++.++.+|+.||+|||++|||||||||+||||+.+|++||+|||.|+.+...
T Consensus 149 LYFvLe~A~nGdll~~i~-K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIK-KYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred eEEEEEecCCCcHHHHHH-HhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 999999999999999997 4578999999999999999999999999999999999999999999999999999877543
Q ss_pred ccc-------------cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCcc
Q 004088 341 MSK-------------RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPML 407 (774)
Q Consensus 341 ~~~-------------~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~ 407 (774)
... ..+++||..|++||+|.....+..+|||+||||+|.|+.|+|||...+.......|.....
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y--- 304 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY--- 304 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc---
Confidence 211 2458999999999999999999999999999999999999999999888777766654433
Q ss_pred ccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 408 EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 408 ~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
..++.+++.+.|||+++|..||.+|+|+++|.+||||..+.+
T Consensus 305 ~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 305 EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence 345677899999999999999999999999999999987654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=434.50 Aligned_cols=261 Identities=27% Similarity=0.423 Sum_probs=225.7
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-CCCcccccccccCCc-eEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQGEE-YLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~~~-~l~L 263 (774)
..++|.++++||.|.||.||+|+.+.+|..||||.+++....-..-.-+||++.|++|+ |||||+|++++.+.+ .+|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 45789999999999999999999999999999999975443322223468999999998 999999999998887 9999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
||||| ..+|.++++.+++.|++..++.|+.||++||+|+|.+|+.||||||+|||+..+..+||+|||+|+.+... ..
T Consensus 88 VfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk-pP 165 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK-PP 165 (538)
T ss_pred eHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC-CC
Confidence 99999 56899999988899999999999999999999999999999999999999998889999999999987654 56
Q ss_pred cccccccccccchhhhh-hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-CCCccc-------------
Q 004088 344 RNTFIGTPHWMAPEVIQ-ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-PAPMLE------------- 408 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~-~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-~~~~~~------------- 408 (774)
.+.++.|.||+|||++. ...|+.++||||+|||++|+.+-++.|.+.+..+.++.|..- ..|...
T Consensus 166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn 245 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN 245 (538)
T ss_pred cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence 67889999999999986 456999999999999999999999999999988887765321 111100
Q ss_pred -------------cchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 409 -------------DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 409 -------------~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
-...++.++.++|.+||.+||.+||||.|+|+||||+.+.
T Consensus 246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 0123577889999999999999999999999999998654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=429.08 Aligned_cols=258 Identities=34% Similarity=0.492 Sum_probs=229.7
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC---h-hhHHHHHHHHHHHHhCC-CCCcccccccccCCc
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG---E-EGYEEIRGEIEMLQQCS-HPNVVRYLGSYQGEE 259 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~---~-~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~~~ 259 (774)
...++|.+.+.||+|+||+|++|.+..+++.||||++.+... . ...+.+.+|+.+|+++. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 456799999999999999999999999999999998765421 1 34566789999999998 999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC-CcEEEeecccccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ-GEVKLGDFGVAAQLT 338 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~-g~vKL~DFGlA~~i~ 338 (774)
.+|||||||.||+|.+++.. .+++.|.+++.+++||+.|++|||++||+||||||+|||++.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 99999999999999999976 7899999999999999999999999999999999999999999 999999999998764
Q ss_pred ccccccccccccccccchhhhhhcC-CC-CccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhc-hH
Q 004088 339 RTMSKRNTFIGTPHWMAPEVIQESR-YD-GKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKW-SL 415 (774)
Q Consensus 339 ~~~~~~~~~~GT~~Y~APEvl~~~~-~s-~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~-s~ 415 (774)
.......+.|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+...+...+....... +..+ +.
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~---p~~~~S~ 249 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKI---PSYLLSP 249 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccC---CCCcCCH
Confidence 3445667889999999999999977 86 68999999999999999999999977777776655443332 3344 89
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 416 VFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 416 ~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
.+++||.+||..||.+|+|+.++++||||+.
T Consensus 250 ~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 250 EARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 9999999999999999999999999999986
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=405.58 Aligned_cols=257 Identities=30% Similarity=0.499 Sum_probs=234.1
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
....+|++++.||.|+||.|.+++++.+|..||+|++.+.. .....+...+|..+|+.+.||++++|++.|.+...+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 45678999999999999999999999999999999997654 3445677889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
|||||++||.|+.+++ +.+++++..++.++.||+.||+|||+++||+|||||+|||||.+|.+||+|||+|+.+...
T Consensus 121 mvmeyv~GGElFS~Lr-k~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLR-KSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred EEEeccCCccHHHHHH-hcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 9999999999999997 5578999999999999999999999999999999999999999999999999999876543
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
..+.||||.|+|||++....|+.++|+|||||++|||+.|.+||...+++..+..|..... ..+..++..+++||.
T Consensus 198 -T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v---~fP~~fs~~~kdLl~ 273 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV---KFPSYFSSDAKDLLK 273 (355)
T ss_pred -EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc---cCCcccCHHHHHHHH
Confidence 5678999999999999999999999999999999999999999999999888888765543 345678899999999
Q ss_pred hhcccCCCCC-----CCHHHHHhhhhhhhhc
Q 004088 423 KCLTKEPRAR-----PTAAEMLKHKFIERCK 448 (774)
Q Consensus 423 kcL~~DP~kR-----PTa~ElL~HPwf~~~~ 448 (774)
++|+.|-.+| ....+|.+||||+...
T Consensus 274 ~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 274 KLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred HHHhhhhHhhhcCcCCCccccccCccccccc
Confidence 9999999999 4578999999998654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=428.82 Aligned_cols=266 Identities=31% Similarity=0.535 Sum_probs=231.5
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
....++|++++.||+|+||.||+|+.+.+|..||+|+++++. ....++.++.|-.+|....+|+||+||..|++.+++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 346789999999999999999999999999999999998765 344567889999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc--
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR-- 339 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~-- 339 (774)
||||||++||++..+|. +.+.|++..++.++.+++.|++-||++|+|||||||+|+|||..|++||+|||+|.-+..
T Consensus 217 YLiMEylPGGD~mTLL~-~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLM-RKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEEEEecCCccHHHHHH-hcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 99999999999999985 668899999999999999999999999999999999999999999999999999953211
Q ss_pred ---------------------ccc----cc--------------------ccccccccccchhhhhhcCCCCccchhhhH
Q 004088 340 ---------------------TMS----KR--------------------NTFIGTPHWMAPEVIQESRYDGKVDVWALG 374 (774)
Q Consensus 340 ---------------------~~~----~~--------------------~~~~GT~~Y~APEvl~~~~~s~ksDIWSLG 374 (774)
... .. ...+|||.|||||++.+..|+..+|+||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 000 00 125899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCchhhhhhhhc-CCCCccccchhchHHHHHHHHhhcccCCCCCC---CHHHHHhhhhhhhhccC
Q 004088 375 VSAVEMAEGLPPRSTVHPMRVLFMISI-EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARP---TAAEMLKHKFIERCKCG 450 (774)
Q Consensus 375 viLyELLtG~~Pf~~~~~~~~i~~i~~-~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRP---Ta~ElL~HPwf~~~~~~ 450 (774)
|||||||.|.|||...++.+....|.. ...-..+....++.+++|||.+||. ||++|. .++||.+||||+.+.+.
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence 999999999999999999888776532 2222334455678999999999999 999997 49999999999987654
Q ss_pred c
Q 004088 451 A 451 (774)
Q Consensus 451 ~ 451 (774)
.
T Consensus 455 ~ 455 (550)
T KOG0605|consen 455 H 455 (550)
T ss_pred h
Confidence 3
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=414.65 Aligned_cols=266 Identities=42% Similarity=0.745 Sum_probs=237.6
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
......|++...||.|.-++||+|+.+.+++.||||++.........+.+++|+..|+.++||||++++.+|..+..+|+
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence 34567899999999999999999999999999999999988776778999999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhc-cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 264 VMEYCGGGSVADLMNV-TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 264 VmEy~~ggsL~dll~~-~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
||.||.+|++.++++. ....+.|..+..|++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+..+.....
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 9999999999999974 345699999999999999999999999999999999999999999999999999876654432
Q ss_pred c---c-ccccccccccchhhhhh--cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCC-------cccc
Q 004088 343 K---R-NTFIGTPHWMAPEVIQE--SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAP-------MLED 409 (774)
Q Consensus 343 ~---~-~~~~GT~~Y~APEvl~~--~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~-------~~~~ 409 (774)
. + ++++||++|||||++.. ..|+.|+||||||++..||.+|..||....+++++.+...+..| ....
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~ 261 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDE 261 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHH
Confidence 1 2 56799999999999643 46999999999999999999999999999999988766555544 3344
Q ss_pred chhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 410 KEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 410 ~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
..+++..++.+|..||++||.+||||.++|+|+||++++.
T Consensus 262 ~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 262 DKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred hhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 5677889999999999999999999999999999998753
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-48 Score=395.31 Aligned_cols=261 Identities=32% Similarity=0.474 Sum_probs=225.0
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhh-HHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEG-YEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~-~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
.+|..+++||+|.||.||+|++..+|+.||||.++.....+. .....|||++|+.++||||+.|+++|.....+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 478899999999999999999999999999999987654333 3457899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
|+ ..+|..+++.....++..+++.++.++++||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+.........
T Consensus 82 fm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~ 160 (318)
T KOG0659|consen 82 FM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH 160 (318)
T ss_pred ec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence 99 56999999988889999999999999999999999999999999999999999999999999999998876555555
Q ss_pred ccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhh---hcCCCC-ccc-------------
Q 004088 347 FIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI---SIEPAP-MLE------------- 408 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i---~~~~~~-~~~------------- 408 (774)
.+-|.||+|||++.+. .|+..+||||.|||+.||+.|.|-|.+....+.+..+ ...+.+ .++
T Consensus 161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~ 240 (318)
T KOG0659|consen 161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQ 240 (318)
T ss_pred ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhc
Confidence 5789999999999876 5999999999999999999999999887766655433 111110 000
Q ss_pred --------cchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 409 --------DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 409 --------~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
-....+..+.||+.+||.+||.+|+++.|+|+|+||+..+.
T Consensus 241 ~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~ 289 (318)
T KOG0659|consen 241 FPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL 289 (318)
T ss_pred CCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence 01122556789999999999999999999999999997643
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-48 Score=423.26 Aligned_cols=282 Identities=29% Similarity=0.460 Sum_probs=232.1
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCC--ceEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE--EYLW 262 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~--~~l~ 262 (774)
....|+.+++||+|.||.||+|++..+|+.||+|.++... ......-..|||.||++|+||||++|.+..... ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 3467999999999999999999999999999999998765 344455678999999999999999999988765 7899
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
||+|||+. +|..++....-.|++.+++.|++||+.||+|||.+||+|||||.+||||+.+|.+||+|||+|+++.....
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 99999954 88888877777899999999999999999999999999999999999999999999999999997765433
Q ss_pred c-cccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhh---cCCCC------cc----
Q 004088 343 K-RNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMIS---IEPAP------ML---- 407 (774)
Q Consensus 343 ~-~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~---~~~~~------~~---- 407 (774)
. .+..+-|+||+|||++.+. .|+.++|+||.||||.||+.|++.|.+....+.+..|- ..+.. .+
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~ 353 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT 353 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence 3 5556789999999999875 59999999999999999999999999988776665442 11110 00
Q ss_pred -------------ccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhccCc-cccchhHHHHHHHHHHH
Q 004088 408 -------------EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGA-TAMLPKIEKARQIRASM 468 (774)
Q Consensus 408 -------------~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~~~-~~~lp~~~~~r~~~~~~ 468 (774)
+....++....+|+..||..||.+|.||.++|+|+||...+... ...+|.......+....
T Consensus 354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p~~Lp~y~~s~E~~~K~ 428 (560)
T KOG0600|consen 354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDPSSLPKYPPSHELDAKR 428 (560)
T ss_pred ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCcccCCCCCcchhHHHHH
Confidence 01123356678999999999999999999999999995433222 23566655554444433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-49 Score=405.15 Aligned_cols=249 Identities=33% Similarity=0.553 Sum_probs=221.6
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccc-cccCCc-eEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLG-SYQGEE-YLW 262 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~-~~~~~~-~l~ 262 (774)
....|+++++||+|+||+||++.+..+|+.||.|.+.... +......+..|+.+|++|+|||||++++ .|..+. -++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 3457999999999999999999999999999999987443 4455677899999999999999999999 455444 499
Q ss_pred EEEEecCCCchhhhhhc---cCCchhHHHHHHHHHHHHHHHHHHHh--cC--cccccccccceEecCCCcEEEeeccccc
Q 004088 263 IVMEYCGGGSVADLMNV---TEEPLEEYQIAYICREALKGLAYLHS--IF--KVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~---~~~~Lse~~i~~I~~QIl~gL~YLHs--~g--IIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
||||||.+|+|..+++. .++.++|..++.++.|++.||..||. .. |+||||||.||+|+.+|.|||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 99999999999998863 45679999999999999999999999 44 9999999999999999999999999999
Q ss_pred cccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchH
Q 004088 336 QLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSL 415 (774)
Q Consensus 336 ~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~ 415 (774)
.+........+++|||.||+||.+.+.+|+.++||||+||++|||+.-++||.+.+-..+...|.....+.++ ...+|.
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p-~~~YS~ 255 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP-DEHYST 255 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc-HHHhhh
Confidence 9988777777889999999999999999999999999999999999999999999888877777766554332 256789
Q ss_pred HHHHHHHhhcccCCCCCCCH
Q 004088 416 VFHDFVAKCLTKEPRARPTA 435 (774)
Q Consensus 416 ~l~dLI~kcL~~DP~kRPTa 435 (774)
.+..+|..|+..||+.||+.
T Consensus 256 ~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 256 DLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHHHHccCCcccCCCc
Confidence 99999999999999999985
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-48 Score=413.87 Aligned_cols=259 Identities=40% Similarity=0.644 Sum_probs=221.3
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCc--eEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE--YLWIV 264 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~--~l~LV 264 (774)
..+|..++.||+|+||.||++.+..+|...|||.+....... .+.+.+|+.+|++++|||||+++|...... .++|.
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 457889999999999999999999999999999997664333 677899999999999999999999754443 79999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC-CCcEEEeecccccccccc---
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD-QGEVKLGDFGVAAQLTRT--- 340 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~-~g~vKL~DFGlA~~i~~~--- 340 (774)
|||+++|+|.+++...++.|++..++.+.+||++||.|||++|||||||||+||||+. ++.+||+|||+++.....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 9999999999999866658999999999999999999999999999999999999999 799999999999876631
Q ss_pred ccccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCC-CCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 341 MSKRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRST-VHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 341 ~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~-~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
......+.||+.|||||++... ....++|||||||++.||++|++||.. ......++.+.... .....+..++.+++
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~P~ip~~ls~~a~ 253 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SLPEIPDSLSDEAK 253 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CCCCCCcccCHHHH
Confidence 1223457899999999999963 233499999999999999999999998 45555555554443 12244566899999
Q ss_pred HHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 419 DFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
+||.+||.+||++||||.++|+|||.+..
T Consensus 254 ~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 254 DFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred HHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 99999999999999999999999999754
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=425.72 Aligned_cols=255 Identities=35% Similarity=0.567 Sum_probs=234.0
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
++|.+.+.||+|+||.||+|+.+.+.+.||||.+.+.. .......+++|++|++.|+|||||.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57899999999999999999999999999999997654 45567889999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
||.| +|..++. ..+.++|..+..|+.|++.||.|||+++|+|||+||.|||+...|.+|+||||+|+.+.........
T Consensus 82 ~a~g-~L~~il~-~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts 159 (808)
T KOG0597|consen 82 YAVG-DLFTILE-QDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS 159 (808)
T ss_pred hhhh-hHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence 9976 9999996 5678999999999999999999999999999999999999999999999999999988776666667
Q ss_pred ccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcc
Q 004088 347 FIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLT 426 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~ 426 (774)
..|||.|||||++.+..|+..+|+||+|||+|||+.|+|||.......++..|...+... +...+..+.+|+..+|.
T Consensus 160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~---p~~~S~~f~nfl~gLL~ 236 (808)
T KOG0597|consen 160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKP---PSTASSSFVNFLQGLLI 236 (808)
T ss_pred ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCC---cccccHHHHHHHHHHhh
Confidence 789999999999999999999999999999999999999999988888888877665443 33678899999999999
Q ss_pred cCCCCCCCHHHHHhhhhhhhh
Q 004088 427 KEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 427 ~DP~kRPTa~ElL~HPwf~~~ 447 (774)
+||.+|.+..+++.|||.+..
T Consensus 237 kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 237 KDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred cChhhcccHHHHhcChHHhhh
Confidence 999999999999999999754
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=429.68 Aligned_cols=260 Identities=30% Similarity=0.460 Sum_probs=233.2
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCC-CCCcccccccccCCceE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~~~~l 261 (774)
....+|.+++.||+|+||+|++++.+.+++.||||++++.. ..+.++....|.+|+...+ ||.+++|+.+|+..+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34568999999999999999999999999999999998765 4566788999999998885 99999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|+||||+.||++..+. ..+.|++..++.++..|+.||.|||++||||||||.+|||||.+|++||+|||+++......
T Consensus 445 ~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCC
Confidence 9999999999954443 45789999999999999999999999999999999999999999999999999998766555
Q ss_pred cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI 421 (774)
....++||||.|||||++.+..|+..+|+|||||+|||||.|.+||.+.+..++...|...... -+..++.++.++|
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~---yP~~ls~ea~~il 599 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVR---YPRFLSKEAIAIM 599 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC---CCCcccHHHHHHH
Confidence 6778899999999999999999999999999999999999999999999988887777655332 2456789999999
Q ss_pred HhhcccCCCCCCC-----HHHHHhhhhhhhhcc
Q 004088 422 AKCLTKEPRARPT-----AAEMLKHKFIERCKC 449 (774)
Q Consensus 422 ~kcL~~DP~kRPT-----a~ElL~HPwf~~~~~ 449 (774)
+++|.+||++|.. +.+|..||||+.+.+
T Consensus 600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w 632 (694)
T KOG0694|consen 600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW 632 (694)
T ss_pred HHHhccCcccccCCCCCCchhhhhCCccccCCH
Confidence 9999999999975 589999999987643
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=396.01 Aligned_cols=257 Identities=27% Similarity=0.435 Sum_probs=215.3
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
..+|+++++||.|+||.||+|++..+++.||||++...........+.+|+.+|++++||||+++++++......|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 46799999999999999999999999999999999755444444567899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
|+.+ +|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~ 162 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN 162 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccC
Confidence 9975 888888656667899999999999999999999999999999999999999999999999999765443333344
Q ss_pred ccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC---C-------------------
Q 004088 347 FIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE---P------------------- 403 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~---~------------------- 403 (774)
..|++.|+|||++.+ ..++.++|||||||++|+|++|++||......+.+..+... +
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd07871 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLF 242 (288)
T ss_pred ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcccc
Confidence 578999999999875 56899999999999999999999999876654433222100 0
Q ss_pred -----CCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 404 -----APMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 404 -----~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
.+........+.++.+||.+||++||.+|||+.|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 243 PQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred CccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00001112346788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=396.87 Aligned_cols=262 Identities=29% Similarity=0.439 Sum_probs=214.1
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
..++|++++.||+|+||.||+|++..+++.||||++...........+.+|+.+|+.++||||+++++++......|+||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 35789999999999999999999999999999999975543344456788999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
|||. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 161 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS 161 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence 9995 577777766667799999999999999999999999999999999999999999999999999975543333334
Q ss_pred cccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhh-hhh---hcCCC----------Ccc---
Q 004088 346 TFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVL-FMI---SIEPA----------PML--- 407 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i-~~i---~~~~~----------~~~--- 407 (774)
..+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||......... ..+ ...+. +..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd07869 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPE 241 (303)
T ss_pred CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccc
Confidence 4578999999999875 45888999999999999999999999875432211 111 00000 000
Q ss_pred -------------ccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 408 -------------EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 408 -------------~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.....++..+.+||.+||++||.+|||+.++|+||||+..+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred cccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 00012346788999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=399.93 Aligned_cols=268 Identities=29% Similarity=0.476 Sum_probs=227.9
Q ss_pred ccCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHH-HHHHHHHHHHhCCCCCcccccccccC--C
Q 004088 182 TREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYE-EIRGEIEMLQQCSHPNVVRYLGSYQG--E 258 (774)
Q Consensus 182 ~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~-~~~~Ei~iL~~L~HPNIVkL~~~~~~--~ 258 (774)
......+.|+.+++|++|+||.||+|+++.+++.||+|+++......+.. ..+|||.+|.+++|||||.+.++... -
T Consensus 70 ~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~ 149 (419)
T KOG0663|consen 70 GGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM 149 (419)
T ss_pred cCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence 34456678999999999999999999999999999999998765433322 35799999999999999999988764 4
Q ss_pred ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 259 EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
+.+|||||||+ .+|..++....++|...+++.++.|+++||+|||.+.|+|||||++|+|++..|.+||+|||+|+.+.
T Consensus 150 d~iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 150 DKIYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred ceeeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhc
Confidence 57999999995 58999998888899999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc---CCCC-------cc
Q 004088 339 RTMSKRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI---EPAP-------ML 407 (774)
Q Consensus 339 ~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~---~~~~-------~~ 407 (774)
.........+-|.||+|||++.+. .|+.++||||+|||+.||+.++|-|.+......+..|-. .+.. .+
T Consensus 229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 887778888899999999999876 499999999999999999999999998877666544321 1100 00
Q ss_pred c-----------------cch--hchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhccC
Q 004088 408 E-----------------DKE--KWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCG 450 (774)
Q Consensus 408 ~-----------------~~~--~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~~ 450 (774)
+ ... .++....+|+..+|.+||.+|.||.|.|+|.||...+.+
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p 370 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP 370 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence 0 000 134667899999999999999999999999999985433
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-47 Score=423.58 Aligned_cols=258 Identities=31% Similarity=0.491 Sum_probs=231.2
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
..+-|++++.||.|+-|.|.+|++..||+.+|||++.+.. .......+.+||-||+.|.||||++||++|++..++|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 3567999999999999999999999999999999998653 22334568899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|.||++||.|++++- .++++++.++.+++.||+.|+.|||..+|+||||||+|+||+..+++||+|||+|..- .....
T Consensus 90 vlEyv~gGELFdylv-~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe-~~gkl 167 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLV-RKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE-VPGKL 167 (786)
T ss_pred EEEecCCchhHHHHH-hhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc-cCCcc
Confidence 999999999999985 6688999999999999999999999999999999999999999999999999999643 34456
Q ss_pred cccccccccccchhhhhhcCCC-CccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESRYD-GKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s-~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
..+.||+|.|.+||++.+.+|+ .++||||.|||||.||+|+.||.+.+...++..+..... +.+..++.++++||.
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f---~MPs~Is~eaQdLLr 244 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF---EMPSNISSEAQDLLR 244 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc---cCCCcCCHHHHHHHH
Confidence 6788999999999999999886 589999999999999999999998777776666655433 345778999999999
Q ss_pred hhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 423 KCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
+||..||++|.|.+||++|||+..+.
T Consensus 245 ~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 245 RMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHhccCccccccHHHHhhCchhhcCC
Confidence 99999999999999999999997653
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=394.64 Aligned_cols=253 Identities=30% Similarity=0.488 Sum_probs=219.9
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.+|++++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999986532 2234466889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
||+.+++|.+++. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+... ..
T Consensus 81 e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---~~ 156 (291)
T cd05612 81 EYVPGGELFSYLR-NSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---TW 156 (291)
T ss_pred eCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---cc
Confidence 9999999999986 3457899999999999999999999999999999999999999999999999999765432 23
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhc
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCL 425 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL 425 (774)
..+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..... ..+..++..+.+||.+||
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~l 233 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL---EFPRHLDLYAKDLIKKLL 233 (291)
T ss_pred cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc---CCCccCCHHHHHHHHHHc
Confidence 45799999999999998899999999999999999999999988776655544433322 123345788999999999
Q ss_pred ccCCCCCCC-----HHHHHhhhhhhhh
Q 004088 426 TKEPRARPT-----AAEMLKHKFIERC 447 (774)
Q Consensus 426 ~~DP~kRPT-----a~ElL~HPwf~~~ 447 (774)
+.||.+||+ +.++++||||...
T Consensus 234 ~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 234 VVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred CCCHHHccCCccCCHHHHhcCccccCC
Confidence 999999995 9999999999753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=389.11 Aligned_cols=256 Identities=28% Similarity=0.419 Sum_probs=213.1
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
++|++.+.||+|+||.||+|++..+++.||||++..... ....+.+.+|+.+++.++||||++++++|.....+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 479999999999999999999999999999999975432 3345668899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc-ccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS-KRN 345 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~-~~~ 345 (774)
|++++.+..+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 99987776554 3456799999999999999999999999999999999999999999999999999987643221 223
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCC---------------------
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA--------------------- 404 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~--------------------- 404 (774)
...||+.|+|||++.+..++.++|||||||++|+|++|++||...........+.....
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07848 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF 239 (287)
T ss_pred ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence 45799999999999988899999999999999999999999987654433222111000
Q ss_pred Cccc--------cchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 405 PMLE--------DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 405 ~~~~--------~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
+... ....++..+.+||.+||++||++|||+.++|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0000 011256779999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=402.76 Aligned_cols=250 Identities=30% Similarity=0.469 Sum_probs=216.6
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCCC
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGG 271 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~gg 271 (774)
+.||+|+||.||+|++..+|+.||||++.... .......+.+|+.+|++++||||++++++|...+.+||||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997532 2234456789999999999999999999999999999999999999
Q ss_pred chhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccccccc
Q 004088 272 SVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP 351 (774)
Q Consensus 272 sL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT~ 351 (774)
+|.+++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+||+
T Consensus 81 ~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 159 (323)
T cd05571 81 ELFFHLS-RERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred cHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence 9998886 446789999999999999999999999999999999999999999999999999975433333344568999
Q ss_pred cccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCC
Q 004088 352 HWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRA 431 (774)
Q Consensus 352 ~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~k 431 (774)
.|+|||++.+..++.++|||||||++|||++|+.||...+.......+..... ..+..++..+.+||.+||++||++
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~---~~p~~~~~~~~~li~~~L~~dP~~ 236 (323)
T cd05571 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI---RFPRTLSPEAKSLLAGLLKKDPKQ 236 (323)
T ss_pred cccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHHHHHHccCCHHH
Confidence 99999999998999999999999999999999999987766555444433222 223467889999999999999999
Q ss_pred CC-----CHHHHHhhhhhhhh
Q 004088 432 RP-----TAAEMLKHKFIERC 447 (774)
Q Consensus 432 RP-----Ta~ElL~HPwf~~~ 447 (774)
|| ++.++++||||...
T Consensus 237 R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 237 RLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred cCCCCCCCHHHHHcCCCcCCC
Confidence 99 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=401.43 Aligned_cols=255 Identities=28% Similarity=0.436 Sum_probs=222.1
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
...+|++.+.||+|+||.||+|++..+++.||||++.... .....+.+.+|+.+|++++||||+++++++..++.+|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 4578999999999999999999999999999999997532 22345678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|||||.+++|.+++. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 96 v~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 171 (329)
T PTZ00263 96 LLEFVVGGELFTHLR-KAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--- 171 (329)
T ss_pred EEcCCCCChHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC---
Confidence 999999999999886 3467899999999999999999999999999999999999999999999999999765432
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHh
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAK 423 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~k 423 (774)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..... ..+..++..+.+||.+
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~li~~ 248 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL---KFPNWFDGRARDLVKG 248 (329)
T ss_pred cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCc---CCCCCCCHHHHHHHHH
Confidence 2345799999999999998999999999999999999999999988776655554433221 2234467889999999
Q ss_pred hcccCCCCCCC-----HHHHHhhhhhhhh
Q 004088 424 CLTKEPRARPT-----AAEMLKHKFIERC 447 (774)
Q Consensus 424 cL~~DP~kRPT-----a~ElL~HPwf~~~ 447 (774)
||+.||.+|++ +.++++||||...
T Consensus 249 ~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 249 LLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 99999999987 7999999999753
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=387.54 Aligned_cols=258 Identities=26% Similarity=0.346 Sum_probs=215.6
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
.|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|++++|+||++++++|...+.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3889999999999999999999999999999986433 12233457899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 267 YCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 267 y~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
||++|+|..++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+... ....
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~ 159 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVR 159 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-Ceec
Confidence 99999998877533 346899999999999999999999999999999999999999999999999999765432 2223
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhh-cCCCCccccchhchHHHHHHHHhh
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMIS-IEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~-~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
..+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+. ............++..+.+||.+|
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 239 (285)
T cd05631 160 GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRML 239 (285)
T ss_pred CCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHH
Confidence 4579999999999999899999999999999999999999998654322111111 011111223345788999999999
Q ss_pred cccCCCCCCC-----HHHHHhhhhhhhh
Q 004088 425 LTKEPRARPT-----AAEMLKHKFIERC 447 (774)
Q Consensus 425 L~~DP~kRPT-----a~ElL~HPwf~~~ 447 (774)
|+.||.+||+ ++++++||||...
T Consensus 240 l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 240 LTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred hhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 9999999997 9999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=402.40 Aligned_cols=258 Identities=29% Similarity=0.507 Sum_probs=218.9
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
++|++++.||+|+||.||+|++..+|+.||||++.... .......+.+|+.+|+.++||||++++++|.....+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997532 2234456789999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc---
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS--- 342 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~--- 342 (774)
|||++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 81 EYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred CCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 99999999999863 45799999999999999999999999999999999999999999999999999865432110
Q ss_pred -----------------------------------ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCC
Q 004088 343 -----------------------------------KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPR 387 (774)
Q Consensus 343 -----------------------------------~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf 387 (774)
.....+||+.|+|||++....++.++|||||||++|+|++|.+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence 011346999999999999989999999999999999999999999
Q ss_pred CCCCchhhhhhhhcC-CCCccccchhchHHHHHHHHhhcccCCCCCCC---HHHHHhhhhhhhh
Q 004088 388 STVHPMRVLFMISIE-PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPT---AAEMLKHKFIERC 447 (774)
Q Consensus 388 ~~~~~~~~i~~i~~~-~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPT---a~ElL~HPwf~~~ 447 (774)
...........+... ..........++..+.+||.+||. +|.+|++ +.++++||||+..
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 887766554443221 111222233568899999999996 9999998 9999999999764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=417.19 Aligned_cols=262 Identities=46% Similarity=0.840 Sum_probs=244.9
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
+.+-|.|+..||.|+||.||+|.++.++-..|-|+|.. .....++.+.-||.||..+.||+||+|++.|..++.+||+.
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet-kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET-KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc-cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 45678999999999999999999999999999999864 34566788999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
|||+||-+..++-.-...|++.++..+++|+|.||.|||+++|||||||..|||++-+|.++|+|||.+.........+.
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD 188 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD 188 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence 99999999988877788999999999999999999999999999999999999999999999999999987777777788
Q ss_pred cccccccccchhhhh-----hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHH
Q 004088 346 TFIGTPHWMAPEVIQ-----ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~-----~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
+++|||+|||||++. ..+|++++||||||++|.||..+.||....+++.++..+....+|.+..+..|+..|.||
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~Df 268 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDF 268 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHH
Confidence 899999999999974 457999999999999999999999999999999999999999899999999999999999
Q ss_pred HHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 421 VAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
+.+||.+||..||++.++|+||||.+..
T Consensus 269 Lk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 269 LKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred HHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 9999999999999999999999998764
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=399.36 Aligned_cols=265 Identities=30% Similarity=0.470 Sum_probs=232.8
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
.....|+++++||.|.-|+||+|+...++..+|+|++.+.. ......++..|-+||+.++||.++.||..|+.+.+.|
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 34568999999999999999999999999999999997654 2334556788999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhc-cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc--
Q 004088 263 IVMEYCGGGSVADLMNV-TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR-- 339 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~-~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~-- 339 (774)
+|||||+||+|..+++. ..+.+++..++.++..++.||+|||.+|||+|||||+||||.++|+|.|+||.++.....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 99999999999998864 456799999999999999999999999999999999999999999999999999843210
Q ss_pred -------------------------------c-c----------------------cccccccccccccchhhhhhcCCC
Q 004088 340 -------------------------------T-M----------------------SKRNTFIGTPHWMAPEVIQESRYD 365 (774)
Q Consensus 340 -------------------------------~-~----------------------~~~~~~~GT~~Y~APEvl~~~~~s 365 (774)
. . ...+.++||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0 011346899999999999999999
Q ss_pred CccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCC----HHHHHhh
Q 004088 366 GKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPT----AAEMLKH 441 (774)
Q Consensus 366 ~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPT----a~ElL~H 441 (774)
.++|+|+|||++||||.|..||.+.+..+.+..+...+..... ....+..++|||+++|.+||.+|.. |+||.+|
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~-~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPE-EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCC-CCcchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 9999999999999999999999999999999888776655433 3467889999999999999999998 9999999
Q ss_pred hhhhhhccC
Q 004088 442 KFIERCKCG 450 (774)
Q Consensus 442 Pwf~~~~~~ 450 (774)
|||+.+++.
T Consensus 393 pFF~gVnWa 401 (459)
T KOG0610|consen 393 PFFEGVNWA 401 (459)
T ss_pred ccccCCChh
Confidence 999977653
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=396.68 Aligned_cols=256 Identities=29% Similarity=0.498 Sum_probs=219.8
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.+|..++||||+++++++.....+||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997542 2234566889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
|||++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 81 e~~~g~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~ 156 (333)
T cd05600 81 EYVPGGDFRTLLN-NLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YAN 156 (333)
T ss_pred eCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccC
Confidence 9999999999986 445789999999999999999999999999999999999999999999999999976543 234
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCC----CCc-cccchhchHHHHHH
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEP----APM-LEDKEKWSLVFHDF 420 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~----~~~-~~~~~~~s~~l~dL 420 (774)
..+||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+.... .+. ......++..+.+|
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~l 236 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDL 236 (333)
T ss_pred CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHH
Confidence 5579999999999999899999999999999999999999998776655443332111 111 11112458889999
Q ss_pred HHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 421 VAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
|.+||..+|.+||++.++++||||...
T Consensus 237 i~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 237 ITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 999999999999999999999999753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=401.92 Aligned_cols=258 Identities=27% Similarity=0.462 Sum_probs=216.5
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
++|++++.||+|+||+||+|++..+++.||||++.+.. .......+.+|+.++.+++||||+++++++.+...+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999997532 2233456889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc---
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS--- 342 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~--- 342 (774)
|||++|+|.+++. ..+.+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 81 EFLPGGDMMTLLM-KKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred cCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 9999999999986 346799999999999999999999999999999999999999999999999999875432100
Q ss_pred --------------------------------ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCC
Q 004088 343 --------------------------------KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTV 390 (774)
Q Consensus 343 --------------------------------~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~ 390 (774)
.....+||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 012457999999999999989999999999999999999999999887
Q ss_pred CchhhhhhhhcC-CCCccccchhchHHHHHHHHhhcccCCC---CCCCHHHHHhhhhhhhh
Q 004088 391 HPMRVLFMISIE-PAPMLEDKEKWSLVFHDFVAKCLTKEPR---ARPTAAEMLKHKFIERC 447 (774)
Q Consensus 391 ~~~~~i~~i~~~-~~~~~~~~~~~s~~l~dLI~kcL~~DP~---kRPTa~ElL~HPwf~~~ 447 (774)
........+... .....+....++..+++||.+|+. +|. .||++.++++||||+..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 766655544332 111122223467889999999775 444 46899999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=398.21 Aligned_cols=258 Identities=29% Similarity=0.500 Sum_probs=221.4
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
++|++++.||+|+||+||+|++..+++.||||++.... .......+.+|+.+|..++||||+++++++.+++++|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999997532 2234567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc----
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM---- 341 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~---- 341 (774)
|||.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 999999999998644 679999999999999999999999999999999999999999999999999997665432
Q ss_pred -------------------------cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhh
Q 004088 342 -------------------------SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVL 396 (774)
Q Consensus 342 -------------------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i 396 (774)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 1223457999999999999999999999999999999999999999887765554
Q ss_pred hhhhcC-CCCccccchhchHHHHHHHHhhcccCCCCCCC-HHHHHhhhhhhhh
Q 004088 397 FMISIE-PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPT-AAEMLKHKFIERC 447 (774)
Q Consensus 397 ~~i~~~-~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPT-a~ElL~HPwf~~~ 447 (774)
..+... .....+....++..+.+||.+||. ||.+||+ +.++++||||+..
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 443321 111122223368899999999997 9999999 9999999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=404.46 Aligned_cols=260 Identities=32% Similarity=0.522 Sum_probs=221.0
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-------------hhhHHHHHHHHHHHHhCCCCCcccc
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-------------EEGYEEIRGEIEMLQQCSHPNVVRY 251 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-------------~~~~~~~~~Ei~iL~~L~HPNIVkL 251 (774)
...++|++++.||+|.||.|-+|++..+++.||||++.+... ....+.+++||.||++|.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 346799999999999999999999999999999999975421 1224689999999999999999999
Q ss_pred cccccC--CceEEEEEEecCCCchhhhhhccCCc-hhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEE
Q 004088 252 LGSYQG--EEYLWIVMEYCGGGSVADLMNVTEEP-LEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKL 328 (774)
Q Consensus 252 ~~~~~~--~~~l~LVmEy~~ggsL~dll~~~~~~-Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL 328 (774)
+++..+ .+.+|||+|||..|.+...- ..+. +++.+++.|+++++.||+|||.+|||||||||+|+||+.+|+|||
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence 999864 56899999999988775432 2344 999999999999999999999999999999999999999999999
Q ss_pred eecccccccccc-----ccccccccccccccchhhhhhc----CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhh
Q 004088 329 GDFGVAAQLTRT-----MSKRNTFIGTPHWMAPEVIQES----RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI 399 (774)
Q Consensus 329 ~DFGlA~~i~~~-----~~~~~~~~GT~~Y~APEvl~~~----~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i 399 (774)
+|||.+..+... .......+|||.|+|||...+. ..+.+.||||+||+||+|+.|+.||.+....++...|
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI 331 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI 331 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence 999999766222 1112235899999999998763 2456899999999999999999999999888888888
Q ss_pred hcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 400 SIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 400 ~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
...+..+. ..+.+...++|||.+||++||++|+++.+|..|||..+-
T Consensus 332 vn~pL~fP-~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 332 VNDPLEFP-ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred hcCcccCC-CcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 76655443 334568889999999999999999999999999999753
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=393.95 Aligned_cols=247 Identities=31% Similarity=0.469 Sum_probs=214.3
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCCCch
Q 004088 196 LGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSV 273 (774)
Q Consensus 196 LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~ggsL 273 (774)
||+|+||.||+|++..+++.||||++.... .......+.+|+.+|++++||||++++++|...+.+|+|||||++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999999999999999986432 233456788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccccccccc
Q 004088 274 ADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHW 353 (774)
Q Consensus 274 ~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y 353 (774)
.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||+.|
T Consensus 81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y 159 (312)
T cd05585 81 FHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159 (312)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence 998863 4679999999999999999999999999999999999999999999999999997544333334456899999
Q ss_pred cchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCC
Q 004088 354 MAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARP 433 (774)
Q Consensus 354 ~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRP 433 (774)
+|||++.+..++.++|||||||++|+|++|++||...........+...+. ..+..++..+.+||.+||..||.+||
T Consensus 160 ~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dp~~R~ 236 (312)
T cd05585 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL---RFPDGFDRDAKDLLIGLLSRDPTRRL 236 (312)
T ss_pred CCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC---CCCCcCCHHHHHHHHHHcCCCHHHcC
Confidence 999999998999999999999999999999999987766655544433322 22346788999999999999999997
Q ss_pred ---CHHHHHhhhhhhh
Q 004088 434 ---TAAEMLKHKFIER 446 (774)
Q Consensus 434 ---Ta~ElL~HPwf~~ 446 (774)
++.++|+||||..
T Consensus 237 ~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 237 GYNGAQEIKNHPFFSQ 252 (312)
T ss_pred CCCCHHHHHcCCCcCC
Confidence 5899999999975
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=412.29 Aligned_cols=263 Identities=49% Similarity=0.882 Sum_probs=238.8
Q ss_pred CcccCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccC
Q 004088 180 SVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG 257 (774)
Q Consensus 180 ~~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~ 257 (774)
.+....+...|.-++.||.|+||.||-|++..+.+.||||.+..+. .......+..|++.|+++.|||+|.+.+||..
T Consensus 18 LF~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr 97 (948)
T KOG0577|consen 18 LFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR 97 (948)
T ss_pred HHccCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec
Confidence 3344556677999999999999999999999999999999997543 33445678999999999999999999999999
Q ss_pred CceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccc
Q 004088 258 EEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL 337 (774)
Q Consensus 258 ~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i 337 (774)
+...||||||| -|+-.+++...++++.+.++..|+.+.+.||.|||+++.||||||..|||+++.|.|||+|||.|...
T Consensus 98 e~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 98 EHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM 176 (948)
T ss_pred cchHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc
Confidence 99999999999 66889999888899999999999999999999999999999999999999999999999999999765
Q ss_pred cccccccccccccccccchhhhh---hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhch
Q 004088 338 TRTMSKRNTFIGTPHWMAPEVIQ---ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWS 414 (774)
Q Consensus 338 ~~~~~~~~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s 414 (774)
. ..++++|||.||||||+. .+.|+.++||||||++..||...+||+..++.+..++.|..+..|.+. ...|+
T Consensus 177 ~----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq-s~eWS 251 (948)
T KOG0577|consen 177 A----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ-SNEWS 251 (948)
T ss_pred C----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC-CchhH
Confidence 3 347789999999999986 467999999999999999999999999999999999998877777665 57899
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 415 LVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 415 ~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
..|++||..||++-|.+|||.+++|.|+|+.+-+
T Consensus 252 ~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 252 DYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred HHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence 9999999999999999999999999999998754
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=390.92 Aligned_cols=260 Identities=31% Similarity=0.553 Sum_probs=219.4
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
..++|++++.||+|+||.||++++..++..||+|++...........+.+|+++|++++||||+++++++..+..+++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 45789999999999999999999999999999999976545555677999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhc-CcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI-FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~-gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+... ..
T Consensus 83 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 159 (331)
T cd06649 83 EHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MA 159 (331)
T ss_pred ecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--cc
Confidence 99999999999863 45689999999999999999999986 6999999999999999999999999999765433 23
Q ss_pred ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc-----------------------
Q 004088 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI----------------------- 401 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~----------------------- 401 (774)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP 239 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccc
Confidence 345799999999999998999999999999999999999999976544322111100
Q ss_pred ----------------------CCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 402 ----------------------EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 402 ----------------------~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
...........++..+.+||.+||++||++|||+.++|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 00000001123567899999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=402.48 Aligned_cols=258 Identities=27% Similarity=0.442 Sum_probs=215.7
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
.|++++.||+|+||+||+|++..+++.||||++.... .......+.+|+.+|++++||||+++++++.+...+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 6899999999999999999999999999999997543 23345678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc-----
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM----- 341 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~----- 341 (774)
||++|+|.+++. ....+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~-~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 82 YIPGGDMMSLLI-RMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred cCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 999999999986 34578999999999999999999999999999999999999999999999999975431100
Q ss_pred ------------------------------------------cccccccccccccchhhhhhcCCCCccchhhhHHHHHH
Q 004088 342 ------------------------------------------SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVE 379 (774)
Q Consensus 342 ------------------------------------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyE 379 (774)
......+||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 00123579999999999998889999999999999999
Q ss_pred HHhCCCCCCCCCchhhhhhhhc-CCCCccccchhchHHHHHHHHhhcc--cCCCCCCCHHHHHhhhhhhhh
Q 004088 380 MAEGLPPRSTVHPMRVLFMISI-EPAPMLEDKEKWSLVFHDFVAKCLT--KEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 380 LLtG~~Pf~~~~~~~~i~~i~~-~~~~~~~~~~~~s~~l~dLI~kcL~--~DP~kRPTa~ElL~HPwf~~~ 447 (774)
|++|.+||...........+.. ......+....++..+.+||.+||. .+|..|+++.++++||||...
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 9999999987765544433322 1122223334578899999999654 455569999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=402.75 Aligned_cols=257 Identities=28% Similarity=0.456 Sum_probs=216.7
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
.|+++++||+|+||.||+|++..+++.||||++.+.. .......+.+|+.+|++++||||++++++|.+...+|||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 6999999999999999999999999999999986432 22345678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc-----
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM----- 341 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~----- 341 (774)
||++|+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|..+....
T Consensus 82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 82 YIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 9999999998863 4578999999999999999999999999999999999999999999999999975331100
Q ss_pred ------------------------------------------cccccccccccccchhhhhhcCCCCccchhhhHHHHHH
Q 004088 342 ------------------------------------------SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVE 379 (774)
Q Consensus 342 ------------------------------------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyE 379 (774)
......+||+.|+|||++.+..|+.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence 00123579999999999999899999999999999999
Q ss_pred HHhCCCCCCCCCchhhhhhhhc-CCCCccccchhchHHHHHHHHhhcccCCCCCCC---HHHHHhhhhhhhh
Q 004088 380 MAEGLPPRSTVHPMRVLFMISI-EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPT---AAEMLKHKFIERC 447 (774)
Q Consensus 380 LLtG~~Pf~~~~~~~~i~~i~~-~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPT---a~ElL~HPwf~~~ 447 (774)
|++|++||...........+.. ......+....++..+.++|.+|+ .+|.+|++ +.++++||||+..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 9999999988776555444332 122222333457889999999987 59999997 9999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=397.78 Aligned_cols=257 Identities=25% Similarity=0.392 Sum_probs=221.2
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCC-cEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCce
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTS-ELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEY 260 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g-~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~ 260 (774)
....++|++++.||+|+||.||+|.+..++ ..||||++.... .....+.+.+|+.+|+.++||||+++++++.....
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 345678999999999999999999876654 689999986432 23345678899999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
+|+|||||.+|+|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 106 ~~lv~Ey~~~g~L~~~i~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLR-RNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 999999999999999986 3457999999999999999999999999999999999999999999999999999765432
Q ss_pred ccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHH
Q 004088 341 MSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 341 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.......+..... ..+..++..+.++
T Consensus 185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~l 258 (340)
T PTZ00426 185 ---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII---YFPKFLDNNCKHL 258 (340)
T ss_pred ---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCHHHHHH
Confidence 2456899999999999988899999999999999999999999998776655544433322 1234567889999
Q ss_pred HHhhcccCCCCCC-----CHHHHHhhhhhhhh
Q 004088 421 VAKCLTKEPRARP-----TAAEMLKHKFIERC 447 (774)
Q Consensus 421 I~kcL~~DP~kRP-----Ta~ElL~HPwf~~~ 447 (774)
|++||+.||.+|+ +++++++||||...
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999995 89999999999754
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=401.96 Aligned_cols=262 Identities=37% Similarity=0.580 Sum_probs=231.6
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh--hhHHHHHHHHHHHHhCC-CCCcccccccccCCc
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE--EGYEEIRGEIEMLQQCS-HPNVVRYLGSYQGEE 259 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~--~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~~~ 259 (774)
.......|++.++||.|.||.||+|+++.+|+.||+|++.+.... ...+.+.+|+.+|+++. |||||.++++|+...
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 344567899999999999999999999999999999999765532 34578999999999998 999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC----CcEEEeeccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ----GEVKLGDFGVAA 335 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~----g~vKL~DFGlA~ 335 (774)
.+++|||+|.||.|.+.+... .++|..+..++.||+.++.|||+.||+||||||+|+|+... +.+|++|||+|.
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 999999999999999998755 39999999999999999999999999999999999999644 479999999998
Q ss_pred cccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCC-Cccccchhch
Q 004088 336 QLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA-PMLEDKEKWS 414 (774)
Q Consensus 336 ~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~-~~~~~~~~~s 414 (774)
.... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||...........+..... ...+....++
T Consensus 188 ~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is 266 (382)
T KOG0032|consen 188 FIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDIS 266 (382)
T ss_pred EccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccC
Confidence 8766 4566778999999999999989999999999999999999999999999887776666544432 2233345668
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 415 LVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 415 ~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
..+++||++||..||.+|+|+.++|+|||+...
T Consensus 267 ~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 267 ESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 899999999999999999999999999999864
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=384.23 Aligned_cols=259 Identities=29% Similarity=0.466 Sum_probs=229.2
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
..+.|++-+.||+|.|+.||++.+..+|+.+|+|+++... .....+.+.+|++|-+.|+|||||+|++.+......|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4568999999999999999999999999999999987443 344678899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC---cEEEeeccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG---EVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g---~vKL~DFGlA~~i~~~~ 341 (774)
+|++.|++|..-+-. +-.++|..+-.+++||+.+|.|+|.+||||||+||+|+|+-+.. .+||+|||+|..+. ..
T Consensus 89 Fe~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g 166 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DG 166 (355)
T ss_pred EecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-Cc
Confidence 999999999755432 25689999999999999999999999999999999999996543 59999999998887 44
Q ss_pred cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCc-cccchhchHHHHHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPM-LEDKEKWSLVFHDF 420 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~-~~~~~~~s~~l~dL 420 (774)
.....++|||+|||||++...+|+..+|||+.|||||-|+.|.+||.+.+..+++..|....... .+....+++++++|
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~L 246 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSL 246 (355)
T ss_pred cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHH
Confidence 55667799999999999999999999999999999999999999999988888887776554333 23556778999999
Q ss_pred HHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 421 VAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
|++||..||.+|+|+.|+|+|||+++
T Consensus 247 vrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 247 IRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred HHHHhccChhhhccHHHHhCCchhcc
Confidence 99999999999999999999999974
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=395.97 Aligned_cols=256 Identities=34% Similarity=0.507 Sum_probs=213.0
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
....+|+++++||+|+||.||+|++..+++.||||++...........+.+|+++|+.++|+||++++++|.....+|+|
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 34568999999999999999999999999999999997555555567789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
||||.+++|.... .+.+..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+.......
T Consensus 151 ~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 225 (353)
T PLN00034 151 LEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225 (353)
T ss_pred EecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence 9999999986532 35677888999999999999999999999999999999999999999999998765443334
Q ss_pred ccccccccccchhhhhh-----cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhh---hhhhhcCCCCccccchhchHH
Q 004088 345 NTFIGTPHWMAPEVIQE-----SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRV---LFMISIEPAPMLEDKEKWSLV 416 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~-----~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~---i~~i~~~~~~~~~~~~~~s~~ 416 (774)
...+||..|+|||++.. ..++.++|||||||++|+|++|+.||........ ...+... ........++..
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 303 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS--QPPEAPATASRE 303 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc--CCCCCCCccCHH
Confidence 45689999999999843 2345689999999999999999999974332211 1111111 112223456788
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 417 FHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 417 l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
+.+||.+||+.||++|||+.|+|+||||...
T Consensus 304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 304 FRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 9999999999999999999999999999865
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=394.39 Aligned_cols=249 Identities=29% Similarity=0.462 Sum_probs=214.9
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCCC
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGG 271 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~gg 271 (774)
+.||+|+||.||+|++..+|+.||||++.... .......+.+|+.+|+.++||||+++++++...+.+||||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997532 2334567889999999999999999999999999999999999999
Q ss_pred chhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccccccc
Q 004088 272 SVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP 351 (774)
Q Consensus 272 sL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT~ 351 (774)
+|..++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||+
T Consensus 81 ~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 159 (328)
T cd05593 81 ELFFHLS-RERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP 159 (328)
T ss_pred CHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence 9988875 345799999999999999999999999999999999999999999999999999875433323334567999
Q ss_pred cccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCC
Q 004088 352 HWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRA 431 (774)
Q Consensus 352 ~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~k 431 (774)
.|+|||++.+..++.++|||||||++|+|++|+.||...........+..... ..+..++..+.+||.+||++||.+
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~---~~p~~~~~~~~~li~~~L~~dP~~ 236 (328)
T cd05593 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI---KFPRTLSADAKSLLSGLLIKDPNK 236 (328)
T ss_pred CccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCc---cCCCCCCHHHHHHHHHHcCCCHHH
Confidence 99999999988999999999999999999999999987766555444332221 223457889999999999999999
Q ss_pred CC-----CHHHHHhhhhhhh
Q 004088 432 RP-----TAAEMLKHKFIER 446 (774)
Q Consensus 432 RP-----Ta~ElL~HPwf~~ 446 (774)
|+ ++.++++||||..
T Consensus 237 R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 237 RLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred cCCCCCCCHHHHhcCCCcCC
Confidence 97 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=401.72 Aligned_cols=258 Identities=25% Similarity=0.458 Sum_probs=215.5
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
++|+++++||+|+||.||+|++..+++.||||++.+.. .......+.+|+++|++++||||++++++|.+...+||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999986432 2334567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc---
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS--- 342 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~--- 342 (774)
|||++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 81 EFLPGGDLMTMLI-KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred eCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 9999999999886 446789999999999999999999999999999999999999999999999999863321000
Q ss_pred --------------------------------------------ccccccccccccchhhhhhcCCCCccchhhhHHHHH
Q 004088 343 --------------------------------------------KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAV 378 (774)
Q Consensus 343 --------------------------------------------~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLy 378 (774)
.....+||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence 001247999999999999989999999999999999
Q ss_pred HHHhCCCCCCCCCchhhhhhhhcC-CCCccccchhchHHHHHHHHhhcccCCCCC---CCHHHHHhhhhhhhh
Q 004088 379 EMAEGLPPRSTVHPMRVLFMISIE-PAPMLEDKEKWSLVFHDFVAKCLTKEPRAR---PTAAEMLKHKFIERC 447 (774)
Q Consensus 379 ELLtG~~Pf~~~~~~~~i~~i~~~-~~~~~~~~~~~s~~l~dLI~kcL~~DP~kR---PTa~ElL~HPwf~~~ 447 (774)
||++|.+||...........+... .....+....++..+.+||.+||. +|.+| +++.++++||||+..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 999999999877665544433221 111122233567889999999998 67665 599999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=388.64 Aligned_cols=258 Identities=26% Similarity=0.422 Sum_probs=208.7
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCC-----ceEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE-----EYLW 262 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~-----~~l~ 262 (774)
+|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|++++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 6999999999999999999999999999999986432 223345688999999999999999999987532 3589
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
+|||||+ ++|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~~-~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 81 VVFELME-SDLHQVIK-ANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEecCC-CCHHHHHH-hcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 9999995 68888875 345699999999999999999999999999999999999999999999999999975432211
Q ss_pred ---ccccccccccccchhhhhh--cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhh-----------------
Q 004088 343 ---KRNTFIGTPHWMAPEVIQE--SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMIS----------------- 400 (774)
Q Consensus 343 ---~~~~~~GT~~Y~APEvl~~--~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~----------------- 400 (774)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||...........+.
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 1234579999999999875 578999999999999999999999997655432221110
Q ss_pred -----------cCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 401 -----------IEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 401 -----------~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
..+.+........+..+.+||.+||+.||++|||+.++|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 000111111123467789999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=399.90 Aligned_cols=254 Identities=30% Similarity=0.507 Sum_probs=216.8
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcCCCcE-EEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCc-
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLKTSEL-VAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE- 259 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~-VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~- 259 (774)
+........+.+.||.|+||+||++.+. |.. ||||++.... .....+.|.+|+.+|.+++|||||+|+|++.+..
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3444556677778999999999999864 555 9999997433 2222678999999999999999999999999887
Q ss_pred eEEEEEEecCCCchhhhhhc-cCCchhHHHHHHHHHHHHHHHHHHHhcC-cccccccccceEecCCC-cEEEeecccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNV-TEEPLEEYQIAYICREALKGLAYLHSIF-KVHRDIKGGNILLTDQG-EVKLGDFGVAAQ 336 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~-~~~~Lse~~i~~I~~QIl~gL~YLHs~g-IIHRDLKPeNILLd~~g-~vKL~DFGlA~~ 336 (774)
.++|||||+++|+|.+++.. .+..++...+..|+.||++||.|||+++ ||||||||+||||+.++ ++||+|||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 79999999999999999986 4788999999999999999999999999 99999999999999998 999999999987
Q ss_pred ccccccccccccccccccchhhhh--hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-CCCccccchhc
Q 004088 337 LTRTMSKRNTFIGTPHWMAPEVIQ--ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-PAPMLEDKEKW 413 (774)
Q Consensus 337 i~~~~~~~~~~~GT~~Y~APEvl~--~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-~~~~~~~~~~~ 413 (774)
............||+.|||||++. ...|+.|+||||||+++|||++|..||...........+... ..+. .+..+
T Consensus 194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~--~p~~~ 271 (362)
T KOG0192|consen 194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP--IPKEC 271 (362)
T ss_pred eccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC--CCccC
Confidence 765433333468999999999999 568999999999999999999999999999886665554322 2222 23347
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 414 SLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 414 s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
++.+..+|.+||..||.+||++.+++.
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 889999999999999999999999974
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=393.01 Aligned_cols=250 Identities=30% Similarity=0.463 Sum_probs=215.1
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCCC
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGG 271 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~gg 271 (774)
+.||+|+||.||++++..+|+.||+|++.... .......+.+|+.+|+.++||||++++++|.....+|||||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997532 2234456788999999999999999999999999999999999999
Q ss_pred chhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccccccc
Q 004088 272 SVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP 351 (774)
Q Consensus 272 sL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT~ 351 (774)
+|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus 81 ~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 159 (323)
T cd05595 81 ELFFHLS-RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred cHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence 9988875 345789999999999999999999999999999999999999999999999999875433323334567999
Q ss_pred cccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCC
Q 004088 352 HWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRA 431 (774)
Q Consensus 352 ~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~k 431 (774)
.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..... ..+..++..+.+||.+||++||.+
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~---~~p~~~~~~~~~li~~~L~~dP~~ 236 (323)
T cd05595 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---RFPRTLSPEAKSLLAGLLKKDPKQ 236 (323)
T ss_pred CcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCHHHHHHHHHHccCCHHH
Confidence 99999999988999999999999999999999999987766655444432222 123467889999999999999999
Q ss_pred CC-----CHHHHHhhhhhhhh
Q 004088 432 RP-----TAAEMLKHKFIERC 447 (774)
Q Consensus 432 RP-----Ta~ElL~HPwf~~~ 447 (774)
|+ ++.++++||||...
T Consensus 237 R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 237 RLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred hCCCCCCCHHHHHcCCCcCCC
Confidence 98 99999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=401.08 Aligned_cols=258 Identities=26% Similarity=0.426 Sum_probs=216.3
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.+|++++||||+++++.|..++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986432 1223456889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc----
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM---- 341 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~---- 341 (774)
|||++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|..+....
T Consensus 81 E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 81 DYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 99999999999863 4578999999999999999999999999999999999999999999999999975331000
Q ss_pred ---------------------------------------cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh
Q 004088 342 ---------------------------------------SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE 382 (774)
Q Consensus 342 ---------------------------------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt 382 (774)
......+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence 00123579999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhcC-CCCccccchhchHHHHHHHHhhcccCCCCCC---CHHHHHhhhhhhhh
Q 004088 383 GLPPRSTVHPMRVLFMISIE-PAPMLEDKEKWSLVFHDFVAKCLTKEPRARP---TAAEMLKHKFIERC 447 (774)
Q Consensus 383 G~~Pf~~~~~~~~i~~i~~~-~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRP---Ta~ElL~HPwf~~~ 447 (774)
|+.||...........+... ..........++..+.+||.+|+ .+|.+|+ ++.++++||||+..
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 99999887765544433221 11122233457888999999977 5999999 99999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=390.38 Aligned_cols=253 Identities=30% Similarity=0.452 Sum_probs=215.8
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHH---HhCCCCCcccccccccCCceEEEE
Q 004088 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEML---QQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 190 Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL---~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
|++++.||+|+||.||+|.+..+++.||||+++... .....+.+.+|++++ +.++||||+++++++.....+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 789999999999999999999999999999997432 223345667776665 466899999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
||||.+++|..++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT 158 (324)
T ss_pred EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence 99999999988874 3579999999999999999999999999999999999999999999999999987544333334
Q ss_pred ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
...+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...... .+..++..+.+||.+|
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~---~p~~~~~~~~~li~~~ 235 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR---YPRFLSREAISIMRRL 235 (324)
T ss_pred cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---CCCCCCHHHHHHHHHH
Confidence 4568999999999999989999999999999999999999999887766555444332221 2345688899999999
Q ss_pred cccCCCCCC-----CHHHHHhhhhhhhh
Q 004088 425 LTKEPRARP-----TAAEMLKHKFIERC 447 (774)
Q Consensus 425 L~~DP~kRP-----Ta~ElL~HPwf~~~ 447 (774)
|+.||.+|| ++.++++||||+..
T Consensus 236 L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 236 LRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred hhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 999999999 79999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=384.46 Aligned_cols=261 Identities=28% Similarity=0.432 Sum_probs=216.9
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
..+|.++++||+|+||.||+|++..+++.||||++...........+.+|+.++++++||||+++++++..++..|+|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 46799999999999999999999999999999999765444444567889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
|+++ +|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 163 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN 163 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccccc
Confidence 9965 787777655667899999999999999999999999999999999999999999999999999765443333334
Q ss_pred ccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC---C-------------------
Q 004088 347 FIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE---P------------------- 403 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~---~------------------- 403 (774)
..+|+.|+|||++.+ ..++.++|||||||++|+|++|++||...........+... +
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07872 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243 (309)
T ss_pred ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhc
Confidence 578999999999865 45889999999999999999999999876544332221100 0
Q ss_pred -----CCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 404 -----APMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 404 -----~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.+.......++..+.+||.+||+.||.+|||+.|+|+||||+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 000011123577889999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=373.10 Aligned_cols=259 Identities=29% Similarity=0.469 Sum_probs=231.9
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCce
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEY 260 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~ 260 (774)
.....++|++++.||+|.||.||+|+.+.++-.||+|++.++. ......++.+|++|-..|+||||+++|++|.+...
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 4456789999999999999999999999999999999997665 22334578999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhc-cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNV-TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~-~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
+||++||...|+|...++. ...++++.....++.|++.||.|+|..+||||||||+|+|+..++.+||+|||.+.. .
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~--~ 174 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVH--A 174 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceee--c
Confidence 9999999999999988863 346799999999999999999999999999999999999999999999999999843 3
Q ss_pred cccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHH
Q 004088 340 TMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHD 419 (774)
Q Consensus 340 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~d 419 (774)
....+.+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||......+.+..|..... ..+..++..+.|
T Consensus 175 p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~---~~p~~is~~a~d 251 (281)
T KOG0580|consen 175 PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL---KFPSTISGGAAD 251 (281)
T ss_pred CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc---cCCcccChhHHH
Confidence 35677889999999999999999999999999999999999999999998887777776654432 234678899999
Q ss_pred HHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 420 FVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 420 LI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
+|.+||.++|.+|.+..|++.|||+..
T Consensus 252 lI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 252 LISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHhccCccccccHHHHhhhHHHHh
Confidence 999999999999999999999999964
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=389.38 Aligned_cols=255 Identities=29% Similarity=0.430 Sum_probs=218.3
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCC-CcccccccccCCceEEEEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHP-NVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HP-NIVkL~~~~~~~~~l~LVm 265 (774)
+|++++.||+|+||.||+|++..+++.||||++.+.. .....+.+..|+.++..+.|+ +|++++++|...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5899999999999999999999999999999997532 233456788899999999765 5888999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
|||++++|..++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 81 E~~~~g~L~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05587 81 EYVNGGDLMYHIQ-QVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR 159 (324)
T ss_pred cCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence 9999999998886 345689999999999999999999999999999999999999999999999999865433333344
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhc
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCL 425 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL 425 (774)
..+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..... ..+..++..+.+||.+||
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~l 236 (324)
T cd05587 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV---SYPKSLSKEAVSICKGLL 236 (324)
T ss_pred eecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHHHHHHh
Confidence 56799999999999998999999999999999999999999988776665555443222 123456888999999999
Q ss_pred ccCCCCCCCH-----HHHHhhhhhhhh
Q 004088 426 TKEPRARPTA-----AEMLKHKFIERC 447 (774)
Q Consensus 426 ~~DP~kRPTa-----~ElL~HPwf~~~ 447 (774)
.+||.+|+++ .++++||||+..
T Consensus 237 ~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 237 TKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred hcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999976 899999999753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=390.17 Aligned_cols=250 Identities=29% Similarity=0.436 Sum_probs=214.8
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEEEEEEecCC
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIVMEYCGG 270 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~LVmEy~~g 270 (774)
+.||+|+||.||+|++..+++.||||++.+.. .....+.+..|+.++..+ +||||+++++++.....+|+|||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999987432 223456677899988876 799999999999999999999999999
Q ss_pred CchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccccc
Q 004088 271 GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350 (774)
Q Consensus 271 gsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT 350 (774)
++|..++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||
T Consensus 81 g~L~~~i~-~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (320)
T cd05590 81 GDLMFHIQ-KSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT 159 (320)
T ss_pred chHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence 99998886 34579999999999999999999999999999999999999999999999999987643333334456799
Q ss_pred ccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCC
Q 004088 351 PHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPR 430 (774)
Q Consensus 351 ~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~ 430 (774)
+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..... ..+..++..+.+||.+||++||.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~L~~dP~ 236 (320)
T cd05590 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV---VYPTWLSQDAVDILKAFMTKNPT 236 (320)
T ss_pred ccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCHHHHHHHHHHcccCHH
Confidence 999999999988999999999999999999999999988776665555443222 12345688899999999999999
Q ss_pred CCCCH------HHHHhhhhhhhh
Q 004088 431 ARPTA------AEMLKHKFIERC 447 (774)
Q Consensus 431 kRPTa------~ElL~HPwf~~~ 447 (774)
+||++ .++++||||...
T Consensus 237 ~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 237 MRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred HCCCCCCCCCHHHHHcCCCcCCC
Confidence 99998 999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=388.27 Aligned_cols=262 Identities=27% Similarity=0.441 Sum_probs=219.7
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeec-CCChhhHHHHHHHHHHHHhCCCCCcccccccccC-----Cc
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISL-SEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG-----EE 259 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~-~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~-----~~ 259 (774)
....|..++.||.|+||.|+.|.+..+|+.||||.+.. .......++..||+++|+.++|+||+.+++++.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 34567778999999999999999999999999999862 2345566788999999999999999999998864 45
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
.+|+|+|+| +.+|..+++ .++.|++..+..+++||++||.|+|+.+|+||||||+|+|++.+..+||||||+|+....
T Consensus 100 DvYiV~elM-etDL~~iik-~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK-SQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred eeEEehhHH-hhHHHHHHH-cCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 799999999 779999986 455699999999999999999999999999999999999999999999999999987754
Q ss_pred c--ccccccccccccccchhhhh-hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-CCC----------
Q 004088 340 T--MSKRNTFIGTPHWMAPEVIQ-ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-PAP---------- 405 (774)
Q Consensus 340 ~--~~~~~~~~GT~~Y~APEvl~-~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-~~~---------- 405 (774)
. ....+.++-|.||+|||++. ...|+..+||||+|||+.||++|++-|.+.+....+..+... +.|
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 2 23345678899999999986 457999999999999999999999999988776655443211 111
Q ss_pred -----------------ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 406 -----------------MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 406 -----------------~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
.....+..++.+.+|+.+||..||.+|+|++|+|.|||+.....
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd 318 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD 318 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence 01112234677889999999999999999999999999987643
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=387.76 Aligned_cols=261 Identities=32% Similarity=0.459 Sum_probs=220.5
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh-hhHHHHHHHHHHHHhCCCCC-cccccccccCCc-----
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE-EGYEEIRGEIEMLQQCSHPN-VVRYLGSYQGEE----- 259 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~-~~~~~~~~Ei~iL~~L~HPN-IVkL~~~~~~~~----- 259 (774)
...|..+++||+|+||+||+|+.+.+|+.||+|+++..... ..-....+|+.+|+.|+|+| ||+|++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45688889999999999999999999999999999876542 23345789999999999999 999999998776
Q ss_pred -eEEEEEEecCCCchhhhhhccC---CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccc
Q 004088 260 -YLWIVMEYCGGGSVADLMNVTE---EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 260 -~l~LVmEy~~ggsL~dll~~~~---~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
.+++|+||+ ..+|..++.... ..++...++.+++||+.||+|||+++|+||||||.||||+.+|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 899999999 558888887555 468889999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhh---cCCC-------
Q 004088 336 QLTRTMSKRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMIS---IEPA------- 404 (774)
Q Consensus 336 ~i~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~---~~~~------- 404 (774)
.+.-+.......++|.+|+|||++.+. .|+..+||||+|||++||+++++.|.+....+.+..|- ..+.
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 777666666677899999999999987 69999999999999999999999999877766654431 1110
Q ss_pred ----------Cccccc-------hhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 405 ----------PMLEDK-------EKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 405 ----------~~~~~~-------~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
+....+ ...+....+++.+||+++|.+|.|+..+|.||||....
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 000001 11124678999999999999999999999999998653
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=391.60 Aligned_cols=259 Identities=28% Similarity=0.435 Sum_probs=220.4
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
++|++.+.||+|+||.||+|++..+|+.||||+++... .......+.+|+.+++.++||||+++++++.....+||||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999997542 2234566889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc-c
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK-R 344 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~-~ 344 (774)
|||++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...... .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 999999999999766678999999999999999999999999999999999999999999999999999766433221 2
Q ss_pred ccccccccccchhhhh------hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCC-CCccccchhchHHH
Q 004088 345 NTFIGTPHWMAPEVIQ------ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEP-APMLEDKEKWSLVF 417 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~------~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~-~~~~~~~~~~s~~l 417 (774)
...+||+.|+|||++. ...++.++|||||||++|+|++|..||........+..+.... ....+....++..+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence 2347999999999987 4567899999999999999999999998776655544432221 11222334578889
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 418 HDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 418 ~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
.+||.+||. +|.+||++.++++||||...
T Consensus 241 ~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 241 LDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred HHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 999999998 99999999999999999754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=391.78 Aligned_cols=249 Identities=30% Similarity=0.470 Sum_probs=214.1
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCCC
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGG 271 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~gg 271 (774)
+.||+|+||.||+|++..+|+.||||++.... .......+.+|+++++.++||||++++++|.....+|||||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997532 2234456788999999999999999999999999999999999999
Q ss_pred chhhhhhccCCchhHHHHHHHHHHHHHHHHHHHh-cCcccccccccceEecCCCcEEEeecccccccccccccccccccc
Q 004088 272 SVADLMNVTEEPLEEYQIAYICREALKGLAYLHS-IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350 (774)
Q Consensus 272 sL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs-~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT 350 (774)
+|..++. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++............+||
T Consensus 81 ~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (325)
T cd05594 81 ELFFHLS-RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT 159 (325)
T ss_pred cHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCC
Confidence 9998875 34579999999999999999999997 799999999999999999999999999987544333333456799
Q ss_pred ccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCC
Q 004088 351 PHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPR 430 (774)
Q Consensus 351 ~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~ 430 (774)
+.|+|||++.+..++.++|||||||++|+|++|..||...........+..... ..+..++..+.+||.+||++||+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~li~~~L~~dP~ 236 (325)
T cd05594 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI---RFPRTLSPEAKSLLSGLLKKDPK 236 (325)
T ss_pred cccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCHHHHHHHHHHhhcCHH
Confidence 999999999988999999999999999999999999987766555444433222 12345688899999999999999
Q ss_pred CCC-----CHHHHHhhhhhhh
Q 004088 431 ARP-----TAAEMLKHKFIER 446 (774)
Q Consensus 431 kRP-----Ta~ElL~HPwf~~ 446 (774)
+|+ ++.++++||||..
T Consensus 237 ~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 237 QRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred HhCCCCCCCHHHHhcCCCcCC
Confidence 997 9999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=396.35 Aligned_cols=260 Identities=25% Similarity=0.426 Sum_probs=220.4
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
....+|++.+.||+|+||.||+|++..+++.||||++.+.. .......+.+|+.+|+.++||||+++++++.....+|
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34678999999999999999999999999999999996432 2233445778999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
+|||||++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 120 lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99999999999998853 4588999999999999999999999999999999999999999999999999976643321
Q ss_pred -ccccccccccccchhhhhhc----CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCC-CCccccchhchHH
Q 004088 343 -KRNTFIGTPHWMAPEVIQES----RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEP-APMLEDKEKWSLV 416 (774)
Q Consensus 343 -~~~~~~GT~~Y~APEvl~~~----~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~-~~~~~~~~~~s~~ 416 (774)
.....+||+.|+|||++... .++.++|||||||++|+|++|++||...........+.... ....+....++..
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQ 277 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHH
Confidence 22356799999999998753 47889999999999999999999999877665555443321 1222333457889
Q ss_pred HHHHHHhhcccCCCC--CCCHHHHHhhhhhhh
Q 004088 417 FHDFVAKCLTKEPRA--RPTAAEMLKHKFIER 446 (774)
Q Consensus 417 l~dLI~kcL~~DP~k--RPTa~ElL~HPwf~~ 446 (774)
+.+||.+||..+|.+ |+++.++++||||+.
T Consensus 278 ~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 278 AKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred HHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 999999999999998 999999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=394.80 Aligned_cols=258 Identities=28% Similarity=0.476 Sum_probs=217.5
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.+|..++||||++++++|...+.+||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46999999999999999999999999999999997432 2334567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc---
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS--- 342 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~--- 342 (774)
|||++|+|.+++. ....+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 81 EFLPGGDMMTLLM-KKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred eCCCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 9999999999986 346799999999999999999999999999999999999999999999999999875432100
Q ss_pred --------------------------------ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCC
Q 004088 343 --------------------------------KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTV 390 (774)
Q Consensus 343 --------------------------------~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~ 390 (774)
.....+||+.|+|||++.+..++.++|||||||++|+|++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence 012357999999999999999999999999999999999999999887
Q ss_pred CchhhhhhhhcCC-CCccccchhchHHHHHHHHhhcccCCCCCC---CHHHHHhhhhhhhh
Q 004088 391 HPMRVLFMISIEP-APMLEDKEKWSLVFHDFVAKCLTKEPRARP---TAAEMLKHKFIERC 447 (774)
Q Consensus 391 ~~~~~i~~i~~~~-~~~~~~~~~~s~~l~dLI~kcL~~DP~kRP---Ta~ElL~HPwf~~~ 447 (774)
........+.... ....+....++..+++||.+|+. ||.+|+ ++.++++||||+..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 7666554443211 11122223467889999999874 999998 58999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=387.06 Aligned_cols=250 Identities=30% Similarity=0.424 Sum_probs=214.6
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEEEEEEecCC
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIVMEYCGG 270 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~LVmEy~~g 270 (774)
+.||+|+||.||+|++..+++.||||++.... .......+..|++++..+ +||||++++++|.....+|+|||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999987532 233445677899999876 799999999999999999999999999
Q ss_pred CchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccccc
Q 004088 271 GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350 (774)
Q Consensus 271 gsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT 350 (774)
++|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||
T Consensus 81 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05591 81 GDLMFQIQ-RSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT 159 (321)
T ss_pred CcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence 99998886 34578999999999999999999999999999999999999999999999999987544333334456799
Q ss_pred ccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCC
Q 004088 351 PHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPR 430 (774)
Q Consensus 351 ~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~ 430 (774)
+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..... ..+..++..+.+||.+||++||.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~ll~~~L~~dp~ 236 (321)
T cd05591 160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV---LYPVWLSKEAVSILKAFMTKNPN 236 (321)
T ss_pred ccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHHHHHHhccCHH
Confidence 999999999988999999999999999999999999998777666555443322 12334678899999999999999
Q ss_pred CCC-------CHHHHHhhhhhhhh
Q 004088 431 ARP-------TAAEMLKHKFIERC 447 (774)
Q Consensus 431 kRP-------Ta~ElL~HPwf~~~ 447 (774)
+|| ++.++++||||...
T Consensus 237 ~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 237 KRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred HcCCCCCCCCCHHHHhcCCccCCC
Confidence 999 99999999999653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=375.69 Aligned_cols=255 Identities=32% Similarity=0.463 Sum_probs=205.9
Q ss_pred CCeeEEeeeeccCceEEEEEEEcC-CCcEEEEEEeecCCCh-hhHHHHHHHHHHHHhC---CCCCccccccccc-----C
Q 004088 188 TKYELLNELGKGSYGAVYKARDLK-TSELVAIKVISLSEGE-EGYEEIRGEIEMLQQC---SHPNVVRYLGSYQ-----G 257 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~-~g~~VAVKvi~~~~~~-~~~~~~~~Ei~iL~~L---~HPNIVkL~~~~~-----~ 257 (774)
.+|++++.||+|+||.||+|++.. +++.||||++...... .....+.+|+.+++.+ .||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 379999999999999999999854 4788999998754322 2234566788777766 6999999999874 3
Q ss_pred CceEEEEEEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccc
Q 004088 258 EEYLWIVMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQ 336 (774)
Q Consensus 258 ~~~l~LVmEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~ 336 (774)
...+++||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 467999999996 5888887543 34589999999999999999999999999999999999999999999999999976
Q ss_pred ccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC---CCC--------
Q 004088 337 LTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE---PAP-------- 405 (774)
Q Consensus 337 i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~---~~~-------- 405 (774)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|++||........+..+... +.+
T Consensus 160 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (290)
T cd07862 160 YSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238 (290)
T ss_pred ccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence 5433 2334557999999999999888999999999999999999999999877654443332110 000
Q ss_pred -------------ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 406 -------------MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 406 -------------~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
.......++..+.+||.+||+.||++|||+.++|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred ccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 000112356778999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=386.59 Aligned_cols=250 Identities=30% Similarity=0.462 Sum_probs=213.5
Q ss_pred EeeeeccCceEEEEEEEc---CCCcEEEEEEeecCC---ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 193 LNELGKGSYGAVYKARDL---KTSELVAIKVISLSE---GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~---~~g~~VAVKvi~~~~---~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
++.||+|+||.||+|++. .+++.||||++.... .......+.+|+.+|+.++||||++++++|..+..+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 478899999987432 22334567889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
|+.+++|.+++. ..+.+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (323)
T cd05584 81 YLSGGELFMHLE-REGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT 159 (323)
T ss_pred CCCCchHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccc
Confidence 999999999886 3457889999999999999999999999999999999999999999999999998754433333445
Q ss_pred ccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcc
Q 004088 347 FIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLT 426 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~ 426 (774)
.+||+.|+|||++.+..++.++|||||||++|+|++|++||...+.......+..... ..+..++..+.+||.+||+
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~ 236 (323)
T cd05584 160 FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL---NLPPYLTPEARDLLKKLLK 236 (323)
T ss_pred cCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHHHHHHcc
Confidence 6799999999999988899999999999999999999999988776655544433221 2234567889999999999
Q ss_pred cCCCCCC-----CHHHHHhhhhhhh
Q 004088 427 KEPRARP-----TAAEMLKHKFIER 446 (774)
Q Consensus 427 ~DP~kRP-----Ta~ElL~HPwf~~ 446 (774)
++|++|| ++.++++||||+.
T Consensus 237 ~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 237 RNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred cCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999 8999999999975
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=375.75 Aligned_cols=252 Identities=27% Similarity=0.381 Sum_probs=210.3
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCCCch
Q 004088 196 LGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSV 273 (774)
Q Consensus 196 LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~ggsL 273 (774)
||+|+||+||+|.+..+++.||||++.... .....+.+..|+.+|+.++||||++++++|.....+|+|||||++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999999999999999986432 222345678899999999999999999999999999999999999999
Q ss_pred hhhhhc---cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccccc
Q 004088 274 ADLMNV---TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350 (774)
Q Consensus 274 ~dll~~---~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT 350 (774)
..++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...........||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 877642 34569999999999999999999999999999999999999999999999999997665443334456799
Q ss_pred ccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhh-hcCCCCccccchhchHHHHHHHHhhcccCC
Q 004088 351 PHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI-SIEPAPMLEDKEKWSLVFHDFVAKCLTKEP 429 (774)
Q Consensus 351 ~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i-~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP 429 (774)
+.|+|||++.+..++.++|||||||++|+|++|+.||...........+ ..........+..++..+.+++.+||+.||
T Consensus 161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 240 (280)
T cd05608 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDP 240 (280)
T ss_pred cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCH
Confidence 9999999999999999999999999999999999999765432111111 001111122234578889999999999999
Q ss_pred CCCC-----CHHHHHhhhhhhhh
Q 004088 430 RARP-----TAAEMLKHKFIERC 447 (774)
Q Consensus 430 ~kRP-----Ta~ElL~HPwf~~~ 447 (774)
++|| +++++++||||+..
T Consensus 241 ~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 241 EKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred HHhcCCCCCCHHHHhcChhhhcC
Confidence 9999 88999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=384.97 Aligned_cols=255 Identities=28% Similarity=0.413 Sum_probs=218.1
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEEEEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~LVm 265 (774)
+|++++.||+|+||.||+|++..+++.||||++.+.. .......+..|..++..+ .||+|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5899999999999999999999999999999997532 223345567788888877 5889999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
||+++|+|..++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 81 E~~~~g~L~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~ 159 (323)
T cd05616 81 EYVNGGDLMYQIQ-QVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK 159 (323)
T ss_pred cCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence 9999999998885 345789999999999999999999999999999999999999999999999999975443333344
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhc
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCL 425 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL 425 (774)
..+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..... ..+..++..+.++|.+||
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~~l 236 (323)
T cd05616 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV---AYPKSMSKEAVAICKGLM 236 (323)
T ss_pred cCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCCcCCHHHHHHHHHHc
Confidence 56899999999999999999999999999999999999999998776665555443322 123456888999999999
Q ss_pred ccCCCCCCC-----HHHHHhhhhhhhh
Q 004088 426 TKEPRARPT-----AAEMLKHKFIERC 447 (774)
Q Consensus 426 ~~DP~kRPT-----a~ElL~HPwf~~~ 447 (774)
+++|.+|++ ..++++||||+..
T Consensus 237 ~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 237 TKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred ccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 999999998 4899999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=394.23 Aligned_cols=259 Identities=26% Similarity=0.448 Sum_probs=218.0
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
..++|++.+.||+|+||.||+|++..+++.||+|++.+.. .......+.+|+.+++.++||||++++++|..+..+|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 4578999999999999999999999999999999986432 22234567899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc-
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS- 342 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~- 342 (774)
|||||++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|..+.....
T Consensus 121 v~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 121 VMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred EEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 9999999999998853 4689999999999999999999999999999999999999999999999999976643322
Q ss_pred ccccccccccccchhhhhhc----CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCC-CCccccchhchHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQES----RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEP-APMLEDKEKWSLVF 417 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~----~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~-~~~~~~~~~~s~~l 417 (774)
...+.+||+.|+|||++... .++.++|||||||++|+|++|++||...........+.... ....+....++..+
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 278 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHA 278 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHH
Confidence 22456799999999999764 37889999999999999999999998877655554443221 12222334568889
Q ss_pred HHHHHhhcccCCCC--CCCHHHHHhhhhhhh
Q 004088 418 HDFVAKCLTKEPRA--RPTAAEMLKHKFIER 446 (774)
Q Consensus 418 ~dLI~kcL~~DP~k--RPTa~ElL~HPwf~~ 446 (774)
+++|.+||..++.+ |+++.++++||||+.
T Consensus 279 ~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 279 KNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred HHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 99999999866654 899999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=386.63 Aligned_cols=251 Identities=29% Similarity=0.465 Sum_probs=209.7
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEEEEEEecCC
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIVMEYCGG 270 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~LVmEy~~g 270 (774)
+.||+|+||.||+|++..+++.||||+++... .......+.+|+.+++.+ +||||++++++|.....+|||||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999997532 233455688999999998 799999999999999999999999999
Q ss_pred CchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccccc
Q 004088 271 GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350 (774)
Q Consensus 271 gsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT 350 (774)
++|..++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||
T Consensus 81 g~L~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (329)
T cd05588 81 GDLMFHMQ-RQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT 159 (329)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence 99988875 34679999999999999999999999999999999999999999999999999987543333334456899
Q ss_pred ccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCch--------hhhhhhhcCCCCccccchhchHHHHHHHH
Q 004088 351 PHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPM--------RVLFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 351 ~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~--------~~i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
+.|+|||++.+..++.++|||||||++|+|++|+.||...... ........... ...+..++..+.++|.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~ 237 (329)
T cd05588 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKASSVLK 237 (329)
T ss_pred ccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--CCCCCCCCHHHHHHHH
Confidence 9999999999989999999999999999999999999632211 11111111111 1223456788999999
Q ss_pred hhcccCCCCCCC------HHHHHhhhhhhhh
Q 004088 423 KCLTKEPRARPT------AAEMLKHKFIERC 447 (774)
Q Consensus 423 kcL~~DP~kRPT------a~ElL~HPwf~~~ 447 (774)
+||+.||.+|++ +.++++||||...
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 999999999987 7999999999653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=384.60 Aligned_cols=258 Identities=33% Similarity=0.587 Sum_probs=217.1
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
..++|++.++||+|+||.||+|.+..++..||+|++...........+.+|+++|++++||||++++++|...+.+|+||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 45789999999999999999999999999999999876544555677899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhc-CcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI-FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~-gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
||+.+++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+... ..
T Consensus 83 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~ 159 (333)
T cd06650 83 EHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MA 159 (333)
T ss_pred ecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--cc
Confidence 99999999999863 45689999999999999999999975 7999999999999999999999999999765432 22
Q ss_pred ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhh-------------------------
Q 004088 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI------------------------- 399 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i------------------------- 399 (774)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||............
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS 239 (333)
T ss_pred ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhh
Confidence 3457999999999999888999999999999999999999999754432221110
Q ss_pred -------------------hcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 400 -------------------SIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 400 -------------------~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
.....+. .....++.++.+||.+||++||.+|||+.++++||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 240 SYGPDSRPPMAIFELLDYIVNEPPPK-LPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred hhcccccccccHHHHHHHHhcCCCcc-CCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0000000 0011346788999999999999999999999999999854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=384.68 Aligned_cols=250 Identities=27% Similarity=0.428 Sum_probs=211.6
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEEEEEEecCC
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIVMEYCGG 270 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~LVmEy~~g 270 (774)
+.||+|+||.||+|++..+|+.||||+++... .......+..|+.++..+ +||||+++++++...+++|+|||||.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999999999999999997532 123345667788888764 899999999999999999999999999
Q ss_pred CchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccccc
Q 004088 271 GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350 (774)
Q Consensus 271 gsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT 350 (774)
++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+||
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence 999988863 4678999999999999999999999999999999999999999999999999987543322334456899
Q ss_pred ccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCC
Q 004088 351 PHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPR 430 (774)
Q Consensus 351 ~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~ 430 (774)
+.|+|||++.+..++.++|||||||++|+|++|..||...........+.... + ..+..++..+.+||.+||+.||.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~dP~ 236 (316)
T cd05620 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT-P--HYPRWITKESKDILEKLFERDPT 236 (316)
T ss_pred cCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-C--CCCCCCCHHHHHHHHHHccCCHH
Confidence 99999999999899999999999999999999999998776655554443322 1 12335678899999999999999
Q ss_pred CCCCH-HHHHhhhhhhhh
Q 004088 431 ARPTA-AEMLKHKFIERC 447 (774)
Q Consensus 431 kRPTa-~ElL~HPwf~~~ 447 (774)
+||++ .++++||||+..
T Consensus 237 ~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 237 RRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred HcCCChHHHHcCCCcCCC
Confidence 99998 588899999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=383.98 Aligned_cols=249 Identities=29% Similarity=0.446 Sum_probs=211.1
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHh-CCCCCcccccccccCCceEEEEEEecCC
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQ-CSHPNVVRYLGSYQGEEYLWIVMEYCGG 270 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~-L~HPNIVkL~~~~~~~~~l~LVmEy~~g 270 (774)
+.||+|+||.||+|++..+++.||||+++... .....+.+..|..++.. ++||||+++++++.....+|+|||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997532 22334456667777765 4899999999999999999999999999
Q ss_pred CchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccccc
Q 004088 271 GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350 (774)
Q Consensus 271 gsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT 350 (774)
++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt 159 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT 159 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence 999988863 4579999999999999999999999999999999999999999999999999997654333344556899
Q ss_pred ccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCC
Q 004088 351 PHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPR 430 (774)
Q Consensus 351 ~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~ 430 (774)
+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..... ..+..++..+.+||.+||..||.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~ll~~~l~~~P~ 236 (316)
T cd05592 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP---HFPRWISKEAKDCLSKLFERDPT 236 (316)
T ss_pred ccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHHHHHHccCCHH
Confidence 999999999998899999999999999999999999988776655544433221 12345678899999999999999
Q ss_pred CCCCH-HHHHhhhhhhh
Q 004088 431 ARPTA-AEMLKHKFIER 446 (774)
Q Consensus 431 kRPTa-~ElL~HPwf~~ 446 (774)
+||++ .++++||||..
T Consensus 237 ~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 237 KRLGVDGDIRQHPFFRG 253 (316)
T ss_pred HcCCChHHHHcCcccCC
Confidence 99986 58889999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=388.03 Aligned_cols=254 Identities=29% Similarity=0.477 Sum_probs=228.2
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
...+|++.+.||+|.||.|-+|.....|+.||||.|++.. +.+..-.+++||+||..|+||||+.+|++|++.+.+.|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 3568999999999999999999999999999999998654 44556678999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
||||..+|.|.+++. ..+.|+|.+++.+++||..|+.|||.++++|||||.+|||++.++++||+|||++..+... ..
T Consensus 131 vMEYaS~GeLYDYiS-er~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~-kf 208 (668)
T KOG0611|consen 131 VMEYASGGELYDYIS-ERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK-KF 208 (668)
T ss_pred EEEecCCccHHHHHH-HhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc-cH
Confidence 999999999999996 5678999999999999999999999999999999999999999999999999999766543 56
Q ss_pred cccccccccccchhhhhhcCCC-CccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESRYD-GKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s-~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
..++||+|-|.+||++.+.+|. +.+|.|||||+||-|+.|..||.+.+...++..|........+ -+..+.-||+
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~----~PSdA~gLIR 284 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE----TPSDASGLIR 284 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC----CCchHHHHHH
Confidence 6789999999999999998875 6899999999999999999999999988888777655433222 2345778999
Q ss_pred hhcccCCCCCCCHHHHHhhhhhh
Q 004088 423 KCLTKEPRARPTAAEMLKHKFIE 445 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~HPwf~ 445 (774)
+||..||++|.|+.+|-.|-|+.
T Consensus 285 wmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 285 WMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHhcCcccchhHHHHhhhheee
Confidence 99999999999999999999985
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=384.11 Aligned_cols=255 Identities=29% Similarity=0.461 Sum_probs=210.8
Q ss_pred CeeEEeeeeccCceEEEEEEEc---CCCcEEEEEEeecCC---ChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceE
Q 004088 189 KYELLNELGKGSYGAVYKARDL---KTSELVAIKVISLSE---GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~---~~g~~VAVKvi~~~~---~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l 261 (774)
+|++++.||+|+||.||++++. .+++.||+|++.+.. .....+.+.+|+.+|+.+ .||||+++++++.....+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 478999999986432 223345678899999999 599999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|+|||||.+++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 ~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLY-QRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 99999999999999885 34578999999999999999999999999999999999999999999999999997654322
Q ss_pred -cccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchh---hh-hhhhcCCCCccccchhchH
Q 004088 342 -SKRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMR---VL-FMISIEPAPMLEDKEKWSL 415 (774)
Q Consensus 342 -~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~---~i-~~i~~~~~~~~~~~~~~s~ 415 (774)
......+||+.|+|||++.+. .++.++|||||||++|+|++|..||....... .+ ..+... .+ ..+..++.
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~ 236 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC-DP--PFPSFIGP 236 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC-CC--CCCCCCCH
Confidence 222346799999999999865 47889999999999999999999996432211 11 111111 11 12345678
Q ss_pred HHHHHHHhhcccCCCCCC-----CHHHHHhhhhhhhh
Q 004088 416 VFHDFVAKCLTKEPRARP-----TAAEMLKHKFIERC 447 (774)
Q Consensus 416 ~l~dLI~kcL~~DP~kRP-----Ta~ElL~HPwf~~~ 447 (774)
.+.+||.+||+.||++|| +++++++||||+..
T Consensus 237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 899999999999999999 88999999999753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=395.18 Aligned_cols=254 Identities=24% Similarity=0.384 Sum_probs=207.3
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
...+|+++++||+|+||.||+|.+..+++.||||+... ..+.+|+++|++|+|||||+++++|......|+||
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 45689999999999999999999999999999997531 34678999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc-cccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT-MSKR 344 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~-~~~~ 344 (774)
|++. ++|..++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+..... ....
T Consensus 163 e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~ 240 (391)
T PHA03212 163 PRYK-TDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240 (391)
T ss_pred ecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccc
Confidence 9995 678877753 456899999999999999999999999999999999999999999999999999654322 1223
Q ss_pred ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCch-------hhhhhh---hcC------------
Q 004088 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPM-------RVLFMI---SIE------------ 402 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~-------~~i~~i---~~~------------ 402 (774)
...+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..+..+ ...
T Consensus 241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~ 320 (391)
T PHA03212 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN 320 (391)
T ss_pred ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence 3467999999999999889999999999999999999999877543210 000000 000
Q ss_pred -----------------CCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 403 -----------------PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 403 -----------------~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
..+.+......+..+.+||.+||++||.+|||+.|+|+||||+...
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 0000011112356789999999999999999999999999998754
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=365.84 Aligned_cols=254 Identities=43% Similarity=0.696 Sum_probs=212.5
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhH-HHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEec
Q 004088 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY-EEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYC 268 (774)
Q Consensus 190 Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~-~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~ 268 (774)
|++++.||+|+||+||++++..+++.||+|++......... ....+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999865433222 23456999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccc
Q 004088 269 GGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFI 348 (774)
Q Consensus 269 ~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~ 348 (774)
.+++|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||.+..+...........
T Consensus 81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 159 (260)
T PF00069_consen 81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV 159 (260)
T ss_dssp TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred cccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999987 557789999999999999999999999999999999999999999999999999975433333444567
Q ss_pred ccccccchhhhh-hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCcccc----chhchHHHHHHHHh
Q 004088 349 GTPHWMAPEVIQ-ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLED----KEKWSLVFHDFVAK 423 (774)
Q Consensus 349 GT~~Y~APEvl~-~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~----~~~~s~~l~dLI~k 423 (774)
+++.|+|||++. +..++.++||||||+++|+|++|..||...........+.......... .......+.++|.+
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 239 (260)
T PF00069_consen 160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKK 239 (260)
T ss_dssp SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHH
Confidence 899999999998 7889999999999999999999999998773222222111110000111 11113789999999
Q ss_pred hcccCCCCCCCHHHHHhhhhh
Q 004088 424 CLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 424 cL~~DP~kRPTa~ElL~HPwf 444 (774)
||+.||++||++.++++||||
T Consensus 240 ~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 240 MLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HSSSSGGGSTTHHHHHTSGGG
T ss_pred HccCChhHCcCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=384.58 Aligned_cols=250 Identities=31% Similarity=0.484 Sum_probs=210.9
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHH-HHHhCCCCCcccccccccCCceEEEEEEecCC
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIE-MLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGG 270 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~-iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~g 270 (774)
+.||+|+||+||+|++..+|+.||||++.... .......+..|.. +++.++||||+++++++...+.+|+|||||.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999997432 1222334555554 56789999999999999999999999999999
Q ss_pred CchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccccc
Q 004088 271 GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350 (774)
Q Consensus 271 gsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT 350 (774)
++|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||
T Consensus 81 g~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (323)
T cd05575 81 GELFFHLQ-RERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT 159 (323)
T ss_pred CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence 99998886 34678999999999999999999999999999999999999999999999999987543333334456799
Q ss_pred ccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCC
Q 004088 351 PHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPR 430 (774)
Q Consensus 351 ~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~ 430 (774)
+.|+|||++.+..++.++|||||||++|+|++|.+||...+.......+...... ....++..+.++|.+||+.||.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~li~~~l~~~p~ 236 (323)
T cd05575 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR---LKPNISVSARHLLEGLLQKDRT 236 (323)
T ss_pred hhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCHHHHHHHHHHhhcCHH
Confidence 9999999999989999999999999999999999999887665555444333222 2345688899999999999999
Q ss_pred CCCCH----HHHHhhhhhhhh
Q 004088 431 ARPTA----AEMLKHKFIERC 447 (774)
Q Consensus 431 kRPTa----~ElL~HPwf~~~ 447 (774)
+||++ .++++||||...
T Consensus 237 ~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 237 KRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred hCCCCCCCHHHHHcCCCcCCC
Confidence 99987 699999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=383.58 Aligned_cols=260 Identities=26% Similarity=0.417 Sum_probs=216.0
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
++|++++.||+|+||.||++++..+++.||||++.+.. .......+.+|+.+++.++||||++++++|..+.++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999996422 2233456889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc-c
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK-R 344 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~-~ 344 (774)
||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...... .
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 999999999999765678999999999999999999999999999999999999999999999999998765433222 2
Q ss_pred ccccccccccchhhhhh-----cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCC--CCccccchhchHHH
Q 004088 345 NTFIGTPHWMAPEVIQE-----SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEP--APMLEDKEKWSLVF 417 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~-----~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~--~~~~~~~~~~s~~l 417 (774)
...+||+.|+|||++.. ..++.++|||||||++|+|++|+.||...........+.... .........++..+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA 240 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence 23469999999999973 457889999999999999999999998766554443332211 11112233478899
Q ss_pred HHHHHhhcccCCCC--CCCHHHHHhhhhhhhh
Q 004088 418 HDFVAKCLTKEPRA--RPTAAEMLKHKFIERC 447 (774)
Q Consensus 418 ~dLI~kcL~~DP~k--RPTa~ElL~HPwf~~~ 447 (774)
++||.+||..++.+ |+++.++++||||...
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 241 KDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred HHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 99999998764444 7899999999999753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=372.18 Aligned_cols=261 Identities=47% Similarity=0.869 Sum_probs=227.4
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
+.++|++++.||.|+||.||++.+..+++.||+|++... .....+.+.+|+.++++++||||+++++++.....+|+||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 456899999999999999999999889999999998653 3445567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
||+++++|..++......+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...........
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD 161 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence 99999999999876667899999999999999999999999999999999999999999999999999876544433344
Q ss_pred cccccccccchhhhh-----hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHH
Q 004088 346 TFIGTPHWMAPEVIQ-----ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~-----~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
...|++.|+|||++. ...++.++|||||||++|+|++|++||...........+.....+....+..++..+.+|
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDF 241 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHH
Confidence 557999999999985 334778999999999999999999999887766655555444444444556788899999
Q ss_pred HHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 421 VAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
|.+||+.+|.+||++.++|+||||...
T Consensus 242 i~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 242 LKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHhccChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=382.82 Aligned_cols=250 Identities=29% Similarity=0.434 Sum_probs=214.1
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEEEEEEecCC
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIVMEYCGG 270 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~LVmEy~~g 270 (774)
+.||+|+||+||+|++..+++.||||++.+.. .......+.+|+.++..+ +||||+++++++...+.+|+|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999997542 223455677899999888 699999999999999999999999999
Q ss_pred CchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccccc
Q 004088 271 GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350 (774)
Q Consensus 271 gsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT 350 (774)
++|..++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||
T Consensus 81 ~~L~~~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~ 159 (318)
T cd05570 81 GDLMFHIQ-RSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT 159 (318)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence 99998886 34579999999999999999999999999999999999999999999999999986543333333456799
Q ss_pred ccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCC
Q 004088 351 PHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPR 430 (774)
Q Consensus 351 ~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~ 430 (774)
+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..... ..+..++..+.+||.+||+.||.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~l~~dP~ 236 (318)
T cd05570 160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV---RYPRWLSKEAKSILKSFLTKNPE 236 (318)
T ss_pred ccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC---CCCCcCCHHHHHHHHHHccCCHH
Confidence 999999999999999999999999999999999999987766555444332221 12345678899999999999999
Q ss_pred CCCCH-----HHHHhhhhhhhh
Q 004088 431 ARPTA-----AEMLKHKFIERC 447 (774)
Q Consensus 431 kRPTa-----~ElL~HPwf~~~ 447 (774)
+||++ .++++||||+..
T Consensus 237 ~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 237 KRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred HcCCCCCCCHHHHhcCCCcCCC
Confidence 99999 999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=382.27 Aligned_cols=250 Identities=29% Similarity=0.443 Sum_probs=212.4
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHh-CCCCCcccccccccCCceEEEEEEecCC
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQ-CSHPNVVRYLGSYQGEEYLWIVMEYCGG 270 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~-L~HPNIVkL~~~~~~~~~l~LVmEy~~g 270 (774)
+.||+|+||.||+|++..+++.||||+++... .......+..|..++.. ++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999997532 12334556778888876 4999999999999999999999999999
Q ss_pred CchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccccc
Q 004088 271 GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350 (774)
Q Consensus 271 gsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT 350 (774)
|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT 159 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence 999998863 4578999999999999999999999999999999999999999999999999987543332333456799
Q ss_pred ccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCC
Q 004088 351 PHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPR 430 (774)
Q Consensus 351 ~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~ 430 (774)
+.|+|||++.+..++.++|||||||++|+|++|..||...........+..... . .+..++..+.+||.+||+.||.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-~--~~~~~~~~~~~li~~~l~~~P~ 236 (316)
T cd05619 160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNP-C--YPRWLTREAKDILVKLFVREPE 236 (316)
T ss_pred ccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-C--CCccCCHHHHHHHHHHhccCHh
Confidence 999999999988999999999999999999999999988776655544433221 1 2235678899999999999999
Q ss_pred CCCCHH-HHHhhhhhhhh
Q 004088 431 ARPTAA-EMLKHKFIERC 447 (774)
Q Consensus 431 kRPTa~-ElL~HPwf~~~ 447 (774)
+||++. ++++||||+..
T Consensus 237 ~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 237 RRLGVKGDIRQHPFFREI 254 (316)
T ss_pred hcCCChHHHHcCcccCCC
Confidence 999996 89999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=362.92 Aligned_cols=255 Identities=57% Similarity=1.006 Sum_probs=224.7
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
.++|++.+.||.|+||.||+|.+..+++.||+|.+.... ..+.+.+|++++++++||||+++++++.....+|+|+|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 468999999999999999999998889999999986432 26789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
|+.+++|.+++......+++..+..++.|++.||.|||..+|+||||+|+||+++.++.+||+|||++..+.........
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence 99999999999766778999999999999999999999999999999999999999999999999999876554333344
Q ss_pred ccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcc
Q 004088 347 FIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLT 426 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~ 426 (774)
..|+..|+|||++.+..++.++|||||||++|+|++|++||...........+.....+.......++..+.+||.+||+
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLV 238 (256)
T ss_pred ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHh
Confidence 56899999999999889999999999999999999999999877665555444333333344455677889999999999
Q ss_pred cCCCCCCCHHHHHhhhhh
Q 004088 427 KEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 427 ~DP~kRPTa~ElL~HPwf 444 (774)
.+|.+|||+.++|+||||
T Consensus 239 ~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 239 KDPEERPSAIQLLQHPFI 256 (256)
T ss_pred cChhhCcCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=384.29 Aligned_cols=251 Identities=31% Similarity=0.490 Sum_probs=208.7
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEEEEEEecCC
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIVMEYCGG 270 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~LVmEy~~g 270 (774)
+.||+|+||.||+|++..+++.||+|++.+.. .......+.+|+.++.++ +||||+++++++.....+|+|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999997542 233455678899998876 899999999999999999999999999
Q ss_pred CchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccccc
Q 004088 271 GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350 (774)
Q Consensus 271 gsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT 350 (774)
++|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||
T Consensus 81 ~~L~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (329)
T cd05618 81 GDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT 159 (329)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence 99988875 34679999999999999999999999999999999999999999999999999997543333334456899
Q ss_pred ccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCch--------hhhhhhhcCCCCccccchhchHHHHHHHH
Q 004088 351 PHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPM--------RVLFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 351 ~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~--------~~i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
+.|+|||++.+..++.++|||||||++|+|++|+.||...... ........... ...+..++..+.+||.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKAASVLK 237 (329)
T ss_pred ccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--CCCCCCCCHHHHHHHH
Confidence 9999999999999999999999999999999999999532111 11111111111 1223456788999999
Q ss_pred hhcccCCCCCCC------HHHHHhhhhhhhh
Q 004088 423 KCLTKEPRARPT------AAEMLKHKFIERC 447 (774)
Q Consensus 423 kcL~~DP~kRPT------a~ElL~HPwf~~~ 447 (774)
+||+.||.+||+ +.++++||||+..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 999999999998 5899999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=397.73 Aligned_cols=256 Identities=29% Similarity=0.431 Sum_probs=206.3
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccC--------
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG-------- 257 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~-------- 257 (774)
...+|++++.||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.++|||||+++++|..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 4568999999999999999999999999999999885332 224579999999999999999887632
Q ss_pred CceEEEEEEecCCCchhhhhh---ccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC-cEEEeeccc
Q 004088 258 EEYLWIVMEYCGGGSVADLMN---VTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG-EVKLGDFGV 333 (774)
Q Consensus 258 ~~~l~LVmEy~~ggsL~dll~---~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g-~vKL~DFGl 333 (774)
...+++|||||++ +|.+++. .....+++..++.++.||+.||.|||++|||||||||+||||+.++ .+||+|||+
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 2357899999975 6666554 2346799999999999999999999999999999999999999765 699999999
Q ss_pred cccccccccccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-CCC------
Q 004088 334 AAQLTRTMSKRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-PAP------ 405 (774)
Q Consensus 334 A~~i~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-~~~------ 405 (774)
|+.+... ......+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+......+..+... ..+
T Consensus 218 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 218 AKNLLAG-QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred chhccCC-CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 9866433 223346789999999998764 6899999999999999999999999876654433322110 000
Q ss_pred ------------cc-------ccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 406 ------------ML-------EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 406 ------------~~-------~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.. ..+...+.++.+||.+||++||.+|||+.|+|+||||..+.
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 00 01123467899999999999999999999999999998764
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=373.97 Aligned_cols=262 Identities=27% Similarity=0.413 Sum_probs=216.7
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
..++|+++++||.|+||.||+|.+..+++.||+|.+...........+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 35689999999999999999999999999999999976544444456789999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
||+. ++|..++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (301)
T cd07873 84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS 162 (301)
T ss_pred eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccc
Confidence 9996 588888766666789999999999999999999999999999999999999999999999999976543333333
Q ss_pred cccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc---CC------------------
Q 004088 346 TFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI---EP------------------ 403 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~---~~------------------ 403 (774)
...+++.|+|||++.+. .++.++|||||||++|+|++|++||...+.......+.. .+
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (301)
T cd07873 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN 242 (301)
T ss_pred ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccc
Confidence 44679999999998754 478899999999999999999999987654433221100 00
Q ss_pred CCc------cccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 404 APM------LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 404 ~~~------~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.+. ......++..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 000 001124577889999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=361.56 Aligned_cols=256 Identities=63% Similarity=1.118 Sum_probs=223.3
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
.++|++.+.||.|+||.||+|.+..+++.||+|++..... .....+.+|+.++++++||||+++++++.....+|+|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 5689999999999999999999988999999999975443 356788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
|+++++|.+++......+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++..+.........
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence 99999999998766578999999999999999999999999999999999999999999999999999776554333445
Q ss_pred ccccccccchhhhhhc---CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC--CCCccccchhchHHHHHHH
Q 004088 347 FIGTPHWMAPEVIQES---RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE--PAPMLEDKEKWSLVFHDFV 421 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~~---~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~--~~~~~~~~~~~s~~l~dLI 421 (774)
..++..|+|||++... .++.++|||||||++|+|++|++||...........+... ..+.......++..+.+||
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFI 240 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHH
Confidence 6789999999999776 7899999999999999999999999887665555443333 2222333456778899999
Q ss_pred HhhcccCCCCCCCHHHHHhhhh
Q 004088 422 AKCLTKEPRARPTAAEMLKHKF 443 (774)
Q Consensus 422 ~kcL~~DP~kRPTa~ElL~HPw 443 (774)
.+||..+|.+|||+.+++.|+|
T Consensus 241 ~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 241 KKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHcCCChhhCCCHHHHhcCCC
Confidence 9999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=372.44 Aligned_cols=262 Identities=45% Similarity=0.860 Sum_probs=224.8
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
+.+.|+++++||.|+||.||+|++..+++.||+|++... .......+.+|+.+++.++||||+++++++..+..+|+||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 457899999999999999999999999999999998653 3445677889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
||+++++|..++......+++..+..++.||+.+|.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 168 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD 168 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence 99999999888765567799999999999999999999999999999999999999999999999999876544333334
Q ss_pred cccccccccchhhhh-----hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHH
Q 004088 346 TFIGTPHWMAPEVIQ-----ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~-----~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
...+++.|+|||++. ...++.++|||||||++|+|++|.+||...+.......+.....+....+..++..+.+|
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDF 248 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHH
Confidence 557899999999985 345788999999999999999999999877665544444333333334455678889999
Q ss_pred HHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 421 VAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
|.+||..+|.+||++.++++||||....
T Consensus 249 i~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 249 LKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred HHHHhcCCcccCcCHHHHhcCccccccc
Confidence 9999999999999999999999997654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=373.46 Aligned_cols=268 Identities=31% Similarity=0.482 Sum_probs=232.1
Q ss_pred CCCcccCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-------hhhHHHHHHHHHHHHhC-CCCCcc
Q 004088 178 PESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-------EEGYEEIRGEIEMLQQC-SHPNVV 249 (774)
Q Consensus 178 ~~~~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-------~~~~~~~~~Ei~iL~~L-~HPNIV 249 (774)
|...........|.--+.||.|..++|..|.++.+|..+|+|++..... ....+..++|+.||+++ .||||+
T Consensus 7 pd~~aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II 86 (411)
T KOG0599|consen 7 PDKDAAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYII 86 (411)
T ss_pred cchhhHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEE
Confidence 3333444556788889999999999999999999999999999964321 22345677899999998 699999
Q ss_pred cccccccCCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEe
Q 004088 250 RYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLG 329 (774)
Q Consensus 250 kL~~~~~~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~ 329 (774)
++.++|+.+..+++|+|.|+.|.|++++. ..-.++|...+.|++||+.|++|||.++||||||||+|||++++.++||+
T Consensus 87 ~l~D~yes~sF~FlVFdl~prGELFDyLt-s~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~is 165 (411)
T KOG0599|consen 87 DLQDVYESDAFVFLVFDLMPRGELFDYLT-SKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKIS 165 (411)
T ss_pred EeeeeccCcchhhhhhhhcccchHHHHhh-hheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEe
Confidence 99999999999999999999999999996 55689999999999999999999999999999999999999999999999
Q ss_pred eccccccccccccccccccccccccchhhhhh------cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCC
Q 004088 330 DFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQE------SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEP 403 (774)
Q Consensus 330 DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~------~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~ 403 (774)
|||+|+.+... ......||||+|+|||.+.. ..|+..+|+|++|||||-|+.|.+||....++-++.+|....
T Consensus 166 DFGFa~~l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk 244 (411)
T KOG0599|consen 166 DFGFACQLEPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK 244 (411)
T ss_pred ccceeeccCCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc
Confidence 99999988655 55667899999999999864 358889999999999999999999999888887777765544
Q ss_pred CCc-cccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 404 APM-LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 404 ~~~-~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
..+ .+....++...+|||.+||+.||.+|.|+.|+|.||||...
T Consensus 245 yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 245 YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 332 23455668889999999999999999999999999999654
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=369.13 Aligned_cols=254 Identities=31% Similarity=0.434 Sum_probs=204.8
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh-hhHHHHHHHHHHHHhC---CCCCcccccccccC-----Cc
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE-EGYEEIRGEIEMLQQC---SHPNVVRYLGSYQG-----EE 259 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~-~~~~~~~~Ei~iL~~L---~HPNIVkL~~~~~~-----~~ 259 (774)
+|++++.||+|+||+||+|++..+++.||||++...... .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 599999999999999999999999999999998754322 2223456777777665 79999999998753 35
Q ss_pred eEEEEEEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
.+++||||+.+ +|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 68999999974 788777543 3458999999999999999999999999999999999999999999999999997654
Q ss_pred ccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC---C------------
Q 004088 339 RTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE---P------------ 403 (774)
Q Consensus 339 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~---~------------ 403 (774)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|++||...........+... +
T Consensus 160 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07863 160 CQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238 (288)
T ss_pred Cc-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence 33 2223457899999999999888999999999999999999999999766544332221100 0
Q ss_pred ---------CCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 404 ---------APMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 404 ---------~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
.+.......++..+.+||.+||++||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00001112456778999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=372.14 Aligned_cols=266 Identities=44% Similarity=0.761 Sum_probs=227.7
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
.....+|++++.||+|+||.||+|.+..+++.||||.+..... ...+.+.+|+.+++.++||||++++++|......|+
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 4456799999999999999999999999999999999875433 334668899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
||||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.........
T Consensus 94 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 94 VMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred eecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 9999999999998853 46889999999999999999999999999999999999999999999999999765444333
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHh
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAK 423 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~k 423 (774)
.....|++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+.....+....+..++..+.+||.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNR 251 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHH
Confidence 34457899999999999888999999999999999999999999876654444333333333333455677889999999
Q ss_pred hcccCCCCCCCHHHHHhhhhhhhhccCcc
Q 004088 424 CLTKEPRARPTAAEMLKHKFIERCKCGAT 452 (774)
Q Consensus 424 cL~~DP~kRPTa~ElL~HPwf~~~~~~~~ 452 (774)
||..+|.+||++.++++||||+.++....
T Consensus 252 ~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 280 (297)
T cd06656 252 CLEMDVDRRGSAKELLQHPFLKLAKPLSS 280 (297)
T ss_pred HccCChhhCcCHHHHhcCchhcccccccc
Confidence 99999999999999999999998764443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=382.84 Aligned_cols=257 Identities=24% Similarity=0.374 Sum_probs=208.1
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCC------
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE------ 258 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~------ 258 (774)
...+|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||++++++|...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999999999999999986432 234456788999999999999999999988643
Q ss_pred ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 259 EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
..+|+||||+++ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 357999999965 5555553 357889999999999999999999999999999999999999999999999997653
Q ss_pred ccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC----------------
Q 004088 339 RTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE---------------- 402 (774)
Q Consensus 339 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~---------------- 402 (774)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...
T Consensus 175 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 175 TN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred cC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 32 2233457899999999999989999999999999999999999999876543322111000
Q ss_pred -----CCCcc------------------ccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 403 -----PAPML------------------EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 403 -----~~~~~------------------~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
..+.. ......+..+.+||.+||+.||++|||+.|+|+||||...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 321 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence 00000 0011124678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=379.93 Aligned_cols=255 Identities=29% Similarity=0.427 Sum_probs=217.1
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCC-CCCcccccccccCCceEEEEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~~~~l~LVm 265 (774)
+|++.+.||+|+||.||+|++..+|+.||||++.+.. .....+.+..|+.++..+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4789999999999999999999999999999997532 2234456788999998886 577888999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
|||++++|..++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 81 Ey~~~g~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~ 159 (323)
T cd05615 81 EYVNGGDLMYHIQ-QVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR 159 (323)
T ss_pred cCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence 9999999999885 345799999999999999999999999999999999999999999999999999875433323334
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhc
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCL 425 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL 425 (774)
..+||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+..... ..+..++..+.+++.+||
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~li~~~l 236 (323)
T cd05615 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV---SYPKSLSKEAVSICKGLM 236 (323)
T ss_pred CccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCccCCHHHHHHHHHHc
Confidence 56799999999999988899999999999999999999999988776655554433222 123456788999999999
Q ss_pred ccCCCCCCC-----HHHHHhhhhhhhh
Q 004088 426 TKEPRARPT-----AAEMLKHKFIERC 447 (774)
Q Consensus 426 ~~DP~kRPT-----a~ElL~HPwf~~~ 447 (774)
+++|.+|++ ..++++||||+..
T Consensus 237 ~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 237 TKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred ccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 999999997 5899999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=383.40 Aligned_cols=251 Identities=27% Similarity=0.431 Sum_probs=214.1
Q ss_pred EeeeeccCceEEEEEEEc---CCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEec
Q 004088 193 LNELGKGSYGAVYKARDL---KTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYC 268 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~---~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~ 268 (774)
++.||+|+||.||++++. .+|+.||||++.... .......+.+|+++|++++||||+++++++.....+|+|||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 367999999999999863 578999999997533 1223345778999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccc
Q 004088 269 GGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFI 348 (774)
Q Consensus 269 ~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~ 348 (774)
++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+
T Consensus 81 ~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 159 (318)
T cd05582 81 RGGDLFTRLS-KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC 159 (318)
T ss_pred CCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceeccc
Confidence 9999999885 345799999999999999999999999999999999999999999999999999976544433344568
Q ss_pred ccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccC
Q 004088 349 GTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKE 428 (774)
Q Consensus 349 GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~D 428 (774)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..... ..+..++..+.+||.+||+.|
T Consensus 160 g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~li~~~l~~~ 236 (318)
T cd05582 160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL---GMPQFLSPEAQSLLRALFKRN 236 (318)
T ss_pred CChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHHHHHHhhcC
Confidence 99999999999988899999999999999999999999988776655554433222 223456788999999999999
Q ss_pred CCCCCC-----HHHHHhhhhhhhh
Q 004088 429 PRARPT-----AAEMLKHKFIERC 447 (774)
Q Consensus 429 P~kRPT-----a~ElL~HPwf~~~ 447 (774)
|.+||+ +.++++||||...
T Consensus 237 P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 237 PANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HhHcCCCCCCCHHHHhCCCCcCCC
Confidence 999999 7889999999753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=371.68 Aligned_cols=257 Identities=27% Similarity=0.368 Sum_probs=214.6
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
.|++.+.||+|+||+||++.+..+++.||||++.... .......+.+|+.+|+.++||||+++++++...+.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4899999999999999999999999999999986432 12223457789999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 267 YCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 267 y~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
||++++|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..+... ....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~ 159 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-ETIR 159 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-Cccc
Confidence 99999999887543 356999999999999999999999999999999999999999999999999999765432 2223
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-CCCccccchhchHHHHHHHHhh
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-PAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-~~~~~~~~~~~s~~l~dLI~kc 424 (774)
..+|++.|+|||++.+..++.++|||||||++|+|++|..||...........+... ..........++..+.+||.+|
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05605 160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQL 239 (285)
T ss_pred cccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHH
Confidence 457999999999999888999999999999999999999999875543222111100 0111112345678899999999
Q ss_pred cccCCCCCC-----CHHHHHhhhhhhh
Q 004088 425 LTKEPRARP-----TAAEMLKHKFIER 446 (774)
Q Consensus 425 L~~DP~kRP-----Ta~ElL~HPwf~~ 446 (774)
|..||.+|| ++.++++||||..
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 240 LTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred ccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999 9999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=369.47 Aligned_cols=262 Identities=45% Similarity=0.788 Sum_probs=224.8
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
.....+|++++.||+|+||.||+|.+..+++.||||.+..... ...+.+.+|+.+++.+.||||++++++|....+.|+
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 4456799999999999999999999999999999999875443 334678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
||||+++++|.+++. ...+++.++..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 95 v~e~~~~~~L~~~~~--~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 95 VMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred eecccCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 999999999999885 345889999999999999999999999999999999999999999999999998765443333
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHh
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAK 423 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~k 423 (774)
.....|++.|+|||.+.+..++.++|||||||++|+|++|++||.................+.......++..+.++|.+
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHH
Confidence 33457899999999999888999999999999999999999999877654444333333333333345677889999999
Q ss_pred hcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 424 CLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 424 cL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
||.++|++||++.++++||||..+.
T Consensus 253 ~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 253 CLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred HCcCCcccCcCHHHHhhChhhhccC
Confidence 9999999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=380.23 Aligned_cols=257 Identities=25% Similarity=0.448 Sum_probs=208.0
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCccccccccc
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDL-----KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQ 256 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~-----~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~ 256 (774)
+..+.++|+++++||+|+||.||+|.+. .+++.||||++...........+.+|+.+|.++ +||||++++++|.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 3456789999999999999999999752 345789999987544445556789999999999 8999999999876
Q ss_pred C-CceEEEEEEecCCCchhhhhhccC------------------------------------------------------
Q 004088 257 G-EEYLWIVMEYCGGGSVADLMNVTE------------------------------------------------------ 281 (774)
Q Consensus 257 ~-~~~l~LVmEy~~ggsL~dll~~~~------------------------------------------------------ 281 (774)
. ...+|+|||||++|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 5 456899999999999999886321
Q ss_pred -------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc--cccccccccc
Q 004088 282 -------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS--KRNTFIGTPH 352 (774)
Q Consensus 282 -------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~--~~~~~~GT~~ 352 (774)
.++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..... ......+++.
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 3477888999999999999999999999999999999999999999999999976533211 1223356788
Q ss_pred ccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCC
Q 004088 353 WMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRA 431 (774)
Q Consensus 353 Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~k 431 (774)
|+|||++.+..++.++|||||||++|||++ |..||................. ....+..++..+.+||.+||+.||.+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~ 320 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT-RMRAPENATPEIYRIMLACWQGDPKE 320 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHccCChhh
Confidence 999999998899999999999999999996 9999987554332222211111 12223456788999999999999999
Q ss_pred CCCHHHHHh
Q 004088 432 RPTAAEMLK 440 (774)
Q Consensus 432 RPTa~ElL~ 440 (774)
|||+.++++
T Consensus 321 RPs~~el~~ 329 (338)
T cd05102 321 RPTFSALVE 329 (338)
T ss_pred CcCHHHHHH
Confidence 999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=388.10 Aligned_cols=260 Identities=27% Similarity=0.446 Sum_probs=218.5
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
...++|++++.||+|+||.||+|++..+++.||+|++.+.. .......+.+|+.+++.++||||+++++++.....+|
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34579999999999999999999999999999999986432 2233455788999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
+|||||++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 120 lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 99999999999998853 4588999999999999999999999999999999999999999999999999976643321
Q ss_pred -ccccccccccccchhhhhhcC----CCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCC-CCccccchhchHH
Q 004088 343 -KRNTFIGTPHWMAPEVIQESR----YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEP-APMLEDKEKWSLV 416 (774)
Q Consensus 343 -~~~~~~GT~~Y~APEvl~~~~----~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~-~~~~~~~~~~s~~ 416 (774)
.....+||+.|+|||++.... ++.++|||||||++|+|++|.+||...+.......+.... ....+....++..
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 277 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHH
Confidence 223567999999999997543 7889999999999999999999998877655555443322 1223334567889
Q ss_pred HHHHHHhhcccCCCC--CCCHHHHHhhhhhhh
Q 004088 417 FHDFVAKCLTKEPRA--RPTAAEMLKHKFIER 446 (774)
Q Consensus 417 l~dLI~kcL~~DP~k--RPTa~ElL~HPwf~~ 446 (774)
++++|.+||..++.+ |+++.++++||||+.
T Consensus 278 ~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 278 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred HHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 999999999855544 789999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=382.60 Aligned_cols=250 Identities=33% Similarity=0.477 Sum_probs=210.8
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHH-HHHhCCCCCcccccccccCCceEEEEEEecCC
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIE-MLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGG 270 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~-iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~g 270 (774)
+.||+|+||+||+|++..+|+.||||++.+.. .......+..|.. +++.++||||++++++|...+.+|+|||||.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999996532 1223344555654 56779999999999999999999999999999
Q ss_pred CchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccccc
Q 004088 271 GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350 (774)
Q Consensus 271 gsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT 350 (774)
++|..++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||
T Consensus 81 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (325)
T cd05604 81 GELFFHLQ-RERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT 159 (325)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence 99988875 45679999999999999999999999999999999999999999999999999987543333334456899
Q ss_pred ccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCC
Q 004088 351 PHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPR 430 (774)
Q Consensus 351 ~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~ 430 (774)
+.|+|||++.+..++.++|||||||++|+|++|.+||...+.......+..... ......+..+.++|.+||+++|.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ll~~ll~~~p~ 236 (325)
T cd05604 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL---VLRPGASLTAWSILEELLEKDRQ 236 (325)
T ss_pred hhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc---cCCCCCCHHHHHHHHHHhccCHH
Confidence 999999999998999999999999999999999999988776655544433222 12234678899999999999999
Q ss_pred CCCCH----HHHHhhhhhhhh
Q 004088 431 ARPTA----AEMLKHKFIERC 447 (774)
Q Consensus 431 kRPTa----~ElL~HPwf~~~ 447 (774)
+||++ .++++||||+..
T Consensus 237 ~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 237 RRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred hcCCCCCCHHHHhcCCCcCCC
Confidence 99976 599999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=356.92 Aligned_cols=254 Identities=34% Similarity=0.550 Sum_probs=220.9
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
+|.+.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+++++.++||||+++++++......|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4889999999999999999999999999999987543 344566788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 268 CGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 268 ~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
+++++|.+++... ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..+.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence 9999999998754 467899999999999999999999999999999999999999999999999999876554433445
Q ss_pred ccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcc
Q 004088 347 FIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLT 426 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~ 426 (774)
..|++.|+|||++....++.++|||||||++|+|++|+.||...........+.....+.. ...++..+.++|.+||+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~ 238 (256)
T cd08529 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV--SQMYSQQLAQLIDQCLT 238 (256)
T ss_pred cccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--ccccCHHHHHHHHHHcc
Confidence 6789999999999988899999999999999999999999987775554444433322222 22567889999999999
Q ss_pred cCCCCCCCHHHHHhhhhh
Q 004088 427 KEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 427 ~DP~kRPTa~ElL~HPwf 444 (774)
.+|++||++.++++|||+
T Consensus 239 ~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 239 KDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CCcccCcCHHHHhhCCCC
Confidence 999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=380.29 Aligned_cols=260 Identities=24% Similarity=0.407 Sum_probs=217.5
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
++|+++++||+|+||.||++++..+++.||+|++.+.. .......+.+|+.++..++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999986422 2223345788999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc-c
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK-R 344 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~-~ 344 (774)
|||.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...... .
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 999999999999765678999999999999999999999999999999999999999999999999999765432221 2
Q ss_pred ccccccccccchhhhh-----hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCC--CccccchhchHHH
Q 004088 345 NTFIGTPHWMAPEVIQ-----ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA--PMLEDKEKWSLVF 417 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~-----~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~--~~~~~~~~~s~~l 417 (774)
...+||+.|+|||++. ...++.++|||||||++|||++|+.||...........+..... +.......++..+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~ 240 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA 240 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence 2357999999999986 34588999999999999999999999988776666555433221 1112234568899
Q ss_pred HHHHHhhcccCCCC--CCCHHHHHhhhhhhhh
Q 004088 418 HDFVAKCLTKEPRA--RPTAAEMLKHKFIERC 447 (774)
Q Consensus 418 ~dLI~kcL~~DP~k--RPTa~ElL~HPwf~~~ 447 (774)
.+||.+||..++.+ |+++.++++||||...
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 241 KDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred HHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 99999999765555 6899999999999754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=382.76 Aligned_cols=257 Identities=29% Similarity=0.459 Sum_probs=213.2
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccC-----CceE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG-----EEYL 261 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~-----~~~l 261 (774)
.-.|.-.+.+|.|+||.||+|....+++.||||.+-...... -+|+.+|+.+.|||||+|..+|.. .-+.
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 346899999999999999999999999999999885433222 379999999999999999988852 2256
Q ss_pred EEEEEecCCCchhhhhhc---cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC-CcEEEeeccccccc
Q 004088 262 WIVMEYCGGGSVADLMNV---TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ-GEVKLGDFGVAAQL 337 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~---~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~-g~vKL~DFGlA~~i 337 (774)
.+||||++ .+|.++++. .+..++.-.++-++.||++||.|||++||+||||||.|||+|.+ |.+||||||.|+.+
T Consensus 98 nlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 78999995 588888864 36789999999999999999999999999999999999999977 89999999999887
Q ss_pred cccccccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-CCC----------
Q 004088 338 TRTMSKRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-PAP---------- 405 (774)
Q Consensus 338 ~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-~~~---------- 405 (774)
... ....++..|..|+|||.+.+. .|+.+.||||.||++.||+.|++-|.+.+....+..|... ..|
T Consensus 177 ~~~-epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 177 VKG-EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred ccC-CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 665 444778899999999999876 5999999999999999999999999987765554333110 000
Q ss_pred --------ccc-------cchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhccC
Q 004088 406 --------MLE-------DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCG 450 (774)
Q Consensus 406 --------~~~-------~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~~ 450 (774)
... .....++++.+|+.++|+++|.+|.++.|+|.||||..++..
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 000 122346788999999999999999999999999999987654
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=365.11 Aligned_cols=257 Identities=53% Similarity=0.951 Sum_probs=217.0
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccccC------
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQG------ 257 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~------ 257 (774)
.+.+.|++.+.||.|+||.||+|.+..+++.||||++.... .....+.+|+.+++++ +||||++++++|..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 45678999999999999999999999999999999987543 3346788999999998 69999999998864
Q ss_pred CceEEEEEEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccc
Q 004088 258 EEYLWIVMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQ 336 (774)
Q Consensus 258 ~~~l~LVmEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~ 336 (774)
...+|+||||+++++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 35789999999999999988753 35689999999999999999999999999999999999999999999999999976
Q ss_pred ccccccccccccccccccchhhhh-----hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccch
Q 004088 337 LTRTMSKRNTFIGTPHWMAPEVIQ-----ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKE 411 (774)
Q Consensus 337 i~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~ 411 (774)
+...........|++.|+|||++. ...++.++|||||||++|+|++|..||................... ....
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~ 239 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR-LKSK 239 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCC-CCCC
Confidence 654434445567999999999986 3458889999999999999999999998766555444333222222 1233
Q ss_pred hchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 412 KWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 412 ~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
.++..+.+||.+||..+|.+|||+.++++||||
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 240 KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 567889999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=365.65 Aligned_cols=258 Identities=56% Similarity=0.988 Sum_probs=225.2
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
++|++.+.||.|+||.||+|.+..+++.||||++...........+.+|+.+++.++||||+++++++.++..+|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 47899999999999999999999999999999997655445566788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccc
Q 004088 268 CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF 347 (774)
Q Consensus 268 ~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~ 347 (774)
+++++|.+++... ++++..+..++.||+.||.|||+++|+||||+|+||+++.++.++|+|||+++.+..........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF 158 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccc
Confidence 9999999998643 78999999999999999999999999999999999999999999999999998776554444456
Q ss_pred cccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhccc
Q 004088 348 IGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTK 427 (774)
Q Consensus 348 ~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~ 427 (774)
.|++.|+|||++.+..++.++|||||||++|+|++|.+||...+.......+.....+.... ..++..+.++|.+||..
T Consensus 159 ~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~l~~ 237 (274)
T cd06609 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEG-NKFSKPFKDFVSLCLNK 237 (274)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcc-cccCHHHHHHHHHHhhC
Confidence 78999999999998889999999999999999999999998776655554444333332222 12678899999999999
Q ss_pred CCCCCCCHHHHHhhhhhhhhc
Q 004088 428 EPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 428 DP~kRPTa~ElL~HPwf~~~~ 448 (774)
+|.+|||+.++++||||.+..
T Consensus 238 ~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 238 DPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred ChhhCcCHHHHhhChhhcCCC
Confidence 999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=380.68 Aligned_cols=249 Identities=31% Similarity=0.469 Sum_probs=209.7
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCCC--hhhHHHHHHHH-HHHHhCCCCCcccccccccCCceEEEEEEecCC
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSEG--EEGYEEIRGEI-EMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGG 270 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~--~~~~~~~~~Ei-~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~g 270 (774)
+.||+|+||+||+|++..+++.||||++..... ......+..|. .+++.++||||+++++++...+.+|+|||||.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999999999999999999974321 12223444444 457889999999999999999999999999999
Q ss_pred CchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccccc
Q 004088 271 GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350 (774)
Q Consensus 271 gsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT 350 (774)
++|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||
T Consensus 81 ~~L~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 159 (325)
T cd05602 81 GELFYHLQ-RERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT 159 (325)
T ss_pred CcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence 99999886 34568899999999999999999999999999999999999999999999999997654333334556899
Q ss_pred ccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCC
Q 004088 351 PHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPR 430 (774)
Q Consensus 351 ~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~ 430 (774)
+.|+|||++.+..++.++|||||||++|+|++|.+||...........+...+. .....++..+.++|.+||+++|.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~l~~~p~ 236 (325)
T cd05602 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL---QLKPNITNSARHLLEGLLQKDRT 236 (325)
T ss_pred ccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc---CCCCCCCHHHHHHHHHHcccCHH
Confidence 999999999998999999999999999999999999988776665544433322 22345788899999999999999
Q ss_pred CCCCHH----HHHhhhhhhh
Q 004088 431 ARPTAA----EMLKHKFIER 446 (774)
Q Consensus 431 kRPTa~----ElL~HPwf~~ 446 (774)
+|+++. ++++|+||..
T Consensus 237 ~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 237 KRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred HCCCCCCCHHHHhcCcccCC
Confidence 999865 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=379.52 Aligned_cols=249 Identities=31% Similarity=0.479 Sum_probs=209.2
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHH-HHHhCCCCCcccccccccCCceEEEEEEecCC
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIE-MLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGG 270 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~-iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~g 270 (774)
+.||+|+||.||+|++..+++.||||++.+.. .......+..|.. +++.++||||++++++|...+.+|+|||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999986432 1222344555554 67889999999999999999999999999999
Q ss_pred CchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccccc
Q 004088 271 GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350 (774)
Q Consensus 271 gsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT 350 (774)
++|...+. ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++............+||
T Consensus 81 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05603 81 GELFFHLQ-RERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT 159 (321)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence 99988875 34678999999999999999999999999999999999999999999999999987543333334456799
Q ss_pred ccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCC
Q 004088 351 PHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPR 430 (774)
Q Consensus 351 ~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~ 430 (774)
+.|+|||++.+..++.++|||||||++|+|++|.+||...+.......+...+. ..+...+..+.++|.+||+++|.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~l~~~p~ 236 (321)
T cd05603 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL---QLPGGKTVAACDLLVGLLHKDQR 236 (321)
T ss_pred cccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCHHHHHHHHHHccCCHh
Confidence 999999999988899999999999999999999999988776555444433322 22345677899999999999999
Q ss_pred CCCCH----HHHHhhhhhhh
Q 004088 431 ARPTA----AEMLKHKFIER 446 (774)
Q Consensus 431 kRPTa----~ElL~HPwf~~ 446 (774)
+||++ .++++|+||..
T Consensus 237 ~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 237 RRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred hcCCCCCCHHHHhCCCCcCC
Confidence 99875 59999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=367.90 Aligned_cols=258 Identities=46% Similarity=0.839 Sum_probs=221.8
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEec
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYC 268 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~ 268 (774)
.|++++.||.|+||.||+|.+..++..||+|.+... .....+.+.+|+.+++.++||||++++++|......|+||||+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 478899999999999999999999999999998643 3345667889999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccc
Q 004088 269 GGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFI 348 (774)
Q Consensus 269 ~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~ 348 (774)
++++|..++.....++++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..............
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 164 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 164 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccccc
Confidence 99999988765567899999999999999999999999999999999999999999999999999976544333344557
Q ss_pred ccccccchhhhh-----hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHh
Q 004088 349 GTPHWMAPEVIQ-----ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAK 423 (774)
Q Consensus 349 GT~~Y~APEvl~-----~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~k 423 (774)
|++.|+|||++. ...++.++|||||||++|+|++|.+||...........+.....+....+..++..+.+||.+
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 244 (282)
T cd06643 165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKK 244 (282)
T ss_pred ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHH
Confidence 899999999984 345788999999999999999999999887765555444333333333445678899999999
Q ss_pred hcccCCCCCCCHHHHHhhhhhhhh
Q 004088 424 CLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 424 cL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
||+.+|.+||++.++++||||+..
T Consensus 245 ~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 245 CLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HccCChhhCcCHHHHhcCCCEecc
Confidence 999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=399.70 Aligned_cols=254 Identities=33% Similarity=0.471 Sum_probs=214.8
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-C-----CCcccccccccCCceE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-H-----PNVVRYLGSYQGEEYL 261 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-H-----PNIVkL~~~~~~~~~l 261 (774)
.+|.+++.||+|+||.|.+|.+..+++.||||+++. ......+...|+++|..|+ | -|||+++++|...+++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN--~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN--KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeecc--ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 389999999999999999999999999999999964 3455677889999999997 4 3899999999999999
Q ss_pred EEEEEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC--cEEEeecccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG--EVKLGDFGVAAQLT 338 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g--~vKL~DFGlA~~i~ 338 (774)
|||+|.+ ..+|.++++.+ ...|+...++.|+.||+.||.+||+.||||+||||+||||..-+ .|||+|||+|+...
T Consensus 264 ciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred eeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 9999999 67999999754 36799999999999999999999999999999999999997654 69999999998765
Q ss_pred ccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc---CCC-----------
Q 004088 339 RTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI---EPA----------- 404 (774)
Q Consensus 339 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~---~~~----------- 404 (774)
... .+++.+..|+|||++.+.+|+.+.||||||||++||++|.|.|.+.+..+.+..|.. .+.
T Consensus 343 q~v---ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~ 419 (586)
T KOG0667|consen 343 QRV---YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAH 419 (586)
T ss_pred Ccc---eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccc
Confidence 543 378999999999999999999999999999999999999999988777655532210 000
Q ss_pred ---------Cccc--------------------------cc---h--------hchHHHHHHHHhhcccCCCCCCCHHHH
Q 004088 405 ---------PMLE--------------------------DK---E--------KWSLVFHDFVAKCLTKEPRARPTAAEM 438 (774)
Q Consensus 405 ---------~~~~--------------------------~~---~--------~~s~~l~dLI~kcL~~DP~kRPTa~El 438 (774)
+... .+ . .-...|.|||++||.+||.+|+|+.++
T Consensus 420 kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qa 499 (586)
T KOG0667|consen 420 KFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQA 499 (586)
T ss_pred eehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHH
Confidence 0000 00 0 012357899999999999999999999
Q ss_pred Hhhhhhhhh
Q 004088 439 LKHKFIERC 447 (774)
Q Consensus 439 L~HPwf~~~ 447 (774)
|+||||...
T Consensus 500 l~Hpfl~~~ 508 (586)
T KOG0667|consen 500 LNHPFLTGT 508 (586)
T ss_pred hcCcccccc
Confidence 999999854
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=379.02 Aligned_cols=259 Identities=25% Similarity=0.432 Sum_probs=216.8
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
++|++++.||+|+||.||++++..+++.||||++.+.. .......+.+|+.++..++|+||+++++++...+.+||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986422 2223455788999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc-c
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK-R 344 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~-~ 344 (774)
|||.+|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...... .
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 999999999999765678999999999999999999999999999999999999999999999999999766443221 2
Q ss_pred ccccccccccchhhhhh-----cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCC--CccccchhchHHH
Q 004088 345 NTFIGTPHWMAPEVIQE-----SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA--PMLEDKEKWSLVF 417 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~-----~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~--~~~~~~~~~s~~l 417 (774)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..... +.......++..+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~ 240 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA 240 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence 23579999999999875 4688899999999999999999999987766555444332211 1111223467889
Q ss_pred HHHHHhhcccCCCC--CCCHHHHHhhhhhhh
Q 004088 418 HDFVAKCLTKEPRA--RPTAAEMLKHKFIER 446 (774)
Q Consensus 418 ~dLI~kcL~~DP~k--RPTa~ElL~HPwf~~ 446 (774)
.+||.+||..++.+ |++++++++||||+.
T Consensus 241 ~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 241 KDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 99999999976655 579999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=392.58 Aligned_cols=258 Identities=32% Similarity=0.535 Sum_probs=233.3
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccCCce-EEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEY-LWIV 264 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~-l~LV 264 (774)
.++|.+++.+|+|+||.+++++++.+++.|++|.+..... ........+|+.+++++.|||||.+++.|..++. +|||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 4689999999999999999999999999999999987653 3333468899999999999999999999988777 9999
Q ss_pred EEecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|+||+||+|.+.+...+ ..++|..+..|+.||+.|+.|||+++|+|||||+.|||++.++.|||.|||+|+.+......
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 99999999999987554 67999999999999999999999999999999999999999999999999999998887667
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHh
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAK 423 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~k 423 (774)
..+.+||+.||.||++.+.+|+.|+|||||||++|||++-+++|...+...++..+.... ..+.+..++.+++.+|..
T Consensus 163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~--~~Plp~~ys~el~~lv~~ 240 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL--YSPLPSMYSSELRSLVKS 240 (426)
T ss_pred hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc--CCCCCccccHHHHHHHHH
Confidence 778899999999999999999999999999999999999999999988888777765544 334467889999999999
Q ss_pred hcccCCCCCCCHHHHHhhhhhhh
Q 004088 424 CLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 424 cL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
||.++|..||++.++|.+|.+..
T Consensus 241 ~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 241 MLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HhhcCCccCCCHHHHhhChhhhh
Confidence 99999999999999999987753
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=367.99 Aligned_cols=260 Identities=43% Similarity=0.764 Sum_probs=226.1
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
...+|++++.||.|+||.||+|.+..+++.||||.+.... ....+.+.+|+.+++.++||||+++++++.....+|+||
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 4567999999999999999999999999999999987543 233567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
||+.+++|..++. ...+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..+........
T Consensus 96 e~~~~~~L~~~~~--~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 96 EYLAGGSLTDVVT--ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred EecCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence 9999999999885 34689999999999999999999999999999999999999999999999999876654433334
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhc
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCL 425 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL 425 (774)
...|++.|+|||.+....++.++|||||||++|+|++|+.||...........+.....+.......++..+.+||.+||
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 253 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCL 253 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHh
Confidence 45789999999999988899999999999999999999999988776555444433333334445567888999999999
Q ss_pred ccCCCCCCCHHHHHhhhhhhhhc
Q 004088 426 TKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 426 ~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
..+|.+||++.++++||||+.++
T Consensus 254 ~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 254 EMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred hcChhhCCCHHHHhhChHhhhcc
Confidence 99999999999999999998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=359.88 Aligned_cols=258 Identities=53% Similarity=0.942 Sum_probs=221.0
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccccC------
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQG------ 257 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~------ 257 (774)
.+.++|++.+.||.|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++++ .||||++++++|..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 35689999999999999999999998899999999987543 2346789999999999 79999999999865
Q ss_pred CceEEEEEEecCCCchhhhhhcc---CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccc
Q 004088 258 EEYLWIVMEYCGGGSVADLMNVT---EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA 334 (774)
Q Consensus 258 ~~~l~LVmEy~~ggsL~dll~~~---~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA 334 (774)
...+|+||||+++++|.+++... ...+++..+..++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 34589999999999999988642 367999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccccccchhhhhh-----cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCcccc
Q 004088 335 AQLTRTMSKRNTFIGTPHWMAPEVIQE-----SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLED 409 (774)
Q Consensus 335 ~~i~~~~~~~~~~~GT~~Y~APEvl~~-----~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~ 409 (774)
..............|++.|+|||++.. ..++.++|||||||++|+|++|.+||...........+.....+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd06608 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS 240 (275)
T ss_pred eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCc
Confidence 766554444455679999999999853 347789999999999999999999998776666555554444444444
Q ss_pred chhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 410 KEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 410 ~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
...++..+.+||.+||..||.+|||+.++++|||+
T Consensus 241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 241 PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 55578899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=382.78 Aligned_cols=257 Identities=26% Similarity=0.382 Sum_probs=210.8
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCc-----eEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE-----YLW 262 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~-----~l~ 262 (774)
+|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.++||||+++++++.... .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4789999999999999999999999999999986432 2334567889999999999999999999998776 899
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
+||||+. ++|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~~-~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 81 VVTELMQ-SDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEeeccc-cCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 9999996 57777764 446799999999999999999999999999999999999999999999999999976543221
Q ss_pred -ccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC------------------
Q 004088 343 -KRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE------------------ 402 (774)
Q Consensus 343 -~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~------------------ 402 (774)
......+|+.|+|||++.+. .++.++|||||||++|+|++|++||...+....+..+...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 238 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence 22334689999999999874 4789999999999999999999999877655443322110
Q ss_pred -----CC--Ccc----ccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 403 -----PA--PML----EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 403 -----~~--~~~----~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
+. +.. ......+..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 00 000 0112346788999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=381.71 Aligned_cols=249 Identities=31% Similarity=0.465 Sum_probs=208.2
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhC---CCCCcccccccccCCceEEEEEEecCC
Q 004088 196 LGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQC---SHPNVVRYLGSYQGEEYLWIVMEYCGG 270 (774)
Q Consensus 196 LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L---~HPNIVkL~~~~~~~~~l~LVmEy~~g 270 (774)
||+|+||+||+|++..+++.||||++.+.. .......+..|..++.++ .||||++++++|.....+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999986432 122234455677777665 699999999999999999999999999
Q ss_pred CchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccccc
Q 004088 271 GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350 (774)
Q Consensus 271 gsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT 350 (774)
++|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||
T Consensus 81 g~L~~~l~-~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt 159 (330)
T cd05586 81 GELFWHLQ-KEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT 159 (330)
T ss_pred ChHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence 99998886 45679999999999999999999999999999999999999999999999999997544333334556899
Q ss_pred ccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCC
Q 004088 351 PHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEP 429 (774)
Q Consensus 351 ~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP 429 (774)
+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+....... ....++..+.+||.+||++||
T Consensus 160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~~li~~~L~~~P 237 (330)
T cd05586 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF--PKNVLSDEGRQFVKGLLNRNP 237 (330)
T ss_pred ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCC--CCccCCHHHHHHHHHHcCCCH
Confidence 999999999764 48999999999999999999999998876655544443322211 123467889999999999999
Q ss_pred CCCC----CHHHHHhhhhhhhh
Q 004088 430 RARP----TAAEMLKHKFIERC 447 (774)
Q Consensus 430 ~kRP----Ta~ElL~HPwf~~~ 447 (774)
.+|| ++.++++||||...
T Consensus 238 ~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 238 QHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred HHCCCCCCCHHHHhcCccccCC
Confidence 9998 79999999999753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=378.28 Aligned_cols=251 Identities=28% Similarity=0.463 Sum_probs=209.9
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEEEEEEecCC
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIVMEYCGG 270 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~LVmEy~~g 270 (774)
+.||+|+||.||+|++..+++.||||++.+.. .......+.+|+.++.++ .||||+++++++.....+|+|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999997543 233456688999999888 699999999999999999999999999
Q ss_pred CchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccccc
Q 004088 271 GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350 (774)
Q Consensus 271 gsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT 350 (774)
++|..++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||
T Consensus 81 ~~L~~~~~-~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (327)
T cd05617 81 GDLMFHMQ-RQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT 159 (327)
T ss_pred CcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence 99998875 34579999999999999999999999999999999999999999999999999997543333334456899
Q ss_pred ccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCc------hhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 351 PHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHP------MRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 351 ~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~------~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
+.|+|||++.+..++.++|||||||++|+|++|..||..... ............ ...+..++..+.++|.+|
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--IRIPRFLSVKASHVLKGF 237 (327)
T ss_pred cccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHH
Confidence 999999999999999999999999999999999999964221 111222111111 122345678899999999
Q ss_pred cccCCCCCCC------HHHHHhhhhhhhh
Q 004088 425 LTKEPRARPT------AAEMLKHKFIERC 447 (774)
Q Consensus 425 L~~DP~kRPT------a~ElL~HPwf~~~ 447 (774)
|++||.+|++ +.++++||||...
T Consensus 238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 238 LNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred hccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 9999999998 5799999999754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=385.82 Aligned_cols=261 Identities=28% Similarity=0.445 Sum_probs=234.2
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
..+-|.+.+.||+|.|+.|-+|++..+|+.||||++.+.. +.-....+.+|++.|+.++|||||+||++......+|||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 4567999999999999999999999999999999998765 334456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEec-CCCcEEEeeccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLT-DQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd-~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
+|+=.+|+|+++|-+....+.|..+++++.||+.|+.|||...+|||||||+||.+- .-|-|||.|||++..+... ..
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-~k 174 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-KK 174 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc-ch
Confidence 999999999999987888999999999999999999999999999999999998775 4589999999999877654 56
Q ss_pred cccccccccccchhhhhhcCCCC-ccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDG-KVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~-ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
..+.||++.|-|||++.+..|+. ++||||||||||-|++|++||...+..+.+.+|..... ..+..++.++++||.
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY---tvPshvS~eCrdLI~ 251 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY---TVPSHVSKECRDLIQ 251 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc---cCchhhhHHHHHHHH
Confidence 77889999999999999999985 79999999999999999999999988888877755433 335678899999999
Q ss_pred hhcccCCCCCCCHHHHHhhhhhhhhccC
Q 004088 423 KCLTKEPRARPTAAEMLKHKFIERCKCG 450 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~HPwf~~~~~~ 450 (774)
.||+.||.+|.+.++|..|+|++....+
T Consensus 252 sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 252 SMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred HHHhcCchhhccHHHHhccccccCCCCC
Confidence 9999999999999999999999865433
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=363.16 Aligned_cols=257 Identities=53% Similarity=0.969 Sum_probs=217.4
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
...++|++.+.||+|+||.||+|++..+++.||||+++... ......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 34568999999999999999999999999999999987543 23345688999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
||||++++|.+++. ..+.+++.++..++.|++.||.|||++||+|+||||+|||++.++.+||+|||++..+.......
T Consensus 85 ~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 85 MEFCGGGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR 163 (267)
T ss_pred EeccCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence 99999999999886 34579999999999999999999999999999999999999999999999999997665443334
Q ss_pred ccccccccccchhhhh---hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC--CCCccccchhchHHHHH
Q 004088 345 NTFIGTPHWMAPEVIQ---ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE--PAPMLEDKEKWSLVFHD 419 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~--~~~~~~~~~~~s~~l~d 419 (774)
....|++.|+|||++. ...++.++|||||||++|+|++|.+||....+.......... ..+.......++..+.+
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH 243 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHH
Confidence 4567999999999985 445888999999999999999999998766554433322211 11222223356788999
Q ss_pred HHHhhcccCCCCCCCHHHHHhhhh
Q 004088 420 FVAKCLTKEPRARPTAAEMLKHKF 443 (774)
Q Consensus 420 LI~kcL~~DP~kRPTa~ElL~HPw 443 (774)
||.+||+.+|++||++.++++|||
T Consensus 244 li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 244 FVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=363.71 Aligned_cols=255 Identities=28% Similarity=0.448 Sum_probs=209.3
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
+|++++.||+|+||.||+|++..+++.||||++..... ......+.+|+.++++++||||+++++++..+..+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 58999999999999999999999999999999865432 23346688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcc--CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 268 CGGGSVADLMNVT--EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 268 ~~ggsL~dll~~~--~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence 97 5787777532 25789999999999999999999999999999999999999999999999999976543333333
Q ss_pred cccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC---C------------------
Q 004088 346 TFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE---P------------------ 403 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~---~------------------ 403 (774)
...+++.|+|||++.+. .++.++|||||||++|+|++|++||...........+... +
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence 44678999999998754 4788999999999999999999999865543322211000 0
Q ss_pred -----CCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 404 -----APMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 404 -----~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
.........++.++.+||.+||+.||.+|||+.+|++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00000122357788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=356.97 Aligned_cols=257 Identities=46% Similarity=0.809 Sum_probs=220.9
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
++|++++.||.|+||+||+|.+..++..||+|++...........+.+|+.+|+.++||||+++++.+......|+||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47999999999999999999998899999999997655444667899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcc--CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc--
Q 004088 268 CGGGSVADLMNVT--EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK-- 343 (774)
Q Consensus 268 ~~ggsL~dll~~~--~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~-- 343 (774)
+++++|.+++... ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..+......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 9999999998643 246899999999999999999999999999999999999999999999999999766543222
Q ss_pred --cccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccc---hhchHHH
Q 004088 344 --RNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDK---EKWSLVF 417 (774)
Q Consensus 344 --~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~---~~~s~~l 417 (774)
....+|+..|+|||++... .++.++|+|||||++|+|++|+.||.................+..... ..++..+
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSF 240 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHH
Confidence 2345789999999999876 789999999999999999999999987766555444333322222221 3567889
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 418 HDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 418 ~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
.+||.+||..||.+||++.++++||||
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 241 RKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=379.31 Aligned_cols=257 Identities=25% Similarity=0.376 Sum_probs=208.3
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCC------
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE------ 258 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~------ 258 (774)
..++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++||||++++++|...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3568999999999999999999999999999999986533 333456788999999999999999999988543
Q ss_pred ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 259 EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
...|+||||+++ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999965 5666554 358889999999999999999999999999999999999999999999999997654
Q ss_pred ccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC----------------
Q 004088 339 RTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE---------------- 402 (774)
Q Consensus 339 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~---------------- 402 (774)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...
T Consensus 171 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 171 TS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred Cc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 33 2234457999999999999989999999999999999999999999876543322111000
Q ss_pred -------CC------C------c----cccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 403 -------PA------P------M----LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 403 -------~~------~------~----~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
+. + . .......+..+.+||.+||+.||++|||+.|+|+||||...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 00 0 0 00011234568899999999999999999999999999744
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=378.81 Aligned_cols=257 Identities=25% Similarity=0.363 Sum_probs=209.1
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCC------
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE------ 258 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~------ 258 (774)
..++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999999999999999986432 233456688999999999999999999987543
Q ss_pred ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 259 EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
..+|+||||+++ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 467999999965 6666664 347888999999999999999999999999999999999999999999999997654
Q ss_pred ccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCC--------------
Q 004088 339 RTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA-------------- 404 (774)
Q Consensus 339 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~-------------- 404 (774)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 178 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 178 TS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred CC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 33 223345799999999999999999999999999999999999999987665443322211000
Q ss_pred -------Cc------------------cccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 405 -------PM------------------LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 405 -------~~------------------~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
+. .......+..+.+||.+||+.||.+|||+.++|+||||..+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 00 00001124568899999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=357.47 Aligned_cols=255 Identities=36% Similarity=0.623 Sum_probs=217.1
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC----hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG----EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~----~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
+.|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.++++++||||+++++++.....+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 469999999999999999999989999999999865432 1234568899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
||||+++++|.+++. ....+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++.+......
T Consensus 82 v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 82 FMEYMPGGSVKDQLK-AYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EEEECCCCcHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 999999999999886 3456899999999999999999999999999999999999999999999999999765432111
Q ss_pred c---ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHH
Q 004088 344 R---NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 344 ~---~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
. ....|+..|+|||++.+..++.++|||||||++|+|++|+.||.................. ...+...+..+.++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 239 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN-PQLPSHVSPDARNF 239 (263)
T ss_pred cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC-CCCCccCCHHHHHH
Confidence 1 2346889999999999988999999999999999999999999876665544433322211 22334567889999
Q ss_pred HHhhcccCCCCCCCHHHHHhhhhh
Q 004088 421 VAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
|.+||..+|.+|||+.++++||||
T Consensus 240 i~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 240 LRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHhhcCcccCCCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=394.91 Aligned_cols=255 Identities=22% Similarity=0.377 Sum_probs=202.8
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCC------CCcccccccccCC-
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSH------PNVVRYLGSYQGE- 258 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~H------PNIVkL~~~~~~~- 258 (774)
..++|+++++||+|+||+||+|.+..+++.||||+++.. ......+..|+.+++.+.| ++|++++++|...
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV--PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc--hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 357899999999999999999999999999999998642 2233456678888877755 4588888888654
Q ss_pred ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHh-cCcccccccccceEecCCC-------------
Q 004088 259 EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS-IFKVHRDIKGGNILLTDQG------------- 324 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs-~gIIHRDLKPeNILLd~~g------------- 324 (774)
.++|||||++ +++|.+++. ..+.+++..++.|+.||+.||.|||+ .|||||||||+||||+.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIM-KHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred ceEEEEEecc-CCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5899999999 677888775 34679999999999999999999998 5999999999999998765
Q ss_pred ---cEEEeeccccccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 004088 325 ---EVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI 401 (774)
Q Consensus 325 ---~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~ 401 (774)
.+||+|||++.... ......+||+.|+|||++.+..|+.++|||||||++|||++|++||........+..+..
T Consensus 283 ~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 359 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359 (467)
T ss_pred CCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 49999999885432 223456899999999999999999999999999999999999999987665443322111
Q ss_pred CCCCc-------------------------ccc--------------chhchHHHHHHHHhhcccCCCCCCCHHHHHhhh
Q 004088 402 EPAPM-------------------------LED--------------KEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHK 442 (774)
Q Consensus 402 ~~~~~-------------------------~~~--------------~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HP 442 (774)
..... ... .......+.+||.+||++||.+|||+.|+|+||
T Consensus 360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp 439 (467)
T PTZ00284 360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP 439 (467)
T ss_pred HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence 00000 000 001134577999999999999999999999999
Q ss_pred hhhhh
Q 004088 443 FIERC 447 (774)
Q Consensus 443 wf~~~ 447 (774)
||.+.
T Consensus 440 ~~~~~ 444 (467)
T PTZ00284 440 YVLKY 444 (467)
T ss_pred ccccc
Confidence 99864
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=354.36 Aligned_cols=254 Identities=31% Similarity=0.526 Sum_probs=217.0
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccC-CceEEEEEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG-EEYLWIVME 266 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~-~~~l~LVmE 266 (774)
.|++++.||+|+||.||++.+..+++.||||++.... .....+.+.+|++++++++||||+++++.+.. +..+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4899999999999999999999999999999987543 23445678899999999999999999998764 457899999
Q ss_pred ecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 267 YCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 267 y~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
|+++++|.+++... ...+++.+++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++..+........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 99999999988643 35689999999999999999999999999999999999999999999999999987654433444
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhc
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCL 425 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL 425 (774)
...|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.....+. ....++..+.+||.+||
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l 238 (257)
T cd08223 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP--MPKDYSPELGELIATML 238 (257)
T ss_pred cccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--CccccCHHHHHHHHHHh
Confidence 5678999999999998889999999999999999999999998766555444333222211 23456788999999999
Q ss_pred ccCCCCCCCHHHHHhhhhh
Q 004088 426 TKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 426 ~~DP~kRPTa~ElL~HPwf 444 (774)
+.+|.+||++.++++||||
T Consensus 239 ~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 239 SKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ccCcccCCCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=364.20 Aligned_cols=254 Identities=33% Similarity=0.593 Sum_probs=212.8
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
++|++++.||+|+||.||+|.+..+++.||||++...........+.+|+++|++++||||++++++|...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36889999999999999999999999999999997654455556789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccc
Q 004088 268 CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF 347 (774)
Q Consensus 268 ~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~ 347 (774)
+++++|..+ ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+... .....
T Consensus 81 ~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~~~ 153 (279)
T cd06619 81 MDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTY 153 (279)
T ss_pred CCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cccCC
Confidence 999988654 24678889999999999999999999999999999999999999999999999765433 23345
Q ss_pred cccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchh------hhhhhhcCCCCccccchhchHHHHHHH
Q 004088 348 IGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMR------VLFMISIEPAPMLEDKEKWSLVFHDFV 421 (774)
Q Consensus 348 ~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~------~i~~i~~~~~~~~~~~~~~s~~l~dLI 421 (774)
+||..|+|||++.+..++.++|||||||++|+|++|+.||....... ..........+.......++..+.+||
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 233 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI 233 (279)
T ss_pred CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHH
Confidence 79999999999998889999999999999999999999997533211 011111111111111234677899999
Q ss_pred HhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 422 AKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 422 ~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.+||+.+|.+||++.++++||||....
T Consensus 234 ~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 234 TQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HHHhhCChhhCCCHHHHhcCccccccc
Confidence 999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=368.15 Aligned_cols=258 Identities=34% Similarity=0.566 Sum_probs=216.6
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
++|++.+.||+|+||.||++.+..++..||+|.+...........+.+|+++|++++||||++++++|..++.+|+||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36999999999999999999999999999999987554445556788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHh-cCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 268 CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS-IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 268 ~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs-~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
+++++|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+... ....
T Consensus 81 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~ 157 (308)
T cd06615 81 MDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANS 157 (308)
T ss_pred cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--cccc
Confidence 999999999864 3678999999999999999999997 68999999999999999999999999998765432 2234
Q ss_pred ccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCC----------------------
Q 004088 347 FIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA---------------------- 404 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~---------------------- 404 (774)
.+|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.............
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM 237 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence 5789999999999888899999999999999999999999875443322211110000
Q ss_pred -------------CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 405 -------------PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 405 -------------~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
+.......++..+.+||.+||..+|++||++.++++||||.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294 (308)
T ss_pred hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence 00000113567899999999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=363.35 Aligned_cols=255 Identities=29% Similarity=0.460 Sum_probs=207.7
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
+|++.+.||.|+||.||+|++..+|+.||+|++..... ......+.+|+.++++++||||+++++++.+...+|+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 58999999999999999999999999999999875432 22335677899999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccc
Q 004088 268 CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF 347 (774)
Q Consensus 268 ~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~ 347 (774)
+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE 159 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence 96 47777776556779999999999999999999999999999999999999999999999999997664433333345
Q ss_pred cccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCC-Cchhhhhhhhc-------------------CCCCc
Q 004088 348 IGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTV-HPMRVLFMISI-------------------EPAPM 406 (774)
Q Consensus 348 ~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~-~~~~~i~~i~~-------------------~~~~~ 406 (774)
.+++.|+|||++.+. .++.++|||||||++|+|++|..||... +.......+.. ...+.
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07839 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPM 239 (284)
T ss_pred ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCC
Confidence 688999999998764 4789999999999999999998875432 22211111100 00000
Q ss_pred c-------ccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 407 L-------EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 407 ~-------~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
. .....++..+.+||.+||+.||.+|||+.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 240 YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0112457788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=359.45 Aligned_cols=257 Identities=55% Similarity=0.999 Sum_probs=216.1
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
....+|++++.||+|+||.||+|++..+++.||+|++.... ......+.+|+.++++++||||+++++++.....+|+|
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 34568999999999999999999999999999999986443 23345688999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
|||+++++|.+++. ....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+.......
T Consensus 85 ~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06646 85 MEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR 163 (267)
T ss_pred EeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence 99999999999886 34578999999999999999999999999999999999999999999999999998765443333
Q ss_pred ccccccccccchhhhh---hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC--CCCccccchhchHHHHH
Q 004088 345 NTFIGTPHWMAPEVIQ---ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE--PAPMLEDKEKWSLVFHD 419 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~--~~~~~~~~~~~s~~l~d 419 (774)
....|++.|+|||.+. ...++.++|||||||++|+|++|.+||....+......+... ..+.......++..+.+
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN 243 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHH
Confidence 4557899999999985 345788999999999999999999999765544333222111 11222223457889999
Q ss_pred HHHhhcccCCCCCCCHHHHHhhhh
Q 004088 420 FVAKCLTKEPRARPTAAEMLKHKF 443 (774)
Q Consensus 420 LI~kcL~~DP~kRPTa~ElL~HPw 443 (774)
||.+||..+|++||+++++|+|+|
T Consensus 244 li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 244 FVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=376.39 Aligned_cols=256 Identities=24% Similarity=0.429 Sum_probs=209.0
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCC------c
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE------E 259 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~------~ 259 (774)
.++|++++.||.|+||.||+|.+..+++.||||++.... .......+.+|+.+|++++||||++++++|... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 468999999999999999999999999999999986432 223345677899999999999999999988533 4
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
..|++|+++ +++|..++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred cEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 579999999 778888774 35699999999999999999999999999999999999999999999999999976543
Q ss_pred cccccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc---CCC-----------
Q 004088 340 TMSKRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI---EPA----------- 404 (774)
Q Consensus 340 ~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~---~~~----------- 404 (774)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........+..+.. .+.
T Consensus 171 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07878 171 E---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247 (343)
T ss_pred C---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence 2 234579999999999976 4689999999999999999999999987654333222110 000
Q ss_pred --------Cccc------cchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 405 --------PMLE------DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 405 --------~~~~------~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
+... .....++.+.+||.+||+.||.+|||+.++|+||||....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 0000 0112355678999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=394.38 Aligned_cols=262 Identities=25% Similarity=0.421 Sum_probs=221.2
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCc---
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE--- 259 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~--- 259 (774)
.....+|++.+.||+|+||+||+|++..+|+.||||++.... .......+.+|+.+|..++|+||++++..+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 445679999999999999999999999999999999997543 3344567889999999999999999988764322
Q ss_pred -----eEEEEEEecCCCchhhhhhcc---CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeec
Q 004088 260 -----YLWIVMEYCGGGSVADLMNVT---EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDF 331 (774)
Q Consensus 260 -----~l~LVmEy~~ggsL~dll~~~---~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DF 331 (774)
.+++||||+++|+|.+++... ...+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 478999999999999988532 356899999999999999999999999999999999999999999999999
Q ss_pred cccccccccc--cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCcccc
Q 004088 332 GVAAQLTRTM--SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLED 409 (774)
Q Consensus 332 GlA~~i~~~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~ 409 (774)
|+++.+.... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...... ..
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~--~~ 265 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD--PL 265 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC--CC
Confidence 9997654321 2234568999999999999989999999999999999999999999877665554443332221 22
Q ss_pred chhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 410 KEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 410 ~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
+..++..+.+||.+||+.||.+||++.++++|||++..
T Consensus 266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 34678889999999999999999999999999998753
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=361.60 Aligned_cols=260 Identities=46% Similarity=0.835 Sum_probs=218.5
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccccCC----
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGE---- 258 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~---- 258 (774)
....++|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++++ +||||++++++|...
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 345788999999999999999999999999999999986432 2345678899999999 899999999988643
Q ss_pred -ceEEEEEEecCCCchhhhhhc---cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccc
Q 004088 259 -EYLWIVMEYCGGGSVADLMNV---TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA 334 (774)
Q Consensus 259 -~~l~LVmEy~~ggsL~dll~~---~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA 334 (774)
..+|+||||+++++|.++++. ....+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 468999999999999998752 3457899999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccccccchhhhhhc-----CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCcccc
Q 004088 335 AQLTRTMSKRNTFIGTPHWMAPEVIQES-----RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLED 409 (774)
Q Consensus 335 ~~i~~~~~~~~~~~GT~~Y~APEvl~~~-----~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~ 409 (774)
..+...........|+..|+|||++... .++.++|||||||++|+|++|++||........+..+.....+....
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 255 (291)
T cd06639 176 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLH 255 (291)
T ss_pred hhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCc
Confidence 7665433333445789999999998643 36889999999999999999999998877655555444333333344
Q ss_pred chhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhh
Q 004088 410 KEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445 (774)
Q Consensus 410 ~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~ 445 (774)
...++..+.+||.+||+.+|++||++.++++||||+
T Consensus 256 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 256 PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 556778899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=373.81 Aligned_cols=257 Identities=31% Similarity=0.545 Sum_probs=207.2
Q ss_pred EEeeeecc--CceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEec
Q 004088 192 LLNELGKG--SYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYC 268 (774)
Q Consensus 192 ilk~LG~G--~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~ 268 (774)
++++||+| +|++||++.+..+|+.||||++.... .....+.+.+|+.+++.++||||++++++|..++..|+|||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 78999999999999999999997543 2334566788999999999999999999999999999999999
Q ss_pred CCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc-----
Q 004088 269 GGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS----- 342 (774)
Q Consensus 269 ~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~----- 342 (774)
++++|.+++... ...+++..++.++.||+.||.|||++|||||||||+|||++.++.++++|||.+........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 161 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence 999999998643 34589999999999999999999999999999999999999999999999987644322111
Q ss_pred --ccccccccccccchhhhhh--cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCC-------------
Q 004088 343 --KRNTFIGTPHWMAPEVIQE--SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAP------------- 405 (774)
Q Consensus 343 --~~~~~~GT~~Y~APEvl~~--~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~------------- 405 (774)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.................+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (327)
T cd08227 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEEL 241 (327)
T ss_pred ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhc
Confidence 0112357788999999976 45899999999999999999999999764432221111100000
Q ss_pred ------------------------------ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 406 ------------------------------MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 406 ------------------------------~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.......++..+.+||.+||+.||++|||+.++|+||||++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 242 TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred ccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 0001123467899999999999999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=360.27 Aligned_cols=258 Identities=49% Similarity=0.869 Sum_probs=215.0
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCccccccccc-----CC
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQ-----GE 258 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~-----~~ 258 (774)
...++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++++ +||||+++++++. .+
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 45789999999999999999999999999999999875422 2235678899999999 6999999999873 45
Q ss_pred ceEEEEEEecCCCchhhhhhc---cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccc
Q 004088 259 EYLWIVMEYCGGGSVADLMNV---TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~---~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
..+|+||||+++++|.+++.. ....+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||++.
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCcee
Confidence 679999999999999988742 33568999999999999999999999999999999999999999999999999997
Q ss_pred cccccccccccccccccccchhhhhh-----cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccc
Q 004088 336 QLTRTMSKRNTFIGTPHWMAPEVIQE-----SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDK 410 (774)
Q Consensus 336 ~i~~~~~~~~~~~GT~~Y~APEvl~~-----~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~ 410 (774)
.+...........|++.|+|||++.. ..++.++|||||||++|+|++|+.||.................+....+
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (286)
T cd06638 173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQP 252 (286)
T ss_pred ecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCC
Confidence 76543333344579999999999853 3478899999999999999999999987665544433322222223334
Q ss_pred hhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 411 EKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 411 ~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
..++..+.+||.+||+.+|.+|||+.++++|+||
T Consensus 253 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 4567789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=392.83 Aligned_cols=258 Identities=27% Similarity=0.462 Sum_probs=220.3
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCC-CcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKT-SELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~-g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
...|.+.+.||+|+||.||+|.+..+ ++.||+|.+... .......+.+|+.+|+.++|||||+++++|...+.+||||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 34599999999999999999998777 788999987543 3344456788999999999999999999999999999999
Q ss_pred EecCCCchhhhhhc---cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 266 EYCGGGSVADLMNV---TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 266 Ey~~ggsL~dll~~---~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
|||++|+|.+++.. ...++++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+.....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999999987753 235689999999999999999999999999999999999999999999999999987644322
Q ss_pred --ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHH
Q 004088 343 --KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 343 --~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...... ..+..++..+.+|
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~l 302 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD--PFPCPVSSGMKAL 302 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCCccCCHHHHHH
Confidence 234567999999999999989999999999999999999999999877666555544332222 1234567889999
Q ss_pred HHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 421 VAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
|.+||.+||++||++.++|.|+|++..
T Consensus 303 i~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 303 LDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred HHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 999999999999999999999999754
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=359.58 Aligned_cols=256 Identities=33% Similarity=0.536 Sum_probs=212.9
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
++|++.+.||+|+||.||+|.+..+|+.||+|++..... ....+.+.+|+.++++++||||+++++++.....+++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 479999999999999999999998999999999865432 2233567899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
|+++++|..++. ....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+.........
T Consensus 81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07847 81 YCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159 (286)
T ss_pred ccCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence 999988877764 3456899999999999999999999999999999999999999999999999999876554333344
Q ss_pred ccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-----------------------
Q 004088 347 FIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE----------------------- 402 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~----------------------- 402 (774)
..++..|+|||++.+ ..++.++|||||||++|+|++|.+||......+....+...
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07847 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI 239 (286)
T ss_pred cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence 568899999999876 45889999999999999999999999876654333221100
Q ss_pred CCCc-----cccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 403 PAPM-----LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 403 ~~~~-----~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
+.+. ......++..+.+||.+||+.+|++||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000 00112356788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=368.86 Aligned_cols=248 Identities=25% Similarity=0.428 Sum_probs=192.7
Q ss_pred EeeeeccCceEEEEEEEc--CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCccccccccc--CCceEEEEEEec
Q 004088 193 LNELGKGSYGAVYKARDL--KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ--GEEYLWIVMEYC 268 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~--~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~--~~~~l~LVmEy~ 268 (774)
.++||+|+||+||+|++. .+++.||||++.... ....+.+|+.+|++++||||++++++|. ....+|+||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 468999999999999965 467899999986432 2345778999999999999999999884 456789999999
Q ss_pred CCCchhhhhhcc--------CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEe----cCCCcEEEeecccccc
Q 004088 269 GGGSVADLMNVT--------EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL----TDQGEVKLGDFGVAAQ 336 (774)
Q Consensus 269 ~ggsL~dll~~~--------~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILL----d~~g~vKL~DFGlA~~ 336 (774)
. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||+|+.
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 5 5777776421 2358999999999999999999999999999999999999 4557899999999987
Q ss_pred cccccc---ccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchh---------h---hhhhh
Q 004088 337 LTRTMS---KRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMR---------V---LFMIS 400 (774)
Q Consensus 337 i~~~~~---~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~---------~---i~~i~ 400 (774)
+..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|++||....... . +....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 644321 22346789999999999864 58999999999999999999999996433210 0 00000
Q ss_pred cCCC----------Cc----------------------cccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 401 IEPA----------PM----------------------LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 401 ~~~~----------~~----------------------~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
..+. +. .......+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0000 00 00001124567899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=389.33 Aligned_cols=253 Identities=26% Similarity=0.406 Sum_probs=219.3
Q ss_pred ccCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 182 TREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 182 ~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
.++.....++++++||+|.||.||+|.+..+ ..||+|.++.. ....+.|.+|+++|++|+|+|||+|+++|..+..+
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~--~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEG--SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecc--ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 3455666788899999999999999997533 36999998643 34446788999999999999999999999998999
Q ss_pred EEEEEecCCCchhhhhhc-cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNV-TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~-~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
||||||++.|+|.++|+. .+..+...+...++.|||+||+||+++++|||||...||||+++..+||+|||+|+.+.+.
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 999999999999999986 5678999999999999999999999999999999999999999999999999999965443
Q ss_pred ccc-cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 341 MSK-RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 341 ~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
... .....-+..|.|||.+...+++.|||||||||+||||++ |+.||......+++..+.... .++.+..++..+.
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~Gy--Rlp~P~~CP~~vY 434 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGY--RLPRPEGCPDEVY 434 (468)
T ss_pred ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccC--cCCCCCCCCHHHH
Confidence 221 112233678999999999999999999999999999995 899999999999888776543 3556778999999
Q ss_pred HHHHhhcccCCCCCCCHHHHH
Q 004088 419 DFVAKCLTKEPRARPTAAEML 439 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL 439 (774)
++|..||..+|++|||++.+.
T Consensus 435 ~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 435 ELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHHHhhCCcccCCCHHHHH
Confidence 999999999999999999664
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=370.66 Aligned_cols=260 Identities=30% Similarity=0.504 Sum_probs=233.7
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
..++|..++.||+|.||+|.+|+.+.+++.||||++++.- ..........|-++|+..+||.+..|...|+..+++|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3468999999999999999999999999999999997643 33445667789999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
||||+.||.|+-++. +...++|...+.+-..|+.||.|||+++||+||||.+|+|++.+|++||+|||+++.-......
T Consensus 246 VMeyanGGeLf~HLs-rer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t 324 (516)
T KOG0690|consen 246 VMEYANGGELFFHLS-RERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDT 324 (516)
T ss_pred EEEEccCceEeeehh-hhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccce
Confidence 999999999998885 5678999999999999999999999999999999999999999999999999999876666667
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHh
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAK 423 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~k 423 (774)
..++||||.|+|||++....|+..+|+|.+||+||||++|+.||...+...+...|.... +..+..++++++.|+..
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed---~kFPr~ls~eAktLLsG 401 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED---LKFPRTLSPEAKTLLSG 401 (516)
T ss_pred eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh---ccCCccCCHHHHHHHHH
Confidence 788999999999999999999999999999999999999999999998888776665433 33466789999999999
Q ss_pred hcccCCCCCC-----CHHHHHhhhhhhhhcc
Q 004088 424 CLTKEPRARP-----TAAEMLKHKFIERCKC 449 (774)
Q Consensus 424 cL~~DP~kRP-----Ta~ElL~HPwf~~~~~ 449 (774)
+|.+||.+|. .+.||.+|+||....+
T Consensus 402 LL~kdP~kRLGgGpdDakEi~~h~FF~~v~W 432 (516)
T KOG0690|consen 402 LLKKDPKKRLGGGPDDAKEIMRHRFFASVDW 432 (516)
T ss_pred HhhcChHhhcCCCchhHHHHHhhhhhccCCH
Confidence 9999999996 4899999999986644
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=364.18 Aligned_cols=255 Identities=27% Similarity=0.375 Sum_probs=212.8
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC--hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG--EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~--~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
.|++.+.||+|+||.||+|.+..+++.||||.+..... ......+.+|+.+|++++|+||+.+++.+...+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999865332 2233557789999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 267 YCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 267 y~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
|+.+++|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....... ...
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~ 159 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIK 159 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-ccc
Confidence 99999999887533 3468999999999999999999999999999999999999999999999999986553322 223
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchh---hhhhhhcCCCCccccchhchHHHHHHHH
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMR---VLFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~---~i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
...|++.|+|||++.+..++.++|||||||++|+|++|..||....... .......... ......++..+.+||.
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~ 237 (285)
T cd05630 160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ--EEYSEKFSPDARSLCK 237 (285)
T ss_pred CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh--hhcCccCCHHHHHHHH
Confidence 3479999999999998889999999999999999999999998643321 1111111101 1123456778999999
Q ss_pred hhcccCCCCCCC-----HHHHHhhhhhhh
Q 004088 423 KCLTKEPRARPT-----AAEMLKHKFIER 446 (774)
Q Consensus 423 kcL~~DP~kRPT-----a~ElL~HPwf~~ 446 (774)
+||+.||.+||| +.++++||||+.
T Consensus 238 ~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 238 MLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 999999999999 999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=363.36 Aligned_cols=249 Identities=27% Similarity=0.368 Sum_probs=205.2
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCCC--hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCCCch
Q 004088 196 LGKGSYGAVYKARDLKTSELVAIKVISLSEG--EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSV 273 (774)
Q Consensus 196 LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~--~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~ggsL 273 (774)
||+|+||.||++++..+|+.||+|++..... ......+..|+++|++++||||++++++|..+.++|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999999999999999999999864321 12234456799999999999999999999999999999999999999
Q ss_pred hhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccccccc
Q 004088 274 ADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH 352 (774)
Q Consensus 274 ~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT~~ 352 (774)
..++... ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+.... ......|++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~ 159 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNG 159 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCCC
Confidence 8877533 3468899999999999999999999999999999999999999999999999997664332 2233468999
Q ss_pred ccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCch----hhhhhhhcCCCCccccchhchHHHHHHHHhhcccC
Q 004088 353 WMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPM----RVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKE 428 (774)
Q Consensus 353 Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~----~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~D 428 (774)
|+|||++.+..++.++|||||||++|+|++|+.||...... ........... ......++..+.+||.+||++|
T Consensus 160 y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~~ 237 (277)
T cd05607 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV--KFEHQNFTEESKDICRLFLAKK 237 (277)
T ss_pred ccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc--ccccccCCHHHHHHHHHHhccC
Confidence 99999999888999999999999999999999999754321 11111111111 1112356888999999999999
Q ss_pred CCCCCCH----HHHHhhhhhhhh
Q 004088 429 PRARPTA----AEMLKHKFIERC 447 (774)
Q Consensus 429 P~kRPTa----~ElL~HPwf~~~ 447 (774)
|.+||++ +++++||||+..
T Consensus 238 P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 238 PEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred HhhCCCCccchhhhhcChhhcCC
Confidence 9999999 778899999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=360.14 Aligned_cols=257 Identities=53% Similarity=0.951 Sum_probs=216.9
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCccccccccc------C
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQ------G 257 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~------~ 257 (774)
.+.+.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++++ +||||++++++|. .
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 45679999999999999999999999999999999986532 3346688999999998 7999999999985 3
Q ss_pred CceEEEEEEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccc
Q 004088 258 EEYLWIVMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQ 336 (774)
Q Consensus 258 ~~~l~LVmEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~ 336 (774)
...+|+||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 56889999999999999988643 34688999999999999999999999999999999999999999999999999876
Q ss_pred ccccccccccccccccccchhhhh-----hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccch
Q 004088 337 LTRTMSKRNTFIGTPHWMAPEVIQ-----ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKE 411 (774)
Q Consensus 337 i~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~ 411 (774)
............|++.|+|||++. ...++.++|||||||++|+|++|.+||....+...+..+.....+. ....
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~ 249 (282)
T cd06636 171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK-LKSK 249 (282)
T ss_pred hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCC-Cccc
Confidence 654433445567999999999986 3468889999999999999999999998766555544433322222 2234
Q ss_pred hchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 412 KWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 412 ~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
.++..+.+||.+||..||.+||++.++|+||||
T Consensus 250 ~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=356.70 Aligned_cols=256 Identities=39% Similarity=0.676 Sum_probs=218.6
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
++|++.+.||.|+||.||+|.+..+++.||+|++...........+.+|+++++++.||||+++++++.....+|+|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36888999999999999999999999999999997665555667789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHh-cCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 268 CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS-IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 268 ~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs-~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
+++++|.+++......+++..+..++.||+.||.|||+ .|++||||||+||+++.++.++|+|||.+..+...... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~ 158 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--T 158 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh--c
Confidence 99999999997655789999999999999999999999 99999999999999999999999999998766433222 2
Q ss_pred ccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCC-----chhhhhhhhcCCCCccccchhchHHHHHHH
Q 004088 347 FIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVH-----PMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~-----~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI 421 (774)
..++..|+|||++.+..++.++|||||||++|+|++|..||.... .......+.....+... ...++..+.+||
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li 237 (265)
T cd06605 159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP-SGKFSPDFQDFV 237 (265)
T ss_pred ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCC-hhhcCHHHHHHH
Confidence 678999999999998899999999999999999999999997542 11222222222222211 112788899999
Q ss_pred HhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 422 AKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 422 ~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
.+||..||.+|||+.+++.||||++
T Consensus 238 ~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 238 NLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHcCCCchhCcCHHHHhhCchhhc
Confidence 9999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=359.99 Aligned_cols=259 Identities=35% Similarity=0.546 Sum_probs=217.2
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
++|++++.||+|+||.||+|.+..+++.||+|.+...........+.+|+.+|++++||||+++++++.....+|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36899999999999999999999899999999987554445567889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcc--CCchhHHHHHHHHHHHHHHHHHHHh-cCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 268 CGGGSVADLMNVT--EEPLEEYQIAYICREALKGLAYLHS-IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 268 ~~ggsL~dll~~~--~~~Lse~~i~~I~~QIl~gL~YLHs-~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
|++++|..++... ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++..+... ..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~ 158 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--LA 158 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--cc
Confidence 9999999888643 3478999999999999999999996 59999999999999999999999999999765433 22
Q ss_pred ccccccccccchhhhhhc------CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhh---hhcCCCCccccchhchH
Q 004088 345 NTFIGTPHWMAPEVIQES------RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFM---ISIEPAPMLEDKEKWSL 415 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~------~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~---i~~~~~~~~~~~~~~s~ 415 (774)
....|++.|+|||++.+. .++.++|||||||++|+|++|+.||........... +..... ...+..++.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (286)
T cd06622 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP--PTLPSGYSD 236 (286)
T ss_pred ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC--CCCCcccCH
Confidence 334688999999998543 357899999999999999999999976544332221 111111 122334788
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhccC
Q 004088 416 VFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCG 450 (774)
Q Consensus 416 ~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~~ 450 (774)
.+.+||.+||+.+|.+||++.++++||||......
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 237 DAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred HHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 99999999999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=361.47 Aligned_cols=258 Identities=27% Similarity=0.369 Sum_probs=215.3
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
.|+..+.||+|+||+||+|.+..+++.||||++.... .......+.+|+.+|++++|+||+.+++++..++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 4788999999999999999999999999999986533 12233557889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 267 YCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 267 y~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
|+.+++|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~ 159 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIR 159 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-Cccc
Confidence 99999998887533 346999999999999999999999999999999999999999999999999998654332 2223
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-CCCccccchhchHHHHHHHHhh
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-PAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-~~~~~~~~~~~s~~l~dLI~kc 424 (774)
...|++.|+|||++.+..++.++|||||||++|+|++|..||...........+... ..........++..+.+|+.+|
T Consensus 160 ~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05632 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239 (285)
T ss_pred CCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHH
Confidence 457999999999999888999999999999999999999999876543322221111 1111122345678899999999
Q ss_pred cccCCCCCCC-----HHHHHhhhhhhhh
Q 004088 425 LTKEPRARPT-----AAEMLKHKFIERC 447 (774)
Q Consensus 425 L~~DP~kRPT-----a~ElL~HPwf~~~ 447 (774)
|+.||++||+ +.++++|+||+..
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 240 LTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred ccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999 8999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=364.12 Aligned_cols=260 Identities=32% Similarity=0.465 Sum_probs=220.8
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh--hhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE--EGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~--~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
.+|++.+.||+|+||.||+|.+..+++.||||.+...... .....+.+|+++|+.++||||+++++++......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3799999999999999999999989999999999765432 34567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc---
Q 004088 266 EYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM--- 341 (774)
Q Consensus 266 Ey~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~--- 341 (774)
||+.+++|.+++... ...+++..+..++.||+.||.|||+.||+||||||+||||+.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999988643 3579999999999999999999999999999999999999999999999999986543211
Q ss_pred --------------------------cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhh
Q 004088 342 --------------------------SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRV 395 (774)
Q Consensus 342 --------------------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~ 395 (774)
......+||..|+|||++.+..++.++|||||||++|+|++|+.||........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 011234789999999999988899999999999999999999999987766554
Q ss_pred hhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCC----HHHHHhhhhhhhhc
Q 004088 396 LFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPT----AAEMLKHKFIERCK 448 (774)
Q Consensus 396 i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPT----a~ElL~HPwf~~~~ 448 (774)
...+..... ........+..+.+||.+||+.+|++||+ +.++|+||||+...
T Consensus 241 ~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 241 FSNILKKEV-TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred HHHHhcCCc-cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 443332221 12222336888999999999999999999 99999999998654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=359.05 Aligned_cols=257 Identities=54% Similarity=0.945 Sum_probs=222.7
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
..|+.+++||.|+||.||+|.+..++..||||++...........+.+|+.+++++.||||+++++++.+....|+||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 46888999999999999999998899999999997655555667899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccc
Q 004088 268 CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF 347 (774)
Q Consensus 268 ~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~ 347 (774)
+++++|.+++. ..++++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+..........
T Consensus 84 ~~~~~L~~~i~--~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06640 84 LGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccc
Confidence 99999999885 3568999999999999999999999999999999999999999999999999997765443333445
Q ss_pred cccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhccc
Q 004088 348 IGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTK 427 (774)
Q Consensus 348 ~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~ 427 (774)
.++..|+|||++.+..++.++|+|||||++|+|++|.+||...........+.....+ .....++..+.+||.+||+.
T Consensus 162 ~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~ 239 (277)
T cd06640 162 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPP--TLTGEFSKPFKEFIDACLNK 239 (277)
T ss_pred cCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCC--CCchhhhHHHHHHHHHHccc
Confidence 6899999999998888999999999999999999999999877665554443222222 22334677899999999999
Q ss_pred CCCCCCCHHHHHhhhhhhhhc
Q 004088 428 EPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 428 DP~kRPTa~ElL~HPwf~~~~ 448 (774)
+|.+||++.++++||||.+..
T Consensus 240 ~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 240 DPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred CcccCcCHHHHHhChHhhhcc
Confidence 999999999999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=360.78 Aligned_cols=257 Identities=56% Similarity=0.956 Sum_probs=221.1
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
..|+.++.||+|+||.||+|.+..+++.||||++...........+.+|+.++++++||||++++++|......|+||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 45788899999999999999998899999999987555455567789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccc
Q 004088 268 CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF 347 (774)
Q Consensus 268 ~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~ 347 (774)
+++++|.+++. ...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..+..........
T Consensus 84 ~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06642 84 LGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred cCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence 99999999875 3568999999999999999999999999999999999999999999999999997765443333445
Q ss_pred cccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhccc
Q 004088 348 IGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTK 427 (774)
Q Consensus 348 ~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~ 427 (774)
.|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+.....+. .....+..+.++|.+||+.
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~ 239 (277)
T cd06642 162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT--LEGQYSKPFKEFVEACLNK 239 (277)
T ss_pred cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCC--CCcccCHHHHHHHHHHccC
Confidence 78999999999998889999999999999999999999998665554443332222221 2234577899999999999
Q ss_pred CCCCCCCHHHHHhhhhhhhhc
Q 004088 428 EPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 428 DP~kRPTa~ElL~HPwf~~~~ 448 (774)
+|.+||++.++++||||..+.
T Consensus 240 ~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 240 DPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred CcccCcCHHHHHHhHHHHHHh
Confidence 999999999999999998765
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=378.21 Aligned_cols=257 Identities=26% Similarity=0.366 Sum_probs=208.2
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEc--CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDL--KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~--~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
...+|++++.||+|+||.||+|... ..++.||||.+... ....+|+++|++++||||++++++|.....+|+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 3457999999999999999999754 35678999987532 234689999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
||||+. ++|.+++. ....+++..++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||+++.+......
T Consensus 164 v~e~~~-~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 164 VMPKYK-CDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred EehhcC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 999995 67888773 4567999999999999999999999999999999999999999999999999999766543221
Q ss_pred --cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchh---hhhhh----hcCC-----------
Q 004088 344 --RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMR---VLFMI----SIEP----------- 403 (774)
Q Consensus 344 --~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~---~i~~i----~~~~----------- 403 (774)
.....||+.|+|||++....|+.++|||||||++|+|++|+.||....... .+..+ ...+
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 321 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL 321 (392)
T ss_pred ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence 234579999999999999899999999999999999999999997643211 00000 0000
Q ss_pred ----------------CCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhccC
Q 004088 404 ----------------APMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCG 450 (774)
Q Consensus 404 ----------------~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~~ 450 (774)
.+.......++..+.+||.+||..||++|||+.++|+||||++.+..
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~ 384 (392)
T PHA03207 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN 384 (392)
T ss_pred HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence 00001112345678899999999999999999999999999875543
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=377.25 Aligned_cols=250 Identities=26% Similarity=0.368 Sum_probs=201.7
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
..|++++.||+|+||.||+|++..+++.||+|+.... ....|+.+|++++||||+++++++......|+||||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 4699999999999999999999999999999985322 235699999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccc
Q 004088 268 CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF 347 (774)
Q Consensus 268 ~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~ 347 (774)
+. ++|..++......+++..++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||+++..... ......
T Consensus 139 ~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~ 216 (357)
T PHA03209 139 YS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLGL 216 (357)
T ss_pred cC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-cccccc
Confidence 95 5788887666678999999999999999999999999999999999999999999999999999653322 222345
Q ss_pred cccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCC-CCCCCch----------hhhhhh---hcCCCCcc------
Q 004088 348 IGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPP-RSTVHPM----------RVLFMI---SIEPAPML------ 407 (774)
Q Consensus 348 ~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~P-f~~~~~~----------~~i~~i---~~~~~~~~------ 407 (774)
.||+.|+|||++.+..++.++|||||||++|||+++..| |...... .....+ ...+....
T Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 296 (357)
T PHA03209 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR 296 (357)
T ss_pred cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccH
Confidence 799999999999998999999999999999999986444 3332111 000000 00000000
Q ss_pred ---------------------ccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 408 ---------------------EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 408 ---------------------~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
.....++..+.+||.+||+.||.+|||+.|||+||||++
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 297 LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 001233556778999999999999999999999999975
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=350.07 Aligned_cols=254 Identities=30% Similarity=0.497 Sum_probs=220.8
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
+|++++.||.|+||.||.+++..+++.|++|.+.... .......+.+|+.+|++++|+||+++++++.+...+++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5999999999999999999999999999999987543 344556788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 268 CGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 268 ~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
|++++|.+++... ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++............
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence 9999999998654 456899999999999999999999999999999999999999999999999999776554433445
Q ss_pred ccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcc
Q 004088 347 FIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLT 426 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~ 426 (774)
..|++.|+|||++.+..++.++|||||||++|+|++|..||...........+...... .....++..+.++|.+||.
T Consensus 161 ~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08221 161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT--PVVSVYSSELISLVHSLLQ 238 (256)
T ss_pred cCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--CCccccCHHHHHHHHHHcc
Confidence 67999999999998888999999999999999999999999876665554444322222 1224567889999999999
Q ss_pred cCCCCCCCHHHHHhhhhh
Q 004088 427 KEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 427 ~DP~kRPTa~ElL~HPwf 444 (774)
++|.+||++.++|+|||+
T Consensus 239 ~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 239 QDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cCcccCCCHHHHhhCcCC
Confidence 999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=350.97 Aligned_cols=254 Identities=32% Similarity=0.544 Sum_probs=219.0
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
+|++.+.||+|+||.||++++..+|+.||||++.... .......+.+|+.++++++||||+++++++......|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5999999999999999999999999999999987542 233456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 268 CGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 268 ~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
+.+++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++..+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence 9999999988643 346899999999999999999999999999999999999999999999999999766544333334
Q ss_pred ccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcc
Q 004088 347 FIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLT 426 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~ 426 (774)
..|++.|+|||++.+..++.++|+|||||++|+|++|+.||...........+.....+ .....++..+.++|.+||+
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08218 161 CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP--PVSSHYSYDLRNLVSQLFK 238 (256)
T ss_pred ccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC--CCcccCCHHHHHHHHHHhh
Confidence 56899999999999888999999999999999999999999876655554443332222 2234567889999999999
Q ss_pred cCCCCCCCHHHHHhhhhh
Q 004088 427 KEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 427 ~DP~kRPTa~ElL~HPwf 444 (774)
.+|.+||++.++++||||
T Consensus 239 ~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 239 RNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CChhhCcCHHHHhhCcCC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=363.86 Aligned_cols=261 Identities=39% Similarity=0.692 Sum_probs=224.4
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
....|.....||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.+.||||++++++|..++..|+||
T Consensus 19 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 19 PRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred chhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 34556677789999999999999988999999999865432 33466889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
||+++++|..++. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+........
T Consensus 98 e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 98 EFLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred ecCCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence 9999999998774 35689999999999999999999999999999999999999999999999999976654433444
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhc
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCL 425 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL 425 (774)
..+|++.|+|||++.+..++.++|||||||++|+|++|+.||...........+.....+.......++..+.++|.+||
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l 255 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERML 255 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHh
Confidence 56799999999999988899999999999999999999999987666555544443333333444566788999999999
Q ss_pred ccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 426 TKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 426 ~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
+.+|.+||++.++++||||.++..
T Consensus 256 ~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 256 TREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred cCCcccCcCHHHHhhChhhccCCC
Confidence 999999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=359.99 Aligned_cols=253 Identities=29% Similarity=0.484 Sum_probs=219.5
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
++|++.+.||+|+||.||++.+..+++.||||++.... .....+.+.+|+++|+++.||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999986432 2234567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.||+||||+|+||||+.++.+||+|||++..+... ..
T Consensus 81 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~ 156 (290)
T cd05580 81 EYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TY 156 (290)
T ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CC
Confidence 99999999999864 467999999999999999999999999999999999999999999999999999776443 33
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhc
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCL 425 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL 425 (774)
..+|++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+..... ..+..++..+.++|.+||
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l 233 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKV---RFPSFFSPDAKDLIRNLL 233 (290)
T ss_pred CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc---cCCccCCHHHHHHHHHHc
Confidence 45789999999999888889999999999999999999999987765444443332221 123345788999999999
Q ss_pred ccCCCCCC-----CHHHHHhhhhhhhh
Q 004088 426 TKEPRARP-----TAAEMLKHKFIERC 447 (774)
Q Consensus 426 ~~DP~kRP-----Ta~ElL~HPwf~~~ 447 (774)
..||.+|+ +++++++||||+.+
T Consensus 234 ~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 234 QVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred cCCHHHccCcccCCHHHHHcCcccccC
Confidence 99999999 99999999999764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=360.47 Aligned_cols=261 Identities=45% Similarity=0.792 Sum_probs=223.8
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
....+|++++.||+|+||.||++.+..++..||+|++.... ....+.+.+|+.+++.++||||++++++|...+..|+|
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 34579999999999999999999988899999999986433 23346788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
+||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..+.......
T Consensus 95 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~ 172 (293)
T cd06647 95 MEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (293)
T ss_pred EecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence 999999999998853 457889999999999999999999999999999999999999999999999987665443334
Q ss_pred ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
....|++.|+|||++....++.++|||||||++|+|++|+.||...........+.....+........+..+.++|.+|
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 252 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHH
Confidence 44578999999999988889999999999999999999999998766544443333333333333445677899999999
Q ss_pred cccCCCCCCCHHHHHhhhhhhhhc
Q 004088 425 LTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 425 L~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
|..+|.+||++.+++.||||+.++
T Consensus 253 l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 253 LEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred ccCChhhCcCHHHHhcCHHHhcCc
Confidence 999999999999999999999776
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=355.01 Aligned_cols=257 Identities=46% Similarity=0.820 Sum_probs=219.5
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC---CCCcccccccccCCceEEEEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS---HPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~---HPNIVkL~~~~~~~~~l~LVm 265 (774)
.|++++.||+|+||.||+|.+..+++.||||++...........+.+|+.+++++. ||||+++++++..+...|+||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 58889999999999999999999999999999876545555677889999999996 999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
||+++++|.++++. ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++..+........
T Consensus 82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06917 82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS 159 (277)
T ss_pred ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccc
Confidence 99999999998863 4789999999999999999999999999999999999999999999999999987655444444
Q ss_pred cccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 346 TFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
...|+..|+|||++.+ ..++.++|+|||||++|+|++|.+||...........+.....+... ...++..+.+||.+|
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~ 238 (277)
T cd06917 160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLE-DNGYSKLLREFVAAC 238 (277)
T ss_pred cccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCC-cccCCHHHHHHHHHH
Confidence 5579999999999875 34788999999999999999999999876655444333222222111 123678899999999
Q ss_pred cccCCCCCCCHHHHHhhhhhhhhc
Q 004088 425 LTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 425 L~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
|..||.+||++.++++|+||++..
T Consensus 239 l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 239 LDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred cCCCcccCcCHHHHhhChHhhccc
Confidence 999999999999999999998644
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=364.12 Aligned_cols=262 Identities=37% Similarity=0.660 Sum_probs=223.2
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
..+...|.....||.|+||.||++.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++.+...+..|+
T Consensus 18 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l 96 (292)
T cd06658 18 GDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV 96 (292)
T ss_pred CchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence 334556777888999999999999998899999999986433 3445678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
||||+++++|.+++. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+......
T Consensus 97 v~e~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~ 174 (292)
T cd06658 97 VMEFLEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174 (292)
T ss_pred EEeCCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence 999999999999874 346889999999999999999999999999999999999999999999999999765444333
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHh
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAK 423 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~k 423 (774)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||...........+.....+........+..+.+||.+
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 254 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL 254 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence 44567899999999998888999999999999999999999999876665544433332223333344567889999999
Q ss_pred hcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 424 CLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 424 cL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
||..+|.+|||+.++++||||+...
T Consensus 255 ~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 255 MLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred HccCChhHCcCHHHHhhChhhhccC
Confidence 9999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=359.55 Aligned_cols=257 Identities=30% Similarity=0.448 Sum_probs=208.6
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
.++|++.+.||.|+||.||+|.+..+++.||||.+...........+.+|+.++++++||||+++++++......|+|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 46899999999999999999999889999999998754433333457789999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
|+.+ +|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN 162 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence 9975 898888765667899999999999999999999999999999999999999999999999998654322222223
Q ss_pred ccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCc-hhhhhhhhc---C-------------------
Q 004088 347 FIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHP-MRVLFMISI---E------------------- 402 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~-~~~i~~i~~---~------------------- 402 (774)
..++..|+|||++.+ ..++.++|||||||++|+|++|++||..... ......+.. .
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS 242 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence 357889999999875 4588999999999999999999999976542 111110000 0
Q ss_pred -----CCCccccchhch--HHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 403 -----PAPMLEDKEKWS--LVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 403 -----~~~~~~~~~~~s--~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
..+.......++ ..+.++|.+||+.+|.+|||+.++|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000000011223 678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=355.85 Aligned_cols=258 Identities=34% Similarity=0.586 Sum_probs=209.4
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHH-HHhCCCCCcccccccccCCceEEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEM-LQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~i-L~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
++|++++.||+|+||.||+|.+..+|+.||||++...........+..|+.+ ++.++||||+++++++..+...|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4799999999999999999999999999999998765433334456667665 666799999999999999999999999
Q ss_pred ecCCCchhhhhhc---cCCchhHHHHHHHHHHHHHHHHHHHhc-CcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 267 YCGGGSVADLMNV---TEEPLEEYQIAYICREALKGLAYLHSI-FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 267 y~~ggsL~dll~~---~~~~Lse~~i~~I~~QIl~gL~YLHs~-gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
|++ ++|.+++.. ....+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 158 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV- 158 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 996 677776643 235689999999999999999999997 99999999999999999999999999997664332
Q ss_pred ccccccccccccchhhhhh----cCCCCccchhhhHHHHHHHHhCCCCCCCCC-chhhhhhhhcCCCCccccchhchHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQE----SRYDGKVDVWALGVSAVEMAEGLPPRSTVH-PMRVLFMISIEPAPMLEDKEKWSLVF 417 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~----~~~s~ksDIWSLGviLyELLtG~~Pf~~~~-~~~~i~~i~~~~~~~~~~~~~~s~~l 417 (774)
......|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||.... ....+..+.....+.. ....++..+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l 237 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQL-PAEKFSPEF 237 (283)
T ss_pred ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCC-CccccCHHH
Confidence 1223468999999999864 457889999999999999999999997532 2222222222222211 123568889
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 418 HDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 418 ~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.+||.+||..+|.+||++.++++||||....
T Consensus 238 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 238 QDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 9999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=361.33 Aligned_cols=254 Identities=22% Similarity=0.386 Sum_probs=205.8
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcC----------------CCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcc
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLK----------------TSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVV 249 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~----------------~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIV 249 (774)
+.++|++.++||+|+||.||+|.+.. ++..||||++...........+.+|+.+|.+++||||+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 45789999999999999999997532 34579999987554455567799999999999999999
Q ss_pred cccccccCCceEEEEEEecCCCchhhhhhccC------------------CchhHHHHHHHHHHHHHHHHHHHhcCcccc
Q 004088 250 RYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE------------------EPLEEYQIAYICREALKGLAYLHSIFKVHR 311 (774)
Q Consensus 250 kL~~~~~~~~~l~LVmEy~~ggsL~dll~~~~------------------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHR 311 (774)
++++++......|+||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 99999999999999999999999999875321 246788899999999999999999999999
Q ss_pred cccccceEecCCCcEEEeecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh--CCCCC
Q 004088 312 DIKGGNILLTDQGEVKLGDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE--GLPPR 387 (774)
Q Consensus 312 DLKPeNILLd~~g~vKL~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt--G~~Pf 387 (774)
||||+|||++.++.+||+|||+++.+..... ......++..|+|||++....++.++|||||||++|+|++ +..||
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 9999999999999999999999976543221 1223356889999999998889999999999999999986 56788
Q ss_pred CCCCchhhhhhhhc-----CCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHH
Q 004088 388 STVHPMRVLFMISI-----EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEML 439 (774)
Q Consensus 388 ~~~~~~~~i~~i~~-----~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL 439 (774)
........+..+.. ........+..++..+.+||.+||+.+|.+|||+.+|.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 243 GELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 76655443322211 00111122345677899999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=352.31 Aligned_cols=253 Identities=38% Similarity=0.634 Sum_probs=215.2
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh--------hhHHHHHHHHHHHHhCCCCCcccccccccCCce
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE--------EGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEY 260 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~--------~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~ 260 (774)
+|.+...||.|+||.||+|.+..+++.||+|++...... ...+.+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 478889999999999999999889999999988643321 223568899999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred cEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 9999999999999999863 467899999999999999999999999999999999999999999999999999766522
Q ss_pred c------cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhch
Q 004088 341 M------SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWS 414 (774)
Q Consensus 341 ~------~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s 414 (774)
. .......|++.|+|||++.+..++.++|||||||++|+|++|+.||........+..+.....+ ..+..++
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~ 237 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASP--EIPSNIS 237 (267)
T ss_pred cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCC--cCCcccC
Confidence 1 1112346889999999999888999999999999999999999999876655544443322221 2234567
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 415 LVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 415 ~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
..+.++|.+||+.+|.+||++.++++||||
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 238 SEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=358.16 Aligned_cols=258 Identities=29% Similarity=0.421 Sum_probs=208.7
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
..++|++++.||+|+||.||+|.+..+|+.||||++...........+.+|+.+|+.++|+||+++++++..+...|+||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 35789999999999999999999999999999999875544444456788999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
||+. ++|..++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 161 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS 161 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence 9995 567666654456688889999999999999999999999999999999999999999999999976544333334
Q ss_pred cccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCch-hhhhhhhc---------------CC-----
Q 004088 346 TFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPM-RVLFMISI---------------EP----- 403 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~-~~i~~i~~---------------~~----- 403 (774)
...+++.|+|||++.+. .++.++|||||||++|+|++|..||...... +.+..+.. .+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence 45689999999998753 4788999999999999999999999765432 11111100 00
Q ss_pred ------CCcc---ccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 404 ------APML---EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 404 ------~~~~---~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
.... ......+..+.++|.+||..||.+|||+.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0000 0001124678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=353.99 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=212.1
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEc---CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDL---KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~---~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
...+|++.+.||+|+||.||+|.+. ..+..||+|+++..........+.+|+.+|++++||||+++++++......|
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 3567999999999999999999865 3567899999876544455567889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc-
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM- 341 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~- 341 (774)
|||||+++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+.......
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~ 162 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI 162 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccch
Confidence 9999999999999987656689999999999999999999999999999999999999999999999999875432221
Q ss_pred cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHH-hCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMA-EGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELL-tG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
.......++..|+|||++.+..++.++|||||||++|+|+ +|..||...........+..... .+.+..++..+.++
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l 240 (266)
T cd05064 163 YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR--LPAPRNCPNLLHQL 240 (266)
T ss_pred hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC--CCCCCCCCHHHHHH
Confidence 1111234567899999999999999999999999999977 49999987766655444433221 22345577889999
Q ss_pred HHhhcccCCCCCCCHHHHHh
Q 004088 421 VAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~ 440 (774)
+.+||+.+|.+||++.++++
T Consensus 241 i~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 241 MLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHcCCCchhCCCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=349.21 Aligned_cols=251 Identities=29% Similarity=0.527 Sum_probs=217.4
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEec
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYC 268 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~ 268 (774)
+|++.+.||.|+||.||++.+..+++.||+|.++........+.+.+|+.+++.++||||+++++++.....+|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 58999999999999999999999999999999876555556678889999999999999999999999999999999999
Q ss_pred CCCchhhhhhc-cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccc
Q 004088 269 GGGSVADLMNV-TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF 347 (774)
Q Consensus 269 ~ggsL~dll~~-~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~ 347 (774)
++++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+..........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY 160 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccccc
Confidence 99999988754 34568999999999999999999999999999999999999999999999999997665443334456
Q ss_pred cccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhccc
Q 004088 348 IGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTK 427 (774)
Q Consensus 348 ~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~ 427 (774)
.|++.|+|||++.+..++.++|||||||++|+|++|.+||...+.......+....... .+..++..+.+||.+||+.
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~ 238 (255)
T cd08219 161 VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP--LPSHYSYELRSLIKQMFKR 238 (255)
T ss_pred cCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC--CCcccCHHHHHHHHHHHhC
Confidence 79999999999998889999999999999999999999998766555544443322221 2345678899999999999
Q ss_pred CCCCCCCHHHHHhh
Q 004088 428 EPRARPTAAEMLKH 441 (774)
Q Consensus 428 DP~kRPTa~ElL~H 441 (774)
||.+||++.+++.-
T Consensus 239 ~P~~Rp~~~~il~~ 252 (255)
T cd08219 239 NPRSRPSATTILSR 252 (255)
T ss_pred CcccCCCHHHHhhc
Confidence 99999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.30 Aligned_cols=256 Identities=32% Similarity=0.509 Sum_probs=211.8
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh-hhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE-EGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~-~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
++|++.++||+|+||.||+|.+..+++.||||++...... ...+.+.+|+++|+.++||||+++++++......|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4799999999999999999999889999999998654322 234568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
|+++++|..+.. ....+++..++.++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++..+.........
T Consensus 81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07846 81 FVDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD 159 (286)
T ss_pred cCCccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence 999988887764 3445899999999999999999999999999999999999999999999999999776544333344
Q ss_pred ccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC---------------------CC
Q 004088 347 FIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE---------------------PA 404 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~---------------------~~ 404 (774)
..++..|+|||++.+ ..++.++|||||||++|+|++|.+||...........+... ..
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence 578999999999875 34788999999999999999999999765433222111100 00
Q ss_pred -------CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 405 -------PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 405 -------~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
+.......++..+.+||.+||..+|.+||++.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0001123457789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=360.88 Aligned_cols=264 Identities=30% Similarity=0.472 Sum_probs=214.7
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh-hhHHHHHHHHHHHHhCCCCCcccccccccCC--ceE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE-EGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE--EYL 261 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~-~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~--~~l 261 (774)
....+|++.+.||.|+||.||+|.+..+|+.||+|++...... .....+.+|+.+|++++|+||+++++++... ..+
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 3567899999999999999999999999999999998754322 2233467899999999999999999998654 578
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|+||||+. ++|.+++......+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 99999996 47888876556779999999999999999999999999999999999999999999999999998765433
Q ss_pred cccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCC-C---------------
Q 004088 342 SKRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEP-A--------------- 404 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~-~--------------- 404 (774)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+....+..+.... .
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV 242 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence 33333456889999999875 458899999999999999999999998766554433221100 0
Q ss_pred ----------Cccc-cchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 405 ----------PMLE-DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 405 ----------~~~~-~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
.... .....++.+.+||.+||+.||++|||+.++|+||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence 0000 01124678899999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=352.13 Aligned_cols=254 Identities=37% Similarity=0.689 Sum_probs=213.7
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-----hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-----EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-----~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
+|++.+.||.|+||.||+|.+ .+++.||||.+..... ......+.+|+.+|++++|+||+++++++.....+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588899999999999999986 5788999999864331 2234568899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc---
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT--- 340 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~--- 340 (774)
||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+|+|+||||+||+++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 80 FMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred EEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 9999999999999863 356899999999999999999999999999999999999999999999999998765321
Q ss_pred ---ccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHH
Q 004088 341 ---MSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVF 417 (774)
Q Consensus 341 ---~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l 417 (774)
........|+..|+|||++.+..++.++|||||||++|+|++|..||...+.......+.............++..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 11122346899999999999888999999999999999999999999876655443333222112222344578889
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 418 HDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 418 ~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
.+||.+||..+|.+||++.++++||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=346.89 Aligned_cols=257 Identities=39% Similarity=0.677 Sum_probs=221.9
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
++|++.+.||.|+||.||+|.+..+++.||||++...........+.+|+.++.+++||||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36899999999999999999999999999999987654435567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHh-cCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 268 CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS-IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 268 ~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs-~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
+++++|.+++... ..+++..+..++.||+.||.|||+ .|++||||+|+||+++.++.++|+|||++..+.........
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 159 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT 159 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccc
Confidence 9999999998643 679999999999999999999999 99999999999999999999999999999876554444345
Q ss_pred ccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCC---chhhhhhhhcCCCCccccchh-chHHHHHHHH
Q 004088 347 FIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVH---PMRVLFMISIEPAPMLEDKEK-WSLVFHDFVA 422 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~---~~~~i~~i~~~~~~~~~~~~~-~s~~l~dLI~ 422 (774)
..++..|+|||.+....++.++||||||+++|+|++|..||.... .......+.....+. .... ++..+.++|.
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~ 237 (264)
T cd06623 160 FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS--LPAEEFSPEFRDFIS 237 (264)
T ss_pred eeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC--CCcccCCHHHHHHHH
Confidence 678999999999998889999999999999999999999997764 222222222222221 2233 6788999999
Q ss_pred hhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 423 KCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
+||..+|.+||++.++++||||+.+
T Consensus 238 ~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 238 ACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHccCChhhCCCHHHHHhCHHHHhc
Confidence 9999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=354.03 Aligned_cols=255 Identities=32% Similarity=0.512 Sum_probs=212.8
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
+|++.+.||.|+||.||+|.+..+|+.||||++..... ......+.+|+.++++++||||+++++++.....+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 58999999999999999999999999999999976542 33456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc-cccc
Q 004088 268 CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS-KRNT 346 (774)
Q Consensus 268 ~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~-~~~~ 346 (774)
+ +++|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 9 9999999876667899999999999999999999999999999999999999999999999999976644321 1234
Q ss_pred ccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC---C-------------------
Q 004088 347 FIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE---P------------------- 403 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~---~------------------- 403 (774)
..|+..|+|||++.+. .++.++|||||||++|+|++|.+||........+..+... +
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF 239 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccC
Confidence 5789999999998654 4688999999999999999998888765543332221100 0
Q ss_pred --C---CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 404 --A---PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 404 --~---~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
. +........+..+.+||.+||..+|.+||++.++|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~ 285 (286)
T cd07832 240 PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285 (286)
T ss_pred CCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence 0 0000112346788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=346.35 Aligned_cols=254 Identities=33% Similarity=0.556 Sum_probs=217.8
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCccccccccc--CCceEEEEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ--GEEYLWIVM 265 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~--~~~~l~LVm 265 (774)
+|++++.||.|+||.||+|.+..+++.||+|++.... .....+.+.+|+.++++++||||+++++++. .....|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5899999999999999999999999999999987543 3344567889999999999999999999774 456789999
Q ss_pred EecCCCchhhhhhcc---CCchhHHHHHHHHHHHHHHHHHHH-----hcCcccccccccceEecCCCcEEEeeccccccc
Q 004088 266 EYCGGGSVADLMNVT---EEPLEEYQIAYICREALKGLAYLH-----SIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL 337 (774)
Q Consensus 266 Ey~~ggsL~dll~~~---~~~Lse~~i~~I~~QIl~gL~YLH-----s~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i 337 (774)
||+++++|.+++... ..++++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++..+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999988643 467899999999999999999999 889999999999999999999999999999876
Q ss_pred cccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHH
Q 004088 338 TRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVF 417 (774)
Q Consensus 338 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l 417 (774)
...........|++.|+|||++....++.++|+|||||++|+|++|+.||...........+.....+ ..+..++..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 238 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR--RIPYRYSSEL 238 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC--CCccccCHHH
Confidence 55433234557899999999999888999999999999999999999999887655544444333222 2234677889
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 418 HDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 418 ~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
.+++.+||+.+|.+||++.+|++|||+
T Consensus 239 ~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 239 NEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=350.26 Aligned_cols=256 Identities=36% Similarity=0.583 Sum_probs=209.3
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
...+.....||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.++++++||||+++++++..+..+++|||
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 344445568999999999999998899999999886433 3445678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCch--hHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC-CCcEEEeeccccccccccccc
Q 004088 267 YCGGGSVADLMNVTEEPL--EEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD-QGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~L--se~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~-~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|+++++|.+++......+ ++..+..++.||+.||.|||++||+||||||+|||++. ++.++|+|||++..+......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence 999999999987554555 88889999999999999999999999999999999976 678999999998765433233
Q ss_pred cccccccccccchhhhhhcC--CCCccchhhhHHHHHHHHhCCCCCCCCCchhhh-hhhhcCCCCccccchhchHHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESR--YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVL-FMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~--~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i-~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
.....|++.|+|||++.... ++.++|||||||++|+|++|.+||......... ...... ......+..++..+.+|
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 244 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF-KIHPEIPESLSAEAKNF 244 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh-ccCCCCCcccCHHHHHH
Confidence 33446899999999986543 788999999999999999999999764432211 111100 01111233567789999
Q ss_pred HHhhcccCCCCCCCHHHHHhhhhh
Q 004088 421 VAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
|.+||..+|.+|||+.+++.||||
T Consensus 245 i~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 245 ILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHcCCCchhCCCHHHHHhCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=349.57 Aligned_cols=252 Identities=30% Similarity=0.468 Sum_probs=216.8
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
+|++.+.||.|+||.||+|.+..+++.||+|++.... .....+.+.+|++++++++||||+++++++......|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5899999999999999999998899999999997543 22456788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
|+.+++|.+++... ..+++..+..++.||+.||.|||.+||+|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~ 158 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTS 158 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cccc
Confidence 99999999998643 679999999999999999999999999999999999999999999999999987654432 2334
Q ss_pred ccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCc--hhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 347 FIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHP--MRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~--~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
..|+..|+|||++....++.++|+|||||++|+|++|..||..... ...+...... .....+..++..+.++|.+|
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred cCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHHHHH
Confidence 5689999999999988899999999999999999999999987664 2221111111 22233446778999999999
Q ss_pred cccCCCCCCCH--HHHHhhhhh
Q 004088 425 LTKEPRARPTA--AEMLKHKFI 444 (774)
Q Consensus 425 L~~DP~kRPTa--~ElL~HPwf 444 (774)
|..||.+||++ .++++||||
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCccHHHHhcCCCC
Confidence 99999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=356.20 Aligned_cols=259 Identities=30% Similarity=0.430 Sum_probs=213.8
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh----hhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE----EGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~----~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
+|++.+.||.|+||.||+|.+..+++.||||++...... .....+..|+.++++++||||+++++++.....+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999989999999999754322 2334567899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
|||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 889999987544479999999999999999999999999999999999999999999999999998765543333
Q ss_pred ccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC---C-----------------
Q 004088 345 NTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE---P----------------- 403 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~---~----------------- 403 (774)
....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||........+..+... +
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF 239 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence 44467889999999865 45788999999999999999998888766554332221100 0
Q ss_pred -----CCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 404 -----APMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 404 -----~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.+........+..+.+||.+||.++|.+|||+.++|+||||++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 000001123467789999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=340.49 Aligned_cols=253 Identities=55% Similarity=0.971 Sum_probs=221.4
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEec
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYC 268 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~ 268 (774)
.|++.+.||+|+||.||++.+..+++.|++|++..... .....+.+|+.++++++||||+++++++......++|+||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 48899999999999999999988999999999865433 35678899999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccc
Q 004088 269 GGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFI 348 (774)
Q Consensus 269 ~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~ 348 (774)
++++|.+++......+++..+..++.|++.||.|||.+|++||||+|+||+++.++.++|+|||.+........ .....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 158 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMV 158 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-cccee
Confidence 99999999876556899999999999999999999999999999999999999999999999999976654322 34557
Q ss_pred ccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccC
Q 004088 349 GTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKE 428 (774)
Q Consensus 349 GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~D 428 (774)
|+..|+|||++....++.++|||||||++|+|++|..||...+.............+.......++..+.++|.+||..|
T Consensus 159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 238 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKN 238 (253)
T ss_pred cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCC
Confidence 89999999999988899999999999999999999999987765555544443333444444445888999999999999
Q ss_pred CCCCCCHHHHHhhhh
Q 004088 429 PRARPTAAEMLKHKF 443 (774)
Q Consensus 429 P~kRPTa~ElL~HPw 443 (774)
|.+|||+.++++|||
T Consensus 239 p~~R~t~~~~l~~~~ 253 (253)
T cd05122 239 PEKRPTAEQLLKHPF 253 (253)
T ss_pred hhhCCCHHHHhcCCC
Confidence 999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=353.08 Aligned_cols=255 Identities=29% Similarity=0.456 Sum_probs=211.3
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEec
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYC 268 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~ 268 (774)
+|+++++||.|+||.||+|++..+|+.||||++...........+.+|+.++++++||||+++++++...+..+|||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 58999999999999999999999999999999976554444567788999999999999999999999999999999999
Q ss_pred CCCchhhhhhccC--CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 269 GGGSVADLMNVTE--EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 269 ~ggsL~dll~~~~--~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
++ +|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+.........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN 159 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccc
Confidence 75 7888775433 56899999999999999999999999999999999999999999999999999765443333334
Q ss_pred ccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC---C-----------------CC
Q 004088 347 FIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE---P-----------------AP 405 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~---~-----------------~~ 405 (774)
..+++.|++||++.+. .++.++|||||||++|+|++|++||......+....+... + .+
T Consensus 160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07836 160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP 239 (284)
T ss_pred ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccccc
Confidence 5678999999998654 5788999999999999999999999876654332221100 0 00
Q ss_pred cc------ccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 406 ML------EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 406 ~~------~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
.. ......+..+.++|.+||+.||.+||++.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 0012346778999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=352.08 Aligned_cols=256 Identities=55% Similarity=0.949 Sum_probs=220.8
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
.-|+++++||.|+||.||+|.+..+++.||||++...........+.+|+.++++++||||+++++++..+...|+||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 45888999999999999999998899999999987655555567789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccc
Q 004088 268 CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF 347 (774)
Q Consensus 268 ~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~ 347 (774)
+++++|..++. ...+++..+..++.|++.+|.|||+.||+|+||||+||+++.++.++|+|||++..+..........
T Consensus 84 ~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06641 84 LGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence 99999998885 3468999999999999999999999999999999999999999999999999987665443333445
Q ss_pred cccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhccc
Q 004088 348 IGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTK 427 (774)
Q Consensus 348 ~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~ 427 (774)
.|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+.....+. ....++..+.++|.+||+.
T Consensus 162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~ 239 (277)
T cd06641 162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT--LEGNYSKPLKEFVEACLNK 239 (277)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCC--CCcccCHHHHHHHHHHccC
Confidence 78999999999988889999999999999999999999998766554444432222221 2334677899999999999
Q ss_pred CCCCCCCHHHHHhhhhhhhh
Q 004088 428 EPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 428 DP~kRPTa~ElL~HPwf~~~ 447 (774)
+|.+||++.++++||||.+.
T Consensus 240 ~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 240 EPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ChhhCcCHHHHHhCHHHhhh
Confidence 99999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=353.97 Aligned_cols=255 Identities=29% Similarity=0.450 Sum_probs=209.2
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
+|++++.||.|+||.||+|++..+++.||||++..... ......+.+|++++++++||||+++++++.+....|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 48999999999999999999999999999999865432 22335688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 268 CGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 268 ~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
+. ++|..++... ...+++..+..++.||+.||+|||++||+||||+|+||+++.++.+||+|||++..+.........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 159 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence 95 5788877533 456899999999999999999999999999999999999999999999999999766443333334
Q ss_pred ccccccccchhhhhhcC-CCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-CCC-------------------
Q 004088 347 FIGTPHWMAPEVIQESR-YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-PAP------------------- 405 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~~~-~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-~~~------------------- 405 (774)
..+++.|+|||++.+.. ++.++|||||||++|+|++|+.||...........+... ..+
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07860 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP 239 (284)
T ss_pred ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence 46789999999987644 688999999999999999999999766544333221110 000
Q ss_pred ------ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 406 ------MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 406 ------~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
.......++..++++|.+||+.||.+|||+.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 000112356778999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=345.29 Aligned_cols=255 Identities=38% Similarity=0.695 Sum_probs=216.2
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
+|.+.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.++++++|+||+++++++.....+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 68999999999999999999988999999999976543 24567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc---
Q 004088 268 CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR--- 344 (774)
Q Consensus 268 ~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~--- 344 (774)
+++++|.+++.. ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 81 CSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred CCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 999999999863 4568999999999999999999999999999999999999999999999999997664432221
Q ss_pred -ccccccccccchhhhhhcC---CCCccchhhhHHHHHHHHhCCCCCCCCCc-hhhhhhhhcCCCCccccchhchHHHHH
Q 004088 345 -NTFIGTPHWMAPEVIQESR---YDGKVDVWALGVSAVEMAEGLPPRSTVHP-MRVLFMISIEPAPMLEDKEKWSLVFHD 419 (774)
Q Consensus 345 -~~~~GT~~Y~APEvl~~~~---~s~ksDIWSLGviLyELLtG~~Pf~~~~~-~~~i~~i~~~~~~~~~~~~~~s~~l~d 419 (774)
....+++.|+|||++.... ++.++|||||||++|+|++|..||..... ......+.....+..+.....+..+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 1346889999999998766 88999999999999999999999976532 222222232333333333445788999
Q ss_pred HHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 420 FVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 420 LI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
||.+||+.+|.+||++.+++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=353.46 Aligned_cols=253 Identities=26% Similarity=0.421 Sum_probs=214.6
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCC-----cEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTS-----ELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g-----~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
..+|++++.||+|+||.||+|.+...+ ..||+|.+...........+.+|+.+|.+++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 457999999999999999999876554 679999987555555567789999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccC---------------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcE
Q 004088 262 WIVMEYCGGGSVADLMNVTE---------------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEV 326 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~---------------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~v 326 (774)
|++|||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcE
Confidence 99999999999999886321 458889999999999999999999999999999999999999999
Q ss_pred EEeecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCC
Q 004088 327 KLGDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEP 403 (774)
Q Consensus 327 KL~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~ 403 (774)
||+|||++..+..... ......+++.|+|||++....++.++|||||||++|||++ |..||......+....+....
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~ 243 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ 243 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999976533211 1223457889999999988889999999999999999997 999998877666655544332
Q ss_pred CCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 404 APMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 404 ~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.+ ..+..++..+.+|+.+||+.||.+||++.+++++
T Consensus 244 ~~--~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 244 LL--PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cC--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22 2345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=354.86 Aligned_cols=258 Identities=37% Similarity=0.667 Sum_probs=222.3
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
..|...+.||+|+||.||++.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++...++.|+|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 45777789999999999999998899999999986433 23345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccc
Q 004088 268 CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF 347 (774)
Q Consensus 268 ~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~ 347 (774)
+.+++|.+++.. .++++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.............
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 175 (285)
T cd06648 98 LEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL 175 (285)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence 999999998864 568999999999999999999999999999999999999999999999999987655443333445
Q ss_pred cccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhccc
Q 004088 348 IGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTK 427 (774)
Q Consensus 348 ~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~ 427 (774)
.|++.|+|||++.+..++.++|||||||++|+|++|..||...........+.....+.......++..+.+||.+||..
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 255 (285)
T cd06648 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVR 255 (285)
T ss_pred cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHccc
Confidence 79999999999988889999999999999999999999998776655554444333333333344678899999999999
Q ss_pred CCCCCCCHHHHHhhhhhhhhc
Q 004088 428 EPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 428 DP~kRPTa~ElL~HPwf~~~~ 448 (774)
+|.+||++.++++||||+++.
T Consensus 256 ~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 256 DPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred ChhhCcCHHHHccCcccccCC
Confidence 999999999999999998865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=349.52 Aligned_cols=255 Identities=37% Similarity=0.623 Sum_probs=212.3
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC----ChhhHHHHHHHHHHHHhCCCCCcccccccccC--CceE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE----GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG--EEYL 261 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~----~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~--~~~l 261 (774)
..|++.+.||+|+||.||+|.+..++..||+|++.... .......+.+|+.++++++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47899999999999999999999999999999986432 12334568899999999999999999998864 4678
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+|+||||||+||+++.++.+||+|||++..+....
T Consensus 82 ~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 999999999999998863 4568999999999999999999999999999999999999999999999999987653321
Q ss_pred ---cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 342 ---SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 342 ---~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
.......++..|+|||++.+..++.++|||||||++|+|++|++||........+..+...... ...+...+..+.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 239 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN-PQLPSHISEHAR 239 (266)
T ss_pred ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCC-CCCchhcCHHHH
Confidence 1122346899999999999888999999999999999999999999877655554443322211 122344577788
Q ss_pred HHHHhhcccCCCCCCCHHHHHhhhhhh
Q 004088 419 DFVAKCLTKEPRARPTAAEMLKHKFIE 445 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~HPwf~ 445 (774)
++| +||..+|++||++.++++||||+
T Consensus 240 ~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 240 DFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 898 68888999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=357.93 Aligned_cols=259 Identities=29% Similarity=0.428 Sum_probs=217.4
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC--hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG--EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~--~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
++|++++.||+|+||.||++.+..+++.||||.+..... ......+.+|+.+++.++||||+++++.+..+.++|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 469999999999999999999999999999999875431 234457889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc----
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM---- 341 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~---- 341 (774)
||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 81 EYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred ecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 99999999999864 4578999999999999999999999999999999999999999999999999986311100
Q ss_pred -----------cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccc
Q 004088 342 -----------SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDK 410 (774)
Q Consensus 342 -----------~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~ 410 (774)
.......|+..|+|||.+....++.++|||||||++|+|++|..||...........+...........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 011124678899999999888899999999999999999999999987766555544433322222222
Q ss_pred hhchHHHHHHHHhhcccCCCCCCC---HHHHHhhhhhhhh
Q 004088 411 EKWSLVFHDFVAKCLTKEPRARPT---AAEMLKHKFIERC 447 (774)
Q Consensus 411 ~~~s~~l~dLI~kcL~~DP~kRPT---a~ElL~HPwf~~~ 447 (774)
..++..+.+||.+||+.+|++||+ +.++|+||||...
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 356788999999999999999998 7999999999653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=360.15 Aligned_cols=248 Identities=25% Similarity=0.434 Sum_probs=191.8
Q ss_pred EeeeeccCceEEEEEEEcC--CCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCccccccccc--CCceEEEEEEec
Q 004088 193 LNELGKGSYGAVYKARDLK--TSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ--GEEYLWIVMEYC 268 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~~--~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~--~~~~l~LVmEy~ 268 (774)
..+||+|+||.||+|++.. ++..||+|.+.... ....+.+|+.+|++++||||+++++++. .+..+|+||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 4689999999999999653 56889999986432 2345778999999999999999999884 467889999999
Q ss_pred CCCchhhhhhc--------cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEe----cCCCcEEEeecccccc
Q 004088 269 GGGSVADLMNV--------TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL----TDQGEVKLGDFGVAAQ 336 (774)
Q Consensus 269 ~ggsL~dll~~--------~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILL----d~~g~vKL~DFGlA~~ 336 (774)
++ +|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 64 67666532 12358899999999999999999999999999999999999 4567899999999987
Q ss_pred cccccc---ccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhh------------hhhhh
Q 004088 337 LTRTMS---KRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRV------------LFMIS 400 (774)
Q Consensus 337 i~~~~~---~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~------------i~~i~ 400 (774)
+..... ......||+.|+|||++.+. .++.++|||||||++|+|++|++||........ .....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 654322 22345789999999999764 588999999999999999999999975332100 00000
Q ss_pred cCCC-------------Cc-------------------cccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 401 IEPA-------------PM-------------------LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 401 ~~~~-------------~~-------------------~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
..+. +. .......+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 00 00011224567899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=343.61 Aligned_cols=253 Identities=28% Similarity=0.495 Sum_probs=216.4
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
+|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|++++||||+++++.+.....+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5899999999999999999999999999999987543 234456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC-cEEEeeccccccccccccccc
Q 004088 268 CGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG-EVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 268 ~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g-~vKL~DFGlA~~i~~~~~~~~ 345 (774)
+++++|.+++... ...+++..+..++.|++.+|.|||++||+||||||+||+++.++ .+||+|||++....... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~ 159 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KAY 159 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-ccc
Confidence 9999999998754 34589999999999999999999999999999999999998654 58999999997664432 223
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhc
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCL 425 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL 425 (774)
...|+..|+|||++....++.++|||||||++|+|++|..||...+.......+...... .....++..+.++|.+||
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l 237 (256)
T cd08220 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA--PISDRYSPDLRQLILSML 237 (256)
T ss_pred ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC--CCCCCcCHHHHHHHHHHc
Confidence 457899999999999888999999999999999999999999877655544443322221 123356788999999999
Q ss_pred ccCCCCCCCHHHHHhhhhh
Q 004088 426 TKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 426 ~~DP~kRPTa~ElL~HPwf 444 (774)
..+|.+|||+.++++||||
T Consensus 238 ~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 238 NLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred cCChhhCCCHHHHhhCCCC
Confidence 9999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=373.00 Aligned_cols=265 Identities=25% Similarity=0.382 Sum_probs=213.3
Q ss_pred CCCCCcccCCCCCCeeEEeeeeccCceEEEEEEE-----cCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcc
Q 004088 176 SIPESVTREDPTTKYELLNELGKGSYGAVYKARD-----LKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVV 249 (774)
Q Consensus 176 s~~~~~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d-----~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIV 249 (774)
..+....+..+.++|++.+.||+|+||.||+|++ ..++..||||+++........+.+.+|+.+|+.+ +||||+
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv 102 (375)
T cd05104 23 QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIV 102 (375)
T ss_pred CCCCccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCccee
Confidence 3444445566778999999999999999999974 3456789999986544444556788999999999 899999
Q ss_pred cccccccCCceEEEEEEecCCCchhhhhhccC------------------------------------------------
Q 004088 250 RYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE------------------------------------------------ 281 (774)
Q Consensus 250 kL~~~~~~~~~l~LVmEy~~ggsL~dll~~~~------------------------------------------------ 281 (774)
+++++|......++|||||++|+|.++++...
T Consensus 103 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 182 (375)
T cd05104 103 NLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTK 182 (375)
T ss_pred eeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccc
Confidence 99999999999999999999999998885321
Q ss_pred --------------------------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccc
Q 004088 282 --------------------------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 282 --------------------------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 262 (375)
T cd05104 183 ADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 262 (375)
T ss_pred cccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccce
Confidence 246788899999999999999999999999999999999999999999999997
Q ss_pred cccccccc--cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchh
Q 004088 336 QLTRTMSK--RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEK 412 (774)
Q Consensus 336 ~i~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~ 412 (774)
.+...... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.................. ...+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~ 341 (375)
T cd05104 263 DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR-MLSPEC 341 (375)
T ss_pred eccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc-CCCCCC
Confidence 66433211 112345678999999999899999999999999999997 89999765543333222221111 112234
Q ss_pred chHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 413 WSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 413 ~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.+..+.+||.+||+.||++||++.++++.
T Consensus 342 ~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 342 APSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 56789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=346.79 Aligned_cols=255 Identities=35% Similarity=0.601 Sum_probs=213.0
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC----ChhhHHHHHHHHHHHHhCCCCCcccccccccC--CceE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE----GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG--EEYL 261 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~----~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~--~~~l 261 (774)
.+|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++++.||||+++++++.. ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57999999999999999999999999999999986432 12335678899999999999999999998865 3578
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++|+|+||||+|||++.++.++|+|||++..+....
T Consensus 82 ~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 899999999999998863 3568899999999999999999999999999999999999999999999999987653211
Q ss_pred ---cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 342 ---SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 342 ---~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
.......|+..|+|||++.+..++.++|||||||++|+|++|+.||........+..+...+. ....+...+..+.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 239 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT-NPVLPPHVSDHCR 239 (265)
T ss_pred ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCC-CCCCchhhCHHHH
Confidence 122334689999999999888899999999999999999999999987655554444332221 1222345677899
Q ss_pred HHHHhhcccCCCCCCCHHHHHhhhhhh
Q 004088 419 DFVAKCLTKEPRARPTAAEMLKHKFIE 445 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~HPwf~ 445 (774)
++|.+||. +|++||+++++++|||++
T Consensus 240 ~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 240 DFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 99999995 999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=347.21 Aligned_cols=255 Identities=32% Similarity=0.582 Sum_probs=212.9
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-----hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-----EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-----~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
+|+..+.||+|+||.||++.+..+++.||||++..... ......+.+|+++|++++||||+++++++...+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 48889999999999999999999999999999874331 1235678999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC-cEEEeecccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG-EVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g-~vKL~DFGlA~~i~~~~~ 342 (774)
||||+.+++|.+++. ...++++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++..+.....
T Consensus 81 v~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 81 FVEWMAGGSVSHLLS-KYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEeccCCCcHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 999999999999986 345789999999999999999999999999999999999998776 599999999976654311
Q ss_pred ----ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhh---hhhcCCCCccccchhchH
Q 004088 343 ----KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLF---MISIEPAPMLEDKEKWSL 415 (774)
Q Consensus 343 ----~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~---~i~~~~~~~~~~~~~~s~ 415 (774)
......|+..|+|||++.+..++.++|||||||++|+|++|..||.......... .+... ......+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA-TTAPSIPEHLSP 238 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc-CCCCCCchhhCH
Confidence 1223468999999999988889999999999999999999999997544322111 11111 111223345678
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhhhhhh
Q 004088 416 VFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445 (774)
Q Consensus 416 ~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~ 445 (774)
.+.++|.+||..+|.+||++.++++||||+
T Consensus 239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 899999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=373.02 Aligned_cols=264 Identities=24% Similarity=0.404 Sum_probs=213.8
Q ss_pred CCCCcccCCCCCCeeEEeeeeccCceEEEEEEEcCC-----CcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCccc
Q 004088 177 IPESVTREDPTTKYELLNELGKGSYGAVYKARDLKT-----SELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVR 250 (774)
Q Consensus 177 ~~~~~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~-----g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVk 250 (774)
.|....+..+.++|++++.||+|+||.||+|++... ++.||||++.........+.+.+|+.+|+.+ +|||||+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~ 106 (374)
T cd05106 27 LPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVN 106 (374)
T ss_pred ccccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceee
Confidence 444444566778999999999999999999986443 3579999997655555567789999999999 8999999
Q ss_pred ccccccCCceEEEEEEecCCCchhhhhhccC-------------------------------------------------
Q 004088 251 YLGSYQGEEYLWIVMEYCGGGSVADLMNVTE------------------------------------------------- 281 (774)
Q Consensus 251 L~~~~~~~~~l~LVmEy~~ggsL~dll~~~~------------------------------------------------- 281 (774)
++++|.....+|+|||||.+|+|.++++...
T Consensus 107 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (374)
T cd05106 107 LLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRP 186 (374)
T ss_pred EeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCC
Confidence 9999999999999999999999998875321
Q ss_pred --------------------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 282 --------------------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 282 --------------------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
.++++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~ 266 (374)
T cd05106 187 VSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266 (374)
T ss_pred ccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCc
Confidence 247888999999999999999999999999999999999999999999999997654321
Q ss_pred c--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 342 S--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 342 ~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
. ......+++.|+|||++....++.++|||||||++|+|++ |+.||................. ....+...+..+.
T Consensus 267 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 345 (374)
T cd05106 267 NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY-QMSRPDFAPPEIY 345 (374)
T ss_pred ceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc-CccCCCCCCHHHH
Confidence 1 1112335678999999998889999999999999999997 9999987654433332222111 1112334578899
Q ss_pred HHHHhhcccCCCCCCCHHHHHhh
Q 004088 419 DFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
++|.+||+.||.+|||+.++++.
T Consensus 346 ~li~~cl~~dp~~RPs~~~l~~~ 368 (374)
T cd05106 346 SIMKMCWNLEPTERPTFSQISQL 368 (374)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=352.68 Aligned_cols=260 Identities=50% Similarity=0.884 Sum_probs=226.2
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
.....|++.+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+.+|++++|+||+++++++......|+|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 456779999999999999999999988899999999975433 456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
+||+++++|.+++......+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++..........
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 173 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR 173 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhh
Confidence 99999999999997654589999999999999999999999999999999999999999999999999987654433333
Q ss_pred ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
....+++.|+|||++.+..++.++|||||||++|+|++|+.||...........+.....+.......++..+.+||.+|
T Consensus 174 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 253 (286)
T cd06614 174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKC 253 (286)
T ss_pred ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHH
Confidence 44568899999999998889999999999999999999999998776655444443333333334445788999999999
Q ss_pred cccCCCCCCCHHHHHhhhhhhh
Q 004088 425 LTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 425 L~~DP~kRPTa~ElL~HPwf~~ 446 (774)
|+.+|.+||++.++++|+||++
T Consensus 254 l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 254 LVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred hccChhhCcCHHHHhhChHhhc
Confidence 9999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=383.21 Aligned_cols=253 Identities=25% Similarity=0.344 Sum_probs=205.0
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
....|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+++|++|+|||||++++++......||||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 35589999999999999999999999999999996421 23568999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc--c
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS--K 343 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~--~ 343 (774)
|++. ++|..++......+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+..... .
T Consensus 240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 9995 688888765556799999999999999999999999999999999999999999999999999976543221 1
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCc--------hhhhhhhhcCC-----CCc----
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHP--------MRVLFMISIEP-----APM---- 406 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~--------~~~i~~i~~~~-----~~~---- 406 (774)
....+||+.|+|||++.+..++.++|||||||++|||++|..|+..... ......+.... .+.
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence 2245799999999999999999999999999999999998765432211 11111111000 000
Q ss_pred ----------------------cccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 407 ----------------------LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 407 ----------------------~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
+.....++..+.+||.+||+.||.+|||+.|||+||||+.
T Consensus 399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0001123457889999999999999999999999999963
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=354.19 Aligned_cols=257 Identities=31% Similarity=0.436 Sum_probs=207.7
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCC-CCCcccccccccCCce-----
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQGEEY----- 260 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~~~~----- 260 (774)
++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++++. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 479999999999999999999999999999999865432 223456888999999995 6999999999876555
Q ss_pred EEEEEEecCCCchhhhhhcc----CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC-CCcEEEeeccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVT----EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD-QGEVKLGDFGVAA 335 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~----~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~-~g~vKL~DFGlA~ 335 (774)
.|+||||+++ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999975 787776532 246899999999999999999999999999999999999998 8899999999997
Q ss_pred cccccccccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC---C--------
Q 004088 336 QLTRTMSKRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE---P-------- 403 (774)
Q Consensus 336 ~i~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~---~-------- 403 (774)
.+...........+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+... +
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 66443333333467899999999865 45789999999999999999999999876554433221110 0
Q ss_pred --------------CCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhh
Q 004088 404 --------------APMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445 (774)
Q Consensus 404 --------------~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~ 445 (774)
.........++..+.+||.+||..||.+||++.++|.||||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 000011134678899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=351.30 Aligned_cols=256 Identities=32% Similarity=0.492 Sum_probs=212.6
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
++|++.+.||+|+||.||+|.+..+++.||||+++... .....+.+.+|+++|++++||||+++++++...+..|+|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47999999999999999999999999999999986533 23345678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc-ccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS-KRN 345 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~-~~~ 345 (774)
|++++.+..+.. ....+++..+..++.||+.||.|||.+||+||||||+||+++.++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 81 YVERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 998877766554 445689999999999999999999999999999999999999999999999999987655432 333
Q ss_pred cccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCC---------------------
Q 004088 346 TFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEP--------------------- 403 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~--------------------- 403 (774)
...++..|+|||++... .++.++|||||||++|+|++|++||...........+....
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence 46789999999999887 78999999999999999999999997654433222111000
Q ss_pred CCcc--------ccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 404 APML--------EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 404 ~~~~--------~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
.+.. ..+..++..+.+||.+||..+|.+||++.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0000 0012237789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=350.60 Aligned_cols=259 Identities=38% Similarity=0.636 Sum_probs=214.7
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccC--CceEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG--EEYLWIVM 265 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~--~~~l~LVm 265 (774)
++|+..++||.|+||.||+|.+..+++.||+|++...........+.+|+++|++++||||++++++|.. ...+|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4799999999999999999999999999999999765554556778999999999999999999998854 45789999
Q ss_pred EecCCCchhhhhhc---cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 266 EYCGGGSVADLMNV---TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 266 Ey~~ggsL~dll~~---~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
||+++++|.+++.. ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 99999999887642 345689999999999999999999999999999999999999999999999999875543221
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCc-----hhhhhhhhcCCCCccc----cchhc
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHP-----MRVLFMISIEPAPMLE----DKEKW 413 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~-----~~~i~~i~~~~~~~~~----~~~~~ 413 (774)
....++..|+|||.+.+..++.++|||||||++|+|++|..||..... .+....+.....+... ....+
T Consensus 161 --~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd06621 161 --GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKW 238 (287)
T ss_pred --ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCch
Confidence 234678999999999988899999999999999999999999976521 2222221111111111 11346
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 414 SLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 414 s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
+..+.+||.+||..+|.+|||+.|+++||||++..
T Consensus 239 ~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 239 SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred HHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 78899999999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=342.32 Aligned_cols=253 Identities=40% Similarity=0.696 Sum_probs=215.6
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC----hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG----EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~----~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
+|+..+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.++||||+++++++.....+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 57888999999999999999988999999999865431 23456789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++....... ..
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~ 158 (258)
T cd06632 81 LELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FA 158 (258)
T ss_pred EEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-cc
Confidence 999999999999863 3568999999999999999999999999999999999999999999999999987654432 23
Q ss_pred ccccccccccchhhhhhcC-CCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHh
Q 004088 345 NTFIGTPHWMAPEVIQESR-YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAK 423 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~k 423 (774)
....|++.|+|||.+.... ++.++|+|||||++|+|++|.+||...........+.... .....+..++..+.+||.+
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-ELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-cCCCcCCCcCHHHHHHHHH
Confidence 4456899999999997766 8999999999999999999999998766544444333211 1112234567889999999
Q ss_pred hcccCCCCCCCHHHHHhhhhh
Q 004088 424 CLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 424 cL~~DP~kRPTa~ElL~HPwf 444 (774)
||..+|.+||++.+++.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=342.42 Aligned_cols=254 Identities=32% Similarity=0.559 Sum_probs=216.0
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
+|++.+.||+|+||.||++.+..+|..||+|.+.... .....+.+.+|+.++++++||||+++++++......|+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5899999999999999999999999999999986542 123345788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC-cEEEeeccccccccccccccc
Q 004088 268 CGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG-EVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 268 ~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g-~vKL~DFGlA~~i~~~~~~~~ 345 (774)
+++++|.+++.... ..+++..+..++.||+.||.|||+.+|+|+||||+||+++.++ .+||+|||.+...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 99999999886433 3589999999999999999999999999999999999999886 469999999977654433333
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhc
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCL 425 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL 425 (774)
...|++.|+|||++....++.++|+|||||++|+|++|..||...........+..... ......++..+.++|.+||
T Consensus 161 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l 238 (257)
T cd08225 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF--APISPNFSRDLRSLISQLF 238 (257)
T ss_pred ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC--CCCCCCCCHHHHHHHHHHh
Confidence 45689999999999888899999999999999999999999987665554443332221 1223456778999999999
Q ss_pred ccCCCCCCCHHHHHhhhhh
Q 004088 426 TKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 426 ~~DP~kRPTa~ElL~HPwf 444 (774)
..+|++|||+.++++||||
T Consensus 239 ~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 239 KVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ccChhhCcCHHHHhhCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=353.03 Aligned_cols=257 Identities=32% Similarity=0.564 Sum_probs=216.6
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
.++|++++.||+|+||+||++.+..+|+.||+|++.........+.+.+|+++++.++||||+++++++.....+|+|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 46799999999999999999999999999999998765555556789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHh-cCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS-IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs-~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
|+++++|.+++.. .+.+++..+..++.+++.+|.|||+ ++|+||||||+||+++.++.++|+|||++..+... ...
T Consensus 84 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--~~~ 160 (284)
T cd06620 84 FMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--IAD 160 (284)
T ss_pred cCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--ccC
Confidence 9999999988863 4578999999999999999999997 68999999999999999999999999998655332 123
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCch-----------hhhhhhhcCCCCccccchhch
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPM-----------RVLFMISIEPAPMLEDKEKWS 414 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~-----------~~i~~i~~~~~~~~~~~~~~s 414 (774)
..+|+..|+|||++.+..++.++|||||||++|+|++|..||...... .....+.....+.. ....++
T Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 239 (284)
T cd06620 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL-PSSDFP 239 (284)
T ss_pred ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCC-CchhcC
Confidence 457999999999998888999999999999999999999999865432 11111111111111 112366
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 415 LVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 415 ~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
..+.+||.+||++||.+|||+.++++|+||.+.
T Consensus 240 ~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 789999999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=339.29 Aligned_cols=254 Identities=35% Similarity=0.592 Sum_probs=220.6
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
+|++.+.||.|+||.||++.+..+++.||+|++..... ......+.+|+++++.++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 58999999999999999999998999999999875432 34556788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcc---CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 268 CGGGSVADLMNVT---EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 268 ~~ggsL~dll~~~---~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
+++++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 9999999988754 3779999999999999999999999999999999999999999999999999997665543233
Q ss_pred ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
....|++.|+|||.+....++.++|+||||+++|+|++|..||................... .+..++..+.++|.+|
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~ 238 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP--IPSQYSSELRNLVSSL 238 (258)
T ss_pred cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHH
Confidence 44578999999999988889999999999999999999999998776555444433322222 2336678899999999
Q ss_pred cccCCCCCCCHHHHHhhhhh
Q 004088 425 LTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 425 L~~DP~kRPTa~ElL~HPwf 444 (774)
|..+|.+|||+.++|+||||
T Consensus 239 l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 239 LQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred cCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=348.80 Aligned_cols=252 Identities=28% Similarity=0.390 Sum_probs=205.2
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-CCCcccccccccCC--ceEEEEEE
Q 004088 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQGE--EYLWIVME 266 (774)
Q Consensus 190 Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~~--~~l~LVmE 266 (774)
|+++++||+|+||.||+|.+..+++.||||+++............+|+.++.++. ||||+++++++.+. +.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 7889999999999999999999999999999875433223334567999999885 99999999999877 89999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
|+. ++|.+++......+++..+..++.||+.||.|||+.||+||||||+||+++. +.+||+|||++..+.... ....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-~~~~ 157 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-PYTE 157 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC-CcCC
Confidence 996 4777777655567999999999999999999999999999999999999999 999999999997664432 2233
Q ss_pred ccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC---CCC-----------------
Q 004088 347 FIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE---PAP----------------- 405 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~---~~~----------------- 405 (774)
..+++.|+|||++.. ..++.++|||||||++|+|++|.+||...+..+.+..+... +..
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07831 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP 237 (282)
T ss_pred CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence 568999999998754 45788999999999999999999999876654432221100 000
Q ss_pred ------ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 406 ------MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 406 ------~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
........+..+.+||.+||.++|.+||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 000112457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=355.53 Aligned_cols=259 Identities=50% Similarity=0.914 Sum_probs=219.0
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
..+...|.+.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||++++++|......
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 345567999999999999999999998899999999986432 233446788999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|+||||+. ++|.+++......+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++......
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 99999996 5677776655667999999999999999999999999999999999999999999999999998654322
Q ss_pred cccccccccccccchhhhh---hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQ---ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
....|++.|+|||++. ...++.++|||||||++|+|++|.+||...+.......+.....+.. ....++..+.
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 244 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL-SSNDWSDYFR 244 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC-CchhhCHHHH
Confidence 3456899999999974 35688999999999999999999999987776655544433322222 2345788899
Q ss_pred HHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 419 DFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
++|.+||..+|.+||++.+++.||||....
T Consensus 245 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 245 NFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 999999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=351.75 Aligned_cols=260 Identities=30% Similarity=0.434 Sum_probs=210.7
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
++|++.+.||.|+||.||+|.+..+|+.||||.+..... ....+.+.+|++++++++||||+++++++......|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 579999999999999999999999999999999865432 2334568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC-CCcEEEeecccccccccccccc
Q 004088 267 YCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD-QGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 267 y~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~-~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
|++ ++|..++.... ..+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++..+.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence 996 47777664332 34688899999999999999999999999999999999985 4579999999997654433333
Q ss_pred ccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc---CCCC---------------
Q 004088 345 NTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI---EPAP--------------- 405 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~---~~~~--------------- 405 (774)
....+++.|+|||++.+. .++.++|||||||++|+|++|.+||........+..+.. .+..
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (294)
T PLN00009 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSA 240 (294)
T ss_pred ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhh
Confidence 344678999999998764 578999999999999999999999987655444332211 0000
Q ss_pred --------ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 406 --------MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 406 --------~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
........+..+.++|.+||+.+|++||++.++++||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 241 FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 0001134567889999999999999999999999999998653
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=344.12 Aligned_cols=253 Identities=28% Similarity=0.491 Sum_probs=211.3
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
++|++.+.||+|+||.||+|++..+++.||||++.... .......+.+|+.+|+.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999999999999999886432 3344556889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhc---cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 266 EYCGGGSVADLMNV---TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 266 Ey~~ggsL~dll~~---~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
||+++++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999999988752 234589999999999999999999999999999999999999999999999999977654333
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCc--hhhhhhhhcCCCCccccchhchHHHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHP--MRVLFMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~--~~~i~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
......|++.|+|||++.+..++.++|||||||++|+|++|..||..... ......+.....+.. ....++..+.++
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 240 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL-PTEHYSEKLREL 240 (267)
T ss_pred HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC-ChhhcCHHHHHH
Confidence 33345789999999999988899999999999999999999999865432 222222222111111 123567789999
Q ss_pred HHhhcccCCCCCCCHHHHHhh
Q 004088 421 VAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~H 441 (774)
|.+||..+|.+||++.++++.
T Consensus 241 i~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 241 VSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHCCCCcccCcCHHHHHHH
Confidence 999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=344.52 Aligned_cols=249 Identities=31% Similarity=0.515 Sum_probs=211.9
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCCC--hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCCCch
Q 004088 196 LGKGSYGAVYKARDLKTSELVAIKVISLSEG--EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSV 273 (774)
Q Consensus 196 LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~--~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~ggsL 273 (774)
||.|+||.||+|++..+++.||||++..... ....+.+.+|+.+++.++||||+++++++..+..+|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 7999999999999998999999999975432 23456789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccccccccc
Q 004088 274 ADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHW 353 (774)
Q Consensus 274 ~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y 353 (774)
.+++.. ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..+.... ......|++.|
T Consensus 81 ~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~ 158 (262)
T cd05572 81 WTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEY 158 (262)
T ss_pred HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCc
Confidence 999863 3568999999999999999999999999999999999999999999999999997765432 22345789999
Q ss_pred cchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCC--chhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCC
Q 004088 354 MAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVH--PMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRA 431 (774)
Q Consensus 354 ~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~--~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~k 431 (774)
+|||++....++.++|+|||||++|+|++|..||.... .......+.... .....+...+..+.+||.+||..+|.+
T Consensus 159 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~ 237 (262)
T cd05572 159 VAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN-GKLEFPNYIDKAAKDLIKQLLRRNPEE 237 (262)
T ss_pred cChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC-CCCCCCcccCHHHHHHHHHHccCChhh
Confidence 99999988889999999999999999999999998766 333333332111 111223334788999999999999999
Q ss_pred CCC-----HHHHHhhhhhhhh
Q 004088 432 RPT-----AAEMLKHKFIERC 447 (774)
Q Consensus 432 RPT-----a~ElL~HPwf~~~ 447 (774)
||+ +.|+++||||+..
T Consensus 238 R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 238 RLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred CcCCcccCHHHHhcChhhhCC
Confidence 999 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=386.29 Aligned_cols=261 Identities=51% Similarity=0.920 Sum_probs=241.3
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCccccccccc-----CC
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQ-----GE 258 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~-----~~ 258 (774)
.+...|++.+.||.|.+|.||+++++.+++.+|||++.... ..-+++..|.+||+.+ .|||++.+|++|. .+
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 45678999999999999999999999999999999986543 3346778899999887 6999999999985 56
Q ss_pred ceEEEEEEecCCCchhhhhhc-cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccc
Q 004088 259 EYLWIVMEYCGGGSVADLMNV-TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL 337 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~-~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i 337 (774)
+.+|||||||.||+..++++. ...++.|..+..|++.++.||.+||.+.+||||||-.|||++.++.|||+|||++.++
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 789999999999999999863 3568999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccccchhhhhh-----cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchh
Q 004088 338 TRTMSKRNTFIGTPHWMAPEVIQE-----SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEK 412 (774)
Q Consensus 338 ~~~~~~~~~~~GT~~Y~APEvl~~-----~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~ 412 (774)
..+...+++.+|||.|||||++.. ..|+.++|+||||++..||..|.||+.+.+++..++.|...|.|.+..+.+
T Consensus 174 dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~k 253 (953)
T KOG0587|consen 174 DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKK 253 (953)
T ss_pred ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhh
Confidence 998888999999999999999964 348889999999999999999999999999999999999999999999999
Q ss_pred chHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 413 WSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 413 ~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
|++.|.+||..||.+|-++||+..++|+|||+++.
T Consensus 254 Ws~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 254 WSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred HHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 99999999999999999999999999999999843
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=348.57 Aligned_cols=252 Identities=25% Similarity=0.400 Sum_probs=213.1
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcC-----CCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLK-----TSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~-----~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
..+|.+.+.||+|+||.||+|.+.. +++.||||++...........+.+|+++|+++.||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4679999999999999999998743 36789999987655554567899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcc-------------CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEE
Q 004088 262 WIVMEYCGGGSVADLMNVT-------------EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKL 328 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~-------------~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL 328 (774)
|+||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEE
Confidence 9999999999999998643 235788999999999999999999999999999999999999999999
Q ss_pred eecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCC
Q 004088 329 GDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAP 405 (774)
Q Consensus 329 ~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~ 405 (774)
+|||++..+..... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+......
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLL 243 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99999975533211 1223356789999999999999999999999999999998 99999877766655554432221
Q ss_pred ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 406 MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 406 ~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
.....++..+.+||.+||+.||.+||++.|+++
T Consensus 244 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 244 --QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 223457788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=353.93 Aligned_cols=257 Identities=28% Similarity=0.457 Sum_probs=211.1
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh-hhHHHHHHHHHHHHhCCCCCcccccccccCC--ceEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE-EGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE--EYLWI 263 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~-~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~--~~l~L 263 (774)
.++|++.+.||.|+||.||+|.+..+++.||||.++..... .....+.+|+.+|++++||||+++++++... ...|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 35799999999999999999999989999999999754322 2234567899999999999999999998777 89999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 162 (293)
T cd07843 84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162 (293)
T ss_pred EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence 999996 4888888755567999999999999999999999999999999999999999999999999999876554333
Q ss_pred cccccccccccchhhhhhcC-CCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCC-------------------
Q 004088 344 RNTFIGTPHWMAPEVIQESR-YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEP------------------- 403 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~------------------- 403 (774)
.....+++.|+|||++.+.. ++.++|||||||++|+|++|.+||...........+....
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 34456889999999987643 6889999999999999999999998765443332211000
Q ss_pred -----C---Cccc-cchh-chHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 404 -----A---PMLE-DKEK-WSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 404 -----~---~~~~-~~~~-~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
. .... .+.. ++..+.+||.+||+.+|++|||+.|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0 0000 0111 47778999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=351.68 Aligned_cols=258 Identities=28% Similarity=0.424 Sum_probs=205.2
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccCC------
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE------ 258 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~------ 258 (774)
..++|+++++||+|+||.||+|.+..+++.||||++..... ......+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 45689999999999999999999999999999999865432 22234567899999999999999999987544
Q ss_pred --ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccc
Q 004088 259 --EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQ 336 (774)
Q Consensus 259 --~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~ 336 (774)
...|+||||+. ++|.+++......+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 35699999996 478777765555799999999999999999999999999999999999999999999999999976
Q ss_pred ccccccc----cccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCC----CCcc
Q 004088 337 LTRTMSK----RNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEP----APML 407 (774)
Q Consensus 337 i~~~~~~----~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~----~~~~ 407 (774)
+...... .....++..|+|||++.+. .++.++|||||||++|+|++|.+||...........+.... ....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW 248 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 6433211 1234678899999998764 37889999999999999999999997765433221111100 0000
Q ss_pred --------------c-----------cchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 408 --------------E-----------DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 408 --------------~-----------~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
. .....+..+.+||.+||..||.+|||++++|+||||
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0 000124567899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=399.12 Aligned_cols=262 Identities=28% Similarity=0.505 Sum_probs=215.2
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCccccccccc--CCce
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ--GEEY 260 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~--~~~~ 260 (774)
+....+|+++++||+|+||+||+|++..+++.||+|++.... .......+.+|+.+|++|+|||||+++++|. ....
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 345679999999999999999999999999999999987543 3344567899999999999999999999884 3567
Q ss_pred EEEEEEecCCCchhhhhhcc---CCchhHHHHHHHHHHHHHHHHHHHhc-------CcccccccccceEecCC-------
Q 004088 261 LWIVMEYCGGGSVADLMNVT---EEPLEEYQIAYICREALKGLAYLHSI-------FKVHRDIKGGNILLTDQ------- 323 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~---~~~Lse~~i~~I~~QIl~gL~YLHs~-------gIIHRDLKPeNILLd~~------- 323 (774)
+|||||||++++|.+++... ...+++..++.|+.||+.||.|||+. +||||||||+||||+..
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 99999999999999988632 35799999999999999999999985 49999999999999642
Q ss_pred ----------CcEEEeeccccccccccccccccccccccccchhhhhh--cCCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 004088 324 ----------GEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQE--SRYDGKVDVWALGVSAVEMAEGLPPRSTVH 391 (774)
Q Consensus 324 ----------g~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~--~~~s~ksDIWSLGviLyELLtG~~Pf~~~~ 391 (774)
+.+||+|||++..+... ......+||+.|+|||++.. ..++.++||||||||||+|++|..||....
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 34899999999765432 22334579999999999864 458899999999999999999999998665
Q ss_pred chhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 392 PMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 392 ~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
....+....... +.+ .....+..+.+||..||..+|.+||++.++|.||||+...
T Consensus 248 ~~~qli~~lk~~-p~l-pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 248 NFSQLISELKRG-PDL-PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred cHHHHHHHHhcC-CCC-CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 544333322211 111 1234578899999999999999999999999999998653
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=343.42 Aligned_cols=253 Identities=23% Similarity=0.367 Sum_probs=213.8
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCC---CcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKT---SELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~---g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
.++|++.+.||+|+||.||+|.+..+ ...||||++...........+.+|+.+|++++||||+++++++......|+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 45799999999999999999998644 457999998765555556678999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
||||+++++|.+++......+++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||++..+......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 99999999999998766668999999999999999999999999999999999999999999999999999876422111
Q ss_pred cc--cccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHH
Q 004088 344 RN--TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 344 ~~--~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
.. ...+++.|+|||.+.+..++.++|||||||++|+|++ |..||...........+..... .+....++..+.+|
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l 240 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR--LPPPMDCPSALYQL 240 (266)
T ss_pred eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHH
Confidence 11 2235678999999998889999999999999999997 9999977665555444433211 12234567889999
Q ss_pred HHhhcccCCCCCCCHHHHHhh
Q 004088 421 VAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~H 441 (774)
+.+||+.+|++||++.+++++
T Consensus 241 i~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 241 MLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=355.76 Aligned_cols=253 Identities=24% Similarity=0.381 Sum_probs=210.4
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcE----EEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSEL----VAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~----VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
...+|++.+.||+|+||.||+|++..+++. ||||++...........+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 456899999999999999999998766654 8999986544455567889999999999999999999998765 56
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
++|+||+.+|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCC
Confidence 79999999999999998666678999999999999999999999999999999999999999999999999998765432
Q ss_pred ccc--ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 342 SKR--NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 342 ~~~--~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
... ....++..|+|||++....++.++|||||||++|||++ |..||...........+.... ....+..++..+.
T Consensus 164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 241 (316)
T cd05108 164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--RLPQPPICTIDVY 241 (316)
T ss_pred cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC--CCCCCCCCCHHHH
Confidence 211 12234678999999999899999999999999999997 999998765544333222221 1222345677899
Q ss_pred HHHHhhcccCCCCCCCHHHHHhh
Q 004088 419 DFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
++|.+||..+|.+||++.+++.+
T Consensus 242 ~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 242 MIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=345.37 Aligned_cols=255 Identities=37% Similarity=0.640 Sum_probs=212.0
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC---------hhhHHHHHHHHHHHHhCCCCCcccccccccCCc
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG---------EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE 259 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~---------~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~ 259 (774)
+|.+.+.||.|+||.||+|.+..+|+.||||.+..... ....+.+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 68899999999999999999988999999998864221 112356788999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
.+++||||+.+++|.++++.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 999999999999999998644 6789999999999999999999999999999999999999999999999999976533
Q ss_pred ccc--ccccccccccccchhhhhhcC--CCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCC-CCc--cccchh
Q 004088 340 TMS--KRNTFIGTPHWMAPEVIQESR--YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEP-APM--LEDKEK 412 (774)
Q Consensus 340 ~~~--~~~~~~GT~~Y~APEvl~~~~--~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~-~~~--~~~~~~ 412 (774)
... ......|+..|+|||++.... ++.++|+|||||++|+|++|..||...........+.... ... ......
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMN 240 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccccc
Confidence 211 123346899999999987654 8899999999999999999999997665544433322111 111 111234
Q ss_pred chHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 413 WSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 413 ~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
++..+.+||.+||.++|.+||++.++|+||||
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 241 LSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 57889999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=346.70 Aligned_cols=255 Identities=24% Similarity=0.393 Sum_probs=209.8
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCc
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDL-----KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE 259 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~-----~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~ 259 (774)
...++|++.++||+|+||.||+|.+. .++..||||++...........+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678999999999999999999864 2456799999864443344567889999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhccC---------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEee
Q 004088 260 YLWIVMEYCGGGSVADLMNVTE---------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGD 330 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~---------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~D 330 (774)
..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence 9999999999999999886322 2357788999999999999999999999999999999999999999999
Q ss_pred ccccccccccccc--cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCcc
Q 004088 331 FGVAAQLTRTMSK--RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPML 407 (774)
Q Consensus 331 FGlA~~i~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~ 407 (774)
||+++.+...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+.....+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~-- 240 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL-- 240 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC--
Confidence 9998765432211 112346788999999998889999999999999999998 78999877665554433332221
Q ss_pred ccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 408 EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 408 ~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
......+..+.+||.+||+.+|.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2234567789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=359.84 Aligned_cols=256 Identities=25% Similarity=0.391 Sum_probs=207.8
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCC------c
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE------E 259 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~------~ 259 (774)
..+|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.++++++||||++++++|... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 468999999999999999999999999999999986432 333445678899999999999999999988643 3
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
..|+|||||. ++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred cEEEEEeccC-CCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 5799999995 477777642 288999999999999999999999999999999999999999999999999976544
Q ss_pred cccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC---C-------------
Q 004088 340 TMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE---P------------- 403 (774)
Q Consensus 340 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~---~------------- 403 (774)
.. ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+... +
T Consensus 171 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (353)
T cd07850 171 SF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR 249 (353)
T ss_pred CC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence 32 233456899999999999999999999999999999999999999766543322111000 0
Q ss_pred -----------CCc-------------cccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 404 -----------APM-------------LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 404 -----------~~~-------------~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
.+. .......+..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW 317 (353)
T ss_pred HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence 000 00011235568899999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=380.35 Aligned_cols=251 Identities=35% Similarity=0.609 Sum_probs=218.8
Q ss_pred eeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCCCchh
Q 004088 195 ELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVA 274 (774)
Q Consensus 195 ~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~ggsL~ 274 (774)
.||+|.||+||.|++..+...+|||-+... .......+..||.+.++|+|.|||+++|++..++++-|.||-++||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek-dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK-DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc-cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 699999999999999999999999998643 3345567889999999999999999999999999999999999999999
Q ss_pred hhhhccCCch--hHHHHHHHHHHHHHHHHHHHhcCcccccccccceEec-CCCcEEEeeccccccccccccccccccccc
Q 004088 275 DLMNVTEEPL--EEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLT-DQGEVKLGDFGVAAQLTRTMSKRNTFIGTP 351 (774)
Q Consensus 275 dll~~~~~~L--se~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd-~~g~vKL~DFGlA~~i~~~~~~~~~~~GT~ 351 (774)
.+++..-+++ .|..+-.+.+||++||.|||++.|||||||.+||||+ -.|.+||+|||.++.+..-.....++.||.
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTL 740 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTL 740 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccch
Confidence 9999887888 8999999999999999999999999999999999997 458999999999988876655667889999
Q ss_pred cccchhhhhhc--CCCCccchhhhHHHHHHHHhCCCCCCCCCchh-hhhhhhcCCCCccccchhchHHHHHHHHhhcccC
Q 004088 352 HWMAPEVIQES--RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMR-VLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKE 428 (774)
Q Consensus 352 ~Y~APEvl~~~--~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~-~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~D 428 (774)
.|||||++-.+ .|+.++|||||||++.||.||+|||....... ..+.+ .......+.+..++.++++||.+|+.++
T Consensus 741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV-GmyKvHP~iPeelsaeak~FilrcFepd 819 (1226)
T KOG4279|consen 741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV-GMYKVHPPIPEELSAEAKNFILRCFEPD 819 (1226)
T ss_pred hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh-cceecCCCCcHHHHHHHHHHHHHHcCCC
Confidence 99999999654 49999999999999999999999997654333 22322 1222223346678899999999999999
Q ss_pred CCCCCCHHHHHhhhhhhhh
Q 004088 429 PRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 429 P~kRPTa~ElL~HPwf~~~ 447 (774)
|..||+|.++|..||++.-
T Consensus 820 ~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 820 PCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred cccCccHHHhccCcccccC
Confidence 9999999999999999765
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=337.34 Aligned_cols=246 Identities=29% Similarity=0.481 Sum_probs=212.2
Q ss_pred eeeeccCceEEEEEEEcCC---CcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCC
Q 004088 194 NELGKGSYGAVYKARDLKT---SELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGG 270 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~---g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~g 270 (774)
+.||+|+||.||+|.+... +..||||++...........+.+|+++++.++|+||+++++++.....+++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4699999999999998766 8899999997655444567899999999999999999999999999999999999999
Q ss_pred Cchhhhhhcc--------CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc-
Q 004088 271 GSVADLMNVT--------EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM- 341 (774)
Q Consensus 271 gsL~dll~~~--------~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~- 341 (774)
++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||.+..+....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 9999999755 4779999999999999999999999999999999999999999999999999998765432
Q ss_pred -cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHH
Q 004088 342 -SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHD 419 (774)
Q Consensus 342 -~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~d 419 (774)
.......+++.|+|||.+....++.++|||||||++|+|++ |..||...........+.... ....+..++..+.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 238 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY--RLPKPEYCPDELYE 238 (262)
T ss_pred cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCccCChHHHH
Confidence 12233467889999999988889999999999999999998 699998876665555544322 22334556889999
Q ss_pred HHHhhcccCCCCCCCHHHHHhh
Q 004088 420 FVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 420 LI~kcL~~DP~kRPTa~ElL~H 441 (774)
+|.+||..+|.+||++.+++++
T Consensus 239 li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 239 LMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHccCCcccCcCHHHHHHh
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=374.25 Aligned_cols=256 Identities=26% Similarity=0.478 Sum_probs=222.2
Q ss_pred cccCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCc
Q 004088 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE 259 (774)
Q Consensus 181 ~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~ 259 (774)
..|+++.+...++..||+|.||+||+|+|..+ ||||+++... ..+..+.|++|+.+|++-+|-||+-+.|+|....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 45788889999999999999999999998665 9999998665 4556788999999999999999999999999888
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc-
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT- 338 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~- 338 (774)
. .||+.+|+|.+|+.+++....+|.....+.|++||++||.|||.++|||||||..||++.+++.|||+|||++..-.
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence 7 99999999999999999888889999999999999999999999999999999999999999999999999985321
Q ss_pred -ccccccccccccccccchhhhhh---cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCC--CCccccchh
Q 004088 339 -RTMSKRNTFIGTPHWMAPEVIQE---SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEP--APMLEDKEK 412 (774)
Q Consensus 339 -~~~~~~~~~~GT~~Y~APEvl~~---~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~--~~~~~~~~~ 412 (774)
..........|...|||||+++. .+|+..+|||||||++|||++|..||.......+++++.... .........
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~ 620 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSN 620 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhcc
Confidence 12222334468889999999974 469999999999999999999999999777777778765552 222333456
Q ss_pred chHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 413 WSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 413 ~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
.++++++|+..||.+++++||.+.+||.
T Consensus 621 ~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 621 CPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred CHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 6789999999999999999999999986
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=340.93 Aligned_cols=245 Identities=24% Similarity=0.420 Sum_probs=204.4
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCCCch
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSV 273 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~ggsL 273 (774)
+.||+|+||.||+|++..+++.||+|.+...........+.+|+++|++++||||+++++++......|+||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999999899999999886544455567799999999999999999999999999999999999999999
Q ss_pred hhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc--ccccccc
Q 004088 274 ADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR--NTFIGTP 351 (774)
Q Consensus 274 ~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~--~~~~GT~ 351 (774)
.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......... ....++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 160 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV 160 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCce
Confidence 99987555678999999999999999999999999999999999999999999999999987543221110 1112345
Q ss_pred cccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCC
Q 004088 352 HWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPR 430 (774)
Q Consensus 352 ~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~ 430 (774)
.|+|||.+.+..++.++|||||||++|+|++ |.+||...........+..... ......++..+.+||.+||+.+|+
T Consensus 161 ~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~ 238 (252)
T cd05084 161 KWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR--LPCPELCPDAVYRLMERCWEYDPG 238 (252)
T ss_pred eecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC--CCCcccCCHHHHHHHHHHcCCChh
Confidence 7999999998889999999999999999997 8999976655443333322211 122345678899999999999999
Q ss_pred CCCCHHHHHh
Q 004088 431 ARPTAAEMLK 440 (774)
Q Consensus 431 kRPTa~ElL~ 440 (774)
+|||+.++++
T Consensus 239 ~Rps~~~~~~ 248 (252)
T cd05084 239 QRPSFSTVHQ 248 (252)
T ss_pred hCcCHHHHHH
Confidence 9999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=340.14 Aligned_cols=250 Identities=32% Similarity=0.497 Sum_probs=212.1
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCCC--hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCCCch
Q 004088 196 LGKGSYGAVYKARDLKTSELVAIKVISLSEG--EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSV 273 (774)
Q Consensus 196 LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~--~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~ggsL 273 (774)
||.|+||.||+|++..+|+.||||++..... ....+.+.+|+.++++++||||+++++.+......|+||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999988899999999864432 24556788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc--------ccc
Q 004088 274 ADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS--------KRN 345 (774)
Q Consensus 274 ~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~--------~~~ 345 (774)
.+++... ..+++..+..++.||+.||.|||+.||+||||+|+|||++.++.++|+|||++........ ...
T Consensus 81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 159 (265)
T cd05579 81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159 (265)
T ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence 9998643 4789999999999999999999999999999999999999999999999999875433211 223
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhc
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCL 425 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL 425 (774)
...++..|+|||++....++.++|||||||++|+|++|..||...........+...... ......++..+.+||.+||
T Consensus 160 ~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l 238 (265)
T cd05579 160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIE-WPEDVEVSDEAIDLISKLL 238 (265)
T ss_pred CcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcC-CCccccCCHHHHHHHHHHh
Confidence 456889999999998888999999999999999999999999877766555444332211 1222234788999999999
Q ss_pred ccCCCCCCCH---HHHHhhhhhhhh
Q 004088 426 TKEPRARPTA---AEMLKHKFIERC 447 (774)
Q Consensus 426 ~~DP~kRPTa---~ElL~HPwf~~~ 447 (774)
+.+|.+|||+ .++|+||||+..
T Consensus 239 ~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 239 VPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred cCCHhhcCCCccHHHHhcCccccCC
Confidence 9999999999 999999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=334.09 Aligned_cols=254 Identities=44% Similarity=0.715 Sum_probs=216.9
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccCC--ceEEEEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE--EYLWIVM 265 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~--~~l~LVm 265 (774)
+|++.+.||+|+||.||+|.+..+++.|++|++..... ....+.+.+|+.++++++||||+++++++... ..+++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 58899999999999999999988999999999875432 34567889999999999999999999999888 8999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc--c
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS--K 343 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~--~ 343 (774)
||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 81 EYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 999999999998744 3899999999999999999999999999999999999999999999999999977655432 1
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCC-chhhhhhhhcCCCCccccchhchHHHHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVH-PMRVLFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~-~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
.....++..|+|||.+....++.++|||||||++|+|++|..||.... .......+.. .......+..++..+.+||.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-SGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc-cCCCcCCCcccCHHHHHHHH
Confidence 334578999999999988889999999999999999999999998765 2222222221 11222234455888999999
Q ss_pred hhcccCCCCCCCHHHHHhhhhh
Q 004088 423 KCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~HPwf 444 (774)
+||..+|.+||++.++++||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=349.77 Aligned_cols=241 Identities=19% Similarity=0.249 Sum_probs=202.0
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCCC--hhhHHHHHHHHHHHHhCCCCCcccccccccC----CceEEEEEEe
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSEG--EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG----EEYLWIVMEY 267 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~--~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~----~~~l~LVmEy 267 (774)
..||+|+++.||+|.. +|+.||||++..... ....+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999986 789999999875432 2235678899999999999999999999865 4578999999
Q ss_pred cCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHh-cCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 268 CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS-IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 268 ~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs-~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
|++|+|.+++.. ...+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++.+... ...
T Consensus 104 ~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---~~~ 179 (283)
T PHA02988 104 CTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---PFK 179 (283)
T ss_pred CCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc---ccc
Confidence 999999999864 4578999999999999999999998 49999999999999999999999999999765432 123
Q ss_pred ccccccccchhhhhh--cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 347 FIGTPHWMAPEVIQE--SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~--~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
.+|++.|+|||++.+ ..++.++|||||||++|||++|+.||...........+..... ....+...+..+.+||.+|
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~l~~li~~c 258 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN-SLKLPLDCPLEIKCIVEAC 258 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC-CCCCCCcCcHHHHHHHHHH
Confidence 468999999999976 6799999999999999999999999998766555444322211 1122335678899999999
Q ss_pred cccCCCCCCCHHHHHhh
Q 004088 425 LTKEPRARPTAAEMLKH 441 (774)
Q Consensus 425 L~~DP~kRPTa~ElL~H 441 (774)
|+.||.+|||+.++++.
T Consensus 259 l~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 259 TSHDSIKRPNIKEILYN 275 (283)
T ss_pred hcCCcccCcCHHHHHHH
Confidence 99999999999999853
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=349.75 Aligned_cols=258 Identities=30% Similarity=0.531 Sum_probs=209.7
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-CCCcccccccccCCceEEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~~~~l~LVmE 266 (774)
.+|...+.||+|+||.||++.+..+++.||||++...........+.+|+.++.++. ||||+++++++..+...++|||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 357778899999999999999999999999999876554455667889999999996 9999999999999999999999
Q ss_pred ecCCCchhhhhh----ccCCchhHHHHHHHHHHHHHHHHHHHhc-CcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 267 YCGGGSVADLMN----VTEEPLEEYQIAYICREALKGLAYLHSI-FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 267 y~~ggsL~dll~----~~~~~Lse~~i~~I~~QIl~gL~YLHs~-gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|+. ++|.++.. .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 995 45555432 1236799999999999999999999974 99999999999999999999999999997664432
Q ss_pred cccccccccccccchhhhhhc---CCCCccchhhhHHHHHHHHhCCCCCCCCCch-hhhhhhhcCCCCcc--ccchhchH
Q 004088 342 SKRNTFIGTPHWMAPEVIQES---RYDGKVDVWALGVSAVEMAEGLPPRSTVHPM-RVLFMISIEPAPML--EDKEKWSL 415 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~---~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~-~~i~~i~~~~~~~~--~~~~~~s~ 415 (774)
. .....|++.|+|||++... .++.++|||||||++|+|++|++||...... ..+..+.....+.. .....++.
T Consensus 163 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd06616 163 A-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSP 241 (288)
T ss_pred c-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCH
Confidence 2 2334689999999999866 6899999999999999999999999765421 11111111111111 11234678
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 416 VFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 416 ~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
.+.+||.+||+++|.+|||+.++++||||+..
T Consensus 242 ~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 242 SFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 89999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=343.52 Aligned_cols=254 Identities=28% Similarity=0.420 Sum_probs=212.8
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCC-----CcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCc
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKT-----SELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE 259 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~-----g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~ 259 (774)
...++|++.+.||+|+||.||+|.+... +..||+|.+...........+.+|+.+|+.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 4567899999999999999999987643 47899999865544455567889999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhccC---------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEee
Q 004088 260 YLWIVMEYCGGGSVADLMNVTE---------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGD 330 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~---------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~D 330 (774)
..|+||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECC
Confidence 9999999999999999885321 2467889999999999999999999999999999999999999999999
Q ss_pred cccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCcc
Q 004088 331 FGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPML 407 (774)
Q Consensus 331 FGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~ 407 (774)
||+++.+..... ......++..|+|||.+....++.++|||||||++|+|++ |.+||...........+..... .
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--~ 240 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH--L 240 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC--C
Confidence 999976544321 1223457889999999988889999999999999999998 9999987766555544442222 2
Q ss_pred ccchhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 408 EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 408 ~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
..+..++..+.++|.+||+.+|.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 223456888999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=346.49 Aligned_cols=251 Identities=28% Similarity=0.383 Sum_probs=207.6
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCCCch
Q 004088 196 LGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSV 273 (774)
Q Consensus 196 LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~ggsL 273 (774)
||+|+||+||+|.+..+|+.||||++.... .......+.+|+++|++++||||+++++++...+.+|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999999999999999986532 122344567899999999999999999999999999999999999999
Q ss_pred hhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccccccc
Q 004088 274 ADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH 352 (774)
Q Consensus 274 ~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT~~ 352 (774)
.+++.... ..+++..+..++.|++.||.|||++||+||||+|+|||++.++.+||+|||++...... .......++..
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~ 159 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTPG 159 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCCCC
Confidence 99886433 36999999999999999999999999999999999999999999999999998765432 22234468889
Q ss_pred ccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-CCCccccchhchHHHHHHHHhhcccCCCC
Q 004088 353 WMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-PAPMLEDKEKWSLVFHDFVAKCLTKEPRA 431 (774)
Q Consensus 353 Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-~~~~~~~~~~~s~~l~dLI~kcL~~DP~k 431 (774)
|+|||++.+..++.++|||||||++|+|++|+.||...........+... ..........++..+.++|.+||+.+|.+
T Consensus 160 y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 239 (277)
T cd05577 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEK 239 (277)
T ss_pred cCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhH
Confidence 99999998888999999999999999999999999765431111111110 01111223456888999999999999999
Q ss_pred CC-----CHHHHHhhhhhhhh
Q 004088 432 RP-----TAAEMLKHKFIERC 447 (774)
Q Consensus 432 RP-----Ta~ElL~HPwf~~~ 447 (774)
|| ++.++++||||.+.
T Consensus 240 R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 240 RLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred ccCCCcccHHHHHhChhhhcC
Confidence 99 89999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=357.70 Aligned_cols=260 Identities=28% Similarity=0.422 Sum_probs=208.9
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCC-----ceE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE-----EYL 261 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~-----~~l 261 (774)
.++|++.++||+|+||.||+|.+..+|+.||||++...........+.+|+.+|++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999999999999999986444444556788999999999999999999876533 468
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|+||||+. ++|..++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~-~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 84 YIVQELME-TDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEehhcc-cCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 99999996 47777764 3579999999999999999999999999999999999999999999999999997654322
Q ss_pred cc---cccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhh---cCC-----------
Q 004088 342 SK---RNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMIS---IEP----------- 403 (774)
Q Consensus 342 ~~---~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~---~~~----------- 403 (774)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+.......+. ..+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence 11 123578999999998765 468899999999999999999999997654322211110 000
Q ss_pred -----------CCcc---ccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 404 -----------APML---EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 404 -----------~~~~---~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
.+.. ......+..+.+||.+||+.+|.+|||+.++++||||+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0000 001234667899999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=340.84 Aligned_cols=249 Identities=27% Similarity=0.432 Sum_probs=209.3
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
.++|++.+.||+|+||.||++.+. .+..||+|.+.... .....+.+|+.+|++++||||+++++++......|+|||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 357999999999999999999864 55679999875332 234678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc-cc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK-RN 345 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~-~~ 345 (774)
|+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++........ ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 99999999998755567899999999999999999999999999999999999999999999999999765432211 12
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
...++..|+|||++.+..++.++|||||||++|+|++ |++||...........+...... ..+...+..+.++|.+|
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~li~~c 237 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL--YRPKLASMTVYEVMYSC 237 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC--CCCCCCCHHHHHHHHHH
Confidence 2235678999999988889999999999999999999 99999887766655555433222 12334567899999999
Q ss_pred cccCCCCCCCHHHHHh
Q 004088 425 LTKEPRARPTAAEMLK 440 (774)
Q Consensus 425 L~~DP~kRPTa~ElL~ 440 (774)
|+.+|.+||++.++++
T Consensus 238 ~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 238 WHEKPEGRPTFAELLR 253 (256)
T ss_pred ccCCcccCcCHHHHHH
Confidence 9999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=346.62 Aligned_cols=254 Identities=30% Similarity=0.468 Sum_probs=209.0
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh-hhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEec
Q 004088 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE-EGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYC 268 (774)
Q Consensus 190 Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~-~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~ 268 (774)
|++.++||.|++|.||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++++.+....|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67889999999999999999999999999998754322 23356888999999999999999999999999999999999
Q ss_pred CCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccc
Q 004088 269 GGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF 347 (774)
Q Consensus 269 ~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~ 347 (774)
+ ++|.+++.... ..+++..+..++.||+.||.|||+++++||||+|+|||++.++.++|+|||++..+..........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 159 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE 159 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence 5 68888876433 468999999999999999999999999999999999999999999999999997654332222334
Q ss_pred cccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC------------------------
Q 004088 348 IGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE------------------------ 402 (774)
Q Consensus 348 ~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~------------------------ 402 (774)
.+++.|+|||++.+. .++.++|||||||++|+|++|++||...........+...
T Consensus 160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd07835 160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK 239 (283)
T ss_pred ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccc
Confidence 678999999988654 4788999999999999999999999876543332221100
Q ss_pred --CCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 403 --PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 403 --~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
..........++..+.++|.+||+.+|.+|||+.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 000011123456789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=337.74 Aligned_cols=252 Identities=30% Similarity=0.511 Sum_probs=210.7
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
++|++.+.||+|+||.||+|.+..+|+.||+|.++... .......+.+|++++++++|+||+++++++......++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 58999999999999999999998899999999986432 2334567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhc---cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 266 EYCGGGSVADLMNV---TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 266 Ey~~ggsL~dll~~---~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
||+++++|..++.. ....+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999999988753 235689999999999999999999999999999999999999999999999999976654433
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCc--hhhhhhhhcCCCCccccchhchHHHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHP--MRVLFMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~--~~~i~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+.....+... ...++..+.++
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 240 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLP-ADHYSEELRDL 240 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCC-hhhcCHHHHHH
Confidence 33445789999999999988899999999999999999999999865432 1122222111111111 22567789999
Q ss_pred HHhhcccCCCCCCCHHHHHh
Q 004088 421 VAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~ 440 (774)
|.+||..+|.+||++.+|++
T Consensus 241 i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 241 VSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=345.54 Aligned_cols=254 Identities=26% Similarity=0.428 Sum_probs=211.5
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcC-----CCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCce
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLK-----TSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEY 260 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~-----~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~ 260 (774)
..++|.+.+.||+|+||.||+|.+.. ++..||+|.+...........+.+|+.++++++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45789999999999999999999876 7788999988654444455678999999999999999999999998899
Q ss_pred EEEEEEecCCCchhhhhhccC------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC---cEEEeec
Q 004088 261 LWIVMEYCGGGSVADLMNVTE------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG---EVKLGDF 331 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g---~vKL~DF 331 (774)
.|+||||+.+++|.+++.... ..+++..+..++.||+.||.|||+++++||||||+|||++.++ .+||+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 999999999999999886432 2589999999999999999999999999999999999998765 5999999
Q ss_pred cccccccccccc--cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccc
Q 004088 332 GVAAQLTRTMSK--RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLE 408 (774)
Q Consensus 332 GlA~~i~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~ 408 (774)
|+++.+...... .....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+..... ..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~--~~ 241 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR--LD 241 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc--CC
Confidence 999866332111 112234578999999998889999999999999999996 9999987766555444333222 12
Q ss_pred cchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 409 DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 409 ~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.+..++..+.+||.+||+.+|++||++.+|++|
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 234567889999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=345.79 Aligned_cols=253 Identities=25% Similarity=0.459 Sum_probs=211.5
Q ss_pred CCCeeEEeeeeccCceEEEEEEEc----CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDL----KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~----~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
...|++.++||+|+||+||+|.+. .+++.||+|.+...........+.+|+.++++++||||+++++++......|
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 467999999999999999999853 4567899999875555555677899999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcc----------------CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcE
Q 004088 263 IVMEYCGGGSVADLMNVT----------------EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEV 326 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~----------------~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~v 326 (774)
+||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcE
Confidence 999999999999987422 2347889999999999999999999999999999999999999999
Q ss_pred EEeeccccccccccc--cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCC
Q 004088 327 KLGDFGVAAQLTRTM--SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEP 403 (774)
Q Consensus 327 KL~DFGlA~~i~~~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~ 403 (774)
||+|||+++.+.... .......++..|+|||++.+..++.++|||||||++|+|++ |.+||...........+....
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 243 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ 243 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999997654321 11223356778999999988889999999999999999998 999998766555444443322
Q ss_pred CCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 404 APMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 404 ~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
. ......++..+.++|.+||+.||.+||++.+++++
T Consensus 244 ~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 244 L--LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred c--CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 2 22344567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=355.10 Aligned_cols=262 Identities=29% Similarity=0.423 Sum_probs=216.4
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccCCc-----eEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE-----YLW 262 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~-----~l~ 262 (774)
+|++.+.||.|+||.||+|++..+++.||||++..... ....+.+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 58999999999999999999988899999999865432 344567889999999999999999999998765 889
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc-
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM- 341 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~- 341 (774)
+||||++ ++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 81 lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 81 IVTELME-TDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEecchh-hhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 9999996 578888753 3489999999999999999999999999999999999999999999999999998765442
Q ss_pred --cccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCC-------------
Q 004088 342 --SKRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAP------------- 405 (774)
Q Consensus 342 --~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~------------- 405 (774)
.......+++.|+|||++.+. .++.++|||||||++|+|++|++||...........+......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 123345689999999999887 7899999999999999999999999876654433222110000
Q ss_pred ---------------ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhccCcc
Q 004088 406 ---------------MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGAT 452 (774)
Q Consensus 406 ---------------~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~~~~ 452 (774)
........+..+.+||.+||+++|.+||++.++++||||+..+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~ 300 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPED 300 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccccc
Confidence 00011234677899999999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=343.35 Aligned_cols=253 Identities=28% Similarity=0.453 Sum_probs=216.7
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCC-CCCcccccccccCCceEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~~~~l~LV 264 (774)
++|.+.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++++. ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999986532 2334467889999999998 99999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc---
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM--- 341 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~--- 341 (774)
|||+.+++|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 81 LEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 999999999999864 4579999999999999999999999999999999999999999999999999997654432
Q ss_pred -----------------cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCC
Q 004088 342 -----------------SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA 404 (774)
Q Consensus 342 -----------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~ 404 (774)
.......|+..|+|||++....++.++|||||||++|+|++|..||...........+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-- 237 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL-- 237 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc--
Confidence 1223346889999999998888999999999999999999999999877654433332211
Q ss_pred CccccchhchHHHHHHHHhhcccCCCCCCCH----HHHHhhhhh
Q 004088 405 PMLEDKEKWSLVFHDFVAKCLTKEPRARPTA----AEMLKHKFI 444 (774)
Q Consensus 405 ~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa----~ElL~HPwf 444 (774)
....+..++..+.+||.+||..+|.+||++ .++++||||
T Consensus 238 -~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 238 -EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred -CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 112234557889999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=347.96 Aligned_cols=261 Identities=26% Similarity=0.403 Sum_probs=212.3
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcC-----CCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCC
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLK-----TSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE 258 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~-----~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~ 258 (774)
+....+|++.++||+|+||.||+|.+.. .+..||||.+...........+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4456799999999999999999997542 35589999986544444445678999999999999999999999999
Q ss_pred ceEEEEEEecCCCchhhhhhccC---------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEe
Q 004088 259 EYLWIVMEYCGGGSVADLMNVTE---------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLG 329 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~~---------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~ 329 (774)
...|+||||+.+|+|.+++.... ..++...+..++.||+.||.|||+++|+||||||+|||++.++.+||+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 99999999999999999986321 234667888999999999999999999999999999999999999999
Q ss_pred ecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCc
Q 004088 330 DFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPM 406 (774)
Q Consensus 330 DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~ 406 (774)
|||+++.+..... ......++..|+|||.+.+..++.++|||||||++|+|++ |.+||......+....+......
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~- 240 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL- 240 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence 9999976543221 1122345778999999998889999999999999999998 78899876665544433322211
Q ss_pred cccchhchHHHHHHHHhhcccCCCCCCCHHHHHh------hhhhhh
Q 004088 407 LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK------HKFIER 446 (774)
Q Consensus 407 ~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~------HPwf~~ 446 (774)
..+...+..+.++|.+||+.+|.+|||+.++++ ||||..
T Consensus 241 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 241 -DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 223345678999999999999999999999987 777753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=346.09 Aligned_cols=258 Identities=25% Similarity=0.460 Sum_probs=214.4
Q ss_pred ccCCCCCCeeEEeeeeccCceEEEEEEEcCC-----CcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccc
Q 004088 182 TREDPTTKYELLNELGKGSYGAVYKARDLKT-----SELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSY 255 (774)
Q Consensus 182 ~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~-----g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~ 255 (774)
..+...++|++.+.||+|+||.||++.+... ...||+|++...........+.+|+.+++++ +||||+++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3455678999999999999999999987643 3789999987554445556788999999999 899999999999
Q ss_pred cCCceEEEEEEecCCCchhhhhhc---------------cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEe
Q 004088 256 QGEEYLWIVMEYCGGGSVADLMNV---------------TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL 320 (774)
Q Consensus 256 ~~~~~l~LVmEy~~ggsL~dll~~---------------~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILL 320 (774)
.....+|+||||+++++|..++.. ....+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 999999999999999999998853 23568999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccccccc--cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhh
Q 004088 321 TDQGEVKLGDFGVAAQLTRTMSK--RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLF 397 (774)
Q Consensus 321 d~~g~vKL~DFGlA~~i~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~ 397 (774)
+.++.+||+|||+++.+...... .....++..|+|||++.+..++.++|||||||++|+|++ |..||..........
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 99999999999999866443211 112235678999999988889999999999999999997 999998776555444
Q ss_pred hhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 398 MISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 398 ~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.+..... ...+...+..+.+|+.+||..||.+|||+.+++++
T Consensus 246 ~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 246 LLKEGYR--MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHcCCc--CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 4332221 22334557789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=340.25 Aligned_cols=253 Identities=26% Similarity=0.412 Sum_probs=213.4
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
....+|.+.++||+|+||.||+|.+..+++.||+|++... ......+.+|+++|++++||||+++++++..+..+++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 3456799999999999999999999989999999998633 33456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 265 mEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|||+++++|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999999988643 346899999999999999999999999999999999999999999999999999765432211
Q ss_pred -cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHH
Q 004088 344 -RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421 (774)
Q Consensus 344 -~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI 421 (774)
.....+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+..... ...+..++..+.++|
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li 238 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR--MERPEGCPPKVYELM 238 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC--CCCCCCCCHHHHHHH
Confidence 112234678999999998899999999999999999998 9999987666555444333222 223456688999999
Q ss_pred HhhcccCCCCCCCHHHHHhh
Q 004088 422 AKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 422 ~kcL~~DP~kRPTa~ElL~H 441 (774)
.+||..+|.+||++.++++.
T Consensus 239 ~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 239 RACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHHccCCcccCCCHHHHHHH
Confidence 99999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=373.64 Aligned_cols=247 Identities=30% Similarity=0.521 Sum_probs=218.0
Q ss_pred ccCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 182 TREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 182 ~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
.|+.+.....-++-||+|+.|.||+|+. .++.||||.++. .-..+|+-|++|+||||+.|.|+|...-.+
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~e--------lkETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVRE--------LKETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHhh--------hhhhhHHHHHhccCcceeeEeeeecCCcee
Confidence 4566666667778899999999999984 567899998741 123588999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|||||||..|-|..+|+ ...+++...+..|..+|+.||.|||.+.|||||||.-||||+.+..|||+|||.++.+...
T Consensus 188 CIiMEfCa~GqL~~VLk-a~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~- 265 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLK-AGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK- 265 (904)
T ss_pred EEeeeccccccHHHHHh-ccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-
Confidence 99999999999999996 5677888999999999999999999999999999999999999999999999999876554
Q ss_pred cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI 421 (774)
.....++||..|||||++.+.+.+.|+|||||||+|||||||..||.+.+...+++-+..+ .-.++.+..++..|+=||
T Consensus 266 STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsN-sL~LpvPstcP~GfklL~ 344 (904)
T KOG4721|consen 266 STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSN-SLHLPVPSTCPDGFKLLL 344 (904)
T ss_pred hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCC-cccccCcccCchHHHHHH
Confidence 5556789999999999999999999999999999999999999999999988877765433 223455667788999999
Q ss_pred HhhcccCCCCCCCHHHHHhh
Q 004088 422 AKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 422 ~kcL~~DP~kRPTa~ElL~H 441 (774)
++||+-.|..||++.++|.|
T Consensus 345 Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 345 KQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred HHHHhcCCCCCccHHHHHHH
Confidence 99999999999999999999
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=350.33 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=203.7
Q ss_pred CeeEEeeeeccCceEEEEEEEcC--CCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCC--ceEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLK--TSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE--EYLW 262 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~--~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~--~~l~ 262 (774)
+|++.++||+|+||.||+|.+.. +++.||||++.... .....+.+.+|+.++++++||||+++++++... ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 89999999987532 123345678899999999999999999999877 8899
Q ss_pred EEEEecCCCchhhhhhcc----CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC----CCcEEEeecccc
Q 004088 263 IVMEYCGGGSVADLMNVT----EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD----QGEVKLGDFGVA 334 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~----~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~----~g~vKL~DFGlA 334 (774)
+||||+++ +|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999965 566655321 236899999999999999999999999999999999999999 899999999999
Q ss_pred cccccccc---ccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhh------------hhh
Q 004088 335 AQLTRTMS---KRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRV------------LFM 398 (774)
Q Consensus 335 ~~i~~~~~---~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~------------i~~ 398 (774)
..+..... .....++++.|+|||++.+. .++.++|||||||++|+|++|++||........ +..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 86644322 22345689999999998764 588999999999999999999999976543220 000
Q ss_pred hhc----------------------CCCCccc---------cchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 399 ISI----------------------EPAPMLE---------DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 399 i~~----------------------~~~~~~~---------~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
... ....... .....+..+.++|.+||+.||++|||+.++++||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 000 0000000 001345678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=371.31 Aligned_cols=261 Identities=23% Similarity=0.425 Sum_probs=209.6
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEee-cCCChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVIS-LSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~-~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~ 262 (774)
.....|+++++||+||.+.||++... +.+.||+|.+. ...+.....-+.+|+.+|.+| .|.+||+||+|-..++++|
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 34568999999999999999999854 34556666554 445667778899999999999 5899999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
|||||= ..+|..+|+....-++...++.+..|++.++.++|.+||||.||||.|+|+-. |.+||+|||.|..+.....
T Consensus 437 mvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred EEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 999975 67999999876666665689999999999999999999999999999999987 8999999999988765433
Q ss_pred c--cccccccccccchhhhhhcC-----------CCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCcccc
Q 004088 343 K--RNTFIGTPHWMAPEVIQESR-----------YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLED 409 (774)
Q Consensus 343 ~--~~~~~GT~~Y~APEvl~~~~-----------~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~ 409 (774)
. ..+.+||+.||+||.+.... .+.++||||||||||+|+.|++||........-......+....+.
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ief 594 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEF 594 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccc
Confidence 2 34569999999999986432 5578999999999999999999998754322222222233222222
Q ss_pred chhch-HHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 410 KEKWS-LVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 410 ~~~~s-~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
+.--+ .++.++++.||+.||.+||++.++|+|||+.-..
T Consensus 595 p~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~ 634 (677)
T KOG0596|consen 595 PDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP 634 (677)
T ss_pred cCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence 21112 2289999999999999999999999999997533
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=346.03 Aligned_cols=255 Identities=24% Similarity=0.398 Sum_probs=210.3
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCC----------------cEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcc
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTS----------------ELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVV 249 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g----------------~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIV 249 (774)
...+|+++++||+|+||.||+|.+...+ ..||+|++.........+.+.+|+++|++++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 4568999999999999999999876533 568999987655555667899999999999999999
Q ss_pred cccccccCCceEEEEEEecCCCchhhhhhccC----------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceE
Q 004088 250 RYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE----------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNIL 319 (774)
Q Consensus 250 kL~~~~~~~~~l~LVmEy~~ggsL~dll~~~~----------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNIL 319 (774)
++++++..+...++||||+.+++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 99999999999999999999999999886432 26899999999999999999999999999999999999
Q ss_pred ecCCCcEEEeeccccccccccc--cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh--CCCCCCCCCchhh
Q 004088 320 LTDQGEVKLGDFGVAAQLTRTM--SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE--GLPPRSTVHPMRV 395 (774)
Q Consensus 320 Ld~~g~vKL~DFGlA~~i~~~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt--G~~Pf~~~~~~~~ 395 (774)
++.++.++|+|||+++.+.... .......+++.|+|||++....++.++|||||||++|+|++ |..||........
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV 242 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH
Confidence 9999999999999997653321 11233456789999999998889999999999999999997 6788876655444
Q ss_pred hhhhhcC-----CCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 396 LFMISIE-----PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 396 i~~i~~~-----~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
+...... .......+...+..+.++|.+||+.||.+|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 243 IENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 3332211 11112223445688999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=347.49 Aligned_cols=250 Identities=24% Similarity=0.413 Sum_probs=199.6
Q ss_pred eeeccCceEEEEEEEcCCCcEEEEEEeecCCCh--hhHHHHHHHHHHHH---hCCCCCcccccccccCCceEEEEEEecC
Q 004088 195 ELGKGSYGAVYKARDLKTSELVAIKVISLSEGE--EGYEEIRGEIEMLQ---QCSHPNVVRYLGSYQGEEYLWIVMEYCG 269 (774)
Q Consensus 195 ~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~--~~~~~~~~Ei~iL~---~L~HPNIVkL~~~~~~~~~l~LVmEy~~ 269 (774)
.||+|+||.||++.+..+++.||||++...... .....+.+|..+++ ...||||+.+++++...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999998654321 11223444544443 4479999999999999999999999999
Q ss_pred CCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccccc
Q 004088 270 GGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIG 349 (774)
Q Consensus 270 ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~G 349 (774)
+++|.+++. ....+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...... ......|
T Consensus 81 ~~~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~ 157 (279)
T cd05633 81 GGDLHYHLS-QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVG 157 (279)
T ss_pred CCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--CccCcCC
Confidence 999998886 3456999999999999999999999999999999999999999999999999998755432 1223469
Q ss_pred cccccchhhhh-hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccC
Q 004088 350 TPHWMAPEVIQ-ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKE 428 (774)
Q Consensus 350 T~~Y~APEvl~-~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~D 428 (774)
++.|+|||++. +..++.++|||||||++|+|++|..||......................+..++..+.++|.+||..|
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 237 (279)
T cd05633 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRD 237 (279)
T ss_pred CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCC
Confidence 99999999986 45689999999999999999999999975432211111000111111223457889999999999999
Q ss_pred CCCCC-----CHHHHHhhhhhhhh
Q 004088 429 PRARP-----TAAEMLKHKFIERC 447 (774)
Q Consensus 429 P~kRP-----Ta~ElL~HPwf~~~ 447 (774)
|.+|| ++.++++||||+..
T Consensus 238 p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 238 VSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred HHHhcCCCCCCHHHHHhCccccCC
Confidence 99999 69999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=349.37 Aligned_cols=257 Identities=37% Similarity=0.658 Sum_probs=218.4
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEec
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYC 268 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~ 268 (774)
.|....+||+|+||.||++.+..+++.||||++.... ......+.+|+.+++.++||||++++++|...+..|+||||+
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 4445578999999999999999999999999986432 344567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccc
Q 004088 269 GGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFI 348 (774)
Q Consensus 269 ~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~ 348 (774)
++++|.+++. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..+...........
T Consensus 100 ~~~~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 177 (292)
T cd06657 100 EGGALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 177 (292)
T ss_pred CCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccc
Confidence 9999998874 34688999999999999999999999999999999999999999999999999876644333334457
Q ss_pred ccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccC
Q 004088 349 GTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKE 428 (774)
Q Consensus 349 GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~D 428 (774)
|++.|+|||++....++.++|+|||||++|+|++|.+||...........+.............++..+.++|.+||..+
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 257 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCC
Confidence 89999999999888899999999999999999999999987665554444333222233333456778999999999999
Q ss_pred CCCCCCHHHHHhhhhhhhhc
Q 004088 429 PRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 429 P~kRPTa~ElL~HPwf~~~~ 448 (774)
|.+||++.++++||||.+..
T Consensus 258 P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 258 PAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred cccCcCHHHHhcChHHhccC
Confidence 99999999999999998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=339.97 Aligned_cols=250 Identities=31% Similarity=0.458 Sum_probs=205.8
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCCC--hhhHHHHHHHHHHH-HhCCCCCcccccccccCCceEEEEEEecCC
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSEG--EEGYEEIRGEIEML-QQCSHPNVVRYLGSYQGEEYLWIVMEYCGG 270 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~--~~~~~~~~~Ei~iL-~~L~HPNIVkL~~~~~~~~~l~LVmEy~~g 270 (774)
+.||.|+||.||+|.+..+++.||||++.+... ......+..|..++ ..+.||||+++++++...+.+|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 579999999999999999999999999864331 12223345555544 455899999999999999999999999999
Q ss_pred CchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccccc
Q 004088 271 GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350 (774)
Q Consensus 271 gsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT 350 (774)
++|.++++. ...+++..+..++.||+.||.|||+.+|+||||+|+|||++.++.+||+|||++..... .....|+
T Consensus 82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~ 156 (260)
T cd05611 82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGT 156 (260)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCCC
Confidence 999999863 45789999999999999999999999999999999999999999999999999865432 2345689
Q ss_pred ccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCC-CccccchhchHHHHHHHHhhcccCC
Q 004088 351 PHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA-PMLEDKEKWSLVFHDFVAKCLTKEP 429 (774)
Q Consensus 351 ~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~-~~~~~~~~~s~~l~dLI~kcL~~DP 429 (774)
+.|+|||.+.+..++.++|||||||++|+|++|.+||...........+..... ........++..+.++|.+||+.+|
T Consensus 157 ~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 236 (260)
T cd05611 157 PDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP 236 (260)
T ss_pred cCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCH
Confidence 999999999888889999999999999999999999987766554443322211 1111223567889999999999999
Q ss_pred CCCC---CHHHHHhhhhhhhhc
Q 004088 430 RARP---TAAEMLKHKFIERCK 448 (774)
Q Consensus 430 ~kRP---Ta~ElL~HPwf~~~~ 448 (774)
.+|| ++.|+|.||||++.+
T Consensus 237 ~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 237 AKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred HHccCCCcHHHHHcChHhhcCC
Confidence 9999 458999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=384.66 Aligned_cols=254 Identities=27% Similarity=0.429 Sum_probs=212.7
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-CCCccccccc-cc-----
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPNVVRYLGS-YQ----- 256 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~-~~----- 256 (774)
+....+++|.+.|.+|||+.||+|++...|..||+|++-.. +....+.+.+||.+|++|. |||||.|++. ..
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 44556899999999999999999999888899999998655 7788899999999999996 9999999993 32
Q ss_pred C-CceEEEEEEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcC--cccccccccceEecCCCcEEEeecc
Q 004088 257 G-EEYLWIVMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIF--KVHRDIKGGNILLTDQGEVKLGDFG 332 (774)
Q Consensus 257 ~-~~~l~LVmEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~g--IIHRDLKPeNILLd~~g~vKL~DFG 332 (774)
. .-.++|.||||.||.|.++++.+ ...|+|.++++|+.|+++|+.+||... |||||||-+||||..+|+.||||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccc
Confidence 1 24688999999999999998733 345999999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccccc---------ccccccccccchhhh---hhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 004088 333 VAAQLTRTMSKR---------NTFIGTPHWMAPEVI---QESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMIS 400 (774)
Q Consensus 333 lA~~i~~~~~~~---------~~~~GT~~Y~APEvl---~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~ 400 (774)
.|.......... .....|+.|+|||++ .+...+.|+|||+|||+||-|+....||.......++.
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIln--- 268 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILN--- 268 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEe---
Confidence 996443322111 123579999999997 46678999999999999999999999999865444321
Q ss_pred cCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhh
Q 004088 401 IEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKF 443 (774)
Q Consensus 401 ~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPw 443 (774)
....++....++..+++||+.||+.||.+||++.|++.+-+
T Consensus 269 --g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 269 --GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred --ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 12223334678999999999999999999999999997744
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=341.66 Aligned_cols=252 Identities=22% Similarity=0.375 Sum_probs=213.8
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
.+..+|+++++||.|+||.||+|.+.. ++.||+|++.... ......+.+|+.+|+.++||||+++++++.....+|+|
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 355689999999999999999999876 8899999986543 33456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 265 mEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999999998643 356899999999999999999999999999999999999999999999999999766443222
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
.....++..|+|||++....++.++|||||||++|+|++ |+.||...........+..... ...+...+..+.++|.
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~ 238 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR--MPCPAKCPQEIYKIML 238 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc--CCCCCCCCHHHHHHHH
Confidence 223346778999999988889999999999999999998 8999987766555544432211 2233566788999999
Q ss_pred hhcccCCCCCCCHHHHHh
Q 004088 423 KCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~ 440 (774)
+||+.||.+|||+.++++
T Consensus 239 ~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 239 ECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHcCCCchhCcCHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=333.72 Aligned_cols=253 Identities=42% Similarity=0.733 Sum_probs=219.3
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
+|++.+.||+|+||.||++.+..+++.||||.+..... ......+.+|+++++++.||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 58999999999999999999988999999999875432 24557789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccc
Q 004088 268 CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF 347 (774)
Q Consensus 268 ~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~ 347 (774)
+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV 159 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence 9999999998643 679999999999999999999999999999999999999999999999999998776544333455
Q ss_pred cccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhccc
Q 004088 348 IGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTK 427 (774)
Q Consensus 348 ~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~ 427 (774)
.++..|+|||.+.+..++.++||||||+++|+|++|..||.................+ ..+...+..+.++|.+||..
T Consensus 160 ~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~ 237 (254)
T cd06627 160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP--PLPEGISPELKDFLMQCFQK 237 (254)
T ss_pred ccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCC--CCCCCCCHHHHHHHHHHHhC
Confidence 7899999999998878899999999999999999999999876654444443322222 22345678899999999999
Q ss_pred CCCCCCCHHHHHhhhhh
Q 004088 428 EPRARPTAAEMLKHKFI 444 (774)
Q Consensus 428 DP~kRPTa~ElL~HPwf 444 (774)
+|++||++.+++.||||
T Consensus 238 ~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 238 DPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ChhhCcCHHHHhcCCCC
Confidence 99999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=358.64 Aligned_cols=258 Identities=27% Similarity=0.451 Sum_probs=208.5
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcC-----CCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCccccccccc
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLK-----TSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQ 256 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~-----~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~ 256 (774)
|..+.++|++++.||+|+||.||+|.+.. +++.||+|++...........+.+|+.+++++ +||||++++++|.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 34566799999999999999999997433 45789999987544445556788999999999 8999999999875
Q ss_pred -CCceEEEEEEecCCCchhhhhhccC------------------------------------------------------
Q 004088 257 -GEEYLWIVMEYCGGGSVADLMNVTE------------------------------------------------------ 281 (774)
Q Consensus 257 -~~~~l~LVmEy~~ggsL~dll~~~~------------------------------------------------------ 281 (774)
.+..+++||||+++++|.+++....
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 4567899999999999998875321
Q ss_pred ------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc--ccccccccccc
Q 004088 282 ------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS--KRNTFIGTPHW 353 (774)
Q Consensus 282 ------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~--~~~~~~GT~~Y 353 (774)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... ......++..|
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 2678999999999999999999999999999999999999999999999999987643221 12234567889
Q ss_pred cchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCC
Q 004088 354 MAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRAR 432 (774)
Q Consensus 354 ~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kR 432 (774)
+|||++.+..++.++|||||||++|+|++ |..||......+.......... ....+..++..+.+++.+||+.+|++|
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~cl~~~p~~R 320 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT-RMRAPEYATPEIYSIMLDCWHNNPEDR 320 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC-CCCCCccCCHHHHHHHHHHccCChhhC
Confidence 99999999999999999999999999997 9999976543332221111111 112234567789999999999999999
Q ss_pred CCHHHHHhh
Q 004088 433 PTAAEMLKH 441 (774)
Q Consensus 433 PTa~ElL~H 441 (774)
|++.++++|
T Consensus 321 Ps~~ell~~ 329 (337)
T cd05054 321 PTFSELVEI 329 (337)
T ss_pred cCHHHHHHH
Confidence 999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=341.83 Aligned_cols=254 Identities=30% Similarity=0.477 Sum_probs=212.4
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh-hhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEec
Q 004088 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE-EGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYC 268 (774)
Q Consensus 190 Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~-~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~ 268 (774)
|++.+.||.|++|.||+|.+..+++.||+|++...... .....+.+|+.+|++++||||+++++++.....+|+||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 67889999999999999999889999999998654322 34567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccc
Q 004088 269 GGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFI 348 (774)
Q Consensus 269 ~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~ 348 (774)
++ +|..++......+++..+..++.||+.||.|||.++|+|+||||+||+++.++.++|+|||.+..............
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~ 159 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV 159 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCcc
Confidence 65 88888766557899999999999999999999999999999999999999999999999999977655432233356
Q ss_pred ccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-CC----------------------
Q 004088 349 GTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-PA---------------------- 404 (774)
Q Consensus 349 GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-~~---------------------- 404 (774)
++..|+|||.+.+. .++.++|||||||++|+|++|++||...+....+..+... ..
T Consensus 160 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05118 160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239 (283)
T ss_pred CcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcc
Confidence 88999999999876 7899999999999999999999999876654443222110 00
Q ss_pred ----CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 405 ----PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 405 ----~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
.........+..+.+||.+||.+||.+||++.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0001122356789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=348.62 Aligned_cols=261 Identities=24% Similarity=0.431 Sum_probs=213.1
Q ss_pred CCcccCCCCCCeeEEeeeeccCceEEEEEEEcC-------CCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCccc
Q 004088 179 ESVTREDPTTKYELLNELGKGSYGAVYKARDLK-------TSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVR 250 (774)
Q Consensus 179 ~~~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~-------~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVk 250 (774)
....++...++|.+.+.||+|+||.||+|++.. +...||+|++...........+.+|+.+++.+ +||||++
T Consensus 9 ~~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~ 88 (307)
T cd05098 9 EDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 88 (307)
T ss_pred CCCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEee
Confidence 333455667899999999999999999998643 23579999987544445566788999999999 7999999
Q ss_pred ccccccCCceEEEEEEecCCCchhhhhhccC---------------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q 004088 251 YLGSYQGEEYLWIVMEYCGGGSVADLMNVTE---------------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKG 315 (774)
Q Consensus 251 L~~~~~~~~~l~LVmEy~~ggsL~dll~~~~---------------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKP 315 (774)
+++++.....+|+||||+++++|.+++.... ..+++.++..++.||+.||+|||++||+||||||
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 168 (307)
T cd05098 89 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA 168 (307)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH
Confidence 9999999999999999999999999986432 2488899999999999999999999999999999
Q ss_pred cceEecCCCcEEEeecccccccccccccc--ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCc
Q 004088 316 GNILLTDQGEVKLGDFGVAAQLTRTMSKR--NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHP 392 (774)
Q Consensus 316 eNILLd~~g~vKL~DFGlA~~i~~~~~~~--~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~ 392 (774)
+|||++.++.+||+|||++..+....... ....+++.|+|||++.+..++.++|||||||++|+|++ |.+||.....
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 99999999999999999997654321111 11234578999999998889999999999999999998 8899977655
Q ss_pred hhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 393 MRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 393 ~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
......+.... ....+..++..+.+||.+||..+|.+||++.+++++
T Consensus 249 ~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 249 EELFKLLKEGH--RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHcCC--CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 44443333222 122334567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=354.35 Aligned_cols=260 Identities=27% Similarity=0.414 Sum_probs=211.1
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCC-----ce
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE-----EY 260 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~-----~~ 260 (774)
..+|.+++.||+|+||+||+|++..+++.||||.+.... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 468999999999999999999999999999999986432 223345677899999999999999999988643 35
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
.|+||||+. ++|.+++. ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~lv~e~~~-~~L~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR-SSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred EEEEEeCCC-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 899999995 67888875 3467999999999999999999999999999999999999999999999999999766443
Q ss_pred ccccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc------------------
Q 004088 341 MSKRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI------------------ 401 (774)
Q Consensus 341 ~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~------------------ 401 (774)
........++..|+|||++.. ..++.++|||||||++|+|++|++||...+.......+..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 333345578999999999875 4689999999999999999999999976543221111100
Q ss_pred ---------CC-CCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 402 ---------EP-APMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 402 ---------~~-~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.. .........++..+.+||.+||+.+|++|||+.++|+||||....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 00 000111234578899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=345.89 Aligned_cols=262 Identities=34% Similarity=0.546 Sum_probs=213.5
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~L 263 (774)
...++|++.+.||+|+||.||+|.+..+++.||||++...........+..|+.++.++ .||||+++++++.....+|+
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 35578999999999999999999998889999999997654444455677788777666 59999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHh-cCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS-IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs-~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
||||+. ++|..++......+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++..+.....
T Consensus 92 v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 92 CMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred EeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 999995 57777776555689999999999999999999997 6999999999999999999999999999976644322
Q ss_pred ccccccccccccchhhhhhcC----CCCccchhhhHHHHHHHHhCCCCCCCCCch-hhhhhhhcCCCCccccchhchHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESR----YDGKVDVWALGVSAVEMAEGLPPRSTVHPM-RVLFMISIEPAPMLEDKEKWSLVF 417 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~----~s~ksDIWSLGviLyELLtG~~Pf~~~~~~-~~i~~i~~~~~~~~~~~~~~s~~l 417 (774)
. ....+++.|+|||++.... ++.++|||||||++|+|++|+.||...... +.+..+.....+.......++..+
T Consensus 171 ~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (296)
T cd06618 171 K-TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDF 249 (296)
T ss_pred c-cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHH
Confidence 2 2335788999999987553 788999999999999999999999764332 222222222222222333567889
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 418 HDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 418 ~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.+||.+||..||.+||++.++++||||....
T Consensus 250 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 250 CSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred HHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 9999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=341.79 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=209.7
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCc----EEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSE----LVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~----~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
...+|++++.||+|+||+||+|++..+++ .||||++...........+.+|+.+++.+.||||+++++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence 45689999999999999999999877776 48999987655555567789999999999999999999988754 57
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
+++|||+++|+|.+++......+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+....
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 89999999999999997666779999999999999999999999999999999999999999999999999998664322
Q ss_pred cc--cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 342 SK--RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 342 ~~--~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
.. .....+++.|+|||++.+..++.++|||||||++|||++ |.+||...........+...... .....++..+.
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 241 (279)
T cd05109 164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL--PQPPICTIDVY 241 (279)
T ss_pred ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC--CCCccCCHHHH
Confidence 11 111234678999999998889999999999999999998 99999876554443333222111 22345678899
Q ss_pred HHHHhhcccCCCCCCCHHHHHh
Q 004088 419 DFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
++|.+||..||++||++.+++.
T Consensus 242 ~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 242 MIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=339.53 Aligned_cols=252 Identities=27% Similarity=0.467 Sum_probs=210.0
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
++|++.+.||.|+||.||+|++..+++.||||.+.... .......+.+|+.+++.+.||||++++++|..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 47899999999999999999999999999999886533 2234467889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhc---cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 266 EYCGGGSVADLMNV---TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 266 Ey~~ggsL~dll~~---~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
||+++++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999999998753 235689999999999999999999999999999999999999999999999999876654433
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCch--hhhhhhhcCCCCccccchhchHHHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPM--RVLFMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~--~~i~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
......|+..|+|||++.+..++.++|||||||++|+|++|..||...... .....+.....+. .....++..+.++
T Consensus 162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 240 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP-LPSDHYSEELRQL 240 (267)
T ss_pred ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCC-CCcccccHHHHHH
Confidence 334457899999999998888999999999999999999999999754322 1111111111111 1123467789999
Q ss_pred HHhhcccCCCCCCCHHHHHh
Q 004088 421 VAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~ 440 (774)
|.+||..+|.+|||+.+|++
T Consensus 241 i~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 241 VNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHhcCCCcccCCCHHHHHH
Confidence 99999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=345.44 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=210.9
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCC-----CcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKT-----SELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~-----g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
..+|++.++||.|+||.||+|.+..+ ++.||||++.........+.+.+|+.++..++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 34688899999999999999987543 5789999987554444456788999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcc---------------CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcE
Q 004088 262 WIVMEYCGGGSVADLMNVT---------------EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEV 326 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~---------------~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~v 326 (774)
++++||+.+++|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCce
Confidence 9999999999999887421 2357888999999999999999999999999999999999999999
Q ss_pred EEeecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCC
Q 004088 327 KLGDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEP 403 (774)
Q Consensus 327 KL~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~ 403 (774)
||+|||+++.+..... ......+++.|+|||++....++.++|||||||++|||++ |.+||...........+....
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~ 243 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ 243 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999876543221 1223356789999999988889999999999999999997 889998776665555544333
Q ss_pred CCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 404 APMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 404 ~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.. ..+..++..+.+|+.+||+.+|.+||++.+++..
T Consensus 244 ~~--~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 244 VL--PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cC--CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 22 2234577889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=353.66 Aligned_cols=261 Identities=25% Similarity=0.440 Sum_probs=211.8
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCccccccccc----CCceE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ----GEEYL 261 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~----~~~~l 261 (774)
..+|++.+.||.|+||.||+|.+..+|+.||||++.... .......+.+|+.+|++++||||++++++|. ....+
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999999999999999987543 2234566788999999999999999999885 34578
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|+||||+. ++|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~lv~e~~~-~~l~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 84 YVVMDLME-SDLHHIIH-SDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEEehhh-hhHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 99999995 58888875 34569999999999999999999999999999999999999999999999999997654332
Q ss_pred cc----cccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC--------------
Q 004088 342 SK----RNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-------------- 402 (774)
Q Consensus 342 ~~----~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-------------- 402 (774)
.. .....|+..|+|||++.. ..++.++|||||||++|+|++|++||........+..+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 11 123478999999999865 45889999999999999999999999776543322111100
Q ss_pred ----------C-CCcc---ccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 403 ----------P-APML---EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 403 ----------~-~~~~---~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
+ .... ......+..+.+||.+||+.+|.+||++.+++.||||+..+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 0 0000 011235778999999999999999999999999999986643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=345.94 Aligned_cols=257 Identities=31% Similarity=0.479 Sum_probs=205.6
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh-hhHHHHHHHHHHHHhCCCCCcccccccccC--------
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE-EGYEEIRGEIEMLQQCSHPNVVRYLGSYQG-------- 257 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~-~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~-------- 257 (774)
.++|++.++||+|+||.||+|.+..+++.||||++...... .....+.+|+++|++++||||+++++++..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57999999999999999999999999999999998654322 223456789999999999999999998743
Q ss_pred CceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccc
Q 004088 258 EEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL 337 (774)
Q Consensus 258 ~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i 337 (774)
...+|+||||+.+ +|...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 3357999999965 676666555567999999999999999999999999999999999999999999999999999765
Q ss_pred cccccc-----------cccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC---
Q 004088 338 TRTMSK-----------RNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE--- 402 (774)
Q Consensus 338 ~~~~~~-----------~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~--- 402 (774)
...... .....|++.|+|||++.+. .++.++|||||||++|+|++|++||...........+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 432111 1234678899999998654 5889999999999999999999999876554332221100
Q ss_pred C------------------------CCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 403 P------------------------APMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 403 ~------------------------~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
+ .........+...+.+||.+||+.||.+|||+.+++.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0 00000012334678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=343.69 Aligned_cols=248 Identities=31% Similarity=0.547 Sum_probs=205.0
Q ss_pred eEEeeeeccCceEEEEEEEc----CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 191 ELLNELGKGSYGAVYKARDL----KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 191 ~ilk~LG~G~FG~Vy~a~d~----~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
++.+.||.|.||.||+|.+. ..+..|+||+++........+.+.+|+++|++++||||+++++++.....+++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 57889999999999999987 34678999999654455567889999999999999999999999998888999999
Q ss_pred ecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc--cc
Q 004088 267 YCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM--SK 343 (774)
Q Consensus 267 y~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~--~~ 343 (774)
||++|+|.+++... ...+++..+..|+.||+.||.|||+++|+|++|+++|||++.++.+||+|||++....... ..
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~ 161 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKN 161 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999865 5789999999999999999999999999999999999999999999999999997763221 11
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
.....+...|+|||++....++.++||||||+++|||++ |+.||...........+.... ....+..++..+.++|.
T Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~ 239 (259)
T PF07714_consen 162 DSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ--RLPIPDNCPKDIYSLIQ 239 (259)
T ss_dssp STTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE--ETTSBTTSBHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cceeccchhHHHHHHHH
Confidence 223457789999999999889999999999999999999 789998887766555543222 22345567888999999
Q ss_pred hhcccCCCCCCCHHHHHh
Q 004088 423 KCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~ 440 (774)
+||..+|.+||++.++++
T Consensus 240 ~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 240 QCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHT-SSGGGS--HHHHHH
T ss_pred HHcCCChhhCcCHHHHHh
Confidence 999999999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=345.97 Aligned_cols=257 Identities=30% Similarity=0.418 Sum_probs=214.6
Q ss_pred CCCCCeeEE-eeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccccC----C
Q 004088 185 DPTTKYELL-NELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQG----E 258 (774)
Q Consensus 185 ~~~~~Y~il-k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~----~ 258 (774)
..+.+|.+- ++||-|-.|.|..|.++.+|+.+|+|++... ...++|+++.... .|||||+++++|++ .
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 345677776 4799999999999999999999999998522 3467899987776 69999999999864 4
Q ss_pred ceEEEEEEecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC---CcEEEeecccc
Q 004088 259 EYLWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ---GEVKLGDFGVA 334 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~---g~vKL~DFGlA 334 (774)
..+.||||.++||.|+..++.++ +.++|.++..|++||+.|+.|||+++|.||||||+|+|.+.. ..+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 67889999999999999997544 579999999999999999999999999999999999999755 46999999999
Q ss_pred ccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhh----hhhcC-CCCcccc
Q 004088 335 AQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLF----MISIE-PAPMLED 409 (774)
Q Consensus 335 ~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~----~i~~~-~~~~~~~ 409 (774)
+.-... ....+.|-||.|.|||++-..+|+..+|+||+||+||-|++|.|||...+...+-. .|... .....+.
T Consensus 212 K~t~~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE 290 (400)
T KOG0604|consen 212 KETQEP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE 290 (400)
T ss_pred cccCCC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh
Confidence 765432 34556788999999999999999999999999999999999999999876533221 12222 1122234
Q ss_pred chhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 410 KEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 410 ~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
...+|+..+++|+++|..+|.+|.|+.++++|||+....
T Consensus 291 Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 291 WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 456688999999999999999999999999999997653
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=333.08 Aligned_cols=252 Identities=33% Similarity=0.559 Sum_probs=217.1
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
+|++.++||.|+||.||++++..+++.||||++.... .......+.+|+.++++++||||+++++++......|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5899999999999999999999999999999987543 233455678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcc---CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 268 CGGGSVADLMNVT---EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 268 ~~ggsL~dll~~~---~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
+++++|..++... ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++...... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~~ 158 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MA 158 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--Cc
Confidence 9999999987542 356899999999999999999999999999999999999999999999999999766544 22
Q ss_pred ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+.....+.. ...++..+.++|.+|
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~ 236 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI--PPIYSQDLQNFIRSM 236 (256)
T ss_pred ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC--chhhCHHHHHHHHHH
Confidence 234689999999999988899999999999999999999999988776554444333322222 236778899999999
Q ss_pred cccCCCCCCCHHHHHhhhhh
Q 004088 425 LTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 425 L~~DP~kRPTa~ElL~HPwf 444 (774)
|..+|.+||++.++++||++
T Consensus 237 l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 237 LQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred cCCCcccCCCHHHHhcCCCC
Confidence 99999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=340.15 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=210.8
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCc---EEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSE---LVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~---~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
..+|++.+.||+|+||.||+|++..++. .||+|.+.........+.+.+|+.+|++++||||+++++++...+..|+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4579999999999999999999865543 7999998654444556788999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
||||+++++|.+++......+++.++..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..+......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence 99999999999999766667899999999999999999999999999999999999999999999999999766443221
Q ss_pred cc---cccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHH
Q 004088 344 RN---TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHD 419 (774)
Q Consensus 344 ~~---~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~d 419 (774)
.. ...++..|+|||++.+..++.++|+|||||++|++++ |..||...........+..... .+....++..+.+
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 240 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR--LPAPMDCPAALHQ 240 (267)
T ss_pred eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc--CCCCCCCCHHHHH
Confidence 11 1223568999999998889999999999999999886 9999987665544443332211 1223456788999
Q ss_pred HHHhhcccCCCCCCCHHHHHh
Q 004088 420 FVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 420 LI~kcL~~DP~kRPTa~ElL~ 440 (774)
++.+||+++|.+||++.++++
T Consensus 241 li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 241 LMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHcccCchhCCCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=347.90 Aligned_cols=255 Identities=49% Similarity=0.867 Sum_probs=215.5
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
..|...++||+|+||+||+|++..+++.||||++.... .......+.+|+.+++.++||||+++++++......|+||
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 34778889999999999999999999999999986533 2234457889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
||+. ++|.+++.....++++..+..++.||+.+|.|||++||+||||||+||+++.++.+||+|||++.... ...
T Consensus 101 e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~----~~~ 175 (313)
T cd06633 101 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS----PAN 175 (313)
T ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC----CCC
Confidence 9995 57777776566779999999999999999999999999999999999999999999999999985432 223
Q ss_pred cccccccccchhhhh---hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHH
Q 004088 346 TFIGTPHWMAPEVIQ---ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
...|+..|+|||++. ...++.++|||||||++|+|++|.+||...........+.....+.. ....++..+.+||.
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~ 254 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL-QSNEWTDSFRGFVD 254 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CccccCHHHHHHHH
Confidence 457899999999984 35688899999999999999999999987766555544433322222 23456778999999
Q ss_pred hhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 423 KCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
+||+++|.+||++.++++||||+.++
T Consensus 255 ~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 255 YCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HHccCChhhCcCHHHHhcCcccCCCc
Confidence 99999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=346.96 Aligned_cols=259 Identities=50% Similarity=0.881 Sum_probs=218.4
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
..+...|...+.||+|+||.||++++..++..||||++.... .......+.+|+.+|++++|||++++++++..+...
T Consensus 21 ~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (317)
T cd06635 21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTA 100 (317)
T ss_pred CCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeE
Confidence 344566999999999999999999999999999999986432 233456788999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|+||||+.+ +|.+++.....++++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.....
T Consensus 101 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 101 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred EEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 999999965 77777765667799999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccccccccchhhhh---hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQ---ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
.....|++.|+|||++. ...++.++|||||||++|+|++|++||...........+.....+. .....++..+.
T Consensus 178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 254 (317)
T cd06635 178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT-LQSNEWSDYFR 254 (317)
T ss_pred --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC-CCCccccHHHH
Confidence 23446899999999984 4568899999999999999999999998776655555443332222 22345678899
Q ss_pred HHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 419 DFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
+||.+||+.+|.+||++.++++|+|+....
T Consensus 255 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 255 NFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 999999999999999999999999997543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=336.93 Aligned_cols=254 Identities=35% Similarity=0.603 Sum_probs=213.9
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC----ChhhHHHHHHHHHHHHhCCCCCcccccccccC--CceE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE----GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG--EEYL 261 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~----~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~--~~~l 261 (774)
.+|++.+.||+|+||.||+|++..+++.||+|++.... .......+.+|+.++++++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999986432 23345678899999999999999999998865 3568
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||+++.+....
T Consensus 82 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 999999999999998863 3468899999999999999999999999999999999999999999999999997653321
Q ss_pred ---cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 342 ---SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 342 ---~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
.......|+..|+|||++.+..++.++|||||||++|+|++|++||........+..+...+.. ...+..++..+.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~ 239 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTK-PMLPDGVSDACR 239 (264)
T ss_pred ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCC-CCCCcccCHHHH
Confidence 1122356899999999999888999999999999999999999999877666555444332221 223456788899
Q ss_pred HHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 419 DFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
++|.+||. +|.+||++.+++.|||+
T Consensus 240 ~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 240 DFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHhc-CcccCccHHHHhcCCCC
Confidence 99999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=364.87 Aligned_cols=264 Identities=23% Similarity=0.394 Sum_probs=213.4
Q ss_pred CCCCcccCCCCCCeeEEeeeeccCceEEEEEEEcCC-----CcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-CCCccc
Q 004088 177 IPESVTREDPTTKYELLNELGKGSYGAVYKARDLKT-----SELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPNVVR 250 (774)
Q Consensus 177 ~~~~~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~-----g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HPNIVk 250 (774)
.+....++.+.++|.+++.||+|+||.||+|.+... +..||||++.........+.+.+|+++|+++. ||||++
T Consensus 26 ~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~ 105 (400)
T cd05105 26 LPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVN 105 (400)
T ss_pred CCCCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeee
Confidence 333445667788999999999999999999987433 35799999975555555567899999999996 999999
Q ss_pred ccccccCCceEEEEEEecCCCchhhhhhccC-------------------------------------------------
Q 004088 251 YLGSYQGEEYLWIVMEYCGGGSVADLMNVTE------------------------------------------------- 281 (774)
Q Consensus 251 L~~~~~~~~~l~LVmEy~~ggsL~dll~~~~------------------------------------------------- 281 (774)
++++|.....+|||||||++|+|.+++....
T Consensus 106 l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (400)
T cd05105 106 LLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADT 185 (400)
T ss_pred EEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccc
Confidence 9999999999999999999999998875321
Q ss_pred ----------------------------------------------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccc
Q 004088 282 ----------------------------------------------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKG 315 (774)
Q Consensus 282 ----------------------------------------------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKP 315 (774)
..+++..+..++.||+.||.|||+.+|+||||||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp 265 (400)
T cd05105 186 TQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAA 265 (400)
T ss_pred cccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence 2477888899999999999999999999999999
Q ss_pred cceEecCCCcEEEeecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCc
Q 004088 316 GNILLTDQGEVKLGDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHP 392 (774)
Q Consensus 316 eNILLd~~g~vKL~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~ 392 (774)
+|||++.++.+||+|||+++.+..... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 266 ~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred HhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 999999999999999999976543221 1223457788999999998889999999999999999996 9999876543
Q ss_pred hhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 393 MRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 393 ~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
............ .......++..+.++|.+||+.+|++||++.+|.+.
T Consensus 346 ~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 393 (400)
T cd05105 346 DSTFYNKIKSGY-RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI 393 (400)
T ss_pred hHHHHHHHhcCC-CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence 333222211111 122334567889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=336.78 Aligned_cols=251 Identities=23% Similarity=0.384 Sum_probs=210.4
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
...++|+++++||+|+||.||+|.+ .++..||+|.+.... ...+.+.+|+.++++++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 4567899999999999999999985 456779999875432 3356789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 265 mEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|||+++++|.+++... ...+++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||++..+......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999999988643 356888999999999999999999999999999999999999999999999999766433211
Q ss_pred -cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHH
Q 004088 344 -RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421 (774)
Q Consensus 344 -~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI 421 (774)
.....++..|+|||++....++.++|||||||++|+|++ |..||...........+..... .+....++..+.++|
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li 237 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR--MPRMENCPDELYDIM 237 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHH
Confidence 122346778999999988889999999999999999998 9999987666555444433221 222345678899999
Q ss_pred HhhcccCCCCCCCHHHHHh
Q 004088 422 AKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 422 ~kcL~~DP~kRPTa~ElL~ 440 (774)
.+||..+|++||+++++++
T Consensus 238 ~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 238 KTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHccCCcccCcCHHHHHH
Confidence 9999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=352.02 Aligned_cols=256 Identities=28% Similarity=0.517 Sum_probs=204.5
Q ss_pred eeeecc--CceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCC
Q 004088 194 NELGKG--SYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGG 270 (774)
Q Consensus 194 k~LG~G--~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~g 270 (774)
.+||.| +||+||+|++..+|+.||||++.... .....+.+.+|+.+++.++||||++++++|..+..+|+||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456776 99999999999999999999987543 334457789999999999999999999999999999999999999
Q ss_pred Cchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc-----
Q 004088 271 GSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR----- 344 (774)
Q Consensus 271 gsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~----- 344 (774)
++|.+++... ...+++..+..++.||+.||+|||+.||+||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 9999988643 3468999999999999999999999999999999999999999999999998664332211111
Q ss_pred --ccccccccccchhhhhhc--CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCC----------------
Q 004088 345 --NTFIGTPHWMAPEVIQES--RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA---------------- 404 (774)
Q Consensus 345 --~~~~GT~~Y~APEvl~~~--~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~---------------- 404 (774)
....++..|+|||++.+. .++.++|||||||++|+|++|++||.................
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM 243 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence 112356679999999763 478999999999999999999999976543332211110000
Q ss_pred ----------------------------CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 405 ----------------------------PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 405 ----------------------------~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
........++..+.+||.+||+.||.+|||+.++|+||||+..+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 000112235677899999999999999999999999999987654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=341.87 Aligned_cols=252 Identities=28% Similarity=0.415 Sum_probs=207.5
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCc----EEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSE----LVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~----~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
...+|++++.||+|+||+||+|.+..+++ .||+|.+...........+..|+.+++++.||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~ 83 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL 83 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence 34689999999999999999999877776 4777777543334445678889999999999999999998764 457
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
++|+||+++|+|.+++......+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.+....
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 88999999999999997666789999999999999999999999999999999999999999999999999997654322
Q ss_pred c--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 342 S--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 342 ~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
. ......++..|+|||++.+..++.++|||||||++|||++ |..||...........+.....+ ..+..++..+.
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 241 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERL--AQPQICTIDVY 241 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC--CCCCCCCHHHH
Confidence 1 1223457788999999998889999999999999999998 99999877655443333222211 22334567789
Q ss_pred HHHHhhcccCCCCCCCHHHHHh
Q 004088 419 DFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
+++.+||..||.+|||+.++++
T Consensus 242 ~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 242 MVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=395.05 Aligned_cols=262 Identities=27% Similarity=0.437 Sum_probs=227.3
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
...+|.+++.||+|+||.|.+++++.+++.||+|++++.. ......-|..|-.+|.-.+.+=|++|+..|.++.++|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 4568999999999999999999999999999999997532 12334568899999999899999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc-
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS- 342 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~- 342 (774)
||||++||+|..++.... ++++..++.++..|+.||.-||+.|+|||||||+||||+..|++||+|||.|-.+.....
T Consensus 153 VMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred EEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence 999999999999997555 899999999999999999999999999999999999999999999999999988774433
Q ss_pred ccccccccccccchhhhhh-----cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCC-CCccccchhchHH
Q 004088 343 KRNTFIGTPHWMAPEVIQE-----SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEP-APMLEDKEKWSLV 416 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~-----~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~-~~~~~~~~~~s~~ 416 (774)
.....+|||.|++||++.. +.|+..+|+||+||++|||+.|..||+...-...+-.|.... .-.++....+|..
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSee 311 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEE 311 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHH
Confidence 3456799999999999962 569999999999999999999999999888777776664431 1112234568999
Q ss_pred HHHHHHhhcccCCCCCCC---HHHHHhhhhhhhhcc
Q 004088 417 FHDFVAKCLTKEPRARPT---AAEMLKHKFIERCKC 449 (774)
Q Consensus 417 l~dLI~kcL~~DP~kRPT---a~ElL~HPwf~~~~~ 449 (774)
+++||.+++. +|+.|.. ++++.+||||....+
T Consensus 312 akdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 312 AKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred HHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 9999999885 6888988 999999999987654
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=337.10 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=208.2
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
..+|++++.||+|+||.||+|.+.. +..||||.+.... ...+.+.+|+.++++++||||+++++++.....+|+|||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 3579999999999999999998643 4569999886432 234678999999999999999999999998899999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc-cc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK-RN 345 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~-~~ 345 (774)
|+.+++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||.++.+...... ..
T Consensus 80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 99999999998765567999999999999999999999999999999999999999999999999998765433211 11
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
...++..|+|||++.+..++.++|||||||++|+|++ |..||...........+...... ......+..+.+++.+|
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~c 237 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL--YRPHLASEKVYAIMYSC 237 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHH
Confidence 2235678999999998889999999999999999998 99999876655444443332221 12334578899999999
Q ss_pred cccCCCCCCCHHHHHhh
Q 004088 425 LTKEPRARPTAAEMLKH 441 (774)
Q Consensus 425 L~~DP~kRPTa~ElL~H 441 (774)
|+.+|.+||++.+++.+
T Consensus 238 l~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 238 WHEKAEERPTFQQLLSS 254 (256)
T ss_pred cCCCcccCCCHHHHHHh
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=346.59 Aligned_cols=253 Identities=26% Similarity=0.421 Sum_probs=207.6
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcE--EEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSEL--VAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~--VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~ 262 (774)
..++|++.+.||+|+||.||+|.+..++.. +|+|.+...........+.+|+.++.++ +||||+++++++.....+|
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 456899999999999999999998877764 5777765433444556788999999999 8999999999999999999
Q ss_pred EEEEecCCCchhhhhhccC---------------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEE
Q 004088 263 IVMEYCGGGSVADLMNVTE---------------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVK 327 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~---------------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vK 327 (774)
+||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEE
Confidence 9999999999999886332 3578999999999999999999999999999999999999999999
Q ss_pred EeeccccccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCc
Q 004088 328 LGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPM 406 (774)
Q Consensus 328 L~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~ 406 (774)
|+|||++...... .......++..|+|||++.+..++.++|||||||++|+|++ |.+||...........+.... .
T Consensus 165 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--~ 241 (303)
T cd05088 165 IADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--R 241 (303)
T ss_pred eCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC--c
Confidence 9999998643211 11112234678999999988889999999999999999998 999998766555443332211 1
Q ss_pred cccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 407 LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 407 ~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
...+..++..+.+||.+||+.+|.+||++.++|.+
T Consensus 242 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 242 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12233457789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=336.32 Aligned_cols=254 Identities=22% Similarity=0.356 Sum_probs=212.2
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCc---EEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSE---LVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~---~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
..++|+..+.||+|+||.||+|.+..++. .||||++...........+.+|++++++++||||+++++++...+..|
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 35689999999999999999999876654 799999865544455677899999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
+||||+++++|.+++......+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence 99999999999999876667899999999999999999999999999999999999999999999999999976543222
Q ss_pred ccc---cccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 343 KRN---TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 343 ~~~---~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
... ....++.|+|||++....++.++|||||||++|+|++ |..||...........+.... ..+.....+..+.
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~ 240 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF--RLPAPMDCPSAVY 240 (268)
T ss_pred cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC--CCCCCCCCCHHHH
Confidence 111 1123457999999998889999999999999999997 999998766655544443221 1222334677899
Q ss_pred HHHHhhcccCCCCCCCHHHHHhh
Q 004088 419 DFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
+++.+||+.+|.+||++.++++.
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~~ 263 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVNL 263 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHHH
Confidence 99999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=342.50 Aligned_cols=251 Identities=24% Similarity=0.410 Sum_probs=201.3
Q ss_pred eeeccCceEEEEEEEcCCCcEEEEEEeecCCCh--hhHHHHHHHH---HHHHhCCCCCcccccccccCCceEEEEEEecC
Q 004088 195 ELGKGSYGAVYKARDLKTSELVAIKVISLSEGE--EGYEEIRGEI---EMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCG 269 (774)
Q Consensus 195 ~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~--~~~~~~~~Ei---~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~ 269 (774)
.||+|+||.||+|.+..+++.||||++...... .....+..|. .+++...||||+++++++...+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999998754321 1112233343 44555689999999999999999999999999
Q ss_pred CCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccccc
Q 004088 270 GGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIG 349 (774)
Q Consensus 270 ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~G 349 (774)
|++|..++. ....+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++..+... ......|
T Consensus 81 g~~L~~~l~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~ 157 (278)
T cd05606 81 GGDLHYHLS-QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVG 157 (278)
T ss_pred CCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCcCC
Confidence 999998885 4467999999999999999999999999999999999999999999999999998765432 2234579
Q ss_pred cccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccC
Q 004088 350 TPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKE 428 (774)
Q Consensus 350 T~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~D 428 (774)
+..|+|||++.+. .++.++||||+||++|+|++|+.||......................+..++..+.++|.+||..+
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~ 237 (278)
T cd05606 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRD 237 (278)
T ss_pred CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcC
Confidence 9999999999754 689999999999999999999999976532221111111111111223346889999999999999
Q ss_pred CCCCC-----CHHHHHhhhhhhhhc
Q 004088 429 PRARP-----TAAEMLKHKFIERCK 448 (774)
Q Consensus 429 P~kRP-----Ta~ElL~HPwf~~~~ 448 (774)
|.+|| ++.++++||||+...
T Consensus 238 p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 238 VNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred HHhccCCCCCCHHHHHhCccccCCC
Confidence 99999 999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=338.86 Aligned_cols=254 Identities=35% Similarity=0.533 Sum_probs=211.2
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEec
Q 004088 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYC 268 (774)
Q Consensus 190 Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~ 268 (774)
|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+.+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 678899999999999999999999999999997643 2333466788999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccc
Q 004088 269 GGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFI 348 (774)
Q Consensus 269 ~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~ 348 (774)
+ ++|.+++......+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++..............
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV 159 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence 7 589999875546799999999999999999999999999999999999999999999999999977654433333445
Q ss_pred ccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC--------------------CCC--
Q 004088 349 GTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE--------------------PAP-- 405 (774)
Q Consensus 349 GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~--------------------~~~-- 405 (774)
++..|+|||++... .++.++|||||||++|+|++|.+||........+..+... ..+
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd07829 160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKF 239 (282)
T ss_pred cCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccccc
Confidence 78889999999766 7899999999999999999999999776544332211100 000
Q ss_pred ----ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 406 ----MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 406 ----~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
........+..+.++|.+||..+|.+||++.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 240 PPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred CccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 000111236679999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.66 Aligned_cols=250 Identities=25% Similarity=0.393 Sum_probs=208.6
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
..+|++.+.||+|+||.||+|.+. ++..+|||++.... .....+.+|+.++++++||||+++++++......|+|||
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 346899999999999999999875 56679999985432 223568889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc-c
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR-N 345 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~-~ 345 (774)
|+++++|.+++......+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......... .
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 999999999987656678999999999999999999999999999999999999999999999999997654321111 1
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
...++..|+|||++.+..++.++|||||||++|+|++ |..||...........+..... ...+..++..+.+++.+|
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~c 237 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR--LYRPKLAPTEVYTIMYSC 237 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHH
Confidence 1123457999999998889999999999999999998 8999987666555444433221 122345688899999999
Q ss_pred cccCCCCCCCHHHHHhh
Q 004088 425 LTKEPRARPTAAEMLKH 441 (774)
Q Consensus 425 L~~DP~kRPTa~ElL~H 441 (774)
|..+|++|||+.++++.
T Consensus 238 l~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 238 WHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred hcCChhhCcCHHHHHHH
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=335.42 Aligned_cols=253 Identities=32% Similarity=0.543 Sum_probs=211.9
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC----ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE----GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~----~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
+|.+.++||+|+||.||++.+...+..+++|+++... .......+.+|+.+++.++||||+++++++......|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 6899999999999999999998877777777765321 122334577899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhc---cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 265 MEYCGGGSVADLMNV---TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 265 mEy~~ggsL~dll~~---~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|||+++++|.+++.. ....+++..++.++.|++.||.|||++||+|+||||+||+++. +.+||+|||++..+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988753 3457899999999999999999999999999999999999975 679999999997765443
Q ss_pred cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI 421 (774)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+.....+. ....++..+.++|
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li 237 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS--LPETYSRQLNSIM 237 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC--CcchhcHHHHHHH
Confidence 34445578999999999988889999999999999999999999997665544444333222222 2346678899999
Q ss_pred HhhcccCCCCCCCHHHHHhhhhh
Q 004088 422 AKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 422 ~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
.+||..+|.+||++.++++||||
T Consensus 238 ~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 238 QSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHhcCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=343.41 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=207.2
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCc--EEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSE--LVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~--~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~LV 264 (774)
++|++.+.||+|+||.||+|.+..++. .+|+|.++........+.+.+|+.++.++ +||||+++++++.....+|+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 579999999999999999999877664 47888876433444556789999999999 799999999999999999999
Q ss_pred EEecCCCchhhhhhccC---------------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEe
Q 004088 265 MEYCGGGSVADLMNVTE---------------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLG 329 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~---------------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~ 329 (774)
|||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence 99999999999986322 358899999999999999999999999999999999999999999999
Q ss_pred eccccccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccc
Q 004088 330 DFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLE 408 (774)
Q Consensus 330 DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~ 408 (774)
|||++....... .......+..|+|||++....++.++|||||||++|+|++ |..||...........+..... ..
T Consensus 162 dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~--~~ 238 (297)
T cd05089 162 DFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--ME 238 (297)
T ss_pred CcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC--CC
Confidence 999986432211 1111223567999999998889999999999999999997 9999987766554444332211 12
Q ss_pred cchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 409 DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 409 ~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.+..++..+.+||.+||+.+|.+||++.++++.
T Consensus 239 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 239 KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 234577889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=346.23 Aligned_cols=249 Identities=30% Similarity=0.520 Sum_probs=200.4
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecC-CChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCCCchhhhhh
Q 004088 200 SYGAVYKARDLKTSELVAIKVISLS-EGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN 278 (774)
Q Consensus 200 ~FG~Vy~a~d~~~g~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~ggsL~dll~ 278 (774)
++|.||++++..+++.||||++... ........+.+|+.+|++++||||++++++|......|++||||++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 4556666666679999999999765 244556789999999999999999999999999999999999999999999987
Q ss_pred cc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc-------cccccccc
Q 004088 279 VT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS-------KRNTFIGT 350 (774)
Q Consensus 279 ~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~-------~~~~~~GT 350 (774)
.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||.+..+..... ......++
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccccc
Confidence 43 35689999999999999999999999999999999999999999999999999865532211 11234578
Q ss_pred ccccchhhhhh--cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCC------------------------
Q 004088 351 PHWMAPEVIQE--SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA------------------------ 404 (774)
Q Consensus 351 ~~Y~APEvl~~--~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~------------------------ 404 (774)
..|+|||++.. ..++.++|||||||++|+|++|+.||.................
T Consensus 172 ~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
T cd08216 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNE 251 (314)
T ss_pred ccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccccc
Confidence 89999999976 3588999999999999999999999986554332211100000
Q ss_pred -------CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 405 -------PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 405 -------~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
........++..+.+||.+||+.||++|||+.++|+||||+.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 252 HPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred ccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00011123356788999999999999999999999999998765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=325.32 Aligned_cols=257 Identities=29% Similarity=0.499 Sum_probs=218.0
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhH-HHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY-EEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~-~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
+|.-+++||+|.||+||+|++..+++.||+|.++...+.+.. ....+||-+|+.+.|.|||+++++...+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 577789999999999999999999999999999877654443 4578999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccc
Q 004088 268 CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF 347 (774)
Q Consensus 268 ~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~ 347 (774)
| ..+|..++...++.++...++.++.|+++||.|+|++++.||||||.|+||+.+|.+||+|||+|+.++-+.......
T Consensus 83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysae 161 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE 161 (292)
T ss_pred h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeece
Confidence 9 457888877778889999999999999999999999999999999999999999999999999999887765555556
Q ss_pred cccccccchhhhhhcC-CCCccchhhhHHHHHHHH-hCCCCCCCCCchhhhhhhhcC-------------------CCCc
Q 004088 348 IGTPHWMAPEVIQESR-YDGKVDVWALGVSAVEMA-EGLPPRSTVHPMRVLFMISIE-------------------PAPM 406 (774)
Q Consensus 348 ~GT~~Y~APEvl~~~~-~s~ksDIWSLGviLyELL-tG~~Pf~~~~~~~~i~~i~~~-------------------~~~~ 406 (774)
+-|.+|++|.++.+.+ |+...|+||.|||+.|+. .|+|.|.+.+-.+.+..|-.. +.|.
T Consensus 162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ 241 (292)
T KOG0662|consen 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPI 241 (292)
T ss_pred eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCC
Confidence 7899999999998865 899999999999999998 578888887766555433111 0111
Q ss_pred cccchhchH-------HHHHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 407 LEDKEKWSL-------VFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 407 ~~~~~~~s~-------~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
.+....|++ .-+++++++|..+|.+|++++++|+||||..
T Consensus 242 ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 242 YPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred ccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 111122222 2479999999999999999999999999964
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=359.91 Aligned_cols=254 Identities=31% Similarity=0.484 Sum_probs=203.3
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCc-eEEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE-YLWI 263 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~-~l~L 263 (774)
..++.|.-.+.||+|+||.||+|. ..+|..||||++....... ..+|.+|+.+|.+++|||+|+|+|||.+.+ ..+|
T Consensus 72 ~AT~~Fs~~~~ig~Ggfg~VYkG~-l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 72 KATNNFSESNLIGEGGFGTVYKGV-LSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred HHHhCCchhcceecCCCeEEEEEE-ECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 456789999999999999999998 4566899999886544332 466999999999999999999999999888 5999
Q ss_pred EEEecCCCchhhhhhccCC-chhHHHHHHHHHHHHHHHHHHHhcC---cccccccccceEecCCCcEEEeeccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEE-PLEEYQIAYICREALKGLAYLHSIF---KVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~-~Lse~~i~~I~~QIl~gL~YLHs~g---IIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
|+||+++|+|.+++..... .++|..+.+|+.++++||+|||... |||||||++|||||.+.++||+|||+|+....
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 9999999999999986655 8999999999999999999999865 99999999999999999999999999965433
Q ss_pred cccccccc-cccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCC---chhhhh----hhhc-----CCCCc
Q 004088 340 TMSKRNTF-IGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVH---PMRVLF----MISI-----EPAPM 406 (774)
Q Consensus 340 ~~~~~~~~-~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~---~~~~i~----~i~~-----~~~~~ 406 (774)
......+. .||.+|+|||++.....+.|+|||||||+|.||++|+.+..... ...... .+.. ...+.
T Consensus 230 ~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~ 309 (361)
T KOG1187|consen 230 GDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPR 309 (361)
T ss_pred cccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCC
Confidence 12222233 79999999999998899999999999999999999998776432 111111 0000 01111
Q ss_pred cc-cc-h--hchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 407 LE-DK-E--KWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 407 ~~-~~-~--~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
+. .. . ..-..+..+..+|++.+|..||++.||++
T Consensus 310 l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 310 LKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred ccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 11 00 0 11223567889999999999999999864
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=345.43 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=211.9
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCccccccccc
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDL-----KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQ 256 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~-----~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~ 256 (774)
+....++|.+.+.||+|+||.||+|.+. .++..||||+++........+.+.+|+.+++++ +||||+++++++.
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 4455678999999999999999999752 345689999987554455567789999999999 7999999999999
Q ss_pred CCceEEEEEEecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccc
Q 004088 257 GEEYLWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 257 ~~~~l~LVmEy~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
..+..|+||||+.+++|.++++... ..+++.++..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||+++
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999999999986433 348999999999999999999999999999999999999999999999999997
Q ss_pred ccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchh
Q 004088 336 QLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEK 412 (774)
Q Consensus 336 ~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~ 412 (774)
.+..... ......+++.|+|||++.+..++.++|||||||++|+|++ |.+||.................. ...+..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~ 268 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR-MAQPEH 268 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc-CCCCCC
Confidence 6543321 1122346788999999998889999999999999999998 99999876544333222221111 122334
Q ss_pred chHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 413 WSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 413 ~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.+..+.+||.+||.++|++||++.++++.
T Consensus 269 ~~~~~~~li~~cl~~~p~~Rpt~~ell~~ 297 (302)
T cd05055 269 APAEIYDIMKTCWDADPLKRPTFKQIVQL 297 (302)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 57889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=334.91 Aligned_cols=250 Identities=23% Similarity=0.374 Sum_probs=205.7
Q ss_pred eeEEeeeeccCceEEEEEEEcCC---CcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCc------
Q 004088 190 YELLNELGKGSYGAVYKARDLKT---SELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE------ 259 (774)
Q Consensus 190 Y~ilk~LG~G~FG~Vy~a~d~~~---g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~------ 259 (774)
|++++.||+|+||.||+|....+ +..||||++.... .......+.+|+.+|+.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67889999999999999987543 4789999987543 2344567899999999999999999999876544
Q ss_pred eEEEEEEecCCCchhhhhhcc-----CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVT-----EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA 334 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~-----~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA 334 (774)
..++||||+++++|..++... ...+++..+..++.|++.||.|||+.+|+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 379999999999999887432 246899999999999999999999999999999999999999999999999999
Q ss_pred cccccccccc--ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccch
Q 004088 335 AQLTRTMSKR--NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKE 411 (774)
Q Consensus 335 ~~i~~~~~~~--~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~ 411 (774)
+.+....... ....++..|+|||++....++.++|||||||++|||++ |.+||......+....+..... ...+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~ 238 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR--LKQPE 238 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCc
Confidence 7664432211 12235678999999988889999999999999999998 8999987766655544433222 22344
Q ss_pred hchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 412 KWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 412 ~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.++..+.++|.+||+.||.+||++.+++++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 678889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=342.62 Aligned_cols=258 Identities=31% Similarity=0.464 Sum_probs=208.2
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccCCc-----
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE----- 259 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~----- 259 (774)
..++|++.+.||+|+||.||+|.+..+|+.||||+++.... ......+.+|+.++++++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 45689999999999999999999999999999999975432 233356778999999999999999999887554
Q ss_pred -----eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccc
Q 004088 260 -----YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA 334 (774)
Q Consensus 260 -----~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA 334 (774)
.+|+||||+++ ++..++......+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 89999999976 666666555567999999999999999999999999999999999999999999999999999
Q ss_pred cccccccc-ccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc---CCCC----
Q 004088 335 AQLTRTMS-KRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI---EPAP---- 405 (774)
Q Consensus 335 ~~i~~~~~-~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~---~~~~---- 405 (774)
..+..... ......++..|+|||++.+ ..++.++|||||||++|+|++|++||...........+.. .+.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP 243 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 76644321 1122356888999998865 3578899999999999999999999986554333221111 1000
Q ss_pred --------------------ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 406 --------------------MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 406 --------------------~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
.......++..+.++|.+||..+|.+||++.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 001112357789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=345.48 Aligned_cols=257 Identities=23% Similarity=0.436 Sum_probs=211.4
Q ss_pred ccCCCCCCeeEEeeeeccCceEEEEEEEcC-------CCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccc
Q 004088 182 TREDPTTKYELLNELGKGSYGAVYKARDLK-------TSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLG 253 (774)
Q Consensus 182 ~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~-------~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~ 253 (774)
.+..+..+|.+.++||+|+||.||+|++.. ....||+|++...........+.+|+.+++++ .||||+++++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 345566799999999999999999998632 34579999987544455567788999999999 6999999999
Q ss_pred cccCCceEEEEEEecCCCchhhhhhcc---------------CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccce
Q 004088 254 SYQGEEYLWIVMEYCGGGSVADLMNVT---------------EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNI 318 (774)
Q Consensus 254 ~~~~~~~l~LVmEy~~ggsL~dll~~~---------------~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNI 318 (774)
++.....+|+||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 999999999999999999999998642 23588899999999999999999999999999999999
Q ss_pred EecCCCcEEEeecccccccccccccc--ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhh
Q 004088 319 LLTDQGEVKLGDFGVAAQLTRTMSKR--NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRV 395 (774)
Q Consensus 319 LLd~~g~vKL~DFGlA~~i~~~~~~~--~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~ 395 (774)
|++.++.+||+|||+++.+....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999997654321111 11234568999999998889999999999999999998 8999987765555
Q ss_pred hhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 396 LFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 396 i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
...+..... ......++..+.++|.+||..+|.+||++.++++
T Consensus 246 ~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 246 FKLLREGHR--MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 444433221 1223456778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=341.23 Aligned_cols=252 Identities=26% Similarity=0.419 Sum_probs=209.9
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCce
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDL-----KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEY 260 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~-----~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~ 260 (774)
...+|.+.+.||+|+||.||++... .++..||+|.+... .......+.+|+.+|++++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 3568999999999999999999852 34567999988643 33445678999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhccC------------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEE
Q 004088 261 LWIVMEYCGGGSVADLMNVTE------------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKL 328 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~------------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL 328 (774)
+|+||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence 999999999999999886322 34899999999999999999999999999999999999999999999
Q ss_pred eecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCC
Q 004088 329 GDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAP 405 (774)
Q Consensus 329 ~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~ 405 (774)
+|||+++.+..... ......+++.|+|||++.+..++.++|||||||++|+|++ |.+||...........+......
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~ 241 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 241 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99999976543221 1122346788999999998889999999999999999998 99999877665555444333222
Q ss_pred ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 406 MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 406 ~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
.....++..+.+|+.+||+.||.+|||+.+++.
T Consensus 242 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 242 --QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred --CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 223456788999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=362.47 Aligned_cols=260 Identities=27% Similarity=0.385 Sum_probs=221.8
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
..+.|+.-+.||+|+||.||-|+...+|+.||+|.+.+.. .........+|..||.+++.+.||.|-..|+..+.+|+
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3467999999999999999999999999999999986443 23344557899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
||..|+||+|.-+|.+. +..+++..+..++.+|+.||++||+.+||+|||||+|||+|+.|+|+|+|+|+|..+.....
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~ 342 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP 342 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCc
Confidence 99999999998777543 35799999999999999999999999999999999999999999999999999988766533
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCch----hhhhhhhcCCCCccccchhchHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPM----RVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~----~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
. ...+||.+|||||++.+..|+...|+|||||++|||+.|+.||.....- ++-.++...+ .+-+.+++++++
T Consensus 343 ~-~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~---~ey~~kFS~eak 418 (591)
T KOG0986|consen 343 I-RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP---EEYSDKFSEEAK 418 (591)
T ss_pred c-ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch---hhcccccCHHHH
Confidence 3 3448999999999999999999999999999999999999999753321 2222222221 223478899999
Q ss_pred HHHHhhcccCCCCCC-----CHHHHHhhhhhhhhcc
Q 004088 419 DFVAKCLTKEPRARP-----TAAEMLKHKFIERCKC 449 (774)
Q Consensus 419 dLI~kcL~~DP~kRP-----Ta~ElL~HPwf~~~~~ 449 (774)
+|.+.+|++||.+|. .++++.+||||+.+.+
T Consensus 419 slc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 419 SLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred HHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence 999999999999996 4679999999987653
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=352.76 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=206.4
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEE-----cCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCccccccccc
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARD-----LKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQ 256 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d-----~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~ 256 (774)
+..+.++|++.+.||+|+||.||+|.+ ..+++.||||+++..........+.+|+.+|.++ +||||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 345667999999999999999999984 3467899999997554445566788999999999 6899999999875
Q ss_pred C-CceEEEEEEecCCCchhhhhhccC------------------------------------------------------
Q 004088 257 G-EEYLWIVMEYCGGGSVADLMNVTE------------------------------------------------------ 281 (774)
Q Consensus 257 ~-~~~l~LVmEy~~ggsL~dll~~~~------------------------------------------------------ 281 (774)
. +..+++|||||++|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 4 457899999999999999875321
Q ss_pred ------------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc--ccccc
Q 004088 282 ------------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS--KRNTF 347 (774)
Q Consensus 282 ------------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~--~~~~~ 347 (774)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... .....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 2367788889999999999999999999999999999999999999999999976533211 11223
Q ss_pred cccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcc
Q 004088 348 IGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLT 426 (774)
Q Consensus 348 ~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~ 426 (774)
.+++.|+|||++.+..++.++|||||||++|+|++ |..||................ .....+...+..+.+++.+||+
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~cl~ 320 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-TRMRAPDYTTPEMYQTMLDCWH 320 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhcc-CCCCCCCCCCHHHHHHHHHHcc
Confidence 45678999999988889999999999999999996 999997654332222211111 1112233456789999999999
Q ss_pred cCCCCCCCHHHHHhh
Q 004088 427 KEPRARPTAAEMLKH 441 (774)
Q Consensus 427 ~DP~kRPTa~ElL~H 441 (774)
.+|.+||++.++++|
T Consensus 321 ~~p~~Rps~~eil~~ 335 (343)
T cd05103 321 GEPSQRPTFSELVEH 335 (343)
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=343.84 Aligned_cols=256 Identities=23% Similarity=0.394 Sum_probs=206.8
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCC--------------CcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCccc
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKT--------------SELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVR 250 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~--------------g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVk 250 (774)
.+..+|++.++||+|+||.||+|++... ...||||+++..........+.+|+++|++++||||++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 3567899999999999999999986543 23599999875444455667899999999999999999
Q ss_pred ccccccCCceEEEEEEecCCCchhhhhhccC-----------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceE
Q 004088 251 YLGSYQGEEYLWIVMEYCGGGSVADLMNVTE-----------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNIL 319 (774)
Q Consensus 251 L~~~~~~~~~l~LVmEy~~ggsL~dll~~~~-----------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNIL 319 (774)
+++++......|+|||||.+++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999885321 23688899999999999999999999999999999999
Q ss_pred ecCCCcEEEeecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh--CCCCCCCCCchhh
Q 004088 320 LTDQGEVKLGDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE--GLPPRSTVHPMRV 395 (774)
Q Consensus 320 Ld~~g~vKL~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt--G~~Pf~~~~~~~~ 395 (774)
++.++.+||+|||++..+..... ......+++.|+|||++....++.++|||||||++|+|++ |..||........
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999976533211 1122345778999999998889999999999999999987 6778877655443
Q ss_pred hhhhhc-----CCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 396 LFMISI-----EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 396 i~~i~~-----~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
+..+.. ............+..+.+||.+||+.+|.+||++.+|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 332211 011111223345678999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=337.62 Aligned_cols=254 Identities=35% Similarity=0.525 Sum_probs=208.4
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCC--ceEEEEEE
Q 004088 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE--EYLWIVME 266 (774)
Q Consensus 190 Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~--~~l~LVmE 266 (774)
|+++++||.|+||.||+|.+..+++.||||++.... .......+.+|+.++++++||||+++++++... ...|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 789999999999999999999899999999997653 233345688999999999999999999999887 89999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc-ccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS-KRN 345 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~-~~~ 345 (774)
|+++ +|..++......+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++........ ...
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 9964 88888865556899999999999999999999999999999999999999999999999999976654321 122
Q ss_pred cccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC---CC----Ccc----------
Q 004088 346 TFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE---PA----PML---------- 407 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~---~~----~~~---------- 407 (774)
...++..|+|||.+.+ ..++.++|||||||++|+|++|++||...........+... +. +..
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07840 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLK 239 (287)
T ss_pred ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcc
Confidence 3357889999998765 45789999999999999999999999876654332221110 00 000
Q ss_pred ----------ccchh-chHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 408 ----------EDKEK-WSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 408 ----------~~~~~-~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
..... .+..+.++|.+||..+|.+||++.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00011 26788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=335.35 Aligned_cols=250 Identities=21% Similarity=0.352 Sum_probs=203.8
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCc--EEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccC------Cce
Q 004088 190 YELLNELGKGSYGAVYKARDLKTSE--LVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG------EEY 260 (774)
Q Consensus 190 Y~ilk~LG~G~FG~Vy~a~d~~~g~--~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~------~~~ 260 (774)
|.+.+.||+|+||.||+|++..++. .||||.++... .....+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4577899999999999999877765 69999886542 33446778899999999999999999987632 235
Q ss_pred EEEEEEecCCCchhhhhhc-----cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccc
Q 004088 261 LWIVMEYCGGGSVADLMNV-----TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~-----~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
.++||||+.+++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 7899999999999887632 23458999999999999999999999999999999999999999999999999998
Q ss_pred cccccccc--cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchh
Q 004088 336 QLTRTMSK--RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEK 412 (774)
Q Consensus 336 ~i~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~ 412 (774)
.+...... .....+++.|+|||++....++.++|||||||++|+|++ |..||...........+..... ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~ 238 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR--LKQPPD 238 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC--CCCCCC
Confidence 76433211 122346778999999998889999999999999999998 8999987666554444433222 122345
Q ss_pred chHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 413 WSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 413 ~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
++..+.++|.+||+.+|.+|||+.+++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 67889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=344.05 Aligned_cols=258 Identities=49% Similarity=0.877 Sum_probs=216.8
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecC--CChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS--EGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
.+...|...+.||+|+||.||+|++..+++.||||.+... ........+.+|+++++.++|||++++++++......|
T Consensus 12 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred CcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence 3556799999999999999999999999999999998643 22334567889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
+||||+. ++|.+++......+++..+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||++......
T Consensus 92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 9999996 5777777555667899999999999999999999999999999999999999999999999998655322
Q ss_pred ccccccccccccchhhhh---hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQ---ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHD 419 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~d 419 (774)
....|++.|+|||++. ...++.++|||||||++|+|++|..||...........+.....+. .....++..+.+
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 245 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA-LQSGHWSEYFRN 245 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCC-cCcccccHHHHH
Confidence 3456899999999985 3457889999999999999999999998766554444333222221 123457788999
Q ss_pred HHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 420 FVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 420 LI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
||.+||..+|.+||++.++++|||+..+.
T Consensus 246 li~~cl~~~P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred HHHHHhhCCcccCCCHHHHhhCccccccC
Confidence 99999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=333.49 Aligned_cols=252 Identities=23% Similarity=0.380 Sum_probs=210.3
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
+...++|++.+.||+|+||.||+|.+. +++.||||.++... ...+.+.+|+.++++++||||+++++++...+..|+
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence 345678999999999999999999864 55789999986432 234678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999999999999986443 4689999999999999999999999999999999999999999999999999987653211
Q ss_pred cc-ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHH
Q 004088 343 KR-NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 343 ~~-~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
.. ....++..|+|||++.+..++.++|||||||++|+|++ |+.||...........+..... ......++..+.++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l 236 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR--MPCPPGCPKELYDI 236 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCcCCHHHHHH
Confidence 11 11123457999999998889999999999999999998 9999987766655544433221 12234567889999
Q ss_pred HHhhcccCCCCCCCHHHHHh
Q 004088 421 VAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~ 440 (774)
|.+||+.+|.+||++.++++
T Consensus 237 i~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 237 MLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHhhcCcccCCCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=335.62 Aligned_cols=253 Identities=23% Similarity=0.403 Sum_probs=211.4
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCc---EEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSE---LVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~---~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
...|++.+.||+|+||.||+|.+..+++ .||||++...........+..|+.+++.++||||+++++++..+...++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 3569999999999999999999877665 6999998755455556789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
||||+++++|.+++....+.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++..+......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 162 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence 99999999999998766677899999999999999999999999999999999999999999999999998765432211
Q ss_pred c--c-cc--cccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHH
Q 004088 344 R--N-TF--IGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVF 417 (774)
Q Consensus 344 ~--~-~~--~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l 417 (774)
. . .. ..+..|+|||++....++.++|||||||++|||++ |..||...........+.... ..+....++..+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~ 240 (269)
T cd05065 163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY--RLPPPMDCPTAL 240 (269)
T ss_pred cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC--cCCCcccCCHHH
Confidence 1 1 11 12457999999998889999999999999999886 999998776655444443221 112234567789
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhh
Q 004088 418 HDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 418 ~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.+++.+||+.+|.+||++.+++..
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 241 HQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=340.26 Aligned_cols=250 Identities=27% Similarity=0.476 Sum_probs=207.9
Q ss_pred CeeEEeeeeccCceEEEEEEEcC-----CCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLK-----TSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~-----~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
+|++.+.||+|+||.||+|.+.. ....||+|++...........+.+|+.+|+.++||||+++++.+......|+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 48899999999999999998743 2357999988755545556788999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcc-----------------------CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEe
Q 004088 264 VMEYCGGGSVADLMNVT-----------------------EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL 320 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~-----------------------~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILL 320 (774)
||||+.+++|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999999987532 1357889999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhh
Q 004088 321 TDQGEVKLGDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLF 397 (774)
Q Consensus 321 d~~g~vKL~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~ 397 (774)
+.++.+||+|||+++.+..... ......++..|+|||++.+..++.++|||||||++|+|++ |..||..........
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 240 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN 240 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999999976533221 1122346778999999988889999999999999999998 999998776655544
Q ss_pred hhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 398 MISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 398 ~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
.+..... ...+..++..+.+||.+||+.+|.+||++.++++
T Consensus 241 ~~~~~~~--~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 241 LLKTGYR--MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHhCCCC--CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 4332211 1223456788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=340.03 Aligned_cols=247 Identities=25% Similarity=0.331 Sum_probs=201.0
Q ss_pred CCeeEEeee--eccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEEEE
Q 004088 188 TKYELLNEL--GKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 188 ~~Y~ilk~L--G~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~LV 264 (774)
++|++.+.+ |.|+||.||++.+..+++.||+|++....... .|+.+...+ +||||++++++|...+.+|+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 456676666 99999999999999999999999986432111 123233222 799999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC-cEEEeeccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG-EVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g-~vKL~DFGlA~~i~~~~~~ 343 (774)
|||+++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--- 163 (267)
T PHA03390 88 MDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--- 163 (267)
T ss_pred EEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence 9999999999998643 4899999999999999999999999999999999999999998 9999999998765432
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhh-hhhhcCCCCccccchhchHHHHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVL-FMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i-~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
....|+..|+|||++.+..++.++|||||||++|+|++|..||......... ................++..+.+||.
T Consensus 164 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 242 (267)
T PHA03390 164 -SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQ 242 (267)
T ss_pred -ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHH
Confidence 2346899999999999888999999999999999999999999754432211 11111111112233467889999999
Q ss_pred hhcccCCCCCCC-HHHHHhhhhhh
Q 004088 423 KCLTKEPRARPT-AAEMLKHKFIE 445 (774)
Q Consensus 423 kcL~~DP~kRPT-a~ElL~HPwf~ 445 (774)
+||+.+|.+||+ ++++|+||||+
T Consensus 243 ~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 243 SMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHhccChhhCCchHHHHhcCCccc
Confidence 999999999996 69999999996
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=334.69 Aligned_cols=244 Identities=26% Similarity=0.405 Sum_probs=201.7
Q ss_pred eeeccCceEEEEEEEc--CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCCCc
Q 004088 195 ELGKGSYGAVYKARDL--KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGS 272 (774)
Q Consensus 195 ~LG~G~FG~Vy~a~d~--~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~ggs 272 (774)
.||+|+||.||+|.+. ..+..||||++.........+.+.+|+.+|++++||||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999764 34567999998755444555678999999999999999999998864 57899999999999
Q ss_pred hhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc---ccccc
Q 004088 273 VADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR---NTFIG 349 (774)
Q Consensus 273 L~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~---~~~~G 349 (774)
|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....... ....+
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCC
Confidence 999987666789999999999999999999999999999999999999999999999999997554332111 11223
Q ss_pred cccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccC
Q 004088 350 TPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKE 428 (774)
Q Consensus 350 T~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~D 428 (774)
++.|+|||++....++.++|||||||++|+|++ |..||...........+...... ..+...+..+.++|.+||..+
T Consensus 161 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~c~~~~ 238 (257)
T cd05115 161 PLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL--DCPAECPPEMYALMKDCWIYK 238 (257)
T ss_pred CcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC--CCCCCCCHHHHHHHHHHcCCC
Confidence 578999999988889999999999999999996 99999877666554443332221 223455788999999999999
Q ss_pred CCCCCCHHHHHhh
Q 004088 429 PRARPTAAEMLKH 441 (774)
Q Consensus 429 P~kRPTa~ElL~H 441 (774)
|++||++.++++.
T Consensus 239 ~~~Rp~~~~i~~~ 251 (257)
T cd05115 239 WEDRPNFAKVEER 251 (257)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=333.33 Aligned_cols=251 Identities=24% Similarity=0.420 Sum_probs=208.3
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
+...+.|+++++||+|+||.||+|.. .+++.||+|.+.... .....+.+|+.++++++||||+++++++. ...+|+
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 34567899999999999999999985 567889999986433 23467889999999999999999999874 457899
Q ss_pred EEEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc-
Q 004088 264 VMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM- 341 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~- 341 (774)
||||+.+++|.+++... ...+++.++..++.|++.||+|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999999988643 3568999999999999999999999999999999999999999999999999997665221
Q ss_pred cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
.......++..|+|||++....++.++|||||||++|+|++ |++||...........+..... .+.....+..+.++
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l 235 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR--MPRPDNCPEELYEL 235 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC--CCCCCCCCHHHHHH
Confidence 11223346778999999988889999999999999999998 9999987766555444332221 12234567789999
Q ss_pred HHhhcccCCCCCCCHHHHHh
Q 004088 421 VAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~ 440 (774)
|.+||..+|++||+++++++
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 236 MRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHccCChhhCCCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=341.33 Aligned_cols=255 Identities=22% Similarity=0.378 Sum_probs=206.2
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcC----------------CCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcc
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLK----------------TSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVV 249 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~----------------~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIV 249 (774)
+.++|++.++||+|+||.||++++.. ++..||||++...........+.+|+.+|+.++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 45689999999999999999986432 34579999987554455567889999999999999999
Q ss_pred cccccccCCceEEEEEEecCCCchhhhhhccC----------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceE
Q 004088 250 RYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE----------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNIL 319 (774)
Q Consensus 250 kL~~~~~~~~~l~LVmEy~~ggsL~dll~~~~----------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNIL 319 (774)
++++++......|+||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 99999999999999999999999999886422 24778899999999999999999999999999999999
Q ss_pred ecCCCcEEEeecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh--CCCCCCCCCchhh
Q 004088 320 LTDQGEVKLGDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE--GLPPRSTVHPMRV 395 (774)
Q Consensus 320 Ld~~g~vKL~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt--G~~Pf~~~~~~~~ 395 (774)
++.++.++|+|||+++.+..... ......+++.|+|||++....++.++|||||||++|||++ |..||......+.
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence 99999999999999976543221 1122345678999999988889999999999999999998 7788876554443
Q ss_pred hhhhhc-----CCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 396 LFMISI-----EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 396 i~~i~~-----~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
+..... ......+....++..+.+||.+||+.||.+||++.+|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 243 IENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 321110 011112223446688999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=348.97 Aligned_cols=258 Identities=28% Similarity=0.432 Sum_probs=207.4
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCC--------
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE-------- 258 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~-------- 258 (774)
..+|.+.+.||.|+||.||+|.+..+|+.||||++..... ...+.+.+|+.+|++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 4789999999999999999999999999999999865443 4456788999999999999999999877543
Q ss_pred ------ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC-CCcEEEeec
Q 004088 259 ------EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD-QGEVKLGDF 331 (774)
Q Consensus 259 ------~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~-~g~vKL~DF 331 (774)
...|+||||++ ++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 36899999996 58887774 346899999999999999999999999999999999999975 457899999
Q ss_pred cccccccccccc---cccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCC----
Q 004088 332 GVAAQLTRTMSK---RNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEP---- 403 (774)
Q Consensus 332 GlA~~i~~~~~~---~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~---- 403 (774)
|++..+...... .....|+..|+|||++.. ..++.++|||||||++|+|++|+.||...........+....
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 999765332111 122367889999998754 568889999999999999999999998765443332211100
Q ss_pred -----------------------CCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 404 -----------------------APMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 404 -----------------------~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.+........+..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence 000001123567889999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=339.03 Aligned_cols=253 Identities=25% Similarity=0.458 Sum_probs=210.3
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcC-----CCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCce
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLK-----TSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEY 260 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~-----~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~ 260 (774)
..++|++++.||+|+||.||+|.+.. ++..||||++...........+.+|+.+++++.||||+++++++..+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 45789999999999999999998743 5788999998755555556779999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhccC---------------------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceE
Q 004088 261 LWIVMEYCGGGSVADLMNVTE---------------------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNIL 319 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~---------------------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNIL 319 (774)
.|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+.|++||||||+|||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 999999999999999886321 24788899999999999999999999999999999999
Q ss_pred ecCCCcEEEeecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhh
Q 004088 320 LTDQGEVKLGDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVL 396 (774)
Q Consensus 320 Ld~~g~vKL~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i 396 (774)
++.++.++|+|||++..+..... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||......+..
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~ 242 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI 242 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999876533211 1122245678999999998899999999999999999997 88898776665554
Q ss_pred hhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 397 FMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 397 ~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
..+..... ...+...+..+.+||.+||+.+|.+|||+.|+++
T Consensus 243 ~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 243 YYVRDGNV--LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHhcCCC--CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 44332221 1223456788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=329.14 Aligned_cols=249 Identities=29% Similarity=0.462 Sum_probs=210.2
Q ss_pred eeEEeeeeccCceEEEEEEEcCCC----cEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 190 YELLNELGKGSYGAVYKARDLKTS----ELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 190 Y~ilk~LG~G~FG~Vy~a~d~~~g----~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
+++.+.||.|+||.||+|.+...+ ..||+|++...........+..|+.+|+.++||||+++++++...+..|+||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 457889999999999999988766 8999999965544445678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCc-hhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEP-LEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~-Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
||+++++|.+++...... +++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 999999999998754433 9999999999999999999999999999999999999999999999999997665432111
Q ss_pred c-cccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHH
Q 004088 345 N-TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 345 ~-~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
. ...+++.|+|||.+....++.++|||||||++|+|++ |.+||...........+...... ......+..+.+++.
T Consensus 161 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~ 238 (258)
T smart00219 161 KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL--PKPENCPPEIYKLML 238 (258)
T ss_pred cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--CCCCcCCHHHHHHHH
Confidence 1 1236789999999988889999999999999999998 88998876655554444333222 223446888999999
Q ss_pred hhcccCCCCCCCHHHHHh
Q 004088 423 KCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~ 440 (774)
+||..+|.+|||+.++++
T Consensus 239 ~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 239 QCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHCcCChhhCcCHHHHHh
Confidence 999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=334.20 Aligned_cols=250 Identities=27% Similarity=0.397 Sum_probs=205.9
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
...++|++.++||+|+||.||+|++..+ ..||||++.... ...+.+.+|+.++++++||||+++++++. ....|+|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV 78 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc--cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEE
Confidence 4567899999999999999999987655 459999986433 23457889999999999999999999875 4568999
Q ss_pred EEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 265 mEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|||+++++|.+++... ...+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||.+..+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999999998643 345889999999999999999999999999999999999999999999999999766433211
Q ss_pred -cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHH
Q 004088 344 -RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421 (774)
Q Consensus 344 -~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI 421 (774)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+...... .....++..+.++|
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li 236 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--PCPPECPESLHDLM 236 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC--CCccccCHHHHHHH
Confidence 122346778999999988889999999999999999999 88899876655544443322111 12345678899999
Q ss_pred HhhcccCCCCCCCHHHHHh
Q 004088 422 AKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 422 ~kcL~~DP~kRPTa~ElL~ 440 (774)
.+||+++|++||++.++++
T Consensus 237 ~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 237 CQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHccCCcccCCCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=335.73 Aligned_cols=253 Identities=34% Similarity=0.464 Sum_probs=205.0
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh-hhHHHHHHHHHHHHhC---CCCCcccccccccCCce-----
Q 004088 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE-EGYEEIRGEIEMLQQC---SHPNVVRYLGSYQGEEY----- 260 (774)
Q Consensus 190 Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~-~~~~~~~~Ei~iL~~L---~HPNIVkL~~~~~~~~~----- 260 (774)
|++.+.||.|+||.||+|++..+++.||||++...... .....+.+|+.+++++ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 78999999999999999999888999999999754322 2234566788877766 59999999999987766
Q ss_pred EEEEEEecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
+++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++..+..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 9999999964 7888776433 3689999999999999999999999999999999999999999999999999976644
Q ss_pred cccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-----------------
Q 004088 340 TMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE----------------- 402 (774)
Q Consensus 340 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~----------------- 402 (774)
.. ......++..|+|||++.+..++.++|||||||++|+|++|.+||......+.+..+...
T Consensus 160 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07838 160 EM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR 238 (287)
T ss_pred Cc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence 32 223346889999999999888999999999999999999999999876544333221100
Q ss_pred -------CCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 403 -------PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 403 -------~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
...........+..+.+||.+||+.||.+||++.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 000000112345678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=381.35 Aligned_cols=258 Identities=27% Similarity=0.463 Sum_probs=227.7
Q ss_pred CCcccCCCCCCeeEEeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccc
Q 004088 179 ESVTREDPTTKYELLNELGKGSYGAVYKARDL-----KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLG 253 (774)
Q Consensus 179 ~~~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~-----~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~ 253 (774)
.....+.+..+.++.++||+|+||+||+|+-. .....||||.++.....+...+|+||+++|..|+|||||+|+|
T Consensus 477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 33445667778889999999999999999853 2346799999987777778899999999999999999999999
Q ss_pred cccCCceEEEEEEecCCCchhhhhhcc-------------CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEe
Q 004088 254 SYQGEEYLWIVMEYCGGGSVADLMNVT-------------EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL 320 (774)
Q Consensus 254 ~~~~~~~l~LVmEy~~ggsL~dll~~~-------------~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILL 320 (774)
+|..++.+|||+|||..|+|.++|+.. +.+|+..+...|+.||+.||.||-++.+|||||..+|+||
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV 636 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee
Confidence 999999999999999999999999732 2238899999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccccccccc--cccccccccchhhhhhcCCCCccchhhhHHHHHHHH-hCCCCCCCCCchhhhh
Q 004088 321 TDQGEVKLGDFGVAAQLTRTMSKRN--TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMA-EGLPPRSTVHPMRVLF 397 (774)
Q Consensus 321 d~~g~vKL~DFGlA~~i~~~~~~~~--~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELL-tG~~Pf~~~~~~~~i~ 397 (774)
.++..|||+|||+++.+......+. .-.-+.+|||||.|...+|+.++|||||||+|||++ .|+.||.+..+.+++.
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe 716 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE 716 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence 9999999999999998766533221 123477999999999999999999999999999998 5999999999999998
Q ss_pred hhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHH
Q 004088 398 MISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEM 438 (774)
Q Consensus 398 ~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~El 438 (774)
.+..... ++.++.++.++.+||..||+.+|.+||++.||
T Consensus 717 ~i~~g~l--L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 717 CIRAGQL--LSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred HHHcCCc--ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 8766544 77888999999999999999999999999998
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=341.28 Aligned_cols=257 Identities=24% Similarity=0.428 Sum_probs=212.3
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEc-------CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCccccccc
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDL-------KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGS 254 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~-------~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~ 254 (774)
+.....+|.+.+.||+|+||.||+|++. ..+..||+|++...........+.+|+.+++.+ +||||++++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 3455778999999999999999999753 234579999986544445567789999999999 89999999999
Q ss_pred ccCCceEEEEEEecCCCchhhhhhcc---------------CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceE
Q 004088 255 YQGEEYLWIVMEYCGGGSVADLMNVT---------------EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNIL 319 (774)
Q Consensus 255 ~~~~~~l~LVmEy~~ggsL~dll~~~---------------~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNIL 319 (774)
+......|+||||+.+++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 99999999999999999999988642 135788889999999999999999999999999999999
Q ss_pred ecCCCcEEEeeccccccccccccc--cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhh
Q 004088 320 LTDQGEVKLGDFGVAAQLTRTMSK--RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVL 396 (774)
Q Consensus 320 Ld~~g~vKL~DFGlA~~i~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i 396 (774)
++.++.+||+|||+++.+...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 999999999999999766432211 122345778999999998889999999999999999998 78888776665554
Q ss_pred hhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 397 FMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 397 ~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
..+..... ......++..+.+||.+||..+|.+||++.++++.
T Consensus 250 ~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 250 KLLKEGHR--MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHcCCc--CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 44433222 12234567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=342.98 Aligned_cols=259 Identities=31% Similarity=0.552 Sum_probs=226.9
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-CCCcccccccccCCceEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~~~~l~LVm 265 (774)
.++.+++..||.|+-|+||+++.+.+|...|||.+.+....+..++++..+.++.... .|+||+.+|+|..+...+|.|
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 4567778899999999999999999999999999988777777888888998877664 899999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHh-cCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS-IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs-~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
|.| ...+..+++...++++|..+-++...++.||.||.+ |||||||+||+|||+|+.|++||||||.+..+.....+.
T Consensus 171 elM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht 249 (391)
T KOG0983|consen 171 ELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT 249 (391)
T ss_pred HHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccc
Confidence 999 556777777778899999999999999999999985 689999999999999999999999999998887664443
Q ss_pred ccccccccccchhhhh---hcCCCCccchhhhHHHHHHHHhCCCCCCCCC-chhhhhhhhcCCCCccccchhchHHHHHH
Q 004088 345 NTFIGTPHWMAPEVIQ---ESRYDGKVDVWALGVSAVEMAEGLPPRSTVH-PMRVLFMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~-~~~~i~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
...|.+.|||||.+. ...|+.++||||||++++||.||+.||...+ ..+.+..+.....|.+....++++.|.+|
T Consensus 250 -rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~f 328 (391)
T KOG0983|consen 250 -RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSF 328 (391)
T ss_pred -cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHH
Confidence 346999999999985 4469999999999999999999999998754 44555555555567777777799999999
Q ss_pred HHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 421 VAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
+..||.+|+.+||...++|+|||++..
T Consensus 329 v~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 329 VKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred HHHHhhcCcccCcchHHHhcCcceeec
Confidence 999999999999999999999999754
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=384.32 Aligned_cols=256 Identities=25% Similarity=0.320 Sum_probs=209.5
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
++|+++++||+|+||.||+|.+..+|+.||||++.... .....+.+.+|++++++++||||+++++++...+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 58999999999999999999999999999999986432 2334567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcc----------CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccc
Q 004088 266 EYCGGGSVADLMNVT----------EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 266 Ey~~ggsL~dll~~~----------~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
|||+|++|.+++... ...++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999988531 1235567788999999999999999999999999999999999999999999997
Q ss_pred ccccc------------------ccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhh
Q 004088 336 QLTRT------------------MSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLF 397 (774)
Q Consensus 336 ~i~~~------------------~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~ 397 (774)
..... .......+||+.|+|||++.+..++.++|||||||++|+|++|.+||..........
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~ 241 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY 241 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh
Confidence 65211 011123579999999999999999999999999999999999999998755443332
Q ss_pred hhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhh
Q 004088 398 MISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKF 443 (774)
Q Consensus 398 ~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPw 443 (774)
...............++..+.+++.+||..||++|++..+.+.+.+
T Consensus 242 ~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~L 287 (932)
T PRK13184 242 RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDL 287 (932)
T ss_pred hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 2211111111222456788999999999999999988777766543
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=328.95 Aligned_cols=245 Identities=26% Similarity=0.420 Sum_probs=204.7
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCCCch
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSV 273 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~ggsL 273 (774)
+.||+|+||.||+|.. .++..||+|++...........+.+|+.++++++||||+++++++......++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 3689999999999985 578899999986544444455788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc-cccccccc
Q 004088 274 ADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR-NTFIGTPH 352 (774)
Q Consensus 274 ~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~-~~~~GT~~ 352 (774)
.+++......+++..+..++.|++.+|.|||++|++||||||+||+++.++.+||+|||++.......... ....+++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence 99887556678999999999999999999999999999999999999999999999999997543322111 12234678
Q ss_pred ccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCC
Q 004088 353 WMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRA 431 (774)
Q Consensus 353 Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~k 431 (774)
|+|||++....++.++|||||||++|+|++ |..||...........+..... ......++..+.+|+.+||..+|++
T Consensus 160 y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~ 237 (250)
T cd05085 160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR--MSCPQKCPDDVYKVMQRCWDYKPEN 237 (250)
T ss_pred ccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcccCccc
Confidence 999999998889999999999999999998 9999987765554444332221 1223456788999999999999999
Q ss_pred CCCHHHHHhh
Q 004088 432 RPTAAEMLKH 441 (774)
Q Consensus 432 RPTa~ElL~H 441 (774)
||++.++++.
T Consensus 238 Rp~~~~l~~~ 247 (250)
T cd05085 238 RPKFSELQKE 247 (250)
T ss_pred CCCHHHHHHH
Confidence 9999999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=331.43 Aligned_cols=243 Identities=28% Similarity=0.438 Sum_probs=202.4
Q ss_pred eeeeccCceEEEEEEEcCCC---cEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCC
Q 004088 194 NELGKGSYGAVYKARDLKTS---ELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGG 270 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g---~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~g 270 (774)
++||+|+||.||+|.+...+ ..||+|.+.........+.+.+|+.+|+.+.||||+++++++. ....++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999876554 7899999875554445677899999999999999999999876 4568999999999
Q ss_pred CchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc---cc
Q 004088 271 GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN---TF 347 (774)
Q Consensus 271 gsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~---~~ 347 (774)
++|.+++... ..+++..+..++.|++.||.|||..+|+||||||+|||++.++.+||+|||+++.+........ ..
T Consensus 80 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05060 80 GPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG 158 (257)
T ss_pred CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCc
Confidence 9999998643 4789999999999999999999999999999999999999999999999999986644322111 11
Q ss_pred cccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcc
Q 004088 348 IGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLT 426 (774)
Q Consensus 348 ~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~ 426 (774)
.++..|+|||.+....++.++|||||||++|+|++ |.+||...........+.... ....+..++..+.++|.+||.
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 159 RWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE--RLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred cccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC--cCCCCCCCCHHHHHHHHHHhc
Confidence 23567999999998889999999999999999997 999998776655544443322 123345667889999999999
Q ss_pred cCCCCCCCHHHHHh
Q 004088 427 KEPRARPTAAEMLK 440 (774)
Q Consensus 427 ~DP~kRPTa~ElL~ 440 (774)
.+|.+||++.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=335.36 Aligned_cols=253 Identities=30% Similarity=0.473 Sum_probs=206.1
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-CCCcccccccccCCceEEEEEEec
Q 004088 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQGEEYLWIVMEYC 268 (774)
Q Consensus 190 Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~~~~l~LVmEy~ 268 (774)
|++.+.||+|+||+||+|....+++.||||++.............+|+..++++. ||||+++++++..+...|+||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 7889999999999999999988899999999865433223334567999999999 999999999999999999999999
Q ss_pred CCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccc
Q 004088 269 GGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF 347 (774)
Q Consensus 269 ~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~ 347 (774)
+++|.+++.... ..+++..+..++.|++.+|.|||++||+|+||||+||+++.++.++|+|||++....... .....
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~~~ 158 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-PYTDY 158 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-CcCCC
Confidence 778888876443 578999999999999999999999999999999999999999999999999997654332 22345
Q ss_pred cccccccchhhhh-hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCC----------------------
Q 004088 348 IGTPHWMAPEVIQ-ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA---------------------- 404 (774)
Q Consensus 348 ~GT~~Y~APEvl~-~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~---------------------- 404 (774)
.|+..|+|||++. ...++.++|+|||||++|+|++|++||...........+.....
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07830 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP 238 (283)
T ss_pred CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence 6899999999885 44578999999999999999999999976654433322110000
Q ss_pred ----C-ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 405 ----P-MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 405 ----~-~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
. ........+..+.+||.+||+.+|.+|||+.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0 000011125678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=338.54 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=204.2
Q ss_pred CCeeEEeeeeccCceEEEEEEE----cCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCC--ceE
Q 004088 188 TKYELLNELGKGSYGAVYKARD----LKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE--EYL 261 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d----~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~--~~l 261 (774)
.-|+++++||+|+||.||+|+. ..+++.||+|.+...........+.+|+.+|+++.||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3578999999999999999974 4568899999987554455567899999999999999999999988764 678
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
++||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 99999999999999987555578999999999999999999999999999999999999999999999999997664332
Q ss_pred c---ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchh--------------hhhhhhcCCC
Q 004088 342 S---KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMR--------------VLFMISIEPA 404 (774)
Q Consensus 342 ~---~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~--------------~i~~i~~~~~ 404 (774)
. ......|+..|+|||++.+..++.++|||||||++|+|+++..|+....... .........
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 242 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG- 242 (284)
T ss_pred cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC-
Confidence 1 1123457778999999988889999999999999999999876643211000 000000000
Q ss_pred CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 405 PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 405 ~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
........++..+.+||.+||+.+|.+||++.+++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1111234467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=332.30 Aligned_cols=243 Identities=27% Similarity=0.403 Sum_probs=201.7
Q ss_pred eeeeccCceEEEEEEE--cCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCC
Q 004088 194 NELGKGSYGAVYKARD--LKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGG 270 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d--~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~g 270 (774)
++||+|+||.||+|.+ ..++..||||++.... .....+.+.+|+.+|+.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 3689999999999964 4568899999986443 2344567899999999999999999999875 4567899999999
Q ss_pred CchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc---cccc
Q 004088 271 GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK---RNTF 347 (774)
Q Consensus 271 gsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~---~~~~ 347 (774)
++|.+++. ....+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++..+...... ....
T Consensus 80 ~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 80 GPLNKFLQ-KNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred CcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 99999986 3457899999999999999999999999999999999999999999999999999766443221 1122
Q ss_pred cccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcc
Q 004088 348 IGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLT 426 (774)
Q Consensus 348 ~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~ 426 (774)
.+++.|+|||++....++.++|||||||++|||++ |.+||...........+..... ...+..++..+.+||.+||+
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~~~ 236 (257)
T cd05116 159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER--MECPQRCPPEMYDLMKLCWT 236 (257)
T ss_pred CCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC--CCCCCCCCHHHHHHHHHHhc
Confidence 34678999999988889999999999999999997 9999987766555555443322 22344678899999999999
Q ss_pred cCCCCCCCHHHHHh
Q 004088 427 KEPRARPTAAEMLK 440 (774)
Q Consensus 427 ~DP~kRPTa~ElL~ 440 (774)
.||.+||++.+|..
T Consensus 237 ~~p~~Rp~~~~i~~ 250 (257)
T cd05116 237 YGVDERPGFAVVEL 250 (257)
T ss_pred cCchhCcCHHHHHH
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=348.62 Aligned_cols=260 Identities=26% Similarity=0.379 Sum_probs=209.3
Q ss_pred CCCeeE-EeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChh-------------hHHHHHHHHHHHHhCCCCCccccc
Q 004088 187 TTKYEL-LNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEE-------------GYEEIRGEIEMLQQCSHPNVVRYL 252 (774)
Q Consensus 187 ~~~Y~i-lk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~-------------~~~~~~~Ei~iL~~L~HPNIVkL~ 252 (774)
.++|.. .+.||.|+||+||+|.+..+++.||||++....... ....+.+|+.+|++++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 457765 467999999999999999999999999986543211 012477899999999999999999
Q ss_pred ccccCCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecc
Q 004088 253 GSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFG 332 (774)
Q Consensus 253 ~~~~~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFG 332 (774)
+++......|+||||+. ++|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVD-RKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 99999999999999996 58888885 44568999999999999999999999999999999999999999999999999
Q ss_pred ccccccc--------------cccccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhh
Q 004088 333 VAAQLTR--------------TMSKRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLF 397 (774)
Q Consensus 333 lA~~i~~--------------~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~ 397 (774)
++..+.. .........+++.|+|||++.+. .++.++|||||||++|+|++|.+||...+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9976541 11112233578899999998764 47889999999999999999999998776544332
Q ss_pred hhhc---CCCC----------------------ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 398 MISI---EPAP----------------------MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 398 ~i~~---~~~~----------------------~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.+.. .+.. ........+..+.+||.+||+.+|.+||++.++|.||||+...
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 2211 0000 0001123467789999999999999999999999999998653
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=329.53 Aligned_cols=252 Identities=26% Similarity=0.405 Sum_probs=210.1
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
+...++|++.+.||+|+||.||+|.+. +++.||||++.... ...+.+.+|+.++++++||||+++++++......++
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 346779999999999999999999864 56789999986433 334678999999999999999999999999899999
Q ss_pred EEEecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..+.....
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999999986543 4689999999999999999999999999999999999999999999999999976643211
Q ss_pred -ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHH
Q 004088 343 -KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 343 -~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
......++..|+|||.+.+..++.++|||||||++|+|++ |+.||...........+..... ...+...+..+.++
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 236 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR--MPRPPNCPEELYDL 236 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHH
Confidence 1112234678999999998889999999999999999998 9999987766555544433221 12223447789999
Q ss_pred HHhhcccCCCCCCCHHHHHh
Q 004088 421 VAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~ 440 (774)
+.+||..+|.+||++.++++
T Consensus 237 i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 237 MLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHcccCcccCCCHHHHHH
Confidence 99999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=328.33 Aligned_cols=245 Identities=35% Similarity=0.522 Sum_probs=210.8
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCCC--hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCCCch
Q 004088 196 LGKGSYGAVYKARDLKTSELVAIKVISLSEG--EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSV 273 (774)
Q Consensus 196 LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~--~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~ggsL 273 (774)
||.|+||.||++.+..+++.||+|++..... ......+.+|+.++++++||||+++++.+..+...|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6999999999999988899999999875432 23456788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccccccccc
Q 004088 274 ADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHW 353 (774)
Q Consensus 274 ~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y 353 (774)
.+++.. ...+++..+..++.||+.||.|||+.+++|+||||+||+++.++.++|+|||++..............++..|
T Consensus 81 ~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05123 81 FSHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159 (250)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence 999863 3468999999999999999999999999999999999999999999999999997665432233445789999
Q ss_pred cchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCC
Q 004088 354 MAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARP 433 (774)
Q Consensus 354 ~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRP 433 (774)
+|||.+.+..++.++|+|||||++|+|++|..||...........+.. .....+...+..+.+||.+||..||.+||
T Consensus 160 ~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~i~~~l~~~p~~R~ 236 (250)
T cd05123 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK---DPLRFPEFLSPEARDLISGLLQKDPTKRL 236 (250)
T ss_pred cChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc---CCCCCCCCCCHHHHHHHHHHhcCCHhhCC
Confidence 999999888889999999999999999999999987765444333322 12223444578899999999999999999
Q ss_pred CH---HHHHhhhhh
Q 004088 434 TA---AEMLKHKFI 444 (774)
Q Consensus 434 Ta---~ElL~HPwf 444 (774)
++ .++++||||
T Consensus 237 ~~~~~~~l~~~~~f 250 (250)
T cd05123 237 GSGGAEEIKAHPFF 250 (250)
T ss_pred CcccHHHHHhCCCC
Confidence 99 999999997
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=334.65 Aligned_cols=252 Identities=27% Similarity=0.413 Sum_probs=211.3
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCc----EEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSE----LVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~----~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
...+|++++.||+|+||.||+|.+..+|+ .||+|++...........+.+|+.+|++++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 45789999999999999999999876665 5899988765555556778999999999999999999999887 789
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
++||||+++++|.+++......+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.+....
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 99999999999999997666679999999999999999999999999999999999999999999999999998665332
Q ss_pred cccc--cccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 342 SKRN--TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 342 ~~~~--~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
.... ...++..|+|||.+....++.++|||||||++|+|++ |+.||...........+.... ....+...+..+.
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 241 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE--RLPQPPICTIDVY 241 (279)
T ss_pred cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC--CCCCCCCCCHHHH
Confidence 2111 1223568999999988889999999999999999998 999998876655444333221 1222334567899
Q ss_pred HHHHhhcccCCCCCCCHHHHHh
Q 004088 419 DFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
+++.+||..+|.+||++.++++
T Consensus 242 ~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 242 MVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHcCCChhhCCCHHHHHH
Confidence 9999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=348.53 Aligned_cols=258 Identities=27% Similarity=0.429 Sum_probs=212.4
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCce----
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEY---- 260 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~---- 260 (774)
..++|++.+.||+|+||.||+|++..+++.||||++.... .......+.+|+.+++++.||||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3568999999999999999999999999999999986432 22344567889999999999999999998876554
Q ss_pred --EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 261 --LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 261 --l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
+|+|+||+ +++|.+++.. .++++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999999 6789888853 569999999999999999999999999999999999999999999999999997654
Q ss_pred ccccccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCC-CCc----------
Q 004088 339 RTMSKRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEP-APM---------- 406 (774)
Q Consensus 339 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~-~~~---------- 406 (774)
.. .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||........+..+.... .+.
T Consensus 170 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07851 170 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE 246 (343)
T ss_pred cc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence 32 234578999999999865 367889999999999999999999998766544333221110 000
Q ss_pred -----------------cccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 407 -----------------LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 407 -----------------~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
......++..+.+||.+||..+|.+|||+.+|++||||.+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306 (343)
T ss_pred hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence 0001234778999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=331.02 Aligned_cols=250 Identities=25% Similarity=0.418 Sum_probs=206.6
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
...++|+++++||+|+||.||+|.+. .+..||+|.+..... ..+.+.+|+.+|++++||||+++++++. ....|+|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV 78 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence 34568999999999999999999864 566799999864332 3456899999999999999999999875 4568899
Q ss_pred EEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc-
Q 004088 265 MEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS- 342 (774)
Q Consensus 265 mEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~- 342 (774)
|||+.+++|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..+.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999999988643 34589999999999999999999999999999999999999999999999999976543221
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI 421 (774)
......++..|+|||++....++.++|||||||++|+|++ |.+||...........+...... +.+...+..+.+||
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li 236 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM--PCPQDCPISLHELM 236 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCcCCHHHHHHH
Confidence 1122345678999999988889999999999999999998 89999877665555444332222 22345678899999
Q ss_pred HhhcccCCCCCCCHHHHHh
Q 004088 422 AKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 422 ~kcL~~DP~kRPTa~ElL~ 440 (774)
.+||.++|.+|||+.++++
T Consensus 237 ~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 237 LQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHcccCcccCcCHHHHHH
Confidence 9999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=347.21 Aligned_cols=258 Identities=29% Similarity=0.446 Sum_probs=210.6
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCc-----
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE----- 259 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~----- 259 (774)
..++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|++++||||++++++|....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999999999999999986432 2233456889999999999999999999987543
Q ss_pred -eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 260 -YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 260 -~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
.+|+||||+ +++|..++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 469999999 778888875 3568999999999999999999999999999999999999999999999999997653
Q ss_pred ccccccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCC------------
Q 004088 339 RTMSKRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAP------------ 405 (774)
Q Consensus 339 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~------------ 405 (774)
.. .....+++.|+|||++.+ ..++.++|+|||||++|+|++|.+||...........+......
T Consensus 170 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07880 170 SE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246 (343)
T ss_pred cC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence 32 233467999999999876 45888999999999999999999999866543322221110000
Q ss_pred ----------------ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 406 ----------------MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 406 ----------------~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
........+..+.++|.+||+.||.+|||+.+++.||||+.+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 00011245667899999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=329.33 Aligned_cols=245 Identities=26% Similarity=0.400 Sum_probs=205.1
Q ss_pred eeeeccCceEEEEEEEcC-CCc--EEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCC
Q 004088 194 NELGKGSYGAVYKARDLK-TSE--LVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGG 270 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~-~g~--~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~g 270 (774)
+.||+|+||.||+|.+.. .++ .||||++.........+.+.+|+.+|++++||||+++++++.. ..+++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999755 333 6999998765443556789999999999999999999999988 899999999999
Q ss_pred CchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc---ccc
Q 004088 271 GSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK---RNT 346 (774)
Q Consensus 271 gsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~---~~~ 346 (774)
++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++..+...... ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence 99999987544 57899999999999999999999999999999999999999999999999999876442211 112
Q ss_pred ccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhc
Q 004088 347 FIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCL 425 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL 425 (774)
..++..|+|||++....++.++|||||||++|+|++ |..||......+....+.... .........+..+.+++.+||
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l 238 (257)
T cd05040 160 LKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG-ERLERPEACPQDIYNVMLQCW 238 (257)
T ss_pred CCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-CcCCCCccCCHHHHHHHHHHC
Confidence 357789999999998889999999999999999998 999998766665544433221 122233456788999999999
Q ss_pred ccCCCCCCCHHHHHh
Q 004088 426 TKEPRARPTAAEMLK 440 (774)
Q Consensus 426 ~~DP~kRPTa~ElL~ 440 (774)
+.+|++||++.++++
T Consensus 239 ~~~p~~Rps~~~~~~ 253 (257)
T cd05040 239 AHNPADRPTFAALRE 253 (257)
T ss_pred CCCcccCCCHHHHHH
Confidence 999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=345.57 Aligned_cols=258 Identities=23% Similarity=0.424 Sum_probs=212.3
Q ss_pred ccCCCCCCeeEEeeeeccCceEEEEEEEcCC-------CcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccc
Q 004088 182 TREDPTTKYELLNELGKGSYGAVYKARDLKT-------SELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLG 253 (774)
Q Consensus 182 ~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~-------g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~ 253 (774)
.++....+|++++.||+|+||.||+|++... +..||+|++...........+.+|+.+++++ +||||+++++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 4555667899999999999999999986432 2369999887544455567899999999999 8999999999
Q ss_pred cccCCceEEEEEEecCCCchhhhhhcc---------------CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccce
Q 004088 254 SYQGEEYLWIVMEYCGGGSVADLMNVT---------------EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNI 318 (774)
Q Consensus 254 ~~~~~~~l~LVmEy~~ggsL~dll~~~---------------~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNI 318 (774)
+|.....+|+||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 999999999999999999999988642 13478888999999999999999999999999999999
Q ss_pred EecCCCcEEEeeccccccccccccc--cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhh
Q 004088 319 LLTDQGEVKLGDFGVAAQLTRTMSK--RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRV 395 (774)
Q Consensus 319 LLd~~g~vKL~DFGlA~~i~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~ 395 (774)
|++.++.+||+|||+++.+...... .....++..|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 245 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 9999999999999999765432111 112234578999999999889999999999999999998 8999987766555
Q ss_pred hhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 396 LFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 396 i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
...+..... ...+...+..+.+||.+||+.+|.+||++.+++++
T Consensus 246 ~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 246 FKLLKEGHR--MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHcCCC--CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 544433222 12234557789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=348.32 Aligned_cols=255 Identities=30% Similarity=0.451 Sum_probs=206.5
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCC------c
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE------E 259 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~------~ 259 (774)
..+|.+.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||++++++|... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 358999999999999999999999999999999986532 223345678999999999999999999988644 3
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
.+|+||||+. .+|..++ ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred eEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 5799999995 4666554 24689999999999999999999999999999999999999999999999999875432
Q ss_pred cccccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-C--------------
Q 004088 340 TMSKRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-P-------------- 403 (774)
Q Consensus 340 ~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-~-------------- 403 (774)
. .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..+... .
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (342)
T cd07879 170 E---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246 (342)
T ss_pred C---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence 2 234568999999999876 46889999999999999999999999876644333221110 0
Q ss_pred -------CCc------cccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 404 -------APM------LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 404 -------~~~------~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.+. .......+..+.+||.+||+.||.+||++.+++.||||+.++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 000 000123466789999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=342.54 Aligned_cols=254 Identities=26% Similarity=0.456 Sum_probs=211.5
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEEEEEEecCCCc
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIVMEYCGGGS 272 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~LVmEy~~ggs 272 (774)
+.||+|+|+.|--|....+|..||||++.+. .......+.+|++++.++ .|+||++|+++|++++.+|||||-+.||.
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 5799999999999999999999999999765 445667899999999999 59999999999999999999999999999
Q ss_pred hhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC---cEEEeeccccccccccc-------c
Q 004088 273 VADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG---EVKLGDFGVAAQLTRTM-------S 342 (774)
Q Consensus 273 L~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g---~vKL~DFGlA~~i~~~~-------~ 342 (774)
|..+|+ ....|+|.++.+++++|+.||.|||.+||.||||||+|||...-. .||||||.+...+.... .
T Consensus 163 lLshI~-~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP 241 (463)
T KOG0607|consen 163 LLSHIQ-KRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP 241 (463)
T ss_pred HHHHHH-HhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence 999986 456799999999999999999999999999999999999997655 48999999886543221 1
Q ss_pred ccccccccccccchhhhh-----hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchh--------------hhh-hhhcC
Q 004088 343 KRNTFIGTPHWMAPEVIQ-----ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMR--------------VLF-MISIE 402 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~-----~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~--------------~i~-~i~~~ 402 (774)
...+.+|+..|||||+.. ...|+.++|.||||||+|-||+|.+||.+.-... .++ .|...
T Consensus 242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEG 321 (463)
T KOG0607|consen 242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG 321 (463)
T ss_pred cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhcc
Confidence 223568999999999873 3469999999999999999999999997533211 112 22222
Q ss_pred CCC-ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 403 PAP-MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 403 ~~~-~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
... +..+...++.+.+++|..+|..++.+|.++.++++|||+..|..
T Consensus 322 kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 322 KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 111 12234556889999999999999999999999999999998753
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=370.68 Aligned_cols=261 Identities=22% Similarity=0.306 Sum_probs=194.7
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCC-CcEEEEEEe--------------ec--CCChhhHHHHHHHHHHHHhCCCCCc
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKT-SELVAIKVI--------------SL--SEGEEGYEEIRGEIEMLQQCSHPNV 248 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~-g~~VAVKvi--------------~~--~~~~~~~~~~~~Ei~iL~~L~HPNI 248 (774)
...+|+++++||+|+||+||+|..... +..+++|.+ .+ .........+.+|+.+|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 346899999999999999999876432 222222211 00 1122334568899999999999999
Q ss_pred ccccccccCCceEEEEEEecCCCchhhhhhcc----CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC
Q 004088 249 VRYLGSYQGEEYLWIVMEYCGGGSVADLMNVT----EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG 324 (774)
Q Consensus 249 VkL~~~~~~~~~l~LVmEy~~ggsL~dll~~~----~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g 324 (774)
|++++++...+..|+|++++. ++|..++... ........++.|+.||+.||.|||++|||||||||+||||+.++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 999999999999999999995 4666655321 12234567788999999999999999999999999999999999
Q ss_pred cEEEeecccccccccccc-ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCC-CCCCCC--chhhhhh-h
Q 004088 325 EVKLGDFGVAAQLTRTMS-KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLP-PRSTVH--PMRVLFM-I 399 (774)
Q Consensus 325 ~vKL~DFGlA~~i~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~-Pf~~~~--~~~~i~~-i 399 (774)
.+||+|||+++.+..... .....+||+.|+|||++.+..|+.++|||||||++|||++|.. ||.... ....+.. +
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~ 384 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence 999999999987654322 2234679999999999999999999999999999999999865 443322 1111111 0
Q ss_pred hcCC-----CC-----------------------ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 400 SIEP-----AP-----------------------MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 400 ~~~~-----~~-----------------------~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
.... .+ .+.....++..+.++|.+||+.||.+|||+.|+|.||||...
T Consensus 385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 0000 00 000111234567888999999999999999999999999754
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=363.34 Aligned_cols=258 Identities=27% Similarity=0.460 Sum_probs=224.5
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
...+.|.+.+.||+|.|+.|.+|++..++..||||++.+.. .......+.+|+++|+.|+|||||+++.+.+....+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34678999999999999999999999999999999998765 33444568999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
||||+.+|.+++++. +.+++.+..+..++.|+++|++|||+++|||||||++||||+.+.++||+|||++..+.. ...
T Consensus 133 V~eya~~ge~~~yl~-~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-~~~ 210 (596)
T KOG0586|consen 133 VMEYASGGELFDYLV-KHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY-GLM 210 (596)
T ss_pred EEEeccCchhHHHHH-hcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc-ccc
Confidence 999999999999996 456677799999999999999999999999999999999999999999999999987763 356
Q ss_pred cccccccccccchhhhhhcCCC-CccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESRYD-GKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s-~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
..++||++.|.|||++.+..|. +.+|+||+|+++|-|+.|..||.+......-...... .+..+...+.++.++|+
T Consensus 211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g---k~rIp~~ms~dce~lLr 287 (596)
T KOG0586|consen 211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG---KYRIPFYMSCDCEDLLR 287 (596)
T ss_pred ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee---eecccceeechhHHHHH
Confidence 6788999999999999988775 6899999999999999999999976544433222111 11223445778999999
Q ss_pred hhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 423 KCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
++|.++|.+|++++++.+|.|+...
T Consensus 288 k~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 288 KFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred HhhccCccccCCHHHhhhhcccchh
Confidence 9999999999999999999999643
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=351.64 Aligned_cols=262 Identities=29% Similarity=0.415 Sum_probs=228.5
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhC-CCCCcccccccccCCce
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEY 260 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~ 260 (774)
.....+|.++..||+|+||.|.+|+.+.+.+.||||++++.- .....+--..|-++|... +-|.+++|+.+|+.-++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 345578999999999999999999999999999999997643 223344456788888877 46789999999999999
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
+|+||||+.||+|--.+++ -+++.|..+..++..|+.||-|||++|||+||||.+|||++.+|++||+|||+++.-...
T Consensus 425 LyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred eeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence 9999999999999888863 467999999999999999999999999999999999999999999999999999865555
Q ss_pred ccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHH
Q 004088 341 MSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 341 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
.....++||||.|+|||++...+|+..+|+||+||+||||+.|++||.+.+..++...|..... ..+..+|.++.++
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv---syPKslSkEAv~i 580 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV---SYPKSLSKEAVAI 580 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC---cCcccccHHHHHH
Confidence 5566789999999999999999999999999999999999999999999998888776654332 2356778999999
Q ss_pred HHhhcccCCCCCCCH-----HHHHhhhhhhhhcc
Q 004088 421 VAKCLTKEPRARPTA-----AEMLKHKFIERCKC 449 (774)
Q Consensus 421 I~kcL~~DP~kRPTa-----~ElL~HPwf~~~~~ 449 (774)
++.+|.+.|.+|..+ .+|-.||||+++.+
T Consensus 581 ckg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 581 CKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred HHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence 999999999999754 78999999987643
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=337.70 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=208.8
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCce
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDL-----KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEY 260 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~-----~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~ 260 (774)
...+|.+.+.||+|+||.||+|++. .++..||+|.+... .......+.+|+.++++++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc-cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence 3467999999999999999999853 34567999987532 23344678899999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcc---------------CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCc
Q 004088 261 LWIVMEYCGGGSVADLMNVT---------------EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE 325 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~---------------~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~ 325 (774)
.++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 99999999999999998632 234889999999999999999999999999999999999999999
Q ss_pred EEEeecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcC
Q 004088 326 VKLGDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIE 402 (774)
Q Consensus 326 vKL~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~ 402 (774)
++|+|||++........ ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 241 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 241 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC
Confidence 99999999976543211 1223457889999999998899999999999999999998 99999877665544433322
Q ss_pred CCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 403 PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 403 ~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
..+ .....++..+.++|.+||+.+|.+||++.++++
T Consensus 242 ~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 242 RVL--ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCC--CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 221 223446788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=327.97 Aligned_cols=245 Identities=24% Similarity=0.404 Sum_probs=205.6
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCCCch
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSV 273 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~ggsL 273 (774)
++||+|+||.||+|.+.. ++.||+|++...........+.+|+++++++.||||+++++++......|+||||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 469999999999999877 9999999987654444567899999999999999999999999999999999999999999
Q ss_pred hhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc--ccccccc
Q 004088 274 ADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR--NTFIGTP 351 (774)
Q Consensus 274 ~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~--~~~~GT~ 351 (774)
.+++......+++..+..++.|++.+|.|||+++|+||||||+|||++.++.+||+|||++.......... ....++.
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence 99987656678999999999999999999999999999999999999999999999999997654221111 1123466
Q ss_pred cccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCC
Q 004088 352 HWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPR 430 (774)
Q Consensus 352 ~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~ 430 (774)
.|+|||++.+..++.++|||||||++|+|++ |..||...........+.... ....+...+..+.+||.+||..+|.
T Consensus 160 ~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~ 237 (251)
T cd05041 160 KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY--RMPAPQLCPEEIYRLMLQCWAYDPE 237 (251)
T ss_pred ccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC--CCCCCccCCHHHHHHHHHHhccChh
Confidence 7999999988889999999999999999998 899998766555444433221 1122345677899999999999999
Q ss_pred CCCCHHHHHhh
Q 004088 431 ARPTAAEMLKH 441 (774)
Q Consensus 431 kRPTa~ElL~H 441 (774)
+||++.++++.
T Consensus 238 ~Rp~~~ell~~ 248 (251)
T cd05041 238 NRPSFSEIYNE 248 (251)
T ss_pred hCcCHHHHHHH
Confidence 99999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=328.52 Aligned_cols=247 Identities=24% Similarity=0.395 Sum_probs=209.0
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
..++|++.+.||.|+||.||+|.. .|+.||||.+..... ....+.+|+.+++.++|+||+++++++......|+||
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 356899999999999999999985 478999999864432 4577899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999999986443 3689999999999999999999999999999999999999999999999999976633221
Q ss_pred ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHh
Q 004088 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAK 423 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~k 423 (774)
...++..|+|||++....++.++|||||||++|+|++ |..||...........+..... ......++..+.++|.+
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~ 234 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR--MEAPEGCPPEVYKVMKD 234 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--CCCccCCCHHHHHHHHH
Confidence 2345678999999988889999999999999999997 9999987765554443332222 12234567889999999
Q ss_pred hcccCCCCCCCHHHHHhh
Q 004088 424 CLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 424 cL~~DP~kRPTa~ElL~H 441 (774)
||..+|.+||++.++++.
T Consensus 235 ~l~~~p~~Rp~~~~l~~~ 252 (256)
T cd05039 235 CWELDPAKRPTFKQLREQ 252 (256)
T ss_pred HhccChhhCcCHHHHHHH
Confidence 999999999999999853
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=327.77 Aligned_cols=250 Identities=25% Similarity=0.410 Sum_probs=208.8
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
..+|++.+.||+|+||.||+|.+. .+..+|||++.... .....+.+|++++++++||||+++++++......|+|||
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC--CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 457999999999999999999875 46789999886432 223568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc-cc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK-RN 345 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~-~~ 345 (774)
|+.+++|.+++......+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++......... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99999999998766667899999999999999999999999999999999999999999999999998765432111 11
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
...++..|+|||++.+..++.++|||||||++|+|++ |..||...........+...... ..+...+..+.+|+.+|
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~ 237 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL--YKPRLASQSVYELMQHC 237 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC--CCCCCCCHHHHHHHHHH
Confidence 2235678999999998889999999999999999998 99999876655554443322111 12234578899999999
Q ss_pred cccCCCCCCCHHHHHhh
Q 004088 425 LTKEPRARPTAAEMLKH 441 (774)
Q Consensus 425 L~~DP~kRPTa~ElL~H 441 (774)
|+.+|++||++.+++++
T Consensus 238 l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 238 WKERPEDRPSFSLLLHQ 254 (256)
T ss_pred cccChhhCCCHHHHHHh
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.75 Aligned_cols=253 Identities=27% Similarity=0.399 Sum_probs=209.5
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCC---CcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKT---SELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~---g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
...+|.+.++||+|+||.||+|.+... ...||||.+.........+.+.+|+.+++++.||||+++++++.. ...|
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 356799999999999999999987543 346999988655445566789999999999999999999998875 4578
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
+||||+++++|.+++......+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++..+.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 99999999999999976556789999999999999999999999999999999999999999999999999976543321
Q ss_pred c-cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHH
Q 004088 343 K-RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 343 ~-~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
. .....+++.|+|||++....++.++|||||||++|+|++ |..||...........+...... ..+..++..+.++
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l 240 (270)
T cd05056 163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL--PMPPNCPPTLYSL 240 (270)
T ss_pred eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHH
Confidence 1 112234568999999988889999999999999999885 99999877665544443332221 2234567889999
Q ss_pred HHhhcccCCCCCCCHHHHHhh
Q 004088 421 VAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~H 441 (774)
|.+||..+|.+|||+.+++..
T Consensus 241 i~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 241 MTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=329.58 Aligned_cols=246 Identities=26% Similarity=0.402 Sum_probs=198.8
Q ss_pred eeeeccCceEEEEEEEcC---CCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCccccccccc-CCceEEEEEEecC
Q 004088 194 NELGKGSYGAVYKARDLK---TSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ-GEEYLWIVMEYCG 269 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~---~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~-~~~~l~LVmEy~~ 269 (774)
+.||+|+||.||+|.+.. .+..||||.+.........+.+.+|+.+++.++||||+++++++. .+...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998653 345799999864444455678889999999999999999999764 5667899999999
Q ss_pred CCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc----cccc
Q 004088 270 GGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM----SKRN 345 (774)
Q Consensus 270 ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~----~~~~ 345 (774)
+++|.+++......+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.+.... ....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 160 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccc
Confidence 999999987555567788889999999999999999999999999999999999999999999997653321 1112
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
...+++.|+|||++....++.++|||||||++|||++ |.+||...........+..... .......+..+.+++.+|
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~c 238 (262)
T cd05058 161 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR--LLQPEYCPDPLYEVMLSC 238 (262)
T ss_pred cCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC--CCCCCcCCHHHHHHHHHH
Confidence 2346788999999988889999999999999999999 5677776655444433322211 112334577899999999
Q ss_pred cccCCCCCCCHHHHHhh
Q 004088 425 LTKEPRARPTAAEMLKH 441 (774)
Q Consensus 425 L~~DP~kRPTa~ElL~H 441 (774)
|..+|++||++.++++.
T Consensus 239 l~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 239 WHPKPEMRPTFSELVSR 255 (262)
T ss_pred cCCChhhCCCHHHHHHH
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=346.45 Aligned_cols=257 Identities=25% Similarity=0.416 Sum_probs=208.3
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCC------
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE------ 258 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~------ 258 (774)
..++|.+++.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.++++++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 3578999999999999999999999999999999986432 223345688999999999999999999987532
Q ss_pred ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 259 EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
...|+|++++ +++|.++++. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 4578999988 7789887753 468999999999999999999999999999999999999999999999999987543
Q ss_pred ccccccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC---------------
Q 004088 339 RTMSKRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE--------------- 402 (774)
Q Consensus 339 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~--------------- 402 (774)
. ......|++.|+|||++.+ ..++.++|||||||++|+|++|++||...........+...
T Consensus 172 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (345)
T cd07877 172 D---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 248 (345)
T ss_pred c---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccH
Confidence 2 2234578999999999876 46888999999999999999999999765543322211000
Q ss_pred ------------CCCcc-ccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 403 ------------PAPML-EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 403 ------------~~~~~-~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
+.... ......+..+.+||.+||+.||.+||++.++++||||....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 00000 00113467789999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=335.35 Aligned_cols=251 Identities=25% Similarity=0.408 Sum_probs=208.2
Q ss_pred CCCeeEEeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDL-----KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~-----~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
..+|.+.++||+|+||.||+++.. .++..||+|.+... .......+.+|+++++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 467899999999999999999742 34678999987643 344556799999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccC--------------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEE
Q 004088 262 WIVMEYCGGGSVADLMNVTE--------------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVK 327 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~--------------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vK 327 (774)
|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEE
Confidence 99999999999999886432 3588999999999999999999999999999999999999999999
Q ss_pred Eeecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCC
Q 004088 328 LGDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPA 404 (774)
Q Consensus 328 L~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~ 404 (774)
|+|||++..+..... ......+++.|+|||++.+..++.++|||||||++|+|++ |.+||...........+.....
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRE 242 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCcc
Confidence 999999975533211 1122345788999999998899999999999999999998 9999977665554444333222
Q ss_pred CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 405 PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 405 ~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
...+..++..+.+||.+||+.||.+||++.+|++
T Consensus 243 --~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 243 --LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1223456788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=329.27 Aligned_cols=250 Identities=26% Similarity=0.393 Sum_probs=205.6
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
....+|++...||+|+||.||+|.+..+ ..||+|++.... ...+.+.+|+.++++++||||+++++++. ....|+|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 3456799999999999999999987554 469999875432 23466889999999999999999999875 4568999
Q ss_pred EEecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc-
Q 004088 265 MEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS- 342 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~- 342 (774)
|||+.+++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999999986433 4588999999999999999999999999999999999999999999999999976543221
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI 421 (774)
......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+...... ......+..+.++|
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li 236 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM--PCPQGCPESLHELM 236 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--CCCcccCHHHHHHH
Confidence 1122346778999999988889999999999999999999 89999877665554444333222 22345678899999
Q ss_pred HhhcccCCCCCCCHHHHHh
Q 004088 422 AKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 422 ~kcL~~DP~kRPTa~ElL~ 440 (774)
.+||.+||.+||+++++++
T Consensus 237 ~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 237 KLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHccCCcccCcCHHHHHH
Confidence 9999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=327.74 Aligned_cols=246 Identities=24% Similarity=0.406 Sum_probs=204.8
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccc-cCCceEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSY-QGEEYLWIV 264 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~-~~~~~l~LV 264 (774)
...+|++.+.||+|+||.||++.. .|..||+|.+... ...+.+.+|+.++++++|+||+++++++ ......|+|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 345899999999999999999975 4788999998532 2345788999999999999999999875 456779999
Q ss_pred EEecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999999986543 358899999999999999999999999999999999999999999999999987543321
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
....++..|+|||++....++.++|||||||++|+|++ |+.||...........+.....+ .....++..+.++|.
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~ 233 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM--DAPDGCPPVVYDVMK 233 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHH
Confidence 23345678999999998889999999999999999997 99999876655544444332222 223456788999999
Q ss_pred hhcccCCCCCCCHHHHHhh
Q 004088 423 KCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~H 441 (774)
+||+.+|.+|||+.+++++
T Consensus 234 ~~l~~~p~~Rpt~~~l~~~ 252 (256)
T cd05082 234 QCWHLDAATRPSFLQLREQ 252 (256)
T ss_pred HHhcCChhhCcCHHHHHHH
Confidence 9999999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=332.53 Aligned_cols=253 Identities=28% Similarity=0.454 Sum_probs=201.2
Q ss_pred CCCeeEEeeeeccCceEEEEEEE----cCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCccccccccc--CCce
Q 004088 187 TTKYELLNELGKGSYGAVYKARD----LKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ--GEEY 260 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d----~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~--~~~~ 260 (774)
...|++++.||+|+||.||+|.. ..+++.||||++... .......+.+|+++|++++||||+++++++. +...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 35799999999999999999973 457889999998643 3344567899999999999999999999764 3457
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
+|+||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 89999999999999998755567899999999999999999999999999999999999999999999999999866433
Q ss_pred ccc---cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhh---------------hhhhcC
Q 004088 341 MSK---RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVL---------------FMISIE 402 (774)
Q Consensus 341 ~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i---------------~~i~~~ 402 (774)
... .....++..|+|||++.+..++.++|||||||++|||++|..|+......... .... .
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 240 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL-K 240 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH-h
Confidence 211 11122345699999999888999999999999999999987765432211000 0000 0
Q ss_pred CCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 403 PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 403 ~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
..........++..+.+||.+||..+|++|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 011112234567789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=332.18 Aligned_cols=253 Identities=20% Similarity=0.320 Sum_probs=210.4
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcC----CCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccC-Cce
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLK----TSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG-EEY 260 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~----~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~-~~~ 260 (774)
..++|++.+.||+|+||.||+|.+.. ++..||+|++...........+.+|+.+|++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45789999999999999999999865 3688999998755455566778999999999999999999998654 578
Q ss_pred EEEEEEecCCCchhhhhhccC-------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTE-------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGV 333 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~-------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGl 333 (774)
.++++||+++++|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~ 163 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL 163 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence 899999999999999886432 4589999999999999999999999999999999999999999999999999
Q ss_pred cccccccccc--cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccc
Q 004088 334 AAQLTRTMSK--RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDK 410 (774)
Q Consensus 334 A~~i~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~ 410 (774)
++.+...... .....++..|+|||++.+..++.++|||||||++|++++ |++||...........+..... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~ 241 (280)
T cd05043 164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR--LAQP 241 (280)
T ss_pred cccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC--CCCC
Confidence 9765432111 112346778999999998889999999999999999998 9999987766554443332221 1223
Q ss_pred hhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 411 EKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 411 ~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
..++..+.++|.+||..+|++|||+.++++
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 242 INCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 445788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=363.66 Aligned_cols=260 Identities=27% Similarity=0.484 Sum_probs=233.5
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
..+++++..||-|+||.|-++........+|+|++++.. .....+.+..|-+||..++.|.||+||..|.+..++||+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 456778889999999999999865555568999997654 445567899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
||-|-||.|+.+++ .++.|.+..++.++..+++|++|||++|||+|||||+|+|++.+|-+||.|||+|+.+... ...
T Consensus 499 mEaClGGElWTiLr-dRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-~KT 576 (732)
T KOG0614|consen 499 MEACLGGELWTILR-DRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-RKT 576 (732)
T ss_pred HHhhcCchhhhhhh-hcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC-Cce
Confidence 99999999999996 5678999999999999999999999999999999999999999999999999999988765 566
Q ss_pred ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
.++||||.|.|||++.+...+.++|.||||+++|||++|.|||.+.+++..+..|... ...+..+..+.....+||+++
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG-id~i~~Pr~I~k~a~~Lik~L 655 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG-IDKIEFPRRITKTATDLIKKL 655 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh-hhhhhcccccchhHHHHHHHH
Confidence 7899999999999999999999999999999999999999999999999988776543 334556677888899999999
Q ss_pred cccCCCCCCC-----HHHHHhhhhhhhhcc
Q 004088 425 LTKEPRARPT-----AAEMLKHKFIERCKC 449 (774)
Q Consensus 425 L~~DP~kRPT-----a~ElL~HPwf~~~~~ 449 (774)
+..+|.+|.. +.++-+|.||....+
T Consensus 656 Cr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 656 CRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred HhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 9999999976 899999999986644
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.00 Aligned_cols=254 Identities=27% Similarity=0.454 Sum_probs=210.5
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcC-----CCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLK-----TSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~-----~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
..+|++++.||+|+||.||+|+... ..+.||+|.+...........+.+|+++|++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 4689999999999999999999653 35679999886544444567899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccC--------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccc
Q 004088 262 WIVMEYCGGGSVADLMNVTE--------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGV 333 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~--------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGl 333 (774)
|+||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||+
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccccc
Confidence 99999999999999986433 1689999999999999999999999999999999999999999999999999
Q ss_pred ccccccc-ccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccch
Q 004088 334 AAQLTRT-MSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKE 411 (774)
Q Consensus 334 A~~i~~~-~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~ 411 (774)
+...... ........++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+..... ......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 242 (275)
T cd05046 164 SKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL-ELPVPE 242 (275)
T ss_pred ccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCc-CCCCCC
Confidence 8654322 112233456788999999988888999999999999999998 8889976655554443332211 122234
Q ss_pred hchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 412 KWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 412 ~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.++..+.++|.+||+.+|.+||++.+++.+
T Consensus 243 ~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 243 GCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=330.51 Aligned_cols=246 Identities=24% Similarity=0.392 Sum_probs=194.6
Q ss_pred eeeeccCceEEEEEEEcC--CCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCCC
Q 004088 194 NELGKGSYGAVYKARDLK--TSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGG 271 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~--~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~gg 271 (774)
++||+|+||.||+|.... ....+|+|.+...........+.+|+.+++.++||||+++++++.....+|+||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 469999999999996432 345789998765444455567889999999999999999999999999999999999999
Q ss_pred chhhhhhccC----CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc--ccc
Q 004088 272 SVADLMNVTE----EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS--KRN 345 (774)
Q Consensus 272 sL~dll~~~~----~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~--~~~ 345 (774)
+|.+++.... ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence 9999986432 2346788899999999999999999999999999999999999999999999865432211 112
Q ss_pred cccccccccchhhhhh-------cCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCC---Cccccchhch
Q 004088 346 TFIGTPHWMAPEVIQE-------SRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPA---PMLEDKEKWS 414 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~-------~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~---~~~~~~~~~s 414 (774)
...+++.|+|||++.. ..++.++|||||||++|+|++ |..||................. +.......++
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYS 240 (269)
T ss_pred CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCC
Confidence 2346778999999753 356789999999999999998 7889887665544433222211 1112234567
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 415 LVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 415 ~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
..+.+++..|| .||.+|||+.+|++
T Consensus 241 ~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 241 DRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred HHHHHHHHHHh-cCcccccCHHHHHH
Confidence 88899999999 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=366.91 Aligned_cols=258 Identities=31% Similarity=0.547 Sum_probs=215.0
Q ss_pred CCCCCCe-eEEeeeeccCceEEEEEEEcCCCcEEE---EEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCc
Q 004088 184 EDPTTKY-ELLNELGKGSYGAVYKARDLKTSELVA---IKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE 259 (774)
Q Consensus 184 ~~~~~~Y-~ilk~LG~G~FG~Vy~a~d~~~g~~VA---VKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~ 259 (774)
..+.++| +...+||+|+|-+||+|.|..+|..|| ||.-.........+.|..|+.+|+.|+|||||++|++|.+..
T Consensus 35 ~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~ 114 (632)
T KOG0584|consen 35 KDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD 114 (632)
T ss_pred cCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC
Confidence 3455565 455689999999999999999998887 443334456667789999999999999999999999997655
Q ss_pred --eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcC--cccccccccceEecCC-CcEEEeecccc
Q 004088 260 --YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF--KVHRDIKGGNILLTDQ-GEVKLGDFGVA 334 (774)
Q Consensus 260 --~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~g--IIHRDLKPeNILLd~~-g~vKL~DFGlA 334 (774)
.+.+|+|++..|+|..+++ +.++++...++.|++||++||.|||++. |||||||-+||+|+.+ |.|||+|+|+|
T Consensus 115 n~~in~iTEL~TSGtLr~Y~k-k~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA 193 (632)
T KOG0584|consen 115 NKTINFITELFTSGTLREYRK-KHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA 193 (632)
T ss_pred CceeeeeeecccCCcHHHHHH-HhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHH
Confidence 4889999999999999986 4567889999999999999999999986 9999999999999876 89999999999
Q ss_pred ccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhch
Q 004088 335 AQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWS 414 (774)
Q Consensus 335 ~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s 414 (774)
...... .....+|||.|||||++. ..|+..+||||||++|+||+|+..||........++........+......-.
T Consensus 194 tl~r~s--~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d 270 (632)
T KOG0584|consen 194 TLLRKS--HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD 270 (632)
T ss_pred HHhhcc--ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC
Confidence 876544 334479999999999998 46999999999999999999999999876655555543333222222222226
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 415 LVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 415 ~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
+++++||.+||.. ...|+|+.|+|+||||..
T Consensus 271 Pevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 271 PEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred HHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 7899999999999 999999999999999975
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=359.33 Aligned_cols=255 Identities=28% Similarity=0.449 Sum_probs=218.8
Q ss_pred eeEE--eeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 190 YELL--NELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 190 Y~il--k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
|++. +.||+|.||+||-|+++++|+.||||+|.+-. ......++++|+.||+.+.||.||.|.-.|+..+.++.|||
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVME 643 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVME 643 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEeh
Confidence 4443 68999999999999999999999999997543 33445789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC---cEEEeeccccccccccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG---EVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g---~vKL~DFGlA~~i~~~~~~ 343 (774)
-+.|.-|.-++....++|++...+.++.||+.||.|||.++|+|.||||+|||+.+.. ++||||||+|+.+... ..
T Consensus 644 Kl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-sF 722 (888)
T KOG4236|consen 644 KLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-SF 722 (888)
T ss_pred hhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-hh
Confidence 9977666666667788999999999999999999999999999999999999998664 6999999999988654 56
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhh-hhhhhcCCCCccccchhchHHHHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRV-LFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~-i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
+.+.+|||.|+|||+++...|+..-||||.|||+|.-+.|..||........ ++..... .| ......++..+.|||.
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFM-yP-p~PW~eis~~AidlIn 800 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFM-YP-PNPWSEISPEAIDLIN 800 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccc-cC-CCchhhcCHHHHHHHH
Confidence 7788999999999999999999999999999999999999999986544322 2221111 11 1224456888999999
Q ss_pred hhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 423 KCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
.+|+..-.+|.+....|.|||++..
T Consensus 801 ~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 801 NLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHhcchHhhccchhhhcc
Confidence 9999999999999999999999753
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=356.05 Aligned_cols=263 Identities=23% Similarity=0.401 Sum_probs=213.1
Q ss_pred CCCcccCCCCCCeeEEeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-CCCcccc
Q 004088 178 PESVTREDPTTKYELLNELGKGSYGAVYKARDL-----KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPNVVRY 251 (774)
Q Consensus 178 ~~~~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~-----~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HPNIVkL 251 (774)
+....++.+..+|.++++||+|+||.||+|++. ..++.||||++...........+.+|+++|.++. ||||+++
T Consensus 27 ~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~ 106 (401)
T cd05107 27 PYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNL 106 (401)
T ss_pred CCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEE
Confidence 333446667788999999999999999999864 3457899999976544444567889999999997 9999999
Q ss_pred cccccCCceEEEEEEecCCCchhhhhhccC--------------------------------------------------
Q 004088 252 LGSYQGEEYLWIVMEYCGGGSVADLMNVTE-------------------------------------------------- 281 (774)
Q Consensus 252 ~~~~~~~~~l~LVmEy~~ggsL~dll~~~~-------------------------------------------------- 281 (774)
++++......|||||||.+|+|.++++...
T Consensus 107 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (401)
T cd05107 107 LGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES 186 (401)
T ss_pred EEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence 999999999999999999999999885321
Q ss_pred -----------------------------------------------CchhHHHHHHHHHHHHHHHHHHHhcCccccccc
Q 004088 282 -----------------------------------------------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIK 314 (774)
Q Consensus 282 -----------------------------------------------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLK 314 (774)
..+++..+..++.||+.||.|||+.+|+|||||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlk 266 (401)
T cd05107 187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLA 266 (401)
T ss_pred cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCC
Confidence 135677888999999999999999999999999
Q ss_pred ccceEecCCCcEEEeecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCC
Q 004088 315 GGNILLTDQGEVKLGDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVH 391 (774)
Q Consensus 315 PeNILLd~~g~vKL~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~ 391 (774)
|+|||++.++.+||+|||+++.+..... ......+++.|+|||++....++.++|||||||++|||++ |..||....
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999976533211 1223457889999999998889999999999999999998 889987655
Q ss_pred chhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 392 PMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 392 ~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
..+.......... ....+..++..+.+||.+||..+|.+||++.+|++.
T Consensus 347 ~~~~~~~~~~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 347 MNEQFYNAIKRGY-RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred chHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4443322211111 112234567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=376.24 Aligned_cols=148 Identities=28% Similarity=0.515 Sum_probs=135.1
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
.++|.++++||+|+||+||+|++..+++.||||++.... .......+.+|+.+++.++||||+++++++....++|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 468999999999999999999999999999999997533 233456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
|||+.+++|.+++.. .+.+++..++.|+.||+.||.|||.+|||||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999863 4568899999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=333.19 Aligned_cols=251 Identities=26% Similarity=0.425 Sum_probs=200.2
Q ss_pred CCe-eEEeeeeccCceEEEEEE----EcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccC--Cce
Q 004088 188 TKY-ELLNELGKGSYGAVYKAR----DLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG--EEY 260 (774)
Q Consensus 188 ~~Y-~ilk~LG~G~FG~Vy~a~----d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~--~~~ 260 (774)
++| ++++.||+|+||+||++. ...+++.||+|++...........+.+|+.+|++++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 355 999999999999998865 3456889999998754444455678899999999999999999998754 456
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
+|+||||+.+++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 83 ~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 8999999999999998863 45999999999999999999999999999999999999999999999999999766432
Q ss_pred ccc---cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchh--hhhhhh-----------cCCC
Q 004088 341 MSK---RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMR--VLFMIS-----------IEPA 404 (774)
Q Consensus 341 ~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~--~i~~i~-----------~~~~ 404 (774)
... .....++..|+|||++....++.++|||||||++|+|++|..||....... ...... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 211 112245677999999988889999999999999999999999986432210 000000 0000
Q ss_pred CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 405 PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 405 ~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
.....+..++..+.+|+.+||+.+|.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 111123456788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=334.74 Aligned_cols=256 Identities=28% Similarity=0.476 Sum_probs=209.4
Q ss_pred CeeEEeeeeccCceEEEEEEEc---CCCcEEEEEEeecCC---ChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceE
Q 004088 189 KYELLNELGKGSYGAVYKARDL---KTSELVAIKVISLSE---GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~---~~g~~VAVKvi~~~~---~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l 261 (774)
.|++.+.||.|+||.||+|++. .+|+.||+|++.... .....+.+.+|+.+|+++ +||||++++++|..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999874 478999999986432 123346678899999999 599999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 999999999999998863 4578999999999999999999999999999999999999999999999999997654321
Q ss_pred -cccccccccccccchhhhhhc--CCCCccchhhhHHHHHHHHhCCCCCCCCCchh----hhhhhhcCCCCccccchhch
Q 004088 342 -SKRNTFIGTPHWMAPEVIQES--RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMR----VLFMISIEPAPMLEDKEKWS 414 (774)
Q Consensus 342 -~~~~~~~GT~~Y~APEvl~~~--~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~----~i~~i~~~~~~~~~~~~~~s 414 (774)
.......|+..|+|||++... .++.++|||||||++|+|++|..||....... ....+..... ..+..++
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 236 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP---PYPQEMS 236 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC---CCCccCC
Confidence 122345689999999998753 47789999999999999999999996432211 1111111111 1233467
Q ss_pred HHHHHHHHhhcccCCCCCC-----CHHHHHhhhhhhhhc
Q 004088 415 LVFHDFVAKCLTKEPRARP-----TAAEMLKHKFIERCK 448 (774)
Q Consensus 415 ~~l~dLI~kcL~~DP~kRP-----Ta~ElL~HPwf~~~~ 448 (774)
..+.+|+.+||..+|.+|| ++.+++.||||.+..
T Consensus 237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 8899999999999999997 899999999998654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=345.29 Aligned_cols=260 Identities=34% Similarity=0.488 Sum_probs=209.5
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhC-CCCCcccccccccC--CceE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQG--EEYL 261 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~--~~~l 261 (774)
..++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++++ +||||++++++|.. ...+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3568999999999999999999998899999999885422 223345677899999999 99999999998864 4478
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|+||||+. ++|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 99999996 5888887532 78899999999999999999999999999999999999999999999999997654332
Q ss_pred c-----ccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-------------
Q 004088 342 S-----KRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE------------- 402 (774)
Q Consensus 342 ~-----~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~------------- 402 (774)
. ....+.||+.|+|||++.+ ..++.++|||||||++|+|++|++||...........+...
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 1 2234578999999998764 45788999999999999999999999765543322211000
Q ss_pred ---------------CCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 403 ---------------PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 403 ---------------~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
..+.......++..+.+||.+||+.+|.+|||+.++++||||+.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 0001111123577899999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=330.37 Aligned_cols=246 Identities=24% Similarity=0.347 Sum_probs=194.8
Q ss_pred eeeeccCceEEEEEEEc--CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCCC
Q 004088 194 NELGKGSYGAVYKARDL--KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGG 271 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~--~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~gg 271 (774)
+.||+|+||.||+|.+. .++..+|+|.++..........+.+|+.++++++||||+++++++.....+|+||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46899999999999854 3456799999865544444557889999999999999999999999999999999999999
Q ss_pred chhhhhhccC----CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc--ccc
Q 004088 272 SVADLMNVTE----EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS--KRN 345 (774)
Q Consensus 272 sL~dll~~~~----~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~--~~~ 345 (774)
+|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++........ ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD 160 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence 9999886322 2456778889999999999999999999999999999999999999999999865433211 112
Q ss_pred cccccccccchhhhhhc-------CCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCC---ccccchhch
Q 004088 346 TFIGTPHWMAPEVIQES-------RYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAP---MLEDKEKWS 414 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~-------~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~---~~~~~~~~s 414 (774)
...|++.|+|||++... .++.++|||||||++|+|++ |..||......+........... ........+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05087 161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLS 240 (269)
T ss_pred CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCC
Confidence 34678899999998642 35789999999999999996 99999876655443322211111 111122356
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 415 LVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 415 ~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
..+.++|.+|| .+|.+|||+.+|+.
T Consensus 241 ~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 241 DRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred hHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 77899999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=341.28 Aligned_cols=258 Identities=27% Similarity=0.414 Sum_probs=205.7
Q ss_pred CeeEEeeeeccCceEEEEEEEcCC--CcEEEEEEeecCC-ChhhHHHHHHHHHHHHhC-CCCCccccccccc----CCce
Q 004088 189 KYELLNELGKGSYGAVYKARDLKT--SELVAIKVISLSE-GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQ----GEEY 260 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~--g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~----~~~~ 260 (774)
+|++.+.||+|+||.||++.+..+ +..||||++.... .......+.+|+.+++++ .||||+++++++. ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999887 8999999986432 222345678899999999 5999999998643 2356
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
+|+++||+. ++|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 81 ~~~~~e~~~-~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 81 LYLYEELME-ADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred EEEEEeccc-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 889999995 68888875 4567999999999999999999999999999999999999999999999999999765432
Q ss_pred cc----ccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc--------------
Q 004088 341 MS----KRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI-------------- 401 (774)
Q Consensus 341 ~~----~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~-------------- 401 (774)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+..
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 1233578999999998865 4689999999999999999999999986553322211100
Q ss_pred -------------CC-CCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 402 -------------EP-APMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 402 -------------~~-~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.+ ..........+..+.+||.+||+.||.+|||+.+++.||||+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 00 000001122467899999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=328.38 Aligned_cols=257 Identities=27% Similarity=0.386 Sum_probs=211.0
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCC-----
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE----- 258 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~----- 258 (774)
....++|++.++||+|||+.||++++..++..||+|++.... .+..+..++|++..++++||||++++++...+
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 345789999999999999999999999999999999997544 56678899999999999999999999987533
Q ss_pred ceEEEEEEecCCCchhhhhhc---cCCchhHHHHHHHHHHHHHHHHHHHhcC--cccccccccceEecCCCcEEEeeccc
Q 004088 259 EYLWIVMEYCGGGSVADLMNV---TEEPLEEYQIAYICREALKGLAYLHSIF--KVHRDIKGGNILLTDQGEVKLGDFGV 333 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~---~~~~Lse~~i~~I~~QIl~gL~YLHs~g--IIHRDLKPeNILLd~~g~vKL~DFGl 333 (774)
...||++.|...|+|.+.++. .+..++|.++.+|+.+|++||++||+.. ++||||||.|||+.+.+.++|.|||.
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccC
Confidence 459999999999999998863 3347999999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccc---------ccccccccccchhhhh---hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhh-hhhhh
Q 004088 334 AAQLTRTMSKR---------NTFIGTPHWMAPEVIQ---ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRV-LFMIS 400 (774)
Q Consensus 334 A~~i~~~~~~~---------~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~-i~~i~ 400 (774)
+....-..... ..-..|..|+|||.+. +...+.++|||||||++|.|+.|..||...-.... +....
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv 255 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV 255 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee
Confidence 97653222111 1224689999999986 44578899999999999999999999975322111 11111
Q ss_pred cCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 401 IEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 401 ~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
......++....++..+.+||++||+.||.+||++.+++.+
T Consensus 256 ~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 256 QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 12222334445589999999999999999999999999875
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=330.41 Aligned_cols=245 Identities=27% Similarity=0.435 Sum_probs=199.6
Q ss_pred eeeeccCceEEEEEEEcCCCc--EEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEEEEEEecCC
Q 004088 194 NELGKGSYGAVYKARDLKTSE--LVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIVMEYCGG 270 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~--~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~LVmEy~~g 270 (774)
+.||+|+||.||+|++..++. .+|+|.+.........+.+.+|+.+++++ .||||+++++++.....+|+||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999887776 46888876433445556788999999999 899999999999999999999999999
Q ss_pred CchhhhhhccC---------------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccc
Q 004088 271 GSVADLMNVTE---------------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 271 gsL~dll~~~~---------------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 99999986322 247899999999999999999999999999999999999999999999999985
Q ss_pred cccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhch
Q 004088 336 QLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWS 414 (774)
Q Consensus 336 ~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s 414 (774)
..... ........+..|+|||++....++.++|||||||++|+|++ |..||...........+.... ........+
T Consensus 161 ~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~ 237 (270)
T cd05047 161 GQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RLEKPLNCD 237 (270)
T ss_pred ccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC--CCCCCCcCC
Confidence 33211 11111234667999999988889999999999999999996 999997766554443332221 112233456
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 415 LVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 415 ~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
..+.+++.+||..+|.+|||+.+++..
T Consensus 238 ~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 238 DEVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred HHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=336.49 Aligned_cols=253 Identities=25% Similarity=0.400 Sum_probs=207.7
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCc----EEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSE----LVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~----~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
...+|+..+.||+|+||.||+|.+..+|. .||+|++...........+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 45689999999999999999999877776 47899886544444455788999999999999999999988754 46
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
++|+||+++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcc
Confidence 79999999999999987666678999999999999999999999999999999999999999999999999997654322
Q ss_pred cc--cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 342 SK--RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 342 ~~--~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
.. .....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+..... ......++..+.
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 241 (303)
T cd05110 164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER--LPQPPICTIDVY 241 (303)
T ss_pred cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC--CCCCCCCCHHHH
Confidence 21 122345778999999998889999999999999999997 8999977654443333322211 122334567889
Q ss_pred HHHHhhcccCCCCCCCHHHHHhh
Q 004088 419 DFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
++|.+||..+|++||++.++++.
T Consensus 242 ~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 242 MVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=393.27 Aligned_cols=258 Identities=36% Similarity=0.652 Sum_probs=223.6
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
-+|.-...||.|.||.||-|.+..+|+..|+|-+.... .......+.+|+++|..|+|||+|++||+-.+.+..+|.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 46777889999999999999999999999999886543 34556778999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc----
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS---- 342 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~---- 342 (774)
||.+|+|.++++ ..+-.+|.....+..|++.|+.|||++|||||||||.|||++.+|.+|++|||.|..+.....
T Consensus 1315 yC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1315 YCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred HhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 999999999986 556688899999999999999999999999999999999999999999999999988866531
Q ss_pred ccccccccccccchhhhhhcC---CCCccchhhhHHHHHHHHhCCCCCCCCCchhh-hhhhhcCCCCccccchhchHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESR---YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRV-LFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~---~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~-i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
..+..+||+.|||||++.+.. ...+.|||||||++.||+||+.||...+..-. .+.+.....|..+ ..++.+.+
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P--~~ls~~g~ 1471 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP--ERLSSEGR 1471 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc--hhhhHhHH
Confidence 234568999999999997643 56789999999999999999999987765433 3344444444443 34899999
Q ss_pred HHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 419 DFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
+||.+||+.||++|.++.|+|+|.|-+.+.
T Consensus 1472 dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1472 DFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred HHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence 999999999999999999999999987665
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=360.41 Aligned_cols=257 Identities=32% Similarity=0.481 Sum_probs=216.7
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcCCCc---E-EEEEEeec--CCChhhHHHHHHHHHHHHhCCCCCccccccccc
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLKTSE---L-VAIKVISL--SEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ 256 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~---~-VAVKvi~~--~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~ 256 (774)
|+....+-.+.++||+|+||.||+|+....+. . ||||..+. ........++.+|+++|++++|||||++||+..
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 55566677778999999999999999765422 3 89999874 234566788999999999999999999999999
Q ss_pred CCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccc
Q 004088 257 GEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQ 336 (774)
Q Consensus 257 ~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~ 336 (774)
....++||||+|.||+|.++++.....++..+...++.+.+.||+|||++++|||||-.+|+|+..++.+||+|||+++.
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 99999999999999999999987777899999999999999999999999999999999999999999999999999875
Q ss_pred ccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchH
Q 004088 337 LTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSL 415 (774)
Q Consensus 337 i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~ 415 (774)
-...........-+..|+|||.+....|+.++|||||||++||+++ |..||.+.....+...+.....+.. .+...+.
T Consensus 312 ~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~-~~~~~p~ 390 (474)
T KOG0194|consen 312 GSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP-IPSKTPK 390 (474)
T ss_pred CcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC-CCCCCHH
Confidence 4321111111124678999999999999999999999999999997 8889999988877766643333222 2335577
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 416 VFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 416 ~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
.+..++.+||..+|++||++.++.+
T Consensus 391 ~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 391 ELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHHhccCChhhccCHHHHHH
Confidence 8889999999999999999999964
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=324.48 Aligned_cols=251 Identities=22% Similarity=0.375 Sum_probs=207.3
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
+....+|++.++||+|+||.||++.+. .+..||+|++... ......+.+|+.++++++|+||+++++++.. ...|+
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 456789999999999999999999854 5567999987632 2345678899999999999999999999887 77899
Q ss_pred EEEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
||||+++++|.+++... ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++..+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999998643 34678889999999999999999999999999999999999999999999999976543211
Q ss_pred -ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHH
Q 004088 343 -KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 343 -~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
......++..|+|||++....++.++|||||||++|+|++ |..||...........+..... .......+..+.++
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 235 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR--MPRPENCPEELYNI 235 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC--CCCcccCCHHHHHH
Confidence 1122345678999999988889999999999999999998 9999987665554443332221 22234567889999
Q ss_pred HHhhcccCCCCCCCHHHHHh
Q 004088 421 VAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~ 440 (774)
+.+||+.+|++||++.++++
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 236 MMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHcccCcccCcCHHHHHH
Confidence 99999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=325.51 Aligned_cols=236 Identities=22% Similarity=0.351 Sum_probs=193.1
Q ss_pred eeeeccCceEEEEEEEcCCC----------cEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 194 NELGKGSYGAVYKARDLKTS----------ELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g----------~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
+.||+|+||.||+|.+..++ ..|++|++...... ...+.+|+.+|++++||||+++++++.. ...|+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 46999999999999987766 35888877543322 5778899999999999999999999887 77899
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC-------cEEEeecccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG-------EVKLGDFGVAAQ 336 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g-------~vKL~DFGlA~~ 336 (774)
||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~ 157 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157 (259)
T ss_pred EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence 9999999999999876555789999999999999999999999999999999999999887 799999999976
Q ss_pred ccccccccccccccccccchhhhhhc--CCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhc
Q 004088 337 LTRTMSKRNTFIGTPHWMAPEVIQES--RYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKW 413 (774)
Q Consensus 337 i~~~~~~~~~~~GT~~Y~APEvl~~~--~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~ 413 (774)
... .....++..|+|||++... .++.++|||||||++|+|++ |..||................ .. +...
T Consensus 158 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~--~~--~~~~ 229 (259)
T cd05037 158 VLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH--RL--PMPD 229 (259)
T ss_pred ccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC--CC--CCCC
Confidence 543 2234577889999999876 78999999999999999998 578887664332222111111 01 1112
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 414 SLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 414 s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
...+.++|.+||..+|.+|||+.++++
T Consensus 230 ~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 230 CAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred chHHHHHHHHHhccChhhCCCHHHHHH
Confidence 367899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=327.41 Aligned_cols=245 Identities=27% Similarity=0.501 Sum_probs=202.2
Q ss_pred eeeeccCceEEEEEEEcCCC------cEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 194 NELGKGSYGAVYKARDLKTS------ELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g------~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
+.||+|+||.||+|++.... +.||||.+...........+.+|+.+|+.++||||+++++++......|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36899999999999976433 789999886544344567788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcc------CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC-----cEEEeecccccc
Q 004088 268 CGGGSVADLMNVT------EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG-----EVKLGDFGVAAQ 336 (774)
Q Consensus 268 ~~ggsL~dll~~~------~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g-----~vKL~DFGlA~~ 336 (774)
+++++|.+++... ...+++..+..++.||+.||.|||+.+|+|+||||+|||++.++ .++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999988632 23478899999999999999999999999999999999999887 899999999976
Q ss_pred cccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhc
Q 004088 337 LTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKW 413 (774)
Q Consensus 337 i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~ 413 (774)
+..... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+.... ........
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~ 238 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG--RLQKPENC 238 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC--ccCCcccc
Confidence 543211 1122346788999999998889999999999999999998 999998766555444433222 12223456
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 414 SLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 414 s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
+..+.+||.+||..+|.+||++.++++
T Consensus 239 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 239 PDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred hHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 788999999999999999999999975
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=340.17 Aligned_cols=257 Identities=31% Similarity=0.468 Sum_probs=209.4
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccC-CceEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG-EEYLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~-~~~l~L 263 (774)
..++|++++.||.|+||.||+|.+..+++.||||++.+.. .....+.+.+|+.++++++||||++++++|.. ....|+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 5678999999999999999999999999999999886432 22334668899999999999999999998865 568899
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
||||+ +++|..++. ..++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 88 v~e~~-~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--- 161 (328)
T cd07856 88 VTELL-GTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--- 161 (328)
T ss_pred Eeehh-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC---
Confidence 99999 568888775 346888889999999999999999999999999999999999999999999998754322
Q ss_pred cccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc---------------------
Q 004088 344 RNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI--------------------- 401 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~--------------------- 401 (774)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|++||...........+..
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 234468899999999865 5689999999999999999999999976554221110000
Q ss_pred -------CCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 402 -------EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 402 -------~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.+.+.......++..+.++|.+||+.+|++||++.+++.||||....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 00011111234567899999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=328.62 Aligned_cols=253 Identities=26% Similarity=0.447 Sum_probs=205.2
Q ss_pred CCCeeEEeeeeccCceEEEEEEEc----CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccC--Cce
Q 004088 187 TTKYELLNELGKGSYGAVYKARDL----KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG--EEY 260 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~----~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~--~~~ 260 (774)
...|++.+.||+|+||.||+|... .+++.||||++...........+.+|+++++.+.||||+++++++.. ...
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 356888999999999999999864 34789999999755443356789999999999999999999998876 668
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
.|+||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 99999999999999999765557999999999999999999999999999999999999999999999999999876532
Q ss_pred ccc---cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhh--------------hhhhcCC
Q 004088 341 MSK---RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVL--------------FMISIEP 403 (774)
Q Consensus 341 ~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i--------------~~i~~~~ 403 (774)
... .....++..|+|||.+....++.++|||||||++|+|++|..|+......... .... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 241 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL-KE 241 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH-Hc
Confidence 111 11224566799999998888999999999999999999999987653221100 0000 01
Q ss_pred CCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 404 APMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 404 ~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
.........++..+.+|+.+||+.+|.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1111223345678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=328.33 Aligned_cols=239 Identities=20% Similarity=0.290 Sum_probs=192.5
Q ss_pred eeeeccCceEEEEEEEcC------------CCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 194 NELGKGSYGAVYKARDLK------------TSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~------------~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
+.||+|+||.||+|+... ....||+|++.... ......+.+|+.+++.++||||+++++++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 468999999999998532 23358999875432 33445788899999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCc-------EEEeecccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE-------VKLGDFGVA 334 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~-------vKL~DFGlA 334 (774)
++||||+++++|..++......+++..+..++.||+.||.|||++||+||||||+|||++.++. ++++|||++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 9999999999999888765667999999999999999999999999999999999999987664 899999998
Q ss_pred ccccccccccccccccccccchhhhh-hcCCCCccchhhhHHHHHHHH-hCCCCCCCCCchhhhhhhhcCCCCccccchh
Q 004088 335 AQLTRTMSKRNTFIGTPHWMAPEVIQ-ESRYDGKVDVWALGVSAVEMA-EGLPPRSTVHPMRVLFMISIEPAPMLEDKEK 412 (774)
Q Consensus 335 ~~i~~~~~~~~~~~GT~~Y~APEvl~-~~~~s~ksDIWSLGviLyELL-tG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~ 412 (774)
..+... ....|+..|+|||++. ...++.++|||||||++|+|+ .|..||............. ... .....
T Consensus 160 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~---~~~~~ 231 (262)
T cd05077 160 ITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYE-GQC---MLVTP 231 (262)
T ss_pred ccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHh-cCc---cCCCC
Confidence 654322 2346889999999987 456899999999999999998 5888887654333221111 111 11122
Q ss_pred chHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 413 WSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 413 ~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.+..+.+||.+||+.||.+||++.+|+++
T Consensus 232 ~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 232 SCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 35678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=330.27 Aligned_cols=256 Identities=30% Similarity=0.458 Sum_probs=207.8
Q ss_pred CeeEEeeeeccCceEEEEEEEc---CCCcEEEEEEeecCC---ChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceE
Q 004088 189 KYELLNELGKGSYGAVYKARDL---KTSELVAIKVISLSE---GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~---~~g~~VAVKvi~~~~---~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l 261 (774)
+|++.+.||+|+||.||++++. .+++.||||++.... .......+.+|+.++.++ +||||+++++++..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 467889999986432 123345678999999999 599999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|+||||+.+++|.+++.. ...+++..++.++.|++.+|.|||+.|++||||||+||+++.++.++|+|||++..+....
T Consensus 81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 999999999999998863 3568999999999999999999999999999999999999999999999999987654432
Q ss_pred cc-cccccccccccchhhhhhcC--CCCccchhhhHHHHHHHHhCCCCCCCCCch----hhhhhhhcCCCCccccchhch
Q 004088 342 SK-RNTFIGTPHWMAPEVIQESR--YDGKVDVWALGVSAVEMAEGLPPRSTVHPM----RVLFMISIEPAPMLEDKEKWS 414 (774)
Q Consensus 342 ~~-~~~~~GT~~Y~APEvl~~~~--~s~ksDIWSLGviLyELLtG~~Pf~~~~~~----~~i~~i~~~~~~~~~~~~~~s 414 (774)
.. .....|+..|+|||.+.+.. .+.++||||||+++|+|++|..||...... .....+.... ...+..++
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 236 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK---PPFPKTMS 236 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC---CCCCcccC
Confidence 21 22346899999999987654 788999999999999999999999643221 1111111111 11233467
Q ss_pred HHHHHHHHhhcccCCCCCCC---HHHHHhhhhhhhhc
Q 004088 415 LVFHDFVAKCLTKEPRARPT---AAEMLKHKFIERCK 448 (774)
Q Consensus 415 ~~l~dLI~kcL~~DP~kRPT---a~ElL~HPwf~~~~ 448 (774)
..+.++|.+||+.+|++||| +.++|+||||+...
T Consensus 237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred HHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 78999999999999999998 56779999997653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=338.07 Aligned_cols=261 Identities=27% Similarity=0.456 Sum_probs=206.8
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCC----cEEEEEEeecCCChhhH-HHHHHHHHHHHhCCCCCcccccccccC-Cce
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTS----ELVAIKVISLSEGEEGY-EEIRGEIEMLQQCSHPNVVRYLGSYQG-EEY 260 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g----~~VAVKvi~~~~~~~~~-~~~~~Ei~iL~~L~HPNIVkL~~~~~~-~~~ 260 (774)
...|+++.+||+|.||.||+|....++ +.||||.++...+..++ ....+|+.+++.|+||||+.|..+|.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 457999999999999999999654432 36999999765433333 346799999999999999999999976 889
Q ss_pred EEEEEEecCCCchhhhhhcc----CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC----CcEEEeecc
Q 004088 261 LWIVMEYCGGGSVADLMNVT----EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ----GEVKLGDFG 332 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~----~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~----g~vKL~DFG 332 (774)
+||++||.+. +|+.+++.. .+.++...++.|+.||+.|+.|||++-|+||||||.||||..+ |.|||+|||
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999999965 788887632 2468999999999999999999999999999999999999988 899999999
Q ss_pred ccccccccccc---cccccccccccchhhhhhcC-CCCccchhhhHHHHHHHHhCCCCCCCCCc------------hhhh
Q 004088 333 VAAQLTRTMSK---RNTFIGTPHWMAPEVIQESR-YDGKVDVWALGVSAVEMAEGLPPRSTVHP------------MRVL 396 (774)
Q Consensus 333 lA~~i~~~~~~---~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGviLyELLtG~~Pf~~~~~------------~~~i 396 (774)
+|+.+...... ....+-|.||+|||++.+.+ |+.++||||+|||+.||++-.|.|.+... ...+
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 99988765443 23457799999999998764 99999999999999999998887765321 1122
Q ss_pred hhhhcCCCC-ccccc---hh---------------------------chHHHHHHHHhhcccCCCCCCCHHHHHhhhhhh
Q 004088 397 FMISIEPAP-MLEDK---EK---------------------------WSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445 (774)
Q Consensus 397 ~~i~~~~~~-~~~~~---~~---------------------------~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~ 445 (774)
+.+...+.. .++.. +. -++...+|+.+||.+||.+|.|+.++|+|+||.
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~ 341 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT 341 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence 222211110 00000 00 023366999999999999999999999999998
Q ss_pred hhc
Q 004088 446 RCK 448 (774)
Q Consensus 446 ~~~ 448 (774)
.-+
T Consensus 342 ~d~ 344 (438)
T KOG0666|consen 342 EDP 344 (438)
T ss_pred cCC
Confidence 653
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=330.13 Aligned_cols=239 Identities=20% Similarity=0.326 Sum_probs=194.4
Q ss_pred eeeeccCceEEEEEEEcCCCc-------EEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 194 NELGKGSYGAVYKARDLKTSE-------LVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~-------~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
+.||.|+||.||+|.+...+. .||+|++... .....+.+.+|+.+|+.+.||||+++++++..+...++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch-hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 369999999999999765443 4888887532 23445678899999999999999999999999899999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCc--------EEEeecccccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE--------VKLGDFGVAAQLT 338 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~--------vKL~DFGlA~~i~ 338 (774)
||.+|+|..++......+++..+..++.||+.||.|||++||+||||||+|||++.++. ++++|||++....
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 99999999999766667899999999999999999999999999999999999987764 6999999986543
Q ss_pred ccccccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhC-CCCCCCCCchhhhhhhhcCCCCccccchhchHH
Q 004088 339 RTMSKRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEG-LPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLV 416 (774)
Q Consensus 339 ~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG-~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~ 416 (774)
. .....+++.|+|||++.+. .++.++|||||||++|+|++| .+||................ ..+...+..
T Consensus 160 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 231 (258)
T cd05078 160 P----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRH----QLPAPKWTE 231 (258)
T ss_pred C----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccc----cCCCCCcHH
Confidence 2 2334688999999999864 588999999999999999998 56766555443322211111 112233467
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 417 FHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 417 l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
+.+||.+||+.+|.+|||+.++++.
T Consensus 232 ~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 232 LANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHhccChhhCCCHHHHHHh
Confidence 8999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=324.65 Aligned_cols=251 Identities=29% Similarity=0.518 Sum_probs=208.2
Q ss_pred CeeEEeeeeccCceEEEEEEEcC-CCcEEEEEEeecCC---------ChhhHHHHHHHHHHHHh-CCCCCcccccccccC
Q 004088 189 KYELLNELGKGSYGAVYKARDLK-TSELVAIKVISLSE---------GEEGYEEIRGEIEMLQQ-CSHPNVVRYLGSYQG 257 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~-~g~~VAVKvi~~~~---------~~~~~~~~~~Ei~iL~~-L~HPNIVkL~~~~~~ 257 (774)
.|++.+.||+|+||.||+|.+.. .++.||||.+.... .......+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999877 68899999885321 22344567789998875 799999999999999
Q ss_pred CceEEEEEEecCCCchhhhhhc---cCCchhHHHHHHHHHHHHHHHHHHHh-cCcccccccccceEecCCCcEEEeeccc
Q 004088 258 EEYLWIVMEYCGGGSVADLMNV---TEEPLEEYQIAYICREALKGLAYLHS-IFKVHRDIKGGNILLTDQGEVKLGDFGV 333 (774)
Q Consensus 258 ~~~l~LVmEy~~ggsL~dll~~---~~~~Lse~~i~~I~~QIl~gL~YLHs-~gIIHRDLKPeNILLd~~g~vKL~DFGl 333 (774)
+...|+||||+++++|.+++.. ....+++..++.++.|++.||.|||. .||+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988742 34578999999999999999999996 7899999999999999999999999999
Q ss_pred cccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhc
Q 004088 334 AAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKW 413 (774)
Q Consensus 334 A~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~ 413 (774)
+....... ......|+..|+|||++.+..++.++|||||||++|+|++|++||...........+........ ....+
T Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 238 (269)
T cd08528 161 AKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL-PEGMY 238 (269)
T ss_pred eeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC-CcccC
Confidence 97654432 23345789999999999988899999999999999999999999987665544433322221111 12356
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 414 SLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 414 s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
+..+.+||.+||+.||.+||++.|+..+
T Consensus 239 ~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 239 SEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 7889999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=343.91 Aligned_cols=258 Identities=31% Similarity=0.423 Sum_probs=212.5
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCC--CC----cccccccccC
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSH--PN----VVRYLGSYQG 257 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~H--PN----IVkL~~~~~~ 257 (774)
....++|.+++++|+|.||.|-.|.+..++..||||+++ ......+..+-|+++|++|.+ |+ +|++.+||.-
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik--~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK--NVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHH--HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 344789999999999999999999999999999999985 344556677889999999943 32 7899999999
Q ss_pred CceEEEEEEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC--------------
Q 004088 258 EEYLWIVMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD-------------- 322 (774)
Q Consensus 258 ~~~l~LVmEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~-------------- 322 (774)
.++.|||+|.+ |-++.+++..+ ..+++..+++.|..||+.+++|||+.+++|-||||+|||+.+
T Consensus 163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccc
Confidence 99999999999 77999999753 467999999999999999999999999999999999999952
Q ss_pred ------CCcEEEeeccccccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhh
Q 004088 323 ------QGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVL 396 (774)
Q Consensus 323 ------~g~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i 396 (774)
+..|+|+|||.|...... ..+.+.|..|+|||++.+..|+.++||||+||||+||.+|...|...++.+.+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL 318 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL 318 (415)
T ss_pred eeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence 234899999999764433 36678999999999999999999999999999999999999999877755533
Q ss_pred hh---hhcCCCCccc-cch-----------h-----------------------------chHHHHHHHHhhcccCCCCC
Q 004088 397 FM---ISIEPAPMLE-DKE-----------K-----------------------------WSLVFHDFVAKCLTKEPRAR 432 (774)
Q Consensus 397 ~~---i~~~~~~~~~-~~~-----------~-----------------------------~s~~l~dLI~kcL~~DP~kR 432 (774)
.+ +.. +.|... ... . --..+.|||++||..||.+|
T Consensus 319 aMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 319 AMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 22 211 111100 000 0 01236799999999999999
Q ss_pred CCHHHHHhhhhhhhhc
Q 004088 433 PTAAEMLKHKFIERCK 448 (774)
Q Consensus 433 PTa~ElL~HPwf~~~~ 448 (774)
+|+.|+|.||||+..+
T Consensus 398 iTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 398 ITLREALSHPFFARLT 413 (415)
T ss_pred ccHHHHhcCHHhhcCC
Confidence 9999999999998653
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=375.46 Aligned_cols=254 Identities=26% Similarity=0.448 Sum_probs=224.4
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCC-C----cEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCc
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKT-S----ELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE 259 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~-g----~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~ 259 (774)
.+...-++++.||+|+||.||.|..... | ..||||.++.....+...+|.+|..+|+.++|||||+++|++....
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 4567788999999999999999986542 2 3499999987777888899999999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhcc------CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVT------EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGV 333 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~------~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGl 333 (774)
..+|++|||++|+|..+|+.. ...++...+..++.||++|+.||+++++|||||..+|+||+....|||+|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999999876 56799999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccc--ccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccc
Q 004088 334 AAQLTRTMSKRNT--FIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDK 410 (774)
Q Consensus 334 A~~i~~~~~~~~~--~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~ 410 (774)
|+.+......+.. ..-...|||||.+....|+.|+|||||||++||+++ |..||...++.++........ .+..+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg--RL~~P 926 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG--RLDPP 926 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC--ccCCC
Confidence 9966554322221 234578999999999999999999999999999995 899999999988877554443 56777
Q ss_pred hhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 411 EKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 411 ~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
..++..+.++|..||+.+|++||++..|++
T Consensus 927 ~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 927 SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 888999999999999999999999999986
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=330.60 Aligned_cols=238 Identities=21% Similarity=0.302 Sum_probs=191.6
Q ss_pred eeeccCceEEEEEEEcCC------------------------CcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCccc
Q 004088 195 ELGKGSYGAVYKARDLKT------------------------SELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVR 250 (774)
Q Consensus 195 ~LG~G~FG~Vy~a~d~~~------------------------g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVk 250 (774)
+||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 699999999999975321 2458999885432 233456888999999999999999
Q ss_pred ccccccCCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC------
Q 004088 251 YLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG------ 324 (774)
Q Consensus 251 L~~~~~~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g------ 324 (774)
+++++......|+|||||++++|..++......+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~ 160 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS 160 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence 99999999999999999999999999876667889999999999999999999999999999999999998654
Q ss_pred -cEEEeeccccccccccccccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHH-hCCCCCCCCCchhhhhhhhc
Q 004088 325 -EVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMA-EGLPPRSTVHPMRVLFMISI 401 (774)
Q Consensus 325 -~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELL-tG~~Pf~~~~~~~~i~~i~~ 401 (774)
.+||+|||++...... ....++..|+|||++.+ ..++.++|||||||++|||+ +|..||..............
T Consensus 161 ~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 236 (274)
T cd05076 161 PFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEK 236 (274)
T ss_pred ceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHh
Confidence 3899999988544222 22357888999999875 56899999999999999984 79999977654433222111
Q ss_pred CCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 402 EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 402 ~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
... .+......+.++|.+||+.+|.+||++.++|++
T Consensus 237 ~~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 237 KHR----LPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred ccC----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 111 112234678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=345.07 Aligned_cols=257 Identities=31% Similarity=0.489 Sum_probs=204.0
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-----CC---Cccccccccc-
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-----HP---NVVRYLGSYQ- 256 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-----HP---NIVkL~~~~~- 256 (774)
..++|.+.++||+|.|++||+|.+..+.++||+|+.+ ......+....||++|++++ |+ +||+|++.|.
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK--SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK--SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEe--hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 3579999999999999999999999999999999986 44566678899999999983 33 6999999996
Q ss_pred ---CCceEEEEEEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhc-CcccccccccceEec----------
Q 004088 257 ---GEEYLWIVMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSI-FKVHRDIKGGNILLT---------- 321 (774)
Q Consensus 257 ---~~~~l~LVmEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~-gIIHRDLKPeNILLd---------- 321 (774)
++.++|||+|++ |.+|..+|... -+.++...++.|++||+.||.|||+. ||||.||||+|||+.
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhh
Confidence 677999999999 66777776543 46799999999999999999999975 899999999999984
Q ss_pred --------------------------------------------------------------------------------
Q 004088 322 -------------------------------------------------------------------------------- 321 (774)
Q Consensus 322 -------------------------------------------------------------------------------- 321 (774)
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence
Q ss_pred ------------------------CC----------------------------------------------------Cc
Q 004088 322 ------------------------DQ----------------------------------------------------GE 325 (774)
Q Consensus 322 ------------------------~~----------------------------------------------------g~ 325 (774)
.. -.
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 00 02
Q ss_pred EEEeeccccccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCc------hhhh-hh
Q 004088 326 VKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHP------MRVL-FM 398 (774)
Q Consensus 326 vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~------~~~i-~~ 398 (774)
|||+|||.|+++..+.+. -+.|..|+||||+.+..|+..+||||++|++|||+||-..|..... ...+ .+
T Consensus 393 vKIaDlGNACW~~khFT~---DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i 469 (590)
T KOG1290|consen 393 VKIADLGNACWVHKHFTE---DIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI 469 (590)
T ss_pred EEEeeccchhhhhhhhch---hhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence 799999999887665433 3689999999999999999999999999999999999776653211 1111 00
Q ss_pred h--hc-----------------------------CCCC---ccccchhch----HHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 399 I--SI-----------------------------EPAP---MLEDKEKWS----LVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 399 i--~~-----------------------------~~~~---~~~~~~~~s----~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
+ .. .+.+ .+.++..|+ ..+.+|+.-||+.+|++||||.++|+
T Consensus 470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 0 00 0000 011122232 45789999999999999999999999
Q ss_pred hhhhhhhc
Q 004088 441 HKFIERCK 448 (774)
Q Consensus 441 HPwf~~~~ 448 (774)
|||+....
T Consensus 550 hPwLn~~~ 557 (590)
T KOG1290|consen 550 HPWLNPVA 557 (590)
T ss_pred CccccCCC
Confidence 99998654
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=323.73 Aligned_cols=246 Identities=22% Similarity=0.355 Sum_probs=193.3
Q ss_pred eeeeccCceEEEEEEEcCC--CcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCCC
Q 004088 194 NELGKGSYGAVYKARDLKT--SELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGG 271 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~--g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~gg 271 (774)
++||+|+||.||+++.... ...+++|.+.........+.+.+|+.+++.++||||++++++|......|+|||||+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975433 33567777765444455678999999999999999999999999999999999999999
Q ss_pred chhhhhhcc---CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc--cccccc
Q 004088 272 SVADLMNVT---EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT--MSKRNT 346 (774)
Q Consensus 272 sL~dll~~~---~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~--~~~~~~ 346 (774)
+|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++...... ......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 999988643 234677788899999999999999999999999999999999999999999998543221 112234
Q ss_pred ccccccccchhhhhh-------cCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCc---cccchhchH
Q 004088 347 FIGTPHWMAPEVIQE-------SRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPM---LEDKEKWSL 415 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~-------~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~---~~~~~~~s~ 415 (774)
.+|+..|+|||++.. ..++.++|||||||++|||++ |.+||........+..+....... ......++.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSE 240 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcH
Confidence 568899999999853 245789999999999999996 577887666554444332221111 111234678
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 416 VFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 416 ~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
.+.+++..|| .+|.+||++.+|++
T Consensus 241 ~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 241 RWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHHHHHHh-hCcccCCCHHHHHH
Confidence 8999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=320.04 Aligned_cols=243 Identities=26% Similarity=0.405 Sum_probs=202.6
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
..+|++.+.||+|+||.||++. .+++.||+|++.... ....+.+|+.++++++||||+++++++..+ ..|+|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 3579999999999999999986 478889999985432 235788999999999999999999998654 4799999
Q ss_pred ecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 267 YCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 267 y~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
|+.+++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++...... ..
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---~~ 155 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---VD 155 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---CC
Confidence 999999999986443 45899999999999999999999999999999999999999999999999998654322 12
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
....+..|+|||++.+..++.++|||||||++|+|++ |++||...........+...... .....++..+.++|.+|
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~ 233 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM--EPPEGCPADVYVLMTSC 233 (254)
T ss_pred CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCC--CCCCcCCHHHHHHHHHH
Confidence 2234678999999988889999999999999999997 99999877665544443332211 12345678899999999
Q ss_pred cccCCCCCCCHHHHHh
Q 004088 425 LTKEPRARPTAAEMLK 440 (774)
Q Consensus 425 L~~DP~kRPTa~ElL~ 440 (774)
|+.+|.+||++.+++.
T Consensus 234 l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 234 WETEPKKRPSFHKLRE 249 (254)
T ss_pred cCCChhhCcCHHHHHH
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=320.92 Aligned_cols=229 Identities=22% Similarity=0.220 Sum_probs=191.4
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCCCchhhhhh
Q 004088 199 GSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN 278 (774)
Q Consensus 199 G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~ggsL~dll~ 278 (774)
|.||.||++++..+++.||+|++.... ...+|...+....||||+++++++......|+||||+++++|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999999999999999986532 23345556666789999999999999999999999999999999886
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccccccccccchhh
Q 004088 279 VTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEV 358 (774)
Q Consensus 279 ~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEv 358 (774)
. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..+.... ....++..|+|||.
T Consensus 78 ~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~y~aPE~ 153 (237)
T cd05576 78 K-FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENMYCAPEV 153 (237)
T ss_pred H-hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCccccCCcc
Confidence 3 3468999999999999999999999999999999999999999999999999886654432 23356788999999
Q ss_pred hhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCH---
Q 004088 359 IQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTA--- 435 (774)
Q Consensus 359 l~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa--- 435 (774)
+....++.++||||+||++|+|++|..|+....... . .......+..++..+.+||.+||+.||.+||++
T Consensus 154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-N------THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-c------cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCcc
Confidence 988889999999999999999999998875432110 0 001112234567889999999999999999986
Q ss_pred --HHHHhhhhh
Q 004088 436 --AEMLKHKFI 444 (774)
Q Consensus 436 --~ElL~HPwf 444 (774)
.++++||||
T Consensus 227 ~~~~~~~h~~~ 237 (237)
T cd05576 227 GVEDIKSHPFF 237 (237)
T ss_pred chHHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=326.21 Aligned_cols=256 Identities=16% Similarity=0.194 Sum_probs=191.3
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcCC---CcEEEEEEeecCCChhhHH----------HHHHHHHHHHhCCCCCcc
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLKT---SELVAIKVISLSEGEEGYE----------EIRGEIEMLQQCSHPNVV 249 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~---g~~VAVKvi~~~~~~~~~~----------~~~~Ei~iL~~L~HPNIV 249 (774)
.+....+|++.++||+|+||+||+|.+..+ +..+|+|+..........+ ....+...+..+.|+||+
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 344567999999999999999999998777 6778888754332211111 122334455667899999
Q ss_pred cccccccCCc----eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCc
Q 004088 250 RYLGSYQGEE----YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE 325 (774)
Q Consensus 250 kL~~~~~~~~----~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~ 325 (774)
++++++.... ..+++++++. .++.+++.. ....++..++.++.||+.||.|||+++|+||||||+|||++.++.
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhc-cCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc
Confidence 9998765332 4578899884 466666542 234678889999999999999999999999999999999999999
Q ss_pred EEEeeccccccccccc-------cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCc-hhhhh
Q 004088 326 VKLGDFGVAAQLTRTM-------SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHP-MRVLF 397 (774)
Q Consensus 326 vKL~DFGlA~~i~~~~-------~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~-~~~i~ 397 (774)
++|+|||+|+.+.... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||..... ...+.
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 9999999997664321 112234699999999999999999999999999999999999999987632 22111
Q ss_pred hhh----cCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 398 MIS----IEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 398 ~i~----~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
... .............+..+.+++..||..+|++||++.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 245 AAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 100 0000000112334678999999999999999999999875
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=319.29 Aligned_cols=250 Identities=22% Similarity=0.377 Sum_probs=201.5
Q ss_pred eeEEeeeeccCceEEEEEEEcC---CCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCc------
Q 004088 190 YELLNELGKGSYGAVYKARDLK---TSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE------ 259 (774)
Q Consensus 190 Y~ilk~LG~G~FG~Vy~a~d~~---~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~------ 259 (774)
|++.+.||+|+||.||+|.+.. +++.||||++.... .....+.+.+|+++|++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6788999999999999998643 57899999986433 3345677889999999999999999999875432
Q ss_pred eEEEEEEecCCCchhhhhhcc-----CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVT-----EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA 334 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~-----~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA 334 (774)
..+++++|+.+++|..++... ...+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 347899999999998776421 235788999999999999999999999999999999999999999999999999
Q ss_pred cccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccch
Q 004088 335 AQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKE 411 (774)
Q Consensus 335 ~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~ 411 (774)
+.+..... ......+++.|++||.+....++.++|||||||++|+|++ |++||...........+..... .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~ 238 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR--LKQPP 238 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc--CCCCC
Confidence 76543211 1122345678999999998889999999999999999998 8999987665544333322211 12223
Q ss_pred hchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 412 KWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 412 ~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
..+..+.+++.+||+.+|.+||++.+++++
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 567789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=368.77 Aligned_cols=255 Identities=32% Similarity=0.531 Sum_probs=199.3
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccC---------
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG--------- 257 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~--------- 257 (774)
.++|+.++.||+||||.||+++++-+|+.||||+|...........+.+|+.+|.+|+|||||++|..|.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 35789999999999999999999999999999999877666677889999999999999999998732100
Q ss_pred --------------------------------------------------------------------------------
Q 004088 258 -------------------------------------------------------------------------------- 257 (774)
Q Consensus 258 -------------------------------------------------------------------------------- 257 (774)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred ----------------------C--------ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcC
Q 004088 258 ----------------------E--------EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307 (774)
Q Consensus 258 ----------------------~--------~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~g 307 (774)
+ ..+||-||||+..+|.++++.+...-.....++++++|++||.|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 2378999999998888888644322256788999999999999999999
Q ss_pred cccccccccceEecCCCcEEEeecccccccc---c---------------cccccccccccccccchhhhhhc---CCCC
Q 004088 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQLT---R---------------TMSKRNTFIGTPHWMAPEVIQES---RYDG 366 (774)
Q Consensus 308 IIHRDLKPeNILLd~~g~vKL~DFGlA~~i~---~---------------~~~~~~~~~GT~~Y~APEvl~~~---~~s~ 366 (774)
||||||||.||+++.++.|||+|||+|.... . .....+..+||.-|+|||++.+. .|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999997621 0 01123456899999999999765 4999
Q ss_pred ccchhhhHHHHHHHHhCCCCCCCC-CchhhhhhhhcCCCCccc--cchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhh
Q 004088 367 KVDVWALGVSAVEMAEGLPPRSTV-HPMRVLFMISIEPAPMLE--DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKF 443 (774)
Q Consensus 367 ksDIWSLGviLyELLtG~~Pf~~~-~~~~~i~~i~~~~~~~~~--~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPw 443 (774)
|+||||||||++||+. ||... .....+..+.....|... ..... +.-..+|++||+.||.+||||.|+|++.|
T Consensus 798 KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~-~~e~slI~~Ll~hdP~kRPtA~eLL~s~l 873 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEH-PEEASLIRWLLSHDPSKRPTATELLNSEL 873 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccc-hHHHHHHHHHhcCCCccCCCHHHHhhccC
Confidence 9999999999999984 45432 222222222211111110 11111 23458999999999999999999999999
Q ss_pred hh
Q 004088 444 IE 445 (774)
Q Consensus 444 f~ 445 (774)
|-
T Consensus 874 lp 875 (1351)
T KOG1035|consen 874 LP 875 (1351)
T ss_pred CC
Confidence 85
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=347.69 Aligned_cols=244 Identities=30% Similarity=0.408 Sum_probs=206.7
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~LV 264 (774)
....|.+...+|.|+|+.|-.|.+..+++.+++|++.+.. .+..+|+.++... +||||++++++|.+..+.|+|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 4678999999999999999999999999999999997652 2234677665554 799999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEe-cCCCcEEEeeccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL-TDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILL-d~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
||++.|+.|.+.+.... .+. .++..|+++|+.|+.|||++|||||||||+|||+ +..++++|+|||.++.....
T Consensus 395 ~e~l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred ehhccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 99999998888775332 233 7888899999999999999999999999999999 58899999999999876554
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCch-hhhhhhhcCCCCccccchhchHHHHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPM-RVLFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~-~~i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
..+.+=|..|.|||++....|+.++||||||++||+||+|+.||...... ++...+.. . .....+|..+++||.
T Consensus 470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~--~---~~s~~vS~~AKdLl~ 544 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQM--P---KFSECVSDEAKDLLQ 544 (612)
T ss_pred hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcC--C---ccccccCHHHHHHHH
Confidence 23345688999999999999999999999999999999999999765444 22222211 1 122678999999999
Q ss_pred hhcccCCCCCCCHHHHHhhhhh
Q 004088 423 KCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~HPwf 444 (774)
+||+.||.+|+++.+++.||||
T Consensus 545 ~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 545 QLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HhccCChhhCcChhhhccCcch
Confidence 9999999999999999999999
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=301.18 Aligned_cols=243 Identities=42% Similarity=0.646 Sum_probs=204.1
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCCCchhhhhhc
Q 004088 200 SYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNV 279 (774)
Q Consensus 200 ~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~ggsL~dll~~ 279 (774)
+||.||+|.+..+++.||+|++.........+.+.+|++++++++|+||+++++++......++||||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999998889999999987544333267899999999999999999999999999999999999999999998864
Q ss_pred cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccccccccccchhhh
Q 004088 280 TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVI 359 (774)
Q Consensus 280 ~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl 359 (774)
.. .+++..+..++.+++.+|.|||+.+|+|+||+|.||+++.++.++|+|||.+....... ......++..|++||.+
T Consensus 81 ~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 81 RG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEVL 158 (244)
T ss_pred cc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHHH
Confidence 33 38899999999999999999999999999999999999999999999999997765432 33445789999999999
Q ss_pred hhcCCCCccchhhhHHHHHHHHhCCCCCCCC-CchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHH
Q 004088 360 QESRYDGKVDVWALGVSAVEMAEGLPPRSTV-HPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEM 438 (774)
Q Consensus 360 ~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~-~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~El 438 (774)
....++.++||||||+++|+|++|..||... ......................++..+.+++.+||..+|.+||++.++
T Consensus 159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~ 238 (244)
T smart00220 159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEA 238 (244)
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHH
Confidence 9888999999999999999999999999873 333333222222222111111267889999999999999999999999
Q ss_pred Hhhhhh
Q 004088 439 LKHKFI 444 (774)
Q Consensus 439 L~HPwf 444 (774)
++||||
T Consensus 239 ~~~~~~ 244 (244)
T smart00220 239 LQHPFF 244 (244)
T ss_pred hhCCCC
Confidence 999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=343.16 Aligned_cols=260 Identities=25% Similarity=0.424 Sum_probs=218.2
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
...-|..++.||-|+||.|.++....+...||+|.+++.. .......++.|-.||..-..+-||+||..|.+.+.+|+
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence 3456899999999999999999988899999999997654 23345668889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc----
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR---- 339 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~---- 339 (774)
||+|++||++-.+|- ..+-|.|..++.++..+.+|+++.|.+|+|||||||+|||||.+|++||.|||+|.-+.-
T Consensus 707 VMdYIPGGDmMSLLI-rmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLI-RMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EEeccCCccHHHHHH-HhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 999999999998874 557899999999999999999999999999999999999999999999999999953210
Q ss_pred ----cccc----------------------------------cccccccccccchhhhhhcCCCCccchhhhHHHHHHHH
Q 004088 340 ----TMSK----------------------------------RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMA 381 (774)
Q Consensus 340 ----~~~~----------------------------------~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELL 381 (774)
...+ ....+||+.|+|||++....|+..+|+||.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 0000 01257999999999999999999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhh-hcCCCCccccchhchHHHHHHHHhhcccCCCCCC---CHHHHHhhhhhhhh
Q 004088 382 EGLPPRSTVHPMRVLFMI-SIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARP---TAAEMLKHKFIERC 447 (774)
Q Consensus 382 tG~~Pf~~~~~~~~i~~i-~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRP---Ta~ElL~HPwf~~~ 447 (774)
.|++||....+.+....+ .+...-.+....+++.++.++|.+++ ..++.|. .+++|..||||+.+
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred hCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCcccccc
Confidence 999999987776655443 33333334445678999999998866 4678886 47789999999854
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=336.82 Aligned_cols=253 Identities=28% Similarity=0.422 Sum_probs=218.3
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcC--CC--cEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCce
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLK--TS--ELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEY 260 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~--~g--~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~ 260 (774)
.......+.++||.|.||.||+|.... .| --||||..+........+.|..|..+|+.++|||||+|+|+|. +..
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQP 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-ccc
Confidence 333444556789999999999998632 23 3489999887677777899999999999999999999999986 457
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
.|||||+++-|.|..+++.++..|+...+..++.||+.||.|||+..+|||||...|||+.....|||+|||+++.+...
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 89999999999999999988899999999999999999999999999999999999999999999999999999988765
Q ss_pred cccccc-ccccccccchhhhhhcCCCCccchhhhHHHHHHHH-hCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 341 MSKRNT-FIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMA-EGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 341 ~~~~~~-~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELL-tG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
.....+ ..-+..|||||-+...+++.++|||-|||+|||++ .|..||.+..+.+++..+.... .++.++.+++.+.
T Consensus 545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGe--RlP~P~nCPp~LY 622 (974)
T KOG4257|consen 545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGE--RLPCPPNCPPALY 622 (974)
T ss_pred chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCC--CCCCCCCCChHHH
Confidence 433222 22356899999999999999999999999999977 6999999998888877665443 3455678899999
Q ss_pred HHHHhhcccCCCCCCCHHHHHh
Q 004088 419 DFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
.|+.+||.++|.+||++.++..
T Consensus 623 slmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 623 SLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHHHHhccCcccCCcHHHHHH
Confidence 9999999999999999999864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=320.96 Aligned_cols=262 Identities=28% Similarity=0.429 Sum_probs=211.2
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccC-------
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG------- 257 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~------- 257 (774)
..+.|+-+.+||+|.||.||+|+...+|+.||+|++-... ....-....+|+++|..|.|+|++.+++.|..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 3567888999999999999999999999999999765433 22223457899999999999999999998852
Q ss_pred -CceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccc
Q 004088 258 -EEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQ 336 (774)
Q Consensus 258 -~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~ 336 (774)
...+|+||.+|+ .+|..++.....+++..+++.++.++..||.|+|+..|+|||+|+.|+||+.+|.+||+|||+++.
T Consensus 95 ~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 235899999995 589999877778899999999999999999999999999999999999999999999999999987
Q ss_pred ccccccc----cccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-------CC
Q 004088 337 LTRTMSK----RNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-------PA 404 (774)
Q Consensus 337 i~~~~~~----~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-------~~ 404 (774)
+...... ....+-|.+|++||.+.+. .|+++.|||+.||||.||.++.+-+.+......+..|... -.
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 6543211 2234569999999999875 5999999999999999999999988877665554433210 00
Q ss_pred Cc--------------ccc--chh---------chHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 405 PM--------------LED--KEK---------WSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 405 ~~--------------~~~--~~~---------~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
|. +.. ... -.+...+|+.++|..||.+|+++.++|+|.||..-+
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 00 000 000 134577999999999999999999999999997543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=340.20 Aligned_cols=260 Identities=25% Similarity=0.429 Sum_probs=221.6
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
.+.+.....+.++||+|.||.|.+|+ ...+.+||||.++..........|.+|+++|.+|+|||||.|+++|..++.+|
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEE-ecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 35667788999999999999999998 45679999999987666677789999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCch-hHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPL-EEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~L-se~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|||||+++|+|.+++..+..+. .......|+.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++.+....
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 9999999999999997664433 555667799999999999999999999999999999999999999999999765543
Q ss_pred ccc--ccccccccccchhhhhhcCCCCccchhhhHHHHHHHH--hCCCCCCCCCchhhhhhhhc-----CCCCccccchh
Q 004088 342 SKR--NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMA--EGLPPRSTVHPMRVLFMISI-----EPAPMLEDKEK 412 (774)
Q Consensus 342 ~~~--~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELL--tG~~Pf~~~~~~~~i~~i~~-----~~~~~~~~~~~ 412 (774)
..+ ...+-+.+|||||.+...+++.++|+|+||+++||++ +...||........+..... .....+..+..
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~ 771 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPA 771 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCc
Confidence 332 2345678999999999999999999999999999976 67889998887776654321 12234456677
Q ss_pred chHHHHHHHHhhcccCCCCCCCHHHHHhhhhhh
Q 004088 413 WSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445 (774)
Q Consensus 413 ~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~ 445 (774)
++..+.++|.+||..+-++||+++++ |.+|.
T Consensus 772 cp~~lyelml~Cw~~es~~RPsFe~l--h~~lq 802 (807)
T KOG1094|consen 772 CPQGLYELMLRCWRRESEQRPSFEQL--HLFLQ 802 (807)
T ss_pred CcHHHHHHHHHHhchhhhcCCCHHHH--HHHHH
Confidence 88899999999999999999999998 44443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=319.99 Aligned_cols=263 Identities=29% Similarity=0.463 Sum_probs=223.1
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhC-CCCCcccccccccCCce
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEY 260 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~ 260 (774)
.....+|.+++.||+|+|++|.+++.+.+.+.||+|++++.- ..+.+.-++.|..+..+. +||.+|-|+.+|..+.+
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 344578999999999999999999999999999999997542 344455677888888776 79999999999999999
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
+++|.||++||+|--+++ ..++++|..++.+...|+.||.|||+.|||+||||.+|+|++.+|++||.|+|+++.-...
T Consensus 326 lffvieyv~ggdlmfhmq-rqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEEEEecCcceeeehh-hhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 999999999999987775 5678999999999999999999999999999999999999999999999999999876666
Q ss_pred ccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCC-------CchhhhhhhhcCCCCccccchhc
Q 004088 341 MSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTV-------HPMRVLFMISIEPAPMLEDKEKW 413 (774)
Q Consensus 341 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~-------~~~~~i~~i~~~~~~~~~~~~~~ 413 (774)
.....++||||.|+|||++.+..|...+|+|+|||+|+||+.|+.||.-. +....++.+..... ...+..+
T Consensus 405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq--iriprsl 482 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ--IRIPRSL 482 (593)
T ss_pred CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc--cccccee
Confidence 67778899999999999999999999999999999999999999999732 12223333322211 2234455
Q ss_pred hHHHHHHHHhhcccCCCCCC------CHHHHHhhhhhhhhcc
Q 004088 414 SLVFHDFVAKCLTKEPRARP------TAAEMLKHKFIERCKC 449 (774)
Q Consensus 414 s~~l~dLI~kcL~~DP~kRP------Ta~ElL~HPwf~~~~~ 449 (774)
+..+..+++..|.+||.+|. .+.++..|+||+.+.+
T Consensus 483 svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw 524 (593)
T KOG0695|consen 483 SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW 524 (593)
T ss_pred ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence 66677899999999999995 4789999999986543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=321.97 Aligned_cols=264 Identities=30% Similarity=0.495 Sum_probs=219.6
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHh-CCCCCcccccccccCCceE
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQ-CSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~-L~HPNIVkL~~~~~~~~~l 261 (774)
.+......+-+..||.|+||+|++..++.+|+..|||.|+.........+++.|.....+ -+.||||++||.+..++..
T Consensus 59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc 138 (361)
T KOG1006|consen 59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC 138 (361)
T ss_pred cccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence 344455666778999999999999999999999999999877766777888899876544 4789999999999999999
Q ss_pred EEEEEecCCCchhhhhh----ccCCchhHHHHHHHHHHHHHHHHHHHh-cCcccccccccceEecCCCcEEEeecccccc
Q 004088 262 WIVMEYCGGGSVADLMN----VTEEPLEEYQIAYICREALKGLAYLHS-IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQ 336 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~----~~~~~Lse~~i~~I~~QIl~gL~YLHs-~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~ 336 (774)
||.||+| ..+|..+.. ..+..++|..+-.|....+.||.||.. +.|||||+||+|||++..|.+||||||.+..
T Consensus 139 WiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 139 WICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ 217 (361)
T ss_pred eeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHh
Confidence 9999999 557665543 235679999999999999999999985 6799999999999999999999999999988
Q ss_pred ccccccccccccccccccchhhhh--hcCCCCccchhhhHHHHHHHHhCCCCCCCCCc-hhhhhhhhcCCCCccccchh-
Q 004088 337 LTRTMSKRNTFIGTPHWMAPEVIQ--ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHP-MRVLFMISIEPAPMLEDKEK- 412 (774)
Q Consensus 337 i~~~~~~~~~~~GT~~Y~APEvl~--~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~-~~~i~~i~~~~~~~~~~~~~- 412 (774)
+....... .-.|...|||||.+. +..|+.++|+||||++|||+.+|..||..++. .+.+..+.....|.+.....
T Consensus 218 Lv~SiAkT-~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~ 296 (361)
T KOG1006|consen 218 LVDSIAKT-VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKEC 296 (361)
T ss_pred HHHHHHhh-hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccc
Confidence 76653332 236899999999985 34599999999999999999999999987654 44444455555554444433
Q ss_pred --chHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 413 --WSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 413 --~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
++..+..||.-||.+|-..||...+++++||++...
T Consensus 297 ~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 297 VHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred cccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 788999999999999999999999999999998653
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=348.63 Aligned_cols=256 Identities=24% Similarity=0.388 Sum_probs=227.9
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCc---EEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCce
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSE---LVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEY 260 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~---~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~ 260 (774)
++..+...|.+.||.|.||.||+|+.+..|+ .||||.++.........+|+.|+.||-++.||||++|.|+......
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 4455677889999999999999999876664 6999999877777788899999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
..||+|||++|+|..+|+.+.+.|+.-++.-+++.|+.||.||-++|+|||||...||||+.+-.+|++|||+++.+.+.
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999987655
Q ss_pred cccccc-ccc--cccccchhhhhhcCCCCccchhhhHHHHHHHH-hCCCCCCCCCchhhhhhhhcCCCCccccchhchHH
Q 004088 341 MSKRNT-FIG--TPHWMAPEVIQESRYDGKVDVWALGVSAVEMA-EGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLV 416 (774)
Q Consensus 341 ~~~~~~-~~G--T~~Y~APEvl~~~~~s~ksDIWSLGviLyELL-tG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~ 416 (774)
.....+ .-| +.+|.|||.+...+++.++||||+||+|||.+ .|..||.++.+.+++..+.... .++.+..++..
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy--RLPpPmDCP~a 862 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY--RLPPPMDCPAA 862 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc--CCCCCCCCcHH
Confidence 422222 212 46899999999999999999999999999965 7999999999999888775543 34556678899
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 417 FHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 417 l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
+..||..||++|-.+||.+.||+.+
T Consensus 863 L~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 863 LYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 9999999999999999999999875
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=341.47 Aligned_cols=205 Identities=33% Similarity=0.532 Sum_probs=180.3
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCc------eE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE------YL 261 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~------~l 261 (774)
.-|..-+.||+|+||.||+++++.+|+.||||.++........+..-+|+++|++|+|||||+++++-+... ..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 567778899999999999999999999999999986555556677889999999999999999999876543 56
Q ss_pred EEEEEecCCCchhhhhhcc--CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC--CC--cEEEeeccccc
Q 004088 262 WIVMEYCGGGSVADLMNVT--EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD--QG--EVKLGDFGVAA 335 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~--~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~--~g--~vKL~DFGlA~ 335 (774)
.+|||||.||+|..+++.. ...|++.++..++.+++.||.|||++|||||||||.||++-. +| .-||+|||.|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 8999999999999999743 357999999999999999999999999999999999999853 24 36999999999
Q ss_pred cccccccccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCch
Q 004088 336 QLTRTMSKRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPM 393 (774)
Q Consensus 336 ~i~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~ 393 (774)
.+.+. ....+++||+.|.+||++.. ..|+..+|.|||||++|+++||..||-.....
T Consensus 173 el~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 173 ELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 88765 46677899999999999985 78999999999999999999999998754443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=331.46 Aligned_cols=256 Identities=26% Similarity=0.398 Sum_probs=222.3
Q ss_pred CcccCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCc
Q 004088 180 SVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE 259 (774)
Q Consensus 180 ~~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~ 259 (774)
.-.|+....+..+-.+||-|.||.||.|.|++-...||||.++ .+...+++|+.|+.+|+.+.|||+|+|+++|..+-
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK--EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhh--hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 3456666677888899999999999999999988999999985 45567899999999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhccCC-chhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEE-PLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~-~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
.+|||+|||..|+|.++++..++ -++.-.+..++.||..||+||..+++|||||...|+||.++..|||+|||+++.+.
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 99999999999999999986543 46777788999999999999999999999999999999999999999999999886
Q ss_pred ccccc-cccccccccccchhhhhhcCCCCccchhhhHHHHHHHH-hCCCCCCCCCchhhhhhhhcCCCCccccchhchHH
Q 004088 339 RTMSK-RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMA-EGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLV 416 (774)
Q Consensus 339 ~~~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELL-tG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~ 416 (774)
..... .....-...|.|||-+....++.|+|||+|||+|||+. .|..||.+.+...++..+... .....+..+++.
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg--yRM~~PeGCPpk 494 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG--YRMDGPEGCPPK 494 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc--ccccCCCCCCHH
Confidence 54211 11223367899999999999999999999999999998 589999998887776655433 335567888999
Q ss_pred HHHHHHhhcccCCCCCCCHHHHH
Q 004088 417 FHDFVAKCLTKEPRARPTAAEML 439 (774)
Q Consensus 417 l~dLI~kcL~~DP~kRPTa~ElL 439 (774)
+.+||+.||+++|..||++.|+-
T Consensus 495 VYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 495 VYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHHHHHHHhcCCcccCccHHHHH
Confidence 99999999999999999999983
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=330.51 Aligned_cols=258 Identities=26% Similarity=0.425 Sum_probs=214.4
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC------ChhhHHHHHHHHHHHHhCCCCCccccccccc-CCc
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE------GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ-GEE 259 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~------~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~-~~~ 259 (774)
..+|-++.+||+|+|+.||+|.+....++||||+-.... .....+...+|..|.+.|.||-||++|++|. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 468999999999999999999999999999999865433 2233456779999999999999999999996 667
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcC--cccccccccceEecC---CCcEEEeecccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF--KVHRDIKGGNILLTD---QGEVKLGDFGVA 334 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~g--IIHRDLKPeNILLd~---~g~vKL~DFGlA 334 (774)
.+|-|+|||+|.+|.-+++ ..+.++|.+++.|+.||+.||.||.+.. |||-||||.|||+.. .|.+||.|||++
T Consensus 542 sFCTVLEYceGNDLDFYLK-QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLK-QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred cceeeeeecCCCchhHHHH-hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 8999999999999988886 4567999999999999999999999875 999999999999954 467999999999
Q ss_pred ccccccccc-------cccccccccccchhhhhh----cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhh-hh--hh
Q 004088 335 AQLTRTMSK-------RNTFIGTPHWMAPEVIQE----SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVL-FM--IS 400 (774)
Q Consensus 335 ~~i~~~~~~-------~~~~~GT~~Y~APEvl~~----~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i-~~--i~ 400 (774)
+.+...... .....||.||++||.+.- .+.+.++||||+|||+|.++.|+.||........+ .. |.
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl 700 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL 700 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence 988654322 223579999999999853 35888999999999999999999999865433222 11 22
Q ss_pred cCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhh
Q 004088 401 IEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445 (774)
Q Consensus 401 ~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~ 445 (774)
......++.++.++.++++||++||++.-+.|....++..||||.
T Consensus 701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 222233455677889999999999999999999999999999985
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=342.42 Aligned_cols=259 Identities=24% Similarity=0.321 Sum_probs=180.6
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcCC----CcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccc---
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLKT----SELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSY--- 255 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~----g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~--- 255 (774)
.....++|++.++||+|+||.||+|++..+ +..||||++..... .+....| .+....+.+++.++..|
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 344578999999999999999999999888 89999998753221 1111111 12222333444333322
Q ss_pred ---cCCceEEEEEEecCCCchhhhhhccCCc-------------------hhHHHHHHHHHHHHHHHHHHHhcCcccccc
Q 004088 256 ---QGEEYLWIVMEYCGGGSVADLMNVTEEP-------------------LEEYQIAYICREALKGLAYLHSIFKVHRDI 313 (774)
Q Consensus 256 ---~~~~~l~LVmEy~~ggsL~dll~~~~~~-------------------Lse~~i~~I~~QIl~gL~YLHs~gIIHRDL 313 (774)
.....++|||||+++++|.+++...... ..+..+..++.||+.||.|||++|||||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 4567899999999999999988643211 223456789999999999999999999999
Q ss_pred cccceEecC-CCcEEEeeccccccccccc-cccccccccccccchhhhhhc----------------------CCCCccc
Q 004088 314 KGGNILLTD-QGEVKLGDFGVAAQLTRTM-SKRNTFIGTPHWMAPEVIQES----------------------RYDGKVD 369 (774)
Q Consensus 314 KPeNILLd~-~g~vKL~DFGlA~~i~~~~-~~~~~~~GT~~Y~APEvl~~~----------------------~~s~ksD 369 (774)
||+|||++. ++.+||+|||+|+.+.... .....++||+.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 5789999999997654322 223456899999999976432 2345679
Q ss_pred hhhhHHHHHHHHhCCCCCCCCCchhhhhh-hhcCCC-----------Ccccc-------chhchHHHHHHHHhhcccCCC
Q 004088 370 VWALGVSAVEMAEGLPPRSTVHPMRVLFM-ISIEPA-----------PMLED-------KEKWSLVFHDFVAKCLTKEPR 430 (774)
Q Consensus 370 IWSLGviLyELLtG~~Pf~~~~~~~~i~~-i~~~~~-----------~~~~~-------~~~~s~~l~dLI~kcL~~DP~ 430 (774)
||||||++|||+++..++... ...+.. +..... ..... .......+++||.+||++||.
T Consensus 362 VwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 999999999999876654321 111100 000000 00000 000122356899999999999
Q ss_pred CCCCHHHHHhhhhhhhhc
Q 004088 431 ARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 431 kRPTa~ElL~HPwf~~~~ 448 (774)
+|||+.++|+||||....
T Consensus 440 kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 440 QRISAKAALAHPYFDREG 457 (566)
T ss_pred cCCCHHHHhCCcCcCCCC
Confidence 999999999999998654
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=332.97 Aligned_cols=260 Identities=23% Similarity=0.338 Sum_probs=224.4
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcC-CCc--EEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCc
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLK-TSE--LVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE 259 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~-~g~--~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~ 259 (774)
.-++.++.++.++||+|.||.||.|.|.. +|+ .||||+++..........|++|+.+|.+|+|||+|+|||+..+ .
T Consensus 105 clIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 105 CLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred eeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 34566778889999999999999999865 343 5899999765555577899999999999999999999999987 7
Q ss_pred eEEEEEEecCCCchhhhhhc-cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNV-TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~-~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
.+.||||+|+.|+|.+.|+. ....|....+..++.||+.||.||.++++|||||...||||-....|||+|||+.+.+.
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 88999999999999999986 55678899999999999999999999999999999999999998899999999999876
Q ss_pred ccccccc---cccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhch
Q 004088 339 RTMSKRN---TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWS 414 (774)
Q Consensus 339 ~~~~~~~---~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s 414 (774)
.....+. ...-...|+|||.+...+++.++|||+|||++|||++ |..||.+.....++..+. ....+..++.++
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD--~~erLpRPk~cs 341 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID--AGERLPRPKYCS 341 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc--ccccCCCCCCCh
Confidence 6533321 0112457999999999999999999999999999995 789999999888887765 455677788899
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhhhhhh
Q 004088 415 LVFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445 (774)
Q Consensus 415 ~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~ 445 (774)
+.+.++++.||..+|++|||+..|...-+..
T Consensus 342 edIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 342 EDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 9999999999999999999999987654544
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=323.89 Aligned_cols=261 Identities=23% Similarity=0.336 Sum_probs=188.5
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEc----------------CCCcEEEEEEeecCCChh-------------hHHHHHH
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDL----------------KTSELVAIKVISLSEGEE-------------GYEEIRG 235 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~----------------~~g~~VAVKvi~~~~~~~-------------~~~~~~~ 235 (774)
...++|++.++||+|+||+||+|... ..++.||||.+....... ..+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 45779999999999999999999742 345679999986432111 1122345
Q ss_pred HHHHHHhCCCCCc-----ccccccccC--------CceEEEEEEecCCCchhhhhhccC---------------------
Q 004088 236 EIEMLQQCSHPNV-----VRYLGSYQG--------EEYLWIVMEYCGGGSVADLMNVTE--------------------- 281 (774)
Q Consensus 236 Ei~iL~~L~HPNI-----VkL~~~~~~--------~~~l~LVmEy~~ggsL~dll~~~~--------------------- 281 (774)
|+.++.+++|.++ ++++++|.. ....||||||+++++|.++++...
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777888876554 677777653 356899999999999999885321
Q ss_pred --CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc-cccccccccccchhh
Q 004088 282 --EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK-RNTFIGTPHWMAPEV 358 (774)
Q Consensus 282 --~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~-~~~~~GT~~Y~APEv 358 (774)
..+++..++.++.||+.+|.|||+++|+||||||+|||++.++.+||+|||++..+...... .....+|+.|+|||+
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 12356678899999999999999999999999999999999999999999999765432111 111245899999999
Q ss_pred hhhcC--------------------CC--CccchhhhHHHHHHHHhCCC-CCCCCCchhhhh----------hhhcCCCC
Q 004088 359 IQESR--------------------YD--GKVDVWALGVSAVEMAEGLP-PRSTVHPMRVLF----------MISIEPAP 405 (774)
Q Consensus 359 l~~~~--------------------~s--~ksDIWSLGviLyELLtG~~-Pf~~~~~~~~i~----------~i~~~~~~ 405 (774)
+.... |+ .+.||||+||++|+|++|.. ||.......... ........
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~ 461 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY 461 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence 85322 12 24799999999999999875 665322111110 00011111
Q ss_pred ccccchhchHHHHHHHHhhcccCC---CCCCCHHHHHhhhhhh
Q 004088 406 MLEDKEKWSLVFHDFVAKCLTKEP---RARPTAAEMLKHKFIE 445 (774)
Q Consensus 406 ~~~~~~~~s~~l~dLI~kcL~~DP---~kRPTa~ElL~HPwf~ 445 (774)
.+......+...++||.+||.++| .+|+|+.|+|+||||.
T Consensus 462 ~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 462 DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 122233457889999999999876 6899999999999995
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=320.58 Aligned_cols=257 Identities=26% Similarity=0.354 Sum_probs=210.2
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCC------CCcccccccccC
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSH------PNVVRYLGSYQG 257 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~H------PNIVkL~~~~~~ 257 (774)
+....+|.+.-..|+|-|++|..|.+..-|..||||+|.. .....+.=+.|++||++|+. -|+++|+-.|..
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn--NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN--NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec--chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 4455789999999999999999999999999999999974 34455667789999999962 489999999999
Q ss_pred CceEEEEEEecCCCchhhhhhccC--CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC-cEEEeecccc
Q 004088 258 EEYLWIVMEYCGGGSVADLMNVTE--EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG-EVKLGDFGVA 334 (774)
Q Consensus 258 ~~~l~LVmEy~~ggsL~dll~~~~--~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g-~vKL~DFGlA 334 (774)
.+++|||+|-+ ..+|.++++..+ -.|....+..++.|++.||..|...||+|.||||+||||+... .+||||||.|
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence 99999999998 678999997554 3588889999999999999999999999999999999999765 5899999999
Q ss_pred ccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhh--hhhhcCCCCc------
Q 004088 335 AQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVL--FMISIEPAPM------ 406 (774)
Q Consensus 335 ~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i--~~i~~~~~~~------ 406 (774)
...... ....+.-+..|+|||++.+..|+...|+||+||+||||.+|+..|.+..+-.++ ++-...+.|.
T Consensus 585 ~~~~en--eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg 662 (752)
T KOG0670|consen 585 SFASEN--EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG 662 (752)
T ss_pred cccccc--cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence 766543 223345578899999999999999999999999999999999988876554333 1111111100
Q ss_pred -------------------------------------------------cccchhchHHHHHHHHhhcccCCCCCCCHHH
Q 004088 407 -------------------------------------------------LEDKEKWSLVFHDFVAKCLTKEPRARPTAAE 437 (774)
Q Consensus 407 -------------------------------------------------~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~E 437 (774)
.......-..|.+|+.+||..||++|.|..+
T Consensus 663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq 742 (752)
T KOG0670|consen 663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ 742 (752)
T ss_pred chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence 0001112345789999999999999999999
Q ss_pred HHhhhhhh
Q 004088 438 MLKHKFIE 445 (774)
Q Consensus 438 lL~HPwf~ 445 (774)
+|+||||.
T Consensus 743 AL~HpFi~ 750 (752)
T KOG0670|consen 743 ALKHPFIT 750 (752)
T ss_pred HhcCCccc
Confidence 99999996
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=344.74 Aligned_cols=240 Identities=21% Similarity=0.356 Sum_probs=189.9
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
..|...+.||+|+||.||+|++..++..||||++..... ....|+++|++++|||||+++++|......|+||||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 356677899999999999999989999999999864322 123568899999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHH---hcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 268 CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLH---SIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 268 ~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLH---s~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
|++|+|.++++ .+++..+..|+.||+.||+||| +.+|+||||||+|||++.++..++. ||.+..... .
T Consensus 765 ~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----~ 835 (968)
T PLN00113 765 IEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----D 835 (968)
T ss_pred CCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----C
Confidence 99999999985 3789999999999999999999 6699999999999999998888775 666543322 1
Q ss_pred ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchh--hhh--hhhcC-------CCCcc----cc
Q 004088 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMR--VLF--MISIE-------PAPML----ED 409 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~--~i~--~i~~~-------~~~~~----~~ 409 (774)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... ..... ..+.. ..
T Consensus 836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 23368999999999999899999999999999999999999985322110 000 00000 00000 11
Q ss_pred chhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 410 KEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 410 ~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.......+.+++.+||+.+|++||++.|+++.
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 11223457789999999999999999999864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=290.68 Aligned_cols=253 Identities=25% Similarity=0.427 Sum_probs=206.0
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-CCCcccccccccCC--ceEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQGE--EYLW 262 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~~--~~l~ 262 (774)
..++|++++++|+|.|+.||.|.+..+.+.++||+++. -..+.+.+|++||+.|. ||||++|+++..+. ....
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 46789999999999999999999999999999999852 33467899999999996 99999999998754 4678
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC-cEEEeeccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG-EVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g-~vKL~DFGlA~~i~~~~ 341 (774)
||+||+.+.+...+. ..|+...+..++.+|+.||.|||++||+|||+||.|++|+... .++|+|+|+|.+....
T Consensus 112 LiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~- 186 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG- 186 (338)
T ss_pred hHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC-
Confidence 999999887766654 4688899999999999999999999999999999999999764 6999999999766544
Q ss_pred cccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCC-CCCchhhhhhhhc----------------CC
Q 004088 342 SKRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRS-TVHPMRVLFMISI----------------EP 403 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~-~~~~~~~i~~i~~----------------~~ 403 (774)
...+..+.+..|--||++... .|+..-|+|||||++..|+..+.||. +.++.+.+..|.. ..
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 444556788899999998754 58999999999999999999988875 3344333322210 01
Q ss_pred CCccc------------------cchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 404 APMLE------------------DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 404 ~~~~~------------------~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
.+... ...-.++++.||+.++|.+|-.+|+||.|++.||||...
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 11110 011225788999999999999999999999999999754
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=326.33 Aligned_cols=257 Identities=26% Similarity=0.473 Sum_probs=214.7
Q ss_pred ccCCCCCCeeEEeeeeccCceEEEEEEEcC-------CCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccc
Q 004088 182 TREDPTTKYELLNELGKGSYGAVYKARDLK-------TSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLG 253 (774)
Q Consensus 182 ~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~-------~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~ 253 (774)
.++....+..+.+.||+|.||.||+|.-.. ....||||.++........+.+..|+++|+.+ .||||+.+++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 566677777888899999999999997421 14569999987666667778899999999998 5999999999
Q ss_pred cccCCceEEEEEEecCCCchhhhhhccC---------------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccce
Q 004088 254 SYQGEEYLWIVMEYCGGGSVADLMNVTE---------------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNI 318 (774)
Q Consensus 254 ~~~~~~~l~LVmEy~~ggsL~dll~~~~---------------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNI 318 (774)
++.....+++|+|||..|+|..+++.++ ..++...+..++.||+.|++||++..+|||||-.+||
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 9999999999999999999999998665 3489999999999999999999999999999999999
Q ss_pred EecCCCcEEEeecccccccccccccc-ccccc--cccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCC-ch
Q 004088 319 LLTDQGEVKLGDFGVAAQLTRTMSKR-NTFIG--TPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVH-PM 393 (774)
Q Consensus 319 LLd~~g~vKL~DFGlA~~i~~~~~~~-~~~~G--T~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~-~~ 393 (774)
|+..+..+||+|||+|+......... ..-.| ...|||||.+....|+.++|||||||+|||+++ |..||.+.. ..
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~ 529 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE 529 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence 99999999999999998655432222 11122 456999999999999999999999999999985 789998865 33
Q ss_pred hhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 394 RVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 394 ~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
+.+. ..........+..++.++.++|+.||+.+|++||++.++.+
T Consensus 530 ~l~~--~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 530 ELLE--FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHH--HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 3322 22333344556677899999999999999999999999974
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=301.73 Aligned_cols=254 Identities=26% Similarity=0.383 Sum_probs=207.3
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCC------
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE------ 258 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~------ 258 (774)
...+|.-++-+|.|.- .|..|-+.-.++.||+|.+.... .....+...+|+.++..++|+||++++.+|...
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 3568999999999998 88888888899999999875432 334456788999999999999999999999643
Q ss_pred ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 259 EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
...|+||||+ ..+|..++. ..++-..+..|+.|++.|+.|||+.||+||||||+||++..++.+||.|||+|+...
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 4689999999 557887775 446778899999999999999999999999999999999999999999999997654
Q ss_pred ccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC---CCCc---------
Q 004088 339 RTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE---PAPM--------- 406 (774)
Q Consensus 339 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~---~~~~--------- 406 (774)
.. -....++.|..|+|||++.+..|...+||||+||++.||++|..-|.+.+.......+... +.+.
T Consensus 170 ~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 170 TD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred cc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 43 2445678999999999999999999999999999999999999988877765554332110 0000
Q ss_pred ---------------------------cccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhh
Q 004088 407 ---------------------------LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445 (774)
Q Consensus 407 ---------------------------~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~ 445 (774)
.+....-...+++++.+||..||++|.+++++|+||||+
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 000001123478999999999999999999999999997
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=300.28 Aligned_cols=253 Identities=26% Similarity=0.419 Sum_probs=204.1
Q ss_pred EEeeeeccCceEEEEEEEcCCCcEEEEEEeecC-CChhhHHHHHHHHHHHHhCCCCCcccccccccCC-----ceEEEEE
Q 004088 192 LLNELGKGSYGAVYKARDLKTSELVAIKVISLS-EGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE-----EYLWIVM 265 (774)
Q Consensus 192 ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~-----~~l~LVm 265 (774)
--+-||.|+||.||.+.+..+|+.||+|.+..- ..-...+.+.+|+++|...+|.|++..++..... ..+|.|+
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 346799999999999999999999999987521 2334457788999999999999999998876543 2478899
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc-cc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS-KR 344 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~-~~ 344 (774)
|++ ..+|..++- ..+.++...++-+++||++||.|||+.+|.||||||.|+|+++|..+||||||+|+....... +.
T Consensus 137 ELm-QSDLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM 214 (449)
T KOG0664|consen 137 ELM-QSDLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM 214 (449)
T ss_pred HHH-Hhhhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence 999 557877774 678899999999999999999999999999999999999999999999999999987654322 22
Q ss_pred ccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-CCCcccc-------------
Q 004088 345 NTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-PAPMLED------------- 409 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-~~~~~~~------------- 409 (774)
...+-|..|+|||++.+. .|+.++||||.|||+.||+..+..|....+.+.+..|... ..|..+.
T Consensus 215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~L 294 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVL 294 (449)
T ss_pred HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhh
Confidence 334568899999999876 5999999999999999999988888887777666544211 1111111
Q ss_pred -----------------chhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 410 -----------------KEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 410 -----------------~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
+..-..+..+++.++|..||.+|.+.++++.|+|..+
T Consensus 295 R~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 295 RAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred ccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 0011234668999999999999999999999999864
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=328.24 Aligned_cols=244 Identities=31% Similarity=0.480 Sum_probs=192.7
Q ss_pred EEeeeeccCceE-EEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEEEEEEecC
Q 004088 192 LLNELGKGSYGA-VYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIVMEYCG 269 (774)
Q Consensus 192 ilk~LG~G~FG~-Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~LVmEy~~ 269 (774)
--+.+|.|+-|+ ||+|. ..|+.||||.+- .....-..+||.+|+.. .|||||++|+.-.+...+||+.|.|
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll----~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGV--YEGREVAVKRLL----EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred cHHHcccCCCCcEEEEEe--eCCceehHHHHh----hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 335789998885 69996 578999999874 23345678999999988 6999999999999999999999999
Q ss_pred CCchhhhhhccCC--c-hhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC---CC--cEEEeeccccccccccc
Q 004088 270 GGSVADLMNVTEE--P-LEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD---QG--EVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 270 ggsL~dll~~~~~--~-Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~---~g--~vKL~DFGlA~~i~~~~ 341 (774)
..+|.+++..... . ......+.++.|++.||++||+.+||||||||.||||+. ++ .++|+|||+++.+....
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 6699999975311 1 111345778999999999999999999999999999986 34 68999999999886543
Q ss_pred c---ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhC-CCCCCCCCchhhhhhhhcCCCCccccchhchHHH
Q 004088 342 S---KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEG-LPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVF 417 (774)
Q Consensus 342 ~---~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG-~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l 417 (774)
. ...+..||-+|+|||++....-+.++|||||||++|+.++| ..||...-..+.-..........+.....+ ++
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~--eA 743 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDC--EA 743 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchH--HH
Confidence 2 23456799999999999998888899999999999998876 899987543332211111111111111222 78
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 418 HDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 418 ~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
.+||.+||.++|..||+|.+||.||||
T Consensus 744 ~dLI~~ml~~dP~~RPsa~~VL~HPlF 770 (903)
T KOG1027|consen 744 KDLISRMLNPDPQLRPSATDVLNHPLF 770 (903)
T ss_pred HHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence 999999999999999999999999999
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=316.44 Aligned_cols=250 Identities=26% Similarity=0.387 Sum_probs=217.8
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCc----EEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSE----LVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~----~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
...+..++||+|+||+||+|.+...|+ +||||++......+...++.+|+.+|.+|.|||+++|++++.... +-|
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 456667899999999999999976665 689999987777777889999999999999999999999998766 889
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|++|++.|+|.++++.++..+-......|+.||++||.|||.+++|||||-.+||||..-.++||.|||+|+.+......
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999999999999988899999999999999999999999999999999999999999999999999999877655433
Q ss_pred ccccc--ccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHH
Q 004088 344 RNTFI--GTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 344 ~~~~~--GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
..... -.+.|||=|.+....|+.++|||||||++||++| |..|+.+....++...+.... .+.+++..+.++.-+
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge--RLsqPpiCtiDVy~~ 932 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE--RLSQPPICTIDVYMV 932 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc--cCCCCCCccHHHHHH
Confidence 33322 2567999999999999999999999999999884 899998887666554443332 267788889999999
Q ss_pred HHhhcccCCCCCCCHHHHHh
Q 004088 421 VAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~ 440 (774)
|.+||..|+..||++.++..
T Consensus 933 mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 933 MVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHhccCcccCccHHHHHH
Confidence 99999999999999998764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=259.15 Aligned_cols=213 Identities=46% Similarity=0.753 Sum_probs=188.2
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCCCchhh
Q 004088 196 LGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVAD 275 (774)
Q Consensus 196 LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~ggsL~d 275 (774)
||.|++|.||++....+++.++||++...........+.+|+.+++.+.|++|+++++++......++||||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999998888999999998754433245678999999999999999999999999999999999999999999
Q ss_pred hhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC-CCcEEEeecccccccccccccccccccccccc
Q 004088 276 LMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD-QGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWM 354 (774)
Q Consensus 276 ll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~-~g~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~ 354 (774)
++......+++..+..++.+++.+|.|||+.|++|+||+|.||+++. ++.++|+|||.+..............+...|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYM 160 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCcc
Confidence 98754357899999999999999999999999999999999999999 89999999999976644321233346788999
Q ss_pred chhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCC
Q 004088 355 APEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARP 433 (774)
Q Consensus 355 APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRP 433 (774)
+||.+... .++.+.|+|++|+++++| ..+.+++.+||..+|.+||
T Consensus 161 ~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~~l~~~p~~R~ 206 (215)
T cd00180 161 APEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELKDLIRKMLQKDPEKRP 206 (215)
T ss_pred ChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHHHHhhCCcccCc
Confidence 99999877 788999999999999999 4578999999999999999
Q ss_pred CHHHHHhhh
Q 004088 434 TAAEMLKHK 442 (774)
Q Consensus 434 Ta~ElL~HP 442 (774)
++.++++|+
T Consensus 207 ~~~~l~~~~ 215 (215)
T cd00180 207 SAKEILEHL 215 (215)
T ss_pred CHHHHhhCC
Confidence 999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=275.40 Aligned_cols=224 Identities=30% Similarity=0.513 Sum_probs=189.7
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~ 262 (774)
+.+.+....+..||+|+||.|-+.++..+|...|+|.+...-..+...++++|+.+..+. ..|++|.+||.+..+...|
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 334556667789999999999999999999999999998766667778889999887665 7899999999999999999
Q ss_pred EEEEecCCCchhhhhh---ccCCchhHHHHHHHHHHHHHHHHHHHhc-CcccccccccceEecCCCcEEEeecccccccc
Q 004088 263 IVMEYCGGGSVADLMN---VTEEPLEEYQIAYICREALKGLAYLHSI-FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 263 LVmEy~~ggsL~dll~---~~~~~Lse~~i~~I~~QIl~gL~YLHs~-gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
|.||.| ..+|..+.+ ..++.++|..+-+|+..++.||.|||++ .|||||+||+||||+.+|+|||||||.+..+.
T Consensus 122 IcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 122 ICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred EeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 999999 567776654 3567899999999999999999999986 79999999999999999999999999998776
Q ss_pred ccccccccccccccccchhhhh----hcCCCCccchhhhHHHHHHHHhCCCCCCC-CCchhhhhhhhcCCCCcccc
Q 004088 339 RTMSKRNTFIGTPHWMAPEVIQ----ESRYDGKVDVWALGVSAVEMAEGLPPRST-VHPMRVLFMISIEPAPMLED 409 (774)
Q Consensus 339 ~~~~~~~~~~GT~~Y~APEvl~----~~~~s~ksDIWSLGviLyELLtG~~Pf~~-~~~~~~i~~i~~~~~~~~~~ 409 (774)
+..... .-.|...|||||.+. ...|+.++||||||++++||.+++.||.. ..+.+.+..+...+.|.++.
T Consensus 201 dSiAkt-~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp~ 275 (282)
T KOG0984|consen 201 DSIAKT-MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLPA 275 (282)
T ss_pred hhhHHH-HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCcc
Confidence 653322 135888999999985 33699999999999999999999999975 45666777777777776654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=293.72 Aligned_cols=245 Identities=26% Similarity=0.484 Sum_probs=187.5
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHh--CCCCCcccccccccCCc----e
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQ--CSHPNVVRYLGSYQGEE----Y 260 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~--L~HPNIVkL~~~~~~~~----~ 260 (774)
.....+++.||+|.||.||+|+. +++.||||++.. .....+++|-+|.+. +.|+||+++++.-.... .
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 45677889999999999999974 569999999863 334567778777765 58999999999876555 8
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhc---------CcccccccccceEecCCCcEEEeec
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI---------FKVHRDIKGGNILLTDQGEVKLGDF 331 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~---------gIIHRDLKPeNILLd~~g~vKL~DF 331 (774)
++||++|.+.|+|.+++. ...++|....+|+..+++||+|||+. .|+|||||..||||..++++.|+||
T Consensus 283 ywLVt~fh~kGsL~dyL~--~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLK--ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred eeEEeeeccCCcHHHHHH--hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 999999999999999996 45799999999999999999999962 4999999999999999999999999
Q ss_pred cccccccccccc--cccccccccccchhhhhhcC-CC-----CccchhhhHHHHHHHHhCCCCC--CCCCchhhhhhhhc
Q 004088 332 GVAAQLTRTMSK--RNTFIGTPHWMAPEVIQESR-YD-----GKVDVWALGVSAVEMAEGLPPR--STVHPMRVLFMISI 401 (774)
Q Consensus 332 GlA~~i~~~~~~--~~~~~GT~~Y~APEvl~~~~-~s-----~ksDIWSLGviLyELLtG~~Pf--~~~~~~~~i~~i~~ 401 (774)
|+|..+...... ....+||.+|||||++.+.. +. .+.||||+|.+||||++...-+ ....+....+....
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 999877654322 22358999999999997642 22 2699999999999999764332 11122222222111
Q ss_pred CCCCcccc--------------chhc-----hHHHHHHHHhhcccCCCCCCCHHHHH
Q 004088 402 EPAPMLED--------------KEKW-----SLVFHDFVAKCLTKEPRARPTAAEML 439 (774)
Q Consensus 402 ~~~~~~~~--------------~~~~-----s~~l~dLI~kcL~~DP~kRPTa~ElL 439 (774)
...|.+++ +..| ...+++.+..||..||+.|.||.-+-
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 11111111 1111 34578999999999999999998664
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=285.73 Aligned_cols=254 Identities=28% Similarity=0.474 Sum_probs=190.1
Q ss_pred CCCCCCcccCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHh--CCCCCccccc
Q 004088 175 SSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQ--CSHPNVVRYL 252 (774)
Q Consensus 175 ss~~~~~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~--L~HPNIVkL~ 252 (774)
+.+|-.+.+ ....+..+.+.||+|.||.||+|.+ .|+.||||++.-... ..+.+|.+|.+. |+|+||+.|+
T Consensus 199 SGlplLVQR-TiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE----~SWfrEtEIYqTvmLRHENILgFI 271 (513)
T KOG2052|consen 199 SGLPLLVQR-TIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDE----RSWFRETEIYQTVMLRHENILGFI 271 (513)
T ss_pred CCchhHhHH-hhhheeEEEEEecCccccceeeccc--cCCceEEEEecccch----hhhhhHHHHHHHHHhccchhhhhh
Confidence 344444333 3456889999999999999999985 588899999864332 446677777765 5999999999
Q ss_pred ccccCC----ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhc--------CcccccccccceEe
Q 004088 253 GSYQGE----EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI--------FKVHRDIKGGNILL 320 (774)
Q Consensus 253 ~~~~~~----~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~--------gIIHRDLKPeNILL 320 (774)
+.-..+ ..+|||++|.+.|||+|+|.. ..++.....+++..++.||++||.. .|.|||||..||||
T Consensus 272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV 349 (513)
T KOG2052|consen 272 AADNKDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 349 (513)
T ss_pred hccccCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE
Confidence 876433 478999999999999999964 6789999999999999999999952 39999999999999
Q ss_pred cCCCcEEEeecccccccccc----ccccccccccccccchhhhhhcC----CC--CccchhhhHHHHHHHHhC-------
Q 004088 321 TDQGEVKLGDFGVAAQLTRT----MSKRNTFIGTPHWMAPEVIQESR----YD--GKVDVWALGVSAVEMAEG------- 383 (774)
Q Consensus 321 d~~g~vKL~DFGlA~~i~~~----~~~~~~~~GT~~Y~APEvl~~~~----~s--~ksDIWSLGviLyELLtG------- 383 (774)
.++|.+.|+|||+|-..... ....+..+||.+|||||++...- +. ..+||||||.++||++..
T Consensus 350 Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ 429 (513)
T KOG2052|consen 350 KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIV 429 (513)
T ss_pred ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEe
Confidence 99999999999999655433 12345679999999999986532 21 269999999999999742
Q ss_pred ---CCCCCCCCchhhhhh-----hhcC-CCCccccchhc-----hHHHHHHHHhhcccCCCCCCCHHHHH
Q 004088 384 ---LPPRSTVHPMRVLFM-----ISIE-PAPMLEDKEKW-----SLVFHDFVAKCLTKEPRARPTAAEML 439 (774)
Q Consensus 384 ---~~Pf~~~~~~~~i~~-----i~~~-~~~~~~~~~~~-----s~~l~dLI~kcL~~DP~kRPTa~ElL 439 (774)
++||.+.-+.+..+. +... ..|.. +..| -..+..+|+.||..||.-|.||--+.
T Consensus 430 eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~i--pnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 430 EEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNI--PNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred hhhcCCcccCCCCCCCHHHHhcceeecccCCCC--CcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 568776443322211 1111 11111 1122 12356789999999999999987664
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=290.59 Aligned_cols=254 Identities=30% Similarity=0.469 Sum_probs=200.5
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcC---CCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLK---TSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~---~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~ 262 (774)
.+.|.++++||+|.|++||++.+.. ..+.||+|.+..... ...+.+|+++|..+ .+.||+++.+++..++..+
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 4679999999999999999999877 788999999865443 34588999999998 5899999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC-CcEEEeecccccccccc-
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ-GEVKLGDFGVAAQLTRT- 340 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~-g~vKL~DFGlA~~i~~~- 340 (774)
+||||++.....+++. .++..++.++++.++.||.++|.+|||||||||+|+|.+.. +.-.|+|||+|......
T Consensus 112 ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred EEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 9999999988888775 46688999999999999999999999999999999999865 57899999999621000
Q ss_pred ------------cc-------------------------------ccccccccccccchhhhhhc-CCCCccchhhhHHH
Q 004088 341 ------------MS-------------------------------KRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVS 376 (774)
Q Consensus 341 ------------~~-------------------------------~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvi 376 (774)
.. ......||++|+|||++... ..+.++||||.|||
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 00 00124699999999998754 47889999999999
Q ss_pred HHHHHhCCCCCCCCCc-hhhhhhh--------------------hcC--C-----------C---------------Ccc
Q 004088 377 AVEMAEGLPPRSTVHP-MRVLFMI--------------------SIE--P-----------A---------------PML 407 (774)
Q Consensus 377 LyELLtG~~Pf~~~~~-~~~i~~i--------------------~~~--~-----------~---------------~~~ 407 (774)
+..+++++.||..... ...+..+ .+. . . ...
T Consensus 268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~ 347 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE 347 (418)
T ss_pred eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence 9999999999864322 1111000 000 0 0 000
Q ss_pred ccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 408 EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 408 ~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
.....++..+.+|+.+||..||.+|.||+++|+||||..+
T Consensus 348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred cccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 0011224468899999999999999999999999999743
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=296.51 Aligned_cols=201 Identities=29% Similarity=0.472 Sum_probs=175.8
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC--hhh-----HHHHHHHHHHHHhCC---CCCcccccccc
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG--EEG-----YEEIRGEIEMLQQCS---HPNVVRYLGSY 255 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~--~~~-----~~~~~~Ei~iL~~L~---HPNIVkL~~~~ 255 (774)
....|..++.+|+|+||.|++|.++.+...|+||.|.+... ..+ +-.+-.||.||..|+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 34579999999999999999999999999999999976541 111 123557999999997 99999999999
Q ss_pred cCCceEEEEEEecC-CCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccc
Q 004088 256 QGEEYLWIVMEYCG-GGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA 334 (774)
Q Consensus 256 ~~~~~l~LVmEy~~-ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA 334 (774)
++++++||+||-.. |.+|++++. .+..++|.+++.|++|++.|+++||+.||||||||-+|+.++.+|-+||+|||.|
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE-~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIE-FKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhh-ccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence 99999999999876 457889986 4567999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccccccchhhhhhcCCC-CccchhhhHHHHHHHHhCCCCCCC
Q 004088 335 AQLTRTMSKRNTFIGTPHWMAPEVIQESRYD-GKVDVWALGVSAVEMAEGLPPRST 389 (774)
Q Consensus 335 ~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s-~ksDIWSLGviLyELLtG~~Pf~~ 389 (774)
...... .-..++||..|.|||++.+.+|- ..-|||++|++||-++....||..
T Consensus 718 a~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 776543 34567999999999999998875 468999999999999999888864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=252.05 Aligned_cols=206 Identities=42% Similarity=0.669 Sum_probs=178.4
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecC
Q 004088 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCG 269 (774)
Q Consensus 190 Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~ 269 (774)
|.+.+.||.|+||.||++.+..+++.||||.+.........+.+.+|+..+++++|+|++++++++......++|+||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 67889999999999999999888999999998754432256788999999999999999999999999999999999999
Q ss_pred CCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc-ccccccc
Q 004088 270 GGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM-SKRNTFI 348 (774)
Q Consensus 270 ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~-~~~~~~~ 348 (774)
+++|.+++......+++..+..++.+++.+|.|||.++++|+||+|.||+++.++.++|+|||++..+.... .......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 160 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVK 160 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccccee
Confidence 999999986433338899999999999999999999999999999999999999999999999997665432 1223457
Q ss_pred ccccccchhhh-hhcCCCCccchhhhHHHHHHHHhCCCCCCC-CCchhh
Q 004088 349 GTPHWMAPEVI-QESRYDGKVDVWALGVSAVEMAEGLPPRST-VHPMRV 395 (774)
Q Consensus 349 GT~~Y~APEvl-~~~~~s~ksDIWSLGviLyELLtG~~Pf~~-~~~~~~ 395 (774)
++..|++||.+ ....++.++|+|+||+++|+|++|+.||.. ..+...
T Consensus 161 ~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~ 209 (225)
T smart00221 161 GTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSL 209 (225)
T ss_pred ccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHH
Confidence 88899999998 666788899999999999999999999977 444433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=311.73 Aligned_cols=201 Identities=18% Similarity=0.200 Sum_probs=150.7
Q ss_pred hCCC-CCcccccccc-------cCCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccc
Q 004088 242 QCSH-PNVVRYLGSY-------QGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDI 313 (774)
Q Consensus 242 ~L~H-PNIVkL~~~~-------~~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDL 313 (774)
.++| +||++++++| .....++++|||+ +++|.+++......+++.+++.++.||+.||.|||++|||||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3455 5888888887 2335678889988 66999999765667999999999999999999999999999999
Q ss_pred cccceEecC-------------------CCcEEEeeccccccccccc----------------cccccccccccccchhh
Q 004088 314 KGGNILLTD-------------------QGEVKLGDFGVAAQLTRTM----------------SKRNTFIGTPHWMAPEV 358 (774)
Q Consensus 314 KPeNILLd~-------------------~g~vKL~DFGlA~~i~~~~----------------~~~~~~~GT~~Y~APEv 358 (774)
||+||||+. ++.+||+|||+++...... ......+||++|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999964 3456677777765421100 00112468999999999
Q ss_pred hhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHH
Q 004088 359 IQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEM 438 (774)
Q Consensus 359 l~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~El 438 (774)
+.+..|+.++|||||||+||||++|.+|+...... ...+.....+. ..........+++.+||+++|.+||++.|+
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~L~~~P~~Rps~~ei 262 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT--MSSLRHRVLPP--QILLNWPKEASFCLWLLHPEPSCRPSMSEL 262 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH--HHHHHHhhcCh--hhhhcCHHHHHHHHHhCCCChhhCcChHHH
Confidence 99999999999999999999999999987643211 11111111111 001113345689999999999999999999
Q ss_pred Hhhhhhhhh
Q 004088 439 LKHKFIERC 447 (774)
Q Consensus 439 L~HPwf~~~ 447 (774)
|+||||...
T Consensus 263 l~h~~~~~~ 271 (793)
T PLN00181 263 LQSEFINEP 271 (793)
T ss_pred hhchhhhhh
Confidence 999999753
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=235.74 Aligned_cols=255 Identities=38% Similarity=0.608 Sum_probs=208.1
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChh--hHHHHHHHHHHHHhCCCC-CcccccccccCCceEEEEEE
Q 004088 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEE--GYEEIRGEIEMLQQCSHP-NVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 190 Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~--~~~~~~~Ei~iL~~L~HP-NIVkL~~~~~~~~~l~LVmE 266 (774)
|.+.+.||.|+||.||++.+. ..+|+|.+....... ....+.+|+.++..+.|+ +|+++++++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999976 779999997554433 467899999999999988 79999999988888999999
Q ss_pred ecCCCchhhhhhccC--CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC-cEEEeecccccccccccc-
Q 004088 267 YCGGGSVADLMNVTE--EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG-EVKLGDFGVAAQLTRTMS- 342 (774)
Q Consensus 267 y~~ggsL~dll~~~~--~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g-~vKL~DFGlA~~i~~~~~- 342 (774)
|+.++++.+++.... ..+.+..+..++.|++.++.|+|+.+++||||||+|||++..+ .++++|||+++.+.....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999997775443 2799999999999999999999999999999999999999988 799999999975544332
Q ss_pred -----ccccccccccccchhhhhh---cCCCCccchhhhHHHHHHHHhCCCCCCCCCc----hhhhhhhhcCCCC-cccc
Q 004088 343 -----KRNTFIGTPHWMAPEVIQE---SRYDGKVDVWALGVSAVEMAEGLPPRSTVHP----MRVLFMISIEPAP-MLED 409 (774)
Q Consensus 343 -----~~~~~~GT~~Y~APEvl~~---~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~----~~~i~~i~~~~~~-~~~~ 409 (774)
.....+||..|+|||.+.. ..+....|+||+|+++++++.|..||..... ......+.....+ ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 2356689999999999987 5788999999999999999999999776653 2333333333222 1111
Q ss_pred -chh----chHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 410 -KEK----WSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 410 -~~~----~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
... ....+.+++.+|+..+|..|.+..+...++|....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 111 12568899999999999999999999988766543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-28 Score=235.58 Aligned_cols=163 Identities=32% Similarity=0.404 Sum_probs=131.6
Q ss_pred CchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccccccc
Q 004088 271 GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350 (774)
Q Consensus 271 gsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT 350 (774)
|+|.+++...+..+++.+++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||++....... ..||
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----~~g~ 67 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----SRVD 67 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc-----CCCc
Confidence 6889999766678999999999999999999999999 999999999999999 99997654321 2689
Q ss_pred ccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhh-hhcCCCCc----cccchhchH--HHHHHHHh
Q 004088 351 PHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFM-ISIEPAPM----LEDKEKWSL--VFHDFVAK 423 (774)
Q Consensus 351 ~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~-i~~~~~~~----~~~~~~~s~--~l~dLI~k 423 (774)
+.|||||++.+..|+.++|||||||++|||++|++||........... +....... ......++. .+.+||.+
T Consensus 68 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 147 (176)
T smart00750 68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV 147 (176)
T ss_pred ccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence 999999999999999999999999999999999999976543322211 11111111 111233344 68999999
Q ss_pred hcccCCCCCCCHHHHHhhhhhhh
Q 004088 424 CLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 424 cL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
||..+|.+||++.++++|+|+..
T Consensus 148 cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 148 CASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=253.89 Aligned_cols=251 Identities=21% Similarity=0.324 Sum_probs=210.9
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCC-----CcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCccccccccc-CCceE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKT-----SELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ-GEEYL 261 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~-----g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~-~~~~l 261 (774)
.++++...+-+|.||.||.|.++.. .+.|-+|.++....+-....+..|--+|.-+.|||+..+.+++. +....
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P 363 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP 363 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence 4688888999999999999987643 34477787765556666778899999999999999999999875 45667
Q ss_pred EEEEEecCCCchhhhhhc-------cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccc
Q 004088 262 WIVMEYCGGGSVADLMNV-------TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA 334 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~-------~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA 334 (774)
+.++.+++-|+|..+++. ..+.++..++..++.|++.|++|||++||||.||..+|++|++.-+|||+|=.++
T Consensus 364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLS 443 (563)
T KOG1024|consen 364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALS 443 (563)
T ss_pred eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhc
Confidence 888999999999999872 2346888899999999999999999999999999999999999999999999999
Q ss_pred cccccccccc--ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccch
Q 004088 335 AQLTRTMSKR--NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKE 411 (774)
Q Consensus 335 ~~i~~~~~~~--~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~ 411 (774)
+.+-....+. ..--.+..||+||.+....|+.++|+|||||+||||++ |+.||...++.++..++... ..+.++.
T Consensus 444 RDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG--yRlaQP~ 521 (563)
T KOG1024|consen 444 RDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG--YRLAQPF 521 (563)
T ss_pred cccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc--ceecCCC
Confidence 8764432211 11124678999999999999999999999999999985 89999999999988776543 3356677
Q ss_pred hchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 412 KWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 412 ~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
.+++++..+|.-||...|++||+++|+..
T Consensus 522 NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 522 NCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 88999999999999999999999999874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=246.56 Aligned_cols=252 Identities=21% Similarity=0.291 Sum_probs=192.7
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCccccccc-ccCCceEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGS-YQGEEYLWIV 264 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~-~~~~~~l~LV 264 (774)
.+.|.+.+.||+|.||.+.+|+++.+...+++|.+... .....+|.+|..---.| .|.||+.-|++ |+..+.++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p--~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP--QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc--hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 46899999999999999999999999999999998643 34567899998765555 58999988874 6788899999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC--CcEEEeecccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ--GEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~--g~vKL~DFGlA~~i~~~~~ 342 (774)
+|||+.|+|..-+. ...+-|...+.++.|+++||.|||++++||||||.+||||-.. -.|||||||+.+..+....
T Consensus 101 qE~aP~gdL~snv~--~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~ 178 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVE--AAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK 178 (378)
T ss_pred eccCccchhhhhcC--cccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence 99999999988764 3568899999999999999999999999999999999999533 3799999999976654433
Q ss_pred ccccccccccccchhhhhhc-----CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhh---hhhh-cCCC-Cccccchh
Q 004088 343 KRNTFIGTPHWMAPEVIQES-----RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVL---FMIS-IEPA-PMLEDKEK 412 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~-----~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i---~~i~-~~~~-~~~~~~~~ 412 (774)
... -+..|.+||+.... ...+..|||.||+++|.+++|++||.....+..- ++.. .... ........
T Consensus 179 ~~~---~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~ 255 (378)
T KOG1345|consen 179 YLE---YVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNP 255 (378)
T ss_pred hhh---hhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcc
Confidence 222 35679999987532 3567899999999999999999999743322211 1111 1111 11122344
Q ss_pred chHHHHHHHHhhcccCCCCC---CCHHHHHhhhhhh
Q 004088 413 WSLVFHDFVAKCLTKEPRAR---PTAAEMLKHKFIE 445 (774)
Q Consensus 413 ~s~~l~dLI~kcL~~DP~kR---PTa~ElL~HPwf~ 445 (774)
+++.+..+.++-|..+|++| .++.......|.+
T Consensus 256 fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 256 FSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred cCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 57778899999999999999 4444444444443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=240.60 Aligned_cols=251 Identities=22% Similarity=0.277 Sum_probs=194.1
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCC-cEEEEEEeecCCChhhHHHHHHHHHHHHhCCC----CCcccccccc-cCCceEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTS-ELVAIKVISLSEGEEGYEEIRGEIEMLQQCSH----PNVVRYLGSY-QGEEYLW 262 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g-~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~H----PNIVkL~~~~-~~~~~l~ 262 (774)
+|++.++||+|+||.||+|.+..++ ..+|+|+.......... .+..|+.+|..+.+ +++..+++.. ..+.+.|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 8999999999999999999987764 67999988654333322 67889999999873 5899999988 5888999
Q ss_pred EEEEecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC-----CcEEEeeccccc-
Q 004088 263 IVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ-----GEVKLGDFGVAA- 335 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~-----g~vKL~DFGlA~- 335 (774)
|||+.+ |.+|.++..... +.++...+..|+.|++.+|++||+.|+|||||||+|+++... ..+.|.|||+|+
T Consensus 98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 999999 889999886554 789999999999999999999999999999999999999865 359999999998
Q ss_pred -ccccccc-------c-cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCc
Q 004088 336 -QLTRTMS-------K-RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPM 406 (774)
Q Consensus 336 -~i~~~~~-------~-~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~ 406 (774)
.+..... . ...+.||..|.++.+..+...+.+.|+||++.++.+|+.|..||...................
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~ 256 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKL 256 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhh
Confidence 3221111 1 223569999999999999999999999999999999999999996654322222111111111
Q ss_pred cc--cchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 407 LE--DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 407 ~~--~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.. .....+..+..+...+-..+...+|....+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 257 LTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred ccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 11 112234556667766666788888888776543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=270.90 Aligned_cols=256 Identities=25% Similarity=0.354 Sum_probs=202.0
Q ss_pred eEEeeeeccCceEEEEEEEcCCCcEEEEEEeec----CC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 191 ELLNELGKGSYGAVYKARDLKTSELVAIKVISL----SE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 191 ~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~----~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
.....+|.|+||.|+.+......+.++.|.+.. .. .......+..|+.+-..+.|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456789999999999988877777677775542 11 1222233677888888899999998888877766666669
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc---
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS--- 342 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~--- 342 (774)
|||++ +|+.++. ....+...++..++.||+.||.|||.+||.||||||+|++++.+|.+||+|||.+..+.-...
T Consensus 401 E~~~~-Dlf~~~~-~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~ 478 (601)
T KOG0590|consen 401 EYCPY-DLFSLVM-SNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI 478 (601)
T ss_pred hcccH-HHHHHHh-cccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence 99999 9999885 335789999999999999999999999999999999999999999999999999976644322
Q ss_pred -ccccccccccccchhhhhhcCCCC-ccchhhhHHHHHHHHhCCCCCCCCCchhhhh--hhhcCCC----Cccccchhch
Q 004088 343 -KRNTFIGTPHWMAPEVIQESRYDG-KVDVWALGVSAVEMAEGLPPRSTVHPMRVLF--MISIEPA----PMLEDKEKWS 414 (774)
Q Consensus 343 -~~~~~~GT~~Y~APEvl~~~~~s~-ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~--~i~~~~~----~~~~~~~~~s 414 (774)
.....+|+..|+|||++.+..|++ .+||||.|++++.|++|+.||......+..+ ....... ........++
T Consensus 479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp 558 (601)
T KOG0590|consen 479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLP 558 (601)
T ss_pred hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhch
Confidence 234568999999999999999987 5899999999999999999998765554431 1111111 1111123345
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 415 LVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 415 ~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
...+.+|.+||+.||.+|.|+++|++.+||+...
T Consensus 559 ~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 559 RETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred hhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 6678999999999999999999999999998764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-25 Score=244.13 Aligned_cols=165 Identities=18% Similarity=0.139 Sum_probs=131.4
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcC-CCcEEEEEEeecCC----ChhhHHHHHHHHHHHHhCCCCCccc-ccccccCCc
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLK-TSELVAIKVISLSE----GEEGYEEIRGEIEMLQQCSHPNVVR-YLGSYQGEE 259 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~-~g~~VAVKvi~~~~----~~~~~~~~~~Ei~iL~~L~HPNIVk-L~~~~~~~~ 259 (774)
...+|.+.+.||+|+||+||+|.+.. +++.||||++.... .......+.+|+++|++++|+||+. ++++ .
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 35689999999999999999999876 68888999875321 2234566899999999999999985 5442 3
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccc-cccceEecCCCcEEEeecccccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDI-KGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDL-KPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
..|||||||+|++|... . ... ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+|+.+.
T Consensus 92 ~~~LVmE~~~G~~L~~~-~-~~~------~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-R-PHG------DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CcEEEEEccCCCCHHHh-C-ccc------hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 57999999999999632 1 111 1467889999999999999999999 9999999999999999999998665
Q ss_pred ccccc--------cccccccccccchhhhhhc
Q 004088 339 RTMSK--------RNTFIGTPHWMAPEVIQES 362 (774)
Q Consensus 339 ~~~~~--------~~~~~GT~~Y~APEvl~~~ 362 (774)
..... ....++++.|+|||++...
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 43211 1345789999999998643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-24 Score=217.24 Aligned_cols=247 Identities=20% Similarity=0.272 Sum_probs=197.2
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCC-CCcccccccccCCceEEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSH-PNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~H-PNIVkL~~~~~~~~~l~L 263 (774)
...++|+++++||+|+||.+|+|....+|+.||||+-... ....++.-|.++.+.|++ ..|..+..+..+..+-.+
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~---a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK---AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc---CCCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 4568999999999999999999999999999999986432 233567789999999976 567777888888899999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC---CcEEEeecccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ---GEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~---g~vKL~DFGlA~~i~~~ 340 (774)
||+++ |.+|.++++.....++..++.-++-|++.-++|+|.+++|||||||+|+|+.-+ ..+.|+|||+|+.+...
T Consensus 89 VMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred eeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 99999 789999998888899999999999999999999999999999999999999643 46899999999876543
Q ss_pred cc-------ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhh---hhhcC--CCCccc
Q 004088 341 MS-------KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLF---MISIE--PAPMLE 408 (774)
Q Consensus 341 ~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~---~i~~~--~~~~~~ 408 (774)
.+ ......||..|.+--...+...+.+-|+-|+|.+|..+..|..||.+.......+ .|... ..+...
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~ 247 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEV 247 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHH
Confidence 21 1234679999999888888888899999999999999999999998765433222 22111 111112
Q ss_pred cchhchHHHHHHHHhhcccCCCCCCCH
Q 004088 409 DKEKWSLVFHDFVAKCLTKEPRARPTA 435 (774)
Q Consensus 409 ~~~~~s~~l~dLI~kcL~~DP~kRPTa 435 (774)
--..++.++.-.+.-|-..--++-|..
T Consensus 248 LC~G~P~EF~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 248 LCKGFPAEFAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred HhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence 234556777777777776666666664
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=220.86 Aligned_cols=201 Identities=22% Similarity=0.354 Sum_probs=177.1
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-CCCcccccccccCCceEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~~~~l~LVm 265 (774)
.-.|+++++||+|+||..|+|++..++++||||.-... ....+++.|.+..+.|. .++|...|.+-..+.+-.|||
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecccc---CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 34799999999999999999999999999999976433 23456788888888884 689999998888888999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC-----cEEEeecccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG-----EVKLGDFGVAAQLTRT 340 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g-----~vKL~DFGlA~~i~~~ 340 (774)
|++ |-+|.+++....++|+...+..++.|++.-++|+|++.+|+|||||+|+||..-+ .+.|+|||+|+.+.+.
T Consensus 104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 999 7899999999999999999999999999999999999999999999999996433 5899999999987654
Q ss_pred ccc-------cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 004088 341 MSK-------RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVH 391 (774)
Q Consensus 341 ~~~-------~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~ 391 (774)
.+. .....||.+||+-....+..-+.+-|+-|||-+++++|.|..||.+..
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 332 235679999999999999999999999999999999999999998754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-24 Score=245.48 Aligned_cols=240 Identities=26% Similarity=0.395 Sum_probs=198.2
Q ss_pred eeeccCceEEEEEEE---cCCCcEEEEEEeecCCChh-hHHHHHHHHHHHHhCC-CCCcccccccccCCceEEEEEEecC
Q 004088 195 ELGKGSYGAVYKARD---LKTSELVAIKVISLSEGEE-GYEEIRGEIEMLQQCS-HPNVVRYLGSYQGEEYLWIVMEYCG 269 (774)
Q Consensus 195 ~LG~G~FG~Vy~a~d---~~~g~~VAVKvi~~~~~~~-~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~~~~l~LVmEy~~ 269 (774)
.+|.|+||.|++++. ...|..||+|+.++..... .......|..++..++ ||.+|+++..|+.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998763 3457789999987654211 1114556888888886 9999999999999999999999999
Q ss_pred CCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccccc
Q 004088 270 GGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIG 349 (774)
Q Consensus 270 ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~G 349 (774)
||.|...+. ....+.+.....+...++.+++++|..+|+|||+|++||+++.+|++++.|||+++........ ||
T Consensus 81 gg~lft~l~-~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----cg 155 (612)
T KOG0603|consen 81 GGDLFTRLS-KEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----CG 155 (612)
T ss_pred cchhhhccc-cCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc----cc
Confidence 999988875 4456888888999999999999999999999999999999999999999999999876554222 99
Q ss_pred cccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCC
Q 004088 350 TPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEP 429 (774)
Q Consensus 350 T~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP 429 (774)
|..|||||++. .....+|.||||+++++|++|..||.. +....|... .+..+...+..+.+++..++..+|
T Consensus 156 t~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~---~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 156 TYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA---ELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred chhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh---ccCCchhhhHHHHHHHHHHHhhCH
Confidence 99999999998 578899999999999999999999988 222233221 223455677889999999999999
Q ss_pred CCCCC-----HHHHHhhhhhhhhc
Q 004088 430 RARPT-----AAEMLKHKFIERCK 448 (774)
Q Consensus 430 ~kRPT-----a~ElL~HPwf~~~~ 448 (774)
.+|.- +.++++|+||....
T Consensus 227 ~nrLg~~~~~~~eik~h~f~~~i~ 250 (612)
T KOG0603|consen 227 ENRLGAGPDGVDEIKQHEFFQSID 250 (612)
T ss_pred HHHhccCcchhHHHhccchheeee
Confidence 99975 58999999997543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6e-23 Score=241.60 Aligned_cols=225 Identities=29% Similarity=0.469 Sum_probs=174.5
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
....|..++.|..|+||.||+++++.+.+.+|+|+ ++.. - +.+- +|.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~--l----ilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN--L----ILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccc--h----hhhc--cccccCCccee----------------
Confidence 35689999999999999999999999999999964 2211 1 1111 34444455544
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc---
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS--- 342 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~--- 342 (774)
|+-..+++ .-++++... +.+++|||+.||+|||+||+|+||+.-|++|+.|||+++.......
T Consensus 136 -----gDc~tllk-~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 -----GDCATLLK-NIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred -----chhhhhcc-cCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 44455554 223444322 6799999999999999999999999999999999999864322110
Q ss_pred ------------ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccc
Q 004088 343 ------------KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDK 410 (774)
Q Consensus 343 ------------~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~ 410 (774)
.....||||.|+||||+....|+..+|+|++|+|+||++.|+.||.+..+++++...........+..
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~d 281 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEED 281 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccC
Confidence 11235899999999999999999999999999999999999999999988887766544444444446
Q ss_pred hhchHHHHHHHHhhcccCCCCC---CCHHHHHhhhhhhhhcc
Q 004088 411 EKWSLVFHDFVAKCLTKEPRAR---PTAAEMLKHKFIERCKC 449 (774)
Q Consensus 411 ~~~s~~l~dLI~kcL~~DP~kR---PTa~ElL~HPwf~~~~~ 449 (774)
..+..+++++|.++|+.+|..| +.+-+|.+|+||+.+.+
T Consensus 282 ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw 323 (1205)
T KOG0606|consen 282 EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW 323 (1205)
T ss_pred cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence 6778899999999999999999 56889999999986543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.5e-22 Score=201.93 Aligned_cols=140 Identities=19% Similarity=0.167 Sum_probs=109.4
Q ss_pred EeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh-hh------------------------HHHHHHHHHHHHhCCCCC
Q 004088 193 LNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE-EG------------------------YEEIRGEIEMLQQCSHPN 247 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~-~~------------------------~~~~~~Ei~iL~~L~HPN 247 (774)
...||+|+||.||+|.+. +|+.||||+++..... .. .....+|+++|.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999986 8999999999754210 00 112345999999998887
Q ss_pred cccccccccCCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHH-HhcCcccccccccceEecCCCcE
Q 004088 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYL-HSIFKVHRDIKGGNILLTDQGEV 326 (774)
Q Consensus 248 IVkL~~~~~~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YL-Hs~gIIHRDLKPeNILLd~~g~v 326 (774)
+...+.+... ..+|||||++|+++...+. ....+++..+..++.|++.+|.|| |+.|||||||||+|||++ ++.+
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence 7443332222 2389999999877665432 345789999999999999999999 799999999999999998 4789
Q ss_pred EEeeccccccc
Q 004088 327 KLGDFGVAAQL 337 (774)
Q Consensus 327 KL~DFGlA~~i 337 (774)
+|+|||+|...
T Consensus 157 ~LiDFG~a~~~ 167 (190)
T cd05147 157 YIIDVSQSVEH 167 (190)
T ss_pred EEEEccccccC
Confidence 99999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.7e-22 Score=205.44 Aligned_cols=173 Identities=14% Similarity=0.117 Sum_probs=134.1
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHH------HHHHHHHHHhCCCCCccccccccc
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEE------IRGEIEMLQQCSHPNVVRYLGSYQ 256 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~------~~~Ei~iL~~L~HPNIVkL~~~~~ 256 (774)
...++|++++.||.|+||.||++.. ++..||||++.... ....... +.+|+..+.++.||+|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 3467999999999999999999764 46679999996332 2222222 579999999999999999988865
Q ss_pred CC--------ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEE
Q 004088 257 GE--------EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKL 328 (774)
Q Consensus 257 ~~--------~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL 328 (774)
.. ...+|||||++|.+|.++.. +++ ..+.+++.+|..||+.||+||||||+||+++.+| ++|
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEE
Confidence 32 35899999999999988742 222 2456999999999999999999999999999988 999
Q ss_pred eeccccccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHH
Q 004088 329 GDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMA 381 (774)
Q Consensus 329 ~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELL 381 (774)
+|||........... ..++....|+.++|+|+||+++..+.
T Consensus 176 iDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 176 IDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999988654221110 11444556778999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.3e-21 Score=193.16 Aligned_cols=142 Identities=22% Similarity=0.193 Sum_probs=111.7
Q ss_pred EeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChh-------------------------hHHHHHHHHHHHHhCCCCC
Q 004088 193 LNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEE-------------------------GYEEIRGEIEMLQQCSHPN 247 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~-------------------------~~~~~~~Ei~iL~~L~HPN 247 (774)
...||+|+||.||+|.+. +|+.||||+++...... ....+.+|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999976 89999999987542100 0122468999999999998
Q ss_pred cccccccccCCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHh-cCcccccccccceEecCCCcE
Q 004088 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS-IFKVHRDIKGGNILLTDQGEV 326 (774)
Q Consensus 248 IVkL~~~~~~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs-~gIIHRDLKPeNILLd~~g~v 326 (774)
|.....+.... .||||||++|+++..... ....+++..+..++.|++.+|.+||+ .||+||||||+|||++ ++.+
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 75444333222 489999998875543321 23567888999999999999999999 9999999999999999 7899
Q ss_pred EEeeccccccccc
Q 004088 327 KLGDFGVAAQLTR 339 (774)
Q Consensus 327 KL~DFGlA~~i~~ 339 (774)
+|+|||+|..+..
T Consensus 157 ~liDFG~a~~~~~ 169 (190)
T cd05145 157 YIIDVSQAVELDH 169 (190)
T ss_pred EEEEcccceecCC
Confidence 9999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=201.23 Aligned_cols=233 Identities=23% Similarity=0.310 Sum_probs=154.7
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC--hhhHHHHHHHHHHHHhCCC---C-------Cccccccc--
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG--EEGYEEIRGEIEMLQQCSH---P-------NVVRYLGS-- 254 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~--~~~~~~~~~Ei~iL~~L~H---P-------NIVkL~~~-- 254 (774)
.+.....||.|+|+.||.+++..+|+.+|||++..... ....+++++|.-....+.+ | .++--++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 56778899999999999999999999999999865442 3346677777755554432 1 11111111
Q ss_pred -------cc---CCc-----eEEEEEEecCCCchhhhhhc---cC---CchhHHHHHHHHHHHHHHHHHHHhcCcccccc
Q 004088 255 -------YQ---GEE-----YLWIVMEYCGGGSVADLMNV---TE---EPLEEYQIAYICREALKGLAYLHSIFKVHRDI 313 (774)
Q Consensus 255 -------~~---~~~-----~l~LVmEy~~ggsL~dll~~---~~---~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDL 313 (774)
+. +.. ..+++|+-+ .++|.+++.. .. ..+.......+..|+++.+++||++||||+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 111 236788888 6688777542 11 12444445667799999999999999999999
Q ss_pred cccceEecCCCcEEEeeccccccccccccccccccccccccchhhhhhc--------CCCCccchhhhHHHHHHHHhCCC
Q 004088 314 KGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQES--------RYDGKVDVWALGVSAVEMAEGLP 385 (774)
Q Consensus 314 KPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~--------~~s~ksDIWSLGviLyELLtG~~ 385 (774)
||+|+|++.+|.++|+||+.....+..... ...+..|.+||..... .++.+.|.|+||+++|.|.+|..
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 999999999999999999987554433221 2456789999987542 47889999999999999999999
Q ss_pred CCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCC
Q 004088 386 PRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRAR 432 (774)
Q Consensus 386 Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kR 432 (774)
||........... .+..-...+..++.||..+|++||.+|
T Consensus 249 Pf~~~~~~~~~~~-------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW-------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG-------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc-------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9987644332211 111222667889999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-21 Score=229.75 Aligned_cols=244 Identities=20% Similarity=0.263 Sum_probs=182.6
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhH---HHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY---EEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~---~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
+|...+.||++.|=+|.+|++ ..|. |+||++-+....-.. .+-..|++ ...++|||++.+..+-..+...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 788999999999999999986 4565 999999765533333 34445555 55679999999999988899999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
+|+ ..+|.|.+. .+..+...+.++|+.||+.||.-+|..||+|+|||.+||||+.-+-+.|+||..-+...-+..+..
T Consensus 101 qyv-khnLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 101 QYV-KHNLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHH-hhhhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 999 558999885 456788999999999999999999999999999999999999988899999987654322211111
Q ss_pred -------cccccccccchhhhhhc----------C-CCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCc
Q 004088 346 -------TFIGTPHWMAPEVIQES----------R-YDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPM 406 (774)
Q Consensus 346 -------~~~GT~~Y~APEvl~~~----------~-~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~ 406 (774)
+...-.+|+|||.+... . .+++.||||+||+++||++ |+|||.-.. ++.........
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----L~aYr~~~~~~ 254 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----LLAYRSGNADD 254 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----HHhHhccCccC
Confidence 11223469999988542 2 6778999999999999874 788886311 11111110000
Q ss_pred cc--cchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 407 LE--DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 407 ~~--~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.+ -..--+..++++|..|++.||.+|.+|++.|+.
T Consensus 255 ~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 255 PEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 00 001113358899999999999999999999975
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-20 Score=188.57 Aligned_cols=185 Identities=17% Similarity=0.111 Sum_probs=139.1
Q ss_pred eEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC---hhhHHHHHHHHHHHHhCC-CCCcccccccccCCceEEEEEE
Q 004088 191 ELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG---EEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 191 ~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~---~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~~~~l~LVmE 266 (774)
.+...|++|+||+||++.. .+..++.+.+..... .-....+.+|+++|++|. |++|++++++ ...|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4567899999999998863 677788777653332 111225789999999995 5789999886 34799999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccc-cccceEecCCCcEEEeeccccccccccccc--
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDI-KGGNILLTDQGEVKLGDFGVAAQLTRTMSK-- 343 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDL-KPeNILLd~~g~vKL~DFGlA~~i~~~~~~-- 343 (774)
|+.|.+|...+.. . ...++.|++.+|.+||++||||||| ||+|||++.++.++|+|||+|.........
T Consensus 79 yI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 79 YLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred eecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 9999988654321 1 1347789999999999999999999 799999999999999999999754432210
Q ss_pred -----------cccccccccccchhhhhhc-CCC-CccchhhhHHHHHHHHhCCCCCCC
Q 004088 344 -----------RNTFIGTPHWMAPEVIQES-RYD-GKVDVWALGVSAVEMAEGLPPRST 389 (774)
Q Consensus 344 -----------~~~~~GT~~Y~APEvl~~~-~~s-~ksDIWSLGviLyELLtG~~Pf~~ 389 (774)
......++.|++|+...-. ..+ ...+.++.|+-+|.++|+..++..
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0012367888888875432 233 456888999999999999887654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.4e-20 Score=187.38 Aligned_cols=134 Identities=22% Similarity=0.255 Sum_probs=107.5
Q ss_pred EeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-----CCCCcccccccccCCc---e-EEE
Q 004088 193 LNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-----SHPNVVRYLGSYQGEE---Y-LWI 263 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-----~HPNIVkL~~~~~~~~---~-l~L 263 (774)
.+.||+|+||.||. +..++.. +||++.... ....+.+.+|+.+++.+ .||||+++|++++++. . +.+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 46899999999995 6777766 699986543 23456799999999999 5799999999998763 4 448
Q ss_pred EEEe--cCCCchhhhhhccCCchhHHHHHHHHHHHHHHH-HHHHhcCcccccccccceEecCC----CcEEEeecccc
Q 004088 264 VMEY--CGGGSVADLMNVTEEPLEEYQIAYICREALKGL-AYLHSIFKVHRDIKGGNILLTDQ----GEVKLGDFGVA 334 (774)
Q Consensus 264 VmEy--~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL-~YLHs~gIIHRDLKPeNILLd~~----g~vKL~DFGlA 334 (774)
|||| +.+++|.+++.. ..+++. ..++.|++.++ +|||+++||||||||+|||++.. +.++|+||+.+
T Consensus 83 I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 9999 557999999964 346655 35678888888 99999999999999999999743 37999995444
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=195.87 Aligned_cols=261 Identities=24% Similarity=0.306 Sum_probs=177.0
Q ss_pred CCCCcccCCCCCCeeEEeeeeccCceEEEEEEEcCCCc-----------------------------------EEEEEEe
Q 004088 177 IPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSE-----------------------------------LVAIKVI 221 (774)
Q Consensus 177 ~~~~~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~-----------------------------------~VAVKvi 221 (774)
++.........++|+++.-||+|.-+.||.|....+|. +.|||.+
T Consensus 146 i~~r~dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmM 225 (598)
T KOG4158|consen 146 IPNRIDSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMM 225 (598)
T ss_pred CcchhhcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHh
Confidence 34444445556789999999999999999887543210 2456655
Q ss_pred ecCCChh----hHHHHHHHH------HHH--------Hh--------CCCCCcccccccccC------------------
Q 004088 222 SLSEGEE----GYEEIRGEI------EML--------QQ--------CSHPNVVRYLGSYQG------------------ 257 (774)
Q Consensus 222 ~~~~~~~----~~~~~~~Ei------~iL--------~~--------L~HPNIVkL~~~~~~------------------ 257 (774)
-.-.... ..+.+.+|+ .++ +. -.|||||++...|.+
T Consensus 226 fN~~~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~ 305 (598)
T KOG4158|consen 226 FNFEHDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPA 305 (598)
T ss_pred cccccCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccc
Confidence 3211111 122222222 011 11 249999999887642
Q ss_pred ---------CceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC--CC--
Q 004088 258 ---------EEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD--QG-- 324 (774)
Q Consensus 258 ---------~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~--~g-- 324 (774)
...+|+||-.. ..+|..++-. ...+.....-|+.|+++|+.|||.+||.|||||.+||||.- ++
T Consensus 306 R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~--~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P 382 (598)
T KOG4158|consen 306 RWYPSGAGEPKTLYLVMKRY-RQTLREYLWT--RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIP 382 (598)
T ss_pred eecccccCCCceEEEehhcc-hhhHHHHHhc--CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCc
Confidence 34689999988 4588888753 34666777889999999999999999999999999999953 33
Q ss_pred cEEEeecccccccccc------ccccccccccccccchhhhhhcC-----C-CCccchhhhHHHHHHHHhCCCCCCCCCc
Q 004088 325 EVKLGDFGVAAQLTRT------MSKRNTFIGTPHWMAPEVIQESR-----Y-DGKVDVWALGVSAVEMAEGLPPRSTVHP 392 (774)
Q Consensus 325 ~vKL~DFGlA~~i~~~------~~~~~~~~GT~~Y~APEvl~~~~-----~-s~ksDIWSLGviLyELLtG~~Pf~~~~~ 392 (774)
.+.|+|||.+---... .+.....-|....||||+....+ . -.++|.|+.|.+.||++....||.....
T Consensus 383 ~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe 462 (598)
T KOG4158|consen 383 QLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE 462 (598)
T ss_pred EEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch
Confidence 5899999987322111 11222345788899999986432 1 2489999999999999999999987443
Q ss_pred hhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCH---HHHHhh
Q 004088 393 MRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTA---AEMLKH 441 (774)
Q Consensus 393 ~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa---~ElL~H 441 (774)
+.+-... .........+..+++.+++++..+|+.||.+|++. ..+|+-
T Consensus 463 m~L~~r~-Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~L 513 (598)
T KOG4158|consen 463 MLLDTRT-YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNL 513 (598)
T ss_pred heechhh-hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHH
Confidence 3222111 11122223355678889999999999999999884 556653
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.2e-19 Score=212.83 Aligned_cols=193 Identities=25% Similarity=0.340 Sum_probs=158.1
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC---CCCcccccccccCCceEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS---HPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~---HPNIVkL~~~~~~~~~l~L 263 (774)
...|.|-+.||+|+||.||+|.... |+.||||+-+.... -+|.--.+++.+|+ -+.|+.+...+.-.+..+|
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~----WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP----WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc----eeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 3579999999999999999999765 99999998543221 12333345555665 3466777777777888899
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC-------CcEEEeecccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ-------GEVKLGDFGVAAQ 336 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~-------g~vKL~DFGlA~~ 336 (774)
|+||.+.|+|.++++ ..+.++|..+..++.|++..++.||.++|||+||||+|+||... ..++|+|||.+-.
T Consensus 772 v~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred eeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 999999999999997 66789999999999999999999999999999999999999532 3589999999865
Q ss_pred cccc--ccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCC
Q 004088 337 LTRT--MSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLP 385 (774)
Q Consensus 337 i~~~--~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~ 385 (774)
+.-- ...-...++|-.+--+|+..+..|+..+|.|.|+-+++.||.|+.
T Consensus 851 m~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 851 MKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 5332 122344578889999999999999999999999999999999965
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=4e-19 Score=185.79 Aligned_cols=145 Identities=21% Similarity=0.156 Sum_probs=114.1
Q ss_pred CeeEEeeeeccCceEEEEEE-EcCCCcEEEEEEeecCCCh-------------------h----hHHHHHHHHHHHHhCC
Q 004088 189 KYELLNELGKGSYGAVYKAR-DLKTSELVAIKVISLSEGE-------------------E----GYEEIRGEIEMLQQCS 244 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~-d~~~g~~VAVKvi~~~~~~-------------------~----~~~~~~~Ei~iL~~L~ 244 (774)
-|.+.+.||+|+||.||+|. +..+|+.||||+++..... . ....+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998 6779999999998743210 0 1123568999999997
Q ss_pred CCC--cccccccccCCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcC-cccccccccceEec
Q 004088 245 HPN--VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF-KVHRDIKGGNILLT 321 (774)
Q Consensus 245 HPN--IVkL~~~~~~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~g-IIHRDLKPeNILLd 321 (774)
+.+ +.+++++ ...+|||||++|.+|..... ....+....+..++.||+.+|.|||.+| |+||||||+|||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL-KDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc-ccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 532 3344432 23589999999988876542 2345667778899999999999999999 99999999999999
Q ss_pred CCCcEEEeeccccccccc
Q 004088 322 DQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 322 ~~g~vKL~DFGlA~~i~~ 339 (774)
++.++|+|||+|.....
T Consensus 184 -~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 184 -DGKVVIIDVSQSVELDH 200 (237)
T ss_pred -CCCEEEEEChhhhccCC
Confidence 78999999999865443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.7e-19 Score=203.88 Aligned_cols=296 Identities=19% Similarity=0.292 Sum_probs=203.1
Q ss_pred HHhCCCCCcccccccccCCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCc-ccccccccce
Q 004088 240 LQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFK-VHRDIKGGNI 318 (774)
Q Consensus 240 L~~L~HPNIVkL~~~~~~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gI-IHRDLKPeNI 318 (774)
|+.+.|.|+.++++.+.++...++|.+||..|+|.+.+......+++.....++++|+.||.|||.-.| .|+-|+..|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 457899999999999999999999999999999999998777889999999999999999999999876 9999999999
Q ss_pred EecCCCcEEEeecccccccccc--ccccccccccccccchhhhhhcC-------CCCccchhhhHHHHHHHHhCCCCCCC
Q 004088 319 LLTDQGEVKLGDFGVAAQLTRT--MSKRNTFIGTPHWMAPEVIQESR-------YDGKVDVWALGVSAVEMAEGLPPRST 389 (774)
Q Consensus 319 LLd~~g~vKL~DFGlA~~i~~~--~~~~~~~~GT~~Y~APEvl~~~~-------~s~ksDIWSLGviLyELLtG~~Pf~~ 389 (774)
+++....+||+|||+....... ........-..-|.|||.+.... .+.+.||||||++++|+++...||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 9999999999999998765321 01111112345699999997642 46679999999999999999999976
Q ss_pred CCc----hhhhhhhhc-CCC---CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhccCccccchhHHHH
Q 004088 390 VHP----MRVLFMISI-EPA---PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKA 461 (774)
Q Consensus 390 ~~~----~~~i~~i~~-~~~---~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~~~~~~lp~~~~~ 461 (774)
... .+.+..+.. ... |.........+.+..++..||..+|.+||++.++-.. ++.........-......
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~--~~~~~~~~~~~~nl~D~m 238 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK--LLTINKGGSSKGNLMDSL 238 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh--hhhhcccccccchhHHHH
Confidence 322 234444333 111 1111112445578899999999999999999998542 111111110000112222
Q ss_pred HHHHHHHHHHHHHHhcCCcchhhhcccccccccCCCCCCCCccccccccccccccccccccccccCCCceeEEEec
Q 004088 462 RQIRASMAQQAQNILSDEPEVNATMGLKLNEDYGDTVPSKPQVQVTNEVLATSTLKKQHTLEDMEEGDFGTVVVHE 537 (774)
Q Consensus 462 r~~~~~~~~~~~~iLs~e~e~~at~~lk~n~~~~~~~ps~~~~~v~~~~~~~~t~~~q~t~e~~de~~~Gtivi~~ 537 (774)
-...+.+....+....+..........+.......++|.++...++......|......++.+.+.-+|.++.-++
T Consensus 239 ~~~le~Y~~nLe~~v~eRt~~l~~e~~k~d~LL~~mLP~~VA~~lk~G~~v~pe~~~~vti~fsDiv~fT~l~~~~ 314 (484)
T KOG1023|consen 239 FRMLESYADNLEKLVDERTAELEEEKKKTDTLLGQMLPKSVAESLKLGKTVDPESFDSVTIYFSDIVGFTVLSSNS 314 (484)
T ss_pred HHHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHhcCHHHhhHhhcCCcCCccccCceeeeeHHHHHHHHHHhcC
Confidence 2222333322222222222222333344555567788888888888777777777766666666666665544443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-19 Score=187.31 Aligned_cols=243 Identities=19% Similarity=0.343 Sum_probs=191.7
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
.....++.+|.+...|..|+|++..+ -+++|++..... ......|..|.-.|+-+.||||+.+++.|....++.++.
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred hhhhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 34566777899999999999997544 467787765442 233356888999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcC--cccccccccceEecCCCcEEE--eecccccccccc
Q 004088 266 EYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIF--KVHRDIKGGNILLTDQGEVKL--GDFGVAAQLTRT 340 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~g--IIHRDLKPeNILLd~~g~vKL--~DFGlA~~i~~~ 340 (774)
.||+.|+|+.+++... -..+..++.+++.+|++|++|||+.- |.---|....++|+++.+.+| +|--++.+.
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe--- 343 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE--- 343 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec---
Confidence 9999999999997433 34778899999999999999999975 444568899999999887665 443333111
Q ss_pred ccccccccccccccchhhhhhcCCC---CccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHH
Q 004088 341 MSKRNTFIGTPHWMAPEVIQESRYD---GKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVF 417 (774)
Q Consensus 341 ~~~~~~~~GT~~Y~APEvl~~~~~s---~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l 417 (774)
....-.|.||+||.++..+-+ .++|+|||++++|||.+...||....+++.--.+..+... ...++.++..+
T Consensus 344 ----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglr-v~ippgis~hm 418 (448)
T KOG0195|consen 344 ----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLR-VHIPPGISRHM 418 (448)
T ss_pred ----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccc-ccCCCCccHHH
Confidence 111337889999999876543 4799999999999999999999999988876555444322 23456778889
Q ss_pred HHHHHhhcccCCCCCCCHHHHH
Q 004088 418 HDFVAKCLTKEPRARPTAAEML 439 (774)
Q Consensus 418 ~dLI~kcL~~DP~kRPTa~ElL 439 (774)
..||.-|+..||.+||.+..++
T Consensus 419 ~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 419 NKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHhcCCCCcCCCcceeh
Confidence 9999999999999999998875
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=3e-18 Score=173.28 Aligned_cols=136 Identities=24% Similarity=0.280 Sum_probs=113.1
Q ss_pred EeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC--h-----hhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 193 LNELGKGSYGAVYKARDLKTSELVAIKVISLSEG--E-----EGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~--~-----~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
++.||+|++|.||+|.+ .|..|+||+...... . .....+.+|+.++..+.|++|+....++......++||
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 36799999999999986 677899998643221 1 11245778999999999999887777777777889999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQ 336 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~ 336 (774)
||++|++|.+++.... . .+..++.+++.+|.+||..|++|||++|.|||++ ++.++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999885321 2 7888999999999999999999999999999999 78899999998854
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.8e-19 Score=201.14 Aligned_cols=248 Identities=23% Similarity=0.330 Sum_probs=165.6
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCC---CcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccc-------ccc-
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKT---SELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLG-------SYQ- 256 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~---g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~-------~~~- 256 (774)
..+.+.+-.+..+++.++..+...+ .+.+.-|....... .......+++-.+.-..|-+..-+.+ .+.
T Consensus 244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~-~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~ 322 (516)
T KOG1033|consen 244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSL-CACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKR 322 (516)
T ss_pred ccccccccccccccCCchhhhhcccchhhhhccchhhhccch-hhhhhhhhhhhheeccccCCcccccCCCCchhhhccc
Confidence 3455566667777777665543322 33344443322211 22233444555555444433322222 111
Q ss_pred ----CCceEEEEEEecCCCchhhhhhcc--CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEee
Q 004088 257 ----GEEYLWIVMEYCGGGSVADLMNVT--EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGD 330 (774)
Q Consensus 257 ----~~~~l~LVmEy~~ggsL~dll~~~--~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~D 330 (774)
...++||.|++|...+|.+++..+ ....+....+.++.|++.|++| +|.+|||+||.||++..+..+||.|
T Consensus 323 ~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgD 399 (516)
T KOG1033|consen 323 NKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGD 399 (516)
T ss_pred cccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhh
Confidence 234689999999999999999633 3457788899999999999999 9999999999999999999999999
Q ss_pred ccccccccccc------cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCC
Q 004088 331 FGVAAQLTRTM------SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEP 403 (774)
Q Consensus 331 FGlA~~i~~~~------~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~ 403 (774)
||+........ ......+||.+||+||.+.+..|+.++||||||+||+||+. -..+|........ +....
T Consensus 400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d---~r~g~ 476 (516)
T KOG1033|consen 400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTD---IRDGI 476 (516)
T ss_pred hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhh---hhcCC
Confidence 99987654432 12345689999999999999999999999999999999986 2233322211111 11111
Q ss_pred CCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 404 APMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 404 ~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
.|. .....+ +.-..|+.+||.+.|.+||++.+.--|+|.
T Consensus 477 ip~-~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 477 IPP-EFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred CCh-HHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 110 011111 223589999999999999988887777764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.2e-18 Score=170.93 Aligned_cols=131 Identities=23% Similarity=0.227 Sum_probs=105.8
Q ss_pred eeeccCceEEEEEEEcCCCcEEEEEEeecCCC-h------hhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 195 ELGKGSYGAVYKARDLKTSELVAIKVISLSEG-E------EGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 195 ~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~------~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
.||+|+||.||+|. .+|..|+||+...... . ...+.+.+|+++++.+.|+++.....++......++||||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 48999999999998 4678899998643221 1 1135677899999999988765555555556667899999
Q ss_pred cCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccc
Q 004088 268 CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQ 336 (774)
Q Consensus 268 ~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~ 336 (774)
++|++|.+++.... . .++.+++.+|.+||+.|++|||+||.|||++ ++.++|+|||++..
T Consensus 79 ~~g~~l~~~~~~~~--~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN--D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH--H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998875321 1 7899999999999999999999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.7e-18 Score=170.45 Aligned_cols=138 Identities=21% Similarity=0.187 Sum_probs=109.1
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh---------------------hhHHHHHHHHHHHHhCCCCC
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE---------------------EGYEEIRGEIEMLQQCSHPN 247 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~---------------------~~~~~~~~Ei~iL~~L~HPN 247 (774)
.|.+.+.||.|+||.||++.+ .+|+.||||++...... .......+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 378889999999999999986 48999999997643210 01123567899999998874
Q ss_pred --cccccccccCCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCc
Q 004088 248 --VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE 325 (774)
Q Consensus 248 --IVkL~~~~~~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~ 325 (774)
++..++. ...++||||++|++|..+... .....++.+++.++.++|..||+||||||+||+++.++.
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence 4444432 345899999999998776431 335678899999999999999999999999999999999
Q ss_pred EEEeecccccccc
Q 004088 326 VKLGDFGVAAQLT 338 (774)
Q Consensus 326 vKL~DFGlA~~i~ 338 (774)
++|+|||++..+.
T Consensus 164 ~~liDfg~~~~~~ 176 (198)
T cd05144 164 IYIIDWPQMVSTD 176 (198)
T ss_pred EEEEECCccccCC
Confidence 9999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.4e-19 Score=209.70 Aligned_cols=261 Identities=25% Similarity=0.351 Sum_probs=208.2
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCC-CcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCC-CCCcccccccccCCceEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKT-SELVAIKVISLSE-GEEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~-g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~~~~l~ 262 (774)
+...|.+.+.||+|+|+.|-++....+ ...+|+|.+.... .....+.+..|..+-+.+. |+|++.+++...+....+
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 356788899999999999998876443 4557788776443 3344455667888888887 999999999999999999
Q ss_pred EEEEecCCCchhhhh-hccCCchhHHHHHHHHHHHHHHHHHHH-hcCcccccccccceEecCCC-cEEEeeccccccccc
Q 004088 263 IVMEYCGGGSVADLM-NVTEEPLEEYQIAYICREALKGLAYLH-SIFKVHRDIKGGNILLTDQG-EVKLGDFGVAAQLTR 339 (774)
Q Consensus 263 LVmEy~~ggsL~dll-~~~~~~Lse~~i~~I~~QIl~gL~YLH-s~gIIHRDLKPeNILLd~~g-~vKL~DFGlA~~i~~ 339 (774)
++++|..|+++.+.+ .......+......++.|+..++.|+| ..++.||||||+|.+++..+ .++++|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999988 433236778888999999999999999 99999999999999999999 999999999987765
Q ss_pred -ccc--ccccccc-cccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCC--CCccccchh
Q 004088 340 -TMS--KRNTFIG-TPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEP--APMLEDKEK 412 (774)
Q Consensus 340 -~~~--~~~~~~G-T~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~--~~~~~~~~~ 412 (774)
... .....+| ++.|+|||...+. ......|+||.|+++.-+++|..||.........+...... .........
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 222 2234578 9999999999884 45678999999999999999999987655443322211111 111223345
Q ss_pred chHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 413 WSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 413 ~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
.+....+++.++|..+|..|.+..++..+||+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 5677889999999999999999999999999975
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.6e-17 Score=190.91 Aligned_cols=139 Identities=24% Similarity=0.228 Sum_probs=111.8
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-C------hhhHHHHHHHHHHHHhCCCCCcccccccccCCc
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-G------EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE 259 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~------~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~ 259 (774)
...|...+.||+|+||+||++.+... .+++|+..... . ....+.+.+|+++|+.++|++|+..+.++....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 34567789999999999999986443 34444432111 1 112356889999999999999988777777777
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL 337 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i 337 (774)
..++||||++|++|.+++. ....++.+++.+|.|||+.||+||||||+|||+ .++.++|+|||+++..
T Consensus 410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 7899999999999998874 356789999999999999999999999999999 5689999999999653
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=9.9e-17 Score=159.19 Aligned_cols=138 Identities=22% Similarity=0.236 Sum_probs=98.1
Q ss_pred EeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChh-hHHH----------------------HHHHHHHHHhCCCCC--
Q 004088 193 LNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEE-GYEE----------------------IRGEIEMLQQCSHPN-- 247 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~-~~~~----------------------~~~Ei~iL~~L~HPN-- 247 (774)
++.||+|+||+||+|.+. +++.||||++....... .... ...|...+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999875 89999999986432110 1111 134556666654332
Q ss_pred cccccccccCCceEEEEEEecCCCchhh-hhhccCCchhHHHHHHHHHHHHHHHHHHHh-cCcccccccccceEecCCCc
Q 004088 248 VVRYLGSYQGEEYLWIVMEYCGGGSVAD-LMNVTEEPLEEYQIAYICREALKGLAYLHS-IFKVHRDIKGGNILLTDQGE 325 (774)
Q Consensus 248 IVkL~~~~~~~~~l~LVmEy~~ggsL~d-ll~~~~~~Lse~~i~~I~~QIl~gL~YLHs-~gIIHRDLKPeNILLd~~g~ 325 (774)
+.+.+++ ...++||||++++.+.. .+... .. ...+..++.+++.++.++|. .||+||||||+|||++ ++.
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~--~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV--RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh--hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 3444433 23589999999854322 11110 01 15678899999999999999 9999999999999999 889
Q ss_pred EEEeeccccccccc
Q 004088 326 VKLGDFGVAAQLTR 339 (774)
Q Consensus 326 vKL~DFGlA~~i~~ 339 (774)
++|+|||.+.....
T Consensus 153 ~~liDfg~a~~~~~ 166 (187)
T cd05119 153 VYIIDVPQAVEIDH 166 (187)
T ss_pred EEEEECcccccccC
Confidence 99999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.4e-16 Score=144.76 Aligned_cols=132 Identities=23% Similarity=0.297 Sum_probs=111.6
Q ss_pred EEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCC--CCcccccccccCCceEEEEEEecC
Q 004088 192 LLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSH--PNVVRYLGSYQGEEYLWIVMEYCG 269 (774)
Q Consensus 192 ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~H--PNIVkL~~~~~~~~~l~LVmEy~~ 269 (774)
+++.||.|.++.||++... +..++||++..... ...+.+|+.+++.+.| .++++++.++...+..+++|||+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 4678999999999999864 36799999754332 4568899999999976 589999998888889999999998
Q ss_pred CCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhc---CcccccccccceEecCCCcEEEeecccccc
Q 004088 270 GGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI---FKVHRDIKGGNILLTDQGEVKLGDFGVAAQ 336 (774)
Q Consensus 270 ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~---gIIHRDLKPeNILLd~~g~vKL~DFGlA~~ 336 (774)
++.+..+ +......++.+++.+|.+||.. +++|+||+|.|||++..+.++++|||.+..
T Consensus 77 g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8777654 4456677889999999999985 699999999999999989999999998854
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.1e-15 Score=156.72 Aligned_cols=135 Identities=19% Similarity=0.181 Sum_probs=103.0
Q ss_pred eeee-ccCceEEEEEEEcCCCcEEEEEEeecCC------------ChhhHHHHHHHHHHHHhCCCCCc--ccccccccCC
Q 004088 194 NELG-KGSYGAVYKARDLKTSELVAIKVISLSE------------GEEGYEEIRGEIEMLQQCSHPNV--VRYLGSYQGE 258 (774)
Q Consensus 194 k~LG-~G~FG~Vy~a~d~~~g~~VAVKvi~~~~------------~~~~~~~~~~Ei~iL~~L~HPNI--VkL~~~~~~~ 258 (774)
..|| .|+.|+||.+.. .+..++||.+.... .......+.+|+.++.+|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 788888888874 37789999885321 01223467889999999998875 6666654322
Q ss_pred -c---eEEEEEEecCC-CchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccc
Q 004088 259 -E---YLWIVMEYCGG-GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGV 333 (774)
Q Consensus 259 -~---~l~LVmEy~~g-gsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGl 333 (774)
. ..+|||||++| .+|.+++.. ..+++.. +.+|+.+|.+||++||+||||||.|||++.++.++|+|||.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 2 23599999997 688888753 3455443 56899999999999999999999999999988999999998
Q ss_pred ccc
Q 004088 334 AAQ 336 (774)
Q Consensus 334 A~~ 336 (774)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 854
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=4.3e-15 Score=168.75 Aligned_cols=255 Identities=24% Similarity=0.251 Sum_probs=195.6
Q ss_pred CCCCeeEEeeeec--cCceEEEEEEE--cCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhC-CCCCcccccccccCCc
Q 004088 186 PTTKYELLNELGK--GSYGAVYKARD--LKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEE 259 (774)
Q Consensus 186 ~~~~Y~ilk~LG~--G~FG~Vy~a~d--~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~ 259 (774)
....|.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.... ......-.+|+...+++ .|+|.++.+..++..+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 3456778889999 99999999988 88899999998432211 12222334677777777 5999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHH----HHHHHHhcCcccccccccceEecCC-CcEEEeecccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALK----GLAYLHSIFKVHRDIKGGNILLTDQ-GEVKLGDFGVA 334 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~----gL~YLHs~gIIHRDLKPeNILLd~~-g~vKL~DFGlA 334 (774)
..|+-+|+| +.+|..+.......+++..++.++.+... ||.++|+.+|+|-|+||.||++..+ ..++++|||+.
T Consensus 192 ~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 192 ILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred cceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 999999999 57888877666666899999999999999 9999999999999999999999999 78999999999
Q ss_pred ccccccccccc-----cccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCC--CchhhhhhhhcCCCCcc
Q 004088 335 AQLTRTMSKRN-----TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTV--HPMRVLFMISIEPAPML 407 (774)
Q Consensus 335 ~~i~~~~~~~~-----~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~--~~~~~i~~i~~~~~~~~ 407 (774)
..+....-... ...|...|++||++.+. ++...|||++|.++.+-.++..++... .....+. ... ...
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r---~~~-ip~ 345 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR---QGY-IPL 345 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCccccc---ccc-Cch
Confidence 88765432222 22578889999998774 899999999999999988886554322 1111110 000 111
Q ss_pred ccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 408 EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 408 ~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
+.-...+..+.-.+..|+..+|..|++++.+++|++++.
T Consensus 346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 112233445566899999999999999999999999863
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.5e-15 Score=178.12 Aligned_cols=264 Identities=26% Similarity=0.404 Sum_probs=210.2
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
.....+.+.+-+-+|.|+.++.+.-..+|-..++|+..+.. .....+.++.+-.++....||-++...-.+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34567888889999999999999877778777777764332 1222344555556665566788887777777788999
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc--
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT-- 340 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~-- 340 (774)
||++|..+++|...++.. ...++.-.+.++..+..+++|||...++|||++|.|+|+..+++.+++|||......--
T Consensus 881 L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred hhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 999999999999988643 35677777778888999999999999999999999999999999999999844322100
Q ss_pred -------------------------c----cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 004088 341 -------------------------M----SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVH 391 (774)
Q Consensus 341 -------------------------~----~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~ 391 (774)
. .......||+.|.+||.+.+......+|+|++|++++|.++|.+||....
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 0 01123579999999999999999999999999999999999999999988
Q ss_pred chhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHH---HHHhhhhhhhhcc
Q 004088 392 PMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAA---EMLKHKFIERCKC 449 (774)
Q Consensus 392 ~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~---ElL~HPwf~~~~~ 449 (774)
+.+....+.....+-..-....+...++++..+|..+|.+|..+. ++-.|+||+...+
T Consensus 1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence 888877666554444444566688899999999999999998877 8999999986544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1e-14 Score=165.87 Aligned_cols=419 Identities=33% Similarity=0.412 Sum_probs=280.6
Q ss_pred CCcccceeEEEEecCCCCCCCccccc----------cCCccCcccc--cCcccccCC---CCCchhhhcCCccCCCCCCC
Q 004088 14 PSRSEIYSTVVIHDDDDDDDDDEETR----------YDSDSRTNYS--QNDAVMEDD---DSLPPLLKRLPKDFGAAPPE 78 (774)
Q Consensus 14 ~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~--~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 78 (774)
-.++|+|++++||-+.+-|-.-.-|+ -+-.-.++|+ |....|++| ..+++++++++++|+...-|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 45789999999999887764322111 1112233443 444445443 46899999999999999999
Q ss_pred C----CCCcCCCccchhhhhccc-------ccccccccccCCCcccccccC------CCC---------ccceEEEEeCC
Q 004088 79 D----DDEEDGDFGTMIIKTRTK-------TKAKNSRTIVNKPYSEFKKTD------GDD---------EFGTFVVRSKD 132 (774)
Q Consensus 79 ~----~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~------~~~---------~~~~f~~r~~~ 132 (774)
| +--.|..|++.+-+..+- -+--.--+++..+--..|+.+ |.. .++.|+..+++
T Consensus 92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks 171 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS 171 (829)
T ss_pred EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence 8 233456778776652221 111111122221111111111 111 22445554432
Q ss_pred --Cc-----------cccCCCCCCccchhhhcccccCCCCCCCCccc---c-ccccccCCCCCCCcccCCCCCCeeEEee
Q 004088 133 --GE-----------RRSGGYDDSTMGRAVASMRRFGSSSSLHGEDV---R-QQTKVSSSSIPESVTREDPTTKYELLNE 195 (774)
Q Consensus 133 --g~-----------~~~gg~~~s~~~~~~~~~~r~~ssss~~~~~~---~-~~~~~ssss~~~~~~~~~~~~~Y~ilk~ 195 (774)
|. -+.|||..----.+.+ ....+.+..++... . +.....+.+.+.....+.++..|.....
T Consensus 172 fiGtpywmapEvaaverkggynqlcdiwa~g--itAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~ 249 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALG--ITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHN 249 (829)
T ss_pred ccCCccccchhHHHHHhcccccccccccccc--cchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHH
Confidence 11 1223332110000000 00001111111111 0 1122345566677778888889999999
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCC-cccccccccCCceEEEEEEecCCC-ch
Q 004088 196 LGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPN-VVRYLGSYQGEEYLWIVMEYCGGG-SV 273 (774)
Q Consensus 196 LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPN-IVkL~~~~~~~~~l~LVmEy~~gg-sL 273 (774)
+++|+++.+++.+...+...+ .+++... ....-++++|.+++||| .+..++-++.+.+.+++|++|.++ +.
T Consensus 250 fvK~altknpKkRptaeklL~-h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQ-HPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHhcCCCccCCChhhhee-ceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 999999999999876666555 7776432 44567899999999999 888888899999999999999887 44
Q ss_pred hhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccccccccc
Q 004088 274 ADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHW 353 (774)
Q Consensus 274 ~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y 353 (774)
........-.+.+.+...+++.-.++|+|||+.--+||| |||..+ +..+..||+....+.... ..++..+|+.+
T Consensus 323 ~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~~~~~~~ 396 (829)
T KOG0576|consen 323 ALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRTAIGTPEP 396 (829)
T ss_pred cccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-ccccCCCCCCC
Confidence 433333334566677777888889999999999889999 888876 679999999998877664 55677899999
Q ss_pred cchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCC-CCccccchhchHHHHH-HHHhhcccCCCC
Q 004088 354 MAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEP-APMLEDKEKWSLVFHD-FVAKCLTKEPRA 431 (774)
Q Consensus 354 ~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~-~~~~~~~~~~s~~l~d-LI~kcL~~DP~k 431 (774)
+|||+.....+....|.|++|+-..++.-|.+|-.. +......+...+ .+.+.....|+..+.+ +...|+...|..
T Consensus 397 ~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~ 474 (829)
T KOG0576|consen 397 LAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPT 474 (829)
T ss_pred CCchhhcccccccCCCccCCCcchhhcCCCCCCCCC--CccccCCCCCCCCccccchhhhcCcccccCCcccccCCCCCC
Confidence 999999999999999999999988888888888654 455555555554 4555555677776666 999999999999
Q ss_pred CCCHHHHHhhhhhhhhcc
Q 004088 432 RPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 432 RPTa~ElL~HPwf~~~~~ 449 (774)
|+....++.|.+|..|+-
T Consensus 475 pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 475 PKVHMGACFSKVFNGCPL 492 (829)
T ss_pred CcchhhHHHHHHhccCcc
Confidence 999999999999998853
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.1e-13 Score=154.85 Aligned_cols=139 Identities=22% Similarity=0.266 Sum_probs=96.3
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhh-----------------------------HH----------HHH
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEG-----------------------------YE----------EIR 234 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~-----------------------------~~----------~~~ 234 (774)
+.||.|++|.||+|+. .+|+.||||+.+..-.... .+ ++.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5699999999999985 5899999999753211000 00 234
Q ss_pred HHHHHHHhCC-----CCCc--ccccccccCCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHH-HHHHHHhc
Q 004088 235 GEIEMLQQCS-----HPNV--VRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALK-GLAYLHSI 306 (774)
Q Consensus 235 ~Ei~iL~~L~-----HPNI--VkL~~~~~~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~-gL~YLHs~ 306 (774)
+|+..+.++. +++| .+++. ......+|||||++|++|.++.......+. ...++.+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 4555555542 3332 22222 223456899999999999887643222222 3345555555 47889999
Q ss_pred CcccccccccceEecCCCcEEEeecccccccc
Q 004088 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 307 gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
|++|+|+||.||+++.++.++|+|||++..+.
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.5e-13 Score=158.87 Aligned_cols=142 Identities=20% Similarity=0.252 Sum_probs=97.9
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh---------------------------------hhHHHHH
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE---------------------------------EGYEEIR 234 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~---------------------------------~~~~~~~ 234 (774)
..|+. +.||+|++|.||+|+...+|+.||||+++..-.. +..+.+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35666 7899999999999998777999999998633100 1112233
Q ss_pred HHHHHHHhCCCCCcccccccccC-------------CceEEEEEEecCCCchhhhhh--ccC---CchhHHHHHHHHHHH
Q 004088 235 GEIEMLQQCSHPNVVRYLGSYQG-------------EEYLWIVMEYCGGGSVADLMN--VTE---EPLEEYQIAYICREA 296 (774)
Q Consensus 235 ~Ei~iL~~L~HPNIVkL~~~~~~-------------~~~l~LVmEy~~ggsL~dll~--~~~---~~Lse~~i~~I~~QI 296 (774)
+|+.+++.. .|+.++...|.+ ....+||||||.|+.+.++.. ..+ ..+.+..+..++.|+
T Consensus 199 ~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 199 DELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HhhCHHHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 344443333 244444433332 334569999999999987532 111 135566666666666
Q ss_pred HHHHHHHHhcCcccccccccceEecCCC----cEEEeeccccccccc
Q 004088 297 LKGLAYLHSIFKVHRDIKGGNILLTDQG----EVKLGDFGVAAQLTR 339 (774)
Q Consensus 297 l~gL~YLHs~gIIHRDLKPeNILLd~~g----~vKL~DFGlA~~i~~ 339 (774)
+ ..|++|+|+||.||+++.+| .++++|||++..+..
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4 59999999999999999988 999999999976644
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.6e-12 Score=149.45 Aligned_cols=169 Identities=22% Similarity=0.349 Sum_probs=133.0
Q ss_pred EEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCCCchhhhhhccCCchh
Q 004088 206 KARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLE 285 (774)
Q Consensus 206 ~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~ggsL~dll~~~~~~Ls 285 (774)
.|..+.++.+|.|.+.+.+.. .....+.+-++-|+.++||||++|++.++.++.+|||+|.+.. |..++. .+.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk----~l~ 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLK----ELG 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHH----HhH
Confidence 455677899999999876655 5556788889999999999999999999999999999999964 455554 244
Q ss_pred HHHHHHHHHHHHHHHHHHH-hcCcccccccccceEecCCCcEEEeeccccccccccccccccccccccccchhhhhhcCC
Q 004088 286 EYQIAYICREALKGLAYLH-SIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRY 364 (774)
Q Consensus 286 e~~i~~I~~QIl~gL~YLH-s~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~ 364 (774)
...+...+.||+.||.||| ..+++|++|....|+|+..|..||++|-++..............---.|..|+.+....
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc-
Confidence 7788889999999999998 56799999999999999999999999998865433321111112223466676654433
Q ss_pred CCccchhhhHHHHHHHHhC
Q 004088 365 DGKVDVWALGVSAVEMAEG 383 (774)
Q Consensus 365 s~ksDIWSLGviLyELLtG 383 (774)
...|.|-|||++++++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 457999999999999998
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.1e-12 Score=127.52 Aligned_cols=127 Identities=18% Similarity=0.152 Sum_probs=95.9
Q ss_pred EeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcc-cccccccCCceEEEEEEecCCC
Q 004088 193 LNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVV-RYLGSYQGEEYLWIVMEYCGGG 271 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIV-kL~~~~~~~~~l~LVmEy~~gg 271 (774)
++.|+.|.++.||+++.. +..|+||+...... ....+.+|+.+++.+.+.+++ +++.+.. ...++||||++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCC
Confidence 467899999999999853 77899998753321 123467899999998665544 4554433 2357999999998
Q ss_pred chhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCc-----ccccccccceEecCCCcEEEeeccccc
Q 004088 272 SVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFK-----VHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 272 sL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gI-----IHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
++.... .....++.+++.+|..||..++ +|+|++|.||+++ ++.++|+|||.+.
T Consensus 77 ~l~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 77 ELLTED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 776431 1123456799999999999885 9999999999999 6789999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.5e-13 Score=141.60 Aligned_cols=201 Identities=23% Similarity=0.366 Sum_probs=142.6
Q ss_pred HHHHhCCCCCcccccccccCCc-----eEEEEEEecCCCchhhhhhc---cCCchhHHHHHHHHHHHHHHHHHHHhcC--
Q 004088 238 EMLQQCSHPNVVRYLGSYQGEE-----YLWIVMEYCGGGSVADLMNV---TEEPLEEYQIAYICREALKGLAYLHSIF-- 307 (774)
Q Consensus 238 ~iL~~L~HPNIVkL~~~~~~~~-----~l~LVmEy~~ggsL~dll~~---~~~~Lse~~i~~I~~QIl~gL~YLHs~g-- 307 (774)
.-|-++.|.|||+++.|+.+.. +..+++||+..|+|..+|+. ....+.....++|+-||+.||.|||+..
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 4455567999999999986543 58899999999999999874 3456888899999999999999999985
Q ss_pred cccccccccceEecCCCcEEEeecccccccccccc-----ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh
Q 004088 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS-----KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE 382 (774)
Q Consensus 308 IIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~-----~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt 382 (774)
|+|+.+..+-|++..+|-+||.---... +..... ......+-++|.+||.=.....+.++|||+||....+|..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 9999999999999999988874221111 110000 0111246788999998777778889999999999999987
Q ss_pred CCCC-CCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhh
Q 004088 383 GLPP-RSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445 (774)
Q Consensus 383 G~~P-f~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~ 445 (774)
+..- -...........+... ...++ ...-+++|.+||+..|..||++.++|.||.+-
T Consensus 278 lEiq~tnseS~~~~ee~ia~~-i~~le-----n~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANV-IIGLE-----NGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred heeccCCCcceeehhhhhhhh-eeecc-----CccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 7432 1111111111111000 00000 01124789999999999999999999999764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=7.2e-13 Score=150.77 Aligned_cols=252 Identities=23% Similarity=0.285 Sum_probs=185.3
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEc-CCCcEEEEEEeecCCCh-hhHHHHHHHHHHHHhC-CCCCcccccccccCCceEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDL-KTSELVAIKVISLSEGE-EGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~-~~g~~VAVKvi~~~~~~-~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~ 262 (774)
...+|.++..||.|.|+.|+.+... .++..|++|-+...... .....-..|+.+...+ .|.+++.++..|......|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 4568999999999999999988754 67888999977533211 1111234677777666 5999999999998888888
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC-CcEEEeeccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ-GEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~-g~vKL~DFGlA~~i~~~~ 341 (774)
|-.|||.++++...+ .....+.+...+.+..|++.++.++|++.++|+|+||+||++..+ +..++.|||.+..+...
T Consensus 343 ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~- 420 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS- 420 (524)
T ss_pred CchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee-
Confidence 999999999887665 344568888999999999999999999999999999999999887 78899999988643211
Q ss_pred ccccccccccccc--chhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHH
Q 004088 342 SKRNTFIGTPHWM--APEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHD 419 (774)
Q Consensus 342 ~~~~~~~GT~~Y~--APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~d 419 (774)
. ....+.-++. +|+......+..+.|++|||..+.+.++|.+--........+ ..... .........+..
T Consensus 421 -~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i---~~~~~---p~~~~~~~~~q~ 492 (524)
T KOG0601|consen 421 -S-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTI---RSGDT---PNLPGLKLQLQV 492 (524)
T ss_pred -c-ccccccccccccchhhccccccccccccccccccccccccCcccCcccccceee---ecccc---cCCCchHHhhhh
Confidence 1 1122333444 555556667888999999999999999886532222221111 11111 112233366788
Q ss_pred HHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 420 FVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 420 LI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
+.+.++.+++..||.+.++..|+=|.+.
T Consensus 493 ~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 493 LLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred hhhhhcCCccccchhhhhhcccchhhhh
Confidence 9999999999999999999988766543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.4e-11 Score=125.69 Aligned_cols=137 Identities=20% Similarity=0.203 Sum_probs=99.9
Q ss_pred eeeeccCceEEEEEEEcC------CCcEEEEEEeecCC------------C---------hhhHHHHH----HHHHHHHh
Q 004088 194 NELGKGSYGAVYKARDLK------TSELVAIKVISLSE------------G---------EEGYEEIR----GEIEMLQQ 242 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~------~g~~VAVKvi~~~~------------~---------~~~~~~~~----~Ei~iL~~ 242 (774)
..||.|--+.||.|.... .+..+|||+.+... . ......+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 35789999975321 0 01122333 89999999
Q ss_pred CCC--CCcccccccccCCceEEEEEEecCCCchhh-hhhccCCchhHHHHHHHHHHHHHHHHHH-HhcCcccccccccce
Q 004088 243 CSH--PNVVRYLGSYQGEEYLWIVMEYCGGGSVAD-LMNVTEEPLEEYQIAYICREALKGLAYL-HSIFKVHRDIKGGNI 318 (774)
Q Consensus 243 L~H--PNIVkL~~~~~~~~~l~LVmEy~~ggsL~d-ll~~~~~~Lse~~i~~I~~QIl~gL~YL-Hs~gIIHRDLKPeNI 318 (774)
+.. -++.+++++ ...+|||||+++..+.. .++ ...+++..+..++.+++.+|.+| |..||||+||++.||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 853 355556654 45789999997654422 222 22455566778889999999999 899999999999999
Q ss_pred EecCCCcEEEeeccccccc
Q 004088 319 LLTDQGEVKLGDFGVAAQL 337 (774)
Q Consensus 319 LLd~~g~vKL~DFGlA~~i 337 (774)
|+.. +.++|+|||.|...
T Consensus 157 L~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 157 LWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred EEEC-CcEEEEECCCceeC
Confidence 9974 78999999988554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.22 E-value=7.3e-11 Score=119.14 Aligned_cols=139 Identities=20% Similarity=0.191 Sum_probs=105.9
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCC--CCcccccccccCC---ceEEEEEEec
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSH--PNVVRYLGSYQGE---EYLWIVMEYC 268 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~H--PNIVkL~~~~~~~---~~l~LVmEy~ 268 (774)
+.||.|.++.||+++. .+|+.|+||+............+.+|+.+++.+.+ .++.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~-~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTA-GGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEe-cCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 5689999999999985 34688999987543322234578899999999976 3456677766653 3678999999
Q ss_pred CCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 004088 269 GGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS------------------------------------------- 305 (774)
Q Consensus 269 ~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs------------------------------------------- 305 (774)
+|.++...+.. ..+++.....++.+++.+|.+||+
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99888775521 346667777777788888888873
Q ss_pred -------------cCcccccccccceEecC--CCcEEEeeccccc
Q 004088 306 -------------IFKVHRDIKGGNILLTD--QGEVKLGDFGVAA 335 (774)
Q Consensus 306 -------------~gIIHRDLKPeNILLd~--~g~vKL~DFGlA~ 335 (774)
..++|+|++|.|||++. ++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23699999999999998 5678999999885
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.5e-09 Score=109.03 Aligned_cols=131 Identities=21% Similarity=0.222 Sum_probs=96.7
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEe-ecCCChh------hHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVI-SLSEGEE------GYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi-~~~~~~~------~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
..+++|+-+.+|.+.+ -|..+.+|.= ++.-... ..+...+|+++|.++.--.|.--+-++.+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4578999999999965 3445666642 1111111 12456789999998865444444444456667789999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
|++|..|.+.+... ...++..+-.-+.-||..||||+||.++||++...+ +.++|||++.
T Consensus 80 ~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 80 YIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred EeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence 99999988888633 245677788888999999999999999999998854 9999999985
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.00 E-value=9.7e-09 Score=115.72 Aligned_cols=214 Identities=16% Similarity=0.178 Sum_probs=157.0
Q ss_pred ceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCccccccccc----CCceEEEEEEecCC-Cchhh
Q 004088 201 YGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ----GEEYLWIVMEYCGG-GSVAD 275 (774)
Q Consensus 201 FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~----~~~~l~LVmEy~~g-gsL~d 275 (774)
-.+.|+|....+|..|++|+++...... ......-+++++++.|+|||+|.++|. .+..+++|++|.++ ++|.+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~-~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQS-TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccC-cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 4577999999999999999995333211 122334578999999999999999986 45679999999975 46666
Q ss_pred hhhc--------------cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 276 LMNV--------------TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 276 ll~~--------------~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
+... .+...+|..+|.++.||..||.++|+.|+.-+-|.|.+||++.+.+++|.-.|....+....
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP 447 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence 5431 23457889999999999999999999999999999999999999899998888765443331
Q ss_pred cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI 421 (774)
+ |.+.. -.+-|.-.||.+++.|.+|..--...+...... .......++.+++++|
T Consensus 448 -------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~--------~~~I~~~yS~D~rn~v 502 (655)
T KOG3741|consen 448 -------T-------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSH--------LTRITTTYSTDLRNVV 502 (655)
T ss_pred -------C-------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHH--------HHHhhhhhhHHHHHHH
Confidence 1 11221 125688999999999999964321111111100 0112345678899999
Q ss_pred HhhcccCCCCCCCHHHHHhh
Q 004088 422 AKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 422 ~kcL~~DP~kRPTa~ElL~H 441 (774)
.-+...++++ -++.+++.|
T Consensus 503 ~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 503 EYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHhcCccc-ccHHHHHHH
Confidence 9999999988 789999876
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.93 E-value=5.4e-09 Score=106.14 Aligned_cols=126 Identities=29% Similarity=0.282 Sum_probs=83.3
Q ss_pred EEEEEEEcCCCcEEEEEEeecCCC------------h-------------hhHHHHHHHHHHHHhCCCC--Ccccccccc
Q 004088 203 AVYKARDLKTSELVAIKVISLSEG------------E-------------EGYEEIRGEIEMLQQCSHP--NVVRYLGSY 255 (774)
Q Consensus 203 ~Vy~a~d~~~g~~VAVKvi~~~~~------------~-------------~~~~~~~~Ei~iL~~L~HP--NIVkL~~~~ 255 (774)
.||.|.. .+|..+|||+.+.... . .......+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899985 5788999999753210 0 0123467899999999765 456666543
Q ss_pred cCCceEEEEEEecC--CCchhhhhhccCCchhHHHHHHHHHHHHHHHHH-HHhcCcccccccccceEecCCCcEEEeecc
Q 004088 256 QGEEYLWIVMEYCG--GGSVADLMNVTEEPLEEYQIAYICREALKGLAY-LHSIFKVHRDIKGGNILLTDQGEVKLGDFG 332 (774)
Q Consensus 256 ~~~~~l~LVmEy~~--ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~Y-LHs~gIIHRDLKPeNILLd~~g~vKL~DFG 332 (774)
..+|||||++ |..+..+.. ..++......++.+++..+.. +|..||||+||.+.|||++.+ .+.|+|||
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~---~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~ 151 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKD---VDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFG 151 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHH---CGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GT
T ss_pred ----CCEEEEEecCCCccchhhHHh---ccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecC
Confidence 3469999998 666655443 122244566777888885555 579999999999999999986 89999999
Q ss_pred ccccc
Q 004088 333 VAAQL 337 (774)
Q Consensus 333 lA~~i 337 (774)
.+...
T Consensus 152 qav~~ 156 (188)
T PF01163_consen 152 QAVDS 156 (188)
T ss_dssp TEEET
T ss_pred cceec
Confidence 88543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=5.9e-09 Score=104.63 Aligned_cols=142 Identities=23% Similarity=0.233 Sum_probs=103.0
Q ss_pred EEeeeeccCceEEEEEEEcCCCcEEEEEEee-cCCC------hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 192 LLNELGKGSYGAVYKARDLKTSELVAIKVIS-LSEG------EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 192 ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~-~~~~------~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
.+..|-+|+-+.|+++. ..|+.+.||.=. +.-. .-......+|+++|.++.--.|.--.-+|.+...-+|+
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 56788899999999997 468888888521 1111 11234577899999988644444333345555666799
Q ss_pred EEecCC-CchhhhhhccCCchhHHH-HHHHHHHHHHHHHHHHhcCcccccccccceEecCCC---cEEEeeccccc
Q 004088 265 MEYCGG-GSVADLMNVTEEPLEEYQ-IAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG---EVKLGDFGVAA 335 (774)
Q Consensus 265 mEy~~g-gsL~dll~~~~~~Lse~~-i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g---~vKL~DFGlA~ 335 (774)
|||++| .++.+++......-.+.. ...++.+|-..+.-||..+|||+||..+||++..++ .+.|+|||++.
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 999977 467777754333333333 377889999999999999999999999999998776 35899999984
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.2e-08 Score=109.00 Aligned_cols=130 Identities=13% Similarity=0.040 Sum_probs=92.5
Q ss_pred EEEEEEcCCCcEEEEEEeecCCChhhHH----------HHHHHHHHHHhCCCCCc--ccccccccC-----CceEEEEEE
Q 004088 204 VYKARDLKTSELVAIKVISLSEGEEGYE----------EIRGEIEMLQQCSHPNV--VRYLGSYQG-----EEYLWIVME 266 (774)
Q Consensus 204 Vy~a~d~~~g~~VAVKvi~~~~~~~~~~----------~~~~Ei~iL~~L~HPNI--VkL~~~~~~-----~~~l~LVmE 266 (774)
|+.++ ..|+.|.||...........+ .+.+|...+.+|..-+| +.++.+.+. ....+||||
T Consensus 38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 55554 357789999763222111111 36789998888753333 233334332 345789999
Q ss_pred ecCCC-chhhhhhc-cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC-------CCcEEEeeccccc
Q 004088 267 YCGGG-SVADLMNV-TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD-------QGEVKLGDFGVAA 335 (774)
Q Consensus 267 y~~gg-sL~dll~~-~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~-------~g~vKL~DFGlA~ 335 (774)
++++. +|.+++.. .....+......++.+++..+.-||..||+|+||++.|||++. +..+.|+||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99886 78888752 1344566777889999999999999999999999999999985 4579999999874
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=3.3e-09 Score=123.00 Aligned_cols=153 Identities=20% Similarity=0.266 Sum_probs=114.8
Q ss_pred HHHHHHHHHHhc-CcccccccccceEecCCCcEEEeecccccccccccc----cc-----ccccccccccchhhhhhcCC
Q 004088 295 EALKGLAYLHSI-FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS----KR-----NTFIGTPHWMAPEVIQESRY 364 (774)
Q Consensus 295 QIl~gL~YLHs~-gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~----~~-----~~~~GT~~Y~APEvl~~~~~ 364 (774)
+++.||.|+|.. ++||+.|.|++|.++.++.+||+-|+++........ .+ ....-...|.|||++.....
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~ 186 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN 186 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence 444899999976 699999999999999999999999998854433111 00 01123567999999999888
Q ss_pred CCccchhhhHHHHHHHH-hCCCCCCCCCchhhh-hhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhh
Q 004088 365 DGKVDVWALGVSAVEMA-EGLPPRSTVHPMRVL-FMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHK 442 (774)
Q Consensus 365 s~ksDIWSLGviLyELL-tG~~Pf~~~~~~~~i-~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HP 442 (774)
+.++|+||+||++|.+. .|++-+......... +...............++.++++=|.++|..++..||++.+++..|
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ 266 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIP 266 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhccc
Confidence 99999999999999998 566655443322211 1222222333333467788999999999999999999999999999
Q ss_pred hhhhh
Q 004088 443 FIERC 447 (774)
Q Consensus 443 wf~~~ 447 (774)
||...
T Consensus 267 ff~D~ 271 (700)
T KOG2137|consen 267 FFSDP 271 (700)
T ss_pred ccCCc
Confidence 99754
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=7.3e-08 Score=102.11 Aligned_cols=137 Identities=25% Similarity=0.220 Sum_probs=101.3
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-----------------C----hhhHHHHHHHHHHHHhCCCC-
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-----------------G----EEGYEEIRGEIEMLQQCSHP- 246 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-----------------~----~~~~~~~~~Ei~iL~~L~HP- 246 (774)
-+.++..||.|--|.||.|.+ ..|.++|||.=+... . .-......+|.++|++|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 356778999999999999985 478999999643211 0 01123467899999998654
Q ss_pred -CcccccccccCCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCc
Q 004088 247 -NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE 325 (774)
Q Consensus 247 -NIVkL~~~~~~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~ 325 (774)
.|.+.+++ +...+||||++|..|...- ++......++..|+.-+.-+-..||||+|+.+-|||++.+|.
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 66666654 5678999999987665442 123344455566666666666999999999999999999999
Q ss_pred EEEeecccccc
Q 004088 326 VKLGDFGVAAQ 336 (774)
Q Consensus 326 vKL~DFGlA~~ 336 (774)
++++||--+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999976643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=5.7e-07 Score=99.64 Aligned_cols=238 Identities=16% Similarity=0.177 Sum_probs=152.9
Q ss_pred EEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCccc--------ccccccCCceEE
Q 004088 192 LLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVR--------YLGSYQGEEYLW 262 (774)
Q Consensus 192 ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVk--------L~~~~~~~~~l~ 262 (774)
..+.||+|+-+.+|-.-...+ -+-|++....... .. +-+..|... .||-+-. |+|- .....+-
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~-~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iG 86 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAA-QA---QKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIG 86 (637)
T ss_pred CCccccCCccceeeecchhhc---hhheeecCCCchH-HH---HHHHHhccCCCCcchhhhhcccHHHhhCC-CccceeE
Confidence 356799999999996543222 2447776443221 11 222333333 5664332 2221 1223477
Q ss_pred EEEEecCCCc-hhhhhh-----ccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccc
Q 004088 263 IVMEYCGGGS-VADLMN-----VTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQ 336 (774)
Q Consensus 263 LVmEy~~ggs-L~dll~-----~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~ 336 (774)
+.|..+.|.. +..+++ .......|..+.+..+.|+.+.+-||.+|.+-+|+.++|+|+.+++.|.|+|=..-.
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq- 165 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ- 165 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee-
Confidence 8888887652 222322 223457889999999999999999999999999999999999999999998865432
Q ss_pred ccccccccccccccccccchhhhh-----hcCCCCccchhhhHHHHHHHHhC-CCCCCCCCchhhh----h-hh------
Q 004088 337 LTRTMSKRNTFIGTPHWMAPEVIQ-----ESRYDGKVDVWALGVSAVEMAEG-LPPRSTVHPMRVL----F-MI------ 399 (774)
Q Consensus 337 i~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDIWSLGviLyELLtG-~~Pf~~~~~~~~i----~-~i------ 399 (774)
+..........+|...|.+||.-. +..-+...|.|.||+++++|+.| +.||.+....... . .|
T Consensus 166 i~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 166 INANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred eccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 222333344568999999999854 33456789999999999999876 9999864321100 0 01
Q ss_pred -------hcCCCCccccchhchHHHHHHHHhhccc--CCCCCCCHHHH
Q 004088 400 -------SIEPAPMLEDKEKWSLVFHDFVAKCLTK--EPRARPTAAEM 438 (774)
Q Consensus 400 -------~~~~~~~~~~~~~~s~~l~dLI~kcL~~--DP~kRPTa~El 438 (774)
...+.|.......+++.+..+..+|+.. ++.-|||++.-
T Consensus 246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW 293 (637)
T COG4248 246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAW 293 (637)
T ss_pred echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHH
Confidence 0011111112234466788888888875 46789998753
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.5e-07 Score=96.57 Aligned_cols=105 Identities=20% Similarity=0.179 Sum_probs=81.4
Q ss_pred HHHHHHHHHHHhCCCCC--cccccccccC----CceEEEEEEecCCC-chhhhhhccCCchhHHHHHHHHHHHHHHHHHH
Q 004088 231 EEIRGEIEMLQQCSHPN--VVRYLGSYQG----EEYLWIVMEYCGGG-SVADLMNVTEEPLEEYQIAYICREALKGLAYL 303 (774)
Q Consensus 231 ~~~~~Ei~iL~~L~HPN--IVkL~~~~~~----~~~l~LVmEy~~gg-sL~dll~~~~~~Lse~~i~~I~~QIl~gL~YL 303 (774)
....+|...+.+|..-. +.+.+++.+. ....+||+|++++. +|.+++..... ++......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 45778888888775332 3344444432 13568999999874 78888863222 66777888999999999999
Q ss_pred HhcCcccccccccceEecCCC---cEEEeecccccc
Q 004088 304 HSIFKVHRDIKGGNILLTDQG---EVKLGDFGVAAQ 336 (774)
Q Consensus 304 Hs~gIIHRDLKPeNILLd~~g---~vKL~DFGlA~~ 336 (774)
|..||+|+|+++.|||++.++ .+.|+||+.++.
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999887 899999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=3.4e-07 Score=106.02 Aligned_cols=143 Identities=24% Similarity=0.256 Sum_probs=93.0
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCCChh-----------------------------hH----H------HHH
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSEGEE-----------------------------GY----E------EIR 234 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~-----------------------------~~----~------~~~ 234 (774)
+-|+.++-|.||+|+. .+|+.||||+.+..-... .. + ++.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 5688999999999995 569999999974221000 00 0 133
Q ss_pred HHHHHHHhCC-----CCCcccccccccCCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcc
Q 004088 235 GEIEMLQQCS-----HPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKV 309 (774)
Q Consensus 235 ~Ei~iL~~L~-----HPNIVkL~~~~~~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gII 309 (774)
+|...+.++. .|+|.=-.-+++-...-.|+|||+.|..+.++.......++...+...+.++ .+..+-..|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dgff 287 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcCcc
Confidence 4444444442 2332221222333455679999999999988854333445544433333222 23344458999
Q ss_pred cccccccceEecCCCcEEEeeccccccccc
Q 004088 310 HRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 310 HRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
|.|.+|.||+++.+|.+.+.|||+...+..
T Consensus 288 HaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 288 HADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999876644
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.9e-06 Score=89.47 Aligned_cols=139 Identities=14% Similarity=0.165 Sum_probs=92.2
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhh--H------HHHHHHHHHHHhCCCC---Ccccccc
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEG--Y------EEIRGEIEMLQQCSHP---NVVRYLG 253 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~--~------~~~~~Ei~iL~~L~HP---NIVkL~~ 253 (774)
...++|++.+.+-......|.+-. .+|+.+.+|..+....... . ....+++..+.++... .++.++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 345789999999888888887775 5678899998753221110 0 1123444444444322 2222222
Q ss_pred c-----ccCCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEE
Q 004088 254 S-----YQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKL 328 (774)
Q Consensus 254 ~-----~~~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL 328 (774)
+ +.-....+|||||++|..|.++.. +++ .+...|..++.-||..|++|+|++|.|++++.+ .+++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~i 175 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRI 175 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEE
Confidence 2 222345679999999998877643 222 244566778999999999999999999999965 4999
Q ss_pred eeccccc
Q 004088 329 GDFGVAA 335 (774)
Q Consensus 329 ~DFGlA~ 335 (774)
+||+..+
T Consensus 176 ID~~~k~ 182 (229)
T PF06176_consen 176 IDTQGKR 182 (229)
T ss_pred EECcccc
Confidence 9998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.5e-06 Score=87.13 Aligned_cols=137 Identities=15% Similarity=0.162 Sum_probs=101.0
Q ss_pred eccCceEEEEEEEcCCCcEEEEEEeecC--C---ChhhHHHHHHHHHHHHhCCCCC--ccccccccc-----CCceEEEE
Q 004088 197 GKGSYGAVYKARDLKTSELVAIKVISLS--E---GEEGYEEIRGEIEMLQQCSHPN--VVRYLGSYQ-----GEEYLWIV 264 (774)
Q Consensus 197 G~G~FG~Vy~a~d~~~g~~VAVKvi~~~--~---~~~~~~~~~~Ei~iL~~L~HPN--IVkL~~~~~-----~~~~l~LV 264 (774)
|+||.+-|+.... .|+.|-||.-... . .+.....|.+|+..|++|..-+ +.+.. ++. ..-..+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 5789999998763 4457888875311 0 1345678999999999985432 44444 221 12357899
Q ss_pred EEecCC-Cchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCc--EEEeecccccc
Q 004088 265 MEYCGG-GSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE--VKLGDFGVAAQ 336 (774)
Q Consensus 265 mEy~~g-gsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~--vKL~DFGlA~~ 336 (774)
+|-++| .+|.+++... -.+.++.....++.+++..+.-||..|+.|+|+.+.|||++.++. ++++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998854 5788777432 235677778899999999999999999999999999999987776 99999987654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.28 E-value=5.2e-06 Score=86.64 Aligned_cols=133 Identities=16% Similarity=0.220 Sum_probs=83.4
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCC--cccccccccCCceEEEEEEecCCC
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPN--VVRYLGSYQGEEYLWIVMEYCGGG 271 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPN--IVkL~~~~~~~~~l~LVmEy~~gg 271 (774)
..||.|..+.||+. .+..+++|+..... ....+.+|.++|+.+..-. +.+.+.+....+..++|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 56899999999984 24457889875322 3345789999999886433 466777777777889999999886
Q ss_pred c-hhhhh---------------------hc---cCCchhHHHHHHHHHH----------HHH-HHHHHHh----cCcccc
Q 004088 272 S-VADLM---------------------NV---TEEPLEEYQIAYICRE----------ALK-GLAYLHS----IFKVHR 311 (774)
Q Consensus 272 s-L~dll---------------------~~---~~~~Lse~~i~~I~~Q----------Il~-gL~YLHs----~gIIHR 311 (774)
. +...+ +. ....+... ...+..+ +.. ...+|.. ..++|+
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 3 11111 00 00111110 0011000 111 1222221 237899
Q ss_pred cccccceEecCCCcEEEeeccccc
Q 004088 312 DIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 312 DLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
|+.|.||+++.++ +.|+||+.+.
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcC
Confidence 9999999999888 9999999874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.27 E-value=7.9e-06 Score=82.56 Aligned_cols=138 Identities=24% Similarity=0.329 Sum_probs=82.3
Q ss_pred EeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCC--Ccccccccc---cCCceEEEEEEe
Q 004088 193 LNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHP--NVVRYLGSY---QGEEYLWIVMEY 267 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HP--NIVkL~~~~---~~~~~l~LVmEy 267 (774)
++.|+.|..+.||++.... ..+++|+.... .....+.+|+.+++.+... .+.+++.+. ......+++|++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~ 76 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY 76 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence 5789999999999998644 48999986422 4556788999998888533 245566533 233457999999
Q ss_pred cCCCchhh----------------hhh---cc---CCchhH-H--------HHHHH------------HHHHHH-HHHHH
Q 004088 268 CGGGSVAD----------------LMN---VT---EEPLEE-Y--------QIAYI------------CREALK-GLAYL 303 (774)
Q Consensus 268 ~~ggsL~d----------------ll~---~~---~~~Lse-~--------~i~~I------------~~QIl~-gL~YL 303 (774)
++|..+.. .+. .. ...+.. . ..... +..+.. .+..+
T Consensus 77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (239)
T PF01636_consen 77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL 156 (239)
T ss_dssp ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence 99987776 110 00 001000 0 00000 111222 33444
Q ss_pred Hh-------cCcccccccccceEec-CCCcEEEeeccccc
Q 004088 304 HS-------IFKVHRDIKGGNILLT-DQGEVKLGDFGVAA 335 (774)
Q Consensus 304 Hs-------~gIIHRDLKPeNILLd-~~g~vKL~DFGlA~ 335 (774)
+. ..++|+|+.|.|||++ .++.+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 42 3599999999999999 56667899999874
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.5e-05 Score=83.96 Aligned_cols=137 Identities=23% Similarity=0.254 Sum_probs=92.5
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh-h-----------------hHH-----HHHHHHHHHHhCC--CCCc
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSEGE-E-----------------GYE-----EIRGEIEMLQQCS--HPNV 248 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~-~-----------------~~~-----~~~~Ei~iL~~L~--HPNI 248 (774)
-.|..|--+.||+|. ..++..||||+++..... . ... -...|+.-|+++. +=.+
T Consensus 54 g~istGKEA~Vy~a~-~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAE-TGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeec-cCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 377888999999998 467899999998643210 0 001 1245777777663 2233
Q ss_pred ccccccccCCceEEEEEEecCCCch-hhhhhccCCchhHHHHHHHHHHHHHHHHHHHh-cCcccccccccceEecCCCcE
Q 004088 249 VRYLGSYQGEEYLWIVMEYCGGGSV-ADLMNVTEEPLEEYQIAYICREALKGLAYLHS-IFKVHRDIKGGNILLTDQGEV 326 (774)
Q Consensus 249 VkL~~~~~~~~~l~LVmEy~~ggsL-~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs-~gIIHRDLKPeNILLd~~g~v 326 (774)
.+-+.+. .-.|||||++...+ .-.| ..-.+...++..+..++++.+.-|-. .++||+||..-|||+. ++.+
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 3444443 24689999965411 1111 12233333677788888888888866 8999999999999999 7899
Q ss_pred EEeecccccccc
Q 004088 327 KLGDFGVAAQLT 338 (774)
Q Consensus 327 KL~DFGlA~~i~ 338 (774)
.|+|||-|....
T Consensus 206 ~iID~~QaV~~~ 217 (268)
T COG1718 206 YIIDVSQAVTID 217 (268)
T ss_pred EEEECccccccC
Confidence 999999886544
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.7e-05 Score=97.48 Aligned_cols=82 Identities=12% Similarity=0.180 Sum_probs=58.2
Q ss_pred EEeeeeccCceEEEEEEEcCCC--cEEEEEEeecCCChhhHHHHHHHHHHHHhCC-CCCc--ccccccccCC---ceEEE
Q 004088 192 LLNELGKGSYGAVYKARDLKTS--ELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPNV--VRYLGSYQGE---EYLWI 263 (774)
Q Consensus 192 ilk~LG~G~FG~Vy~a~d~~~g--~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HPNI--VkL~~~~~~~---~~l~L 263 (774)
.++.|+.|.+..+|+......+ ..+++|+............+.+|+++|+.+. |++| .+++.++.+. +..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 3678899999999998754332 4677887543222223356889999999995 6665 6777777654 46789
Q ss_pred EEEecCCCch
Q 004088 264 VMEYCGGGSV 273 (774)
Q Consensus 264 VmEy~~ggsL 273 (774)
||||++|..+
T Consensus 122 VME~v~G~~~ 131 (822)
T PLN02876 122 IMEYLEGRIF 131 (822)
T ss_pred EEEecCCccc
Confidence 9999988643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1e-05 Score=99.01 Aligned_cols=200 Identities=23% Similarity=0.324 Sum_probs=142.6
Q ss_pred HHHHHHHHHHhCCCCCcccccccccCCce----EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcC
Q 004088 232 EIRGEIEMLQQCSHPNVVRYLGSYQGEEY----LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307 (774)
Q Consensus 232 ~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~----l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~g 307 (774)
...-|+..+.++.|+|++.++.|-..... ..+..++|...++...++ .-..++...++.+..++++||.|+|+..
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q-~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ-SVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh-hccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 34457788888999999999887654332 234567888888888875 4567888899999999999999999997
Q ss_pred ccccccccc---ceEecCCCcEEEe--eccccccccccccccccccccccccchhhhhhcCCCCc--cchhhhHHHHHHH
Q 004088 308 KVHRDIKGG---NILLTDQGEVKLG--DFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGK--VDVWALGVSAVEM 380 (774)
Q Consensus 308 IIHRDLKPe---NILLd~~g~vKL~--DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~k--sDIWSLGviLyEL 380 (774)
..|.=|..+ +-.++.++.+.+. ||+.++.+.... ......-+..|.+||......+..+ .|+|.+|.....+
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~-~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE-KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcc-cchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence 666666555 4445566667776 898887665432 2223345667888988876655554 7999999999999
Q ss_pred HhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhh
Q 004088 381 AEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445 (774)
Q Consensus 381 LtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~ 445 (774)
..|..+-........+ +. ........+++.+|+..++++|+++.+++.|+|.+
T Consensus 386 ~~~~~i~~~~~~~~~~----------l~--~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~ 438 (1351)
T KOG1035|consen 386 SQGEDISEKSAVPVSL----------LD--VLSTSELLDALPKCLDEDSEERLSALELLTHPFLR 438 (1351)
T ss_pred hhcCcccccccchhhh----------hc--cccchhhhhhhhhhcchhhhhccchhhhhhchhcc
Confidence 8876542221111100 00 00111466889999999999999999999999985
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.07 E-value=2.2e-05 Score=81.77 Aligned_cols=135 Identities=18% Similarity=0.193 Sum_probs=82.0
Q ss_pred eeeccCc-eEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-CCCcccccccccCCceEEEEEEecCCCc
Q 004088 195 ELGKGSY-GAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQGEEYLWIVMEYCGGGS 272 (774)
Q Consensus 195 ~LG~G~F-G~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~~~~l~LVmEy~~ggs 272 (774)
.|-.|.. +.||+... .+..+.||+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 78 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP 78 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence 3445555 78999964 34678889864322 345678999988884 3335567777766667899999999977
Q ss_pred hhhhhh-------------------cc---CCchhHH---HHHHH---HH----------------HHHHHHHHHH----
Q 004088 273 VADLMN-------------------VT---EEPLEEY---QIAYI---CR----------------EALKGLAYLH---- 304 (774)
Q Consensus 273 L~dll~-------------------~~---~~~Lse~---~i~~I---~~----------------QIl~gL~YLH---- 304 (774)
|..... .. ..++... ..... +. .+...+..|-
T Consensus 79 l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 158 (244)
T cd05150 79 AAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP 158 (244)
T ss_pred HhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence 654310 00 0011100 00000 00 0111122221
Q ss_pred ---hcCcccccccccceEecCCCcEEEeeccccc
Q 004088 305 ---SIFKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 305 ---s~gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
...++|+|+.|.|||++.++.+.|+||+.|.
T Consensus 159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 1248999999999999997778899999874
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.03 E-value=1.8e-05 Score=91.87 Aligned_cols=141 Identities=24% Similarity=0.219 Sum_probs=90.4
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh------------------------------hhHHH------HHHHH
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSEGE------------------------------EGYEE------IRGEI 237 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~------------------------------~~~~~------~~~Ei 237 (774)
+-||.-+.|.||+|+. .+|+.|||||-+..-.. +..+. |.+|+
T Consensus 167 ~piaaASlaQVhrA~L-~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARL-KNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEe-cCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 5699999999999995 55999999985321100 00111 23333
Q ss_pred HHHHh----CCCCC------cccccccccCCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcC
Q 004088 238 EMLQQ----CSHPN------VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307 (774)
Q Consensus 238 ~iL~~----L~HPN------IVkL~~~~~~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~g 307 (774)
+-..+ +.|-+ |.++|- .-.....|+||||+|..+.++-......++...+..-+.++. +.-|=..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~--~~qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY--LEQIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 33222 23434 233332 223456899999999988887654455566655544433332 22334578
Q ss_pred cccccccccceEecC----CCcEEEeeccccccccc
Q 004088 308 KVHRDIKGGNILLTD----QGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 308 IIHRDLKPeNILLd~----~g~vKL~DFGlA~~i~~ 339 (774)
++|.|-+|.||++.. ++.+.+.|||+...+..
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999994 56899999999876644
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00011 Score=75.69 Aligned_cols=127 Identities=26% Similarity=0.303 Sum_probs=90.4
Q ss_pred CCCeeEEeeeeccCc-eEEEEEEEcCCCcEEEEEEeec---CCC----------h-------hhHHHHHHHHHHHHhC--
Q 004088 187 TTKYELLNELGKGSY-GAVYKARDLKTSELVAIKVISL---SEG----------E-------EGYEEIRGEIEMLQQC-- 243 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~F-G~Vy~a~d~~~g~~VAVKvi~~---~~~----------~-------~~~~~~~~Ei~iL~~L-- 243 (774)
...++.++.||.|.- |.||+++ ..|+.||||++.. ... . .....|..|.+..-+|
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 378999999999999 9999997 4688999999421 000 0 1223577788776666
Q ss_pred -CCCCc--ccccccccC------------------CceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHH
Q 004088 244 -SHPNV--VRYLGSYQG------------------EEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAY 302 (774)
Q Consensus 244 -~HPNI--VkL~~~~~~------------------~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~Y 302 (774)
.+.++ |+.+||..- .....||.||+.... .+... -+.+|++-|..
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~dl~~ 179 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRDLKI 179 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHHHHH
Confidence 35566 888887621 113467888886543 12222 34567778889
Q ss_pred HHhcCcccccccccceEecCCCcEEEeecccc
Q 004088 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA 334 (774)
Q Consensus 303 LHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA 334 (774)
+|..||+-+|+|+.|.. .-||+|||.+
T Consensus 180 ~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999999986 2489999965
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00012 Score=76.29 Aligned_cols=73 Identities=16% Similarity=0.269 Sum_probs=45.7
Q ss_pred eeeeccCce-EEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCC---CcccccccccCC---ceEEEEEE
Q 004088 194 NELGKGSYG-AVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHP---NVVRYLGSYQGE---EYLWIVME 266 (774)
Q Consensus 194 k~LG~G~FG-~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HP---NIVkL~~~~~~~---~~l~LVmE 266 (774)
+.|+.|+.. .||+.. ..+.+|+.+. ......+.+|+++|..+... -+.++++..... ...|+||+
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~---~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~ 74 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSA---AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR 74 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCc---cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence 567777766 489762 2477786532 22345788999999887532 233444433322 24589999
Q ss_pred ecCCCchh
Q 004088 267 YCGGGSVA 274 (774)
Q Consensus 267 y~~ggsL~ 274 (774)
+++|.++.
T Consensus 75 ~i~G~~l~ 82 (235)
T cd05155 75 WLEGETAT 82 (235)
T ss_pred eecCCCCC
Confidence 99987664
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00012 Score=73.76 Aligned_cols=132 Identities=20% Similarity=0.186 Sum_probs=91.9
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCccc-ccccccCCceEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVR-YLGSYQGEEYLWIVM 265 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVk-L~~~~~~~~~l~LVm 265 (774)
...-++.+.||+|.+|.||+|.+ .|..+|+|+-+ .......+..|+++|..+.--++.. +|.|-+ .++.|
T Consensus 21 ~~~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr---~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~m 91 (201)
T COG2112 21 KYELRVEKELAKGTTSVVYLGEW--RGGEVALKVRR---RDSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRM 91 (201)
T ss_pred chhhhhhhhhhcccccEEEEeec--cCceEEEEEec---CCcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhh
Confidence 34456678899999999999985 45689999753 2344567889999999987666543 443322 33559
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCccccccc-ccceEecCCCcEEEeeccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIK-GGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLK-PeNILLd~~g~vKL~DFGlA~ 335 (774)
||+.|-.|..+.... +.. -+..+++.---|-..||-|..|. |..++|..++.+.|+||..|+
T Consensus 92 e~i~G~~L~~~~~~~----~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 92 EYIDGRPLGKLEIGG----DRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhcCcchhhhhhcc----cHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 999988887664311 222 23345556556678899999985 555555555689999999986
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00048 Score=70.84 Aligned_cols=132 Identities=22% Similarity=0.301 Sum_probs=94.7
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCC---------------ChhhHHHHHHHHHHHHhCC------CCCccccc
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSE---------------GEEGYEEIRGEIEMLQQCS------HPNVVRYL 252 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~---------------~~~~~~~~~~Ei~iL~~L~------HPNIVkL~ 252 (774)
..||+|+.=.||.-- .....+||++.... ......+..+|+.-...+. +.+|.++|
T Consensus 7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 468999999999642 33447889986443 1123456777777666665 77899999
Q ss_pred ccccCCceEEEEEEecCC------CchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC--
Q 004088 253 GSYQGEEYLWIVMEYCGG------GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG-- 324 (774)
Q Consensus 253 ~~~~~~~~l~LVmEy~~g------gsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g-- 324 (774)
|+.+++.-.-+|+|.+.. .+|.+++. ...+++ .+. ..+-.-..||-.++|+.+||+|.||++....
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK--EGGLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH--cCCccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 999999999999998753 35667764 234555 333 3444556888999999999999999996543
Q ss_pred --cEEEee-cccc
Q 004088 325 --EVKLGD-FGVA 334 (774)
Q Consensus 325 --~vKL~D-FGlA 334 (774)
.+.|+| ||..
T Consensus 158 ~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 158 EFRLVLIDGLGEK 170 (199)
T ss_pred ceEEEEEeCCCCc
Confidence 578888 5644
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.58 E-value=6.9e-06 Score=101.95 Aligned_cols=156 Identities=13% Similarity=0.093 Sum_probs=122.0
Q ss_pred HHHHHHHHHhCCCCCccccccccc--CCceEEEEEEecCCCchhhhhhc---cCCchhHHHHHHHHHHHHHHHHHHHhcC
Q 004088 233 IRGEIEMLQQCSHPNVVRYLGSYQ--GEEYLWIVMEYCGGGSVADLMNV---TEEPLEEYQIAYICREALKGLAYLHSIF 307 (774)
Q Consensus 233 ~~~Ei~iL~~L~HPNIVkL~~~~~--~~~~l~LVmEy~~ggsL~dll~~---~~~~Lse~~i~~I~~QIl~gL~YLHs~g 307 (774)
...|...++...|+++...+.-.. .....|++++||.+|.++..+-+ ....+.+.-+.....+.+.+..-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 445556666778999887766554 34567899999999999998742 2234556666666666577777777642
Q ss_pred -----cccccccccceEecCCCcEEEeeccccccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh
Q 004088 308 -----KVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE 382 (774)
Q Consensus 308 -----IIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt 382 (774)
.+|++||+-|.+|..+-++|+.++|+.+............++++.|+.|++...-.++.++|+|..|+.+|++..
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 799999999999999999999999999844444444556788999999999999999999999999999999988
Q ss_pred CCCCCC
Q 004088 383 GLPPRS 388 (774)
Q Consensus 383 G~~Pf~ 388 (774)
|.++|-
T Consensus 1436 ~n~~fi 1441 (2724)
T KOG1826|consen 1436 GNAYFI 1441 (2724)
T ss_pred ccHHHH
Confidence 877654
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00041 Score=71.66 Aligned_cols=75 Identities=13% Similarity=0.235 Sum_probs=48.7
Q ss_pred EeeeeccCceEEEEEEEcC-CCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCC-cccccccccCCceEEEEEEecCC
Q 004088 193 LNELGKGSYGAVYKARDLK-TSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPN-VVRYLGSYQGEEYLWIVMEYCGG 270 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~~-~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPN-IVkL~~~~~~~~~l~LVmEy~~g 270 (774)
++.|..|-...||++.... .++.|++|+..... ...-...+|+.+++.+...+ ..+++..+.. .+||||++|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~--~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G 76 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT--ELIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPG 76 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc--cceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCC
Confidence 4678888888999997432 35679999764321 11123457999999885433 3444444332 379999998
Q ss_pred Cch
Q 004088 271 GSV 273 (774)
Q Consensus 271 gsL 273 (774)
.++
T Consensus 77 ~~l 79 (235)
T cd05157 77 RTL 79 (235)
T ss_pred CcC
Confidence 765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0002 Score=72.88 Aligned_cols=100 Identities=26% Similarity=0.203 Sum_probs=80.2
Q ss_pred HHHHHHHHhCCC-CCcccccccccCCceEEEEEEecCCCchhhhhh--ccCCchhHHHHHHHHHHHHHHHHHHHh---cC
Q 004088 234 RGEIEMLQQCSH-PNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN--VTEEPLEEYQIAYICREALKGLAYLHS---IF 307 (774)
Q Consensus 234 ~~Ei~iL~~L~H-PNIVkL~~~~~~~~~l~LVmEy~~ggsL~dll~--~~~~~Lse~~i~~I~~QIl~gL~YLHs---~g 307 (774)
..|.-+|+.+.+ +++++++|+|- .++|.||.+.+++..... ..-..-+|..+..|+.++++.+.+|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358889999976 69999999983 367999998776643210 011236889999999999999999997 45
Q ss_pred cccccccccceEecCCCcEEEeeccccccc
Q 004088 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQL 337 (774)
Q Consensus 308 IIHRDLKPeNILLd~~g~vKL~DFGlA~~i 337 (774)
+.-.|++|+|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 788999999999999999999999987543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00072 Score=71.21 Aligned_cols=132 Identities=20% Similarity=0.245 Sum_probs=75.9
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCc-ccccccccCCceEEEEEEecCCCchh
Q 004088 196 LGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV-VRYLGSYQGEEYLWIVMEYCGGGSVA 274 (774)
Q Consensus 196 LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNI-VkL~~~~~~~~~l~LVmEy~~ggsL~ 274 (774)
+..|-...+|+.. .+++.+++|+.......-. -...+|..+|+.+..-.+ .+++.... -++||||++|..+.
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALG-VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCccccccc-CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 4567778899886 4567788997543221111 135679999998864333 33443332 26899999986653
Q ss_pred hh--------------h---hcc---CCchhH-HHHHHHHHHH---------HHHHHHHHh--------cCccccccccc
Q 004088 275 DL--------------M---NVT---EEPLEE-YQIAYICREA---------LKGLAYLHS--------IFKVHRDIKGG 316 (774)
Q Consensus 275 dl--------------l---~~~---~~~Lse-~~i~~I~~QI---------l~gL~YLHs--------~gIIHRDLKPe 316 (774)
.. + +.. ..+++. ..+..+..++ ...+..+-. ..++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 21 1 000 111111 1111221111 111222221 24899999999
Q ss_pred ceEecCCCcEEEeeccccc
Q 004088 317 NILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 317 NILLd~~g~vKL~DFGlA~ 335 (774)
|||++.++ +.|+||..|.
T Consensus 157 Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred cEEEeCCC-CEEEeccccC
Confidence 99999877 8899999874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00029 Score=76.89 Aligned_cols=135 Identities=16% Similarity=0.212 Sum_probs=95.5
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-----------------ChhhH----HHHHHHHHHHHhCC-CC
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-----------------GEEGY----EEIRGEIEMLQQCS-HP 246 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-----------------~~~~~----~~~~~Ei~iL~~L~-HP 246 (774)
-|.+++.||-|.-+.||.+-+ ..|.+.++|.-+... ...+. -...+|+..|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 467789999999999999985 578889999643211 00111 12457888888774 32
Q ss_pred -CcccccccccCCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCc
Q 004088 247 -NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE 325 (774)
Q Consensus 247 -NIVkL~~~~~~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~ 325 (774)
-+.+.+++ .+.|+|||++.|-.|..+-+... ...+...+..-+.-|-.+|+||+|..-=||+|++++.
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d-------~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRHVED-------PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeeecCC-------hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence 24444443 56899999999988776543221 2334445555566788999999999999999999999
Q ss_pred EEEeeccccc
Q 004088 326 VKLGDFGVAA 335 (774)
Q Consensus 326 vKL~DFGlA~ 335 (774)
++++||--+.
T Consensus 241 i~vIDFPQmv 250 (465)
T KOG2268|consen 241 IVVIDFPQMV 250 (465)
T ss_pred EEEeechHhh
Confidence 9999997553
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0028 Score=67.93 Aligned_cols=137 Identities=15% Similarity=0.088 Sum_probs=83.2
Q ss_pred EeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCC--cccccccc------cCCceEEEE
Q 004088 193 LNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPN--VVRYLGSY------QGEEYLWIV 264 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPN--IVkL~~~~------~~~~~l~LV 264 (774)
++.|..|....+|+... .+..+++|+... .....+..|+.++..|.+-+ +.+++... ...+..++|
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l 92 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL 92 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence 56777888889999863 334689998753 22345677888888874322 44444321 234567899
Q ss_pred EEecCCCchhh----hh----------hc-c---CC------chhHHHH--H--------HHHHHHHHHHHHHHh-----
Q 004088 265 MEYCGGGSVAD----LM----------NV-T---EE------PLEEYQI--A--------YICREALKGLAYLHS----- 305 (774)
Q Consensus 265 mEy~~ggsL~d----ll----------~~-~---~~------~Lse~~i--~--------~I~~QIl~gL~YLHs----- 305 (774)
++|++|..+.. .. +. . .. ...+... . .....+..++.++..
T Consensus 93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~ 172 (296)
T cd05153 93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD 172 (296)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 99999876532 00 00 0 00 0011000 0 011123334455543
Q ss_pred --cCcccccccccceEecCCCcEEEeeccccc
Q 004088 306 --IFKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 306 --~gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 469999999999999997777899999873
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.003 Score=68.49 Aligned_cols=141 Identities=18% Similarity=0.135 Sum_probs=83.1
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCC--cccccccc------cCCceE
Q 004088 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPN--VVRYLGSY------QGEEYL 261 (774)
Q Consensus 190 Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPN--IVkL~~~~------~~~~~l 261 (774)
...++.++.|....||++.. .+| .+++|+...... .+.+..|+.++..|.... +.+++... ...+..
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRVK---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred ceeccccCCccccceEEEEe-CCC-cEEEEEecCCCC---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 34466777888889999863 344 577898653221 244566777777774222 34444321 234567
Q ss_pred EEEEEecCCCchhh-----------hh---hc--cC--C------ch-hHHHH--H----------HHHHHHHHHHHHHH
Q 004088 262 WIVMEYCGGGSVAD-----------LM---NV--TE--E------PL-EEYQI--A----------YICREALKGLAYLH 304 (774)
Q Consensus 262 ~LVmEy~~ggsL~d-----------ll---~~--~~--~------~L-se~~i--~----------~I~~QIl~gL~YLH 304 (774)
++|++|++|..+.. .+ +. .. . .+ .+... . .....+...++++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 89999998854321 00 10 00 0 00 11100 0 01122334555554
Q ss_pred h-------cCcccccccccceEecCCCcEEEeeccccc
Q 004088 305 S-------IFKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 305 s-------~gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
. .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 2 579999999999999998777899999873
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0032 Score=68.34 Aligned_cols=137 Identities=12% Similarity=0.097 Sum_probs=75.3
Q ss_pred EeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCC--ccccccc------ccCCceEEEE
Q 004088 193 LNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPN--VVRYLGS------YQGEEYLWIV 264 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPN--IVkL~~~------~~~~~~l~LV 264 (774)
++.|+.|....+|+... .+| .+++|++. ... .+.+..|+.++..|...+ +.+.+.. ....+..+++
T Consensus 27 ~~~l~~G~~n~~y~v~t-~~g-~~vLK~~~-~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l 100 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT-TQG-EYVLTLFE-RLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAI 100 (319)
T ss_pred cchhccccccceEEEEe-CCC-cEEEEEec-cCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEE
Confidence 45577788889999874 344 58999875 212 233445666666653211 2333321 1234567899
Q ss_pred EEecCCCchhh-----h------hh---c-cC---------CchhH-HHH-H-----------HHHHH-HHHHHHHHH--
Q 004088 265 MEYCGGGSVAD-----L------MN---V-TE---------EPLEE-YQI-A-----------YICRE-ALKGLAYLH-- 304 (774)
Q Consensus 265 mEy~~ggsL~d-----l------l~---~-~~---------~~Lse-~~i-~-----------~I~~Q-Il~gL~YLH-- 304 (774)
++|++|..+.. . +. . .. ..+.+ ... . ..+.+ +...+..+.
T Consensus 101 ~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 180 (319)
T PRK05231 101 VTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASA 180 (319)
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcc
Confidence 99998864321 1 10 0 00 00111 010 0 01111 111223332
Q ss_pred -----hcCcccccccccceEecCCCcEEEeeccccc
Q 004088 305 -----SIFKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 305 -----s~gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
..++||+|++|.|||++.+...-|+||+.+.
T Consensus 181 ~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 181 AWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2379999999999999976556899999874
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0039 Score=67.79 Aligned_cols=78 Identities=14% Similarity=0.035 Sum_probs=55.0
Q ss_pred eEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCC---CCcccccccccC---CceEEEE
Q 004088 191 ELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSH---PNVVRYLGSYQG---EEYLWIV 264 (774)
Q Consensus 191 ~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~H---PNIVkL~~~~~~---~~~l~LV 264 (774)
.-.+.||.|..+.||.... .++ .+.+|..+ .. .....+..|...|+.|.. -.+.++++++.. .+..+||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~-~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 17 SRVECISEQPYAALWALYD-SQG-NPMPLMAR-SF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred heeeecCCccceeEEEEEc-CCC-CEEEEEec-cc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 3456799999999999863 334 47778743 21 122468899999988853 356777876643 4668999
Q ss_pred EEecCCCch
Q 004088 265 MEYCGGGSV 273 (774)
Q Consensus 265 mEy~~ggsL 273 (774)
||+++|.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998754
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0048 Score=69.97 Aligned_cols=77 Identities=23% Similarity=0.190 Sum_probs=54.3
Q ss_pred EeeeeccCceEEEEEEEcCCCcEEEEEEeecC-----C-ChhhHHHHHHHHHHHHhCC---CCCcccccccccCCceEEE
Q 004088 193 LNELGKGSYGAVYKARDLKTSELVAIKVISLS-----E-GEEGYEEIRGEIEMLQQCS---HPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~-----~-~~~~~~~~~~Ei~iL~~L~---HPNIVkL~~~~~~~~~l~L 263 (774)
.+.||-|.+..||++.....++.|+||.-... . .....+....|.+.|+.+. ..++.+++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46799999999999997543358999985311 1 1234567788888888863 2456677766 3456789
Q ss_pred EEEecCCC
Q 004088 264 VMEYCGGG 271 (774)
Q Consensus 264 VmEy~~gg 271 (774)
||||+++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99999864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0024 Score=68.80 Aligned_cols=76 Identities=18% Similarity=0.240 Sum_probs=48.6
Q ss_pred EeeeeccCceEEEEEEEcC------CCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCc-ccccccccCCceEEEEE
Q 004088 193 LNELGKGSYGAVYKARDLK------TSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV-VRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~~------~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNI-VkL~~~~~~~~~l~LVm 265 (774)
++.|..|--..||++.... .++.|++|+..... .......+|+++++.+....+ .+++.++.+ .+|+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~ 76 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV--ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIE 76 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC--cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence 4556667777899887432 25789999864322 223456789888888854333 345555542 3589
Q ss_pred EecCCCchh
Q 004088 266 EYCGGGSVA 274 (774)
Q Consensus 266 Ey~~ggsL~ 274 (774)
||++|..+.
T Consensus 77 e~i~G~~l~ 85 (302)
T cd05156 77 EFIPSRTLT 85 (302)
T ss_pred heeCCCcCC
Confidence 999887654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0053 Score=68.27 Aligned_cols=139 Identities=17% Similarity=0.183 Sum_probs=93.0
Q ss_pred EeeeeccCceEEEEEEEcCCCcEEEEEEeecCC----C--------------------hhhHHH-HHHHHHHHHhCCCCC
Q 004088 193 LNELGKGSYGAVYKARDLKTSELVAIKVISLSE----G--------------------EEGYEE-IRGEIEMLQQCSHPN 247 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~----~--------------------~~~~~~-~~~Ei~iL~~L~HPN 247 (774)
-..|..|--+.||.|. ..+|..+|||+++.+- + ...+.- ...|++-|++|+...
T Consensus 149 nGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 149 NGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred ccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 3467889999999998 5788899999975220 0 001111 235788888876544
Q ss_pred cccccccccCCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHH-HhcCcccccccccceEecCCCcE
Q 004088 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYL-HSIFKVHRDIKGGNILLTDQGEV 326 (774)
Q Consensus 248 IVkL~~~~~~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YL-Hs~gIIHRDLKPeNILLd~~g~v 326 (774)
|..---.. -....|||+|+.. +=+-.-......++...+..+-.|++.-|.-| |..++||.||.--|+|+-. |.+
T Consensus 228 IP~PePIl--Lk~hVLVM~FlGr-dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~l 303 (520)
T KOG2270|consen 228 IPCPEPIL--LKNHVLVMEFLGR-DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GKL 303 (520)
T ss_pred CCCCCcee--eecceEeeeeccC-CCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CEE
Confidence 32211111 0235689999963 32222222345677777888888888888777 5568999999999999976 789
Q ss_pred EEeecccccc
Q 004088 327 KLGDFGVAAQ 336 (774)
Q Consensus 327 KL~DFGlA~~ 336 (774)
.|+|.+-+..
T Consensus 304 yiIDVSQSVE 313 (520)
T KOG2270|consen 304 YIIDVSQSVE 313 (520)
T ss_pred EEEEcccccc
Confidence 9999987743
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.002 Score=73.96 Aligned_cols=164 Identities=24% Similarity=0.277 Sum_probs=102.0
Q ss_pred HHHHHHHHHHHhCCCCCcccccccccC-CceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcc
Q 004088 231 EEIRGEIEMLQQCSHPNVVRYLGSYQG-EEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKV 309 (774)
Q Consensus 231 ~~~~~Ei~iL~~L~HPNIVkL~~~~~~-~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gII 309 (774)
.++.--..+++.+.|+|...++++-.. ..+..+|||++ +.+|.+++.... +-.. ++. .+++.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~~~-------s~~-------~~~~~ 89 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LKDE-------SLL-------AHGVL 89 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cchh-------hhc-------ccccc
Confidence 345667889999999999999887764 34578899999 779998875332 1110 111 22222
Q ss_pred cccccccceEecCCCcEEEeeccccccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCC
Q 004088 310 HRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRST 389 (774)
Q Consensus 310 HRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~ 389 (774)
|- +.++++| -++ +...+..| +|+||||+|.++.++.-|..-+..
T Consensus 90 ~~------------~~~~~td-~~~-------t~~~~~~~----------------pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 90 HL------------NIIYITD-HFL-------TKYPSPIG----------------PKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred ee------------hhhhccc-ccc-------ccCCCCCC----------------cchhhhhHHHHHHHHHHhhHHHHH
Confidence 22 1233444 011 01111112 399999999999999988776655
Q ss_pred CCchhhhhhhhcCCCCcc---------ccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 390 VHPMRVLFMISIEPAPML---------EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 390 ~~~~~~i~~i~~~~~~~~---------~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
....+....+........ ......+..+.++..+|+-..|..||...++.+|+-|...
T Consensus 134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 134 LTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 544444333222111100 0011224456788999999999999999999999988754
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.034 Score=59.77 Aligned_cols=29 Identities=38% Similarity=0.344 Sum_probs=25.5
Q ss_pred cCcccccccccceEecCCCcEEEeeccccc
Q 004088 306 IFKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 306 ~gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
.+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999988 678999999763
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.032 Score=60.09 Aligned_cols=29 Identities=31% Similarity=0.480 Sum_probs=24.8
Q ss_pred CcccccccccceEecCCCc-EEEeeccccc
Q 004088 307 FKVHRDIKGGNILLTDQGE-VKLGDFGVAA 335 (774)
Q Consensus 307 gIIHRDLKPeNILLd~~g~-vKL~DFGlA~ 335 (774)
.++|+|++|.|||++.++. .-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 3899999999999997555 5699999884
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.028 Score=62.49 Aligned_cols=138 Identities=17% Similarity=0.208 Sum_probs=80.6
Q ss_pred EEeeeeccCceEEEEEEEcC----CCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCc-ccccccccCCceEEEEEE
Q 004088 192 LLNELGKGSYGAVYKARDLK----TSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV-VRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 192 ilk~LG~G~FG~Vy~a~d~~----~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNI-VkL~~~~~~~~~l~LVmE 266 (774)
-++.|-.|-.-.+|++.... .++.|.+|+..... ...+ .-.+|+.+++.+..-++ .++++.+.+. .|++
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~e 113 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEE 113 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-Ceee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEE
Confidence 34455558888999987432 34689999875332 2222 23679999988854443 3556666443 5899
Q ss_pred ecCCCchhhh-------h----------hccC-----CchhHHHHHHHHHHH-----------------HHHHHHH----
Q 004088 267 YCGGGSVADL-------M----------NVTE-----EPLEEYQIAYICREA-----------------LKGLAYL---- 303 (774)
Q Consensus 267 y~~ggsL~dl-------l----------~~~~-----~~Lse~~i~~I~~QI-----------------l~gL~YL---- 303 (774)
|+++.+|... + +... .......+..++.++ ...+..|
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 9987665311 0 0000 011222333333221 1112222
Q ss_pred H----hcCcccccccccceEecC-CCcEEEeeccccc
Q 004088 304 H----SIFKVHRDIKGGNILLTD-QGEVKLGDFGVAA 335 (774)
Q Consensus 304 H----s~gIIHRDLKPeNILLd~-~g~vKL~DFGlA~ 335 (774)
. ...++|+|+++.|||++. ++.++|+||..|.
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 225899999999999986 4679999999874
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.055 Score=59.71 Aligned_cols=141 Identities=18% Similarity=0.225 Sum_probs=80.9
Q ss_pred EEeeeeccCceEEEEEEEcCCCcEEEEEEee-cCCChhhHHHHHHHHHHHHhCCC--CCcccccccccCCc--eEEEEEE
Q 004088 192 LLNELGKGSYGAVYKARDLKTSELVAIKVIS-LSEGEEGYEEIRGEIEMLQQCSH--PNVVRYLGSYQGEE--YLWIVME 266 (774)
Q Consensus 192 ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~-~~~~~~~~~~~~~Ei~iL~~L~H--PNIVkL~~~~~~~~--~l~LVmE 266 (774)
+++.+-.|.--.+|..... ++.++|. .. ............+|..+|+.+.- --+...+++|..+. ..|.||+
T Consensus 29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred eeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 3444433333334444432 7778887 32 12333445667789999888743 23445566666555 7799999
Q ss_pred ecCCCchhhh------------------hhc-------------cCCchhHHHHHHHHHH--------------HHHHHH
Q 004088 267 YCGGGSVADL------------------MNV-------------TEEPLEEYQIAYICRE--------------ALKGLA 301 (774)
Q Consensus 267 y~~ggsL~dl------------------l~~-------------~~~~Lse~~i~~I~~Q--------------Il~gL~ 301 (774)
|++|..+... |.. ........++..+..+ +..-..
T Consensus 106 ~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~ 185 (321)
T COG3173 106 WVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK 185 (321)
T ss_pred EecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence 9988422221 110 0000011111111111 223345
Q ss_pred HHHhc--------CcccccccccceEecCCCcEEEeeccccc
Q 004088 302 YLHSI--------FKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 302 YLHs~--------gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
+|+.+ .++|+|+.+.||+|+..+.+=|+||+++.
T Consensus 186 Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~ 227 (321)
T COG3173 186 WLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELAT 227 (321)
T ss_pred HHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccc
Confidence 55543 38999999999999999889999999985
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.046 Score=61.30 Aligned_cols=76 Identities=21% Similarity=0.179 Sum_probs=50.3
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEee----c--CCChhhHHHHHHHHHHHHhCC--CC-CcccccccccCCceEEEE
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVIS----L--SEGEEGYEEIRGEIEMLQQCS--HP-NVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~----~--~~~~~~~~~~~~Ei~iL~~L~--HP-NIVkL~~~~~~~~~l~LV 264 (774)
++||-|....||++.+...++.|+||.-. . ...+-..++..-|...|+... -| .+.++|. .+.....+|
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~v 78 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTV 78 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccccceeh
Confidence 36899999999999975434679999752 1 112334556677888887763 24 3445443 345566799
Q ss_pred EEecCCC
Q 004088 265 MEYCGGG 271 (774)
Q Consensus 265 mEy~~gg 271 (774)
||+++..
T Consensus 79 MEdL~~~ 85 (370)
T TIGR01767 79 MEDLSHH 85 (370)
T ss_pred HhhCccc
Confidence 9999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.15 Score=55.47 Aligned_cols=29 Identities=17% Similarity=0.177 Sum_probs=26.9
Q ss_pred CcccccccccceEecCCCcEEEeeccccc
Q 004088 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 307 gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
+++|+|+.+.|||++.++.+.|+||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 69999999999999999999999999874
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.1 Score=57.68 Aligned_cols=137 Identities=15% Similarity=0.262 Sum_probs=77.4
Q ss_pred EeeeeccCceEEEEEEEcCC---CcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCc-ccccccccCCceEEEEEEec
Q 004088 193 LNELGKGSYGAVYKARDLKT---SELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV-VRYLGSYQGEEYLWIVMEYC 268 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~~~---g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNI-VkL~~~~~~~~~l~LVmEy~ 268 (774)
++.|..|-...+|++..... +..|.+|+...... ..-.-.+|..+++.+..-++ .++++++.++ +|.+|+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi 92 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFI 92 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eEechHHHHHHHHHHHhcCCCCceeEEeCCc----Eeehhh
Confidence 34454577778898864332 34789998753221 12223578889988865444 3556555322 589999
Q ss_pred CCCchhh-------hh-------h---ccC---C--chhHHHHHHHHHHH----------------------HHHHHHHH
Q 004088 269 GGGSVAD-------LM-------N---VTE---E--PLEEYQIAYICREA----------------------LKGLAYLH 304 (774)
Q Consensus 269 ~ggsL~d-------ll-------~---~~~---~--~Lse~~i~~I~~QI----------------------l~gL~YLH 304 (774)
++..|.. .+ + ... . +-.+..+..++.++ ..-+..+.
T Consensus 93 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~ 172 (330)
T PLN02421 93 NARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELK 172 (330)
T ss_pred cCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHH
Confidence 7765421 01 0 000 0 11122222222221 11122221
Q ss_pred ----hcC----cccccccccceEecC-CCcEEEeeccccc
Q 004088 305 ----SIF----KVHRDIKGGNILLTD-QGEVKLGDFGVAA 335 (774)
Q Consensus 305 ----s~g----IIHRDLKPeNILLd~-~g~vKL~DFGlA~ 335 (774)
..+ ++|.|+.+.|||++. ++.++++||..|.
T Consensus 173 ~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 173 EITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 222 789999999999975 4689999999884
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.85 E-value=0.35 Score=55.25 Aligned_cols=75 Identities=21% Similarity=0.133 Sum_probs=52.0
Q ss_pred EEeeeeccCceEEEEEEEcCCCcEEEEEEeec-----CC-ChhhHHHHHHHHHHHHhCC---CCCcccccccccCCceEE
Q 004088 192 LLNELGKGSYGAVYKARDLKTSELVAIKVISL-----SE-GEEGYEEIRGEIEMLQQCS---HPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 192 ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~-----~~-~~~~~~~~~~Ei~iL~~L~---HPNIVkL~~~~~~~~~l~ 262 (774)
..+.||-|....||+..+ .+..|+||.-.. .. ..........|+..|+.+. ..++.++|.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 367899999999999886 345699997541 11 1123455566777777663 246778888776 4567
Q ss_pred EEEEecCC
Q 004088 263 IVMEYCGG 270 (774)
Q Consensus 263 LVmEy~~g 270 (774)
+||||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 89999976
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.84 E-value=0.081 Score=57.59 Aligned_cols=76 Identities=18% Similarity=0.280 Sum_probs=47.8
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC--C-CCcccccccccCCceEEEEEE
Q 004088 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS--H-PNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 190 Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~--H-PNIVkL~~~~~~~~~l~LVmE 266 (774)
-+-.+.|+-|....+|... .+++.|.||+-. ......+..|..-|+.|. . -.+.+.+++....+..|||||
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~----~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle 92 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS----ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE 92 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEE----GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecC----hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence 3446778999999999987 678889999865 223345778888888883 3 346678887766666799999
Q ss_pred ecCCC
Q 004088 267 YCGGG 271 (774)
Q Consensus 267 y~~gg 271 (774)
|++.+
T Consensus 93 ~l~~~ 97 (288)
T PF03881_consen 93 FLEMG 97 (288)
T ss_dssp -----
T ss_pred eecCC
Confidence 99766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.79 E-value=0.34 Score=61.39 Aligned_cols=137 Identities=21% Similarity=0.265 Sum_probs=75.8
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-------CCCccccc-cc----cc---CC
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-------HPNVVRYL-GS----YQ---GE 258 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-------HPNIVkL~-~~----~~---~~ 258 (774)
+.|+ |.+-.+|+.. ..+|..|++|+.+.... ...+..|..+|..|. -|.+++-. +- .. ..
T Consensus 31 ~~L~-s~~d~nf~v~-~~~g~~yVLKi~~~~~~---~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~ 105 (1013)
T PRK06148 31 TPLD-GERDLNFRLT-TDDGADYILKIVNPSEP---RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGE 105 (1013)
T ss_pred eecC-CcCCceEEEE-eCCCCeEEEEEcCCccc---hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCc
Confidence 4564 4567788886 45677899999864322 223344555665442 23333322 11 11 11
Q ss_pred ceEEEEEEecCCCchhhh-------hh----------c------c---CCchhHH-----------------HHHHHHHH
Q 004088 259 EYLWIVMEYCGGGSVADL-------MN----------V------T---EEPLEEY-----------------QIAYICRE 295 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dl-------l~----------~------~---~~~Lse~-----------------~i~~I~~Q 295 (774)
.+.+-+++|++|..+.+. +. . . ...+.|. ..+.++.+
T Consensus 106 ~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~ 185 (1013)
T PRK06148 106 PRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVER 185 (1013)
T ss_pred eEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHH
Confidence 257789999999776541 00 0 0 0111111 11222333
Q ss_pred HHHHHH-----HHH--hcCcccccccccceEecCCC--cEE-Eeeccccc
Q 004088 296 ALKGLA-----YLH--SIFKVHRDIKGGNILLTDQG--EVK-LGDFGVAA 335 (774)
Q Consensus 296 Il~gL~-----YLH--s~gIIHRDLKPeNILLd~~g--~vK-L~DFGlA~ 335 (774)
++..+. .|. .+++||+|+.+.|||++.++ .+. |+|||-+.
T Consensus 186 ~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 186 FLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 333222 122 25799999999999999875 555 99999874
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.78 E-value=0.16 Score=56.37 Aligned_cols=131 Identities=18% Similarity=0.224 Sum_probs=79.1
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCC------cccccc----cccCCceEEEEEEecC
Q 004088 200 SYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPN------VVRYLG----SYQGEEYLWIVMEYCG 269 (774)
Q Consensus 200 ~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPN------IVkL~~----~~~~~~~l~LVmEy~~ 269 (774)
.-..||+... .+|+. ++|+.+.. ....++.-|+.+|..|.-.. |..+-| .+....+.+-|++|++
T Consensus 37 ~eN~~f~~~~-~~g~~-iLki~~~~---~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~ 111 (331)
T COG2334 37 EENSNFRVQT-EDGRY-ILKIYRPG---WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLP 111 (331)
T ss_pred ccCceEEEEe-cCCCe-EEEEecCC---CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecC
Confidence 4466888873 45554 99987643 33456777888888773211 222222 2222247888999999
Q ss_pred CCchhh-h--------------hhc--------cCC---chhHH----H---------HHHHHHHHHHHHHHHHh-----
Q 004088 270 GGSVAD-L--------------MNV--------TEE---PLEEY----Q---------IAYICREALKGLAYLHS----- 305 (774)
Q Consensus 270 ggsL~d-l--------------l~~--------~~~---~Lse~----~---------i~~I~~QIl~gL~YLHs----- 305 (774)
|..+.. . ++. +.. ...|. . -.....++...+..+.+
T Consensus 112 G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~ 191 (331)
T COG2334 112 GRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAH 191 (331)
T ss_pred CcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhh
Confidence 987772 1 000 000 11121 0 01133444555555553
Q ss_pred ---cC--cccccccccceEecCCCc-EEEeeccccc
Q 004088 306 ---IF--KVHRDIKGGNILLTDQGE-VKLGDFGVAA 335 (774)
Q Consensus 306 ---~g--IIHRDLKPeNILLd~~g~-vKL~DFGlA~ 335 (774)
.+ |||+|+.|.|||++.+.. +.++|||-|.
T Consensus 192 lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 192 LPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred CCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 23 999999999999999875 8999999773
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.34 E-value=0.16 Score=57.66 Aligned_cols=76 Identities=25% Similarity=0.218 Sum_probs=52.5
Q ss_pred EeeeeccCceEEEEEEEcCCCcEEEEEEee----cC-CChhhHHHHHHHHHHHHhCC--CC-CcccccccccCCceEEEE
Q 004088 193 LNELGKGSYGAVYKARDLKTSELVAIKVIS----LS-EGEEGYEEIRGEIEMLQQCS--HP-NVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~----~~-~~~~~~~~~~~Ei~iL~~L~--HP-NIVkL~~~~~~~~~l~LV 264 (774)
++.||-|.-..||++.+...++.|+||.-. .. ...-..++..-|..+|+.+. -| ++.++|.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 678999999999999974445679999742 11 12344567778888888763 24 45555543 45566789
Q ss_pred EEecCC
Q 004088 265 MEYCGG 270 (774)
Q Consensus 265 mEy~~g 270 (774)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.33 E-value=0.4 Score=52.80 Aligned_cols=71 Identities=17% Similarity=0.151 Sum_probs=43.0
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCC--ccccc---c--cccCCceEEEEEEecCCC
Q 004088 199 GSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPN--VVRYL---G--SYQGEEYLWIVMEYCGGG 271 (774)
Q Consensus 199 G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPN--IVkL~---~--~~~~~~~l~LVmEy~~gg 271 (774)
+.-..||+.. ..+|..|++|+.+... .....+..|+.++..|.... ++... + ...-++..+.|+++++|.
T Consensus 36 s~eN~vy~v~-~~~~~~~vlKv~r~~~--~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~ 112 (325)
T PRK11768 36 SYENRVYQFG-DEDGRRVVAKFYRPER--WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGR 112 (325)
T ss_pred cccceEEEEe-cCCCCEEEEEEcCccc--CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCC
Confidence 3446789886 3567789999874221 23456778888887763211 22211 1 122245678899999875
Q ss_pred c
Q 004088 272 S 272 (774)
Q Consensus 272 s 272 (774)
.
T Consensus 113 ~ 113 (325)
T PRK11768 113 A 113 (325)
T ss_pred C
Confidence 4
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.30 E-value=0.1 Score=58.46 Aligned_cols=74 Identities=20% Similarity=0.257 Sum_probs=56.7
Q ss_pred cCCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhc-CcccccccccceEecCCCcEEEeecccc
Q 004088 256 QGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI-FKVHRDIKGGNILLTDQGEVKLGDFGVA 334 (774)
Q Consensus 256 ~~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~-gIIHRDLKPeNILLd~~g~vKL~DFGlA 334 (774)
.+..+.|++|++. |+.|.-+ ......++..|+.+.+..+.-+..+ ..=||++...||||+ +|+|-|+||-++
T Consensus 296 de~~y~yl~~kdh-gt~is~i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 296 DETLYLYLHFKDH-GTPISII-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred CCceEEEEEEecC-Cceeeee-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeee
Confidence 3456788999988 6565432 2235667778888877776666654 478999999999999 899999999999
Q ss_pred cc
Q 004088 335 AQ 336 (774)
Q Consensus 335 ~~ 336 (774)
+.
T Consensus 369 Rl 370 (488)
T COG5072 369 RL 370 (488)
T ss_pred ec
Confidence 74
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.69 E-value=0.39 Score=49.08 Aligned_cols=117 Identities=23% Similarity=0.339 Sum_probs=59.0
Q ss_pred CcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCc-ccccccccCCceEEEEEEecCCCchhh--h-----hh------
Q 004088 213 SELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV-VRYLGSYQGEEYLWIVMEYCGGGSVAD--L-----MN------ 278 (774)
Q Consensus 213 g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNI-VkL~~~~~~~~~l~LVmEy~~ggsL~d--l-----l~------ 278 (774)
++.|.|++.... ....-.-.+|..+++.+..-++ .++++++.+. +|++|+++..|.. + +.
T Consensus 2 ~~~~~~Ri~g~~--t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l 75 (211)
T PF01633_consen 2 PEKYLVRIPGEG--TENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLL 75 (211)
T ss_dssp TSEEEEEEEESC--GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHH
T ss_pred CCEEEEEeCCCC--cccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHH
Confidence 467889987533 3344556678888888864444 4556655433 5779997655422 1 00
Q ss_pred -------c---cCCchhHHHHHHH----------------------HHHHHHHHHHHHh--------cCcccccccccce
Q 004088 279 -------V---TEEPLEEYQIAYI----------------------CREALKGLAYLHS--------IFKVHRDIKGGNI 318 (774)
Q Consensus 279 -------~---~~~~Lse~~i~~I----------------------~~QIl~gL~YLHs--------~gIIHRDLKPeNI 318 (774)
. .....-+..+..+ +..+..-+..+.+ ..+.|.||.+.||
T Consensus 76 ~~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Ni 155 (211)
T PF01633_consen 76 AKLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNI 155 (211)
T ss_dssp HHHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGE
T ss_pred HHHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccE
Confidence 0 0001111222222 1112222333221 2478999999999
Q ss_pred Ee-cCCCcEEEeeccccc
Q 004088 319 LL-TDQGEVKLGDFGVAA 335 (774)
Q Consensus 319 LL-d~~g~vKL~DFGlA~ 335 (774)
|+ +.++.++|+||..|.
T Consensus 156 l~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 156 LINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EETSSSSCEEE--GTT-E
T ss_pred EeccCCCeEEEecHHHHh
Confidence 99 788899999999884
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=93.10 E-value=0.02 Score=65.88 Aligned_cols=70 Identities=27% Similarity=0.517 Sum_probs=62.1
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCccccccccc
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ 256 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~ 256 (774)
.+.|+.+..+|.|+||+|+.+....++..+|||.|.............+|+.-+..+.|++|++++..|.
T Consensus 48 a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~ 117 (516)
T KOG1033|consen 48 ANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWY 117 (516)
T ss_pred hccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheecee
Confidence 4678899999999999999999888888999999988777777778889999999999999999887664
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.64 E-value=1 Score=50.99 Aligned_cols=77 Identities=16% Similarity=0.249 Sum_probs=45.9
Q ss_pred EEeeeeccCceEEEEEEEcCC-CcE-----EEEEEeecCCChhhHHHHHHHHHHHHhCCCCCc-ccccccccCCceEEEE
Q 004088 192 LLNELGKGSYGAVYKARDLKT-SEL-----VAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV-VRYLGSYQGEEYLWIV 264 (774)
Q Consensus 192 ilk~LG~G~FG~Vy~a~d~~~-g~~-----VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNI-VkL~~~~~~~~~l~LV 264 (774)
.++.|..|--..+|++..... +.. |.+.+.. ......-.-.+|+.+++.+...++ .++++.+.+ ++|
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g--~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l 127 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS--TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTI 127 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEecc--CCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEE
Confidence 345565688889999874332 122 4444321 111111223578999999865544 456666653 589
Q ss_pred EEecCCCchh
Q 004088 265 MEYCGGGSVA 274 (774)
Q Consensus 265 mEy~~ggsL~ 274 (774)
.||++|..|.
T Consensus 128 ~efIeGr~l~ 137 (383)
T PTZ00384 128 QEWVEGNTMG 137 (383)
T ss_pred EEEeccccCC
Confidence 9999987653
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=92.47 E-value=0.38 Score=50.77 Aligned_cols=116 Identities=15% Similarity=0.087 Sum_probs=70.2
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCCCchhhhhh
Q 004088 199 GSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN 278 (774)
Q Consensus 199 G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~ggsL~dll~ 278 (774)
|+-++.-.++... |- ..+|.+....-.-....+..+.+++.++. .|++|..- +.-.+-++.|+|-...
T Consensus 73 ~gNsTl~~~kt~i-G~-L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~------ 140 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-GP-LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK------ 140 (308)
T ss_pred CCceEEEEecccc-ch-hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc------
Confidence 3344444443222 33 44555542222212345678888888763 57777632 4445678999993211
Q ss_pred ccCCchhHHHHHHHHHHHHHHHHHHHh--cCcccccccccceEecCCCcEEEeecccc
Q 004088 279 VTEEPLEEYQIAYICREALKGLAYLHS--IFKVHRDIKGGNILLTDQGEVKLGDFGVA 334 (774)
Q Consensus 279 ~~~~~Lse~~i~~I~~QIl~gL~YLHs--~gIIHRDLKPeNILLd~~g~vKL~DFGlA 334 (774)
-.. ..++.-=+..|.-.|+ .+.+|+|..|+|||-+..|.+||.|=+..
T Consensus 141 ----i~~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 141 ----INF----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred ----cch----hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 111 1111122467888894 35999999999999999999999997743
|
The function of this family is unknown. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.25 E-value=0.35 Score=55.02 Aligned_cols=63 Identities=22% Similarity=0.218 Sum_probs=43.9
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHH-HhcCcccccccccceEecCCC
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYL-HSIFKVHRDIKGGNILLTDQG 324 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YL-Hs~gIIHRDLKPeNILLd~~g 324 (774)
...||-+|..|.++..++.... .++...+.++.--..||--+ --.+++|.|+.|.||++.-+.
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~--~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS--QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK 382 (565)
T ss_pred cceeeeeccccccHHhhhhccc--ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence 4567888998988888886443 44555555555555554433 456899999999999997543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 774 | ||||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-78 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-76 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-76 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-76 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-75 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-75 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-74 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-69 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-65 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-64 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-64 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-64 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-64 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-62 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-62 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-62 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-61 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-61 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-61 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-61 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-61 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-54 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-53 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-49 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-45 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-45 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-45 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-45 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-45 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-45 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-44 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-38 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-37 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-36 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-33 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-33 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-33 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-33 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-33 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-33 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-33 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-33 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-30 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-28 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-28 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-28 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-28 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-28 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-28 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-28 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-27 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-27 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-27 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-27 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-27 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-27 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-27 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-26 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-26 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-26 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-26 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-26 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-26 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-26 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-26 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-26 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-26 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-26 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-26 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-26 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-26 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-26 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-26 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-26 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-25 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-25 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-25 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-25 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-25 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-25 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-25 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-25 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-25 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-25 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-25 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-25 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-25 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-25 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-25 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-25 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-25 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-25 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-25 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-25 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 6e-25 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-25 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-25 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-25 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-24 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-24 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-24 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-24 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-24 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-24 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-24 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-24 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-24 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-24 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-24 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-24 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-24 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-24 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-24 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-24 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-24 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-24 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-24 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-24 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-24 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-24 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-24 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-24 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-24 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-24 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-24 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-24 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-24 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-24 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-24 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-24 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-24 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-24 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-24 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-23 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-23 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-23 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-23 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-23 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-23 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-23 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-23 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-23 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-23 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-23 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-23 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-23 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-23 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-23 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-23 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-23 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-23 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-22 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-22 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-22 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-22 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-22 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-22 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-22 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-22 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-22 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-22 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-22 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-22 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-22 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-22 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-22 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-22 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-22 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-22 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-22 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-22 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-22 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-22 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-22 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-22 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-22 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-22 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-22 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-22 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-22 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-22 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-22 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-22 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-22 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-22 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-22 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-22 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-22 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-22 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-22 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-22 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-22 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-22 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-22 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-22 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-22 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-22 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-22 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-22 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-22 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-22 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-22 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-22 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-22 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-22 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-22 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-22 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-22 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-22 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-22 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-22 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-22 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-21 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-21 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-21 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-21 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-21 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-21 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-21 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-21 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-21 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-21 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-21 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-21 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-21 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-21 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-21 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-21 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-21 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-21 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-21 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-21 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-21 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-21 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-21 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-21 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-21 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-21 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-21 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-21 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-21 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-21 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-21 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-21 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-21 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-21 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-21 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-21 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-21 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-21 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-21 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-21 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-21 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-21 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-21 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-21 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-21 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-21 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-21 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-21 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-21 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-21 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-21 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-21 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-21 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-21 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-21 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-21 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-21 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-21 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-21 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-21 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-21 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-21 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-21 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-20 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-20 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-20 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-20 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-20 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-20 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-20 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-20 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-20 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-20 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-20 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-20 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-20 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-20 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-20 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-20 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-20 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-20 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-20 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-20 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-20 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-20 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-20 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-20 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-20 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-20 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-20 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-20 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-20 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-20 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-20 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-20 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-20 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-20 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-20 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-20 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-20 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-20 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-20 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-20 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-20 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-20 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-20 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-20 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-20 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-20 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-20 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-20 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-20 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-20 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-20 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-20 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-20 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-20 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-20 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-20 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-20 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-20 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-20 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-20 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-20 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-20 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-20 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-20 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-20 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-20 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-20 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-20 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-20 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-20 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-20 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-20 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-20 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-20 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-20 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-20 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-20 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-20 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-20 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-20 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-20 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-20 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-20 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-19 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-19 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-19 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-19 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-19 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-19 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-19 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-19 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-19 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-19 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-19 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-19 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-19 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-19 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-19 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-19 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-19 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-19 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-19 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-19 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-19 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-19 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-19 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-19 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-19 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-19 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-19 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-19 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-19 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-19 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-19 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-19 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-19 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-19 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-19 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-18 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-18 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-18 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-18 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-18 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-18 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-18 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-18 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-18 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-18 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-18 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-18 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-18 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-18 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-18 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-18 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-18 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-18 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-18 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-18 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-18 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-17 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-17 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-17 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-17 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-17 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-17 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-17 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-17 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-17 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-17 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-17 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-17 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-17 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-17 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-17 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-17 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-17 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-17 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-17 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-17 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-17 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-17 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-17 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-17 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 8e-17 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-17 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-17 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-16 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-16 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-16 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-16 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-16 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-16 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-16 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-16 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-16 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-16 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-16 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-16 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-16 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-16 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-16 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-16 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-16 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-16 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-16 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-16 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-16 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-16 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-16 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-16 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-16 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-16 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-16 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-16 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-16 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-16 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-16 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-16 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-16 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-16 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-16 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-16 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-16 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-16 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-16 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-16 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-16 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-16 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-16 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-16 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-16 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-16 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-16 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-16 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-16 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-16 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-16 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-16 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-16 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-16 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-16 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-16 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-16 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-16 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-16 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-16 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-16 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-16 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-16 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-16 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-16 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-16 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-16 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-16 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-16 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-16 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-16 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-16 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-16 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-16 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-16 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-16 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-16 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-16 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-16 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-16 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-16 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-16 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-16 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-16 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-16 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-16 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-16 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-16 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-16 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-16 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 9e-16 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-16 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-16 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-15 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-15 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-15 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-15 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-15 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-15 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-15 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-15 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-15 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-15 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-15 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-15 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-15 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-15 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-15 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-15 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-15 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-15 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-15 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-15 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-15 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-15 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-15 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-15 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-15 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-15 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-15 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-15 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-15 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-15 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-15 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-15 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-15 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-15 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-14 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-14 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-14 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-14 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-14 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-14 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-14 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-14 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-14 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-14 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-14 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-14 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-14 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-14 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-14 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-13 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-13 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-13 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-11 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-11 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-11 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-11 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-11 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-10 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-10 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-10 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-10 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-10 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-10 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 7e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-09 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-09 |
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 481 bits (1241), Expect = e-166
Identities = 146/314 (46%), Positives = 197/314 (62%), Gaps = 4/314 (1%)
Query: 160 SLHGEDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIK 219
SL +R + + E + P +++L +LG+GSYG+VYKA +T ++VAIK
Sbjct: 1 SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60
Query: 220 VISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNV 279
+ + E +EI EI ++QQC P+VV+Y GSY LWIVMEYCG GSV+D++ +
Sbjct: 61 QVPV---ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL 117
Query: 280 TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339
+ L E +IA I + LKGL YLH + K+HRDIK GNILL +G KL DFGVA QLT
Sbjct: 118 RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177
Query: 340 TMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI 399
TM+KRNT IGTP WMAPEVIQE Y+ D+W+LG++A+EMAEG PP + +HPMR +FMI
Sbjct: 178 TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI 237
Query: 400 SIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIE 459
P P E WS F DFV +CL K P R TA ++L+H F+ K G + + I
Sbjct: 238 PTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK-GVSILRDLIN 296
Query: 460 KARQIRASMAQQAQ 473
+A ++ + Q
Sbjct: 297 EAMDVKLKRQESQQ 310
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 480 bits (1238), Expect = e-166
Identities = 149/304 (49%), Positives = 196/304 (64%), Gaps = 4/304 (1%)
Query: 168 QQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE 227
+ V S + DP + L ++GKGS+G V+K D +T ++VAIK+I L E E
Sbjct: 2 AHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE 61
Query: 228 EGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEY 287
+ E+I+ EI +L QC P V +Y GSY + LWI+MEY GGGS DL+ PL+E
Sbjct: 62 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDET 119
Query: 288 QIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF 347
QIA I RE LKGL YLHS K+HRDIK N+LL++ GEVKL DFGVA QLT T KRNTF
Sbjct: 120 QIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 179
Query: 348 IGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPML 407
+GTP WMAPEVI++S YD K D+W+LG++A+E+A G PP S +HPM+VLF+I P L
Sbjct: 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL 239
Query: 408 EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRAS 467
E +S +FV CL KEP RPTA E+LKHKFI R + + I++ ++ +A
Sbjct: 240 EG--NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAE 297
Query: 468 MAQQ 471
+
Sbjct: 298 QSHD 301
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 474 bits (1221), Expect = e-163
Identities = 120/298 (40%), Positives = 183/298 (61%), Gaps = 7/298 (2%)
Query: 174 SSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEI 233
S DP +E++ ELG G++G VYKA++ +T L A KVI EE E+
Sbjct: 5 SREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-LEDY 63
Query: 234 RGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYIC 293
EIE+L C HP +V+ LG+Y + LWI++E+C GG+V +M + L E QI +C
Sbjct: 64 IVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVC 123
Query: 294 REALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHW 353
R+ L+ L +LHS +HRD+K GN+L+T +G+++L DFGV+A+ +T+ KR++FIGTP+W
Sbjct: 124 RQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYW 183
Query: 354 MAPEVI-----QESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLE 408
MAPEV+ +++ YD K D+W+LG++ +EMA+ PP ++PMRVL I+ P L
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLL 243
Query: 409 DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRA 466
KWS+ F DF+ L K P RP+AA++L+H F+ A+ + +A+
Sbjct: 244 TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT-SNKALRELVAEAKAEVM 300
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 471 bits (1213), Expect = e-162
Identities = 110/319 (34%), Positives = 182/319 (57%), Gaps = 9/319 (2%)
Query: 154 RFGSSSSLHGEDVRQQTKVSS-----SSIPESVTREDPTTKYELLNELGKGSYGAVYKAR 208
S L E++ Q+ V + +++ V + DP + ++G+GS G V AR
Sbjct: 6 HHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAR 65
Query: 209 DLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYC 268
+ + VA+K++ L + + E + E+ +++ H NVV SY E LW++ME+
Sbjct: 66 EKHSGRQVAVKMMDLRKQQR-RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124
Query: 269 GGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKL 328
GG++ D++ ++ L E QIA +C L+ LAYLH+ +HRDIK +ILLT G VKL
Sbjct: 125 QGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKL 182
Query: 329 GDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRS 388
DFG AQ+++ + KR + +GTP+WMAPEVI S Y +VD+W+LG+ +EM +G PP
Sbjct: 183 SDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYF 242
Query: 389 TVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448
+ P++ + + P P L++ K S V DF+ + L ++P+ R TA E+L H F+ +
Sbjct: 243 SDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT- 301
Query: 449 CGATAMLPKIEKARQIRAS 467
++P I+ R+ ++
Sbjct: 302 GLPECLVPLIQLYRKQTST 320
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 466 bits (1200), Expect = e-160
Identities = 121/287 (42%), Positives = 182/287 (63%), Gaps = 4/287 (1%)
Query: 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEML 240
V+ DP KY ++G+G+ G VY A D+ T + VAI+ ++L + + E I EI ++
Sbjct: 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVM 71
Query: 241 QQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGL 300
++ +PN+V YL SY + LW+VMEY GGS+ D++ TE ++E QIA +CRE L+ L
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQAL 129
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ 360
+LHS +HRDIK NILL G VKL DFG AQ+T SKR+T +GTP+WMAPEV+
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 361 ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420
Y KVD+W+LG+ A+EM EG PP +P+R L++I+ P L++ EK S +F DF
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249
Query: 421 VAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRAS 467
+ +CL + R +A E+L+H+F++ +++ P I A++ +
Sbjct: 250 LNRCLEMDVEKRGSAKELLQHQFLKIA-KPLSSLTPLIAAAKEATKN 295
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 461 bits (1188), Expect = e-158
Identities = 130/310 (41%), Positives = 193/310 (62%), Gaps = 12/310 (3%)
Query: 167 RQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS-- 224
+ + + E ++DP + L E+G GS+GAVY ARD++ SE+VAIK +S S
Sbjct: 33 GRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK 92
Query: 225 EGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPL 284
+ E +++I E+ LQ+ HPN ++Y G Y E W+VMEYC G S +DL+ V ++PL
Sbjct: 93 QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPL 151
Query: 285 EEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344
+E +IA + AL+GLAYLHS +HRD+K GNILL++ G VKLGDFG A+ +
Sbjct: 152 QEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA----PA 207
Query: 345 NTFIGTPHWMAPEVI---QESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI 401
N+F+GTP+WMAPEVI E +YDGKVDVW+LG++ +E+AE PP ++ M L+ I+
Sbjct: 208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 267
Query: 402 EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKA 461
+P L+ WS F +FV CL K P+ RPT+ +LKH+F+ R + T ++ I++
Sbjct: 268 NESPALQSG-HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER-PPTVIMDLIQRT 325
Query: 462 RQIRASMAQQ 471
+ +
Sbjct: 326 KDAVRELDNL 335
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 454 bits (1169), Expect = e-155
Identities = 139/315 (44%), Positives = 193/315 (61%), Gaps = 16/315 (5%)
Query: 170 TKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEG 229
+ S + DP +EL+ +G G+YG VYK R +KT +L AIKV+ ++ EE
Sbjct: 6 SPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE- 64
Query: 230 YEEIRGEIEMLQQ-CSHPNVVRYLGSY------QGEEYLWIVMEYCGGGSVADLMNVTEE 282
EEI+ EI ML++ H N+ Y G++ ++ LW+VME+CG GSV DL+ T+
Sbjct: 65 -EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG 123
Query: 283 -PLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341
L+E IAYICRE L+GL++LH +HRDIKG N+LLT+ EVKL DFGV+AQL RT+
Sbjct: 124 NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 183
Query: 342 SKRNTFIGTPHWMAPEVIQ-----ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVL 396
+RNTFIGTP+WMAPEVI ++ YD K D+W+LG++A+EMAEG PP +HPMR L
Sbjct: 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243
Query: 397 FMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLP 456
F+I PAP L+ K KWS F F+ CL K RP +++KH FI +
Sbjct: 244 FLIPRNPAPRLKSK-KWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQ 302
Query: 457 KIEKARQIRASMAQQ 471
+ + + ++
Sbjct: 303 LKDHIDRTKKKRGEK 317
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 437 bits (1127), Expect = e-149
Identities = 118/296 (39%), Positives = 169/296 (57%), Gaps = 24/296 (8%)
Query: 173 SSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE 232
SS++P S+ R+D YEL +G G+ V A E VAIK I+L + + +E
Sbjct: 4 DSSALPWSINRDD----YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDE 59
Query: 233 IRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLM-------NVTEEPLE 285
+ EI+ + QC HPN+V Y S+ ++ LW+VM+ GGSV D++ L+
Sbjct: 60 LLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD 119
Query: 286 EYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT----- 340
E IA I RE L+GL YLH ++HRD+K GNILL + G V++ DFGV+A L
Sbjct: 120 ESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179
Query: 341 MSKRNTFIGTPHWMAPEVIQESR-YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI 399
R TF+GTP WMAPEV+++ R YD K D+W+ G++A+E+A G P PM+VL +
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT 239
Query: 400 SIEPAPMLED-------KEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448
P LE +K+ F ++ CL K+P RPTAAE+L+HKF ++ K
Sbjct: 240 LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 419 bits (1079), Expect = e-141
Identities = 90/365 (24%), Positives = 153/365 (41%), Gaps = 57/365 (15%)
Query: 167 RQQTKVSSSSIPESVTREDPTTKYELLNELGKG--SYGAVYKARDLKTSELVAIKVISL- 223
+ + + YELL +GKG V AR T E V ++ I+L
Sbjct: 4 HHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLE 63
Query: 224 SEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVT-EE 282
+ E ++GE+ + + +HPN+V Y ++ + LW+V + GS DL+ +
Sbjct: 64 ACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD 123
Query: 283 PLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342
+ E IAYI + LK L Y+H + VHR +K +IL++ G+V L +
Sbjct: 124 GMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183
Query: 343 KRNT-------FIGTPHWMAPEVIQESR--YDGKVDVWALGVSAVEMAEGLPPRSTVHPM 393
++ + W++PEV+Q++ YD K D++++G++A E+A G P +
Sbjct: 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 243
Query: 394 RVLFMISIEPAPMLED-------------------------------------------K 410
++L P L D
Sbjct: 244 QMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYH 303
Query: 411 EKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPK-IEKARQIRASMA 469
+S FH FV +CL + P ARP+A+ +L H F ++ K A+ LP+ + I
Sbjct: 304 RTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEG 363
Query: 470 QQAQN 474
Q+Q+
Sbjct: 364 SQSQD 368
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 378 bits (973), Expect = e-126
Identities = 80/341 (23%), Positives = 134/341 (39%), Gaps = 14/341 (4%)
Query: 133 GERRSGGYDDSTMGRAVASMRRFGSSSSLHGEDVRQQTKVSSSSIPESVTREDPTTKYEL 192
G SG S + + ++ P +
Sbjct: 3 GSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTH 62
Query: 193 LNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYL 252
+G+GS+G V++ +D +T A+K + L E+ S P +V
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE------ELVACAGLSSPRIVPLY 116
Query: 253 GSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRD 312
G+ + ++ I ME GGS+ L+ L E + Y +AL+GL YLH+ +H D
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIK-QMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 175
Query: 313 IKGGNILLTDQG-EVKLGDFGVAAQLT-----RTMSKRNTFIGTPHWMAPEVIQESRYDG 366
+K N+LL+ G L DFG A L +++ + GT MAPEV+ D
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA 235
Query: 367 KVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLT 426
KVD+W+ + M G P + + I+ EP P+ E + + + + L
Sbjct: 236 KVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLR 295
Query: 427 KEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRAS 467
KEP R +A E+ + + G P + ++ R +
Sbjct: 296 KEPVHRASAMELRRKVGKALQEVGG-LKSPWKGEYKEPRGN 335
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 372 bits (958), Expect = e-123
Identities = 84/277 (30%), Positives = 140/277 (50%), Gaps = 13/277 (4%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIE-MLQQCSHPNV 248
+ L E+G+G+YG+V K + +++A+K I + E+ +++ +++ +++ P +
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 249 VRYLGSYQGEEYLWIVMEYCGGGSVADL---MNVTEEPLEEYQIAYICREALKGLAYLHS 305
V++ G+ E WI ME +V ++ + E + I +K L +L
Sbjct: 84 VQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 306 IFKV-HRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESR- 363
K+ HRDIK NILL G +KL DFG++ QL +++K G +MAPE I S
Sbjct: 144 NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERIDPSAS 202
Query: 364 ---YDGKVDVWALGVSAVEMAEGLPPRSTVHPM-RVLFMISIEPAPMLEDKE--KWSLVF 417
YD + DVW+LG++ E+A G P + + L + P L + E ++S F
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSF 262
Query: 418 HDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAM 454
+FV CLTK+ RP E+LKH FI + A +
Sbjct: 263 INFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEV 299
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 365 bits (940), Expect = e-121
Identities = 85/306 (27%), Positives = 145/306 (47%), Gaps = 25/306 (8%)
Query: 182 TREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEM-L 240
+ E E + ELG+G+YG V K R + + +++A+K I + + + + ++++ +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 241 QQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEE--PLEEYQIAYICREALK 298
+ P V + G+ E +WI ME V ++ + E + I +K
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 299 GLAYLHSIFKV-HRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPE 357
L +LHS V HRD+K N+L+ G+VK+ DFG++ L ++K + G +MAPE
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK-DIDAGCKPYMAPE 179
Query: 358 VI----QESRYDGKVDVWALGVSAVEMAEGLPP-RSTVHPMRVLFMISIEPAPMLEDKEK 412
I + Y K D+W+LG++ +E+A P S P + L + EP+P L +K
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA-DK 238
Query: 413 WSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRASMAQQA 472
+S F DF ++CL K + RPT E+++H F +A
Sbjct: 239 FSAEFVDFTSQCLKKNSKERPTYPELMQHPF--------------FTLHESKGTDVASFV 284
Query: 473 QNILSD 478
+ IL D
Sbjct: 285 KLILGD 290
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 363 bits (934), Expect = e-120
Identities = 87/267 (32%), Positives = 139/267 (52%), Gaps = 10/267 (3%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEML-QQCSHPNV 248
E L E+G G+ G V+K R KT ++A+K + S +E + I +++++ + P +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 249 VRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFK 308
V+ G++ ++I ME G + L + P+ E + + +K L YL
Sbjct: 87 VQCFGTFITNTDVFIAMELMGTCAE-KLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG 145
Query: 309 V-HRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ-----ES 362
V HRD+K NILL ++G++KL DFG++ +L +K + G +MAPE I +
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-DRSAGCAAYMAPERIDPPDPTKP 204
Query: 363 RYDGKVDVWALGVSAVEMAEGLPPRSTVHP-MRVLFMISIEPAPMLEDKEKWSLVFHDFV 421
YD + DVW+LG+S VE+A G P VL + E P+L +S F FV
Sbjct: 205 DYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFV 264
Query: 422 AKCLTKEPRARPTAAEMLKHKFIERCK 448
CLTK+ R RP ++L+H FI+R +
Sbjct: 265 KDCLTKDHRKRPKYNKLLEHSFIKRYE 291
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 348 bits (895), Expect = e-114
Identities = 95/327 (29%), Positives = 154/327 (47%), Gaps = 47/327 (14%)
Query: 165 DVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS 224
D +Q+ ++ + + E +E ++ELG G+ G V+K + ++A K+I L
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE 69
Query: 225 EGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPL 284
+I E+++L +C+ P +V + G++ + + I ME+ GGS+ ++ +
Sbjct: 70 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRI 128
Query: 285 EEYQIAYICREALKGLAYLHSIFKV-HRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343
E + + +KGL YL K+ HRD+K NIL+ +GE+KL DFGV+ QL +M
Sbjct: 129 PEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 186
Query: 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPP----------------- 386
N+F+GT +M+PE +Q + Y + D+W++G+S VEMA G P
Sbjct: 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 246
Query: 387 ---------------------RSTVHPMRVLF----MISIEPAPMLEDKEKWSLVFHDFV 421
P +F I EP P L +SL F DFV
Sbjct: 247 EGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKL-PSGVFSLEFQDFV 305
Query: 422 AKCLTKEPRARPTAAEMLKHKFIERCK 448
KCL K P R +++ H FI+R
Sbjct: 306 NKCLIKNPAERADLKQLMVHAFIKRSD 332
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 336 bits (864), Expect = e-110
Identities = 95/289 (32%), Positives = 141/289 (48%), Gaps = 16/289 (5%)
Query: 173 SSSSIPESVTREDPT-TKYELLNE-----LGKGSYGAVYKARDLKTSELVAIKVISLSEG 226
S S E D YE LGKG+YG VY RDL +AIK I +
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60
Query: 227 EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLE- 285
+ + EI + + H N+V+YLGS+ ++ I ME GGS++ L+ PL+
Sbjct: 61 RY-SQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKD 119
Query: 286 -EYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL-TDQGEVKLGDFGVAAQLTRTMSK 343
E I + ++ L+GL YLH VHRDIKG N+L+ T G +K+ DFG + +L
Sbjct: 120 NEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179
Query: 344 RNTFIGTPHWMAPEVIQESR--YDGKVDVWALGVSAVEMAEGLPPRSTV-HPMRVLFMI- 399
TF GT +MAPE+I + Y D+W+LG + +EMA G PP + P +F +
Sbjct: 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG 239
Query: 400 SIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448
+ P + + S F+ KC +P R A ++L +F++
Sbjct: 240 MFKVHPEIPE--SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 318 bits (817), Expect = e-103
Identities = 67/289 (23%), Positives = 119/289 (41%), Gaps = 34/289 (11%)
Query: 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISL-SEGEEGYEEIRGEIEMLQQ- 242
TT++ L ++G G +G+V+K + AIK G + E+
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 243 CSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLM---NVTEEPLEEYQIAYICREALKG 299
H +VVRY ++ ++++ I EYC GGS+AD + +E ++ + + +G
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 300 LAYLHSIFKVHRDIKGGNILLTDQGE-------------------VKLGDFGVAAQLTRT 340
L Y+HS+ VH DIK NI ++ K+GD G ++
Sbjct: 128 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI--- 184
Query: 341 MSKRNTFIGTPHWMAPEVIQESR-YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI 399
S G ++A EV+QE+ + K D++AL ++ V A P +
Sbjct: 185 -SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQG 243
Query: 400 SIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448
+ P + S F + + + +P RP+A ++KH +
Sbjct: 244 RLPRIP-----QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 313 bits (803), Expect = e-101
Identities = 75/290 (25%), Positives = 134/290 (46%), Gaps = 13/290 (4%)
Query: 164 EDVRQQTKVSSSSIPESVTREDPTTKYELLNE-LGKGSYGAVYKARDLKTSELVAIKVIS 222
++ R Q + + ++ + +G+GS+ VYK D +T+ VA +
Sbjct: 1 QEERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ 60
Query: 223 LSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSY----QGEEYLWIVMEYCGGGSVADLM 277
+ + + + E EML+ HPN+VR+ S+ +G++ + +V E G++ +
Sbjct: 61 DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120
Query: 278 NVTEEPLEEYQIAYICREALKGLAYLHSIFK--VHRDIKGGNILLT-DQGEVKLGDFGVA 334
+ ++ + CR+ LKGL +LH+ +HRD+K NI +T G VK+GD G+A
Sbjct: 121 KRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179
Query: 335 AQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMR 394
+ +K IGTP +MAPE+ +E YD VDV+A G+ +EMA P S
Sbjct: 180 TLKRASFAK--AVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAA 236
Query: 395 VLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
++ + + + C+ + R + ++L H F
Sbjct: 237 QIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 313 bits (805), Expect = e-101
Identities = 86/317 (27%), Positives = 133/317 (41%), Gaps = 15/317 (4%)
Query: 134 ERRSGGYDDSTMGRAVASMRRFGSSSSLHGEDVRQ--QTKVSSSSIPESVTREDPTTKYE 191
S G D T SM + + + Q+ S PES ++ ++
Sbjct: 5 HHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQS----FQ 60
Query: 192 LLNELGKGSYGAVYKARDLKTSELVAIKVISLS-EGEEGYEEIRGEIEMLQQ-CSHPNVV 249
L+ LG GSYG V+K R + L A+K G + E+ ++ HP V
Sbjct: 61 RLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCV 120
Query: 250 RYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKV 309
R +++ L++ E CG S+ L E Q+ R+ L LA+LHS V
Sbjct: 121 RLEQAWEEGGILYLQTELCGP-SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLV 179
Query: 310 HRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVD 369
H D+K NI L +G KLGDFG+ +L T G P +MAPE++Q S Y D
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQEGDPRYMAPELLQGS-YGTAAD 237
Query: 370 VWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEP 429
V++LG++ +E+A + + L + P E S + L +P
Sbjct: 238 VFSLGLTILEVACNMELPHGGEGWQQLRQGYLPP----EFTAGLSSELRSVLVMMLEPDP 293
Query: 430 RARPTAAEMLKHKFIER 446
+ R TA +L + +
Sbjct: 294 KLRATAEALLALPVLRQ 310
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 296 bits (761), Expect = 9e-95
Identities = 69/285 (24%), Positives = 125/285 (43%), Gaps = 14/285 (4%)
Query: 170 TKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG--E 227
+ + + + ++G+G + VY+A L VA+K + + +
Sbjct: 14 PQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDA 73
Query: 228 EGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNV---TEEPL 284
+ + EI++L+Q +HPNV++Y S+ + L IV+E G ++ ++ + +
Sbjct: 74 KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI 133
Query: 285 EEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344
E + + L ++HS +HRDIK N+ +T G VKLGD G+ + +
Sbjct: 134 PERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 193
Query: 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPP-RSTVHPMRVLFMI---- 399
++ +GTP++M+PE I E+ Y+ K D+W+LG EMA P + L
Sbjct: 194 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC 253
Query: 400 SIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
P P + +S V C+ +P RP +
Sbjct: 254 DYPPLP----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKR 294
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 4e-93
Identities = 78/287 (27%), Positives = 136/287 (47%), Gaps = 33/287 (11%)
Query: 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHP 246
+ +E + LG+G++G V KAR+ S AIK I +E + I E+ +L +H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL--STILSEVMLLASLNHQ 62
Query: 247 NVVRYLGSYQGEE-------------YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYIC 293
VVRY ++ L+I MEYC G++ DL++ + + +
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 294 REALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM------------ 341
R+ L+ L+Y+HS +HRD+K NI + + VK+GDFG+A + R++
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 342 --SKRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGL-PPRSTVHPMRVLF 397
+ IGT ++A EV+ + Y+ K+D+++LG+ EM V+ ++ L
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLR 242
Query: 398 MISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
+SIE P +D + V + + +P RP A +L ++
Sbjct: 243 SVSIEFPPDFDDNK--MKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 288 bits (738), Expect = 7e-91
Identities = 81/263 (30%), Positives = 128/263 (48%), Gaps = 10/263 (3%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPN 247
KY L ++G+GS+G + + IK I++S + EE R E+ +L HPN
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSI 306
+V+Y S++ L+IVM+YC GG + +N + +E QI + L ++H
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR 144
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDG 366
+HRDIK NI LT G V+LGDFG+A L T+ IGTP++++PE+ + Y+
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNN 204
Query: 367 KVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI---SIEPAPMLEDKEKWSLVFHDFVAK 423
K D+WALG E+ ++ I S P +S V++
Sbjct: 205 KSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVS-----LHYSYDLRSLVSQ 259
Query: 424 CLTKEPRARPTAAEMLKHKFIER 446
+ PR RP+ +L+ FI +
Sbjct: 260 LFKRNPRDRPSVNSILEKGFIAK 282
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 1e-89
Identities = 68/276 (24%), Positives = 121/276 (43%), Gaps = 30/276 (10%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVV 249
++ + +G G +G V+KA+ + IK + + E+ E++ L + H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIV 67
Query: 250 RYLGSYQGEE----------------YLWIVMEYCGGGSVADLMNV-TEEPLEEYQIAYI 292
Y G + G + L+I ME+C G++ + E L++ +
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 293 CREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH 352
+ KG+ Y+HS ++RD+K NI L D +VK+GDFG+ L KR GT
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG-KRTRSKGTLR 186
Query: 353 WMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEK 412
+M+PE I Y +VD++ALG+ E+ + ++ D
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKFFTDLRDGIISD--I 239
Query: 413 WSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448
+ + K L+K+P RP +E+L+ + +
Sbjct: 240 FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 264 bits (678), Expect = 8e-83
Identities = 75/302 (24%), Positives = 132/302 (43%), Gaps = 36/302 (11%)
Query: 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPN 247
T +E + LG+G +G V++A++ AIK I L E E++ E++ L + HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 248 VVRYLGSYQGEE------------YLWIVMEYCGGGSVADLMNV--TEEPLEEYQIAYIC 293
+VRY ++ + YL+I M+ C ++ D MN T E E +I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 294 REALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF------ 347
+ + + +LHS +HRD+K NI T VK+GDFG+ + + ++
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 348 ------IGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI-- 399
+GT +M+PE I + Y KVD+++LG+ E+ P + + +R L +
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTDVRN 242
Query: 400 -SIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKI 458
P + + V L+ P RP A ++++ E +L +
Sbjct: 243 LKFPPLF-----TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQR 297
Query: 459 EK 460
+
Sbjct: 298 SR 299
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 1e-82
Identities = 72/302 (23%), Positives = 137/302 (45%), Gaps = 29/302 (9%)
Query: 156 GSSSSLHGEDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSEL 215
GSS SL +D ++T V + + LG G+ G + R + +
Sbjct: 2 GSSPSLEQDDGDEETSVVIVG----------KISFCPKDVLGHGAEGTIVY-RGMFDNRD 50
Query: 216 VAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQGEEYLWIVMEYCGGGSVA 274
VA+K I E + E+++L++ HPNV+RY + + ++ +I +E C ++
Sbjct: 51 VAVKRILP----ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA-TLQ 105
Query: 275 DLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE-----VKLG 329
+ + + + + ++ GLA+LHS+ VHRD+K NIL++ +
Sbjct: 106 EYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMIS 165
Query: 330 DFGVAAQLT---RTMSKRNTFIGTPHWMAPEVIQES---RYDGKVDVWALGVSAVEM-AE 382
DFG+ +L + S+R+ GT W+APE++ E VD+++ G + +E
Sbjct: 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
Query: 383 GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHK 442
G P + ++ L ++ ++ + + K + +P+ RP+A +LKH
Sbjct: 226 GSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285
Query: 443 FI 444
F
Sbjct: 286 FF 287
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 261 bits (668), Expect = 2e-81
Identities = 76/272 (27%), Positives = 126/272 (46%), Gaps = 19/272 (6%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPN 247
YE+L +G GSYG K R +++ K + E + + E+ +L++ HPN
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 248 VVRYLGSYQGEE--YLWIVMEYCGGGSVADLMN---VTEEPLEEYQIAYICREALKGLAY 302
+VRY L+IVMEYC GG +A ++ + L+E + + + L
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 303 LHSIFK-----VHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPE 357
H +HRD+K N+ L + VKLGDFG+A L S TF+GTP++M+PE
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPE 186
Query: 358 VIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI---SIEPAPMLEDKEKWS 414
+ Y+ K D+W+LG E+ +PP + + I P ++S
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP-----YRYS 241
Query: 415 LVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446
++ + + L + RP+ E+L++ I
Sbjct: 242 DELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 2e-78
Identities = 76/338 (22%), Positives = 145/338 (42%), Gaps = 27/338 (7%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPN 247
Y +L ++G G V++ + + ++ AIK ++L E + + R EI L + +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 248 --VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS 305
++R ++Y+++VME CG + + ++ ++ ++ + L+ + +H
Sbjct: 69 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 306 IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT--RTMSKRNTFIGTPHWMAPEVIQE-- 361
VH D+K N L+ D G +KL DFG+A Q+ T +++ +GT ++M PE I++
Sbjct: 127 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 362 ---------SRYDGKVDVWALGVSAVEMAEGLPP-RSTVHPMRVLFMISIEPAPMLEDKE 411
S+ K DVW+LG M G P + ++ + L I I+P +E +
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI-IDPNHEIEFPD 244
Query: 412 KWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRASMAQQ 471
D + CL ++P+ R + E+L H +++ M + +
Sbjct: 245 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMK-----YVL 299
Query: 472 AQNILSDEPEVNATMGLKLNEDYGDTVPSKPQVQVTNE 509
Q + + P L E Y T E
Sbjct: 300 GQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFE 337
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 4e-77
Identities = 68/301 (22%), Positives = 135/301 (44%), Gaps = 22/301 (7%)
Query: 161 LHGEDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKV 220
+H + + Y +L ++G G V++ + + ++ AIK
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKY 59
Query: 221 ISLSE-GEEGYEEIRGEIEMLQQCSHPN--VVRYLGSYQGEEYLWIVMEYCGGGSVADLM 277
++L E + + R EI L + + ++R ++Y+++VME CG + +
Sbjct: 60 VNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL 118
Query: 278 NVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL 337
++ ++ ++ + L+ + +H VH D+K N L+ D G +KL DFG+A Q+
Sbjct: 119 -KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQM 176
Query: 338 T--RTMSKRNTFIGTPHWMAPEVIQES-----------RYDGKVDVWALGVSAVEMAEGL 384
T +++ +GT ++M PE I++ + K DVW+LG M G
Sbjct: 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
Query: 385 PP-RSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKF 443
P + ++ + L I I+P +E + D + CL ++P+ R + E+L H +
Sbjct: 237 TPFQQIINQISKLHAI-IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295
Query: 444 I 444
+
Sbjct: 296 V 296
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 1e-76
Identities = 82/393 (20%), Positives = 158/393 (40%), Gaps = 29/393 (7%)
Query: 134 ERRSGGYDDSTMGRAVASMRRFGSSSSLHGEDVRQQTKVSSSSIPESVTREDPTTKYELL 193
S G G + +F + +SSS E ++ + Y +L
Sbjct: 4 HHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKG--RIYSIL 61
Query: 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPN--VVR 250
++G G V++ + + ++ AIK ++L E + + R EI L + + ++R
Sbjct: 62 KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 251 YLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVH 310
++Y+++VME CG + + ++ ++ ++ + L+ + +H VH
Sbjct: 121 LYDYEITDQYIYMVME-CGNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVH 178
Query: 311 RDIKGGNILLTDQGEVKLGDFGVAAQLT--RTMSKRNTFIGTPHWMAPEVIQES------ 362
D+K N L+ D G +KL DFG+A Q+ T +++ +G ++M PE I++
Sbjct: 179 SDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN 237
Query: 363 -----RYDGKVDVWALGVSAVEMAEGLPP-RSTVHPMRVLFMISIEPAPMLEDKEKWSLV 416
+ K DVW+LG M G P + ++ + L I I+P +E +
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI-IDPNHEIEFPDIPEKD 296
Query: 417 FHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRASMAQQAQNIL 476
D + CL ++P+ R + E+L H +++ M + + Q +
Sbjct: 297 LQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMK-----YVLGQLVG 351
Query: 477 SDEPEVNATMGLKLNEDYGDTVPSKPQVQVTNE 509
+ P L E Y T E
Sbjct: 352 LNSPNSILKAAKTLYEHYSGGESHNSSSSKTFE 384
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 3e-69
Identities = 63/278 (22%), Positives = 108/278 (38%), Gaps = 32/278 (11%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV 248
Y + +LG+G + V L A+K I E ++ EE + E +M + +HPN+
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNI 88
Query: 249 VRYLGSY----QGEEYLWIVMEYCGGGSVADLMN---VTEEPLEEYQIAYICREALKGLA 301
+R + + W+++ + G++ + + L E QI ++ +GL
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 302 YLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFI---------GTPH 352
+H+ HRD+K NILL D+G+ L D G Q + + T
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 353 WMAPEVIQESRY---DGKVDVWALGVSAVEMAEGLPP-RSTVHPMRVLFMI-----SIEP 403
+ APE+ + D + DVW+LG M G P + + SI
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQ 268
Query: 404 APMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441
+P S + +T +P RP +L
Sbjct: 269 SPRH------SSALWQLLNSMMTVDPHQRPHIPLLLSQ 300
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 3e-63
Identities = 77/277 (27%), Positives = 132/277 (47%), Gaps = 14/277 (5%)
Query: 174 SSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEE 232
+ IPE + +Y LGKG + ++ D T E+ A K++ S + E
Sbjct: 1 AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 60
Query: 233 -IRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAY 291
+ EI + + +H +VV + G ++ +++++V+E C S+ +L + L E + Y
Sbjct: 61 KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARY 119
Query: 292 ICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP 351
R+ + G YLH +HRD+K GN+ L + EVK+GDFG+A ++ ++ GTP
Sbjct: 120 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP 179
Query: 352 HWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMIS----IEPAPML 407
+++APEV+ + + +VDVW++G + G PP T I P +
Sbjct: 180 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHIN 239
Query: 408 EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
+ K L +P ARPT E+L +F
Sbjct: 240 PVAA-------SLIQKMLQTDPTARPTINELLNDEFF 269
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 1e-62
Identities = 77/284 (27%), Positives = 132/284 (46%), Gaps = 14/284 (4%)
Query: 167 RQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE- 225
+ IPE + +Y LGKG + ++ D T E+ A K++ S
Sbjct: 20 APAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL 79
Query: 226 GEEGYEE-IRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPL 284
+ E + EI + + +H +VV + G ++ +++++V+E C S+ +L + L
Sbjct: 80 LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH-KRRKAL 138
Query: 285 EEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344
E + Y R+ + G YLH +HRD+K GN+ L + EVK+GDFG+A ++ ++
Sbjct: 139 TEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 198
Query: 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMIS---- 400
GTP+++APEV+ + + +VDVW++G + G PP T I
Sbjct: 199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY 258
Query: 401 IEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
P + + K L +P ARPT E+L +F
Sbjct: 259 SIPKHINPVAA-------SLIQKMLQTDPTARPTINELLNDEFF 295
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 5e-61
Identities = 77/264 (29%), Positives = 130/264 (49%), Gaps = 20/264 (7%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY--EEIRGEIEMLQQCSHP 246
+E+ LGKG +G VY AR+ ++ ++A+KV+ ++ E+ ++R E+E+ HP
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI 306
N++R G + +++++EY G+V + +E + A E L+Y HS
Sbjct: 70 NILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK 128
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDG 366
+HRDIK N+LL GE+K+ DFG + S+R GT ++ PE+I+ +D
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRTDLCGTLDYLPPEMIEGRMHDE 186
Query: 367 KVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH------DF 420
KVD+W+LGV E G PP IS + +++ D
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS---------RVEFTFPDFVTEGARDL 237
Query: 421 VAKCLTKEPRARPTAAEMLKHKFI 444
+++ L P RP E+L+H +I
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWI 261
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 7e-61
Identities = 80/308 (25%), Positives = 146/308 (47%), Gaps = 14/308 (4%)
Query: 166 VRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS- 224
+ + + T + +Y+ LGKGS+G V +D T + A+KVIS
Sbjct: 5 MMDHLHATPGMFVQHST-AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ 63
Query: 225 -EGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEP 283
+ + E + E+++L+Q HPN+++ ++ + Y ++V E GG + D + ++ +
Sbjct: 64 VKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKR 122
Query: 284 LEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE---VKLGDFGVAAQLTRT 340
E A I R+ L G+ Y+H VHRD+K N+LL + + +++ DFG++ +
Sbjct: 123 FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182
Query: 341 MSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMIS 400
K IGT +++APEV+ + YD K DVW+ GV + G PP + + + +
Sbjct: 183 -KKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDI--LKK 238
Query: 401 IEPAPMLEDKEKWSLVFH---DFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPK 457
+E + +W V D + K LT P R +A + L H++I+ ++
Sbjct: 239 VEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVP 298
Query: 458 IEKARQIR 465
+
Sbjct: 299 SLDNAILN 306
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 1e-60
Identities = 73/279 (26%), Positives = 132/279 (47%), Gaps = 23/279 (8%)
Query: 174 SSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEE 232
++ I E + +++ N LGKGS+ VY+A + T VAIK+I + G +
Sbjct: 3 ATCIGEKIE------DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQ 56
Query: 233 -IRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAY 291
++ E+++ Q HP+++ ++ Y+++V+E C G + + +P E + +
Sbjct: 57 RVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH 116
Query: 292 ICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP 351
+ + G+ YLHS +HRD+ N+LLT +K+ DFG+A QL K T GTP
Sbjct: 117 FMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTP 176
Query: 352 HWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKE 411
++++PE+ S + + DVW+LG + G PP T L +
Sbjct: 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV---------LA 227
Query: 412 KWSLVFH------DFVAKCLTKEPRARPTAAEMLKHKFI 444
+ + D + + L + P R + + +L H F+
Sbjct: 228 DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 6e-60
Identities = 76/286 (26%), Positives = 135/286 (47%), Gaps = 13/286 (4%)
Query: 166 VRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE 225
+ + + S + Y+ + +LG G+YG V RD T AIK+I +
Sbjct: 16 FQGDLQATPGMFITSKK-GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS 74
Query: 226 -GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPL 284
++ E+ +L+ HPN+++ ++ + ++VME GG + D + +
Sbjct: 75 VSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI-IHRMKF 133
Query: 285 EEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE---VKLGDFGVAAQLTRTM 341
E A I ++ L G+ YLH VHRD+K N+LL + + +K+ DFG++A
Sbjct: 134 NEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ- 192
Query: 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI 401
K +GT +++APEV+++ YD K DVW++GV + G PP + + +
Sbjct: 193 KKMKERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEI--LRKV 249
Query: 402 EPAPMLEDKEKWSLVFH---DFVAKCLTKEPRARPTAAEMLKHKFI 444
E D +W V D + + L + + R +A + L+H +I
Sbjct: 250 EKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 4e-59
Identities = 69/312 (22%), Positives = 117/312 (37%), Gaps = 33/312 (10%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIE-MLQQCSHPN 247
+ + L +G + VY+A+D+ + A+K + +E EE I E+ M + HPN
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPN 87
Query: 248 VVRYLGSYQ--------GEEYLWIVMEYCGGGSVADLMNV-TEEPLEEYQIAYICREALK 298
+V++ + G+ ++ E C G V L + + PL + I + +
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 299 GLAYLHSIFK--VHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN----------- 345
+ ++H +HRD+K N+LL++QG +KL DFG A ++
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 346 -TFIGTPHWMAPEVIQESR---YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI 401
T TP + PE+I K D+WALG + P +R++
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYS 267
Query: 402 EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKA 461
P VFH + L P R + AE++ P E
Sbjct: 268 IPPHD-----TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELL 322
Query: 462 RQIRASMAQQAQ 473
Q +
Sbjct: 323 EQNGGYGSATLS 334
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 4e-59
Identities = 82/281 (29%), Positives = 138/281 (49%), Gaps = 16/281 (5%)
Query: 173 SSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYE 231
SS + +Y ++ LGKGS+G V K +D T + A+KVI+ + +
Sbjct: 7 HSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS 66
Query: 232 EIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAY 291
I E+E+L++ HPN+++ + +IV E GG + D + + + E+ A
Sbjct: 67 TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAAR 125
Query: 292 ICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE---VKLGDFGVAAQLTRTMSKRNTFI 348
I ++ G+ Y+H VHRD+K NILL + + +K+ DFG++ + +K I
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI 184
Query: 349 GTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPP--RSTVHPMRVLFMISIEPAPM 406
GT +++APEV++ + YD K DVW+ GV + G PP + + + +E
Sbjct: 185 GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDI----LKRVETGKY 239
Query: 407 LEDKEKWSLVFH---DFVAKCLTKEPRARPTAAEMLKHKFI 444
D +W + D + K LT P R TA + L+H +I
Sbjct: 240 AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 4e-58
Identities = 82/325 (25%), Positives = 141/325 (43%), Gaps = 28/325 (8%)
Query: 157 SSSSLHGEDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELV 216
SS Q ++ Y + +LG G+YG V ++
Sbjct: 6 HHSSGRENLYFQGIAINPGMYVRKKE-GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEK 64
Query: 217 AIKVISLS------------EGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264
AIKVI S E+ +EEI EI +L+ HPN+++ ++ ++Y ++V
Sbjct: 65 AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLV 124
Query: 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG 324
E+ GG + + + + +E A I ++ L G+ YLH VHRDIK NILL ++
Sbjct: 125 TEFYEGGELFEQI-INRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN 183
Query: 325 E---VKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMA 381
+K+ DFG+++ ++ K +GT +++APEV+++ Y+ K DVW+ GV +
Sbjct: 184 SLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILL 241
Query: 382 EGLPP--RSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH---DFVAKCLTKEPRARPTAA 436
G PP + + +E D W + + + LT + R TA
Sbjct: 242 CGYPPFGGQNDQDI----IKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAE 297
Query: 437 EMLKHKFIERCKCGATAMLPKIEKA 461
E L ++I++ K
Sbjct: 298 EALNSRWIKKYANNINKSDQKTLCG 322
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 8e-58
Identities = 74/262 (28%), Positives = 130/262 (49%), Gaps = 20/262 (7%)
Query: 191 ELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVV 249
+ ++G GS+G V++A S+ VA+K++ + E E E+ ++++ HPN+V
Sbjct: 40 NIKEKIGAGSFGTVHRAE-WHGSD-VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 250 RYLGSYQGEEYLWIVMEYCGGGSVADLM--NVTEEPLEEYQIAYICREALKGLAYLHS-- 305
++G+ L IV EY GS+ L+ + E L+E + + + KG+ YLH+
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 306 --IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESR 363
I VHR++K N+L+ + VK+ DFG++ T + GTP WMAPEV+++
Sbjct: 158 PPI--VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP 215
Query: 364 YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE----PAPMLEDKEKWSLVFHD 419
+ K DV++ GV E+A P ++P +V+ + + P +
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP-----RNLNPQVAA 270
Query: 420 FVAKCLTKEPRARPTAAEMLKH 441
+ C T EP RP+ A ++
Sbjct: 271 IIEGCWTNEPWKRPSFATIMDL 292
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-57
Identities = 84/297 (28%), Positives = 131/297 (44%), Gaps = 26/297 (8%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVIS----LSEGEEGYEEIRGEIEMLQQCS 244
YEL +GKG + V + + +T + A+K++ S E+++ E +
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 245 HPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN------VTEEPLEEYQIAYICREALK 298
HP++V L +Y + L++V E+ G DL E ++ R+ L+
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGA---DLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 299 GLAYLHSIFKVHRDIKGGNILLTDQGE---VKLGDFGVAAQLTRTMSKRNTFIGTPHWMA 355
L Y H +HRD+K +LL + VKLG FGVA QL + +GTPH+MA
Sbjct: 142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMA 201
Query: 356 PEVIQESRYDGKVDVWALGVSAVEMAEGLPP-RSTVHPMRVLFMISIEPAPMLEDKEKWS 414
PEV++ Y VDVW GV + G P T + I + +WS
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL----FEGIIKGKYKMNPRQWS 257
Query: 415 LVFH---DFVAKCLTKEPRARPTAAEMLKHKFI-ERCKCGATAMLPK-IEKARQIRA 466
+ D V + L +P R T E L H ++ ER + LP+ +E+ R+ A
Sbjct: 258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNA 314
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-57
Identities = 84/314 (26%), Positives = 139/314 (44%), Gaps = 21/314 (6%)
Query: 171 KVSSSSIPESVTREDP--TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEE 228
V SI + + R T YE+ ++G GSY + T+ A+K+I S+
Sbjct: 3 TVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK--- 59
Query: 229 GYEEIRGEIEMLQQCS-HPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN--VTEEPLE 285
+ EIE+L + HPN++ Y +Y+++V E GG +L++ + ++
Sbjct: 60 --RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGG---ELLDKILRQKFFS 114
Query: 286 EYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE----VKLGDFGVAAQLTRTM 341
E + + + K + YLH+ VHRD+K NIL D+ +++ DFG A QL
Sbjct: 115 EREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPP-RSTVHPMRVLFMIS 400
T T +++APEV++ YD D+W+LGV M G P + +
Sbjct: 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR 234
Query: 401 IEPAPMLEDKEKWSLVFH---DFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPK 457
I W+ V D V+K L +P R TAA +L+H +I L +
Sbjct: 235 IGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNR 294
Query: 458 IEKARQIRASMAQQ 471
+ ++ +MA
Sbjct: 295 QDAPHLVKGAMAAT 308
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 3e-57
Identities = 70/278 (25%), Positives = 126/278 (45%), Gaps = 20/278 (7%)
Query: 175 SSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY--EE 232
+++ E R+ +++ LGKG +G VY AR+ + ++A+KV+ S+ E+ +
Sbjct: 1 TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 233 IRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYI 292
+R EIE+ HPN++R + + +++++E+ G + + +E + A
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATF 119
Query: 293 CREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH 352
E L Y H +HRDIK N+L+ +GE+K+ DFG + +R T GT
Sbjct: 120 MEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRTMCGTLD 177
Query: 353 WMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEK 412
++ PE+I+ +D KVD+W GV E G+PP + I
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV---------NVD 228
Query: 413 WSLVFH------DFVAKCLTKEPRARPTAAEMLKHKFI 444
D ++K L P R +++H ++
Sbjct: 229 LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 5e-57
Identities = 72/282 (25%), Positives = 125/282 (44%), Gaps = 18/282 (6%)
Query: 174 SSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEI 233
SS + + +LG G++G V+ + + IK I+ + E+I
Sbjct: 8 SSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQI 67
Query: 234 RGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLM---NVTEEPLEEYQIA 290
EIE+L+ HPN+++ ++ ++IVME C GG + + + + L E +A
Sbjct: 68 EAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA 127
Query: 291 YICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE---VKLGDFGVAAQLTRTMSKRNTF 347
+ ++ + LAY HS VH+D+K NIL D +K+ DFG+A
Sbjct: 128 ELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNA 186
Query: 348 IGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPP--RSTVHPMRVLFMISIEPAP 405
GT +MAPEV + K D+W+ GV + G P +++ +
Sbjct: 187 AGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV----QQKATYKE 241
Query: 406 MLEDKEKWSLVFH---DFVAKCLTKEPRARPTAAEMLKHKFI 444
+ + D + + LTK+P RP+AA++L H++
Sbjct: 242 -PNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 8e-57
Identities = 82/280 (29%), Positives = 138/280 (49%), Gaps = 16/280 (5%)
Query: 174 SSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEE 232
SS + +Y ++ LGKGS+G V K +D T + A+KVI+ + +
Sbjct: 8 SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST 67
Query: 233 IRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYI 292
I E+E+L++ HPN+++ + +IV E GG + D + + + E+ A I
Sbjct: 68 ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAARI 126
Query: 293 CREALKGLAYLHSIFKVHRDIKGGNILLTDQGE---VKLGDFGVAAQLTRTMSKRNTFIG 349
++ G+ Y+H VHRD+K NILL + + +K+ DFG++ + +K IG
Sbjct: 127 IKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIG 185
Query: 350 TPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPP--RSTVHPMRVLFMISIEPAPML 407
T +++APEV++ + YD K DVW+ GV + G PP + + + +E
Sbjct: 186 TAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDI----LKRVETGKYA 240
Query: 408 EDKEKWSLVFH---DFVAKCLTKEPRARPTAAEMLKHKFI 444
D +W + D + K LT P R TA + L+H +I
Sbjct: 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-56
Identities = 79/286 (27%), Positives = 133/286 (46%), Gaps = 21/286 (7%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPN 247
Y++ ELGKG++ V + T A K+I+ + ++++ E + ++ HPN
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 66
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMN--VTEEPLEEYQIAYICREALKGLAYLHS 305
+VR S Q E + ++V + GG +L V E E ++ ++ L+ +AY HS
Sbjct: 67 IVRLHDSIQEESFHYLVFDLVTGG---ELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 306 IFKVHRDIKGGNILLTDQGE---VKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQES 362
VHR++K N+LL + + VKL DFG+A ++ + F GTP +++PEV+++
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 363 RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLE-DKEKWSLVFH--- 418
Y VD+WA GV + G PP R+ I A + +W V
Sbjct: 183 PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK---AGAYDYPSPEWDTVTPEAK 239
Query: 419 DFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQI 464
+ LT P+ R TA + LK +I C + I + +
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWI----CNRERVASAIHRQDTV 281
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 5e-56
Identities = 77/271 (28%), Positives = 129/271 (47%), Gaps = 16/271 (5%)
Query: 182 TREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQ 241
T+ D Y L N +G+GS+G V A T A K I E + + EIE+++
Sbjct: 3 TKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-VEDVDRFKQEIEIMK 61
Query: 242 QCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLA 301
HPN++R +++ +++VME C GG + + + V + E A I ++ L +A
Sbjct: 62 SLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV-VHKRVFRESDAARIMKDVLSAVA 120
Query: 302 YLHSIFKVHRDIKGGNILLTDQGE---VKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEV 358
Y H + HRD+K N L +KL DFG+AA+ T +GTP++++P+V
Sbjct: 121 YCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQV 179
Query: 359 IQESRYDGKVDVWALGVSAVEMAEGLPP--RSTVHPMRVLFMISIEPAPMLEDKEKWSLV 416
++ Y + D W+ GV + G PP T + M+ I ++ W V
Sbjct: 180 LEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV----MLKIREGTFTFPEKDWLNV 234
Query: 417 FH---DFVAKCLTKEPRARPTAAEMLKHKFI 444
+ + LTK P+ R T+ + L+H++
Sbjct: 235 SPQAESLIRRLLTKSPKQRITSLQALEHEWF 265
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 6e-56
Identities = 77/276 (27%), Positives = 131/276 (47%), Gaps = 18/276 (6%)
Query: 180 SVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEG-YEEIRGEIE 238
++T T +Y+L ELGKG++ V + + + A +I+ + ++++ E
Sbjct: 3 TITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREAR 62
Query: 239 MLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN--VTEEPLEEYQIAYICREA 296
+ + HPN+VR S E + +++ + GG +L V E E ++ ++
Sbjct: 63 ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG---ELFEDIVAREYYSEADASHCIQQI 119
Query: 297 LKGLAYLHSIFKVHRDIKGGNILLTDQGE---VKLGDFGVAAQLTRTMSKRNTFIGTPHW 353
L+ + + H + VHR++K N+LL + + VKL DFG+A ++ F GTP +
Sbjct: 120 LEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179
Query: 354 MAPEVIQESRYDGKVDVWALGVSAVEMAEGLPP--RSTVHPMRVLFMISIEPAPMLEDKE 411
++PEV+++ Y VD+WA GV + G PP H + I+
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL----YQQIKAGAYDFPSP 235
Query: 412 KWSLVFH---DFVAKCLTKEPRARPTAAEMLKHKFI 444
+W V D + K LT P R TAAE LKH +I
Sbjct: 236 EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 9e-56
Identities = 74/334 (22%), Positives = 145/334 (43%), Gaps = 26/334 (7%)
Query: 164 EDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISL 223
+ + P V + Y++L ELG G++G V++ + T + K I+
Sbjct: 27 DKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT 86
Query: 224 SEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEP 283
+ ++ EI ++ Q HP ++ +++ + + +++E+ GG + D + +
Sbjct: 87 PYPLD-KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK 145
Query: 284 LEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE--VKLGDFGVAAQLTRTM 341
+ E ++ R+A +GL ++H VH DIK NI+ + VK+ DFG+A +L
Sbjct: 146 MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 204
Query: 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI 401
T + APE++ D+WA+GV + GL P F
Sbjct: 205 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP----------FAGED 254
Query: 402 EPAPMLE--------DKEKWSLVFH---DFVAKCLTKEPRARPTAAEMLKHKFIERCKCG 450
+ + D++ +S V DF+ L KEPR R T + L+H +++
Sbjct: 255 DLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314
Query: 451 ATAMLPKIEKARQIRASMAQQAQNILSDEPEVNA 484
T+ +P + +IR + ++ + + +P +
Sbjct: 315 LTSRIPS-SRYNKIRQKIKEKYADWPAPQPAIGR 347
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-55
Identities = 81/290 (27%), Positives = 138/290 (47%), Gaps = 19/290 (6%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS--EGEEGYEEIRGEIEMLQQCSHP 246
Y++ ELGKG++ V + T A K+I+ + ++++ E + ++ HP
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHP 88
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN--VTEEPLEEYQIAYICREALKGLAYLH 304
N+VR S Q E + ++V + GG +L V E E ++ ++ L+ +AY H
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGG---ELFEDIVAREFYSEADASHCIQQILESIAYCH 145
Query: 305 SIFKVHRDIKGGNILLTDQGE---VKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQE 361
S VHR++K N+LL + + VKL DFG+A ++ + F GTP +++PEV+++
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHGFAGTPGYLSPEVLKK 204
Query: 362 SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH--- 418
Y VD+WA GV + G PP R+ I A E W V
Sbjct: 205 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-KAGAYDYPSPE-WDTVTPEAK 262
Query: 419 DFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPK--IEKARQIRA 466
+ LT P+ R TA + LK +I + A+A+ + ++ ++ A
Sbjct: 263 SLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNA 312
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-55
Identities = 76/392 (19%), Positives = 144/392 (36%), Gaps = 25/392 (6%)
Query: 151 SMRRFGSSSSLHGEDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDL 210
+ R + S + ++ P + + Y++ ELG G++G V++ +
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTER 179
Query: 211 KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGG 270
T A K + + E +R EI+ + HP +V +++ + + ++ E+ G
Sbjct: 180 ATGNNFAAKFVMTPHESD-KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238
Query: 271 GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE--VKL 328
G + + + + E + R+ KGL ++H VH D+K NI+ T + +KL
Sbjct: 239 GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKL 298
Query: 329 GDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRS 388
DFG+ A L GT + APEV + D+W++GV + + GL P
Sbjct: 299 IDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP-- 355
Query: 389 TVHPMRVLF--------MISIEPAPMLEDKEKWSLVFH---DFVAKCLTKEPRARPTAAE 437
F + +++ D +S + DF+ K L +P R T +
Sbjct: 356 --------FGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQ 407
Query: 438 MLKHKFIERCKCGATAMLPKIEKARQIRASMAQQAQNILSDEPEVNATMGLKLNEDYGDT 497
L+H ++ + +IR S+ + P + +
Sbjct: 408 ALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQ 467
Query: 498 VPSKPQVQVTNEVLATSTLKKQHTLEDMEEGD 529
S + K + E E
Sbjct: 468 EYSIRDAFWDRSEAQPRFIVKPYGTEVGEGQS 499
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 2e-55
Identities = 74/306 (24%), Positives = 133/306 (43%), Gaps = 24/306 (7%)
Query: 187 TTKYELLN---ELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC 243
Y+L LG+GS+ K K+++ A+K+IS + EI L+ C
Sbjct: 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLC 62
Query: 244 S-HPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAY 302
HPN+V+ + + + ++VME GG + + + ++ E + +YI R+ + +++
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERI-KKKKHFSETEASYIMRKLVSAVSH 121
Query: 303 LHSIFKVHRDIKGGNILLTDQGE---VKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVI 359
+H + VHRD+K N+L TD+ + +K+ DFG A T T H+ APE++
Sbjct: 122 MHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL 181
Query: 360 QESRYDGKVDVWALGVSAVEMAEGLPP-----RSTVHPMRVLFMISIEPAPMLEDKEKWS 414
++ YD D+W+LGV M G P RS V M I+ + E W
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK 241
Query: 415 LVFH---DFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLP----KIEKARQIRAS 467
V D + LT +P R + + +++++ ++ L +
Sbjct: 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTC 301
Query: 468 MAQQAQ 473
+
Sbjct: 302 VKATFH 307
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-55
Identities = 69/291 (23%), Positives = 124/291 (42%), Gaps = 31/291 (10%)
Query: 172 VSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE---- 227
+ S P+S + E ++GKG +G V+K R +K +VAIK + L + E
Sbjct: 3 MGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 228 --EGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLE 285
E ++E + E+ ++ +HPN+V+ G +VME+ G + + P++
Sbjct: 63 MIEKFQEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIK 120
Query: 286 EYQIAYICREALKGLAYLHSIFK--VHRDIKGGNILLTDQGE-----VKLGDFGVAAQLT 338
+ + G+ Y+ + VHRD++ NI L E K+ DFG++ Q
Sbjct: 121 WSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV 180
Query: 339 RTMSKRNTFIGTPHWMAPEVI--QESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVL 396
++S +G WMAPE I +E Y K D ++ + + G P ++
Sbjct: 181 HSVS---GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237
Query: 397 FMISIE------PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441
F+ I P E + + C + +P+ RP + ++K
Sbjct: 238 FINMIREEGLRPTIP-----EDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-55
Identities = 69/284 (24%), Positives = 123/284 (43%), Gaps = 28/284 (9%)
Query: 176 SIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRG 235
S+P R + LGKG +G K +T E++ +K + + EE
Sbjct: 1 SMPH---RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKEL-IRFDEETQRTFLK 56
Query: 236 EIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICRE 295
E+++++ HPNV++++G ++ L + EY GG++ ++ + Q ++
Sbjct: 57 EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116
Query: 296 ALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA--------------AQLTRTM 341
G+AYLHS+ +HRD+ N L+ + V + DFG+A +
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176
Query: 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI 401
KR T +G P+WMAPE+I YD KVDV++ G+ E+ + P + F +++
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV 236
Query: 402 E-----PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440
P F +C +P RP+ ++
Sbjct: 237 RGFLDRYCPP-----NCPPSFFPITVRCCDLDPEKRPSFVKLEH 275
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 3e-55
Identities = 78/302 (25%), Positives = 129/302 (42%), Gaps = 19/302 (6%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVIS-----LSEGEEGYEEIRGEIE 238
+ Y++ ELG G + V K R+ T A K I S EEI E+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 239 MLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALK 298
+L+Q H NV+ Y+ + +++E GG + D + +E L E + ++ L
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILD 126
Query: 299 GLAYLHSIFKVHRDIKGGNILLT----DQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWM 354
G+ YLH+ H D+K NI+L +KL DFG+A ++ + GTP ++
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFV 185
Query: 355 APEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLE-DKEKW 413
APE++ + D+W++GV + G P L I+ + + D+E +
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT---SVSYDFDEEFF 242
Query: 414 SLVFH---DFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPK-IEKARQIRASMA 469
S DF+ K L KE R R T E L+H +I + + + R
Sbjct: 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYV 302
Query: 470 QQ 471
++
Sbjct: 303 RR 304
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 3e-55
Identities = 61/294 (20%), Positives = 112/294 (38%), Gaps = 43/294 (14%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVV 249
+ L + LG+G+ V++ R KT +L AIKV + + E E+L++ +H N+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 250 RYLGSYQGE--EYLWIVMEYCGGGSVADLM--NVTEEPLEEYQIAYICREALKGLAYLHS 305
+ + + ++ME+C GS+ ++ L E + + R+ + G+ +L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 306 IFKVHRDIKGGNILLT----DQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQE 361
VHR+IK GNI+ Q KL DFG A +L + + GT ++ P++ +
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYER 189
Query: 362 S--------RYDGKVDVWALGVSAVEMAEGLPP-------------------RSTVHPMR 394
+ +Y VD+W++GV+ A G P +
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249
Query: 395 VLFMISIEPAPMLEDKEKWSLV-------FHDFVAKCLTKEPRARPTAAEMLKH 441
+ P D + +A L + +
Sbjct: 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 6e-55
Identities = 67/307 (21%), Positives = 135/307 (43%), Gaps = 26/307 (8%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC 243
++ KY + +LG+G +G V++ + + + K + + ++ ++ EI +L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ--VLVKKEISILNIA 58
Query: 244 SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYL 303
H N++ S++ E L ++ E+ G + + +N + L E +I + + L +L
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 304 HSIFKVHRDIKGGNILLTDQGE--VKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQE 361
HS H DI+ NI+ + +K+ +FG A QL P + APEV Q
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQH 177
Query: 362 SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLE--------DKEKW 413
D+W+LG + G+ P F+ + D+E +
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINP----------FLAETNQQIIENIMNAEYTFDEEAF 227
Query: 414 SLVFH---DFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRASMAQ 470
+ DFV + L KE ++R TA+E L+H ++++ + + + K R+ ++ +
Sbjct: 228 KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIK 287
Query: 471 QAQNILS 477
+ N++
Sbjct: 288 KDLNMVV 294
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 7e-55
Identities = 75/302 (24%), Positives = 133/302 (44%), Gaps = 34/302 (11%)
Query: 183 REDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVIS-----LSEGEEGYEEIRGEI 237
+E+ Y+ ELG G + V K R+ T A K I S E+I E+
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 238 EMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREAL 297
+L++ HPNV+ Y+ + + +++E GG + D + +E L E + ++ L
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQIL 124
Query: 298 KGLAYLHSIFKVHRDIKGGNILLTDQGE----VKLGDFGVAAQLTRTMSKRNTFIGTPHW 353
G+ YLHS+ H D+K NI+L D+ +K+ DFG+A ++ ++ GTP +
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEF 183
Query: 354 MAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLE----- 408
+APE++ + D+W++GV + G P F+ + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP----------FLGDTKQETLANVSAVN 233
Query: 409 ---DKEKWSLVFH---DFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKAR 462
+ E +S DF+ + L K+P+ R T + L+H +I L + A
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI--KPKDTQQALSRKASAV 291
Query: 463 QI 464
+
Sbjct: 292 NM 293
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 9e-55
Identities = 75/332 (22%), Positives = 133/332 (40%), Gaps = 56/332 (16%)
Query: 167 RQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS-- 224
+ + + + + KY L +G+GSYG V A + +T + AIK+++ +
Sbjct: 5 HHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKI 64
Query: 225 --EGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGG----------- 271
+ E I+ E+ ++++ HPN+ R Y+ E+Y+ +VME C GG
Sbjct: 65 RQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFID 124
Query: 272 ----------------------------SVADLMNVTEEPLEEYQIAYICREALKGLAYL 303
S+ + E I+ I R+ L YL
Sbjct: 125 DSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184
Query: 304 HSIFKVHRDIKGGNILLTDQGE--VKLGDFGVAAQLTRT----MSKRNTFIGTPHWMAPE 357
H+ HRDIK N L + +KL DFG++ + + T GTP+++APE
Sbjct: 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244
Query: 358 VIQES--RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSL 415
V+ + Y K D W+ GV + G P V+ + + + + +++
Sbjct: 245 VLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCF--ENPNYNV 302
Query: 416 VFH---DFVAKCLTKEPRARPTAAEMLKHKFI 444
+ D ++ L + R A L+H +I
Sbjct: 303 LSPLARDLLSNLLNRNVDERFDAMRALQHPWI 334
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-54
Identities = 70/269 (26%), Positives = 118/269 (43%), Gaps = 29/269 (10%)
Query: 191 ELLNELGKGSYGAVYKARDLKTSELVAIKVI---SLSEGEEGYEEIRGEIEMLQQCSHPN 247
L +G G +G VY+A E VA+K + + E +R E ++ HPN
Sbjct: 10 TLEEIIGIGGFGKVYRAF-WIGDE-VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS-- 305
++ G E L +VME+ GG + +++ + + + + +G+ YLH
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 306 -IFKVHRDIKGGNILLTDQGE--------VKLGDFGVAAQLTRTMSKRNTFIGTPHWMAP 356
+ +HRD+K NIL+ + E +K+ DFG+A + RT + G WMAP
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM--SAAGAYAWMAP 183
Query: 357 EVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE----PAPMLEDKEK 412
EVI+ S + DVW+ GV E+ G P + + V + +++ P P
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP-----ST 238
Query: 413 WSLVFHDFVAKCLTKEPRARPTAAEMLKH 441
F + C +P +RP+ +L
Sbjct: 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 1e-54
Identities = 87/334 (26%), Positives = 152/334 (45%), Gaps = 33/334 (9%)
Query: 136 RSGGYDDSTMGRAVASMRRFGSSSSLHGEDVRQQTKVSSSSIPESVTREDPTTKYELLNE 195
RS D S +A ++ + E++ Q+ +P+ ++ KY+ +
Sbjct: 42 RSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDV 101
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISLS-------EGEEGYEEIRGEIEMLQQCS-HPN 247
+G+G V + T A+K++ ++ + EE E R E +L+Q + HP+
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMN--VTEEPLEEYQIAYICREALKGLAYLHS 305
++ + SY+ ++++V + G +L + + L E + I R L+ +++LH+
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKG---ELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA 218
Query: 306 IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQES--- 362
VHRD+K NILL D +++L DFG + L K GTP ++APE+++ S
Sbjct: 219 NNIVHRDLKPENILLDDNMQIRLSDFGFSCHL-EPGEKLRELCGTPGYLAPEILKCSMDE 277
Query: 363 ---RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI-------SIEPAPMLEDKEK 412
Y +VD+WA GV + G PP + +L MI S K
Sbjct: 278 THPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVK 337
Query: 413 WSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446
D +++ L +P AR TA + L+H F ER
Sbjct: 338 ------DLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 1e-54
Identities = 97/383 (25%), Positives = 155/383 (40%), Gaps = 47/383 (12%)
Query: 90 MIIKTRTKTKAKNSRTIVNKPYSEFKKTDGDDEF----------GTFVVRSKDGERRSGG 139
+ RT K + F++ + + GTFV
Sbjct: 40 YCFDEPLLKRTDKYRTYSKKHFRIFREVGPKNSYIAYIEDHSGNGTFV------------ 87
Query: 140 YDDSTMGRAVASMRRFGSSSSLHGEDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKG 199
+ +G+ S +L + + +SV + +Y + LG G
Sbjct: 88 -NTELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSG 146
Query: 200 SYGAVYKARDLKTSELVAIKVIS-------LSEGEEGYEEIRGEIEMLQQCSHPNVVRYL 252
+ G V A + KT + VAI++IS + + + EIE+L++ +HP +++
Sbjct: 147 ACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK 206
Query: 253 GSYQGEEYLWIVMEYCGGGSVADLMN--VTEEPLEEYQIAYICREALKGLAYLHSIFKVH 310
+ E +IV+E GG +L + V + L+E + L + YLH +H
Sbjct: 207 NFFD-AEDYYIVLELMEGG---ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 262
Query: 311 RDIKGGNILLTDQGE---VKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESR---Y 364
RD+K N+LL+ Q E +K+ DFG + L S T GTP ++APEV+ Y
Sbjct: 263 RDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGY 321
Query: 365 DGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH---DFV 421
+ VD W+LGV G PP S L I E W+ V D V
Sbjct: 322 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK-DQITSGKYNFIPEVWAEVSEKALDLV 380
Query: 422 AKCLTKEPRARPTAAEMLKHKFI 444
K L +P+AR T E L+H ++
Sbjct: 381 KKLLVVDPKARFTTEEALRHPWL 403
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-54
Identities = 84/294 (28%), Positives = 133/294 (45%), Gaps = 34/294 (11%)
Query: 175 SSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS--------EG 226
+++P S + YE LG+G V + T + A+K+I ++ E
Sbjct: 4 AALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEV 63
Query: 227 EEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN--VTEEP 283
+E E E+++L++ S HPN+++ +Y+ + ++V + G +L + +
Sbjct: 64 QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG---ELFDYLTEKVT 120
Query: 284 LEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343
L E + I R L+ + LH + VHRD+K NILL D +KL DFG + QL K
Sbjct: 121 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEK 179
Query: 344 RNTFIGTPHWMAPEVIQES------RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLF 397
GTP ++APE+I+ S Y +VD+W+ GV + G PP M +L
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR 239
Query: 398 MI-------SIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
MI D K D V++ L +P+ R TA E L H F
Sbjct: 240 MIMSGNYQFGSPEWDDYSDTVK------DLVSRFLVVQPQKRYTAEEALAHPFF 287
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 2e-54
Identities = 67/290 (23%), Positives = 121/290 (41%), Gaps = 40/290 (13%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPN 247
LG GS G V VA+K + + + EI++L + HPN
Sbjct: 16 LVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPN 70
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLM------NVTEEPLEEYQIAYICREALKGLA 301
V+RY S + +L+I +E C ++ DL+ + + +EY + R+ G+A
Sbjct: 71 VIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 302 YLHSIFKVHRDIKGGNILLTDQGE-------------VKLGDFGVAAQL----TRTMSKR 344
+LHS+ +HRD+K NIL++ + + DFG+ +L + +
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 345 NTFIGTPHWMAPEVIQES-------RYDGKVDVWALGVSAVEM-AEGLPP--RSTVHPMR 394
N GT W APE+++ES R +D++++G + ++G P
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
Query: 395 VLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
++ I D +++ + +P RPTA ++L+H
Sbjct: 250 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-54
Identities = 67/332 (20%), Positives = 122/332 (36%), Gaps = 49/332 (14%)
Query: 156 GSSSSLHGEDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSEL 215
G S+ + + + ++ Y ++ L +G + + K ++
Sbjct: 1 GPLGSMKDILSNYSNLIYLNKYVKE--KDKYINDYRIIRTLNQGKFNKIILCE--KDNKF 56
Query: 216 VAIKVISLSEGEEG----------------YEEIRGEIEMLQQCSHPNVVRYLGSYQGEE 259
A+K S E+ Y++ + E++++ + + G +
Sbjct: 57 YALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYD 116
Query: 260 YLWIVMEYCGGGSVAD-------LMNVTEEPLEEYQIAYICREALKGLAYLHSIFKV-HR 311
++I+ EY S+ L + I I + L +Y+H+ + HR
Sbjct: 117 EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHR 176
Query: 312 DIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ-ESRYDG-KVD 369
D+K NIL+ G VKL DFG + + K GT +M PE ES Y+G KVD
Sbjct: 177 DVKPSNILMDKNGRVKLSDFGESEYMVD--KKIKGSRGTYEFMPPEFFSNESSYNGAKVD 234
Query: 370 VWALGVSAVEMAEGLPP---------------RSTVH-PMRVLFMISIEPAPMLEDKEKW 413
+W+LG+ M + P + P+ + +
Sbjct: 235 IWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNF 294
Query: 414 -SLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
S DF+ L K P R T+ + LKH+++
Sbjct: 295 LSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-54
Identities = 78/314 (24%), Positives = 133/314 (42%), Gaps = 33/314 (10%)
Query: 179 ESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVI-----SLSEGEEGYEEI 233
E+ ++ Y++ ELG G + V K R+ T A K I S EEI
Sbjct: 3 ETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEI 62
Query: 234 RGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYIC 293
E+ +L+Q HPN++ Y+ + +++E GG + D + +E L E +
Sbjct: 63 EREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFI 121
Query: 294 REALKGLAYLHSIFKVHRDIKGGNILLTDQGE----VKLGDFGVAAQLTRTMSKRNTFIG 349
++ L G+ YLH+ H D+K NI+L D+ +KL DFG+A ++ + G
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFG 180
Query: 350 TPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLE- 408
TP ++APE++ + D+W++GV + G P F+ + +
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----------FLGDTKQETLANI 230
Query: 409 -------DKEKWSLVFH---DFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKI 458
D+E +S DF+ K L KE R R T E L+H +I + +
Sbjct: 231 TAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRES 290
Query: 459 EKA-RQIRASMAQQ 471
+ ++
Sbjct: 291 VVNLENFKKQYVRR 304
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 4e-54
Identities = 74/317 (23%), Positives = 135/317 (42%), Gaps = 30/317 (9%)
Query: 143 STMGRAVASMRRFGSSSSLHGEDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYG 202
S+ F S SS+ + + R+ + +E+ +ELG+G+
Sbjct: 8 SSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATS 67
Query: 203 AVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262
VY+ + T + A+KV+ + ++ +R EI +L + SHPN+++ ++ +
Sbjct: 68 IVYRCKQKGTQKPYALKVLKKTVDKK---IVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124
Query: 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD 322
+V+E GG + D + V + E A ++ L+ +AYLH VHRD+K N+L
Sbjct: 125 LVLELVTGGELFDRI-VEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYAT 183
Query: 323 QGE---VKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVE 379
+K+ DFG++ + T GTP + APE+++ Y +VD+W++G+
Sbjct: 184 PAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYI 242
Query: 380 MAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH------------DFVAKCLTK 427
+ G P F M F D V K +
Sbjct: 243 LLCGFEP----------FYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVL 292
Query: 428 EPRARPTAAEMLKHKFI 444
+P+ R T + L+H ++
Sbjct: 293 DPKKRLTTFQALQHPWV 309
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 5e-54
Identities = 68/276 (24%), Positives = 119/276 (43%), Gaps = 22/276 (7%)
Query: 180 SVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVIS-LSEGEEGYEEIRGEIE 238
S+ + + + LG G++ V+ + T +L A+K I + + EI
Sbjct: 1 SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--SSLENEIA 58
Query: 239 MLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN--VTEEPLEEYQIAYICREA 296
+L++ H N+V Y+ + ++VM+ GG +L + + E + + ++
Sbjct: 59 VLKKIKHENIVTLEDIYESTTHYYLVMQLVSGG---ELFDRILERGVYTEKDASLVIQQV 115
Query: 297 LKGLAYLHSIFKVHRDIKGGNILLTDQGE---VKLGDFGVAAQLTRTMSKRNTFIGTPHW 353
L + YLH VHRD+K N+L E + + DFG++ +T GTP +
Sbjct: 116 LSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMSTACGTPGY 173
Query: 354 MAPEVIQESRYDGKVDVWALGVSAVEMAEGLPP--RSTVHPMRVLFMISIEPAPMLEDKE 411
+APEV+ + Y VD W++GV + G PP T + I+ +
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL----FEKIKEGYYEFESP 229
Query: 412 KWSLVFH---DFVAKCLTKEPRARPTAAEMLKHKFI 444
W + DF+ L K+P R T + L H +I
Sbjct: 230 FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI 265
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 7e-54
Identities = 75/276 (27%), Positives = 128/276 (46%), Gaps = 32/276 (11%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVIS-----LSEGEEGYEEIRGEIEMLQQC 243
YE+ ELG G + V K R T + A K I S EEI E+ +L++
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 244 SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYL 303
HPN++ ++ + + +++E GG + D + +E L E + ++ L G+ YL
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEATQFLKQILDGVHYL 124
Query: 304 HSIFKVHRDIKGGNILLTDQGE----VKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVI 359
HS H D+K NI+L D+ +KL DFG+A ++ ++ GTP ++APE++
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGNEFKNIFGTPEFVAPEIV 183
Query: 360 QESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLE--------DKE 411
+ D+W++GV + G P F+ + + D+E
Sbjct: 184 NYEPLGLEADMWSIGVITYILLSGASP----------FLGETKQETLTNISAVNYDFDEE 233
Query: 412 KWSLVFH---DFVAKCLTKEPRARPTAAEMLKHKFI 444
+S DF+ + L K+P+ R T A+ L+H +I
Sbjct: 234 YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 4e-53
Identities = 81/326 (24%), Positives = 140/326 (42%), Gaps = 27/326 (8%)
Query: 182 TREDPTTKYELLNE-LGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEML 240
+ T Y+L + LG G G V + +T + A+K++ S + R E++
Sbjct: 22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------KARQEVDHH 75
Query: 241 QQCS-HPNVVRYLGSYQ----GEEYLWIVMEYCGGGSVAD-LMNVTEEPLEEYQIAYICR 294
Q S P++V L Y+ G+ L I+ME GG + + ++ E + A I R
Sbjct: 76 WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR 135
Query: 295 EALKGLAYLHSIFKVHRDIKGGNILLTDQGE---VKLGDFGVAAQLTRTMSKRNTFIGTP 351
+ + +LHS HRD+K N+L T + + +KL DFG A + T+ + T TP
Sbjct: 136 DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQTPCYTP 193
Query: 352 HWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPP--RSTVHPMRVLFMISIEPAPMLED 409
+++APEV+ +YD D+W+LGV + G PP +T + I
Sbjct: 194 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP 253
Query: 410 KEKWSLVFH---DFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRA 466
+WS V + L +P R T + + H +I + L ++ +
Sbjct: 254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKD 313
Query: 467 SMAQQAQNILSDEPEVNATMGLKLNE 492
+ + + S ATM + ++
Sbjct: 314 HWDEVKEEMTS----ALATMRVDYDQ 335
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 9e-53
Identities = 72/329 (21%), Positives = 131/329 (39%), Gaps = 29/329 (8%)
Query: 161 LHGEDVRQQTKVSSSSIPESVTREDPTTKYELLN-ELGKGSYGAVYKARDLKTSELVAIK 219
+H + + E+ Y L + ELG+G + V + T + A K
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAK 60
Query: 220 VISLSE-GEEGYEEIRGEIEMLQQCSH-PNVVRYLGSYQGEEYLWIVMEYCGGGSVAD-L 276
+ G++ EI EI +L+ P V+ Y+ + +++EY GG +
Sbjct: 61 FLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC 120
Query: 277 MNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE---VKLGDFGV 333
+ E + E + + ++ L+G+ YLH VH D+K NILL+ +K+ DFG+
Sbjct: 121 LPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180
Query: 334 AAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPM 393
+ ++ + +GTP ++APE++ D+W +G+ A + P
Sbjct: 181 SRKI-GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP------- 232
Query: 394 RVLFMISIEPAPMLE--------DKEKWSLVFH---DFVAKCLTKEPRARPTAAEMLKHK 442
F+ L +E +S V DF+ L K P RPTA L H
Sbjct: 233 ---FVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289
Query: 443 FIERCKCGATAMLPKIEKARQIRASMAQQ 471
++++ + + Q + +
Sbjct: 290 WLQQWDFENLFHPEETSSSSQTQDHSVRS 318
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 1e-52
Identities = 42/298 (14%), Positives = 100/298 (33%), Gaps = 30/298 (10%)
Query: 168 QQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKAR-----DLKTSELVAIKVIS 222
+ + +I + + + + LG+G++ VY+A D K + +KV
Sbjct: 45 FEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK 104
Query: 223 LSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN---- 278
+ E Y + +E L+ +++ ++ + +V E G++ + +N
Sbjct: 105 PANPWEFYIGTQ-LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKN 163
Query: 279 VTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ-----------GEVK 327
E+ + + + L + +H +H DIK N +L + +
Sbjct: 164 TPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLA 223
Query: 328 LGDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLP 385
L D G + + T + E++ ++ ++D + + + M G
Sbjct: 224 LIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283
Query: 386 PRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKF 443
+ P + W+ +F L + ++L+ K
Sbjct: 284 MKVKNEGGECKPEGLFRRLP---HLDMWN----EFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-52
Identities = 75/302 (24%), Positives = 140/302 (46%), Gaps = 28/302 (9%)
Query: 180 SVTREDPTTKYEL--LNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEI 237
+ + + Y + LG G +G V+K + T +A K+I G + EE++ EI
Sbjct: 79 TAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR-GMKDKEEVKNEI 137
Query: 238 EMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREAL 297
++ Q H N+++ +++ + + +VMEY GG + D + L E ++
Sbjct: 138 SVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQIC 197
Query: 298 KGLAYLHSIFKVHRDIKGGNILLTDQGE--VKLGDFGVAAQLTRTMSKRNTFIGTPHWMA 355
+G+ ++H ++ +H D+K NIL ++ +K+ DFG+A + K GTP ++A
Sbjct: 198 EGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLA 256
Query: 356 PEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLF--------MISIEPAPML 407
PEV+ D+W++GV A + GL P F + +I
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP----------FLGDNDAETLNNILACRWD 306
Query: 408 EDKEKWSLVFH---DFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQI 464
+ E++ + +F++K L KE R +A+E LKH ++ K + + + +K R
Sbjct: 307 LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKL-HSRLSAQKKKNRGS 365
Query: 465 RA 466
A
Sbjct: 366 DA 367
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-52
Identities = 74/308 (24%), Positives = 133/308 (43%), Gaps = 40/308 (12%)
Query: 173 SSSSIPESVTREDPTTKYELLNE-LGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYE 231
S+ S Y+L + LG+G++ V +L TS+ A+K+I G
Sbjct: 2 STDSFSGRFED-----VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH-IRS 55
Query: 232 EIRGEIEMLQQCS-HPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIA 290
+ E+EML QC H NV+ + ++ E+ ++V E GGS+ + E + +
Sbjct: 56 RVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHI-HKRRHFNELEAS 114
Query: 291 YICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE---VKLGDFGVAAQLTRTMSKR--- 344
+ ++ L +LH+ HRD+K NIL + VK+ DF + + +
Sbjct: 115 VVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 345 ----NTFIGTPHWMAPEVI-----QESRYDGKVDVWALGVSAVEMAEGLPP----RSTVH 391
T G+ +MAPEV+ + S YD + D+W+LGV + G PP +
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC 234
Query: 392 PMRVLFMISIEPAPMLE---------DKEKWSLVFH---DFVAKCLTKEPRARPTAAEML 439
+ E + W+ + D ++K L ++ + R +AA++L
Sbjct: 235 GWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294
Query: 440 KHKFIERC 447
+H +++ C
Sbjct: 295 QHPWVQGC 302
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-52
Identities = 62/294 (21%), Positives = 116/294 (39%), Gaps = 43/294 (14%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVV 249
+ L + LG+G+ V++ R KT +L AIKV + + E E+L++ +H N+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 250 RYLGSYQ--GEEYLWIVMEYCGGGSVADLM--NVTEEPLEEYQIAYICREALKGLAYLHS 305
+ + + ++ME+C GS+ ++ L E + + R+ + G+ +L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 306 IFKVHRDIKGGNILLT----DQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQE 361
VHR+IK GNI+ Q KL DFG A +L + + GT ++ P++ +
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYER 189
Query: 362 S--------RYDGKVDVWALGVSAVEMAEGLPP----RSTVHPMRVLFMI----SIEPAP 405
+ +Y VD+W++GV+ A G P V++ I
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249
Query: 406 MLEDKEKWSLVF------------------HDFVAKCLTKEPRARPTAAEMLKH 441
++ E + + +A L + +
Sbjct: 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 3e-52
Identities = 72/287 (25%), Positives = 110/287 (38%), Gaps = 33/287 (11%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV 248
+E+ LG G +G V + T E VAIK + E EI+++++ +HPNV
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 249 VR------YLGSYQGEEYLWIVMEYCGGGSVADLMNVTE--EPLEEYQIAYICREALKGL 300
V L + + MEYC GG + +N E L+E I + + L
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGE---VKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPE 357
YLH +HRD+K NI+L + K+ D G A +L + F+GT ++APE
Sbjct: 135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAPE 193
Query: 358 VIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI-------SIEPAPMLEDK 410
++++ +Y VD W+ G A E G P I L
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGA 253
Query: 411 EKWSLVF--------------HDFVAKCLTKEPRARPTAAEMLKHKF 443
K+S V ++ L R R T +
Sbjct: 254 VKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 4e-52
Identities = 89/288 (30%), Positives = 136/288 (47%), Gaps = 29/288 (10%)
Query: 175 SSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVIS-------LSEGE 227
S P+++ +Y + LG G+ G V A + KT + VAIK+IS +
Sbjct: 2 SVYPKALRD-----EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREA 56
Query: 228 EGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN--VTEEPLE 285
+ + EIE+L++ +HP +++ + E+Y +IV+E GG +L + V + L+
Sbjct: 57 DPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGG---ELFDKVVGNKRLK 112
Query: 286 EYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE---VKLGDFGVAAQLTRTMS 342
E + L + YLH +HRD+K N+LL+ Q E +K+ DFG + L T S
Sbjct: 113 EATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-S 171
Query: 343 KRNTFIGTPHWMAPEVIQES---RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI 399
T GTP ++APEV+ Y+ VD W+LGV G PP S L
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD- 230
Query: 400 SIEPAPMLEDKEKWSLVFH---DFVAKCLTKEPRARPTAAEMLKHKFI 444
I E W+ V D V K L +P+AR T E L+H ++
Sbjct: 231 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 4e-52
Identities = 42/340 (12%), Positives = 89/340 (26%), Gaps = 44/340 (12%)
Query: 158 SSSLHGEDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVA 217
+ E V ++ K +L+ L G V+ RD++ E A
Sbjct: 32 EPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA 91
Query: 218 IKVISLSEGEEG--YEEIRGEIEMLQQCSHPN------------------------VVRY 251
+KV ++ E + + + +
Sbjct: 92 LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151
Query: 252 LGSYQGEEY--LWIVMEYCGG-----GSVADLMNVTEEPLEEYQIAYICREALKGLAYLH 304
++M S D + V + + + ++ A L
Sbjct: 152 SPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ 211
Query: 305 SIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ--ES 362
S VH N+ + G + LGD + ++ + E + +
Sbjct: 212 SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW---KVGTRGPASSVPVTYAPREFLNASTA 268
Query: 363 RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH---- 418
+ ++ W LG+S + P V P D +
Sbjct: 269 TFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDF 328
Query: 419 --DFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLP 456
+ + L + R R E ++ + + ++ L
Sbjct: 329 VKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSLS 368
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 4e-52
Identities = 69/304 (22%), Positives = 129/304 (42%), Gaps = 36/304 (11%)
Query: 165 DVRQQTKVSSSSIP-----ESVTRED---PTTKYELLNELGKGSYGAVYKARDLKTSELV 216
+ +S+ S P S+ ++ P + E+ +GKG +G VY R V
Sbjct: 2 PEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE---V 58
Query: 217 AIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVAD 275
AI++I + E+ + + E+ +Q H NVV ++G+ +L I+ C G ++
Sbjct: 59 AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYS 118
Query: 276 LMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAA 335
++ + L+ + I +E +KG+ YLH+ +H+D+K N+ D G+V + DFG+ +
Sbjct: 119 VVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFS 177
Query: 336 QLTRTMSKRNT-----FIGTPHWMAPEVIQESR---------YDGKVDVWALGVSAVEMA 381
+ R G +APE+I++ + DV+ALG E+
Sbjct: 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH 237
Query: 382 EGLPPRSTVHPMRVLFMISI----EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAE 437
P T +++ + + + KE D + C E RPT +
Sbjct: 238 AREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKE-----ISDILLFCWAFEQEERPTFTK 292
Query: 438 MLKH 441
++
Sbjct: 293 LMDM 296
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-51
Identities = 72/291 (24%), Positives = 118/291 (40%), Gaps = 47/291 (16%)
Query: 191 ELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVR 250
LL +GKG YG V++ + E VA+K+ S + + + E E+ H N++
Sbjct: 11 TLLECVGKGRYGEVWRGS-WQ-GENVAVKIFSSRDEKSWFRET--ELYNTVMLRHENILG 66
Query: 251 YLGS----YQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI 306
++ S LW++ Y GS+ D + +T L+ I GLA+LH
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIE 124
Query: 307 FK--------VHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS----KRNTFIGTPHWM 354
HRD+K NIL+ G+ + D G+A +++ + N +GT +M
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 355 APEVIQES------RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLE 408
APEV+ E+ +VD+WA G+ E+A + V + F + P E
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 409 D--------------KEKWSL-----VFHDFVAKCLTKEPRARPTAAEMLK 440
D +W + +C + P AR TA + K
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-51
Identities = 45/264 (17%), Positives = 101/264 (38%), Gaps = 25/264 (9%)
Query: 191 ELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVV 249
L +L + G ++K R + +KV+ + + + E L+ SHPNV+
Sbjct: 13 NFLTKLNENHSGELWKGRWQGND--IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 250 RYLG--SYQGEEYLWIVMEYCGGGSVADLM-NVTEEPLEEYQIAYICREALKGLAYLHSI 306
LG + ++ + GS+ +++ T +++ Q + +G+A+LH++
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130
Query: 307 FK--VHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRY 364
+ ++++ + ++ V + P W+APE +Q+
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-----GRMYAPAWVAPEALQKKPE 185
Query: 365 DG---KVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE----PAPMLEDKEKWSLVF 417
D D+W+ V E+ P + + M + +++E P S
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP-----PGISPHV 240
Query: 418 HDFVAKCLTKEPRARPTAAEMLKH 441
+ C+ ++P RP ++
Sbjct: 241 SKLMKICMNEDPAKRPKFDMIVPI 264
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-51
Identities = 76/261 (29%), Positives = 127/261 (48%), Gaps = 24/261 (9%)
Query: 191 ELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVR 250
E+ +G+G++G V KA+ ++ VAIK I E E + E+ L + +HPN+V+
Sbjct: 11 EVEEVVGRGAFGVVCKAK--WRAKDVAIKQI---ESESERKAFIVELRQLSRVNHPNIVK 65
Query: 251 YLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEP--LEEYQIAYICREALKGLAYLHSIFK 308
G+ + +VMEY GGS+ ++++ E C + +G+AYLHS+
Sbjct: 66 LYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 309 ---VHRDIKGGNILLTDQGEV-KLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRY 364
+HRD+K N+LL G V K+ DFG A + M+ G+ WMAPEV + S Y
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN---KGSAAWMAPEVFEGSNY 180
Query: 365 DGKVDVWALGVSAVEMAEGLPPRSTVH--PMRVLFMISIEPAPMLEDK--EKWSLVFHDF 420
K DV++ G+ E+ P + R+++ + P L +
Sbjct: 181 SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE----SL 236
Query: 421 VAKCLTKEPRARPTAAEMLKH 441
+ +C +K+P RP+ E++K
Sbjct: 237 MTRCWSKDPSQRPSMEEIVKI 257
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-51
Identities = 70/265 (26%), Positives = 131/265 (49%), Gaps = 23/265 (8%)
Query: 191 ELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVV 249
+ +G GS+G VYK + VA+K+++++ + + + E+ +L++ H N++
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 250 RYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKV 309
++G + L IV ++C G S+ ++ +E E ++ I R+ +G+ YLH+ +
Sbjct: 84 LFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSII 142
Query: 310 HRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM--SKRNTFIGTPHWMAPEVIQ---ESRY 364
HRD+K NI L + VK+GDFG+A + +R + G+ WMAPEVI+ + Y
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 365 DGKVDVWALGVSAVEMAEGLPPRSTVHPM-RVLFMI-------SIEPAPMLEDKEKWSLV 416
+ DV+A G+ E+ G P S ++ +++ M+ + K
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR----- 257
Query: 417 FHDFVAKCLTKEPRARPTAAEMLKH 441
+A+CL K+ RP+ +L
Sbjct: 258 MKRLMAECLKKKRDERPSFPRILAE 282
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 1e-50
Identities = 83/363 (22%), Positives = 151/363 (41%), Gaps = 25/363 (6%)
Query: 127 VVRSKDGERRSGGYDDSTMGRAVASMRRFGSSSSLHGEDVRQQTKVSSSSIPESVTREDP 186
++ + G+ + + + +Q + S +
Sbjct: 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAI- 59
Query: 187 TTKYELLNE-LGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS- 244
Y++ ++ LG G G V + + +T E A+K++ + R E+E+ + S
Sbjct: 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQ 113
Query: 245 HPNVVRYLGSYQ----GEEYLWIVMEYCGGGSVAD-LMNVTEEPLEEYQIAYICREALKG 299
P++VR + Y+ G + L IVME GG + + + ++ E + + I + +
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 173
Query: 300 LAYLHSIFKVHRDIKGGNILLTDQGE---VKLGDFGVAAQLTRTMSKRNTFIGTPHWMAP 356
+ YLHSI HRD+K N+L T + +KL DFG A + T + + T TP+++AP
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYVAP 232
Query: 357 EVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI--SIEPAPMLEDKEKWS 414
EV+ +YD D+W+LGV + G PP + H + + + I +WS
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 292
Query: 415 LVFH---DFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAML--PKIEKARQIRASMA 469
V + L EP R T E + H +I + L ++ K + R
Sbjct: 293 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDV 352
Query: 470 QQA 472
++
Sbjct: 353 KEE 355
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 4e-50
Identities = 83/291 (28%), Positives = 139/291 (47%), Gaps = 39/291 (13%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVIS-------------------------L 223
+Y L +E+GKGSYG V A + + A+KV+S
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 224 SEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ-----GEEYLWIVMEYCGGGSVADLMN 278
+ E++ EI +L++ HPNVV+ L + E++L++V E G V ++
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVK-L--VEVLDDPNEDHLYMVFELVNQGPVMEV-- 128
Query: 279 VTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338
T +PL E Q + ++ +KG+ YLH +HRDIK N+L+ + G +K+ DFGV+ +
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 339 RTMSKRNTFIGTPHWMAPEVIQESR--YDG-KVDVWALGVSAVEMAEGLPPRSTVHPMRV 395
+ + + +GTP +MAPE + E+R + G +DVWA+GV+ G P M +
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248
Query: 396 LFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446
I + D+ + D + + L K P +R E+ H ++ R
Sbjct: 249 HSKIKSQALEF-PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 1e-49
Identities = 71/333 (21%), Positives = 132/333 (39%), Gaps = 52/333 (15%)
Query: 151 SMRRFGSSSSLHGEDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDL 210
SM SL + Q+ S S +P V R + +++ ++GKG YG V+ +
Sbjct: 1 SMTYIPPGESLRDLIEQSQSSGSGSGLPLLVQRTIAK-QIQMVKQIGKGRYGEVWMGK-W 58
Query: 211 KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGS----YQGEEYLWIVME 266
+ E VA+KV EE EI H N++ ++ + L+++ +
Sbjct: 59 R-GEKVAVKV--FFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITD 115
Query: 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFK--------VHRDIKGGNI 318
Y GS+ D + L+ + + ++ GL +LH+ HRD+K NI
Sbjct: 116 YHENGSLYDYLK--STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNI 173
Query: 319 LLTDQGEVKLGDFGVAAQLTRTMSKR----NTFIGTPHWMAPEVIQES------RYDGKV 368
L+ G + D G+A + ++ NT +GT +M PEV+ ES +
Sbjct: 174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMA 233
Query: 369 DVWALGVSAV--EMAEGLPPRSTVHPMRVLF--MISIEPA-----------------PML 407
D+++ G+ + E+A V ++ + ++ +P+ P
Sbjct: 234 DMYSFGL--ILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNR 291
Query: 408 EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440
++ + +C P +R TA + K
Sbjct: 292 WSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 2e-49
Identities = 56/235 (23%), Positives = 98/235 (41%), Gaps = 22/235 (9%)
Query: 227 EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLM--NVTEEPL 284
+ +I + S N V L + YL+I M+ C ++ D M + E
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161
Query: 285 EEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344
E +I + + + +LHS +HRD+K NI T VK+GDFG+ + + ++
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221
Query: 345 NTF------------IGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHP 392
+GT +M+PE I + Y KVD+++LG+ E+ L ST
Sbjct: 222 TVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL---LYSFSTQME 278
Query: 393 MRVLFMI--SIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445
+ +++ + K H V L+ P RP A +++++ E
Sbjct: 279 RVRIITDVRNLKFPLLFTQK---YPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 22/123 (17%), Positives = 49/123 (39%)
Query: 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPN 247
T +E + +G+G +G V++A++ AIK I L E E++ E++ L + HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307
+VRY ++ E + + + + + +++
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 308 KVH 310
++
Sbjct: 126 QLQ 128
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 171 bits (437), Expect = 1e-48
Identities = 71/265 (26%), Positives = 124/265 (46%), Gaps = 16/265 (6%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV 248
++L+ LG+G+YG V A + T E VA+K++ + + E I+ EI + + +H NV
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 249 VRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFK 308
V++ G + ++ +EYC GG + D + + + E + + G+ YLH I
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 309 VHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR--NTFIGTPHWMAPEVIQESRYDG 366
HRDIK N+LL ++ +K+ DFG+A +R N GT ++APE+++ +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 367 -KVDVWALGVSAVEMAEG-LPPRSTVHPMRVLFMI-----SIEPAPMLEDKEKWSLVFHD 419
VDVW+ G+ M G LP + + P ++
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL------A 240
Query: 420 FVAKCLTKEPRARPTAAEMLKHKFI 444
+ K L + P AR T ++ K ++
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWY 265
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-48
Identities = 80/318 (25%), Positives = 144/318 (45%), Gaps = 19/318 (5%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV 248
++L+ LG+G+YG V A + T E VA+K++ + + E I+ EI + + +H NV
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 249 VRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFK 308
V++ G + ++ +EYC GG + D + + + E + + G+ YLH I
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 309 VHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR--NTFIGTPHWMAPEVIQESRYDG 366
HRDIK N+LL ++ +K+ DFG+A +R N GT ++APE+++ +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 367 -KVDVWALGVSAVEMAEG-LPPRSTVHPMRVLFMI-----SIEPAPMLEDKEKWSLVFHD 419
VDVW+ G+ M G LP + + P ++
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL------A 240
Query: 420 FVAKCLTKEPRARPTAAEMLKHK-FIERCKCGATAMLPKIEKARQIRASMAQQAQNILSD 478
+ K L + P AR T ++ K + + + K GA + + ++ Q+ L
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDF 300
Query: 479 EPEVNA--TMGLKLNEDY 494
P +A T G ++++
Sbjct: 301 SPVNSASRTPGSGWSKEH 318
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 5e-48
Identities = 82/291 (28%), Positives = 131/291 (45%), Gaps = 43/291 (14%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE--IRGEIEMLQQCSHP 246
KYE + ++G+GSYG V+K R+ T ++VAIK SE + ++ +R EI ML+Q HP
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHP 62
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI 306
N+V L ++ + L +V EYC +V ++ + + E+ + I + L+ + + H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH----WM-APEVI-Q 360
+HRD+K NIL+T +KL DFG A LT + + W +PE++
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLT---GPSDYY--DDEVATRWYRSPELLVG 176
Query: 361 ESRYDGKVDVWALGVSAVEMAEGLP--------------------PRSTVHP-MRVLFMI 399
+++Y VDVWA+G E+ G+P
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236
Query: 400 SIEPAPMLEDKEKWSLVFH-------DFVAKCLTKEPRARPTAAEMLKHKF 443
S P ED E L F + CL +P R T ++L H +
Sbjct: 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-48
Identities = 84/289 (29%), Positives = 129/289 (44%), Gaps = 39/289 (13%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE--IRGEIEMLQQCSHP 246
KYE L +G+GSYG V K R+ T +VAIK S+ ++ ++ +R EI++L+Q H
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHE 84
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI 306
N+V L + ++ ++V E+ ++ D + + L+ + + + G+ + HS
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT---RTMSKRNTFIGTPHWMAPEVIQESR 363
+HRDIK NIL++ G VKL DFG A L + T + APE++
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE---VATRWYRAPELLVGDV 200
Query: 364 -YDGKVDVWALGVSAVEMAEGLP--------------------PRSTVHPM-------RV 395
Y VDVWA+G EM G P +
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260
Query: 396 LFMISIEPAPMLEDK-EKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKF 443
+ + I+ LE + K S V D KCL +P RP AE+L H F
Sbjct: 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 6e-48
Identities = 68/309 (22%), Positives = 129/309 (41%), Gaps = 47/309 (15%)
Query: 173 SSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE 232
SS + + +LL +G +G V+KA+ +E VA+K+ ++ +
Sbjct: 9 SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ--LLNEYVAVKI--FPIQDKQSWQ 64
Query: 233 IRGEIEMLQQCSHPNVVRYLGS----YQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQ 288
E+ L H N+++++G+ + LW++ + GS++D + + +
Sbjct: 65 NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK--ANVVSWNE 122
Query: 289 IAYICREALKGLAYLHSIFK----------VHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338
+ +I +GLAYLH HRDIK N+LL + + DFG+A +
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 339 RTMSKRNT--FIGTPHWMAPEVIQES-----RYDGKVDVWALGVSAVEMAEGLPPRSTVH 391
S +T +GT +MAPEV++ + ++D++A+G+ E+A
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 392 PMRVL-FMISIEPAPMLED--------------KEKWS-----LVFHDFVAKCLTKEPRA 431
+L F I P LED ++ W + + + +C + A
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 432 RPTAAEMLK 440
R +A + +
Sbjct: 303 RLSAGCVGE 311
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 9e-48
Identities = 78/291 (26%), Positives = 129/291 (44%), Gaps = 44/291 (15%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE--IRGEIEMLQQCSHP 246
KYE L ++G+G+YG V+KA++ +T E+VA+K + L + +EG +R EI +L++ H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHK 61
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADL---MNVTEEPLEEYQIAYICREALKGLAYL 303
N+VR ++ L +V E+C DL + L+ + + LKGL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 304 HSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT---RTMSKRNTFIGTPHWMAPEVI- 359
HS +HRD+K N+L+ GE+KL +FG+A R S + T + P+V+
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE---VVTLWYRPPDVLF 174
Query: 360 QESRYDGKVDVWALGVSAVEMAEG----LPPRSTVHPMRVLFMI---------------- 399
Y +D+W+ G E+A P ++ +F +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 400 SIEPAPMLEDKEKWSLVFH-------DFVAKCLTKEPRARPTAAEMLKHKF 443
+P PM V D + L P R +A E L+H +
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-47
Identities = 79/276 (28%), Positives = 134/276 (48%), Gaps = 15/276 (5%)
Query: 175 SSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEI 233
+SI + Y LL +GKG++ V AR + T VAIK+I ++ +++
Sbjct: 2 NSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKL 61
Query: 234 RGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYIC 293
E+ +++ +HPN+V+ + E+ L+++MEY GG V D + V ++E +
Sbjct: 62 FREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL-VAHGRMKEKEARSKF 120
Query: 294 REALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHW 353
R+ + + Y H VHRD+K N+LL +K+ DFG + + T K + F G P +
Sbjct: 121 RQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFCGAPPY 179
Query: 354 MAPEVIQESRYDG-KVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMIS----IEPAPMLE 408
APE+ Q +YDG +VDVW+LGV + G P + + + P M
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 239
Query: 409 DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
D E + + + L P R T +++K ++I
Sbjct: 240 DCE-------NLLKRFLVLNPIKRGTLEQIMKDRWI 268
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-47
Identities = 72/325 (22%), Positives = 122/325 (37%), Gaps = 48/325 (14%)
Query: 157 SSSSLHGEDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELV 216
++L T S S +P V R L +GKG +G V++ + + E V
Sbjct: 12 EGTTLKDLIYDMTTSGSGSGLPLLVQRTIAR-TIVLQESIGKGRFGEVWRGK-WRGEE-V 68
Query: 217 AIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGS----YQGEEYLWIVMEYCGGGS 272
A+K+ S E + E EI H N++ ++ + LW+V +Y GS
Sbjct: 69 AVKIFSSREERSWFREA--EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGS 126
Query: 273 VADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFK--------VHRDIKGGNILLTDQG 324
+ D +N + + + GLA+LH HRD+K NIL+ G
Sbjct: 127 LFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184
Query: 325 EVKLGDFGVAAQLTRTMS----KRNTFIGTPHWMAPEVIQES------RYDGKVDVWALG 374
+ D G+A + N +GT +MAPEV+ +S + D++A+G
Sbjct: 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 244
Query: 375 VSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDK--------------EKWSL----- 415
+ E+A ++ + + P +E+ +W
Sbjct: 245 LVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALR 304
Query: 416 VFHDFVAKCLTKEPRARPTAAEMLK 440
V + +C AR TA + K
Sbjct: 305 VMAKIMRECWYANGAARLTALRIKK 329
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-47
Identities = 45/362 (12%), Positives = 101/362 (27%), Gaps = 68/362 (18%)
Query: 139 GYDDSTMGRAVASMRRFGSSSSLHGEDVRQQTKVSSSSIPESV------TREDPTTKYEL 192
G D + + + ++ + VS+S +
Sbjct: 18 GPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVR 77
Query: 193 LNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEI------------- 237
LG+ A +A D +T E + V +E ++++ E+
Sbjct: 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 137
Query: 238 ------------EMLQQCSHPNVVRYLGSYQGEEYLWIVMEY----CGGGSVADLM---N 278
++++ ++R + L Y + +++ +
Sbjct: 138 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 197
Query: 279 VTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338
T + L + + + ++ LA LH VH ++ +I+L +G V L F
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL---- 253
Query: 339 RTMSKRNTFIGTPHWMAPEVIQ-----------ESRYDGKVDVWALGVSAVEMAEGLPP- 386
R + + PE+ + D WALG+ + P
Sbjct: 254 VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313
Query: 387 --RSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
+ + +F + + L R + ++
Sbjct: 314 TKDAALGGSEWIF----------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363
Query: 445 ER 446
E+
Sbjct: 364 EQ 365
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 1e-47
Identities = 48/361 (13%), Positives = 108/361 (29%), Gaps = 53/361 (14%)
Query: 142 DSTMGRAVASMRRFGSSSSLHGEDVRQQTKVSSSSIPESVTREDPTT---KYELLNE--- 195
D + + + ++ + VS+S + + L
Sbjct: 26 DVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTV 85
Query: 196 LGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQ----------- 242
LG+ A +A D +T E + V +E ++++ E+ L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 243 -----------CSHPNVVRYLGSYQGEEYLWIVMEY-------CGGGSVADLMN---VTE 281
P + + E +W++ + + +++ T
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 282 EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL-TRT 340
+ L + + + ++ LA LH VH ++ +I+L +G V L F +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASA 265
Query: 341 MSKRNTFIGTPHWMAPEVIQESRYDGK-----VDVWALGVSAVEMAEGLPPRSTVHPMRV 395
+S P A ++ ++ D W LG++ + P + +
Sbjct: 266 VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG 325
Query: 396 LFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAML 455
I + + L R + ++ E+ + +A L
Sbjct: 326 SEWIFRSCKNI-------PQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAAL 378
Query: 456 P 456
P
Sbjct: 379 P 379
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 1e-47
Identities = 77/350 (22%), Positives = 143/350 (40%), Gaps = 42/350 (12%)
Query: 168 QQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVI------ 221
++ + + + + KY ++ LG G++G V+ A D + ++ V +K I
Sbjct: 4 EEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVL 63
Query: 222 -SLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN-- 278
+ ++ EI +L + H N+++ L ++ + + +VME G G DL
Sbjct: 64 EDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG--LDLFAFI 121
Query: 279 VTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338
L+E +YI R+ + + YL +HRDIK NI++ + +KL DFG AA L
Sbjct: 122 DRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181
Query: 339 RTMSKRNTFIGTPHWMAPEVIQESRYDG-KVDVWALGVSAVEMAEGLPPRSTVHPMRVLF 397
R TF GT + APEV+ + Y G ++++W+LGV L+
Sbjct: 182 RG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGV-------------------TLY 221
Query: 398 MISIEPAPMLEDKEKWSLVFH----------DFVAKCLTKEPRARPTAAEMLKHKFIERC 447
+ E P E +E H V+ L P R T +++ ++ +
Sbjct: 222 TLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281
Query: 448 KCGATAMLPKIEKARQIRASMAQQAQNILSDEPEVNATMGLKLNEDYGDT 497
A ++ + + + + A + + + +L G
Sbjct: 282 VNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQELCGGEGHH 331
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-47
Identities = 72/289 (24%), Positives = 124/289 (42%), Gaps = 34/289 (11%)
Query: 173 SSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVIS----LSEGEE 228
P ED ++ LG+GS+ V AR+L TS AIK++ + E +
Sbjct: 19 QPPPQPRKKRPED----FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKV 74
Query: 229 GYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNV--TEEPLEE 286
Y + E +++ + HP V+ ++Q +E L+ + Y G +L+ +E
Sbjct: 75 PY--VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNG---ELLKYIRKIGSFDE 129
Query: 287 YQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR--TMSKR 344
+ E + L YLH +HRD+K NILL + +++ DFG A L+ ++
Sbjct: 130 TCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 189
Query: 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA 404
N+F+GT +++PE++ E D+WALG ++ GLPP + + I
Sbjct: 190 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI----- 244
Query: 405 PMLEDKEKWSLVFH----DFVAKCLTKEPRARPT------AAEMLKHKF 443
++ + + F D V K L + R + H F
Sbjct: 245 --IKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 6e-47
Identities = 73/307 (23%), Positives = 120/307 (39%), Gaps = 58/307 (18%)
Query: 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSH 245
+LL +G+G YGAVYK L VA+KV S + + E I + H
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGS-LD-ERPVAVKVFSFANRQNFINEK--NIYRVPLMEH 66
Query: 246 PNVVRYLG-----SYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGL 300
N+ R++ + G +VMEY GS+ ++ + + +GL
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--LHTSDWVSSCRLAHSVTRGL 124
Query: 301 AYLHSIFK---------VHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR------- 344
AYLH+ HRD+ N+L+ + G + DFG++ +LT R
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 345 -NTFIGTPHWMAPEVIQES-------RYDGKVDVWALGVSAVEMA---EGLPPRSTVHPM 393
+ +GT +MAPEV++ + +VD++ALG+ E+ L P +V
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244
Query: 394 RVLFMISIEPAPMLED--------------KEKWSL------VFHDFVAKCLTKEPRARP 433
++ F + P ED E W + + C ++ AR
Sbjct: 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL 304
Query: 434 TAAEMLK 440
TA +
Sbjct: 305 TAQXAEE 311
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 8e-47
Identities = 72/319 (22%), Positives = 123/319 (38%), Gaps = 45/319 (14%)
Query: 145 MGRAVASMRRFGSSSSLHGEDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAV 204
MG + S G + + ++ + +E ++Y++ LG G +G+V
Sbjct: 1 MGSSHHHHHH-SSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSV 59
Query: 205 YKARDLKTSELVAIKVIS-----LSEGEEGYEEIRGEIEMLQQCSH--PNVVRYLGSYQG 257
Y + + VAIK + + E+ +L++ S V+R L ++
Sbjct: 60 YSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119
Query: 258 EEYLWIVMEYCGGGSVADLMN--VTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKG 315
+ +++E DL + L+E + L+ + + H+ +HRDIK
Sbjct: 120 PDSFVLILERPEPV--QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKD 177
Query: 316 GNILL-TDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDG-KVDVWAL 373
NIL+ ++GE+KL DFG A L T+ F GT + PE I+ RY G VW+L
Sbjct: 178 ENILIDLNRGELKLIDFGSGALLKDTVYT--DFDGTRVYSPPEWIRYHRYHGRSAAVWSL 235
Query: 374 GVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH----------DFVAK 423
G+ +L+ + P D+E +
Sbjct: 236 GI-------------------LLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 276
Query: 424 CLTKEPRARPTAAEMLKHK 442
CL P RPT E+ H
Sbjct: 277 CLALRPSDRPTFEEIQNHP 295
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-46
Identities = 66/257 (25%), Positives = 113/257 (43%), Gaps = 25/257 (9%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSE-LVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV 248
YE+ + G G +Y A D + V +K + S E E + L + HP++
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 249 VRYL-----GSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYL 303
V+ G+ +IVMEY GG S+ + L + E L L+YL
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYL 198
Query: 304 HSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESR 363
HSI V+ D+K NI+LT++ +KL D G +++ GTP + APE+++ +
Sbjct: 199 HSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSF----GYLYGTPGFQAPEIVR-TG 252
Query: 364 YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAK 423
D++ +G + + LP R+ + + E P+L+ + + + +
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----PEDDPVLKTYDS----YGRLLRR 303
Query: 424 CLTKEPRARP-TAAEML 439
+ +PR R TA EM
Sbjct: 304 AIDPDPRQRFTTAEEMS 320
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 4e-46
Identities = 77/272 (28%), Positives = 129/272 (47%), Gaps = 26/272 (9%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVIS---LSEGEEGYEEIRGEIEMLQQCSH 245
KY + + LG+GSYG V + D +T A+K++ L G ++ EI++L++ H
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 246 PNVVRYLGSYQGEE--YLWIVMEYCGGGSVADLMN-VTEEPLEEYQIAYICREALKGLAY 302
NV++ + EE +++VMEYC G ++++ V E+ Q + + GL Y
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGM-QEMLDSVPEKRFPVCQAHGYFCQLIDGLEY 124
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR--NTFIGTPHWMAPEVIQ 360
LHS VH+DIK GN+LLT G +K+ GVA L + T G+P + PE+
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 361 ESR-YDG-KVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418
+ G KVD+W+ GV+ + GL P + ++ I K +++
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG---------KGSYAIPGD 235
Query: 419 ------DFVAKCLTKEPRARPTAAEMLKHKFI 444
D + L EP R + ++ +H +
Sbjct: 236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 5e-46
Identities = 73/307 (23%), Positives = 115/307 (37%), Gaps = 46/307 (14%)
Query: 160 SLHGEDVRQQTKVSSSSIPESVTREDPTT--KYELLNELGKGSYGAVYKARDLKTSELVA 217
S+ + ++ + P ++ +Y L LGKG +G V+ L VA
Sbjct: 1 SMLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVA 60
Query: 218 IKVIS-----LSEGEEGYEEIRGEIEMLQQCS----HPNVVRYLGSYQGEEYLWIVMEY- 267
IKVI E+ +L + HP V+R L ++ +E +V+E
Sbjct: 61 IKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERP 120
Query: 268 CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL-TDQGEV 326
+ D + + PL E + + + + HS VHRDIK NIL+ +G
Sbjct: 121 LPAQDLFDYI-TEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCA 179
Query: 327 KLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDG-KVDVWALGVSAVEMAEGLP 385
KL DFG A L F GT + PE I +Y VW+LG+
Sbjct: 180 KLIDFGSGALLHDEPYT--DFDGTRVYSPPEWISRHQYHALPATVWSLGI---------- 227
Query: 386 PRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH----------DFVAKCLTKEPRARPTA 435
+L+ + P D+E H + +CL +P +RP+
Sbjct: 228 ---------LLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSL 278
Query: 436 AEMLKHK 442
E+L
Sbjct: 279 EEILLDP 285
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-45
Identities = 79/314 (25%), Positives = 134/314 (42%), Gaps = 47/314 (14%)
Query: 166 VRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE 225
+ SS E++ + KY+ L ++G+G+YG VYKA+D +VA+K I L
Sbjct: 1 MHHHHHHSSGR--ENLYFQGLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDA 57
Query: 226 GEEGYEE--IRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADL---MNVT 280
+EG IR EI +L++ HPN+V + E L +V E+ DL ++
Sbjct: 58 EDEGIPSTAIR-EISLLKELHHPNIVSLIDVIHSERCLTLVFEFME----KDLKKVLDEN 112
Query: 281 EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT-- 338
+ L++ QI + L+G+A+ H +HRD+K N+L+ G +KL DFG+A
Sbjct: 113 KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172
Query: 339 -RTMSKRNTFIGTPHWMAPEVI-QESRYDGKVDVWALGVSAVEMAEGLP----------- 385
R+ + + T + AP+V+ +Y VD+W++G EM G P
Sbjct: 173 VRSYTHE---VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL 229
Query: 386 ---------------PRSTVHPMRVLFMISIEPAPMLEDKEKW-SLVFHDFVAKCLTKEP 429
P+ P+ + D ++ L +P
Sbjct: 230 PKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDP 289
Query: 430 RARPTAAEMLKHKF 443
R +A + + H +
Sbjct: 290 NKRISARDAMNHPY 303
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-45
Identities = 91/350 (26%), Positives = 144/350 (41%), Gaps = 64/350 (18%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE------IRGEIEMLQQ 242
+YE L+ LG+G + VYKARD T+++VAIK I L ++ +R EI++LQ+
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKL-GHRSEAKDGINRTALR-EIKLLQE 68
Query: 243 CSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADL---MNVTEEPLEEYQIAYICREALKG 299
SHPN++ L ++ + + +V ++ DL + L I L+G
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 300 LAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL---TRTMSKRNTFIGTPH---- 352
L YLH + +HRD+K N+LL + G +KL DFG+A R + H
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT---------HQVVT 175
Query: 353 -WM-APEVIQESR-YDGKVDVWALGVSAVEMAEG---LPPRSTVHPMRVLFMI------- 399
W APE++ +R Y VD+WA+G E+ LP S + + +F
Sbjct: 176 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 235
Query: 400 --------------SIEPAPMLEDKEKW-SLVFHDFVAKCLTKEPRARPTAAEMLKHK-F 443
P L D + P AR TA + LK K F
Sbjct: 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295
Query: 444 IERCKCGATAMLPK---IEKARQIRASMAQQAQNILSDEPEVNATMGLKL 490
R LP+ + + +++ A + ++ E + KL
Sbjct: 296 SNRPGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALE-QGGLPKKL 344
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 2e-45
Identities = 86/314 (27%), Positives = 127/314 (40%), Gaps = 83/314 (26%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE-----IRGEIEMLQQ- 242
+YE + E+G G+YG VYKARD + VA+K + + G G +R E+ +L++
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVALLRRL 68
Query: 243 --CSHPNVVRYL-----GSYQGEEYLWIVMEYCGGGSVADLM----NVTEEPLEEYQIAY 291
HPNVVR + E + +V E+ DL L I
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKD 124
Query: 292 ICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP 351
+ R+ L+GL +LH+ VHRD+K NIL+T G VKL DFG+A R S + TP
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA----RIYSYQMAL--TP 178
Query: 352 H----WM-APEVIQESRYDGKVDVWALGVSAVEMAEGLP--------------------- 385
W APEV+ +S Y VD+W++G EM P
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238
Query: 386 ----------------PRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEP 429
P P++ + P +E+ + + LT P
Sbjct: 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVV-------PEMEESG------AQLLLEMLTFNP 285
Query: 430 RARPTAAEMLKHKF 443
R +A L+H +
Sbjct: 286 HKRISAFRALQHSY 299
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 3e-45
Identities = 78/309 (25%), Positives = 120/309 (38%), Gaps = 72/309 (23%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE--IRGEIEMLQQCSHP 246
+++ L +LG G+Y VYK + T VA+K + L + EEG IR EI ++++ H
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKL-DSEEGTPSTAIR-EISLMKELKHE 63
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLM--------NVTEEPLEEYQIAYICREALK 298
N+VR E L +V E+ DL T LE + Y + L+
Sbjct: 64 NIVRLYDVIHTENKLTLVFEFMD----NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 299 GLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL---TRTMSKRNTFIGTPHWM- 354
GLA+ H +HRD+K N+L+ +G++KLGDFG+A T S + T W
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE---VVT-LWYR 175
Query: 355 APEVI-QESRYDGKVDVWALGVSAVEMAEGLP---------------------------- 385
AP+V+ Y +D+W+ G EM G P
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS 235
Query: 386 -----------PRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPT 434
+ +R + L+ DF+ L P R +
Sbjct: 236 VTKLPKYNPNIQQRPPRDLRQVL--QPHTKEPLDGNL------MDFLHGLLQLNPDMRLS 287
Query: 435 AAEMLKHKF 443
A + L H +
Sbjct: 288 AKQALHHPW 296
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 7e-45
Identities = 82/290 (28%), Positives = 134/290 (46%), Gaps = 44/290 (15%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE--IRGEIEMLQQCSHP 246
KY L ++G+G+YG VYKA++ E A+K I L + +EG IR EI +L++ H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHS 60
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADL---MNVTEEPLEEYQIAYICREALKGLAYL 303
N+V+ ++ L +V E+ DL ++V E LE + L G+AY
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 304 HSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT---RTMSKRNTFIGTPHWMAPEVI- 359
H +HRD+K N+L+ +GE+K+ DFG+A R + I T + AP+V+
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE---IVTLWYRAPDVLM 173
Query: 360 QESRYDGKVDVWALGVSAVEMAEG---LPPRSTVHPMRVLFMI----SIEPAPMLEDKEK 412
+Y +D+W++G EM G P S + +F I + + P + + K
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 413 WSLVFH-------------------DFVAKCLTKEPRARPTAAEMLKHKF 443
+ F D ++K L +P R TA + L+H +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-44
Identities = 76/277 (27%), Positives = 126/277 (45%), Gaps = 24/277 (8%)
Query: 179 ESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGE 236
E V + +E+L +GKGS+G V + T ++ A+K ++ + + E
Sbjct: 10 EDVNFDH----FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKE 65
Query: 237 IEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN--VTEEPLEEYQIA-YIC 293
++++Q HP +V S+Q EE +++V++ GG DL +E + +IC
Sbjct: 66 LQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGG---DLRYHLQQNVHFKEETVKLFIC 122
Query: 294 REALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHW 353
E + L YL + +HRD+K NILL + G V + DF +AA L R ++ T GT +
Sbjct: 123 -ELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTMAGTKPY 180
Query: 354 MAPEVIQESR---YDGKVDVWALGVSAVEMAEGLPP---RSTVHPMRVLFMISIEPAPML 407
MAPE+ + Y VD W+LGV+A E+ G P RS+ ++
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY- 239
Query: 408 EDKEKWSLVFHDFVAKCLTKEPRAR-PTAAEMLKHKF 443
WS + K L P R +++ +
Sbjct: 240 --PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPY 274
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-44
Identities = 75/316 (23%), Positives = 123/316 (38%), Gaps = 49/316 (15%)
Query: 187 TTKYELLNE-LGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS- 244
Y++ ++ LG G G V + + +T E A+K++ + R E+E+ + S
Sbjct: 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQ 69
Query: 245 HPNVVRYLGSYQ----GEEYLWIVMEYCGGGSVAD-LMNVTEEPLEEYQIAYICREALKG 299
P++VR + Y+ G + L IVME GG + + + ++ E + + I + +
Sbjct: 70 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 300 LAYLHSIFKVHRDIKGGNILLTDQGE---VKLGDFGVAAQLTRTMSKRNTFIGTPHWMAP 356
+ YLHSI HRD+K N+L T + +KL DFG A
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG---------------------FAK 168
Query: 357 EVIQESRYDGKVDVWALGVSAVEMAEGLPP---RSTVHPMRVLFMISIEPAPMLEDKEKW 413
E E YD D+W+LGV + G PP + + I +W
Sbjct: 169 ETTGEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-RIRMGQYEFPNPEW 226
Query: 414 SLVFH---DFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRASMAQ 470
S V + L EP R T E + H +I + L ++ +
Sbjct: 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWED 286
Query: 471 QAQNILSDEPEVNATM 486
+ + S ATM
Sbjct: 287 VKEEMTS----ALATM 298
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-44
Identities = 69/278 (24%), Positives = 119/278 (42%), Gaps = 13/278 (4%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVI--SLSEGEEGYEEIRGEIEMLQQCSHPN 247
Y+++++LG G VY A D + VAIK I E EE + E+ Q SH N
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 248 VVR-Y-LGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS 305
+V + Y +VMEY G ++++ + + PL + L G+ + H
Sbjct: 73 IVSMIDVDEEDDCYY--LVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 306 IFKVHRDIKGGNILLTDQGEVKLGDFGVA-AQLTRTMSKRNTFIGTPHWMAPEVIQESRY 364
+ VHRDIK NIL+ +K+ DFG+A A ++++ N +GT + +PE +
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 365 DGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSL--VFHDFVA 422
D D++++G+ EM G PP + + + + P + + + + +
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVIL 249
Query: 423 KCLTKEPRARP-TAAEMLKHKFIERCKCGATAMLPKIE 459
+ K+ R T EM + A E
Sbjct: 250 RATEKDKANRYKTIQEMKDD--LSSVLHENRANEDVYE 285
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-44
Identities = 68/262 (25%), Positives = 110/262 (41%), Gaps = 21/262 (8%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVIS--LSEGEEGYEEIRGEIEMLQQCSHPN 247
Y L +G+G G VY+A D +VA+K++S LS ++ E + P+
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 248 VVRYLGSY-QGEE--YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLH 304
VV + GE L++ M G +A ++ + PL + I R+ L H
Sbjct: 96 VV---PIHDFGEIDGQLYVDMRLINGVDLAAMLR-RQGPLAPPRAVAIVRQIGSALDAAH 151
Query: 305 SIFKVHRDIKGGNILLTDQGEVKLGDFGVA-----AQLTRTMSKRNTFIGTPHWMAPEVI 359
+ HRD+K NIL++ L DFG+A +LT+ +GT ++MAPE
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL----GNTVGTLYYMAPERF 207
Query: 360 QESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKW-SLVFH 418
ES + D++AL E G PP + V+ + P + F
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPPY-QGDQLSVMGAHINQAIPRPSTVRPGIPVAFD 266
Query: 419 DFVAKCLTKEPRAR-PTAAEML 439
+A+ + K P R T ++
Sbjct: 267 AVIARGMAKNPEDRYVTCGDLS 288
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 7e-44
Identities = 75/312 (24%), Positives = 135/312 (43%), Gaps = 40/312 (12%)
Query: 156 GSSSSLHGEDVRQQTKVSSSSIPESVTREDPTTK--------YELLNELGKGSYGAVYKA 207
G++++ ++ K + E ++ T ++ + LG GS+G V
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 208 RDLKTSELVAIKVIS----LSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263
+ ++ A+K++ + + E E +LQ + P +V+ S++ L++
Sbjct: 61 KHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 264 VMEYCGGGSVADLMNV--TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLT 321
VMEY GG ++ + E + + + YLHS+ ++RD+K N+L+
Sbjct: 119 VMEYVAGG---EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 322 DQGEVKLGDFGVAAQL-TRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEM 380
QG +++ DFG A ++ RT T GTP +APE+I Y+ VD WALGV EM
Sbjct: 176 QQGYIQVTDFGFAKRVKGRT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 381 AEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH----DFVAKCLTKEPRAR---- 432
A G PP P+++ I + K ++ F D + L + R
Sbjct: 232 AAGYPPFFADQPIQIYEKI-------VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNL 284
Query: 433 -PTAAEMLKHKF 443
++ HK+
Sbjct: 285 KNGVNDIKNHKW 296
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 7e-44
Identities = 69/286 (24%), Positives = 120/286 (41%), Gaps = 35/286 (12%)
Query: 179 ESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGE 236
+ + + + LG+G +G V+ + T +L A K ++ +GY+ E
Sbjct: 180 QPMGEDW----FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE 235
Query: 237 IEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLM------NVTEEPLEEYQIA 290
++L + +V +++ + L +VM GG D+ + +E +
Sbjct: 236 KKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG---DIRYHIYNVDEDNPGFQEPRAI 292
Query: 291 YICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350
+ + + GL +LH ++RD+K N+LL D G V++ D G+A +L +K + GT
Sbjct: 293 FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGT 352
Query: 351 PHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPP---RSTVHPMRVLF-MISIEPAPM 406
P +MAPE++ YD VD +ALGV+ EM P R + L +
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV------- 405
Query: 407 LEDKEKWSLVF----HDFVAKCLTKEPRAR-----PTAAEMLKHKF 443
LE + F DF L K+P R + + H
Sbjct: 406 LEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-43
Identities = 82/291 (28%), Positives = 128/291 (43%), Gaps = 45/291 (15%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE--IRGEIEMLQQCSHP 246
Y L++LG+G+Y VYK + T LVA+K I L E EEG IR E+ +L+ H
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL-EHEEGAPCTAIR-EVSLLKDLKHA 60
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADL---MNVTEEPLEEYQIAYICREALKGLAYL 303
N+V E+ L +V EY DL ++ + + + + L+GLAY
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 304 HSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL---TRTMSKRNTFIGTPHWMAPEVI- 359
H +HRD+K N+L+ ++GE+KL DFG+A T+T + T + P+++
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE---VVTLWYRPPDILL 173
Query: 360 QESRYDGKVDVWALGVSAVEMAEG---LPPRSTVHPMRVLFMISIEPAP-------MLED 409
+ Y ++D+W +G EMA G P + + +F I P E+
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233
Query: 410 ----------KEKWSLVFH-------DFVAKCLTKEPRARPTAAEMLKHKF 443
E D + K L E R R +A + +KH F
Sbjct: 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 2e-43
Identities = 96/339 (28%), Positives = 141/339 (41%), Gaps = 84/339 (24%)
Query: 189 KYELLNELGKGSYGAVYKARDLK-TSELVAIKVISLSEGEEGYEE--IRGEIEMLQQ--- 242
+YE + E+G+G+YG V+KARDLK VA+K + + GEEG IR E+ +L+
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLET 70
Query: 243 CSHPNVVR-----YLGSYQGEEYLWIVMEYCGGGSVADLM----NVTEEPLEEYQIAYIC 293
HPNVVR + E L +V E+ DL V E + I +
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMM 126
Query: 294 REALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH- 352
+ L+GL +LHS VHRD+K NIL+T G++KL DFG+A R S + T
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA----RIYSFQMAL--TSVV 180
Query: 353 ---WM-APEVIQESRYDGKVDVWALGVSAVEMAEGLP----------------------- 385
W APEV+ +S Y VD+W++G EM P
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 386 --------------PRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRA 431
+ P+ +++ D + KCLT P
Sbjct: 241 EDWPRDVALPRQAFHSKSAQPIEKFV-------TDIDELG------KDLLLKCLTFNPAK 287
Query: 432 RPTAAEMLKHKF---IERCKCGATAMLPKIEKARQIRAS 467
R +A L H + +ERCK + LP + ++ +
Sbjct: 288 RISAYSALSHPYFQDLERCKENLDSHLPPSQNTSELNTA 326
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-43
Identities = 72/284 (25%), Positives = 120/284 (42%), Gaps = 34/284 (11%)
Query: 179 ESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGE 236
+ VT+ + LGKG +G V + T ++ A K + +G E
Sbjct: 179 QPVTKNT----FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE 234
Query: 237 IEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLM----NVTEEPLEEYQIAYI 292
++L++ + VV +Y+ ++ L +V+ GG DL ++ + E + +
Sbjct: 235 KQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG---DLKFHIYHMGQAGFPEARAVFY 291
Query: 293 CREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH 352
E GL LH V+RD+K NILL D G +++ D G+A + +GT
Sbjct: 292 AAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVG 350
Query: 353 WMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPP----RSTVHPMRVLFMISIEPAPMLE 408
+MAPEV++ RY D WALG EM G P + + V ++ E
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-------KE 403
Query: 409 DKEKWSLVF----HDFVAKCLTKEPRAR-----PTAAEMLKHKF 443
E++S F ++ L K+P R +A E+ +H
Sbjct: 404 VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-43
Identities = 88/300 (29%), Positives = 139/300 (46%), Gaps = 20/300 (6%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVI--SLSEGEEGYEEIRGEIEMLQQCSHPN 247
YEL LG G V+ ARDL+ VA+KV+ L+ Y R E + +HP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 248 VVRYLGSY-QGEE------YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGL 300
+V Y GE +IVMEY G ++ D+++ TE P+ + + +A + L
Sbjct: 74 IV---AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQAL 129
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA---AQLTRTMSKRNTFIGTPHWMAPE 357
+ H +HRD+K NI+++ VK+ DFG+A A ++++ IGT +++PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 358 VIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFM-ISIEPAPMLEDKEKWSLV 416
+ D + DV++LG E+ G PP + P+ V + + +P P E S
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 249
Query: 417 FHDFVAKCLTKEPRARP-TAAEMLKHKFIERCKCGATAMLPKIEKARQIRASMAQQAQNI 475
V K L K P R TAAEM + R G PK+ + + ++ A N+
Sbjct: 250 LDAVVLKALAKNPENRYQTAAEMRAD--LVRVHNGEPPEAPKVLTDAERTSLLSSAAGNL 307
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 4e-43
Identities = 77/308 (25%), Positives = 123/308 (39%), Gaps = 64/308 (20%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY--EEIRGEIEMLQQCSHP 246
KYE L ++G+G++G V+KAR KT + VA+K + + +EG+ +R EI++LQ H
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHE 76
Query: 247 NVVR----------YLGSYQGEEYLWIVMEYCGGGSVADL---MNVTEEPLEEYQIAYIC 293
NVV +G YL V ++C DL ++ +I +
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYL--VFDFC----EHDLAGLLSNVLVKFTLSEIKRVM 130
Query: 294 REALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH- 352
+ L GL Y+H +HRD+K N+L+T G +KL DFG+A R S +
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA----RAFSLAKNSQPNRYT 186
Query: 353 ------WM-APEVI-QESRYDGKVDVWALGVSAVEMAEG---LPPRSTVH---------- 391
W PE++ E Y +D+W G EM + + H
Sbjct: 187 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 246
Query: 392 -------------PMRVLFMISIEPAPMLEDKEKW---SLVFHDFVAKCLTKEPRARPTA 435
+ + ++D+ K D + K L +P R +
Sbjct: 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 306
Query: 436 AEMLKHKF 443
+ L H F
Sbjct: 307 DDALNHDF 314
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 8e-43
Identities = 56/190 (29%), Positives = 94/190 (49%), Gaps = 5/190 (2%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS--EGEEGYEEIRGEIEMLQQCSHP 246
Y L + LG G++G V T VA+K+++ + +I+ EI+ L+ HP
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI 306
++++ ++VMEY GG + D + +EE + + ++ L + Y H
Sbjct: 72 HIIKLYQVISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDG 366
VHRD+K N+LL K+ DFG++ + T G+P++ APEVI Y G
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRTSCGSPNYAAPEVISGRLYAG 189
Query: 367 -KVDVWALGV 375
+VD+W+ GV
Sbjct: 190 PEVDIWSCGV 199
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-42
Identities = 69/270 (25%), Positives = 122/270 (45%), Gaps = 32/270 (11%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVIS----LSEGEEGYEEIRGEIEMLQQCSH 245
+++L LG GS+G V+ R A+KV+ + + E E ML +H
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQV--EHTNDERLMLSIVTH 65
Query: 246 PNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNV--TEEPLEEYQIAYICREALKGLAYL 303
P ++R G++Q + ++++M+Y GG +L ++ + + E L YL
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGG---ELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122
Query: 304 HSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL-TRTMSKRNTFIGTPHWMAPEVIQES 362
HS ++RD+K NILL G +K+ DFG A + T T GTP ++APEV+
Sbjct: 123 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTK 178
Query: 363 RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH---- 418
Y+ +D W+ G+ EM G P + M+ I L + ++ F+
Sbjct: 179 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI-------LNAELRFPPFFNEDVK 231
Query: 419 DFVAKCLTKEPRAR-----PTAAEMLKHKF 443
D +++ +T++ R ++ H +
Sbjct: 232 DLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-42
Identities = 66/236 (27%), Positives = 123/236 (52%), Gaps = 20/236 (8%)
Query: 162 HGEDVRQQTKVSSSSIPES-VTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKV 220
+ ++ + K + + I + + ED YE++ +G+G++G V R T ++ A+K+
Sbjct: 46 NIDNFLSRYKDTINKIRDLRMKAED----YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 101
Query: 221 IS----LSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADL 276
+S + + E +++ + P VV+ ++Q + YL++VMEY GG DL
Sbjct: 102 LSKFEMIKRSDS--AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG---DL 156
Query: 277 MNV-TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAA 335
+N+ + + E + E + L +HS+ +HRD+K N+LL G +KL DFG
Sbjct: 157 VNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216
Query: 336 QLTRTMSKR-NTFIGTPHWMAPEVIQ----ESRYDGKVDVWALGVSAVEMAEGLPP 386
++ + R +T +GTP +++PEV++ + Y + D W++GV EM G P
Sbjct: 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 74/295 (25%), Positives = 118/295 (40%), Gaps = 48/295 (16%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEG--YEEIRGEIEMLQQCSHP 246
+Y + +LG+G+YG VYKA D T+E VAIK I L EEG IR E+ +L++ H
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKELQHR 93
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNV--TEEPLEEYQIAYICREALKGLAYLH 304
N++ L ++ EY DL + I + + G+ + H
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAE----NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 305 SIFKVHRDIKGGNILLT-----DQGEVKLGDFGVAAQLT---RTMSKRNTFIGTPHWMAP 356
S +HRD+K N+LL+ + +K+GDFG+A R + I T + P
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE---IITLWYRPP 206
Query: 357 EVI-QESRYDGKVDVWALGVSAVEMAEG---LPPRSTVHPMRVLFMI----SIEPAPMLE 408
E++ Y VD+W++ EM P S + + +F + P +
Sbjct: 207 EILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266
Query: 409 DKEKWSLVFH--------------------DFVAKCLTKEPRARPTAAEMLKHKF 443
W F D + L +P R +A L+H +
Sbjct: 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-42
Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 18/218 (8%)
Query: 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVIS----LSEGEEGYEEIRGE 236
+ R+D +E+L +G+G++ V + +T ++ A+K+++ L GE R E
Sbjct: 58 LQRDD----FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEV--SCFREE 111
Query: 237 IEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREA 296
++L + + ++Q E YL++VMEY GG + L++ E + + E
Sbjct: 112 RDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEI 171
Query: 297 LKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR-NTFIGTPHWMA 355
+ + +H + VHRDIK NILL G ++L DFG +L + R +GTP +++
Sbjct: 172 VMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLS 231
Query: 356 PEVIQ-------ESRYDGKVDVWALGVSAVEMAEGLPP 386
PE++Q Y + D WALGV A EM G P
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-41
Identities = 70/294 (23%), Positives = 126/294 (42%), Gaps = 20/294 (6%)
Query: 164 EDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVIS- 222
E + +S + RED +E+L +G+G++G V + ++ A+K+++
Sbjct: 54 EYLEWAKPFTSKVKQMRLHRED----FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNK 109
Query: 223 ---LSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNV 279
L E R E ++L + ++Q + L++VM+Y GG + L++
Sbjct: 110 WEMLKRAET--ACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSK 167
Query: 280 TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339
E+ L E + E + + +H + VHRDIK NIL+ G ++L DFG +L
Sbjct: 168 FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227
Query: 340 TMSKR-NTFIGTPHWMAPEVIQE-----SRYDGKVDVWALGVSAVEMAEGLPP--RSTVH 391
+ + + +GTP +++PE++Q RY + D W+LGV EM G P ++
Sbjct: 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 287
Query: 392 PMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPR--ARPTAAEMLKHKF 443
M E S D + + + + + KH F
Sbjct: 288 ETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPF 341
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 7/206 (3%)
Query: 173 SSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE 232
++ P + + +Y+ + ++G G++G RD T ELVA+K I + E
Sbjct: 5 PVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID--EN 62
Query: 233 IRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYI 292
++ EI + HPN+VR+ +L I+MEY GG + + + E + +
Sbjct: 63 VQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI-CNAGRFSEDEARFF 121
Query: 293 CREALKGLAYLHSIFKVHRDIKGGNILLTDQ--GEVKLGDFGVAAQLTRTMSKRNTFIGT 350
++ L G++Y HS+ HRD+K N LL +K+ DFG + + S+ + +GT
Sbjct: 122 FQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGT 180
Query: 351 PHWMAPEVIQESRYDG-KVDVWALGV 375
P ++APEV+ YDG DVW+ GV
Sbjct: 181 PAYIAPEVLLRQEYDGKIADVWSCGV 206
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-41
Identities = 82/299 (27%), Positives = 134/299 (44%), Gaps = 24/299 (8%)
Query: 157 SSSSLHGEDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELV 216
S S ++ +VS + VT + +E L LGKG++G V ++ T
Sbjct: 121 RSGSPSDNSGAEEMEVSLAKPKHRVTMNE----FEYLKLLGKGTFGKVILVKEKATGRYY 176
Query: 217 AIKVIS----LSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGS 272
A+K++ +++ E E +LQ HP + S+Q + L VMEY GG
Sbjct: 177 AMKILKKEVIVAKDEV--AHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG- 233
Query: 273 VADLMN--VTEEPLEEYQIAYICREALKGLAYLHSIFK-VHRDIKGGNILLTDQGEVKLG 329
+L E E + + E + L YLHS V+RD+K N++L G +K+
Sbjct: 234 --ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKIT 291
Query: 330 DFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRST 389
DFG+ + + + TF GTP ++APEV++++ Y VD W LGV EM G P
Sbjct: 292 DFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351
Query: 390 VHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRAR----PT-AAEMLKHKF 443
++ +I +E ++ L K+P+ R A E+++H+F
Sbjct: 352 QDHEKLFELILMEEIRF---PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-41
Identities = 88/347 (25%), Positives = 140/347 (40%), Gaps = 51/347 (14%)
Query: 135 RRSGGYDDSTMGRAVASMRRFGSSSSLHGEDVRQQTKVSSSSIPESVTREDPTTKYELLN 194
R + + + ++ S G V Y
Sbjct: 6 RTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQE-----VSYTDTK 60
Query: 195 ELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYL-- 252
+G GS+G VY+A+ + ELVAIK + + + R E++++++ H N+VR
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----R-ELQIMRKLDHCNIVRLRYF 115
Query: 253 ----GSYQGEEYLWIVMEYCGG--GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI 306
G + E YL +V++Y VA + ++ L + + + LAY+HS
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 175
Query: 307 FKVHRDIKGGNILL-TDQGEVKLGDFGVAAQLTRTMSKRNT-FIGTPHWMAPEVI-QESR 363
HRDIK N+LL D +KL DFG A QL R + N +I + ++ APE+I +
Sbjct: 176 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPELIFGATD 233
Query: 364 YDGKVDVWALGVSAVEMAEGLP--P-RSTVHP----MRVL------FMISIEPA------ 404
Y +DVW+ G E+ G P P S V ++VL + + P
Sbjct: 234 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 293
Query: 405 PMLEDKEKWSLVFH--------DFVAKCLTKEPRARPTAAEMLKHKF 443
P ++ W+ VF ++ L P AR T E H F
Sbjct: 294 PQIK-AHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-41
Identities = 67/265 (25%), Positives = 120/265 (45%), Gaps = 21/265 (7%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEG--YEEIRGEIEMLQQCSHP 246
Y + LG+GS+G V A KT + VA+K IS ++ + + EI L+ HP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN--VTEEPLEEYQIAYICREALKGLAYLH 304
++++ + +V+EY GG +L + V ++ + E + ++ + + Y H
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYAGG----ELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH 125
Query: 305 SIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRY 364
VHRD+K N+LL D VK+ DFG++ + + T G+P++ APEVI Y
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSN-IMTDGNFLKTSCGSPNYAAPEVINGKLY 184
Query: 365 DG-KVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMIS----IEPAPMLEDKEKWSLVFHD 419
G +VDVW+ G+ M G P + ++ + P + +
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQ-------S 237
Query: 420 FVAKCLTKEPRARPTAAEMLKHKFI 444
+ + + +P R T E+ + +
Sbjct: 238 LIRRMIVADPMQRITIQEIRRDPWF 262
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-41
Identities = 80/265 (30%), Positives = 125/265 (47%), Gaps = 19/265 (7%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVIS----LSEGEEGYEEIRGEIEMLQQCSH 245
++ L LGKG++G V R+ T A+K++ +++ E E +LQ H
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVLQNTRH 64
Query: 246 PNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN--VTEEPLEEYQIAYICREALKGLAYL 303
P + ++Q + L VMEY GG +L E E + + E + L YL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGG---ELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 304 HSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESR 363
HS V+RDIK N++L G +K+ DFG+ + + TF GTP ++APEV++++
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 364 YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAK 423
Y VD W LGV EM G P R+ +I +E S +A
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF---PRTLSPEAKSLLAG 238
Query: 424 CLTKEPRAR----PT-AAEMLKHKF 443
L K+P+ R P+ A E+++H+F
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRF 263
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-40
Identities = 79/288 (27%), Positives = 133/288 (46%), Gaps = 23/288 (7%)
Query: 169 QTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDL---KTSELVAIKVI---S 222
++ S + PE + E +ELL LGKG YG V++ R + T ++ A+KV+
Sbjct: 2 SSETSVNRGPEKIRPEC----FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM 57
Query: 223 LSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN--VT 280
+ + + E +L++ HP +V + ++Q L++++EY GG +L
Sbjct: 58 IVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGG---ELFMQLER 114
Query: 281 EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340
E E + E L +LH ++RD+K NI+L QG VKL DFG+ +
Sbjct: 115 EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174
Query: 341 MSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMIS 400
+ +TF GT +MAPE++ S ++ VD W+LG +M G PP + + + + I
Sbjct: 175 GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL 234
Query: 401 IEPAPMLEDKEKWSLVFHDFVAKCLTKEPRAR----PT-AAEMLKHKF 443
+ + D + K L + +R P A E+ H F
Sbjct: 235 KCKLNL---PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-40
Identities = 84/312 (26%), Positives = 139/312 (44%), Gaps = 28/312 (8%)
Query: 151 SMRRFGSSSSLHGEDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDL 210
++ G+ S E+ S S+ +D ++LL +G+GSY V R
Sbjct: 19 NLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQD----FDLLRVIGRGSYAKVLLVRLK 74
Query: 211 KTSELVAIKVIS----LSEGEEGYEEIRGEIEMLQQ-CSHPNVVRYLGSYQGEEYLWIVM 265
KT + A++V+ + + + ++ E + +Q +HP +V +Q E L+ V+
Sbjct: 75 KTDRIYAMRVVKKELVNDDEDI--DWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132
Query: 266 EYCGGGSVADLMN--VTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ 323
EY GG DLM + L E + E L YLH ++RD+K N+LL +
Sbjct: 133 EYVNGG---DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 189
Query: 324 GEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEG 383
G +KL D+G+ + R +TF GTP+++APE+++ Y VD WALGV EM G
Sbjct: 190 GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 249
Query: 384 LPPRSTVHPMRVLFMISIEP--APMLEDKEKW----SLVFHDFVAKCLTKEPRAR----- 432
P V + + +LE + + S+ + L K+P+ R
Sbjct: 250 RSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHP 309
Query: 433 -PTAAEMLKHKF 443
A++ H F
Sbjct: 310 QTGFADIQGHPF 321
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-40
Identities = 58/190 (30%), Positives = 97/190 (51%), Gaps = 5/190 (2%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS--EGEEGYEEIRGEIEMLQQCSHP 246
Y L + LG G++G V + T VA+K+++ + +IR EI+ L+ HP
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI 306
++++ +++VMEY GG + D + L+E + + ++ L G+ Y H
Sbjct: 77 HIIKLYQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDG 366
VHRD+K N+LL K+ DFG++ + T G+P++ APEVI Y G
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRTSCGSPNYAAPEVISGRLYAG 194
Query: 367 -KVDVWALGV 375
+VD+W+ GV
Sbjct: 195 PEVDIWSSGV 204
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-40
Identities = 80/284 (28%), Positives = 130/284 (45%), Gaps = 28/284 (9%)
Query: 179 ESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVIS----LSEGEEGYEEIR 234
+ + +D ++LL +G+GSY V R KT + A+KV+ + + + ++
Sbjct: 4 DPLGLQD----FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDI--DWVQ 57
Query: 235 GEIEMLQQ-CSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN--VTEEPLEEYQIAY 291
E + +Q +HP +V +Q E L+ V+EY GG DLM + L E +
Sbjct: 58 TEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARF 114
Query: 292 ICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP 351
E L YLH ++RD+K N+LL +G +KL D+G+ + R +TF GTP
Sbjct: 115 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP 174
Query: 352 HWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEP--APMLED 409
+++APE+++ Y VD WALGV EM G P V + + +LE
Sbjct: 175 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 234
Query: 410 K----EKWSLVFHDFVAKCLTKEPRAR------PTAAEMLKHKF 443
+ S+ + L K+P+ R A++ H F
Sbjct: 235 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 9e-40
Identities = 83/324 (25%), Positives = 133/324 (41%), Gaps = 63/324 (19%)
Query: 166 VRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE 225
+ KV + T E Y +G GS+G V++A+ +++ E VAIK + +
Sbjct: 18 LDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK 76
Query: 226 GEEGYEEIRGEIEMLQQCSHPNVVRYL------GSYQGEEYLWIVMEYCGG--GSVADLM 277
+ R E+++++ HPNVV G + E +L +V+EY +
Sbjct: 77 RFKN----R-ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHY 131
Query: 278 NVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL-TDQGEVKLGDFGVAAQ 336
++ + I + L+ LAY+HSI HRDIK N+LL G +KL DFG A
Sbjct: 132 AKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA-- 189
Query: 337 LTRTMSKRNTFIG---TPHWMAPEVI-QESRYDGKVDVWALGVSAVEMAE---------- 382
+ + + + ++ APE+I + Y +D+W+ G E+ +
Sbjct: 190 --KILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247
Query: 383 -----------GLPPRSTVHPMRVLFMIS----IEPAPMLEDKEKWSLVFH--------D 419
G P R + M +M I P P +S VF D
Sbjct: 248 IDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHP-------FSKVFRPRTPPDAID 300
Query: 420 FVAKCLTKEPRARPTAAEMLKHKF 443
+++ L P AR TA E L H F
Sbjct: 301 LISRLLEYTPSARLTAIEALCHPF 324
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 76/296 (25%), Positives = 125/296 (42%), Gaps = 25/296 (8%)
Query: 161 LHGEDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKAR---DLKTSELVA 217
+ G E +ELL LG+GS+G V+ + +L A
Sbjct: 1 MEGSIKEIAITHHVKEGHEKADPSQ----FELLKVLGQGSFGKVFLVKKISGSDARQLYA 56
Query: 218 IKVI---SLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVA 274
+KV+ +L + + E ++L + +HP +V+ ++Q E L++++++ GG
Sbjct: 57 MKVLKKATLKVRDR--VRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGG--- 111
Query: 275 DLMN--VTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFG 332
DL E E + + E L +LHS+ ++RD+K NILL ++G +KL DFG
Sbjct: 112 DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG 171
Query: 333 VAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHP 392
++ + K +F GT +MAPEV+ + D W+ GV EM G P
Sbjct: 172 LSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR 231
Query: 393 MRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRAR----PTAAEMLK-HKF 443
+ MI M + S + + P R P E +K H F
Sbjct: 232 KETMTMILKAKLGM---PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-39
Identities = 79/302 (26%), Positives = 126/302 (41%), Gaps = 57/302 (18%)
Query: 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVIS-----LSEGEEGYEEIRGEIEMLQ 241
Y +G G+YG+V A D ++ E VAIK +S + Y E+ +L+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL----LLK 78
Query: 242 QCSHPNVVRYL------GSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICRE 295
H NV+ L S + ++VM + DL + E +I Y+ +
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TDLQKIMGLKFSEEKIQYLVYQ 134
Query: 296 ALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT-FIGTPHWM 354
LKGL Y+HS VHRD+K GN+ + + E+K+ DFG L R T ++ T +
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG----LARHADAEMTGYVVTRWYR 190
Query: 355 APEVIQES-RYDGKVDVWALGVSAVEMAEG---LPPRSTVHPMRVLFMISIEPAPMLED- 409
APEVI Y+ VD+W++G EM G + + + ++ + P E
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ--ILKVTGVPGTEFV 248
Query: 410 -------------------KEKWSLVFH-------DFVAKCLTKEPRARPTAAEMLKHKF 443
++ ++ +F D + K L + R TAA+ L H F
Sbjct: 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308
Query: 444 IE 445
E
Sbjct: 309 FE 310
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-39
Identities = 83/324 (25%), Positives = 143/324 (44%), Gaps = 31/324 (9%)
Query: 141 DDSTMGRAVASMRRFGSSSSLHGEDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGS 200
+ + G A + G + + + E V E+ +ELL LG G+
Sbjct: 11 EGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIEN----FELLKVLGTGA 66
Query: 201 YGAVYKARDL---KTSELVAIKVI---SLSEGEEGYEEIRGEIEMLQQCSH-PNVVRYLG 253
YG V+ R + T +L A+KV+ ++ + + E R E ++L+ P +V
Sbjct: 67 YGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY 126
Query: 254 SYQGEEYLWIVMEYCGGGSVADLMN--VTEEPLEEYQIAYICREALKGLAYLHSIFKVHR 311
++Q E L ++++Y GG +L E E+++ E + L +LH + ++R
Sbjct: 127 AFQTETKLHLILDYINGG---ELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYR 183
Query: 312 DIKGGNILLTDQGEVKLGDFGVA-AQLTRTMSKRNTFIGTPHWMAPEVIQESR--YDGKV 368
DIK NILL G V L DFG++ + + F GT +MAP++++ +D V
Sbjct: 184 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV 243
Query: 369 DVWALGVSAVEMAEGLPP---RSTVHPMRVLF-MISIEPAPMLEDKEKWSLVFHDFVAKC 424
D W+LGV E+ G P + + I P ++ S + D + +
Sbjct: 244 DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY---PQEMSALAKDLIQRL 300
Query: 425 LTKEPRAR----PT-AAEMLKHKF 443
L K+P+ R P A E+ +H F
Sbjct: 301 LMKDPKKRLGCGPRDADEIKEHLF 324
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-39
Identities = 69/230 (30%), Positives = 111/230 (48%), Gaps = 16/230 (6%)
Query: 164 EDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVIS- 222
++ ++ + + ++ +E + LGKGS+G V AR +T +L A+KV+
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDN----FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKK 58
Query: 223 ---LSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN 278
L + + E E +L +HP + + +Q + L+ VME+ GG DLM
Sbjct: 59 DVILQDDD--VECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGG---DLMF 113
Query: 279 --VTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQ 336
+E + + E + L +LH ++RD+K N+LL +G KL DFG+ +
Sbjct: 114 HIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173
Query: 337 LTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPP 386
TF GTP ++APE++QE Y VD WA+GV EM G P
Sbjct: 174 GICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 6e-39
Identities = 81/283 (28%), Positives = 125/283 (44%), Gaps = 20/283 (7%)
Query: 169 QTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVIS----LS 224
+ S+ + ED + L LGKGS+G V+ A KT++ AIK + L
Sbjct: 2 ELNKERPSLQIKLKIED----FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM 57
Query: 225 EGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN--VTE 281
+ + E E +L HP + ++Q +E L+ VMEY GG DLM +
Sbjct: 58 DDDV--ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGG---DLMYHIQSC 112
Query: 282 EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341
+ + + E + GL +LHS V+RD+K NILL G +K+ DFG+ +
Sbjct: 113 HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172
Query: 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI 401
+K NTF GTP ++APE++ +Y+ VD W+ GV EM G P + I +
Sbjct: 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 232
Query: 402 EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK-HKF 443
+ D + K +EP R ++ H
Sbjct: 233 DNPFY---PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 152 bits (384), Expect = 1e-38
Identities = 66/236 (27%), Positives = 106/236 (44%), Gaps = 14/236 (5%)
Query: 157 SSSSLHGEDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELV 216
+ + + +K ++ + + D + L LGKGS+G V + T EL
Sbjct: 314 GTKAPEEKTANTISKFDNNGNRDRMKLTD----FNFLMVLGKGSFGKVMLSERKGTDELY 369
Query: 217 AIKVIS---LSEGEEGYEEIRGEIEMLQQ-CSHPNVVRYLGSYQGEEYLWIVMEYCGGGS 272
A+K++ + + ++ E E +L P + + +Q + L+ VMEY GG
Sbjct: 370 AVKILKKDVVIQDDD-VECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG- 427
Query: 273 VADLMN--VTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGD 330
DLM +E + E GL +L S ++RD+K N++L +G +K+ D
Sbjct: 428 --DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIAD 485
Query: 331 FGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPP 386
FG+ + TF GTP ++APE+I Y VD WA GV EM G P
Sbjct: 486 FGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-38
Identities = 86/304 (28%), Positives = 126/304 (41%), Gaps = 24/304 (7%)
Query: 156 GSSSSLHGEDVRQQTKVSSSSIPESVTREDPTTKY-----ELLNELGKGSYGAVYKARDL 210
G S E + + + L +GKGS+G V AR
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHK 60
Query: 211 KTSELVAIKVIS----LSEGEEGYEEIRGEIEML-QQCSHPNVVRYLGSYQGEEYLWIVM 265
A+KV+ L + EE + I E +L + HP +V S+Q + L+ V+
Sbjct: 61 AEEVFYAVKVLQKKAILKKKEE--KHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118
Query: 266 EYCGGGSVADLMN--VTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ 323
+Y GG +L E E + + E L YLHS+ V+RD+K NILL Q
Sbjct: 119 DYINGG---ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ 175
Query: 324 GEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEG 383
G + L DFG+ + S +TF GTP ++APEV+ + YD VD W LG EM G
Sbjct: 176 GHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235
Query: 384 LPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRAR----PTAAEML 439
LPP + + + I +P + K + + L K+ R E+
Sbjct: 236 LPPFYSRNTAEMYDNILNKPLQL---KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 292
Query: 440 KHKF 443
H F
Sbjct: 293 SHVF 296
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-38
Identities = 68/284 (23%), Positives = 120/284 (42%), Gaps = 22/284 (7%)
Query: 170 TKVSSSSIPESVTRED---PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG 226
TK S + +V ++ L ++G+G++G V+ R + LVA+K +
Sbjct: 93 TKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP 152
Query: 227 EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEE 286
+ + E +L+Q SHPN+VR +G ++ ++IVME GG + L
Sbjct: 153 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV 212
Query: 287 YQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346
+ + +A G+ YL S +HRD+ N L+T++ +K+ DFG ++R +
Sbjct: 213 KTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFG----MSREEADGVY 268
Query: 347 FIGTPH------WMAPEVIQESRYDGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMI 399
W APE + RY + DVW+ G+ E + G P + + +
Sbjct: 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV 328
Query: 400 SIE---PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440
P P E + +C EP RP+ + + +
Sbjct: 329 EKGGRLPCP-----ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-38
Identities = 66/223 (29%), Positives = 103/223 (46%), Gaps = 14/223 (6%)
Query: 170 TKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVIS---LSEG 226
+K ++ + + D + L LGKGS+G V + T EL A+K++ + +
Sbjct: 6 SKFDNNGNRDRMKLTD----FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD 61
Query: 227 EEGYEEIRGEIEMLQQ-CSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN--VTEEP 283
++ E E +L P + + +Q + L+ VMEY GG DLM
Sbjct: 62 DD-VECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG---DLMYHIQQVGR 117
Query: 284 LEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343
+E + E GL +L S ++RD+K N++L +G +K+ DFG+ +
Sbjct: 118 FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 177
Query: 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPP 386
TF GTP ++APE+I Y VD WA GV EM G P
Sbjct: 178 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-38
Identities = 66/301 (21%), Positives = 120/301 (39%), Gaps = 32/301 (10%)
Query: 161 LHGEDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKV 220
+ + + + + + +T D + + +G+G +G VY R T ++ A+K
Sbjct: 166 IESDKFTRFCQWKNVELNIHLTMND----FSVHRIIGRGGFGEVYGCRKADTGKMYAMKC 221
Query: 221 ISLSE--GEEGYEEIRGEIEMLQQCS---HPNVVRYLGSYQGEEYLWIVMEYCGGGSVAD 275
+ ++G E ML S P +V ++ + L +++ GG D
Sbjct: 222 LDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG---D 278
Query: 276 LMN--VTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGV 333
L E + + E + GL ++H+ F V+RD+K NILL + G V++ D G+
Sbjct: 279 LHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL 338
Query: 334 AAQLTRTMSKRNTFIGTPHWMAPEVIQ-ESRYDGKVDVWALGVSAVEMAEGLPP-RSTVH 391
A ++ K + +GT +MAPEV+Q YD D ++LG ++ G P R
Sbjct: 339 ACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396
Query: 392 PMRVLFMISIEPAPMLEDKEKWSLVF----HDFVAKCLTKEPRAR----PTAAEMLK-HK 442
+ L + F + L ++ R A+ +K
Sbjct: 397 KDKHEIDRMT-----LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451
Query: 443 F 443
F
Sbjct: 452 F 452
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-38
Identities = 70/307 (22%), Positives = 126/307 (41%), Gaps = 54/307 (17%)
Query: 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHP 246
++ ++L + LG+G+YG V A T E+VAIK I + EI++L+ H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 247 NVVRYL-----GSYQGEEYLWIVMEYCGGGSVADLMNV-TEEPLEEYQIAYICREALKGL 300
N++ S++ ++I+ E DL V + + L + I Y + L+ +
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWM------ 354
LH +HRD+K N+L+ ++K+ DFG+A + + + + G M
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 355 ----APEVI-QESRYDGKVDVWALGVSAVEMAEG---LPPRSTVHPMRVLFMISIEPAPM 406
APEV+ ++Y +DVW+ G E+ P R H + + + I P
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL--IFGIIGTPH 243
Query: 407 LED---------------------KEKWSLVFH-------DFVAKCLTKEPRARPTAAEM 438
++ +F D + + L +P R TA E
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 439 LKHKFIE 445
L+H +++
Sbjct: 304 LEHPYLQ 310
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 70/297 (23%), Positives = 122/297 (41%), Gaps = 48/297 (16%)
Query: 175 SSIPESVTREDPT----TKYELLNELGKGSYGAVYKAR----DLKTSELVAIKVISLSEG 226
S + T DPT + + +LG+G +G V R T E VA+K + G
Sbjct: 4 VSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG 63
Query: 227 EEGYEEIRGEIEMLQQCSHPNVVRYLG--SYQGEEYLWIVMEYCGGGSVADLMNVTEEPL 284
+++ EIE+L+ H N+V+Y G + G + ++ME+ GS+ + + + +
Sbjct: 64 GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI 123
Query: 285 EEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344
Q + KG+ YL S VHRD+ N+L+ + +VK+GDFG LT+ +
Sbjct: 124 NLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG----LTKAIETD 179
Query: 345 NTFIGTPH-------WMAPEVIQESRYDGKVDVWALGV---------------SAVEMAE 382
+ W APE + +S++ DVW+ GV A+ +
Sbjct: 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKM 239
Query: 383 GLPPRSTVHPMRVLFMISIE-----PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPT 434
P + R++ ++ P P + + KC +P R +
Sbjct: 240 IGPTHGQMTVTRLVNT--LKEGKRLPCP-----PNCPDEVYQLMRKCWEFQPSNRTS 289
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-38
Identities = 75/316 (23%), Positives = 127/316 (40%), Gaps = 73/316 (23%)
Query: 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVIS-----LSEGEEGYEEIRGEIEMLQ 241
+Y+ L +G G+ G V A D VAIK +S + + Y E+ +++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV----LMK 79
Query: 242 QCSHPNVVRYL------GSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICRE 295
+H N++ L S + + ++IVME A+L V + L+ +++Y+ +
Sbjct: 80 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQ 135
Query: 296 ALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWM- 354
L G+ +LHS +HRD+K NI++ +K+ DFG L RT +F+ TP+ +
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMTPYVVT 189
Query: 355 ----APEVIQESRYDGKVDVWALGVSAVEMAEG---LPPRSTVHPMRVLFMISIEPAPML 407
APEVI Y VD+W++G EM +G P + +I P
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK--VIEQLGTPCP 247
Query: 408 ED-------------------KEKWSLVFH-------------------DFVAKCLTKEP 429
E + +F D ++K L +
Sbjct: 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 307
Query: 430 RARPTAAEMLKHKFIE 445
R + E L+H +I
Sbjct: 308 SKRISVDEALQHPYIN 323
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 81/313 (25%), Positives = 128/313 (40%), Gaps = 64/313 (20%)
Query: 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHP 246
++Y L LG G G V+ A D + VAIK I L++ + +R EI+++++ H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHD 68
Query: 247 NVVR--------------YLGSYQGEEYLWIVMEYCGGGSVADLMNVTE-EPLEEYQIAY 291
N+V+ +GS ++IV EY DL NV E PL E
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME----TDLANVLEQGPLLEEHARL 124
Query: 292 ICREALKGLAYLHSIFKVHRDIKGGNILL-TDQGEVKLGDFGVAAQLTRTMSKRNTFIG- 349
+ L+GL Y+HS +HRD+K N+ + T+ +K+GDFG L R M + G
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFG----LARIMDPHYSHKGH 180
Query: 350 ------TPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEG---LPPRSTVHPMRVLFMI 399
T + +P ++ Y +D+WA G EM G + M++ ++
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL--IL 238
Query: 400 SIEPAPMLED-------------------KEKWSLVFH-------DFVAKCLTKEPRARP 433
P ED + + + DF+ + LT P R
Sbjct: 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL 298
Query: 434 TAAEMLKHKFIER 446
TA E L H ++
Sbjct: 299 TAEEALSHPYMSI 311
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 71/313 (22%), Positives = 111/313 (35%), Gaps = 66/313 (21%)
Query: 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEI-----------RG 235
+ Y + + GSYGAV D VAIK + + + I R
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR- 78
Query: 236 EIEMLQQCSHPNVVRYL-----GSYQGEEYLWIVMEYCGGGSVADLMNV---TEEPLEEY 287
EI +L HPN++ L++V E DL V +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR----TDLAQVIHDQRIVISPQ 134
Query: 288 QIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT- 346
I Y L GL LH VHRD+ GNILL D ++ + DF +A R +
Sbjct: 135 HIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA----REDTADANK 190
Query: 347 --FIGTPHWMAPEVI-QESRYDGKVDVWALGVSAVEMAEG---LPPRSTVHPMRVLFMIS 400
++ + APE++ Q + VD+W+ G EM + + + ++
Sbjct: 191 THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK--IVE 248
Query: 401 IEPAPMLED---------------------KEKWSLVFH-------DFVAKCLTKEPRAR 432
+ P +ED W+ V D +AK L P+ R
Sbjct: 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR 308
Query: 433 PTAAEMLKHKFIE 445
+ + L+H + E
Sbjct: 309 ISTEQALRHPYFE 321
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 64/326 (19%), Positives = 126/326 (38%), Gaps = 74/326 (22%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS---- 244
+Y L+ +LG G + V+ A+D+ + VA+K++ + E EI++LQ+ +
Sbjct: 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV--RGDKVYTEAAEDEIKLLQRVNDADN 77
Query: 245 -------HPNVVRYLGS--YQGEEY--LWIVMEYCGGGSVADLMNVTEE-PLEEYQIAYI 292
++++ L ++G + +V E G ++ L+ E + + I
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQI 136
Query: 293 CREALKGLAYLHSIFKV-HRDIKGGNILL------TDQGEVKLGDFGVAAQLTRTMSKRN 345
++ L GL Y+H + H DIK N+L+ + ++K+ D G A +
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT--- 193
Query: 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGL---PPRSTVHPMRVLFMIS-- 400
I T + +PEV+ + + D+W+ E+ G P + I+
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
Query: 401 IE-----PAPMLEDKEK-------------------WSL----------------VFHDF 420
IE P+ +L + + W L DF
Sbjct: 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 313
Query: 421 VAKCLTKEPRARPTAAEMLKHKFIER 446
++ L +PR R A ++ H +++
Sbjct: 314 LSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-37
Identities = 72/323 (22%), Positives = 131/323 (40%), Gaps = 51/323 (15%)
Query: 165 DVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS 224
+ ++++ E +E ++++ G+G++G V ++ T VAIK + +
Sbjct: 2 PGSMMSLNAAAAADERSRKE--MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQ 58
Query: 225 EGEEGYEEIRGEIEMLQQCSHPNVVR-------YLGSYQGEEYLWIVMEYCGG--GSVAD 275
+ E++ ++ L HPN+V+ + + YL +VMEY
Sbjct: 59 DPRFRNRELQ-IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCR 117
Query: 276 LMNVTEEPLEEYQIAYICREALKGLAYLH--SIFKVHRDIKGGNILL-TDQGEVKLGDFG 332
+ I + ++ + LH S+ HRDIK N+L+ G +KL DFG
Sbjct: 118 NYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG 177
Query: 333 VAAQLTRTMSKRNT-FIGTPHWMAPEVIQESR-YDGKVDVWALGVSAVEMAEGLP--P-R 387
A +L+ + N +I + ++ APE+I ++ Y VD+W++G EM G P
Sbjct: 178 SAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235
Query: 388 STVHP----MRVL------FMISIEPA------PMLEDKEKWSLVFH-----------DF 420
++ +RVL + + P+ + WS VF D
Sbjct: 236 NSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSK-GIPWSNVFSDHSLKDAKEAYDL 294
Query: 421 VAKCLTKEPRARPTAAEMLKHKF 443
++ L P R E L H +
Sbjct: 295 LSALLQYLPEERMKPYEALCHPY 317
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-37
Identities = 79/363 (21%), Positives = 142/363 (39%), Gaps = 76/363 (20%)
Query: 144 TMGRAVASMRRFGSSSSLHGEDVRQQTKVSSSSIPESVTREDP-------TTKYELLNEL 196
T+ +A + G + + + +S S + + +Y+ L +
Sbjct: 13 TLDVKIAFCQ--GFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPI 70
Query: 197 GKGSYGAVYKARDLKTSELVAIKVIS-----LSEGEEGYEEIRGEIEMLQQCSHPNVVRY 251
G G+ G V A D VAIK +S + + Y E+ +++ +H N++
Sbjct: 71 GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV----LMKCVNHKNIISL 126
Query: 252 L------GSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS 305
L + + + +++VME A+L V + L+ +++Y+ + L G+ +LHS
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 182
Query: 306 IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT---FIGTPHWMAPEVIQES 362
+HRD+K NI++ +K+ DFG L RT ++ T ++ APEVI
Sbjct: 183 AGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAGTSFMMTPYVVTRYYRAPEVILGM 238
Query: 363 RYDGKVDVWALGVSAVEMAEG---LPPRSTVH---------------------------- 391
Y VD+W++G EM P R +
Sbjct: 239 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 298
Query: 392 ---------PMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHK 442
LF S+ PA +K K + D ++K L +P R + + L+H
Sbjct: 299 ENRPKYAGLTFPKLFPDSLFPADSEHNKLK-ASQARDLLSKMLVIDPAKRISVDDALQHP 357
Query: 443 FIE 445
+I
Sbjct: 358 YIN 360
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 30/253 (11%), Positives = 62/253 (24%), Gaps = 36/253 (14%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVI--SLSEGEEGYEEIRGEIEMLQQCSHPN 247
Y LL G ++A D VA+ + ++ +E L + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307
V R L +V E+ GGS+ ++ + + H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAHRAG 149
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGK 367
+ ++ G+V L + +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPATMPDA---------------------------NPQ 182
Query: 368 VDVWALGVSAVEMAEGLPP---RSTVHPMRVLFM-ISIEPAPMLEDKEKWSLVFHDFVAK 423
D+ +G S + P + + +P + A+
Sbjct: 183 DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAAR 242
Query: 424 CLTKEPRARPTAA 436
+ + R +
Sbjct: 243 SVQGDGGIRSAST 255
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 65/297 (21%), Positives = 128/297 (43%), Gaps = 49/297 (16%)
Query: 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQ-CSH 245
Y+L+ +LG+G Y V++A ++ +E V +K++ ++I+ EI++L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGG 90
Query: 246 PNVVRYLG--SYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYL 303
PN++ +V E+ D + + L +Y I + E LK L Y
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNN---TDFKQLY-QTLTDYDIRFYMYEILKALDYC 146
Query: 304 HSIFKVHRDIKGGNILL-TDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQES 362
HS+ +HRD+K N+++ + +++L D+G+ A+ + N + + ++ PE++ +
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPELLVDY 205
Query: 363 R-YDGKVDVWALGVSAVEMAEGLPP----RSTVH-------------PMRVLFMISIEPA 404
+ YD +D+W+LG M P + +IE
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265
Query: 405 PMLED------KEKWSLVFH------------DFVAKCLTKEPRARPTAAEMLKHKF 443
P D +++W H DF+ K L + ++R TA E ++H +
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-36
Identities = 79/303 (26%), Positives = 127/303 (41%), Gaps = 58/303 (19%)
Query: 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVIS-----LSEGEEGYEEIRGEIEMLQ 241
Y L +G G+YGAV A D +T VAIK + + Y E+R +L+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLK 79
Query: 242 QCSHPNVVRYL------GSYQGEEYLWIVMEYCGGGSVADLMNV-TEEPLEEYQIAYICR 294
H NV+ L + ++VM + G DL + E L E +I ++
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG----TDLGKLMKHEKLGEDRIQFLVY 135
Query: 295 EALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT-FIGTPHW 353
+ LKGL Y+H+ +HRD+K GN+ + + E+K+ DFG+A R T ++ T +
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA----RQADSEMTGYVVTRWY 191
Query: 354 MAPEVI-QESRYDGKVDVWALGVSAVEMAEG---LPPRSTVHPMRVLFMISIEPAPMLED 409
APEVI RY VD+W++G EM G + ++ ++ + P E
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE--IMKVTGTPPAEF 249
Query: 410 --------------------KEKWSLVFH-------DFVAKCLTKEPRARPTAAEMLKHK 442
K+ ++ + + + K L + R TA E L H
Sbjct: 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309
Query: 443 FIE 445
+ E
Sbjct: 310 YFE 312
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 74/309 (23%), Positives = 128/309 (41%), Gaps = 38/309 (12%)
Query: 158 SSSLHGEDVRQQTKVSSSSIPESVTREDPT----TKYELLNELGKGSYGAVYKAR----D 209
+ + ++ + DPT + L +LGKG++G+V R
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQ 66
Query: 210 LKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLG--SYQGEEYLWIVMEY 267
T E+VA+K + EE + EIE+L+ H N+V+Y G G L ++MEY
Sbjct: 67 DNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 125
Query: 268 CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVK 327
GS+ D + +E ++ ++ + KG+ YL + +HRD+ NIL+ ++ VK
Sbjct: 126 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 185
Query: 328 LGDFGVAAQLTRTMSKRNTFIGTPH-------WMAPEVIQESRYDGKVDVWALGVSAVEM 380
+GDFG LT+ + + + W APE + ES++ DVW+ GV E+
Sbjct: 186 IGDFG----LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 241
Query: 381 AEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLV---------------FHDFVAKCL 425
+S P + MI + + L+ + + +C
Sbjct: 242 FT-YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECW 300
Query: 426 TKEPRARPT 434
RP+
Sbjct: 301 NNNVNQRPS 309
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-36
Identities = 75/302 (24%), Positives = 134/302 (44%), Gaps = 56/302 (18%)
Query: 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVI-----SLSEGEEGYEEIRGEIEMLQ 241
+Y+ L+ +G G+YG+V A D KT VA+K + S+ + Y E+R +L+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR----LLK 83
Query: 242 QCSHPNVVRYL------GSYQGEEYLWIVMEYCGGGSVADLMNV-TEEPLEEYQIAYICR 294
H NV+ L S + +++V G ADL N+ + L + + ++
Sbjct: 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIY 139
Query: 295 EALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWM 354
+ L+GL Y+HS +HRD+K N+ + + E+K+ DFG+A M+ ++ T +
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG---YVATRWYR 196
Query: 355 APEVIQES-RYDGKVDVWALGVSAVEMAEG---LPPRSTVHPMRVLFMISIEPAPMLED- 409
APE++ Y+ VD+W++G E+ G P + +++ ++ + P E
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL--ILRLVGTPGAELL 254
Query: 410 -------------------KEKWSLVFH-------DFVAKCLTKEPRARPTAAEMLKHKF 443
K ++ VF D + K L + R TAA+ L H +
Sbjct: 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314
Query: 444 IE 445
Sbjct: 315 FA 316
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-36
Identities = 78/325 (24%), Positives = 132/325 (40%), Gaps = 56/325 (17%)
Query: 167 RQQTKVSSSSIPESV--TREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS 224
++++ PE V D +Y L+ +G+G+YG V A D VAIK IS
Sbjct: 4 HHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF 63
Query: 225 EGEEGYEEIRGEIEMLQQCSHPNVVRYL-----GSYQGEEYLWIVMEYCGGGSVADLMNV 279
E + + EI++L + H N++ + + + ++IV + DL +
Sbjct: 64 EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME----TDLYKL 119
Query: 280 TE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338
+ + L I Y + L+GL Y+HS +HRD+K N+LL ++K+ DFG L
Sbjct: 120 LKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG----LA 175
Query: 339 RTMSKRNTFIG-------TPHWMAPEVI-QESRYDGKVDVWALGVSAVEMAEG---LPPR 387
R + G T + APE++ Y +D+W++G EM P +
Sbjct: 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 235
Query: 388 STVHPMRVLFMISIEPAPMLEDKEK--------------------WSLVFH-------DF 420
+ + ++ I +P ED W+ +F D
Sbjct: 236 HYLDQLNH--ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 293
Query: 421 VAKCLTKEPRARPTAAEMLKHKFIE 445
+ K LT P R + L H ++E
Sbjct: 294 LDKMLTFNPHKRIEVEQALAHPYLE 318
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 34/280 (12%)
Query: 183 REDPTTKYELLNELGKGSYGAVYKAR----DLKTSELVAIKVISLSEGEEGYEEIRGEIE 238
+ + L +LGKG++G+V R T E+VA+K + EE + EIE
Sbjct: 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIE 63
Query: 239 MLQQCSHPNVVRYLG--SYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREA 296
+L+ H N+V+Y G G L ++MEY GS+ D + +E ++ ++ +
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 297 LKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH---- 352
KG+ YL + +HRD+ NIL+ ++ VK+GDFG LT+ + + F
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG----LTKVLPQDKEFFKVKEPGES 179
Query: 353 ---WMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLED 409
W APE + ES++ DVW+ GV E+ +S P + MI + +
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFT-YIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 410 KEKWSLV---------------FHDFVAKCLTKEPRARPT 434
L+ + + +C RP+
Sbjct: 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPS 278
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 63/278 (22%), Positives = 113/278 (40%), Gaps = 31/278 (11%)
Query: 183 REDPTTKYELLNELGKGSYGAVYKAR----DLKTSELVAIKVISLSEGEEGYEEIRGEIE 238
+ +++LGKG++G+V R T LVA+K + G + + + EI+
Sbjct: 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQ 76
Query: 239 MLQQCSHPNVVRYLG--SYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREA 296
+L+ +V+Y G G + L +VMEY G + D + L+ ++ +
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI 136
Query: 297 LKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM-SKRNTFIGTPH--- 352
KG+ YL S VHRD+ NIL+ + VK+ DFG L + + ++ ++
Sbjct: 137 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG----LAKLLPLDKDYYVVREPGQS 192
Query: 353 ---WMAPEVIQESRYDGKVDVWALGVSAVEMA-------EGLPPRSTVHPMRVLFMISIE 402
W APE + ++ + + DVW+ GV E+ +
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 403 PAPMLEDK------EKWSLVFHDFVAKCLTKEPRARPT 434
+LE+ H+ + C P+ RP+
Sbjct: 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPS 290
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 63/272 (23%), Positives = 112/272 (41%), Gaps = 28/272 (10%)
Query: 179 ESVTREDPTTKYELLNELGKGSYGAVYKAR----DLKTSELVAIKVISLSEGEEGYEEIR 234
+++ R T+++ + LG G++G VYK K VAIK + + + +EI
Sbjct: 6 QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 65
Query: 235 GEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICR 294
E ++ +P+V R LG + ++ + G + D + ++ + + C
Sbjct: 66 DEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 295 EALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH-- 352
+ KG+ YL VHRD+ N+L+ VK+ DFG L + +
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG----LAKLLGAEEKEYHAEGGK 180
Query: 353 ----WMAPEVIQESRYDGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMISIE----- 402
WMA E I Y + DVW+ GV+ E M G P + + + +E
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI--LEKGERL 238
Query: 403 PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPT 434
P P + ++ + + KC + +RP
Sbjct: 239 PQPPI-----CTIDVYMIMRKCWMIDADSRPK 265
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 62/273 (22%), Positives = 104/273 (38%), Gaps = 19/273 (6%)
Query: 175 SSIPESVTREDPTTKYELLNELGKGSYGAVYKAR---DLKTSELVAIKVISLSEGEEGYE 231
+ V + +G+G +G VY + A+K ++
Sbjct: 12 VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS 71
Query: 232 EIRGEIEMLQQCSHPNVVRYLG-SYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIA 290
+ E +++ SHPNV+ LG + E +V+ Y G + + + +
Sbjct: 72 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 131
Query: 291 YICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350
+ KG+ YL S VHRD+ N +L ++ VK+ DFG L R M + +
Sbjct: 132 GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFG----LARDMYDKEYYSVH 187
Query: 351 PH--------WMAPEVIQESRYDGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMISI 401
WMA E +Q ++ K DVW+ GV E M G PP V+ + +
Sbjct: 188 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY--L 245
Query: 402 EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPT 434
L E ++ + KC + RP+
Sbjct: 246 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPS 278
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-35
Identities = 62/333 (18%), Positives = 127/333 (38%), Gaps = 84/333 (25%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC 243
E + KY L LG GS+G V + D+++ + A+K + ++ + R E+++++
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL----QDPRYKNR-ELDIMKVL 57
Query: 244 SHPNVVR--------------------------------------YLGSYQGEEYLWIVM 265
H N+++ + + +YL ++M
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 266 EYCGGGSVADLMNV------TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNIL 319
EY L V + + I+ + + + ++HS+ HRDIK N+L
Sbjct: 118 EYVP----DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL 173
Query: 320 L-TDQGEVKLGDFGVAAQLTRTMSKRNT-FIGTPHWMAPEVI-QESRYDGKVDVWALGVS 376
+ + +KL DFG A +L + + + +I + + APE++ + Y +D+W++G
Sbjct: 174 VNSKDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231
Query: 377 AVEMAEGLP--P-RSTVHP----MRVL---------FMISIEPAPMLEDKEK--WSLVFH 418
E+ G P +++ ++++ M + W +
Sbjct: 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILP 291
Query: 419 --------DFVAKCLTKEPRARPTAAEMLKHKF 443
D + + L EP R E + H F
Sbjct: 292 EGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF 324
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 183 REDPTTKYELLNELGKGSYGAVYKAR----DLKTSELVAIKVISLSEGEEGYEEIRGEIE 238
+ + +LG+G +G V + T E+VA+K + G + + EI+
Sbjct: 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEID 85
Query: 239 MLQQCSHPNVVRYLG--SYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEE-----YQIAY 291
+L+ H ++++Y G G L +VMEY GS+ D + L + QI
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQIC- 144
Query: 292 ICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP 351
+G+AYLH+ +HRD+ N+LL + VK+GDFG L + + + + +
Sbjct: 145 ------EGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG----LAKAVPEGHEYYRVR 194
Query: 352 H-------WMAPEVIQESRYDGKVDVWALGVSAVEM 380
W APE ++E ++ DVW+ GV+ E+
Sbjct: 195 EDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 230
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-34
Identities = 72/336 (21%), Positives = 122/336 (36%), Gaps = 79/336 (23%)
Query: 178 PESVTREDPTTKYELLNE-LGKGSYGAVYKAR--DLKTSELVAIKVISLSEGEEGYEE-- 232
S RE +E +G+G+YG VYKA+ D K + A+K I G
Sbjct: 10 KLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI----EGTGISMSA 65
Query: 233 IRGEIEMLQQCSHPNVVRYLG--SYQGEEYLWIVMEYCGGGSVADLM-----------NV 279
R EI +L++ HPNV+ + +W++ +Y DL N
Sbjct: 66 CR-EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANK 120
Query: 280 TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLT----DQGEVKLGDFGVA- 334
L + + + L G+ YLH+ + +HRD+K NIL+ ++G VK+ D G A
Sbjct: 121 KPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180
Query: 335 --AQLTRTMSKRNTFIGTPHWMAPEVIQESR-YDGKVDVWALGVSAVEMAEGLP------ 385
+ ++ + + T + APE++ +R Y +D+WA+G E+ P
Sbjct: 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240
Query: 386 ---PRSTVHPMRVLFMI--------------------------SIEPAPMLEDKEKWSLV 416
S + L I +
Sbjct: 241 EDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYME 300
Query: 417 FH---------DFVAKCLTKEPRARPTAAEMLKHKF 443
H + K LT +P R T+ + ++ +
Sbjct: 301 KHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-34
Identities = 68/317 (21%), Positives = 117/317 (36%), Gaps = 25/317 (7%)
Query: 137 SGGYDDSTMGRAVASMRRFGSSSSLHGEDVRQQTKVSSSSIPE------SVTREDPTTKY 190
G ++ S+ + S +L+ + S+ PE V +
Sbjct: 32 PGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIV 91
Query: 191 ELLNELGKGSYGAVYKAR---DLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPN 247
+G+G +G VY + A+K ++ + E +++ SHPN
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 248 VVRYLG-SYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI 306
V+ LG + E +V+ Y G + + + + + KG+ +L S
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 211
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH--------WMAPEV 358
VHRD+ N +L ++ VK+ DFG L R M + WMA E
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFG----LARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 359 IQESRYDGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVF 417
+Q ++ K DVW+ GV E M G PP V+ + + L E
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY--LLQGRRLLQPEYCPDPL 325
Query: 418 HDFVAKCLTKEPRARPT 434
++ + KC + RP+
Sbjct: 326 YEVMLKCWHPKAEMRPS 342
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-34
Identities = 69/321 (21%), Positives = 124/321 (38%), Gaps = 71/321 (22%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQ------ 242
+YE+L +GKGS+G V KA D K + VA+K++ + + + EI +L+
Sbjct: 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR--NEKRFHRQAAEEIRILEHLRKQDK 155
Query: 243 CSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLA 301
+ NV+ L ++ ++ + E ++ +L+ + + + L+ L
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 302 YLHSIFKVHRDIKGGNILLTDQG--EVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVI 359
LH +H D+K NILL QG +K+ DFG + + + T+I + + APEVI
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY---TYIQSRFYRAPEVI 271
Query: 360 QESRYDGKVDVWALGVSAVEMA---------------------EGLPPRSTVH------- 391
+RY +D+W+LG E+ G+P + +
Sbjct: 272 LGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKN 331
Query: 392 ---------------------------PMRVLFMISIEPAPMLEDKEKWS-LVFHDFVAK 423
R E + +F DF+ +
Sbjct: 332 FVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQ 391
Query: 424 CLTKEPRARPTAAEMLKHKFI 444
CL +P R T + L+H ++
Sbjct: 392 CLEWDPAVRMTPGQALRHPWL 412
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-34
Identities = 67/268 (25%), Positives = 105/268 (39%), Gaps = 24/268 (8%)
Query: 182 TREDPTTKYELLNELGKGSYGAVYKAR----DLKTSELVAIKVISLSEGEEGYEEIRGEI 237
T E + +G G +G VYK K VAIK + E+ + GE
Sbjct: 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 97
Query: 238 EMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREAL 297
++ Q SH N++R G + + I+ EY G++ + + Q+ + R
Sbjct: 98 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 157
Query: 298 KGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH----- 352
G+ YL ++ VHRD+ NIL+ K+ DFG L+R + T
Sbjct: 158 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG----LSRVLEDDPEATYTTSGGKIP 213
Query: 353 --WMAPEVIQESRYDGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMISIE---PAPM 406
W APE I ++ DVW+ G+ E M G P + V+ I+ P PM
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM 273
Query: 407 LEDKEKWSLVFHDFVAKCLTKEPRARPT 434
+ + +C +E RP
Sbjct: 274 -----DCPSAIYQLMMQCWQQERARRPK 296
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-34
Identities = 65/254 (25%), Positives = 107/254 (42%), Gaps = 23/254 (9%)
Query: 191 ELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVR 250
+ E+G G +G V+ + VAIK + EG E+ E E++ + SHP +V+
Sbjct: 11 TFVQEIGSGQFGLVHLGY-WLNKDKVAIKT--IREGAMSEEDFIEEAEVMMKLSHPKLVQ 67
Query: 251 YLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVH 310
G + + +V E+ G ++D + + +C + +G+AYL +H
Sbjct: 68 LYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 127
Query: 311 RDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH------WMAPEVIQESRY 364
RD+ N L+ + +K+ DFG +TR + + + + W +PEV SRY
Sbjct: 128 RDLAARNCLVGENQVIKVSDFG----MTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSRY 182
Query: 365 DGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMISIE---PAPMLEDKEKWSLVFHDF 420
K DVW+ GV E +EG P V+ IS P L +
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH-----VYQI 237
Query: 421 VAKCLTKEPRARPT 434
+ C + P RP
Sbjct: 238 MNHCWRERPEDRPA 251
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 181 VTREDPTT------KYE-------LLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE 227
++ P+T +E L ELG G +G V + + VAIK+ + EG
Sbjct: 4 GSKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKM--IKEGS 60
Query: 228 EGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEY 287
+E E +++ SH +V+ G + ++I+ EY G + + + +
Sbjct: 61 MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ 120
Query: 288 QIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF 347
Q+ +C++ + + YL S +HRD+ N L+ DQG VK+ DFG L+R + + +
Sbjct: 121 QLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG----LSRYV-LDDEY 175
Query: 348 IGTPH------WMAPEVIQESRYDGKVDVWALGV 375
+ W PEV+ S++ K D+WA GV
Sbjct: 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGV 209
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-33
Identities = 76/376 (20%), Positives = 129/376 (34%), Gaps = 101/376 (26%)
Query: 167 RQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG 226
+ + ++S+P + +YE+ + +G GSYG V +A D +VAIK I
Sbjct: 32 QHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE 91
Query: 227 EEGYEE--IRGEIEMLQQCSHPNVVRYL-----GSYQGEEYLWIVMEYCGGGSVADLMNV 279
+ + +R EI +L + +H +VV+ L + + L++V+E +D +
Sbjct: 92 DLIDCKRILR-EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD----SDFKKL 146
Query: 280 --TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL 337
T L E I + L G+ Y+HS +HRD+K N L+ VK+ DFG+A +
Sbjct: 147 FRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206
Query: 338 TRTMSKRNTFIGTPHWM---------------------------APEVI-QESRYDGKVD 369
+ + +P APE+I + Y +D
Sbjct: 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAID 266
Query: 370 VWAL--------------------------GVSAVEMAEGLPPRSTVHPMRV-----LFM 398
VW++ G S ++ + L +
Sbjct: 267 VWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNV 326
Query: 399 I-SIEPAPMLED--------------------KEKWSLVFH-------DFVAKCLTKEPR 430
I +I P ED + F + + L P
Sbjct: 327 IFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPN 386
Query: 431 ARPTAAEMLKHKFIER 446
R T E L H F +
Sbjct: 387 KRITINECLAHPFFKE 402
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-33
Identities = 80/321 (24%), Positives = 127/321 (39%), Gaps = 22/321 (6%)
Query: 126 FVVRSKDGERRSGGYDDSTMGRAVASMRRFGSSSSLHGEDVRQQTKVSSSSIPESVTRED 185
F++R + R+ +R S S + + + ++P + E
Sbjct: 328 FIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEI 387
Query: 186 PTTKYELLNELGKGSYGAVYKAR---DLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQ 242
+ EL +G+G +G V++ + VAIK + E+ E ++Q
Sbjct: 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQ 447
Query: 243 CSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAY 302
HP++V+ +G +WI+ME C G + + V + L+ + + LAY
Sbjct: 448 FDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP-----HWMAPE 357
L S VHRDI N+L++ VKLGDFG L+R M + + WMAPE
Sbjct: 507 LESKRFVHRDIAARNVLVSSNDCVKLGDFG----LSRYMEDSTYYKASKGKLPIKWMAPE 562
Query: 358 VIQESRYDGKVDVWALGVSAVEMA-EGLPPRSTVHPMRVLFMIS---IEPAPMLEDKEKW 413
I R+ DVW GV E+ G+ P V V+ I P P
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP-----PNC 617
Query: 414 SLVFHDFVAKCLTKEPRARPT 434
+ + KC +P RP
Sbjct: 618 PPTLYSLMTKCWAYDPSRRPR 638
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-33
Identities = 69/280 (24%), Positives = 118/280 (42%), Gaps = 23/280 (8%)
Query: 166 VRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE 225
++ P E T + ++LG G YG VY+ K S VA+K L E
Sbjct: 198 PKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKE 255
Query: 226 GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVAD-LMNVTEEPL 284
EE E ++++ HPN+V+ LG E +I+ E+ G++ D L + +
Sbjct: 256 DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV 315
Query: 285 EEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344
+ Y+ + + YL +HR++ N L+ + VK+ DFG L+R M
Sbjct: 316 SAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFG----LSRLM-TG 370
Query: 345 NTFIGTPH------WMAPEVIQESRYDGKVDVWALGVSAVEMA-EGLPPRSTVHPMRVLF 397
+T+ W APE + +++ K DVWA GV E+A G+ P + +V
Sbjct: 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 430
Query: 398 MIS---IEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPT 434
++ P ++ ++ + C P RP+
Sbjct: 431 LLEKDYRMERPEGCPEK-----VYELMRACWQWNPSDRPS 465
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 67/280 (23%), Positives = 105/280 (37%), Gaps = 23/280 (8%)
Query: 169 QTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKAR---DLKTSELVAIKVISLSE 225
T + +E T + +G G +G V R K VAIK + +
Sbjct: 26 HTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY 85
Query: 226 GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLE 285
E+ + GE ++ Q HPN++R G + + IV EY GS+ + +
Sbjct: 86 TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 286 EYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345
Q+ + R G+ YL + VHRD+ NIL+ K+ DFG L R +
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFG----LGRVLEDDP 201
Query: 346 TFIGTPH-------WMAPEVIQESRYDGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLF 397
T W +PE I ++ DVW+ G+ E M+ G P + V+
Sbjct: 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIK 261
Query: 398 MISIE---PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPT 434
+ P PM + + C K+ RP
Sbjct: 262 AVDEGYRLPPPM-----DCPAALYQLMLDCWQKDRNNRPK 296
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 68/267 (25%), Positives = 100/267 (37%), Gaps = 23/267 (8%)
Query: 182 TREDPTTKYELLNELGKGSYGAVYKAR---DLKTSELVAIKVISLSEGEEGYEEIRGEIE 238
TRE ++ + +G G G V R + VAIK + E + E
Sbjct: 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEAS 102
Query: 239 MLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALK 298
++ Q HPN++R G IV EY GS+ + + Q+ + R
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGA 162
Query: 299 GLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH------ 352
G+ YL + VHRD+ N+L+ K+ DFG L+R + T
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFG----LSRVLEDDPDAAYTTTGGKIPI 218
Query: 353 -WMAPEVIQESRYDGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMISIE---PAPML 407
W APE I + DVW+ GV E +A G P + V+ + PAPM
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMG 278
Query: 408 EDKEKWSLVFHDFVAKCLTKEPRARPT 434
H + C K+ RP
Sbjct: 279 CPHA-----LHQLMLDCWHKDRAQRPR 300
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 68/262 (25%), Positives = 112/262 (42%), Gaps = 23/262 (8%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC 243
E T + ++LG G YG VY+ K S VA+K L E EE E ++++
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEI 66
Query: 244 SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVAD-LMNVTEEPLEEYQIAYICREALKGLAY 302
HPN+V+ LG E +I+ E+ G++ D L + + + Y+ + + Y
Sbjct: 67 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH------WMAP 356
L +HRD+ N L+ + VK+ DFG L+R M+ +T+ W AP
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLVKVADFG----LSRLMTG-DTYTAHAGAKFPIKWTAP 181
Query: 357 EVIQESRYDGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMIS---IEPAPMLEDKEK 412
E + +++ K DVWA GV E G+ P + +V ++ P
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG----- 236
Query: 413 WSLVFHDFVAKCLTKEPRARPT 434
++ + C P RP+
Sbjct: 237 CPEKVYELMRACWQWNPSDRPS 258
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 65/269 (24%), Positives = 107/269 (39%), Gaps = 28/269 (10%)
Query: 182 TREDPTTKYELLNELGKGSYGAVYKAR----DLKTSELVAIKVISLSEGEEGYEEIRGEI 237
R T+ L LG G +G V+K V IKVI G + ++ + +
Sbjct: 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHM 66
Query: 238 EMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREAL 297
+ H ++VR LG G L +V +Y GS+ D + L + +
Sbjct: 67 LAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 298 KGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH----- 352
KG+ YL VHR++ N+LL +V++ DFG + + + +
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFG----VADLLPPDDKQLLYSEAKTPI 181
Query: 353 -WMAPEVIQESRYDGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMISIE-----PAP 405
WMA E I +Y + DVW+ GV+ E M G P + + V + +E P
Sbjct: 182 KWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL--LEKGERLAQP 239
Query: 406 MLEDKEKWSLVFHDFVAKCLTKEPRARPT 434
+ ++ + + KC + RPT
Sbjct: 240 QI-----CTIDVYMVMVKCWMIDENIRPT 263
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 73/262 (27%), Positives = 116/262 (44%), Gaps = 23/262 (8%)
Query: 183 REDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQ 242
E + LL ELG G +G V + K VA+K+ + EG +E E + + +
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGK-WKGQYDVAVKM--IKEGSMSEDEFFQEAQTMMK 59
Query: 243 CSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAY 302
SHP +V++ G E ++IV EY G + + + + LE Q+ +C + +G+A+
Sbjct: 60 LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH------WMAP 356
L S +HRD+ N L+ VK+ DFG +TR + + ++ + W AP
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFG----MTRYV-LDDQYVSSVGTKFPVKWSAP 174
Query: 357 EVIQESRYDGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMIS---IEPAPMLEDKEK 412
EV +Y K DVWA G+ E + G P V+ +S P L
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHL----- 229
Query: 413 WSLVFHDFVAKCLTKEPRARPT 434
S + + C + P RPT
Sbjct: 230 ASDTIYQIMYSCWHELPEKRPT 251
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-33
Identities = 70/351 (19%), Positives = 111/351 (31%), Gaps = 99/351 (28%)
Query: 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVIS-----LSEGEEGYEEIRGEIEMLQ 241
Y + + +G+GSYG VY A D T + VAIK ++ L + + EI +L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREIT----ILN 80
Query: 242 QCSHPNVVRYL-----GSYQGEEYLWIVMEYCGGGSVADLMNV--TEEPLEEYQIAYICR 294
+ ++R + L+IV+E +DL + T L E I I
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD----SDLKKLFKTPIFLTEEHIKTILY 136
Query: 295 EALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA------------AQLTRTMS 342
L G ++H +HRD+K N LL VK+ DFG+A L
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 343 KRNTFIGTPHWM----------APEVI-QESRYDGKVDVWALGVSAVEMAEGLPPRSTVH 391
+ APE+I + Y +D+W+ G E+ L
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256
Query: 392 PMRV-LF----------------------------MISIEPAPMLED------------- 409
R LF + +I P +D
Sbjct: 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYI 316
Query: 410 -------KEKWSLVFH-------DFVAKCLTKEPRARPTAAEMLKHKFIER 446
+ + + L P R T + L H +++
Sbjct: 317 KLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 65/273 (23%), Positives = 113/273 (41%), Gaps = 27/273 (9%)
Query: 179 ESVTREDPTTKYELLNELGKGSYGAVYKAR---DLKTSELVAIKVI--SLSEGEEGYEEI 233
+S+T LL +LG GS+G V + + VA+K + + E ++
Sbjct: 9 QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF 68
Query: 234 RGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYIC 293
E+ + H N++R G + +V E GS+ D + + ++
Sbjct: 69 IREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 127
Query: 294 REALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK-RNTFIGTPH 352
+ +G+ YL S +HRD+ N+LL + VK+GDFG L R + + + ++ H
Sbjct: 128 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG----LMRALPQNDDHYVMQEH 183
Query: 353 ------WMAPEVIQESRYDGKVDVWALGVSAVEMA-EGLPPRSTVHPMRVLFMISIE--- 402
W APE ++ + D W GV+ EM G P ++ ++L I E
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 243
Query: 403 -PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPT 434
P P ++ + +C +P RPT
Sbjct: 244 LPRPED-----CPQDIYNVMVQCWAHKPEDRPT 271
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 1e-32
Identities = 73/259 (28%), Positives = 112/259 (43%), Gaps = 15/259 (5%)
Query: 182 TREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQ 241
E P L +LG+G +G V+ + VAIK L G E E ++++
Sbjct: 178 AWEIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKT--LKPGTMSPEAFLQEAQVMK 234
Query: 242 QCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVAD-LMNVTEEPLEEYQIAYICREALKGL 300
+ H +V+ EE ++IV EY GS+ D L T + L Q+ + + G+
Sbjct: 235 KLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 293
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP-HWMAPEVI 359
AY+ + VHRD++ NIL+ + K+ DFG+A + P W APE
Sbjct: 294 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 353
Query: 360 QESRYDGKVDVWALGVSAVEMA-EGLPPRSTVHPMRVLFMISIE---PAPMLEDKEKWSL 415
R+ K DVW+ G+ E+ +G P + VL + P P +
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES---- 409
Query: 416 VFHDFVAKCLTKEPRARPT 434
HD + +C KEP RPT
Sbjct: 410 -LHDLMCQCWRKEPEERPT 427
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 61/257 (23%), Positives = 99/257 (38%), Gaps = 19/257 (7%)
Query: 191 ELLNELGKGSYGAVYKAR---DLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPN 247
+GKG +G VY + AIK +S + E E +++ +HPN
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 248 VVRYLG-SYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI 306
V+ +G E +++ Y G + + + + + +G+ YL
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ 143
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH--------WMAPEV 358
VHRD+ N +L + VK+ DFG L R + R + H W A E
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFG----LARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 359 IQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVF 417
+Q R+ K DVW+ GV E+ G PP + P + + L E
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF--LAQGRRLPQPEYCPDSL 257
Query: 418 HDFVAKCLTKEPRARPT 434
+ + +C +P RPT
Sbjct: 258 YQVMQQCWEADPAVRPT 274
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 61/275 (22%), Positives = 107/275 (38%), Gaps = 32/275 (11%)
Query: 176 SIPESVTREDPTTKYELLNELGKGSYGAVYKAR----DLKTSELVAIKVISLSEGEEGYE 231
++ + + + LG G++G VYK K VAIK + + + +
Sbjct: 7 ALLRILKETEFK----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 62
Query: 232 EIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAY 291
EI E ++ +P+V R LG + ++ + G + D + ++ + +
Sbjct: 63 EILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 292 ICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP 351
C + KG+ YL VHRD+ N+L+ VK+ DFG L + +
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG----LAKLLGAEEKEYHAE 177
Query: 352 H------WMAPEVIQESRYDGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMISIE-- 402
WMA E I Y + DVW+ GV+ E M G P + + + +E
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI--LEKG 235
Query: 403 ---PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPT 434
P P ++ + + KC + +RP
Sbjct: 236 ERLPQPP-----ICTIDVYMIMVKCWMIDADSRPK 265
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-32
Identities = 79/334 (23%), Positives = 131/334 (39%), Gaps = 83/334 (24%)
Query: 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVIS-----LSEGEEGYEEIRGEIEMLQ 241
KYEL+ +LGKG+YG V+K+ D +T E+VA+K I ++ + + EI +L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIM----ILT 63
Query: 242 Q-CSHPNVVRYLGSYQGEEY--LWIVMEYCGGGSVADLMNV-TEEPLEEYQIAYICREAL 297
+ H N+V L + + +++V +Y DL V LE Y+ + +
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYME----TDLHAVIRANILEPVHKQYVVYQLI 119
Query: 298 KGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA-----------AQLTRTMSKRNT 346
K + YLHS +HRD+K NILL + VK+ DFG++
Sbjct: 120 KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 347 FIGTPHWM----------APEVI-QESRYDGKVDVWALGVSAVEMAEG---LPPRSTVHP 392
F + APE++ ++Y +D+W+LG E+ G P ST++
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239
Query: 393 MRVLFMI----------------------------SIEPAPMLEDKEKWSLVFH------ 418
+ + + I + + KW +
Sbjct: 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKA 299
Query: 419 -------DFVAKCLTKEPRARPTAAEMLKHKFIE 445
D + K L P R +A + LKH F+
Sbjct: 300 DCNEEALDLLDKLLQFNPNKRISANDALKHPFVS 333
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 74/328 (22%), Positives = 126/328 (38%), Gaps = 48/328 (14%)
Query: 155 FGSSSSL-----HGEDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKAR- 208
GS SSL G ++ + ++ L ELG+G++G V+ A
Sbjct: 3 MGSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAEC 62
Query: 209 ----DLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263
+ LVA+K +L E E ++ + E E+L H ++VR+ G L +
Sbjct: 63 HNLLPEQDKMLVAVK--ALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120
Query: 264 VMEYCGGGS--------------VADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKV 309
V EY G +A +V PL Q+ + + G+ YL + V
Sbjct: 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFV 180
Query: 310 HRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH------WMAPEVIQESR 363
HRD+ N L+ VK+GDFG ++R + + + WM PE I +
Sbjct: 181 HRDLATRNCLVGQGLVVKIGDFG----MSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK 236
Query: 364 YDGKVDVWALGVSAVEMA-EGLPPRSTVHPMRVLFMIS---IEPAPMLEDKEKWSLVFHD 419
+ + DVW+ GV E+ G P + + I+ P +
Sbjct: 237 FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERP-----RACPPEVYA 291
Query: 420 FVAKCLTKEPRARPTAAEMLKHKFIERC 447
+ C +EP+ R + ++ H ++
Sbjct: 292 IMRGCWQREPQQRHSIKDV--HARLQAL 317
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 75/267 (28%), Positives = 111/267 (41%), Gaps = 22/267 (8%)
Query: 183 REDPTTKYELLNELGKGSYGAVYKAR---DLKTSELVAIKVISLSEGEEGYEEIRGEIEM 239
E + EL +G+G +G V++ + VAIK + E+ E
Sbjct: 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALT 69
Query: 240 LQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKG 299
++Q HP++V+ +G +WI+ME C G + + V + L+ + +
Sbjct: 70 MRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 128
Query: 300 LAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT----P-HWM 354
LAYL S VHRDI N+L++ VKLGDFG L+R M + + P WM
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG----LSRYMEDSTYYKASKGKLPIKWM 184
Query: 355 APEVIQESRYDGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMIS---IEPAPMLEDK 410
APE I R+ DVW GV E + G+ P V V+ I P P
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---- 240
Query: 411 EKWSLVFHDFVAKCLTKEPRARPTAAE 437
+ + KC +P RP E
Sbjct: 241 -NCPPTLYSLMTKCWAYDPSRRPRFTE 266
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 53/195 (27%), Positives = 89/195 (45%), Gaps = 12/195 (6%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC 243
+ +LL +GKG +G V + ++ VA+K + + E ++ Q
Sbjct: 17 ALNMKELKLLQTIGKGEFGDVMLGD-YRGNK-VAVKC--IKNDATA-QAFLAEASVMTQL 71
Query: 244 SHPNVVRYLGS-YQGEEYLWIVMEYCGGGSVAD-LMNVTEEPLEEYQIAYICREALKGLA 301
H N+V+ LG + + L+IV EY GS+ D L + L + + + +
Sbjct: 72 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 131
Query: 302 YLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP-HWMAPEVIQ 360
YL VHRD+ N+L+++ K+ DFG LT+ S P W APE ++
Sbjct: 132 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLPVKWTAPEALR 187
Query: 361 ESRYDGKVDVWALGV 375
E ++ K DVW+ G+
Sbjct: 188 EKKFSTKSDVWSFGI 202
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-32
Identities = 73/259 (28%), Positives = 112/259 (43%), Gaps = 15/259 (5%)
Query: 182 TREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQ 241
E P L +LG+G +G V+ + VAIK L G E E ++++
Sbjct: 261 AWEIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKT--LKPGTMSPEAFLQEAQVMK 317
Query: 242 QCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVAD-LMNVTEEPLEEYQIAYICREALKGL 300
+ H +V+ EE ++IV EY GS+ D L T + L Q+ + + G+
Sbjct: 318 KLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 376
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP-HWMAPEVI 359
AY+ + VHRD++ NIL+ + K+ DFG+A + P W APE
Sbjct: 377 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 436
Query: 360 QESRYDGKVDVWALGVSAVEMA-EGLPPRSTVHPMRVLFMISIE---PAPMLEDKEKWSL 415
R+ K DVW+ G+ E+ +G P + VL + P P +
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP-----PECPE 491
Query: 416 VFHDFVAKCLTKEPRARPT 434
HD + +C KEP RPT
Sbjct: 492 SLHDLMCQCWRKEPEERPT 510
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 20/201 (9%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC 243
E P +L+ LG G +G V+ VA+K L +G + E +++Q
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKS--LKQGSMSPDAFLAEANLMKQL 65
Query: 244 SHPNVVRYLG--SYQGEEYLWIVMEYCGGGSVAD-LMNVTEEPLEEYQIAYICREALKGL 300
H +VR + +E ++I+ EY GS+ D L + L ++ + + +G+
Sbjct: 66 QHQRLVRLYAVVT---QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH------WM 354
A++ +HRD++ NIL++D K+ DFG L R + + N + W
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSCKIADFG----LARLI-EDNEYTAREGAKFPIKWT 177
Query: 355 APEVIQESRYDGKVDVWALGV 375
APE I + K DVW+ G+
Sbjct: 178 APEAINYGTFTIKSDVWSFGI 198
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-32
Identities = 62/259 (23%), Positives = 107/259 (41%), Gaps = 23/259 (8%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY--EEIRGEIEMLQ 241
+ +LL +GKG +G V + ++ VA+K I + E ++
Sbjct: 189 ALNMKELKLLQTIGKGEFGDVMLGD-YRGNK-VAVKCIK-----NDATAQAFLAEASVMT 241
Query: 242 QCSHPNVVRYLG-SYQGEEYLWIVMEYCGGGSVAD-LMNVTEEPLEEYQIAYICREALKG 299
Q H N+V+ LG + + L+IV EY GS+ D L + L + + +
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 301
Query: 300 LAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVI 359
+ YL VHRD+ N+L+++ K+ DFG+ + + T + W APE +
Sbjct: 302 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEAL 358
Query: 360 QESRYDGKVDVWALGVSAVEMA-EGLPPRSTVHPMRVLFMISIE---PAPMLEDKEKWSL 415
+E ++ K DVW+ G+ E+ G P + V+ + AP
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA---- 414
Query: 416 VFHDFVAKCLTKEPRARPT 434
+D + C + RPT
Sbjct: 415 -VYDVMKNCWHLDAATRPT 432
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 69/256 (26%), Positives = 108/256 (42%), Gaps = 22/256 (8%)
Query: 191 ELLNELGKGSYGAVYKAR---DLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPN 247
L LG+G +G VY+ VA+K + E+ E +++ HP+
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 74
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307
+V+ +G + E WI+ME G + + + L+ + + K +AYL SI
Sbjct: 75 IVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN 133
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT----P-HWMAPEVIQES 362
VHRDI NIL+ VKLGDFG L+R + + + + P WM+PE I
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFG----LSRYIEDEDYYKASVTRLPIKWMSPESINFR 189
Query: 363 RYDGKVDVWALGVSAVEMA-EGLPPRSTVHPMRVLFMIS---IEPAPMLEDKEKWSLVFH 418
R+ DVW V E+ G P + V+ ++ P P L V +
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDL-----CPPVLY 244
Query: 419 DFVAKCLTKEPRARPT 434
+ +C +P RP
Sbjct: 245 TLMTRCWDYDPSDRPR 260
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 66/337 (19%), Positives = 122/337 (36%), Gaps = 92/337 (27%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY-EEIRGEIEMLQQCSHP- 246
+YE+ + +GKGS+G V KA D E VAIK+I + ++ + + + E+ +L+ +
Sbjct: 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII---KNKKAFLNQAQIEVRLLELMNKHD 111
Query: 247 -----NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE-------EPLEEYQIAYICR 294
+V + +L +V E N+ + + +
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLS-------YNLYDLLRNTNFRGVSLNLTRKFAQ 164
Query: 295 EALKGLAYLHSIFK--VHRDIKGGNILLTDQG--EVKLGDFGVAAQLTRTMSKRNTFIGT 350
+ L +L + +H D+K NILL + +K+ DFG + QL + + +I +
Sbjct: 165 QMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY---QYIQS 221
Query: 351 PHWMAPEVIQESRYDGKVDVWALGVSAVE-------------------MAE--GLPPRST 389
+ +PEV+ YD +D+W+LG VE + E G+PP
Sbjct: 222 RFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281
Query: 390 VH------------------------------------PMRVLFMISIEPA----PMLED 409
+ +L + + P
Sbjct: 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGH 341
Query: 410 KEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446
L F D + + L +P+ R L+H F ++
Sbjct: 342 TVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 66/253 (26%), Positives = 112/253 (44%), Gaps = 23/253 (9%)
Query: 195 ELGKGSYGAVYKA--RDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYL 252
ELG G++G+V + R K VAIKV+ + EE+ E +++ Q +P +VR +
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 253 GSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRD 312
G Q E L +VME GGG + + E + +A + + G+ YL VHRD
Sbjct: 77 GVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 135
Query: 313 IKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH-------WMAPEVIQESRYD 365
+ N+LL ++ K+ DFG L++ + +++ W APE I ++
Sbjct: 136 LAARNVLLVNRHYAKISDFG----LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 366 GKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMISIE---PAPMLEDKEKWSLVFHDFV 421
+ DVW+ GV+ E ++ G P + V+ I P + + +
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP-----ECPPELYALM 246
Query: 422 AKCLTKEPRARPT 434
+ C + RP
Sbjct: 247 SDCWIYKWEDRPD 259
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 54/275 (19%), Positives = 107/275 (38%), Gaps = 32/275 (11%)
Query: 191 ELLNELGKGSYGAVYKAR---DLKTSELVAIKVISLSEGEEGYEEIR---GEIEMLQQCS 244
L LGKG +G+V +A+ + + VA+K L +I E +++
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVK--MLKADIIASSDIEEFLREAACMKEFD 83
Query: 245 HPNVVRYLG------SYQGEEYLWIVMEYCGGGSVAD-----LMNVTEEPLEEYQIAYIC 293
HP+V + +G + +++ + G + + L +
Sbjct: 84 HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 294 REALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH- 352
+ G+ YL S +HRD+ N +L + V + DFG L+R + + +
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFG----LSRKIYSGDYYRQGCAS 199
Query: 353 -----WMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPM 406
W+A E + ++ Y DVWA GV+ E+ G P + + + +
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY--LIGGNR 257
Query: 407 LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441
L+ + +D + +C + +P+ RP+ +
Sbjct: 258 LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRME 292
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 66/300 (22%), Positives = 122/300 (40%), Gaps = 35/300 (11%)
Query: 172 VSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKAR-----DLKTSELVAIKVISLSEG 226
S++ + E K + ELG+GS+G VY+ + VAIK ++ +
Sbjct: 9 FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 68
Query: 227 EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVAD---------LM 277
E E ++++ + +VVR LG + ++ME G +
Sbjct: 69 MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 128
Query: 278 NVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL 337
N P ++ + E G+AYL++ VHRD+ N ++ + VK+GDFG +
Sbjct: 129 NPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG----M 184
Query: 338 TRTMSKRNTFIGTPH------WMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTV 390
TR + + + + WM+PE +++ + DVW+ GV E+A P +
Sbjct: 185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244
Query: 391 HPMRVLFMIS---IEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447
+VL + + P + + + + C P+ RP+ E+ I+
Sbjct: 245 SNEQVLRFVMEGGLLDKP-----DNCPDMLFELMRMCWQYNPKMRPSFLEI--ISSIKEE 297
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 76/360 (21%), Positives = 143/360 (39%), Gaps = 42/360 (11%)
Query: 120 DDEFGTFVVRSKDGERRSGGYDDSTMGRAVASMRRFGSSSSLHGEDVRQQTKVSSSSIPE 179
D + + R+ +S+ + ++ D VS +PE
Sbjct: 13 DPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPE 72
Query: 180 SVTREDPTTKYELLNELGKGSYGAVYKAR-------DLKTSELVAIKVISLSEG--EEGY 230
E P K L LG+G +G V A K + VA+K L + E+
Sbjct: 73 DPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDL 130
Query: 231 EEIRGEIEMLQQ-CSHPNVVRYLGSYQGEEYLWIVMEYCGGGS---------------VA 274
++ E+EM++ H N++ LG+ + L++++EY G+
Sbjct: 131 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 275 DLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA 334
D+ V EE + + + +G+ YL S +HRD+ N+L+T+ +K+ DFG
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG-- 248
Query: 335 AQLTRTMSKRNTFIGTPH------WMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPR 387
L R ++ + + T + WMAPE + + Y + DVW+ GV E+ G P
Sbjct: 249 --LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306
Query: 388 STVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447
+ + + ++ ++ + + + C P RPT ++ + ++R
Sbjct: 307 PGIPVEELFKL--LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL--VEDLDRI 362
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 62/235 (26%), Positives = 107/235 (45%), Gaps = 33/235 (14%)
Query: 170 TKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKAR-------DLKTSELVAIKVIS 222
VS +PE E P K L LG+G++G V A K + VA+K++
Sbjct: 17 AGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 76
Query: 223 LSEGEEGYEEIRGEIEMLQQ-CSHPNVVRYLGSYQGEEYLWIVMEYCGGGS--------- 272
E+ ++ E+EM++ H N++ LG+ + L++++EY G+
Sbjct: 77 DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR 136
Query: 273 ------VADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEV 326
D+ V EE + + + +G+ YL S +HRD+ N+L+T+ +
Sbjct: 137 PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVM 196
Query: 327 KLGDFGVAAQLTRTMSKRNTFIGTPH------WMAPEVIQESRYDGKVDVWALGV 375
K+ DFG L R ++ + + T + WMAPE + + Y + DVW+ GV
Sbjct: 197 KIADFG----LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 247
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 71/335 (21%), Positives = 127/335 (37%), Gaps = 39/335 (11%)
Query: 169 QTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKAR-----DLKTSELVAIKVISL 223
+ + S +E P L+ LG G++G VY+ + + + VA+K +
Sbjct: 11 NYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE 70
Query: 224 SEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVAD------LM 277
E+ + E ++ + +H N+VR +G +I+ME GG +
Sbjct: 71 VCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPR 130
Query: 278 NVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE---VKLGDFGVA 334
L + ++ R+ G YL +HRDI N LLT G K+GDFG
Sbjct: 131 PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG-- 188
Query: 335 AQLTRTMSKRNTFIGTPH------WMAPEVIQESRYDGKVDVWALGVSAVEMA-EGLPPR 387
+ R + + + + WM PE E + K D W+ GV E+ G P
Sbjct: 189 --MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246
Query: 388 STVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447
+ VL + ++ + + + +C +P RP A + + IE C
Sbjct: 247 PSKSNQEVLEF--VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII--LERIEYC 302
Query: 448 KCGATAMLPKIEKARQIRASMAQQAQNILSDEPEV 482
+ I ++ + ++ +E +V
Sbjct: 303 ----------TQDPDVINTALPIEYGPLVEEEEKV 327
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 33/217 (15%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKAR--DLKTSELVAIKVISLSEG--EEGYEEIRGEIEM 239
+ + +G+G++G V KAR AIK + E ++ + + GE+E+
Sbjct: 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIK--RMKEYASKDDHRDFAGELEV 78
Query: 240 LQQ-CSHPNVVRYLGSYQGEEYLWIVMEYCGGGS---------------VADLMNVTEEP 283
L + HPN++ LG+ + YL++ +EY G+ + N T
Sbjct: 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 284 LEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT--- 340
L Q+ + + +G+ YL +HRD+ NIL+ + K+ DFG L+R
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG----LSRGQEV 194
Query: 341 -MSKRNTFIGTP-HWMAPEVIQESRYDGKVDVWALGV 375
+ K + P WMA E + S Y DVW+ GV
Sbjct: 195 YVKKTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGV 229
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 57/221 (25%), Positives = 91/221 (41%), Gaps = 33/221 (14%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKAR-----DLKTSELVAIKVISLSEGEEGYEEIRGEIE 238
E P + LG G++G V +A + VA+K++ S E + E++
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 239 MLQQ-CSHPNVVRYLGSYQGEEYLWIVMEYCGGGS-----------------VADLMNVT 280
+L +H N+V LG+ ++ EYC G +M
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 281 EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340
E L+ + + KG+A+L S +HRD+ NILLT K+ DFG L R
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG----LARD 194
Query: 341 MSKRNTFIGTPH------WMAPEVIQESRYDGKVDVWALGV 375
+ + ++ + WMAPE I Y + DVW+ G+
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 63/274 (22%), Positives = 110/274 (40%), Gaps = 31/274 (11%)
Query: 191 ELLNELGKGSYGAVYKAR---DLKTSELVAIKVISLSEGEEGYEEIR---GEIEMLQQCS 244
L LG+G +G+V + + TS VA+K ++ EI E ++ S
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVK--TMKLDNSSQREIEEFLSEAACMKDFS 94
Query: 245 HPNVVRYLG-----SYQGEEYLWIVMEYCGGGSVAD-----LMNVTEEPLEEYQIAYICR 294
HPNV+R LG S QG +++ + G + + + + +
Sbjct: 95 HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154
Query: 295 EALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH-- 352
+ G+ YL + +HRD+ N +L D V + DFG L++ + + +
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG----LSKKIYSGDYYRQGRIAK 210
Query: 353 ----WMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPML 407
W+A E + + Y K DVWA GV+ E+A G+ P V + + L
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY--LLHGHRL 268
Query: 408 EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441
+ E ++ + C +P RPT + +
Sbjct: 269 KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 68/304 (22%), Positives = 117/304 (38%), Gaps = 29/304 (9%)
Query: 165 DVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKAR-----DLKTSELVAIK 219
D + + S +E P L+ LG G++G VY+ + + + VA+K
Sbjct: 48 DYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK 107
Query: 220 VISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLM-- 277
+ E+ + E ++ + +H N+VR +G +I++E GG + +
Sbjct: 108 TLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE 167
Query: 278 ----NVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE---VKLGD 330
L + ++ R+ G YL +HRDI N LLT G K+GD
Sbjct: 168 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 227
Query: 331 FGVAAQLTRTMSKRNTFIGTPH------WMAPEVIQESRYDGKVDVWALGVSAVEMA-EG 383
FG + R + + + WM PE E + K D W+ GV E+ G
Sbjct: 228 FG----MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLG 283
Query: 384 LPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKF 443
P + VL + ++ + + + +C +P RP A + +
Sbjct: 284 YMPYPSKSNQEVLEF--VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII--LER 339
Query: 444 IERC 447
IE C
Sbjct: 340 IEYC 343
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-30
Identities = 67/285 (23%), Positives = 117/285 (41%), Gaps = 27/285 (9%)
Query: 165 DVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKA--RDLKTSELVAIKVIS 222
V + + + ELG G++G+V + R K VAIKV+
Sbjct: 313 SVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK 372
Query: 223 LSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEE 282
+ EE+ E +++ Q +P +VR +G Q E L +VME GGG + + E
Sbjct: 373 QGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKRE 431
Query: 283 PLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342
+ +A + + G+ YL VHR++ N+LL ++ K+ DFG L++ +
Sbjct: 432 EIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFG----LSKALG 487
Query: 343 KRNTFIGTPH-------WMAPEVIQESRYDGKVDVWALGVSAVE-MAEGLPPRSTVHPMR 394
+++ W APE I ++ + DVW+ GV+ E ++ G P +
Sbjct: 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547
Query: 395 VLFMISIE-----PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPT 434
V+ IE P + + ++ C + RP
Sbjct: 548 VMAF--IEQGKRMECPP-----ECPPELYALMSDCWIYKWEDRPD 585
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-30
Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 16/213 (7%)
Query: 170 TKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEG 229
E E P +L +LG G +G V+ A VA+K + G
Sbjct: 170 MSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKT--MKPGSMS 226
Query: 230 YEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVAD-LMNVTEEPLEEYQ 288
E E +++ H +V+ +E ++I+ E+ GS+ D L + +
Sbjct: 227 VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPK 285
Query: 289 IAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFI 348
+ + +G+A++ +HRD++ NIL++ K+ DFG L R + + N +
Sbjct: 286 LIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG----LARVI-EDNEYT 340
Query: 349 GTPH------WMAPEVIQESRYDGKVDVWALGV 375
W APE I + K DVW+ G+
Sbjct: 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGI 373
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 34/221 (15%)
Query: 183 REDPTTKYELLNELGKGSYGAVYKAR-----DLKTSELVAIKVISLSEG--EEGYEEIRG 235
+E + + ELG+ +G VYK + ++ VAIK +L + EE R
Sbjct: 4 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK--TLKDKAEGPLREEFRH 61
Query: 236 EIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGS---------------VADLMNVT 280
E + + HPNVV LG ++ L ++ YC G D
Sbjct: 62 EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 281 EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340
+ LE ++ + G+ YL S VH+D+ N+L+ D+ VK+ D G L R
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLG----LFRE 177
Query: 341 MSKRNTFIGTPH------WMAPEVIQESRYDGKVDVWALGV 375
+ + + + WMAPE I ++ D+W+ GV
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGV 218
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-30
Identities = 59/237 (24%), Positives = 103/237 (43%), Gaps = 33/237 (13%)
Query: 168 QQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKAR-------DLKTSELVAIKV 220
VS +PE E P + L LG+G++G V A VA+K+
Sbjct: 49 MLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM 108
Query: 221 ISLSEGEEGYEEIRGEIEMLQQ-CSHPNVVRYLGSYQGEEYLWIVMEYCGGGS------- 272
+ E+ ++ E+EM++ H N++ LG+ + L++++EY G+
Sbjct: 109 LKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA 168
Query: 273 --------VADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG 324
+ + EE L + + +G+ YL S +HRD+ N+L+T+
Sbjct: 169 RRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 228
Query: 325 EVKLGDFGVAAQLTRTMSKRNTFIGTPH------WMAPEVIQESRYDGKVDVWALGV 375
+K+ DFG L R + + + T + WMAPE + + Y + DVW+ GV
Sbjct: 229 VMKIADFG----LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 281
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 36/222 (16%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKAR-----DLKTSELVAIKVISLSEG--EEGYEEIRGE 236
E P + +L LG+G++G V +A T VA+K L EG + + E
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK--MLKEGATHSEHRALMSE 80
Query: 237 IEMLQQ-CSHPNVVRYLG-SYQGEEYLWIVMEYCGGGS---------------VADLMNV 279
+++L H NVV LG + L +++E+C G+ ++
Sbjct: 81 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 280 TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339
++ L + + KG+ +L S +HRD+ NILL+++ VK+ DFG L R
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG----LAR 196
Query: 340 TMSKRNTFIGTPH------WMAPEVIQESRYDGKVDVWALGV 375
+ K ++ WMAPE I + Y + DVW+ GV
Sbjct: 197 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 33/212 (15%)
Query: 191 ELLNELGKGSYGAVYKAR-----DLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCS 244
L ELG+G++G V+ A K LVA+K +L + ++ + E E+L
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARKDFQREAELLTNLQ 75
Query: 245 HPNVVRYLGSYQGEEYLWIVMEYCGGGS---------------VADLMNVTEEPLEEYQI 289
H ++V++ G + L +V EY G V + L Q+
Sbjct: 76 HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 290 AYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIG 349
+I + G+ YL S VHRD+ N L+ VK+GDFG ++R + + +
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFG----MSRDVYSTDYYRV 191
Query: 350 TPH------WMAPEVIQESRYDGKVDVWALGV 375
H WM PE I ++ + DVW+ GV
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 223
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 59/241 (24%), Positives = 104/241 (43%), Gaps = 42/241 (17%)
Query: 171 KVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKAR-----DLKTSELVAIKVISLSE 225
++ P+ ++ E P E + ++G+G++G V++AR + +VA+K L E
Sbjct: 30 RMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK--MLKE 87
Query: 226 G--EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGS----------- 272
+ + + E ++ + +PN+V+ LG + + ++ EY G
Sbjct: 88 EASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPH 147
Query: 273 ------------VADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL 320
A + + PL + I R+ G+AYL VHRD+ N L+
Sbjct: 148 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV 207
Query: 321 TDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH------WMAPEVIQESRYDGKVDVWALG 374
+ VK+ DFG L+R + + + + WM PE I +RY + DVWA G
Sbjct: 208 GENMVVKIADFG----LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYG 263
Query: 375 V 375
V
Sbjct: 264 V 264
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 74/337 (21%), Positives = 126/337 (37%), Gaps = 88/337 (26%)
Query: 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY-EEIRGEIEMLQQ--- 242
+ ++ ++G G++G V + + + A+KV+ + Y + E ++L++
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV---RNIKKYTRSAKIEADILKKIQN 90
Query: 243 --CSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKG 299
++ N+V+Y G + +++ ++ E G S+ +++ I C E LK
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 300 LAYLHSIFKVHRDIKGGNILLTDQG-------------------------EVKLGDFGVA 334
L YL + H D+K NILL D +KL DFG A
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 335 AQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLP--PRSTVHP 392
+ + I T + APEVI +D D+W+ G E+ G
Sbjct: 210 TFKSDYHG---SIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHME 266
Query: 393 MRVLFMISIE-----PAPMLE-----------DKEKWSL--------------------- 415
L M+ P ML +K++ L
Sbjct: 267 H--LAMM-ESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPL 323
Query: 416 -------VFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445
+F DF+ L +P RP+ AE+LKHKF+E
Sbjct: 324 YKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 57/238 (23%), Positives = 101/238 (42%), Gaps = 38/238 (15%)
Query: 172 VSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKAR-----DLKTSELVAIKVISLSEG 226
V + I E E P L LG+G +G V KA VA+K++ +
Sbjct: 7 VDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS 66
Query: 227 EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGS-------------- 272
++ E +L+Q +HP+V++ G+ + L +++EY GS
Sbjct: 67 PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126
Query: 273 ---------VADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ 323
+ L + E L + + +G+ YL + VHRD+ NIL+ +
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEG 186
Query: 324 GEVKLGDFGVAAQLTRTMSKRNTFIGTPH------WMAPEVIQESRYDGKVDVWALGV 375
++K+ DFG L+R + + ++++ WMA E + + Y + DVW+ GV
Sbjct: 187 RKMKISDFG----LSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 71/295 (24%), Positives = 126/295 (42%), Gaps = 57/295 (19%)
Query: 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS---EGEEGYEEIRGEIEMLQ 241
D N++G+G +G VYK + + VA+K ++ EE ++ EI+++
Sbjct: 28 DERPISVGGNKMGEGGFGVVYKGY-VNNTT-VAVKKLAAMVDITTEELKQQFDQEIKVMA 85
Query: 242 QCSHPNVVRYLG-SYQGEEYLWIVMEYCGGGSVAD--LMNVTEEPLEEYQIAYICREALK 298
+C H N+V LG S G++ +V Y GS+ D PL + I + A
Sbjct: 86 KCQHENLVELLGFSSDGDDLC-LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN 144
Query: 299 GLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL---------TRTMSKRNTFIG 349
G+ +LH +HRDIK NILL + K+ DFG+A +R + G
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIV-------G 197
Query: 350 TPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA-PMLE 408
T +MAPE + K D+++ GV +E+ GLP ++L ++ + +
Sbjct: 198 TTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL----LDIKEEIED 252
Query: 409 DKEKWSLVFHDFV-------------------AKCLTKEPRARPTAAE---MLKH 441
+++ D++ ++CL ++ RP + +L+
Sbjct: 253 EEKT----IEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 54/231 (23%), Positives = 94/231 (40%), Gaps = 33/231 (14%)
Query: 172 VSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKA-----RDLKTSELVAIKVISLSEG 226
+ + +P + E P + LG G++G V +A VA+K L
Sbjct: 30 IDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK--MLKST 87
Query: 227 --EEGYEEIRGEIEMLQQ-CSHPNVVRYLGSYQGEEYLWIVMEYCGGGS----------- 272
+ E + E++++ H N+V LG+ + ++ EYC G
Sbjct: 88 AHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRV 147
Query: 273 --VADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGD 330
+ + + + +G+A+L S +HRD+ N+LLT+ K+GD
Sbjct: 148 LETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGD 207
Query: 331 FGVAAQLTRTMSKRNTFIGTPH------WMAPEVIQESRYDGKVDVWALGV 375
FG L R + + +I + WMAPE I + Y + DVW+ G+
Sbjct: 208 FG----LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 78/334 (23%), Positives = 121/334 (36%), Gaps = 82/334 (24%)
Query: 187 TTKYELLNELGKGSYGAVYKARDLKT-SELVAIKVISLSEGEEGY-EEIRGEIEMLQQ-- 242
+ +YE+++ LG+G++G V + D K VA+K++ + + Y E R EI++L+
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV---KNVDRYCEAARSEIQVLEHLN 69
Query: 243 ----CSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLM-NVTEEPLEEYQIAYICREAL 297
S V+ L ++ ++ IV E G S D + P I + +
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 298 KGLAYLHSIFKVHRDIKGGNILLTDQG-------------------EVKLGDFGVAAQLT 338
K + +LHS H D+K NIL ++K+ DFG A
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 339 RTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLP--PRSTVHPMRVL 396
S T + T H+ APEVI + DVW++G +E G P L
Sbjct: 189 EHHS---TLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH--L 243
Query: 397 FMISIE-----PAPMLEDKEKWSLVFH--------------------------------- 418
M+ P M++ K H
Sbjct: 244 AMM-ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEH 302
Query: 419 ----DFVAKCLTKEPRARPTAAEMLKHKFIERCK 448
D + K L +P R T E LKH F + K
Sbjct: 303 ERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 64/256 (25%), Positives = 106/256 (41%), Gaps = 29/256 (11%)
Query: 195 ELGKGSYGAVYKA--RDLKTSELVAIKVI-SLSEGEEGYEEIRGEIEMLQQCSHPNVVRY 251
ELG G++G V K + K + VA+K++ + + +E+ E ++QQ +P +VR
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 252 LGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHR 311
+G + E +VME G + + +++ I + + G+ YL VHR
Sbjct: 84 IGICEAES-WMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 141
Query: 312 DIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH-------WMAPEVIQESRY 364
D+ N+LL Q K+ DFG L++ + + W APE I ++
Sbjct: 142 DLAARNVLLVTQHYAKISDFG----LSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197
Query: 365 DGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMISIE-----PAPMLEDKEKWSLVFH 418
K DVW+ GV E + G P + V M +E P +
Sbjct: 198 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM--LEKGERMGCPAG-----CPREMY 250
Query: 419 DFVAKCLTKEPRARPT 434
D + C T + RP
Sbjct: 251 DLMNLCWTYDVENRPG 266
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 51/275 (18%), Positives = 99/275 (36%), Gaps = 34/275 (12%)
Query: 181 VTREDPTTKYELLNELGKGSYGAVYKAR-------DLKTSELVAIKVISLSEG-EEGYEE 232
V + LG+G++ ++K V +KV L + E
Sbjct: 1 VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKV--LDKAHRNYSES 58
Query: 233 IRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYI 292
M+ + SH ++V G + +V E+ GS+ + + + +
Sbjct: 59 FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV 118
Query: 293 CREALKGLAYLHSIFKVHRDIKGGNILLTDQGE--------VKLGDFGVAAQLTRTMSKR 344
++ + +L +H ++ NILL + + +KL D G ++ T+ +
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG----ISITVLPK 174
Query: 345 NTFIGTPHWMAPEVIQESR-YDGKVDVWALGVSAVE-MAEGLPPRSTVHPMRVLFMIS-- 400
+ W+ PE I+ + + D W+ G + E + G P S + R L
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234
Query: 401 -IEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPT 434
PAP + + + C+ EP RP+
Sbjct: 235 HQLPAPKAAE-------LANLINNCMDYEPDHRPS 262
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 69/270 (25%), Positives = 111/270 (41%), Gaps = 41/270 (15%)
Query: 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLG 253
+G G +G VYK L+ VA+K + E +G EE EIE L C HP++V +G
Sbjct: 45 FLIGHGVFGKVYKGV-LRDGAKVALKRRT-PESSQGIEEFETEIETLSFCRHPHLVSLIG 102
Query: 254 SYQGEEYLWIVMEYCGGGSVADLM---NVTEEPLEEYQIAYICREALKGLAYLHSIFKVH 310
+ ++ +Y G++ + ++ + Q IC A +GL YLH+ +H
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIH 162
Query: 311 RDIKGGNILLTDQGEVKLGDFGVAAQL---------TRTMSKRNTFIGTPHWMAPEVIQE 361
RD+K NILL + K+ DFG++ + T GT ++ PE +
Sbjct: 163 RDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK-------GTLGYIDPEYFIK 215
Query: 362 SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI-EPA-PMLEDKEKWSLV--- 416
R K DV++ GV E+ + M+++ E A + + +V
Sbjct: 216 GRLTEKSDVYSFGVVLFEVLCARSA---IVQSLPREMVNLAEWAVESHNNGQLEQIVDPN 272
Query: 417 ------------FHDFVAKCLTKEPRARPT 434
F D KCL RP+
Sbjct: 273 LADKIRPESLRKFGDTAVKCLALSSEDRPS 302
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 4e-28
Identities = 76/277 (27%), Positives = 125/277 (45%), Gaps = 35/277 (12%)
Query: 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLG 253
N LG+G +G VYK R L LVA+K + + G + + E+EM+ H N++R G
Sbjct: 36 NILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94
Query: 254 SYQGEEYLWIVMEYCGGGSVADLM---NVTEEPLEEYQIAYICREALKGLAYLHSIFK-- 308
+V Y GSVA + ++ PL+ + I + +GLAYLH
Sbjct: 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK 154
Query: 309 -VHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFI-----GTPHWMAPEVIQES 362
+HRD+K NILL ++ E +GDFG+A + M ++T + GT +APE +
Sbjct: 155 IIHRDVKAANILLDEEFEAVVGDFGLA----KLMDYKDTHVTTAVRGTIGHIAPEYLSTG 210
Query: 363 RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA-PMLEDKEKWSLV----F 417
+ K DV+ GV +E+ G ++ ++ +L++K+ +LV
Sbjct: 211 KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQ 270
Query: 418 HDFVAK-----------CLTKEPRARPTAAE---MLK 440
++ + C P RP +E ML+
Sbjct: 271 GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-28
Identities = 77/366 (21%), Positives = 132/366 (36%), Gaps = 114/366 (31%)
Query: 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC--- 243
+Y ++ +LG G + V+ + D++ + VA+KV+ + E E EI +L+
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNS 93
Query: 244 --SHPN---VVRYLGS--YQGEE--YLWIVMEYCGGGSVADLMNVTEE-PLEEYQIAYIC 293
+ PN VV+ L G ++ +V E G + + + L + I
Sbjct: 94 DPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKII 152
Query: 294 REALKGLAYLHSIFK-VHRDIKGGNILLT------------------------------- 321
++ L+GL YLH+ + +H DIK NILL+
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 322 ------------------DQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESR 363
++ +VK+ D G A I T + + EV+ S
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNA---CWVHKHFTEDIQTRQYRSLEVLIGSG 269
Query: 364 YDGKVDVWALGVSAVEMAEGLPP----------RSTVH-----------PMRVL------ 396
Y+ D+W+ A E+A G R H P +++
Sbjct: 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS 329
Query: 397 -----------FMISIEPAPM---LEDKEKWSL----VFHDFVAKCLTKEPRARPTAAEM 438
+ ++P + L +K +WS F DF+ L P R TAAE
Sbjct: 330 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC 389
Query: 439 LKHKFI 444
L+H ++
Sbjct: 390 LRHPWL 395
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 55/219 (25%), Positives = 86/219 (39%), Gaps = 38/219 (17%)
Query: 191 ELLNELGKGSYGAVYKAR-----DLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQ-CS 244
E LG G++G V A S VA+K++ E + E++M+ Q S
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 245 HPNVVRYLGSYQGEEYLWIVMEYCGGGS----------------------VADLMNVTEE 282
H N+V LG+ ++++ EYC G
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 283 PLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342
L + + KG+ +L VHRD+ N+L+T VK+ DFG L R +
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFG----LARDIM 223
Query: 343 KRNTFIGTPH------WMAPEVIQESRYDGKVDVWALGV 375
+ ++ + WMAPE + E Y K DVW+ G+
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 262
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-28
Identities = 65/329 (19%), Positives = 108/329 (32%), Gaps = 76/329 (23%)
Query: 187 TTKYELLNELGKGSYGAVYKARDLKTS-ELVAIKVISLSEGEEGY-EEIRGEIEMLQQ-- 242
+YE++ LG+G++G V + D VA+K+I Y E R EI +L++
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII---RNVGKYREAARLEINVLKKIK 74
Query: 243 ----CSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLM-NVTEEPLEEYQIAYICREAL 297
+ V + ++ I E G + + + +P + ++ +
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 298 KGLAYLHSIFKVHRDIKGGNILLTDQG-------------------EVKLGDFGVAAQLT 338
L +LH H D+K NIL + +++ DFG A
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193
Query: 339 RTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLP--PRSTVHPMRVL 396
+ T + T H+ PEVI E + DVW++G E G V+
Sbjct: 194 EHHT---TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250
Query: 397 FMISIEPAP--MLEDKEKWSLVFH------------------------------------ 418
+ P P M+ K +
Sbjct: 251 MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQL 310
Query: 419 -DFVAKCLTKEPRARPTAAEMLKHKFIER 446
D + + L +P R T AE L H F
Sbjct: 311 FDLMRRMLEFDPAQRITLAEALLHPFFAG 339
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 99.2 bits (246), Expect = 1e-22
Identities = 50/321 (15%), Positives = 98/321 (30%), Gaps = 66/321 (20%)
Query: 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISL-------SEGEEGYEEIRGEIE 238
PT K + ++G+G +G V++ VAIK+I++ ++ +EEI EI
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 239 MLQQC---------SHPNVVRYLGSY------------------------------QGEE 259
+ ++ + + ++
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFK-VHRDIKGGNI 318
L+IV+E+ GG DL + + I + LA + + HRD+ GN+
Sbjct: 136 QLFIVLEFEFGGI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193
Query: 319 LLTDQGEVKL-----------GDFGVAAQLTRTMSKRNTFIGTPHWM---APEVIQESRY 364
LL KL G+ + R G + E +
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDG 253
Query: 365 DGKVDVWALGVSAVEM-AEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAK 423
D + D++ L P S V + L ++ ++ +
Sbjct: 254 DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQ 313
Query: 424 CLTKEPRARPTAAEMLKHKFI 444
+ +A ++L +
Sbjct: 314 EFHRTMLNFSSATDLLCQHSL 334
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 49/212 (23%), Positives = 86/212 (40%), Gaps = 22/212 (10%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSH-PN 247
+Y L ++G GS+G +Y D+ E VAIK+ + + ++ E ++ +
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMMQGGVG 66
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307
+ +Y +VME G S+ DL N + + + + + Y+HS
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 125
Query: 308 KVHRDIKGGNILL---TDQGEVKLGDFGVAAQLTRTMSK-------RNTFIGTPHWM--- 354
+HRD+K N L+ V + DFG+A + + GT +
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 185
Query: 355 APEVIQESRYDGKVDVWALGVSAVEMAEG-LP 385
I++SR D D+ +LG + G LP
Sbjct: 186 THLGIEQSRRD---DLESLGYVLMYFNLGSLP 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 6e-17
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYE-EIRGEIEMLQQCSH-P 246
K+ L ++G GS+G +Y +++T+E VAIK+ ++ E + +LQ + P
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK-IYRILQGGTGIP 66
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI 306
N VR+ G +Y +VM+ G S+ DL N L + + + + + ++HS
Sbjct: 67 N-VRWFGVE--GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
Query: 307 FKVHRDIKGGNILL---TDQGEVKLGDFGVAAQLTRTMSKR-------NTFIGTPHWM-- 354
+HRDIK N L+ +V + DFG+A + T + + GT +
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASV 182
Query: 355 -APEVIQESRYDGKVDVWALGVSAVEMAEG-LP 385
I++SR D D+ +LG + G LP
Sbjct: 183 NTHLGIEQSRRD---DLESLGYVLMYFLRGSLP 212
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 45/214 (21%), Positives = 87/214 (40%), Gaps = 24/214 (11%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQ-CSHPN 247
Y++ +G+GS+G +++ +L ++ VAIK ++R E +
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAPQLRDEYRTYKLLAGCTG 67
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307
+ Q + +V++ G S+ DL+++ +A ++ L + +H
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 126
Query: 308 KVHRDIKGGNILL-----TDQGEVKLGDFGVAAQLTRTMSK-------RNTFIGTPHWM- 354
V+RDIK N L+ + + + DFG+ ++K + GT +M
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186
Query: 355 --APEVIQESRYDGKVDVWALGVSAVEMAEG-LP 385
++SR D D+ ALG + G LP
Sbjct: 187 INTHLGREQSRRD---DLEALGHVFMYFLRGSLP 217
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 47/214 (21%), Positives = 90/214 (42%), Gaps = 24/214 (11%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQ-CSHPN 247
+ + ++G G++G + ++L T+E VAIK+ + E +Q S
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL---EYRFYKQLGSGDG 66
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307
+ + +Y +V+E G S+ DL ++ + + I + + + Y+HS
Sbjct: 67 IPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125
Query: 308 KVHRDIKGGNILL-----TDQGEVKLGDFGVAAQLTRTMSK-------RNTFIGTPHWMA 355
++RD+K N L+ Q + + DF +A + +K + GT +M+
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS 185
Query: 356 PEV---IQESRYDGKVDVWALGVSAVEMAEG-LP 385
++SR D D+ ALG + G LP
Sbjct: 186 INTHLGKEQSRRD---DLEALGHMFMYFLRGSLP 216
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 43/253 (16%), Positives = 92/253 (36%), Gaps = 39/253 (15%)
Query: 167 RQQTKVSSSSIPESVTREDPT-TKYELLNELGKGSYGAVYKARDLKTS--------ELVA 217
Q S ++P D + +++L + + + G +Y+A T + +
Sbjct: 20 FQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFS 79
Query: 218 IKV----------ISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGS-YQGEEYLWIVME 266
+K+ + + ++ + L + +G ++Y ++V+
Sbjct: 80 LKLDAKDGRLFNEQNFFQRAAKPLQVNKWKK-LYSTPLLAIPTCMGFGVHQDKYRFLVLP 138
Query: 267 YCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL--TDQ 323
G S+ ++V+ L E + + L L +LH VH ++ NI + DQ
Sbjct: 139 SLGR-SLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ 197
Query: 324 GEVKLGDFGVAAQLTRT-------MSKRNTFIGTPHWM---APEVIQESRYDGKVDVWAL 373
+V L +G A + + R+ G ++ + SR D+ +L
Sbjct: 198 SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRS---DLQSL 254
Query: 374 GVSAVEMAEG-LP 385
G ++ G LP
Sbjct: 255 GYCMLKWLYGFLP 267
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 49/232 (21%), Positives = 86/232 (37%), Gaps = 35/232 (15%)
Query: 173 SSSSIPESVTREDPT-TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEG-- 229
S PE +D ++ L ++G G +G +Y A E A V+ + E G
Sbjct: 21 QSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPL 80
Query: 230 ------YEEIRGEIEMLQQCSHPNV-------VRYLGS--YQGEEYLWIVMEYCGGGSVA 274
Y+ + + + + + G ++G Y ++VME G +
Sbjct: 81 FSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ 139
Query: 275 DLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL--TDQGEVKLGDFG 332
+ ++ + + L L Y+H VH DIK N+LL + +V L D+G
Sbjct: 140 KISGQNGT-FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYG 198
Query: 333 VAAQLTRTMSK-------RNTFIGTPHWM---APEVIQESRYDGKVDVWALG 374
++ + + R GT + A + + SR DV LG
Sbjct: 199 LSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRS---DVEILG 247
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 25/212 (11%)
Query: 237 IEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREA 296
I Q + V EE Y ++ L+ + +Q+A
Sbjct: 156 ITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYS------FQVA------ 203
Query: 297 LKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH---- 352
KG+ +L S +HRD+ NILL+++ VK+ DFG L R + K ++
Sbjct: 204 -KGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG----LARDIYKDPDYVRKGDARLP 258
Query: 353 --WMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLED 409
WMAPE I + Y + DVW+ GV E+ G P V + F ++ +
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEEFCRRLKEGTRMRA 317
Query: 410 KEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441
+ + + + C EP RPT +E+++H
Sbjct: 318 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 30/142 (21%), Positives = 58/142 (40%), Gaps = 8/142 (5%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKAR-----DLKTSELVAIKVISLSEGEEGYEEIRGEIE 238
E P + +L LG+G++G V +A T VA+K++ + + E++
Sbjct: 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 77
Query: 239 MLQQ-CSHPNVVRYLG-SYQGEEYLWIVMEYCGGGSVAD-LMNVTEEPLEEYQIAYICRE 295
+L H NVV LG + L +++E+C G+++ L + E + R+
Sbjct: 78 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQ 137
Query: 296 ALKGLAYLHSIFKVHRDIKGGN 317
+ + K D +
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSS 159
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 47/256 (18%), Positives = 88/256 (34%), Gaps = 40/256 (15%)
Query: 151 SMRRFGSSSSLHGEDVRQQTKVSSSSIPESVTREDPT-TKYELLNELGKGSYGAVYKAR- 208
SMR + + + D +++ +G+G +G +Y A
Sbjct: 1 SMRV----KAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADM 56
Query: 209 ----DLKTSELVAIKVISLSEG----EEGYEEIRGEIEMLQQCSHPNVVRYLG------- 253
+ + +KV G E + + + E +Q+ ++YLG
Sbjct: 57 NSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS 116
Query: 254 ---SYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVH 310
G+ Y +++M+ G + + + + + L L Y+H VH
Sbjct: 117 GLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVH 175
Query: 311 RDIKGGNILL--TDQGEVKLGDFGVAAQLTRTMSK-------RNTFIGTPHWM---APEV 358
DIK N+LL + +V L D+G+A + + GT + A
Sbjct: 176 GDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG 235
Query: 359 IQESRYDGKVDVWALG 374
+ SR D+ LG
Sbjct: 236 VAPSRRG---DLEILG 248
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 774 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.73 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.17 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.97 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.84 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.55 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.46 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.31 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.27 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.23 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.19 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.1 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.59 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.43 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.39 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.36 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.32 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.27 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.22 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.2 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.16 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.1 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.06 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.67 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.62 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.54 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.07 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.76 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-60 Score=522.02 Aligned_cols=260 Identities=37% Similarity=0.653 Sum_probs=237.5
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
+...|+++++||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus 72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 45679999999999999999999999999999999976543 33456889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
|||+||+|.+++.. .++++.+++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+........
T Consensus 151 Ey~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 151 EFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp CCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred eCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence 99999999999863 5699999999999999999999999999999999999999999999999999998876656667
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhc
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCL 425 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL 425 (774)
+.+||+.|||||++.+..|+.++|||||||++|||++|++||...+....+..+.....+.......++..+++||.+||
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L 308 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLL 308 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHS
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHc
Confidence 78999999999999999999999999999999999999999999888887777766655556666788999999999999
Q ss_pred ccCCCCCCCHHHHHhhhhhhhhc
Q 004088 426 TKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 426 ~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
++||++|||+.|+|+||||++..
T Consensus 309 ~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 309 VRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp CSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCChhHCcCHHHHhcCHhhcCCC
Confidence 99999999999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-60 Score=517.07 Aligned_cols=259 Identities=31% Similarity=0.522 Sum_probs=227.1
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
..++|+++++||+|+||+||+|+++.+|+.||||++.+.. .....+.+.+|+++|++|+|||||+++++|++++.+|||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 3478999999999999999999999999999999997654 344567899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 265 mEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
||||+||+|.+++... ...+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+......
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence 9999999999999644 346899999999999999999999999999999999999999999999999999877654444
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHh
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAK 423 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~k 423 (774)
..+.+||+.|||||++.+..|+.++|||||||++|||++|++||...+....+..+.....+. ....++..+.+||.+
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~--~~~~~s~~~~~li~~ 259 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP--VSLHYSYDLRSLVSQ 259 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--CCTTSCHHHHHHHHH
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC--CCccCCHHHHHHHHH
Confidence 456789999999999999999999999999999999999999999988877777665554332 345688999999999
Q ss_pred hcccCCCCCCCHHHHHhhhhhhh
Q 004088 424 CLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 424 cL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
||++||.+|||+.|+|+||||++
T Consensus 260 ~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 260 LFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp HTCSSGGGSCCHHHHHTSHHHHT
T ss_pred HccCChhHCcCHHHHhcCHHhhc
Confidence 99999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-59 Score=525.80 Aligned_cols=261 Identities=37% Similarity=0.656 Sum_probs=238.8
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
.+...|+++++||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|++|+|||||+++++|..++.+|||
T Consensus 148 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 148 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 345789999999999999999999999999999999976543 3346688999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
||||+||+|.+++.. ..+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+.......
T Consensus 227 mEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 304 (423)
T 4fie_A 227 MEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 304 (423)
T ss_dssp EECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred EeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence 999999999999863 569999999999999999999999999999999999999999999999999999887666666
Q ss_pred ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
.+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+......+..+.....+.......++..+++||.+|
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 384 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 384 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHH
Confidence 78899999999999999999999999999999999999999999988888877776665556666678899999999999
Q ss_pred cccCCCCCCCHHHHHhhhhhhhhc
Q 004088 425 LTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 425 L~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
|++||.+|||+.|+|+||||++..
T Consensus 385 L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 385 LVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred cCCChhHCcCHHHHhcCHHhcCCC
Confidence 999999999999999999998754
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-60 Score=508.39 Aligned_cols=259 Identities=27% Similarity=0.432 Sum_probs=230.4
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+.+|+++|++|+|||||+++++|++++.+|||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 457999999999999999999999999999999997542 233457799999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc--cc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT--MS 342 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~--~~ 342 (774)
||||+||+|.++++ ..+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+... ..
T Consensus 111 mEy~~gG~L~~~i~-~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 111 LSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp ECCCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred EecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 99999999999996 4467999999999999999999999999999999999999999999999999999877533 22
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
...+.+||+.|||||++.+..|+.++|||||||++|+|++|++||...+.......+...... .+..+++.+++||.
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~---~p~~~s~~~~dli~ 266 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD---FPEKFFPKARDLVE 266 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---CCTTCCHHHHHHHH
T ss_pred cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---CCcccCHHHHHHHH
Confidence 345679999999999999999999999999999999999999999988877777666554332 23568899999999
Q ss_pred hhcccCCCCCCCHHH------HHhhhhhhhhcc
Q 004088 423 KCLTKEPRARPTAAE------MLKHKFIERCKC 449 (774)
Q Consensus 423 kcL~~DP~kRPTa~E------lL~HPwf~~~~~ 449 (774)
+||++||.+|||+.| +++||||+...+
T Consensus 267 ~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw 299 (311)
T 4aw0_A 267 KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 299 (311)
T ss_dssp HHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred HHccCCHhHCcChHHHcCCHHHHCCCCcCCCCH
Confidence 999999999999987 688999987644
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-58 Score=491.81 Aligned_cols=256 Identities=29% Similarity=0.490 Sum_probs=219.3
Q ss_pred CCCe-eEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccC----Cce
Q 004088 187 TTKY-ELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG----EEY 260 (774)
Q Consensus 187 ~~~Y-~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~----~~~ 260 (774)
.++| ++.++||+|+||+||+|.+..+++.||||++.... .....+.+.+|+.+|++|+|||||+++++|.. +..
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 3455 78889999999999999999999999999997543 34456779999999999999999999999864 467
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcC--cccccccccceEecC-CCcEEEeeccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF--KVHRDIKGGNILLTD-QGEVKLGDFGVAAQL 337 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~g--IIHRDLKPeNILLd~-~g~vKL~DFGlA~~i 337 (774)
+|||||||+||+|.+++. ....+++..++.|+.||+.||.|||++| ||||||||+||||+. +|.+||+|||+|+..
T Consensus 104 ~~lvmEy~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEeCCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 899999999999999996 4567999999999999999999999999 999999999999985 789999999999754
Q ss_pred cccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHH
Q 004088 338 TRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVF 417 (774)
Q Consensus 338 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l 417 (774)
.. ....+.+||+.|||||++.+ .|+.++|||||||++|||++|++||........+................+++.+
T Consensus 183 ~~--~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 259 (290)
T 3fpq_A 183 RA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259 (290)
T ss_dssp CT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred CC--CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHH
Confidence 33 33456799999999999875 6999999999999999999999999876655544443333333333445678899
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 418 HDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 418 ~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
.+||.+||++||.+|||+.|+|+||||++
T Consensus 260 ~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 260 KEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 99999999999999999999999999974
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-58 Score=489.36 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=210.0
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
.++|++++.||+|+||+||+|++..+|+.||||++.+.. .......+.+|+.+|++++|||||+++++|.+++.+|||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 468999999999999999999999999999999997543 234456799999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
|||| +|+|.+++. ..+++++.+++.++.||+.||+|||++|||||||||+||||+.++++||+|||+|+..... ...
T Consensus 92 mEy~-~g~L~~~l~-~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~ 168 (275)
T 3hyh_A 92 IEYA-GNELFDYIV-QRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFL 168 (275)
T ss_dssp EECC-CEEHHHHHH-HSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred EeCC-CCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC-Ccc
Confidence 9999 679999886 4567999999999999999999999999999999999999999999999999999866543 334
Q ss_pred ccccccccccchhhhhhcCC-CCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHh
Q 004088 345 NTFIGTPHWMAPEVIQESRY-DGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAK 423 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~~-s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~k 423 (774)
.+.+||+.|||||++.+..| +.++|||||||++|+|++|++||...+.......+...... .+..+++.+++||.+
T Consensus 169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~li~~ 245 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT---LPKFLSPGAAGLIKR 245 (275)
T ss_dssp ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---CCTTSCHHHHHHHHH
T ss_pred CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCHHHHHHHHH
Confidence 56789999999999998876 57999999999999999999999987776666555544332 235678999999999
Q ss_pred hcccCCCCCCCHHHHHhhhhhhh
Q 004088 424 CLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 424 cL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
||++||++|||++|+|+||||+.
T Consensus 246 ~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 246 MLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HccCChhHCcCHHHHHcCccccc
Confidence 99999999999999999999973
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-58 Score=497.03 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=220.0
Q ss_pred CCCeeEEeeeeccCceEEEEEEEc---CCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDL---KTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~---~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
.++|++++.||+|+||+||+|++. .+++.||||++++.. .......+.+|+.+|++++|||||+++++|++++.+|
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 357999999999999999999974 468899999997543 1222346789999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
||||||+||+|.+++. ..+.+++.+++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.......
T Consensus 103 ivmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 181 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLS-KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181 (304)
T ss_dssp EEECCCTTCEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C
T ss_pred EEEEcCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc
Confidence 9999999999999996 446799999999999999999999999999999999999999999999999999987665555
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
...+.+||+.|||||++.+..|+.++|||||||++|||++|++||...+..+....+...... .+..+++.+.+||.
T Consensus 182 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~li~ 258 (304)
T 3ubd_A 182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG---MPQFLSPEAQSLLR 258 (304)
T ss_dssp CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTSCHHHHHHHH
T ss_pred cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCC---CCCcCCHHHHHHHH
Confidence 566789999999999999999999999999999999999999999998887777766554332 24568899999999
Q ss_pred hhcccCCCCCCC-----HHHHHhhhhhhhh
Q 004088 423 KCLTKEPRARPT-----AAEMLKHKFIERC 447 (774)
Q Consensus 423 kcL~~DP~kRPT-----a~ElL~HPwf~~~ 447 (774)
+||++||++||| ++|+++||||+..
T Consensus 259 ~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 259 MLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp HHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 999999999998 5899999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-57 Score=496.07 Aligned_cols=256 Identities=29% Similarity=0.394 Sum_probs=224.2
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
....|++.++||+|+||+||+|+++.+|+.||||++++... ..+|+.+|++|+|||||+++++|.+++.+||||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm 129 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFM 129 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 45679999999999999999999999999999999975432 247999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC-cEEEeecccccccccccc--
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG-EVKLGDFGVAAQLTRTMS-- 342 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g-~vKL~DFGlA~~i~~~~~-- 342 (774)
|||+||+|.++++. .+.+++..++.|+.||+.||.|||++|||||||||+||||+.+| ++||+|||+|+.+.....
T Consensus 130 Ey~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp CCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred eccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 99999999999964 46799999999999999999999999999999999999999988 699999999987654321
Q ss_pred ---ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHH
Q 004088 343 ---KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHD 419 (774)
Q Consensus 343 ---~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~d 419 (774)
.....+||+.|||||++.+..|+.++|||||||++|||++|++||...........+...+.+....+..++..+.+
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~ 288 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQ 288 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHH
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHH
Confidence 12346899999999999999999999999999999999999999998877777777766665555556788999999
Q ss_pred HHHhhcccCCCCCCCHHHHH-------------hhhhhhhhc
Q 004088 420 FVAKCLTKEPRARPTAAEML-------------KHKFIERCK 448 (774)
Q Consensus 420 LI~kcL~~DP~kRPTa~ElL-------------~HPwf~~~~ 448 (774)
||.+||++||.+|||+.|++ +|||+...+
T Consensus 289 li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 289 AIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred HHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 99999999999999999985 577776543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=472.12 Aligned_cols=256 Identities=29% Similarity=0.443 Sum_probs=203.8
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCc--------
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE-------- 259 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~-------- 259 (774)
++|++++.||+|+||+||+|+++.+|+.||||+++........+.+.+|+++|++|+|||||+++++|...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 359999999999999999999999999999999987666666778999999999999999999999986433
Q ss_pred ----eEEEEEEecCCCchhhhhhccCC--chhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccc
Q 004088 260 ----YLWIVMEYCGGGSVADLMNVTEE--PLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGV 333 (774)
Q Consensus 260 ----~l~LVmEy~~ggsL~dll~~~~~--~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGl 333 (774)
++|||||||.+|+|.+++..... ...+..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 57999999999999999974322 245567889999999999999999999999999999999999999999999
Q ss_pred ccccccccc------------ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCc-hhhhhhhh
Q 004088 334 AAQLTRTMS------------KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHP-MRVLFMIS 400 (774)
Q Consensus 334 A~~i~~~~~------------~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~-~~~i~~i~ 400 (774)
|+.+..... ...+.+||+.|||||++.+..|+.++|||||||++|||++ ||..... ...+..+.
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~ 241 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVR 241 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHh
Confidence 987654321 1234689999999999999999999999999999999996 7754322 22222222
Q ss_pred cCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 401 IEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 401 ~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
....+ +.....++.+.+||.+||++||.+|||+.|+|+||||+...
T Consensus 242 ~~~~p--~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 242 NLKFP--PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp TTCCC--HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred cCCCC--CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 22222 22334456778999999999999999999999999998654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-55 Score=484.70 Aligned_cols=260 Identities=26% Similarity=0.434 Sum_probs=218.8
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCccccccccc------CCc
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ------GEE 259 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~------~~~ 259 (774)
.++|+++++||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+++|++|+|||||++++++. +.+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 468999999999999999999999999999999997543 3344567889999999999999999999865 446
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
.+|||||||+ |+|.+++. ..+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+..
T Consensus 133 ~~~ivmE~~~-g~L~~~i~-~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH-SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT-SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEEEEEeCCC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 8999999995 67998886 456899999999999999999999999999999999999999999999999999987643
Q ss_pred c----ccccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC---CCC------
Q 004088 340 T----MSKRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE---PAP------ 405 (774)
Q Consensus 340 ~----~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~---~~~------ 405 (774)
. .....+.+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.+....+..+... +..
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~ 290 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV 290 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence 2 2234567999999999999875 4699999999999999999999999988776655443211 100
Q ss_pred -------------------ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 406 -------------------MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 406 -------------------~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.......++..+.+||.+||++||.+|||+.|+|+||||++..
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 0001124578899999999999999999999999999998754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-55 Score=467.72 Aligned_cols=259 Identities=25% Similarity=0.415 Sum_probs=222.7
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCC
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDL-----KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE 258 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~-----~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~ 258 (774)
....++|.+.++||+|+||+||+|++. .++..||||+++.. .....+.|.+|+++|++|+|||||+++++|.+.
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 87 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 445678999999999999999999875 35789999999643 455667899999999999999999999999999
Q ss_pred ceEEEEEEecCCCchhhhhhcc------------CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcE
Q 004088 259 EYLWIVMEYCGGGSVADLMNVT------------EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEV 326 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~------------~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~v 326 (774)
+.+|||||||++|+|.++++.. ...+++.++..|+.||+.||.|||+++||||||||+||||+.++.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence 9999999999999999999643 2469999999999999999999999999999999999999999999
Q ss_pred EEeeccccccccccccc--cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCC
Q 004088 327 KLGDFGVAAQLTRTMSK--RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEP 403 (774)
Q Consensus 327 KL~DFGlA~~i~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~ 403 (774)
||+|||+|+.+...... ....+||+.|||||++.+..|+.++|||||||++|||++ |++||......+....+....
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999876543222 233579999999999999999999999999999999998 899999988877776665443
Q ss_pred CCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 404 APMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 404 ~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
.+ ..+..++..+.+||.+||+.||++|||+.+| |+|+++.
T Consensus 248 ~~--~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~ 287 (299)
T 4asz_A 248 VL--QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNL 287 (299)
T ss_dssp CC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHH
T ss_pred CC--CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHH
Confidence 32 3345788999999999999999999999999 6677754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-54 Score=464.46 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=222.0
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCC
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDL-----KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE 258 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~-----~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~ 258 (774)
+.....++++++||+|+||+||+|++. .+++.||||+++........+.|.+|+.+|++++|||||+++++|..+
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 455678999999999999999999863 367899999997655555668899999999999999999999999999
Q ss_pred ceEEEEEEecCCCchhhhhhcc---------------CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC
Q 004088 259 EYLWIVMEYCGGGSVADLMNVT---------------EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ 323 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~---------------~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~ 323 (774)
..+|||||||++|+|.+++... ...+++..+..|+.||+.||.|||+++||||||||+||||+.+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC
Confidence 9999999999999999998532 2458999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccccc--cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 004088 324 GEVKLGDFGVAAQLTRTM--SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMIS 400 (774)
Q Consensus 324 g~vKL~DFGlA~~i~~~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~ 400 (774)
+.+||+|||+|+.+.... ......+||+.|||||++.+..|+.++|||||||++|||++ |.+||.+....+....+.
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~ 261 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 261 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999998764432 22345689999999999999999999999999999999998 899999988877776665
Q ss_pred cCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 401 IEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 401 ~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
....+ +.+..++..+.+||.+||+.||.+|||+.||+++
T Consensus 262 ~~~~~--~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 262 NRQVL--PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp TTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCC--CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44332 3355788999999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-54 Score=464.24 Aligned_cols=257 Identities=28% Similarity=0.500 Sum_probs=213.7
Q ss_pred ccCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCce
Q 004088 182 TREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEY 260 (774)
Q Consensus 182 ~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~ 260 (774)
.|+...++|++.++||+|+||+||+|++. ..||||+++... .....+.|.+|+.+|++++|||||++++++.. +.
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN 105 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence 46778889999999999999999999853 259999997543 44566789999999999999999999998865 56
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
+|||||||++|+|.+++.....++++.++..|+.||+.||.|||+++||||||||+||||+.++.+||+|||+|+.....
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 89999999999999999877778999999999999999999999999999999999999999999999999999866432
Q ss_pred c--cccccccccccccchhhhhh---cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC--CCC-ccccchh
Q 004088 341 M--SKRNTFIGTPHWMAPEVIQE---SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE--PAP-MLEDKEK 412 (774)
Q Consensus 341 ~--~~~~~~~GT~~Y~APEvl~~---~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~--~~~-~~~~~~~ 412 (774)
. ......+||+.|||||++.+ ..|+.++|||||||++|||++|+.||........+..+... ..+ .......
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 265 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKN 265 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTT
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Confidence 2 22345689999999999974 35899999999999999999999999887665544433222 111 2233456
Q ss_pred chHHHHHHHHhhcccCCCCCCCHHHHHhhh
Q 004088 413 WSLVFHDFVAKCLTKEPRARPTAAEMLKHK 442 (774)
Q Consensus 413 ~s~~l~dLI~kcL~~DP~kRPTa~ElL~HP 442 (774)
++..+.+||.+||+.||++|||+.||+++-
T Consensus 266 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~L 295 (307)
T 3omv_A 266 CPKAMKRLVADCVKKVKEERPLFPQILSSI 295 (307)
T ss_dssp SCHHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 789999999999999999999999998764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-54 Score=465.84 Aligned_cols=255 Identities=25% Similarity=0.406 Sum_probs=214.3
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCC
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDL-----KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE 258 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~-----~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~ 258 (774)
.....+|.+.++||+|+||+||+|++. .+++.||||+++. ......+.|.+|+++|++|+|||||+++++|.+.
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQHIVRFFGVCTEG 115 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC-CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 345578999999999999999999865 3688999999964 3455667899999999999999999999999999
Q ss_pred ceEEEEEEecCCCchhhhhhcc--------------CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC
Q 004088 259 EYLWIVMEYCGGGSVADLMNVT--------------EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG 324 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~--------------~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g 324 (774)
..+|||||||++|+|.++++.. ..++++.++..|+.||+.||.|||+++||||||||+||||+.++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence 9999999999999999998643 24689999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhc
Q 004088 325 EVKLGDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISI 401 (774)
Q Consensus 325 ~vKL~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~ 401 (774)
.+||+|||+|+.+..... .....+||+.|||||++.+..|+.++|||||||++|||++ |+.||......+.+..+..
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 275 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999987644322 2234679999999999999999999999999999999998 8999998888777766554
Q ss_pred CCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 402 EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 402 ~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
... .+.+..+++.+.+||.+||+.||++|||+.||+++
T Consensus 276 g~~--~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 276 GRE--LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp TCC--CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCC--CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 332 23345788999999999999999999999999865
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=467.48 Aligned_cols=254 Identities=26% Similarity=0.367 Sum_probs=207.8
Q ss_pred CCCeeEEeeeeccCceEEEEEEEc---CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDL---KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~---~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~ 262 (774)
.++|+++++||+|+||+||+|+++ .+++.||||++.... ....+.+|+++|+.+ +|||||+++++|.+.+++|
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 468999999999999999999875 467899999986443 235678999999998 6999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC-CcEEEeeccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ-GEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~-g~vKL~DFGlA~~i~~~~ 341 (774)
||||||++++|.++++ .+++.+++.++.||+.||+|||++|||||||||+||||+.+ +.+||+|||+|+......
T Consensus 97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 9999999999999884 58999999999999999999999999999999999999877 799999999997553321
Q ss_pred ----------------------------cccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCc
Q 004088 342 ----------------------------SKRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHP 392 (774)
Q Consensus 342 ----------------------------~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~ 392 (774)
....+.+||++|||||++.+. .|+.++||||+||++|||++|++||.....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 112345899999999999875 489999999999999999999999965432
Q ss_pred -hhhhhhhhc---------------------C--C----------------------------CCccccchhchHHHHHH
Q 004088 393 -MRVLFMISI---------------------E--P----------------------------APMLEDKEKWSLVFHDF 420 (774)
Q Consensus 393 -~~~i~~i~~---------------------~--~----------------------------~~~~~~~~~~s~~l~dL 420 (774)
...+..+.. . + .........+++++.||
T Consensus 253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL 332 (361)
T 4f9c_A 253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL 332 (361)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence 222211100 0 0 00011123457889999
Q ss_pred HHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 421 VAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
|.+||++||.+|||++|+|+||||+++
T Consensus 333 l~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 333 LDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-53 Score=491.06 Aligned_cols=261 Identities=25% Similarity=0.378 Sum_probs=232.8
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
.++|++++.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|+.|+|||||+|+++|.+...+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 468999999999999999999999999999999997543 3445778999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC--CcEEEeecccccccccccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ--GEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~--g~vKL~DFGlA~~i~~~~~~~ 344 (774)
||.||+|.+++......+++.+++.|+.||+.||.|||++|||||||||+|||++.+ +.+||+|||+|+.+... ...
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-~~~ 313 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSV 313 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-SEE
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-Cce
Confidence 999999999987666789999999999999999999999999999999999999864 79999999999877544 334
Q ss_pred ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCC-ccccchhchHHHHHHHHh
Q 004088 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAP-MLEDKEKWSLVFHDFVAK 423 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~-~~~~~~~~s~~l~dLI~k 423 (774)
.+.+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+....+..+...... .......++..+++||.+
T Consensus 314 ~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ 393 (573)
T 3uto_A 314 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 393 (573)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHT
T ss_pred eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHH
Confidence 5678999999999999999999999999999999999999999998888777666544332 233345689999999999
Q ss_pred hcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 424 CLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 424 cL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
||++||.+|||+.|+|+||||+....
T Consensus 394 ~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 394 LLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp TSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HccCChhHCcCHHHHhcCcCcCCCCC
Confidence 99999999999999999999986543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-53 Score=462.21 Aligned_cols=258 Identities=26% Similarity=0.429 Sum_probs=220.2
Q ss_pred ccCCCCCCeeEEeeeeccCceEEEEEEEcCC-----CcEEEEEEeecCCChhhHHHHHHHHHHHHhCCC-CCcccccccc
Q 004088 182 TREDPTTKYELLNELGKGSYGAVYKARDLKT-----SELVAIKVISLSEGEEGYEEIRGEIEMLQQCSH-PNVVRYLGSY 255 (774)
Q Consensus 182 ~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~-----g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~H-PNIVkL~~~~ 255 (774)
.|+.+.++|+++++||+|+||+||+|++... ++.||||++.........+.+.+|+++|.++.| ||||+++++|
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 3677889999999999999999999997654 468999999766666667789999999999965 8999999998
Q ss_pred cC-CceEEEEEEecCCCchhhhhhcc---------------CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceE
Q 004088 256 QG-EEYLWIVMEYCGGGSVADLMNVT---------------EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNIL 319 (774)
Q Consensus 256 ~~-~~~l~LVmEy~~ggsL~dll~~~---------------~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNIL 319 (774)
.. +..+|||||||++|+|.++++.. ...+++..+..|+.||+.||.|||+++||||||||+|||
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 65 56799999999999999999643 235899999999999999999999999999999999999
Q ss_pred ecCCCcEEEeecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhh
Q 004088 320 LTDQGEVKLGDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVL 396 (774)
Q Consensus 320 Ld~~g~vKL~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i 396 (774)
|+.++.+||+|||+|+.+..... .....+||+.|||||++.+..|+.++|||||||++|||++ |++||........+
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~ 297 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 297 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999987654322 2345689999999999999999999999999999999998 99999887654443
Q ss_pred hh-hhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 397 FM-ISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 397 ~~-i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.. +..... ...+..+++.+.+||.+||+.||.+|||+.+|++|
T Consensus 298 ~~~i~~g~~--~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 298 CRRLKEGTR--MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCC--CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 33 222222 23345678999999999999999999999999988
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-53 Score=493.95 Aligned_cols=256 Identities=23% Similarity=0.409 Sum_probs=217.8
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-----ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-----GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-----~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........++++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 468999999999999999999999999999999997532 122223334556777788999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|||||||+||+|..++. ..+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 268 ylVmEy~~GGdL~~~l~-~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~- 345 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 345 (689)
T ss_dssp EEEECCCCSCBHHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EEEEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC-
Confidence 99999999999999996 4467999999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCch---hhhhhhhcCCCCccccchhchHHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPM---RVLFMISIEPAPMLEDKEKWSLVF 417 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~---~~i~~i~~~~~~~~~~~~~~s~~l 417 (774)
...+.+||+.|||||++.. ..|+.++|||||||++|||++|++||...... .....+..... ..+..++..+
T Consensus 346 -~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~---~~p~~~S~~a 421 (689)
T 3v5w_A 346 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV---ELPDSFSPEL 421 (689)
T ss_dssp -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC---CCCTTSCHHH
T ss_pred -CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC---CCCccCCHHH
Confidence 3456799999999999964 57999999999999999999999999764332 22222222222 2345689999
Q ss_pred HHHHHhhcccCCCCCCC-----HHHHHhhhhhhhhc
Q 004088 418 HDFVAKCLTKEPRARPT-----AAEMLKHKFIERCK 448 (774)
Q Consensus 418 ~dLI~kcL~~DP~kRPT-----a~ElL~HPwf~~~~ 448 (774)
++||.+||++||.+|++ ++||++||||+.+.
T Consensus 422 ~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 422 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp HHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred HHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence 99999999999999998 79999999998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=428.26 Aligned_cols=260 Identities=44% Similarity=0.782 Sum_probs=232.9
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
...+|++++.||+|+||+||+|.+..+++.||||++..... ...+.+.+|+.+|++++||||++++++|...+.+|+||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 45789999999999999999999999999999999975443 33567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
|||.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+........
T Consensus 97 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp ECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred ECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence 99999999999864 4689999999999999999999999999999999999999999999999999987766555556
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhc
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCL 425 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL 425 (774)
..+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.....+....+..++..+.+||.+||
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 254 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHS
T ss_pred CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHc
Confidence 67899999999999999999999999999999999999999998877766665554444455556778999999999999
Q ss_pred ccCCCCCCCHHHHHhhhhhhhhc
Q 004088 426 TKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 426 ~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
+.||.+|||+.|+|+||||+..+
T Consensus 255 ~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 255 EMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp CSSTTTSCCHHHHTTCGGGGGCC
T ss_pred cCChhHCcCHHHHhhChhhcccC
Confidence 99999999999999999998654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=428.10 Aligned_cols=257 Identities=28% Similarity=0.470 Sum_probs=226.9
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
..++|++++.||+|+||.||+|++..+|+.||||++.... .....+.+.+|+++|+.++||||+++++++.....+|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 4578999999999999999999999999999999997543 345567789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
||||++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+... ...
T Consensus 93 ~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~ 170 (328)
T 3fe3_A 93 MEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKL 170 (328)
T ss_dssp ECCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-CGG
T ss_pred EECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-Ccc
Confidence 999999999999863 467999999999999999999999999999999999999999999999999999766543 334
Q ss_pred ccccccccccchhhhhhcCCC-CccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHh
Q 004088 345 NTFIGTPHWMAPEVIQESRYD-GKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAK 423 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~~s-~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~k 423 (774)
...+||+.|+|||++.+..+. .++|||||||++|+|++|++||...+.......+...... .+..++..+.+||.+
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~li~~ 247 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR---IPFYMSTDCENLLKR 247 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTSCHHHHHHHHH
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---CCCCCCHHHHHHHHH
Confidence 566899999999999988775 7899999999999999999999988776666555443222 234568899999999
Q ss_pred hcccCCCCCCCHHHHHhhhhhhhh
Q 004088 424 CLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 424 cL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
||+.||.+|||+.|+|+||||...
T Consensus 248 ~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 248 FLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp HCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred HCCCChhHCcCHHHHhcCHhhcCC
Confidence 999999999999999999999754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-50 Score=435.19 Aligned_cols=260 Identities=28% Similarity=0.431 Sum_probs=222.6
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l 261 (774)
...++|++++.||+|+||.||+|++..+|+.||||++.+.. .....+.+.+|+.+|+.+ +||||++++++|.....+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 45679999999999999999999999999999999997532 233456788999999988 799999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|||||||.+|+|..++.. ...+++..++.++.||+.||.|||++|||||||||+||||+.++++||+|||+|+......
T Consensus 100 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 999999999999999863 4679999999999999999999999999999999999999999999999999998654444
Q ss_pred cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI 421 (774)
....+.+||+.|+|||++.+..|+.++|||||||++|+|++|++||...+.......+...... .+..++..+.+||
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~~~~~~~li 255 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV---YPTWLHEDATGIL 255 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTSCHHHHHHH
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCHHHHHHH
Confidence 4456678999999999999999999999999999999999999999988877776666544322 2345788999999
Q ss_pred HhhcccCCCCCCCH------HHHHhhhhhhhhc
Q 004088 422 AKCLTKEPRARPTA------AEMLKHKFIERCK 448 (774)
Q Consensus 422 ~kcL~~DP~kRPTa------~ElL~HPwf~~~~ 448 (774)
.+||++||.+||++ .++++||||+.+.
T Consensus 256 ~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp HHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred HHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence 99999999999999 9999999998653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=430.01 Aligned_cols=248 Identities=25% Similarity=0.368 Sum_probs=192.3
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCc----eEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE----YLWI 263 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~----~l~L 263 (774)
.+|.+.++||+|+||+||+|++ +|+.||||+++... ........|+.++.+++|||||++++++..++ .+||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 4689999999999999999986 68999999986432 11122345666677899999999999997543 6899
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhc--------CcccccccccceEecCCCcEEEeeccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI--------FKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~--------gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
|||||++|+|.++++. .++++..+..++.|++.||.|||++ +||||||||+||||+.++++||+|||+|+
T Consensus 79 V~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 9999999999999963 4689999999999999999999987 89999999999999999999999999998
Q ss_pred ccccccc----ccccccccccccchhhhhhc------CCCCccchhhhHHHHHHHHhCCCCCCCCCchhh----------
Q 004088 336 QLTRTMS----KRNTFIGTPHWMAPEVIQES------RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRV---------- 395 (774)
Q Consensus 336 ~i~~~~~----~~~~~~GT~~Y~APEvl~~~------~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~---------- 395 (774)
....... .....+||+.|||||++.+. .|+.++|||||||++|||++|.+||........
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 7654322 12345899999999999764 467899999999999999999887653322111
Q ss_pred ----hhh-hhc-CCCCccc---cchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 396 ----LFM-ISI-EPAPMLE---DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 396 ----i~~-i~~-~~~~~~~---~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
... +.. ...+..+ .....+..+.+||.+||+.||++|||+.||++.
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 111 111 1111111 112334678899999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=428.41 Aligned_cols=257 Identities=30% Similarity=0.465 Sum_probs=227.0
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
.++|++++.||+|+||+||+|++..+|+.||||++++.. .......+.+|+.+|+.++||||++++++|.....+|||
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999999999999999997532 223456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
||||++|+|..++. ....+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+++.........
T Consensus 84 ~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~ 162 (337)
T 1o6l_A 84 MEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162 (337)
T ss_dssp EECCTTCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred EeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcc
Confidence 99999999999886 34679999999999999999999999999999999999999999999999999998654444445
Q ss_pred ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
...+||+.|+|||++.+..|+.++|||||||++|||++|.+||...+.......+...... .+..++..+.+||.+|
T Consensus 163 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~li~~l 239 (337)
T 1o6l_A 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR---FPRTLSPEAKSLLAGL 239 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTSCHHHHHHHHHH
T ss_pred cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCHHHHHHHHHH
Confidence 6678999999999999999999999999999999999999999987776665555433222 2346788999999999
Q ss_pred cccCCCCCC-----CHHHHHhhhhhhhh
Q 004088 425 LTKEPRARP-----TAAEMLKHKFIERC 447 (774)
Q Consensus 425 L~~DP~kRP-----Ta~ElL~HPwf~~~ 447 (774)
|++||.+|| ++.++++||||+..
T Consensus 240 L~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred hhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 999999999 99999999999764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=420.57 Aligned_cols=259 Identities=25% Similarity=0.383 Sum_probs=227.6
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
..++|++++.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+|+.++||||++++++|.+...+|+||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 457899999999999999999999999999999998643 334567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC--CCcEEEeeccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD--QGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~--~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..+... ..
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-~~ 159 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DN 159 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CE
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-Cc
Confidence 999999999999766668999999999999999999999999999999999999987 789999999999876543 23
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCc-cccchhchHHHHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPM-LEDKEKWSLVFHDFVA 422 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~-~~~~~~~s~~l~dLI~ 422 (774)
....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+....... ......++..+.+||.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 239 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHH
Confidence 345679999999999999889999999999999999999999999877766665554433222 2223467889999999
Q ss_pred hhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 423 KCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
+||..||.+|||+.|+|+||||+..
T Consensus 240 ~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 240 RLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp TTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHcCCChhHCcCHHHHhcChhhccC
Confidence 9999999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=417.81 Aligned_cols=263 Identities=28% Similarity=0.441 Sum_probs=217.6
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
....++|+++++||+|+||+||+|++. +|+.||||++..... ......+.+|+.+|++++||||+++++++.....+|
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 345689999999999999999999984 589999999965432 233467889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
+|||||++ +|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 96 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp EEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred EEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 99999974 78888776667799999999999999999999999999999999999999999999999999987755444
Q ss_pred ccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc---CCCCc------------
Q 004088 343 KRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI---EPAPM------------ 406 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~---~~~~~------------ 406 (774)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||...........+.. .+.+.
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence 4455689999999999976 5689999999999999999999999987665544333211 11100
Q ss_pred ------------cccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 407 ------------LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 407 ------------~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
......++..+.+||.+||++||.+|||+.|+|+||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 011223567899999999999999999999999999998653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=428.45 Aligned_cols=260 Identities=29% Similarity=0.447 Sum_probs=227.4
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh-----hhHHHHHHHHHHHHhCCCCCcccccccccCCc
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE-----EGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE 259 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~-----~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~ 259 (774)
...++|++++.||+|+||.||+|++..+|+.||||++...... ...+.+.+|+.+|++++||||++++++|.+..
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 3456899999999999999999999999999999999765422 23577899999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC----cEEEeeccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG----EVKLGDFGVAA 335 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g----~vKL~DFGlA~ 335 (774)
.+|||||||.+++|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 89 ~~~lv~e~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEEEECCCSCBHHHHHT-TCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEEEcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 9999999999999999986 456799999999999999999999999999999999999998877 79999999998
Q ss_pred cccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCc-cccchhch
Q 004088 336 QLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPM-LEDKEKWS 414 (774)
Q Consensus 336 ~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~-~~~~~~~s 414 (774)
.+... ......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...........+....... ......++
T Consensus 168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 246 (361)
T 2yab_A 168 EIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246 (361)
T ss_dssp ECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred EcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence 76543 23345689999999999999899999999999999999999999999887776665554433222 12235678
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 415 LVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 415 ~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
..+.+||.+||.+||.+|||+.|+|+||||+.
T Consensus 247 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 89999999999999999999999999999974
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=410.76 Aligned_cols=259 Identities=27% Similarity=0.444 Sum_probs=216.7
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
++|+++++||+|+||+||+|++..+++.||||++..... ......+.+|+.+|++++||||+++++++.++..+|||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 589999999999999999999999999999999976543 3345678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
||++ +|...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.........
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCS
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccC
Confidence 9975 566666556678999999999999999999999999999999999999999999999999999877655445556
Q ss_pred ccccccccchhhhhhcC-CCCccchhhhHHHHHHHHhCCCCC-CCCCchhhhhhhhc---CCC-----------------
Q 004088 347 FIGTPHWMAPEVIQESR-YDGKVDVWALGVSAVEMAEGLPPR-STVHPMRVLFMISI---EPA----------------- 404 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~~~-~s~ksDIWSLGviLyELLtG~~Pf-~~~~~~~~i~~i~~---~~~----------------- 404 (774)
.+||+.|+|||++.+.. ++.++|||||||++|+|++|..|| ...........+.. .+.
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T 3o0g_A 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccc
Confidence 68999999999998766 899999999999999999887775 44443333222211 000
Q ss_pred ------CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 405 ------PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 405 ------~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
........++..+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 0011123467889999999999999999999999999999863
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=420.61 Aligned_cols=261 Identities=27% Similarity=0.451 Sum_probs=220.7
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
..++|++++.||+|+||.||+|++..+++.||||++.........+.+.+|+.+++.++||||+++++++......|+||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 35789999999999999999999999999999999976554444567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc--cc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM--SK 343 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~--~~ 343 (774)
|||++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.... ..
T Consensus 85 e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 85 EYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp ECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred EcCCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 9999999999986 44579999999999999999999999999999999999999999999999999997654322 22
Q ss_pred cccccccccccchhhhhhcCC-CCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESRY-DGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~-s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.........................++..+.+||.
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHH
Confidence 345689999999999987765 6789999999999999999999987655433333222223333334567889999999
Q ss_pred hhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 423 KCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
+||+.||.+|||+.|+++||||...
T Consensus 244 ~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 244 KILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp HHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHccCChhhCcCHHHHhhChhhccc
Confidence 9999999999999999999999753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=423.39 Aligned_cols=260 Identities=28% Similarity=0.424 Sum_probs=220.8
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC----ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE----GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~----~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
.++|++++.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.+|+.++||||++++++|.....+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 457999999999999999999999999999999986432 1223577899999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcc---CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCc---EEEeecccccc
Q 004088 263 IVMEYCGGGSVADLMNVT---EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE---VKLGDFGVAAQ 336 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~---~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~---vKL~DFGlA~~ 336 (774)
||||||++++|.+++... ...+++..++.++.||+.||.|||++|||||||||+|||++.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999998877532 235899999999999999999999999999999999999987654 99999999987
Q ss_pred ccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCC-CccccchhchH
Q 004088 337 LTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA-PMLEDKEKWSL 415 (774)
Q Consensus 337 i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~-~~~~~~~~~s~ 415 (774)
+..........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||..... .....+..... ........++.
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~~~~~~~~~~~~~s~ 261 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSHISE 261 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcCCCCCCccccccCCH
Confidence 76554444556899999999999998999999999999999999999999987543 22222222221 12222345688
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 416 VFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 416 ~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 262 ~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 262 SAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 99999999999999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=411.50 Aligned_cols=258 Identities=31% Similarity=0.514 Sum_probs=216.4
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh-------------------------hhHHHHHHHHHHH
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE-------------------------EGYEEIRGEIEML 240 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~-------------------------~~~~~~~~Ei~iL 240 (774)
..++|++.+.||+|+||.||+|++..+++.||||++...... ...+.+.+|+.+|
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 356899999999999999999999999999999999754311 1235688999999
Q ss_pred HhCCCCCcccccccccC--CceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccce
Q 004088 241 QQCSHPNVVRYLGSYQG--EEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNI 318 (774)
Q Consensus 241 ~~L~HPNIVkL~~~~~~--~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNI 318 (774)
++++||||+++++++.. ...+|||||||++++|.+++. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 99999999999999976 678999999999999988764 45799999999999999999999999999999999999
Q ss_pred EecCCCcEEEeeccccccccccccccccccccccccchhhhhhcC---CCCccchhhhHHHHHHHHhCCCCCCCCCchhh
Q 004088 319 LLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESR---YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRV 395 (774)
Q Consensus 319 LLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~---~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~ 395 (774)
|++.++.+||+|||+++.+..........+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 248 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence 999999999999999987655433344568999999999997654 47789999999999999999999988766554
Q ss_pred hhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 396 LFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 396 i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
...+..... .......++..+.+||.+||+.||.+|||+.|+|+||||++
T Consensus 249 ~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 249 HSKIKSQAL-EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHCCC-CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHhcccC-CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 444333222 12233567889999999999999999999999999999963
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=410.11 Aligned_cols=257 Identities=30% Similarity=0.460 Sum_probs=213.2
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
++|++++.||+|+||.||+|++ .+|+.||||++..... ......+.+|+.+|++++||||+++++++.....+|+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 5899999999999999999998 6789999999965432 2234678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
|+++ +|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159 (288)
T ss_dssp CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccccc
Confidence 9975 898888766678999999999999999999999999999999999999999999999999999876544334445
Q ss_pred ccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc---CC-------------------
Q 004088 347 FIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI---EP------------------- 403 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~---~~------------------- 403 (774)
.+||+.|+|||++.+. .++.++|||||||++|+|++|.+||...........+.. .+
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T 1ob3_A 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239 (288)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccc
Confidence 6799999999999764 589999999999999999999999987765544332211 00
Q ss_pred ----CCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 404 ----APMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 404 ----~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
.+.......++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0000112346788999999999999999999999999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=426.20 Aligned_cols=260 Identities=28% Similarity=0.441 Sum_probs=227.0
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l 261 (774)
...++|++++.||+|+||.||+|++..+|+.||||++++.. .....+.+.+|..+|..+ +||||++++++|.+...+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 35679999999999999999999999999999999997532 123456688899999876 999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|||||||++|+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+++......
T Consensus 94 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp EEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 999999999999999863 4579999999999999999999999999999999999999999999999999997654443
Q ss_pred cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI 421 (774)
......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...+.......+...... .+..++..+.+||
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~li 249 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF---YPRWLEKEAKDLL 249 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTSCHHHHHHH
T ss_pred CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCC---CCcccCHHHHHHH
Confidence 4456678999999999999999999999999999999999999999988777666655443322 2345788999999
Q ss_pred HhhcccCCCCCCCHH-HHHhhhhhhhhc
Q 004088 422 AKCLTKEPRARPTAA-EMLKHKFIERCK 448 (774)
Q Consensus 422 ~kcL~~DP~kRPTa~-ElL~HPwf~~~~ 448 (774)
.+||+.||.+||++. ++++||||+...
T Consensus 250 ~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 250 VKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp HHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred HHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 999999999999998 999999998653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=416.59 Aligned_cols=262 Identities=28% Similarity=0.446 Sum_probs=208.0
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
.++|++++.||+|+||.||+|.+..+|+.||||++...........+.+|+.+|++++||||+++++++..++.+|||||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46899999999999999999999999999999999866555555778899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccC-----CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 267 YCGGGSVADLMNVTE-----EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 267 y~~ggsL~dll~~~~-----~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
||+ ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 997 58888875332 458999999999999999999999999999999999999999999999999998765444
Q ss_pred cccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc---CCCC-c----------
Q 004088 342 SKRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI---EPAP-M---------- 406 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~---~~~~-~---------- 406 (774)
......+||+.|+|||++.+. .++.++|||||||++|+|++|++||...........+.. .+.. .
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T 2pmi_A 163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242 (317)
T ss_dssp CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTC
T ss_pred ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhc
Confidence 444456899999999999864 689999999999999999999999988766544332211 0000 0
Q ss_pred -----------------cccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 407 -----------------LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 407 -----------------~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
......++..+.+||.+||+.||.+|||+.|+|+||||++...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp CTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred ccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 0011245788999999999999999999999999999987653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=423.08 Aligned_cols=264 Identities=31% Similarity=0.538 Sum_probs=219.4
Q ss_pred CCCCeeEEeeeecc--CceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 186 PTTKYELLNELGKG--SYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G--~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
..++|+++++||+| +||.||+|++..+|+.||||++.... .....+.+.+|+.+|++++|||||+++++|.....+|
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45789999999999 99999999999999999999997544 3445567889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
||||||++++|.+++... ...+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||++..+....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 999999999999998643 3569999999999999999999999999999999999999999999999999986543221
Q ss_pred -------cccccccccccccchhhhhh--cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCC-------
Q 004088 342 -------SKRNTFIGTPHWMAPEVIQE--SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAP------- 405 (774)
Q Consensus 342 -------~~~~~~~GT~~Y~APEvl~~--~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~------- 405 (774)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||...........+.....+
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccc
Confidence 11223479999999999987 57999999999999999999999999876655544332211110
Q ss_pred ------------------------------------ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 406 ------------------------------------MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 406 ------------------------------------~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
.......++..+.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~ 342 (389)
T 3gni_B 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 342 (389)
T ss_dssp -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhh
Confidence 01123446788999999999999999999999999999987654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=407.25 Aligned_cols=259 Identities=27% Similarity=0.453 Sum_probs=219.4
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
..++|.+.++||+|+||.||+|++..+++.||||++.........+.+.+|+++|++++||||+++++++......|+||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 34689999999999999999999999999999999986655556688999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhc---cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEe---cCCCcEEEeeccccccccc
Q 004088 266 EYCGGGSVADLMNV---TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL---TDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 266 Ey~~ggsL~dll~~---~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILL---d~~g~vKL~DFGlA~~i~~ 339 (774)
|||++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+..
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 99999999998853 23679999999999999999999999999999999999999 4457899999999976544
Q ss_pred cccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHH
Q 004088 340 TMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHD 419 (774)
Q Consensus 340 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~d 419 (774)
. .......||+.|+|||++.. .++.++|||||||++|+|++|+.||...........+.............++..+.+
T Consensus 180 ~-~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (285)
T 3is5_A 180 D-EHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVD 257 (285)
T ss_dssp --------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHH
T ss_pred c-ccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHH
Confidence 3 23345579999999999864 689999999999999999999999998776666555444333333333456888999
Q ss_pred HHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 420 FVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 420 LI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
||.+||+.||.+|||+.|+|+||||++
T Consensus 258 li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 258 LLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 999999999999999999999999975
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=412.46 Aligned_cols=258 Identities=38% Similarity=0.681 Sum_probs=230.1
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
..|+..+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.+|++++||||+++++++......|+||||
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 35889999999999999999999899999999997543 34457789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccc
Q 004088 268 CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF 347 (774)
Q Consensus 268 ~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~ 347 (774)
+++++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..........
T Consensus 124 ~~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 201 (321)
T 2c30_A 124 LQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 201 (321)
T ss_dssp CCSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred CCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence 99999999885 3569999999999999999999999999999999999999999999999999998776554445567
Q ss_pred cccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhccc
Q 004088 348 IGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTK 427 (774)
Q Consensus 348 ~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~ 427 (774)
+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.....+.......++..+.+||.+||+.
T Consensus 202 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 281 (321)
T 2c30_A 202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVR 281 (321)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCS
T ss_pred cCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccC
Confidence 89999999999999999999999999999999999999998877766666655555555555667889999999999999
Q ss_pred CCCCCCCHHHHHhhhhhhhhc
Q 004088 428 EPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 428 DP~kRPTa~ElL~HPwf~~~~ 448 (774)
||.+|||+.++|+||||....
T Consensus 282 dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 282 DPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp STTTSCCHHHHHTSGGGGGCC
T ss_pred ChhhCcCHHHHhcChhhccCC
Confidence 999999999999999998643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=419.77 Aligned_cols=258 Identities=30% Similarity=0.469 Sum_probs=221.5
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~ 262 (774)
..++|++++.||+|+||.||+|++..+++.||||++.+.. .......+.+|+.+|+++ +||||++++++|.....+|
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 3568999999999999999999999999999999997543 334556788999999988 8999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
||||||++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++++||+|||+++.......
T Consensus 87 lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp EEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 99999999999999863 45799999999999999999999999999999999999999999999999999986544444
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCC---------chhhhhhhhcCCCCccccchhc
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVH---------PMRVLFMISIEPAPMLEDKEKW 413 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~---------~~~~i~~i~~~~~~~~~~~~~~ 413 (774)
.....+||+.|+|||++.+..|+.++|||||||++|||++|++||.... .......+..... ..+..+
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---~~p~~~ 242 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---RIPRSL 242 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC---CCCTTS
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC---CCCCCC
Confidence 4556789999999999999999999999999999999999999997521 1111222222211 223467
Q ss_pred hHHHHHHHHhhcccCCCCCCCH------HHHHhhhhhhhh
Q 004088 414 SLVFHDFVAKCLTKEPRARPTA------AEMLKHKFIERC 447 (774)
Q Consensus 414 s~~l~dLI~kcL~~DP~kRPTa------~ElL~HPwf~~~ 447 (774)
+..+.+||.+||++||.+||++ .++++||||+..
T Consensus 243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 8899999999999999999995 899999999764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=416.59 Aligned_cols=255 Identities=26% Similarity=0.455 Sum_probs=225.2
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
..++|++++.||+|+||.||+|++..+|+.||||++.+.. .....+.+.+|+.+|+.++||||++++++|.+...+|+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 3568999999999999999999999999999999997532 12345678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... .
T Consensus 84 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---~ 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---V 159 (318)
T ss_dssp EECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---C
T ss_pred EEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC---c
Confidence 9999999999999963 46799999999999999999999999999999999999999999999999999976543 2
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHh
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAK 423 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~k 423 (774)
..+.+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.......+..... ..+..++..+.+||.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~li~~ 236 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL---RFPPFFNEDVKDLLSR 236 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC---CCCTTSCHHHHHHHHH
T ss_pred cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCCCCCHHHHHHHHH
Confidence 3456899999999999999999999999999999999999999998877666655544322 2234678899999999
Q ss_pred hcccCCCCCC-----CHHHHHhhhhhhhh
Q 004088 424 CLTKEPRARP-----TAAEMLKHKFIERC 447 (774)
Q Consensus 424 cL~~DP~kRP-----Ta~ElL~HPwf~~~ 447 (774)
||..||.+|| ++.++++||||+..
T Consensus 237 lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 237 LITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 9999999999 99999999999754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=407.31 Aligned_cols=262 Identities=52% Similarity=0.942 Sum_probs=227.8
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
.....+|++++.||+|+||.||+|.+..+|+.||||++.... ....+.+|+.+|++++||||+++++++.....+|+
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 446778999999999999999999999999999999997543 34678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 181 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK 181 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc
Confidence 99999999999999766778999999999999999999999999999999999999999999999999999877655444
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHh
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAK 423 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~k 423 (774)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.....+.......++..+.+||.+
T Consensus 182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 261 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQ 261 (314)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHH
T ss_pred cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHH
Confidence 55668999999999999989999999999999999999999999988776666655555555555566788999999999
Q ss_pred hcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 424 CLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 424 cL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
||..||.+|||+.++|+||||+...
T Consensus 262 ~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 262 CLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp HTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred HccCChhhCcCHHHHHhCHHHhcCC
Confidence 9999999999999999999998654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=431.68 Aligned_cols=259 Identities=29% Similarity=0.476 Sum_probs=220.3
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~ 262 (774)
...+|++++.||+|+||+||+|++..+++.||||++++.. .......+.+|+.+|.++ +||||++++++|.....+|
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 4568999999999999999999999999999999997543 223345688999999887 8999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
||||||++|+|..++.. ...+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.......
T Consensus 130 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 208 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208 (396)
T ss_dssp EEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCC
Confidence 99999999999998863 46799999999999999999999999999999999999999999999999999986544444
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCc--------hh-hhhhhhcCCCCccccchhc
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHP--------MR-VLFMISIEPAPMLEDKEKW 413 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~--------~~-~i~~i~~~~~~~~~~~~~~ 413 (774)
...+.+||+.|+|||++.+..|+.++|||||||++|||++|++||..... .. ....+.... ...+..+
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---~~~p~~~ 285 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---IRIPRSL 285 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC---CCCCTTS
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc---cCCCCcC
Confidence 55677999999999999999999999999999999999999999964321 11 112222221 1223467
Q ss_pred hHHHHHHHHhhcccCCCCCCCH------HHHHhhhhhhhhc
Q 004088 414 SLVFHDFVAKCLTKEPRARPTA------AEMLKHKFIERCK 448 (774)
Q Consensus 414 s~~l~dLI~kcL~~DP~kRPTa------~ElL~HPwf~~~~ 448 (774)
+..+.+||.+||++||.+||++ .++++||||+.+.
T Consensus 286 s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~ 326 (396)
T 4dc2_A 286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326 (396)
T ss_dssp CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence 8899999999999999999985 8999999998653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=435.12 Aligned_cols=260 Identities=28% Similarity=0.420 Sum_probs=226.5
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
.++|++++.||+|+||.||+|.+..+|+.||+|++..... ....+.+.+|+.+|++++||||++++++|.+...+|+||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 4579999999999999999999999999999999976543 334567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEec---CCCcEEEeecccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLT---DQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd---~~g~vKL~DFGlA~~i~~~~~ 342 (774)
|||.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+.....
T Consensus 90 E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 90 DLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp CCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred EeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 99999999998863 46799999999999999999999999999999999999998 457899999999987765544
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCC-ccccchhchHHHHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAP-MLEDKEKWSLVFHDFV 421 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~-~~~~~~~~s~~l~dLI 421 (774)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...........+...... .......++..+.+||
T Consensus 169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 248 (444)
T 3soa_A 169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI 248 (444)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHH
T ss_pred eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence 455678999999999999989999999999999999999999999988777666655443222 1223346789999999
Q ss_pred HhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 422 AKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 422 ~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
.+||+.||.+|||+.|+|+||||...
T Consensus 249 ~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 249 NKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHcCCChhHCCCHHHHhcCccccCC
Confidence 99999999999999999999999764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=412.60 Aligned_cols=259 Identities=28% Similarity=0.453 Sum_probs=224.6
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh-----hhHHHHHHHHHHHHhCCCCCcccccccccCCce
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE-----EGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEY 260 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~-----~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~ 260 (774)
..++|++.+.||+|+||.||+|.+..+|+.||||++...... ...+.+.+|+.+|++++||||++++++|.....
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 345799999999999999999999999999999999754321 235779999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC----cEEEeecccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG----EVKLGDFGVAAQ 336 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g----~vKL~DFGlA~~ 336 (774)
+|+|||||++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 89 ~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 89 VILILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEEEECCCSCBHHHHHT-TSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEcCCCCCHHHHHH-hcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 999999999999999986 456799999999999999999999999999999999999999887 799999999987
Q ss_pred ccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCc-cccchhchH
Q 004088 337 LTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPM-LEDKEKWSL 415 (774)
Q Consensus 337 i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~-~~~~~~~s~ 415 (774)
+... ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+....... ......++.
T Consensus 168 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (326)
T 2y0a_A 168 IDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246 (326)
T ss_dssp CCTT-SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred CCCC-CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCH
Confidence 6533 23345679999999999998899999999999999999999999998877666554443322221 222345688
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 416 VFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 416 ~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 247 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 8999999999999999999999999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=420.03 Aligned_cols=259 Identities=28% Similarity=0.453 Sum_probs=225.2
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
.++|++++.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.+|++++||||++++++|.+....|+||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 357999999999999999999999999999999997544 3445577899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC---cEEEeecccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG---EVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g---~vKL~DFGlA~~i~~~~~ 342 (774)
|||.+++|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..+... .
T Consensus 108 e~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~-~ 185 (362)
T 2bdw_A 108 DLVTGGELFEDIV-AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-E 185 (362)
T ss_dssp CCCCSCBHHHHHT-TCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-C
T ss_pred ecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-c
Confidence 9999999999886 346799999999999999999999999999999999999998654 5999999999776543 2
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCC-ccccchhchHHHHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAP-MLEDKEKWSLVFHDFV 421 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~-~~~~~~~~s~~l~dLI 421 (774)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...+.......+...... .......++..+.+||
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 265 (362)
T 2bdw_A 186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 265 (362)
T ss_dssp SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHH
T ss_pred ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 334568999999999999989999999999999999999999999987776665554433222 2223356788999999
Q ss_pred HhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 422 AKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 422 ~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
.+||+.||.+|||+.++|+||||...
T Consensus 266 ~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 266 DSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp HHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred HHHcCCChhhCcCHHHHhcCcccCCC
Confidence 99999999999999999999999753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=407.41 Aligned_cols=261 Identities=31% Similarity=0.501 Sum_probs=214.8
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
.++|+++++||+|+||+||+|++..+|+.||||++..... ....+.+.+|+.+|++++||||+++++++......|+||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 3689999999999999999999999999999999865443 334566889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
|||++++|..++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+........
T Consensus 82 e~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (311)
T 4agu_A 82 EYCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD 160 (311)
T ss_dssp ECCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EeCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence 9999999988875 456799999999999999999999999999999999999999999999999999987665444445
Q ss_pred cccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC----------------------
Q 004088 346 TFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE---------------------- 402 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~---------------------- 402 (774)
..+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+...
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240 (311)
T ss_dssp -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence 5689999999999986 56899999999999999999999999887665443322110
Q ss_pred -CC-----CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 403 -PA-----PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 403 -~~-----~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
+. +.......++..+.+||.+||+.||.+|||+.|+|+||||+.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 00 00011135677899999999999999999999999999998764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=415.93 Aligned_cols=261 Identities=26% Similarity=0.396 Sum_probs=207.2
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
...++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.+|++++||||++++++|.....+|+|
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 34568999999999999999999999999999999997532 235678999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC---CCcEEEeeccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD---QGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~---~g~vKL~DFGlA~~i~~~~ 341 (774)
||||++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 127 ~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~- 204 (349)
T 2w4o_A 127 LELVTGGELFDRIV-EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ- 204 (349)
T ss_dssp ECCCCSCBHHHHHT-TCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred EEeCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence 99999999999886 4467999999999999999999999999999999999999975 789999999999766443
Q ss_pred cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhh-hhhhcCCC-CccccchhchHHHHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVL-FMISIEPA-PMLEDKEKWSLVFHD 419 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i-~~i~~~~~-~~~~~~~~~s~~l~d 419 (774)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..+..... ........++..+.+
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 284 (349)
T 2w4o_A 205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD 284 (349)
T ss_dssp --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHH
Confidence 2234567999999999999989999999999999999999999999876654422 22222211 111223467889999
Q ss_pred HHHhhcccCCCCCCCHHHHHhhhhhhhhccC
Q 004088 420 FVAKCLTKEPRARPTAAEMLKHKFIERCKCG 450 (774)
Q Consensus 420 LI~kcL~~DP~kRPTa~ElL~HPwf~~~~~~ 450 (774)
||.+||+.||.+|||+.++|+||||......
T Consensus 285 li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 315 (349)
T 2w4o_A 285 LVRKLIVLDPKKRLTTFQALQHPWVTGKAAN 315 (349)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred HHHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence 9999999999999999999999999876543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=414.96 Aligned_cols=259 Identities=28% Similarity=0.432 Sum_probs=214.3
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEc---CCCcEEEEEEeecCC---ChhhHHHHHHHHHHHHhCCCCCcccccccccCC
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDL---KTSELVAIKVISLSE---GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE 258 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~---~~g~~VAVKvi~~~~---~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~ 258 (774)
...++|++++.||+|+||.||+|++. .+|+.||||++.... .......+.+|+.+|++++||||++++++|...
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 34578999999999999999999985 689999999997542 223345678999999999999999999999999
Q ss_pred ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 259 EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
+.+|||||||.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 999999999999999999863 4578999999999999999999999999999999999999999999999999997654
Q ss_pred ccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 339 RTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 339 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
.........+||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+...... .+..++..+.
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~---~p~~~~~~~~ 249 (327)
T 3a62_A 173 HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN---LPPYLTQEAR 249 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---CCTTSCHHHH
T ss_pred cCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC---CCCCCCHHHH
Confidence 4434445668999999999999989999999999999999999999999987776665554433222 2345788999
Q ss_pred HHHHhhcccCCCCCC-----CHHHHHhhhhhhhh
Q 004088 419 DFVAKCLTKEPRARP-----TAAEMLKHKFIERC 447 (774)
Q Consensus 419 dLI~kcL~~DP~kRP-----Ta~ElL~HPwf~~~ 447 (774)
+||.+||..||.+|| ++.++++||||+..
T Consensus 250 ~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 250 DLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 999999999999999 89999999999754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=422.71 Aligned_cols=259 Identities=27% Similarity=0.389 Sum_probs=226.2
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l 261 (774)
...++|++++.||+|+||.||+|++..+|+.||||++.+.. .....+.+.+|..+|..+ .||||++++++|.....+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 34678999999999999999999999999999999997532 123456788999999988 899999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|||||||+||+|.+++.. .+.+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 97 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 999999999999999863 3579999999999999999999999999999999999999999999999999998654443
Q ss_pred cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI 421 (774)
......+||+.|+|||++.+..|+.++|||||||++|||++|++||...+.......+...... .+..++..+.+||
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~li 252 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA---YPKSMSKEAVAIC 252 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTSCHHHHHHH
T ss_pred cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC---CCCCCCHHHHHHH
Confidence 4455678999999999999999999999999999999999999999988777666555443322 2346789999999
Q ss_pred HhhcccCCCCCC-----CHHHHHhhhhhhhh
Q 004088 422 AKCLTKEPRARP-----TAAEMLKHKFIERC 447 (774)
Q Consensus 422 ~kcL~~DP~kRP-----Ta~ElL~HPwf~~~ 447 (774)
.+||.+||.+|| ++.++++||||+..
T Consensus 253 ~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 253 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp HHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 999999999999 47999999999754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=417.12 Aligned_cols=260 Identities=28% Similarity=0.425 Sum_probs=211.4
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
++|+++++||+|+||.||+|++..+++.||||++...........+.+|+.+|++++||||+++++++.....+||||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999999999999999997544333223456799999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccccc
Q 004088 268 CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTF 347 (774)
Q Consensus 268 ~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~ 347 (774)
|+ ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 160 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE 160 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccc
Confidence 96 58888887667789999999999999999999999999999999999999999999999999997665444444556
Q ss_pred cccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc---CCCC------------------
Q 004088 348 IGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI---EPAP------------------ 405 (774)
Q Consensus 348 ~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~---~~~~------------------ 405 (774)
+||+.|+|||++.+ ..++.++|||||||++|+|++|++||...........+.. .+..
T Consensus 161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (324)
T 3mtl_A 161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYP 240 (324)
T ss_dssp --CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCC
T ss_pred cCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccc
Confidence 89999999999986 5689999999999999999999999988776554433211 0000
Q ss_pred ------ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 406 ------MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 406 ------~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.......++..+.+||.+||+.||.+|||+.|+|+||||....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 241 KYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp CCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred cccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 0111234577899999999999999999999999999998764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=434.11 Aligned_cols=260 Identities=31% Similarity=0.502 Sum_probs=227.7
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC--hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG--EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~--~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
..++|++++.||+|+||.||+|++..+|+.||||++..... ....+.+.+|+.+|++++||||++++++|.....+|+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 34689999999999999999999999999999999975432 3456779999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEe---cCCCcEEEeecccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL---TDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILL---d~~g~vKL~DFGlA~~i~~~ 340 (774)
|||||.+++|.+++. ....+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+++.+...
T Consensus 104 v~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 104 VGEVYTGGELFDEII-SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EECCCCSCBHHHHHH-TCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 999999999999886 45679999999999999999999999999999999999999 46688999999999876543
Q ss_pred ccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCC-ccccchhchHHHHH
Q 004088 341 MSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAP-MLEDKEKWSLVFHD 419 (774)
Q Consensus 341 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~-~~~~~~~~s~~l~d 419 (774)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||...........+...... ..+....++..+.+
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 260 (484)
T 3nyv_A 183 -KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260 (484)
T ss_dssp -CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHH
T ss_pred -cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHH
Confidence 23345679999999999977 6999999999999999999999999988877766655444322 23444677899999
Q ss_pred HHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 420 FVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 420 LI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
||.+||++||.+|||+.++|+||||+...
T Consensus 261 li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 261 LIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred HHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 99999999999999999999999998764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=417.67 Aligned_cols=259 Identities=28% Similarity=0.449 Sum_probs=209.1
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
....++|++++.||+|+||+||+|++..+++.||||++.... ...+.+.+|+.++++++||||+++++++.....+||
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 345679999999999999999999999999999999997543 233668899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCc--EEEeeccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE--VKLGDFGVAAQLTRTM 341 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~--vKL~DFGlA~~i~~~~ 341 (774)
|||||.+++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++.....
T Consensus 94 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 94 IMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence 9999999999999863 457999999999999999999999999999999999999987765 999999999754332
Q ss_pred cccccccccccccchhhhhhcCCCCc-cchhhhHHHHHHHHhCCCCCCCCCchhhh----hhhhcCCCCccccchhchHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQESRYDGK-VDVWALGVSAVEMAEGLPPRSTVHPMRVL----FMISIEPAPMLEDKEKWSLV 416 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~~~s~k-sDIWSLGviLyELLtG~~Pf~~~~~~~~i----~~i~~~~~~~~~~~~~~s~~ 416 (774)
......+||+.|+|||++.+..++.+ +|||||||++|+|++|++||......... ..+. ......+....++..
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~ 250 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL-SVKYSIPDDIRISPE 250 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHH-TTCCCCCTTSCCCHH
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh-cCCCCCCCcCCCCHH
Confidence 23345579999999999998888766 89999999999999999999875443222 1121 112222333457889
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 417 FHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 417 l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
+.+||.+||+.||.+|||+.|+++||||.+.
T Consensus 251 ~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 251 CCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 9999999999999999999999999999754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=424.93 Aligned_cols=260 Identities=31% Similarity=0.463 Sum_probs=218.9
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHH-HHhCCCCCcccccccccCCceE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEM-LQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~i-L~~L~HPNIVkL~~~~~~~~~l 261 (774)
...++|++++.||+|+||.||+|++..+++.||||++.+.. .......+.+|..+ ++.++||||++++++|...+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 34578999999999999999999999999999999997543 22334556677776 5778999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|||||||.||+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+++......
T Consensus 115 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 999999999999999863 4578999999999999999999999999999999999999999999999999998655444
Q ss_pred cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI 421 (774)
......+||+.|+|||++.+..|+.++|||||||++|||++|.+||...+.......+...... .+..++..+.+||
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~li 270 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ---LKPNITNSARHLL 270 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCC---CCSSSCHHHHHHH
T ss_pred CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccC---CCCCCCHHHHHHH
Confidence 4556678999999999999999999999999999999999999999988777666655444322 2346788999999
Q ss_pred HhhcccCCCCCCCH----HHHHhhhhhhhhc
Q 004088 422 AKCLTKEPRARPTA----AEMLKHKFIERCK 448 (774)
Q Consensus 422 ~kcL~~DP~kRPTa----~ElL~HPwf~~~~ 448 (774)
.+||++||.+||++ .++++||||+...
T Consensus 271 ~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 271 EGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp HHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred HHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 99999999999986 7999999998643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=395.35 Aligned_cols=261 Identities=28% Similarity=0.444 Sum_probs=226.1
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
..++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.++++++||||+++++++......|+|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4678999999999999999999999999999999997543 344557788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCc---EEEeeccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE---VKLGDFGVAAQLTRTM 341 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~---vKL~DFGlA~~i~~~~ 341 (774)
|||+.+++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++......
T Consensus 84 ~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~- 161 (284)
T 3kk8_A 84 FDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 161 (284)
T ss_dssp ECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS-
T ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC-
Confidence 999999999888863 467999999999999999999999999999999999999987665 999999999766543
Q ss_pred cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCC-CccccchhchHHHHHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA-PMLEDKEKWSLVFHDF 420 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~-~~~~~~~~~s~~l~dL 420 (774)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..... ........++..+.+|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHH
Confidence 233456799999999999999999999999999999999999999988776665554433322 1222334678899999
Q ss_pred HHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 421 VAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
|.+||+.||.+|||+.|+|+||||+...
T Consensus 242 i~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 242 IDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHcccChhhCCCHHHHhcCccccCCh
Confidence 9999999999999999999999998643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=408.36 Aligned_cols=255 Identities=27% Similarity=0.443 Sum_probs=210.2
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCC---------
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE--------- 258 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~--------- 258 (774)
++|++++.||+|+||.||+|++..+|+.||||++.........+.+.+|+.+|++++||||++++++|...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 47999999999999999999999999999999998766556678899999999999999999999987433
Q ss_pred ------------------------------------------------ceEEEEEEecCCCchhhhhhccC--CchhHHH
Q 004088 259 ------------------------------------------------EYLWIVMEYCGGGSVADLMNVTE--EPLEEYQ 288 (774)
Q Consensus 259 ------------------------------------------------~~l~LVmEy~~ggsL~dll~~~~--~~Lse~~ 288 (774)
..+|+|||||++++|.+++.... ....+..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 24899999999999999987543 2355667
Q ss_pred HHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc------------cccccccccccccch
Q 004088 289 IAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM------------SKRNTFIGTPHWMAP 356 (774)
Q Consensus 289 i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~------------~~~~~~~GT~~Y~AP 356 (774)
++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.... ......+||+.|+||
T Consensus 166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 245 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence 89999999999999999999999999999999999999999999998765432 122345799999999
Q ss_pred hhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHH
Q 004088 357 EVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAA 436 (774)
Q Consensus 357 Evl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ 436 (774)
|++.+..++.++|||||||++|+|++|..|+... ......+... .........+..+.+||.+||+.||.+|||+.
T Consensus 246 E~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 321 (332)
T 3qd2_B 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNL--KFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT 321 (332)
T ss_dssp HHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTT--CCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHH
T ss_pred HHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhcc--CCCcccccCChhHHHHHHHHccCCCCcCCCHH
Confidence 9999999999999999999999999998775321 1111112121 11222345567789999999999999999999
Q ss_pred HHHhhhhhhh
Q 004088 437 EMLKHKFIER 446 (774)
Q Consensus 437 ElL~HPwf~~ 446 (774)
|+|+||||++
T Consensus 322 ~~l~~~~f~~ 331 (332)
T 3qd2_B 322 DIIENAIFEN 331 (332)
T ss_dssp HHHHSTTCCC
T ss_pred HHhhchhhhc
Confidence 9999999974
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=419.39 Aligned_cols=255 Identities=27% Similarity=0.442 Sum_probs=226.0
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
..++|++++.||+|+||.||+|++..+|+.||||++.+.. .....+.+.+|+.+|+.++||||++++++|.+...+||
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 4578999999999999999999999999999999996532 22345678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.+...
T Consensus 119 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--- 194 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp EEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred EEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC---
Confidence 9999999999999864 357999999999999999999999999999999999999999999999999999866432
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHh
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAK 423 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~k 423 (774)
....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+...... .+..++..+.+||.+
T Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~---~p~~~~~~~~~li~~ 271 (350)
T 1rdq_E 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR---FPSHFSSDLKDLLRN 271 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTCCHHHHHHHHH
T ss_pred cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCHHHHHHHHH
Confidence 34568999999999999999999999999999999999999999988776666555443322 235678999999999
Q ss_pred hcccCCCCCCC-----HHHHHhhhhhhhh
Q 004088 424 CLTKEPRARPT-----AAEMLKHKFIERC 447 (774)
Q Consensus 424 cL~~DP~kRPT-----a~ElL~HPwf~~~ 447 (774)
||+.||.+||+ +.++++||||+..
T Consensus 272 lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 272 LLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 99999999998 9999999999754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=400.71 Aligned_cols=263 Identities=44% Similarity=0.844 Sum_probs=225.5
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
...++|++++.||+|+||.||+|++..+++.||+|++... .....+.+.+|+.+|++++||||+++++++.....+|+|
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC-CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 3567899999999999999999999999999999998643 334567889999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
||||++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 174 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccccc
Confidence 99999999999987666789999999999999999999999999999999999999999999999999986544333334
Q ss_pred ccccccccccchhhhh-----hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHH
Q 004088 345 NTFIGTPHWMAPEVIQ-----ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHD 419 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~-----~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~d 419 (774)
....||+.|+|||++. ...++.++|||||||++|+|++|.+||...........+.....+....+..++..+.+
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRD 254 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHH
Confidence 4567999999999984 55688999999999999999999999998877666655554444444556778899999
Q ss_pred HHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 420 FVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 420 LI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
||.+||..||.+|||+.++++||||....
T Consensus 255 li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 255 FLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp HHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred HHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 99999999999999999999999998654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=428.60 Aligned_cols=261 Identities=28% Similarity=0.369 Sum_probs=198.9
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCccccccccc-----CCc
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ-----GEE 259 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~-----~~~ 259 (774)
..++|++++.||+|+||+||+|++..+++.||||++.... .....+.+.+|+.+|++++|||||+++++|. ...
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 4578999999999999999999999999999999986432 3445577899999999999999999999984 446
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
.+||||||+ +++|..++. ....+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+..
T Consensus 131 ~~~lv~e~~-~~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp CEEEEECCC-SEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred eEEEEEecc-ccchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 799999999 578988886 456799999999999999999999999999999999999999999999999999987642
Q ss_pred cc---------------------------cccccccccccccchhhhh-hcCCCCccchhhhHHHHHHHHh---------
Q 004088 340 TM---------------------------SKRNTFIGTPHWMAPEVIQ-ESRYDGKVDVWALGVSAVEMAE--------- 382 (774)
Q Consensus 340 ~~---------------------------~~~~~~~GT~~Y~APEvl~-~~~~s~ksDIWSLGviLyELLt--------- 382 (774)
.. ......+||++|+|||++. ...|+.++|||||||++|||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 21 1223468999999999874 5669999999999999999998
Q ss_pred --CCCCCCCCCch--------------------h---hhhhhhcC-------------------------CCCccccchh
Q 004088 383 --GLPPRSTVHPM--------------------R---VLFMISIE-------------------------PAPMLEDKEK 412 (774)
Q Consensus 383 --G~~Pf~~~~~~--------------------~---~i~~i~~~-------------------------~~~~~~~~~~ 412 (774)
|+++|.+.... . .+..+... ..........
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 66777554310 0 00000000 0011112234
Q ss_pred chHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 413 WSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 413 ~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
++..+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 369 SSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 578899999999999999999999999999998764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=435.13 Aligned_cols=265 Identities=24% Similarity=0.393 Sum_probs=226.1
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC--hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG--EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~--~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
...++|+++++||+|+||+||+|++..+++.||||++.+... ......+.+|+.+|..++||||++++++|.+...+|
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 456789999999999999999999999999999999964221 112234789999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
||||||++|+|.+++......+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 99999999999999976567899999999999999999999999999999999999999999999999999976654322
Q ss_pred -ccccccccccccchhhhh-----hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC--CCCccccchhch
Q 004088 343 -KRNTFIGTPHWMAPEVIQ-----ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE--PAPMLEDKEKWS 414 (774)
Q Consensus 343 -~~~~~~GT~~Y~APEvl~-----~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~--~~~~~~~~~~~s 414 (774)
.....+||+.|+|||++. ...|+.++|||||||++|||++|++||...+.......+... ..........++
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s 310 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVS 310 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSC
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCC
Confidence 223468999999999997 456899999999999999999999999988777666554321 111112224578
Q ss_pred HHHHHHHHhhcccCCCC--CCCHHHHHhhhhhhhhcc
Q 004088 415 LVFHDFVAKCLTKEPRA--RPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 415 ~~l~dLI~kcL~~DP~k--RPTa~ElL~HPwf~~~~~ 449 (774)
..+++||.+||+.+|.+ |++++|+++||||+...+
T Consensus 311 ~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w 347 (437)
T 4aw2_A 311 ENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDW 347 (437)
T ss_dssp HHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred HHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCH
Confidence 99999999999998888 999999999999987644
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=432.87 Aligned_cols=261 Identities=29% Similarity=0.482 Sum_probs=224.2
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh------------hhHHHHHHHHHHHHhCCCCCcccccc
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE------------EGYEEIRGEIEMLQQCSHPNVVRYLG 253 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~------------~~~~~~~~Ei~iL~~L~HPNIVkL~~ 253 (774)
..++|+++++||+|+||+||+|++..+++.||||++...... ...+.+.+|+.+|++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 457899999999999999999999999999999999754321 33567899999999999999999999
Q ss_pred cccCCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC---cEEEee
Q 004088 254 SYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG---EVKLGD 330 (774)
Q Consensus 254 ~~~~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g---~vKL~D 330 (774)
+|.+...+|||||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 99999999999999999999998863 46799999999999999999999999999999999999999876 699999
Q ss_pred ccccccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCC-cccc
Q 004088 331 FGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAP-MLED 409 (774)
Q Consensus 331 FGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~-~~~~ 409 (774)
||++..+... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||........+..+...... ....
T Consensus 193 fg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (504)
T 3q5i_A 193 FGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND 270 (504)
T ss_dssp CTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH
T ss_pred CCCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence 9999876543 23345689999999999875 6999999999999999999999999988877766665544322 2233
Q ss_pred chhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 410 KEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 410 ~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
...++..+.+||.+||++||.+|||+.|+|+||||++...
T Consensus 271 ~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 271 WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 4567899999999999999999999999999999987653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=426.54 Aligned_cols=259 Identities=26% Similarity=0.459 Sum_probs=221.8
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
...++|++++.||+|+||.||+|++..+++.||||++.+.. .......+.+|+.+|+.++|||||+++++|.....+|
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 91 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF 91 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34578999999999999999999999999999999996432 2234567889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
+|||||.+|+|..++. ....+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+... .
T Consensus 92 lv~e~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~ 169 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQ-QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-T 169 (384)
T ss_dssp EEECCCTTEEHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-C
T ss_pred EEEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-C
Confidence 9999999999999986 4567999999999999999999999999999999999999999999999999999866443 3
Q ss_pred ccccccccccccchhhhhh---cCCCCccchhhhHHHHHHHHhCCCCCCCCCchh---hhhhhhcCCCCccccchhchHH
Q 004088 343 KRNTFIGTPHWMAPEVIQE---SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMR---VLFMISIEPAPMLEDKEKWSLV 416 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~---~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~---~i~~i~~~~~~~~~~~~~~s~~ 416 (774)
.....+||+.|+|||++.. ..|+.++|||||||++|+|++|++||....... ....+... ....+..++..
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~---~~~~p~~~s~~ 246 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT---VVTYPSAWSQE 246 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC---CCCCCTTSCHH
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc---ccCCCCcCCHH
Confidence 3456789999999999974 458999999999999999999999997543322 22222221 12234567899
Q ss_pred HHHHHHhhcccCCCCCCC-HHHHHhhhhhhhhc
Q 004088 417 FHDFVAKCLTKEPRARPT-AAEMLKHKFIERCK 448 (774)
Q Consensus 417 l~dLI~kcL~~DP~kRPT-a~ElL~HPwf~~~~ 448 (774)
+.+||.+||+.||.+||+ +.++++||||....
T Consensus 247 ~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 247 MVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp HHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred HHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence 999999999999999998 99999999998654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=418.82 Aligned_cols=255 Identities=26% Similarity=0.377 Sum_probs=219.5
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
..++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++||||+++++++.....+|+
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3578999999999999999999999999999999986432 12234578899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
||||+ +|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+... ..
T Consensus 87 v~E~~-~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-~~ 163 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NF 163 (336)
T ss_dssp EECCC-CEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-BT
T ss_pred EEECC-CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-cc
Confidence 99999 7788888753 467999999999999999999999999999999999999999999999999999766543 33
Q ss_pred cccccccccccchhhhhhcCC-CCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESRY-DGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~-s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........+.... ...+..++..+.+||.
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~ 240 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV---YVMPDFLSPGAQSLIR 240 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSC---CCCCTTSCHHHHHHHH
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC---CCCcccCCHHHHHHHH
Confidence 455689999999999988776 689999999999999999999998765544433332221 2234567889999999
Q ss_pred hhcccCCCCCCCHHHHHhhhhhhh
Q 004088 423 KCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
+||+.||.+|||+.|+++||||+.
T Consensus 241 ~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 241 RMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp TTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred HHcCCChhHCcCHHHHHhChhhcc
Confidence 999999999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=431.94 Aligned_cols=259 Identities=29% Similarity=0.458 Sum_probs=216.9
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecC--CChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS--EGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
...++|++++.||+|+||.||+|++..+|+.||||++... ........+.+|+.+|+.++||||++++++|...+.+|
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 3457899999999999999999999999999999999743 12334466789999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHh-cCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS-IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs-~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
||||||++++|.+++.. ...+++..++.++.||+.||.|||+ +|||||||||+||||+.++.+||+|||+|+......
T Consensus 225 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp EEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 99999999999998863 4679999999999999999999998 999999999999999999999999999998655444
Q ss_pred cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI 421 (774)
......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...........+...... .+..++..+.+||
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~---~p~~~~~~~~~li 380 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR---FPRTLGPEAKSLL 380 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTSCHHHHHHH
T ss_pred cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC---CCccCCHHHHHHH
Confidence 4455678999999999999999999999999999999999999999988776666555443322 2345788999999
Q ss_pred HhhcccCCCCCC-----CHHHHHhhhhhhhh
Q 004088 422 AKCLTKEPRARP-----TAAEMLKHKFIERC 447 (774)
Q Consensus 422 ~kcL~~DP~kRP-----Ta~ElL~HPwf~~~ 447 (774)
.+||++||.+|| ++.|+|+||||...
T Consensus 381 ~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 999999999999 99999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=420.59 Aligned_cols=262 Identities=25% Similarity=0.393 Sum_probs=226.9
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
...++|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+|++++||||++++++|.....+|||
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 34568999999999999999999999999999999997543 33446789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC--CCcEEEeecccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD--QGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~--~g~vKL~DFGlA~~i~~~~~ 342 (774)
||||.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++.+... .
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-~ 205 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-E 205 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-S
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC-c
Confidence 9999999999999766668999999999999999999999999999999999999974 467999999999876543 2
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCC-ccccchhchHHHHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAP-MLEDKEKWSLVFHDFV 421 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~-~~~~~~~~s~~l~dLI 421 (774)
.....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+...... .......++..+.+||
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 285 (387)
T 1kob_A 206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 285 (387)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence 233457999999999999989999999999999999999999999987766655544333221 1222346788999999
Q ss_pred HhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 422 AKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 422 ~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.+||+.||.+|||+.++|+||||+...
T Consensus 286 ~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 286 KNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHcCCChhHCcCHHHHhhCccccCCc
Confidence 999999999999999999999998654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=430.19 Aligned_cols=264 Identities=26% Similarity=0.394 Sum_probs=223.7
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
...++|++++.||+|+||.||+|++..+|+.||||++.+.. .....+.+.+|+.+|..++||||++++++|.+...+|
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 45678999999999999999999999999999999997432 1223345789999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
||||||++|+|.+++......+++..++.++.||+.||.|||++|||||||||+||||+.++++||+|||+|+.+.....
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 99999999999999976666899999999999999999999999999999999999999999999999999987654322
Q ss_pred -ccccccccccccchhhhhh-------cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC--CCCccccchh
Q 004088 343 -KRNTFIGTPHWMAPEVIQE-------SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE--PAPMLEDKEK 412 (774)
Q Consensus 343 -~~~~~~GT~~Y~APEvl~~-------~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~--~~~~~~~~~~ 412 (774)
.....+||+.|+|||++.. ..|+.++|||||||++|||++|++||...+.......+... ..........
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 297 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG 297 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----C
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccC
Confidence 2234689999999999973 46899999999999999999999999988776665544321 1111112346
Q ss_pred chHHHHHHHHhhcccCCCCC---CCHHHHHhhhhhhhhcc
Q 004088 413 WSLVFHDFVAKCLTKEPRAR---PTAAEMLKHKFIERCKC 449 (774)
Q Consensus 413 ~s~~l~dLI~kcL~~DP~kR---PTa~ElL~HPwf~~~~~ 449 (774)
++..+++||.+||+ +|.+| |+++++++||||+...+
T Consensus 298 ~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w 336 (412)
T 2vd5_A 298 VPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDW 336 (412)
T ss_dssp CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCS
T ss_pred CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCH
Confidence 78999999999999 99998 59999999999987643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=404.35 Aligned_cols=260 Identities=30% Similarity=0.433 Sum_probs=211.7
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC----hhhHHHHHHHHHHHHhCC---CCCcccccccccCC
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG----EEGYEEIRGEIEMLQQCS---HPNVVRYLGSYQGE 258 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~----~~~~~~~~~Ei~iL~~L~---HPNIVkL~~~~~~~ 258 (774)
..++|+++++||+|+||+||+|++..+++.||||++..... ......+.+|+.+++++. ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 46799999999999999999999999999999999974331 122345677888777764 99999999998754
Q ss_pred c-----eEEEEEEecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecc
Q 004088 259 E-----YLWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFG 332 (774)
Q Consensus 259 ~-----~l~LVmEy~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFG 332 (774)
. .+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 4 6899999996 59999886543 349999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC----CC----
Q 004088 333 VAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE----PA---- 404 (774)
Q Consensus 333 lA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~----~~---- 404 (774)
+++.+... ......+||+.|+|||++.+..++.++|||||||++|+|++|++||...........+... +.
T Consensus 166 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 166 LARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp CTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred cccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 99766443 3334568999999999999999999999999999999999999999887766554433210 00
Q ss_pred ----------------CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 405 ----------------PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 405 ----------------~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
+.......++..+.+||.+||++||.+|||+.|+|+||||++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 0001123467889999999999999999999999999999753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=432.03 Aligned_cols=263 Identities=27% Similarity=0.438 Sum_probs=224.8
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
...++|++++.||+|+||+||+|++..+++.||||++.+.. .......+.+|+.+|+.++|||||+++++|.+...+|
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 45678999999999999999999999999999999996422 1112234789999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
||||||+||+|.++++. ..+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.....
T Consensus 146 lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp EEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred EEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 99999999999999863 4689999999999999999999999999999999999999999999999999987654322
Q ss_pred -ccccccccccccchhhhhhcC----CCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCC-CCccccchhchHH
Q 004088 343 -KRNTFIGTPHWMAPEVIQESR----YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEP-APMLEDKEKWSLV 416 (774)
Q Consensus 343 -~~~~~~GT~~Y~APEvl~~~~----~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~-~~~~~~~~~~s~~ 416 (774)
...+.+||+.|+|||++.+.. |+.++|||||||++|||++|++||...+.......+.... ....+....++..
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 303 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 303 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHH
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHH
Confidence 234678999999999998765 8899999999999999999999999887776665553321 1112233467899
Q ss_pred HHHHHHhhcccCCCC--CCCHHHHHhhhhhhhhcc
Q 004088 417 FHDFVAKCLTKEPRA--RPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 417 l~dLI~kcL~~DP~k--RPTa~ElL~HPwf~~~~~ 449 (774)
+++||.+||+.+|.+ ||++.||++||||+...+
T Consensus 304 ~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w 338 (410)
T 3v8s_A 304 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 338 (410)
T ss_dssp HHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred HHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence 999999999999998 999999999999987543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=397.47 Aligned_cols=261 Identities=55% Similarity=0.938 Sum_probs=231.0
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
.....|++++.||+|+||.||+|.+..+++.||||++.........+.+.+|+.+|+++.||||+++++++.....+|+|
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 34567999999999999999999999999999999998766556678899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
|||+++++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.......
T Consensus 99 ~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 99 MEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp EECCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred EEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence 99999999999985 3579999999999999999999999999999999999999999999999999998776554444
Q ss_pred ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
....||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+.....+. ....++..+.+||.+|
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~ 254 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT--LEGNYSKPLKEFVEAC 254 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--CCSSCCHHHHHHHHHH
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCC--CccccCHHHHHHHHHH
Confidence 56689999999999999999999999999999999999999998877766655544333222 2346788899999999
Q ss_pred cccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 425 LTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 425 L~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
|..||.+|||+.++++||||.....
T Consensus 255 l~~dp~~Rps~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 255 LNKEPSFRPTAKELLKHKFILRNAK 279 (303)
T ss_dssp CCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred cCCChhhCcCHHHHhhChhhhcCCC
Confidence 9999999999999999999986543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=420.75 Aligned_cols=258 Identities=30% Similarity=0.453 Sum_probs=206.1
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCC-CCCcccccccccC--CceEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQG--EEYLW 262 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~--~~~l~ 262 (774)
.++|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.+. ||||++++++|.. ...+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 468999999999999999999999999999999986432 3445567889999999997 9999999999864 34799
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc--
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT-- 340 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~-- 340 (774)
||||||+ ++|..++.. ..+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+...
T Consensus 88 lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 9999996 588888863 57899999999999999999999999999999999999999999999999999765321
Q ss_pred -------------------ccccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 004088 341 -------------------MSKRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMIS 400 (774)
Q Consensus 341 -------------------~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~ 400 (774)
.......+||++|+|||++.+ ..|+.++|||||||++|||++|++||.+.+....+..+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~ 244 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 112234689999999999987 579999999999999999999999999877665554332
Q ss_pred cC-CCCccc-------------------------------------------cchhchHHHHHHHHhhcccCCCCCCCHH
Q 004088 401 IE-PAPMLE-------------------------------------------DKEKWSLVFHDFVAKCLTKEPRARPTAA 436 (774)
Q Consensus 401 ~~-~~~~~~-------------------------------------------~~~~~s~~l~dLI~kcL~~DP~kRPTa~ 436 (774)
.. ..+... ....++..+.+||.+||+.||.+|||+.
T Consensus 245 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~ 324 (388)
T 3oz6_A 245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN 324 (388)
T ss_dssp HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHH
Confidence 10 000000 0114577899999999999999999999
Q ss_pred HHHhhhhhhhh
Q 004088 437 EMLKHKFIERC 447 (774)
Q Consensus 437 ElL~HPwf~~~ 447 (774)
|+|+||||+..
T Consensus 325 e~l~Hp~~~~~ 335 (388)
T 3oz6_A 325 DALKHPFVSIF 335 (388)
T ss_dssp HHTTSTTTTTT
T ss_pred HHhCCHHHHHh
Confidence 99999999764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=406.20 Aligned_cols=262 Identities=30% Similarity=0.479 Sum_probs=220.6
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC----ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE----GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~----~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
.++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.+|++++||||++++++|.+....|
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 468999999999999999999999999999999986432 2345678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcc---------------------------------------CCchhHHHHHHHHHHHHHHHHHH
Q 004088 263 IVMEYCGGGSVADLMNVT---------------------------------------EEPLEEYQIAYICREALKGLAYL 303 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~---------------------------------------~~~Lse~~i~~I~~QIl~gL~YL 303 (774)
||||||++++|.+++... ...+++..++.++.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999988410 22467889999999999999999
Q ss_pred HhcCcccccccccceEecCCC--cEEEeecccccccccccc----ccccccccccccchhhhhh--cCCCCccchhhhHH
Q 004088 304 HSIFKVHRDIKGGNILLTDQG--EVKLGDFGVAAQLTRTMS----KRNTFIGTPHWMAPEVIQE--SRYDGKVDVWALGV 375 (774)
Q Consensus 304 Hs~gIIHRDLKPeNILLd~~g--~vKL~DFGlA~~i~~~~~----~~~~~~GT~~Y~APEvl~~--~~~s~ksDIWSLGv 375 (774)
|++||+||||||+||||+.++ .+||+|||+++.+..... ......||+.|+|||++.+ ..++.++|||||||
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 999999999999999998776 899999999986643221 1245579999999999975 67899999999999
Q ss_pred HHHHHHhCCCCCCCCCchhhhhhhhcCCC-CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 376 SAVEMAEGLPPRSTVHPMRVLFMISIEPA-PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 376 iLyELLtG~~Pf~~~~~~~~i~~i~~~~~-~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
++|+|++|+.||...........+..... ........++..+.+||.+||+.||.+||++.++|+||||+...
T Consensus 265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 99999999999998877666655443322 22233345788999999999999999999999999999998764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=412.91 Aligned_cols=261 Identities=26% Similarity=0.380 Sum_probs=208.8
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
..++|+++++||+|+||+||+|++..+++.||||++..... ......+.+|+.+|++++||||+++++++.....+|||
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 45689999999999999999999999999999999975432 22345678999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEec-----CCCcEEEeeccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLT-----DQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd-----~~g~vKL~DFGlA~~i~~ 339 (774)
||||+ ++|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+++.+..
T Consensus 112 ~e~~~-~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp EECCS-EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred EecCC-CCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 99997 599998863 45699999999999999999999999999999999999995 445699999999987765
Q ss_pred cccccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC---CC-Ccc-------
Q 004088 340 TMSKRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE---PA-PML------- 407 (774)
Q Consensus 340 ~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~---~~-~~~------- 407 (774)
........+||+.|+|||++.+. .++.++|||||||++|+|++|.+||........+..+... +. ..+
T Consensus 190 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (329)
T 3gbz_A 190 PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP 269 (329)
T ss_dssp ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh
Confidence 44444556889999999999875 4899999999999999999999999887765554433210 00 000
Q ss_pred ----------------ccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 408 ----------------EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 408 ----------------~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.....++..+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 00112568899999999999999999999999999998643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=392.87 Aligned_cols=259 Identities=27% Similarity=0.459 Sum_probs=221.8
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEe
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy 267 (774)
++|++++.||+|+||.||+|.+..+++.||||++.........+.+.+|+.+++.++||||+++++++......|+||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 57999999999999999999999999999999997655555667899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc--cccc
Q 004088 268 CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM--SKRN 345 (774)
Q Consensus 268 ~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~--~~~~ 345 (774)
+++++|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... ....
T Consensus 87 ~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 165 (276)
T 2yex_A 87 CSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (276)
T ss_dssp CTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred cCCCcHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhccc
Confidence 99999999985 44679999999999999999999999999999999999999999999999999997654321 1234
Q ss_pred cccccccccchhhhhhcCC-CCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 346 TFIGTPHWMAPEVIQESRY-DGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~-s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
...||+.|+|||++.+..+ +.++|||||||++|+|++|..||.........................++..+.+||.+|
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 245 (276)
T 2yex_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245 (276)
T ss_dssp CCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHH
T ss_pred CCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHH
Confidence 4579999999999987665 678999999999999999999998765433222222222222233456788999999999
Q ss_pred cccCCCCCCCHHHHHhhhhhhhh
Q 004088 425 LTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 425 L~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
|+.||.+|||+.++++||||+..
T Consensus 246 l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 246 LVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp SCSSTTTSCCHHHHTTCTTTTCC
T ss_pred CCCCchhCCCHHHHhcCccccCh
Confidence 99999999999999999999754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=397.96 Aligned_cols=259 Identities=28% Similarity=0.493 Sum_probs=199.6
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
..++|++.+.||+|+||.||+|++..+|+.||||++.... .....+.+.+|+.++++++||||+++++++......|+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 3468999999999999999999999999999999996432 12234678999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 168 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence 99999999999999866678999999999999999999999999999999999999999999999999999876544334
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHh
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAK 423 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~k 423 (774)
.....||+.|+|||++.+..++.++|||||||++|+|++|++||...........+.... ...+..++..+.+||.+
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~ 245 (278)
T 3cok_A 169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD---YEMPSFLSIEAKDLIHQ 245 (278)
T ss_dssp -----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSC---CCCCTTSCHHHHHHHHH
T ss_pred ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcc---cCCccccCHHHHHHHHH
Confidence 445679999999999998889999999999999999999999998765544433322211 12334578899999999
Q ss_pred hcccCCCCCCCHHHHHhhhhhhhh
Q 004088 424 CLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 424 cL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
||+.||.+|||+.++|+||||...
T Consensus 246 ~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 246 LLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HcccCHhhCCCHHHHhcCccccCC
Confidence 999999999999999999999754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=429.36 Aligned_cols=261 Identities=31% Similarity=0.478 Sum_probs=224.5
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
..++|++++.||+|+||+||+|++..+++.||||++.... .......+.+|+.+|++++||||+++++++.....+|+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3568999999999999999999999999999999986432 223456789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEec---CCCcEEEeeccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLT---DQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd---~~g~vKL~DFGlA~~i~~~~ 341 (774)
||||.+++|.+++.. ...+++..++.++.||+.||.|||++|||||||||+||||+ .++.+||+|||+++.+...
T Consensus 100 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~- 177 (486)
T 3mwu_A 100 GELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (486)
T ss_dssp ECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-
Confidence 999999999998863 46799999999999999999999999999999999999995 4457999999999766543
Q ss_pred cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCC-CccccchhchHHHHHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA-PMLEDKEKWSLVFHDF 420 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~-~~~~~~~~~s~~l~dL 420 (774)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||........+..+..... ...+....++..+.+|
T Consensus 178 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (486)
T ss_dssp ----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence 23345689999999999976 599999999999999999999999998877766665544332 2234456778999999
Q ss_pred HHhhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 421 VAKCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
|.+||+.||.+|||+.++|+||||+....
T Consensus 257 i~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 257 IRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp HHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred HHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 99999999999999999999999987653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=391.47 Aligned_cols=258 Identities=29% Similarity=0.463 Sum_probs=223.7
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
.++|++.+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+.+|++++||||+++++++......|+|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 4579999999999999999999999999999999975432 345778999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEe---cCCCcEEEeeccccccccccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL---TDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILL---d~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+... ..
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~-~~ 164 (277)
T 3f3z_A 87 LCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KM 164 (277)
T ss_dssp CCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-SC
T ss_pred ccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-cc
Confidence 9999999998863 4669999999999999999999999999999999999999 77889999999999776543 23
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCc-cccchhchHHHHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPM-LEDKEKWSLVFHDFVA 422 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~-~~~~~~~s~~l~dLI~ 422 (774)
.....||+.|+|||++.+. ++.++|||||||++|+|++|..||...........+....... ......++..+.+||.
T Consensus 165 ~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIR 243 (277)
T ss_dssp BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHH
T ss_pred hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHH
Confidence 3455799999999998765 9999999999999999999999999877766655544432222 2222357889999999
Q ss_pred hhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 423 KCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
+||+.||.+|||+.++|+||||++..
T Consensus 244 ~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 244 RLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred HHccCChhhCcCHHHHhcCHHHhccc
Confidence 99999999999999999999998654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=433.43 Aligned_cols=258 Identities=28% Similarity=0.476 Sum_probs=219.4
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
.++|+++++||+|+||+||+|++..+++.||||++.... .......+.+|+.+|+.++||||++++++|.....+|+||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 347999999999999999999999999999999997543 2334567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC---CcEEEeecccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ---GEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~---g~vKL~DFGlA~~i~~~~~ 342 (774)
|||.+++|.+++. ....+++..++.++.||+.||.|||++|||||||||+||||+.. +.+||+|||+++.+... .
T Consensus 116 e~~~~g~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-~ 193 (494)
T 3lij_A 116 ECYKGGELFDEII-HRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-K 193 (494)
T ss_dssp ECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-B
T ss_pred ecCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-c
Confidence 9999999998885 34679999999999999999999999999999999999999764 45999999999876543 3
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCC-ccccchhchHHHHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAP-MLEDKEKWSLVFHDFV 421 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~-~~~~~~~~s~~l~dLI 421 (774)
.....+||+.|+|||++.. .|+.++|||||||++|+|++|.+||...........+...... .......++..+.+||
T Consensus 194 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 272 (494)
T 3lij_A 194 KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLI 272 (494)
T ss_dssp CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHH
T ss_pred cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHH
Confidence 3445689999999999874 6999999999999999999999999988877766655443322 2233356789999999
Q ss_pred HhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 422 AKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 422 ~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
.+||+.||.+|||+.++|+||||+..
T Consensus 273 ~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 273 KQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHCCCChhhCccHHHHhcCcccccC
Confidence 99999999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=395.90 Aligned_cols=267 Identities=28% Similarity=0.490 Sum_probs=230.9
Q ss_pred CCCcccCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccc
Q 004088 178 PESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSY 255 (774)
Q Consensus 178 ~~~~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~ 255 (774)
|+........++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+.+|+.++++++||||+++++++
T Consensus 5 p~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (294)
T 2rku_A 5 PEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 84 (294)
T ss_dssp CSEEEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceeeCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 333344456779999999999999999999999999999999997543 344567789999999999999999999999
Q ss_pred cCCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccc
Q 004088 256 QGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 256 ~~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
...+..|+|||||++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 163 (294)
T 2rku_A 85 EDNDFVFVVLELCRRRSLLELHK-RRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 163 (294)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ccCCEEEEEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCce
Confidence 99999999999999999999886 34579999999999999999999999999999999999999999999999999998
Q ss_pred cccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchH
Q 004088 336 QLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSL 415 (774)
Q Consensus 336 ~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~ 415 (774)
.+...........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..... ..+..++.
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~ 240 (294)
T 2rku_A 164 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY---SIPKHINP 240 (294)
T ss_dssp ECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---CCCTTSCH
T ss_pred ecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC---CCccccCH
Confidence 765444444556799999999999998899999999999999999999999988766555444433222 22346778
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 416 VFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 416 ~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.+.+||.+||+.||.+|||+.++++||||....
T Consensus 241 ~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 241 VAASLIQKMLQTDPTARPTINELLNDEFFTSGY 273 (294)
T ss_dssp HHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence 899999999999999999999999999998654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=408.97 Aligned_cols=255 Identities=28% Similarity=0.442 Sum_probs=214.8
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-----CCCcccccccccCCc
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-----HPNVVRYLGSYQGEE 259 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-----HPNIVkL~~~~~~~~ 259 (774)
...++|+++++||+|+||+||+|++..+++.||||++.. .......+..|+.+|+.+. ||||+++++++...+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN--IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc--chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 346799999999999999999999999999999999863 3445567788999999996 999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC----------------
Q 004088 260 YLWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD---------------- 322 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~---------------- 322 (774)
.+||||||| +++|.+++.... ..+++..++.++.||+.||.|||++|||||||||+||||+.
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccc
Confidence 999999999 889999987543 46999999999999999999999999999999999999975
Q ss_pred ---------CCcEEEeeccccccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCch
Q 004088 323 ---------QGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPM 393 (774)
Q Consensus 323 ---------~g~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~ 393 (774)
++.+||+|||+|+..... ....+||+.|+|||++.+..++.++|||||||++|+|++|++||......
T Consensus 189 ~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 265 (360)
T 3llt_A 189 KKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265 (360)
T ss_dssp CEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHH
Confidence 788999999999764332 34568999999999999999999999999999999999999999877655
Q ss_pred hhhhhhhcCCCCccc-------------------------------------------cchhchHHHHHHHHhhcccCCC
Q 004088 394 RVLFMISIEPAPMLE-------------------------------------------DKEKWSLVFHDFVAKCLTKEPR 430 (774)
Q Consensus 394 ~~i~~i~~~~~~~~~-------------------------------------------~~~~~s~~l~dLI~kcL~~DP~ 430 (774)
.....+.....+... .....+..+.+||.+||+.||.
T Consensus 266 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 345 (360)
T 3llt_A 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPT 345 (360)
T ss_dssp HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChh
Confidence 444332211110000 0011136688999999999999
Q ss_pred CCCCHHHHHhhhhhh
Q 004088 431 ARPTAAEMLKHKFIE 445 (774)
Q Consensus 431 kRPTa~ElL~HPwf~ 445 (774)
+|||+.|+|+||||+
T Consensus 346 ~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 346 LRPSPAELLKHKFLE 360 (360)
T ss_dssp GSCCHHHHTTSGGGC
T ss_pred hCCCHHHHhcCcccC
Confidence 999999999999995
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=400.74 Aligned_cols=259 Identities=29% Similarity=0.441 Sum_probs=224.9
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh-----hhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE-----EGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~-----~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
.++|++++.||+|+||.||+|++..+|+.||||++...... ...+.+.+|+.+|++++||||+++++++.....+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 46799999999999999999999999999999999754322 1357799999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC----cEEEeeccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG----EVKLGDFGVAAQL 337 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g----~vKL~DFGlA~~i 337 (774)
|+|||||++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..+
T Consensus 91 ~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 91 VLILELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEECCCCSCBHHHHHH-TCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 99999999999999986 456799999999999999999999999999999999999999888 7999999999876
Q ss_pred cccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCc-cccchhchHH
Q 004088 338 TRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPM-LEDKEKWSLV 416 (774)
Q Consensus 338 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~-~~~~~~~s~~ 416 (774)
... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+....... ......++..
T Consensus 170 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (321)
T 2a2a_A 170 EDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248 (321)
T ss_dssp CTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred Ccc-ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHH
Confidence 543 22344579999999999999899999999999999999999999998877666555444332221 1223456888
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 417 FHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 417 l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
+.+||.+||..||.+|||+.++|+||||...
T Consensus 249 ~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp HHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 9999999999999999999999999999743
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=427.59 Aligned_cols=256 Identities=24% Similarity=0.362 Sum_probs=208.2
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCC------c
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE------E 259 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~------~ 259 (774)
.++|++++.||+|+||+||+|.+..+++.||||++.... .......+.+|+.+|+.++||||++++++|... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999999999999999997542 344567788999999999999999999998543 5
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
.+|||||||+++ |.+.+. ..+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+....
T Consensus 141 ~~~lv~E~~~~~-l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred eEEEEEeCCCCC-HHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 689999999764 555554 3589999999999999999999999999999999999999999999999999986654
Q ss_pred cccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-CCC-------------
Q 004088 340 TMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-PAP------------- 405 (774)
Q Consensus 340 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-~~~------------- 405 (774)
. ......+||++|+|||++.+..|+.++|||||||++|+|++|++||.+.+....+..+... ..+
T Consensus 217 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~ 295 (464)
T 3ttj_A 217 S-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 295 (464)
T ss_dssp C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred C-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence 3 2345568999999999999999999999999999999999999999987765544332110 000
Q ss_pred ----------ccc---------------cchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 406 ----------MLE---------------DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 406 ----------~~~---------------~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
... .....+..+.+||.+||+.||.+|||+.|+|+||||...
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 000 001115678999999999999999999999999999854
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=415.35 Aligned_cols=258 Identities=28% Similarity=0.418 Sum_probs=218.2
Q ss_pred CCeeE--EeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 188 TKYEL--LNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 188 ~~Y~i--lk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
..|.+ .+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.+|++++||||++++++|.....+||||
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 165 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM 165 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 34555 678999999999999999999999999997543 345577999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEe--cCCCcEEEeeccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL--TDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILL--d~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+... ..
T Consensus 166 E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~-~~ 244 (373)
T 2x4f_A 166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EK 244 (373)
T ss_dssp ECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT-CB
T ss_pred eCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc-cc
Confidence 9999999999887666679999999999999999999999999999999999999 56678999999999876543 23
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCC-CccccchhchHHHHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA-PMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~-~~~~~~~~~s~~l~dLI~ 422 (774)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||........+..+..... ........++..+.+||.
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 324 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFIS 324 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHH
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHH
Confidence 3445799999999999988899999999999999999999999998877666555443322 222233567899999999
Q ss_pred hhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 423 KCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
+||+.||.+|||+.|+|+||||...
T Consensus 325 ~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 325 KLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp TTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHcCCChhhCCCHHHHhcCcCcCCC
Confidence 9999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=393.68 Aligned_cols=259 Identities=29% Similarity=0.468 Sum_probs=221.8
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
...++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.++++++||||+++++++......|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 35678999999999999999999999999999999986432 1223466889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 86 lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-- 162 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 162 (279)
T ss_dssp EEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc--
Confidence 99999999999998863 356999999999999999999999999999999999999999999999999998654332
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...... .+..++..+.+||.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~ 239 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---FPDFVTEGARDLIS 239 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC---CCTTSCHHHHHHHH
T ss_pred cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC---CCCcCCHHHHHHHH
Confidence 234457999999999999999999999999999999999999999987766655544433222 23457888999999
Q ss_pred hhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 423 KCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
+||+.||.+|||+.|+|+||||+....
T Consensus 240 ~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 240 RLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp HHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred HHhccChhhCCCHHHHhhCccccCCcc
Confidence 999999999999999999999987543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=409.66 Aligned_cols=255 Identities=31% Similarity=0.459 Sum_probs=216.0
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~LVm 265 (774)
.++|++++.||+|+||.||+|.+..+|+.||||++..... ...+|+++|.++ +||||++++++|.+...+||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4579999999999999999999999999999999975432 234788888887 7999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC-C---cEEEeeccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ-G---EVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~-g---~vKL~DFGlA~~i~~~~ 341 (774)
|||.+|+|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||+..+ + .+||+|||+++.+....
T Consensus 96 E~~~gg~L~~~i~-~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 96 ELMKGGELLDKIL-RQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp CCCCSCBHHHHHH-TCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred eCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 9999999999886 44679999999999999999999999999999999999998543 2 59999999998776554
Q ss_pred cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCC---CchhhhhhhhcCCCCc-cccchhchHHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTV---HPMRVLFMISIEPAPM-LEDKEKWSLVF 417 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~---~~~~~i~~i~~~~~~~-~~~~~~~s~~l 417 (774)
....+.+||+.|+|||++.+..|+.++|||||||++|+|++|.+||... ........+....... ......++..+
T Consensus 175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 254 (342)
T 2qr7_A 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA 254 (342)
T ss_dssp CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHH
T ss_pred CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHH
Confidence 4455678999999999999888999999999999999999999999853 2223333332222211 11234678899
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 418 HDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 418 ~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
.+||.+||..||.+|||+.++|+||||...
T Consensus 255 ~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 255 KDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred HHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 999999999999999999999999999764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=400.62 Aligned_cols=262 Identities=52% Similarity=0.936 Sum_probs=217.5
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccccC-----
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQG----- 257 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~----- 257 (774)
....++|++++.||+|+||.||+|++..+|+.||||++.... ...+.+.+|+.+|+++ .||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 346789999999999999999999999999999999997543 2346788999999998 89999999999875
Q ss_pred -CceEEEEEEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccc
Q 004088 258 -EEYLWIVMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 258 -~~~l~LVmEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
...+|+|||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 56899999999999999998753 3578999999999999999999999999999999999999999999999999998
Q ss_pred cccccccccccccccccccchhhhh-----hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccc
Q 004088 336 QLTRTMSKRNTFIGTPHWMAPEVIQ-----ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDK 410 (774)
Q Consensus 336 ~i~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~ 410 (774)
.+...........||+.|+|||++. ...++.++|||||||++|+|++|..||...........+.....+.. ..
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~ 256 (326)
T 2x7f_A 178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL-KS 256 (326)
T ss_dssp -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SC
T ss_pred ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccC-Cc
Confidence 7655433445568999999999997 56689999999999999999999999988777666555444433322 24
Q ss_pred hhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 411 EKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 411 ~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
..++..+.+||.+||..||.+||++.++++||||+...
T Consensus 257 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 257 KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred cccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 56788999999999999999999999999999998643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=399.37 Aligned_cols=261 Identities=28% Similarity=0.438 Sum_probs=210.7
Q ss_pred CCCCeeEE-eeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEEE
Q 004088 186 PTTKYELL-NELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 186 ~~~~Y~il-k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~L 263 (774)
..++|++. +.||+|+||.||+|++..+++.||||++.... ......+.+|+.+|.++ +||||+++++++...+.+|+
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 45689996 78999999999999999999999999997543 34457789999999985 79999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCc---EEEeecccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE---VKLGDFGVAAQLTRT 340 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~---vKL~DFGlA~~i~~~ 340 (774)
|||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..+...
T Consensus 89 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 9999999999999864 457999999999999999999999999999999999999998776 999999999765322
Q ss_pred c-------cccccccccccccchhhhhh-----cCCCCccchhhhHHHHHHHHhCCCCCCCCCchh--------------
Q 004088 341 M-------SKRNTFIGTPHWMAPEVIQE-----SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMR-------------- 394 (774)
Q Consensus 341 ~-------~~~~~~~GT~~Y~APEvl~~-----~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~-------------- 394 (774)
. ......+||+.|+|||++.. ..++.++|||||||++|+|++|++||.......
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 1 11224569999999999975 568999999999999999999999998654321
Q ss_pred -hhhhhhcCCCC-ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 395 -VLFMISIEPAP-MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 395 -~i~~i~~~~~~-~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
....+...... .......++..+.+||.+||+.||.+|||+.|+|+||||+.+.
T Consensus 248 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 11112111111 1112245688899999999999999999999999999998654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=402.76 Aligned_cols=252 Identities=29% Similarity=0.401 Sum_probs=208.3
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~LVm 265 (774)
++|+++++||+|+||+||+|++..+|+.||||++.... ..........|+..+.++ .||||++++++|.....+||||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 67999999999999999999999999999999986433 233334455566555554 9999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
||| +++|.+++......+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||++...... ....
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~ 214 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAGE 214 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-------
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC-CCCc
Confidence 999 67898888766778999999999999999999999999999999999999999999999999999766443 2334
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhc
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCL 425 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL 425 (774)
...||+.|+|||++.+ .++.++|||||||++|+|++|..|+........+. .. .........++..+.+||.+||
T Consensus 215 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~~l~~li~~~L 289 (311)
T 3p1a_A 215 VQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLR---QG-YLPPEFTAGLSSELRSVLVMML 289 (311)
T ss_dssp CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHT---TT-CCCHHHHTTSCHHHHHHHHHHS
T ss_pred ccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHh---cc-CCCcccccCCCHHHHHHHHHHc
Confidence 4579999999999886 69999999999999999999977665543322221 11 1122234567889999999999
Q ss_pred ccCCCCCCCHHHHHhhhhhhh
Q 004088 426 TKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 426 ~~DP~kRPTa~ElL~HPwf~~ 446 (774)
+.||.+|||+.++|+||||++
T Consensus 290 ~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 290 EPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp CSSTTTSCCHHHHHTSGGGSC
T ss_pred CCChhhCcCHHHHHhCccccC
Confidence 999999999999999999964
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=394.09 Aligned_cols=262 Identities=29% Similarity=0.491 Sum_probs=204.3
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHH-HHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE-IRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~-~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
+...++|++++.||+|+||.||+|++..+|+.||||++........... +.++..+++.++||||+++++++......|
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 3456789999999999999999999999999999999975544333333 445555678889999999999999999999
Q ss_pred EEEEecCCCchhhhhhc---cCCchhHHHHHHHHHHHHHHHHHHHhc-CcccccccccceEecCCCcEEEeecccccccc
Q 004088 263 IVMEYCGGGSVADLMNV---TEEPLEEYQIAYICREALKGLAYLHSI-FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~---~~~~Lse~~i~~I~~QIl~gL~YLHs~-gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
+|||||+ ++|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..+.
T Consensus 83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9999996 588777643 456799999999999999999999998 99999999999999999999999999997665
Q ss_pred ccccccccccccccccchhhh----hhcCCCCccchhhhHHHHHHHHhCCCCCCCCCc-hhhhhhhhcCCCCccccchhc
Q 004088 339 RTMSKRNTFIGTPHWMAPEVI----QESRYDGKVDVWALGVSAVEMAEGLPPRSTVHP-MRVLFMISIEPAPMLEDKEKW 413 (774)
Q Consensus 339 ~~~~~~~~~~GT~~Y~APEvl----~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~-~~~i~~i~~~~~~~~~~~~~~ 413 (774)
... ......||+.|+|||++ ....++.++|||||||++|+|++|..||..... ............+ ......+
T Consensus 162 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 239 (290)
T 3fme_A 162 DDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP-QLPADKF 239 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC-CCCTTTS
T ss_pred ccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC-CcccccC
Confidence 432 23344799999999996 456789999999999999999999999986433 2222222222222 2223467
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 414 SLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 414 s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
+..+.+||.+||+.||.+|||+.++++||||+...
T Consensus 240 ~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred CHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 88999999999999999999999999999998653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=404.77 Aligned_cols=267 Identities=28% Similarity=0.488 Sum_probs=231.0
Q ss_pred CCCcccCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccc
Q 004088 178 PESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSY 255 (774)
Q Consensus 178 ~~~~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~ 255 (774)
+..........+|.+++.||+|+||.||+|++..+++.||+|++.... .....+.+.+|+.++++++||||+++++++
T Consensus 31 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 110 (335)
T 2owb_A 31 PEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 110 (335)
T ss_dssp CSEEEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceecCcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 333344456679999999999999999999999999999999997543 334567789999999999999999999999
Q ss_pred cCCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccc
Q 004088 256 QGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 256 ~~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
...+.+|+|||||.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 189 (335)
T 2owb_A 111 EDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 189 (335)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ecCCeEEEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCce
Confidence 999999999999999999998863 4679999999999999999999999999999999999999999999999999998
Q ss_pred cccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchH
Q 004088 336 QLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSL 415 (774)
Q Consensus 336 ~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~ 415 (774)
.+...........||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..... ..+..++.
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~ 266 (335)
T 2owb_A 190 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY---SIPKHINP 266 (335)
T ss_dssp ECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC---CCCTTSCH
T ss_pred ecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC---CCCccCCH
Confidence 765444444556899999999999998999999999999999999999999988766555444433222 12345778
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 416 VFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 416 ~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.+.+||.+||+.||.+|||+.++|+||||....
T Consensus 267 ~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 267 VAASLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 899999999999999999999999999998653
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=405.84 Aligned_cols=261 Identities=32% Similarity=0.465 Sum_probs=215.5
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
...++|++++.||+|+||.||+|++..+|+.||||++..... ....+.+.+|+.+|++++||||+++++++.....+|+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 346789999999999999999999999999999999865443 3345567899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
||||+++++|.+++. ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 102 v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 102 VFEFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp EEECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EEecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence 999999998888764 4467999999999999999999999999999999999999999999999999999876554444
Q ss_pred cccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC--------------------
Q 004088 344 RNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-------------------- 402 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-------------------- 402 (774)
....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||...........+...
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 4556899999999999875 6899999999999999999999999887655443322110
Q ss_pred --------CCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 403 --------PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 403 --------~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
..+.......++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 00111112356788999999999999999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=391.43 Aligned_cols=258 Identities=28% Similarity=0.469 Sum_probs=219.2
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccC----Cc
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG----EE 259 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~----~~ 259 (774)
.....|++.+.||+|+||.||+|.+..++..||+|++.... .......+.+|+.+|++++||||++++++|.. ..
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 34557999999999999999999999999999999997543 34456778999999999999999999998754 56
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcC--cccccccccceEec-CCCcEEEeecccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF--KVHRDIKGGNILLT-DQGEVKLGDFGVAAQ 336 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~g--IIHRDLKPeNILLd-~~g~vKL~DFGlA~~ 336 (774)
.+|+|||||++++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eEEEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 79999999999999999963 467899999999999999999999999 99999999999998 788999999999965
Q ss_pred ccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHH
Q 004088 337 LTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLV 416 (774)
Q Consensus 337 i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~ 416 (774)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||..........................+..
T Consensus 182 ~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (290)
T 1t4h_A 182 KRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258 (290)
T ss_dssp CCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred cccc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHH
Confidence 4332 2344579999999998875 599999999999999999999999987665554444333333333445566788
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 417 FHDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 417 l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 259 l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 999999999999999999999999999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=408.86 Aligned_cols=262 Identities=29% Similarity=0.410 Sum_probs=214.8
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh----hhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE----EGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~----~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
..++|++++.||+|+||.||+|++..+|+.||||++...... .....+.+|+.+|++++||||++++++|.....+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 457899999999999999999999999999999998643321 1234678999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|+|||||++ +|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 999999975 8888887666789999999999999999999999999999999999999999999999999998775554
Q ss_pred cccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC---CC-Ccc---------
Q 004088 342 SKRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE---PA-PML--------- 407 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~---~~-~~~--------- 407 (774)
......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||........+..+... +. ..+
T Consensus 167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T 1ua2_A 167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 246 (346)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccc
Confidence 445566899999999999764 4899999999999999999999999887765544332110 00 000
Q ss_pred ------------ccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 408 ------------EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 408 ------------~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.....++..+.+||.+||+.||.+|||+.|+|+||||....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 247 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 01134568899999999999999999999999999998654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=407.64 Aligned_cols=257 Identities=49% Similarity=0.878 Sum_probs=223.3
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
....|++++.||+|+||.||+|++..+|+.||||++.... .....+.+.+|+.+|++++||||++++++|......||
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 3457999999999999999999999999999999997543 23345678999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|||||. |+|.+++......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 132 v~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp EEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred EEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 999996 6888888666678999999999999999999999999999999999999999999999999999765432
Q ss_pred cccccccccccchhhhh---hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQ---ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
...+||+.|+|||++. ...++.++|||||||++|+|++|++||........+..+.....+. .....++..+.+|
T Consensus 208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 285 (348)
T 1u5q_A 208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA-LQSGHWSEYFRNF 285 (348)
T ss_dssp -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CCCTTSCHHHHHH
T ss_pred -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCCCCCHHHHHH
Confidence 3457999999999985 4578999999999999999999999998877666555544433332 2245678899999
Q ss_pred HHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 421 VAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
|.+||+.||.+|||+.++|+||||.+..
T Consensus 286 i~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 286 VDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp HHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHcccChhhCcCHHHHhhChhhhccC
Confidence 9999999999999999999999997643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=404.87 Aligned_cols=256 Identities=27% Similarity=0.423 Sum_probs=197.4
Q ss_pred CCeeEE---eeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-CCCcccccccccCCceEEE
Q 004088 188 TKYELL---NELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 188 ~~Y~il---k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~~~~l~L 263 (774)
.+|++. +.||+|+||.||+|.+..+++.||||++... ....+.+|+.+|+.+. ||||++++++|.+....||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 357765 7899999999999999999999999998642 3466789999999997 9999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC---cEEEeecccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG---EVKLGDFGVAAQLTRT 340 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g---~vKL~DFGlA~~i~~~ 340 (774)
|||||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 84 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 84 VMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp EECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred EEEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9999999999999864 46799999999999999999999999999999999999998766 7999999999876554
Q ss_pred ccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCc-------hhhhhhhhcCCCC-ccccchh
Q 004088 341 MSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHP-------MRVLFMISIEPAP-MLEDKEK 412 (774)
Q Consensus 341 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~-------~~~i~~i~~~~~~-~~~~~~~ 412 (774)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||..... ......+...... .......
T Consensus 163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (325)
T 3kn6_A 163 NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN 242 (325)
T ss_dssp ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHT
T ss_pred CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccC
Confidence 4445566899999999999999999999999999999999999999986443 2222222222211 1222345
Q ss_pred chHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 413 WSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 413 ~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
++..+.+||.+||+.||.+|||+.++++||||+...
T Consensus 243 ~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 243 VSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp SCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred CCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 788999999999999999999999999999998653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=398.93 Aligned_cols=266 Identities=42% Similarity=0.724 Sum_probs=199.9
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
.....++|++++.||+|+||.||+|.+..+++.||||++.........+.+.+|+.+|++++||||+++++++...+..|
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 44567899999999999999999999888999999999875544455677889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhc-------cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccc
Q 004088 263 IVMEYCGGGSVADLMNV-------TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~-------~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
+||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999998863 24569999999999999999999999999999999999999999999999999997
Q ss_pred cccccc-----cccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCcc--
Q 004088 336 QLTRTM-----SKRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPML-- 407 (774)
Q Consensus 336 ~i~~~~-----~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~-- 407 (774)
.+.... .......||+.|+|||++.. ..++.++|||||||++|+|++|..||.................+..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence 654321 11234579999999999976 5689999999999999999999999988766554433222211111
Q ss_pred -----ccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 408 -----EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 408 -----~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.....++..+.+||.+||+.||.+||++.++++||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 11245678899999999999999999999999999998654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=417.05 Aligned_cols=263 Identities=25% Similarity=0.356 Sum_probs=209.7
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCC-----
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE----- 258 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~----- 258 (774)
...++|++++.||+|+||.||+|++..+++.||||++.... .....+.+.+|+.+|++++||||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 34679999999999999999999999999999999996432 334557789999999999999999999998765
Q ss_pred ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 259 EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
..+|||||||+ ++|.+++. ....+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+.
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFK-TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred CeEEEEEecCC-cCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 67999999995 59999886 45679999999999999999999999999999999999999999999999999998764
Q ss_pred cccc----------------------ccccccccccccchhhh-hhcCCCCccchhhhHHHHHHHHhC-----------C
Q 004088 339 RTMS----------------------KRNTFIGTPHWMAPEVI-QESRYDGKVDVWALGVSAVEMAEG-----------L 384 (774)
Q Consensus 339 ~~~~----------------------~~~~~~GT~~Y~APEvl-~~~~~s~ksDIWSLGviLyELLtG-----------~ 384 (774)
.... .....+||++|+|||++ ....|+.++|||||||++|||++| +
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 4321 13556899999999997 455699999999999999999984 4
Q ss_pred CCCCCCCch-----------------hh---hhhhhcCC-------------------------CCccccchhchHHHHH
Q 004088 385 PPRSTVHPM-----------------RV---LFMISIEP-------------------------APMLEDKEKWSLVFHD 419 (774)
Q Consensus 385 ~Pf~~~~~~-----------------~~---i~~i~~~~-------------------------~~~~~~~~~~s~~l~d 419 (774)
++|.+.... .. +..+...+ .........++..+.+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 444332210 00 00000000 0000111346889999
Q ss_pred HHHhhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 420 FVAKCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 420 LI~kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
||.+||+.||.+|||+.|+|+||||+....
T Consensus 341 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 341 LLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred HHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 999999999999999999999999987643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=407.91 Aligned_cols=261 Identities=34% Similarity=0.588 Sum_probs=222.4
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
+...++|++++.||+|+||.||+|.+..+++.||+|++.........+.+.+|+.+|++++||||+++++++.....+|+
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 34567899999999999999999999999999999999876566667789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhc-CcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI-FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~-gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
|||||++++|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+||||+.++.+||+|||++..+...
T Consensus 109 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp EECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 9999999999999864 45799999999999999999999996 9999999999999999999999999999765433
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhh-----------------------
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI----------------------- 399 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i----------------------- 399 (774)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||............
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence 233457999999999999999999999999999999999999999876543322111
Q ss_pred -------------------hcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 400 -------------------SIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 400 -------------------~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.....+ ......++..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 266 KFGMDSRPPMAIFELLDYIVNEPPP-KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp --------CCCHHHHHHHHHHSCCC-CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccccCCCCcccchhhhhHHhccCCC-CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 001111 111234678899999999999999999999999999998764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=388.36 Aligned_cols=259 Identities=29% Similarity=0.452 Sum_probs=220.7
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh-----hhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE-----EGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~-----~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
++|++++.||+|+||.||+|++..+++.||||++...... ...+.+.+|+.+|++++||||+++++++......|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 4799999999999999999999999999999999754321 23678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC----cEEEeecccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG----EVKLGDFGVAAQLT 338 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g----~vKL~DFGlA~~i~ 338 (774)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..+.
T Consensus 85 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999999999999863 45799999999999999999999999999999999999998877 79999999997664
Q ss_pred ccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCC-ccccchhchHHH
Q 004088 339 RTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAP-MLEDKEKWSLVF 417 (774)
Q Consensus 339 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~-~~~~~~~~s~~l 417 (774)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...... .......++..+
T Consensus 164 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T 3bhy_A 164 AGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA 242 (283)
T ss_dssp ---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHH
T ss_pred CCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHH
Confidence 432 233457999999999999889999999999999999999999999887766555444332222 122234567889
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 418 HDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 418 ~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.+||.+||..||.+|||+.++|+||||+...
T Consensus 243 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 243 KDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 9999999999999999999999999998754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=404.99 Aligned_cols=259 Identities=24% Similarity=0.452 Sum_probs=210.7
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCC--CCcccccccccCCceE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSH--PNVVRYLGSYQGEEYL 261 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~H--PNIVkL~~~~~~~~~l 261 (774)
....+|++++.||+|+||.||+|.+ .+++.||||++.... .....+.+.+|+.+|+++.| |||+++++++.....+
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 3467899999999999999999986 568999999997544 34455778999999999986 9999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|||||| .+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.+....
T Consensus 85 ~lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 85 YMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEEECC-CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEEeC-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 999995 58899999864 56799999999999999999999999999999999999997 5889999999998765432
Q ss_pred c--ccccccccccccchhhhhh-----------cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccc
Q 004088 342 S--KRNTFIGTPHWMAPEVIQE-----------SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLE 408 (774)
Q Consensus 342 ~--~~~~~~GT~~Y~APEvl~~-----------~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~ 408 (774)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....................
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 241 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence 2 2235679999999999975 67889999999999999999999999865433222221122222223
Q ss_pred cchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 409 DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 409 ~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
.+...+..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 344556789999999999999999999999999999853
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=405.48 Aligned_cols=262 Identities=27% Similarity=0.406 Sum_probs=215.1
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccC-------
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG------- 257 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~------- 257 (774)
..++|+++++||+|+||.||+|++..+|+.||||++..... ......+.+|+.+|++++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 35789999999999999999999999999999999865432 2334567899999999999999999999875
Q ss_pred -CceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccc
Q 004088 258 -EEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQ 336 (774)
Q Consensus 258 -~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~ 336 (774)
...+|||||||++ +|...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 4578999999965 77777766667899999999999999999999999999999999999999999999999999976
Q ss_pred cccc----ccccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc---CCC-Ccc
Q 004088 337 LTRT----MSKRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI---EPA-PML 407 (774)
Q Consensus 337 i~~~----~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~---~~~-~~~ 407 (774)
+... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+.. ... ...
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 253 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 6422 122234578999999999976 4589999999999999999999999988766544433211 110 000
Q ss_pred ccc-------------------------hhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 408 EDK-------------------------EKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 408 ~~~-------------------------~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
... ...++.+.+||.+||+.||.+|||+.|+|+||||....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 000 01256789999999999999999999999999998644
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=404.21 Aligned_cols=258 Identities=27% Similarity=0.393 Sum_probs=217.8
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCC-----ceE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE-----EYL 261 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~-----~~l 261 (774)
..+|++++.||+|+||.||+|.+..+++.||||++...........+.+|+++|++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999999999999999997655556667899999999999999999999998644 479
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 106 ~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 99999996 589888853 469999999999999999999999999999999999999999999999999998665432
Q ss_pred cc---cccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-CC------------
Q 004088 342 SK---RNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-PA------------ 404 (774)
Q Consensus 342 ~~---~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-~~------------ 404 (774)
.. ....+||+.|+|||++.+. .++.++|||||||++|+|++|++||........+..+... ..
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 21 2345899999999997654 4899999999999999999999999887765554433210 00
Q ss_pred ---------------CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 405 ---------------PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 405 ---------------~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
+.......++..+.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 0011123457889999999999999999999999999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=408.80 Aligned_cols=257 Identities=30% Similarity=0.444 Sum_probs=211.8
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCC------
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE------ 258 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~------ 258 (774)
..++|++++.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.+|+.++||||+++++++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3578999999999999999999999999999999986433 334456789999999999999999999998765
Q ss_pred ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 259 EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
..+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 3569999999 8899999864 568999999999999999999999999999999999999999999999999998654
Q ss_pred ccccccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc---CC-----------
Q 004088 339 RTMSKRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI---EP----------- 403 (774)
Q Consensus 339 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~---~~----------- 403 (774)
.. ....+||++|+|||++.+ ..++.++|||||||++|+|++|++||...+....+..+.. .+
T Consensus 180 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 256 (367)
T 1cm8_A 180 SE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256 (367)
T ss_dssp SS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred cc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence 32 345689999999999987 6799999999999999999999999998776554433211 00
Q ss_pred --------------CCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 404 --------------APMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 404 --------------~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
..........+..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 001111234578899999999999999999999999999998653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=390.75 Aligned_cols=259 Identities=27% Similarity=0.437 Sum_probs=224.4
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
....++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.++++++||||+++++++.....+
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 345678999999999999999999999999999999986432 122346788999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp EEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 999999999999999864 357899999999999999999999999999999999999999999999999998655432
Q ss_pred cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI 421 (774)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..... ..+..++..+.+||
T Consensus 168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li 243 (284)
T 2vgo_A 168 -RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL---KFPPFLSDGSKDLI 243 (284)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---CCCTTSCHHHHHHH
T ss_pred -ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc---CCCCcCCHHHHHHH
Confidence 23456799999999999998999999999999999999999999988776655444433221 22345788999999
Q ss_pred HhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 422 AKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 422 ~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.+||+.||.+||++.++++||||+...
T Consensus 244 ~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 244 SKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 999999999999999999999998654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=413.53 Aligned_cols=256 Identities=29% Similarity=0.417 Sum_probs=206.7
Q ss_pred CCCCeeEE-eeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHH-hCCCCCcccccccccC----Cc
Q 004088 186 PTTKYELL-NELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQ-QCSHPNVVRYLGSYQG----EE 259 (774)
Q Consensus 186 ~~~~Y~il-k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~-~L~HPNIVkL~~~~~~----~~ 259 (774)
..++|.+. +.||+|+||+||+|.+..+|+.||||++... ..+.+|+.++. .++||||++++++|.. ..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 34678887 7899999999999999999999999998632 45678998874 4589999999998865 67
Q ss_pred eEEEEEEecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC---CCcEEEeeccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD---QGEVKLGDFGVAA 335 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~---~g~vKL~DFGlA~ 335 (774)
.+|||||||.+|+|.+++.... ..+++..++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|||+++
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 8999999999999999997543 46999999999999999999999999999999999999998 7889999999998
Q ss_pred cccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhh----hhhhhcCCC-Cccccc
Q 004088 336 QLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRV----LFMISIEPA-PMLEDK 410 (774)
Q Consensus 336 ~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~----i~~i~~~~~-~~~~~~ 410 (774)
..... ......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||........ ...+..... ......
T Consensus 213 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 291 (400)
T 1nxk_A 213 ETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291 (400)
T ss_dssp ECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTT
T ss_pred ccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccc
Confidence 65433 233456899999999999988999999999999999999999999986554321 111211111 111223
Q ss_pred hhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 411 EKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 411 ~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
..++..+.+||.+||+.||.+|||+.++|+||||....
T Consensus 292 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 45788999999999999999999999999999998653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=397.08 Aligned_cols=260 Identities=25% Similarity=0.455 Sum_probs=217.1
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
..++|++.+.||+|+||+||+|.+..+++.||||++.. ......+.+.+|+.+|++++||||+++++++......|+||
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 45789999999999999999999999999999999853 34566678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc--
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK-- 343 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~-- 343 (774)
|||.+++|.+++......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+......
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 999999999999876778999999999999999999999999999999999999999999999999999766433221
Q ss_pred ------------cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccch
Q 004088 344 ------------RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKE 411 (774)
Q Consensus 344 ------------~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~ 411 (774)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||......................+.
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPP 246 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCT
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCC
Confidence 11457999999999999999999999999999999999999998764432221111000000001124
Q ss_pred hchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 412 KWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 412 ~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.++..+.+||.+||+.||.+|||+.++++ |++.+.
T Consensus 247 ~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~ 281 (310)
T 3s95_A 247 NCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLR 281 (310)
T ss_dssp TCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHH
Confidence 55677999999999999999999999986 565543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=425.33 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=224.7
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
..++|.+++.||+|+||.||+|++..+|+.||||++.... .......+.+|+.+|+.++||||+++++++.....+||
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4578999999999999999999999999999999996432 12345678999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|||||++++|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+... ..
T Consensus 94 v~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-~~ 171 (476)
T 2y94_A 94 VMEYVSGGELFDYIC-KNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EF 171 (476)
T ss_dssp EEECCSSEEHHHHTT-SSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-CC
T ss_pred EEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-cc
Confidence 999999999999986 4567999999999999999999999999999999999999999999999999999876543 33
Q ss_pred cccccccccccchhhhhhcCC-CCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESRY-DGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~-s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
..+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........+..... ..+..++..+.+||.
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~ 248 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF---YTPQYLNPSVISLLK 248 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC---CCCTTCCHHHHHHHH
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc---CCCccCCHHHHHHHH
Confidence 445689999999999998766 6799999999999999999999998776665555443322 223457889999999
Q ss_pred hhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 423 KCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
+||+.||.+|||+.++++||||+..
T Consensus 249 ~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 249 HMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHcCCCchhCcCHHHHHhCHHhhhc
Confidence 9999999999999999999999853
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=388.12 Aligned_cols=263 Identities=30% Similarity=0.481 Sum_probs=223.4
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC--------hhhHHHHHHHHHHHHhCC-CCCccccccc
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG--------EEGYEEIRGEIEMLQQCS-HPNVVRYLGS 254 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~--------~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~ 254 (774)
....++|++.+.||+|+||.||+|.+..+|+.||||++..... ....+.+.+|+.+|+++. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 3456799999999999999999999999999999999975431 123456789999999995 9999999999
Q ss_pred ccCCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccc
Q 004088 255 YQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA 334 (774)
Q Consensus 255 ~~~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA 334 (774)
+......|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eccCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 9999999999999999999999864 467999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccccccchhhhh------hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCC-cc
Q 004088 335 AQLTRTMSKRNTFIGTPHWMAPEVIQ------ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAP-ML 407 (774)
Q Consensus 335 ~~i~~~~~~~~~~~GT~~Y~APEvl~------~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~-~~ 407 (774)
..+... .......||+.|+|||++. ...++.++|||||||++|+|++|..||...........+...... ..
T Consensus 172 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1phk_A 172 CQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250 (298)
T ss_dssp EECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred hhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence 766543 2334557999999999986 345888999999999999999999999887766555444332221 22
Q ss_pred ccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 408 EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 408 ~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.....++..+.+||.+||+.||.+|||+.++|+||||++..
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 23356788999999999999999999999999999998643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=396.10 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=213.0
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCc--eEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE--YLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~--~l~L 263 (774)
..++|++.+.||+|+||+||+|++..+++.||||++.........+.+.+|+++|++++||||+++++++.... .+||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 45689999999999999999999999999999999975544455677889999999999999999999987554 8899
Q ss_pred EEEecCCCchhhhhhccCC--chhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEe----cCCCcEEEeeccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEE--PLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL----TDQGEVKLGDFGVAAQL 337 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~--~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILL----d~~g~vKL~DFGlA~~i 337 (774)
|||||++++|.+++..... .+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||+++.+
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 9999999999999975432 39999999999999999999999999999999999999 77788999999999876
Q ss_pred cccccccccccccccccchhhhh--------hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchh----hhhhhhc-CCC
Q 004088 338 TRTMSKRNTFIGTPHWMAPEVIQ--------ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMR----VLFMISI-EPA 404 (774)
Q Consensus 338 ~~~~~~~~~~~GT~~Y~APEvl~--------~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~----~i~~i~~-~~~ 404 (774)
... ......+||+.|+|||++. +..++.++|||||||++|+|++|..||....... ....+.. .+.
T Consensus 167 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~ 245 (319)
T 4euu_A 167 EDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245 (319)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCT
T ss_pred CCC-CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCc
Confidence 544 2334567999999999987 4678999999999999999999999997543221 1111111 110
Q ss_pred ---------------------CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhh
Q 004088 405 ---------------------PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKF 443 (774)
Q Consensus 405 ---------------------~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPw 443 (774)
........++..+.+||.+||+.||++|||+.|+|+||-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 001112345678999999999999999999999999974
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=391.70 Aligned_cols=259 Identities=25% Similarity=0.409 Sum_probs=220.5
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
.++|++++.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+|++++||||+++++++.....+|+|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 4589999999999999999999999999999999975432 234568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEe---cCCCcEEEeeccccccccccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL---TDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILL---d~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...... .
T Consensus 87 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--~ 163 (304)
T 2jam_A 87 LVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--I 163 (304)
T ss_dssp CCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--T
T ss_pred cCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--c
Confidence 9999999998863 4578999999999999999999999999999999999999 67789999999999654332 2
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCC-ccccchhchHHHHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAP-MLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~-~~~~~~~~s~~l~dLI~ 422 (774)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...... .......++..+.+||.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 243 (304)
T 2jam_A 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFIC 243 (304)
T ss_dssp THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHH
T ss_pred cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHH
Confidence 33457999999999999989999999999999999999999999887766555444333221 11223467889999999
Q ss_pred hhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 423 KCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
+||..||.+|||+.++|+||||.....
T Consensus 244 ~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (304)
T 2jam_A 244 HLLEKDPNERYTCEKALSHPWIDGNTA 270 (304)
T ss_dssp HHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred HHcCCChhHCcCHHHHhcCccccCCCc
Confidence 999999999999999999999986543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=416.46 Aligned_cols=258 Identities=32% Similarity=0.454 Sum_probs=206.3
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-------ChhhHHHHHHHHHHHHhCCCCCcccccccccCC
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-------GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE 258 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-------~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~ 258 (774)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 3578999999999999999999999999999999997532 11122347899999999999999999999865
Q ss_pred ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC---cEEEeeccccc
Q 004088 259 EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG---EVKLGDFGVAA 335 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g---~vKL~DFGlA~ 335 (774)
..+|||||||++++|.+++. ....+++..++.++.||+.||.|||++|||||||||+|||++.++ .+||+|||+|+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred CceEEEEEcCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 45799999999999999886 456799999999999999999999999999999999999997654 59999999998
Q ss_pred cccccccccccccccccccchhhhhh---cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhh-hhhcCCCC-ccccc
Q 004088 336 QLTRTMSKRNTFIGTPHWMAPEVIQE---SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLF-MISIEPAP-MLEDK 410 (774)
Q Consensus 336 ~i~~~~~~~~~~~GT~~Y~APEvl~~---~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~-~i~~~~~~-~~~~~ 410 (774)
.+... ......+||+.|+|||++.. ..|+.++|||||||++|+|++|++||.......... .+...... .....
T Consensus 291 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 291 ILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp SCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred ecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence 76543 33345689999999999863 568889999999999999999999998654433222 22222221 12223
Q ss_pred hhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 411 EKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 411 ~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
..++..+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 457889999999999999999999999999999974
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-47 Score=399.90 Aligned_cols=263 Identities=28% Similarity=0.437 Sum_probs=217.7
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCc---
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE--- 259 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~--- 259 (774)
...++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 34678999999999999999999999999999999997543 3344567899999999999999999999986543
Q ss_pred -eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 260 -YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 260 -~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
..|||||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cccEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 45999999999999999863 4579999999999999999999999999999999999999999999999999997664
Q ss_pred cccc---ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-CCCccccchhch
Q 004088 339 RTMS---KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-PAPMLEDKEKWS 414 (774)
Q Consensus 339 ~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-~~~~~~~~~~~s 414 (774)
.... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||............... ..+.......++
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 247 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCC
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCC
Confidence 4321 223457999999999999999999999999999999999999999887766655443332 333333345678
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 415 LVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 415 ~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
..+.+||.+||+.||.+||++.++|.|+|++...
T Consensus 248 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 248 ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 8999999999999999999999999999998653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=404.45 Aligned_cols=256 Identities=24% Similarity=0.355 Sum_probs=205.4
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCc------
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE------ 259 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~------ 259 (774)
.++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999999999999999997543 3445567889999999999999999999987554
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
.+|+|||||++ +|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred ceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 88999999964 7777775 4589999999999999999999999999999999999999999999999999976543
Q ss_pred cccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCc-------------
Q 004088 340 TMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPM------------- 406 (774)
Q Consensus 340 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~------------- 406 (774)
. ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+....+..+.......
T Consensus 180 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 258 (371)
T 2xrw_A 180 S-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 258 (371)
T ss_dssp -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred c-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence 3 22344689999999999999999999999999999999999999998877655443332110000
Q ss_pred --------------------------cccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 407 --------------------------LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 407 --------------------------~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
.......+..+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 00011225678999999999999999999999999999753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=385.66 Aligned_cols=252 Identities=26% Similarity=0.418 Sum_probs=211.1
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~LV 264 (774)
.++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.++.++ +||||+++++++...+.+|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 357999999999999999999999999999999997543 234456788999999999 999999999999999999999
Q ss_pred EEecCCCchhhhhhcc---CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC------------------
Q 004088 265 MEYCGGGSVADLMNVT---EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ------------------ 323 (774)
Q Consensus 265 mEy~~ggsL~dll~~~---~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~------------------ 323 (774)
||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999999998643 2568999999999999999999999999999999999999844
Q ss_pred -CcEEEeeccccccccccccccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc
Q 004088 324 -GEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI 401 (774)
Q Consensus 324 -g~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~ 401 (774)
..+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+|+........+ ..
T Consensus 170 ~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~ 242 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI---RQ 242 (289)
T ss_dssp CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHH---HT
T ss_pred ceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHH---Hc
Confidence 47999999999766443 234699999999999876 5668999999999999999999887654433222 22
Q ss_pred CCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 402 EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 402 ~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
...+ ..+..++..+.+||.+||+.||.+|||+.++|+||||...
T Consensus 243 ~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 243 GRLP--RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp TCCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred CCCC--CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 2111 2234678899999999999999999999999999999753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=414.14 Aligned_cols=252 Identities=15% Similarity=0.123 Sum_probs=204.8
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHH---HHHHhCCCCCccccc-------
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEI---EMLQQCSHPNVVRYL------- 252 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei---~iL~~L~HPNIVkL~------- 252 (774)
...++|++.+.||+|+||.||+|++..+|+.||||++.... .....+.+.+|+ ++|++++|||||+++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 34678999999999999999999998899999999997532 334567889999 555566899999998
Q ss_pred ccccCCc-----------------eEEEEEEecCCCchhhhhhccC------CchhHHHHHHHHHHHHHHHHHHHhcCcc
Q 004088 253 GSYQGEE-----------------YLWIVMEYCGGGSVADLMNVTE------EPLEEYQIAYICREALKGLAYLHSIFKV 309 (774)
Q Consensus 253 ~~~~~~~-----------------~l~LVmEy~~ggsL~dll~~~~------~~Lse~~i~~I~~QIl~gL~YLHs~gII 309 (774)
+++...+ ..||||||| +|+|.+++.... ..+++..++.|+.||+.||.|||++|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 4444332 389999999 689999986421 2355688889999999999999999999
Q ss_pred cccccccceEecCCCcEEEeeccccccccccccccccccccccccchhhhhhc-----------CCCCccchhhhHHHHH
Q 004088 310 HRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQES-----------RYDGKVDVWALGVSAV 378 (774)
Q Consensus 310 HRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~-----------~~s~ksDIWSLGviLy 378 (774)
||||||+||||+.++.+||+|||+|+.... .....+| +.|+|||++.+. .|+.++|||||||++|
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 999999999999999999999999975432 2345578 999999999988 8999999999999999
Q ss_pred HHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 379 EMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 379 ELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
+|++|+.||...........+... ...++..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 305 elltg~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 305 WIWCADLPITKDAALGGSEWIFRS-------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp HHHHSSCCC------CCSGGGGSS-------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred HHHHCCCCCcccccccchhhhhhh-------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 999999999876654443333221 245678899999999999999999999999999998643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=385.23 Aligned_cols=257 Identities=25% Similarity=0.402 Sum_probs=213.6
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
..++|++++.||+|+||.||+|++..+|+.||||++.... .....+.+.+|+.+|+.++||||+++++++......|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 4578999999999999999999999999999999986432 22345678999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|||||.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 89 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~ 166 (276)
T 2h6d_A 89 VMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EF 166 (276)
T ss_dssp EEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred EEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC-cc
Confidence 9999999999999864 356899999999999999999999999999999999999999999999999999766443 22
Q ss_pred cccccccccccchhhhhhcCC-CCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESRY-DGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~-s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
.....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........+...... .+..++..+.++|.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~ 243 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY---IPEYLNRSVATLLM 243 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTSCHHHHHHHH
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc---CchhcCHHHHHHHH
Confidence 334579999999999987765 57999999999999999999999887665555444332221 23456788999999
Q ss_pred hhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 423 KCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
+||+.||.+|||+.++++||||++.
T Consensus 244 ~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 244 HMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHccCChhhCCCHHHHHhChhhccC
Confidence 9999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=407.80 Aligned_cols=257 Identities=24% Similarity=0.414 Sum_probs=210.4
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCccccccccc--------
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ-------- 256 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~-------- 256 (774)
...++|++++.||+|+||+||+|++..+|+.||||++...... ..+|+.+|+.++||||++++++|.
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 3467899999999999999999999999999999998644321 237999999999999999999883
Q ss_pred ------------------------------CCceEEEEEEecCCCchhhhhh---ccCCchhHHHHHHHHHHHHHHHHHH
Q 004088 257 ------------------------------GEEYLWIVMEYCGGGSVADLMN---VTEEPLEEYQIAYICREALKGLAYL 303 (774)
Q Consensus 257 ------------------------------~~~~l~LVmEy~~ggsL~dll~---~~~~~Lse~~i~~I~~QIl~gL~YL 303 (774)
...++++|||||+ ++|.+.+. .....+++..++.++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3445899999997 57777664 2456799999999999999999999
Q ss_pred HhcCcccccccccceEec-CCCcEEEeeccccccccccccccccccccccccchhhhhhcC-CCCccchhhhHHHHHHHH
Q 004088 304 HSIFKVHRDIKGGNILLT-DQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESR-YDGKVDVWALGVSAVEMA 381 (774)
Q Consensus 304 Hs~gIIHRDLKPeNILLd-~~g~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGviLyELL 381 (774)
|++||+||||||+|||++ .++.+||+|||+|+.+... ......+||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 999999999999999998 5789999999999866443 2334567999999999998754 899999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhcC-CCC------------------cc-------ccchhchHHHHHHHHhhcccCCCCCCCH
Q 004088 382 EGLPPRSTVHPMRVLFMISIE-PAP------------------ML-------EDKEKWSLVFHDFVAKCLTKEPRARPTA 435 (774)
Q Consensus 382 tG~~Pf~~~~~~~~i~~i~~~-~~~------------------~~-------~~~~~~s~~l~dLI~kcL~~DP~kRPTa 435 (774)
+|++||........+..+... ..+ .. ..+...+..+.+||.+||+.||.+|||+
T Consensus 237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (383)
T 3eb0_A 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316 (383)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 999999987766554433210 000 00 0123457789999999999999999999
Q ss_pred HHHHhhhhhhhhc
Q 004088 436 AEMLKHKFIERCK 448 (774)
Q Consensus 436 ~ElL~HPwf~~~~ 448 (774)
.|+|+||||+...
T Consensus 317 ~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 317 YEAMAHPFFDHLR 329 (383)
T ss_dssp HHHHTSGGGHHHH
T ss_pred HHHhcCHHHHHHH
Confidence 9999999998754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=409.30 Aligned_cols=256 Identities=25% Similarity=0.481 Sum_probs=209.9
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCC--CCCcccccccccCCceEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCS--HPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~--HPNIVkL~~~~~~~~~l~L 263 (774)
..+|++++.||+|+||.||+|.+.. ++.||||++.... .....+.+.+|+.+|+++. ||||+++++++.....+||
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 4569999999999999999999754 8999999997654 3455678999999999996 5999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc-
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS- 342 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~- 342 (774)
||| +.+++|.+++.. ...+++..++.++.||+.||.|||++|||||||||+||||+ ++.+||+|||+++.+.....
T Consensus 134 v~E-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EEE-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred EEe-cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 999 568899999874 45789999999999999999999999999999999999995 58999999999987654322
Q ss_pred -ccccccccccccchhhhhh-----------cCCCCccchhhhHHHHHHHHhCCCCCCCCCch-hhhhhhhcCCCCcccc
Q 004088 343 -KRNTFIGTPHWMAPEVIQE-----------SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPM-RVLFMISIEPAPMLED 409 (774)
Q Consensus 343 -~~~~~~GT~~Y~APEvl~~-----------~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~-~~i~~i~~~~~~~~~~ 409 (774)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||...... ..+..+. ........
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~-~~~~~~~~ 289 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII-DPNHEIEF 289 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH-CTTSCCCC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh-CccccCCC
Confidence 2345689999999999975 36889999999999999999999999865432 2222222 22222223
Q ss_pred chhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 410 KEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 410 ~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
+...+..+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 290 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 290 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 34457789999999999999999999999999999753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=405.81 Aligned_cols=250 Identities=26% Similarity=0.435 Sum_probs=215.1
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh-------hhHHHHHHHHHHHHhCCCCCcccccccccCCc
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE-------EGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE 259 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~-------~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~ 259 (774)
.++|++++.||+|+||.||+|++..+++.||||++...... .....+.+|+.+|++++||||++++++|....
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 46899999999999999999999999999999999754311 12345778999999999999999999999999
Q ss_pred eEEEEEEecCCC-chhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 260 YLWIVMEYCGGG-SVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 260 ~l~LVmEy~~gg-sL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
.+++||||+.+| +|.+++. ....+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFID-RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHH-TCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEEeCCCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 999999999776 9999886 44579999999999999999999999999999999999999999999999999998765
Q ss_pred ccccccccccccccccchhhhhhcCC-CCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHH
Q 004088 339 RTMSKRNTFIGTPHWMAPEVIQESRY-DGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVF 417 (774)
Q Consensus 339 ~~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l 417 (774)
.. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ .....+..++..+
T Consensus 182 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---------~~~~~~~~~~~~l 251 (335)
T 3dls_A 182 RG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE---------AAIHPPYLVSKEL 251 (335)
T ss_dssp TT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT---------TCCCCSSCCCHHH
T ss_pred CC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh---------hccCCCcccCHHH
Confidence 43 23345679999999999988876 7899999999999999999999976322110 1112234468889
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 418 HDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 418 ~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
.+||.+||++||.+|||+.++|+||||+..
T Consensus 252 ~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 252 MSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 999999999999999999999999999753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=396.79 Aligned_cols=262 Identities=27% Similarity=0.440 Sum_probs=221.1
Q ss_pred CCCCeeEE-eeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEE
Q 004088 186 PTTKYELL-NELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 186 ~~~~Y~il-k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~ 262 (774)
..++|.+. +.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+++ .||||++++++|.....+|
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 34678888 89999999999999999999999999997543 233457789999999999 5699999999999999999
Q ss_pred EEEEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC---CCcEEEeecccccccc
Q 004088 263 IVMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD---QGEVKLGDFGVAAQLT 338 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~---~g~vKL~DFGlA~~i~ 338 (774)
+|||||.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.+.
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 999999999999988532 467999999999999999999999999999999999999998 7899999999998765
Q ss_pred ccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCC-CCccccchhchHHH
Q 004088 339 RTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEP-APMLEDKEKWSLVF 417 (774)
Q Consensus 339 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~-~~~~~~~~~~s~~l 417 (774)
... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.... .........++..+
T Consensus 186 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 264 (327)
T 3lm5_A 186 HAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLA 264 (327)
T ss_dssp ---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred Ccc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHH
Confidence 432 2344679999999999999999999999999999999999999998877666554443322 22223345678899
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 418 HDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 418 ~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.+||.+||+.||.+|||+.++|+||||+...
T Consensus 265 ~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 265 TDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred HHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 9999999999999999999999999998654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=403.43 Aligned_cols=256 Identities=30% Similarity=0.516 Sum_probs=219.9
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-------hhhHHHHHHHHHHHHhC-CCCCcccccccccCCc
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-------EEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEE 259 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-------~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~ 259 (774)
.+|++.+.||+|+||.||+|.+..+|+.||||++..... ....+.+.+|+.+|+++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 579999999999999999999988999999999975431 12245678999999999 8999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
..|+|||||.+++|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 174 ~~~lv~e~~~g~~L~~~l~-~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLT-EKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp EEEEEECCCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEEEEeCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 9999999999999999986 345799999999999999999999999999999999999999999999999999987654
Q ss_pred cccccccccccccccchhhhhhc------CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCC-ccccchh
Q 004088 340 TMSKRNTFIGTPHWMAPEVIQES------RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAP-MLEDKEK 412 (774)
Q Consensus 340 ~~~~~~~~~GT~~Y~APEvl~~~------~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~-~~~~~~~ 412 (774)
. ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+...... ..+....
T Consensus 253 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 331 (365)
T 2y7j_A 253 G-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDD 331 (365)
T ss_dssp T-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSS
T ss_pred C-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence 3 233456899999999998743 5888999999999999999999999887766555444332222 2222345
Q ss_pred chHHHHHHHHhhcccCCCCCCCHHHHHhhhhhh
Q 004088 413 WSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445 (774)
Q Consensus 413 ~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~ 445 (774)
.+..+.+||.+||+.||.+|||+.++|+||||+
T Consensus 332 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 332 RSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 678899999999999999999999999999996
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=404.85 Aligned_cols=254 Identities=27% Similarity=0.375 Sum_probs=207.8
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC--------CCCccccccccc--
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS--------HPNVVRYLGSYQ-- 256 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~--------HPNIVkL~~~~~-- 256 (774)
.++|+++++||+|+||+||+|++..+++.||||++.. .....+.+.+|+.+|+++. ||||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS--AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec--CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 5789999999999999999999999999999999863 3445677899999999985 788999999987
Q ss_pred --CCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhc-CcccccccccceEecCCC---------
Q 004088 257 --GEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI-FKVHRDIKGGNILLTDQG--------- 324 (774)
Q Consensus 257 --~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~-gIIHRDLKPeNILLd~~g--------- 324 (774)
....+|||||||.++.+..++......+++..++.|+.||+.||.|||++ |||||||||+||||+.++
T Consensus 114 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 114 GVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp ETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred CCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence 67789999999955444444444446799999999999999999999998 999999999999999775
Q ss_pred ----------------------------------------cEEEeeccccccccccccccccccccccccchhhhhhcCC
Q 004088 325 ----------------------------------------EVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRY 364 (774)
Q Consensus 325 ----------------------------------------~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~ 364 (774)
.+||+|||+++..... ....+||+.|+|||++.+..+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~ 270 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIGSGY 270 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHTSCC
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcCCCC
Confidence 7999999999766443 334579999999999999999
Q ss_pred CCccchhhhHHHHHHHHhCCCCCCCCCchhh------hhhh---hcCCCC------------------------------
Q 004088 365 DGKVDVWALGVSAVEMAEGLPPRSTVHPMRV------LFMI---SIEPAP------------------------------ 405 (774)
Q Consensus 365 s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~------i~~i---~~~~~~------------------------------ 405 (774)
+.++|||||||++|+|++|++||........ +..+ ......
T Consensus 271 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (397)
T 1wak_A 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGL 350 (397)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCH
T ss_pred CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcch
Confidence 9999999999999999999999976543211 0000 000000
Q ss_pred ------ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhh
Q 004088 406 ------MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445 (774)
Q Consensus 406 ------~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~ 445 (774)
........+..+.+||.+||+.||.+|||+.|+|+||||+
T Consensus 351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 351 FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp HHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred hHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0011233456789999999999999999999999999996
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=440.48 Aligned_cols=260 Identities=27% Similarity=0.389 Sum_probs=228.9
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l 261 (774)
...++|++++.||+|+||.||+|++..+++.||||++.+.. .....+.+..|..+|..+ +||||++++++|.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 34578999999999999999999999999999999997532 223456788999999987 799999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|||||||++|+|..++.. ...+++..++.|+.||+.||.|||++|||||||||+||||+.++++||+|||+|+......
T Consensus 418 ~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred EEEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 999999999999999874 3579999999999999999999999999999999999999999999999999998654444
Q ss_pred cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI 421 (774)
....+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||...+.......+...... .+..++..+.+||
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~li 573 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA---YPKSMSKEAVAIC 573 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCC---CCTTSCHHHHHHH
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC---CCccCCHHHHHHH
Confidence 4556678999999999999999999999999999999999999999998877777666554322 2356889999999
Q ss_pred HhhcccCCCCCCCH-----HHHHhhhhhhhhc
Q 004088 422 AKCLTKEPRARPTA-----AEMLKHKFIERCK 448 (774)
Q Consensus 422 ~kcL~~DP~kRPTa-----~ElL~HPwf~~~~ 448 (774)
.+||++||.+||++ .+|++||||+.+.
T Consensus 574 ~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 574 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp HHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred HHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 99999999999997 9999999998653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=404.44 Aligned_cols=263 Identities=24% Similarity=0.446 Sum_probs=223.2
Q ss_pred CCCCcccCCCCCCeeEEeeeeccCceEEEEEEEc-------CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCc
Q 004088 177 IPESVTREDPTTKYELLNELGKGSYGAVYKARDL-------KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNV 248 (774)
Q Consensus 177 ~~~~~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~-------~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNI 248 (774)
.+....+....++|++++.||+|+||.||+|++. .++..||||+++........+.+.+|+.+|+++ +||||
T Consensus 70 ~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI 149 (370)
T 2psq_A 70 LPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 149 (370)
T ss_dssp CCCCTTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTB
T ss_pred ccccccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCE
Confidence 3344445566789999999999999999999875 345689999997655556677899999999999 89999
Q ss_pred ccccccccCCceEEEEEEecCCCchhhhhhccC---------------CchhHHHHHHHHHHHHHHHHHHHhcCcccccc
Q 004088 249 VRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE---------------EPLEEYQIAYICREALKGLAYLHSIFKVHRDI 313 (774)
Q Consensus 249 VkL~~~~~~~~~l~LVmEy~~ggsL~dll~~~~---------------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDL 313 (774)
++++++|.....+|+|||||.+|+|.+++.... ..+++..+..++.||+.||.|||++|||||||
T Consensus 150 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDl 229 (370)
T 2psq_A 150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDL 229 (370)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred eeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 999999999999999999999999999987432 35889999999999999999999999999999
Q ss_pred cccceEecCCCcEEEeecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCC
Q 004088 314 KGGNILLTDQGEVKLGDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTV 390 (774)
Q Consensus 314 KPeNILLd~~g~vKL~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~ 390 (774)
||+||||+.++.+||+|||+++.+..... ......||+.|+|||++.+..|+.++|||||||++|||++ |..||...
T Consensus 230 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 230 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp CGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999986654322 2233467899999999999999999999999999999998 99999887
Q ss_pred CchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 391 HPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 391 ~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
........+..... ...+..++..+.+||.+||+.||.+||++.|++++
T Consensus 310 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 310 PVEELFKLLKEGHR--MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp CGGGHHHHHHTTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 76665544433322 22345678899999999999999999999999875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=393.83 Aligned_cols=260 Identities=29% Similarity=0.484 Sum_probs=212.5
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
......+|++.+.||+|+||+||+|++ +|+.||||++.... .....+.+.+|+.+|++++||||+++++++.....+
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 345677999999999999999999986 68899999987544 344556789999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccC--CchhHHHHHHHHHHHHHHHHHHHhcC--cccccccccceEecCCCcEEEeeccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTE--EPLEEYQIAYICREALKGLAYLHSIF--KVHRDIKGGNILLTDQGEVKLGDFGVAAQL 337 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~--~~Lse~~i~~I~~QIl~gL~YLHs~g--IIHRDLKPeNILLd~~g~vKL~DFGlA~~i 337 (774)
|+|||||.+++|.+++.... ..+++..++.++.||+.||.|||++| ||||||||+|||++.++.+||+|||+++..
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999999987433 23899999999999999999999999 999999999999999999999999999765
Q ss_pred cccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHH
Q 004088 338 TRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVF 417 (774)
Q Consensus 338 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l 417 (774)
...........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.... .....+..++..+
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 268 (309)
T 3p86_A 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC-KRLEIPRNLNPQV 268 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC-CCCCCCTTSCHHH
T ss_pred cccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCccCCHHH
Confidence 554444455689999999999999999999999999999999999999999887766655443221 1223345678899
Q ss_pred HHHHHhhcccCCCCCCCHHHHHh--hhhhh
Q 004088 418 HDFVAKCLTKEPRARPTAAEMLK--HKFIE 445 (774)
Q Consensus 418 ~dLI~kcL~~DP~kRPTa~ElL~--HPwf~ 445 (774)
.+||.+||+.||.+|||+.++++ ++|++
T Consensus 269 ~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 269 AAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 99999999999999999999987 45554
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=388.98 Aligned_cols=260 Identities=25% Similarity=0.412 Sum_probs=217.1
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
...++|++++.||+|+||.||+|++..+++.||||++.... .....+.+.+|+.++++++||||+++++++...+.+|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 34578999999999999999999999999999999986543 3445678899999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc-
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM- 341 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~- 341 (774)
+|||||++++|.+++.. ..++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 88 lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999999999999864 4579999999999999999999999999999999999999999999999999998665432
Q ss_pred cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCcc--ccchhchHHHHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPML--EDKEKWSLVFHD 419 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~--~~~~~~s~~l~d 419 (774)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.................+.. .....++..+.+
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 246 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN 246 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHH
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHH
Confidence 223345799999999999999999999999999999999999999988776655444333332222 223567889999
Q ss_pred HHHhhcccCCCCCCCHHHHHhhhhhh
Q 004088 420 FVAKCLTKEPRARPTAAEMLKHKFIE 445 (774)
Q Consensus 420 LI~kcL~~DP~kRPTa~ElL~HPwf~ 445 (774)
+|.+||++||.+||+..+.+.+.|..
T Consensus 247 li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 247 VILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHhcCCHhHccccHHHHHHHHHH
Confidence 99999999999999666666677654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=407.05 Aligned_cols=258 Identities=15% Similarity=0.147 Sum_probs=196.2
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC--hhhHHHHHHHHHHHHhC--CCCCcccccccc-------
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG--EEGYEEIRGEIEMLQQC--SHPNVVRYLGSY------- 255 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~--~~~~~~~~~Ei~iL~~L--~HPNIVkL~~~~------- 255 (774)
...|++++.||+|+||.||+|++..+|+.||||++..... ....+.+.+|+.+++.| +||||++++..+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 4469999999999999999999999999999999986542 33455677885544444 699988855333
Q ss_pred cCC-----------------ceEEEEEEecCCCchhhhhhccCCchhHHHH------HHHHHHHHHHHHHHHhcCccccc
Q 004088 256 QGE-----------------EYLWIVMEYCGGGSVADLMNVTEEPLEEYQI------AYICREALKGLAYLHSIFKVHRD 312 (774)
Q Consensus 256 ~~~-----------------~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i------~~I~~QIl~gL~YLHs~gIIHRD 312 (774)
... ..+|||||||+ ++|.+++......+.+..+ ..++.||+.||.|||++||||||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 211 45899999998 8999999755444555555 67779999999999999999999
Q ss_pred ccccceEecCCCcEEEeeccccccccccccccccccccccccchhhhhh--cCCCCccchhhhHHHHHHHHhCCCCCCCC
Q 004088 313 IKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQE--SRYDGKVDVWALGVSAVEMAEGLPPRSTV 390 (774)
Q Consensus 313 LKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~--~~~s~ksDIWSLGviLyELLtG~~Pf~~~ 390 (774)
|||+||||+.++.+||+|||+|+..... .....||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||...
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999999866432 113467799999999987 77999999999999999999999999876
Q ss_pred Cchhhh--hh----hhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 391 HPMRVL--FM----ISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 391 ~~~~~i--~~----i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
...... .. ..............++..+.+||.+||+.||++|||+.++|+||||+...
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp CTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred CcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 432111 00 00111112222346789999999999999999999999999999998653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=406.41 Aligned_cols=256 Identities=25% Similarity=0.437 Sum_probs=198.8
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCC------c
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE------E 259 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~------~ 259 (774)
.++|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.++||||++++++|... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 478999999999999999999999999999999986432 334556788999999999999999999998643 5
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 689999999 7899988853 5799999999999999999999999999999999999999999999999999976543
Q ss_pred cccccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc---CCC-----------
Q 004088 340 TMSKRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI---EPA----------- 404 (774)
Q Consensus 340 ~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~---~~~----------- 404 (774)
. ....+||++|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+.. .+.
T Consensus 185 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 261 (367)
T 2fst_X 185 E---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred c---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 2 344689999999999987 6799999999999999999999999988776544433211 000
Q ss_pred -----------C---ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 405 -----------P---MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 405 -----------~---~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
+ ........+..+.+||.+||+.||.+|||+.++|+||||....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 0 0001123467899999999999999999999999999998654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=428.45 Aligned_cols=260 Identities=25% Similarity=0.386 Sum_probs=223.3
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
..++|++++.||+|+||.||+|++..+|+.||||++.+.. .......+.+|+.+|++++||||++++++|.....+||
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 4578999999999999999999999999999999997532 12345678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcc---CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 264 VMEYCGGGSVADLMNVT---EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~---~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
|||||+||+|..++... ...+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+++.+...
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~ 342 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence 99999999999988643 346999999999999999999999999999999999999999999999999999877655
Q ss_pred ccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCc----hhhhhhhhcCCCCccccchhchHH
Q 004088 341 MSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHP----MRVLFMISIEPAPMLEDKEKWSLV 416 (774)
Q Consensus 341 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~----~~~i~~i~~~~~~~~~~~~~~s~~ 416 (774)
.......+||+.|+|||++.+..|+.++|||||||++|||++|++||..... ......+..... ..+..++..
T Consensus 343 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~---~~p~~~s~~ 419 (543)
T 3c4z_A 343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV---TYPDKFSPA 419 (543)
T ss_dssp CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC---CCCTTSCHH
T ss_pred CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc---CCCcccCHH
Confidence 4444556899999999999999999999999999999999999999986532 222222222211 223567899
Q ss_pred HHHHHHhhcccCCCCCCC-----HHHHHhhhhhhhhc
Q 004088 417 FHDFVAKCLTKEPRARPT-----AAEMLKHKFIERCK 448 (774)
Q Consensus 417 l~dLI~kcL~~DP~kRPT-----a~ElL~HPwf~~~~ 448 (774)
+.+||.+||++||.+||+ +.++++||||+...
T Consensus 420 ~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 420 SKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp HHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred HHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence 999999999999999996 58999999998643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=395.08 Aligned_cols=254 Identities=25% Similarity=0.399 Sum_probs=211.2
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-CCCcccccccccC--CceEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQG--EEYLW 262 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~--~~~l~ 262 (774)
..++|++++.||+|+||.||+|++..+++.||||++... ..+.+.+|+.+|+++. ||||+++++++.. ....+
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 346899999999999999999999999999999998632 2467889999999997 9999999999987 67899
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC-cEEEeeccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG-EVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g-~vKL~DFGlA~~i~~~~ 341 (774)
+||||+.+++|.++++ .+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++.+...
T Consensus 110 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~- 184 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG- 184 (330)
T ss_dssp EEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT-
T ss_pred EEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC-
Confidence 9999999999998874 488999999999999999999999999999999999999777 8999999999766543
Q ss_pred cccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCch-hhhhhh-------------hcCCC--
Q 004088 342 SKRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPM-RVLFMI-------------SIEPA-- 404 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~-~~i~~i-------------~~~~~-- 404 (774)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ..+..+ .....
T Consensus 185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 23345579999999999987 66999999999999999999999999543321 111110 00000
Q ss_pred -------------------CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 405 -------------------PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 405 -------------------~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
........++..+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 00011223688999999999999999999999999999998653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=385.76 Aligned_cols=258 Identities=29% Similarity=0.506 Sum_probs=220.1
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccc--cCCceEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSY--QGEEYLWI 263 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~--~~~~~l~L 263 (774)
.++|++++.||+|+||.||+|++..+++.||||++.... .....+.+.+|+.+|++++||||+++++++ .....+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999999999999999997544 344567789999999999999999999987 45678999
Q ss_pred EEEecCCCchhhhhhcc---CCchhHHHHHHHHHHHHHHHHHHHhcC-----cccccccccceEecCCCcEEEeeccccc
Q 004088 264 VMEYCGGGSVADLMNVT---EEPLEEYQIAYICREALKGLAYLHSIF-----KVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~---~~~Lse~~i~~I~~QIl~gL~YLHs~g-----IIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
|||||++++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999998643 245999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchH
Q 004088 336 QLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSL 415 (774)
Q Consensus 336 ~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~ 415 (774)
.+...........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.....+ ..+..++.
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~ 242 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR--RIPYRYSD 242 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--CCCTTSCH
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc--cCCcccCH
Confidence 7654433334557999999999999988999999999999999999999999987766555444333222 22346788
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 416 VFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 416 ~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
.+.+||.+||+.||.+||++.++|+|+|+..
T Consensus 243 ~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 243 ELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 9999999999999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=394.57 Aligned_cols=261 Identities=25% Similarity=0.399 Sum_probs=215.9
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCC-----c
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE-----E 259 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~-----~ 259 (774)
...++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+|+.+|++++||||+++++++... .
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 34679999999999999999999999999999999997555555667788999999999999999999987643 7
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
..|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 8999999996 689888763 5699999999999999999999999999999999999999999999999999986643
Q ss_pred ccc----------ccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc---CC--
Q 004088 340 TMS----------KRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI---EP-- 403 (774)
Q Consensus 340 ~~~----------~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~---~~-- 403 (774)
... .....+||+.|+|||++.. ..++.++|||||||++|+|++|++||...........+.. .+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence 211 1223578999999999865 6789999999999999999999999987765433222110 00
Q ss_pred ------------------------CCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 404 ------------------------APMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 404 ------------------------~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.+.......++..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 000111235678899999999999999999999999999998654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=387.38 Aligned_cols=258 Identities=33% Similarity=0.560 Sum_probs=212.1
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
..+|.....||+|+||.||+|++..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.....+++|||
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 345555669999999999999999999999999997543 3445778999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccC--CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC-CCcEEEeeccccccccccccc
Q 004088 267 YCGGGSVADLMNVTE--EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD-QGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 267 y~~ggsL~dll~~~~--~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~-~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..+......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 999999999987543 35678999999999999999999999999999999999987 889999999999876543333
Q ss_pred cccccccccccchhhhhhcC--CCCccchhhhHHHHHHHHhCCCCCCCCCchhhh-hhh-hcCCCCccccchhchHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESR--YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVL-FMI-SIEPAPMLEDKEKWSLVFHD 419 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~--~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i-~~i-~~~~~~~~~~~~~~s~~l~d 419 (774)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|..||......... ... ..... ...+..++..+.+
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 257 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH--PEIPESMSAEAKA 257 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC--CCCCTTSCHHHHH
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc--ccccccCCHHHHH
Confidence 44567999999999997654 889999999999999999999999754432221 111 11111 1223567889999
Q ss_pred HHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 420 FVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 420 LI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
||.+||+.||.+||++.++|+||||+..
T Consensus 258 li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 258 FILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp HHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred HHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 9999999999999999999999999754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=404.55 Aligned_cols=261 Identities=26% Similarity=0.417 Sum_probs=222.5
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEE-----EcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccC
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKAR-----DLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG 257 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~-----d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~ 257 (774)
.+...++|++++.||+|+||.||+|+ +..+++.||||++...........+.+|+.+|++++||||+++++++..
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 34556789999999999999999999 4457889999999765556666788999999999999999999999999
Q ss_pred CceEEEEEEecCCCchhhhhhccC------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC---cEEE
Q 004088 258 EEYLWIVMEYCGGGSVADLMNVTE------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG---EVKL 328 (774)
Q Consensus 258 ~~~l~LVmEy~~ggsL~dll~~~~------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g---~vKL 328 (774)
....|||||||.+++|.+++.... ..+++..++.++.||+.||.|||++|||||||||+||||+.++ .+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999999987433 4589999999999999999999999999999999999999655 4999
Q ss_pred eeccccccccccc--cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCC
Q 004088 329 GDFGVAAQLTRTM--SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAP 405 (774)
Q Consensus 329 ~DFGlA~~i~~~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~ 405 (774)
+|||+|+.+.... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||...........+......
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~ 305 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 305 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999997654322 22334578999999999999999999999999999999998 99999988777766655443322
Q ss_pred ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhh
Q 004088 406 MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445 (774)
Q Consensus 406 ~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~ 445 (774)
.....++..+.+||.+||+.||.+|||+.+|++|.++-
T Consensus 306 --~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 306 --DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 22456788899999999999999999999999998764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=386.82 Aligned_cols=260 Identities=27% Similarity=0.412 Sum_probs=209.8
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccc----------
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSY---------- 255 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~---------- 255 (774)
..++|++++.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+|++++||||+++++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 357899999999999999999999999999999998754 345567889999999999999999999876
Q ss_pred ----cCCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEec-CCCcEEEee
Q 004088 256 ----QGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLT-DQGEVKLGD 330 (774)
Q Consensus 256 ----~~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd-~~g~vKL~D 330 (774)
.....+|+||||++ ++|.+++. .+++++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred cccccccCceeEEeeccC-CCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 34578999999997 69999885 35789999999999999999999999999999999999997 557999999
Q ss_pred ccccccccccc---cccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCC---
Q 004088 331 FGVAAQLTRTM---SKRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEP--- 403 (774)
Q Consensus 331 FGlA~~i~~~~---~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~--- 403 (774)
||+++.+.... .......||+.|+|||++.. ..++.++|||||||++|+|++|+.||...........+....
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99998664321 12234568999999999875 678999999999999999999999998877654443322110
Q ss_pred ------------------------CCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 404 ------------------------APMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 404 ------------------------~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
.+.......++..+.+||.+||+.||.+|||+.++|+||||+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence 0111112346888999999999999999999999999999986543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=395.51 Aligned_cols=257 Identities=24% Similarity=0.358 Sum_probs=220.7
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcCCCc---EEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCc
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLKTSE---LVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE 259 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~---~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~ 259 (774)
.+...++|++.+.||+|+||.||+|++..+++ .||||++.........+.+.+|+.+|++++||||+++++++....
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 44567899999999999999999999976554 599999976556666778999999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
.+|||||||++++|.++++.....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 99999999999999999976667899999999999999999999999999999999999999999999999999987654
Q ss_pred cccc---cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchH
Q 004088 340 TMSK---RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSL 415 (774)
Q Consensus 340 ~~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~ 415 (774)
.... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+..... ...+..++.
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 281 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR--LPAPMGCPH 281 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCH
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC--CCCCCCcCH
Confidence 3221 122346788999999999899999999999999999998 9999988877766655543322 223456788
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 416 VFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 416 ~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.+.+||.+||..||.+|||+.++++.
T Consensus 282 ~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 282 ALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999999863
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=389.90 Aligned_cols=257 Identities=28% Similarity=0.421 Sum_probs=213.8
Q ss_pred CCCCeeEEeeeeccCceEEEEEEE-cCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCC------CcccccccccCC
Q 004088 186 PTTKYELLNELGKGSYGAVYKARD-LKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHP------NVVRYLGSYQGE 258 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d-~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HP------NIVkL~~~~~~~ 258 (774)
..++|++++.||+|+||.||+|.+ ..+++.||||++.. .....+.+.+|+.+++.++|+ +|+++++++...
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN--VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS--SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec--CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 356999999999999999999998 56889999999863 334557788999999998765 499999999999
Q ss_pred ceEEEEEEecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC---------------
Q 004088 259 EYLWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD--------------- 322 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~--------------- 322 (774)
..+|+||||| +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 9999999999 889998886443 46899999999999999999999999999999999999987
Q ss_pred ----CCcEEEeeccccccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhh
Q 004088 323 ----QGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFM 398 (774)
Q Consensus 323 ----~g~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~ 398 (774)
++.+||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.......
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 245 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH
T ss_pred ccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 667999999999764332 3455799999999999998999999999999999999999999987765443322
Q ss_pred hhcC--CCCc---------------------------------------cccchhchHHHHHHHHhhcccCCCCCCCHHH
Q 004088 399 ISIE--PAPM---------------------------------------LEDKEKWSLVFHDFVAKCLTKEPRARPTAAE 437 (774)
Q Consensus 399 i~~~--~~~~---------------------------------------~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~E 437 (774)
+... +.+. .......+..+.+||.+||+.||.+|||+.|
T Consensus 246 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 325 (339)
T 1z57_A 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325 (339)
T ss_dssp HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHH
Confidence 2110 0000 0011223567899999999999999999999
Q ss_pred HHhhhhhhhhc
Q 004088 438 MLKHKFIERCK 448 (774)
Q Consensus 438 lL~HPwf~~~~ 448 (774)
+|+||||+..+
T Consensus 326 ll~hp~f~~~~ 336 (339)
T 1z57_A 326 ALKHPFFDLLK 336 (339)
T ss_dssp HTTSGGGGGGG
T ss_pred HhcCHHHHHHh
Confidence 99999998764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=429.82 Aligned_cols=258 Identities=26% Similarity=0.394 Sum_probs=221.5
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
..++|++++.||+|+||.||+|++..+|+.||||++.+.. .......+.+|+.+|++++|||||+++++|.+...+||
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 4568999999999999999999999999999999996532 12334668899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
|||||+||+|.+++.... ..+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+... .
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~-~ 340 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-Q 340 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT-C
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC-c
Confidence 999999999999886443 35999999999999999999999999999999999999999999999999999876543 2
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCc----hhhhhhhhcCCCCccccchhchHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHP----MRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~----~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||..... ......+...+. ..+..++..+.
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~---~~p~~~s~~~~ 417 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE---EYSERFSPQAR 417 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC---CCCTTSCHHHH
T ss_pred cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc---cCCccCCHHHH
Confidence 23446899999999999998999999999999999999999999987542 122222222221 12356789999
Q ss_pred HHHHhhcccCCCCCC-----CHHHHHhhhhhhhh
Q 004088 419 DFVAKCLTKEPRARP-----TAAEMLKHKFIERC 447 (774)
Q Consensus 419 dLI~kcL~~DP~kRP-----Ta~ElL~HPwf~~~ 447 (774)
+||.+||++||.+|| ++.|+++||||+..
T Consensus 418 dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 418 SLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp HHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred HHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 999999999999999 89999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=398.97 Aligned_cols=259 Identities=26% Similarity=0.420 Sum_probs=216.9
Q ss_pred ccCCCCCCeeEEeeeeccCceEEEEEE-----EcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccc
Q 004088 182 TREDPTTKYELLNELGKGSYGAVYKAR-----DLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSY 255 (774)
Q Consensus 182 ~~~~~~~~Y~ilk~LG~G~FG~Vy~a~-----d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~ 255 (774)
.++...++|++++.||+|+||.||+|+ +..+++.||||++.........+.+.+|+++|+++ +||||+++++++
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 345677899999999999999999998 45567899999997665566667899999999999 789999999998
Q ss_pred cCC-ceEEEEEEecCCCchhhhhhccCC----------------------------------------------------
Q 004088 256 QGE-EYLWIVMEYCGGGSVADLMNVTEE---------------------------------------------------- 282 (774)
Q Consensus 256 ~~~-~~l~LVmEy~~ggsL~dll~~~~~---------------------------------------------------- 282 (774)
... ..+|+|||||.+|+|.+++.....
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 765 459999999999999999864322
Q ss_pred -------------chhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc--ccccc
Q 004088 283 -------------PLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS--KRNTF 347 (774)
Q Consensus 283 -------------~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~--~~~~~ 347 (774)
.+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+..... .....
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence 289999999999999999999999999999999999999999999999999976643321 23345
Q ss_pred cccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcc
Q 004088 348 IGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLT 426 (774)
Q Consensus 348 ~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~ 426 (774)
.||+.|+|||++.+..++.++|||||||++|+|++ |.+||................. ....+..++..+.++|.+||+
T Consensus 256 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~ 334 (359)
T 3vhe_A 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-RMRAPDYTTPEMYQTMLDCWH 334 (359)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC-CCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcc
Confidence 78999999999999999999999999999999998 9999987665443332222111 122345578899999999999
Q ss_pred cCCCCCCCHHHHHhh
Q 004088 427 KEPRARPTAAEMLKH 441 (774)
Q Consensus 427 ~DP~kRPTa~ElL~H 441 (774)
.||.+|||+.++++|
T Consensus 335 ~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 335 GEPSQRPTFSELVEH 349 (359)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CChhhCCCHHHHHHH
Confidence 999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=397.26 Aligned_cols=259 Identities=25% Similarity=0.344 Sum_probs=206.4
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC----------hhhHHHHHHHHHHHHhCCCCCcccccccc
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG----------EEGYEEIRGEIEMLQQCSHPNVVRYLGSY 255 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~----------~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~ 255 (774)
..++|++++.||+|+||.||+|.+. +|+.||||++..... ....+.+.+|+.+|++++||||++++++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 4678999999999999999999975 499999999864322 12247789999999999999999999998
Q ss_pred -----cCCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEee
Q 004088 256 -----QGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGD 330 (774)
Q Consensus 256 -----~~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~D 330 (774)
.....+|+|||||. ++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 34557999999997 688888876667899999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-CC----
Q 004088 331 FGVAAQLTRTMSKRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-PA---- 404 (774)
Q Consensus 331 FGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-~~---- 404 (774)
||++...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||...........+... ..
T Consensus 178 fg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 256 (362)
T 3pg1_A 178 FNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256 (362)
T ss_dssp TTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChH
Confidence 9999754433 23344579999999999987 67999999999999999999999999887654443322110 00
Q ss_pred ------------------------CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 405 ------------------------PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 405 ------------------------~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
.........+..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 0011123446789999999999999999999999999999865
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=410.93 Aligned_cols=256 Identities=28% Similarity=0.404 Sum_probs=213.1
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC------CCCCcccccccccCCc
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC------SHPNVVRYLGSYQGEE 259 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L------~HPNIVkL~~~~~~~~ 259 (774)
...+|++++.||+|+||.||+|.+..+++.||||++.. .......+.+|+.+|+.+ +|+||++++++|....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN--EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC--ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 45689999999999999999999999999999999863 334456788899988887 5779999999999999
Q ss_pred eEEEEEEecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCc--EEEeecccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE--VKLGDFGVAAQ 336 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~--vKL~DFGlA~~ 336 (774)
.+|||||||. ++|.+++.... ..+++..++.|+.||+.||.|||++|||||||||+||||+.++. +||+|||+|+.
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 9999999995 68888886443 45999999999999999999999999999999999999999987 99999999975
Q ss_pred ccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-CCCcc--------
Q 004088 337 LTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-PAPML-------- 407 (774)
Q Consensus 337 i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-~~~~~-------- 407 (774)
.... ..+.+||+.|+|||++.+..|+.++|||||||++|+|++|.+||........+..+... ..+..
T Consensus 252 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~ 328 (429)
T 3kvw_A 252 EHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKR 328 (429)
T ss_dssp TTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTT
T ss_pred cCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhh
Confidence 4332 34568999999999999999999999999999999999999999887665443322110 00000
Q ss_pred ---------------------------------------c--------cchhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 408 ---------------------------------------E--------DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 408 ---------------------------------------~--------~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
. .....+..+.+||.+||+.||.+|||+.|+|+
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~ 408 (429)
T 3kvw_A 329 AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR 408 (429)
T ss_dssp HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence 0 00122677899999999999999999999999
Q ss_pred hhhhhhh
Q 004088 441 HKFIERC 447 (774)
Q Consensus 441 HPwf~~~ 447 (774)
||||++.
T Consensus 409 Hpw~~~~ 415 (429)
T 3kvw_A 409 HPWLRRR 415 (429)
T ss_dssp STTTC--
T ss_pred ChhhccC
Confidence 9999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=392.81 Aligned_cols=257 Identities=33% Similarity=0.466 Sum_probs=210.4
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-------hhhHHHHHHHHHHHHhCCCCCcccccccccCCc
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-------EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE 259 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-------~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~ 259 (774)
.++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+|++++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 3579999999999999999999999999999999864321 122345789999999999999999999987665
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCc---EEEeecccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE---VKLGDFGVAAQ 336 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~---vKL~DFGlA~~ 336 (774)
+|+|||||++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 89 -~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp -EEEEEECCTTEETHHHHS-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred -eEEEEecCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 899999999999999885 4567999999999999999999999999999999999999987664 99999999976
Q ss_pred ccccccccccccccccccchhhhh---hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhh-hhhhcCCCCc-cccch
Q 004088 337 LTRTMSKRNTFIGTPHWMAPEVIQ---ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVL-FMISIEPAPM-LEDKE 411 (774)
Q Consensus 337 i~~~~~~~~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i-~~i~~~~~~~-~~~~~ 411 (774)
+... .......||+.|+|||++. ...++.++|||||||++|+|++|..||........+ ..+....... .....
T Consensus 167 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (322)
T 2ycf_A 167 LGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245 (322)
T ss_dssp CCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHT
T ss_pred cccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhh
Confidence 6433 2223457999999999985 456889999999999999999999999765443222 2222221111 12234
Q ss_pred hchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 412 KWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 412 ~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
.++..+.+||.+||..||.+||++.++|+||||..
T Consensus 246 ~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred hcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 56889999999999999999999999999999974
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=378.79 Aligned_cols=253 Identities=25% Similarity=0.392 Sum_probs=219.4
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
....++|++++.||+|+||.||+|.+. +++.||||++.... ...+.+.+|+.+|++++||||+++++++......|+
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 82 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred EeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEE
Confidence 445678999999999999999999976 57789999997433 234678999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc-c
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM-S 342 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~-~ 342 (774)
|||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 999999999999997767789999999999999999999999999999999999999999999999999997654322 1
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI 421 (774)
......||+.|+|||++.+..++.++|||||||++|+|++ |.+||...........+...... ..+...+..+.+||
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li 240 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--YKPRLASTHVYQIM 240 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--CCCTTSCHHHHHHH
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC--CCCCcCCHHHHHHH
Confidence 2233467889999999999999999999999999999999 99999988777666555443222 23455688899999
Q ss_pred HhhcccCCCCCCCHHHHHhh
Q 004088 422 AKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 422 ~kcL~~DP~kRPTa~ElL~H 441 (774)
.+||+.||.+|||+.++++|
T Consensus 241 ~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 241 NHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCCcccCcCHHHHHHH
Confidence 99999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=398.55 Aligned_cols=255 Identities=30% Similarity=0.420 Sum_probs=211.1
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE----
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL---- 261 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l---- 261 (774)
.++|.+++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.++||||++++++|......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999999999999999997543 334457788999999999999999999999876654
Q ss_pred --EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc
Q 004088 262 --WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 262 --~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 121 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 99999996 67877764 4599999999999999999999999999999999999999999999999999976543
Q ss_pred cccccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-CC-------------
Q 004088 340 TMSKRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-PA------------- 404 (774)
Q Consensus 340 ~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-~~------------- 404 (774)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........+..+... ..
T Consensus 197 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 197 E---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred C---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 3 344579999999999987 67999999999999999999999999887655444332110 00
Q ss_pred --------------CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 405 --------------PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 405 --------------~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
........++..+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 00011234578899999999999999999999999999998653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=391.81 Aligned_cols=257 Identities=25% Similarity=0.442 Sum_probs=221.2
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccC
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDL-----KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG 257 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~-----~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~ 257 (774)
.....++|++++.||+|+||.||+|++. .+++.||||++.........+.+.+|+.+|++++||||+++++++..
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3556789999999999999999999986 35589999999766556667789999999999999999999999999
Q ss_pred CceEEEEEEecCCCchhhhhhccC-----------------------CchhHHHHHHHHHHHHHHHHHHHhcCccccccc
Q 004088 258 EEYLWIVMEYCGGGSVADLMNVTE-----------------------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIK 314 (774)
Q Consensus 258 ~~~l~LVmEy~~ggsL~dll~~~~-----------------------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLK 314 (774)
...+|+|||||++++|.+++.... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 999999999999999999987532 578999999999999999999999999999999
Q ss_pred ccceEecCCCcEEEeeccccccccccc--cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCC
Q 004088 315 GGNILLTDQGEVKLGDFGVAAQLTRTM--SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVH 391 (774)
Q Consensus 315 PeNILLd~~g~vKL~DFGlA~~i~~~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~ 391 (774)
|+|||++.++.+||+|||+++.+.... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 999999999999999999997664332 12234568999999999999999999999999999999998 999998877
Q ss_pred chhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 392 PMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 392 ~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.......+...... ..+..++..+.+||.+||+.||.+||++.+++++
T Consensus 282 ~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 282 HEEVIYYVRDGNIL--ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHhCCCcC--CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 76665554433222 2345678899999999999999999999999865
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=408.78 Aligned_cols=256 Identities=28% Similarity=0.408 Sum_probs=208.2
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCccccccccc------CCce
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ------GEEY 260 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~------~~~~ 260 (774)
..+|++++.||+|+||.||+|++..+|+.||||++..... ...+|+++|++++|||||+++++|. +..+
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 3479999999999999999999999999999999864332 2347999999999999999999883 2345
Q ss_pred EEEEEEecCCCchhhhhh---ccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC-CcEEEeecccccc
Q 004088 261 LWIVMEYCGGGSVADLMN---VTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ-GEVKLGDFGVAAQ 336 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~---~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~-g~vKL~DFGlA~~ 336 (774)
+++||||+++ +|..++. .....+++..++.++.||+.||.|||++|||||||||+||||+.+ +.+||+|||+++.
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 7899999975 5655543 245679999999999999999999999999999999999999965 5689999999987
Q ss_pred ccccccccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-CC----------
Q 004088 337 LTRTMSKRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-PA---------- 404 (774)
Q Consensus 337 i~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-~~---------- 404 (774)
+... ......+||+.|+|||++.+. .|+.++|||||||++|||++|++||........+..+... ..
T Consensus 207 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~ 285 (420)
T 1j1b_A 207 LVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285 (420)
T ss_dssp CCTT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred cccC-CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 6443 233456899999999999765 6999999999999999999999999887655444332110 00
Q ss_pred --------Cccc-------cchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 405 --------PMLE-------DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 405 --------~~~~-------~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
+... .....+..+.+||.+||++||.+|||+.|+|+||||+....
T Consensus 286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence 0000 11234788999999999999999999999999999987643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=381.87 Aligned_cols=259 Identities=31% Similarity=0.491 Sum_probs=222.0
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
.++|++++.||+|+||.||+|++..+++.||||++.... .....+.+.+|+.+|++++||||+++++++.....+|+||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 458999999999999999999999999999999997543 2345677899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC---cEEEeecccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG---EVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g---~vKL~DFGlA~~i~~~~~ 342 (774)
||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..+... .
T Consensus 101 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~-~ 178 (287)
T 2wei_A 101 ELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-T 178 (287)
T ss_dssp CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC-S
T ss_pred EccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC-C
Confidence 99999999988853 35799999999999999999999999999999999999997644 6999999999766443 2
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCC-CccccchhchHHHHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPA-PMLEDKEKWSLVFHDFV 421 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~-~~~~~~~~~s~~l~dLI 421 (774)
......||+.|+|||++.+. ++.++|||||||++|+|++|..||...........+..... ........++..+.+||
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 257 (287)
T 2wei_A 179 KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLI 257 (287)
T ss_dssp SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHH
T ss_pred ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHH
Confidence 23345689999999998764 89999999999999999999999998776665554433322 22233456788999999
Q ss_pred HhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 422 AKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 422 ~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.+||..||.+|||+.++|+||||++..
T Consensus 258 ~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 258 RKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HHHcccChhhCcCHHHHhcCHHHhccc
Confidence 999999999999999999999998753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=387.14 Aligned_cols=262 Identities=31% Similarity=0.442 Sum_probs=215.0
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEc-CCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhC---CCCCccccccccc----
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDL-KTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQC---SHPNVVRYLGSYQ---- 256 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~-~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L---~HPNIVkL~~~~~---- 256 (774)
..++|++++.||+|+||.||+|++. .+|+.||||++..... ......+.+|+.+++.+ .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3468999999999999999999985 6789999999975432 12223466777777666 8999999999987
Q ss_pred -CCceEEEEEEecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccc
Q 004088 257 -GEEYLWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA 334 (774)
Q Consensus 257 -~~~~l~LVmEy~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA 334 (774)
....+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 6678999999997 59999886543 45999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC------------
Q 004088 335 AQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE------------ 402 (774)
Q Consensus 335 ~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~------------ 402 (774)
..+... .......||+.|+|||++.+..++.++|||||||++|+|++|++||........+..+...
T Consensus 168 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (326)
T 1blx_A 168 RIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246 (326)
T ss_dssp CCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred ccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence 766433 2334567999999999999989999999999999999999999999887655443322110
Q ss_pred ------------CCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 403 ------------PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 403 ------------~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
..+.......++..+.+||.+||..||.+|||+.++|+||||+....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 00111122456788999999999999999999999999999987643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=384.82 Aligned_cols=259 Identities=26% Similarity=0.449 Sum_probs=222.4
Q ss_pred cccCCCCCCeeEEeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccc
Q 004088 181 VTREDPTTKYELLNELGKGSYGAVYKARDL-----KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSY 255 (774)
Q Consensus 181 ~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~-----~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~ 255 (774)
........+|++.+.||+|+||.||+|.+. .+++.||||++.........+.+.+|+.+|++++||||+++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 344566789999999999999999999973 456899999997665666678899999999999999999999999
Q ss_pred cCCceEEEEEEecCCCchhhhhhccC-----------------------CchhHHHHHHHHHHHHHHHHHHHhcCccccc
Q 004088 256 QGEEYLWIVMEYCGGGSVADLMNVTE-----------------------EPLEEYQIAYICREALKGLAYLHSIFKVHRD 312 (774)
Q Consensus 256 ~~~~~l~LVmEy~~ggsL~dll~~~~-----------------------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRD 312 (774)
.....+|+|||||++++|.+++.... ..+++..++.++.||+.||.|||++||+|||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 99999999999999999999987432 3489999999999999999999999999999
Q ss_pred ccccceEecCCCcEEEeecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCC
Q 004088 313 IKGGNILLTDQGEVKLGDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRST 389 (774)
Q Consensus 313 LKPeNILLd~~g~vKL~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~ 389 (774)
|||+|||++.++.+||+|||++..+..... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999976644322 1233467889999999999899999999999999999999 9999988
Q ss_pred CCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 390 VHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 390 ~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.........+..... ...+..++..+.+||.+||+.||.+||++.+++++
T Consensus 256 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 256 IPPERLFNLLKTGHR--MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CCGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHhhcCCc--CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 776665544433322 22345678899999999999999999999999976
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=385.39 Aligned_cols=258 Identities=28% Similarity=0.432 Sum_probs=214.6
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC---ChhhHHHHHHHHHHHHhCCCCCcccccccc--cCCceE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE---GEEGYEEIRGEIEMLQQCSHPNVVRYLGSY--QGEEYL 261 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~---~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~--~~~~~l 261 (774)
.++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|++++||||+++++++ .....+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999999999999999996432 123457789999999999999999999998 456689
Q ss_pred EEEEEecCCCchhhhhhc-cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNV-TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~-~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
|+|||||.++ |.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999876 6666543 3467999999999999999999999999999999999999999999999999999765432
Q ss_pred c--cccccccccccccchhhhhhcC--CCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHH
Q 004088 341 M--SKRNTFIGTPHWMAPEVIQESR--YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLV 416 (774)
Q Consensus 341 ~--~~~~~~~GT~~Y~APEvl~~~~--~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~ 416 (774)
. .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...........+..... ..+..++..
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~~~~ 239 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY---AIPGDCGPP 239 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC---CCCSSSCHH
T ss_pred ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC---CCCCccCHH
Confidence 1 1223457999999999997643 47799999999999999999999998776655544433322 223456788
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 417 FHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 417 l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
+.+||.+||..||.+|||+.++++||||+...
T Consensus 240 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 240 LSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred HHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 99999999999999999999999999998654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=393.88 Aligned_cols=257 Identities=24% Similarity=0.405 Sum_probs=216.3
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh--h--------------hHHHHHHHHHHHHhCCCCCccc
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE--E--------------GYEEIRGEIEMLQQCSHPNVVR 250 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~--~--------------~~~~~~~Ei~iL~~L~HPNIVk 250 (774)
.++|++++.||+|+||.||+|++ +|+.||||++...... . ..+.+.+|+.+|++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 47999999999999999999998 8999999998643211 1 1278999999999999999999
Q ss_pred ccccccCCceEEEEEEecCCCchhhh------hhcc-CCchhHHHHHHHHHHHHHHHHHHHh-cCcccccccccceEecC
Q 004088 251 YLGSYQGEEYLWIVMEYCGGGSVADL------MNVT-EEPLEEYQIAYICREALKGLAYLHS-IFKVHRDIKGGNILLTD 322 (774)
Q Consensus 251 L~~~~~~~~~l~LVmEy~~ggsL~dl------l~~~-~~~Lse~~i~~I~~QIl~gL~YLHs-~gIIHRDLKPeNILLd~ 322 (774)
+++++...+.+|+|||||++++|.++ +... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 99999999999999999999999998 5432 5679999999999999999999999 99999999999999999
Q ss_pred CCcEEEeeccccccccccccccccccccccccchhhhhhc-CCCC-ccchhhhHHHHHHHHhCCCCCCCCCc-hhhhhhh
Q 004088 323 QGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQES-RYDG-KVDVWALGVSAVEMAEGLPPRSTVHP-MRVLFMI 399 (774)
Q Consensus 323 ~g~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~-ksDIWSLGviLyELLtG~~Pf~~~~~-~~~i~~i 399 (774)
++.+||+|||++..+... ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||..... ......+
T Consensus 188 ~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i 265 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265 (348)
T ss_dssp TSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHH
T ss_pred CCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 999999999999766443 33445799999999999877 6666 99999999999999999999987765 3333333
Q ss_pred hcCCCCccc----------------cchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 400 SIEPAPMLE----------------DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 400 ~~~~~~~~~----------------~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
......... ....++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 266 RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 222111110 014578899999999999999999999999999999754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=384.29 Aligned_cols=262 Identities=32% Similarity=0.546 Sum_probs=203.7
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHH-HHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEE-IRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~-~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
...++|++++.||+|+||.||+|++..+|+.||||++........... +.++..+++.++||||+++++++.....+|+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 345789999999999999999999999999999999986554443333 4455567888899999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhc-CcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI-FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~-gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
||||+ ++.+..+.......+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..+... .
T Consensus 102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-~ 179 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD-K 179 (318)
T ss_dssp EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC-c
Confidence 99999 6666666655567899999999999999999999995 9999999999999999999999999999766443 2
Q ss_pred ccccccccccccchhhhh-----hcCCCCccchhhhHHHHHHHHhCCCCCCCCC-chhhhhhhhcCCCCccccchhchHH
Q 004088 343 KRNTFIGTPHWMAPEVIQ-----ESRYDGKVDVWALGVSAVEMAEGLPPRSTVH-PMRVLFMISIEPAPMLEDKEKWSLV 416 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~-----~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~-~~~~i~~i~~~~~~~~~~~~~~s~~ 416 (774)
......||+.|+|||++. ...++.++|||||||++|+|++|+.||.... .......+.....+.......++..
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGD 259 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHH
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHH
Confidence 233457999999999994 4568899999999999999999999998643 3333333433444444444567889
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 417 FHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 417 l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
+.+||.+||+.||.+||++.++|+||||++..
T Consensus 260 l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 260 FQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 99999999999999999999999999998754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=397.28 Aligned_cols=265 Identities=24% Similarity=0.439 Sum_probs=226.9
Q ss_pred CCCCCCcccCCCCCCeeEEeeeeccCceEEEEEEEcCC-------CcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCC
Q 004088 175 SSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKT-------SELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHP 246 (774)
Q Consensus 175 ss~~~~~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~-------g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HP 246 (774)
...+....++...++|.+++.||+|+||.||+|++... +..||||++...........+.+|+++|+++ +||
T Consensus 56 ~~~~~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp 135 (382)
T 3tt0_A 56 YELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135 (382)
T ss_dssp CCCCCCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCT
T ss_pred cccccCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCc
Confidence 34455556677788999999999999999999997543 3579999997666666678899999999999 999
Q ss_pred CcccccccccCCceEEEEEEecCCCchhhhhhccC---------------CchhHHHHHHHHHHHHHHHHHHHhcCcccc
Q 004088 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE---------------EPLEEYQIAYICREALKGLAYLHSIFKVHR 311 (774)
Q Consensus 247 NIVkL~~~~~~~~~l~LVmEy~~ggsL~dll~~~~---------------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHR 311 (774)
||++++++|.....+|||||||.+++|.+++.... ..+++..++.|+.||+.||.|||++|||||
T Consensus 136 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 215 (382)
T 3tt0_A 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 215 (382)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred hhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 99999999999999999999999999999987543 359999999999999999999999999999
Q ss_pred cccccceEecCCCcEEEeeccccccccccc--cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCC
Q 004088 312 DIKGGNILLTDQGEVKLGDFGVAAQLTRTM--SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRS 388 (774)
Q Consensus 312 DLKPeNILLd~~g~vKL~DFGlA~~i~~~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~ 388 (774)
||||+||||+.++.+||+|||+++.+.... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 216 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~ 295 (382)
T 3tt0_A 216 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295 (382)
T ss_dssp CCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998664432 12233467899999999999999999999999999999999 999999
Q ss_pred CCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 389 TVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 389 ~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
..........+...... ..+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 296 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 296 GVPVEELFKLLKEGHRM--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp TCCHHHHHHHHHTTCCC--CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHcCCCC--CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 87766665554433222 2345678899999999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=383.31 Aligned_cols=263 Identities=25% Similarity=0.390 Sum_probs=221.7
Q ss_pred CCCcccCCCCCCeeEEeeeeccCceEEEEEEE-----cCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccc
Q 004088 178 PESVTREDPTTKYELLNELGKGSYGAVYKARD-----LKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRY 251 (774)
Q Consensus 178 ~~~~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d-----~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL 251 (774)
+....++...++|++.+.||+|+||.||+|++ ..+++.||||++.........+.+.+|+.+|+++ +||||+++
T Consensus 13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~ 92 (313)
T 1t46_A 13 PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNL 92 (313)
T ss_dssp CCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeE
Confidence 33445667778999999999999999999985 4567899999997665556667899999999999 99999999
Q ss_pred cccccCCceEEEEEEecCCCchhhhhhccCC-----------------chhHHHHHHHHHHHHHHHHHHHhcCccccccc
Q 004088 252 LGSYQGEEYLWIVMEYCGGGSVADLMNVTEE-----------------PLEEYQIAYICREALKGLAYLHSIFKVHRDIK 314 (774)
Q Consensus 252 ~~~~~~~~~l~LVmEy~~ggsL~dll~~~~~-----------------~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLK 314 (774)
++++......|+|||||++++|.+++..... .+++..++.++.||+.||.|||++||+|||||
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 172 (313)
T 1t46_A 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172 (313)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence 9999999999999999999999999875432 48999999999999999999999999999999
Q ss_pred ccceEecCCCcEEEeeccccccccccccc--cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCC
Q 004088 315 GGNILLTDQGEVKLGDFGVAAQLTRTMSK--RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVH 391 (774)
Q Consensus 315 PeNILLd~~g~vKL~DFGlA~~i~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~ 391 (774)
|+|||++.++.+||+|||++..+...... .....||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99999999999999999999876543221 233467889999999999999999999999999999998 999998766
Q ss_pred chhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 392 PMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 392 ~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.............. ......++..+.+||.+||..||.+|||+.+++++
T Consensus 253 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 253 VDSKFYKMIKEGFR-MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SSHHHHHHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhHHHHHhccCCC-CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 54433332221111 12234678899999999999999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=405.93 Aligned_cols=257 Identities=25% Similarity=0.409 Sum_probs=191.0
Q ss_pred CCeeE-EeeeeccCceEEEEEEEc--CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccc--cCCceEE
Q 004088 188 TKYEL-LNELGKGSYGAVYKARDL--KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSY--QGEEYLW 262 (774)
Q Consensus 188 ~~Y~i-lk~LG~G~FG~Vy~a~d~--~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~--~~~~~l~ 262 (774)
+.|++ .++||+|+||+||+|++. .+++.||||++.... ....+.+|+.+|++++||||++++++| .....+|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS---CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC---CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 45776 458999999999999965 578899999986432 234678999999999999999999999 5578999
Q ss_pred EEEEecCCCchhhhhhcc--------CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEe----cCCCcEEEee
Q 004088 263 IVMEYCGGGSVADLMNVT--------EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL----TDQGEVKLGD 330 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~--------~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILL----d~~g~vKL~D 330 (774)
||||||. ++|.+++... ...+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9999996 5777776422 1248999999999999999999999999999999999999 6778999999
Q ss_pred ccccccccccc---cccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCch---------hhhh
Q 004088 331 FGVAAQLTRTM---SKRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPM---------RVLF 397 (774)
Q Consensus 331 FGlA~~i~~~~---~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~---------~~i~ 397 (774)
||+|+.+.... ......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||...... ..+.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 99998765432 223456899999999999874 5899999999999999999999999754431 1111
Q ss_pred h---hhcCCC-Ccccc-------------------------------chhchHHHHHHHHhhcccCCCCCCCHHHHHhhh
Q 004088 398 M---ISIEPA-PMLED-------------------------------KEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHK 442 (774)
Q Consensus 398 ~---i~~~~~-~~~~~-------------------------------~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HP 442 (774)
. ....+. ..+.. ....+..+.+||.+||+.||.+|||+.|+|+||
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 1 000000 00000 001156788999999999999999999999999
Q ss_pred hhhhhc
Q 004088 443 FIERCK 448 (774)
Q Consensus 443 wf~~~~ 448 (774)
||....
T Consensus 336 ~f~~~~ 341 (405)
T 3rgf_A 336 YFLEDP 341 (405)
T ss_dssp GGTSSS
T ss_pred hhccCC
Confidence 998654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=386.75 Aligned_cols=262 Identities=21% Similarity=0.350 Sum_probs=200.4
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCc---EEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCc
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSE---LVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE 259 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~---~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~ 259 (774)
....++|++++.||+|+||.||+|++..++. .||||++.... .....+.+.+|+.+|++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 4567799999999999999999999877665 89999986543 3345678999999999999999999999998766
Q ss_pred eE------EEEEEecCCCchhhhhhccC-----CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEE
Q 004088 260 YL------WIVMEYCGGGSVADLMNVTE-----EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKL 328 (774)
Q Consensus 260 ~l------~LVmEy~~ggsL~dll~~~~-----~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL 328 (774)
.. |+|||||.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEE
Confidence 55 99999999999999885322 25899999999999999999999999999999999999999999999
Q ss_pred eecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCC
Q 004088 329 GDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAP 405 (774)
Q Consensus 329 ~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~ 405 (774)
+|||+++.+..... ......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...........+.....
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~- 257 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR- 257 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC-
Confidence 99999976644321 1223457889999999999999999999999999999999 9999998777666555443322
Q ss_pred ccccchhchHHHHHHHHhhcccCCCCCCC-------HHHHHhhhhhhhh
Q 004088 406 MLEDKEKWSLVFHDFVAKCLTKEPRARPT-------AAEMLKHKFIERC 447 (774)
Q Consensus 406 ~~~~~~~~s~~l~dLI~kcL~~DP~kRPT-------a~ElL~HPwf~~~ 447 (774)
......++..+.+||.+||+.||.+||| ++++++|||+...
T Consensus 258 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 258 -LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp -CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred -CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 2334567889999999999999999999 7788889988653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=377.26 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=217.1
Q ss_pred ccCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 182 TREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 182 ~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
.++...++|++++.||+|+||.||+|.+. ++..||||++.... ...+.+.+|+++|++++||||+++++++.....+
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC--CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 34566789999999999999999999865 67789999997433 2346789999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|+|||||.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 99999999999999998666789999999999999999999999999999999999999999999999999997654321
Q ss_pred -cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHH
Q 004088 342 -SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHD 419 (774)
Q Consensus 342 -~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~d 419 (774)
.......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+...... ..+..++..+.+
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~ 252 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL--YRPHLASEKVYT 252 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--CCCTTCCHHHHH
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC--CCCCcCCHHHHH
Confidence 11223457889999999999999999999999999999998 99999988776666555433222 223456788999
Q ss_pred HHHhhcccCCCCCCCHHHHHhh
Q 004088 420 FVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 420 LI~kcL~~DP~kRPTa~ElL~H 441 (774)
||.+||+.||.+|||+.++++|
T Consensus 253 li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 253 IMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHHHH
Confidence 9999999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=403.14 Aligned_cols=256 Identities=29% Similarity=0.412 Sum_probs=206.7
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCccccccccc------CCce
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ------GEEY 260 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~------~~~~ 260 (774)
..+|++++.||+|+||+||+|++..+++ ||+|++...... ..+|+.+|+.++||||++++++|. ....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 4579999999999999999999877666 888887543321 237999999999999999999984 3345
Q ss_pred EEEEEEecCCCchhhhhh--ccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEec-CCCcEEEeeccccccc
Q 004088 261 LWIVMEYCGGGSVADLMN--VTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLT-DQGEVKLGDFGVAAQL 337 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~--~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd-~~g~vKL~DFGlA~~i 337 (774)
+|+|||||+++.+..+.. .....+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+|+.+
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 899999997754443332 2356799999999999999999999999999999999999999 7899999999999876
Q ss_pred cccccccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-CCC----------
Q 004088 338 TRTMSKRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-PAP---------- 405 (774)
Q Consensus 338 ~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-~~~---------- 405 (774)
... ......+||+.|+|||++.+. .|+.++|||||||++|+|++|++||........+..+... ..+
T Consensus 193 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 271 (394)
T 4e7w_A 193 IAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271 (394)
T ss_dssp CTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred cCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 443 233456899999999999765 5899999999999999999999999987765544332210 000
Q ss_pred --------c-------cccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 406 --------M-------LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 406 --------~-------~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
. ......++..+.+||.+||++||.+|||+.|+|+||||+....
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 0 0011236788999999999999999999999999999987654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=394.39 Aligned_cols=260 Identities=25% Similarity=0.332 Sum_probs=200.4
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCC-------
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE------- 258 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~------- 258 (774)
..++|++.+.||+|+||.||+|++..+|+.||||++.... .......+|++.+..++||||++++++|...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 3568999999999999999999999999999999986433 2234567888889999999999999998542
Q ss_pred ceEEEEEEecCCCchhhhhh---ccCCchhHHHHHHHHHHHHHHHHHHH--hcCcccccccccceEecC-CCcEEEeecc
Q 004088 259 EYLWIVMEYCGGGSVADLMN---VTEEPLEEYQIAYICREALKGLAYLH--SIFKVHRDIKGGNILLTD-QGEVKLGDFG 332 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~---~~~~~Lse~~i~~I~~QIl~gL~YLH--s~gIIHRDLKPeNILLd~-~g~vKL~DFG 332 (774)
..+|+|||||+++ |...+. .....+++..++.++.||+.||.||| ++||+||||||+||||+. ++.+||+|||
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 99 IYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp EEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred eeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 2489999999765 433332 24567899999999999999999999 999999999999999997 8999999999
Q ss_pred ccccccccccccccccccccccchhhhhhcC-CCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-CCCc----
Q 004088 333 VAAQLTRTMSKRNTFIGTPHWMAPEVIQESR-YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-PAPM---- 406 (774)
Q Consensus 333 lA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-~~~~---- 406 (774)
+++.+... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|++||........+..+... ..+.
T Consensus 178 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 178 SAKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp TCBCCCTT-SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CceecCCC-CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 99876543 2334567999999999997654 899999999999999999999999987765544333210 0000
Q ss_pred ------------------------cccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 407 ------------------------LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 407 ------------------------~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
.......+..+.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 0001124678999999999999999999999999999987654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=388.57 Aligned_cols=257 Identities=25% Similarity=0.370 Sum_probs=210.6
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCC-cEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCC------cccccccccCC
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTS-ELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPN------VVRYLGSYQGE 258 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g-~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPN------IVkL~~~~~~~ 258 (774)
..++|++++.||+|+||.||+|.+..++ +.||||++.. .....+.+.+|+.+|+++.|++ ++.+++++...
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN--VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc--cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 3579999999999999999999998776 7899999863 3345567889999999997765 89999999999
Q ss_pred ceEEEEEEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEe-----------------
Q 004088 259 EYLWIVMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL----------------- 320 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILL----------------- 320 (774)
..+||||||| +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999999 55555555433 3579999999999999999999999999999999999999
Q ss_pred --cCCCcEEEeeccccccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhh
Q 004088 321 --TDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFM 398 (774)
Q Consensus 321 --d~~g~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~ 398 (774)
+.++.+||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...........
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 250 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 56788999999999764332 3445899999999999999999999999999999999999999987765443322
Q ss_pred hhcC--CCCc---------------------------------------cccchhchHHHHHHHHhhcccCCCCCCCHHH
Q 004088 399 ISIE--PAPM---------------------------------------LEDKEKWSLVFHDFVAKCLTKEPRARPTAAE 437 (774)
Q Consensus 399 i~~~--~~~~---------------------------------------~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~E 437 (774)
+... ..+. .......+..+.+||.+||+.||.+|||+.|
T Consensus 251 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 330 (355)
T 2eu9_A 251 MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330 (355)
T ss_dssp HHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHH
Confidence 2110 0000 0001122457889999999999999999999
Q ss_pred HHhhhhhhhhc
Q 004088 438 MLKHKFIERCK 448 (774)
Q Consensus 438 lL~HPwf~~~~ 448 (774)
+|+||||+.+.
T Consensus 331 ~l~hp~f~~~~ 341 (355)
T 2eu9_A 331 ALLHPFFAGLT 341 (355)
T ss_dssp HTTSGGGGGCC
T ss_pred HhcChhhcCCC
Confidence 99999998653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=373.87 Aligned_cols=253 Identities=27% Similarity=0.388 Sum_probs=217.7
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
+...++|++++.||+|+||.||+|.+. ++..||||++.... ...+.+.+|+.+|++++||||+++++++......|+
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYI 80 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT--BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC--CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEE
Confidence 345678999999999999999999865 67789999996433 234678999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc-
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS- 342 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~- 342 (774)
|||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred EEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 9999999999999986667799999999999999999999999999999999999999999999999999976544321
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI 421 (774)
......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+...... ..+..++..+.+||
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li 238 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL--YRPHLASDTIYQIM 238 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--CCCTTSCHHHHHHH
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC--CCCCcChHHHHHHH
Confidence 1223356788999999999889999999999999999998 99999887776665554433222 22345678899999
Q ss_pred HhhcccCCCCCCCHHHHHhh
Q 004088 422 AKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 422 ~kcL~~DP~kRPTa~ElL~H 441 (774)
.+||+.||.+|||+.++++|
T Consensus 239 ~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 239 YSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHTTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=390.40 Aligned_cols=255 Identities=29% Similarity=0.417 Sum_probs=210.4
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCce-----
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEY----- 260 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~----- 260 (774)
..+|.+.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999999999999999996543 33445678899999999999999999999976643
Q ss_pred -EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc
Q 004088 261 -LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 261 -l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
+|+||||+. ++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 599999996 68887764 4599999999999999999999999999999999999999999999999999976543
Q ss_pred cccccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC----------------
Q 004088 340 TMSKRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE---------------- 402 (774)
Q Consensus 340 ~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~---------------- 402 (774)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+....+..+...
T Consensus 179 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 179 E---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred C---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 2 234579999999999987 67899999999999999999999999877654433222110
Q ss_pred ------------CCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 403 ------------PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 403 ------------~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
..........++..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 0001111235678899999999999999999999999999998653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=380.32 Aligned_cols=254 Identities=30% Similarity=0.486 Sum_probs=204.2
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccC----------
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG---------- 257 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~---------- 257 (774)
++|++++.||+|+||.||+|++..+++.||||++.. .....+.+.+|+.+|++++||||++++++|..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE--EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec--cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 479999999999999999999999999999999864 23456778999999999999999999998743
Q ss_pred ---CceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccc
Q 004088 258 ---EEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVA 334 (774)
Q Consensus 258 ---~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA 334 (774)
...+|+|||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 163 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA 163 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcch
Confidence 56789999999999999999866667899999999999999999999999999999999999999999999999999
Q ss_pred ccccccc--------------cccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCC-Cchhhhhh
Q 004088 335 AQLTRTM--------------SKRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTV-HPMRVLFM 398 (774)
Q Consensus 335 ~~i~~~~--------------~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~-~~~~~i~~ 398 (774)
..+.... .......||+.|+|||++.+. .++.++|||||||++|+|++ ||... ........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~ 240 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK 240 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHh
Confidence 7654321 122345799999999999864 68999999999999999998 44432 22222222
Q ss_pred hhcCCC-CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 399 ISIEPA-PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 399 i~~~~~-~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
+..... .........+..+.+||.+||+.||.+|||+.++++||||..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred ccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 211111 111123445677899999999999999999999999999963
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=400.40 Aligned_cols=258 Identities=29% Similarity=0.468 Sum_probs=213.5
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEc---CCCcEEEEEEeecCC---ChhhHHHHHHHHHHHHhC-CCCCcccccccccCC
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDL---KTSELVAIKVISLSE---GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGE 258 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~---~~g~~VAVKvi~~~~---~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~ 258 (774)
..++|++++.||+|+||.||+|++. .+++.||||+++... .....+.+.+|+.+|+++ .||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 4578999999999999999999984 489999999986432 122345577899999999 699999999999999
Q ss_pred ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 259 EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
..+|||||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred ceEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 999999999999999999864 4579999999999999999999999999999999999999999999999999998654
Q ss_pred ccc-cccccccccccccchhhhhh--cCCCCccchhhhHHHHHHHHhCCCCCCCCCchh----hhhhhhcCCCCccccch
Q 004088 339 RTM-SKRNTFIGTPHWMAPEVIQE--SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMR----VLFMISIEPAPMLEDKE 411 (774)
Q Consensus 339 ~~~-~~~~~~~GT~~Y~APEvl~~--~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~----~i~~i~~~~~~~~~~~~ 411 (774)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ....+..... ..+.
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~ 287 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP---PYPQ 287 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC---CCCT
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC---CCCc
Confidence 322 22334689999999999985 347899999999999999999999997543221 1111111111 1234
Q ss_pred hchHHHHHHHHhhcccCCCCCC-----CHHHHHhhhhhhhh
Q 004088 412 KWSLVFHDFVAKCLTKEPRARP-----TAAEMLKHKFIERC 447 (774)
Q Consensus 412 ~~s~~l~dLI~kcL~~DP~kRP-----Ta~ElL~HPwf~~~ 447 (774)
.++..+.+||.+||..||.+|| ++.++++||||...
T Consensus 288 ~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 5778899999999999999999 99999999999754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=401.36 Aligned_cols=257 Identities=24% Similarity=0.405 Sum_probs=220.8
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
+....++|++.+.||+|+||.||+|++..+++.||||++.........+.+.+|+++|++++||||+++++++.....+|
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 44566799999999999999999999998999999999875544455567889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
||||||++++|.++++.....+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.......
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 99999999999999986666799999999999999999999999999999999999999999999999999976543211
Q ss_pred c--cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHH
Q 004088 343 K--RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHD 419 (774)
Q Consensus 343 ~--~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~d 419 (774)
. .....+++.|+|||++....++.++|||||||++|||++ |..||...........+..... ...+..++..+.+
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~ 346 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR--LPCPELCPDAVFR 346 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHH
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHH
Confidence 1 112246788999999998899999999999999999998 9999998776665544433222 2234567889999
Q ss_pred HHHhhcccCCCCCCCHHHHHhh
Q 004088 420 FVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 420 LI~kcL~~DP~kRPTa~ElL~H 441 (774)
||.+||+.||.+|||+.++++.
T Consensus 347 li~~cl~~dP~~Rps~~~i~~~ 368 (377)
T 3cbl_A 347 LMEQCWAYEPGQRPSFSTIYQE 368 (377)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCchhCcCHHHHHHH
Confidence 9999999999999999999863
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=378.67 Aligned_cols=255 Identities=28% Similarity=0.432 Sum_probs=208.1
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCC---CcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCce
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKT---SELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEY 260 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~---g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~ 260 (774)
+...++|++.+.||+|+||.||+|.+..+ +..||||++.........+.+.+|+.+|++++||||+++++++. ++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 45667999999999999999999998653 56799999876555566678999999999999999999999985 457
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
.|+|||||.+++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 89999999999999999866668999999999999999999999999999999999999999999999999999876443
Q ss_pred cc-ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 341 MS-KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 341 ~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
.. ......+|+.|+|||++....++.++|||||||++|+|++ |.+||...........+..... ...+..++..+.
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~ 247 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER--LPMPPNCPPTLY 247 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--CCCCTTCCHHHH
T ss_pred cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC--CCCCCCCCHHHH
Confidence 21 1223457889999999999899999999999999999996 9999988776665554443322 223456788999
Q ss_pred HHHHhhcccCCCCCCCHHHHHhh
Q 004088 419 DFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
+||.+||..||.+|||+.+++++
T Consensus 248 ~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 248 SLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=389.04 Aligned_cols=260 Identities=25% Similarity=0.388 Sum_probs=216.3
Q ss_pred ccCCCCCCeeEEeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccc
Q 004088 182 TREDPTTKYELLNELGKGSYGAVYKARDL-----KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSY 255 (774)
Q Consensus 182 ~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~-----~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~ 255 (774)
.++...++|++.+.||+|+||.||+|++. .+++.||||++.........+.+.+|+.+|+++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 35667789999999999999999999973 456789999997554455567899999999999 899999999999
Q ss_pred cCCceEEEEEEecCCCchhhhhhccCC----------------------chhHHHHHHHHHHHHHHHHHHHhcCcccccc
Q 004088 256 QGEEYLWIVMEYCGGGSVADLMNVTEE----------------------PLEEYQIAYICREALKGLAYLHSIFKVHRDI 313 (774)
Q Consensus 256 ~~~~~l~LVmEy~~ggsL~dll~~~~~----------------------~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDL 313 (774)
.....+|+|||||++++|.+++..... .+++..++.++.||+.||.|||++||+||||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 999999999999999999999975432 3789999999999999999999999999999
Q ss_pred cccceEecCCCcEEEeecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCC
Q 004088 314 KGGNILLTDQGEVKLGDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTV 390 (774)
Q Consensus 314 KPeNILLd~~g~vKL~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~ 390 (774)
||+||||+.++.+||+|||++..+..... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999986654322 1234467889999999999999999999999999999998 99999877
Q ss_pred CchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhh
Q 004088 391 HPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHK 442 (774)
Q Consensus 391 ~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HP 442 (774)
.............. ....+..++..+.+||.+||..||.+|||+.++++|.
T Consensus 279 ~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 279 PVDANFYKLIQNGF-KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp CCSHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CcHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 65444333222211 1223455688999999999999999999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=390.17 Aligned_cols=255 Identities=26% Similarity=0.368 Sum_probs=213.7
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcE----EEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCc
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSEL----VAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE 259 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~----VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~ 259 (774)
....++|++++.||+|+||.||+|++..+++. ||+|++...........+.+|+.++++++||||+++++++. ..
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 44567999999999999999999999888775 77777754433344456788999999999999999999886 46
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
..++|||||.+++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 68999999999999999976667899999999999999999999999999999999999999999999999999987644
Q ss_pred ccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHH
Q 004088 340 TMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLV 416 (774)
Q Consensus 340 ~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~ 416 (774)
... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+..... ...+..++..
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 245 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER--LAQPQICTID 245 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB--CCCCTTBCTT
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC--CCCCCcCcHH
Confidence 322 2234568889999999999999999999999999999999 9999988766655544433222 2223446777
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 417 FHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 417 l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
+.+||.+||..||.+||++.++++|
T Consensus 246 ~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 246 VYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8999999999999999999999987
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=387.85 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=209.7
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcE----EEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCce
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSEL----VAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEY 260 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~----VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~ 260 (774)
...++|++++.||+|+||+||+|++..+++. ||+|++...........+.+|+.+|++++||||++++++|....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 4567899999999999999999999888765 47777754444456678999999999999999999999998765
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
.++|+||+.+|+|.+++......+++..++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.+...
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 78999999999999999877778999999999999999999999999999999999999999999999999999876543
Q ss_pred ccc--cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHH
Q 004088 341 MSK--RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVF 417 (774)
Q Consensus 341 ~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l 417 (774)
... .....||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+..... ...+..++..+
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 248 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER--LPQPPICTIDV 248 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--CCCCTTBCHHH
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC--CCCCccCCHHH
Confidence 222 223457889999999999999999999999999999999 9999988776655544433322 22345678889
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhh
Q 004088 418 HDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 418 ~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.+||.+||+.||.+||++.+++++
T Consensus 249 ~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 249 YMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999976
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=382.46 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=220.1
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccC
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDL-----KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG 257 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~-----~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~ 257 (774)
++...++|++.+.||+|+||.||+|.+. .+++.||||++...........+.+|+.+|++++||||+++++++..
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 4556689999999999999999999876 35788999999765555566778999999999999999999999999
Q ss_pred CceEEEEEEecCCCchhhhhhccC---------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEE
Q 004088 258 EEYLWIVMEYCGGGSVADLMNVTE---------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKL 328 (774)
Q Consensus 258 ~~~l~LVmEy~~ggsL~dll~~~~---------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL 328 (774)
....|+|||||.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEE
Confidence 999999999999999999986422 45689999999999999999999999999999999999999999999
Q ss_pred eecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCC
Q 004088 329 GDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAP 405 (774)
Q Consensus 329 ~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~ 405 (774)
+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.....
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~- 258 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL- 258 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC-
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc-
Confidence 99999976644321 1233467899999999999999999999999999999999 8999988776655544433222
Q ss_pred ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 406 MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 406 ~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
......++..+.+||.+||+.||.+|||+.++++|
T Consensus 259 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 259 -LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 22345678899999999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=391.06 Aligned_cols=257 Identities=22% Similarity=0.346 Sum_probs=207.8
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-----------CCCccccccc
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-----------HPNVVRYLGS 254 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-----------HPNIVkL~~~ 254 (774)
..++|++++.||+|+||.||+|++..+++.||||++.. .....+.+.+|+.+|+++. ||||++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC--CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 45789999999999999999999999999999999863 3344567889999999886 8999999999
Q ss_pred ccCCc----eEEEEEEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhc-CcccccccccceEecC------
Q 004088 255 YQGEE----YLWIVMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSI-FKVHRDIKGGNILLTD------ 322 (774)
Q Consensus 255 ~~~~~----~l~LVmEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~-gIIHRDLKPeNILLd~------ 322 (774)
+.... .+++||||+ +++|.+++... ...+++..++.++.||+.||.|||++ |||||||||+||||+.
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence 87544 899999999 88999988653 35699999999999999999999998 9999999999999953
Q ss_pred CCcEEEeeccccccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchh------hh
Q 004088 323 QGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMR------VL 396 (774)
Q Consensus 323 ~g~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~------~i 396 (774)
.+.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||....... .+
T Consensus 174 ~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp EEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred cceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 347999999999766443 234579999999999999999999999999999999999999998654211 11
Q ss_pred hhhh--cCCCC-------------------------------------ccccchhchHHHHHHHHhhcccCCCCCCCHHH
Q 004088 397 FMIS--IEPAP-------------------------------------MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAE 437 (774)
Q Consensus 397 ~~i~--~~~~~-------------------------------------~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~E 437 (774)
..+. ....+ ........+..+.+||.+||+.||.+|||+.|
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 0000 00000 00112345678899999999999999999999
Q ss_pred HHhhhhhhhhc
Q 004088 438 MLKHKFIERCK 448 (774)
Q Consensus 438 lL~HPwf~~~~ 448 (774)
+|+||||+...
T Consensus 331 ll~hp~f~~~~ 341 (373)
T 1q8y_A 331 LVNHPWLKDTL 341 (373)
T ss_dssp HHTCGGGTTCT
T ss_pred HhhChhhhccc
Confidence 99999998653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=375.27 Aligned_cols=253 Identities=25% Similarity=0.433 Sum_probs=211.8
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhh------HHHHHHHHHHHHhCCCCCccccccccc
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEG------YEEIRGEIEMLQQCSHPNVVRYLGSYQ 256 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~------~~~~~~Ei~iL~~L~HPNIVkL~~~~~ 256 (774)
.....++|++.+.||+|+||.||+|++..+++.||||++........ .+.+.+|+.+|++++||||+++++++.
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 34567899999999999999999999999999999999865432211 267899999999999999999999997
Q ss_pred CCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcC--cccccccccceEecCCCc-----EEEe
Q 004088 257 GEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF--KVHRDIKGGNILLTDQGE-----VKLG 329 (774)
Q Consensus 257 ~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~g--IIHRDLKPeNILLd~~g~-----vKL~ 329 (774)
+.. ++||||+.+++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 766 6899999999999988767778999999999999999999999999 999999999999988776 9999
Q ss_pred eccccccccccccccccccccccccchhhhh--hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhh--hhhhhcCCCC
Q 004088 330 DFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ--ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRV--LFMISIEPAP 405 (774)
Q Consensus 330 DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~--~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~--i~~i~~~~~~ 405 (774)
|||+++.... ......||+.|+|||++. ...++.++|||||||++|+|++|..||........ ...+... ..
T Consensus 172 Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~ 247 (287)
T 4f0f_A 172 DFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE-GL 247 (287)
T ss_dssp CCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS-CC
T ss_pred CCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc-CC
Confidence 9999975433 234457999999999983 45678999999999999999999999987654433 2222111 11
Q ss_pred ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 406 MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 406 ~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
....+..++..+.+||.+||+.||.+|||+.++++.
T Consensus 248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 283 (287)
T 4f0f_A 248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283 (287)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 122345678899999999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=385.35 Aligned_cols=265 Identities=30% Similarity=0.503 Sum_probs=197.8
Q ss_pred ccCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHH-HHHhCCCCCcccccccccCCce
Q 004088 182 TREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIE-MLQQCSHPNVVRYLGSYQGEEY 260 (774)
Q Consensus 182 ~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~-iL~~L~HPNIVkL~~~~~~~~~ 260 (774)
.+....++|++++.||+|+||.||+|.+..+|+.||||++...........+..|+. +++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 345567899999999999999999999999999999999986555555566667776 6777899999999999999999
Q ss_pred EEEEEEecCCCchhhhhhc----cCCchhHHHHHHHHHHHHHHHHHHHhc-CcccccccccceEecCCCcEEEeeccccc
Q 004088 261 LWIVMEYCGGGSVADLMNV----TEEPLEEYQIAYICREALKGLAYLHSI-FKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~----~~~~Lse~~i~~I~~QIl~gL~YLHs~-gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
.|+||||+.+ +|.+++.. ....+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 9999999975 77777642 256799999999999999999999999 99999999999999999999999999997
Q ss_pred cccccccccccccccccccchhhh----hhcCCCCccchhhhHHHHHHHHhCCCCCCCCCch-hhhhhhhcCCCCcc--c
Q 004088 336 QLTRTMSKRNTFIGTPHWMAPEVI----QESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPM-RVLFMISIEPAPML--E 408 (774)
Q Consensus 336 ~i~~~~~~~~~~~GT~~Y~APEvl----~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~-~~i~~i~~~~~~~~--~ 408 (774)
.+.... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||...... .....+.....+.. .
T Consensus 175 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3aln_A 175 QLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNS 253 (327)
T ss_dssp C-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCC
T ss_pred eccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCc
Confidence 765432 22334799999999998 4566899999999999999999999999865432 22222211111111 1
Q ss_pred cchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 409 DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 409 ~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
....++..+.+||.+||..||.+|||+.++++||||....
T Consensus 254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 254 EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 1245788999999999999999999999999999998654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=396.20 Aligned_cols=256 Identities=27% Similarity=0.383 Sum_probs=210.5
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-CC-----CcccccccccCCc
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-HP-----NVVRYLGSYQGEE 259 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HP-----NIVkL~~~~~~~~ 259 (774)
..++|++++.||+|+||+||+|++..+++.||||++.. .......+.+|+.+++.+. |+ +|+++++++....
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN--KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS--SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec--cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 45799999999999999999999999999999999863 3344567888999998885 55 4899999999999
Q ss_pred eEEEEEEecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHH--hcCcccccccccceEec--CCCcEEEeecccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLH--SIFKVHRDIKGGNILLT--DQGEVKLGDFGVA 334 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLH--s~gIIHRDLKPeNILLd--~~g~vKL~DFGlA 334 (774)
.+|||||||+ ++|.+++.... ..+++..++.++.||+.||.||| ..|||||||||+||||+ .++.+||+|||+|
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 9999999995 59999886543 56999999999999999999999 57899999999999995 4678999999999
Q ss_pred ccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-CCCccc-----
Q 004088 335 AQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-PAPMLE----- 408 (774)
Q Consensus 335 ~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-~~~~~~----- 408 (774)
+.+... ....+||+.|+|||++.+..++.++|||||||++|+|++|++||........+..+... ..+...
T Consensus 209 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (382)
T 2vx3_A 209 CQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA 285 (382)
T ss_dssp EETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred eecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 876433 34468999999999999999999999999999999999999999987665544332110 000000
Q ss_pred ----------------------------c---------------------------chhchHHHHHHHHhhcccCCCCCC
Q 004088 409 ----------------------------D---------------------------KEKWSLVFHDFVAKCLTKEPRARP 433 (774)
Q Consensus 409 ----------------------------~---------------------------~~~~s~~l~dLI~kcL~~DP~kRP 433 (774)
. .......+.+||.+||+.||.+||
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rp 365 (382)
T 2vx3_A 286 PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRI 365 (382)
T ss_dssp TTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSC
T ss_pred HHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCC
Confidence 0 000114789999999999999999
Q ss_pred CHHHHHhhhhhhhh
Q 004088 434 TAAEMLKHKFIERC 447 (774)
Q Consensus 434 Ta~ElL~HPwf~~~ 447 (774)
|+.|+|+||||+..
T Consensus 366 ta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 366 QPYYALQHSFFKKT 379 (382)
T ss_dssp CHHHHTTSGGGCC-
T ss_pred CHHHHhcCcccccC
Confidence 99999999999753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=384.86 Aligned_cols=268 Identities=25% Similarity=0.438 Sum_probs=223.9
Q ss_pred ccCCCCCCCcccCCCCCCeeEEeeeeccCceEEEEEEEc-------CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-
Q 004088 172 VSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDL-------KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC- 243 (774)
Q Consensus 172 ~ssss~~~~~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~-------~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L- 243 (774)
.+....+....++...++|++++.||+|+||.||+|++. .+++.||||++...........+.+|+.+|+++
T Consensus 19 ~s~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 98 (334)
T 2pvf_A 19 VSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98 (334)
T ss_dssp ----CCCCCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHC
T ss_pred cccccCCCCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhh
Confidence 344456666667778899999999999999999999975 457889999997665666677899999999999
Q ss_pred CCCCcccccccccCCceEEEEEEecCCCchhhhhhccC---------------CchhHHHHHHHHHHHHHHHHHHHhcCc
Q 004088 244 SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE---------------EPLEEYQIAYICREALKGLAYLHSIFK 308 (774)
Q Consensus 244 ~HPNIVkL~~~~~~~~~l~LVmEy~~ggsL~dll~~~~---------------~~Lse~~i~~I~~QIl~gL~YLHs~gI 308 (774)
+||||+++++++.....+|+|||||.+++|.+++.... ..+++..++.++.||+.||.|||++||
T Consensus 99 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 178 (334)
T 2pvf_A 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC 178 (334)
T ss_dssp CCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred cCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 89999999999999999999999999999999987433 248999999999999999999999999
Q ss_pred ccccccccceEecCCCcEEEeecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCC
Q 004088 309 VHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLP 385 (774)
Q Consensus 309 IHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~ 385 (774)
+||||||+|||++.++.+||+|||+++.+..... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 179 vH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 258 (334)
T 2pvf_A 179 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258 (334)
T ss_dssp ECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred eCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999976654321 1223457889999999999889999999999999999999 999
Q ss_pred CCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 386 PRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 386 Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
||...........+...... .....++..+.+||.+||..||.+|||+.+++++
T Consensus 259 p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 259 PYPGIPVEELFKLLKEGHRM--DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp SSTTCCHHHHHHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCcCCHHHHHHHHhcCCCC--CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99887766555444333221 2235678899999999999999999999999976
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=388.69 Aligned_cols=260 Identities=27% Similarity=0.369 Sum_probs=188.2
Q ss_pred CCCCCeeEEe-eeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccC----Cc
Q 004088 185 DPTTKYELLN-ELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG----EE 259 (774)
Q Consensus 185 ~~~~~Y~ilk-~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~----~~ 259 (774)
...++|.+++ .||+|+||.||+|.+..+|+.||||++... .. ...+....++.+.||||++++++|.. ..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 3467899976 599999999999999999999999998642 11 22233345677899999999999875 56
Q ss_pred eEEEEEEecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC---CcEEEeeccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ---GEVKLGDFGVAA 335 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~---g~vKL~DFGlA~ 335 (774)
.+|||||||.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++.
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 6899999999999999997543 479999999999999999999999999999999999999864 459999999997
Q ss_pred cccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhh----hhhc-CCCCccccc
Q 004088 336 QLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLF----MISI-EPAPMLEDK 410 (774)
Q Consensus 336 ~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~----~i~~-~~~~~~~~~ 410 (774)
..... .....+||+.|+|||++....++.++|||||||++|+|++|..||.......... .+.. .........
T Consensus 180 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (336)
T 3fhr_A 180 ETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW 257 (336)
T ss_dssp EC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTS
T ss_pred ecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhh
Confidence 65432 2344578999999999988889999999999999999999999997654433211 1111 111111223
Q ss_pred hhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhccCc
Q 004088 411 EKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGA 451 (774)
Q Consensus 411 ~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~~~ 451 (774)
..++..+.+||.+||+.||.+|||+.++|+||||+......
T Consensus 258 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 298 (336)
T 3fhr_A 258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP 298 (336)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSC
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCC
Confidence 46788999999999999999999999999999998764333
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=374.38 Aligned_cols=257 Identities=26% Similarity=0.406 Sum_probs=222.0
Q ss_pred cccCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCce
Q 004088 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEY 260 (774)
Q Consensus 181 ~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~ 260 (774)
..++....+|++.+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+|++++||||+++++++.....
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC--STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34566778999999999999999999999999999999998643 3445788999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
+|+|||||.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 99999999999999998753 35699999999999999999999999999999999999999999999999999986654
Q ss_pred ccc-ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHH
Q 004088 340 TMS-KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVF 417 (774)
Q Consensus 340 ~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l 417 (774)
... ......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...........+..... ...+..++..+
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l 241 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--MERPEGCPEKV 241 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--CCCCTTCCHHH
T ss_pred CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC--CCCCCCCCHHH
Confidence 321 2233457889999999999999999999999999999999 9999988776665544433322 23345678899
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhh
Q 004088 418 HDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 418 ~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.+||.+||..||.+|||+.++++.
T Consensus 242 ~~li~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 242 YELMRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhCCChhhCcCHHHHHHH
Confidence 999999999999999999999763
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=380.02 Aligned_cols=254 Identities=26% Similarity=0.438 Sum_probs=208.1
Q ss_pred CCCCCeeEEeeeeccCceEEEEEE----EcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccC--C
Q 004088 185 DPTTKYELLNELGKGSYGAVYKAR----DLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG--E 258 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~----d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~--~ 258 (774)
....+|++++.||+|+||+||+|+ +..+++.||||++... .....+.+.+|+.+|++++||||+++++++.. .
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 456789999999999999999998 5668999999998643 44556789999999999999999999998853 4
Q ss_pred ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 259 EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
..+|+|||||++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 56899999999999999998766779999999999999999999999999999999999999999999999999998764
Q ss_pred cccc---ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchh----------------hhhhh
Q 004088 339 RTMS---KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMR----------------VLFMI 399 (774)
Q Consensus 339 ~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~----------------~i~~i 399 (774)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 4321 1223457888999999999999999999999999999999999886432110 00111
Q ss_pred hcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 400 SIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 400 ~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
. .......+..++..+.+||.+||+.||.+|||+.++++.
T Consensus 246 ~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 246 K--NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp H--TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred h--ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 1 111223345678899999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=388.02 Aligned_cols=249 Identities=19% Similarity=0.269 Sum_probs=209.6
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~LVm 265 (774)
.++|++++.||+|+||.||+|++..+|+.||||++..... .+.+.+|+.+|+++ +||||+++++++......||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 4689999999999999999999999999999999875432 23578999999999 9999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCc-----EEEeecccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE-----VKLGDFGVAAQLTRT 340 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~-----vKL~DFGlA~~i~~~ 340 (774)
||| +++|.+++......+++..++.++.||+.||.|||++|||||||||+||||+.++. +||+|||+++.+...
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 999 99999999866678999999999999999999999999999999999999998887 999999999876443
Q ss_pred ccc-------cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhh---hhhhc--CCCCccc
Q 004088 341 MSK-------RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVL---FMISI--EPAPMLE 408 (774)
Q Consensus 341 ~~~-------~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i---~~i~~--~~~~~~~ 408 (774)
... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..+.. ...+...
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 243 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV 243 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHH
Confidence 221 24568999999999999999999999999999999999999999875433221 11111 0111111
Q ss_pred cchhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 409 DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 409 ~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
....++ .+.+||.+||..||.+||++.+|++
T Consensus 244 ~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 244 LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 122344 8999999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=384.34 Aligned_cols=260 Identities=26% Similarity=0.410 Sum_probs=216.5
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEE-----EcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCC
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKAR-----DLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE 258 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~-----d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~ 258 (774)
+...++|++++.||+|+||.||+|+ +..+++.||||++...........+.+|+.+|++++||||+++++++...
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 4567899999999999999999998 55678899999997555566667899999999999999999999999999
Q ss_pred ceEEEEEEecCCCchhhhhhccC------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC---CcEEEe
Q 004088 259 EYLWIVMEYCGGGSVADLMNVTE------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ---GEVKLG 329 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~~------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~---g~vKL~ 329 (774)
...|||||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.+ ..+||+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 99999999999999999997543 458999999999999999999999999999999999999954 469999
Q ss_pred eccccccccccc--cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCc
Q 004088 330 DFGVAAQLTRTM--SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPM 406 (774)
Q Consensus 330 DFGlA~~i~~~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~ 406 (774)
|||++..+.... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+......
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~- 264 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM- 264 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC-
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC-
Confidence 999997654332 12234568999999999999999999999999999999998 99999887766555444333222
Q ss_pred cccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhh
Q 004088 407 LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445 (774)
Q Consensus 407 ~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~ 445 (774)
.....++..+.+||.+||+.||.+||++.++++|.|+-
T Consensus 265 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 265 -DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 22356788999999999999999999999999998874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=376.83 Aligned_cols=256 Identities=24% Similarity=0.388 Sum_probs=210.3
Q ss_pred CCCCCeeEEeeeeccCceEEEEEE----EcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCC--
Q 004088 185 DPTTKYELLNELGKGSYGAVYKAR----DLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE-- 258 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~----d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~-- 258 (774)
....+|++++.||+|+||.||+|+ +..+++.||||++.........+.+.+|+.+|++++||||+++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 345679999999999999999998 56789999999997655555667899999999999999999999999766
Q ss_pred ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 259 EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
..+|+|||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 67999999999999999997677789999999999999999999999999999999999999999999999999998765
Q ss_pred cccc---ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCc--------------hhhhhhhhc
Q 004088 339 RTMS---KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHP--------------MRVLFMISI 401 (774)
Q Consensus 339 ~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~--------------~~~i~~i~~ 401 (774)
.... ......||..|+|||++.+..++.++|||||||++|+|++|..|+..... ........
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 256 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL- 256 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH-
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH-
Confidence 4321 22345688999999999999999999999999999999999987643211 00111111
Q ss_pred CCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 402 EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 402 ~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
........+..++..+.+||.+||+.||.+|||+.++++.
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 296 (302)
T 4e5w_A 257 KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296 (302)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 1111222345678899999999999999999999999863
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=382.50 Aligned_cols=260 Identities=23% Similarity=0.412 Sum_probs=218.9
Q ss_pred cccCCCCCCeeEEeeeeccCceEEEEEEEcCCCc-----EEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCccccccc
Q 004088 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKTSE-----LVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGS 254 (774)
Q Consensus 181 ~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~-----~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~ 254 (774)
...+...++|++.+.||+|+||.||+|.+..+++ .||||++.........+.+.+|+.+|+++ +||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3456778899999999999999999999877654 79999997665556677899999999999 89999999999
Q ss_pred ccCCceEEEEEEecCCCchhhhhhcc-------------CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEec
Q 004088 255 YQGEEYLWIVMEYCGGGSVADLMNVT-------------EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLT 321 (774)
Q Consensus 255 ~~~~~~l~LVmEy~~ggsL~dll~~~-------------~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd 321 (774)
+.....+|+|||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 99999999999999999999998643 24579999999999999999999999999999999999999
Q ss_pred CCCcEEEeecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhh
Q 004088 322 DQGEVKLGDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFM 398 (774)
Q Consensus 322 ~~g~vKL~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~ 398 (774)
.++.+||+|||++..+..... ......||+.|+|||++.+..++.++|||||||++|+|++ |.+||...........
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 278 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence 999999999999986644322 1233467889999999999999999999999999999998 9999987655443333
Q ss_pred hhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 399 ISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 399 i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
...... ....+...+..+.+||.+||+.||.+|||+.+++++
T Consensus 279 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 279 LVKDGY-QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCC-CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 222111 112234567889999999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=373.31 Aligned_cols=252 Identities=18% Similarity=0.239 Sum_probs=212.6
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~LV 264 (774)
..++|++++.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++++ +|+||+++++++......|+|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 45689999999999999999999999999999999864432 24578899999999 799999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCc-----EEEeeccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE-----VKLGDFGVAAQLTR 339 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~-----vKL~DFGlA~~i~~ 339 (774)
|||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.+..
T Consensus 85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 9999 99999999866677999999999999999999999999999999999999987776 99999999987654
Q ss_pred ccc-------ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCch---hhhhhhhc--CCCCcc
Q 004088 340 TMS-------KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPM---RVLFMISI--EPAPML 407 (774)
Q Consensus 340 ~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~---~~i~~i~~--~~~~~~ 407 (774)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+.. ...+..
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH
Confidence 322 134557999999999999999999999999999999999999999875432 11111111 111222
Q ss_pred ccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 408 EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 408 ~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.....++..+.+||.+||+.||.+||++.+|++.
T Consensus 244 ~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 2234678899999999999999999999999764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=372.79 Aligned_cols=256 Identities=26% Similarity=0.383 Sum_probs=218.7
Q ss_pred CCCCCeeEEe-eeeccCceEEEEEEEc--CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 185 DPTTKYELLN-ELGKGSYGAVYKARDL--KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 185 ~~~~~Y~ilk-~LG~G~FG~Vy~a~d~--~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
...++|.+.+ .||+|+||.||+|.+. .+++.||||++.........+.+.+|+.+|++++||||+++++++ ..+..
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~ 84 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL 84 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence 4556788887 9999999999999864 468889999998665666678899999999999999999999999 45568
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|+||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 99999999999999997666789999999999999999999999999999999999999999999999999998764332
Q ss_pred c---ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHH
Q 004088 342 S---KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVF 417 (774)
Q Consensus 342 ~---~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l 417 (774)
. ......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.....+ ..+..++..+
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~l 242 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM--ECPPECPPEL 242 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC--CCCTTCCHHH
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC--CCCCCcCHHH
Confidence 2 1223457899999999998889999999999999999998 99999887766655544433222 2345678899
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhhhh
Q 004088 418 HDFVAKCLTKEPRARPTAAEMLKHKF 443 (774)
Q Consensus 418 ~dLI~kcL~~DP~kRPTa~ElL~HPw 443 (774)
.+||.+||..||.+||++.++++|.+
T Consensus 243 ~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 243 YALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 99999999999999999999998743
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=368.37 Aligned_cols=250 Identities=27% Similarity=0.481 Sum_probs=203.9
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC---hhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG---EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~---~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
...++|++.+.||+|+||.||+|.+. ++.||||++..... ....+.+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 45679999999999999999999964 88999999865432 23456789999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcC---cccccccccceEecC--------CCcEEEee
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF---KVHRDIKGGNILLTD--------QGEVKLGD 330 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~g---IIHRDLKPeNILLd~--------~g~vKL~D 330 (774)
|+||||+++++|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|
T Consensus 82 ~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999999999999885 457999999999999999999999999 899999999999986 67899999
Q ss_pred ccccccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccc
Q 004088 331 FGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDK 410 (774)
Q Consensus 331 FGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~ 410 (774)
||++..+.... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..... ....+
T Consensus 160 fg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~ 236 (271)
T 3dtc_A 160 FGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL-ALPIP 236 (271)
T ss_dssp CCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCC-CCCCC
T ss_pred CCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCC-CCCCC
Confidence 99997665432 2345799999999999999999999999999999999999999998776665554433322 22334
Q ss_pred hhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 411 EKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 411 ~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
..++..+.+||.+||+.||.+|||+.++++|
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 5678899999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=375.47 Aligned_cols=249 Identities=18% Similarity=0.310 Sum_probs=209.6
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCC-------cEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCccccccccc
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTS-------ELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ 256 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g-------~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~ 256 (774)
+...++|++.+.||+|+||.||+|++..++ ..||+|++... .....+.+.+|+.+|++++||||+++++++.
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-GGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 345678999999999999999999988777 47999998643 3345578999999999999999999999999
Q ss_pred CCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCc--------EEE
Q 004088 257 GEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE--------VKL 328 (774)
Q Consensus 257 ~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~--------vKL 328 (774)
.....|+|||||.+++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++. +||
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999999999866666999999999999999999999999999999999999998887 999
Q ss_pred eeccccccccccccccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhC-CCCCCCCCchhhhhhhhcCCCCc
Q 004088 329 GDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEG-LPPRSTVHPMRVLFMISIEPAPM 406 (774)
Q Consensus 329 ~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG-~~Pf~~~~~~~~i~~i~~~~~~~ 406 (774)
+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++| .+||.................
T Consensus 163 ~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~-- 236 (289)
T 4fvq_A 163 SDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ-- 236 (289)
T ss_dssp CCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--
T ss_pred ccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCC--
Confidence 999998655332 33468999999999987 6799999999999999999995 555555544433332222111
Q ss_pred cccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 407 LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 407 ~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.+...+..+.+||.+||+.||.+|||+.++++|
T Consensus 237 --~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 237 --LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp --CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred --CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 122345678999999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=378.18 Aligned_cols=259 Identities=25% Similarity=0.465 Sum_probs=208.3
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCC--CCCcccccccccCCceE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCS--HPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~--HPNIVkL~~~~~~~~~l 261 (774)
....+|++++.||+|+||.||+|.+. +++.||||++.... .....+.+.+|+.+|+++. ||||+++++++.....+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 34568999999999999999999974 58999999997543 3455678899999999997 59999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|+||| +.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++..+....
T Consensus 104 ~lv~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EEEEC-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred EEEEe-cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence 99999 558899999864 457899999999999999999999999999999999999965 899999999997664432
Q ss_pred c--ccccccccccccchhhhhh-----------cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccc
Q 004088 342 S--KRNTFIGTPHWMAPEVIQE-----------SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLE 408 (774)
Q Consensus 342 ~--~~~~~~GT~~Y~APEvl~~-----------~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~ 408 (774)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....................
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 260 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 260 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccC
Confidence 2 1234579999999999975 46888999999999999999999999765432221111112222222
Q ss_pred cchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 409 DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 409 ~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
.+...+..+.+||.+||..||.+||++.++|+||||+..
T Consensus 261 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 261 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 334457889999999999999999999999999999753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=367.30 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=217.6
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
....++|++++.||+|+||.||+|.+. +++.||||++.... ...+.+.+|+.++++++||||+++++++......|+
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 80 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTT--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEE
Confidence 345678999999999999999999975 67889999997543 234678999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc-c
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM-S 342 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~-~ 342 (774)
||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 999999999999998666789999999999999999999999999999999999999999999999999997654321 1
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI 421 (774)
......||+.|+|||++.+..++.++|||||||++|+|++ |.+||...........+...... ..+..++..+.+||
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li 238 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--YKPRLASTHVYQIM 238 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--CCCTTSCHHHHHHH
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC--CCCccCcHHHHHHH
Confidence 1223467889999999999899999999999999999999 89999887766655554433222 22345688899999
Q ss_pred HhhcccCCCCCCCHHHHHhh
Q 004088 422 AKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 422 ~kcL~~DP~kRPTa~ElL~H 441 (774)
.+||..||.+||++.+++++
T Consensus 239 ~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 239 NHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCChhhCcCHHHHHHH
Confidence 99999999999999999976
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=378.71 Aligned_cols=258 Identities=26% Similarity=0.420 Sum_probs=215.3
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEE-----cCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCccccccccc
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARD-----LKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQ 256 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d-----~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~ 256 (774)
+....++|++.+.||+|+||.||+|++ ..+++.||||++.........+.+.+|+.+|+++ +||||+++++++.
T Consensus 22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 345678999999999999999999985 3567899999997665556667899999999999 7999999999987
Q ss_pred CC-ceEEEEEEecCCCchhhhhhccCC---------------chhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEe
Q 004088 257 GE-EYLWIVMEYCGGGSVADLMNVTEE---------------PLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL 320 (774)
Q Consensus 257 ~~-~~l~LVmEy~~ggsL~dll~~~~~---------------~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILL 320 (774)
.. ..+|+|||||++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 64 459999999999999999975432 28999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhh
Q 004088 321 TDQGEVKLGDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLF 397 (774)
Q Consensus 321 d~~g~vKL~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~ 397 (774)
+.++.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||..........
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 261 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence 9999999999999976644322 1234568999999999999999999999999999999998 999998765443332
Q ss_pred hhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 398 MISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 398 ~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
....... ....+..++..+.++|.+||+.||.+|||+.++++|
T Consensus 262 ~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 262 RRLKEGT-RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhccCc-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2211111 112234568889999999999999999999999987
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=394.83 Aligned_cols=256 Identities=24% Similarity=0.379 Sum_probs=208.5
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEc---CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCc
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDL---KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE 259 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~---~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~ 259 (774)
.+....+|++.+.||+|+||.||+|++. .++..||||+++........+.+.+|+.+|++++||||+++++++....
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 3445678999999999999999999876 4677899999976555666678999999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
.+|||||||++++|.+++......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 99999999999999999986667899999999999999999999999999999999999999999999999999987654
Q ss_pred ccccc---ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchH
Q 004088 340 TMSKR---NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSL 415 (774)
Q Consensus 340 ~~~~~---~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~ 415 (774)
..... ....+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+.... .......++.
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~--~~~~~~~~~~ 277 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY--RLPPPMDCPA 277 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE--ECCCCTTCBH
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--CCCCCccccH
Confidence 32211 12245788999999999999999999999999999997 999998877666555443321 1222346778
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 416 VFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 416 ~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
.+.+||.+||+.||.+||++.++++
T Consensus 278 ~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 278 ALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhCcChhhCcCHHHHHH
Confidence 8999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=370.36 Aligned_cols=252 Identities=23% Similarity=0.384 Sum_probs=213.1
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCc---EEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE-EE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSE---LVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL-WI 263 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~---~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l-~L 263 (774)
..|++.+.||+|+||.||+|.+..+++ .||||++.........+.+.+|+.+|++++||||+++++++...+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 367888999999999999999765554 79999997655666678899999999999999999999999766554 99
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc--
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM-- 341 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~-- 341 (774)
||||+.+++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 999999999999998767789999999999999999999999999999999999999999999999999997654321
Q ss_pred --cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 342 --SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 342 --~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
.......||+.|+|||++.+..++.++|||||||++|+|++ |.+||...........+..... ...+..++..+.
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~ 258 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR--LPQPEYCPDSLY 258 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC--CCCCTTCCHHHH
T ss_pred ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC--CCCCccchHHHH
Confidence 22234568999999999999999999999999999999999 5566666655555444433322 223456788999
Q ss_pred HHHHhhcccCCCCCCCHHHHHhh
Q 004088 419 DFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
+||.+||+.||.+|||+.++++.
T Consensus 259 ~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 259 QVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=370.81 Aligned_cols=255 Identities=25% Similarity=0.384 Sum_probs=214.3
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcC---CCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCce
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLK---TSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEY 260 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~---~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~ 260 (774)
....++|++.+.||+|+||.||+|.+.. ++..||||++.........+.+.+|+.+|++++||||+++++++..+ .
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~ 86 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-P 86 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-S
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-C
Confidence 4456789999999999999999998654 34569999997665566678899999999999999999999998754 5
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
.|+||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 68999999999999999876677999999999999999999999999999999999999999999999999999766443
Q ss_pred cc-ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 341 MS-KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 341 ~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
.. ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+...... ..+..++..+.
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~ 244 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL--PKPDLCPPVLY 244 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC--CCCTTCCHHHH
T ss_pred cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC--CCCCCCCHHHH
Confidence 21 1233457889999999999899999999999999999998 99999876666555444332221 22345788899
Q ss_pred HHHHhhcccCCCCCCCHHHHHhh
Q 004088 419 DFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
++|.+||..||.+||++.+++++
T Consensus 245 ~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 245 TLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCchhCcCHHHHHHH
Confidence 99999999999999999999976
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=378.46 Aligned_cols=254 Identities=24% Similarity=0.306 Sum_probs=206.1
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
..++|++.+.||+|+||.||+|++..+++.||||++.... .....+.+.+|+.++++++||||+++++++.....+|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 4678999999999999999999999999999999986432 23345778999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc-c
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM-S 342 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~-~ 342 (774)
||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 112 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp EEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 9999999999999863 4579999999999999999999999999999999999999999999999999997654432 2
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.............++..+.+||.
T Consensus 191 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 270 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIA 270 (309)
T ss_dssp ------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHH
T ss_pred cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHH
Confidence 22345799999999999988999999999999999999999999987665543333333333333345667889999999
Q ss_pred hhcccCCCCCC-CHHHHHh
Q 004088 423 KCLTKEPRARP-TAAEMLK 440 (774)
Q Consensus 423 kcL~~DP~kRP-Ta~ElL~ 440 (774)
+||..||.+|| +++++++
T Consensus 271 ~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 271 RGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHTCSSGGGSCSSHHHHHH
T ss_pred HhccCCHHHHHHhHHHHHH
Confidence 99999999999 7888774
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=381.92 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=211.2
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEE----EEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCce
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELV----AIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEY 260 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~V----AVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~ 260 (774)
...++|++++.||+|+||.||+|++..+++.| |+|.+...........+.+|+.+|++++||||+++++++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 45679999999999999999999998888755 6666654444556678999999999999999999999998765
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
.++|+||+.+++|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 78999999999999999877778999999999999999999999999999999999999999999999999999876443
Q ss_pred ccc--cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHH
Q 004088 341 MSK--RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVF 417 (774)
Q Consensus 341 ~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l 417 (774)
... .....||+.|+|||++.+..++.++|||||||++|+|++ |.+||...........+..... ...+..++..+
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l 248 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER--LPQPPICTIDV 248 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--CCCCTTBCHHH
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC--CCCCccCCHHH
Confidence 221 223457889999999999999999999999999999999 9999988776665554443322 22345678899
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhh
Q 004088 418 HDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 418 ~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.+||.+||..||.+||++.++++.
T Consensus 249 ~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 249 YMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999999864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=379.07 Aligned_cols=257 Identities=26% Similarity=0.400 Sum_probs=213.7
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
....++|++.+.||+|+||.||+|++ .+++.||||++... .....+.+.+|+.+|++++||||+++++++...+..|+
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE-SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC-CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEeccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 44678999999999999999999995 57899999988643 33456789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccC---CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTE---EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~---~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
|||||++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999999986432 35899999999999999999999999999999999999999999999999999765432
Q ss_pred c--cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhh-------c-------CCC
Q 004088 341 M--SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMIS-------I-------EPA 404 (774)
Q Consensus 341 ~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~-------~-------~~~ 404 (774)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....+........ . .+.
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN 272 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChh
Confidence 1 12234569999999999999999999999999999999999999997654432211100 0 011
Q ss_pred CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhh
Q 004088 405 PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHK 442 (774)
Q Consensus 405 ~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HP 442 (774)
.........+..+.++|.+||+.||++|||+.++++|.
T Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 273 LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 11112345577899999999999999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=370.81 Aligned_cols=253 Identities=24% Similarity=0.379 Sum_probs=211.8
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCC---CcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccc-cCCceEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKT---SELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSY-QGEEYLW 262 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~---g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~-~~~~~l~ 262 (774)
..+|++.+.||+|+||.||+|.+..+ ...||||++.........+.+.+|+.+|++++||||+++++++ ..+...|
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 35799999999999999999997543 3468999987655666678899999999999999999999985 5667889
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc-
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM- 341 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~- 341 (774)
+|||||++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 9999999999999998667789999999999999999999999999999999999999999999999999997664322
Q ss_pred ---cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHH
Q 004088 342 ---SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVF 417 (774)
Q Consensus 342 ---~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l 417 (774)
.......||+.|+|||++.+..++.++|||||||++|+|++ |.+||...........+..... ...+..++..+
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l 261 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR--LLQPEYCPDPL 261 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC--CCCCTTCCHHH
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC--CCCCccCCHHH
Confidence 12233467889999999999999999999999999999999 6777777665555444433322 22245578889
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhh
Q 004088 418 HDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 418 ~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.++|.+||..||.+|||+.++++.
T Consensus 262 ~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 262 YEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=379.40 Aligned_cols=257 Identities=24% Similarity=0.359 Sum_probs=214.1
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcCCC----cEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCC
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLKTS----ELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE 258 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g----~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~ 258 (774)
.+....+|++.+.||+|+||.||+|.+..++ ..||||++...........+.+|+.+|++++||||+++++++...
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 4556789999999999999999999976543 469999997655555667799999999999999999999999999
Q ss_pred ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 259 EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
...|||||||++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 99999999999999999998666789999999999999999999999999999999999999999999999999998765
Q ss_pred ccccc---cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhch
Q 004088 339 RTMSK---RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWS 414 (774)
Q Consensus 339 ~~~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s 414 (774)
..... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+..... ......++
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~ 276 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR--LPTPMDCP 276 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC--CCCCTTCB
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc--CCCcccCC
Confidence 43211 122346889999999998899999999999999999998 9999988776665554443322 22244678
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 415 LVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 415 ~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
..+.++|.+||+.||.+||++.+++++
T Consensus 277 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 277 SAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 899999999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=380.29 Aligned_cols=254 Identities=26% Similarity=0.418 Sum_probs=213.5
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEE--EEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELV--AIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~V--AVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l 261 (774)
...++|++.+.||+|+||.||+|++..++..+ |||++.........+.+.+|+.+|+++ +||||+++++++.....+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 44578999999999999999999998888865 999987544455566789999999999 899999999999999999
Q ss_pred EEEEEecCCCchhhhhhccC---------------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcE
Q 004088 262 WIVMEYCGGGSVADLMNVTE---------------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEV 326 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~---------------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~v 326 (774)
|+|||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeE
Confidence 99999999999999986432 468999999999999999999999999999999999999999999
Q ss_pred EEeeccccccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCC
Q 004088 327 KLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAP 405 (774)
Q Consensus 327 KL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~ 405 (774)
||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+.....
T Consensus 182 kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~- 259 (327)
T 1fvr_A 182 KIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR- 259 (327)
T ss_dssp EECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC-
T ss_pred EEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC-
Confidence 99999999744322 22233467899999999999889999999999999999998 9999988776665554433322
Q ss_pred ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 406 MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 406 ~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
...+..++..+.+||.+||..||.+|||+.++++|
T Consensus 260 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 260 -LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp -CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22345678899999999999999999999999976
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=373.68 Aligned_cols=255 Identities=27% Similarity=0.458 Sum_probs=202.0
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
...+|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|++++||||+++++++......++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 4568999999999999999999999999999999997532 34456778999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhc---cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 264 VMEYCGGGSVADLMNV---TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 264 VmEy~~ggsL~dll~~---~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
||||+.+++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999999999998863 3456899999999999999999999999999999999999999999999999999876554
Q ss_pred ccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCch--hhhhhhhcCCCCccccchhchHHHH
Q 004088 341 MSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPM--RVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 341 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~--~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
........||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+.....+. .....++..+.
T Consensus 190 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 268 (310)
T 2wqm_A 190 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP-LPSDHYSEELR 268 (310)
T ss_dssp ---------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC-CCTTTSCHHHH
T ss_pred CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC-CcccccCHHHH
Confidence 33344567999999999999989999999999999999999999999754321 2222222222111 11246788999
Q ss_pred HHHHhhcccCCCCCCCHHHHHhh
Q 004088 419 DFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
+||.+||..||.+|||+.+++++
T Consensus 269 ~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 269 QLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=373.13 Aligned_cols=256 Identities=27% Similarity=0.506 Sum_probs=202.2
Q ss_pred ccCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCce
Q 004088 182 TREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEY 260 (774)
Q Consensus 182 ~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~ 260 (774)
..+...++|++.++||+|+||.||+|++. ..||||++.... .....+.+.+|+.+|++++||||+++++++ ....
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence 45667889999999999999999999853 359999997544 345567799999999999999999999965 5566
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
+++|||||.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 89999999999999999767778999999999999999999999999999999999999999999999999999765432
Q ss_pred --ccccccccccccccchhhhh---hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhh-cC--CCCccccchh
Q 004088 341 --MSKRNTFIGTPHWMAPEVIQ---ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMIS-IE--PAPMLEDKEK 412 (774)
Q Consensus 341 --~~~~~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~-~~--~~~~~~~~~~ 412 (774)
........||+.|+|||++. ...++.++|||||||++|+|++|+.||........+.... .. ..........
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTT
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcccc
Confidence 12223457999999999996 5668889999999999999999999998766544433222 11 1111222346
Q ss_pred chHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 413 WSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 413 ~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
++..+.+||.+||+.||.+|||+.++++.
T Consensus 254 ~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 254 CPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 78899999999999999999999999864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=381.87 Aligned_cols=260 Identities=27% Similarity=0.379 Sum_probs=209.6
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
....++|++.+.||+|+||.||+|++ .+|+.||||++...........+.+|+.+|++++||||+++++++......++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 104 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 104 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence 34567899999999999999999984 57899999999755443344468999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccC---CchhHHHHHHHHHHHHHHHHHHHhc---CcccccccccceEecCCCcEEEeeccccccc
Q 004088 264 VMEYCGGGSVADLMNVTE---EPLEEYQIAYICREALKGLAYLHSI---FKVHRDIKGGNILLTDQGEVKLGDFGVAAQL 337 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~---~~Lse~~i~~I~~QIl~gL~YLHs~---gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i 337 (774)
|||||.+++|.+++.... ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..+
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 184 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence 999999999999987433 3499999999999999999999999 9999999999999999999999999999866
Q ss_pred ccccc-ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCC-----chhhhhhhh-----------
Q 004088 338 TRTMS-KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVH-----PMRVLFMIS----------- 400 (774)
Q Consensus 338 ~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~-----~~~~i~~i~----------- 400 (774)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... .........
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (326)
T 3uim_A 185 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEAL 264 (326)
T ss_dssp CSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTS
T ss_pred CcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhh
Confidence 43322 2334569999999999999899999999999999999999999995211 000000000
Q ss_pred cCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 401 IEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 401 ~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
.............+..+.+||.+||+.||.+|||+.+|++|-.-
T Consensus 265 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 265 VDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred cChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 00000111223446789999999999999999999999998543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=377.90 Aligned_cols=253 Identities=24% Similarity=0.377 Sum_probs=207.0
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCccccccccc----CCceE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ----GEEYL 261 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~----~~~~l 261 (774)
..++|++++.||+|+||.||+|++..+++.||||++... .....+.+.+|+.++++++||||+++++++. .....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 457899999999999999999999999999999998653 3455678899999999999999999999986 45689
Q ss_pred EEEEEecCCCchhhhhhc---cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 262 WIVMEYCGGGSVADLMNV---TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~---~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
|+|||||.+++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999999999998864 35679999999999999999999999999999999999999999999999999987553
Q ss_pred ccccc---------cccccccccccchhhhhhcC---CCCccchhhhHHHHHHHHhCCCCCCCCCch--hhhhhhhcCCC
Q 004088 339 RTMSK---------RNTFIGTPHWMAPEVIQESR---YDGKVDVWALGVSAVEMAEGLPPRSTVHPM--RVLFMISIEPA 404 (774)
Q Consensus 339 ~~~~~---------~~~~~GT~~Y~APEvl~~~~---~s~ksDIWSLGviLyELLtG~~Pf~~~~~~--~~i~~i~~~~~ 404 (774)
..... .....||+.|+|||++.... ++.++|||||||++|+|++|..||...... .....+.. .
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~ 263 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN--Q 263 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC--C
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc--c
Confidence 22111 12346899999999987543 789999999999999999999998642111 11111111 1
Q ss_pred CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 405 PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 405 ~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
........++..+.+||.+||+.||.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 264 LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 1122335678899999999999999999999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=364.37 Aligned_cols=250 Identities=18% Similarity=0.313 Sum_probs=212.0
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCC--ce
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE--EY 260 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~--~~ 260 (774)
....++|++++.||+|+||.||+|++. ++.||||++.... .....+.+.+|+.+|++++||||+++++++... ..
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence 345678999999999999999999974 8899999997554 344556799999999999999999999999876 78
Q ss_pred EEEEEEecCCCchhhhhhccCC-chhHHHHHHHHHHHHHHHHHHHhcC--cccccccccceEecCCCcEEEeeccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEE-PLEEYQIAYICREALKGLAYLHSIF--KVHRDIKGGNILLTDQGEVKLGDFGVAAQL 337 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~-~Lse~~i~~I~~QIl~gL~YLHs~g--IIHRDLKPeNILLd~~g~vKL~DFGlA~~i 337 (774)
+++|||||++++|.+++..... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999999999975443 5899999999999999999999999 999999999999999999999999987543
Q ss_pred cccccccccccccccccchhhhhhcCCCC---ccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhch
Q 004088 338 TRTMSKRNTFIGTPHWMAPEVIQESRYDG---KVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWS 414 (774)
Q Consensus 338 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~---ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s 414 (774)
.. ....||+.|+|||++.+..++. ++|||||||++|+|++|..||...........+...... ...+..++
T Consensus 164 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 237 (271)
T 3kmu_A 164 QS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR-PTIPPGIS 237 (271)
T ss_dssp SC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC-CCCCTTCC
T ss_pred cc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC-CCCCCCCC
Confidence 22 2347899999999998765554 799999999999999999999887766655444332221 12345678
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 415 LVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 415 ~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
..+.+||.+||+.||.+|||+.++++.
T Consensus 238 ~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 238 PHVSKLMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 899999999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=369.94 Aligned_cols=251 Identities=20% Similarity=0.289 Sum_probs=204.5
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccc-cCCceEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSY-QGEEYLWIV 264 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~-~~~~~l~LV 264 (774)
..++|++++.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.++|++++..+..+ ......++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 35789999999999999999999999999999998764432 23478899999999988877766655 677889999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEe---cCCCcEEEeeccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL---TDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILL---d~~g~vKL~DFGlA~~i~~~~ 341 (774)
|||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 9999 999999998667789999999999999999999999999999999999999 788999999999998765432
Q ss_pred c-------ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhh---hhhc--CCCCcccc
Q 004088 342 S-------KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLF---MISI--EPAPMLED 409 (774)
Q Consensus 342 ~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~---~i~~--~~~~~~~~ 409 (774)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... .+.. ...+....
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh
Confidence 2 2234579999999999999999999999999999999999999998654332111 1110 01111112
Q ss_pred chhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 410 KEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 410 ~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
...++..+.+||.+||+.||.+|||+.++++
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 2456788999999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=391.40 Aligned_cols=255 Identities=24% Similarity=0.372 Sum_probs=210.0
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCc--eEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE--YLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~--~l~L 263 (774)
..++|++.+.||+|+||.||+|++..+|+.||||++.........+.+.+|+.+|++++||||+++++++.... ..|+
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 35689999999999999999999999999999999975544455677889999999999999999999987654 7899
Q ss_pred EEEecCCCchhhhhhccC--CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEe----cCCCcEEEeeccccccc
Q 004088 264 VMEYCGGGSVADLMNVTE--EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL----TDQGEVKLGDFGVAAQL 337 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~--~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILL----d~~g~vKL~DFGlA~~i 337 (774)
|||||.+++|.+++.... ..+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+++.+
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 999999999999987433 239999999999999999999999999999999999999 77778999999999876
Q ss_pred cccccccccccccccccchhhhhh--------cCCCCccchhhhHHHHHHHHhCCCCCCCCCc----hhhhhhhhcCCCC
Q 004088 338 TRTMSKRNTFIGTPHWMAPEVIQE--------SRYDGKVDVWALGVSAVEMAEGLPPRSTVHP----MRVLFMISIEPAP 405 (774)
Q Consensus 338 ~~~~~~~~~~~GT~~Y~APEvl~~--------~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~----~~~i~~i~~~~~~ 405 (774)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+.....+
T Consensus 167 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~ 245 (396)
T 4eut_A 167 EDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245 (396)
T ss_dssp CCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCT
T ss_pred cCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCc
Confidence 543 23345679999999999875 5688899999999999999999999964332 2222222111110
Q ss_pred ----------------------ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 406 ----------------------MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 406 ----------------------~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.......++..+.+||.+||+.||++||++.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 001123456788999999999999999999999765
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=383.13 Aligned_cols=253 Identities=26% Similarity=0.390 Sum_probs=213.3
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh-----hhHHHHHHHHHHHHhCC--CCCcccccccc
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE-----EGYEEIRGEIEMLQQCS--HPNVVRYLGSY 255 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~-----~~~~~~~~Ei~iL~~L~--HPNIVkL~~~~ 255 (774)
.+...++|++++.||+|+||.||+|++..+++.||||++...... .....+.+|+.+|+++. ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 345678999999999999999999999999999999999754321 12244678999999996 59999999999
Q ss_pred cCCceEEEEEEecCC-CchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEec-CCCcEEEeeccc
Q 004088 256 QGEEYLWIVMEYCGG-GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLT-DQGEVKLGDFGV 333 (774)
Q Consensus 256 ~~~~~l~LVmEy~~g-gsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd-~~g~vKL~DFGl 333 (774)
......++||||+.+ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 999999999999976 899998864 46789999999999999999999999999999999999999 678999999999
Q ss_pred cccccccccccccccccccccchhhhhhcCC-CCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchh
Q 004088 334 AAQLTRTMSKRNTFIGTPHWMAPEVIQESRY-DGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEK 412 (774)
Q Consensus 334 A~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~ 412 (774)
++.+... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... ... ......
T Consensus 197 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------~~~---~~~~~~ 265 (320)
T 3a99_A 197 GALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII------RGQ---VFFRQR 265 (320)
T ss_dssp CEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH------HCC---CCCSSC
T ss_pred ccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh------ccc---cccccc
Confidence 9876543 2334579999999999987766 678999999999999999999997532211 111 112345
Q ss_pred chHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 413 WSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 413 ~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
++..+.+||.+||+.||.+|||+.++++||||+..
T Consensus 266 ~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 67889999999999999999999999999999754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=370.71 Aligned_cols=256 Identities=23% Similarity=0.347 Sum_probs=206.1
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcC---CCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCc
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLK---TSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE 259 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~---~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~ 259 (774)
....++|++.+.||+|+||.||+|.+.. +++.||||++.... .....+.+.+|+.+|++++||||+++++++....
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 4456789999999999999999998765 55689999987543 3445677899999999999999999999987654
Q ss_pred -----eEEEEEEecCCCchhhhhhc-----cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEe
Q 004088 260 -----YLWIVMEYCGGGSVADLMNV-----TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLG 329 (774)
Q Consensus 260 -----~l~LVmEy~~ggsL~dll~~-----~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~ 329 (774)
..|+||||+.+++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEe
Confidence 45999999999999998842 33569999999999999999999999999999999999999999999999
Q ss_pred eccccccccccc--cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCc
Q 004088 330 DFGVAAQLTRTM--SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPM 406 (774)
Q Consensus 330 DFGlA~~i~~~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~ 406 (774)
|||++..+.... .......+++.|+|||++.+..++.++|||||||++|+|++ |.+||...........+.....
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-- 267 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR-- 267 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC--
Confidence 999997664332 11223467889999999999999999999999999999999 8999988776655544433322
Q ss_pred cccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 407 LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 407 ~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
...+..++..+.+||.+||..||.+|||+.+++++
T Consensus 268 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 268 LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22345678899999999999999999999999976
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=387.30 Aligned_cols=256 Identities=17% Similarity=0.217 Sum_probs=203.0
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCC-----CcEEEEEEeecCCChh----------hHHHHHHHHHHHHhCCCCCc
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKT-----SELVAIKVISLSEGEE----------GYEEIRGEIEMLQQCSHPNV 248 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~-----g~~VAVKvi~~~~~~~----------~~~~~~~Ei~iL~~L~HPNI 248 (774)
....++|++++.||+|+||.||+|.+..+ ++.||||++....... ....+..|+..++.++||||
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 44567999999999999999999998664 5889999987543110 01123456667777889999
Q ss_pred ccccccccCC----ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEec--C
Q 004088 249 VRYLGSYQGE----EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLT--D 322 (774)
Q Consensus 249 VkL~~~~~~~----~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd--~ 322 (774)
+++++++... .+.||||||| +++|.+++......+++..++.|+.||+.||.|||++|||||||||+||||+ .
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 9999998654 5689999999 9999999987667899999999999999999999999999999999999999 8
Q ss_pred CCcEEEeeccccccccccccc-------cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhh
Q 004088 323 QGEVKLGDFGVAAQLTRTMSK-------RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRV 395 (774)
Q Consensus 323 ~g~vKL~DFGlA~~i~~~~~~-------~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~ 395 (774)
++.+||+|||+++.+...... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||........
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 899999999999776443211 1344699999999999999999999999999999999999999985332221
Q ss_pred hhh-hhcC---CCCccc----cchhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 396 LFM-ISIE---PAPMLE----DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 396 i~~-i~~~---~~~~~~----~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
... .... ..+... ....++..+.+||..||..||.+||++.+|++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 111 1000 000000 01345788999999999999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=368.17 Aligned_cols=245 Identities=27% Similarity=0.478 Sum_probs=208.5
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccC----------
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG---------- 257 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~---------- 257 (774)
.+|++++.||+|+||.||+|++..+++.||||++.... +.+.+|+++|++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 57999999999999999999999899999999997543 346789999999999999999998854
Q ss_pred ------CceEEEEEEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEee
Q 004088 258 ------EEYLWIVMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGD 330 (774)
Q Consensus 258 ------~~~l~LVmEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~D 330 (774)
...+|+|||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D 165 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGD 165 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECc
Confidence 45689999999999999998643 35799999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccc
Q 004088 331 FGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDK 410 (774)
Q Consensus 331 FGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~ 410 (774)
||++..+.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....+.... ..
T Consensus 166 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--~~~~~~~~~-----~~ 237 (284)
T 2a19_B 166 FGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK--FFTDLRDGI-----IS 237 (284)
T ss_dssp CTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH--HHHHHHTTC-----CC
T ss_pred chhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH--HHHHhhccc-----cc
Confidence 99997765432 23445799999999999998999999999999999999999988753211 111111111 12
Q ss_pred hhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhh
Q 004088 411 EKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445 (774)
Q Consensus 411 ~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~ 445 (774)
..++..+.+||.+||..||.+|||+.++++|.|.-
T Consensus 238 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 35678899999999999999999999999998764
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=378.00 Aligned_cols=254 Identities=29% Similarity=0.398 Sum_probs=203.9
Q ss_pred ccCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh-----hhHHHHHHHHHHHHhC----CCCCccccc
Q 004088 182 TREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE-----EGYEEIRGEIEMLQQC----SHPNVVRYL 252 (774)
Q Consensus 182 ~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~-----~~~~~~~~Ei~iL~~L----~HPNIVkL~ 252 (774)
..+...++|++++.||+|+||.||+|++..+++.||||++...... .....+.+|+.+++++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3445578899999999999999999999999999999998654321 1223456799999998 899999999
Q ss_pred ccccCCceEEEEEEe-cCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEec-CCCcEEEee
Q 004088 253 GSYQGEEYLWIVMEY-CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLT-DQGEVKLGD 330 (774)
Q Consensus 253 ~~~~~~~~l~LVmEy-~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd-~~g~vKL~D 330 (774)
+++...+..++|||| +.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEE
Confidence 999999999999999 789999999864 45799999999999999999999999999999999999999 789999999
Q ss_pred ccccccccccccccccccccccccchhhhhhcCCC-CccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCcccc
Q 004088 331 FGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYD-GKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLED 409 (774)
Q Consensus 331 FGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s-~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~ 409 (774)
||++..+... ......||+.|+|||++.+..+. .++|||||||++|+|++|+.||....... . .. ...
T Consensus 184 fg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~---~~---~~~ 252 (312)
T 2iwi_A 184 FGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL---E---AE---LHF 252 (312)
T ss_dssp CSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH---H---TC---CCC
T ss_pred cchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh---h---hc---cCC
Confidence 9999776543 23455799999999999877765 48999999999999999999997532211 1 11 112
Q ss_pred chhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 410 KEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 410 ~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
...++..+.+||.+||+.||.+|||+.++++||||+..
T Consensus 253 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 253 PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 34567889999999999999999999999999999754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=367.89 Aligned_cols=250 Identities=20% Similarity=0.294 Sum_probs=207.5
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccc-cCCceEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSY-QGEEYLWIVM 265 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~-~~~~~l~LVm 265 (774)
.++|++++.||+|+||.||+|++..+|+.||||++..... .+.+.+|+.+++.+.|++++..+.++ ......|+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 5789999999999999999999999999999999865432 24588999999999998877666554 6778899999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEe---cCCCcEEEeecccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL---TDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILL---d~~g~vKL~DFGlA~~i~~~~~ 342 (774)
||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+.....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 999 899999997667789999999999999999999999999999999999999 4788999999999987654322
Q ss_pred -------ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchh---hhhhhhc--CCCCccccc
Q 004088 343 -------KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMR---VLFMISI--EPAPMLEDK 410 (774)
Q Consensus 343 -------~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~---~i~~i~~--~~~~~~~~~ 410 (774)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+.. ...+.....
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 243 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHH
Confidence 1245579999999999999999999999999999999999999998643321 1111111 111111122
Q ss_pred hhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 411 EKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 411 ~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
..++..+.+||.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp TTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 456888999999999999999999999976
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=379.83 Aligned_cols=251 Identities=25% Similarity=0.410 Sum_probs=201.7
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCC----ce
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE----EY 260 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~----~~ 260 (774)
...++|++++.||+|+||+||+|++. ++.||||++.... .......+|+.+|++++||||+++++++... ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 34578999999999999999999864 7899999986432 3334566799999999999999999998763 45
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhc----------CcccccccccceEecCCCcEEEee
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI----------FKVHRDIKGGNILLTDQGEVKLGD 330 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~----------gIIHRDLKPeNILLd~~g~vKL~D 330 (774)
+|+|||||++++|.++++. ..+++..++.++.||+.||.|||++ |||||||||+|||++.++.+||+|
T Consensus 97 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 8999999999999999864 4599999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccc--ccccccccccccchhhhhh-----cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhh-------
Q 004088 331 FGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQE-----SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVL------- 396 (774)
Q Consensus 331 FGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~-----~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i------- 396 (774)
||+++.+..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.........
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 999977654322 2234579999999999986 35667899999999999999999999764322111
Q ss_pred --------h-hhh-cCCCCccc---cchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 397 --------F-MIS-IEPAPMLE---DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 397 --------~-~i~-~~~~~~~~---~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
. .+. ....+... .....+..+.+||.+||+.||.+|||+.++++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 000 01111111 112234569999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=368.16 Aligned_cols=248 Identities=28% Similarity=0.451 Sum_probs=199.4
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHh--CCCCCccccccccc----CCc
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQ--CSHPNVVRYLGSYQ----GEE 259 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~--L~HPNIVkL~~~~~----~~~ 259 (774)
..++|++++.||+|+||+||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 457899999999999999999986 6899999998542 33556677777777 79999999999854 346
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHH--------hcCcccccccccceEecCCCcEEEeec
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLH--------SIFKVHRDIKGGNILLTDQGEVKLGDF 331 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLH--------s~gIIHRDLKPeNILLd~~g~vKL~DF 331 (774)
.+|+|||||++++|.++++ ...+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+||
T Consensus 80 ~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred eeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 7999999999999999985 357999999999999999999999 999999999999999999999999999
Q ss_pred cccccccccccc----cccccccccccchhhhhhc------CCCCccchhhhHHHHHHHHhC----------CCCCCCCC
Q 004088 332 GVAAQLTRTMSK----RNTFIGTPHWMAPEVIQES------RYDGKVDVWALGVSAVEMAEG----------LPPRSTVH 391 (774)
Q Consensus 332 GlA~~i~~~~~~----~~~~~GT~~Y~APEvl~~~------~~s~ksDIWSLGviLyELLtG----------~~Pf~~~~ 391 (774)
|+|+........ ....+||+.|+|||++.+. .++.++|||||||++|+|++| .+||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 999765443222 2334799999999999876 455799999999999999999 88886543
Q ss_pred chh----hhhhhh-c-CCCCccc---cchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 392 PMR----VLFMIS-I-EPAPMLE---DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 392 ~~~----~i~~i~-~-~~~~~~~---~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
... ...... . ...+... .....+..+.+||.+||+.||.+|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 221 111111 1 1111111 123456789999999999999999999999864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=377.43 Aligned_cols=255 Identities=26% Similarity=0.430 Sum_probs=213.0
Q ss_pred CCCCCeeEEeeeeccCceEEEEEE----EcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCccccccccc--CC
Q 004088 185 DPTTKYELLNELGKGSYGAVYKAR----DLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ--GE 258 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~----d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~--~~ 258 (774)
....+|++++.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.+|++++||||+++++++. +.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 345789999999999999999998 4678999999998643 3455677899999999999999999999875 56
Q ss_pred ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 259 EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
..+|+|||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 77999999999999999998666779999999999999999999999999999999999999999999999999998664
Q ss_pred cccc---ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhh--------------hhhhc
Q 004088 339 RTMS---KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVL--------------FMISI 401 (774)
Q Consensus 339 ~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i--------------~~i~~ 401 (774)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ....
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 257 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL- 257 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH-
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh-
Confidence 3322 223346889999999999989999999999999999999999998654322110 0000
Q ss_pred CCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 402 EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 402 ~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
........+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1111122345678899999999999999999999999876
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=398.96 Aligned_cols=255 Identities=25% Similarity=0.416 Sum_probs=220.3
Q ss_pred ccCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 182 TREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 182 ~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
.++....+|++.++||+|+||.||+|.+..++..||||++.... ...+.+.+|+.+|++++||||++++++|.....+
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 35566778999999999999999999999889999999986433 3457899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
|||||||.+|+|.++++.. ...+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+...
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 9999999999999999753 356899999999999999999999999999999999999999999999999999876432
Q ss_pred c-cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 341 M-SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 341 ~-~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
. .......+|+.|+|||++....++.++|||||||++|||++ |..||...........+..... ...+..++..+.
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~ 449 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--MERPEGCPEKVY 449 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--CCCCTTCCHHHH
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHH
Confidence 2 11223456789999999999999999999999999999998 9999998776665544433222 233456788999
Q ss_pred HHHHhhcccCCCCCCCHHHHHh
Q 004088 419 DFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
+||.+||+.||.+|||+.+|++
T Consensus 450 ~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 450 ELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCcChhHCcCHHHHHH
Confidence 9999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=385.37 Aligned_cols=253 Identities=23% Similarity=0.372 Sum_probs=205.1
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCC---CcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccc-cCCceEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKT---SELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSY-QGEEYLW 262 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~---g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~-~~~~~l~ 262 (774)
...|++.+.||+|+||.||+|++..+ +..||||++.........+.+.+|+.+|++++||||+++++++ ..+...|
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 34689999999999999999987543 2468999987655556678899999999999999999999986 4566889
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
+|||||++++|.+++......+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+.....
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 99999999999999987677799999999999999999999999999999999999999999999999999986543211
Q ss_pred ----ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHH
Q 004088 343 ----KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVF 417 (774)
Q Consensus 343 ----~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l 417 (774)
......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...........+..... ...+..++..+
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~--~~~p~~~~~~l 325 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR--LLQPEYCPDPL 325 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC--CCCCTTCCHHH
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHH
Confidence 1223467889999999999999999999999999999999 7888887665555444333222 22345678899
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhh
Q 004088 418 HDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 418 ~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.++|.+||..||.+|||+.+++++
T Consensus 326 ~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 326 YEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=366.71 Aligned_cols=256 Identities=24% Similarity=0.374 Sum_probs=207.4
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcC-CCc--EEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCC
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLK-TSE--LVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE 258 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~-~g~--~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~ 258 (774)
....++|++++.||+|+||.||+|++.. +++ .||||++.... .....+.+.+|+.+|++++||||+++++++...
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 3456789999999999999999998643 333 68999986542 334567889999999999999999999999876
Q ss_pred ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 259 EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
. .++||||+.+++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 5 889999999999999998666789999999999999999999999999999999999999999999999999997764
Q ss_pred cccc---ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhch
Q 004088 339 RTMS---KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWS 414 (774)
Q Consensus 339 ~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s 414 (774)
.... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+..... .......++
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 251 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE-RLPRPEDCP 251 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC-CCCCCTTCC
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC-CCCCCcCcC
Confidence 4322 1223467889999999998889999999999999999999 9999998877666555443322 223345678
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 415 LVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 415 ~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
..+.++|.+||..||.+|||+.+++++
T Consensus 252 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 252 QDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 899999999999999999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=391.50 Aligned_cols=248 Identities=25% Similarity=0.398 Sum_probs=211.5
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCc-eE
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE-YL 261 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~-~l 261 (774)
++...++|++++.||+|+||.||+|.+. |+.||||+++... ..+.+.+|+.+|++++||||+++++++.... .+
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence 4566789999999999999999999864 7899999996432 4567899999999999999999999976554 89
Q ss_pred EEEEEecCCCchhhhhhccCC-chhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEE-PLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~-~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
|||||||++|+|.++++.... .+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.....
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 999999999999999975543 4799999999999999999999999999999999999999999999999999754332
Q ss_pred ccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHH
Q 004088 341 MSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHD 419 (774)
Q Consensus 341 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~d 419 (774)
.....+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+..... ...+..++..+.+
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~ 417 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--MDAPDGCPPAVYD 417 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC--CCCCTTCCHHHHH
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCcCCHHHHH
Confidence 223367899999999999999999999999999999998 9999988776666555443322 2334567899999
Q ss_pred HHHhhcccCCCCCCCHHHHHh
Q 004088 420 FVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 420 LI~kcL~~DP~kRPTa~ElL~ 440 (774)
||.+||..||.+|||+.++++
T Consensus 418 li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 418 VMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=361.73 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=213.0
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
++...++|++++.||+|+||.||+|.+. +++.||||++.... ...+.+.+|+++|++++||||+++++++.. +..|
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 83 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcE
Confidence 4556689999999999999999999964 67789999986433 335678999999999999999999999874 4589
Q ss_pred EEEEecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 9999999999999986432 368999999999999999999999999999999999999999999999999997765432
Q ss_pred c-ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHH
Q 004088 342 S-KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHD 419 (774)
Q Consensus 342 ~-~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~d 419 (774)
. ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+...... ..+..++..+.+
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~ 241 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM--VRPDNCPEELYQ 241 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--CCCTTCCHHHHH
T ss_pred cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC--CCcccccHHHHH
Confidence 1 1223457889999999998889999999999999999999 99999887766655544333222 234567889999
Q ss_pred HHHhhcccCCCCCCCHHHHHh
Q 004088 420 FVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 420 LI~kcL~~DP~kRPTa~ElL~ 440 (774)
||.+||..||.+|||+.++++
T Consensus 242 li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 242 LMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccChhhCCCHHHHHH
Confidence 999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=365.40 Aligned_cols=252 Identities=25% Similarity=0.357 Sum_probs=211.0
Q ss_pred CCCCCeeEEe-eeeccCceEEEEEEE--cCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccCCce
Q 004088 185 DPTTKYELLN-ELGKGSYGAVYKARD--LKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEY 260 (774)
Q Consensus 185 ~~~~~Y~ilk-~LG~G~FG~Vy~a~d--~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~ 260 (774)
....+|++.+ .||+|+||.||+|.+ ..+++.||||++..... ....+.+.+|+.+|++++||||+++++++ ....
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 3457899998 999999999999954 56688999999975432 33467799999999999999999999999 5667
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
.|+||||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 92 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp EEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred cEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 8999999999999999964 456999999999999999999999999999999999999999999999999999766443
Q ss_pred ccc---cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHH
Q 004088 341 MSK---RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLV 416 (774)
Q Consensus 341 ~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~ 416 (774)
... .....||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.....+ ..+..++..
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 248 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--GCPAGCPRE 248 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--CCCTTCCHH
T ss_pred CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHH
Confidence 221 122356789999999998889999999999999999999 99999987776655554433222 234567889
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHh
Q 004088 417 FHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 417 l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
+.++|.+||+.||.+||++.++++
T Consensus 249 l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 249 MYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=393.51 Aligned_cols=253 Identities=23% Similarity=0.384 Sum_probs=216.0
Q ss_pred ccCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 182 TREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 182 ~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
.++...++|++.+.||+|+||.||+|.+. ++..||||+++... ...+.+.+|+.+|++++||||+++++++. ...+
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 45667789999999999999999999974 57789999996433 34678999999999999999999999986 5678
Q ss_pred EEEEEecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
|||||||.+|+|.++++... ..+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+...
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 99999999999999997433 36888999999999999999999999999999999999999999999999999876432
Q ss_pred c-cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 341 M-SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 341 ~-~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
. .......+|+.|+|||++....++.++|||||||++|||++ |+.||...........+..... ...+..++..+.
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~ 415 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR--MPRPENCPEELY 415 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC--CCCCTTSCHHHH
T ss_pred ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHH
Confidence 1 11223356889999999999999999999999999999999 9999998877766655443322 223456788999
Q ss_pred HHHHhhcccCCCCCCCHHHHHh
Q 004088 419 DFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
+||.+||..||.+|||+.+|++
T Consensus 416 ~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 416 NIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHHH
Confidence 9999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=394.98 Aligned_cols=255 Identities=24% Similarity=0.395 Sum_probs=202.1
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~LV 264 (774)
...+|.+.+.||+|+||+||.. ...+++.||||++..... ..+.+|+.+|+.+ +|||||++++++.+...+|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 4457999999999999997643 357899999999864322 2356899999999 799999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC-----CcEEEeeccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ-----GEVKLGDFGVAAQLTR 339 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~-----g~vKL~DFGlA~~i~~ 339 (774)
||||. ++|.+++......+.+..+..++.||+.||.|||++|||||||||+||||+.+ ..+||+|||+|+.+..
T Consensus 97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 99995 69999987666566677788999999999999999999999999999999532 2588999999987653
Q ss_pred cc---cccccccccccccchhhhh---hcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchh
Q 004088 340 TM---SKRNTFIGTPHWMAPEVIQ---ESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEK 412 (774)
Q Consensus 340 ~~---~~~~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~ 412 (774)
.. ......+||+.|+|||++. ...++.++|||||||++|+|++ |.+||.........................
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCH
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcccc
Confidence 32 2234567999999999997 4567889999999999999999 999997655444333322222222233344
Q ss_pred chHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 413 WSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 413 ~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
.+..+.+||.+||+.||.+|||+.++|+||||..
T Consensus 256 ~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred ccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 5677899999999999999999999999999964
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=378.57 Aligned_cols=256 Identities=18% Similarity=0.211 Sum_probs=201.3
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcC---CCcEEEEEEeecCCChh----------hHHHHHHHHHHHHhCCCCCccc
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLK---TSELVAIKVISLSEGEE----------GYEEIRGEIEMLQQCSHPNVVR 250 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~---~g~~VAVKvi~~~~~~~----------~~~~~~~Ei~iL~~L~HPNIVk 250 (774)
....++|++++.||+|+||.||+|++.. ++..||||++....... ....+.+|+.+++.++||||++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 3456789999999999999999999987 78899999987543221 1234668889999999999999
Q ss_pred ccccccC----CceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC--
Q 004088 251 YLGSYQG----EEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG-- 324 (774)
Q Consensus 251 L~~~~~~----~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g-- 324 (774)
+++++.. ...+||||||| +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence 9999876 78999999999 99999998644 3899999999999999999999999999999999999999887
Q ss_pred cEEEeecccccccccccc-------ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCc-hhhh
Q 004088 325 EVKLGDFGVAAQLTRTMS-------KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHP-MRVL 396 (774)
Q Consensus 325 ~vKL~DFGlA~~i~~~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~-~~~i 396 (774)
.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 999999999977643221 12345799999999999998999999999999999999999999964221 1111
Q ss_pred hhhh---cCCCCccc----cchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 397 FMIS---IEPAPMLE----DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 397 ~~i~---~~~~~~~~----~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.... ....+... ....++..+.+||.+||..||.+||++.+|++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 1110 00111100 011567889999999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=368.47 Aligned_cols=244 Identities=29% Similarity=0.484 Sum_probs=198.2
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
..++|++.+.||+|+||.||+|++ .++.||||++.. ....+.+.+|+.+|++++||||+++++++.+ ..|+||
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~ 78 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 78 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSS---TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecC---hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence 456899999999999999999986 478899999853 2345678999999999999999999999874 478999
Q ss_pred EecCCCchhhhhhccCC--chhHHHHHHHHHHHHHHHHHHHh---cCcccccccccceEecCCCc-EEEeeccccccccc
Q 004088 266 EYCGGGSVADLMNVTEE--PLEEYQIAYICREALKGLAYLHS---IFKVHRDIKGGNILLTDQGE-VKLGDFGVAAQLTR 339 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~--~Lse~~i~~I~~QIl~gL~YLHs---~gIIHRDLKPeNILLd~~g~-vKL~DFGlA~~i~~ 339 (774)
|||++++|.+++..... .+++..+..++.||+.||.|||+ +||+||||||+|||++.++. +||+|||++..+..
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 99999999999974432 47889999999999999999999 89999999999999998886 79999999976543
Q ss_pred cccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchh--hhhhhhcCCCCccccchhchHHH
Q 004088 340 TMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMR--VLFMISIEPAPMLEDKEKWSLVF 417 (774)
Q Consensus 340 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~--~i~~i~~~~~~~~~~~~~~s~~l 417 (774)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+..... ......++..+
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l 233 (307)
T 2eva_A 159 H---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR--PPLIKNLPKPI 233 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC--CCCBTTCCHHH
T ss_pred c---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC--CCcccccCHHH
Confidence 2 233469999999999999899999999999999999999999998643322 2112222211 22345678899
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhh
Q 004088 418 HDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 418 ~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.+||.+||+.||.+|||+.+++++
T Consensus 234 ~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 234 ESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=377.86 Aligned_cols=249 Identities=14% Similarity=0.163 Sum_probs=202.7
Q ss_pred CCCCCCeeEEeeeeccCceEEEEE-----EEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC---CCCcccccccc
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKA-----RDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS---HPNVVRYLGSY 255 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a-----~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~---HPNIVkL~~~~ 255 (774)
.....+|++.+.||+|+||+||+| .+..+++.||||++... ....+.+|+.+++++. |+||+++++++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 445678999999999999999999 46778999999998643 2356788899988887 89999999999
Q ss_pred cCCceEEEEEEecCCCchhhhhhc----cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC---------
Q 004088 256 QGEEYLWIVMEYCGGGSVADLMNV----TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD--------- 322 (774)
Q Consensus 256 ~~~~~l~LVmEy~~ggsL~dll~~----~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~--------- 322 (774)
...+..|||||||++|+|.+++.. ....+++..++.|+.||+.||.|||++|||||||||+||||+.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence 999999999999999999999864 3467999999999999999999999999999999999999998
Q ss_pred --CCcEEEeecccccccccc--ccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhh
Q 004088 323 --QGEVKLGDFGVAAQLTRT--MSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFM 398 (774)
Q Consensus 323 --~g~vKL~DFGlA~~i~~~--~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~ 398 (774)
++.+||+|||+|+.+... .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.........
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-- 294 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-- 294 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--
Confidence 899999999999765422 22334568999999999999999999999999999999999999998643322111
Q ss_pred hhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhh
Q 004088 399 ISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKF 443 (774)
Q Consensus 399 i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPw 443 (774)
+. ... .....+..+.+++..||+.+|.+|++..+.|.+.+
T Consensus 295 ~~-~~~----~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 295 PE-GLF----RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp EC-SCC----TTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred ec-hhc----cccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence 10 000 01123567889999999999999976555555543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=370.53 Aligned_cols=253 Identities=25% Similarity=0.394 Sum_probs=191.6
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-CCCcccccccc-------
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPNVVRYLGSY------- 255 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~------- 255 (774)
+....+|++.+.||+|+||.||+|++..+++.||||++... .......+.+|+.+|+++. ||||+++++++
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 34456899999999999999999999999999999998643 3455677899999999996 99999999988
Q ss_pred -cCCceEEEEEEecCCCchhhhhhc--cCCchhHHHHHHHHHHHHHHHHHHHhcC--cccccccccceEecCCCcEEEee
Q 004088 256 -QGEEYLWIVMEYCGGGSVADLMNV--TEEPLEEYQIAYICREALKGLAYLHSIF--KVHRDIKGGNILLTDQGEVKLGD 330 (774)
Q Consensus 256 -~~~~~l~LVmEy~~ggsL~dll~~--~~~~Lse~~i~~I~~QIl~gL~YLHs~g--IIHRDLKPeNILLd~~g~vKL~D 330 (774)
.....+|+|||||. |+|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEec
Confidence 45667999999995 688888753 3457999999999999999999999999 99999999999999999999999
Q ss_pred ccccccccccccc------------cccccccccccchhhh---hhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhh
Q 004088 331 FGVAAQLTRTMSK------------RNTFIGTPHWMAPEVI---QESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRV 395 (774)
Q Consensus 331 FGlA~~i~~~~~~------------~~~~~GT~~Y~APEvl---~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~ 395 (774)
||++..+...... ....+||+.|+|||++ .+..++.++|||||||++|+|++|..||........
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 9999766443211 1144699999999998 566789999999999999999999999976554433
Q ss_pred hhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhh
Q 004088 396 LFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKF 443 (774)
Q Consensus 396 i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPw 443 (774)
...... .......+..+.+||.+||+.||.+|||+.++++|-+
T Consensus 262 ~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 262 VNGKYS-----IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ----CC-----CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hcCccc-----CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 222111 1122344566889999999999999999999998843
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=361.25 Aligned_cols=248 Identities=23% Similarity=0.393 Sum_probs=202.7
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCccccccccc-CCceEE
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ-GEEYLW 262 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~-~~~~l~ 262 (774)
....++|++++.||+|+||.||+|++ +|+.||||++... ...+.+.+|+.+|++++||||+++++++. ....+|
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 91 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch---hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceE
Confidence 34567899999999999999999986 4889999998643 24567899999999999999999999865 445799
Q ss_pred EEEEecCCCchhhhhhccCC-chhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEE-PLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~-~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
+||||+++++|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 99999999999999864432 3789999999999999999999999999999999999999999999999999765433
Q ss_pred cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
.....+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+..... ......++..+.++
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l 246 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--MDAPDGCPPAVYEV 246 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC--CCCCTTCCHHHHHH
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--CCCcccCCHHHHHH
Confidence 223467899999999999999999999999999999998 9999988766555544433222 22345678899999
Q ss_pred HHhhcccCCCCCCCHHHHHhh
Q 004088 421 VAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~H 441 (774)
|.+||..||.+||++.++++.
T Consensus 247 i~~~l~~~p~~Rps~~~l~~~ 267 (278)
T 1byg_A 247 MKNCWHLDAAMRPSFLQLREQ 267 (278)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCChhhCCCHHHHHHH
Confidence 999999999999999999863
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=371.12 Aligned_cols=250 Identities=26% Similarity=0.445 Sum_probs=206.8
Q ss_pred CCCe-eEEeeeeccCceEEEEEEE----cCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccC--Cc
Q 004088 187 TTKY-ELLNELGKGSYGAVYKARD----LKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG--EE 259 (774)
Q Consensus 187 ~~~Y-~ilk~LG~G~FG~Vy~a~d----~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~--~~ 259 (774)
..+| +++++||+|+||+||++.. ..+++.||||++.........+.+.+|+.+|++++||||+++++++.. ..
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 3445 9999999999999988754 457899999999866556667789999999999999999999999976 57
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
.+|+|||||++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred eEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 89999999999999999863 3589999999999999999999999999999999999999999999999999987654
Q ss_pred ccc---ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchh---------------hhhhhhc
Q 004088 340 TMS---KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMR---------------VLFMISI 401 (774)
Q Consensus 340 ~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~---------------~i~~i~~ 401 (774)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+.
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 265 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE- 265 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH-
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh-
Confidence 321 1234468899999999999899999999999999999999999987532210 001111
Q ss_pred CCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 402 EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 402 ~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
..........++..+.+||.+||+.||.+|||+.++++
T Consensus 266 -~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 266 -RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11122334567889999999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=401.69 Aligned_cols=252 Identities=26% Similarity=0.407 Sum_probs=211.8
Q ss_pred CCCCeeEEe-eeeccCceEEEEEEEc--CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 186 PTTKYELLN-ELGKGSYGAVYKARDL--KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 186 ~~~~Y~ilk-~LG~G~FG~Vy~a~d~--~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
...+|.+.+ +||+|+||.||+|.+. .++..||||+++........+.+.+|+++|++++|||||++++++.. +.+|
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 445667777 8999999999999875 35677999999765555567889999999999999999999999976 5699
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
||||||.+|+|.+++......+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+.....
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 99999999999999976667899999999999999999999999999999999999999999999999999987643321
Q ss_pred c---cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 343 K---RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 343 ~---~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
. .....+|+.|+|||++....++.++|||||||++|||++ |+.||......+....+..... ...+..++..+.
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~ 569 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR--MECPPECPPELY 569 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC--CCCCTTCCHHHH
T ss_pred eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC--CCCCCcCCHHHH
Confidence 1 122346789999999999999999999999999999998 9999998887776665544322 233456789999
Q ss_pred HHHHhhcccCCCCCCCHHHHHh
Q 004088 419 DFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
+||.+||..||.+||++.+|++
T Consensus 570 ~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 570 ALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=386.94 Aligned_cols=255 Identities=26% Similarity=0.384 Sum_probs=196.6
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~LV 264 (774)
..+.|.+.+.||+|+||+||.+. ..+|+.||||++... ..+.+.+|+.+|+++ +|||||++++++.....+|||
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred hhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 34567788999999999998764 568999999998642 235678999999876 899999999999999999999
Q ss_pred EEecCCCchhhhhhccCCc------hhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC-------------Cc
Q 004088 265 MEYCGGGSVADLMNVTEEP------LEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ-------------GE 325 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~------Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~-------------g~ 325 (774)
||||+ |+|.+++...... .++..++.++.||+.||.|||++|||||||||+||||+.+ +.
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 99995 6999998643221 1334567899999999999999999999999999999754 47
Q ss_pred EEEeeccccccccccccc----cccccccccccchhhhhh-------cCCCCccchhhhHHHHHHHHh-CCCCCCCCCch
Q 004088 326 VKLGDFGVAAQLTRTMSK----RNTFIGTPHWMAPEVIQE-------SRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPM 393 (774)
Q Consensus 326 vKL~DFGlA~~i~~~~~~----~~~~~GT~~Y~APEvl~~-------~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~ 393 (774)
+||+|||+++.+...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 999999999876543221 234579999999999975 568999999999999999998 99999765433
Q ss_pred hhhhhhhcC--CCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 394 RVLFMISIE--PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 394 ~~i~~i~~~--~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
......... ..........++..+.+||.+||+.||.+|||+.++|+||||..
T Consensus 247 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred HHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 221111111 11111123456788999999999999999999999999999953
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=359.37 Aligned_cols=237 Identities=27% Similarity=0.408 Sum_probs=193.6
Q ss_pred CCCCCeeEE-eeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHH-HhCCCCCcccccccccC----C
Q 004088 185 DPTTKYELL-NELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEML-QQCSHPNVVRYLGSYQG----E 258 (774)
Q Consensus 185 ~~~~~Y~il-k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL-~~L~HPNIVkL~~~~~~----~ 258 (774)
...++|.++ +.||+|+||.||+|.+..+++.||||++.. ...+.+|+.++ +.++||||++++++|.. .
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 345678888 789999999999999999999999999863 24567899888 66699999999999876 7
Q ss_pred ceEEEEEEecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC---CCcEEEeecccc
Q 004088 259 EYLWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD---QGEVKLGDFGVA 334 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~---~g~vKL~DFGlA 334 (774)
..+|||||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 78999999999999999987543 47999999999999999999999999999999999999998 788999999998
Q ss_pred ccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc----CC-CCcccc
Q 004088 335 AQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI----EP-APMLED 409 (774)
Q Consensus 335 ~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~----~~-~~~~~~ 409 (774)
.... +..++.++|||||||++|+|++|.+||.............. .. ......
T Consensus 168 ~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (299)
T 3m2w_A 168 KETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225 (299)
T ss_dssp EECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred cccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence 6432 13477899999999999999999999976654332211111 11 111112
Q ss_pred chhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 410 KEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 410 ~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
...++..+.+||.+||+.||.+|||+.++|+||||.....
T Consensus 226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred cccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 2457889999999999999999999999999999987653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=388.40 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=210.5
Q ss_pred ccCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 182 TREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 182 ~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
.++...++|++.++||+|+||.||+|.+.. +..||||+++... ...+.+.+|+.+|++++||||+++++++.. ..+
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 356677899999999999999999999764 5679999986433 234678999999999999999999999876 678
Q ss_pred EEEEEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
|||||||.+|+|.+++... ...+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.+...
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 9999999999999999743 356899999999999999999999999999999999999999999999999999866432
Q ss_pred c-cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 341 M-SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 341 ~-~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
. .......+|+.|+|||++....++.++|||||||++|||++ |..||......+....+..... ...+..++..+.
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~ 411 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--MPCPPECPESLH 411 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--CCCCTTSCHHHH
T ss_pred ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHH
Confidence 2 11223457889999999999999999999999999999999 9999998877666555443322 223456788999
Q ss_pred HHHHhhcccCCCCCCCHHHHHh
Q 004088 419 DFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
+||.+||+.||.+|||+.++++
T Consensus 412 ~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 412 DLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=361.42 Aligned_cols=250 Identities=28% Similarity=0.440 Sum_probs=205.3
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC---ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE---GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~---~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
.|...+.||+|+||.||+|.+ +++.||||++.... .....+.+.+|+.+|++++||||+++++++......|+||
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence 455668999999999999984 68899999986432 2344677899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcc--CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 266 EYCGGGSVADLMNVT--EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 266 Ey~~ggsL~dll~~~--~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence 999999999988633 346999999999999999999999999999999999999999999999999999765432211
Q ss_pred --cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhh----cC--------CCCcccc
Q 004088 344 --RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMIS----IE--------PAPMLED 409 (774)
Q Consensus 344 --~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~----~~--------~~~~~~~ 409 (774)
.....||+.|+|||++.+ .++.++|||||||++|+|++|.+||...........+. .. .......
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 234579999999999876 48999999999999999999999998755433222111 00 0011112
Q ss_pred chhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 410 KEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 410 ~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
....+..+.++|.+||+.||.+|||+.+++++
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 34456789999999999999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=373.93 Aligned_cols=250 Identities=16% Similarity=0.275 Sum_probs=202.9
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcC--------CCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccc-----
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLK--------TSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRY----- 251 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~--------~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL----- 251 (774)
...++|++.+.||+|+||.||+|++.. .++.||||++... ..+.+|+.+|++++||||+++
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 345799999999999999999999887 4889999998743 357899999999999999984
Q ss_pred ----------cccccC-CceEEEEEEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceE
Q 004088 252 ----------LGSYQG-EEYLWIVMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNIL 319 (774)
Q Consensus 252 ----------~~~~~~-~~~l~LVmEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNIL 319 (774)
++++.. ...+||||||| +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 444443 78899999999 99999999754 367999999999999999999999999999999999999
Q ss_pred ecCCC--cEEEeecccccccccccc-------ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCC
Q 004088 320 LTDQG--EVKLGDFGVAAQLTRTMS-------KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTV 390 (774)
Q Consensus 320 Ld~~g--~vKL~DFGlA~~i~~~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~ 390 (774)
++.++ .+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 899999999976654321 123457999999999999989999999999999999999999999865
Q ss_pred C-chhhhhh-h---hcCCCCccc---cchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 391 H-PMRVLFM-I---SIEPAPMLE---DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 391 ~-~~~~i~~-i---~~~~~~~~~---~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
. ....+.. . ......... ....++..+.+||.+||..||.+||++.++++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 4 2221111 1 111111111 113457899999999999999999999999863
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=368.89 Aligned_cols=249 Identities=25% Similarity=0.393 Sum_probs=191.6
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHH--HHhCCCCCcccccccc-----c
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEM--LQQCSHPNVVRYLGSY-----Q 256 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~i--L~~L~HPNIVkL~~~~-----~ 256 (774)
....++|++++.||+|+||.||+|++ +++.||||++.... ...+..|..+ +..++||||+++++++ .
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 34568999999999999999999975 68999999996432 2334444444 4558999999999743 4
Q ss_pred CCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhc---------CcccccccccceEecCCCcEE
Q 004088 257 GEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI---------FKVHRDIKGGNILLTDQGEVK 327 (774)
Q Consensus 257 ~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~---------gIIHRDLKPeNILLd~~g~vK 327 (774)
....+|||||||++++|.+++.. ..+++..+..++.||+.||.|||++ |||||||||+||||+.++.+|
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred CCceEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 55678999999999999999864 3458889999999999999999999 999999999999999999999
Q ss_pred Eeeccccccccccc--------cccccccccccccchhhhhh-------cCCCCccchhhhHHHHHHHHhCCCCCCCCCc
Q 004088 328 LGDFGVAAQLTRTM--------SKRNTFIGTPHWMAPEVIQE-------SRYDGKVDVWALGVSAVEMAEGLPPRSTVHP 392 (774)
Q Consensus 328 L~DFGlA~~i~~~~--------~~~~~~~GT~~Y~APEvl~~-------~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~ 392 (774)
|+|||+++.+.... ......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999997664321 11224579999999999986 4577899999999999999999766543222
Q ss_pred hhhhh-----------------hhh--cCCCC----ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 393 MRVLF-----------------MIS--IEPAP----MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 393 ~~~i~-----------------~i~--~~~~~----~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
..... ... ....+ ........+..+.+||.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 11100 000 00001 11112234567999999999999999999999965
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=363.27 Aligned_cols=249 Identities=24% Similarity=0.416 Sum_probs=196.9
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC--CCCCcccccccccCC----
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC--SHPNVVRYLGSYQGE---- 258 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L--~HPNIVkL~~~~~~~---- 258 (774)
...++|++++.||+|+||.||+|++. ++.||||++... ......+|.+++..+ +||||+++++++...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 34568999999999999999999864 899999998632 223445566666554 999999999998766
Q ss_pred ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhc--------CcccccccccceEecCCCcEEEee
Q 004088 259 EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI--------FKVHRDIKGGNILLTDQGEVKLGD 330 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~--------gIIHRDLKPeNILLd~~g~vKL~D 330 (774)
..+|+|||||++++|.++++. ..+++..++.++.||+.||.|||++ |||||||||+||||+.++.+||+|
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred CceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 789999999999999999863 4699999999999999999999999 999999999999999999999999
Q ss_pred ccccccccccccc----cccccccccccchhhhhhcCCCCc------cchhhhHHHHHHHHhC----------CCCCCCC
Q 004088 331 FGVAAQLTRTMSK----RNTFIGTPHWMAPEVIQESRYDGK------VDVWALGVSAVEMAEG----------LPPRSTV 390 (774)
Q Consensus 331 FGlA~~i~~~~~~----~~~~~GT~~Y~APEvl~~~~~s~k------sDIWSLGviLyELLtG----------~~Pf~~~ 390 (774)
||+++.+...... ....+||+.|+|||++.+..+... +|||||||++|||++| ..||...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 9999766443222 124579999999999988776665 9999999999999999 6666543
Q ss_pred Cchhh----hhh-hhc-C---CCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 391 HPMRV----LFM-ISI-E---PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 391 ~~~~~----i~~-i~~-~---~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
..... ... +.. . ..+.......++..+.+||.+||+.||.+|||+.++++|
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 22111 111 111 1 111111123567789999999999999999999999987
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=368.94 Aligned_cols=253 Identities=26% Similarity=0.437 Sum_probs=209.1
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEE----cCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCC--
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARD----LKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE-- 258 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d----~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~-- 258 (774)
....+|++++.||+|+||.||+|+. ..+++.||||++... .....+.+.+|+.+|++++||||+++++++...
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 3456899999999999999999984 568999999998653 345567899999999999999999999988654
Q ss_pred ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 259 EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
..+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 37899999999999999998766779999999999999999999999999999999999999999999999999998765
Q ss_pred ccccc---cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCch----------------hhhhhh
Q 004088 339 RTMSK---RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPM----------------RVLFMI 399 (774)
Q Consensus 339 ~~~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~----------------~~i~~i 399 (774)
..... .....++..|+|||++.+..++.++|||||||++|+|++|..||...... .....+
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 43221 22345788899999999988999999999999999999999987642110 000111
Q ss_pred hcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 400 SIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 400 ~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
... .....+..++..+.+||.+||..||.+|||+.++++
T Consensus 277 ~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 277 KNN--GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HTT--CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hcC--CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111 112234567889999999999999999999999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=382.96 Aligned_cols=250 Identities=16% Similarity=0.105 Sum_probs=201.1
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC--hhhHHHHHHHHHHHHhCCC-CCccccccc--------
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG--EEGYEEIRGEIEMLQQCSH-PNVVRYLGS-------- 254 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~--~~~~~~~~~Ei~iL~~L~H-PNIVkL~~~-------- 254 (774)
....|++.+.||+|+||+||+|++..+|+.||||++..... ....+.+.+|+.+++.+.| +|+..++.+
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 44569999999999999999999999999999999874332 2336779999999999987 332221111
Q ss_pred -------------ccC-----CceEEEEEEecCCCchhhhhh------ccCCchhHHHHHHHHHHHHHHHHHHHhcCccc
Q 004088 255 -------------YQG-----EEYLWIVMEYCGGGSVADLMN------VTEEPLEEYQIAYICREALKGLAYLHSIFKVH 310 (774)
Q Consensus 255 -------------~~~-----~~~l~LVmEy~~ggsL~dll~------~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIH 310 (774)
+.. ...++++|+++ +++|.++++ .....+++..+..++.||+.||.|||++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 111 22467888877 689998884 23456899999999999999999999999999
Q ss_pred ccccccceEecCCCcEEEeeccccccccccccccccccccccccchhhh----------hhcCCCCccchhhhHHHHHHH
Q 004088 311 RDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVI----------QESRYDGKVDVWALGVSAVEM 380 (774)
Q Consensus 311 RDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl----------~~~~~s~ksDIWSLGviLyEL 380 (774)
|||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ ....|+.++|||||||++|+|
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 999999999999999999999999765443 345578 999999999 455688899999999999999
Q ss_pred HhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 381 AEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 381 LtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
++|+.||...........+.. ....++..+.+||.+||+.||.+||++.++|+||||+.+
T Consensus 311 ltg~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 311 WCADLPNTDDAALGGSEWIFR-------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp HHSSCCCCTTGGGSCSGGGGS-------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHCCCCCCCcchhhhHHHHHh-------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 999999987665544333221 123567889999999999999999999999999999864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=377.43 Aligned_cols=245 Identities=21% Similarity=0.304 Sum_probs=198.2
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-------ChhhHHHHHHHHHHHHhCC--------------
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-------GEEGYEEIRGEIEMLQQCS-------------- 244 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-------~~~~~~~~~~Ei~iL~~L~-------------- 244 (774)
..++|++++.||+|+||+||+|++ +|+.||||++.... .....+.+.+|+.+|+.++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 456899999999999999999997 78999999997653 2234577899999999886
Q ss_pred ------------CCCcccccccccC-------------CceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHH
Q 004088 245 ------------HPNVVRYLGSYQG-------------EEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKG 299 (774)
Q Consensus 245 ------------HPNIVkL~~~~~~-------------~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~g 299 (774)
||||++++++|.. ...+|||||||.+|++.+.+. ...+++..++.|+.||+.|
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHHH
Confidence 6777777777765 789999999999997666653 2568999999999999999
Q ss_pred HHHHH-hcCcccccccccceEecCCC--------------------cEEEeeccccccccccccccccccccccccchhh
Q 004088 300 LAYLH-SIFKVHRDIKGGNILLTDQG--------------------EVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEV 358 (774)
Q Consensus 300 L~YLH-s~gIIHRDLKPeNILLd~~g--------------------~vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEv 358 (774)
|.||| ++|||||||||+||||+.++ .+||+|||+|+.+... ..+||+.|+|||+
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGG
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhh
Confidence 99999 99999999999999999987 8999999999866432 3489999999999
Q ss_pred hhhcCCCCccchhhhHHH-HHHHHhCCCCCCCCCchh----hhh-hhhcCCCCccccchhchHHHHHHHHhhcccCCCCC
Q 004088 359 IQESRYDGKVDVWALGVS-AVEMAEGLPPRSTVHPMR----VLF-MISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRAR 432 (774)
Q Consensus 359 l~~~~~s~ksDIWSLGvi-LyELLtG~~Pf~~~~~~~----~i~-~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kR 432 (774)
+.+.. +.++||||||++ .++++.|..||....... .+. ...............++..+.+||.+||++|
T Consensus 249 ~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---- 323 (336)
T 2vuw_A 249 FTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---- 323 (336)
T ss_dssp GCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred hcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence 98765 889999998777 777889999985421101 111 1112222223334567899999999999977
Q ss_pred CCHHHHH-hhhhhh
Q 004088 433 PTAAEML-KHKFIE 445 (774)
Q Consensus 433 PTa~ElL-~HPwf~ 445 (774)
|+.|+| +||||+
T Consensus 324 -sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 -SATDLLCQHSLFK 336 (336)
T ss_dssp -SHHHHHHHCGGGC
T ss_pred -CHHHHHhcCCCcC
Confidence 999999 999994
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=367.22 Aligned_cols=256 Identities=25% Similarity=0.386 Sum_probs=210.4
Q ss_pred cccCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCc
Q 004088 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE 259 (774)
Q Consensus 181 ~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~ 259 (774)
..++...++|++.+.||+|+||.||+|.+.. .||||++.... .....+.+.+|+.++++++||||+++++++....
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 4456678899999999999999999998754 39999987543 2233455778999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
.+++|||||.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 99999999999999999986666799999999999999999999999999999999999998 68999999999865432
Q ss_pred c-----ccccccccccccccchhhhhh---------cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCC
Q 004088 340 T-----MSKRNTFIGTPHWMAPEVIQE---------SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAP 405 (774)
Q Consensus 340 ~-----~~~~~~~~GT~~Y~APEvl~~---------~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~ 405 (774)
. ........||+.|+|||++.. ..++.++|||||||++|+|++|..||...........+.....+
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 261 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP 261 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC
Confidence 1 112233469999999999974 34788999999999999999999999887766665554433332
Q ss_pred ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 406 MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 406 ~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.. ....++..+.+||.+||..||.+|||+.++++.
T Consensus 262 ~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 262 NL-SQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp CC-CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CC-CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 22 223567789999999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=392.61 Aligned_cols=254 Identities=26% Similarity=0.397 Sum_probs=215.6
Q ss_pred ccCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 182 TREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 182 ~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
.++...++|++.++||+|+||.||+|.+.. +..||||+++... ...+.+.+|+.+|++++||||+++++++.. ..+
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 356677899999999999999999999754 5679999997433 334679999999999999999999999876 678
Q ss_pred EEEEEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
|||||||.+|+|.++++.. ...+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+...
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 9999999999999999743 356899999999999999999999999999999999999999999999999999866432
Q ss_pred c-cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 341 M-SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 341 ~-~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
. .......++..|+|||++....++.++|||||||++|||++ |+.||......+....+..... ......++..+.
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~ 494 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--MPCPPECPESLH 494 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC--CCCCTTCCHHHH
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHH
Confidence 1 11223457889999999999999999999999999999999 9999998877666555443322 223456788999
Q ss_pred HHHHhhcccCCCCCCCHHHHHhh
Q 004088 419 DFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
+||.+||..||.+|||+.+|++.
T Consensus 495 ~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 495 DLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999863
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=399.32 Aligned_cols=258 Identities=27% Similarity=0.407 Sum_probs=217.0
Q ss_pred cccCCCCCCeeEEeeeeccCceEEEEEEEcCC---CcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccC
Q 004088 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKT---SELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG 257 (774)
Q Consensus 181 ~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~---g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~ 257 (774)
...+...++|++++.||+|+||.||+|.+..+ +..||||++.........+.+.+|+.+|++++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 33455668899999999999999999998653 56799999876555566678999999999999999999999985
Q ss_pred CceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccc
Q 004088 258 EEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL 337 (774)
Q Consensus 258 ~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i 337 (774)
++.+|+|||||++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 45689999999999999999866667999999999999999999999999999999999999999999999999999876
Q ss_pred cccccc-cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchH
Q 004088 338 TRTMSK-RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSL 415 (774)
Q Consensus 338 ~~~~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~ 415 (774)
...... .....||+.|+|||++.+..++.++|||||||++|||++ |.+||...........+...... ..+..++.
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~ 619 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL--PMPPNCPP 619 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC--CCCTTCCH
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC--CCCccccH
Confidence 443211 223457889999999999999999999999999999997 99999988776666555433222 23456788
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 416 VFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 416 ~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.+.+||.+||..||.+|||+.+++++
T Consensus 620 ~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 620 TLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=395.76 Aligned_cols=248 Identities=26% Similarity=0.378 Sum_probs=206.7
Q ss_pred eeEE-eeeeccCceEEEEEEE--cCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 190 YELL-NELGKGSYGAVYKARD--LKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 190 Y~il-k~LG~G~FG~Vy~a~d--~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
+.+. ++||+|+||.||+|.+ ..+++.||||+++... .....+.+.+|+.+|++++|||||++++++.. +.++|||
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~ 448 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVM 448 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEE
Confidence 4443 4899999999999955 4567899999997543 33446789999999999999999999999975 4588999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc---
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS--- 342 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~--- 342 (774)
|||.+++|.+++. ....+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 449 E~~~~g~L~~~l~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 449 EMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp ECCTTEEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred EccCCCCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 9999999999996 456799999999999999999999999999999999999999999999999999987654321
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI 421 (774)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||...........+...... ..+..++..+.+||
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~--~~p~~~~~~l~~li 605 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--GCPAGCPREMYDLM 605 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--CCCTTCCHHHHHHH
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHH
Confidence 1223357889999999999999999999999999999998 99999988877766655443322 23456788999999
Q ss_pred HhhcccCCCCCCCHHHHHhh
Q 004088 422 AKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 422 ~kcL~~DP~kRPTa~ElL~H 441 (774)
.+||..||.+||++.+|++.
T Consensus 606 ~~cl~~dP~~RPs~~~l~~~ 625 (635)
T 4fl3_A 606 NLCWTYDVENRPGFAAVELR 625 (635)
T ss_dssp HHHTCSSTTTSCCHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999763
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=383.68 Aligned_cols=250 Identities=20% Similarity=0.285 Sum_probs=207.5
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCC-CcccccccccCCceEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHP-NVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HP-NIVkL~~~~~~~~~l~LVm 265 (774)
.++|+++++||+|+||.||+|++..+++.||||++...... ..+.+|+++++.|.|+ +|..+..++......||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999999999999999998754332 3478899999999875 5556666667888999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEe---cCCCcEEEeecccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL---TDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILL---d~~g~vKL~DFGlA~~i~~~~~ 342 (774)
||| +++|.+++......+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+++.+.....
T Consensus 83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 999 999999998667789999999999999999999999999999999999999 6888999999999987654322
Q ss_pred c-------cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhh---hhhhcC--CCCccccc
Q 004088 343 K-------RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVL---FMISIE--PAPMLEDK 410 (774)
Q Consensus 343 ~-------~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i---~~i~~~--~~~~~~~~ 410 (774)
. ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ..+... ........
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALC 241 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHH
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHh
Confidence 1 22568999999999999999999999999999999999999999875442211 111110 11111222
Q ss_pred hhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 411 EKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 411 ~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
..++..+.+||.+||..+|.+||++.+|++
T Consensus 242 ~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 242 RGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp TTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 456889999999999999999999999876
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=358.43 Aligned_cols=247 Identities=26% Similarity=0.397 Sum_probs=200.6
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHh--CCCCCcccccccccCCc----e
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQ--CSHPNVVRYLGSYQGEE----Y 260 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~--L~HPNIVkL~~~~~~~~----~ 260 (774)
.++|++.+.||+|+||.||+|++ +|+.||||++... ....+.+|+++++. ++||||+++++++.... .
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 46899999999999999999987 5899999998532 34567889999988 78999999999998765 8
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHH--------hcCcccccccccceEecCCCcEEEeecc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLH--------SIFKVHRDIKGGNILLTDQGEVKLGDFG 332 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLH--------s~gIIHRDLKPeNILLd~~g~vKL~DFG 332 (774)
+|+||||+++++|.+++.. ..+++..++.++.||+.||.||| ++||+||||||+||||+.++.+||+|||
T Consensus 115 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 9999999999999999863 46899999999999999999999 8999999999999999999999999999
Q ss_pred cccccccccc----ccccccccccccchhhhhhc------CCCCccchhhhHHHHHHHHhC----------CCCCCCCCc
Q 004088 333 VAAQLTRTMS----KRNTFIGTPHWMAPEVIQES------RYDGKVDVWALGVSAVEMAEG----------LPPRSTVHP 392 (774)
Q Consensus 333 lA~~i~~~~~----~~~~~~GT~~Y~APEvl~~~------~~s~ksDIWSLGviLyELLtG----------~~Pf~~~~~ 392 (774)
++........ ......||+.|+|||++.+. .++.++|||||||++|+|++| ..||.....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 9976654322 12345799999999999765 234689999999999999999 778865432
Q ss_pred h-----hhhhhhhc-CCCCccc---cchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 393 M-----RVLFMISI-EPAPMLE---DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 393 ~-----~~i~~i~~-~~~~~~~---~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
. .....+.. ...+... .....+..+.+||.+||+.||.+|||+.++++|
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 1 11111111 1111111 122445678999999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=405.94 Aligned_cols=261 Identities=26% Similarity=0.337 Sum_probs=211.8
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccC------Cc
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG------EE 259 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~------~~ 259 (774)
..++|++.+.||+|+||.||+|.+..+|+.||||++.........+.+.+|+.+|++++||||+++++++.. ..
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 347899999999999999999999999999999998765556667789999999999999999999998765 77
Q ss_pred eEEEEEEecCCCchhhhhhccC--CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCc---EEEeecccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTE--EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGE---VKLGDFGVA 334 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~--~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~---vKL~DFGlA 334 (774)
..|+|||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 8899999999999999987533 36899999999999999999999999999999999999997765 999999999
Q ss_pred ccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhh--------------hhh
Q 004088 335 AQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLF--------------MIS 400 (774)
Q Consensus 335 ~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~--------------~i~ 400 (774)
..+... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ...
T Consensus 172 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l 250 (676)
T 3qa8_A 172 KELDQG-ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250 (676)
T ss_dssp CBTTSC-CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred cccccc-cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence 876543 23345689999999999999999999999999999999999999997542211100 000
Q ss_pred c-------CCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 401 I-------EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 401 ~-------~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
. ...........++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 0 0000111233467889999999999999999999999999999754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=392.99 Aligned_cols=243 Identities=26% Similarity=0.369 Sum_probs=204.3
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcC-CCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCce----
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLK-TSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEY---- 260 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~-~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~---- 260 (774)
..++|++++.||+|+||.||+|.+.. +|+.||||++...........+.+|+.+|++++||||++++++|.....
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 35799999999999999999999976 7899999998765555666788999999999999999999999976554
Q ss_pred -EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc
Q 004088 261 -LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 261 -l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
.|||||||+|++|.+++. ..+++..++.|+.||+.||.|||++|||||||||+||||+.+ .+||+|||+++.+..
T Consensus 158 ~~~lv~E~~~g~~L~~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEEECCCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred eeEEEEEeCCCCcHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 799999999999998775 279999999999999999999999999999999999999885 899999999976643
Q ss_pred cccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHH
Q 004088 340 TMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHD 419 (774)
Q Consensus 340 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~d 419 (774)
. ...+||+.|+|||++.+. ++.++|||||||++|+|++|.+||....... .+........+..+.+
T Consensus 234 ~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------~~~~~~~~~~~~~l~~ 299 (681)
T 2pzi_A 234 F----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG---------LPEDDPVLKTYDSYGR 299 (681)
T ss_dssp C----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS---------CCTTCHHHHHCHHHHH
T ss_pred C----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc---------ccccccccccCHHHHH
Confidence 3 445799999999999775 5889999999999999999999887532111 0111112234678999
Q ss_pred HHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 420 FVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 420 LI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
||.+||++||.+||+..+++.|+|+.-
T Consensus 300 li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 300 LLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 999999999999999999999999753
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=345.58 Aligned_cols=225 Identities=15% Similarity=0.115 Sum_probs=189.3
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC--hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG--EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~--~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
..++|++++.||+|+||.||+|++..+++.||||++..... ....+.+.+|+.++.+++||||+++++++...+..||
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 45789999999999999999999999999999999975432 4455788999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|||||+|++|.++++. + ....++..|+.||+.||.|||++||+||||||+||||+.+|.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 9999999999999853 2 3455788899999999999999999999999999999999999998543
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhh---h-hhcCCCCccccchhchHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLF---M-ISIEPAPMLEDKEKWSLVFHD 419 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~---~-i~~~~~~~~~~~~~~s~~l~d 419 (774)
|++ .++.++|||||||++|+|++|+.||........+. . +.....+.......++..+.+
T Consensus 175 ---------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (286)
T 3uqc_A 175 ---------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238 (286)
T ss_dssp ---------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHH
T ss_pred ---------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHH
Confidence 333 37889999999999999999999998876544321 1 111122222334567889999
Q ss_pred HHHhhcccCCCCCCCHHHHHhh
Q 004088 420 FVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 420 LI~kcL~~DP~kRPTa~ElL~H 441 (774)
||.+||++||.+| |+.++++.
T Consensus 239 li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 239 VAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHcccCCccC-CHHHHHHH
Confidence 9999999999999 99999874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-34 Score=332.12 Aligned_cols=232 Identities=19% Similarity=0.185 Sum_probs=163.5
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCC---------ChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceEEE
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSE---------GEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~---------~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l~L 263 (774)
..++.|++|.+..++....|+.||||++.+.. .....+++.+|+++|+++ .|+||++++++++++..+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 35678888888888877889999999997542 123346799999999999 79999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|||||+|++|.+++. ..+++++. .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+......
T Consensus 320 VMEyv~G~~L~d~i~-~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 320 VMEKLPGRLLSDMLA-AGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EEECCCSEEHHHHHH-TTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC
T ss_pred EEecCCCCcHHHHHH-hCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc
Confidence 999999999999997 44567664 47899999999999999999999999999999999999999999887666556
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHh
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAK 423 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~k 423 (774)
..+.+||+.|||||++.+. +..++|+||+|+++++|.++..++. ..+...+. ..+ .+..++..
T Consensus 396 ~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~~--------~~l~~~~~------~~~--~~~~l~~~ 458 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNWL--------YAVWQEPV------ERW--NFVLLLAL 458 (569)
T ss_dssp SHHHHHHHHHHHHHHC------------------CCCCTTHHHHH--------HHHHTSCG------GGC--SHHHHHHH
T ss_pred ccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchhH--------HHhhcCCC------CCC--cHHHHHHH
Confidence 6678999999999999864 6778999999999988876644321 01111100 011 14567777
Q ss_pred hcccCCCCCCCHHHHHhhhhhhh
Q 004088 424 CLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 424 cL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
++..+|..|+.......|+|...
T Consensus 459 l~~~~~~~~~~~~~~~~~~~~~~ 481 (569)
T 4azs_A 459 FEKKAKLPSAEQQRGATEQWIIA 481 (569)
T ss_dssp HHTGGGSCCGGGSSCCHHHHHHH
T ss_pred HhCCCCCCCCChhhhccchhHHH
Confidence 88889999988888888888754
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-28 Score=280.38 Aligned_cols=185 Identities=17% Similarity=0.127 Sum_probs=146.4
Q ss_pred eEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC--h-----hhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 191 ELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG--E-----EGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 191 ~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~--~-----~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
...+.||+|+||.||+|. ..++.+|+|+...... . ...+.+.+|+++|++++||||+++..++......||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 456789999999999994 5678899998753221 1 113457999999999999999966665556667799
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|||||++++|.+++.. +..++.||+.||.|||++|||||||||+|||++. .+||+|||+|+.+......
T Consensus 417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence 9999999999999863 6689999999999999999999999999999999 9999999999877543221
Q ss_pred -------cccccccccccchhhhhh--cCCCCccchhhhHHHHHHHHhCCCCCC
Q 004088 344 -------RNTFIGTPHWMAPEVIQE--SRYDGKVDVWALGVSAVEMAEGLPPRS 388 (774)
Q Consensus 344 -------~~~~~GT~~Y~APEvl~~--~~~s~ksDIWSLGviLyELLtG~~Pf~ 388 (774)
....+||+.|||||++.. ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 235689999999999986 568889999999999988887777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.2e-25 Score=233.04 Aligned_cols=159 Identities=16% Similarity=0.144 Sum_probs=127.4
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh-----------------hhHHHHHHHHHHHHhCCCCCccc
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE-----------------EGYEEIRGEIEMLQQCSHPNVVR 250 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~-----------------~~~~~~~~Ei~iL~~L~HPNIVk 250 (774)
..|.+++.||+|+||.||+|.+ .+|+.||||+++..... .....+.+|+.+|++++ | ++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 3466679999999999999998 88999999998643211 13456889999999999 5 67
Q ss_pred ccccccCCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEee
Q 004088 251 YLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGD 330 (774)
Q Consensus 251 L~~~~~~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~D 330 (774)
+++++.. +..|+|||||+|++|.+ +.. .....++.||+.||.|||++|||||||||+||||+ ++.+||+|
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 7776543 55699999999999988 421 12446999999999999999999999999999999 99999999
Q ss_pred ccccccccccccccccccccccccchhhhhh----------cCCCCccchhhh
Q 004088 331 FGVAAQLTRTMSKRNTFIGTPHWMAPEVIQE----------SRYDGKVDVWAL 373 (774)
Q Consensus 331 FGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~----------~~~s~ksDIWSL 373 (774)
||+|+ .+..|+|||++.. .+|...+|+|.+
T Consensus 236 FG~a~-------------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 236 FPQSV-------------EVGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp CTTCE-------------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred CCCCe-------------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 99985 3456789999854 456666777653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.3e-21 Score=203.61 Aligned_cols=139 Identities=20% Similarity=0.254 Sum_probs=109.1
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcE--EEEEEeecCCCh-----------------------hhHHHHHHHHHHHHhC
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSEL--VAIKVISLSEGE-----------------------EGYEEIRGEIEMLQQC 243 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~--VAVKvi~~~~~~-----------------------~~~~~~~~Ei~iL~~L 243 (774)
-|++.+.||+|+||.||+|.+..+|+. ||||+++..... .....+.+|+.+|+++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 488999999999999999998778999 999997543111 0113578999999999
Q ss_pred CCCCc--ccccccccCCceEEEEEEecCC-C----chhhhhhccCCchhHHHHHHHHHHHHHHHHHHH-hcCcccccccc
Q 004088 244 SHPNV--VRYLGSYQGEEYLWIVMEYCGG-G----SVADLMNVTEEPLEEYQIAYICREALKGLAYLH-SIFKVHRDIKG 315 (774)
Q Consensus 244 ~HPNI--VkL~~~~~~~~~l~LVmEy~~g-g----sL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLH-s~gIIHRDLKP 315 (774)
.|++| +.++.+ ...|||||||++ | +|.++.. ..++..+..++.||+.+|.||| ++|||||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR----ELKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG----GGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh----ccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 88764 333332 356899999942 3 5555432 2345678889999999999999 99999999999
Q ss_pred cceEecCCCcEEEeeccccccc
Q 004088 316 GNILLTDQGEVKLGDFGVAAQL 337 (774)
Q Consensus 316 eNILLd~~g~vKL~DFGlA~~i 337 (774)
+|||++. .++|+|||+|...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999998 8999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.73 E-value=4.8e-18 Score=188.16 Aligned_cols=140 Identities=13% Similarity=0.063 Sum_probs=99.1
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-------------hhhHHHHHHHHHHHHhCCCCCcccccccc
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-------------EEGYEEIRGEIEMLQQCSHPNVVRYLGSY 255 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-------------~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~ 255 (774)
-|++++.||.|+||.||+|.+ .+|+.||||+++.... .........++++.....|+|+++++...
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 499999999999999999986 5799999999753210 00111223333333333444444443322
Q ss_pred cC------CceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC-----
Q 004088 256 QG------EEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG----- 324 (774)
Q Consensus 256 ~~------~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g----- 324 (774)
.. ....+|||||++|+.|..+... .....++.||+.+|.|||++|||||||||.||||+.+|
T Consensus 175 v~vp~p~~~~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~ 247 (397)
T 4gyi_A 175 FPVPEPIAQSRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP 247 (397)
T ss_dssp CSCCCEEEEETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred CCCCeeeeccCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence 11 1123799999999988776532 12456789999999999999999999999999998876
Q ss_pred -----cEEEeecccccc
Q 004088 325 -----EVKLGDFGVAAQ 336 (774)
Q Consensus 325 -----~vKL~DFGlA~~ 336 (774)
.+.|+||+-+..
T Consensus 248 ~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 248 SSITLTPIIIXFPQMVS 264 (397)
T ss_dssp TSEEEEEEECCCTTCEE
T ss_pred cccccceEEEEeCCccc
Confidence 389999997743
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=2.5e-12 Score=132.28 Aligned_cols=139 Identities=18% Similarity=0.179 Sum_probs=110.5
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-CCCcccccccccCCceEEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~~~~l~LVmE 266 (774)
..|++...+|.|+++.||++.. .+..|+||+...... .....+.+|+.+|+.+. +..+.++++++...+..|+|||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3689999999999999999973 367899999864211 11235889999999984 6778889999888889999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS----------------------------------------- 305 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs----------------------------------------- 305 (774)
|++|.+|.+.+. +......++.+++.+|..||+
T Consensus 91 ~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 91 EADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp CCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred ecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 999999877532 112234678899999999998
Q ss_pred ------------------cCcccccccccceEecCCCcEEEeeccccc
Q 004088 306 ------------------IFKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 306 ------------------~gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999875556799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.23 E-value=1.6e-11 Score=124.64 Aligned_cols=134 Identities=16% Similarity=0.128 Sum_probs=99.3
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCC--cccccccccCCceEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPN--VVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPN--IVkL~~~~~~~~~l~LVm 265 (774)
..|.+....+.|.++.||++. ..+|..|+||+.... ....+.+|+.+|+.+.+.+ +.+++.++...+..|+||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 356665444566679999996 456778999987532 2245778999999886544 556888888888899999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF-------------------------------------- 307 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~g-------------------------------------- 307 (774)
||++|.+|. ... .. ...++.+++..|..||+..
T Consensus 95 e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 95 GEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp ECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 999998884 211 11 1256677777778887643
Q ss_pred --------------------cccccccccceEecCCCcEEEeeccccc
Q 004088 308 --------------------KVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 308 --------------------IIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876666799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.17 E-value=5.6e-11 Score=128.34 Aligned_cols=141 Identities=14% Similarity=0.177 Sum_probs=105.4
Q ss_pred eEEeeeeccCceEEEEEEEcCCCcEEEEEEee--cCCChhhHHHHHHHHHHHHhCCC--CCcccccccccCC---ceEEE
Q 004088 191 ELLNELGKGSYGAVYKARDLKTSELVAIKVIS--LSEGEEGYEEIRGEIEMLQQCSH--PNVVRYLGSYQGE---EYLWI 263 (774)
Q Consensus 191 ~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~--~~~~~~~~~~~~~Ei~iL~~L~H--PNIVkL~~~~~~~---~~l~L 263 (774)
..++.|+.|.++.||++.. .+..+++|+.. ..........+.+|+.+|+.|.+ ..+.+++.++.+. +..|+
T Consensus 41 ~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CEEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred ceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 3467899999999999974 34678899765 22211223467899999999974 4578888887765 45899
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS-------------------------------------- 305 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs-------------------------------------- 305 (774)
||||++|..+.+.. ...+++.....++.+++..|..||+
T Consensus 119 vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999998775422 1346778888899999999999997
Q ss_pred --------------------cCcccccccccceEecCCCc--EEEeecccccc
Q 004088 306 --------------------IFKVHRDIKGGNILLTDQGE--VKLGDFGVAAQ 336 (774)
Q Consensus 306 --------------------~gIIHRDLKPeNILLd~~g~--vKL~DFGlA~~ 336 (774)
.+++|+|++|.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999997753 68999998853
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.97 E-value=3.2e-10 Score=119.71 Aligned_cols=182 Identities=16% Similarity=0.180 Sum_probs=119.3
Q ss_pred EeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-CCC--cccccccccCCc---eEEEEEE
Q 004088 193 LNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPN--VVRYLGSYQGEE---YLWIVME 266 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HPN--IVkL~~~~~~~~---~l~LVmE 266 (774)
++.++.|.+..||++. ..+++|+.. .......+.+|+.+|+.+. +.. +.+++....... ..|+||+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~---~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPK---HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEES---SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecC---CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 3458999999999863 348899853 2244567899999998883 333 334444433332 3489999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS----------------------------------------- 305 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs----------------------------------------- 305 (774)
+++|..|..... ..++..+...++.+++..|..||+
T Consensus 97 ~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 97 KIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred ccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 999988865332 245667777888888888888885
Q ss_pred -----------------cCcccccccccceEecC--CCcEEEeecccccccccccccccc--------------cccccc
Q 004088 306 -----------------IFKVHRDIKGGNILLTD--QGEVKLGDFGVAAQLTRTMSKRNT--------------FIGTPH 352 (774)
Q Consensus 306 -----------------~gIIHRDLKPeNILLd~--~g~vKL~DFGlA~~i~~~~~~~~~--------------~~GT~~ 352 (774)
..++|+|++|.|||++. .+.+.|+||+.+..-......... +.....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 13799999999999998 456789999988542211000000 000011
Q ss_pred ccc-hhhhhhcCCCCccchhhhHHHHHHHHhCCCCC
Q 004088 353 WMA-PEVIQESRYDGKVDVWALGVSAVEMAEGLPPR 387 (774)
Q Consensus 353 Y~A-PEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf 387 (774)
+.. |+.... .....+.|+++.++|.+.+|.++|
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 112 222211 122358999999999999998765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=5.3e-07 Score=95.74 Aligned_cols=132 Identities=17% Similarity=0.169 Sum_probs=90.4
Q ss_pred EeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCC---Cccccccccc-CCceEEEEEEec
Q 004088 193 LNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHP---NVVRYLGSYQ-GEEYLWIVMEYC 268 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HP---NIVkL~~~~~-~~~~l~LVmEy~ 268 (774)
++.++.|....||+. |..++||+. ........+.+|+.+|+.|.+. .+.+++.+.. ..+..|+||||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~---~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFP---KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEE---SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEec---CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 456789999999988 456888974 2234456789999999999652 2455555553 455678999999
Q ss_pred CCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 004088 269 GGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI------------------------------------------ 306 (774)
Q Consensus 269 ~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~------------------------------------------ 306 (774)
+|..|....- ..++......++.++...|..||+.
T Consensus 96 ~G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 96 QGQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CSEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred CCeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 9988765311 1223344444444444444444431
Q ss_pred ------------------CcccccccccceEecC---CCc-EEEeeccccc
Q 004088 307 ------------------FKVHRDIKGGNILLTD---QGE-VKLGDFGVAA 335 (774)
Q Consensus 307 ------------------gIIHRDLKPeNILLd~---~g~-vKL~DFGlA~ 335 (774)
.++|+|++|.|||++. ++. +.|+||+.+.
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 3599999999999987 455 4899999874
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=7.9e-07 Score=91.35 Aligned_cols=132 Identities=14% Similarity=0.116 Sum_probs=92.4
Q ss_pred eeeccCce-EEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-CCCcccccccccCCceEEEEEEecCCCc
Q 004088 195 ELGKGSYG-AVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQGEEYLWIVMEYCGGGS 272 (774)
Q Consensus 195 ~LG~G~FG-~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~~~~l~LVmEy~~ggs 272 (774)
.+..|..+ .||+......+..+.||+-.. .....+.+|..+|+.|. +--+.+++.++.+.+..|+|||+++|.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 34455544 699887666777899998642 23456889999999884 2236678888888889999999999987
Q ss_pred hhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhc----------------------------------------------
Q 004088 273 VADLMNVTEEPLEEYQIAYICREALKGLAYLHSI---------------------------------------------- 306 (774)
Q Consensus 273 L~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~---------------------------------------------- 306 (774)
+.+..... ......++.++...|.-||..
T Consensus 107 ~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 107 AFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 76654211 111223444455555555521
Q ss_pred ------------CcccccccccceEecCCCcEEEeeccccc
Q 004088 307 ------------FKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 307 ------------gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
.++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 16899999999999987767899999874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=1.8e-06 Score=94.38 Aligned_cols=78 Identities=23% Similarity=0.183 Sum_probs=50.2
Q ss_pred EEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC------hhhHHHHHHHHHHHHhCCC--CC-cccccccccCCceEE
Q 004088 192 LLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG------EEGYEEIRGEIEMLQQCSH--PN-VVRYLGSYQGEEYLW 262 (774)
Q Consensus 192 ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~------~~~~~~~~~Ei~iL~~L~H--PN-IVkL~~~~~~~~~l~ 262 (774)
.++.||.|.++.||++....+++.|+||....... ......+..|.++|+.+.. |. +.+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 36789999999999997555678899998642111 1123456789999988742 33 3455543 234457
Q ss_pred EEEEecCCC
Q 004088 263 IVMEYCGGG 271 (774)
Q Consensus 263 LVmEy~~gg 271 (774)
+||||+++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=1.5e-06 Score=93.16 Aligned_cols=85 Identities=11% Similarity=0.053 Sum_probs=56.1
Q ss_pred eeEEeee-eccCceEEEEEEEc--C----CCcEEEEEEeecCCC--hhhHHHHHHHHHHHHhCC-C--CCcccccccccC
Q 004088 190 YELLNEL-GKGSYGAVYKARDL--K----TSELVAIKVISLSEG--EEGYEEIRGEIEMLQQCS-H--PNVVRYLGSYQG 257 (774)
Q Consensus 190 Y~ilk~L-G~G~FG~Vy~a~d~--~----~g~~VAVKvi~~~~~--~~~~~~~~~Ei~iL~~L~-H--PNIVkL~~~~~~ 257 (774)
...++.| +.|....+|+.... . ++..+++|+...... ......+.+|+.+|+.|. + -.+.+++.++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3446778 88999999988643 1 256789997642210 001245778998888874 2 246677777655
Q ss_pred C---ceEEEEEEecCCCchh
Q 004088 258 E---EYLWIVMEYCGGGSVA 274 (774)
Q Consensus 258 ~---~~l~LVmEy~~ggsL~ 274 (774)
. ...|+||||++|..+.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 4 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.10 E-value=1.9e-05 Score=83.22 Aligned_cols=136 Identities=18% Similarity=0.191 Sum_probs=78.0
Q ss_pred EeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCC--CCccccccc------ccCCceEEEE
Q 004088 193 LNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSH--PNVVRYLGS------YQGEEYLWIV 264 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~H--PNIVkL~~~------~~~~~~l~LV 264 (774)
++.|+.|..+.||++.. .+| .+++|+... .. ..+..|+.+++.|.. -.+.+++.. ....+..++|
T Consensus 37 ~~~l~gG~~n~~~~v~~-~~~-~~vlk~~~~--~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l 109 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT-DSG-AVCLKRIHR--PE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV 109 (346)
T ss_dssp EEECC----CEEEEEEE-TTE-EEEEEEECS--CH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred eeeccccccCcEEEEEe-CCC-CEEEEecCC--CH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence 45677778999999974 334 489998863 11 334455666655531 123333331 1245678999
Q ss_pred EEecCCCchh-----------hh---hhc-cC-C--c---------hhHH--------H---------------------
Q 004088 265 MEYCGGGSVA-----------DL---MNV-TE-E--P---------LEEY--------Q--------------------- 288 (774)
Q Consensus 265 mEy~~ggsL~-----------dl---l~~-~~-~--~---------Lse~--------~--------------------- 288 (774)
|+|++|..+. .. ++. .. . + ..+. .
T Consensus 110 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 189 (346)
T 2q83_A 110 YDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYL 189 (346)
T ss_dssp EECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHH
T ss_pred EEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHH
Confidence 9999986542 00 110 00 0 0 0010 0
Q ss_pred --HHHHHHHHHHHHHHHHh-------------cCcccccccccceEecCCCcEEEeeccccc
Q 004088 289 --IAYICREALKGLAYLHS-------------IFKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 289 --i~~I~~QIl~gL~YLHs-------------~gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
+..++.++..++.+|+. .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 190 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 190 QEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11122234456666652 569999999999999877889999999773
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00043 Score=74.20 Aligned_cols=76 Identities=17% Similarity=0.146 Sum_probs=59.7
Q ss_pred EEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC---CCCcccccccccCCceEEEEEEec
Q 004088 192 LLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS---HPNVVRYLGSYQGEEYLWIVMEYC 268 (774)
Q Consensus 192 ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~---HPNIVkL~~~~~~~~~l~LVmEy~ 268 (774)
-++.|+.|.+..||+... ++..|+||+.... ....+..|+..|+.|. ...+.+++.+....+..|+||||+
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 467799999999999973 5677899987532 3456889999998883 356778888877778899999999
Q ss_pred CCCch
Q 004088 269 GGGSV 273 (774)
Q Consensus 269 ~ggsL 273 (774)
+|..+
T Consensus 114 ~G~~~ 118 (312)
T 3jr1_A 114 NKSKN 118 (312)
T ss_dssp CCCCC
T ss_pred cCCCC
Confidence 98754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00028 Score=77.83 Aligned_cols=31 Identities=16% Similarity=0.280 Sum_probs=27.2
Q ss_pred hcCcccccccccceEecCCCcEEEeecccccc
Q 004088 305 SIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQ 336 (774)
Q Consensus 305 s~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~ 336 (774)
...++|+|++|.|||++.++ ++|+||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 45699999999999999876 99999998853
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00072 Score=70.42 Aligned_cols=78 Identities=15% Similarity=0.095 Sum_probs=54.8
Q ss_pred CeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCC---CcccccccccCCceEEEEE
Q 004088 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHP---NVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 189 ~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HP---NIVkL~~~~~~~~~l~LVm 265 (774)
+..-++.+|.|..+.||+.+ ..+|+.|.||+..... ......+..|+..|+.|.-- -+.+++.+. .-++||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~ 89 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM 89 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred CeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence 45668899999999999998 5689999999864322 22234578899999988421 234444432 237899
Q ss_pred EecCCCc
Q 004088 266 EYCGGGS 272 (774)
Q Consensus 266 Ey~~ggs 272 (774)
||+.++.
T Consensus 90 e~l~~~~ 96 (288)
T 3f7w_A 90 EWVDERP 96 (288)
T ss_dssp ECCCCCC
T ss_pred EeecccC
Confidence 9998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0016 Score=68.51 Aligned_cols=141 Identities=11% Similarity=0.061 Sum_probs=79.8
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCC--cccccccc------cCCceE
Q 004088 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPN--VVRYLGSY------QGEEYL 261 (774)
Q Consensus 190 Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPN--IVkL~~~~------~~~~~l 261 (774)
..-++.|+.|....||++.. .+| .+++|+..... ..+.+..|+.+++.|...+ +.+++... ...+..
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp EEEEEEECC---EEEEEEEE-SSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred ceEeeccCCCcccceEEEEe-CCc-cEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 34567788899999999974 344 58899876421 1234567888877763212 33333221 123567
Q ss_pred EEEEEecCCCchhh----h----------hhcc----CC------c-hhHHHHHH------------HHHHHHHHHHHHH
Q 004088 262 WIVMEYCGGGSVAD----L----------MNVT----EE------P-LEEYQIAY------------ICREALKGLAYLH 304 (774)
Q Consensus 262 ~LVmEy~~ggsL~d----l----------l~~~----~~------~-Lse~~i~~------------I~~QIl~gL~YLH 304 (774)
++||+|++|..+.. . ++.. .. . ..+..... +...+...+.+++
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 99999998865321 0 1100 00 0 11111000 0112344556665
Q ss_pred h-------cCcccccccccceEecCCCcEEEeeccccc
Q 004088 305 S-------IFKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 305 s-------~gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
. .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3 369999999999999986656899999774
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00032 Score=73.62 Aligned_cols=71 Identities=17% Similarity=0.153 Sum_probs=44.4
Q ss_pred EeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCc-ccccccccCCceEEEEEEec-CC
Q 004088 193 LNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV-VRYLGSYQGEEYLWIVMEYC-GG 270 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNI-VkL~~~~~~~~~l~LVmEy~-~g 270 (774)
++.|+.|....+|++ ..|++|+..... ...-...+|+.+++.+..-++ .+++.++.+ .-++|+||+ +|
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~--~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT--EEYINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc--cceeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCC
Confidence 688999999999998 448899875321 111123568887777642222 355554432 346899999 66
Q ss_pred Cch
Q 004088 271 GSV 273 (774)
Q Consensus 271 gsL 273 (774)
..|
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 554
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0013 Score=67.19 Aligned_cols=136 Identities=17% Similarity=0.200 Sum_probs=92.9
Q ss_pred CchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHh-cCcccccccccceEecCCCcEEEeeccccccccccccccccccc
Q 004088 271 GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS-IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIG 349 (774)
Q Consensus 271 gsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs-~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~~~G 349 (774)
.+|.++|+..+.+++|.+++.++.|.+.+|.-+-. ..-..+=+.|..|+|..+|.|.+.+ +.+. ..
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~ 99 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AG 99 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------cc
Confidence 47999999899999999999999999999877621 1122334467999999999987763 2110 11
Q ss_pred cccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhccc-
Q 004088 350 TPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTK- 427 (774)
Q Consensus 350 T~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~- 427 (774)
...+.|||... ...+.+.=|||||+++|.-+- |.+ ......+++.+..||..|..-
T Consensus 100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~---------------------e~eE~eLS~~LE~LL~~Mt~~~ 157 (229)
T 2yle_A 100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK---------------------ENEERELSPPLEQLIDHMANTV 157 (229)
T ss_dssp -------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC---------------------TTEEECCCHHHHHHHHHHTTCC
T ss_pred ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC---------------------cccchhhCHHHHHHHHHHHhcc
Confidence 22456787763 235567889999999999872 221 123456788889999998765
Q ss_pred ------------------------CCCCCCCHHHHHhh
Q 004088 428 ------------------------EPRARPTAAEMLKH 441 (774)
Q Consensus 428 ------------------------DP~kRPTa~ElL~H 441 (774)
.+..|.++++|++.
T Consensus 158 ~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~ 195 (229)
T 2yle_A 158 EADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKL 195 (229)
T ss_dssp C--------------------CCSCCCCCCSHHHHHHH
T ss_pred cccccccccccccccccccccccccccCcCCHHHHHHH
Confidence 34688999999853
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00083 Score=71.28 Aligned_cols=30 Identities=33% Similarity=0.436 Sum_probs=26.4
Q ss_pred cCcccccccccceEecCC----CcEEEeeccccc
Q 004088 306 IFKVHRDIKGGNILLTDQ----GEVKLGDFGVAA 335 (774)
Q Consensus 306 ~gIIHRDLKPeNILLd~~----g~vKL~DFGlA~ 335 (774)
..++|+|+.+.|||++.+ +.+.|+||+.+.
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 469999999999999874 679999999885
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0024 Score=67.24 Aligned_cols=76 Identities=14% Similarity=0.147 Sum_probs=48.4
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCC--Cccccccc-----ccCCceEEEEEE
Q 004088 194 NELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHP--NVVRYLGS-----YQGEEYLWIVME 266 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HP--NIVkL~~~-----~~~~~~l~LVmE 266 (774)
..|+ |....||++. ..+|+.+++|+..... .....+..|+.+++.|... .+++++.. ....+..++||+
T Consensus 32 ~~l~-g~~n~~y~v~-~~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQ-DEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEEC-CTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEE-cCCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4466 8888999886 3456679999975221 1235667788888877422 23444443 122456789999
Q ss_pred ecCCCch
Q 004088 267 YCGGGSV 273 (774)
Q Consensus 267 y~~ggsL 273 (774)
|++|..+
T Consensus 108 ~i~G~~~ 114 (328)
T 1zyl_A 108 SVGGRQF 114 (328)
T ss_dssp CCCCEEC
T ss_pred ecCCCCC
Confidence 9988543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00097 Score=71.96 Aligned_cols=76 Identities=11% Similarity=0.127 Sum_probs=45.1
Q ss_pred EEeeeeccCceEEEEEEEcC--------CCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCC-cccccccccCCceEE
Q 004088 192 LLNELGKGSYGAVYKARDLK--------TSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPN-VVRYLGSYQGEEYLW 262 (774)
Q Consensus 192 ilk~LG~G~FG~Vy~a~d~~--------~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPN-IVkL~~~~~~~~~l~ 262 (774)
-++.|+.|....||++.... .+..|++|+.... .........|..+|+.|...+ +.++++.+. -+
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~ 110 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH--VDELYNTISEFEVYKTMSKYKIAPQLLNTFN----GG 110 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT--GGGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC--ccceecHHHHHHHHHHHHhcCCCCceEEecC----Cc
Confidence 35678888889999997542 1367899986432 121122467888888774333 345665442 26
Q ss_pred EEEEecCCCch
Q 004088 263 IVMEYCGGGSV 273 (774)
Q Consensus 263 LVmEy~~ggsL 273 (774)
+||||++|..+
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999987544
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0014 Score=72.99 Aligned_cols=75 Identities=13% Similarity=0.177 Sum_probs=51.5
Q ss_pred EEeeeeccCceEEEEEEEcC-------CCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCc-ccccccccCCceEEE
Q 004088 192 LLNELGKGSYGAVYKARDLK-------TSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV-VRYLGSYQGEEYLWI 263 (774)
Q Consensus 192 ilk~LG~G~FG~Vy~a~d~~-------~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNI-VkL~~~~~~~~~l~L 263 (774)
-++.|+.|....||++.... .++.|.+|+.... . ..+.+.+|+.+++.|...++ .++++.+.+ .+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-C--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 46778889899999998642 2578999987321 1 12456689999988853333 566766653 28
Q ss_pred EEEecCCCch
Q 004088 264 VMEYCGGGSV 273 (774)
Q Consensus 264 VmEy~~ggsL 273 (774)
||||++|..|
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999987444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0012 Score=72.69 Aligned_cols=137 Identities=15% Similarity=0.198 Sum_probs=83.4
Q ss_pred EeeeeccCceEEEEEEEcC-------CCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-CCCcccccccccCCceEEEE
Q 004088 193 LNELGKGSYGAVYKARDLK-------TSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~~-------~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~~~~l~LV 264 (774)
++.|.-|-...+|++.... +++.|.+|+... .......+.+|..+++.|. +.-..++++++.+. +|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v 128 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--ILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RL 128 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cE
Confidence 3567778888899987532 357899998522 2223456678999998874 32235667766542 89
Q ss_pred EEecCCCchhhh--------------h---hcc----CC-c-hhHHHHHHHHHHHHH-------------------HHHH
Q 004088 265 MEYCGGGSVADL--------------M---NVT----EE-P-LEEYQIAYICREALK-------------------GLAY 302 (774)
Q Consensus 265 mEy~~ggsL~dl--------------l---~~~----~~-~-Lse~~i~~I~~QIl~-------------------gL~Y 302 (774)
|||++|..|..- + +.. .+ + .-+.++..++.++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999998655310 0 000 01 1 134556666554422 2344
Q ss_pred HHh--------cCcccccccccceEecCC----CcEEEeeccccc
Q 004088 303 LHS--------IFKVHRDIKGGNILLTDQ----GEVKLGDFGVAA 335 (774)
Q Consensus 303 LHs--------~gIIHRDLKPeNILLd~~----g~vKL~DFGlA~ 335 (774)
|.. ..++|+|+.+.|||++.+ +.+.|+||..|.
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 432 248999999999999876 689999999874
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.67 E-value=0.01 Score=63.60 Aligned_cols=68 Identities=10% Similarity=0.084 Sum_probs=43.3
Q ss_pred eccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC---CCCccccccc------ccCCceEEEEEEe
Q 004088 197 GKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS---HPNVVRYLGS------YQGEEYLWIVMEY 267 (774)
Q Consensus 197 G~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~---HPNIVkL~~~------~~~~~~l~LVmEy 267 (774)
|.|....||+.. ..+| .|++|+...... ..|+.+|+.|. -|++++.+.. ....+..++||+|
T Consensus 32 G~g~~N~vy~v~-~~~g-~~vLK~~~~~~~-------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~ 102 (339)
T 3i1a_A 32 GADTNAFAYQAD-SESK-SYFIKLKYGYHD-------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPF 102 (339)
T ss_dssp TSCSSCEEEEEE-CSSC-EEEEEEEECSSC-------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEEC
T ss_pred cCccccceEEEE-eCCC-CEEEEEecCccc-------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEec
Confidence 344468999997 3455 899998764331 35666666552 2334555432 2335778999999
Q ss_pred cCCCch
Q 004088 268 CGGGSV 273 (774)
Q Consensus 268 ~~ggsL 273 (774)
++|..+
T Consensus 103 i~G~~~ 108 (339)
T 3i1a_A 103 IHAPNG 108 (339)
T ss_dssp CCCCBT
T ss_pred cCCCcC
Confidence 998765
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0093 Score=67.17 Aligned_cols=76 Identities=12% Similarity=0.133 Sum_probs=49.5
Q ss_pred EEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCc-ccccccccCCceEEEEEEecCC
Q 004088 192 LLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV-VRYLGSYQGEEYLWIVMEYCGG 270 (774)
Q Consensus 192 ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNI-VkL~~~~~~~~~l~LVmEy~~g 270 (774)
-++.|+.|-...+|++.....+..|++|+..... .. .-.-.+|..+|+.|...++ .++++++.+ .+||||++|
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G 185 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DE-IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDG 185 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCS
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCC
Confidence 4577888989999999865445789999874321 11 1112589999998865554 567777642 259999987
Q ss_pred Cch
Q 004088 271 GSV 273 (774)
Q Consensus 271 gsL 273 (774)
..|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 554
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.07 E-value=0.091 Score=58.56 Aligned_cols=76 Identities=7% Similarity=0.140 Sum_probs=48.4
Q ss_pred EEeeeeccCceEEEEEEEcCC-------CcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-CCCcccccccccCCceEEE
Q 004088 192 LLNELGKGSYGAVYKARDLKT-------SELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 192 ilk~LG~G~FG~Vy~a~d~~~-------g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~~~~l~L 263 (774)
-++.|..|-...+|++..... ++.|++|+.... ....-...+|..+++.+. +.-..++++.+.+ ++
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~--t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~~----~~ 147 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH--VGKFYDSKVELDVFRYLSNINIAPNIIADFPE----GR 147 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC--C-CCCCHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC--cchhcCHHHHHHHHHHHHhcCCCCCEEEEcCC----CE
Confidence 456677788889999986421 578999986422 111122357888888874 2223455654432 68
Q ss_pred EEEecCCCch
Q 004088 264 VMEYCGGGSV 273 (774)
Q Consensus 264 VmEy~~ggsL 273 (774)
||||++|..|
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.76 E-value=0.13 Score=56.41 Aligned_cols=28 Identities=36% Similarity=0.566 Sum_probs=24.0
Q ss_pred cccccccccceEe------cCCCcEEEeeccccc
Q 004088 308 KVHRDIKGGNILL------TDQGEVKLGDFGVAA 335 (774)
Q Consensus 308 IIHRDLKPeNILL------d~~g~vKL~DFGlA~ 335 (774)
++|+|+.+.|||+ +..+.++++||-.|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6799999999999 345679999999884
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 774 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-93 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-92 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-91 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-82 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-80 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-80 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-80 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-79 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-79 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-77 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-77 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-76 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-75 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-75 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-74 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-69 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-69 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-68 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-67 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-67 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-67 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-67 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-67 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-66 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-66 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-66 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-65 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-65 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-65 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-64 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-64 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-64 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-64 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-63 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-63 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-63 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-63 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-63 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-62 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-62 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-61 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-61 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-60 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-59 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-58 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-58 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-58 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-57 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-57 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-57 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-56 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-56 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-55 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-55 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-54 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-53 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-42 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-24 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 291 bits (745), Expect = 2e-93
Identities = 125/272 (45%), Positives = 179/272 (65%), Gaps = 7/272 (2%)
Query: 179 ESVTRE-DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEI 237
E VTR+ +P +E++ ELG G++G VYKA++ +TS L A KVI ++ EE E+ EI
Sbjct: 2 EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVID-TKSEEELEDYMVEI 60
Query: 238 EMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREAL 297
++L C HPN+V+ L ++ E LWI++E+C GG+V +M E PL E QI +C++ L
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120
Query: 298 KGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPE 357
L YLH +HRD+K GNIL T G++KL DFGV+A+ TRT+ +R++FIGTP+WMAPE
Sbjct: 121 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 180
Query: 358 VIQ-----ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEK 412
V+ + YD K DVW+LG++ +EMAE PP ++PMRVL I+ P L +
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR 240
Query: 413 WSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
WS F DF+ KCL K AR T +++L+H F+
Sbjct: 241 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 287 bits (735), Expect = 8e-92
Identities = 121/283 (42%), Positives = 181/283 (63%), Gaps = 4/283 (1%)
Query: 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEML 240
V+ DP KY ++G+G+ G VY A D+ T + VAI+ ++L + + E I EI ++
Sbjct: 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVM 71
Query: 241 QQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGL 300
++ +PN+V YL SY + LW+VMEY GGS+ D++ E ++E QIA +CRE L+ L
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQAL 129
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ 360
+LHS +HRDIK NILL G VKL DFG AQ+T SKR+T +GTP+WMAPEV+
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 361 ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420
Y KVD+W+LG+ A+EM EG PP +P+R L++I+ P L++ EK S +F DF
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249
Query: 421 VAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQ 463
+ +CL + R +A E+L+H+F++ K +++ P I A++
Sbjct: 250 LNRCLDMDVEKRGSAKELLQHQFLKIAKP-LSSLTPLIAAAKE 291
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 287 bits (736), Expect = 1e-91
Identities = 134/313 (42%), Positives = 197/313 (62%), Gaps = 16/313 (5%)
Query: 176 SIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS--EGEEGYEEI 233
+ E ++DP + L E+G GS+GAVY ARD++ SE+VAIK +S S + E +++I
Sbjct: 3 DVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI 62
Query: 234 RGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYIC 293
E+ LQ+ HPN ++Y G Y E W+VMEYC G + DL+ V ++PL+E +IA +
Sbjct: 63 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEIAAVT 121
Query: 294 REALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHW 353
AL+GLAYLHS +HRD+K GNILL++ G VKLGDFG A M+ N+F+GTP+W
Sbjct: 122 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANSFVGTPYW 177
Query: 354 MAPEVIQ---ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDK 410
MAPEVI E +YDGKVDVW+LG++ +E+AE PP ++ M L+ I+ +P L+
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG 237
Query: 411 EKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKA----RQIRA 466
WS F +FV CL K P+ RPT+ +LKH+F+ R + T ++ I++ R++
Sbjct: 238 H-WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER-PPTVIMDLIQRTKDAVRELDN 295
Query: 467 SMAQQAQNILSDE 479
++ + IL E
Sbjct: 296 LQYRKMKKILFQE 308
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 262 bits (670), Expect = 1e-82
Identities = 72/261 (27%), Positives = 124/261 (47%), Gaps = 4/261 (1%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV 248
++L+ LG+G+YG V A + T E VA+K++ + + E I+ EI + + +H NV
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 249 VRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFK 308
V++ G + ++ +EYC GG + D + + + E + + G+ YLH I
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 309 VHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR--NTFIGTPHWMAPEVIQESRYDG 366
HRDIK N+LL ++ +K+ DFG+A +R N GT ++APE+++ +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 367 -KVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCL 425
VDVW+ G+ M G P + E L +K + K L
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 244
Query: 426 TKEPRARPTAAEMLKHKFIER 446
+ P AR T ++ K ++ +
Sbjct: 245 VENPSARITIPDIKKDRWYNK 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 258 bits (660), Expect = 2e-80
Identities = 92/303 (30%), Positives = 147/303 (48%), Gaps = 47/303 (15%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV 248
+E ++ELG G+ G V+K + ++A K+I L +I E+++L +C+ P +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 249 VRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFK 308
V + G++ + + I ME+ GGS+ ++ + E + + +KGL YL K
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 309 -VHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGK 367
+HRD+K NIL+ +GE+KL DFGV+ QL +M+ N+F+GT +M+PE +Q + Y +
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQ 183
Query: 368 VDVWALGVSAVEMAEGLPP----------------------------------------- 386
D+W++G+S VEMA G P
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 387 -RSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445
R + +L I EP P L +SL F DFV KCL K P R +++ H FI+
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSG-VFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302
Query: 446 RCK 448
R
Sbjct: 303 RSD 305
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 258 bits (659), Expect = 7e-80
Identities = 74/314 (23%), Positives = 140/314 (44%), Gaps = 6/314 (1%)
Query: 178 PESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEI 237
P V + Y++L ELG G++G V++ + T + K I+ + ++ EI
Sbjct: 19 PVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK-YTVKNEI 77
Query: 238 EMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREAL 297
++ Q HP ++ +++ + + +++E+ GG + D + + + E ++ R+A
Sbjct: 78 SIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 137
Query: 298 KGLAYLHSIFKVHRDIKGGNILL--TDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMA 355
+GL ++H VH DIK NI+ VK+ DFG+A +L T + A
Sbjct: 138 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAA 196
Query: 356 PEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDK-EKWS 414
PE++ D+WA+GV + GL P + + L + ED S
Sbjct: 197 PEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 256
Query: 415 LVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRASMAQQAQN 474
DF+ L KEPR R T + L+H +++ T+ +P + +IR + ++ +
Sbjct: 257 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPS-SRYNKIRQKIKEKYAD 315
Query: 475 ILSDEPEVNATMGL 488
+ +P +
Sbjct: 316 WPAPQPAIGRIANF 329
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 254 bits (651), Expect = 9e-80
Identities = 75/274 (27%), Positives = 128/274 (46%), Gaps = 16/274 (5%)
Query: 182 TREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEML 240
+R + YE+L +G GSYG K R +++ K + E + + E+ +L
Sbjct: 1 SRAE---DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL 57
Query: 241 QQCSHPNVVRYLGSYQGEE--YLWIVMEYCGGGSVADLMN---VTEEPLEEYQIAYICRE 295
++ HPN+VRY L+IVMEYC GG +A ++ + L+E + + +
Sbjct: 58 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 117
Query: 296 ALKGLAYLHSIFK-----VHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGT 350
L H +HRD+K N+ L + VKLGDFG+A L S F+GT
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGT 177
Query: 351 PHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDK 410
P++M+PE + Y+ K D+W+LG E+ +PP + + I +
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP-- 235
Query: 411 EKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
++S ++ + + L + RP+ E+L++ I
Sbjct: 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 256 bits (656), Expect = 2e-79
Identities = 73/309 (23%), Positives = 129/309 (41%), Gaps = 5/309 (1%)
Query: 178 PESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEI 237
P + + Y++ ELG G++G V++ + T A K + E E +R EI
Sbjct: 16 PVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEI 74
Query: 238 EMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREAL 297
+ + HP +V +++ + + ++ E+ GG + + + + E + R+
Sbjct: 75 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134
Query: 298 KGLAYLHSIFKVHRDIKGGNILLTDQ--GEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMA 355
KGL ++H VH D+K NI+ T + E+KL DFG+ A L S GT + A
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-VKVTTGTAEFAA 193
Query: 356 PEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI-SIEPAPMLEDKEKWS 414
PEV + D+W++GV + + GL P + L + S + S
Sbjct: 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 253
Query: 415 LVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRASMAQQAQN 474
DF+ K L +P R T + L+H ++ + +IR S+ +
Sbjct: 254 EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDA 313
Query: 475 ILSDEPEVN 483
P +
Sbjct: 314 WPEPLPPLG 322
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 253 bits (648), Expect = 2e-79
Identities = 77/258 (29%), Positives = 127/258 (49%), Gaps = 8/258 (3%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS--EGEEGYEEIRGEIEMLQQCSHP 246
+E+ LGKG +G VY AR+ ++ ++A+KV+ + E ++R E+E+ HP
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI 306
N++R G + +++++EY G+V + +E + A E L+Y HS
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCHSK 125
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDG 366
+HRDIK N+LL GE+K+ DFG + + +R T GT ++ PE+I+ +D
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDE 183
Query: 367 KVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLT 426
KVD+W+LGV E G PP IS + + D +++ L
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF---PDFVTEGARDLISRLLK 240
Query: 427 KEPRARPTAAEMLKHKFI 444
P RP E+L+H +I
Sbjct: 241 HNPSQRPMLREVLEHPWI 258
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (636), Expect = 1e-77
Identities = 74/264 (28%), Positives = 129/264 (48%), Gaps = 12/264 (4%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNV 248
+ E+G+GS+ VYK D +T+ VA + + + + + E EML+ HPN+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 249 VRYLGSYQ----GEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLH 304
VR+ S++ G++ + +V E G++ + + ++ + CR+ LKGL +LH
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 305 S--IFKVHRDIKGGNILLTDQ-GEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQE 361
+ +HRD+K NI +T G VK+GD G+A + +K IGTP +MAPE+ +E
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFMAPEMYEE 187
Query: 362 SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421
+YD VDV+A G+ +EMA P S ++ + + +
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246
Query: 422 AKCLTKEPRARPTAAEMLKHKFIE 445
C+ + R + ++L H F +
Sbjct: 247 EGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 249 bits (637), Expect = 3e-77
Identities = 80/292 (27%), Positives = 139/292 (47%), Gaps = 8/292 (2%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC 243
ED Y+ + LG G++ V A D +T +LVAIK I+ E + EI +L +
Sbjct: 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI 64
Query: 244 SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYL 303
HPN+V Y+ +L+++M+ GG + D + V + E + + + L + YL
Sbjct: 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI-VEKGFYTERDASRLIFQVLDAVKYL 123
Query: 304 HSIFKVHRDIKGGNILLT---DQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ 360
H + VHRD+K N+L + ++ + DFG+ +++ S +T GTP ++APEV+
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGL-SKMEDPGSVLSTACGTPGYVAPEVLA 182
Query: 361 ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI-SIEPAPMLEDKEKWSLVFHD 419
+ Y VD W++GV A + G PP + ++ I E + S D
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242
Query: 420 FVAKCLTKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRASMAQQ 471
F+ + K+P R T + L+H +I + + + QI+ + A+
Sbjct: 243 FIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSE--QIKKNFAKS 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (634), Expect = 1e-76
Identities = 74/320 (23%), Positives = 148/320 (46%), Gaps = 9/320 (2%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV 248
KY + +LG+G +G V++ + + + K + + ++ ++ EI +L H N+
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ--VLVKKEISILNIARHRNI 63
Query: 249 VRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFK 308
+ S++ E L ++ E+ G + + +N + L E +I + + L +LHS
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 309 VHRDIKGGNILLT--DQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDG 366
H DI+ NI+ +K+ +FG A QL + R P + APEV Q
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR-LLFTAPEYYAPEVHQHDVVST 182
Query: 367 KVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI-SIEPAPMLEDKEKWSLVFHDFVAKCL 425
D+W+LG + G+ P +++ I + E E ++ S+ DFV + L
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLL 242
Query: 426 TKEPRARPTAAEMLKHKFIERCKCGATAMLPKIEKARQIRASMAQQAQNILSDEPEVNAT 485
KE ++R TA+E L+H ++++ + + + K R+ ++ ++ N++ + +
Sbjct: 243 VKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARI--S 300
Query: 486 MGLKLNEDYGDTVPSKPQVQ 505
G + G +V +K +V
Sbjct: 301 CGGAIRSQKGVSV-AKVKVA 319
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (622), Expect = 2e-75
Identities = 71/271 (26%), Positives = 119/271 (43%), Gaps = 12/271 (4%)
Query: 178 PESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRG 235
P ED ++ LG+GS+ V AR+L TS AIK++ E +
Sbjct: 2 PRKKRPED----FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR 57
Query: 236 EIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICRE 295
E +++ + HP V+ ++Q +E L+ + Y G + + +E + E
Sbjct: 58 ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 116
Query: 296 ALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR--TMSKRNTFIGTPHW 353
+ L YLH +HRD+K NILL + +++ DFG A L+ ++ N+F+GT +
Sbjct: 117 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 354 MAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKW 413
++PE++ E D+WALG ++ GLPP + + I EK+
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF---PEKF 233
Query: 414 SLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
D V K L + R EM + +
Sbjct: 234 FPKARDLVEKLLVLDATKRLGCEEMEGYGPL 264
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (619), Expect = 4e-75
Identities = 71/267 (26%), Positives = 132/267 (49%), Gaps = 13/267 (4%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQ 242
E P + + +G GS+G VYK + VA+K+++++ + + + E+ +L++
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRK 60
Query: 243 CSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAY 302
H N++ ++G Y L IV ++C G S+ +++ E E ++ I R+ +G+ Y
Sbjct: 61 TRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM--SKRNTFIGTPHWMAPEVIQ 360
LH+ +HRD+K NI L + VK+GDFG+A +R + G+ WMAPEVI+
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 361 ---ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI---SIEPAPMLEDKEKWS 414
++ Y + DV+A G+ E+ G P S ++ + + + + +
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 415 LVFHDFVAKCLTKEPRARPTAAEMLKH 441
+A+CL K+ RP ++L
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 240 bits (613), Expect = 4e-74
Identities = 82/274 (29%), Positives = 132/274 (48%), Gaps = 18/274 (6%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS--------EGEEGYEEIRGEIEML 240
YE LG+G V + T + A+K+I ++ E +E E E+++L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 241 QQCS-HPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKG 299
++ S HPN+++ +Y+ + ++V + G + D + + L E + I R L+
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLEV 122
Query: 300 LAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVI 359
+ LH + VHRD+K NILL D +KL DFG + QL K GTP ++APE+I
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEII 181
Query: 360 QESR------YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI-SIEPAPMLEDKEK 412
+ S Y +VD+W+ GV + G PP M +L MI S + +
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241
Query: 413 WSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446
+S D V++ L +P+ R TA E L H F ++
Sbjct: 242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 2e-69
Identities = 73/272 (26%), Positives = 127/272 (46%), Gaps = 12/272 (4%)
Query: 183 REDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISL-----SEGEEGYEEIRGEI 237
+E+ Y+ ELG G + V K R+ T A K I S E+I E+
Sbjct: 5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 238 EMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREAL 297
+L++ HPNV+ Y+ + + +++E GG + D +E L E + ++ L
Sbjct: 65 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKESLTEEEATEFLKQIL 123
Query: 298 KGLAYLHSIFKVHRDIKGGNILLTDQGE----VKLGDFGVAAQLTRTMSKRNTFIGTPHW 353
G+ YLHS+ H D+K NI+L D+ +K+ DFG+A ++ ++ GTP +
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEF 182
Query: 354 MAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI-SIEPAPMLEDKEK 412
+APE++ + D+W++GV + G P L + ++ E
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242
Query: 413 WSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
S + DF+ + L K+P+ R T + L+H +I
Sbjct: 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 2e-69
Identities = 74/259 (28%), Positives = 118/259 (45%), Gaps = 8/259 (3%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLS--EGEEGYEEIRGEIEMLQ-QCSHP 246
+ L LGKGS+G V+ A KT++ AIK + ++ E E +L HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI 306
+ ++Q +E L+ VMEY GG + + + + + + E + GL +LHS
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDG 366
V+RD+K NILL G +K+ DFG+ + +K NTF GTP ++APE++ +Y+
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNH 182
Query: 367 KVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLT 426
VD W+ GV EM G P + I ++ D + K
Sbjct: 183 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW---LEKEAKDLLVKLFV 239
Query: 427 KEPRARPTAA-EMLKHKFI 444
+EP R ++ +H
Sbjct: 240 REPEKRLGVRGDIRQHPLF 258
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (568), Expect = 5e-68
Identities = 63/254 (24%), Positives = 107/254 (42%), Gaps = 7/254 (2%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVV 249
L ELG G +G V + + VAIK+I E +E E +++ SH +V
Sbjct: 6 LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLV 62
Query: 250 RYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKV 309
+ G + ++I+ EY G + + + + Q+ +C++ + + YL S +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122
Query: 310 HRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT-FIGTPHWMAPEVIQESRYDGKV 368
HRD+ N L+ DQG VK+ DFG++ + + W PEV+ S++ K
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 369 DVWALGVSAVEM-AEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTK 427
D+WA GV E+ + G P I L S + + C +
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSETAEH--IAQGLRLYRPHLASEKVYTIMYSCWHE 240
Query: 428 EPRARPTAAEMLKH 441
+ RPT +L +
Sbjct: 241 KADERPTFKILLSN 254
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 223 bits (569), Expect = 8e-68
Identities = 75/266 (28%), Positives = 125/266 (46%), Gaps = 11/266 (4%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVI--SLSEGEEGYEEIRGEIEMLQQCSHP 246
+YEL LG G V+ ARDL+ VA+KV+ L+ Y R E + +HP
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 247 NVVRYLGSYQGEE----YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAY 302
+V + + E +IVMEY G ++ D+++ TE P+ + + +A + L +
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNF 126
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL---TRTMSKRNTFIGTPHWMAPEVI 359
H +HRD+K NI+++ VK+ DFG+A + ++++ IGT +++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 360 QESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI-SIEPAPMLEDKEKWSLVFH 418
+ D + DV++LG E+ G PP + P+ V + +P P E S
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246
Query: 419 DFVAKCLTKEPRARPTAAEMLKHKFI 444
V K L K P R A ++ +
Sbjct: 247 AVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 1e-67
Identities = 64/254 (25%), Positives = 107/254 (42%), Gaps = 7/254 (2%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVV 249
+ E+G G +G V+ + VAIK I E E+ E E++ + SHP +V
Sbjct: 7 LTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLV 63
Query: 250 RYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKV 309
+ G + + +V E+ G ++D + + +C + +G+AYL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123
Query: 310 HRDIKGGNILLTDQGEVKLGDFGVAAQLTR-TMSKRNTFIGTPHWMAPEVIQESRYDGKV 368
HRD+ N L+ + +K+ DFG+ + + W +PEV SRY K
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 369 DVWALGVSAVEM-AEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTK 427
DVW+ GV E+ +EG P V+ IS L S + + C +
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS--TGFRLYKPRLASTHVYQIMNHCWKE 241
Query: 428 EPRARPTAAEMLKH 441
P RP + +L+
Sbjct: 242 RPEDRPAFSRLLRQ 255
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 4e-67
Identities = 60/256 (23%), Positives = 110/256 (42%), Gaps = 13/256 (5%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV 248
+ +LL +GKG +G V VA+K I + E ++ Q H N+
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNL 62
Query: 249 VRYLGS-YQGEEYLWIVMEYCGGGSVAD-LMNVTEEPLEEYQIAYICREALKGLAYLHSI 306
V+ LG + + L+IV EY GS+ D L + L + + + + YL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDG 366
VHRD+ N+L+++ K+ DFG+ + + T +T W APE ++E ++
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALREKKFST 179
Query: 367 KVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCL 425
K DVW+ G+ E+ G P + V+ +E ++ + ++ + C
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--VEKGYKMDAPDGCPPAVYEVMKNCW 237
Query: 426 TKEPRARPTAAEMLKH 441
+ RP+ ++ +
Sbjct: 238 HLDAAMRPSFLQLREQ 253
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (565), Expect = 5e-67
Identities = 81/298 (27%), Positives = 125/298 (41%), Gaps = 32/298 (10%)
Query: 191 ELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRG----EIEMLQQCSHP 246
E L+ LG+G + VYKARD T+++VAIK I L E + I EI++LQ+ SHP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI 306
N++ L ++ + + +V ++ + + L I L+GL YLH
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESR-YD 365
+ +HRD+K N+LL + G +KL DFG+A + T + APE++ +R Y
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 366 GKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI-------------------------S 400
VD+WA+G E+ +P + L I S
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 401 IEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI-ERCKCGATAMLPK 457
P+ D + P AR TA + LK K+ R LP+
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 297
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (568), Expect = 7e-67
Identities = 76/317 (23%), Positives = 137/317 (43%), Gaps = 29/317 (9%)
Query: 189 KYELLNE-LGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIE-MLQQCSHP 246
Y++ ++ LG G G V + + +T E A+K++ + R E+E + P
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCP 65
Query: 247 NVVRYLGSYQ----GEEYLWIVMEYCGGGSVADLM-NVTEEPLEEYQIAYICREALKGLA 301
++VR + Y+ G + L IVME GG + + + ++ E + + I + + +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125
Query: 302 YLHSIFKVHRDIKGGNILLT---DQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEV 358
YLHSI HRD+K N+L T +KL DFG A + T + + T TP+++APEV
Sbjct: 126 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPCYTPYYVAPEV 184
Query: 359 IQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI-----SIEPAPMLEDKEKW 413
+ +YD D+W+LGV + G PP + H + + + + + +
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244
Query: 414 SLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK-------CGATAMLPKIEKARQIRA 466
S + L EP R T E + H +I + + + E+ ++
Sbjct: 245 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKE 304
Query: 467 SMAQQAQNILSDEPEVN 483
M + D ++
Sbjct: 305 EMTSALATMRVDYEQIK 321
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 8e-67
Identities = 68/270 (25%), Positives = 117/270 (43%), Gaps = 13/270 (4%)
Query: 186 PTTKYELLN-ELGKGSYGAVYKA--RDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQ 242
+ + ELG G++G+V + R K VAIKV+ + EE+ E +++ Q
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 243 CSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAY 302
+P +VR +G Q E L +VME GGG + + E + +A + + G+ Y
Sbjct: 66 LDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 124
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR---TMSKRNTFIGTPHWMAPEVI 359
L VHRD+ N+LL ++ K+ DFG++ L + R+ W APE I
Sbjct: 125 LEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184
Query: 360 QESRYDGKVDVWALGVSAVEM-AEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418
++ + DVW+ GV+ E + G P + V+ IE +E + +
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF--IEQGKRMECPPECPPELY 242
Query: 419 DFVAKCLTKEPRARPTAAE---MLKHKFIE 445
++ C + RP ++ +
Sbjct: 243 ALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 2e-66
Identities = 72/263 (27%), Positives = 112/263 (42%), Gaps = 8/263 (3%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSE---LVAIKVISLSEGEEGYEEIRGEIEML 240
E + EL +G+G +G V++ + VAIK + E+ E +
Sbjct: 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62
Query: 241 QQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGL 300
+Q HP++V+ +G E +WI+ME C G + + V + L+ + + L
Sbjct: 63 RQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 121
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFI-GTPHWMAPEVI 359
AYL S VHRDI N+L++ VKLGDFG++ + + + + WMAPE I
Sbjct: 122 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 360 QESRYDGKVDVWALGVSAVEM-AEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418
R+ DVW GV E+ G+ P V V+ IE L +
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR--IENGERLPMPPNCPPTLY 239
Query: 419 DFVAKCLTKEPRARPTAAEMLKH 441
+ KC +P RP E+
Sbjct: 240 SLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 220 bits (560), Expect = 2e-66
Identities = 63/287 (21%), Positives = 107/287 (37%), Gaps = 19/287 (6%)
Query: 164 EDVRQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSE---LVAIKV 220
ED + + +E + ++ +G G +G V + VAIK
Sbjct: 10 EDPNEAVR--------EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKT 61
Query: 221 ISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVT 280
+ E+ + E ++ Q HPNV+ G + I+ E+ GS+ +
Sbjct: 62 LKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN 121
Query: 281 EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL--- 337
+ Q+ + R G+ YL + VHRD+ NIL+ K+ DFG++ L
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 338 --TRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEM-AEGLPPRSTVHPMR 394
T + W APE IQ ++ DVW+ G+ E+ + G P +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241
Query: 395 VLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441
V+ IE L H + C K+ RP +++
Sbjct: 242 VINA--IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 219 bits (559), Expect = 6e-66
Identities = 66/263 (25%), Positives = 117/263 (44%), Gaps = 14/263 (5%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVI--SLSEGEEGYEEIRGEIEMLQQCSHPN 247
+++L LG GS+G V+ R A+KV+ + + E E ML +HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307
++R G++Q + ++++M+Y GG + L+ + + E L YLHS
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSKD 124
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGK 367
++RD+K NILL G +K+ DFG A + T GTP ++APEV+ Y+
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY---TLCGTPDYIAPEVVSTKPYNKS 181
Query: 368 VDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTK 427
+D W+ G+ EM G P + M+ I ++ D +++ +T+
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF---PPFFNEDVKDLLSRLITR 238
Query: 428 EPRAR-----PTAAEMLKHKFIE 445
+ R ++ H + +
Sbjct: 239 DLSQRLGNLQNGTEDVKNHPWFK 261
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 1e-65
Identities = 91/297 (30%), Positives = 133/297 (44%), Gaps = 38/297 (12%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTS-ELVAIKVISLSEGEEGYEE-IRGEIEMLQQCS-- 244
+YE + E+G+G+YG V+KARDLK VA+K + + GEEG E+ +L+
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 245 -HPNVVRYLG-----SYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALK 298
HPNVVR E L +V E+ L V E + I + + L+
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 299 GLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEV 358
GL +LHS VHRD+K NIL+T G++KL DFG+ A++ + + T + APEV
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL-ARIYSFQMALTSVVVTLWYRAPEV 186
Query: 359 IQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI------------------- 399
+ +S Y VD+W++G EM P + L I
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 400 -----SIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKF---IERCK 448
S P+ + + D + KCLT P R +A L H + +ERCK
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 303
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 220 bits (561), Expect = 1e-65
Identities = 59/266 (22%), Positives = 115/266 (43%), Gaps = 14/266 (5%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLS-----EGEEGYEEIRGEIEMLQQCS 244
+ + +G+G +G VY R T ++ A+K + +GE R + ++
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 245 HPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLH 304
P +V ++ + L +++ GG + ++ E + + E + GL ++H
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHMH 124
Query: 305 SIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESR- 363
+ F V+RD+K NILL + G V++ D G+A ++ K + +GT +MAPEV+Q+
Sbjct: 125 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVA 182
Query: 364 YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAK 423
YD D ++LG ++ G P + + +E + +S +
Sbjct: 183 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 242
Query: 424 CLTKEPRARPT-----AAEMLKHKFI 444
L ++ R A E+ + F
Sbjct: 243 LLQRDVNRRLGCLGRGAQEVKESPFF 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 4e-65
Identities = 65/262 (24%), Positives = 111/262 (42%), Gaps = 14/262 (5%)
Query: 194 NELGKGSYGAVYKA--RDLKTSELVAIKVISLSEGEEGY-EEIRGEIEMLQQCSHPNVVR 250
ELG G++G V K + K + VA+K++ + +E+ E ++QQ +P +VR
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 251 YLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVH 310
+G + E + +VME G + + +++ I + + G+ YL VH
Sbjct: 73 MIGICEAESW-MLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 311 RDIKGGNILLTDQGEVKLGDFGVAAQLT---RTMSKRNTFIGTPHWMAPEVIQESRYDGK 367
RD+ N+LL Q K+ DFG++ L + W APE I ++ K
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190
Query: 368 VDVWALGVSAVEM-AEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLT 426
DVW+ GV E + G P + V M +E + +D + C T
Sbjct: 191 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM--LEKGERMGCPAGCPREMYDLMNLCWT 248
Query: 427 KEPRARPTAAE---MLKHKFIE 445
+ RP A L++ + +
Sbjct: 249 YDVENRPGFAAVELRLRNYYYD 270
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 217 bits (552), Expect = 4e-65
Identities = 69/300 (23%), Positives = 129/300 (43%), Gaps = 35/300 (11%)
Query: 178 PESVTREDPTTKYELLNELGKGSYGAVYKAR-----DLKTSELVAIKVISLSEGEEGYEE 232
P+ ++ E P E + ++G+G++G V++AR + +VA+K++ + +
Sbjct: 3 PKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD 62
Query: 233 IRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLM--------------- 277
+ E ++ + +PN+V+ LG + + ++ EY G + + +
Sbjct: 63 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 278 --------NVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLG 329
+ PL + I R+ G+AYL VHRD+ N L+ + VK+
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 182
Query: 330 DFGVAAQL--TRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPP 386
DFG++ + WM PE I +RY + DVWA GV E+ GL P
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242
Query: 387 RSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446
+ V++ + +L E L ++ + C +K P RP+ + H+ ++R
Sbjct: 243 YYGMAHEEVIYY--VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI--HRILQR 298
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 1e-64
Identities = 72/285 (25%), Positives = 120/285 (42%), Gaps = 28/285 (9%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISL-SEGEEGYEEIRGEIEMLQQCSHPN 247
++ + ++G+G+YG VYKAR+ T E+VA+K I L +E E EI +L++ +HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307
+V+ L E L++V E+ + + I + L+GLA+ HS
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDG- 366
+HRD+K N+L+ +G +KL DFG+A + + T + APE++ +Y
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 367 KVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI--------------------------S 400
VD+W+LG EM + LF I
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242
Query: 401 IEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445
+ +++ L +P R +A L H F +
Sbjct: 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 2e-64
Identities = 58/260 (22%), Positives = 104/260 (40%), Gaps = 9/260 (3%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC 243
E P +L+ LG G +G V+ VA+K + + E +++Q
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQL 65
Query: 244 SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAY 302
H +VR +E ++I+ EY GS+ D + L ++ + + +G+A+
Sbjct: 66 QHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFI-GTPHWMAPEVIQE 361
+ +HRD++ NIL++D K+ DFG+A + W APE I
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 362 SRYDGKVDVWALGVSAVEMA-EGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420
+ K DVW+ G+ E+ G P + V+ +E + + +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN--LERGYRMVRPDNCPEELYQL 242
Query: 421 VAKCLTKEPRARPTAAEMLK 440
+ C + P RPT +
Sbjct: 243 MRLCWKERPEDRPTFDYLRS 262
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 3e-64
Identities = 65/266 (24%), Positives = 113/266 (42%), Gaps = 20/266 (7%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS-----EGEEGYEEIRGEIEMLQQC 243
+Y++ LG G +G+VY + + VAIK + + E+ +L++
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 244 S--HPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLA 301
S V+R L ++ + +++E L+E + L+ +
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 302 YLHSIFKVHRDIKGGNILLT-DQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQ 360
+ H+ +HRDIK NIL+ ++GE+KL DFG A L T+ F GT + PE I+
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIR 182
Query: 361 ESRYDGK-VDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHD 419
RY G+ VW+LG+ +M G P + + +++ S
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII---------RGQVFFRQRVSSECQH 233
Query: 420 FVAKCLTKEPRARPTAAEMLKHKFIE 445
+ CL P RPT E+ H +++
Sbjct: 234 LIRWCLALRPSDRPTFEEIQNHPWMQ 259
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (547), Expect = 4e-64
Identities = 66/289 (22%), Positives = 113/289 (39%), Gaps = 32/289 (11%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSEL-----VAIKVISLSEGEEGYEEIRGEIE 238
E P E LG G++G V A S+ VA+K++ E + E++
Sbjct: 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 92
Query: 239 MLQQC-SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEE--------------- 282
M+ Q SH N+V LG+ ++++ EYC G + + + E
Sbjct: 93 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 283 -------PLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAA 335
L + + KG+ +L VHRD+ N+L+T VK+ DFG+A
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 212
Query: 336 QLT--RTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEM-AEGLPPRSTVHP 392
+ R WMAPE + E Y K DVW+ G+ E+ + G+ P +
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 393 MRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441
+ + I+ ++ + + + C + R RP+ +
Sbjct: 273 DANFYKL-IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 5e-64
Identities = 62/261 (23%), Positives = 106/261 (40%), Gaps = 11/261 (4%)
Query: 190 YELLNELGKGSYGAVYKARDLKTS---ELVAIKVIS--LSEGEEGYEEIRGEIEMLQQCS 244
LL +LG GS+G V + S VA+K + + E ++ E+ +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 245 HPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLH 304
H N++R G + +V E GS+ D + + ++ + +G+ YL
Sbjct: 70 HRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 305 SIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR---TMSKRNTFIGTPHWMAPEVIQE 361
S +HRD+ N+LL + VK+GDFG+ L + + W APE ++
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 362 SRYDGKVDVWALGVSAVEM-AEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420
+ D W GV+ EM G P ++ ++L I E L E ++
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG-ERLPRPEDCPQDIYNV 247
Query: 421 VAKCLTKEPRARPTAAEMLKH 441
+ +C +P RPT +
Sbjct: 248 MVQCWAHKPEDRPTFVALRDF 268
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 5e-63
Identities = 75/298 (25%), Positives = 123/298 (41%), Gaps = 38/298 (12%)
Query: 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS 244
D +Y L+ +G+G+YG V A D VAIK IS E + + EI++L +
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 245 HPNVVRYLGSYQGEEY----LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGL 300
H N++ + ++ + G + L+ + L I Y + L+GL
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK--TQHLSNDHICYFLYQILRGL 122
Query: 301 AYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT---RTMSKRNTFIGTPHWMAPE 357
Y+HS +HRD+K N+LL ++K+ DFG+A ++ T + APE
Sbjct: 123 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 358 VIQESRYDG-KVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI-SIEPAPMLED------ 409
++ S+ +D+W++G EM P H + L I I +P ED
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 410 --------------KEKWSLVFH-------DFVAKCLTKEPRARPTAAEMLKHKFIER 446
K W+ +F D + K LT P R + L H ++E+
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 210 bits (536), Expect = 5e-63
Identities = 66/259 (25%), Positives = 115/259 (44%), Gaps = 5/259 (1%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC 243
E T + ++LG G YG VY+ K S VA+K + E EE E ++++
Sbjct: 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEI 70
Query: 244 SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVAD-LMNVTEEPLEEYQIAYICREALKGLAY 302
HPN+V+ LG E +I+ E+ G++ D L + + + Y+ + + Y
Sbjct: 71 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 130
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFI-GTPHWMAPEVIQE 361
L +HRD+ N L+ + VK+ DFG++ +T + W APE +
Sbjct: 131 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 362 SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFV 421
+++ K DVWA GV E+A + ++ + +E +E E ++ +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEKDYRMERPEGCPEKVYELM 249
Query: 422 AKCLTKEPRARPTAAEMLK 440
C P RP+ AE+ +
Sbjct: 250 RACWQWNPSDRPSFAEIHQ 268
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 6e-63
Identities = 77/263 (29%), Positives = 122/263 (46%), Gaps = 11/263 (4%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS--EGEEGYEEIRGEIEMLQQCSHP 246
++ L LGKG++G V R+ T A+K++ ++ E +LQ HP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSI 306
+ ++Q + L VMEY GG + ++ E E + + E + L YLHS
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSR 124
Query: 307 FKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDG 366
V+RDIK N++L G +K+ DFG+ + + TF GTP ++APEV++++ Y
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 367 KVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLT 426
VD W LGV EM G P R+ +I +E S +A L
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF---PRTLSPEAKSLLAGLLK 241
Query: 427 KEPRARP-----TAAEMLKHKFI 444
K+P+ R A E+++H+F
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 210 bits (534), Expect = 9e-63
Identities = 78/285 (27%), Positives = 121/285 (42%), Gaps = 30/285 (10%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS-EGEEGYEEIRGEIEMLQQCSHPN 247
KY L ++G+G+YG VYKA++ E A+K I L E E EI +L++ H N
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307
+V+ ++ L +V E+ L E LE + L G+AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDG- 366
+HRD+K N+L+ +GE+K+ DFG+A + K I T + AP+V+ S+
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 367 KVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI--------------------------S 400
+D+W++G EM G P V L I
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 401 IEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445
EP P + D ++K L +P R TA + L+H + +
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 9e-63
Identities = 71/266 (26%), Positives = 115/266 (43%), Gaps = 12/266 (4%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC 243
E P L +LG+G +G V+ T+ VAIK + E E +++++
Sbjct: 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP--EAFLQEAQVMKKL 69
Query: 244 SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLM-NVTEEPLEEYQIAYICREALKGLAY 302
H +V+ E ++IV EY GS+ D + T + L Q+ + + G+AY
Sbjct: 70 RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT-MSKRNTFIGTPHWMAPEVIQE 361
+ + VHRD++ NIL+ + K+ DFG+A + + R W APE
Sbjct: 129 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 362 SRYDGKVDVWALGVSAVEMA-EGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420
R+ K DVW+ G+ E+ +G P + VL +E + + HD
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ--VERGYRMPCPPECPESLHDL 246
Query: 421 VAKCLTKEPRARPTAAE---MLKHKF 443
+ +C KEP RPT L+ F
Sbjct: 247 MCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 5e-62
Identities = 67/271 (24%), Positives = 120/271 (44%), Gaps = 22/271 (8%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSEL--VAIKVISLSEGEEGYEEIRGEIEMLQQCS-HP 246
+ + +G+G++G V KAR K AIK + ++ + + GE+E+L + HP
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 247 NVVRYLGSYQGEEYLWIVMEYCGGGSVADLM---------------NVTEEPLEEYQIAY 291
N++ LG+ + YL++ +EY G++ D + N T L Q+ +
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 292 ICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTP 351
+ +G+ YL +HRD+ NIL+ + K+ DFG+ ++ K+
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL-SRGQEVYVKKTMGRLPV 190
Query: 352 HWMAPEVIQESRYDGKVDVWALGVSAVEM-AEGLPPRSTVHPMRVLFMISIEPAPMLEDK 410
WMA E + S Y DVW+ GV E+ + G P + + + LE
Sbjct: 191 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK--LPQGYRLEKP 248
Query: 411 EKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441
+D + +C ++P RP+ A++L
Sbjct: 249 LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 6e-62
Identities = 67/299 (22%), Positives = 114/299 (38%), Gaps = 25/299 (8%)
Query: 167 RQQTKVSSSSIPESVTREDPTTKYELLNELGKGSYGAVYKARDLK-----TSELVAIKVI 221
+ + +P E P + LG G++G V +A + VA+K++
Sbjct: 2 NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61
Query: 222 SLSEGEEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMN-- 278
S E + E+++L H N+V LG+ ++ EYC G + + +
Sbjct: 62 KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
Query: 279 ---------------VTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ 323
E L+ + + KG+A+L S +HRD+ NILLT
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181
Query: 324 GEVKLGDFGVAAQLTR--TMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMA 381
K+ DFG+A + + WMAPE I Y + DVW+ G+ E+
Sbjct: 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 382 EGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440
P+ F I+ + E +D + C +P RPT ++++
Sbjct: 242 SLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 1e-61
Identities = 76/303 (25%), Positives = 129/303 (42%), Gaps = 44/303 (14%)
Query: 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY-EEIRGEIEMLQQC 243
D +KYE L ++G+G++G V+KAR KT + VA+K + + +EG+ EI++LQ
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 244 SHPNVVRYLGSYQ--------GEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICRE 295
H NVV + + + +++V ++C A L++ +I + +
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDL-AGLLSNVLVKFTLSEIKRVMQM 125
Query: 296 ALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT----MSKRNTFIGTP 351
L GL Y+H +HRD+K N+L+T G +KL DFG+A + ++ + T
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 352 HWMAPEVIQESR-YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI-------EP 403
+ PE++ R Y +D+W G EM P L +IS E
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245
Query: 404 APMLEDKEKW----------------------SLVFHDFVAKCLTKEPRARPTAAEMLKH 441
P +++ E + D + K L +P R + + L H
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305
Query: 442 KFI 444
F
Sbjct: 306 DFF 308
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (528), Expect = 1e-61
Identities = 48/277 (17%), Positives = 101/277 (36%), Gaps = 23/277 (8%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV 248
+Y L ++G GS+G +Y D+ E VAIK+ + + + ++ E ++ +
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV---KTKHPQLHIESKIYKMMQGGVG 64
Query: 249 VRYLG-SYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307
+ + +Y +VME G DL N + + + + + Y+HS
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSL-EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123
Query: 308 KVHRDIKGGNILLTDQG---EVKLGDFGVAAQLTRTMS-------KRNTFIGTPHWMAPE 357
+HRD+K N L+ V + DFG+A + + + GT + +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 358 VIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI-----SIEPAPMLEDKEK 412
+ D+ +LG + G P + P+ +
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243
Query: 413 WSLVFHDFVAKCLTKEPRARPTAA---EMLKHKFIER 446
+ F ++ C + +P + ++ ++ F +
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 4e-61
Identities = 62/261 (23%), Positives = 112/261 (42%), Gaps = 10/261 (3%)
Query: 188 TKYELLNELGKGSYGAVYKARDLKTSEL----VAIKVISLSEGEEGYEEIRGEIEMLQQC 243
T+++ + LG G++G VYK + E VAIK + + + +EI E ++
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 244 SHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYL 303
+P+V R LG + ++ + G + D + ++ + + C + KG+ YL
Sbjct: 69 DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 304 HSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT--FIGTPHWMAPEVIQE 361
VHRD+ N+L+ VK+ DFG+A L + + WMA E I
Sbjct: 128 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 362 SRYDGKVDVWALGVSAVEM-AEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420
Y + DVW+ GV+ E+ G P + + + +E L ++ +
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI--LEKGERLPQPPICTIDVYMI 245
Query: 421 VAKCLTKEPRARPTAAEMLKH 441
+ KC + +RP E++
Sbjct: 246 MVKCWMIDADSRPKFRELIIE 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 5e-61
Identities = 64/267 (23%), Positives = 106/267 (39%), Gaps = 10/267 (3%)
Query: 182 TREDPTTKYELLNELGKGSYGAVYKARDLKTSE----LVAIKVISLSEGEEGYEEIRGEI 237
T E + +G G +G VYK +S VAIK + E+ + GE
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 238 EMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREAL 297
++ Q SH N++R G + + I+ EY G++ + + Q+ + R
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 298 KGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFI---GTPHWM 354
G+ YL ++ VHRD+ NIL+ K+ DFG++ L T W
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 355 APEVIQESRYDGKVDVWALGVSAVEM-AEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKW 413
APE I ++ DVW+ G+ E+ G P + V+ I L
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA--INDGFRLPTPMDC 238
Query: 414 SLVFHDFVAKCLTKEPRARPTAAEMLK 440
+ + +C +E RP A+++
Sbjct: 239 PSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 4e-60
Identities = 59/257 (22%), Positives = 106/257 (41%), Gaps = 11/257 (4%)
Query: 194 NELGKGSYGAVYKARDLKTS---ELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVR 250
+G+G +G VY L A+K ++ + E +++ SHPNV+
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 251 YLG-SYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKV 309
LG + E +V+ Y G + + + + + KG+ +L S V
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 152
Query: 310 HRDIKGGNILLTDQGEVKLGDFGVAAQL----TRTMSKRNTFIGTPHWMAPEVIQESRYD 365
HRD+ N +L ++ VK+ DFG+A + ++ + WMA E +Q ++
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 212
Query: 366 GKVDVWALGVSAVEM-AEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424
K DVW+ GV E+ G PP V+ + + L E ++ + KC
Sbjct: 213 TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY--LLQGRRLLQPEYCPDPLYEVMLKC 270
Query: 425 LTKEPRARPTAAEMLKH 441
+ RP+ +E++
Sbjct: 271 WHPKAEMRPSFSELVSR 287
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 4e-59
Identities = 71/311 (22%), Positives = 118/311 (37%), Gaps = 41/311 (13%)
Query: 171 KVSSS-SIPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEG 229
KV++ + P Y +G GS+G VY+A+ + ELVAIK + +
Sbjct: 2 KVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---- 57
Query: 230 YEEIRGEIEMLQQCSHPNVVRYLGSY------QGEEYLWIVMEYCGGGSVADLMNVT--E 281
E++++++ H N+VR + + E YL +V++Y + + +
Sbjct: 58 -RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 116
Query: 282 EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLT-DQGEVKLGDFGVAAQLTRT 340
+ L + + + LAY+HS HRDIK N+LL D +KL DFG A QL R
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 341 MSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI- 399
+ + + + Y +DVW+ G E+ G P + L I
Sbjct: 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 400 ------------------------SIEPAPMLED-KEKWSLVFHDFVAKCLTKEPRARPT 434
I+ P + + + ++ L P AR T
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296
Query: 435 AAEMLKHKFIE 445
E H F +
Sbjct: 297 PLEACAHSFFD 307
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 200 bits (510), Expect = 1e-58
Identities = 69/303 (22%), Positives = 131/303 (43%), Gaps = 21/303 (6%)
Query: 157 SSSSLHGEDVRQQTKVSSSSIPESVTREDPTT-------KYELLNELGKGSYGAVYKARD 209
++++ G + + + + + + + + + +++ + LG GS+G V +
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKH 62
Query: 210 LKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEY 267
++ A+K++ + + E E +LQ + P +V+ S++ L++VMEY
Sbjct: 63 KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 268 CGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVK 327
GG + + E + + + YLHS+ ++RD+K N+L+ QG ++
Sbjct: 123 VAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181
Query: 328 LGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPR 387
+ DFG A R + T GTP +APE+I Y+ VD WALGV EMA G PP
Sbjct: 182 VTDFGFA---KRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238
Query: 388 STVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEP-----RARPTAAEMLKHK 442
P+++ I +S D + L + + ++ HK
Sbjct: 239 FADQPIQIYEKIVSGKVRF---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295
Query: 443 FIE 445
+
Sbjct: 296 WFA 298
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-58
Identities = 65/290 (22%), Positives = 126/290 (43%), Gaps = 26/290 (8%)
Query: 177 IPESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSE-------LVAIKVISLSEGEEG 229
+PE E P + L LG+G++G V A + + VA+K++ E+
Sbjct: 2 LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD 61
Query: 230 YEEIRGEIEMLQQCS-HPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLM----------- 277
++ E+EM++ H N++ LG+ + L++++EY G++ + +
Sbjct: 62 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 121
Query: 278 ----NVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGV 333
+ EE L + + +G+ YL S +HRD+ N+L+T+ +K+ DFG+
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 181
Query: 334 AAQLTRTMSKRNT--FIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVH 391
A + + T WMAPE + + Y + DVW+ GV E+
Sbjct: 182 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241
Query: 392 PMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441
P+ LF + ++ ++ + + + C P RPT ++++
Sbjct: 242 PVEELFKL-LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-58
Identities = 71/285 (24%), Positives = 125/285 (43%), Gaps = 30/285 (10%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY-EEIRGEIEMLQQCSHPN 247
KYE L ++G+G+YG V+KA++ +T E+VA+K + L + +EG EI +L++ H N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 248 VVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF 307
+VR ++ L +V E+C + + E + + LKGL + HS
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE-IVKSFLFQLLKGLGFCHSRN 121
Query: 308 KVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESR-YDG 366
+HRD+K N+L+ GE+KL +FG+A + + + T + P+V+ ++ Y
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 367 KVDVWALGVSAVEMAEGLPP---------------------------RSTVHPMRVLFMI 399
+D+W+ G E+A P T P + +
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 400 SIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFI 444
++ K + D + L P R +A E L+H +
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (500), Expect = 1e-57
Identities = 64/275 (23%), Positives = 117/275 (42%), Gaps = 19/275 (6%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARD-----LKTSELVAIKVISLSEGEEGYEEIRGEIE 238
E K + ELG+GS+G VY+ + VAIK ++ + E E
Sbjct: 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 75
Query: 239 MLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLM---------NVTEEPLEEYQI 289
++++ + +VVR LG + ++ME G + + N P ++
Sbjct: 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 290 AYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR--NTF 347
+ E G+AYL++ VHRD+ N ++ + VK+GDFG+ + T R
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 348 IGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGL-PPRSTVHPMRVLFMISIEPAPM 406
+ WM+PE +++ + DVW+ GV E+A P + +VL + +
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--VMEGGL 253
Query: 407 LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441
L+ + + + + C P+ RP+ E++
Sbjct: 254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 194 bits (493), Expect = 8e-57
Identities = 48/269 (17%), Positives = 97/269 (36%), Gaps = 20/269 (7%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV 248
Y++ +G+GS+G +++ +L ++ VAIK + ++L C+
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPN 65
Query: 249 VRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFK 308
V Y G + +V++ G S+ DL+++ +A ++ L + +H
Sbjct: 66 VYYFGQE--GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 122
Query: 309 VHRDIKGGNILLTDQ-----GEVKLGDFGVAAQLTRTMSK-------RNTFIGTPHWMAP 356
V+RDIK N L+ + + DFG+ ++K + GT +M+
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 357 EVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI-----SIEPAPMLEDKE 411
+ D+ ALG + G P + + P+ E
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242
Query: 412 KWSLVFHDFVAKCLTKEPRARPTAAEMLK 440
+ F+ ++ A P +
Sbjct: 243 GFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 9e-57
Identities = 65/293 (22%), Positives = 111/293 (37%), Gaps = 47/293 (16%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV 248
L +GKG +G V++ + E VA+K+ S E + E EI H N+
Sbjct: 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREA--EIYQTVMLRHENI 59
Query: 249 VRYLGSYQGEE----YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLH 304
+ ++ + + LW+V +Y GS+ D +N + + + GLA+LH
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLH 117
Query: 305 SIFK--------VHRDIKGGNILLTDQGEVKLGDFGVAAQL----TRTMSKRNTFIGTPH 352
HRD+K NIL+ G + D G+A + N +GT
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 353 WMAPEVIQES------RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPM 406
+MAPEV+ +S + D++A+G+ E+A ++ + + P
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
Query: 407 LEDKEK-------------------WSLVFHDFVAKCLTKEPRARPTAAEMLK 440
+E+ K V + +C AR TA + K
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-56
Identities = 62/282 (21%), Positives = 120/282 (42%), Gaps = 24/282 (8%)
Query: 184 EDPTTKYELLNELGKGSYGAVYKARDLK-----TSELVAIKVISLSEGEEGYEEIRGEIE 238
E P + +L LG+G++G V +A T VA+K++ + + E++
Sbjct: 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 68
Query: 239 MLQQCSHPNVVRYLGSYQGEE--YLWIVMEYCGGGSVADLM---------------NVTE 281
+L H V L + L +++E+C G+++ + ++ +
Sbjct: 69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 282 EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR-- 339
+ L + + KG+ +L S +HRD+ NILL+++ VK+ DFG+A + +
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
Query: 340 TMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI 399
++ WMAPE I + Y + DVW+ GV E+ + F
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248
Query: 400 SIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441
++ + + + + + C EP RPT +E+++H
Sbjct: 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-56
Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 42/293 (14%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGY-EEIRGEIEMLQQCSHPN 247
Y L +G G+YGAV A D +T VAIK + E + + E+ +L+ H N
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHEN 78
Query: 248 VVRYLGSYQGEE------YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLA 301
V+ L + +E ++VM + G + LM E L E +I ++ + LKGL
Sbjct: 79 VIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMK--HEKLGEDRIQFLVYQMLKGLR 135
Query: 302 YLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQE 361
Y+H+ +HRD+K GN+ + + E+K+ DFG+A Q M ++ T + APEVI
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVILN 192
Query: 362 SRYDG-KVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI--------------------- 399
VD+W++G EM G + L I
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252
Query: 400 -------SIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIE 445
+E S + + + K L + R TA E L H + E
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-55
Identities = 80/297 (26%), Positives = 144/297 (48%), Gaps = 22/297 (7%)
Query: 166 VRQQTKVSS-SSIPESVTREDPTTKYELLNELGKGSYGAVYKARDL---KTSELVAIKVI 221
V+ + + ++ + E V E+ +ELL LG G+YG V+ R + T +L A+KV+
Sbjct: 5 VKHELRTANLTGHAEKVGIEN----FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVL 60
Query: 222 ---SLSEGEEGYEEIRGEIEMLQQCSH-PNVVRYLGSYQGEEYLWIVMEYCGGGSVADLM 277
++ + + E R E ++L+ P +V ++Q E L ++++Y GG + +
Sbjct: 61 KKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL 120
Query: 278 NVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL 337
+ E E+++ E + L +LH + ++RDIK NILL G V L DFG++ +
Sbjct: 121 S-QRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179
Query: 338 TRTMSKR-NTFIGTPHWMAPEVIQ--ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMR 394
++R F GT +MAP++++ +S +D VD W+LGV E+ G P +
Sbjct: 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239
Query: 395 VLFMI-SIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARP-----TAAEMLKHKFIE 445
I ++ S + D + + L K+P+ R A E+ +H F +
Sbjct: 240 SQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 190 bits (482), Expect = 7e-55
Identities = 66/295 (22%), Positives = 129/295 (43%), Gaps = 49/295 (16%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPN 247
Y+L+ +LG+G Y V++A ++ +E V +K++ + ++I+ EI++L+ PN
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPN 91
Query: 248 VVRYLGSYQ--GEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS 305
++ + +V E+ L + L +Y I + E LK L Y HS
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHS 147
Query: 306 IFKVHRDIKGGNILLTDQG-EVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESR- 363
+ +HRD+K N+++ + +++L D+G+A + N + + ++ PE++ + +
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDYQM 206
Query: 364 YDGKVDVWALGVSAVEMAEGLPP-----------------RSTVHPMRVLFMISIEPAPM 406
YD +D+W+LG M P T + +IE P
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 407 LED------KEKWSLVFH------------DFVAKCLTKEPRARPTAAEMLKHKF 443
D +++W H DF+ K L + ++R TA E ++H +
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-54
Identities = 67/291 (23%), Positives = 127/291 (43%), Gaps = 40/291 (13%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS-EGEEGYEEIRGEIEMLQQCSHPN 247
+Y+ L+ +G G+YG+V A D KT VA+K +S + + E+ +L+ H N
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 248 VVRYLGSYQGEEYLW-----IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAY 302
V+ L + L ++ + G + +++ + L + + ++ + L+GL Y
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKY 136
Query: 303 LHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQES 362
+HS +HRD+K N+ + + E+K+ DFG+A M ++ T + APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNW 193
Query: 363 R-YDGKVDVWALGVSAVEMAEGLPP---RSTVHPMRVLFMISIEPAPMLED--------- 409
Y+ VD+W++G E+ G + ++++ + P L
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 410 ---------KEKWSLVFH-------DFVAKCLTKEPRARPTAAEMLKHKFI 444
K ++ VF D + K L + R TAA+ L H +
Sbjct: 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 5e-53
Identities = 62/302 (20%), Positives = 118/302 (39%), Gaps = 51/302 (16%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLS-EGEEGYEEIRGEIEMLQQCSHPN 247
+Y+ L +G G+ G V A D VAIK +S + + + E+ +++ +H N
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 248 VVRYLGSYQGE------EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLA 301
++ L + + + +++VME + + +++Y+ + L G+
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE----RMSYLLYQMLCGIK 133
Query: 302 YLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQE 361
+LHS +HRD+K NI++ +K+ DFG+ A+ T ++ T ++ APEVI
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILG 192
Query: 362 SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI-SIEPAPMLEDKEK-------- 412
Y VD+W++G EM + + P E +K
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 413 ------------------------------WSLVFHDFVAKCLTKEPRARPTAAEMLKHK 442
+ D ++K L +P R + + L+H
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312
Query: 443 FI 444
+I
Sbjct: 313 YI 314
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 156 bits (395), Expect = 1e-42
Identities = 57/323 (17%), Positives = 117/323 (36%), Gaps = 72/323 (22%)
Query: 189 KYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV 248
+Y L+ +LG G + V+ A+D+ + VA+K++ + E EI++LQ+ + +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT--EAAEDEIKLLQRVNDADN 71
Query: 249 VRYLGS---------------YQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYIC 293
+ ++ +V E G +A + + + I
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 294 REALKGLAYLHSIFKV-HRDIKGGNILLTDQG------EVKLGDFGVAAQLTRTMSKRNT 346
++ L GL Y+H + H DIK N+L+ ++K+ D G A
Sbjct: 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---YDEHYTN 188
Query: 347 FIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPP----------RSTVHPMRVL 396
I T + +PEV+ + + D+W+ E+ G + H +++
Sbjct: 189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
Query: 397 FMISIEPAPMLEDKEKWSLVFH-----------------------------------DFV 421
++ P+ +L + + F+ DF+
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308
Query: 422 AKCLTKEPRARPTAAEMLKHKFI 444
+ L +PR R A ++ H ++
Sbjct: 309 SPMLQLDPRKRADAGGLVNHPWL 331
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 99.9 bits (248), Expect = 1e-24
Identities = 25/210 (11%), Positives = 59/210 (28%), Gaps = 40/210 (19%)
Query: 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE-----------------EGYEE 232
+ +G+G AV+ + +K +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 233 IRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYI 292
R E LQ+ V + ++ME + + +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRVR--------VENPDEV 108
Query: 293 CREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNTFIGTPH 352
L+ +A + VH D+ N+L++++G + + DF + ++ +
Sbjct: 109 LDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILE----- 162
Query: 353 WMAPEVIQES---RYDGKVDVWALGVSAVE 379
I Y + D+ + ++
Sbjct: 163 -RDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 774 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.32 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.89 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.75 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.04 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.66 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.09 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-59 Score=494.37 Aligned_cols=261 Identities=44% Similarity=0.785 Sum_probs=234.6
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
.+..+|+++++||+|+||+||+|++..+|+.||||++..... ...+.+.+|+.+|++++|||||+++++|...+.+|||
T Consensus 17 dp~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp CTTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC-hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 345689999999999999999999999999999999976543 3356789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
||||+||+|.+++.. ..+++.+++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.......
T Consensus 96 mEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 173 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (293)
T ss_dssp EECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccc
Confidence 999999999998753 569999999999999999999999999999999999999999999999999998876555555
Q ss_pred ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
...+||+.|+|||++.+..|+.++|||||||++|+|++|++||........+..+.....+....+..++..+++||.+|
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 253 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHH
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHH
Confidence 66789999999999999999999999999999999999999999888777666655555555556678899999999999
Q ss_pred cccCCCCCCCHHHHHhhhhhhhhc
Q 004088 425 LTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 425 L~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
|++||.+|||+.|+|+||||+...
T Consensus 254 L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 254 LDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp TCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ccCChhHCcCHHHHhcCHhhCCCC
Confidence 999999999999999999998643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-59 Score=487.84 Aligned_cols=259 Identities=27% Similarity=0.463 Sum_probs=222.1
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
.++|++++.||+|+||+||+|+++.+|+.||||++.........+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 45799999999999999999999999999999999866544555678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc--ccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM--SKR 344 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~--~~~ 344 (774)
||++|+|.+++. ....+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+.... ...
T Consensus 84 y~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 84 YCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp CCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred ccCCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence 999999999986 45689999999999999999999999999999999999999999999999999998764432 223
Q ss_pred ccccccccccchhhhhhcCC-CCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHh
Q 004088 345 NTFIGTPHWMAPEVIQESRY-DGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAK 423 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~~-s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~k 423 (774)
...+||+.|||||++.+..+ +.++|||||||++|+|++|++||.........................++..+.+||.+
T Consensus 163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 242 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242 (271)
T ss_dssp CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHH
T ss_pred cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHH
Confidence 45689999999999988776 56899999999999999999999776544433333333333334456778999999999
Q ss_pred hcccCCCCCCCHHHHHhhhhhhh
Q 004088 424 CLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 424 cL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
||++||.+|||++|+|+||||++
T Consensus 243 ~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 243 ILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HcCCChhHCcCHHHHhcCHhhCc
Confidence 99999999999999999999974
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-58 Score=489.60 Aligned_cols=260 Identities=47% Similarity=0.851 Sum_probs=234.3
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
+.+.|++++.||+|+||+||+|++..+|+.||||++.... ....+.+.+|+++|++++|||||+++++|.+++.+||||
T Consensus 10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 3457999999999999999999999999999999997543 345677899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRN 345 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~ 345 (774)
|||++|+|.+++......+++.+++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+..........
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~ 168 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 168 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence 99999999999876677899999999999999999999999999999999999999999999999999977655444445
Q ss_pred cccccccccchhhhh-----hcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHH
Q 004088 346 TFIGTPHWMAPEVIQ-----ESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~-----~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
+.+||+.|+|||++. ...|+.++|||||||++|+|++|++||......+....+.....+....+..++..+.+|
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~l 248 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence 678999999999984 456899999999999999999999999998888877777666666666677889999999
Q ss_pred HHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 421 VAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
|.+||++||.+|||+.|+|+||||+.
T Consensus 249 i~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 249 LKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHHccCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999963
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-57 Score=477.04 Aligned_cols=254 Identities=30% Similarity=0.492 Sum_probs=226.3
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
.++|++++.||+|+||+||+|+++.+++.||||++.+.. .....+.+.+|+.+|++++|||||++++++.+++.+|||
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 468999999999999999999999999999999996432 223456789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
||||++|+|.+++. ....+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+..... ..
T Consensus 85 mEy~~~g~L~~~l~-~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--~~ 161 (263)
T d2j4za1 85 LEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RR 161 (263)
T ss_dssp EECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--CC
T ss_pred EeecCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC--cc
Confidence 99999999999986 4467999999999999999999999999999999999999999999999999999765443 33
Q ss_pred ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
...+||+.|||||++.+..|+.++|||||||++|+|++|++||...+.......+...... .+..+++.+.+||.+|
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~li~~~ 238 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---FPDFVTEGARDLISRL 238 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC---CCTTSCHHHHHHHHHH
T ss_pred cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCccCCHHHHHHHHHH
Confidence 4568999999999999999999999999999999999999999988777766665443322 2346789999999999
Q ss_pred cccCCCCCCCHHHHHhhhhhhh
Q 004088 425 LTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 425 L~~DP~kRPTa~ElL~HPwf~~ 446 (774)
|++||.+|||+.|+|+||||..
T Consensus 239 L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 239 LKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp TCSSGGGSCCHHHHHTCHHHHH
T ss_pred ccCCHhHCcCHHHHHcCcCcCC
Confidence 9999999999999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-57 Score=488.23 Aligned_cols=260 Identities=33% Similarity=0.585 Sum_probs=222.4
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
...++|+++++||+|+||+||+|+++.+|+.||||+++..........+.+|+.+|++++|||||+++++|.+...+|||
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 45678999999999999999999999999999999998765556667899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHh-cCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS-IFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs-~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
||||+||+|.+++.. .+.+++..++.++.||+.||.|||+ +|||||||||+||||+.+|++||+|||+|+.+... .
T Consensus 83 mEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~ 159 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--M 159 (322)
T ss_dssp EECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--T
T ss_pred EEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--c
Confidence 999999999999963 4579999999999999999999997 59999999999999999999999999999876543 3
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhh------------------------
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI------------------------ 399 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i------------------------ 399 (774)
..+.+||+.|||||++.+..|+.++|||||||++|||++|+.||...+........
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence 34679999999999999999999999999999999999999999765432211100
Q ss_pred ------------------hcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 400 ------------------SIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 400 ------------------~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.....+ ......++.++.+||.+||++||.+|||++|+|+||||++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 240 YGMDSRPPMAIFELLDYIVNEPPP-KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp ------CCCCHHHHHHHHHTSCCC-CCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cccccccchhHHHHHhhhhccCCc-cCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 000001 111234678899999999999999999999999999998754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-57 Score=473.70 Aligned_cols=255 Identities=29% Similarity=0.507 Sum_probs=213.4
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccC--CceEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG--EEYLWIV 264 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~--~~~l~LV 264 (774)
++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+++|++++|||||++++++.+ ...+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999999999999999997654 34456678999999999999999999998854 5678999
Q ss_pred EEecCCCchhhhhhc---cCCchhHHHHHHHHHHHHHHHHHHHhcC-----cccccccccceEecCCCcEEEeecccccc
Q 004088 265 MEYCGGGSVADLMNV---TEEPLEEYQIAYICREALKGLAYLHSIF-----KVHRDIKGGNILLTDQGEVKLGDFGVAAQ 336 (774)
Q Consensus 265 mEy~~ggsL~dll~~---~~~~Lse~~i~~I~~QIl~gL~YLHs~g-----IIHRDLKPeNILLd~~g~vKL~DFGlA~~ 336 (774)
||||++|+|.+++.. ....+++..++.++.||+.||.|||++| ||||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999863 3467999999999999999999999976 99999999999999999999999999988
Q ss_pred ccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHH
Q 004088 337 LTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLV 416 (774)
Q Consensus 337 i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~ 416 (774)
+..........+||+.|||||++.+..|+.++|||||||++|||++|++||...+..+....+.....+. .+..+++.
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~ 241 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR--IPYRYSDE 241 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--CCTTSCHH
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC--CCcccCHH
Confidence 7665445566789999999999999999999999999999999999999999888777666655443332 24568899
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhhhhh
Q 004088 417 FHDFVAKCLTKEPRARPTAAEMLKHKFI 444 (774)
Q Consensus 417 l~dLI~kcL~~DP~kRPTa~ElL~HPwf 444 (774)
+.+||.+||+.||.+|||+.|+|+|||+
T Consensus 242 l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 242 LNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 9999999999999999999999999995
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-56 Score=478.71 Aligned_cols=260 Identities=28% Similarity=0.428 Sum_probs=211.4
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
..+.|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 45679999999999999999999999999999999986554444567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEec---CCCcEEEeecccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLT---DQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd---~~g~vKL~DFGlA~~i~~~~~ 342 (774)
|||+||+|.+++. ..+.+++.++..++.||+.||.|||++|||||||||+|||+. .++.+||+|||+|+..... .
T Consensus 87 E~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~-~ 164 (307)
T d1a06a_ 87 QLVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-S 164 (307)
T ss_dssp CCCCSCBHHHHHH-TCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred eccCCCcHHHhhh-cccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC-C
Confidence 9999999999996 456899999999999999999999999999999999999995 4688999999999865433 3
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCC-ccccchhchHHHHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAP-MLEDKEKWSLVFHDFV 421 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~-~~~~~~~~s~~l~dLI 421 (774)
...+.+||+.|||||++.+..|+.++|||||||++|+|++|++||...........+...... .......+++.+.+||
T Consensus 165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 244 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 244 (307)
T ss_dssp --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHH
Confidence 345578999999999999999999999999999999999999999988777666655443322 2233457889999999
Q ss_pred HhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 422 AKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 422 ~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
.+||++||.+|||+.|+|+||||+..
T Consensus 245 ~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 245 RHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-56 Score=465.99 Aligned_cols=254 Identities=28% Similarity=0.491 Sum_probs=217.2
Q ss_pred CCe-eEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccC----CceE
Q 004088 188 TKY-ELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG----EEYL 261 (774)
Q Consensus 188 ~~Y-~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~----~~~l 261 (774)
++| ++.++||+|+||+||+|++..+++.||||++.... .....+.+.+|+++|++++|||||+++++|.. ...+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 345 78889999999999999999999999999997543 44456778999999999999999999999853 5678
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcC--cccccccccceEec-CCCcEEEeecccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIF--KVHRDIKGGNILLT-DQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~g--IIHRDLKPeNILLd-~~g~vKL~DFGlA~~i~ 338 (774)
|||||||++|+|.+++. ....+++..++.|+.||+.||+|||+++ ||||||||+||||+ .++.+||+|||+|+...
T Consensus 88 ~ivmE~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEeCCCCCcHHHHHh-ccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999999986 3467999999999999999999999999 99999999999997 47899999999997543
Q ss_pred ccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 339 RTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 339 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
.. .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||........+................+++.+.
T Consensus 167 ~~--~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (270)
T d1t4ha_ 167 AS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243 (270)
T ss_dssp TT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred CC--ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHH
Confidence 32 3346689999999999876 59999999999999999999999998766555444333333333334456788899
Q ss_pred HHHHhhcccCCCCCCCHHHHHhhhhhh
Q 004088 419 DFVAKCLTKEPRARPTAAEMLKHKFIE 445 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~HPwf~ 445 (774)
+||.+||++||++|||+.|+|+||||+
T Consensus 244 ~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 244 EIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 999999999999999999999999995
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-56 Score=477.20 Aligned_cols=256 Identities=48% Similarity=0.849 Sum_probs=224.9
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC--hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG--EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~--~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~L 263 (774)
+...|+++++||+|+||+||+|++..+|+.||||++..... ....+.+.+|+++|++++|||||+++++|.+++.+||
T Consensus 13 p~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 92 (309)
T d1u5ra_ 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (309)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred cHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence 34569999999999999999999999999999999976542 3445678999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|||||.+|+|..++. ...++++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+....
T Consensus 93 v~E~~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp EEECCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred EEEecCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence 999999998876654 457899999999999999999999999999999999999999999999999999976543
Q ss_pred cccccccccccchhhhhh---cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQE---SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~---~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
....+||+.|||||++.+ ..|+.++|||||||++|||++|.+||........+..+.....+.. ....+++.+.+|
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~s~~~~~l 246 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL-QSGHWSEYFRNF 246 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SCTTSCHHHHHH
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-CCCCCCHHHHHH
Confidence 245689999999999964 4589999999999999999999999998887776666554444332 245678999999
Q ss_pred HHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 421 VAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
|.+||++||.+|||+.|+|+||||.+.
T Consensus 247 i~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 247 VDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 999999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-56 Score=472.92 Aligned_cols=258 Identities=27% Similarity=0.438 Sum_probs=223.9
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+.+|+++|++++|||||+++++|.+++.+|||
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 357999999999999999999999999999999997532 233456789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc--c
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM--S 342 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~--~ 342 (774)
||||+||+|.+++. ..+.+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+.... .
T Consensus 87 mEy~~gg~L~~~~~-~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 87 LSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp ECCCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEccCCCCHHHhhh-ccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 99999999999886 44679999999999999999999999999999999999999999999999999998765432 2
Q ss_pred ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHH
Q 004088 343 KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~ 422 (774)
...+.+||+.|+|||++.+..|+.++|||||||++|+|++|++||...+.......+...... .+..+++.+.+||.
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~li~ 242 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD---FPEKFFPKARDLVE 242 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC---CCTTCCHHHHHHHH
T ss_pred ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCC---CCccCCHHHHHHHH
Confidence 234568999999999999999999999999999999999999999988777766665544322 23567899999999
Q ss_pred hhcccCCCCCCCHHH------HHhhhhhhhhc
Q 004088 423 KCLTKEPRARPTAAE------MLKHKFIERCK 448 (774)
Q Consensus 423 kcL~~DP~kRPTa~E------lL~HPwf~~~~ 448 (774)
+||++||.+|||++| +++||||+...
T Consensus 243 ~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 243 KLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp TTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred HHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence 999999999999987 57889987654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-56 Score=478.91 Aligned_cols=257 Identities=30% Similarity=0.465 Sum_probs=230.8
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
.++|++++.||+|+||.||+|+++.+|+.||||++++.. .....+.+.+|+.+|++++|||||+++++|.+.+.+|||
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 467999999999999999999999999999999997542 223457789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
||||+||+|..++. ..+.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.........
T Consensus 84 ~ey~~gg~L~~~~~-~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~ 162 (337)
T d1o6la_ 84 MEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162 (337)
T ss_dssp EECCTTCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred eeccCCCchhhhhh-cccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCccc
Confidence 99999999999986 45679999999999999999999999999999999999999999999999999998776555556
Q ss_pred ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
...+||+.|+|||++.+..|+.++|||||||++|||++|++||...+.......+...... .+..++..+++||.+|
T Consensus 163 ~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~dli~~~ 239 (337)
T d1o6la_ 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR---FPRTLSPEAKSLLAGL 239 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTSCHHHHHHHHHH
T ss_pred ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCC---CCccCCHHHHHHHHhh
Confidence 6789999999999999999999999999999999999999999998877766665554332 2456889999999999
Q ss_pred cccCCCCCC-----CHHHHHhhhhhhhh
Q 004088 425 LTKEPRARP-----TAAEMLKHKFIERC 447 (774)
Q Consensus 425 L~~DP~kRP-----Ta~ElL~HPwf~~~ 447 (774)
|++||.+|+ +++|+++||||+..
T Consensus 240 L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ccCCchhhcccccccHHHHHcCcccccC
Confidence 999999999 49999999999753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.5e-55 Score=479.72 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=230.2
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
..++|++++.||+|+||+||+|++..+|+.||||+++... ......+.+|+.+|++|+|||||+++++|.+++.+||||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3467999999999999999999999999999999997543 334567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEec--CCCcEEEeeccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLT--DQGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd--~~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|||+||+|.+++.....++++.+++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|+.+... ..
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-~~ 184 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EI 184 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-SC
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC-Cc
Confidence 99999999998876667899999999999999999999999999999999999998 5689999999999876543 33
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCC-ccccchhchHHHHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAP-MLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~-~~~~~~~~s~~l~dLI~ 422 (774)
..+.+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+......+..+...... .......++..+.+||.
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 264 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 264 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHH
T ss_pred eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence 45568999999999999999999999999999999999999999988877776665443322 22334568899999999
Q ss_pred hhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 423 KCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
+||++||.+|||+.|+|+||||+..
T Consensus 265 ~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 265 NLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp TTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHccCChhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-55 Score=479.26 Aligned_cols=261 Identities=25% Similarity=0.374 Sum_probs=230.4
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
..++|++++.||+|+||+||+|++..+|+.||||++.... ....+.+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3468999999999999999999999999999999996543 445577899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC--CCcEEEeeccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD--QGEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~--~g~vKL~DFGlA~~i~~~~~~ 343 (774)
|||+||+|.+++.....++++..++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|||+|+.+... ..
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-~~ 181 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QS 181 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-SC
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-cc
Confidence 999999999998766678999999999999999999999999999999999999964 578999999999876544 33
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCC-ccccchhchHHHHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAP-MLEDKEKWSLVFHDFVA 422 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~-~~~~~~~~s~~l~dLI~ 422 (774)
..+.+||+.|||||++.+..|+.++|||||||++|+|++|++||...+..+.+..+...... .......++..+++||.
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 261 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 261 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHH
T ss_pred cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence 45578999999999999999999999999999999999999999988777766655443322 23334567899999999
Q ss_pred hhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 423 KCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
+||++||.+|||+.|+|+||||+...
T Consensus 262 ~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 262 KLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHccCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999998654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=464.45 Aligned_cols=259 Identities=28% Similarity=0.448 Sum_probs=227.8
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-----hhhHHHHHHHHHHHHhCCCCCcccccccccCCce
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-----EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEY 260 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-----~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~ 260 (774)
..++|++++.||+|+||+||+|+++.+|+.||||++.+... ....+.+.+|+.+|++++|||||+++++|.+...
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 34679999999999999999999999999999999975432 2245789999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC----cEEEeecccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG----EVKLGDFGVAAQ 336 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g----~vKL~DFGlA~~ 336 (774)
+|||||||++|+|.+++.. .+.+++..++.++.||+.||.|||++|||||||||+|||++.++ .+||+|||+|..
T Consensus 88 ~~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 9999999999999999864 45799999999999999999999999999999999999998876 499999999987
Q ss_pred ccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCc-cccchhchH
Q 004088 337 LTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPM-LEDKEKWSL 415 (774)
Q Consensus 337 i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~-~~~~~~~s~ 415 (774)
+... ....+.+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+....+....... ......++.
T Consensus 167 ~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (293)
T d1jksa_ 167 IDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245 (293)
T ss_dssp CTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred cCCC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence 6543 33445689999999999999999999999999999999999999999888777766654443322 233456789
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 416 VFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 416 ~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
.+.+||.+||++||.+|||++|+|+||||+.
T Consensus 246 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-54 Score=466.03 Aligned_cols=254 Identities=26% Similarity=0.460 Sum_probs=226.3
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+.+|+.+|++++|||||++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 357999999999999999999999999999999997432 233457789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
||||.||+|..++. ....+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+... .
T Consensus 83 mE~~~gg~l~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---T 158 (316)
T ss_dssp ECCCCSCBHHHHHH-HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---B
T ss_pred eeecCCcccccccc-ccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc---c
Confidence 99999999998886 5567889999999999999999999999999999999999999999999999999876543 3
Q ss_pred ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
.+.+||+.|||||++.+..|+.++|||||||++|+|++|+.||...+.......+...... .+..++..+.++|.+|
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~li~~~ 235 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR---FPPFFNEDVKDLLSRL 235 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC---CCTTSCHHHHHHHHHH
T ss_pred ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCC---CCCCCCHHHHHHHHHH
Confidence 4568999999999999999999999999999999999999999988877776665544322 2356788999999999
Q ss_pred cccCCCCCC-----CHHHHHhhhhhhhh
Q 004088 425 LTKEPRARP-----TAAEMLKHKFIERC 447 (774)
Q Consensus 425 L~~DP~kRP-----Ta~ElL~HPwf~~~ 447 (774)
|++||.+|+ |++++|+||||+..
T Consensus 236 L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 236 ITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred hhhCHHhccccchhhHHHHHcCcccccC
Confidence 999999996 99999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-54 Score=463.74 Aligned_cols=259 Identities=25% Similarity=0.384 Sum_probs=228.2
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEE
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVm 265 (774)
..++|++++.||+|+||+||+|.++.+|+.||||++++.. .....+.+|+++|++++|||||+++++|++.+.+||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 3578999999999999999999999999999999997543 33356889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC--CcEEEeeccccccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ--GEVKLGDFGVAAQLTRTMSK 343 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~--g~vKL~DFGlA~~i~~~~~~ 343 (774)
|||+||+|.+++......+++.+++.|+.||+.||.|||++|||||||||+|||++.+ +.+||+|||+++..... ..
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-~~ 159 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DN 159 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CE
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-Cc
Confidence 9999999999997666689999999999999999999999999999999999999854 47999999999876443 33
Q ss_pred cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCc-cccchhchHHHHHHHH
Q 004088 344 RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPM-LEDKEKWSLVFHDFVA 422 (774)
Q Consensus 344 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~-~~~~~~~s~~l~dLI~ 422 (774)
....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...........+....... ......++..+++||.
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 239 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHH
Confidence 455689999999999999999999999999999999999999999888777766655443322 2233467899999999
Q ss_pred hhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 423 KCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 423 kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
+||++||.+|||+.|+|+||||++.
T Consensus 240 ~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 240 RLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp TTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHccCChhHCcCHHHHhcCHhhccC
Confidence 9999999999999999999999753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=459.27 Aligned_cols=258 Identities=29% Similarity=0.406 Sum_probs=215.1
Q ss_pred eEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh----hhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 191 ELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE----EGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 191 ~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~----~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
+.+++||+|+||+||+|++..+|+.||||+++..... ...+.+.+|+.+|++++|||||+++++|..++++|||||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 3578999999999999999999999999999654322 123468899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
||.++++..++. ....+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.+.........
T Consensus 81 ~~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 81 FMETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp CCSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCC
T ss_pred hhcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccc
Confidence 998887766653 5677999999999999999999999999999999999999999999999999999887666555566
Q ss_pred ccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC---CC------------------
Q 004088 347 FIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE---PA------------------ 404 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~---~~------------------ 404 (774)
.+||+.|+|||++... .|+.++|||||||++|||++|.+||......+.+..+... +.
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 7899999999998754 5799999999999999999999999887766554332110 00
Q ss_pred ----CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 405 ----PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 405 ----~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
+........+..+.+||.+||++||++||||.|+|+||||++.+.
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 000111345788999999999999999999999999999987653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-54 Score=456.66 Aligned_cols=263 Identities=27% Similarity=0.399 Sum_probs=219.9
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-hhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-EEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
++|+++++||+|+||+||+|++..+|+.||||+++.... ....+.+.+|+++|++++|||||+++++|.+...+|||||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 589999999999999999999999999999999965432 2345778999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
||.++.+..+.......+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+...........
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~ 161 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTC
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccccee
Confidence 99765555444445677999999999999999999999999999999999999999999999999999887666556666
Q ss_pred ccccccccchhhhhhcC-CCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc---CCC------------------
Q 004088 347 FIGTPHWMAPEVIQESR-YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI---EPA------------------ 404 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~~~-~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~---~~~------------------ 404 (774)
.+||+.|+|||++.... ++.++|||||||++|+|++|+.||...+.......+.. .+.
T Consensus 162 ~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T d1gz8a_ 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241 (298)
T ss_dssp CBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSC
T ss_pred ecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccc
Confidence 78999999999987765 57899999999999999999999988766554433211 000
Q ss_pred -----CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhccC
Q 004088 405 -----PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKCG 450 (774)
Q Consensus 405 -----~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~~ 450 (774)
........++..+.+||.+||++||.+|||+.|+|+||||+++..+
T Consensus 242 ~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp CCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 0000123457889999999999999999999999999999876543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.1e-54 Score=469.44 Aligned_cols=258 Identities=23% Similarity=0.398 Sum_probs=217.3
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-----ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-----GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-----~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
.++|++++.||+|+||.||+|++..+|+.||||++.+.. .........+|+.+|+.++|||||+++++|...+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 468999999999999999999999999999999986432 111122234457777888999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|||||||+||+|.+++. ....+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 83 ~ivmE~~~gg~L~~~l~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~- 160 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 160 (364)
T ss_dssp EEEECCCCSCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred EEEEEecCCCcHHHHHH-hcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence 99999999999999986 3467899999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHH
Q 004088 342 SKRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 342 ~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
.....+||+.|+|||++.. ..|+.++|||||||++|+|++|++||......................+..+++.+.+|
T Consensus 161 -~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (364)
T d1omwa3 161 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 239 (364)
T ss_dssp -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHH
T ss_pred -cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHH
Confidence 3345689999999999974 56899999999999999999999999875543332222222222233345688999999
Q ss_pred HHhhcccCCCCCCC-----HHHHHhhhhhhhh
Q 004088 421 VAKCLTKEPRARPT-----AAEMLKHKFIERC 447 (774)
Q Consensus 421 I~kcL~~DP~kRPT-----a~ElL~HPwf~~~ 447 (774)
|.+||++||.+||| |+|+++||||+.+
T Consensus 240 i~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 240 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 99999999999999 8999999999865
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-53 Score=450.03 Aligned_cols=258 Identities=31% Similarity=0.487 Sum_probs=225.9
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh--------hhHHHHHHHHHHHHhCC-CCCcccccccccC
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE--------EGYEEIRGEIEMLQQCS-HPNVVRYLGSYQG 257 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~--------~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~ 257 (774)
.++|++++.||+|+||+||+|++..+|+.||||++.+.... ...+.+.+|+.+|++++ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 46899999999999999999999999999999999765421 12346889999999997 9999999999999
Q ss_pred CceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccc
Q 004088 258 EEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL 337 (774)
Q Consensus 258 ~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i 337 (774)
++++|||||||++|+|.++++. .+++++.+++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 9999999999999999999964 568999999999999999999999999999999999999999999999999999877
Q ss_pred cccccccccccccccccchhhhhhc------CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCC-CCccccc
Q 004088 338 TRTMSKRNTFIGTPHWMAPEVIQES------RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEP-APMLEDK 410 (774)
Q Consensus 338 ~~~~~~~~~~~GT~~Y~APEvl~~~------~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~-~~~~~~~ 410 (774)
.... .....+||+.|+|||++.+. .++.++||||+||++|+|++|+.||...........+.... .......
T Consensus 161 ~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (277)
T d1phka_ 161 DPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239 (277)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred cCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 6542 33456899999999999743 46889999999999999999999999888777665554432 2233345
Q ss_pred hhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 411 EKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 411 ~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
..+++.+++||.+||++||.+|||+.|||+||||++
T Consensus 240 ~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 578999999999999999999999999999999975
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-54 Score=467.63 Aligned_cols=254 Identities=27% Similarity=0.446 Sum_probs=226.5
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+.+|+++|++++|||||+++++|.....+|+|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 368999999999999999999999999999999996432 223456789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
||||.+|+|..++. ..+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+... .
T Consensus 120 ~e~~~~g~l~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---~ 195 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---T 195 (350)
T ss_dssp EECCTTCBHHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---B
T ss_pred cccccccchhhhHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc---c
Confidence 99999999999886 3457999999999999999999999999999999999999999999999999999876543 3
Q ss_pred ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
.+.+||+.|||||++.+..|+.++|||||||++|+|++|++||...+.......+...... .+..++..+.+||.+|
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~li~~~ 272 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR---FPSHFSSDLKDLLRNL 272 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTCCHHHHHHHHHH
T ss_pred ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCC---CCccCCHHHHHHHHHH
Confidence 4568999999999999999999999999999999999999999988877766665544332 2456889999999999
Q ss_pred cccCCCCCC-----CHHHHHhhhhhhhh
Q 004088 425 LTKEPRARP-----TAAEMLKHKFIERC 447 (774)
Q Consensus 425 L~~DP~kRP-----Ta~ElL~HPwf~~~ 447 (774)
|++||.+|+ |++++++||||+..
T Consensus 273 L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 273 LQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp SCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred hhhCHHhccccccccHHHHHcCccccCC
Confidence 999999994 99999999999754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-54 Score=461.62 Aligned_cols=256 Identities=29% Similarity=0.457 Sum_probs=226.1
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHH-hCCCCCcccccccccCCceEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQ-QCSHPNVVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~-~L~HPNIVkL~~~~~~~~~l~LV 264 (774)
++|++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+.+|+.++. .++|||||+++++|.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999999999999999997532 2233456677777665 68999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccc
Q 004088 265 MEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKR 344 (774)
Q Consensus 265 mEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~ 344 (774)
||||++|+|.+++. ....+++.+++.++.||+.||.|||++|||||||||+|||++.++++||+|||+|+.........
T Consensus 82 mEy~~~g~L~~~i~-~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~ 160 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 160 (320)
T ss_dssp EECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred EeecCCCcHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence 99999999999996 45679999999999999999999999999999999999999999999999999998776555555
Q ss_pred ccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 345 NTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 345 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
...+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.......+...... .+..++..+.+||.+|
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---~p~~~s~~~~dli~~~ 237 (320)
T d1xjda_ 161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF---YPRWLEKEAKDLLVKL 237 (320)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTSCHHHHHHHHHH
T ss_pred cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---CCccCCHHHHHHHHHh
Confidence 6678999999999999999999999999999999999999999988877776666544322 2346789999999999
Q ss_pred cccCCCCCCCHH-HHHhhhhhhhh
Q 004088 425 LTKEPRARPTAA-EMLKHKFIERC 447 (774)
Q Consensus 425 L~~DP~kRPTa~-ElL~HPwf~~~ 447 (774)
|++||.+||++. ++++||||+..
T Consensus 238 L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 238 FVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp SCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred cccCCCCCcCHHHHHHhCchhccC
Confidence 999999999995 89999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-53 Score=448.51 Aligned_cols=260 Identities=32% Similarity=0.452 Sum_probs=215.1
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCC-CcEEEEEEeecCCC-hhhHHHHHHHHHHHHhC---CCCCccccccccc-----
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKT-SELVAIKVISLSEG-EEGYEEIRGEIEMLQQC---SHPNVVRYLGSYQ----- 256 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~-g~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L---~HPNIVkL~~~~~----- 256 (774)
.++|+++++||+|+||+||+|++..+ ++.||||+++.... ......+.+|+.+|+.| +||||++++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999999765 67899999975432 22233456777777665 7999999999884
Q ss_pred CCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccc
Q 004088 257 GEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQ 336 (774)
Q Consensus 257 ~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~ 336 (774)
....+|+|||||.++.+..........+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 44689999999998877666655667899999999999999999999999999999999999999999999999999976
Q ss_pred ccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc---------------
Q 004088 337 LTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI--------------- 401 (774)
Q Consensus 337 i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~--------------- 401 (774)
.... ......+||+.|+|||++.+..|+.++|||||||++|||++|++||...+....+..+..
T Consensus 166 ~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 244 (305)
T d1blxa_ 166 YSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244 (305)
T ss_dssp CCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred hccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccccc
Confidence 5433 344567899999999999999999999999999999999999999988776554433211
Q ss_pred ---------CCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 402 ---------EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 402 ---------~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
...+.......+++.+.+||.+||++||++|||+.|+|+||||+.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred chhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 0011111233467889999999999999999999999999999865
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-53 Score=456.58 Aligned_cols=254 Identities=28% Similarity=0.424 Sum_probs=212.4
Q ss_pred CCCeeEEe-eeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHh-CCCCCcccccccccC----Cce
Q 004088 187 TTKYELLN-ELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQ-CSHPNVVRYLGSYQG----EEY 260 (774)
Q Consensus 187 ~~~Y~ilk-~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~-L~HPNIVkL~~~~~~----~~~ 260 (774)
.++|+++. .||+|+||+||+|++..+++.||||+++.. ..+.+|+.++.+ ++|||||+++++|++ +..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 46899886 599999999999999999999999998632 457789998755 589999999999864 578
Q ss_pred EEEEEEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC---CCcEEEeecccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD---QGEVKLGDFGVAAQ 336 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~---~g~vKL~DFGlA~~ 336 (774)
+|||||||+||+|.+++... ...+++.+++.|+.||+.||+|||++|||||||||+|||++. .+.+||+|||+|+.
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence 99999999999999999754 357999999999999999999999999999999999999986 45799999999987
Q ss_pred ccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhh----hcCCC-Cccccch
Q 004088 337 LTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI----SIEPA-PMLEDKE 411 (774)
Q Consensus 337 i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i----~~~~~-~~~~~~~ 411 (774)
+... ......+||+.|+|||++.+..|+.++|||||||++|+|++|++||...........+ ..... .......
T Consensus 164 ~~~~-~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 242 (335)
T d2ozaa1 164 TTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242 (335)
T ss_dssp CCCC-CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHH
T ss_pred ccCC-CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccc
Confidence 6554 3345568999999999999999999999999999999999999999876544332211 11111 1112234
Q ss_pred hchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 412 KWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 412 ~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
.+++.+.+||.+||++||.+|||+.|+|+||||.+.
T Consensus 243 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 243 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp HSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 678999999999999999999999999999999754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.5e-53 Score=441.54 Aligned_cols=257 Identities=31% Similarity=0.437 Sum_probs=213.0
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
++|+++++||+|+||+||+|++. +|+.||||++.... .....+.+.+|+.+|++++|||||+++++|...+..|+|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 58999999999999999999985 78999999997543 23345779999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
|+.++.+..+. ...+.+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|..+.........
T Consensus 81 ~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (286)
T d1ob3a_ 81 HLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159 (286)
T ss_dssp CCSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred eehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccce
Confidence 99877666655 45678999999999999999999999999999999999999999999999999999877665445556
Q ss_pred ccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc------------------------
Q 004088 347 FIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI------------------------ 401 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~------------------------ 401 (774)
.+|++.|+|||++.+. .++.++|||||||++|||++|++||...+....+..+..
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239 (286)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccc
Confidence 6799999999999764 578999999999999999999999987765544332210
Q ss_pred --CCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 402 --EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 402 --~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
...+.......+++.+.+||.+||++||++|||+.|+|+||||++
T Consensus 240 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 000111123445788999999999999999999999999999973
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-52 Score=445.85 Aligned_cols=256 Identities=23% Similarity=0.372 Sum_probs=212.3
Q ss_pred CCCCCCeeEEeeeeccCceEEEEEEEcCCCc---EEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCce
Q 004088 184 EDPTTKYELLNELGKGSYGAVYKARDLKTSE---LVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEY 260 (774)
Q Consensus 184 ~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~---~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~ 260 (774)
+...++|++.++||+|+||+||+|++..+++ .||||++.........+.+.+|+++|++++|||||+++++|...+.
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 3445789999999999999999999877664 6899998766666667789999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
+|||||||++|+|.+++......+++.++..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+...
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999999998876778999999999999999999999999999999999999999999999999999876543
Q ss_pred ccc-----cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhch
Q 004088 341 MSK-----RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWS 414 (774)
Q Consensus 341 ~~~-----~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s 414 (774)
... .....||+.|||||++.+..|+.++|||||||++|||++ |++||...........+..... .+.+..++
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~ 259 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR--LPPPMDCP 259 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC--CCCCTTCC
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCccch
Confidence 221 122468999999999999999999999999999999997 8999998887776666544332 22345678
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 415 LVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 415 ~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
..+.+||.+||+.||.+|||+.||+++
T Consensus 260 ~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 260 SALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 899999999999999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=450.32 Aligned_cols=260 Identities=25% Similarity=0.394 Sum_probs=218.5
Q ss_pred cccCCCCCCeeEEeeeeccCceEEEEEEEcCCCc-----EEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCccccccc
Q 004088 181 VTREDPTTKYELLNELGKGSYGAVYKARDLKTSE-----LVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGS 254 (774)
Q Consensus 181 ~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~-----~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~ 254 (774)
..++.+.++|+++++||+|+||+||+|++..+++ .||||++...........+.+|+.+|.++ +|||||+++++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 3456677899999999999999999999876543 69999987655555567889999999998 89999999999
Q ss_pred ccCCceEEEEEEecCCCchhhhhhccC----------------------CchhHHHHHHHHHHHHHHHHHHHhcCccccc
Q 004088 255 YQGEEYLWIVMEYCGGGSVADLMNVTE----------------------EPLEEYQIAYICREALKGLAYLHSIFKVHRD 312 (774)
Q Consensus 255 ~~~~~~l~LVmEy~~ggsL~dll~~~~----------------------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRD 312 (774)
|...+.+|||||||++|+|.++++... ..+++..++.|+.||+.||.|||++||||||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 999999999999999999999986443 3488999999999999999999999999999
Q ss_pred ccccceEecCCCcEEEeeccccccccccccc--cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCC
Q 004088 313 IKGGNILLTDQGEVKLGDFGVAAQLTRTMSK--RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRST 389 (774)
Q Consensus 313 LKPeNILLd~~g~vKL~DFGlA~~i~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~ 389 (774)
|||+|||++.++.+||+|||+|+........ ..+.+||+.|||||++.+..|+.++|||||||++|||++ |.+||.+
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876544322 234578999999999999999999999999999999997 8999988
Q ss_pred CCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 390 VHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 390 ~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
......+..+..... ....+..+++.+.+||.+||+.||++|||++||++|
T Consensus 270 ~~~~~~~~~~~~~~~-~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 270 IPVDANFYKLIQNGF-KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCCSHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHhcCC-CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 766555444333222 223456778999999999999999999999999987
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-53 Score=442.81 Aligned_cols=255 Identities=27% Similarity=0.504 Sum_probs=211.7
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
++.+.++|+++++||+|+||+||+|+.. ..||||+++... .....+.+.+|+.+|++++|||||++++++.. ..+
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL 78 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence 4667889999999999999999999743 359999997543 44566789999999999999999999998754 568
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
|||||||++|+|.+++......+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+......
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999999999997667789999999999999999999999999999999999999999999999999997765432
Q ss_pred --cccccccccccccchhhhhhc---CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhh-hcC--CCCccccchhc
Q 004088 342 --SKRNTFIGTPHWMAPEVIQES---RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMI-SIE--PAPMLEDKEKW 413 (774)
Q Consensus 342 --~~~~~~~GT~~Y~APEvl~~~---~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i-~~~--~~~~~~~~~~~ 413 (774)
.......||+.|||||++.+. .|+.++|||||||++|||++|+.||........+... ... ..........+
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 238 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccc
Confidence 223456899999999999743 4889999999999999999999999887665444332 222 11222334567
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 414 SLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 414 s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
++.+.+||.+||..||.+|||+.+|++|
T Consensus 239 ~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 239 PKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 8999999999999999999999999987
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-52 Score=443.15 Aligned_cols=263 Identities=25% Similarity=0.366 Sum_probs=222.0
Q ss_pred CCcccCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCC
Q 004088 179 ESVTREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE 258 (774)
Q Consensus 179 ~~~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~ 258 (774)
....++...++|++.++||+|+||+||+|++..+++.||||+++... ...+++.+|+.+|++++|||||+++++|.++
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence 33456777889999999999999999999999999999999986433 3457899999999999999999999999999
Q ss_pred ceEEEEEEecCCCchhhhhhc-cCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccc
Q 004088 259 EYLWIVMEYCGGGSVADLMNV-TEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQL 337 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~-~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i 337 (774)
+.+|||||||++|+|.+++.. ....+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeec
Confidence 999999999999999998864 3467999999999999999999999999999999999999999999999999999876
Q ss_pred cccccc-cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCC-CCCCchhhhhhhhcCCCCccccchhchH
Q 004088 338 TRTMSK-RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPR-STVHPMRVLFMISIEPAPMLEDKEKWSL 415 (774)
Q Consensus 338 ~~~~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf-~~~~~~~~i~~i~~~~~~~~~~~~~~s~ 415 (774)
...... .....||+.|+|||++.+..|+.++|||||||++|||++|..|| ...+.......+..... ...+..++.
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~--~~~~~~~~~ 243 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--MERPEGCPE 243 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--CCCCTTCCH
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC--CCCCccchH
Confidence 543222 22345899999999999999999999999999999999966554 44444443333333222 233457889
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 416 VFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 416 ~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
.+.+||.+||+.||.+|||+.+|++ +|+.+
T Consensus 244 ~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~ 273 (287)
T d1opja_ 244 KVYELMRACWQWNPSDRPSFAEIHQ--AFETM 273 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence 9999999999999999999999965 56544
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-52 Score=439.25 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=220.7
Q ss_pred CCCCeeEEe-eeeccCceEEEEEEEcC--CCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 186 PTTKYELLN-ELGKGSYGAVYKARDLK--TSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 186 ~~~~Y~ilk-~LG~G~FG~Vy~a~d~~--~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
..++|.+.+ +||+|+||+||+|.+.. ++..||||+++........+.+.+|+++|++++|||||++++++.. +.+|
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence 346788888 49999999999998754 4557999999866666667889999999999999999999999875 4589
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
||||||++|+|.+++...+..+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 99999999999999876677899999999999999999999999999999999999999999999999999987654322
Q ss_pred ---ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 343 ---KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 343 ---~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
......||+.|+|||++....++.++|||||||++|||++ |.+||......+....+.....+ +.+..++..+.
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~--~~p~~~~~~l~ 242 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM--ECPPECPPELY 242 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC--CCCTTCCHHHH
T ss_pred ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--CCCCcCCHHHH
Confidence 2234578999999999999999999999999999999997 99999988777666655443332 33457889999
Q ss_pred HHHHhhcccCCCCCCCHHHH---Hhhhhhh
Q 004088 419 DFVAKCLTKEPRARPTAAEM---LKHKFIE 445 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~El---L~HPwf~ 445 (774)
+||.+||+.||++|||+.+| |+|+|+.
T Consensus 243 ~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 243 ALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999888 5677764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-52 Score=434.04 Aligned_cols=250 Identities=25% Similarity=0.401 Sum_probs=207.8
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
.++|+++++||+|+||+||+|++. +++.||||+++... ...+++.+|+++|++++|||||+++++|..+..+|||||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 468999999999999999999975 67789999986433 344679999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc-cc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK-RN 345 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~-~~ 345 (774)
||++|+|.+++......+++..+..|+.||+.||.|||+++||||||||+||||+.++.+||+|||+|+.+...... ..
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 99999999998777778999999999999999999999999999999999999999999999999999876543222 23
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
...||+.|+|||++.+..|+.++|||||||++|||++ |.+||...........+.....+ ..+..++..+.+||.+|
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~--~~p~~~~~~l~~li~~c 238 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--YKPRLASTHVYQIMNHC 238 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC--CCCTTSCHHHHHHHHHH
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC--CCccccCHHHHHHHHHH
Confidence 4579999999999999999999999999999999998 57777776666665555443322 23456688999999999
Q ss_pred cccCCCCCCCHHHHHhh
Q 004088 425 LTKEPRARPTAAEMLKH 441 (774)
Q Consensus 425 L~~DP~kRPTa~ElL~H 441 (774)
|+.||++|||+++|++|
T Consensus 239 l~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 239 WKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCCHhHCcCHHHHHHH
Confidence 99999999999999987
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-52 Score=435.62 Aligned_cols=258 Identities=22% Similarity=0.377 Sum_probs=218.1
Q ss_pred ccCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceE
Q 004088 182 TREDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 182 ~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l 261 (774)
.++.+.++|+++++||+|+||+||+|++. +++.||||+++... ...+.+.+|+.+|++++|||||++++++.+ +.+
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~ 82 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI 82 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCe
Confidence 35567789999999999999999999964 67889999996433 345679999999999999999999998865 567
Q ss_pred EEEEEecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
|||||||++|+|.+++.... ..+++..+..|+.||+.||.|||+++||||||||+||||+.++.+||+|||+|+.+...
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC
Confidence 89999999999998775333 36899999999999999999999999999999999999999999999999999877543
Q ss_pred cc-ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhC-CCCCCCCCchhhhhhhhcCCCCccccchhchHHHH
Q 004088 341 MS-KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEG-LPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFH 418 (774)
Q Consensus 341 ~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG-~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~ 418 (774)
.. ......||+.|+|||++....|+.++|||||||++|||++| .+||...........+.....+ ..+..++..+.
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~--~~p~~~~~~l~ 240 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM--VRPDNCPEELY 240 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--CCCTTCCHHHH
T ss_pred ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC--CCcccChHHHH
Confidence 22 23345799999999999999999999999999999999985 5666666665555554433222 23456788999
Q ss_pred HHHHhhcccCCCCCCCHHHHHh--hhhhh
Q 004088 419 DFVAKCLTKEPRARPTAAEMLK--HKFIE 445 (774)
Q Consensus 419 dLI~kcL~~DP~kRPTa~ElL~--HPwf~ 445 (774)
+||.+||+.||++|||+.+|++ |+||.
T Consensus 241 ~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 241 QLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 9999999999999999999998 88885
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-53 Score=440.98 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=210.8
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCCh-----hhHHHHHHHHHHHHhCC--CCCcccccccccCCc
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGE-----EGYEEIRGEIEMLQQCS--HPNVVRYLGSYQGEE 259 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~-----~~~~~~~~Ei~iL~~L~--HPNIVkL~~~~~~~~ 259 (774)
.++|++.+.||+|+||+||+|++..+|+.||||++.+.... .....+.+|+.+|++++ |||||+++++|.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46899999999999999999999999999999999754211 11234668999999986 899999999999999
Q ss_pred eEEEEEEecCC-CchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCC-CcEEEeeccccccc
Q 004088 260 YLWIVMEYCGG-GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQ-GEVKLGDFGVAAQL 337 (774)
Q Consensus 260 ~l~LVmEy~~g-gsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~-g~vKL~DFGlA~~i 337 (774)
.+|+||||+.+ +++.+++. ....+++.+++.++.||+.||.|||++|||||||||+|||++.+ +.+||+|||+|+..
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~-~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eEEEEEEeccCcchHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 99999999976 57777775 45679999999999999999999999999999999999999855 78999999999765
Q ss_pred cccccccccccccccccchhhhhhcCC-CCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCCccccchhchHH
Q 004088 338 TRTMSKRNTFIGTPHWMAPEVIQESRY-DGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLV 416 (774)
Q Consensus 338 ~~~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~ 416 (774)
... ...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... . ... ...+..++.+
T Consensus 162 ~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i--~----~~~---~~~~~~~s~~ 230 (273)
T d1xwsa_ 162 KDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--I----RGQ---VFFRQRVSSE 230 (273)
T ss_dssp CSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--H----HCC---CCCSSCCCHH
T ss_pred ccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH--h----hcc---cCCCCCCCHH
Confidence 433 3445689999999999988765 56789999999999999999999763221 1 111 1123467899
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 417 FHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 417 l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
+.+||.+||++||++|||++|+|+||||++.
T Consensus 231 ~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999999754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.7e-52 Score=433.52 Aligned_cols=258 Identities=29% Similarity=0.453 Sum_probs=213.7
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCC----ce
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE----EY 260 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~----~~ 260 (774)
.++|++++.||+|+||+||+|++..+|+.||||+++... .......+.+|+++|++++|||||++++++... ..
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 468999999999999999999999999999999997543 344566799999999999999999999998654 35
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
+|||||||+|++|.+++. ..+.+++.+++.|+.||+.||.|||++|||||||||+||||+.++.++|+|||.+......
T Consensus 86 ~~lvmE~~~g~~L~~~~~-~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEECCCEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEEEEECCCCCEehhhhc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 899999999999998885 4467999999999999999999999999999999999999999999999999998755433
Q ss_pred c---cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-CCCccccchhchHH
Q 004088 341 M---SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-PAPMLEDKEKWSLV 416 (774)
Q Consensus 341 ~---~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-~~~~~~~~~~~s~~ 416 (774)
. ......+||+.|+|||++.+..|+.++|||||||++|+|++|++||......+....+... +.+.......++..
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 244 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHH
T ss_pred cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHH
Confidence 2 2334568999999999999999999999999999999999999999988877666554333 33333445678999
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhhhhhh
Q 004088 417 FHDFVAKCLTKEPRARPTAAEMLKHKFIE 445 (774)
Q Consensus 417 l~dLI~kcL~~DP~kRPTa~ElL~HPwf~ 445 (774)
+.+||.+||++||.+||+..+.|.|+|++
T Consensus 245 l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 245 LDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 99999999999999999544445588875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=428.28 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=221.5
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
.++|+++++||+|+||+||+|++ .+++.||||++++... ..+++.+|+.+|++++|||||+++++|.++..+++|||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 46899999999999999999997 4788999999975443 34679999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc-cc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK-RN 345 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~-~~ 345 (774)
||++|+|..++......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+...... ..
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 99999999998777778999999999999999999999999999999999999999999999999999866543222 23
Q ss_pred cccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhh
Q 004088 346 TFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKC 424 (774)
Q Consensus 346 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kc 424 (774)
...||+.|+|||++.+..|+.++|||||||++|||++ |+.||......+....+..... ...+...+..+.+||.+|
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~c 237 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR--LYRPHLASEKVYTIMYSC 237 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHT
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC--CCCcccccHHHHHHHHHH
Confidence 4579999999999999999999999999999999997 8999998888777766654332 234457788999999999
Q ss_pred cccCCCCCCCHHHHHhh
Q 004088 425 LTKEPRARPTAAEMLKH 441 (774)
Q Consensus 425 L~~DP~kRPTa~ElL~H 441 (774)
|+.||.+|||++++|+|
T Consensus 238 l~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 238 WHEKADERPTFKILLSN 254 (258)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCCHhHCcCHHHHHHH
Confidence 99999999999999998
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=430.66 Aligned_cols=256 Identities=28% Similarity=0.420 Sum_probs=212.5
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcCC---CcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCc
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLKT---SELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE 259 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~---g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~ 259 (774)
++.+.++|++++.||+|+||.||+|++..+ +..||||+++........+.+.+|+.+|++++|||||++++++. ++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 455678999999999999999999998654 35689998876556666778999999999999999999999986 46
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
.+|||||||.+|+|.+++......+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.+..
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 78999999999999998877777899999999999999999999999999999999999999999999999999987654
Q ss_pred ccc-ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHH
Q 004088 340 TMS-KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVF 417 (774)
Q Consensus 340 ~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l 417 (774)
... ......||+.|+|||++.+..|+.++|||||||++|||++ |.+||......+....+.....+ +.+..++..+
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~ 238 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL--PMPPNCPPTL 238 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--CCCTTCCHHH
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHH
Confidence 322 2234578999999999999999999999999999999997 89999988887776665544332 3356788999
Q ss_pred HHHHHhhcccCCCCCCCHHHHHhh
Q 004088 418 HDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 418 ~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.+||.+||+.||.+|||+.||++|
T Consensus 239 ~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 239 YSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999976
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-51 Score=428.81 Aligned_cols=256 Identities=24% Similarity=0.350 Sum_probs=211.2
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcCCC----cEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCC
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLKTS----ELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGE 258 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g----~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~ 258 (774)
.+.....|++.+.||+|+||.||+|.+..++ ..||||++...........+.+|+.+|++++|||||++++++...
T Consensus 2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CcCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 3556678999999999999999999976654 479999997666666667899999999999999999999999999
Q ss_pred ceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 259 EYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 259 ~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
..+++|||||.++++.+++......+++.++..++.||+.||.|||+++||||||||+||||+.++.+||+|||+|+.+.
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999999999999887777889999999999999999999999999999999999999999999999999998765
Q ss_pred ccccc---cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhC-CCCCCCCCchhhhhhhhcCCCCccccchhch
Q 004088 339 RTMSK---RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEG-LPPRSTVHPMRVLFMISIEPAPMLEDKEKWS 414 (774)
Q Consensus 339 ~~~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG-~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s 414 (774)
..... .....||+.|+|||++.+..|+.++|||||||++|||++| .+|+...........+..... .+.+..++
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~--~~~~~~~~ 239 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR--LPTPMDCP 239 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC--CCCCTTCB
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC--CCCchhhH
Confidence 43221 2234689999999999999999999999999999999985 555555555555444433322 22345678
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 415 LVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 415 ~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
..+.+||.+||+.||++|||+.+|++
T Consensus 240 ~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 240 SAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 89999999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=432.49 Aligned_cols=248 Identities=26% Similarity=0.398 Sum_probs=208.1
Q ss_pred eeeeccCceEEEEEEEc--CCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEEecCC
Q 004088 194 NELGKGSYGAVYKARDL--KTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVMEYCGG 270 (774)
Q Consensus 194 k~LG~G~FG~Vy~a~d~--~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmEy~~g 270 (774)
++||+|+||+||+|.+. .+++.||||+++... .....+.+.+|+++|++++|||||+++++|..+ ..|||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 47999999999999864 356789999996543 334456799999999999999999999999754 57899999999
Q ss_pred CchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc---cccc
Q 004088 271 GSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK---RNTF 347 (774)
Q Consensus 271 gsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~---~~~~ 347 (774)
|+|.++++ ....+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+...... ....
T Consensus 92 g~L~~~l~-~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 92 GPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp EEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CcHHHHHh-hccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 99999986 4567999999999999999999999999999999999999999999999999999876543222 2235
Q ss_pred cccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcc
Q 004088 348 IGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLT 426 (774)
Q Consensus 348 ~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~ 426 (774)
.||+.|+|||++.+..|+.++|||||||++|||++ |++||......+....+.....+ ..+..++..+.+||.+||+
T Consensus 171 ~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~--~~p~~~~~~~~~li~~cl~ 248 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--GCPAGCPREMYDLMNLCWT 248 (277)
T ss_dssp CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTC
T ss_pred CCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC--CCCcccCHHHHHHHHHHcC
Confidence 79999999999999999999999999999999997 89999988777666555443322 3345788999999999999
Q ss_pred cCCCCCCCHHHH---Hhhhhhh
Q 004088 427 KEPRARPTAAEM---LKHKFIE 445 (774)
Q Consensus 427 ~DP~kRPTa~El---L~HPwf~ 445 (774)
.||.+|||+.+| |+|+|++
T Consensus 249 ~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 249 YDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp SSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCHhHCcCHHHHHHHhhCHHhh
Confidence 999999999998 5666654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-51 Score=426.56 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=219.6
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~LVmE 266 (774)
++|+++++||+|+||+||+|++..+|+.||||+++... .......+.+|+.+|+.++||||++++++|......++||+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999999999999999997654 33456788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccccccc
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSKRNT 346 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~~~~ 346 (774)
++.+++|..++. ..+.+++..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||.|+...........
T Consensus 82 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~ 160 (292)
T d1unla_ 82 FCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp CCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred eccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence 999998888775 5678899999999999999999999999999999999999999999999999999887665555556
Q ss_pred ccccccccchhhhhhcC-CCCccchhhhHHHHHHHHhCCCCCCCCCc-hhhhhhhh---cC-------------------
Q 004088 347 FIGTPHWMAPEVIQESR-YDGKVDVWALGVSAVEMAEGLPPRSTVHP-MRVLFMIS---IE------------------- 402 (774)
Q Consensus 347 ~~GT~~Y~APEvl~~~~-~s~ksDIWSLGviLyELLtG~~Pf~~~~~-~~~i~~i~---~~------------------- 402 (774)
..+++.|+|||++.... ++.++|||||||++|||++|+.||..... ......+. ..
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T d1unla_ 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccc
Confidence 67899999999998665 68999999999999999999988654333 22222111 00
Q ss_pred ----CCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 403 ----PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 403 ----~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
..........++..+.+||.+||++||.+||||+|+|+||||++.
T Consensus 241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 001111234557889999999999999999999999999999753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-51 Score=439.56 Aligned_cols=257 Identities=31% Similarity=0.444 Sum_probs=210.2
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccCCc-----
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE----- 259 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~----- 259 (774)
..++|+++++||+|+||+||+|++..+|+.||||++++.. .....+.+.+|+++|++++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3578999999999999999999999999999999997543 3445567899999999999999999999987544
Q ss_pred -eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccc
Q 004088 260 -YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLT 338 (774)
Q Consensus 260 -~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~ 338 (774)
++||||||| +.+|..+++ ..++++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ceEEEEEecc-cccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence 679999999 667877764 3579999999999999999999999999999999999999999999999999998765
Q ss_pred ccccccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc----------------
Q 004088 339 RTMSKRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI---------------- 401 (774)
Q Consensus 339 ~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~---------------- 401 (774)
.. ....+||+.|+|||++.+. .++.++|||||||++|+|++|++||...+....+..+..
T Consensus 173 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 173 SE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp SS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred Cc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence 43 3456899999999999764 578999999999999999999999988765544322111
Q ss_pred ------------CCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 402 ------------EPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 402 ------------~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
............++.+.+||.+||+.||.+|||+.|+|+||||+.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00111111234578899999999999999999999999999998653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-51 Score=435.15 Aligned_cols=261 Identities=27% Similarity=0.393 Sum_probs=210.6
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccC-------
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG------- 257 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~------- 257 (774)
..++|+++++||+|+||+||+|++..+|+.||||++.+.. .......+.+|+++|++++||||+++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 3579999999999999999999999999999999986543 23445678899999999999999999998744
Q ss_pred -CceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccc
Q 004088 258 -EEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQ 336 (774)
Q Consensus 258 -~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~ 336 (774)
...+|+|||||.++.+..+. .....+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 45689999999877665443 4567899999999999999999999999999999999999999999999999999976
Q ss_pred ccccc----cccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc---CCCCc-c
Q 004088 337 LTRTM----SKRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI---EPAPM-L 407 (774)
Q Consensus 337 i~~~~----~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~---~~~~~-~ 407 (774)
+.... ......+||+.|+|||++.+. .|+.++|||||||++|||++|++||...+.......+.. ...+. .
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 64322 223446899999999999765 689999999999999999999999987766554433211 00000 0
Q ss_pred --------------------cc-----chhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 408 --------------------ED-----KEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 408 --------------------~~-----~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
.. ....+..+.+||.+||++||++|||+.|+|+||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 00 01235678899999999999999999999999999853
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-51 Score=439.53 Aligned_cols=256 Identities=28% Similarity=0.377 Sum_probs=210.5
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCccccccccc------CCceE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ------GEEYL 261 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~------~~~~l 261 (774)
.+|+.+++||+|+||+||+|++..+|+.||||++...... ..+|+.+|++++|||||+++++|. +..++
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 3799999999999999999999999999999999754322 247999999999999999999884 34568
Q ss_pred EEEEEecCCCchhhhhh--ccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC-cEEEeecccccccc
Q 004088 262 WIVMEYCGGGSVADLMN--VTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG-EVKLGDFGVAAQLT 338 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~--~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g-~vKL~DFGlA~~i~ 338 (774)
|||||||+++.+..+.. .....+++.+++.|+.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+.+.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 99999997765444432 3456799999999999999999999999999999999999999875 89999999998765
Q ss_pred ccccccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC---------------
Q 004088 339 RTMSKRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE--------------- 402 (774)
Q Consensus 339 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~--------------- 402 (774)
.. ....+.+||+.|+|||++.+ ..|+.++|||||||++|||++|++||........+..+...
T Consensus 175 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 175 RG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp TT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred CC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence 43 33455689999999999875 46899999999999999999999999877655544332110
Q ss_pred ----CCCc-------cccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 403 ----PAPM-------LEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 403 ----~~~~-------~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
..+. ......+++.+.+||.+||++||++||||.|+|+||||+....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 0000 0112346788999999999999999999999999999987643
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=435.48 Aligned_cols=260 Identities=27% Similarity=0.378 Sum_probs=211.4
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCc-----eE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEE-----YL 261 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~-----~l 261 (774)
..+|+++++||+|+||+||+|++..+|+.||||++.+.......+.+.+|+.+|++++||||+++++++.... .+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 4579999999999999999999999999999999986666666778999999999999999999999986543 34
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
||| +|+.+++|.+++.. ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|.......
T Consensus 87 ~l~-~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 87 YLV-THLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEE-EECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEE-EeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 555 55668999999863 469999999999999999999999999999999999999999999999999997654432
Q ss_pred c---ccccccccccccchhhhhh-cCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc---C------------
Q 004088 342 S---KRNTFIGTPHWMAPEVIQE-SRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI---E------------ 402 (774)
Q Consensus 342 ~---~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~---~------------ 402 (774)
. .....+||+.|+|||++.. ..++.++||||+||++|+|++|++||.............. .
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 2 2345679999999999854 4578899999999999999999999987665433322110 0
Q ss_pred -------------CCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhcc
Q 004088 403 -------------PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCKC 449 (774)
Q Consensus 403 -------------~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~~ 449 (774)
..+.......++..+.+||.+||++||.+|||+.|+|+||||+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 00001112345678999999999999999999999999999986543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=431.32 Aligned_cols=252 Identities=24% Similarity=0.378 Sum_probs=211.7
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCc----EEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSE----LVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~----~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
..+|+++++||+|+||+||+|++..+|+ .||||+++........+.+.+|+.+|++++|||||+++++|.++ ..+
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 4579999999999999999999988876 58888886555556678899999999999999999999999865 567
Q ss_pred EEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~ 342 (774)
+|||||.+++|.+++......+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 88899999999998887778899999999999999999999999999999999999999999999999999987654332
Q ss_pred c--cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHH
Q 004088 343 K--RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHD 419 (774)
Q Consensus 343 ~--~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~d 419 (774)
. .....||+.|+|||++.+..|+.++|||||||++|||++ |.+||...........+.....+ +.+..++..+.+
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~--~~p~~~~~~~~~ 244 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQPPICTIDVYM 244 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC--CCCTTBCHHHHH
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC--CCCcccCHHHHH
Confidence 2 223468999999999999999999999999999999998 89999887766655544433222 334567899999
Q ss_pred HHHhhcccCCCCCCCHHHHHhh
Q 004088 420 FVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 420 LI~kcL~~DP~kRPTa~ElL~H 441 (774)
||.+||+.||.+|||+.|+++|
T Consensus 245 li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 245 IMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCChhhCcCHHHHHHH
Confidence 9999999999999999999988
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.5e-50 Score=431.02 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=209.7
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-CCCccccccccc--CCceEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQ--GEEYLWI 263 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~--~~~~l~L 263 (774)
.++|+++++||+|+||+||+|+++.+|+.||||+++.. ..+.+.+|+.+|++++ ||||++++++|. ....+|+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 46899999999999999999999999999999998643 2457889999999995 999999999986 4567999
Q ss_pred EEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCC-cEEEeecccccccccccc
Q 004088 264 VMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQG-EVKLGDFGVAAQLTRTMS 342 (774)
Q Consensus 264 VmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g-~vKL~DFGlA~~i~~~~~ 342 (774)
|||||.+++|..+. +.+++..++.++.||+.||.|||++|||||||||+||||+.++ .+||+|||+|+.+... .
T Consensus 110 v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~-~ 184 (328)
T d3bqca1 110 VFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-Q 184 (328)
T ss_dssp EEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-C
T ss_pred EEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC-C
Confidence 99999999987764 4699999999999999999999999999999999999998765 6999999999876543 3
Q ss_pred ccccccccccccchhhhhhc-CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhh-hhhh----------------cC--
Q 004088 343 KRNTFIGTPHWMAPEVIQES-RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVL-FMIS----------------IE-- 402 (774)
Q Consensus 343 ~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i-~~i~----------------~~-- 402 (774)
.....+||+.|+|||++.+. .|+.++||||+||++|+|++|+.||......... ..+. ..
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 34566899999999998865 4799999999999999999999999765432111 0000 00
Q ss_pred ----------CC------CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 403 ----------PA------PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 403 ----------~~------~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
.. ........++.++.+||.+||++||.+|||++|+|+||||+.+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 00 01112234678899999999999999999999999999998653
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=431.50 Aligned_cols=255 Identities=24% Similarity=0.336 Sum_probs=202.1
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCccccccccc------CCce
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ------GEEY 260 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~------~~~~ 260 (774)
++|+++++||+|+||+||+|+++.+|+.||||++.... .......+.+|+.+|++++|||||+++++|. ...+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999999999999999997543 3444567899999999999999999999985 4478
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
+|+|||||.++.+. .+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~~iv~Ey~~~~l~~-~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEECCSEEHHH-HHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEeccchHHHH-hhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 99999999765444 432 46899999999999999999999999999999999999999999999999998766543
Q ss_pred ccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc-------------------
Q 004088 341 MSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI------------------- 401 (774)
Q Consensus 341 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~------------------- 401 (774)
......+||+.|+|||++.+..++.++||||+||++|+|++|++||...+.......+..
T Consensus 173 -~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T d2b1pa1 173 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_dssp ---------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred -cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence 334456899999999999999999999999999999999999999987664433222110
Q ss_pred ---C-----------------CCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhh
Q 004088 402 ---E-----------------PAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERC 447 (774)
Q Consensus 402 ---~-----------------~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~ 447 (774)
. ...........+..+.+||.+||..||++||||+|||+||||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 0 000001122346789999999999999999999999999999863
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-50 Score=424.01 Aligned_cols=258 Identities=26% Similarity=0.412 Sum_probs=205.7
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcC-----CCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCccccccccc
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLK-----TSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQ 256 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~-----~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~ 256 (774)
++.+.++|+++++||+|+||.||+|++.. +++.||||+++........+.+.+|+.++.++ +|||||.+++++.
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 45667899999999999999999999754 45789999997666666667788888888776 6889999999875
Q ss_pred C-CceEEEEEEecCCCchhhhhhcc---------------CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEe
Q 004088 257 G-EEYLWIVMEYCGGGSVADLMNVT---------------EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILL 320 (774)
Q Consensus 257 ~-~~~l~LVmEy~~ggsL~dll~~~---------------~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILL 320 (774)
. +..+|+|||||++|+|.++++.. ...+++.+++.++.||+.||.|||++|||||||||+||||
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 4 56789999999999999998643 2358999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhC-CCCCCCCCchhhhh
Q 004088 321 TDQGEVKLGDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEG-LPPRSTVHPMRVLF 397 (774)
Q Consensus 321 d~~g~vKL~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG-~~Pf~~~~~~~~i~ 397 (774)
+.++.+||+|||+|+....... .....+||+.|+|||++.+..|+.++|||||||++|||++| .+||........+.
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~ 247 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999986644322 23356799999999999999999999999999999999986 56887765544433
Q ss_pred hhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 398 MISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 398 ~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
....... ....+..+++.+.+||.+||+.||.+|||+.||++|
T Consensus 248 ~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 248 RRLKEGT-RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCC-CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3222111 123345678899999999999999999999999988
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-50 Score=425.25 Aligned_cols=261 Identities=25% Similarity=0.436 Sum_probs=223.1
Q ss_pred ccCCCCCCeeEEeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCccccccccc
Q 004088 182 TREDPTTKYELLNELGKGSYGAVYKARDL-----KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ 256 (774)
Q Consensus 182 ~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~-----~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~ 256 (774)
..+.+.++|++++.||+|+||+||+|++. .+++.||||+++........+.+.+|+.+|++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 35667889999999999999999999975 3568899999986666666778999999999999999999999999
Q ss_pred CCceEEEEEEecCCCchhhhhhcc-----------------------CCchhHHHHHHHHHHHHHHHHHHHhcCcccccc
Q 004088 257 GEEYLWIVMEYCGGGSVADLMNVT-----------------------EEPLEEYQIAYICREALKGLAYLHSIFKVHRDI 313 (774)
Q Consensus 257 ~~~~l~LVmEy~~ggsL~dll~~~-----------------------~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDL 313 (774)
.....++|||||++|+|.+++... ...+++..+..|+.||+.||+|||+++||||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 999999999999999999988532 124889999999999999999999999999999
Q ss_pred cccceEecCCCcEEEeecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhC-CCCCCCC
Q 004088 314 KGGNILLTDQGEVKLGDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEG-LPPRSTV 390 (774)
Q Consensus 314 KPeNILLd~~g~vKL~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG-~~Pf~~~ 390 (774)
||+||||+.++.+||+|||+|+.+..... ...+..||+.|+|||++.+..|+.++|||||||++|||++| .+||...
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 99999999999999999999986644322 22346789999999999999999999999999999999998 4788888
Q ss_pred CchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 391 HPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 391 ~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
...+....+.....+ ..+..++..+.+||.+||+.||++|||+.||++ ++++
T Consensus 247 ~~~e~~~~v~~~~~~--~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~--~L~~ 298 (301)
T d1lufa_ 247 AHEEVIYYVRDGNIL--ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQR 298 (301)
T ss_dssp CHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred CHHHHHHHHHcCCCC--CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH--HHHH
Confidence 877776665544332 335567889999999999999999999999954 4554
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-50 Score=423.57 Aligned_cols=259 Identities=25% Similarity=0.387 Sum_probs=211.5
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcccccccccCCceEE
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEYLW 262 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~l~ 262 (774)
++...++|++++.||+|+||+||+|++.. ++.||||+++... ...+.+.+|+.+|++++|||||++++++.+ +.+|
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~ 87 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 87 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence 45567899999999999999999999754 4679999986443 334779999999999999999999999865 5578
Q ss_pred EEEEecCCCchhhhhhcc-CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccc
Q 004088 263 IVMEYCGGGSVADLMNVT-EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTM 341 (774)
Q Consensus 263 LVmEy~~ggsL~dll~~~-~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~ 341 (774)
+|||||++|+|..++... ...+++.++..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+....
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 999999999999887633 3569999999999999999999999999999999999999999999999999998764332
Q ss_pred -cccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhC-CCCCCCCCchhhhhhhhcCCCCccccchhchHHHHH
Q 004088 342 -SKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEG-LPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHD 419 (774)
Q Consensus 342 -~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG-~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~d 419 (774)
.......||+.|+|||++....++.++|||||||++|||++| .+|+........+..+..... .+.+..++..+.+
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~ 245 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--MPCPPECPESLHD 245 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--CCCCTTSCHHHHH
T ss_pred ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC--CCCCcccCHHHHH
Confidence 222345799999999999999999999999999999999995 555565555555555443322 2235677899999
Q ss_pred HHHhhcccCCCCCCCHHHHHh--hhhhhhh
Q 004088 420 FVAKCLTKEPRARPTAAEMLK--HKFIERC 447 (774)
Q Consensus 420 LI~kcL~~DP~kRPTa~ElL~--HPwf~~~ 447 (774)
||.+||+.||++||++.+|++ |+||...
T Consensus 246 li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 246 LMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 999999999999999999987 7888653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=428.49 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=210.0
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCC-ChhhHHHHHHHHHHHHhCCCCCcccccccccC-----Cce
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSE-GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQG-----EEY 260 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~-----~~~ 260 (774)
.++|+++++||+|+||+||+|++..+|+.||||++++.. .....+.+.+|+.+|++++|||||+++++|.. ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999999999999999997543 33445678899999999999999999999853 334
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
.++||+||.+|+|.+++. .+++++..++.++.||+.||+|||++|||||||||+|||++.++.+|++|||+|......
T Consensus 97 ~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~ 174 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174 (348)
T ss_dssp CCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred eEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc
Confidence 466677778999999985 357999999999999999999999999999999999999999999999999999765432
Q ss_pred ccccccccccccccchhhhhhcC-CCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcCCCC--------------
Q 004088 341 MSKRNTFIGTPHWMAPEVIQESR-YDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIEPAP-------------- 405 (774)
Q Consensus 341 ~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~~~~-------------- 405 (774)
..+..||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+.......+......
T Consensus 175 ---~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (348)
T d2gfsa1 175 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251 (348)
T ss_dssp ---GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred ---cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence 34567999999999987654 688999999999999999999999877655444332111000
Q ss_pred --------------ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhhhhhhhhc
Q 004088 406 --------------MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKHKFIERCK 448 (774)
Q Consensus 406 --------------~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~~~ 448 (774)
........+..+.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 0001124578899999999999999999999999999998754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=419.92 Aligned_cols=261 Identities=24% Similarity=0.443 Sum_probs=220.2
Q ss_pred CCCcccCCCCCCeeEEeeeeccCceEEEEEEEcCCC-------cEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcc
Q 004088 178 PESVTREDPTTKYELLNELGKGSYGAVYKARDLKTS-------ELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVV 249 (774)
Q Consensus 178 ~~~~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g-------~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIV 249 (774)
|....++.+.++|++++.||+|+||.||+|++..++ ..||||+++..........+.+|+.++.++ +|||||
T Consensus 3 ~~~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv 82 (299)
T d1fgka_ 3 PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNII 82 (299)
T ss_dssp CCCTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CcCCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEE
Confidence 444557778899999999999999999999976554 479999998766666678899999999888 799999
Q ss_pred cccccccCCceEEEEEEecCCCchhhhhhccC---------------CchhHHHHHHHHHHHHHHHHHHHhcCccccccc
Q 004088 250 RYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE---------------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIK 314 (774)
Q Consensus 250 kL~~~~~~~~~l~LVmEy~~ggsL~dll~~~~---------------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLK 314 (774)
+++++|.++..+|+|||||.+|+|.+++.... ..+++.+++.++.||+.||+|||+++|||||||
T Consensus 83 ~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiK 162 (299)
T d1fgka_ 83 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 162 (299)
T ss_dssp CEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred ecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeec
Confidence 99999999999999999999999999996442 458999999999999999999999999999999
Q ss_pred ccceEecCCCcEEEeeccccccccccccc--cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCC
Q 004088 315 GGNILLTDQGEVKLGDFGVAAQLTRTMSK--RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVH 391 (774)
Q Consensus 315 PeNILLd~~g~vKL~DFGlA~~i~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~ 391 (774)
|+|||++.++.+||+|||+++........ .....||+.|+|||++.+..|+.++|||||||++|||++ |.+||....
T Consensus 163 p~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 163 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp GGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 99999999999999999999877554322 234579999999999999999999999999999999997 799998877
Q ss_pred chhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 392 PMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 392 ~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
.......+..... ...+..++..+.+||.+||++||.+|||+.||++
T Consensus 243 ~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 243 VEELFKLLKEGHR--MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHTTCC--CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCC--CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 7666555443322 2345678899999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=416.95 Aligned_cols=257 Identities=24% Similarity=0.386 Sum_probs=209.7
Q ss_pred CCCCeeEEeeeeccCceEEEEEEEcC-CC--cEEEEEEeecCC--ChhhHHHHHHHHHHHHhCCCCCcccccccccCCce
Q 004088 186 PTTKYELLNELGKGSYGAVYKARDLK-TS--ELVAIKVISLSE--GEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQGEEY 260 (774)
Q Consensus 186 ~~~~Y~ilk~LG~G~FG~Vy~a~d~~-~g--~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~~~~~ 260 (774)
...+|++++.||+|+||.||+|++.. ++ ..||||++.... .....+.+.+|+.+|++++|||||+++++|.+ ..
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP 84 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence 35679999999999999999998643 33 368999986543 34456789999999999999999999999976 46
Q ss_pred EEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 261 LWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 261 l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
+++|||||++++|.+++......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 78999999999999988777778999999999999999999999999999999999999999999999999999877544
Q ss_pred ccc---cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHH
Q 004088 341 MSK---RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLV 416 (774)
Q Consensus 341 ~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~ 416 (774)
... .....||+.|+|||++.+..++.++|||||||++|||++ |.+||...+..+....+..... ..+....++..
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~ 243 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE-RLPRPEDCPQD 243 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC-CCCCCTTCCHH
T ss_pred CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCC-CCCCcccccHH
Confidence 322 223468899999999999999999999999999999997 8999998888877766654432 22445678899
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHhhhhhhh
Q 004088 417 FHDFVAKCLTKEPRARPTAAEMLKHKFIER 446 (774)
Q Consensus 417 l~dLI~kcL~~DP~kRPTa~ElL~HPwf~~ 446 (774)
+.+||.+||..||++|||+.+|+ .++++
T Consensus 244 l~~li~~cl~~dp~~RPt~~ei~--~~L~~ 271 (273)
T d1u46a_ 244 IYNVMVQCWAHKPEDRPTFVALR--DFLLE 271 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHH--HHHHh
Confidence 99999999999999999999996 35543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-50 Score=428.99 Aligned_cols=260 Identities=29% Similarity=0.462 Sum_probs=216.5
Q ss_pred CCCeeEEeeeeccCceEEEEEEEc---CCCcEEEEEEeecCC---ChhhHHHHHHHHHHHHhCCC-CCcccccccccCCc
Q 004088 187 TTKYELLNELGKGSYGAVYKARDL---KTSELVAIKVISLSE---GEEGYEEIRGEIEMLQQCSH-PNVVRYLGSYQGEE 259 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~---~~g~~VAVKvi~~~~---~~~~~~~~~~Ei~iL~~L~H-PNIVkL~~~~~~~~ 259 (774)
.++|+++++||+|+||+||+|++. .+|+.||||++++.. .....+.+.+|+++|++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 467999999999999999999974 468999999986432 22334568899999999976 89999999999999
Q ss_pred eEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccc
Q 004088 260 YLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTR 339 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~ 339 (774)
.+|+|||||.+++|.+++. ..+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.+..
T Consensus 103 ~~~~v~e~~~~~~L~~~i~-~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLS-QRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp EEEEEECCCCSCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred ceeeeeecccccHHHHHHH-hcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 9999999999999999986 445678999999999999999999999999999999999999999999999999987644
Q ss_pred c-ccccccccccccccchhhhhhc--CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhcC-CCCccccchhchH
Q 004088 340 T-MSKRNTFIGTPHWMAPEVIQES--RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISIE-PAPMLEDKEKWSL 415 (774)
Q Consensus 340 ~-~~~~~~~~GT~~Y~APEvl~~~--~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~~-~~~~~~~~~~~s~ 415 (774)
. .....+..|++.|+|||++.+. .++.++|||||||+||+|++|..||...........+... .......+..++.
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 261 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 261 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCH
Confidence 3 2334556899999999999764 4788999999999999999999999876555443333211 0111122346789
Q ss_pred HHHHHHHhhcccCCCCCC-----CHHHHHhhhhhhhh
Q 004088 416 VFHDFVAKCLTKEPRARP-----TAAEMLKHKFIERC 447 (774)
Q Consensus 416 ~l~dLI~kcL~~DP~kRP-----Ta~ElL~HPwf~~~ 447 (774)
.+.+||.+||++||.+|| |++|+|+||||+..
T Consensus 262 ~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 999999999999999999 58999999999754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-49 Score=417.90 Aligned_cols=265 Identities=25% Similarity=0.392 Sum_probs=224.0
Q ss_pred CCCCCCcccCCCCCCeeEEeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCc
Q 004088 175 SSIPESVTREDPTTKYELLNELGKGSYGAVYKARDL-----KTSELVAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNV 248 (774)
Q Consensus 175 ss~~~~~~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~-----~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNI 248 (774)
..++....++.+.++|+++++||+|+||.||+|++. .+++.||||+++..........+.+|+.+++++ +||||
T Consensus 10 ~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnI 89 (311)
T d1t46a_ 10 TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89 (311)
T ss_dssp TTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred ccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCE
Confidence 345555567788899999999999999999999863 467899999998766666677899999999999 69999
Q ss_pred ccccccccCCceEEEEEEecCCCchhhhhhccC-----------------CchhHHHHHHHHHHHHHHHHHHHhcCcccc
Q 004088 249 VRYLGSYQGEEYLWIVMEYCGGGSVADLMNVTE-----------------EPLEEYQIAYICREALKGLAYLHSIFKVHR 311 (774)
Q Consensus 249 VkL~~~~~~~~~l~LVmEy~~ggsL~dll~~~~-----------------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHR 311 (774)
|++++++.....+|||||||++|+|.++++... ..+++..+..|+.||+.||.|||++|||||
T Consensus 90 v~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHr 169 (311)
T d1t46a_ 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR 169 (311)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 999999999999999999999999999986432 358999999999999999999999999999
Q ss_pred cccccceEecCCCcEEEeecccccccccccc--ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCC
Q 004088 312 DIKGGNILLTDQGEVKLGDFGVAAQLTRTMS--KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRS 388 (774)
Q Consensus 312 DLKPeNILLd~~g~vKL~DFGlA~~i~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~ 388 (774)
||||+|||++.++.+||+|||+++.+..... .....+||+.|+|||++.+..++.++|||||||++|||++ |.+||.
T Consensus 170 DLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987654322 2234579999999999999999999999999999999998 677777
Q ss_pred CCCchhhhhhhhcCCCCccccchhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 389 TVHPMRVLFMISIEPAPMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 389 ~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
.......+..+...... ...+..++..+.+||.+||+.||.+|||+.+|++
T Consensus 250 ~~~~~~~~~~~i~~~~~-~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 250 GMPVDSKFYKMIKEGFR-MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp TCCSSHHHHHHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHhcCCC-CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 66655544433222221 2234567899999999999999999999999985
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=412.32 Aligned_cols=249 Identities=23% Similarity=0.382 Sum_probs=207.4
Q ss_pred cCCCCCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCccccccccc-CCceE
Q 004088 183 REDPTTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ-GEEYL 261 (774)
Q Consensus 183 ~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~-~~~~l 261 (774)
|+...++|++++.||+|+||.||+|++ .|..||||+++.. ...+.+.+|+++|++++|||||++++++. ..+.+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence 566778899999999999999999987 4788999999643 33467899999999999999999999885 45678
Q ss_pred EEEEEecCCCchhhhhhccC-CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecccccccccc
Q 004088 262 WIVMEYCGGGSVADLMNVTE-EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~-~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~ 340 (774)
|||||||++|+|.+++.... ..+++..++.|+.||+.||.|||+.+||||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence 99999999999999986433 45899999999999999999999999999999999999999999999999999865433
Q ss_pred ccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHh-CCCCCCCCCchhhhhhhhcCCCCccccchhchHHHHH
Q 004088 341 MSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAE-GLPPRSTVHPMRVLFMISIEPAPMLEDKEKWSLVFHD 419 (774)
Q Consensus 341 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLt-G~~Pf~~~~~~~~i~~i~~~~~~~~~~~~~~s~~l~d 419 (774)
.....+|+.|+|||++.+..++.++|||||||++|||++ |++||...........+.....+ +.+..+++.+.+
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~ 231 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM--DAPDGCPPAVYE 231 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC--CCCTTCCHHHHH
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC--CCCccCCHHHHH
Confidence 234578999999999999999999999999999999998 79999887777766665443333 234567889999
Q ss_pred HHHhhcccCCCCCCCHHHHHhh
Q 004088 420 FVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 420 LI~kcL~~DP~kRPTa~ElL~H 441 (774)
||.+||..||.+|||+.+++++
T Consensus 232 li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 232 VMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcccCHhHCcCHHHHHHH
Confidence 9999999999999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-49 Score=419.31 Aligned_cols=254 Identities=25% Similarity=0.404 Sum_probs=214.2
Q ss_pred CCCCCeeEEeeeeccCceEEEEEEEcCCCcE--EEEEEeecCCChhhHHHHHHHHHHHHhC-CCCCcccccccccCCceE
Q 004088 185 DPTTKYELLNELGKGSYGAVYKARDLKTSEL--VAIKVISLSEGEEGYEEIRGEIEMLQQC-SHPNVVRYLGSYQGEEYL 261 (774)
Q Consensus 185 ~~~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~--VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HPNIVkL~~~~~~~~~l 261 (774)
...++|++.++||+|+||.||+|++..+|.. ||||++.........+.+.+|+++|+++ +|||||+++++|..++.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 3457899999999999999999999888874 6778776544445567799999999999 799999999999999999
Q ss_pred EEEEEecCCCchhhhhhcc---------------CCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcE
Q 004088 262 WIVMEYCGGGSVADLMNVT---------------EEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEV 326 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~---------------~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~v 326 (774)
|||||||++|+|.++++.. ...+++..+..++.||+.||.|||+++||||||||+|||++.++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCce
Confidence 9999999999999998633 3579999999999999999999999999999999999999999999
Q ss_pred EEeeccccccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCC-CCCCCCCchhhhhhhhcCCCC
Q 004088 327 KLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGL-PPRSTVHPMRVLFMISIEPAP 405 (774)
Q Consensus 327 KL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~-~Pf~~~~~~~~i~~i~~~~~~ 405 (774)
||+|||+|+...... ......||+.|+|||.+.+..|+.++|||||||++|||++|. +||...+..+....+.....
T Consensus 167 kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~- 244 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR- 244 (309)
T ss_dssp EECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC-
T ss_pred EEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC-
Confidence 999999997654432 233457999999999999999999999999999999999964 67887777776666544332
Q ss_pred ccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 406 MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 406 ~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
...+..+++.+.+||.+||+.||++|||+.+|++|
T Consensus 245 -~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 245 -LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp -CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 23356788999999999999999999999999976
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-49 Score=417.66 Aligned_cols=258 Identities=24% Similarity=0.390 Sum_probs=222.3
Q ss_pred ccCCCCCCeeEEeeeeccCceEEEEEEEcC-----CCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCccccccccc
Q 004088 182 TREDPTTKYELLNELGKGSYGAVYKARDLK-----TSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ 256 (774)
Q Consensus 182 ~~~~~~~~Y~ilk~LG~G~FG~Vy~a~d~~-----~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~ 256 (774)
.++...++|+++++||+|+||.||+|.+.. ++..||||+++..........+.+|+.+|++++|||||++++++.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 367778999999999999999999998752 357899999976666666677999999999999999999999999
Q ss_pred CCceEEEEEEecCCCchhhhhhccC---------CchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEE
Q 004088 257 GEEYLWIVMEYCGGGSVADLMNVTE---------EPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVK 327 (774)
Q Consensus 257 ~~~~l~LVmEy~~ggsL~dll~~~~---------~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vK 327 (774)
.+...++|||||.+|+|.+++.... ..+++..+..++.||+.||.|||+++||||||||+||||+.++++|
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEE
Confidence 9999999999999999999886321 3468889999999999999999999999999999999999999999
Q ss_pred Eeeccccccccccccc--cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhC-CCCCCCCCchhhhhhhhcCCC
Q 004088 328 LGDFGVAAQLTRTMSK--RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEG-LPPRSTVHPMRVLFMISIEPA 404 (774)
Q Consensus 328 L~DFGlA~~i~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG-~~Pf~~~~~~~~i~~i~~~~~ 404 (774)
|+|||+|+.+...... ....+||+.|+|||.+.+..++.++|||||||++|||++| .+||......+.+..+.....
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~ 253 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC
Confidence 9999999876544222 2334789999999999999999999999999999999998 588888777776665544332
Q ss_pred CccccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 405 PMLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 405 ~~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
...+..++..+.+||.+||+.||.+|||+.+|+++
T Consensus 254 --~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~ 288 (308)
T d1p4oa_ 254 --LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288 (308)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 23345678899999999999999999999999983
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=408.68 Aligned_cols=250 Identities=22% Similarity=0.340 Sum_probs=207.5
Q ss_pred eeEEeeeeccCceEEEEEEEcCCC---cEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCccccccccc-CCceEEEEE
Q 004088 190 YELLNELGKGSYGAVYKARDLKTS---ELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVVRYLGSYQ-GEEYLWIVM 265 (774)
Q Consensus 190 Y~ilk~LG~G~FG~Vy~a~d~~~g---~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIVkL~~~~~-~~~~l~LVm 265 (774)
+.+.++||+|+||+||+|++..++ ..||||+++........+.+.+|+++|++++|||||++++++. .+..+|+||
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 344678999999999999986543 3699999976666677788999999999999999999999875 456899999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeeccccccccccccc--
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFGVAAQLTRTMSK-- 343 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFGlA~~i~~~~~~-- 343 (774)
|||++++|.+++......+++..+..++.|++.||.|||+.+|+||||||+||||+.++.+||+|||+++.+......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999999877778889999999999999999999999999999999999999999999999999876543221
Q ss_pred --cccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCC-CCchhhhhhhhcCCCCccccchhchHHHHHH
Q 004088 344 --RNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRST-VHPMRVLFMISIEPAPMLEDKEKWSLVFHDF 420 (774)
Q Consensus 344 --~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~-~~~~~~i~~i~~~~~~~~~~~~~~s~~l~dL 420 (774)
.....||+.|+|||++....++.++|||||||++|||++|..||.. .........+.....+ ..+..++..+.+|
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~--~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL--LQPEYCPDPLYEV 266 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC--CCCTTCCHHHHHH
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC--CCcccCcHHHHHH
Confidence 2235789999999999999999999999999999999997666654 3333333333322222 2345678899999
Q ss_pred HHhhcccCCCCCCCHHHHHhh
Q 004088 421 VAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 421 I~kcL~~DP~kRPTa~ElL~H 441 (774)
|.+||+.||++||++.||++|
T Consensus 267 i~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999976
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-47 Score=400.41 Aligned_cols=255 Identities=19% Similarity=0.283 Sum_probs=204.7
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCcc-cccccccCCceEEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNVV-RYLGSYQGEEYLWIVME 266 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNIV-kL~~~~~~~~~l~LVmE 266 (774)
++|++++.||+|+||.||+|++..+|+.||||++...... ..+.+|++++++++|+|++ .++.++...+..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 5799999999999999999999999999999998754332 3478899999999877655 45566678889999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC---CCcEEEeecccccccccccc-
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD---QGEVKLGDFGVAAQLTRTMS- 342 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~---~g~vKL~DFGlA~~i~~~~~- 342 (774)
|| +++|...+......+++..+..++.||+.||+|||++|||||||||+|||++. +..+||+|||+|+.+.....
T Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 99 55676666666778999999999999999999999999999999999999864 44699999999987654322
Q ss_pred ------ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhhhhhc-----CCCCccccch
Q 004088 343 ------KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLFMISI-----EPAPMLEDKE 411 (774)
Q Consensus 343 ------~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~~i~~-----~~~~~~~~~~ 411 (774)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+.. ...+......
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTT
T ss_pred cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhcc
Confidence 23456899999999999999999999999999999999999999987554433222110 1112222234
Q ss_pred hchHHHHHHHHhhcccCCCCCCCHHH---HHhhhhhhh
Q 004088 412 KWSLVFHDFVAKCLTKEPRARPTAAE---MLKHKFIER 446 (774)
Q Consensus 412 ~~s~~l~dLI~kcL~~DP~kRPTa~E---lL~HPwf~~ 446 (774)
.++.++.+||.+||+.||.+||++.+ +|+|+|.+.
T Consensus 243 ~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 67889999999999999999999874 567776643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2e-45 Score=388.54 Aligned_cols=250 Identities=18% Similarity=0.242 Sum_probs=208.3
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCC-CCcccccccccCCceEEEEE
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSH-PNVVRYLGSYQGEEYLWIVM 265 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~H-PNIVkL~~~~~~~~~l~LVm 265 (774)
.++|+++++||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.|.| +||+.+++++......|+||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 46899999999999999999999999999999998654322 346789999999976 89999999999999999999
Q ss_pred EecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecC-----CCcEEEeecccccccccc
Q 004088 266 EYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTD-----QGEVKLGDFGVAAQLTRT 340 (774)
Q Consensus 266 Ey~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~-----~g~vKL~DFGlA~~i~~~ 340 (774)
||| +++|.+++......+++..+..++.|++.||.|||++|||||||||+||||+. ++.+||+|||+|+.+...
T Consensus 81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 999 78999998877778999999999999999999999999999999999999974 568999999999876433
Q ss_pred cc-------ccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhhh---hhhh--cCCCCccc
Q 004088 341 MS-------KRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVL---FMIS--IEPAPMLE 408 (774)
Q Consensus 341 ~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i---~~i~--~~~~~~~~ 408 (774)
.. .....+||+.|||||++.+..++.++|||||||++|||++|+.||......... ..+. ....+...
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH
Confidence 21 233568999999999999999999999999999999999999999765433221 1111 11112222
Q ss_pred cchhchHHHHHHHHhhcccCCCCCCCHHHHHh
Q 004088 409 DKEKWSLVFHDFVAKCLTKEPRARPTAAEMLK 440 (774)
Q Consensus 409 ~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~ 440 (774)
....+++++.++|..|+..+|.+||+++.+.+
T Consensus 240 l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 23456788999999999999999999887754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-46 Score=395.17 Aligned_cols=246 Identities=25% Similarity=0.373 Sum_probs=191.0
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHH--HHHHHHHhCCCCCcccccccccCC----ceE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIR--GEIEMLQQCSHPNVVRYLGSYQGE----EYL 261 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~--~Ei~iL~~L~HPNIVkL~~~~~~~----~~l 261 (774)
.+|.+.++||+|+||.||+|++ +|+.||||+++... ...+. .|+..+.+++|||||++++++... ..+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4689999999999999999985 68999999986432 23333 455555678999999999998644 378
Q ss_pred EEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHh--------cCcccccccccceEecCCCcEEEeeccc
Q 004088 262 WIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHS--------IFKVHRDIKGGNILLTDQGEVKLGDFGV 333 (774)
Q Consensus 262 ~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs--------~gIIHRDLKPeNILLd~~g~vKL~DFGl 333 (774)
|||||||.+|+|.++++. ..+++..+..++.|++.||.|||+ +|||||||||+||||+.++.+||+|||+
T Consensus 77 ~lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 999999999999999964 468999999999999999999996 5899999999999999999999999999
Q ss_pred ccccccccc----ccccccccccccchhhhhhc------CCCCccchhhhHHHHHHHHhCCCCCCCCCchhhhh------
Q 004088 334 AAQLTRTMS----KRNTFIGTPHWMAPEVIQES------RYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRVLF------ 397 (774)
Q Consensus 334 A~~i~~~~~----~~~~~~GT~~Y~APEvl~~~------~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~i~------ 397 (774)
++.+..... .....+||+.|+|||++.+. .++.++|||||||++|||++|.+||..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 987654322 22346899999999998764 26778999999999999999988875422211111
Q ss_pred --------hhhc--CCCCcc---ccchhchHHHHHHHHhhcccCCCCCCCHHHHHhh
Q 004088 398 --------MISI--EPAPML---EDKEKWSLVFHDFVAKCLTKEPRARPTAAEMLKH 441 (774)
Q Consensus 398 --------~i~~--~~~~~~---~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL~H 441 (774)
.... ...+.. .........+.+||.+||+.||++|||+.||+++
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0000 011111 1112234568899999999999999999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-44 Score=388.80 Aligned_cols=257 Identities=21% Similarity=0.322 Sum_probs=199.7
Q ss_pred CCCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-----------CCCcccccccc
Q 004088 187 TTKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-----------HPNVVRYLGSY 255 (774)
Q Consensus 187 ~~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-----------HPNIVkL~~~~ 255 (774)
.++|+++++||+|+||+||+|++..+|+.||||++++. ....+.+.+|+++|+.++ ||||+++++++
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 46799999999999999999999999999999999643 334567789999998875 57899999887
Q ss_pred c--CCceEEEEEEecCCCchhhh--hhccCCchhHHHHHHHHHHHHHHHHHHHh-cCcccccccccceEecCCCc-----
Q 004088 256 Q--GEEYLWIVMEYCGGGSVADL--MNVTEEPLEEYQIAYICREALKGLAYLHS-IFKVHRDIKGGNILLTDQGE----- 325 (774)
Q Consensus 256 ~--~~~~l~LVmEy~~ggsL~dl--l~~~~~~Lse~~i~~I~~QIl~gL~YLHs-~gIIHRDLKPeNILLd~~g~----- 325 (774)
. .....++||+++..+..... .......+++..++.++.||+.||.|||+ +|||||||||+||||+.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 5 34567777777765543322 23345678999999999999999999998 89999999999999987653
Q ss_pred -EEEeeccccccccccccccccccccccccchhhhhhcCCCCccchhhhHHHHHHHHhCCCCCCCCCchhh------hh-
Q 004088 326 -VKLGDFGVAAQLTRTMSKRNTFIGTPHWMAPEVIQESRYDGKVDVWALGVSAVEMAEGLPPRSTVHPMRV------LF- 397 (774)
Q Consensus 326 -vKL~DFGlA~~i~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGviLyELLtG~~Pf~~~~~~~~------i~- 397 (774)
++|+|||.|...... ....+||+.|+|||++....|+.++||||+||++++|++|+.||........ ..
T Consensus 170 ~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 999999999765432 3456899999999999999999999999999999999999999975432110 00
Q ss_pred --hhhcC--------------------------CCC----------ccccchhchHHHHHHHHhhcccCCCCCCCHHHHH
Q 004088 398 --MISIE--------------------------PAP----------MLEDKEKWSLVFHDFVAKCLTKEPRARPTAAEML 439 (774)
Q Consensus 398 --~i~~~--------------------------~~~----------~~~~~~~~s~~l~dLI~kcL~~DP~kRPTa~ElL 439 (774)
.+... ... .......++..+.+||.+||++||.+||||.|+|
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 00000 000 0001133467899999999999999999999999
Q ss_pred hhhhhhhhc
Q 004088 440 KHKFIERCK 448 (774)
Q Consensus 440 ~HPwf~~~~ 448 (774)
+||||+++.
T Consensus 327 ~Hp~f~~~~ 335 (362)
T d1q8ya_ 327 NHPWLKDTL 335 (362)
T ss_dssp TCGGGTTCT
T ss_pred cCcccCCCC
Confidence 999998654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=3e-25 Score=218.47 Aligned_cols=166 Identities=14% Similarity=0.095 Sum_probs=122.7
Q ss_pred eeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCC-----------------hhhHHHHHHHHHHHHhCCCCCccccc
Q 004088 190 YELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEG-----------------EEGYEEIRGEIEMLQQCSHPNVVRYL 252 (774)
Q Consensus 190 Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~-----------------~~~~~~~~~Ei~iL~~L~HPNIVkL~ 252 (774)
|.+.++||+|+||+||+|++ .+|+.||||+++.... ........+|...|.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 56899999999999999997 4789999998753210 01123355789999999999999887
Q ss_pred ccccCCceEEEEEEecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHHhcCcccccccccceEecCCCcEEEeecc
Q 004088 253 GSYQGEEYLWIVMEYCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLHSIFKVHRDIKGGNILLTDQGEVKLGDFG 332 (774)
Q Consensus 253 ~~~~~~~~l~LVmEy~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLHs~gIIHRDLKPeNILLd~~g~vKL~DFG 332 (774)
++.. .++||||+++..+..+ ++..+..++.||+.+|.|||++||+||||||+|||++.+ .++|+|||
T Consensus 81 ~~~~----~~lvme~~~~~~~~~l--------~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYRV--------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp EEET----TEEEEECCCCEEGGGC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred EecC----CEEEEEeeccccccch--------hhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECC
Confidence 6543 3799999988655432 334456789999999999999999999999999999965 59999999
Q ss_pred ccccccccccccccccccccccch--h---hhhhcCCCCccchhhhHHHH
Q 004088 333 VAAQLTRTMSKRNTFIGTPHWMAP--E---VIQESRYDGKVDVWALGVSA 377 (774)
Q Consensus 333 lA~~i~~~~~~~~~~~GT~~Y~AP--E---vl~~~~~s~ksDIWSLGviL 377 (774)
+|.....+.. ..|... + .+....|+.++|+||+.--+
T Consensus 148 ~a~~~~~~~~--------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 148 QSVEVGEEGW--------REILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TCEETTSTTH--------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CcccCCCCCc--------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 9966543211 112111 1 11245689999999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.32 E-value=7.1e-07 Score=88.79 Aligned_cols=139 Identities=17% Similarity=0.152 Sum_probs=90.0
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCC-CCCcccccccccCCceEEEEEE
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCS-HPNVVRYLGSYQGEEYLWIVME 266 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HPNIVkL~~~~~~~~~l~LVmE 266 (774)
..|+..+..+-++.+.||+.. .+++.+.||+..... ......+.+|..+|..+. +--+.+++.+...++..|+||+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~-~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~ 90 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRY-KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGG-TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCc-ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence 356777765555667999886 456668889875322 122334678998888774 3235677777788889999999
Q ss_pred ecCCCchhhhhhccCCchhHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 004088 267 YCGGGSVADLMNVTEEPLEEYQIAYICREALKGLAYLH------------------------------------------ 304 (774)
Q Consensus 267 y~~ggsL~dll~~~~~~Lse~~i~~I~~QIl~gL~YLH------------------------------------------ 304 (774)
+++|..+........ ....++.++...|..||
T Consensus 91 ~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T d1j7la_ 91 EADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp CCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred ecccccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence 999887754432100 01112222222222232
Q ss_pred -----------hc------CcccccccccceEecCCCcEEEeeccccc
Q 004088 305 -----------SI------FKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 305 -----------s~------gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
.. .++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 21 27899999999999976666799999874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.89 E-value=3.6e-05 Score=75.60 Aligned_cols=136 Identities=14% Similarity=0.105 Sum_probs=82.5
Q ss_pred eeeccC-ceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCC--CcccccccccCCceEEEEEEecCCC
Q 004088 195 ELGKGS-YGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHP--NVVRYLGSYQGEEYLWIVMEYCGGG 271 (774)
Q Consensus 195 ~LG~G~-FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HP--NIVkL~~~~~~~~~l~LVmEy~~gg 271 (774)
.+..|. -+.||+.. ...+..+.+|...... ...+..|+.+|+.+... .+.+++.+..+++..++||+|++|.
T Consensus 17 ~~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEE-CTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEE-eCCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 344454 46899987 4567778999764322 23467788888877432 3566787778888899999999886
Q ss_pred chhhhh--------------hc-c-----CCc----hhHH---HHHHHH---------------HHHHHHHHHHHhc---
Q 004088 272 SVADLM--------------NV-T-----EEP----LEEY---QIAYIC---------------REALKGLAYLHSI--- 306 (774)
Q Consensus 272 sL~dll--------------~~-~-----~~~----Lse~---~i~~I~---------------~QIl~gL~YLHs~--- 306 (774)
++.... .. + ..+ +... ....+. ......+..+...
T Consensus 92 ~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (255)
T d1nd4a_ 92 DLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD 171 (255)
T ss_dssp ETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred ccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCc
Confidence 654321 00 0 000 0000 000000 0012233444332
Q ss_pred ----CcccccccccceEecCCCcEEEeeccccc
Q 004088 307 ----FKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 307 ----gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
.+||+|+.|.|||++.+..+-|+||+.+.
T Consensus 172 ~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 172 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp SCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 37999999999999987667899999874
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.75 E-value=2.2e-05 Score=83.86 Aligned_cols=78 Identities=23% Similarity=0.146 Sum_probs=49.5
Q ss_pred EeeeeccCceEEEEEEEcCCCcEEEEEEeecC------CChhhHHHHHHHHHHHHhCC-C--CCcccccccccCCceEEE
Q 004088 193 LNELGKGSYGAVYKARDLKTSELVAIKVISLS------EGEEGYEEIRGEIEMLQQCS-H--PNVVRYLGSYQGEEYLWI 263 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~------~~~~~~~~~~~Ei~iL~~L~-H--PNIVkL~~~~~~~~~l~L 263 (774)
.+.||.|....||++.+..+++.|+||.-... ...........|...|+.+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 56789999999999987777888999975310 11123345667888887663 2 235555544 3344578
Q ss_pred EEEecCCCc
Q 004088 264 VMEYCGGGS 272 (774)
Q Consensus 264 VmEy~~ggs 272 (774)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.04 E-value=0.001 Score=68.41 Aligned_cols=69 Identities=16% Similarity=0.184 Sum_probs=45.9
Q ss_pred ceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCCc-----cccc--ccccCCceEEEEEEecCCCc
Q 004088 201 YGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPNV-----VRYL--GSYQGEEYLWIVMEYCGGGS 272 (774)
Q Consensus 201 FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPNI-----VkL~--~~~~~~~~l~LVmEy~~ggs 272 (774)
--.||+++ ..+|+.|++|+.+.. ....+++..|...|..|....| +..- ..+......+.|+++++|..
T Consensus 35 EN~vy~v~-~~dg~~~VlK~~rp~--~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQ-DEDRRRFVVKFYRPE--RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEEC-CTTCCCEEEEEECTT--TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cceeEEEE-cCCCCEEEEEEeCCC--CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 46899997 468889999997532 2234678889988887742221 1111 12345667899999998743
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.66 E-value=0.0035 Score=65.94 Aligned_cols=74 Identities=15% Similarity=0.182 Sum_probs=50.8
Q ss_pred EeeeeccCceEEEEEEEcC-------CCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCCCC-cccccccccCCceEEEE
Q 004088 193 LNELGKGSYGAVYKARDLK-------TSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSHPN-VVRYLGSYQGEEYLWIV 264 (774)
Q Consensus 193 lk~LG~G~FG~Vy~a~d~~-------~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HPN-IVkL~~~~~~~~~l~LV 264 (774)
++.|+-|---.+|++.... .++.|.+++.-. . ...-...+|..+++.+.-.+ ..++++++.+ .+|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 4678888888999998643 346678887642 1 22234568999998885334 4577777754 579
Q ss_pred EEecCCCch
Q 004088 265 MEYCGGGSV 273 (774)
Q Consensus 265 mEy~~ggsL 273 (774)
|||++|..|
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.09 E-value=0.019 Score=57.68 Aligned_cols=143 Identities=12% Similarity=0.065 Sum_probs=75.6
Q ss_pred CCeeEEeeeeccCceEEEEEEEcCCCcEEEEEEeecCCChhhHHHHHHHHHHHHhCCC-----CCccccc-c--cccCCc
Q 004088 188 TKYELLNELGKGSYGAVYKARDLKTSELVAIKVISLSEGEEGYEEIRGEIEMLQQCSH-----PNVVRYL-G--SYQGEE 259 (774)
Q Consensus 188 ~~Y~ilk~LG~G~FG~Vy~a~d~~~g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~H-----PNIVkL~-~--~~~~~~ 259 (774)
+...-.+.|..|---+.|+.+. .+|+ |++|++..... .+.+..|+.+|..|.. |..+... + +..-..
T Consensus 18 g~~~~~~~i~~G~~N~ny~v~t-~~g~-yVLri~~~~~~---~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~ 92 (316)
T d2ppqa1 18 GSLTSYKGIAEGVENSNFLLHT-TKDP-LILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG 92 (316)
T ss_dssp CCEEEEEEECC---EEEEEEEE-SSCC-EEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred CCceEeecCCCCcccCeEEEEE-CCCc-EEEEEcCCCCC---HHHHHHHHHHHHhhhhccccccccceecCCCcceeeec
Confidence 3455556677787788999874 3454 89999854322 2345567777777643 2222211 1 112234
Q ss_pred eEEEEEEecCCCchhhh--------------hhc--------cC-Cch-----------------hHHHHHHHHHHHHHH
Q 004088 260 YLWIVMEYCGGGSVADL--------------MNV--------TE-EPL-----------------EEYQIAYICREALKG 299 (774)
Q Consensus 260 ~l~LVmEy~~ggsL~dl--------------l~~--------~~-~~L-----------------se~~i~~I~~QIl~g 299 (774)
..+.++.++.+...... ++. .. ... ........+..+...
T Consensus 93 ~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 172 (316)
T d2ppqa1 93 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 172 (316)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred ccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHh
Confidence 56677777766432111 000 00 000 000111122222222
Q ss_pred HHHHH----hcCcccccccccceEecCCCcEEEeeccccc
Q 004088 300 LAYLH----SIFKVHRDIKGGNILLTDQGEVKLGDFGVAA 335 (774)
Q Consensus 300 L~YLH----s~gIIHRDLKPeNILLd~~g~vKL~DFGlA~ 335 (774)
+.-.+ ..|+||+|+.++||+++.+...-|+||+.|.
T Consensus 173 ~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 173 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 33322 2579999999999999988777899999874
|